PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Davydova, N; Harris, NC; Roufail, S; Paquet-Fifield, S; Ishaq, M; Streltsov, VA; Williams, SP; Karnezis, T; Stacker, SA; Achen, MG				Davydova, Natalia; Harris, Nicole C.; Roufail, Sally; Paquet-Fifield, Sophie; Ishaq, Musarat; Streltsov, Victor A.; Williams, Steven P.; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.			Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VEGF-D PROMOTES; TUMOR LYMPHANGIOGENESIS; GENE-THERAPY; LYMPHATIC VESSELS; METASTASIS; SPECIFICITY; SPREAD; CANCER; LIGAND; ACTIVATION	VEGF-C and VEGF-D are secreted glycoproteins that induce angiogenesis and lymphangiogenesis in cancer, thereby promoting tumor growth and spread. They exhibit structural homology and activate VEGFR-2 and VEGFR-3, receptors on endothelial cells that signal for growth of blood vessels and lymphatics. VEGF-C and VEGF-D were thought to exhibit similar bioactivities, yet recent studies indicated distinct signaling mechanisms (e.g. tumor-derived VEGF-C promoted expression of the prostaglandin biosynthetic enzyme COX-2 in lymphatics, a response thought to facilitate metastasis via the lymphatic vasculature, whereas VEGF-D did not). Here we explore the basis of the distinct bioactivities of VEGF-D using a neutralizing antibody, peptide mapping, and mutagenesis to demonstrate that the N-terminal alpha-helix of mature VEGF-D (Phe(93)-Arg(108)) is critical for binding VEGFR-2 and VEGFR-3. Importantly, the N-terminal part of this alpha-helix, from Phe(93) to Thr(98), is required for binding VEGFR-3 but not VEGFR-2. Surprisingly, the corresponding part of the alpha-helix in mature VEGF-C did not influence binding to either VEGFR-2 or VEGFR-3, indicating distinct determinants of receptor binding by these growth factors. A variant of mature VEGF-D harboring a mutation in the N-terminal alpha-helix, D103A, exhibited enhanced potency for activating VEGFR-3, was able to promote increased COX-2 mRNA levels in lymphatic endothelial cells, and had enhanced capacity to induce lymphatic sprouting in vivo. This mutant may be useful for developing protein-based therapeutics to drive lymphangiogenesis in clinical settings, such as lymphedema. Our studies shed light on the VEGF-D structure/function relationship and provide a basis for understanding functional differences compared with VEGF-C.	[Davydova, Natalia; Harris, Nicole C.; Roufail, Sally; Paquet-Fifield, Sophie; Ishaq, Musarat; Williams, Steven P.; Karnezis, Tara; Stacker, Steven A.; Achen, Marc G.] Peter MacCallum Canc Ctr, Tumour Angiogenesis & Microenvironm Program, Melbourne, Vic 3000, Australia; [Streltsov, Victor A.] Florey Inst Neurosci & Mental Hlth, 30 Royal Parade, Parkville, Vic 3052, Australia; [Stacker, Steven A.; Achen, Marc G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic 3010, Australia	Peter Maccallum Cancer Center; Florey Institute of Neuroscience & Mental Health; Peter Maccallum Cancer Center; University of Melbourne	Achen, MG (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic 3000, Australia.	marc.achen@petermac.org	Streltsov, Victor/M-9446-2019; Paquet-Fifield, Sophie/AAL-6410-2021	Streltsov, Victor/0000-0002-7846-4396; Stacker, Steven/0000-0003-4096-9273; Williams, Steven/0000-0002-9382-4337; Achen, Marc/0000-0002-3791-803X	National Health and Medical Research Council of Australia; Operational Infrastructure Support Program of the Victorian Government	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Operational Infrastructure Support Program of the Victorian Government	This work was supported by grants and fellowships from the National Health and Medical Research Council of Australia (to M. G. A. and S. A. S.) and the Operational Infrastructure Support Program of the Victorian Government. M. G. A. and S. A. S. are shareholders in Opthea Ltd. and are Inventors on patents assigned to Vegenics Pty. Ltd.	Achen MG, 2012, GROWTH FACTORS, V30, P283, DOI 10.3109/08977194.2012.704917; Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Alitalo AK, 2013, CANCER RES, V73, P4212, DOI 10.1158/0008-5472.CAN-12-4539; Anisimov A, 2009, CIRC RES, V104, P1302, DOI 10.1161/CIRCRESAHA.109.197830; Baldwin ME, 2001, J BIOL CHEM, V276, P19166, DOI 10.1074/jbc.M100097200; Baldwin ME, 2001, J BIOL CHEM, V276, P44307, DOI 10.1074/jbc.M106188200; Butera D, 2014, BLOOD, V123, P2000, DOI 10.1182/blood-2014-01-549816; Chiu J, 2014, BIOCHEMISTRY-US, V53, P7, DOI 10.1021/bi401518b; Davydova N, 2012, PROTEIN EXPRES PURIF, V82, P232, DOI 10.1016/j.pep.2012.01.001; Davydova N, 2011, J MOL BIOL, V407, P581, DOI 10.1016/j.jmb.2011.02.009; Debinski W, 2001, MOL MED, V7, P598, DOI 10.1007/BF03401866; Duong T, 2014, BLOOD, V123, P1102, DOI 10.1182/blood-2013-04-495432; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Goldman J, 2007, FASEB J, V21, P1003, DOI 10.1096/fj.06-6656com; Harris NC, 2013, J BIOL CHEM, V288, P8176, DOI 10.1074/jbc.M112.439299; Harris NC, 2011, FASEB J, V25, P2615, DOI 10.1096/fj.10-179788; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Honkonen KM, 2013, ANN SURG, V257, P961, DOI 10.1097/SLA.0b013e31826ed043; Huggenberger R, 2011, BLOOD, V117, P4667, DOI 10.1182/blood-2010-10-316356; Huggenberger R, 2010, J EXP MED, V207, P2255, DOI 10.1084/jem.20100559; Jeltsch M, 2014, CIRCULATION, V129, P1962, DOI 10.1161/CIRCULATIONAHA.113.002779; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1996, EMBO J, V15, P290; Kajiya K, 2009, J INVEST DERMATOL, V129, P1292, DOI 10.1038/jid.2008.351; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2001, CANCER RES, V61, P1786; Le Guen L, 2014, DEVELOPMENT, V141, P1239, DOI 10.1242/dev.100495; Leppanen VM, 2013, P NATL ACAD SCI USA, V110, P12960, DOI 10.1073/pnas.1301415110; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Leppanen VM, 2010, P NATL ACAD SCI USA, V107, P2425, DOI 10.1073/pnas.0914318107; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Lund AW, 2012, CELL REP, V1, P191, DOI 10.1016/j.celrep.2012.01.005; Lyons TR, 2014, J CLIN INVEST, V124, P3901, DOI 10.1172/JCI73777; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; McColl BK, 2003, J EXP MED, V198, P863, DOI 10.1084/jem.20030361; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; O-charoenrat P, 2001, CANCER-AM CANCER SOC, V92, P556, DOI 10.1002/1097-0142(20010801)92:3<556::AID-CNCR1355>3.0.CO;2-Q; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Paquet-Fifield S, 2013, J INVEST DERMATOL, V133, P2074, DOI 10.1038/jid.2013.83; Saaristo A, 2002, J EXP MED, V196, P719, DOI 10.1084/jem.20020587; Sato T, 2016, J PATHOL, V239, P152, DOI 10.1002/path.4708; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2004, APMIS, V112, P539, DOI 10.1111/j.1600-0463.2004.apm11207-0812.x; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; Stacker SA, 2002, FASEB J, V16, P922, DOI 10.1096/fj.01-0945rev; Stacker SA, 2016, JOVE-J VIS EXP, DOI 10.3791/53867; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Stacker SA, 2013, CHIN J CANCER, V32, P297, DOI 10.5732/cjc.012.10319; Swartz MA, 2014, CANCER IMMUNOL RES, V2, P701, DOI 10.1158/2326-6066.CIR-14-0115; Tammela T, 2007, NAT MED, V13, P1458, DOI 10.1038/nm1689; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tervala TV, 2015, J SURG RES, V196, P200, DOI 10.1016/j.jss.2015.02.031; Toivanen PI, 2009, J BIOL CHEM, V284, P16037, DOI 10.1074/jbc.M109.001123; Visuri MT, 2015, ANGIOGENESIS, V18, P313, DOI 10.1007/s10456-015-9469-2; Wirzenius M, 2007, J EXP MED, V204, P1431, DOI 10.1084/jem.20062642; Wise LM, 2003, J BIOL CHEM, V278, P38004, DOI 10.1074/jbc.M301194200; Yla-Herttuala S, 2013, GENE, V525, P217, DOI 10.1016/j.gene.2013.03.051; Yokoyama Y, 2003, BRIT J CANCER, V88, P237, DOI 10.1038/sj.bjc.6600701	67	25	25	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27265	27278		10.1074/jbc.M116.736801	http://dx.doi.org/10.1074/jbc.M116.736801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27852824	Green Published, hybrid			2022-12-26	WOS:000391576300024
J	Al-Mayouf, YRB; Ismail, M; Abdullah, NF; Wahab, AWA; Mandi, OA; Khan, S; Choo, KKR				Al-Mayouf, Yusor Rafid Behar; Ismail, Mahamod; Abdullah, Nor Fadzilah; Wahab, Ainuddin Wahid Abdul; Mandi, Omar Adil; Khan, Suleman; Choo, Kim-Kwang Raymond			Efficient and Stable Routing Algorithm Based on User Mobility and Node Density in Urban Vehicular Network	PLOS ONE			English	Article							DISSEMINATION; INFORMATION; PROTOCOLS; TAXONOMY	Vehicular ad hoc networks (VANETs) are considered an emerging technology in the industrial and educational fields. This technology is essential in the deployment of the intelligent transportation system, which is targeted to improve safety and efficiency of traffic. The implementation of VANETs can be effectively executed by transmitting data among vehicles with the use of multiple hops. However, the intrinsic characteristics of VANETs, such as its dynamic network topology and intermittent connectivity, limit data delivery. One particular challenge of this network is the possibility that the contributing node may only remain in the network for a limited time. Hence, to prevent data loss from that node, the information must reach the destination node via multi -hop routing techniques. An appropriate, efficient, and stable routing algorithm must be developed for various VANET applications to address the issues of dynamic topology and intermittent connectivity. Therefore, this paper proposes a novel routing algorithm called efficient and stable routing algorithm based on user mobility and node density (ESRA-MD). The proposed algorithm can adapt to significant changes that may occur in the urban vehicular environment. This algorithm works by selecting an optimal route on the basis of hop count and link duration for delivering data from source to destination, thereby satisfying various quality of service considerations. The validity of the proposed algorithm is investigated by its comparison with ARP-QD protocol, which works on the mechanism of optimal route finding in VANETs in urban environments. Simulation results reveal that the proposed ESRA-MD algorithm shows remarkable improvement in terms of delivery ratio, delivery delay, and communication overhead.	[Al-Mayouf, Yusor Rafid Behar; Ismail, Mahamod; Abdullah, Nor Fadzilah] Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi, Selangor, Malaysia; [Wahab, Ainuddin Wahid Abdul; Mandi, Omar Adil; Khan, Suleman] Univ Malaya, Fac Comp Sci & Informat Technol Bldg, Dept Comp Syst & Technol, Kuala Lumpur, Malaysia; [Choo, Kim-Kwang Raymond] Univ Texas San Antonio, Dept Informat Syst & Cyber Secur, San Antonio, TX USA; [Choo, Kim-Kwang Raymond] Univ South Australia, Adv Comp Res Ctr, Informat Assurance Res Grp, Adelaide, SA, Australia	Universiti Kebangsaan Malaysia; Universiti Malaya; University of Texas System; University of Texas at San Antonio (UTSA); University of South Australia	Al-Mayouf, YRB (corresponding author), Univ Kebangsaan Malaysia, Dept Elect Elect & Syst Engn, Fac Engn & Built Environm, Bangi, Selangor, Malaysia.	yusorrafid@siswa.ukm.edu.my	Bahar, Yusor Rafid/AEO-1827-2022; Ismail, Mahamod/P-8145-2015; Abdul Wahab, Ainuddin Wahid/A-9293-2013; Choo, Kim-Kwang Raymond/A-3634-2009; Khan, Suleman/X-3827-2019; Ismail, Mahamod/W-7227-2019; MAHDI, OMAR ADIL/ABA-4310-2021; Abdullah, Nor Fadzilah/J-1687-2016	Abdul Wahab, Ainuddin Wahid/0000-0003-1062-0329; Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Ismail, Mahamod/0000-0002-5509-5735; MAHDI, OMAR ADIL/0000-0001-7618-3155; Abdullah, Nor Fadzilah/0000-0002-6593-5603; Khan, Suleman/0000-0003-1190-258X	Universiti Kebangsaan Malaysia (UKM) [gup-2016-005]	Universiti Kebangsaan Malaysia (UKM)	This work was supported by the Universiti Kebangsaan Malaysia (UKM), through research grant gup-2016-005, which was used to conduct this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge research grant gup-2016-005 from the Universiti Kebangsaan Malaysia (UKM), which was used to conduct this research. We are grateful to Universiti Kebangsaan Malaysia and University of Baghdad for providing their technical expertise as well as the necessary facilities and assistance during the study.	Al-Sultan S, 2014, J NETW COMPUT APPL, V37, P380, DOI 10.1016/j.jnca.2013.02.036; Aminzadeh N, 2015, SIMUL MODEL PRACT TH, V50, P96, DOI 10.1016/j.simpat.2014.05.009; Chen R, 2010, IEEE NETWORK, V24, P20, DOI 10.1109/MNET.2010.5395779; Chen W, 2011, WIREL COMMUN MOB COM, V11, P787, DOI 10.1002/wcm.862; Clausen T., 2003, EXPERIMENTAL; Davis JA, 2001, WEAR COMP 2001 P 5 I; Eiza MH, 2013, IEEE T VEH TECHNOL, V62, P1493, DOI 10.1109/TVT.2013.2244625; Huang H, 2013, INT J DISTRIBUTED SE, V2013; Idris MYI, WIRELESS NETWORKS, P1; Jabbarpour MR, 2014, J NETW COMPUT APPL, V44, P1, DOI 10.1016/j.jnca.2014.05.002; Jalooli A, 2014, INT J DISTRIBUTED SE, V2014; Jerbi M, 2009, IEEE T VEH TECHNOL, V58, P5048, DOI 10.1109/TVT.2009.2024341; Karp B, 2000, P 6 ANN INT C MOB CO; Li F, 2007, IEEE VEH TECHNOL MAG, V2, P12, DOI 10.1109/MVT.2007.912927; Liu JK, 2015, BRAIN RES, V1610, P1, DOI 10.1016/j.brainres.2015.03.044; Lochert C., 2003, INT VEH S 2003 P IEE; Lochert C., 2005, ACM SIGMOBILE MOBILE, V9, P69, DOI DOI 10.1145/1055959.1055970; Mahdi OA, 2016, WIREL COMMUN MOB COM, V16, P2663, DOI 10.1002/wcm.2715; Mahdi OA, 2016, J SENSORS, V2016, DOI 10.1155/2016/3428730; Moustafa H, 2009, VEHICULAR NETWORKS T; Murty RN, 2008, TECHN HOM SEC 2008 I; Nzouonta J, 2009, IEEE T VEH TECHNOL, V58, P3609, DOI 10.1109/TVT.2009.2014455; Olariu S, 2009, CH CRC COMP INFO SCI, P1, DOI 10.1201/9781420085891; Rezende C, 2010, COMM ICC 2010 IEEE I; SALEET H, 2011, VEHICULAR TECHNOLOGY, V60, P4560; Saleet H, 2010, IEEE T VEH TECHNOL, V59, P917, DOI 10.1109/TVT.2009.2033079; Shah SAA, 2014, J ZHEJIANG U-SCI C, V15, P489, DOI 10.1631/jzus.C1300332; Sharef BT, 2014, J NETW COMPUT APPL, V40, P363, DOI 10.1016/j.jnca.2013.09.008; Sun Y, 2015, INT J DISTRIB SENS N, V2015, P5, DOI DOI 10.1038/SREP16988; Taleb T, 2007, IEEE T VEH TECHNOL, V56, P3337, DOI 10.1109/TVT.2007.906873; Tian DX, 2016, AD HOC NETW, V36, P465, DOI 10.1016/j.adhoc.2015.05.018; Tian DX, 2013, IET INTELL TRANSP SY, V7, P464, DOI 10.1049/iet-its.2011.0227; Torrent-Moreno M, 2009, IEEE T VEH TECHNOL, V58, P3684, DOI 10.1109/TVT.2009.2017545; Yang Q, 2008, WIR COMM NETW C 2008; Yu H, 2013, INT J DISTRIBUTED SE, V2013	35	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165966	10.1371/journal.pone.0165966	http://dx.doi.org/10.1371/journal.pone.0165966			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855165	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000387910200015
J	Plegge, T; Hofmann-Winkler, H; Spiegel, M; Pohlmann, S				Plegge, Teresa; Hofmann-Winkler, Heike; Spiegel, Martin; Poehlmann, Stefan			Evidence that Processing of the Severe Fever with Thrombocytopenia Syndrome Virus Gn/Gc Polyprotein Is Critical for Viral Infectivity and Requires an Internal Gc Signal Peptide	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; UUKUNIEMI-VIRUS; GLYCOPROTEIN PRECURSOR; PROPROTEIN CONVERTASES; PROTEIN TRAFFICKING; BETA(3) INTEGRINS; GOLGI RETENTION; CELLULAR ENTRY; DC-SIGN; BUNYAVIRUS	The severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging, highly pathogenic bunyavirus against which neither antivirals nor vaccines are available. The SFTSV glycoproteins, Gn and Gc, facilitate viral entry into host cells. Gn and Gc are generated from a precursor protein, Gn/Gc, but it is currently unknown how the precursor is converted into the single proteins and whether this process is required for viral infectivity. Employing a rhabdoviral pseudotyping system, we demonstrate that a predicted signal sequence at the N -terminus of Gc is required for Gn/Gc processing and viral infectivity while potential proprotein convertase cleavage sites in Gc are dispensable. Moreover, we show that expression of Gn or Gc alone is not sufficient for host cell entry while particles bearing both proteins are infectious, and we provide evidence that Gn facilitates Golgi transport and virion incorporation of Gc. Collectively, these results suggest that signal peptidase liberates mature Gc from the Gn/Gc precursor and that this process is essential for viral infectivity and thus constitutes a potential target for antiviral intervention.	[Plegge, Teresa; Hofmann-Winkler, Heike; Spiegel, Martin; Poehlmann, Stefan] Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany; [Spiegel, Martin] Med Hsch Brandenburg Theodor Fontane, Inst Mikrobiol & Virol, Senftenberg, Germany	Deutsches Primatenzentrum (DPZ)	Pohlmann, S (corresponding author), Deutsch Primatenzentrum GmbH, Abt Infekt Biol, Gottingen, Germany.	spoehlmann@dpz.eu	Spiegel, Martin/H-7843-2019; Pöhlmann, Stefan/H-2395-2011	Pöhlmann, Stefan/0000-0001-6086-9136	Leibniz Association (Graduate School Emerging Infectious Diseases)	Leibniz Association (Graduate School Emerging Infectious Diseases)	SP was supported by the Leibniz Association (Graduate School Emerging Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AM, 1997, J VIROL, V71, P218, DOI 10.1128/JVI.71.1.218-225.1997; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bente DA, 2013, ANTIVIR RES, V100, P159, DOI 10.1016/j.antiviral.2013.07.006; de Jong AS, 2008, J VIROL, V82, P3782, DOI 10.1128/JVI.02076-07; De Jong AS, 2006, J BIOL CHEM, V281, P14144, DOI 10.1074/jbc.M511766200; Dessau M, 2013, P NATL ACAD SCI USA, V110, P1696, DOI 10.1073/pnas.1217780110; Dirks Wilhelm G, 2013, Methods Mol Biol, V946, P27, DOI 10.1007/978-1-62703-128-8_3; Elliott R. M., 2013, FIELDS VIROLOGY; Elliott RM, 2014, CURR OPIN VIROL, V5, P50, DOI 10.1016/j.coviro.2014.01.011; Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999; Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074; Gerrard SR, 2007, VIROLOGY, V357, P124, DOI 10.1016/j.virol.2006.08.002; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Halldorsson S, 2016, P NATL ACAD SCI USA, V113, P7154, DOI 10.1073/pnas.1603827113; Hofmann H, 2013, J VIROL, V87, P4384, DOI 10.1128/JVI.02628-12; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; Liu Q, 2014, LANCET INFECT DIS, V14, P763, DOI 10.1016/S1473-3099(14)70718-2; Liu SL, 2014, REV MED VIROL, V24, P90, DOI 10.1002/rmv.1776; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Lober C, 2001, VIROLOGY, V289, P224, DOI 10.1006/viro.2001.1171; Mansfield KL, 2015, VACCINE, V33, P5520, DOI 10.1016/j.vaccine.2015.08.020; Matsuno K, 2013, J VIROL, V87, P3719, DOI 10.1128/JVI.02845-12; MATSUOKA Y, 1994, J BIOL CHEM, V269, P22565; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; MELIN L, 1995, VIRUS RES, V36, P49, DOI 10.1016/0168-1702(95)00006-C; Mueller SM, 2004, J GEN VIROL, V85, P3291, DOI 10.1099/vir.0.80198-0; Overby AK, 2007, J VIROL, V81, P11381, DOI 10.1128/JVI.00767-07; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rawlings ND, 2016, NUCLEIC ACIDS RES, V44, pD343, DOI 10.1093/nar/gkv1118; RONNHOLM R, 1992, J VIROL, V66, P4525; Sanchez AJ, 2006, J VIROL, V80, P514, DOI 10.1128/JVI.80.1.514-525.2006; Seidah NG, 2013, J BIOL CHEM, V288, P21473, DOI 10.1074/jbc.R113.481549; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shi XH, 2004, J VIROL, V78, P10793, DOI 10.1128/JVI.78.19.10793-10802.2004; Simmons G, 2003, VIROLOGY, V305, P115, DOI 10.1006/viro.2002.1730; Spiegel M, 2016, ROLE PHLEBOVIRUS GLY, V8; Sun YY, 2014, J VIROL, V88, P237, DOI 10.1128/JVI.02141-13; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Tani H, 2016, J VIROL, V90, P5292, DOI 10.1128/JVI.00110-16; Vincent MJ, 2003, J VIROL, V77, P8640, DOI 10.1128/JVI.77.16.8640-8649.2003; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095	48	17	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166013	10.1371/journal.pone.0166013	http://dx.doi.org/10.1371/journal.pone.0166013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855227	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200017
J	Ulrich, W; Lens, L; Tobias, JA; Habel, JC				Ulrich, Werner; Lens, Luc; Tobias, Joseph A.; Habel, Jan C.			Contrasting Patterns of Species Richness and Functional Diversity in Bird Communities of East African Cloud Forest Fragments	PLOS ONE			English	Article							HABITAT FRAGMENTATION; ECOSYSTEM FUNCTION; PLANT-COMMUNITIES; TROPICAL FORESTS; HOME-RANGE; BIODIVERSITY; EXTINCTION; LANDSCAPE; MOVEMENTS; COMPETITION	Rapid fragmentation and degradation of large undisturbed habitats constitute major threats to biodiversity. Several studies have shown that populations in small and highly isolated habitat patches are prone to strong environmental and demographic stochasticity and increased risk of extinction. Based on community assembly theory, we predict recent rapid forest fragmentation to cause a decline in species and functional guild richness of forest birds combined with a high species turnover among habitat patches, and well defined dominance structures, if competition is the major driver of community assembly. To test these predictions, we analysed species co-occurrence, nestedness, and competitive strength to infer effects of interspecific competition, habitat structure, and species' traits on the assembly of bird species communities from 12 cloud forest fragments in southern Kenya. Our results do not point to a single ecological driver of variation in species composition. Interspecific competition does not appear to be a major driver of species segregation in small forest patches, while its relative importance appears to be higher in larger ones, which may be indicative for a generic shift from competition-dominated to colonisation-driven community structure with decreasing fragment size. Functional trait diversity was independent of fragment size after controlling for species richness. As fragmentation effects vary among feeding guilds and habitat generalists, in particular, tend to decline in low quality forest patches, we plead for taking species ecology fully into account when predicting tropical community responses to habitat change.	[Ulrich, Werner] Nicolaus Copernicus Univ Torun, Chair Ecol & Biogeog, PL-87100 Torun, Poland; [Lens, Luc] Univ Ghent, Dept Biol, Terr Ecol Unit, B-9000 Ghent, Belgium; [Tobias, Joseph A.] Imperial Coll London, Dept Life Sci, Silwood Pk,Buckhurst Rd, Ascot SL5 7PY, Berks, England; [Habel, Jan C.] Tech Univ Munich, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, D-85354 Freising Weihenstephan, Germany	Nicolaus Copernicus University; Ghent University; Imperial College London; Technical University of Munich	Ulrich, W (corresponding author), Nicolaus Copernicus Univ Torun, Chair Ecol & Biogeog, PL-87100 Torun, Poland.	ulrichw@umk.pl	Habel, Jan Christian/H-2112-2019	Habel, Jan Christian/0000-0003-1378-9381; Ulrich, Werner/0000-0002-8715-6619; Lens, Luc/0000-0002-0241-2215; Tobias, Joseph/0000-0003-2429-6179	Research Foundation Flanders (FWO) [G.0258.01N, G.0055.08N, G.0149.09N, G.0308.13N]; Flemish Interuniversity Council [02/6/7-338-607]; FWO research community [WO.037.10N]; Natural Environment Research Council [NE/I028068/1]; Polish National Science Centre [NCN 2014/13/B/NZ8/04681]; NERC [NE/I028068/1] Funding Source: UKRI	Research Foundation Flanders (FWO)(FWO); Flemish Interuniversity Council; FWO research community; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Polish National Science Centre; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Fieldwork was funded by research grants G.0258.01N, G.0055.08N, G.0149.09N and G.0308.13N of Research Foundation Flanders (FWO), by Flemish Interuniversity Council project 02/6/7-338-607, and through contacts facilitated by FWO research community WO.037.10N. Biometric data collection was funded by Natural Environment Research Council (grant NE/I028068/1 to JAT); data analyses were supported by Polish National Science Centre (grant NCN 2014/13/B/NZ8/04681 to WU).	Aben J, 2012, ANIM CONSERV, V15, P658, DOI 10.1111/j.1469-1795.2012.00562.x; Allan E, 2013, ECOLOGY, V94, P465, DOI 10.1890/11-2279.1; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; ANDREN H, 1994, OIKOS, V71, P355, DOI 10.2307/3545823; [Anonymous], P 4 INT AIRB REM SEN; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Banks-Leite C, 2012, ECOLOGY, V93, P2560, DOI 10.1890/11-2054.1; Banks-Leite C, 2010, OIKOS, V119, P918, DOI 10.1111/j.1600-0706.2009.18061.x; BEENTJE HJ, 1987, SWARA, V10, P20; Blois JL, 2014, ECOGRAPHY, V37, P1095, DOI 10.1111/ecog.00779; Bregman TP, 2015, ECOLOGY, V96, P2692, DOI [10.1890/14-1731.1, 10.1890/14-1731.1.sm]; Cahill JF, 2008, PERSPECT PLANT ECOL, V10, P41, DOI 10.1016/j.ppees.2007.10.001; Callens T, 2012, THESIS; Callens T, 2011, MOL ECOL, V20, P1829, DOI 10.1111/j.1365-294X.2011.05028.x; Canale GR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041671; CAREY AB, 1990, J WILDLIFE MANAGE, V54, P11, DOI 10.2307/3808894; Chege J, 2005, J EAST AFR NAT HIST, V94, P231, DOI [10.2982/0012-8317(2005)94[231:VSOFSF]2.0.CO;2, DOI 10.2982/0012-8317(2005)94[231:VSOFSF]2.0.CO;2]; Claramunt S, 2012, P ROY SOC B-BIOL SCI, V279, P1567, DOI 10.1098/rspb.2011.1922; Clark BJF, 2010, RECENT ADV REMOTE SE; Collinge SK, 1998, OIKOS, V82, P66, DOI 10.2307/3546918; Debinski DM, 2000, CONSERV BIOL, V14, P342, DOI 10.1046/j.1523-1739.2000.98081.x; Dengler J, 2010, DIVERS DISTRIB, V16, P256, DOI 10.1111/j.1472-4642.2010.00646.x; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; DIAMOND J M, 1975, Biological Conservation, V7, P129, DOI 10.1016/0006-3207(75)90052-X; Diamond J.M., 1975, P342; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Ebenman B, 2004, ECOLOGY, V85, P2591, DOI 10.1890/03-8018; Farmilo BJ, 2014, AUSTRAL ECOL, V39, P416, DOI 10.1111/aec.12099; Gillies CS, 2008, P NATL ACAD SCI USA, V105, P19774, DOI 10.1073/pnas.0803530105; Gotelli NJ, 2002, ECOLOGY, V83, P1604, DOI 10.1890/0012-9658(2002)083[1604:BAARSD]2.0.CO;2; Gotzenberger L, 2012, BIOL REV, V87, P111, DOI 10.1111/j.1469-185X.2011.00187.x; Hansbauer MM, 2008, J TROP ECOL, V24, P291, DOI 10.1017/S0266467408005002; Hanski I, 2013, P NATL ACAD SCI USA, V110, P12715, DOI 10.1073/pnas.1311491110; Harris RJ, 2002, ANN ZOOL FENN, V39, P275; Henle K, 2004, BIODIVERS CONSERV, V13, P1, DOI 10.1023/B:BIOC.0000004311.04226.29; Hildebrandt JM, 1877, Z GESELLSCHAFT ERDKU, V14, P321; Holyoak M, 2005, METACOMMUNITIES: SPATIAL DYNAMICS AND ECOLOGICAL COMMUNITIES, P1; Horner-Devine MC, 2007, ECOLOGY, V88, P1345, DOI 10.1890/06-0286; Hoyle M, 2005, ECOL ENTOMOL, V30, P684, DOI 10.1111/j.0307-6946.2005.00738.x; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Karr J.R., 1981, Studies in Avian Biology, P62; Kennedy CM, 2010, ECOL MONOGR, V80, P651, DOI 10.1890/09-0904.1; Kirika JM, 2008, CONSERV BIOL, V22, P318, DOI 10.1111/j.1523-1739.2007.00874.x; Laird RA, 2006, AM NAT, V168, P182, DOI 10.1086/506259; Lasky JR, 2013, AM NAT, V182, pE142, DOI 10.1086/673205; Laurance SGW, 2004, CONSERV BIOL, V16, P605; Lees AC, 2008, ANIM CONSERV, V11, P128, DOI 10.1111/j.1469-1795.2008.00162.x; Lens L, 2002, SCIENCE, V298, P1236, DOI 10.1126/science.1075664; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Martensen AC, 2008, BIOL CONSERV, V141, P2184, DOI 10.1016/j.biocon.2008.06.008; Martensen AC, 2012, CONSERV BIOL, V26, P1100, DOI 10.1111/j.1523-1739.2012.01940.x; Morrison LW, 2014, J BIOGEOGR, V41, P1007, DOI 10.1111/jbi.12264; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Neuschulz EL, 2013, ANIM CONSERV, V16, P170, DOI 10.1111/j.1469-1795.2012.00582.x; Nupp TE, 2001, MAMM BIOL, V66, P345; PATTERSON BD, 1986, BIOL J LINN SOC, V28, P65, DOI 10.1111/j.1095-8312.1986.tb01749.x; Pellikka P., 1998, Fennia, V176, P1; Pellikka PKE, 2009, INT J APPL EARTH OBS, V11, P221, DOI 10.1016/j.jag.2009.02.002; Pigot AL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2013; Pimm SL, 2013, SCIENCE, V344, P1246; Price OF, 2006, WILDLIFE RES, V33, P521, DOI 10.1071/WR06029; Remsen JV, 1996, AUK, V113, P381, DOI 10.2307/4088905; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Rosindell J, 2012, TRENDS ECOL EVOL, V27, P203, DOI 10.1016/j.tree.2012.01.004; Schmiegelow FKA, 1997, ECOLOGY, V78, P1914, DOI 10.1890/0012-9658(1997)078[1914:ABBRTF]2.0.CO;2; Sekercioglu CH, 2012, J ORNITHOL, V153, pS153, DOI 10.1007/s10336-012-0869-4; Soliveres S, 2015, ECOL LETT, V18, P790, DOI 10.1111/ele.12456; STONE L, 1990, OECOLOGIA, V85, P74, DOI 10.1007/BF00317345; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tjorve E, 2010, J THEOR BIOL, V264, P604, DOI 10.1016/j.jtbi.2010.02.009; Trisos CH, 2014, AM NAT, V184, P593, DOI 10.1086/678233; Trzcinski MK, 1999, ECOL APPL, V9, P586, DOI 10.1890/1051-0761(1999)009[0586:IEOFCA]2.0.CO;2; Tuomisto H, 2010, OECOLOGIA, V164, P853, DOI 10.1007/s00442-010-1812-0; Ulrich W, 2016, OIKOS; Ulrich W, 2011, NODF FORTR PROGR NES; Ulrich W, 2011, TURNOVER FORTRAN PRO; Ulrich W, 2007, OIKOS, V116, P2053, DOI 10.1111/j.2007.0030-1299.16173.x; Ulrich W, 2014, OIKOS, V123, P1057, DOI 10.1111/oik.01217; Ulrich W, 2013, OIKOS, V122, P2, DOI 10.1111/j.1600-0706.2012.20325.x; Ulrich W, 2012, ECOL MODEL, V244, P20, DOI 10.1016/j.ecolmodel.2012.06.030; Villard MA, 2014, J APPL ECOL, V51, P309, DOI 10.1111/1365-2664.12190; Walker B, 1999, ECOSYSTEMS, V2, P95, DOI 10.1007/s100219900062; Waltert M, 2005, ECOL APPL, V15, P1351, DOI 10.1890/04-1002; Wang YP, 2015, BASIC APPL ECOL, V16, P19, DOI 10.1016/j.baae.2014.10.006; Watson DM, 2003, BIOL CONSERV, V111, P283, DOI 10.1016/S0006-3207(02)00271-9; Watson DM, 2002, J BIOGEOGR, V29, P823, DOI 10.1046/j.1365-2699.2002.00726.x; Weiher E., 1999, ECOLOGICAL ASSEMBLY, DOI DOI 10.1017/CBO9780511542237; Wiktander U, 2001, BIOL CONSERV, V100, P387, DOI 10.1016/S0006-3207(01)00045-3; Zimmermann DA, 1996, BIRDS KENYA NO TANZA	91	16	16	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0163338	10.1371/journal.pone.0163338	http://dx.doi.org/10.1371/journal.pone.0163338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855174	gold, Green Published			2022-12-26	WOS:000387910200003
J	Lee, SW; Rho, JH; Lee, SY; Yoo, SH; Kim, HY; Chung, WT; Yoo, YH				Lee, Sung Won; Rho, Jee Hyun; Lee, Sang Yeob; Yoo, Seung Hee; Kim, Hye Young; Chung, Won Tae; Yoo, Young Hyun			Alpha B-Crystallin Protects Rat Articular Chondrocytes against Casein Kinase II Inhibition-Induced Apoptosis	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; PHOSPHORYLATION; EXPRESSION; CK2; INDUCTION; CARTILAGE; CELLS; P53; TRANSLOCATION; PATHOGENESIS	Although alpha alpha B-crystallin is expressed in articular chondrocytes, little is known about its role in these cells. Protein kinase casein kinase 2 (CK2) inhibition induces articular chondrocyte death. The present study examines whether alpha B-crystallin exerts anti-apoptotic activity in articular chondrocytes. Primary rat articular chondrocytes were isolated from knee joint slices. Cells were treated with CK2 inhibitors with or without alpha B-crystallin si RNA. To examine whether the silencing of aB-crystallin sensitizes rat articular chondrocytes to CK2 inhibition induced apoptosis, we assessed apoptosis by performing viability assays, mitochondrial membrane potential measurements, flow cytometry, nuclear morphology observations, and western blot analysis. To investigate the mechanism by which aB-crystallin modulates the extent of CK2 inhibition-mediated chondrocyte death, we utilized confocal microscopy to observe the subcellular location of aB-crystallin and its phosphorylated forms and performed a co-immunoprecipitation assay to observe the interaction between aB-crystallin and CK2. Immunochemistry was employed to examine aB-crystallin expression in cartilage obtained from rats with experimentally induced osteoarthritis (OA). Our results demonstrated that silencing of aB-crystallin sensitized rat articular chondrocytes to CK2 inhibitor -induced apoptosis. Furthermore, CK2 inhibition modulated the expression and subcellular localization of aB-crystallin and its phosphorylated forms and dissociated aB-crystallin from CK2. The population of rat articular chondrocytes expressing aB-crystallin and its phosphorylated forms was reduced in an experimentally induced rat model of OA. In summary, aB-crystallin protects rat articular chondrocytes against CK2 inhibition -induced apoptosis. aB-crystallin may represent a suitable target for pharmacological interventions to prevent OA.	[Lee, Sung Won; Lee, Sang Yeob; Chung, Won Tae] Dong A Univ, Coll Med, Dept Rheumatol, Busan, South Korea; [Rho, Jee Hyun; Yoo, Seung Hee; Kim, Hye Young; Yoo, Young Hyun] Dong A Univ, Coll Med, Dept Anat & Cell Biol, Busan, South Korea; [Rho, Jee Hyun; Yoo, Seung Hee; Kim, Hye Young; Yoo, Young Hyun] Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Busan, South Korea	Dong A University; Dong A University; Dong A University	Yoo, YH (corresponding author), Dong A Univ, Coll Med, Dept Anat & Cell Biol, Busan, South Korea.; Yoo, YH (corresponding author), Dong A Univ, Coll Med, Mitochondria Hub Regulat Ctr, Busan, South Korea.	yhyoo@dau.ac.kr		Lee, Sung Won/0000-0003-1213-1254	National Research Foundation of Korea (NRF) - Korean government (MSIP) [NRF-2015R1A2A1A10051603, NRF-2013R1A1A4A01006046, 2016R1A5A2007009]	National Research Foundation of Korea (NRF) - Korean government (MSIP)	This work was supported by grants from the National Research Foundation of Korea (NRF) funded by the Korean government (MSIP) (NRF-2015R1A2A1A10051603, NRF-2013R1A1A4A01006046, and 2016R1A5A2007009).	Aigner T, 2002, CURR OPIN RHEUMATOL, V14, P578, DOI 10.1097/00002281-200209000-00018; Aizawa T, 2001, J ORTHOP RES, V19, P785, DOI 10.1016/S0736-0266(00)00078-4; ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Amin Ashok R., 1998, Current Opinion in Rheumatology, V10, P263, DOI 10.1097/00002281-199805000-00018; BENNARDINI F, 1995, BIOCHEM BIOPH RES CO, V208, P742, DOI 10.1006/bbrc.1995.1400; BLANCO FJ, 1995, AM J PATHOL, V146, P75; BLOEMENDAL H, 1977, SCIENCE, V197, P127, DOI 10.1126/science.877544; Chen L, 2005, DIFFERENTIATION, V73, P350, DOI 10.1111/j.1432-0436.2005.00038.x; Coustry F, 2012, AM J PATHOL, V180, P738, DOI 10.1016/j.ajpath.2011.10.033; den Engelsman J, 2004, EUR J BIOCHEM, V271, P4195, DOI 10.1111/j.1432-1033.2004.04359.x; den Englesman J, 2005, J BIOL CHEM, V280, P37139, DOI 10.1074/jbc.M504106200; Goldring MB, 2000, ARTHRITIS RHEUM-US, V43, P1916, DOI 10.1002/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hashimoto S, 1997, ARTHRITIS RHEUM-US, V40, P1749, DOI 10.1002/art.1780401004; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1266, DOI 10.1002/1529-0131(199807)41:7<1266::AID-ART18>3.0.CO;2-Y; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Ishihara K, 2003, BIOCHEM J, V371, P917, DOI 10.1042/BJ20021331; Ito H, 1997, J BIOL CHEM, V272, P29934, DOI 10.1074/jbc.272.47.29934; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; Jeong WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045754; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; KATO K, 1991, BIOCHIM BIOPHYS ACTA, V1080, P173, DOI 10.1016/0167-4838(91)90146-Q; Keller DM, 2001, MOL CELL, V7, P283, DOI 10.1016/S1097-2765(01)00176-9; Kim HA, 2000, J RHEUMATOL, V27, P455; Kim KM, 2012, INT J MOL MED, V29, P1039, DOI 10.3892/ijmm.2012.949; Kim SJ, 2002, J BIOL CHEM, V277, P1332, DOI 10.1074/jbc.M107231200; Kuhn K, 2001, ARTHRITIS RHEUM-US, V44, P1644, DOI 10.1002/1529-0131(200107)44:7<1644::AID-ART287>3.0.CO;2-S; Lambrecht S, 2009, ARTHRITIS RHEUM-US, V60, P179, DOI 10.1002/art.24152; Lee JS, 2012, NEURO-ONCOLOGY, V14, P1332, DOI 10.1093/neuonc/nos247; Lee SW, 2015, OSTEOARTHR CARTILAGE, V23, P2269, DOI 10.1016/j.joca.2015.06.005; Lee SW, 2008, ARTHRITIS RHEUM-US, V58, P790, DOI 10.1002/art.23220; Lee SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019163; Lee SW, 2004, ARTHRITIS RHEUM-US, V50, P534, DOI 10.1002/art.20052; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; LUSCHER B, 1989, EMBO J, V8, P1111, DOI 10.1002/j.1460-2075.1989.tb03481.x; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; McElhinny JA, 1996, MOL CELL BIOL, V16, P899; Miwa M, 2000, OSTEOARTHR CARTILAGE, V8, P17, DOI 10.1053/joca.1999.0266; Shin S, 2005, EMBO J, V24, P3532, DOI 10.1038/sj.emboj.7600827; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; van den IJssel P, 1999, CURR BIOL, V9, pR103, DOI 10.1016/S0960-9822(99)80061-X; WISTOW GJ, 1988, ANNU REV BIOCHEM, V57, P479, DOI 10.1146/annurev.bi.57.070188.002403; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996	48	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166450	10.1371/journal.pone.0166450	http://dx.doi.org/10.1371/journal.pone.0166450			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851782	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300050
J	Li, LL; Illeghems, K; Van Kerrebroeck, S; Borremans, W; Cleenwerck, I; Smagghe, G; Vuyst, LD; Vandamme, P				Li, Leilei; Illeghems, Koen; Van Kerrebroeck, Simon; Borremans, Wim; Cleenwerck, Ilse; Smagghe, Guy; Luc De Vuyst; Vandamme, Peter			Whole-Genome Sequence Analysis of Bombella intestini LMG 28161(T), a Novel Acetic Acid Bacterium Isolated from the Crop of a Red-Tailed Bumble Bee, Bombus lapidarius	PLOS ONE			English	Article							HONEY-BEE; SP-NOV.; ACETOBACTER-PASTEURIANUS; GEN. NOV.; IDENTIFICATION; OXIDASE; TRAITS	The whole-genome sequence of Bombella intestini LMG 28161(T), an endosymbiotic acetic acid bacterium (AAB) occurring in bumble bees, was determined to investigate the molecular mechanisms underlying its metabolic capabilities. The draft genome sequence of B. intestini LMG 28161(T) was 2.02 Mb. Metabolic carbohydrate pathways were in agreement with the metabolite analyses of fermentation experiments and revealed its oxidative capacity towards sucrose, D-glucose, D-fructose and D-mannitol, but not ethanol and glycerol. The results of the fermentation experiments also demonstrated that the lack of effective aeration in small-scale carbohydrate consumption experiments may be responsible for the lack of reproducibility of such results in taxonomic studies of AAB. Finally, compared to the genome sequences of its nearest phylogenetic neighbor and of three other insect associated AAB strains, the B. intestini LMG 28161(T) genome lost 69 orthologs and included 89 unique genes. Although many of the latter were hypothetical they also included several type IV secretion system proteins, amino acid transporter/permeases and membrane proteins which might play a role in the interaction with the bumble bee host.	[Li, Leilei; Vandamme, Peter] Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, B-9000 Ghent, Belgium; [Illeghems, Koen; Van Kerrebroeck, Simon; Borremans, Wim; Luc De Vuyst] Vrije Univ Brussel, Fac Sci & Bioengn Sci, Res Grp Ind Microbiol & Food Biotechnol, Pl Laan 2, B-1050 Brussels, Belgium; [Cleenwerck, Ilse] Univ Ghent, Fac Sci, BCCM LMG Bacteria Collect, KL Ledeganckstr 35, B-9000 Ghent, Belgium; [Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Crop Protect, Lab Agrozool, Coupure Links 653, B-9000 Ghent, Belgium	Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University	Vandamme, P (corresponding author), Univ Ghent, Fac Sci, Microbiol Lab, KL Ledeganckstr 35, B-9000 Ghent, Belgium.	Peter.Vandamme@ugent.be	Cleenwerck, Ilse/X-1168-2019; Smagghe, Guy/AAE-8914-2019; Li, Leilei/X-5125-2019; Vandamme, Peter/ABG-3431-2021; Van Kerrebroeck, Simon/ABF-3883-2020; Vandamme, Peter AR/B-7967-2009	Smagghe, Guy/0000-0001-8334-3313; Li, Leilei/0000-0003-0185-510X; Vandamme, Peter/0000-0002-5581-7937; Vandamme, Peter AR/0000-0002-5581-7937; Borremans, Wim/0000-0002-7816-8490; De Vuyst, Luc/0000-0002-7534-7186	Federal Public Planning Service Science Policy, Belgium [C4/00/BCCM]; Research Foundation-Flanders (FWO-Vlaanderen) [G.0.910.10.N.10]; Research Council of Ghent University; Vrije Universiteit Brussel [SRP7, IRP2, IOF342]; Hercules Foundation [UABR09004]; Chinese Scholarship Council [2011533075]; Ghent University [01SC1111]	Federal Public Planning Service Science Policy, Belgium; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); Research Council of Ghent University(Ghent University); Vrije Universiteit Brussel; Hercules Foundation; Chinese Scholarship Council(China Scholarship Council); Ghent University(Ghent University)	The BCCM/LMG collection is supported by the Federal Public Planning Service Science Policy, Belgium (contract no. C4/00/BCCM). The authors acknowledge the financial support of the Research Foundation-Flanders (FWO-Vlaanderen; http://www.fwo.be; grant no. G.0.910.10.N.10), the Research Council of Ghent University and the Vrije Universiteit Brussel (http://www.vub.ac.beien/ research; SRP7, IRP2 and IOF342 projects) and the Hercules Foundation (grant number UABR09004). L.L. acknowledges the Chinese Scholarship Council (http://www.csc.edu.cn; file no. 2011533075) and Ghent University Co-Funding (http://www.ugent.be/nl/ondeizoek/financiering/: grant no. 01SC1111).	Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Backert S, 2015, FUTURE MICROBIOL, V10, P955, DOI [10.2217/FMB.15.32, 10.2217/fmb.15.32]; Bertalan M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-450; Bossi RT, 2002, BIOCHEMISTRY-US, V41, P3018, DOI 10.1021/bi015939r; Cariveau DP, 2014, ISME J, P1; Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062; Cleenwerck I, 2002, INT J SYST EVOL MICR, V52, P1551, DOI 10.1099/00207713-52-5-1551; Cleenwerck I, 2008, INT J SYST EVOL MICR, V58, P2180, DOI 10.1099/ijs.0.65778-0; Cleenwerck I, 2008, INT J FOOD MICROBIOL, V125, P2, DOI 10.1016/j.ijfoodmicro.2007.04.017; Corby-Harris V, 2014, APPL ENVIRON MICROB, V80, P7460, DOI 10.1128/AEM.02043-14; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Fuentes-Ramirez LE, 2001, INT J SYST EVOL MICR, V51, P1305, DOI 10.1099/00207713-51-4-1305; Gossele A F, 1983, INT J SYST BACTERIOL, V33, P65; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Gullo M, 2008, INT J FOOD MICROBIOL, V125, P46, DOI 10.1016/j.ijfoodmicro.2007.11.076; Holscher T, 2006, J BACTERIOL, V188, P7668, DOI 10.1128/JB.01009-06; Illeghems K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-526; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kwong WK, 2014, P NATL ACAD SCI USA, V111, P11509, DOI 10.1073/pnas.1405838111; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li LL, 2015, INT J SYST EVOL MICR, V65, P267, DOI 10.1099/ijs.0.068049-0; Lohaus G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087689; Low HH, 2014, NATURE, V508, P550, DOI 10.1038/nature13081; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Matsutani M, 2014, BBA-BIOENERGETICS, V1837, P1810, DOI 10.1016/j.bbabio.2014.05.355; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159, DOI 10.1099/00207713-39-2-159; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Moens F, 2014, APPL ENVIRON MICROB, V80, P1848, DOI 10.1128/AEM.03344-13; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Prust C, 2005, NAT BIOTECHNOL, V23, P195, DOI 10.1038/nbt1062; Raspor P, 2008, CRIT REV BIOTECHNOL, V28, P101, DOI 10.1080/07388550802046749 ; Spitaels F, 2014, INT J SYST EVOL MICR, V64, P1134, DOI 10.1099/ijs.0.059311-0; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Wieme AD, 2014, INT J FOOD MICROBIOL, V185, P41, DOI 10.1016/j.ijfoodmicro.2014.05.003	38	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165611	10.1371/journal.pone.0165611	http://dx.doi.org/10.1371/journal.pone.0165611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851750	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300022
J	Siddharthan, T; Rabin, T; Canavan, ME; Nassali, F; Kirchhoff, P; Kalyesubula, R; Coca, S; Rastegar, A; Knauf, F				Siddharthan, Trishul; Rabin, Tracy; Canavan, Maureen E.; Nassali, Faith; Kirchhoff, Phillip; Kalyesubula, Robert; Coca, Steven; Rastegar, Asghar; Knauf, Felix			Implementation of Patient-Centered Education for Chronic-Disease Management in Uganda: An Effectiveness Study	PLOS ONE			English	Article							SATISFACTION; ACTIVATION; CARE; ADHERENCE; SERVICES; PROGRAM	Background The majority of non-communicable disease related deaths occur in low- and middle-income countries. Patient-centered care is an essential component of chronic disease management in high income settings. Objective To examine feasibility of implementation of a validated patient-centered education tool among patients with heart failure in Uganda. Design Mixed-methods, prospective cohort. Settings A private and public cardiology clinic in Mulago National Referral and Teaching Hospital, Kampala, Uganda. Participants Adults with a primary diagnosis of heart failure. Interventions PocketDoktor Educational Booklets with patient-centered health education. Main Measures The primary outcomes were the change in Patient Activation Measure (PAM-13), as well as the acceptability of the PocketDoktor intervention, and feasibility of implementing patient centered education in outpatient clinical settings. Secondary outcomes included the change in satisfaction with overall clinical care and doctor-patient communication. Key Results A total of 105 participants were enrolled at two different clinics: the Mulago Outpatient Department (public) and the Uganda Heart Institute (private). 93 participants completed follow up at 3 months and were included in analysis. The primary analysis showed improved patient activation measure scores regarding disease-specific knowledge, treatment options and prevention of exacerbations among both groups (mean change 0.94 [SD = 1.01], 1.02 [SD = 1.15], and 0.92 [SD = 0.89] among private paying patients and 1.98 [SD = 0.98], 1.93 [SD = 1.02], and 1.45 [SD = 1.02] among public paying patients, p<0.001 for all values) after exposure to the intervention; this effect was significantly larger among indigent patients. Participants reported that materials were easy to read, that they had improved knowledge of disease, and stated improved communication with physicians. Conclusions Patient-centered medical education can improve confidence in self-management as well as satisfaction with doctor-patient communication and overall care in Uganda. Our results show that printed booklets are locally appropriate, highly acceptable and feasible to implement in an LMIC outpatient setting across socioeconomic groups.	[Siddharthan, Trishul] Johns Hopkins Univ, Johns Hopkins Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Siddharthan, Trishul; Rabin, Tracy; Coca, Steven; Rastegar, Asghar; Knauf, Felix] Yale Univ, Dept Med, Yale Sch Med, New Haven, CT 06520 USA; [Canavan, Maureen E.] Yale Univ, Global Hlth Leadership Inst, New Haven, CT USA; [Nassali, Faith; Kalyesubula, Robert] Makerere Univ, Coll Hlth Sci, Kampala, Uganda; [Kirchhoff, Phillip] Univ Basel Hosp, Dept Surg, Basel, Switzerland; [Coca, Steven] Mt Sinai Hosp, Mt Sinai Sch Med, Dept Nephrol, New York, NY 10029 USA; [Knauf, Felix] Friedrich Alexander Univ Erlangen Nurnberg, Dept Nephrol, Erlangen, Germany	Johns Hopkins University; Johns Hopkins Medicine; Yale University; Yale University; Makerere University; University of Basel; Icahn School of Medicine at Mount Sinai; University of Erlangen Nuremberg	Siddharthan, T (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA.; Siddharthan, T (corresponding author), Yale Univ, Dept Med, Yale Sch Med, New Haven, CT 06520 USA.	Tsiddhal@jhmi.edu	Coca, Steven/L-7801-2019; Knauf, Felix/ABC-2513-2021; Siddharthan, Trishul/ABI-7593-2020	Coca, Steven/0000-0002-0928-9168; Siddharthan, Trishul/0000-0001-9914-1839; Knauf, Felix/0000-0001-5762-1404; Kalyesubula, Robert/0000-0003-3211-163X	Fulbright Scholar Award; Fogarty International Center of the National Institutes of Health [5R25TW009340]; Else Kroner-Fresenius-Stifung [2016_HA44]	Fulbright Scholar Award; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Else Kroner-Fresenius-Stifung	Trishul Siddharthan received funding in part from a Fulbright Scholar Award and from the Fogarty International Center of the National Institutes of Health under Award No. 5R25TW009340. Felix Knauf, Trishul Siddharthan, Tracy Rabin, Robert Kalyesubula and Asghar Rastegar are supported by the Else Kroner-Fresenius-Stifung to establish a center of excellence for patient-centered care and non communicable disease management in Uganda (2016_HA44). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or respective government or non-governmental organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltussen RMPM, 2002, HEALTH POLICY PLANN, V17, P42, DOI 10.1093/heapol/17.1.42; Beck Rainer S, 2002, J Am Board Fam Pract, V15, P25; Bloom D.E., 2012, PGDA WORKING PAPERS, V8712; Ebrahim S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001377; Eikelboom J, 2001, BRIT MED J, V322, P1192, DOI 10.1136/bmj.322.7296.1192; Glaser BG, DISCOVERY GROUNDED T, P7; Greene J, 2012, J GEN INTERN MED, V27, P520, DOI 10.1007/s11606-011-1931-2; Griffin SJ, 2004, ANN FAM MED, V2, P595, DOI 10.1370/afm.142; Grogan S, 2000, QUAL HEALTH CARE, V9, P210, DOI 10.1136/qhc.9.4.210; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Hibbard JH, 2004, HEALTH SERV RES, V39, P1005, DOI 10.1111/j.1475-6773.2004.00269.x; Houle J, 2012, CAN FAM PHYSICIAN, V58, P1366; Jack BW, 2009, ANN INTERN MED, V150, P178, DOI 10.7326/0003-4819-150-3-200902030-00007; Lorig KR, 1999, MED CARE, V37, P5, DOI 10.1097/00005650-199901000-00003; Nabbuye-Sekandi J, 2011, INT J QUAL HEALTH C, V23, P516, DOI 10.1093/intqhc/mzr040; Odusola A.O., 2015, WORLD J CARDIOVASCUL, V5, P181, DOI [10.4236/wjcd.2015.57021, DOI 10.4236/WJCD.2015.57021]; Oi K, 2012, UNDERSTANDING ROLE P; Otero C, 2015, Yearb Med Inform, V10, P30, DOI 10.15265/IY-2015-013; Perry HB, 2014, ANNU REV PUBL HEALTH, V35, P399, DOI 10.1146/annurev-publhealth-032013-182354; Praveen D, 2013, COMMUNITIES, V5, P6; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Roberts KJ, 2002, AIDS PATIENT CARE ST, V16, P43, DOI 10.1089/108729102753429398; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Saksena P, 2012, TROP MED INT HEALTH, V17, P23, DOI 10.1111/j.1365-3156.2011.02894.x; Siddharthan T, 2015, HEALTH AFFAIR, V34, P1506, DOI 10.1377/hlthaff.2015.0382; Smith SG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074373; Stellefson M, 2013, PREV CHRONIC DIS, P10; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; World Bank, 2015, POP DAT 2015; World Health Organization, GLOBAL STATUS REPORT; World Health Organization, 2010, P 3 GEN C PEOPL CTR	31	20	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166411	10.1371/journal.pone.0166411	http://dx.doi.org/10.1371/journal.pone.0166411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851785	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300046
J	Zschache, J				Zschache, Johannes			Melioration Learning in Two-Person Games	PLOS ONE			English	Article							MATCHING LAW; REINFORCEMENT; CHOICE; CONVERGENCE; PERFORMANCE; ALLOCATION; MODELS	Melioration learning is an empirically well-grounded model of reinforcement learning. By means of computer simulations, this paper derives predictions for several repeatedly played two-person games from this model. The results indicate a likely convergence to a pure Nash equilibrium of the game. If no pure equilibrium exists, the relative frequencies of choice may approach the predictions of the mixed Nash equilibrium. Yet in some games, no stable state is reached.	[Zschache, Johannes] Univ Leipzig, Inst Sociol, Leipzig, Germany	Leipzig University	Zschache, J (corresponding author), Univ Leipzig, Inst Sociol, Leipzig, Germany.	zschache@sozio.uni-leipzig.de			German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	I acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Abdallah S., 2006, AAMAS, P850, DOI 10.1145/1160633.1160786; Alferink LA, 2009, J APPL BEHAV ANAL, V42, P595, DOI 10.1901/jaba.2009.42-595; Antonides G, 2002, J SOCIO-ECON, V31, P155, DOI [10.1016/S1053-5357(01)00130-5, DOI 10.1016/S1053-5357(01)00130-5.]; Babichenko Y, 2012, GAME ECON BEHAV, V76, P1, DOI 10.1016/j.geb.2012.06.004; Barto A.G., 1990, LEARNING COMPUTATION, P539; BAUM WM, 1979, J EXP ANAL BEHAV, V32, P269, DOI 10.1901/jeab.1979.32-269; Borrero JC, 2007, J APPL BEHAV ANAL, V40, P589, DOI 10.1901/jaba.2007.589-601; Brenner T, 2003, J ECON BEHAV ORGAN, V50, P429, DOI 10.1016/S0167-2681(02)00034-3; Brenner T, 2006, HANDB ECON, V13, P895; Bush R. R., 1955, STOCHASTIC MODELS LE, DOI [10.1037/14496-000, DOI 10.1037/14496-000]; Camerer C, 1999, ECONOMETRICA, V67, P827, DOI 10.1111/1468-0262.00054; Claus C, 1998, FIFTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-98) AND TENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICAL INTELLIGENCE (IAAI-98) - PROCEEDINGS, P746; Erev I, 1998, AM ECON REV, V88, P848; Foster DP., 2006, THEOR ECON, V1, P341; Germano F, 2007, GAME ECON BEHAV, V60, P135, DOI 10.1016/j.geb.2006.06.001; HAMBLIN RL, 1979, SOC FORCES, V57, P1141, DOI 10.2307/2577263; Harsanyi JC, 1992, GEN THEORY EQUILIBRI; Harsanyi John C., 1977, RATIONAL BEHAV BARGA; Hart S, 2003, AM ECON REV, V93, P1830, DOI 10.1257/000282803322655581; Herrnstein R. J., 1997, PAPERS PSYCHOL EC; HERRNSTEIN RJ, 1993, J BEHAV DECIS MAKING, V6, P149, DOI 10.1002/bdm.3960060302; Herrnstein RJ, 1980, LIMITS ACTION ALLOCA, P143, DOI DOI 10.1016/B978-0-12-662650-6.50011-8; JAAKKOLA T, 1994, NEURAL COMPUT, V6, P1185, DOI 10.1162/neco.1994.6.6.1185; Kangas BD, 2009, BEHAV PROCESS, V82, P164, DOI 10.1016/j.beproc.2009.06.004; Kianercy A, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.041145; Loewenstein Y, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00017; MAZUR JE, 1981, SCIENCE, V214, P823, DOI 10.1126/science.7292017; McDowell JJ, 2005, J EXP ANAL BEHAV, V84, P111, DOI 10.1901/jeab.2005.59-04; MCDOWELL JJ, 1988, BEHAV ANALYST, V11, P95, DOI 10.1007/BF03392462; Neth H., 2005, P HUMAN FACTORS ERGO, V49, P357; Nowe A, 2012, ADAPT LEARN OPTIM, V12, P441; Pierce W D, 1983, Behav Anal, V6, P57; Rauhut H, 2009, RATION SOC, V21, P359, DOI 10.1177/1043463109337876; Rodrigues Gomes E., 2009, P 26 ANN INT C MACHI, P369; ROTH AE, 1995, GAME ECON BEHAV, V8, P164, DOI 10.1016/S0899-8256(05)80020-X; Sakai Y, 2006, NEURAL NETWORKS, V19, P1091, DOI 10.1016/j.neunet.2006.05.034; Sandholm T. W., 1995, P WORKSH AD LEARN MU, P191; Shoham Y, 2009, MULTIAGENT SYSTEMS: ALGORITHMIC, GAME-THEORETIC, AND LOGICAL FOUNDATIONS, P1; Shteingart H, 2014, CURR OPIN NEUROBIOL, V25, P93, DOI 10.1016/j.conb.2013.12.004; Staddon J.E.R., 2001, ADAPTIVE DYNAMICS TH; Staddon JER, 2003, ANNU REV PSYCHOL, V54, P115, DOI 10.1146/annurev.psych.54.101601.145124; SUNAHARA DF, 1982, CAN J SOCIOL, V7, P145, DOI 10.2307/3340195; Sutton R.S., 2017, REINFORCEMENT LEARNI, V2nd, DOI [10.1109/TNN.1998.712192, DOI 10.1109/TNN.1998.712192]; Sutton R.S., 1990, LEARNING COMPUTATION, P497; Tsebelis George, 1990, RATIONALITY AND SOCI, V2, P255, DOI DOI 10.1177/1043463190002003002; Tunney RJ, 2002, J BEHAV DECIS MAKING, V15, P291, DOI 10.1002/bdm.415; Vaughan Jr W., 1987, ADV BEHAVIORAL EC, V1, P185; VAUGHAN W, 1981, J EXP ANAL BEHAV, V36, P141, DOI 10.1901/jeab.1981.36-141; VILLIERS PAD, 1976, PSYCHOL BULL, V83, P1131, DOI 10.1037/0033-2909.83.6.1131; Vollmer TR, 2000, J APPL BEHAV ANAL, V33, P137, DOI 10.1901/jaba.2000.33-137; Watkins C.J.C.H., 1989, LEARNING DELAYED REW; WATKINS CJCH, 1992, MACH LEARN, V8, P279, DOI 10.1007/BF00992698; Wunder M., 2010, P 27 INT C MACH LEAR; Yechiam E, 2003, HUM FACTORS, V45, P671, DOI 10.1518/hfes.45.4.671.27085; Young HP, 2009, GAME ECON BEHAV, V65, P626, DOI 10.1016/j.geb.2008.02.011; Young HP., 2004, STRATEGIC LEARNING I, DOI [10.1093/acprof:oso/9780199269181.001.0001, DOI 10.1093/ACPROF:OSO/9780199269181.001.0001]	56	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166708	10.1371/journal.pone.0166708	http://dx.doi.org/10.1371/journal.pone.0166708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851815	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300081
J	Simione, L; Nolfi, S				Simione, Luca; Nolfi, Stefano			The Emergence of Selective Attention through Probabilistic Associations between Stimuli and Actions	PLOS ONE			English	Article							NEURAL MECHANISMS; VISUAL-ATTENTION; WORKING-MEMORY; MULTIPLE; COMPETITION; COGNITION; MODEL	In this paper we show how a multilayer neural network trained to master a context-dependent task in which the action co-varies with a certain stimulus in a first context and with a second stimulus in an alternative context exhibits selective attention, i.e. filtering out of irrelevant information. This effect is rather robust and it is observed in several variations of the experiment in which the characteristics of the network as well as of the training procedure have been varied. Our result demonstrates how the filtering out of irrelevant information can originate spontaneously as a consequence of the regularities present in context-dependent training set and therefore does not necessarily depend on specific architectural constraints. The post-evaluation of the network in an instructed-delay experimental scenario shows how the behaviour of the network is consistent with the data collected in neuropsychological studies. The analysis of the network at the end of the training process indicates how selective attention originates as a result of the effects caused by relevant and irrelevant stimuli mediated by context-dependent and context-independent bidirectional associations between stimuli and actions that are extracted by the network during the learning.	[Simione, Luca; Nolfi, Stefano] CNR, Inst Cognit Sci & Technol, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Simione, L (corresponding author), CNR, Inst Cognit Sci & Technol, Rome, Italy.	luca_simione@gmail.com	Simione, Luca/AAL-9181-2020	Simione, Luca/0000-0003-1938-8466				Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Binkofski F, 2013, BRAIN LANG, V127, P222, DOI 10.1016/j.bandl.2012.07.007; Bonfiglioli C, 1998, PERCEPT PSYCHOPHYS, V60, P1426, DOI 10.3758/BF03208003; Bundesen C, 2005, PSYCHOL REV, V112, P291, DOI 10.1037/0033-295X.112.2.291; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Castiello U, 1999, TRENDS COGN SCI, V3, P264, DOI 10.1016/S1364-6613(99)01346-7; Chelazzi L, 2011, WIRES COGN SCI, V2, P392, DOI 10.1002/wcs.117; CHIEFFI S, 1993, BRAIN, V116, P1119, DOI 10.1093/brain/116.5.1119; Chun MM, 2011, ANNU REV PSYCHOL, V62, P73, DOI 10.1146/annurev.psych.093008.100427; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Deco G, 2004, VISION RES, V44, P621, DOI 10.1016/j.visres.2003.09.037; Deco G, 2001, VIS COGN, V8, P119, DOI 10.1080/13506280042000054; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Heinke D, 2011, COGN COMPUT, V3, P185, DOI 10.1007/s12559-010-9076-x; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2007, TRENDS COGN SCI, V11, P428, DOI 10.1016/j.tics.2007.09.004; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Houghton George, 1994, P53; Howard LA, 1997, EXP BRAIN RES, V113, P144, DOI 10.1007/BF02454150; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JACKSON SR, 1995, EXP BRAIN RES, V102, P519; Larochelle H, 2009, J MACH LEARN RES, V10, P1; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Nothdurft HC, 2000, VISION RES, V40, P1183, DOI 10.1016/S0042-6989(00)00031-6; Pastor-Bernier A, 2011, J NEUROSCI, V31, P7083, DOI 10.1523/JNEUROSCI.5681-10.2011; Payne HE, 2011, J COGNITIVE NEUROSCI, V23, P2046, DOI 10.1162/jocn.2010.21562; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Simione L, 2014, CONNECT SCI, V26, P389, DOI 10.1080/09540091.2014.942597; Simione L, 2012, PSYCHOL REV, V119, P745, DOI 10.1037/a0029345; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Strauss S, 2015, NEURAL NETWORKS, V72, P3, DOI 10.1016/j.neunet.2015.10.005; Tankus A, 2012, J COGNITIVE NEUROSCI, V24, P600, DOI 10.1162/jocn_a_00160; Tipper SP, 1998, PHILOS T R SOC B, V353, P1385, DOI 10.1098/rstb.1998.0292; Tipper SP, 1997, VIS COGN, V4, P1, DOI 10.1080/713756749; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Elk M., 2013, PHYS LIFE REV; Zorzi M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00515	40	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166174	10.1371/journal.pone.0166174	http://dx.doi.org/10.1371/journal.pone.0166174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846301	gold, Green Submitted, Green Published			2022-12-26	WOS:000387794600036
J	Zhao, ZY; Wang, XM; Fan, MX; Yin, DZ; Sun, LM; Jia, J; Tang, CZ; Zheng, XH; Jiang, YW; Wu, J; Gong, JY				Zhao, Zhiyong; Wang, Xiangmin; Fan, Mingxia; Yin, Dazhi; Sun, Limin; Jia, Jie; Tang, Chaozheng; Zheng, Xiaohui; Jiang, Yuwei; Wu, Jie; Gong, Jiayu			Altered Effective Connectivity of the Primary Motor Cortex in Stroke: A Resting-State fMRI Study with Granger Causality Analysis	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; HAND MOVEMENTS; FUNCTIONAL REORGANIZATION; CORTICAL CONNECTIVITY; SUBCORTICAL STROKE; MACAQUE MONKEY; HUMAN BRAIN; AREA F5; RECOVERY; EXECUTION	The primary motor cortex (M1) is often abnormally recruited in stroke patients with motor disabilities. However, little is known about the alterations in the causal connectivity of M1 following stroke. The purpose of the present study was to investigate whether the effective connectivity of the ipsilesional M1 is disturbed in stroke patients who show different outcomes in hand motor function. 23 patients with left-hemisphere subcortical stroke were selected and divided into two subgroups: partially paralyzed hands (PPH) and completely paralyzed hands (CPH). Further, 24 matched healthy controls (HCs) were recruited. A voxel-wise Granger causality analysis (GCA) on the resting-state fMRI data between the ipsilesional M1 and the whole brain was performed to explore differences between the three groups. Our results showed that the influence from the frontoparietal cortices to ipsilesional M1 was diminished in both stroke subgroups and the influence from ipsilesional M1 to the sensorimotor cortices decreased greater in the CPH group than in the PPH group. Moreover, compared with the PPH group, the decreased influence from ipsilesional M1 to the contralesional cerebellum and from the contralesional superior parietal lobe to ipsilesional M1 were observed in the CPH group, and their GCA values were positively correlated with the FMA scores; Conversely, the increased influence from ipsilesional M1 to the ipsilesional middle frontal gyrus and middle temporal gyrus were observed, whose GCA values were negatively correlated with the FMA scores. This study suggests that the abnormalities of casual flow in the ipsilesional M1 are related to the severity of stroke-hand dysfunction, providing valuable information to understand the deficits in resting-state effective connectivity of motor execution and the frontoparietal motor control network during brain plasticity following stroke.	[Zhao, Zhiyong; Wang, Xiangmin; Fan, Mingxia; Zheng, Xiaohui; Jiang, Yuwei; Wu, Jie; Gong, Jiayu] East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China; [Yin, Dazhi] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS Ctr Excellence Brain Sci & Intelligence Techn, Inst Neurosci,State Key Lab Neurosci,Key Lab Prim, Shanghai 200031, Peoples R China; [Sun, Limin; Jia, Jie; Tang, Chaozheng] Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200040, Peoples R China	East China Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Fan, MX (corresponding author), East China Normal Univ, Shanghai Key Lab Magnet Resonance, Shanghai 200062, Peoples R China.; Jia, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Rehabil, Shanghai 200040, Peoples R China.	mxfan@phy.ecnu.edu.cn; shannonjj@126.com			China National Natural Science Foundation [81471651]; 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China [2013BA110603]; China National Natural Science Young Foundation [81401859]; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [2014KIP206]; Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China; China National Natural Science Young Foundation; Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences); Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University	This research was supported by the China National Natural Science Foundation grants (grant no. 81471651), the 12th Five-Year Plan supporting project of Ministry of Science and Technology of the People's Republic of China (grant no. 2013BA110603), China National Natural Science Young Foundation (grant no. 81401859), Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (grant no. 2014KIP206), and in part by an Open Foundation of Shanghai Key Laboratory of Magnetic Resonance, East China Normal University.	Bansal AK, 2011, J NEUROPHYSIOL, V105, P1603, DOI 10.1152/jn.00532.2010; Begliomini C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00676; Bressler SL, 2011, NEUROIMAGE, V58, P323, DOI 10.1016/j.neuroimage.2010.02.059; Buch ER, 2010, J NEUROSCI, V30, P1395, DOI 10.1523/JNEUROSCI.4882-09.2010; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Chen HF, 2009, NEUROIMAGE, V47, P1844, DOI 10.1016/j.neuroimage.2009.06.026; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Cunnington R, 2002, NEUROIMAGE, V15, P373, DOI 10.1006/nimg.2001.0976; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Dijkhuizen RM, 2001, P NATL ACAD SCI USA, V98, P12766, DOI 10.1073/pnas.231235598; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Gao Q, 2011, NEUROIMAGE, V54, P1280, DOI 10.1016/j.neuroimage.2010.08.071; Grefkes C, 2008, NEUROIMAGE, V41, P1382, DOI 10.1016/j.neuroimage.2008.03.048; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Grefkes C, 2010, NEUROIMAGE, V50, P233, DOI 10.1016/j.neuroimage.2009.12.029; Guye M, 2003, NEUROIMAGE, V19, P1349, DOI 10.1016/S1053-8119(03)00165-4; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Hamilton JP, 2011, MOL PSYCHIATR, V16, P763, DOI 10.1038/mp.2010.46; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Isomura Y, 2003, J NEUROSCI, V23, P8002; Ito M, 2000, BRAIN RES, V886, P237, DOI 10.1016/S0006-8993(00)03142-5; Ji GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069351; Krams M, 1998, EXP BRAIN RES, V120, P386, DOI 10.1007/s002210050412; Lacourse MG, 2005, NEUROIMAGE, V27, P505, DOI 10.1016/j.neuroimage.2005.04.025; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015238; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Lotze M, 2006, J NEUROSCI, V26, P6096, DOI 10.1523/JNEUROSCI.4564-05.2006; Marshall RS, 2000, STROKE, V31, P656, DOI 10.1161/01.STR.31.3.656; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Park CH, 2011, STROKE, V42, P1357, DOI 10.1161/STROKEAHA.110.596155; Porro CA, 1996, J NEUROSCI, V16, P7688; Prabhu G, 2009, J PHYSIOL-LONDON, V587, P1057, DOI 10.1113/jphysiol.2008.165571; Qi RF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053677; Rehme AK, 2011, NEUROIMAGE, V55, P1147, DOI 10.1016/j.neuroimage.2011.01.014; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Sharma N, 2009, STROKE, V40, P1315, DOI 10.1161/STROKEAHA.108.525766; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Towfighi A, 2011, STROKE, V42, P2351, DOI 10.1161/STROKEAHA.111.621904; Tsai CG, 2012, EUR J NEUROSCI, V35, P634, DOI 10.1111/j.1460-9568.2012.07996.x; van Meer MPA, 2010, J NEUROSCI, V30, P3964, DOI 10.1523/JNEUROSCI.5709-09.2010; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Ward NS, 2003, BRAIN, V126, P2476, DOI 10.1093/brain/awg245; Xie ZJ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/603909; Yin DZ, 2013, NEURORADIOLOGY, V55, P761, DOI 10.1007/s00234-013-1146-9; Yin DZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052727; Zang ZX, 2012, J NEUROSCI METH, V203, P418, DOI 10.1016/j.jneumeth.2011.10.006	49	26	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166210	10.1371/journal.pone.0166210	http://dx.doi.org/10.1371/journal.pone.0166210			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846290	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600038
J	Diaz, IM; Nocon, A; Mehnert, DH; Fredebohm, J; Diehl, F; Holtrup, F				Diaz, Inga Medina; Nocon, Annette; Mehnert, Daniel H.; Fredebohm, Johannes; Diehl, Frank; Holtrup, Frank			Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing	PLOS ONE			English	Article							CELL-FREE DNA; STORAGE-CONDITIONS; SAMPLE STORAGE; PLASMA; MUTATIONS; QUANTIFICATION; RELEASE; SIZE	Objectives Making liquid biopsy testing widely available requires a concept to ship whole blood at ambient temperatures while retaining the integrity of the cell-free DNA (cfDNA) population and stability of blood cells to prevent dilution of circulating tumor DNA (ctDNA) with wild-type genomic DNA. The cell-and DNA-stabilizing properties of Streck Cell-Free DNA BCT blood collection tubes (cfDNA BCTs) were evaluated to determine if they can be utilized in combination with highly sensitive mutation detection technologies. Methods Venous blood from healthy donors or patients with advanced colorectal cancer (CRC) was collected in cfDNA BCTs and standard K2EDTA tubes. Tubes were stored at different temperatures for various times before plasma preparation and DNA extraction. The isolated cfDNA was analyzed for overall DNA yield of short and long DNA fragments using qPCR as well as for mutational changes using BEAMing and Plasma Safe-Sequencing (Safe-SeqS). Results Collection of whole blood from healthy individuals in cfDNA BCTs and storage for up to 5 days at room temperature did not affect the DNA yield and mutation background levels (n = 60). Low-frequency mutant DNA spiked into normal blood samples as well as mutant circulating tumor DNA in blood samples from CRC patients collected in cfDNA BCTs were reliably detected after 3 days of storage at room temperature. However, blood samples stored at <= 10 degrees C and at 40 degrees C for an extended period of time showed elevated normal genomic DNA levels and an abnormally large cellular plasma interface as well as lower plasma volumes. Conclusion Whole blood shipped in cfDNA BCTs over several days can be used for downstream liquid biopsy testing using BEAMing and Safe-SeqS. Since the shipping temperature is a critical factor, special care has to be taken to maintain a defined room temperature range to obtain reliable mutation testing results.	[Diaz, Inga Medina; Nocon, Annette; Mehnert, Daniel H.; Fredebohm, Johannes; Diehl, Frank; Holtrup, Frank] Sysmex Inost GmbH, Res & Dev, Hamburg, Germany		Diehl, F (corresponding author), Sysmex Inost GmbH, Res & Dev, Hamburg, Germany.	diehl.frank@sysmex-inostics.com			Sysmex Inostics GmbH	Sysmex Inostics GmbH	This work was funded by Sysmex Inostics GmbH. The funder provided support in the form of salaries for authors (IMD, AN, DHM, JF, FD, FH) as well as research funds, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors would like to thank Florian Schiffel, Bianca Hohmann, Johanna Weiland and Ann-Kathrin Loeber for their technical help in the laboratory, Matthias Burger for his input during statistical setup of this study, Claudia Stamm and the Service Laboratory team for their contribution during CRC sample analysis as well as the R&D and Production teams of Sysmex Inostics for their support during execution of the study.	Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bronkhorst AJ, 2015, CLIN CHIM ACTA, V450, P243, DOI 10.1016/j.cca.2015.08.028; Chan KCA, 2005, CLIN CHEM, V51, P781, DOI 10.1373/clinchem.2004.046219; Crowley E, 2013, NAT REV CLIN ONCOL, V10, P472, DOI 10.1038/nrclinonc.2013.110; Das K, 2014, ACTA HISTOCHEM, V116, P55, DOI 10.1016/j.acthis.2013.05.002; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Distler J, 2015, EVALUATION DIFFERENT, p[209, 69]; El Messaoudi S, 2013, CLIN CHIM ACTA, V424, P222, DOI 10.1016/j.cca.2013.05.022; Fernando MR, 2010, PRENATAL DIAG, V30, P418, DOI 10.1002/pd.2484; Fleischhacker M, 2011, CLIN CHIM ACTA, V412, P2085, DOI 10.1016/j.cca.2011.07.011; Hidestrand M, 2012, FETAL DIAGN THER, V31, P122, DOI 10.1159/000335020; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Jones FS, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.11538; Kang Q, 2016, CLIN BIOCHEM, V49, P1354, DOI 10.1016/j.clinbiochem.2016.03.012; KARLSEN F, 1994, LAB INVEST, V71, P604; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Lo YMD, 2012, ANNU REV GENOM HUM G, V13, P285, DOI 10.1146/annurev-genom-090711-163806; Malentacchi F, 2015, CLIN CHEM LAB MED, V53, P1935, DOI 10.1515/cclm-2014-1161; Mouliere F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023418; Neil DO, 2014, NEW METHOD DNA EXTRA, P40724; Norton SE, 2013, CLIN BIOCHEM, V46, P1561, DOI 10.1016/j.clinbiochem.2013.06.002; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Sherwood JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150197; Streck, 2014, CELL FREE DNA BCT IN; Thierry AR, 2014, NAT MED, V20, P430, DOI 10.1038/nm.3511; Toro PV, 2015, CLIN BIOCHEM, V48, P993, DOI 10.1016/j.clinbiochem.2015.07.097; Tu M, 2016, ANALYST, V141, P393, DOI 10.1039/c5an01863c; Wong D, 2013, CLIN BIOCHEM, V46, P1099, DOI 10.1016/j.clinbiochem.2013.04.023	33	102	102	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166354	10.1371/journal.pone.0166354	http://dx.doi.org/10.1371/journal.pone.0166354			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832189	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000109
J	Galewski, T; Devictor, V				Galewski, Thomas; Devictor, Vincent			When Common Birds Became Rare: Historical Records Shed Light on Long-Term Responses of Bird Communities to Global Change in the Largest Wetland of France	PLOS ONE			English	Article							CAMARGUE SOUTHERN FRANCE; BASE-LINE SYNDROME; ORNITHOLOGICAL REPORT; POPULATION TRENDS; BIODIVERSITY; IMPACTS; RESTORATION; GENERALISTS; INDICATORS; DECLINE	Many species have suffered large population declines due to the anthropogenic influence on ecosystems. Understanding historical population trends is essential for informing best efforts to preserve species. We propose a new method to reconstruct the past structure of a regional species pool, based on historical naturalist literature. Qualitative information collected from annotated checklists and reports can be relevant to identify major long-term community changes. We reviewed ornithological literature on the Camargue, the largest wetland in France. We reconstructed the entire breeding bird community from 1830 to 2009 and translated historical data into semi-quantitative data. This data permitted a calculation of a Community Commonness Index to measure the average level of abundance of species in a community. The Community Specialization and Community Temperature Indices were used to evaluate the potential long-term impact of land-use and climate changes on the composition of the regional bird species pool. We found a decrease in average abundance and specialization between 1950 and 1989, suggesting that changes in land-use negatively impacted the structure and composition of the local bird community by reducing species abundance and removing habitat-specialists (e.g. Southern Grey Shrike, Greater Short-toed Lark). These results are likely to be linked with a major loss of natural habitats in the Camargue between 1942 and 1984 when natural areas and traditional farmland were converted into intensive cultivated lands. We also found fluctuations among species with high versus low temperature preference. However, long-term effects of climate change on the bird community might be blurred by the impact of land-use changes. Overall, our results contrast with those obtained from well-monitored colonial waterbirds showing long-term increases. Our results plead for a more regular use of historical naturalist data when examining long-term changes in species communities as they allow the establishment of an older temporal point of reference and consideration of species not covered by traditional monitoring schemes.	[Galewski, Thomas] Inst Rech Tour Valat, F-13200 Arles, France; [Devictor, Vincent] Univ Montpellier 2, Inst Sci Evolut, UMR 5554, F-34090 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Galewski, T (corresponding author), Inst Rech Tour Valat, F-13200 Arles, France.	galewski@tourduvalat.org			Prince Albert II of Monaco Foundation; Total Foundation; French Ministry of Environment, Energy and Sea	Prince Albert II of Monaco Foundation; Total Foundation(Total SA); French Ministry of Environment, Energy and Sea	This work was supported by the Prince Albert II of Monaco Foundation, http //www.fpa2.com/ (TG); Total Foundation, http://Mondation.total.com/fr (TG); and French Ministry of Environment, Energy and Sea, http://www.developpement-durable.gouv.fr/(TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We warmly thank Michel Gauthier-Clerc, Yves Kayser, Thomas Blanchon, Damien Cohez, Marc Thibault, Olivier Pineau, Arnaud Bechet, Jocelyn Champagnon, Claire Pernollet, Jacques Blondel and Matthieu Guillemain for long discussions on the past and present status of birds in the Rhone delta as well as Lisa Ernoul and Ilse Geijzendorffer for the improvement to the text. We dedicate this work to all professional and amateur naturalists, of past and present, who gave their time to make the Camargue into one of the most famous birdwatching places in Europe. TG was supported by grants from the Prince Albert II of Monaco Foundation, Total Foundation, and French Ministry of Environment, Energy and Sea.	Askins, 2002, RESTORING N AM BIRDS, P235; Bechet A, 1998, ACTA OECOL, V19, P81, DOI 10.1016/S1146-609X(98)80011-8; Bennett AF, 2010, HABITAT FRAGMENTATIO, P1544; Benton TG, 2002, J APPL ECOL, V39, P673, DOI 10.1046/j.1365-2664.2002.00745.x; BLONDEL J, 1981, GUIDE OISEAUX CAMARG; Bonebrake TC, 2010, CONSERV LETT, V3, P371, DOI 10.1111/j.1755-263X.2010.00139.x; BOUTIN J, 1989, REV ECOL-TERRE VIE, V44, P165; BOUTIN J, 1991, REV ECOL-TERRE VIE, V46, P263; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Butler SJ, 2010, AGR ECOSYST ENVIRON, V137, P348, DOI 10.1016/j.agee.2010.03.005; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Cramp S., 1974, SEABIRDS BRITAIN IRE; Crespon J, 1840, ORNITHOLOGIE GARD PA; Darluc M, 1782, HIST NATURELLE PROVE; Davidson NC, 2014, MAR FRESHWATER RES, V65, P934, DOI 10.1071/MF14173; Devictor V, 2008, P ROY SOC B-BIOL SCI, V275, P2743, DOI 10.1098/rspb.2008.0878; Devictor V, 2008, OIKOS, V117, P507, DOI 10.1111/j.2008.0030-1299.16215.x; Devictor V, 2012, NAT CLIM CHANGE, V2, P121, DOI 10.1038/NCLIMATE1347; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Ernoul L, 2012, DIAGNOSTIC ECHEC CON, V12; Flitti A, 2009, ATLAS OISEAUX NICHEU; Gal R, 2013, EVOLUTION OCCUPATION; Galewski T, 2011, BIOL CONSERV, V144, P1392, DOI 10.1016/j.biocon.2010.10.030; Gauthier-Clerc M, 2012, OBSERVER OISEAUX CAM; Gibson RN, 2007, OCEANOGRAPHY MARINE; Godet L, 2013, APPL GEOGR, V42, P133, DOI 10.1016/j.apgeog.2013.05.011; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; HAFNER H, 1975, Terre et la Vie, V29, P100; Hafner H., 1970, Terre Vie, V24, P570; HAFNER H, 1985, REV ECOL-TERRE VIE, V40, P87; Hagemeijer W., 1997, EBCC ATLAS EUROPEAN; Heath M, 2000, BIRDLIFE CONSERV SER; Hilton G, 2006, BIRD CENSUS NEWS, V19, P9; HOFFMANN L., 1960, TERRE ET VIE, V107, P81; Hugues A, 1937, ALAUDA, V9, P151; Inger R, 2015, ECOL LETT, V18, P28, DOI 10.1111/ele.12387; Isenmann P, 1993, BIRDS CAMARGUE; Isenmann Paul, 2012, Alauda, V80, P241; Jaubert J. B., 1859, RICHESSES ORNITHOLOG; Johnson AR, 1997, COLON WATERBIRD, V20, P306, DOI 10.2307/1521698; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kampichler C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035272; Kayser Y, 2003, REV ECOL-TERRE VIE, V58, P5; Kayser Y, 2008, REV ECOL-TERRE VIE, V63, P299; Kerbiriou C., 2009, DIVERS DISTRIB, V15, P641, DOI DOI 10.1111/J.1472-4642.2009.00569.X; Krebs JR, 1999, NATURE, V400, P611, DOI 10.1038/23127; Kuresoo Andres, 2011, Estonian Journal of Ecology, V60, P88, DOI 10.3176/eco.2011.2.02; Lachat T, 2010, EVOLUTION BIODIVERSI; Laurance WF., 2010, HABITAT DESTRUCTION, P73; Le Viol I, 2012, BIOL LETTERS, V8, P780, DOI 10.1098/rsbl.2012.0496; Lovejoy TE, 2006, CLIMATE CHANGE BIODI; Mathevet R, 2002, BIODIVERS CONSERV, V11, P509, DOI 10.1023/A:1014860617353; Mathevet R, 2002, LAND USE POLICY, V19, P277, DOI 10.1016/S0264-8377(02)00025-X; Mathevet R, 2002, CYBERGEO EUR J GEOGR; Mayaud N., 1938, Oiseau Paris, V8, P284; MESLEARD F, 1995, ECOL ENG, V5, P95, DOI 10.1016/0925-8574(95)00015-B; Moisselin J-M, 2002, CLIMATE CHANGE FRANC; Monsarrat S, 2015, CONSERV BIOL; Muller I, 2013, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013067; Nager RG, 2010, ARDEA, V98, P309, DOI 10.5253/078.098.0305; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; Pain D.J, 1997, FARMING BIRDS EUROPE; Papworth SK, 2009, CONSERV LETT, V2, P93, DOI 10.1111/j.1755-263X.2009.00049.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Pinheiro J., 2014, R PACKAGE VERSION, V3, P1; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Sax DF, 2003, TRENDS ECOL EVOL, V18, P561, DOI 10.1016/S0169-5347(03)00224-6; Shavit A, 2011, BOST STUD PHILOS HIS, V274, P169, DOI 10.1007/978-90-481-9051-5_12; STAFFORD J, 1971, BIRD STUDY, V18, P218, DOI 10.1080/00063657109476316; Stanley DJ, 1998, J COASTAL RES, V14, P794; Swetnam TW, 1999, ECOL APPL, V9, P1189, DOI 10.1890/1051-0761(1999)009[1189:AHEUTP]2.0.CO;2; Szep Tibor, 2012, Ornis Hungarica, V20, P13; Tamisier A., 1999, CAMARGUE CANARDS FOU; Teyssedre A, 2014, BIODIVERS CONSERV, P1; Thibault M, 1997, REV ECOL-TERRE VIE, V52, P261; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Tucker G.M., 1997, HABITATS BIRDS EUROP; Vackar D, 2012, ECOL INDIC, V17, P58, DOI 10.1016/j.ecolind.2011.04.024; Van Kleunen A, 2003, HABITAT USE EUROPEAN; Vorisek Petr, 2008, Revista Catalana d'Ornitologia, V24, P4; Zuur Alain F., 2009, P1	88	11	12	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165542	10.1371/journal.pone.0165542	http://dx.doi.org/10.1371/journal.pone.0165542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832127	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000018
J	Jaroenlak, P; Sanguanrut, P; Williams, BAP; Stentiford, GD; Flegel, TW; Sritunyalucksana, K; Itsathitphaisarn, O				Jaroenlak, Pattana; Sanguanrut, Piyachat; Williams, Bryony A. P.; Stentiford, Grant D.; Flegel, Timothy W.; Sritunyalucksana, Kallaya; Itsathitphaisarn, Ornchuma			A Nested PCR Assay to Avoid False Positive Detection of the Microsporidian Enterocytozoon hepatopenaei (EHP) in Environmental Samples in Shrimp Farms	PLOS ONE			English	Article							SPORE WALL PROTEIN; HYBRIDIZATION; PATHOGENS	Hepatopancreatic microsporidiosis (HPM) caused by Enterocytozoon hepatopenaei (EHP) is an important disease of cultivated shrimp. Heavy infections may lead to retarded growth and unprofitable harvests. Existing PCR detection methods target the EHP small subunit ribosomal RNA (SSU rRNA) gene (SSU-PCR). However, we discovered that they can give false positive test results due to cross reactivity of the SSU-PCR primers with DNA from closely related microsporidia that infect other aquatic organisms. This is problematic for investigating and monitoring EHP infection pathways. To overcome this problem, a sensitive and specific nested PCR method was developed for detection of the spore wall protein (SWP) gene of EHP (SWP-PCR). The new SWP-PCR method did not produce false positive results from closely related microsporidia. The first PCR step of the SWP-PCR method was 100 times (10(4) plasmid copies per reaction vial) more sensitive than that of the existing SSU-PCR method (10(6) copies) but sensitivity was equal for both in the nested step (10 copies). Since the hepatopancreas of cultivated shrimp is not currently known to be infected with microsporidia other than EHP, the SSU-PCR methods are still valid for analyzing hepatopancreatic samples despite the lower sensitivity than the SWP-PCR method. However, due to its greater specificity and sensitivity, we recommend that the SWP-PCR method be used to screen for EHP in feces, feed and environmental samples for potential EHP carriers.	[Jaroenlak, Pattana; Itsathitphaisarn, Ornchuma] Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand; [Jaroenlak, Pattana; Sanguanrut, Piyachat; Flegel, Timothy W.; Itsathitphaisarn, Ornchuma] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok, Thailand; [Sanguanrut, Piyachat; Sritunyalucksana, Kallaya] Natl Ctr Genet Engn & Biotechnol BIOTEC, Shrimp Pathogen Interact Lab SPI, Bangkok, Thailand; [Williams, Bryony A. P.] Univ Exeter, Coll Life & Environm Sci, Biosci, Exeter, Devon, England; [Stentiford, Grant D.] Ctr Environm Fisheries & Aquaculture Sci, European Community Reference Lab Crustacean Dis, Weymouth, Dorset, England; [Flegel, Timothy W.; Sritunyalucksana, Kallaya] NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand	Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of Exeter; Centre for Environment Fisheries & Aquaculture Science; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Itsathitphaisarn, O (corresponding author), Mahidol Univ, Dept Biochem, Fac Sci, Bangkok, Thailand.; Itsathitphaisarn, O (corresponding author), Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol Cente, Bangkok, Thailand.	ornchuma.its@mahidol.ac.th		Williams, Bryony/0000-0003-1123-2176; Jaroenlak, Pattana/0000-0002-2036-232X; Flegel, Timothy W./0000-0002-1913-213X	Agricultural Research Development Agency [CRP5905020530]; Mahidol University; National Research Council Thailand, Division of Plan Administration and Research Budget [2557-79]; Science Achievement Scholarship of Thailand (SAST); DG SANCO of the European Commission; UK Department of Environment, Food and Rural Affairs [FB002]	Agricultural Research Development Agency; Mahidol University; National Research Council Thailand, Division of Plan Administration and Research Budget; Science Achievement Scholarship of Thailand (SAST); DG SANCO of the European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	OI acknowledges support from Agricultural Research Development Agency under project CRP5905020530 and Mahidol University. KS received funding from National Research Council Thailand, Division of Plan Administration and Research Budget/2557-79. PJ is supported by the Science Achievement Scholarship of Thailand (SAST). GDS acknowledges support of DG SANCO of the European Commission, and the UK Department of Environment, Food and Rural Affairs under project FB002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author would like to thank the owners of shrimp farms who provided the shrimp specimen. OI acknowledges support from Agricultural Research Development Agency under project CRP5905020530 and Mahidol University. KS received funding from National Research Council Thailand, Division of Plan Administration and Research Budget/2557-79. PJ is supported by the Science Achievement Scholarship of Thailand (SAST). GDS acknowledges support of DG SANCO of the European Commission and, the UK Department of Environment, Food and Rural Affairs under project FB002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; Bell TA, 1988, HDB NORMAL PENAEID S, P114; Chayaburakul K, 2004, DIS AQUAT ORGAN, V60, P89, DOI 10.3354/dao060089; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; FLEGEL TW, 1992, DIS ASIAN AQUACULTUR, V1, P181; Freeman MA, 2003, J FISH DIS, V26, P667, DOI 10.1046/j.1365-2761.2003.00498.x; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Hayman JR, 2005, INFECT IMMUN, V73, P841, DOI 10.1128/IAI.73.2.841-848.2005; Hitakarun A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0458-x; Kiryu Y, 2009, DIS AQUAT ORGAN, V84, P237, DOI 10.3354/dao02046; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kumar Arbind, 2014, Mol Biol Int, V2014, P937308, DOI 10.1155/2014/937308; Li YH, 2009, INT J PARASITOL, V39, P391, DOI 10.1016/j.ijpara.2008.08.011; Liu Z, 2015, FISH SCI; Lucchi NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031848; Palenzuela O, 2014, INT J PARASITOL, V44, P189, DOI 10.1016/j.ijpara.2013.10.005; Pasharawipas Tirasak, 1994, Asian Fisheries Science, V7, P157; Phromjai J, 2001, DIS AQUAT ORGAN, V46, P153, DOI 10.3354/dao046153; Sambrook J., 2001, MOL CLONING LAB MANU; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Somchai P, 2016, AQUACULT REP, V3, P178, DOI 10.1016/j.aqrep.2016.03.003; Southern TR, 2007, EUKARYOT CELL, V6, P1354, DOI 10.1128/EC.00113-07; Stentiford GD, 2016, TRENDS PARASITOL, V32, P336, DOI 10.1016/j.pt.2015.12.004; Stentiford GD, 2010, INT J PARASITOL, V40, P1433, DOI 10.1016/j.ijpara.2010.04.017; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; Suebsing R, 2013, J APPL MICROBIOL, V114, P1254, DOI 10.1111/jam.12160; Szumowski SC, 2015, CURR OPIN MICROBIOL, V26, P10, DOI 10.1016/j.mib.2015.03.006; Tang KFJ, 2016, J INVERTEBR PATHOL, V140, P1, DOI 10.1016/j.jip.2016.08.004; Tang KFJ, 2015, J INVERTEBR PATHOL, V130, P37, DOI 10.1016/j.jip.2015.06.009; Tangprasittipap A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-139; Texier C, 2010, CURR OPIN MICROBIOL, V13, P443, DOI 10.1016/j.mib.2010.05.005; Thitamadee S, 2016, AQUACULTURE, V452, P69, DOI 10.1016/j.aquaculture.2015.10.028; Tourtip S, 2009, J INVERTEBR PATHOL, V102, P21, DOI 10.1016/j.jip.2009.06.004; VARADARAJ K, 1994, GENE, V140, P1, DOI 10.1016/0378-1119(94)90723-4; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	36	61	78	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166320	10.1371/journal.pone.0166320	http://dx.doi.org/10.1371/journal.pone.0166320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832178	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000096
J	Lee, RTH; Ng, ASM; Ingham, PW				Lee, Raymond Teck Ho; Ng, Ashley Shu Mei; Ingham, Philip W.			Ribozyme Mediated gRNA Generation for In Vitro and In Vivo CRISPR/Cas9 Mutagenesis	PLOS ONE			English	Article							ZEBRAFISH; EXPRESSION; RNA; HEDGEHOG; SYSTEM; TERMINATION; PROMOTER	CRISPR/Cas9 is now regularly used for targeted mutagenesis in a wide variety of systems. Here we report the use of ribozymes for the generation of gRNAs both in vitro and in zebrafish embryos. We show that incorporation of ribozymes increases the types of promoters and number of target sites available for mutagenesis without compromising mutagenesis efficiency. We have tested this by comparing the efficiency of mutagenesis of gRNA constructs with and without ribozymes and also generated a transgenic zebrafish expressing gRNA using a heat shock promoter (RNA polymerase II-dependent promoter) that was able to induce mutagenesis of its target. Our method provides a streamlined approach to test gRNA efficiency as well as increasing the versatility of conditional gene knock out in zebrafish.	[Lee, Raymond Teck Ho; Ng, Ashley Shu Mei; Ingham, Philip W.] ASTAR, Inst Mol & Cell Biol, Dev & Biomed Genet Lab, Singapore, Singapore; [Ingham, Philip W.] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore; [Lee, Raymond Teck Ho] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Lee, RTH; Ingham, PW (corresponding author), ASTAR, Inst Mol & Cell Biol, Dev & Biomed Genet Lab, Singapore, Singapore.; Ingham, PW (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Lee, RTH (corresponding author), Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	raymondlee@duke_nus.edu.sg; gingham@ntu.edu.sg	Ingham, Philip/U-4253-2019; Ingham, Philip W/G-9903-2011; Ingham, Philip William/AAH-5884-2020	Ingham, Philip W/0000-0001-8224-9958; Ingham, Philip William/0000-0001-8224-9958; Lee, Raymond Teck Ho/0000-0001-6522-3043	Agency for Science Technology and Research (A*STAR); Toh Kian Chui Foundation	Agency for Science Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Toh Kian Chui Foundation	This work was supported by the Agency for Science Technology and Research (A*STAR) and by the Toh Kian Chui Foundation to PWI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablain J, 2015, DEV CELL, V32, P756, DOI 10.1016/j.devcel.2015.01.032; Arimbasseri AG, 2013, BBA-GENE REGUL MECH, V1829, P318, DOI 10.1016/j.bbagrm.2012.10.006; Auer TO, 2014, GENOME RES, V24, P142, DOI 10.1101/gr.161638.113; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Chen JB, 2012, DNA RES, V19, P423, DOI 10.1093/dnares/dss023; Darnell JE, 2013, RNA, V19, P443, DOI 10.1261/rna.038596.113; Di Donato V, 2016, GENOME RES, V26, P681, DOI 10.1101/gr.196170.115; Elworthy S, 2008, DEVELOPMENT, V135, P2115, DOI 10.1242/dev.015719; Ferre-D'Amare AR, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003574; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao YB, 2014, J INTEGR PLANT BIOL, V56, P343, DOI 10.1111/jipb.12152; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Ma HM, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.12; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Qin W, 2015, CELL RES, V25, P1074, DOI 10.1038/cr.2015.95; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Song J, 2004, BIOCHEM BIOPH RES CO, V323, P573, DOI 10.1016/j.bbrc.2004.08.128; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Yin LL, 2015, GENETICS, V200, P431, DOI 10.1534/genetics.115.176917	26	18	26	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166020	10.1371/journal.pone.0166020	http://dx.doi.org/10.1371/journal.pone.0166020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832146	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000054
J	Jusu, S; Presley, JF; Kremer, R				Jusu, Sylvester; Presley, John F.; Kremer, Richard			Phosphorylation of Human Retinoid X Receptor alpha at Serine 260 Impairs Its Subcellular Localization, Receptor Interaction, Nuclear Mobility, and 1 alpha,25-Dihydroxyvitamin D-3-dependent DNA Binding in Ras-transformed Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D-RECEPTOR; HUMAN HEPATOCELLULAR-CARCINOMA; CANCER CELL-LINES; ANALOG EB 1089; BREAST-CANCER; LIVING CELLS; RXR-ALPHA; HISTONE H1; MYELODYSPLASTIC SYNDROMES; HETERODIMER FORMATION	Human retinoid X receptor alpha (hRXR alpha) plays a critical role in DNA binding and transcriptional activity through heterodimeric association with several members of the nuclear receptor superfamily, including the human vitamin D receptor (hVDR). We previously showed that hRXR alpha phosphorylation at serine 260 through the Ras-Raf-MAPK ERK1/2 activation is responsible for resistance to the growth inhibitory effects of 1 alpha,25-dihy-droxyvitamin D-3 (1 alpha,25(OH)(2)D-3), the biologically active metabolite of vitamin D-3. To further investigate the mechanism of this resistance, we studied intranuclear dynamics of hVDR and hRXR alpha-tagged constructs in living cells together with endogenous and tagged protein in fixed cells. We find that hVDR-, hRXR alpha-, and hVDR-hRXR alpha complex accumulate in the nucleus in 1 alpha,25(OH)(2)D-3-treated HPK1A cells but to a lesser extent in HPK1A Ras-treated cells. Also, by using fluorescence resonance energy transfer (FRET), we demonstrate increased interaction of the hVDR-hRXR alpha complex in 1 alpha,25(OH)(2)D-3-treated HPK1A but not HPK1ARas cells. In HPK1ARas cells, 1 alpha,25(OH)(2)D-3-induced nuclear localization and interaction of hRXR alpha are restored when cells are treated with the MEK1/2 inhibitor UO126 or following transfection of the non-phosphorylatable hRXR alpha Ala-260 mutant. Finally, we demonstrate using fluorescence loss in photobleaching and quantitative co-localization with chromatin that RXR immobilization and co-localization with chromatin are significantly increased in 1 alpha,25(OH)(2)D(3)treated HPK1ARas cells transfected with the non-phosphory-latable hRXR alpha Ala-260 mutant. This suggests that hRXR alpha phosphorylation significantly disrupts its nuclear localization, interaction with VDR, intra-nuclear trafficking, and binding to chromatin of the hVDR-hRXR complex.	[Jusu, Sylvester; Kremer, Richard] McGill Univ, Royal Victoria Hosp, Calcium Res Lab, Dept Med, Montreal, PQ H4A 3J1, Canada; [Presley, John F.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 0C7, Canada; [Jusu, Sylvester; Kremer, Richard] McGill Univ, Ctr Hlth, Dept Med, Expt Therapeut & Metab Program, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada	McGill University; Royal Victoria Hospital; McGill University; McGill University	Kremer, R (corresponding author), McGill Univ, Ctr Hlth, Dept Med, Expt Therapeut & Metab Program, 1001 Decarie Blvd, Montreal, PQ H4A 3J1, Canada.	richard.kremer@mcgill.ca		Kremer, Richard/0000-0002-7053-2139	Canadian Institutes of Health Research [MOP10839]; Natural Sciences and Engineering Research Council of Canada [RGPIN 262040]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Grant MOP10839 from Canadian Institutes of Health Research (to R. K.) and Grant RGPIN 262040 from Natural Sciences and Engineering Research Council of Canada (to J. F. P.). The authors declare that they have no conflicts of interest with the contents of this article.	ABE E, 1981, P NATL ACAD SCI-BIOL, V78, P4990, DOI 10.1073/pnas.78.8.4990; Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Aguirre RS, 2013, MOL PHARMACOL, V84, P218, DOI 10.1124/mol.113.085555; Akiyama N, 2010, LEUKEMIA RES, V34, P1151, DOI 10.1016/j.leukres.2010.04.006; Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Avis I, 2005, CANCER RES, V65, P4181, DOI 10.1158/0008-5472.CAN-04-3441; BARSONY J, 1990, J CELL BIOL, V111, P2385, DOI 10.1083/jcb.111.6.2385; Barsony J, 1997, J BIOL CHEM, V272, P5774, DOI 10.1074/jbc.272.9.5774; Barsony J., 1997, MICROSC MICROANAL, P131; Bettoun DJ, 2003, MOL ENDOCRINOL, V17, P2320, DOI 10.1210/me.2003-0148; Bikle DD, 2014, CHEM BIOL, V21, P319, DOI 10.1016/j.chembiol.2013.12.016; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Bikle DD, 2012, REV ENDOCR METAB DIS, V13, P3, DOI 10.1007/s11154-011-9194-0; Bjelakovic G, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007470.pub3; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Brosseau C, 2012, APOPTOSIS, V17, P164, DOI 10.1007/s10495-011-0670-5; Carlberg C, 2001, STEROIDS, V66, P213, DOI 10.1016/S0039-128X(00)00150-1; Chandler PD, 2014, CANCER EPIDEM BIOMAR, V23, P1944, DOI 10.1158/1055-9965.EPI-14-0522; Chen JX, 2016, J TISSUE ENG REGEN M, V10, P40, DOI 10.1002/term.1770; COLSTON K, 1981, ENDOCRINOLOGY, V108, P1083, DOI 10.1210/endo-108-3-1083; COLSTON KW, 1994, GUT, V35, P1219, DOI 10.1136/gut.35.9.1219; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; Crowe DL, 2004, BREAST CANCER RES, V6, pR546, DOI 10.1186/bcr913; Davis CD, 2008, AM J CLIN NUTR, V88, p565S, DOI 10.1093/ajcn/88.2.565S; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Deluca HF, 2001, FASEB J, V15, P2579, DOI 10.1096/fj.01-0433rev; Dong D, 1998, BIOCHEMISTRY-US, V37, P10691, DOI 10.1021/bi980561r; Dou YL, 1999, MOL CELL, V4, P641, DOI 10.1016/S1097-2765(00)80215-4; El Abdaimi K, 2000, CANCER RES, V60, P4412; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Fujioka T, 1998, J UROLOGY, V160, P247, DOI 10.1016/S0022-5347(01)63098-2; Getzenberg RH, 1997, UROLOGY, V50, P999, DOI 10.1016/S0090-4295(97)00408-1; Giovannucci E, 2005, CANCER CAUSE CONTROL, V16, P83, DOI 10.1007/s10552-004-1661-4; Gulliford T, 1998, BRIT J CANCER, V78, P6, DOI 10.1038/bjc.1998.434; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; HELLSTROM E, 1990, EUR J HAEMATOL, V45, P255; Huang DC, 2002, MOL CANCER RES, V1, P56; Jain RK, 2011, INVEST NEW DRUG, V29, P1420, DOI 10.1007/s10637-010-9492-5; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Kane KF, 1996, CANCER RES, V56, P623; Kanemura N, 2008, LEUKEMIA RES, V32, P884, DOI 10.1016/j.leukres.2007.11.005; Konopleva M, 2004, MOL CANCER THER, V3, P1249; Kuusisto HV, 2012, FASEB J, V26, P1181, DOI 10.1096/fj.11-191585; Lee HY, 2000, J BIOL CHEM, V275, P32193, DOI 10.1074/jbc.M005490200; Li DS, 2002, MOL CELL BIOL, V22, P5782, DOI 10.1128/MCB.22.16.5782-5792.2002; Li J., 2016, IEEE T COMPUT, V1, P1, DOI DOI 10.1038/0NC.2016.90; Li M, 2001, DEVELOPMENT, V128, P675; Li M, 2000, NATURE, V407, P633, DOI 10.1038/35036595; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LU MJ, 1995, MOL BIOL CELL, V6, P1077, DOI 10.1091/mbc.6.8.1077; Lu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035722; Macoritto M, 2008, J BIOL CHEM, V283, P4943, DOI 10.1074/jbc.M707517200; Matsushima-Nishiwaki R, 2003, CARCINOGENESIS, V24, P1353, DOI 10.1093/carcin/bgg090; Matsushima-Nishiwaki R, 2001, CANCER RES, V61, P7675; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; Moriwaki H, 2007, HEPATOL RES, V37, pS299, DOI 10.1111/j.1872-034X.2007.00201.x; Narayanan R, 2004, J BIOL CHEM, V279, P47298, DOI 10.1074/jbc.M404101200; Olmos-Ortiz A, 2015, NUTRIENTS, V7, P443, DOI 10.3390/nu7010443; Orlov I, 2012, EMBO J, V31, P291, DOI 10.1038/emboj.2011.445; Petrich A, 2008, LEUKEMIA LYMPHOMA, V49, P57, DOI 10.1080/10428190701713648; Pike JW, 2010, ENDOCRIN METAB CLIN, V39, P255, DOI 10.1016/j.ecl.2010.02.007; Polek TC, 2002, J ANDROL, V23, P9, DOI 10.1002/j.1939-4640.2002.tb02596.x; Prufer K, 2002, MOL ENDOCRINOL, V16, P1738, DOI 10.1210/me.2001-0345; Prufer K, 2000, J BIOL CHEM, V275, P41114, DOI 10.1074/jbc.M003791200; Quack M, 2000, MOL PHARMACOL, V57, P375; Racz A, 1999, J BIOL CHEM, V274, P19352, DOI 10.1074/jbc.274.27.19352; Rawson JB, 2012, NUTR CANCER, V64, P919, DOI 10.1080/01635581.2012.711418; Rossdeutscher L, 2015, CANCER PREV RES, V8, P120, DOI 10.1158/1940-6207.CAPR-14-0110; Schwartz GG, 2005, CLIN CANCER RES, V11, P8680, DOI 10.1158/1078-0432.CCR-05-1237; SEBAG M, 1992, J BIOL CHEM, V267, P12162; Shevde NK, 2002, P NATL ACAD SCI USA, V99, P13487, DOI 10.1073/pnas.202471299; Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19; Solomon C, 1999, J CLIN INVEST, V103, P1729, DOI 10.1172/JCI6871; Solomon C, 2001, RADIAT RES, V155, P156, DOI 10.1667/0033-7587(2001)155[0156:VDRIRT]2.0.CO;2; Solomon C, 1998, J BIOL CHEM, V273, P17573, DOI 10.1074/jbc.273.28.17573; Stenoien DL, 2001, NAT CELL BIOL, V3, P15, DOI 10.1038/35050515; Suda T., 1986, BONE MINERAL RES, V4, P1; Truong K, 2001, CURR OPIN STRUC BIOL, V11, P573, DOI 10.1016/S0959-440X(00)00249-9; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; van Leeuwen JPTM, 2001, CRIT REV EUKAR GENE, V11, P199; Yamazaki K, 2007, GUT, V56, P1557, DOI 10.1136/gut.2007.129858; Yasmin R, 2005, J BIOL CHEM, V280, P40152, DOI 10.1074/jbc.M507708200; YU JA, 1995, ANTI-CANCER DRUG, V6, P101, DOI 10.1097/00001813-199502000-00012; Zhang ZT, 2010, J CELL PHYSIOL, V224, P433, DOI 10.1002/jcp.22139	86	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1490	1509		10.1074/jbc.M116.758185	http://dx.doi.org/10.1074/jbc.M116.758185			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27852823	hybrid, Green Published			2022-12-26	WOS:000393339800029
J	Park, SJ; Jeong, IH; Kong, BS; Lee, JE; Kim, KH; Lee, DY; Kim, HJ				Park, Soo Jin; Jeong, In Hye; Kong, Byung Soo; Lee, Jung-Eun; Kim, Kyoung Heon; Lee, Do Yup; Kim, Ho Jin			Disease Type- and Status-Specific Alteration of CSF Metabolome Coordinated with Clinical Parameters in Inflammatory Demyelinating Diseases of CNS	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; MULTIPLE-SCLEROSIS; NEUROMYELITIS-OPTICA; AUTOIMMUNE-DISEASES; PALMITOYL GLYCEROL; L-PHENYLALANINE; DOUBLE-BLIND; MODEL; VITAMIN-B-12; LOFEPRAMINE	Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) are a group of disorders with different aetiologies, characterized by inflammatory lesions. These disorders include multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (ITM). Differential diagnosis of the CNS IDDs still remains challenging due to frequent overlap of clinical and radiological manifestation, leading to increased demands for new biomarker discovery. Since cerebrospinal fluid (CSF) metabolites may reflect the status of CNS tissues and provide an interfacial linkage between blood and CNS tissues, we explored multi-component biomarker for different IDDs from CSF samples using gas chromatography mass spectrometry-based metabolite profiling coupled to multiplex bioinformatics approach. We successfully constructed the single model with multiple metabolite variables in coordinated regression with clinical characteristics, expanded disability status scale, oligoclonal bands, and protein levels. The multi-composite biomarker simultaneously discriminated four different immune statuses (a total of 145 samples; 54 MS, 49 NMOSD, 30 ITM, and 12 normal controls). Furthermore, systematic characterization of transitional metabolic modulation identified relapse-associated metabolites and proposed insights into the disease network underlying type-specific metabolic dysfunctionality. The comparative analysis revealed the lipids, 1-monopalmitin and 1-monostearin were common indicative for MS, NMOSD, and ITM whereas fatty acids were specific for the relapse identified in all types of IDDs.	[Park, Soo Jin; Lee, Jung-Eun; Lee, Do Yup] Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea; [Jeong, In Hye; Kong, Byung Soo; Kim, Ho Jin] Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, Goyang, South Korea; [Kim, Kyoung Heon] Korea Univ, Grad Sch, Dept Biotechnol, Seoul, South Korea	Kookmin University; National Cancer Center - Korea (NCC); Korea University	Lee, DY (corresponding author), Kookmin Univ, PLUS Project BK21, Dept Bio & Fermentat Convergence Technol, Seoul, South Korea.; Kim, HJ (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Dept Neurol, Goyang, South Korea.	rome73@kookmin.ac.kr; hojinkim@ncc.re.kr	Kim, Kyoung Heon/F-1059-2013	Kim, Kyoung Heon/0000-0003-4600-8668; Kong, ByungSoo/0000-0002-7916-7422; park, soojin/0000-0003-4259-0021	Bio & Medical Technology Development Program through the Ministry of Science, ICT & Future Planning [2014M3A9B6069339, 2014M3A9B6069345, 2013M3A9B6046519]	Bio & Medical Technology Development Program through the Ministry of Science, ICT & Future Planning	This study was supported by the Bio & Medical Technology Development Program through the Ministry of Science, ICT & Future Planning (2014M3A9B6069339 to H. J. K., and 2014M3A9B6069345 and 2013M3A9B6046519 to D. Y. L.).	Barcellos LF, 2006, LANCET NEUROL, V5, P924, DOI 10.1016/S1474-4422(06)70552-X; BATES D, 1989, J NEUROL NEUROSUR PS, V52, P18, DOI 10.1136/jnnp.52.1.18; Bhatia M, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/159680; Castellanos-Martin A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0599-z; Ermis U, 2013, NEW ENGL J MED, V368, P1657, DOI 10.1056/NEJMc1211805; Fiehn O, 2011, J BIOL CHEM, V286, P23637, DOI 10.1074/jbc.R110.173617; Filippini G., 2015, MYELIN DISORDERS DEV, P153; HOROWITZ ME, 1983, GASTROENTEROLOGY, V84, P1003; Hyun J-W, 2014, MULTIPLE SCLEROSIS J; Ibanez C, 2012, ANAL CHEM, V84, P8532, DOI 10.1021/ac301243k; Jarius S, 2013, MED HYPOTHESES, V81, P1090, DOI 10.1016/j.mehy.2013.10.011; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Kang J, 2015, J NEUROIMMUNOL, V279, P25, DOI 10.1016/j.jneuroim.2015.01.001; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kitley JL, 2012, MULT SCLER J, V18, P271, DOI 10.1177/1352458511406165; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lee DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068831; Lee DY, 2012, MOL CELL PROTEOMICS, V11, P973, DOI 10.1074/mcp.M111.016733; Lee DY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-7; Lee JE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152935; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Loder C, 2002, MED HYPOTHESES, V59, P594, DOI 10.1016/S0306-9877(02)00261-X; Lutz NW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000595; Mehta LR, 2009, NAT CLIN PRACT NEURO, V5, P82, DOI 10.1038/ncpneuro1009; Minagar A, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/249101; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Morrie RA, 2010, LANCET NEUROL, V9, P820, DOI 10.1016/S1474-4422(10)70135-6; Noga MJ, 2012, METABOLOMICS, V8, P253, DOI 10.1007/s11306-011-0306-3; Pantzaris MC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002170; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Reinke SN, 2014, MULT SCLER J, V20, P1396, DOI 10.1177/1352458513516528; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shriver LP, 2011, SCI REP-UK, V1, DOI 10.1038/srep00079; SIDDHANTI SR, 1987, J NUTR, V117, P1671, DOI 10.1093/jn/117.10.1671; Song IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036637; SPECTOR R, 1987, J NEUROCHEM, V48, P400, DOI 10.1111/j.1471-4159.1987.tb04107.x; Stangel M, 2013, NAT REV NEUROL, V9, P267, DOI 10.1038/nrneurol.2013.41; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Torkildsen O, 2012, ARCH NEUROL-CHICAGO, V69, P1044, DOI 10.1001/archneurol.2012.283; TRUMBO PR, 1987, J NUTR, V117, P1780, DOI 10.1093/jn/117.10.1780; Wade DT, 2002, J NEUROL NEUROSUR PS, V73, P246, DOI 10.1136/jnnp.73.3.246; Whiteman M, 2005, BIOCHEM BIOPH RES CO, V326, P794, DOI 10.1016/j.bbrc.2004.11.110; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Zhang AH, 2012, J PROTEOMICS, V75, P1079, DOI 10.1016/j.jprot.2011.10.027	50	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166277	10.1371/journal.pone.0166277	http://dx.doi.org/10.1371/journal.pone.0166277			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855220	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200025
J	Balazy, R; Ciesielski, M; Sterenczak, K; Borowski, Z				Balazy, Radomir; Ciesielski, Mariusz; Sterenczak, Krzysztof; Borowski, Zbigniew			The Role of Topography in the Distribution and Intensity of Damage Caused by Deer in Polish Mountain Forests	PLOS ONE			English	Article							RED DEER; ECOLOGICAL IMPACTS; SELECTION; HERBIVORY	The increase in the deer population observed in recent decades has strongly impacted forest regeneration and the forest itself. The reduction in the quality of raw wood material, as a consequence of deer-mediated damage, constitutes a significant burden on forest owners. The basis for the commencement of preventive actions in this setting is the understanding of the populations and behaviors of deer in their natural environment. Although multiple studies have been carried out regarding this subject, only a few suggested topography as an important factor that may influence the distribution and intensity of deer-mediated damage. The detailed terrain models based on LiDAR data as well as the data on damage caused by deer from the State Forests database enabled thorough analyses of the distribution and intensity of damage in relation to land form in this study. These analyses were performed on three mountain regions in Poland: the Western Sudety Mountains, the Eastern Sudety Mountains, and the Beskidy Mountains. Even though these three regions are located several dozen to several hundred kilometers apart from each other, not all evaluated factors appeared common among them, and therefore, these regions have been analyzed separately. The obtained results indicated that the forest damage caused by deer increased with increasing altitude above 1000 m ASL. However, much larger areas of damage by deer were observed at elevations ranging from 401 to 1000 m ASL than at elevations below 400 m ASL. Moreover, the locations of damage (forest thickets and old stands) indicated that red deer is the species that exerts the strongest pressure on forest ecosystems. Our results show the importance of deer foraging behavior to the structure of the environment.	[Balazy, Radomir; Ciesielski, Mariusz; Sterenczak, Krzysztof; Borowski, Zbigniew] Forest Res Inst, Sekocin Stary, Braci Lesnej 3, PL-05090 Raszyn, Poland	Forest Research Institute	Balazy, R (corresponding author), Forest Res Inst, Sekocin Stary, Braci Lesnej 3, PL-05090 Raszyn, Poland.	r.balazy@ibles.waw.pl	Ciesielski, Mariusz/R-4971-2018; Borowski, Zbigniew/AAI-6571-2020; Balazy, Radomir/Q-6338-2016; Borowski, Zbigniew/AAF-5230-2020; Borowski, Zbigniew/AAL-6483-2021	Ciesielski, Mariusz/0000-0002-1215-140X; Balazy, Radomir/0000-0003-1633-5115; Borowski, Zbigniew/0000-0003-4109-5205; Sterenczak, Krzysztof/0000-0002-9556-0144	State Forests National Forest Holding	State Forests National Forest Holding	The above article was written under the project named "Creation of a Forest Information System Covering the Areas of the Sudety and the Western Beskidy Mountains within the Scope of Forest Condition Monitoring and Assessment" financed by The State Forests National Forest Holding.	Alves J, 2014, MAMM BIOL, V79, P338, DOI 10.1016/j.mambio.2014.05.007; [Anonymous], 2012, INSTR FOR PROT, VII, P46; Beck JL, 2013, WEST N AM NATURALIST, V73, P442, DOI 10.3398/064.073.0414; Borkowski J, 2011, ACTA THERIOL, V56, P239, DOI 10.1007/s13364-010-0023-8; Bugalho MN, 2013, FOREST ECOL MANAG, V308, P90, DOI 10.1016/j.foreco.2013.07.036; Christopher G, 2005, HUM PSYCHOPHARM CLIN, V20, P47, DOI 10.1002/hup.658; Clutton-Brock TH, 2004, NATURE, V429, P261, DOI 10.1038/429261a; Cote SD, 2004, ANNU REV ECOL EVOL S, V35, P113, DOI 10.1146/annurev.ecolsys.35.021103.105725; Fuller RJ, 2001, FORESTRY, V74, P193, DOI 10.1093/forestry/74.3.193; Gerhardt P, 2013, FOREST ECOL MANAG, V310, P173, DOI 10.1016/j.foreco.2013.08.030; Gill R.M.A., 2006, LARGE HERBIVORE ECOL; GILL RMA, 1992, FORESTRY, V65, P363, DOI 10.1093/forestry/65.4.363-a; Godek M, 2012, PURE APPL GEOPHYS, V169, P1093, DOI 10.1007/s00024-011-0360-9; Heuze P, 2005, FOREST ECOL MANAG, V217, P219, DOI 10.1016/j.foreco.2005.06.003; Homolka M, 2003, FOREST ECOL MANAG, V181, P119, DOI 10.1016/S0378-1127(03)00121-X; Koda R, 2011, FOREST ECOL MANAG, V262, P432, DOI 10.1016/j.foreco.2011.04.009; Kondracki J., 2002, GEOGRAFIA REGIONALNA; Most L, 2015, FOREST ECOL MANAG, V338, P46, DOI 10.1016/j.foreco.2014.11.015; Nopp-Mayr U., 2011, Wildlife Biology in Practice, V7, P66; Pepin D, 2006, FOREST ECOL MANAG, V222, P302, DOI 10.1016/j.foreco.2005.10.034; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Rooney T., 2011, FORESTRY, V74, P201; Rooney TP, 2003, FOREST ECOL MANAG, V181, P165, DOI 10.1016/S0378-1127(03)00130-0; Takeuchi T, 2011, FOREST ECOL MANAG, V261, P2089, DOI 10.1016/j.foreco.2011.03.002; Verheyden H, 2006, MAMMAL REV, V36, P217, DOI 10.1111/j.1365-2907.2006.00085.x	25	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165967	10.1371/journal.pone.0165967	http://dx.doi.org/10.1371/journal.pone.0165967			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851776	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300029
J	Edwards, D; Geng, BY; Li, CS				Edwards, Dianne; Geng, Bao-Yin; Li, Cheng-Sen			New Plants from the Lower Devonian Pingyipu Group, Jiangyou County, Sichuan Province, China	PLOS ONE			English	Article							XUJIACHONG FORMATION; YUNNAN PROVINCE; LAND PLANTS; SP-NOV.; GEN.; ASSEMBLAGES	Descriptions of Lower Devonian plants from Yunnan, South China, have revolutionized concepts of diversity and disparity in tracheophytes soon after they became established on land. Sichuan assemblages have received little attention since their discovery almost 25 years ago and require revision. With this objective, fieldwork involving detailed logging and collection of fossils was undertaken in the Longmenshan Mountain Region, Jiangyou County and yielded the two new taxa described here. They are preserved as coalified compressions and impressions that allowed morphological but not anatomical analyses. Yanmenia (Zosterophyllum) longa comb nov is based on numerous rarely branching shoots with enations resembling lycophyte microphylls, without evidence for vasculature. The presence of sporangia is equivocal making assignation to the Lycopsida conjectural. The plant was recently described as a zosterophyll, but lacks strobili. These are present in the second plant and comprise bivalved sporangia. The strobili terminate aerial stems which arise from a basal axial complex displaying diversity in branching including H-and K-forms. These features characterise the Zosterophyllopsida, although the plant differs from Zosterophyllum in valve shape. Comparisons indicate greatest similarities to the Lower Devonian Guangnania cuneata, from Yunnan, but differences, particularly in the nature of the sporangium border, require the erection of a new species, G. minor. Superficial examination of specimens already published indicate a high degree of endemism at both species and generic level, while this study shows that Yanmenia is confined to Sichuan and Guangnania is one of the very few genera shared with Yunnan, where assemblages also show a high proportion of further endemic genera. Such provincialism noted in the Chinese Lower Devonian is explained by the palaeogeographic isolation of the South China plate, but this cannot account for differences/endemism between the Sichuan and Yunnan floras. Such an enigma demands further integrated geological, palaeobotanical and palynological studies.	[Edwards, Dianne; Geng, Bao-Yin; Li, Cheng-Sen] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Edwards, Dianne] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales	Chinese Academy of Sciences; Institute of Botany, CAS; Cardiff University	Edwards, D (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.; Edwards, D (corresponding author), Cardiff Univ, Sch Earth & Ocean Sci, Cardiff, S Glam, Wales.	Edwardsd2@cardiff.ac.uk			Royal Society of London	Royal Society of London(Royal Society of London)	We are extremely grateful to the Chinese Academy of Sciences for a Visiting Professorship for Senior Scientists (No. 2013T2S0022 to DE) and the Royal Society of London for funding our long standing collaboration.	Cai C. - Y, 1993, GEOL MAG, V130, P155; Cuerda AJ, 1987, ACTAS, V1, P179; Edwards D, 2001, REV PALAEOBOT PALYNO, V116, P1, DOI 10.1016/S0034-6667(01)00059-8; EDWARDS D, 1976, NEW PHYTOL, V76, P173, DOI 10.1111/j.1469-8137.1976.tb01449.x; Edwards D, 2015, REV PALAEOBOT PALYNO, V221, P220, DOI 10.1016/j.revpalbo.2015.03.007; GENG B-Y, 1983, Acta Botanica Sinica, V25, P574; Geng Bao-Yin, 1992, Acta Botanica Sinica, V34, P450; Geng BY, 1992, ACTA PHYTOTAXON SIN, V30, P197; Hao S., 2001, PLANTS INVADE LAND E, P103; Hao S.-G., 2013, EARLY DEVONIAN POSON; Hao S.-G., 1993, PALEONTOTGR ABT B, V230, P27; HAO SG, 1995, INT J PLANT SCI, V156, P896, DOI 10.1086/297312; Hao SG, 2001, REV PALAEOBOT PALYNO, V116, P55; HAO SG, 1991, CAN J BOT, V69, P873; Hao SG, 2007, INT J PLANT SCI, V168, P477, DOI 10.1086/511011; Hao SG, 2010, NEW PHYTOL, V185, P217, DOI 10.1111/j.1469-8137.2009.03056.x; Hou, 1988, DEVONIAN STRATIGRAPH; Hsu J., 1966, ACTA BOT SIN, V14, P50; HUEBER FM, 1992, ANN MO BOT GARD, V79, P474, DOI 10.2307/2399751; Ishchenko TA, 1975, LATE SILURIAN FLORA; Kenrick P., 1997, ORIGIN EARLY DIVERSI; KIDSTON R, 1923, T ROY SOC EDINBURGH, V53, P405; Lang WH., 1927, T R SOC EDINB, V55, P443, DOI 10.1017/S0080456800016422; Lele K.M., 1961, T R SOC EDIN EARTH, V64, P469; Li C.-S., 1982, ACTA PHYTOTAXON SIN, V20, P331; LI CS, 1992, PALAEONTOLOGY, V35, P257; Li X.X., 1977, ACTA PALAEONTOL, V16, P12; Li XX., 1978, ACTA GEOL SINICA, V52, P1; Liu Yu-Hai, 2002, Vertebrata Palasiatica, V40, P52; Pan J, 1978, DEV S S CHIN, P298; Scotese C.R., 2014, ATLAS DEVONIAN PALEO ATLAS DEVONIAN PALEO, V4; Turner Susan, 1995, Geobios Memoire Special (Villeurbanne), V19, P383; Walton J., 1964, PHYTOMORPHOLOGY, V14, P155; Wang DM, 2004, INT J PLANT SCI, V165, P337, DOI 10.1086/381919; Wang DM, 2002, REV PALAEOBOT PALYNO, V122, P13, DOI 10.1016/S0034-6667(02)00089-1; Wang DM, 2007, ACTA GEOL SINICA, V81, P523; Wang H., 1983, ATLAS PALAEOGEOGRAPH; WANG JQ, 1984, VERTEBRAT PALASIATIC, V22, P219; Wang Y, 2007, GEOL J, V42, P339, DOI 10.1002/gj.1082; Wellman CH, 2012, PALAEONTOLOGY, V55, P583, DOI 10.1111/j.1475-4983.2012.01143.x; Xiong CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075706; Xu HH, 2009, REV PALAEOBOT PALYNO, V153, P331, DOI 10.1016/j.revpalbo.2008.09.007; Yang N, 2009, PALYNOLOGY, V33, P113; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhao Wenjin, 2005, Gudili Xuebao, V7, P305	45	16	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0163549	10.1371/journal.pone.0163549	http://dx.doi.org/10.1371/journal.pone.0163549			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851760	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000387909300003
J	Fizelova, M; Jauhiainen, R; Stancakova, A; Kuusisto, J; Laakso, M				Fizelova, Maria; Jauhiainen, Raimo; Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku			Finnish Diabetes Risk Score Is Associated with Impaired Insulin Secretion and Insulin Sensitivity, Drug-Treated Hypertension and Cardiovascular Disease: A Follow-Up Study of the METSIM Cohort	PLOS ONE			English	Article							GLUCOSE-TOLERANCE; RESISTANCE; IDENTIFICATION; DYSFUNCTION; MELLITUS; PREDICT	We investigated the association of the Finnish Diabetes Risk Score (FINDRISC) with insulin secretion, insulin sensitivity, and risk of type 2 diabetes, drug-treated hypertension, cardiovascular (CVD) events and total mortality in a follow-up study of the Metabolic Syndrome in Men (METSIM) cohort. The METSIM study includes 10,197 Finnish men, aged 45-73 years, and examined in 2005-2010. Of 8,749 non-diabetic participants of the METSIM study 693 developed incident type 2 diabetes, 225 started antihypertensive medication, 351 had a CVD event, and 392 died during a 8.2-year follow-up. The FINDRISC was significantly associated with decreases in insulin secretion and insulin sensitivity (P<0.0001), and with a 4.14-fold increased risk of incident type 2 diabetes, 2.43-fold increased risk of drug-treated hypertension, 1.61- fold increased risk of CVD, and 1.55-increased risk of total mortality (the FINDRISC >= 12 vs. < 12 points). In conclusion, the FINDRISC predicts impairment in insulin secretion and insulin sensitivity, the conversion to type 2 diabetes, drug-treated hypertension, CVD events and total mortality.	[Fizelova, Maria; Jauhiainen, Raimo; Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland; [Jauhiainen, Raimo; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Inst Clin Med, Internal Med, Kuopio, Finland.; Laakso, M (corresponding author), Kuopio Univ Hosp, Kuopio, Finland.	markku.laakso@uef.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland; Kuopio University Hospital	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland; Kuopio University Hospital	This work has been supported by the grants from the Academy of Finland, the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland, and VTR and EVO grants from the Kuopio University Hospital to M.L. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation review, or approval of the manuscript. No potential conflicts of interest relevant to this article are reported.r This work has been supported by the grants from the Academy of Finland (to M.L. and A.S.), the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of Eastern Finland, Kuopio, Finland, and VTR and EVO grants from the Kuopio University Hospital to M.L. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation review, or approval of the manuscript. No potential conflicts of interest relevant to this article are reported.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Bianchi C, 2009, DIABETES, V58, pA257; Brodovicz KG, 2011, DIABETIC MED, V28, P1078, DOI 10.1111/j.1464-5491.2011.03315.x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Franciosi M, 2005, DIABETES CARE, V28, P1187, DOI 10.2337/diacare.28.5.1187; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Hacke W, 2003, CEREBROVASC DIS, V16, P311, DOI 10.1159/000072554; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Ku GMV, 2013, PRIM CARE DIABETES, V7, P249, DOI 10.1016/j.pcd.2013.07.004; LAAKSO M, 1991, ARTERIOSCLER THROMB, V11, P1068, DOI 10.1161/01.ATV.11.4.1068; Laakso M, 2014, NAT REV ENDOCRINOL, V10, P293, DOI 10.1038/nrendo.2014.29; LILLIOJA S, 1993, NEW ENGL J MED, V329, P1988, DOI 10.1056/NEJM199312303292703; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lorenzo C, 2010, DIABETES CARE, V33, P67, DOI 10.2337/dc09-1115; Makrilakis K, 2011, DIABETES METAB, V37, P144, DOI 10.1016/j.diabet.2010.09.006; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Saaristo Timo, 2005, Diab Vasc Dis Res, V2, P67, DOI 10.3132/dvdr.2005.011; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Schwarz PEH, 2009, J CLIN ENDOCR METAB, V94, P920, DOI 10.1210/jc.2007-2427; Sliventoinen K, 2005, EUR J CARDIOV PREV R, V12, P451, DOI 10.1097/01.hjr.0000174793.31812.21; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Tankova T, 2011, DIABETES RES CLIN PR, V92, P46, DOI 10.1016/j.diabres.2010.12.020; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Wang JJ, 2010, J CLIN ENDOCR METAB, V95, P3858, DOI 10.1210/jc.2010-0012	34	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166584	10.1371/journal.pone.0166584	http://dx.doi.org/10.1371/journal.pone.0166584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851812	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300070
J	McArt, SH; Miles, TD; Rodriguez-Saona, C; Schilder, A; Adler, LS; Grieshop, MJ				McArt, Scott H.; Miles, Timothy D.; Rodriguez-Saona, Cesar; Schilder, Annemiek; Adler, Lynn S.; Grieshop, Matthew J.			Floral Scent Mimicry and Vector-Pathogen Associations in a Pseudoflower-Inducing Plant Pathogen System	PLOS ONE			English	Article							MONILINIA-VACCINII-CORYMBOSI; VIRUS ATTRACT; HOST-PLANT; POLLINATION; BLUEBERRY; FUNGI; INFECTION; DISEASE; TRAITS; TRANSMISSION	Several fungal plant pathogens induce 'pseudoflowers' on their hosts to facilitate insect-mediated transmission of gametes and spores. When spores must be transmitted to host flowers to complete the fungal life cycle, we predict that pseudoflowers should evolve traits that mimic flowers and attract the most effective vectors in the flower-visiting community. We quantified insect visitation to flowers, healthy leaves and leaves infected with Monilinia vaccinii-corymbosi (Mvc), the causative agent of mummy berry disease of blueberry. We developed a nested PCR assay for detecting Mvc spores on bees, flies and other potential insect vectors. We also collected volatiles from blueberry flowers, healthy leaves and leaves infected with Mvc, and experimentally manipulated specific pathogen-induced volatiles to assess attractiveness to potential vectors. Bees and flies accounted for the majority of contacts with flowers, leaves infected with Mvc and healthy leaves. Flowers were contacted most often, while there was no difference between bee or fly contacts with healthy and infected leaves. While bees contacted flowers more often than flies, flies contacted infected leaves more often than bees. Bees were more likely to have Mvc spores on their bodies than flies, suggesting that bees may be more effective vectors than flies for transmitting Mvc spores to flowers. Leaves infected with Mvc had volatile profiles distinct from healthy leaves but similar to flowers. Two volatiles produced by flowers and infected leaves, cinnamyl alcohol and cinnamic aldehyde, were attractive to bees, while no volatiles manipulated were attractive to flies or any other insects. These results suggest that Mvc infection of leaves induces mimicry of floral volatiles, and that transmission occurs primarily via bees, which had the highest likelihood of carrying Mvc spores and visited flowers most frequently.	[McArt, Scott H.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; [Miles, Timothy D.] Calif State Univ Monterey Bay, Sch Nat Sci, Seaside, CA 93955 USA; [Rodriguez-Saona, Cesar] Rutgers State Univ, Philip E Marucci Ctr, Dept Entomol, Chatsworth, NJ 08019 USA; [Schilder, Annemiek] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Grieshop, Matthew J.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Cornell University; California State University System; California State University Monterey Bay; Rutgers State University New Brunswick; Michigan State University; University of Massachusetts System; University of Massachusetts Amherst; Michigan State University	McArt, SH (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	shm33@cornell.edu			USDA NIFA [2012-67012-19854]	USDA NIFA(United States Department of Agriculture (USDA))	This work was supported by the USDA NIFA 2012-67012-19854. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P., 2004, IDENTIFICATION ESSEN, V3rd ed.; Attaran E, 2009, PLANT CELL, V21, P954, DOI 10.1105/tpc.108.063164; BATRA LR, 1983, MYCOLOGIA, V75, P131, DOI 10.2307/3792928; BATRA LR, 1985, SCIENCE, V228, P1011, DOI 10.1126/science.228.4702.1011; BEAMAN RS, 1988, AM J BOT, V75, P1148, DOI 10.2307/2444098; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bultman TL, 1998, MYCOL RES, V102, P235, DOI 10.1017/S0953756297004802; Cane JH, 2003, AM J BOT, V90, P1425, DOI 10.3732/ajb.90.10.1425; Cane JH, 2001, ECOL ENTOMOL, V26, P117, DOI 10.1046/j.1365-2311.2001.00309.x; Dean JV, 2008, PHYSIOL PLANTARUM, V132, P417, DOI 10.1111/j.1399-3054.2007.01041.X; DOBSON HEM, 1987, OECOLOGIA, V72, P618, DOI 10.1007/BF00378991; Dotterl S, 2010, CAN J ZOOL, V88, P668, DOI 10.1139/Z10-031; Eckhardt LG, 2009, FOREST PATHOL, V39, P157, DOI 10.1111/j.1439-0329.2008.00570.x; Ehlenfeldt MK, 2010, HORTSCIENCE, V45, P1205, DOI 10.21273/HORTSCI.45.8.1205; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; ERHARDT A, 1993, BOT J LINN SOC, V111, P229, DOI 10.1111/j.1095-8339.1993.tb01900.x; Feldman TS, 2008, MICROB ECOL, V56, P742, DOI 10.1007/s00248-008-9393-8; Grieshop Matthew J., 2012, American Entomologist, V58, P172; Hamelin RC, 1996, APPL ENVIRON MICROB, V62, P4026, DOI 10.1128/AEM.62.11.4026-4031.1996; Isaacs R, 2010, J APPL ECOL, V47, P841, DOI 10.1111/j.1365-2664.2010.01823.x; JENNERSTEN O, 1988, OIKOS, V51, P163, DOI 10.2307/3565638; JENNERSTEN O, 1991, OECOLOGIA, V86, P88, DOI 10.1007/BF00317394; Jennings W, 1980, QUALITATIVE ANAL; Jurgens A, 2006, NEW PHYTOL, V172, P452, DOI 10.1111/j.1469-8137.2006.01845.x; Kusumoto N, 2014, FOREST PATHOL, V44, P353, DOI 10.1111/efp.12106; Lara C, 2003, AM J BOT, V90, P262, DOI 10.3732/ajb.90.2.262; MacKenzie K, 2009, ACTA HORTIC, V810, P527, DOI 10.17660/ActaHortic.2009.810.70; MacKenzie KE, 1994, POLLINATION 2 ERICAC; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mauck KE, 2014, PLANT CELL ENVIRON, V37, P1427, DOI 10.1111/pce.12249; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; Mescher MC, 2012, HOST MANIPULATION BY PARASITES, P73; Naef A, 2002, NEW PHYTOL, V154, P717, DOI 10.1046/j.1469-8137.2002.00406.x; Ngugi HK, 2004, PHYSIOL MOL PLANT P, V64, P113, DOI 10.1016/j.pmpp.2004.08.004; Patt JM, 1992, THESIS; Pfunder M, 2000, AM J BOT, V87, P48, DOI 10.2307/2656684; Raguso RA, 1998, MOL ECOL, V7, P1127, DOI 10.1046/j.1365-294x.1998.00426.x; Rao S, 2009, ACTA HORTIC, V810, P539; Rodriguez-Saona C, 2011, ANN BOT-LONDON, V107, P1377, DOI 10.1093/aob/mcr077; Rodriguez-Saona C, 2011, J EXP BOT, V62, P2633, DOI 10.1093/jxb/erq466; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Roy BA, 1998, MYCOLOGIA, V90, P846, DOI 10.2307/3761326; ROY BA, 1993, NATURE, V362, P56, DOI 10.1038/362056a0; ROY BA, 1994, ECOLOGY, V75, P352, DOI 10.2307/1939539; ROY BA, 1994, TRENDS ECOL EVOL, V9, P335, DOI 10.1016/0169-5347(94)90154-6; Roy BA, 1999, TRENDS PLANT SCI, V4, P325, DOI 10.1016/S1360-1385(99)01445-4; Scherm H., 2001, Small Fruits Review, V1, P17, DOI 10.1300/J301v01n04_03; Shapiro L, 2012, ECOL LETT, V15, P1430, DOI 10.1111/ele.12001; Shinners TC, 1996, CAN J PLANT SCI, V76, P493, DOI 10.4141/cjps96-091; VANDENDOOL H, 1963, J CHROMATOGR, V11, P463, DOI 10.1016/S0021-9673(01)80947-X; Von Frisch K., 1971, BEES THEIR VISION CH	53	12	12	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165761	10.1371/journal.pone.0165761	http://dx.doi.org/10.1371/journal.pone.0165761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851747	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300025
J	Takeoka, A; Tayama, J; Yamasaki, H; Kobayashi, M; Ogawa, S; Saigo, T; Hayashida, M; Shirabe, S				Takeoka, Atsushi; Tayama, Jun; Yamasaki, Hironori; Kobayashi, Masakazu; Ogawa, Sayaka; Saigo, Tatsuo; Hayashida, Masaki; Shirabe, Susumu			Impact of Helicobacter pylori Immunoglobulin G Levels and Atrophic Gastritis Status on Risk of Metabolic Syndrome	PLOS ONE			English	Article							BODY-MASS INDEX; REGULATORY T-CELLS; INSULIN-RESISTANCE; INFECTION; ERADICATION; ASSOCIATION; INFLAMMATION; CHILDREN; CANCER; POLYMORPHISMS	Background Helicobacter pylori (HP) infection is implicated in gastric and extra-gastric diseases. While gastritis-related chronic inflammation represents a known trigger of metabolic disturbances, whether metabolic syndrome (MetS) is affected by gastritis status remains unclear. We aimed to clarify the effect of HP-related gastritis on the risk of MetS. Materials and Methods We retrospectively enrolled patients undergoing screening for MetS between 2014 and 2015. Investigations included HP-specific immunoglobulin G (IgG) antibody assays to detect HP infection, and serum pepsinogen assays to evaluate atrophic gastritis status. The risk of MetS was evaluated via multiple logistic regression analyses with two covariates: serum HP infection status (IgG levels) and atrophic gastritis status (two criteria were applied; pepsinogen I/II ratio < 3 or both pepsinogen I levels <= 70 mu g/L and pepsinogen I/II ratio < 3). Results Of 1,044 participants, 247 (23.7%) were HP seropositive, and 62 (6.0%) had MetS. HP seronegative and seropositive patients had similar risks of MetS. On the other hand, AG (defined in terms of serum PG I/II < 3) was significant risk of MetS (OR of 2.52 [95% CI 1.05-7.52]). After stratification according to HP IgG concentration, patients with low HP infection status had the lowest MetS risk (defined as an odds ratio [OR] adjusted for age, sex, smoking, drinking and physical activity status). Taking this result as a reference, patients with negative, moderate, and high HP infection status had ORs (with 95% confidence intervals [CI]) of 2.15 (1.06-4.16), 3.69 (1.12-16.7), and 4.05 (1.05-26.8). Conclusions HP-associated gastritis represents a risk factor for MetS. Research should determine why low and not negative HP infection status is associated with the lowest MetS risk.	[Takeoka, Atsushi; Ogawa, Sayaka; Saigo, Tatsuo; Hayashida, Masaki] Nagasaki Univ, Grad Sch Biomed Sci, Unit Prevent Med, Nagasaki, Japan; [Tayama, Jun] Nagasaki Univ, Grad Sch Educ, Nagasaki, Japan; [Yamasaki, Hironori] Sasebo City Gen Hosp, Dept Endocrinol & Metab, Sasebo, Japan; [Kobayashi, Masakazu; Shirabe, Susumu] Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki, Japan	Nagasaki University; Nagasaki University; Nagasaki University	Shirabe, S (corresponding author), Nagasaki Univ, Ctr Hlth & Community Med, Nagasaki, Japan.	susumushirabe@gmail.com		Tayama, Jun/0000-0002-4689-6880	Grants-in-Aid for Scientific Research [26460837] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Anderson LA, 2008, GUT, V57, P734, DOI 10.1136/gut.2007.132662; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Azuma T, 2002, ALIMENT PHARM THERAP, V16, P240, DOI 10.1046/j.1365-2036.16.s2.31.x; Chen L., 2015, PLOS ONE, V10; Chen TP, 2015, HELICOBACTER, V20, P184, DOI 10.1111/hel.12190; Chen Y, 2012, J INFECT DIS, V205, P1195, DOI 10.1093/infdis/jis106; Correa P, 2008, DIGEST LIVER DIS, V40, P490, DOI 10.1016/j.dld.2008.02.035; D'Elios MM, 2014, HELICOBACTER, V19, P19, DOI 10.1111/hel.12156; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; El-Omar EM, 2000, NATURE, V404, P398, DOI 10.1038/35006081; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Fujioka T, 2000, JPN J MED PHARM SCI, V43, P573; Furuta T, 2002, ALIMENT PHARM THER, V16, P799, DOI 10.1046/j.1365-2036.2002.01222.x; Gulcan M, 2010, DIGEST DIS SCI, V55, P2878, DOI 10.1007/s10620-009-1091-y; Gunji T, 2008, AM J GASTROENTEROL, V103, P3005, DOI 10.1111/j.1572-0241.2008.02151.x; Harris PR, 2008, GASTROENTEROLOGY, V134, P491, DOI 10.1053/j.gastro.2007.11.006; Isomoto H, 2005, AM J GASTROENTEROL, V100, P1711, DOI 10.1111/j.1572-0241.2005.41492.x; Kang JM, 2008, HELICOBACTER, V13, P146, DOI 10.1111/j.1523-5378.2008.00592.x; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kaptan K, 2000, ARCH INTERN MED, V160, P1349, DOI 10.1001/archinte.160.9.1349; Kishikawa H, 2015, DIS MARKERS, V2015; Kishikawa H, 2011, HELICOBACTER, V16, P427, DOI 10.1111/j.1523-5378.2011.00868.x; Lahner E, 2012, HELICOBACTER, V17, P1, DOI 10.1111/j.1523-5378.2011.00892.x; Lane JA, 2011, ALIMENT PHARM THER, V33, P922, DOI 10.1111/j.1365-2036.2011.04610.x; Leja M, 2009, DIGEST DIS SCI, V54, P2377, DOI 10.1007/s10620-009-0947-5; Longo-Mbenza B, 2007, INT J CARDIOL, V121, P229, DOI 10.1016/j.ijcard.2006.12.003; Lu WL, 2005, CARCINOGENESIS, V26, P631, DOI 10.1093/carcin/bgh349; Luczynski W, 2012, ARCH IMMUNOL THER EX, V60, P487, DOI 10.1007/s00005-012-0198-6; Machado JC, 2003, GASTROENTEROLOGY, V125, P364, DOI 10.1016/S0016-5085(03)00899-0; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; Matsuo Keitaro, 2001, Asian Pac J Cancer Prev, V2, P155; Mera RM, 2012, PEDIATR INFECT DIS J, V31, P263, DOI 10.1097/INF.0b013e3182443fec; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Muhsen K, 2008, HELICOBACTER, V13, P323, DOI 10.1111/j.1523-5378.2008.00617.x; Naja F, 2012, HELICOBACTER, V17, P444, DOI 10.1111/j.1523-5378.2012.00970.x; Nakagawa H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/142358; Nam SY, 2015, HELICOBACTER, V20, P125, DOI 10.1111/hel.12182; PATEL P, 1994, BMJ-BRIT MED J, V309, P1119, DOI 10.1136/bmj.309.6962.1119; Perri F, 1997, ARCH DIS CHILD, V77, P46, DOI 10.1136/adc.77.1.46; Plummer M, 2000, CANCER EPIDEM BIOMAR, P9; Polyzos SA, 2011, HELICOBACTER, V16, P79, DOI 10.1111/j.1523-5378.2011.00822.x; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Richter T, 2001, J PEDIATR GASTR NUTR, V33, P472, DOI 10.1097/00005176-200110000-00010; SOBALA GM, 1993, GUT, V34, P1038, DOI 10.1136/gut.34.8.1038; Torisu T, 2008, J GASTROENTEROL, V43, P762, DOI 10.1007/s00535-008-2219-0; Tu HK, 2014, SCAND J GASTROENTERO, V49, P259, DOI 10.3109/00365521.2013.869352; Upala S, 2016, J DIGEST DIS, V17, P433, DOI 10.1111/1751-2980.12367; Wagner NM, 2013, OBESITY, V21, P461, DOI 10.1002/oby.20087; Watabe H, 2009, DIGEST DIS SCI, V54, P988, DOI 10.1007/s10620-008-0468-7; Watanabe Y, 1997, DIGEST DIS SCI, V42, P1383, DOI 10.1023/A:1018833819860	52	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							016658	10.1371/journal.pone.016658	http://dx.doi.org/10.1371/journal.pone.016658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851820				2022-12-26	WOS:000387909300072
J	Versace, E; Schill, J; Nencini, AM; Vallortigara, G				Versace, Elisabetta; Schill, Jana; Nencini, Andrea Maria; Vallortigara, Giorgio			Naive Chicks Prefer Hollow Objects	PLOS ONE			English	Article							COLOR PREFERENCES; NUMBER	Biological predispositions influence approach and avoid responses from the time of birth or hatching. Neonates of species that require parental care (e.g. human babies and chicks of the domestic fowl) are attracted by stimuli associated with animate social partners, such as face-like configurations, biological motion and self-propulsion. The property of being filled is used as a cue of animacy by 8-month-old human infants but it is not known whether this reflects the effect of previous experience. We used chicks of the domestic fowl (Gallus gallus) to investigate whether the property of being filled vs. hollow elicits spontaneous or learned preferences. To this aim we tested preferences of naive and imprinted chicks for hollow and closed cylinders. Contrary to our expectations, we documented an unlearned attraction for hollow stimuli. The preference for hollow stimuli decreased when chicks were imprinted on filled stimuli but did not increase when chicks were imprinted on hollow stimuli, suggesting that hollowness is not crucial to determine affiliative responses for imprinting objects. When chicks were imprinted on occluded stimuli that could be either filled or hollow, the preference for hollow stimuli emerged again, showing that imprinting does not disrupt the spontaneous preference for hollow objects. Further experiments revealed that hollow objects were mainly attractive by means of depth cues such as darker innards, more than as places to hide or as objects with high contrast. Our findings point to predisposed preferences for hollow objects, and suggest that early predispositions might be driven by factors different from animacy cues.	[Versace, Elisabetta; Schill, Jana; Nencini, Andrea Maria; Vallortigara, Giorgio] Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy; [Schill, Jana] Univ Osnabruck, Osnabruck, Germany	University of Trento; University Osnabruck	Versace, E (corresponding author), Univ Trento, Ctr Mind Brain Sci, Rovereto, Italy.	elisabetta.versace@unitn.it		Versace, Elisabetta/0000-0003-4578-1851	ERC Advanced Grant [ERC-2011-ADG_20110406, 295517]	ERC Advanced Grant	GV was funded by the ERC Advanced Grant ERC-2011-ADG_20110406, Project No: 295517, PREMESOR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiandetti C, 2011, P ROY SOC B-BIOL SCI, V278, P2621, DOI 10.1098/rspb.2010.2381; Dekker Teun, 2015, Proceedings of the Royal Society Biological Sciences Series B, V282, P20143018, DOI 10.1098/rspb.2014.3018; Di Giorgio E., 2016, BEHAV BRAIN RES; Egorova O V, 2003, Neurosci Behav Physiol, V33, P209, DOI 10.1023/A:1022186911789; Fabricius E, WILDFOWL TRUST ANN R, P84; GELMAN R, 1990, COGNITIVE SCI, V14, P79, DOI 10.1207/s15516709cog1401_5; GIURFA M, 1995, J COMP PHYSIOL A, V177, P247; Ham AD, 2007, P ROY SOC B-BIOL SCI, V274, P1941, DOI 10.1098/rspb.2007.0538; Horn G, 1985, MEMORY IMPRINTING BR; JOHNSON MH, 1988, ANIM BEHAV, V36, P675, DOI 10.1016/S0003-3472(88)80150-7; Keesey IW, 2015, J CHEM ECOL, V41, P121, DOI 10.1007/s10886-015-0544-3; Knaden M, 2012, CELL REPORTS, V1, P392, DOI 10.1016/j.celrep.2012.03.002; Mascalzoni E, 2010, P NATL ACAD SCI USA, V107, P4483, DOI 10.1073/pnas.0908792107; Mayer U, 2016, BEHAV BRAIN RES, V310, P93, DOI 10.1016/j.bbr.2016.05.019; McCabe BJ, 2013, WIRES COGN SCI, V4, P375, DOI 10.1002/wcs.1231; Miura M, 2016, ANIM BEHAV, V116, P171, DOI 10.1016/j.anbehav.2016.03.025; Raine NE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000556; Rosa-Salva O, 2016, COGNITION; Rosa-Salva O, 2010, DEVELOPMENTAL SCI, V13, P565, DOI 10.1111/j.1467-7687.2009.00914.x; Salva OR, 2015, NEUROSCI BIOBEHAV R, V50, P150, DOI 10.1016/j.neubiorev.2014.12.015; Schaefer HH., 2010, Z TIERPSYCHOL, V16, P161, DOI [10.1111/j.1439-0310.1959.tb02051.x, DOI 10.1111/J.1439-0310.1959.TB02051.X]; SCHULMAN A H, 1970, Animal Behaviour, V18, P461, DOI 10.1016/0003-3472(70)90040-0; Setoh P, 2013, P NATL ACAD SCI USA, V110, P15937, DOI 10.1073/pnas.1314075110; Vallortigara G, 2005, PLOS BIOL, V3, P1312, DOI 10.1371/journal.pbio.0030208; VALLORTIGARA G, 1991, ANIM BEHAV, V41, P187, DOI 10.1016/S0003-3472(05)80470-1; VALLORTIGARA G, 1994, BEHAV PROCESS, V33, P41, DOI 10.1016/0376-6357(94)90059-0; Vallortigara G., 2012, THEORY EVOLUTION ITS, P189, DOI [10.1007/978-88-470-1974-4_12, DOI 10.1007/978-88-470-1974-4_12]; Vallortigara G, 2012, COGN NEUROPSYCHOL, V29, P213, DOI 10.1080/02643294.2012.654772; Versace E, 2016, BIORXIV, P1; Versace E, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00338; Versace E, 2015, PEERJ, V3, DOI 10.7717/peerj.1214	31	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166425	10.1371/journal.pone.0166425	http://dx.doi.org/10.1371/journal.pone.0166425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851773	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300047
J	De Lorenzo, G; Drikic, M; Papa, G; Eichwald, C; Burrone, OR; Arnoldi, F				De Lorenzo, Giuditta; Drikic, Marija; Papa, Guido; Eichwald, Catherine; Burrone, Oscar R.; Arnoldi, Francesca			An Inhibitory Motif on the 5 ' UTR of Several Rotavirus Genome Segments Affects Protein Expression and Reverse Genetics Strategies	PLOS ONE			English	Article							SITE-MEDIATED TRANSLATION; T7 RNA-POLYMERASE; MINUS-STRAND SYNTHESIS; MESSENGER-RNA; LA-AUTOANTIGEN; IN-VITRO; BLUETONGUE VIRUS; TRANSCRIPTION; PROMOTER; SEQUENCE	Rotavirus genome consists of eleven segments of dsRNA, each encoding one single protein. Viral mRNAs contain an open reading frame (ORF) flanked by relatively short untranslated regions (UTRs), whose role in the viral cycle remains elusive. Here we investigated the role of 5' UTRs in T7 polymerase-driven cDNAs expression in uninfected cells. The 5' UTRs of eight genome segments (gs3, gs5-6, gs7-11) of the simian SA11 strain showed a strong inhibitory effect on the expression of viral proteins. Decreased protein expression was due to both compromised transcription and translation and was independent of the ORF and the 3' UTR sequences. Analysis of several mutants of the 21-nucleotide long 5' UTR of gs 11 defined an inhibitory motif (IM) represented by its primary sequence rather than its secondary structure. IM was mapped to the 5' terminal 6-nucleotide long pyrimidine-rich tract 5'GGY(U/A) UY-3'. The 5' terminal position within the mRNA was shown to be essentially required, as inhibitory activity was lost when IM was moved to an internal position. We identified two mutations (insertion of a G upstream the 5' UTR and the U to A mutation of the fifth nucleotide of IM) that render IM non-functional and increase the transcription and translation rate to levels that could considerably improve the efficiency of virus helper-free reverse genetics strategies.	[De Lorenzo, Giuditta; Drikic, Marija; Papa, Guido; Burrone, Oscar R.; Arnoldi, Francesca] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Arnoldi, Francesca] Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy; [Eichwald, Catherine] Univ Zurich, Inst Virol, Zurich, Switzerland; [Drikic, Marija] Univ Calgary, Fac Vet Med UCVM, Dept Prod Anim Hlth, Calgary, AB, Canada	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste; University of Zurich; University of Calgary	Burrone, OR; Arnoldi, F (corresponding author), Int Ctr Genet Engn & Biotechnol, Trieste, Italy.; Arnoldi, F (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Trieste, Italy.	burrone@icgeb.org; farnoldi@units.it	Arnoldi, Francesca/AAQ-6859-2021; De Lorenzo, Giuditta/AAZ-9142-2021; Papa, Guido/AAG-5158-2021; ARNOLDI, Francesca/K-5020-2016	De Lorenzo, Giuditta/0000-0002-2736-8740; Papa, Guido/0000-0002-5215-0014; Eichwald, Catherine/0000-0003-0001-4843; ARNOLDI, Francesca/0000-0003-0651-5526	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy [RBFR13209E]	FIRB-Futuro in Ricerca grant - Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy	FA was partially supported by a FIRB-Futuro in Ricerca grant (RBFR13209E, http://futuronricerca.miurit) funded by the Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Italy. All other authors received no specific funding for this work.	Afrikanova I, 1998, J GEN VIROL, V79, P2679, DOI 10.1099/0022-1317-79-11-2679; Ali N, 2000, J BIOL CHEM, V275, P27531; Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Arnold MM, 2012, J GEN VIROL, V93, P1483, DOI 10.1099/vir.0.041830-0; Arnoldi F, 2007, J VIROL, V81, P2128, DOI 10.1128/JVI.01494-06; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Biswas S, 2014, ARCH VIROL, V159, P235, DOI 10.1007/s00705-013-1802-8; Boyce M, 2008, J VIROL, V82, P8339, DOI 10.1128/JVI.00808-08; Chen D, 1998, J VIROL, V72, P7387, DOI 10.1128/JVI.72.9.7387-7396.1998; Contin R, 2011, J VIROL, V85, P2781, DOI 10.1128/JVI.01631-10; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Desselberger U, 2014, VIRUS RES, V190, P75, DOI 10.1016/j.virusres.2014.06.016; Eichwald C, 2004, J GEN VIROL, V85, P625, DOI 10.1099/vir.0.19611-0; Elroy-Stein O, 2001, CURR PROTOC PROTEIN; Estes M. K., 2014, FIELDS VIROLOGY, P1347; FUERST TR, 1989, J MOL BIOL, V206, P333, DOI 10.1016/0022-2836(89)90483-X; GONZALEZ SA, 1991, VIROLOGY, V182, P8, DOI 10.1016/0042-6822(91)90642-O; GRALLA JD, 1980, BIOCHEMISTRY-US, V19, P5864, DOI 10.1021/bi00566a031; Gratia M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145998; Harb M, 2008, J VIROL; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; IMAI M, 1983, J VIROL, V47, P125, DOI 10.1128/JVI.47.1.125-136.1983; Johne R, 2016, J VIROL, V90, P1439, DOI 10.1128/JVI.02730-15; Kobayashi T, 2007, CELL HOST MICROBE, V1, P147, DOI 10.1016/j.chom.2007.03.003; Kobayashi T, 2010, VIROLOGY, V398, P194, DOI 10.1016/j.virol.2009.11.037; Komoto S, 2008, J VIROL, V82, P6753, DOI 10.1128/JVI.00601-08; Kozak M, 2005, GENE, V361, P13, DOI 10.1016/j.gene.2005.06.037; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Matsuo E, 2009, J VIROL, V83, P8842, DOI 10.1128/JVI.00465-09; MCCRAE MA, 1983, VIROLOGY, V126, P204, DOI 10.1016/0042-6822(83)90472-5; MEEROVITCH K, 1993, J VIROL, V67, P3798, DOI 10.1128/JVI.67.7.3798-3807.1993; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Montero H, 2008, J VIROL, V82, P1496, DOI 10.1128/JVI.01779-07; Montero H, 2006, J VIROL, V80, P9031, DOI 10.1128/JVI.00437-06; Patton JT, 1996, J VIROL, V70, P7940, DOI 10.1128/JVI.70.11.7940-7947.1996; Pudi R, 2003, J BIOL CHEM, V278, P12231, DOI 10.1074/jbc.M210287200; Richards JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074328; Rubio RM, 2013, J VIROL, V87, P6336, DOI 10.1128/JVI.00361-13; SOUTHERN JA, 1991, J GEN VIROL, V72, P1551, DOI 10.1099/0022-1317-72-7-1551; SVITKIN YV, 1994, J VIROL, V68, P7001, DOI 10.1128/JVI.68.11.7001-7007.1994; Trask SD, 2013, METHODS, V59, P199, DOI 10.1016/j.ymeth.2012.05.012; Trask SD, 2010, P NATL ACAD SCI USA, V107, P18652, DOI 10.1073/pnas.1011948107; Trask SD, 2010, J VIROL, V84, P1764, DOI 10.1128/JVI.01682-09; Troupin C, 2010, J VIROL, V84, P6711, DOI 10.1128/JVI.00547-10; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114; Wentz MJ, 1996, J VIROL, V70, P7833, DOI 10.1128/JVI.70.11.7833-7841.1996; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377; Zhu JF, 2001, BBA-GENE STRUCT EXPR, V1521, P19, DOI 10.1016/S0167-4781(01)00277-9	51	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166719	10.1371/journal.pone.0166719	http://dx.doi.org/10.1371/journal.pone.0166719			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846320	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000387794600102
J	Tamaki, T; Hirata, M; Nakajima, N; Saito, K; Hashimoto, H; Soeda, S; Uchiyama, Y; Watanabe, M				Tamaki, Tetsuro; Hirata, Maki; Nakajima, Nobuyuki; Saito, Kosuke; Hashimoto, Hiroyuki; Soeda, Shuichi; Uchiyama, Yoshiyasu; Watanabe, Masahiko			A Long-Gap Peripheral Nerve Injury Therapy Using Human Skeletal Muscle-Derived Stem Cells (Sk-SCs): An Achievement of Significant Morphological, Numerical and Functional Recovery	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; BASIC SCIENCE; STROMAL CELLS; SELF-RENEWAL; REGENERATION; ANGIOGENESIS; RECONSTITUTION; REPAIR; TRANSPLANTATION	Losses in vital functions of the somatic motor and sensory nervous system are induced by severe long-gap peripheral nerve transection injury. In such cases, autologous nerve grafts are the gold standard treatment, despite the unavoidable sacrifice of other healthy functions, whereas the prognosis is not always favorable. Here, we use human skeletal musclederived stem cells (Sk-SCs) to reconstitute the function after long nerve-gap injury. Muscles samples were obtained from the amputated legs from 9 patients following unforeseen accidents. The Sk-SCs were isolated using conditioned collagenase solution, and sorted as CD34(+)/45(-)(Sk-34) and CD34(-)/45(-)/29(+) (Sk-DN/29(+)) cells. Cells were separately cultured/expanded under optimal conditions for 2 weeks, then injected into the athymic nude mice sciatic nerve long-gap model (7-mm) bridging an acellular conduit. After 8-12 weeks, active cell engraftment was observed only in the Sk-34 cell transplanted group, showing preferential differentiation into Schwann cells and perineurial/endoneurial cells, as well as formation of the myelin sheath and perineurium/endoneurium surrounding regenerated axons, resulted in 87% of numerical recovery. Differentiation into vascular cell lineage (pericyte and endothelial cells) were also observed. A significant tetanic tension recovery (over 90%) of downstream muscles following electrical stimulation of the sciatic nerve (at upper portion of the gap) was also achieved. In contrast, Sk-DN/29(+) cells were completely eliminated during the first 4 weeks, but relatively higher numerical (83% vs. 41% in axon) and functional (80% vs. 60% in tetanus) recovery than control were observed. Noteworthy, significant increase in the formation of vascular networks in the conduit during the early stage (first 2 weeks) of recovery was observed in both groups with the expression of key factors (mRNA and protein levels), suggesting the paracrine effects to angiogenesis. These results suggested that the human Sk-SCs may be a practical source for autologous stem cell therapy following severe peripheral nerve injury.	[Tamaki, Tetsuro; Hirata, Maki; Nakajima, Nobuyuki; Saito, Kosuke; Hashimoto, Hiroyuki; Soeda, Shuichi; Uchiyama, Yoshiyasu] Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Tamaki, Tetsuro] Tokai Univ, Sch Med, Dept Human Struct & Funct, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Hirata, Maki; Hashimoto, Hiroyuki; Uchiyama, Yoshiyasu; Watanabe, Masahiko] Tokai Univ, Sch Med, Dept Orthoped, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Nakajima, Nobuyuki; Soeda, Shuichi] Tokai Univ, Sch Med, Dept Urol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan; [Saito, Kosuke] Tokai Univ, Sch Med, Dept Otolaryngol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan	Tokai University; Tokai University; Tokai University; Tokai University; Tokai University	Tamaki, T (corresponding author), Tokai Univ, Sch Med, Muscle Physiol & Cell Biol Unit, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.; Tamaki, T (corresponding author), Tokai Univ, Sch Med, Dept Human Struct & Funct, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	tamaki@is.icc.u-tokai.ac.jp	Tamaki, Tetsuro/I-2615-2019	Tamaki, Tetsuro/0000-0002-9071-049X; Nakajima, Nobuyuki/0000-0001-6307-032X	Tokai University School of Medicine, Project Research, and Tokai University Research Aid [20122013]; Ministry of Education, Science and Culture Japan	Tokai University School of Medicine, Project Research, and Tokai University Research Aid; Ministry of Education, Science and Culture Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a 20122013 grant from the Tokai University School of Medicine, Project Research, and Tokai University Research Aid, and by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture Japan. The funders had no no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2009, J CELL BIOCHEM, V107, P1016, DOI 10.1002/jcb.22204; Aplin AC, 2010, ANGIOGENESIS, V13, P219, DOI 10.1007/s10456-010-9179-8; Castiglioni A, 2014, STEM CELL REP, V2, P92, DOI 10.1016/j.stemcr.2013.12.006; Charville GW, 2015, STEM CELL REP, V5, P621, DOI 10.1016/j.stemcr.2015.08.004; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Crisan M, 2008, CURR PROTOC STEM CEL, DOI DOI 10.1002/9780470151808.SC02B02S4; Deumens R, 2010, PROG NEUROBIOL, V92, P245, DOI 10.1016/j.pneurobio.2010.10.002; Dezawa Mari, 2005, Current Neuropharmacology, V3, P257, DOI 10.2174/157015905774322507; Dubovy Petr, 2004, Anatomical Science International, V79, P198, DOI 10.1111/j.1447-073x.2004.00090.x; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; Gordon T, 2010, EXP NEUROL, V223, P192, DOI 10.1016/j.expneurol.2009.09.020; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Kingham PJ, 2007, EXP NEUROL, V207, P267, DOI 10.1016/j.expneurol.2007.06.029; Kunigal S, 2007, INT J CANCER, V121, P2307, DOI 10.1002/ijc.22962; Lamszus K, 2000, NEUROSURGERY, V46, P938; Lavasani M, 2014, J CLIN INVEST, V124, P1745, DOI 10.1172/JCI44071; Li Aihua, 2005, Angiogenesis, V8, P63, DOI 10.1007/s10456-005-5208-4; Ma J, 2007, BLOOD, V109, P987, DOI 10.1182/blood-2006-07-036400; Matsuse D, 2010, J NEUROPATH EXP NEUR, V69, P973, DOI 10.1097/NEN.0b013e3181eff6dc; Pavlov N, 2001, B CANCER, V88, P725; Pfister Bryan J., 2011, Critical Reviews in Biomedical Engineering, V39, P81, DOI 10.1615/CritRevBiomedEng.v39.i2.20; Pisani DF, 2010, STEM CELLS, V28, P753, DOI 10.1002/stem.317; Radtke C, 2011, CELL TRANSPLANT, V20, P145, DOI 10.3727/096368910X522081; Rochkind S, 2009, PHOTOMED LASER SURG, V27, P219, DOI 10.1089/pho.2009.9955; Rochkind S, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/FOC.2009.26.2.E8; Rosson GD, 2009, MICROSURG, V29, P107, DOI 10.1002/micr.20580; Shimizu S, 2007, BIOCHEM BIOPH RES CO, V359, P915, DOI 10.1016/j.bbrc.2007.05.212; Tamaki T, 2005, CIRCULATION, V112, P2857, DOI 10.1161/CIRCULATIONAHA.105.554832; Tamaki T, 2003, EXP CELL RES, V291, P83, DOI 10.1016/S0014-4827(03)00376-8; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tamaki T, 2007, HISTOCHEM CELL BIOL, V128, P349, DOI 10.1007/s00418-007-0331-5; Tamaki T, 2007, STEM CELLS, V25, P2283, DOI 10.1634/stemcells.2006-0746; Tamaki T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00165; Tamaki T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091257; Tamaki T, 2013, REGEN MED, V8, P437, DOI 10.2217/rme.13.30; Tamaki T, 2011, CELL TISSUE RES, V344, P147, DOI 10.1007/s00441-010-1127-9; Tansey KE, 2011, ANN BIOMED ENG, V39, P1815, DOI 10.1007/s10439-011-0277-6; Uemura T, 2012, BIOCHEM BIOPH RES CO, V419, P130, DOI 10.1016/j.bbrc.2012.01.154; Walsh SK, 2012, STEM CELL RES, V8, P226, DOI 10.1016/j.scr.2011.11.004; Weber RA, 2000, PLAST RECONSTR SURG, V106, P1036, DOI 10.1097/00006534-200010000-00013; Whitlock EL, 2009, MUSCLE NERVE, V39, P787, DOI 10.1002/mus.21220; Xu XT, 2015, STEM CELL REP, V5, P419, DOI 10.1016/j.stemcr.2015.07.016	42	23	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166639	10.1371/journal.pone.0166639	http://dx.doi.org/10.1371/journal.pone.0166639			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846318	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600097
J	Apriasz, R; Krueger, T; Marcjasz, G; Sznajd-Weron, K				Apriasz, Rafal; Krueger, Tyll; Marcjasz, Grzegorz; Sznajd-Weron, Katarzyna			The Hunt Opinion Model-An Agent Based Approach to Recurring Fashion Cycles	PLOS ONE			English	Article							DYNAMICS	We study a simple agent-based model of the recurring fashion cycles in the society that consists of two interacting communities: "snobs" and "followers" (or "opinion hunters", hence the name of the model). Followers conform to all other individuals, whereas snobs conform only to their own group and anticonform to the other. The model allows to examine the role of the social structure, i.e. the influence of the number of inter-links between the two communities, as well as the role of the stability of links. The latter is accomplished by considering two versions of the same model - quenched (parameterized by fraction L of fixed inter-links) and annealed (parameterized by probability p that a given inter-link exists). Using Monte Carlo simulations and analytical treatment (the latter only for the annealed model), we show that there is a critical fraction of inter-links, above which recurring cycles occur. For p <= 0.5 we derive a relation between parameters L and p that allows to compare both models and show that the critical value of inter-connections, p*, is the same for both versions of the model (annealed and quenched) but the period of a fashion cycle is shorter for the quenched model. Near the critical point, the cycles are irregular and a change of fashion is difficult to predict. For the annealed model we also provide a deeper theoretical analysis. We conjecture on topological grounds that the so-called saddle node heteroclinic bifurcation appears at p*. For p >= 0.5 we show analytically the existence of the second critical value of p, for which the system undergoes Hopf's bifurcation.	[Apriasz, Rafal; Sznajd-Weron, Katarzyna] Wroclaw Univ Sci & Technol, Dept Theoret Phys, Fac Fundamental Problems Technol, Wroclaw, Poland; [Krueger, Tyll] Wroclaw Univ Sci & Technol, Dept Control Syst & Mechatron, Wroclaw, Poland; [Marcjasz, Grzegorz] Wroclaw Univ Sci & Technol, Fac Pure & Appl Math, Wroclaw, Poland	Wroclaw University of Science & Technology; Wroclaw University of Science & Technology; Wroclaw University of Science & Technology	Sznajd-Weron, K (corresponding author), Wroclaw Univ Sci & Technol, Dept Theoret Phys, Fac Fundamental Problems Technol, Wroclaw, Poland.	katarzyna.weron@pwr.edu.pl		Krueger, Tyll/0000-0001-6983-7413	National Science Centre (NCN, Poland) [2013/11/B/HS4/01061]	National Science Centre (NCN, Poland)(National Science Centre, Poland)	This work was partially supported by funds from the National Science Centre (NCN, Poland; URL: http://ncn.gov.pl/) through grant no. 2013/11/B/HS4/01061. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; [Anonymous], 1987, CLOTH TEXT RES J, V5, P15, DOI [10.1177/0887302X8700500203, DOI 10.1177/0887302X8700500203]; BAK P, 1982, REP PROG PHYS, V45, P587, DOI 10.1088/0034-4885/45/6/001; Bentley RA, 2007, EVOL HUM BEHAV, V28, P151, DOI 10.1016/j.evolhumbehav.2006.10.002; Benvenuto S., 2000, FASHION G SIMMEL J A, V3; Berger J, 2008, J PERS SOC PSYCHOL, V95, P593, DOI 10.1037/0022-3514.95.3.593; Bond R, 2005, GROUP PROCESS INTERG, V8, P331, DOI 10.1177/1368430205056464; Bouzdine-Chameeva T, 2011, ADV COMPLEX SYST, V14, P871, DOI 10.1142/S0219525911003475; Byrka K, 2016, RENEW SUST ENERG REV, V62, P723, DOI 10.1016/j.rser.2016.04.063; Callahan G, 2015, 2 POPULATION SOCIAL; Cao ZG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049441; Castellano C, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041129; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Curran L., 1999, CLOTH TEXT RES J, V17, P65, DOI [10.1177/0887302X9901700201, DOI 10.1177/0887302X9901700201]; Denrell J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123471; Desportes JP, 1988, ENV SOCIAL PSYCHOL, P57, DOI [10.1007/978-94-009-2802-2_5, DOI 10.1007/978-94-009-2802-2_5]; ELLIOTT RJ, 1961, PHYS REV, V124, P346, DOI 10.1103/PhysRev.124.346; Galak J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153448; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Jedrzejewski A, ARXIV160707307PHYSIC; Kowalska-Pyzalska A, 2014, ENERG POLICY, V72, P164, DOI 10.1016/j.enpol.2014.04.021; Krawczyk MJ, 2014, PHYSICA A, V395, P384, DOI 10.1016/j.physa.2013.10.018; Lancichinetti A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011976; Maciejowska K, 2016, ACTA PHYS POL A, V129, P1045, DOI 10.12693/APhysPolA.129.1045; Marsden JE., 1976, HOPF BIFURCATION ITS, DOI [10.1007/978-1-4612-6374-6, DOI 10.1007/978-1-4612-6374-6, DOI 10.1007/978-1-4612-6374-6_12]; Mellor A, 2016, EPL-EUROPHYS LETT, V113, DOI 10.1209/0295-5075/113/48001; Miller CM, 1993, J MARKETING RES, V81, P1133; Mobilia M, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012803; Murray J. D., 2002, MATH BIOL; Nail PR, 2016, ACTA PHYS POL A, V129, P1050, DOI 10.12693/APhysPolA.129.1050; Nail PR, 2013, REV GEN PSYCHOL, V17, P1, DOI 10.1037/a0030997; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Nyczka P, 2013, J STAT PHYS, V151, P174, DOI 10.1007/s10955-013-0701-4; Nyczka P, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011105; Pareto V., 1916, MIND SOC 3; Rand W, 2011, INT J RES MARK, V28, P181, DOI 10.1016/j.ijresmar.2011.04.002; Richardson J, 1940, ANTHR RECORDS; ROBINSON DE, 1976, AM J SOCIOL, V81, P1133, DOI 10.1086/226188; Ruback RB, 2013, ENVIRON BEHAV, V45, P239, DOI 10.1177/0013916511412589; SELKE W, 1988, PHYS REP, V170, P213, DOI 10.1016/0370-1573(88)90140-8; Shilnikov LP, 2001, METHODS QUALITATIV 2; Siedlecki P, 2016, JASSS-J ARTIF SOC S, V19, DOI 10.18564/jasss.3203; SIMMEL G, 1957, AM J SOCIOL, V62, P541, DOI 10.1086/222102; Smith A., 2012, THEORY MORAL SENTIME; Sood V, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.041121; Sornette D, 2014, REP PROG PHYS, V77, DOI 10.1088/0034-4885/77/6/062001; Steele V., 2005, ENCY CLOTHING FASHIO; Suchecki K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011122; Suchecki K, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031110; Szwabinski J, 2013, PHYSICA A, V392, P3589, DOI 10.1016/j.physa.2013.03.047; Timpanaro AM, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012807; Timpanaro AM, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.052808	54	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166323	10.1371/journal.pone.0166323	http://dx.doi.org/10.1371/journal.pone.0166323			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835679	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200038
J	Wright, NE; Scerpella, D; Lisdahl, KM				Wright, Natasha E.; Scerpella, Danny; Lisdahl, Krista M.			Marijuana Use Is Associated with Behavioral Approach and Depressive Symptoms in Adolescents and Emerging Adults	PLOS ONE			English	Article							WHITE-MATTER INTEGRITY; NATIONAL EPIDEMIOLOGIC SURVEY; CANNABIS USE DISORDERS; AGE-OF-ONSET; ENDOCANNABINOID SYSTEM; SUBSTANCE USE; ALCOHOL-USE; EXECUTIVE DYSFUNCTION; RECEPTOR EXPRESSION; ANXIETY DISORDERS	Background Repeated CB1 binding due to THC results in downregulation of the endocannabinoid system in cortex and limbic regions, perhaps disrupting frontolimbic functioning. This is particularly a concern in young adults who are still undergoing neurodevelopment in frontal and limbic regions. Such disruptions may be linked to increased depressive symptoms, anxiety symptoms, and executive dysfunction, and decreased behavioral approach. Objectives Here we examine the influence of young adult marijuana use on anxiety, depressive symptoms, behavioral approach, and executive dysfunction. The influence of alcohol and gender were also assessed. Methods 84 participants 42 MJ, 42 controls) aged 18- 25 were balanced for gender 39 F). Exclusion criteria included: MRI contraindications, left handed, comorbid Axis-I disorders, major medical or neurologic disorders, prenatal issues, or prenatal alcohol/illicit drug exposure, or excessive other drug use. Participants completed the FrsBE, BIS/BAS, State-Trait Anxiety Inventory State), and BDI-II. Multiple regressions were run to predict anxiety, depressive symptoms, behavioral approach, and executive dysfunction from MJ group status, past year alcohol use, gender, and MJ* gender interactions, controlling for cotinine and ecstasy. Results MJ group predicted increased depressive symptoms p =. 049). Decreased fun-seeking p =. 04), reward response p =. 01), and BAS total p =. 01) were predicted by MJ group. Gender predicted decreased reward responsiveness in females p =. 049) and decreased BIS in females p =. 03). Female marijuana users had increased anxiety symptoms p =. 04) and increased disinhibition p =. 04). Increased cotinine predicted increased drive p =. 046), reward responsiveness p =. 008) and BAS Total p =. 02). Apathy and Executive Dysfunction were not predicted by any measures. All results had small effect sizes. Conclusions/Importance Depressive symptoms were greater in MJ users, while behavioral approach was decreased. Cotinine levels predicted increased behavioral approach. Female MJ users also had greater anxiety and disinhibition. In sum, these findings suggest sub-clinical threshold deficits related to regular marijuana use that are indicative of a need to prevent marijuana use in adolescents and young adults.	[Wright, Natasha E.; Scerpella, Danny; Lisdahl, Krista M.] Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee	Lisdahl, KM (corresponding author), Univ Wisconsin, Dept Psychol, Milwaukee, WI 53201 USA.	krista.medina@gmail.com	Lisdahl, Krista/P-8470-2019	Lisdahl, Krista/0000-0001-9515-1335; Wade, Natasha/0000-0002-9629-2305	National Institute of Drug Abuse [R03 DA027457, R01 DA030354, RO3 DA027457]; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA027457, R01DA030354] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Institute of Drug Abuse grant R03 DA027457. Dr. Lisdahl was also funded by National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the National Institute of Drug Abuse grant RO3 DA027457. Dr. Lisdahl was also funded by National Institute of Drug Abuse (R01 DA030354) during manuscript preparation. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnone D, 2008, NEUROIMAGE, V41, P1067, DOI 10.1016/j.neuroimage.2008.02.064; Ashtari M, 2011, J PSYCHIATR RES, V45, P1055, DOI 10.1016/j.jpsychires.2011.01.004; Ashtari M, 2008, J PSYCHIATR RES, V43, P189, DOI 10.1016/j.jpsychires.2008.12.002; Ashton CH, 2011, ACTA PSYCHIAT SCAND, V124, P250, DOI 10.1111/j.1600-0447.2011.01687.x; BAKAN D, 1966, PSYCHOL BULL, V66, P423, DOI 10.1037/h0020412; Bava S, 2013, ALCOHOL CLIN EXP RES, V37, pE181, DOI 10.1111/j.1530-0277.2012.01920.x; Bava S, 2009, PSYCHIAT RES-NEUROIM, V173, P228, DOI 10.1016/j.pscychresns.2009.04.005; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Becker MP, 2014, J CLIN EXP NEUROPSYC, V36, P379, DOI 10.1080/13803395.2014.893996; Bekman NM, 2013, ALCOHOL CLIN EXP RES, V37, P1432, DOI 10.1111/acer.12096; Bloomfield MAP, 2014, PSYCHOPHARMACOLOGY, V231, P2251, DOI 10.1007/s00213-014-3523-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budney AJ, 2003, J ABNORM PSYCHOL, V112, P393, DOI 10.1037/0021-843X.112.3.393; Butterworth P, 2014, DRUG ALCOHOL REV, V33, P555, DOI 10.1111/dar.12183; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Chen CY, 2002, SOC PSYCH PSYCH EPID, V37, P199, DOI 10.1007/s00127-002-0541-z; Churchwell JC, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00225; DEFONSECA FR, 1993, NEUROREPORT, V4, P135, DOI 10.1097/00001756-199302000-00005; Degenhardt L, 2008, PLOS MED, V5, P1053, DOI 10.1371/journal.pmed.0050141; Demirakca T, 2011, DRUG ALCOHOL DEPEN, V114, P242, DOI 10.1016/j.drugalcdep.2010.09.020; Dorard G, 2008, EUR CHILD ADOLES PSY, V17, P274, DOI 10.1007/s00787-007-0663-7; Dougherty DM, 2013, PSYCHOPHARMACOLOGY, V226, P307, DOI 10.1007/s00213-012-2908-5; Ehrenreich H, 1999, PSYCHOPHARMACOLOGY, V142, P295, DOI 10.1007/s002130050892; Elofson J, 2013, ADDICT BEHAV, V38, P2295, DOI 10.1016/j.addbeh.2013.03.001; Felton JW, 2015, EXP CLIN PSYCHOPHARM, V23, P265, DOI 10.1037/pha0000031; Filbey FM, 2015, BEHAV BRAIN RES, V293, P46, DOI 10.1016/j.bbr.2015.07.029; Fleming RL, 2012, ALCOHOL CLIN EXP RES, V36, P279, DOI 10.1111/j.1530-0277.2011.01615.x; Fontes MA, 2011, BRIT J PSYCHIAT, V198, P442, DOI 10.1192/bjp.bp.110.077479; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Grace J, 1999, FRONTAL SYSTEMS BEHA; Grant B F, 1995, J Subst Abuse, V7, P481, DOI 10.1016/0899-3289(95)90017-9; Griffith-Lendering MFH, 2012, J CLIN EXP NEUROPSYC, V34, P688, DOI 10.1080/13803395.2012.668874; Gruber SA, 2014, PSYCHOPHARMACOLOGY, V231, P1455, DOI 10.1007/s00213-013-3326-z; Gruber SA, 2012, PSYCHOL ADDICT BEHAV, V26, P496, DOI 10.1037/a0026269; Gruber SA, 2012, NEUROSCI LETT, V511, P89, DOI 10.1016/j.neulet.2012.01.039; Gruber SA, 2011, EXP CLIN PSYCHOPHARM, V19, P231, DOI 10.1037/a0023034; Hasin DS, 2015, SOC PSYCH PSYCH EPID, V50, P1609, DOI 10.1007/s00127-015-1088-0; Hasin DS, 2015, LANCET PSYCHIAT, V2, P601, DOI 10.1016/S2215-0366(15)00217-5; Heng LJ, 2011, SYNAPSE, V65, P278, DOI 10.1002/syn.20844; Hervas G, 2013, BEHAV THER, V44, P62, DOI 10.1016/j.beth.2012.07.003; Hill MN, 2009, PSYCHONEUROENDOCRINO, V34, P1257, DOI 10.1016/j.psyneuen.2009.03.013; Hirvonen J, 2012, MOL PSYCHIATR, V17, P642, DOI 10.1038/mp.2011.82; Howard RJ, 2011, ALCOHOL CLIN EXP RES, V35, P1561, DOI 10.1111/j.1530-0277.2011.01502.x; Hungund BL, 2004, ANN NY ACAD SCI, V1025, P515, DOI 10.1196/annals.1316.064; Jacobsen LK, 2007, BIOL PSYCHIAT, V61, P31, DOI 10.1016/j.biopsych.2006.02.014; Jacobsen LK, 2005, BIOL PSYCHIAT, V57, P56, DOI 10.1016/j.biopsych.2004.10.022; Johnston L., 2012, MONITORING FUTURE NA; Johnston L., 2015, MONITORING FUTURE NA; Kedzior KK, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-136; Keeney BK, 2012, PHARMACOL BIOCHEM BE, V101, P528, DOI 10.1016/j.pbb.2012.02.017; Keeney BK, 2008, BEHAV PHARMACOL, V19, P812, DOI 10.1097/FBP.0b013e32831c3b6b; Khan SS, 2013, DRUG ALCOHOL DEPEN, V130, P101, DOI 10.1016/j.drugalcdep.2012.10.015; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Liang WB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596179; Lisdahl Krista M, 2013, Front Psychiatry, V4, P53, DOI 10.3389/fpsyt.2013.00053; Lisdahl Krista M, 2014, Curr Addict Rep, V1, P144; Lisdahl KM, 2012, J INT NEUROPSYCH SOC, V18, P678, DOI 10.1017/S1355617712000276; LoBue C, 2014, AM J DRUG ALCOHOL AB, V40, P455, DOI 10.3109/00952990.2014.939752; Long LE, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-87; Lopez-Larson MP, 2011, BEHAV BRAIN RES, V220, P164, DOI 10.1016/j.bbr.2011.02.001; Maldonado R, 2006, TRENDS NEUROSCI, V29, P225, DOI 10.1016/j.tins.2006.01.008; Martinez-Loredo V, 2015, SUBST ABUSE TREAT PR, V10, DOI 10.1186/s13011-015-0019-0; McFarland BR, 2006, J AFFECT DISORDERS, V91, P229, DOI 10.1016/j.jad.2006.01.012; McHale S, 2008, HUM PSYCHOPHARM CLIN, V23, P409, DOI 10.1002/hup.941; McQueeny T, 2011, BEHAV BRAIN RES, V224, P128, DOI 10.1016/j.bbr.2011.05.031; Medina KL, 2007, DRUG ALCOHOL DEPEN, V87, P303, DOI 10.1016/j.drugalcdep.2006.09.003; Medina KL, 2007, J CHILD PSYCHOL PSYC, V48, P592, DOI 10.1111/j.1469-7610.2007.01728.x; Medina KL, 2007, NEUROTOXICOL TERATOL, V29, P141, DOI 10.1016/j.ntt.2006.10.010; Medina KL, 2007, J INT NEUROPSYCH SOC, V13, P807, DOI 10.1017/S1355617707071032; Medina KL, 2009, ADDICT BIOL, V14, P457, DOI 10.1111/j.1369-1600.2009.00166.x; Midanik LT, 2007, DRUG ALCOHOL DEPEN, V90, P72, DOI 10.1016/j.drugalcdep.2007.02.024; Miech R. A., 2015, MONITORING FUTURE NA, V1; Moreno M, 2012, DRUG ALCOHOL DEPEN, V124, P355, DOI 10.1016/j.drugalcdep.2012.02.011; Pujol J, 2014, J PSYCHIATR RES, V51, P68, DOI 10.1016/j.jpsychires.2013.12.008; Risher ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062940; Rubino T, 2012, J PSYCHOPHARMACOL, V26, P177, DOI 10.1177/0269881111405362; Schacht JP, 2012, NEUROPSYCHOPHARMACOL, V37, P2368, DOI 10.1038/npp.2012.92; Scholes-Balog KE, 2013, J ADOLESCENCE, V36, P519, DOI 10.1016/j.adolescence.2013.03.001; Shollenbarger SG, INTRINSIC FRON UNPUB; Shollenbarger SG, 2015, NEUROIMAGE-CLIN, V8, P117, DOI 10.1016/j.nicl.2015.03.024; Silva L, 2015, NEUROSCI LETT, V602, P89, DOI 10.1016/j.neulet.2015.06.033; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Simons JS, 2014, J ABNORM PSYCHOL, V123, P676, DOI 10.1037/a0036926; SOBELL LC, 1992, MEASURING ALCOHOL CONSUMPTION, P41, DOI 10.1007/978-1-4612-0357-5_3; Solowij N, 2012, PSYCHOPHARMACOLOGY, V219, P575, DOI 10.1007/s00213-011-2486-y; Spear LP, 2014, NEUROTOXICOL TERATOL, V41, P51, DOI 10.1016/j.ntt.2013.11.006; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Takagi M, 2011, DRUG ALCOHOL REV, V30, P629, DOI 10.1111/j.1465-3362.2010.00256.x; Tapert SF, 2002, J INT NEUROPSYCH SOC, V8, P873, DOI 10.1017/S1355617702870011; Taubitz LE, 2015, PERS INDIV DIFFER, V80, P107, DOI 10.1016/j.paid.2015.02.029; van Laar M, 2007, ADDICTION, V102, P1251, DOI 10.1111/j.1360-0443.2007.01875.x; van Leeuwen AP, 2011, J STUD ALCOHOL DRUGS, V72, P70, DOI 10.15288/jsad.2011.72.70; Verdejo-Garcia A, 2006, J INT NEUROPSYCH SOC, V12, P405, DOI 10.1017/S1355617706060486; Winward JL, 2014, J INT NEUROPSYCH SOC, V20, P218, DOI 10.1017/S1355617713001410; Wittchen HU, 2007, DRUG ALCOHOL DEPEN, V88, pS60, DOI 10.1016/j.drugalcdep.2006.12.013; World Health Organization, 2011, GLOB STAT REP ALC HL; Wrege J, 2014, CURR PHARM DESIGN, V20, P2126, DOI 10.2174/13816128113199990428; Xu JS, 2012, HUM BRAIN MAPP, V33, P994, DOI 10.1002/hbm.21275; Zanettini C, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00057	100	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166005	10.1371/journal.pone.0166005	http://dx.doi.org/10.1371/journal.pone.0166005			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835662	Green Submitted, Green Published, gold			2022-12-26	WOS:000387779200018
J	Buzza, G; Lovell, GP; Askew, CD; Kerherve, H; Solomon, C				Buzza, Gavin; Lovell, Geoff P.; Askew, Christopher D.; Kerherve, Hugo; Solomon, Colin			The Effect of Short and Long Term Endurance Training on Systemic, and Muscle and Prefrontal Cortex Tissue Oxygen Utilisation in 40-60 Year Old Women	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; CITRATE SYNTHASE ACTIVITY; ALVEOLAR GAS-EXCHANGE; PULMONARY O-2 UPTAKE; CEREBRAL OXYGENATION; EXERCISE PERFORMANCE; BLOOD-FLOW; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR-RESPONSES; VENTILATORY THRESHOLD	Purpose Aerobic endurance training (ET) increases systemic and peripheral oxygen utilisation over time, the adaptation pattern not being linear. However, the timing and mechanisms of changes in oxygen utilisation, associated with training beyond one year are not known. This study tested the hypothesis that in women aged 40-60 years performing the same current training load; systemic O-2 utilisation (VO2) and tissue deoxyhaemoglobin (HHb) in the Vastus Lateralis (VL) and Gastrocnemius (GAST) would be higher in long term trained (LTT; > 5 yr) compared to a short term trained (STT; 6-24 months) participants during ramp incremental (RI) cycling, but similar during square-wave constant load (SWCL) cycling performed at the same relative intensity (below ventilatory turn point [VTP]); and that pre-frontal cortex (PFC) HHb would be similar between participant groups in both exercise conditions. Methods Thirteen STT and 13 LTT participants performed RI and SWCL conditions on separate days. VO2, and VL, GAST, and PFC HHb were measured simultaneously. Results VO2peak was higher in LTT compared to STT, and VO2 was higher in LTT at each relative intensities of 25%, 80% and 90% of VTP in SWCL. HHb in the VL was significantly higher in LTT compared to STT at peak exercise (4.54 +/- 3.82 vs 1.55 +/- 2.33 mu M), and at 25% (0.99 +/- 1.43 vs 0.04 +/- 0.96 mu M), 80% (3.19 +/- 2.93 vs 1.14 +/- 1.82 mu M) and 90% (4.62 +/- 3.12 vs 2.07 +/- 2.49 mu M) of VTP in SWCL. Conclusions The additional (12.9 +/- 9.3) years of ET in LTT, resulted in higher VO2, and HHb in the VL at peak exercise, and sub D VTP exercise. These results indicate that in women 40-60 years old, systemic and muscle O-2 utilisation continues to improve with ET beyond two years.	[Buzza, Gavin; Askew, Christopher D.; Kerherve, Hugo; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia; [Lovell, Geoff P.] Univ Sunshine Coast, Sch Social Sci, Sippy Downs, Qld, Australia	University of the Sunshine Coast; University of the Sunshine Coast	Buzza, G (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld, Australia.	gbuzza@usc.edu.au		Askew, Christopher/0000-0001-8076-8789				Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; Anaya SA, 2009, MED SCI SPORT EXER, V41, P971, DOI 10.1249/MSS.0b013e3181930009; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bhambhani Y, 2007, RESP PHYSIOL NEUROBI, V156, P196, DOI 10.1016/j.resp.2006.08.009; Bhambhani YN, 1997, MED SCI SPORT EXER, V29, P402, DOI 10.1097/00005768-199703000-00017; Borg G A, 1974, Exerc Sport Sci Rev, V2, P131; Bredin SSD, 2013, CAN FAM PHYSICIAN, V59, P273; CHANCE B, 1992, AM J PHYSIOL, V262, pC766, DOI 10.1152/ajpcell.1992.262.3.C766; Chuang ML, 2002, MED SCI SPORT EXER, V34, P1614, DOI 10.1097/00005768-200210000-00013; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dean TM, 2003, J APPL PHYSIOL, V95, P2537, DOI 10.1152/japplphysiol.00672.2003; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; DESOUZA MJ, 1990, MED SCI SPORT EXER, V22, P575, DOI 10.1249/00005768-199010000-00006; Dogra S, 2013, APPL PHYSIOL NUTR ME, V38, P154, DOI 10.1139/apnm-2012-0173; Dogra S, 2012, J SPORT SCI MED, V11, P745; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Eston R G, 1988, Br J Sports Med, V22, P153; EVANS SL, 1995, J APPL PHYSIOL, V78, P1931, DOI 10.1152/jappl.1995.78.5.1931; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Ferreira LF, 2006, RESP PHYSIOL NEUROBI, V153, P237, DOI 10.1016/j.resp.2005.11.004; Ferreira LF, 2005, J APPL PHYSIOL, V98, P1820, DOI 10.1152/japplphysiol.00907.2004; Fleg JL, 2005, CIRCULATION, V112, P674, DOI 10.1161/CIRCULATIONAHA.105.545459; Gaskill SE, 2001, INT J SPORTS MED, V22, P586, DOI 10.1055/s-2001-18522; Grey TM, 2015, MED SCI SPORT EXER, V47, P289, DOI 10.1249/MSS.0000000000000398; HAGBERG JM, 1988, J APPL PHYSIOL, V65, P101, DOI 10.1152/jappl.1988.65.1.101; Hamaoka T, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2805437; HICKEY MS, 1995, AM J PHYSIOL-ENDOC M, V269, pE150, DOI 10.1152/ajpendo.1995.269.1.E150; Hiroyuki H, 2002, EUR J APPL PHYSIOL, V87, P343, DOI 10.1007/s00421-002-0644-y; Hoppeler H, 2000, ACTA PHYSIOL SCAND, V168, P445, DOI 10.1046/j.1365-201x.2000.00696.x; Houmard JA, 1998, J APPL PHYSIOL, V85, P1337, DOI 10.1152/jappl.1998.85.4.1337; Huang GY, 2016, EUR J PREV CARDIOL, V23, P518, DOI 10.1177/2047487315582322; Iversen N, 2011, EXP GERONTOL, V46, P670, DOI 10.1016/j.exger.2011.03.004; Jakovljevic DG, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002086; Jones B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120338; JURKOWSKI JEH, 1981, J APPL PHYSIOL, V51, P1493, DOI 10.1152/jappl.1981.51.6.1493; KOHRT WM, 1991, J APPL PHYSIOL, V71, P2004, DOI 10.1152/jappl.1991.71.5.2004; MAFFULLI N, 1994, J SPORT MED PHYS FIT, V34, P242; Marcell TJ, 2003, MED SCI SPORT EXER, V35, P810, DOI 10.1249/01.MSS.0000065002.69572.6F; McCole SD, 1999, J APPL PHYSIOL, V87, P2334, DOI 10.1152/jappl.1999.87.6.2334; MCPARLAND C, 1992, RESP PHYSIOL, V90, P311, DOI 10.1016/0034-5687(92)90111-9; MORGAN DW, 1992, MED SCI SPORT EXER, V24, P456; MORGAN DW, 1989, MED SCI SPORT EXER, V21, P78, DOI 10.1249/00005768-198902000-00014; Murias JM, 2011, J GERONTOL A-BIOL, V66, P957, DOI 10.1093/gerona/glr096; Murias JM, 2011, EUR J APPL PHYSIOL, V111, P235, DOI 10.1007/s00421-010-1649-6; Murias JM, 2010, MED SCI SPORT EXER, V42, P1891, DOI 10.1249/MSS.0b013e3181dd0bba; Neary JP, 2008, CLIN PHYSIOL FUNCT I, V28, P364, DOI 10.1111/j.1475-097X.2008.00822.x; OGAWA T, 1992, CIRCULATION, V86, P494, DOI 10.1161/01.CIR.86.2.494; Oussaidene K, 2015, RESP PHYSIOL NEUROBI, V205, P53, DOI 10.1016/j.resp.2014.10.009; Oussaidene K, 2013, EUR J APPL PHYSIOL, V113, P2047, DOI 10.1007/s00421-013-2637-4; Parker BA, 2008, EUR J APPL PHYSIOL, V103, P343, DOI 10.1007/s00421-008-0711-0; Peltonen JE, 2013, RESP PHYSIOL NEUROBI, V188, P102, DOI 10.1016/j.resp.2013.05.014; Peltonen JE, 2012, RESP PHYSIOL NEUROBI, V181, P267, DOI 10.1016/j.resp.2012.04.002; Peltonen JE, 2009, RESP PHYSIOL NEUROBI, V169, P24, DOI 10.1016/j.resp.2009.08.013; Perrey S, 2008, METHODS, V45, P289, DOI 10.1016/j.ymeth.2008.04.005; POSNER JD, 1992, J AM GERIATR SOC, V40, P1; Proctor DN, 2004, MED SCI SPORT EXER, V36, P623, DOI 10.1249/01.MSS.0000121951.10417.B5; Rupp T, 2008, EUR J APPL PHYSIOL, V102, P153, DOI 10.1007/s00421-007-0568-7; SEALS DR, 1984, J APPL PHYSIOL, V57, P1024, DOI 10.1152/jappl.1984.57.4.1024; Sheel AW, 2012, COMPR PHYSIOL, V2, P1093, DOI 10.1002/cphy.c100046; SHVARTZ E, 1990, AVIAT SPACE ENVIR MD, V61, P3; SPINA RJ, 1993, J APPL PHYSIOL, V75, P849, DOI 10.1152/jappl.1993.75.2.849; STEPHENSON LA, 1982, MED SCI SPORT EXER, V14, P270, DOI 10.1249/00005768-198204000-00003; Subudhi AW, 2008, AM J PHYSIOL-HEART C, V294, pH164, DOI 10.1152/ajpheart.01104.2007; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Tanaka H, 1997, J APPL PHYSIOL, V83, P1947, DOI 10.1152/jappl.1997.83.6.1947; Tanaka H, 2003, J APPL PHYSIOL, V95, P2152, DOI 10.1152/japplphysiol.00320.2003; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; van Beekvelt MCP, 2001, CLIN SCI, V101, P21, DOI 10.1042/CS20000247; Vanhees L, 2012, EUR J PREV CARDIOL, V19, P670, DOI 10.1177/2047487312437059; Wang BD, 2012, EUR J APPL PHYSIOL, V112, P567, DOI 10.1007/s00421-011-2007-z	71	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165433	10.1371/journal.pone.0165433	http://dx.doi.org/10.1371/journal.pone.0165433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832088	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000013
J	Schmidt, LB; Goertz, S; Wohlfahrt, J; Melbye, M; Munch, TN				Schmidt, Linnea Boegeskov; Goertz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard			Recurrent Intracerebral Hemorrhage: Associations with Comorbidities and Medicine with Antithrombotic Effects	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; LONG-TERM PROGNOSIS; BLOOD-PRESSURE; RISK; STROKE; ANTICOAGULATION; RESUMPTION; MORTALITY; WARFARIN; VALIDITY	Background Intracerebral hemorrhage (ICH) is a disease with high mortality and a substantial risk of recurrence. However, the recurrence risk is poorly documented and the knowledge of potential predictors for recurrence among co-morbidities and medicine with antithrombotic effect is limited. Objectives 1) To estimate the short- and long-term cumulative risks of recurrent intracerebral hemorrhage (ICH). 2) To investigate associations between typical comorbid diseases, surgical treatment, use of medicine with antithrombotic effects, including antithrombotic treatment (ATT), selective serotonin reuptake inhibitors (SSRI's), and nonsteroidal anti-inflammatory drugs (NSAID's) with recurrent ICH. Methods The cohort consisted of all individuals diagnosed with a primary ICH in Denmark 1996-2011. Information on comorbidities, surgical treatment for the primary ICH, and the use of ATT, SSRI's and NSAID's was retrieved from the Danish national health registers. The cumulative recurrence risk of ICH was estimated using the Aalen-Johansen estimator, thus taking into account the competing risk of death. Associations with potential predictors of recurrent ICH were estimated as rate ratios (RR's) using Poisson regression. Propensity score matching was used for the analyses of medicine with antithrombotic effects. Results Among 15,270 individuals diagnosed with a primary ICH, 2,053 recurrences were recorded, resulting in cumulative recurrence risk of 8.9% after one year and 13.7% after five years. Surgical treatment and renal insufficiency were associated with increased recurrence risks (RR 1.64, 95% CI 1.39-1.93 and RR 1.72, 95% CI 1.34-2.17, respectively), whereas antihypertensive treatment was associated with a reduced risk (RR 0.82, 95% CI 0.74-0.91). We observed non-significant associations between the use of any of the investigated medicines with antithrombotic effect (ATT, SSRI's, NSAID's) and recurrent ICH. Conclusions The substantial short- and long-term recurrence risks warrant aggressive management of hypertension following a primary ICH, particularly in patients treated surgically for the primary ICH, and patients with renal insufficiency.	[Schmidt, Linnea Boegeskov; Goertz, Sanne; Wohlfahrt, Jan; Melbye, Mads; Munch, Tina Noergaard] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Munch, Tina Noergaard] Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark	Statens Serum Institut; University of Copenhagen	Munch, TN (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.; Munch, TN (corresponding author), Copenhagen Univ Hosp, Dept Neurosurg, Copenhagen, Denmark.	TNM@ssi.dk		melbye, mads/0000-0001-8264-6785; Munch, Tina Norgaard/0000-0001-5938-000X; Schmidt, Linnea Boegeskov/0000-0001-6162-3090	Novo Nordisk Foundation; A.P. Moller Foundation for the Advancement of Medical Science	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A.P. Moller Foundation for the Advancement of Medical Science	The study was supported by a scholarship from the Novo Nordisk Foundation and The A.P. Moller Foundation for the Advancement of Medical Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Arakawa S, 1998, STROKE, V29, P1806, DOI 10.1161/01.STR.29.9.1806; Biffi A, 2010, NEUROLOGY, V04, P693; Bjerkreim AT, 2016, J STROKE CEREBROVASC, V25, P157, DOI 10.1016/j.jstrokecerebrovasdis.2015.09.009; Bos MJ, 2007, STROKE, V38, P3127, DOI 10.1161/STROKEAHA.107.489807; Christensen MC, 2009, CEREBROVASC DIS, V27, P353, DOI 10.1159/000202012; FitzMaurice E, 2008, STROKE, V39, P2151, DOI 10.1161/STROKEAHA.107.508861; Flynn RWV, 2010, STROKE, V41, P2606, DOI 10.1161/STROKEAHA.110.589143; Flynn RWV, 2010, CARDIOVASC THER, V28, P177, DOI 10.1111/j.1755-5922.2009.00118.x; Hackam DG, 2012, NEUROLOGY, V79, P1862, DOI 10.1212/WNL.0b013e318271f848; Huhtakangas J, 2013, STROKE, V44, P585, DOI 10.1161/STROKEAHA.112.671230; Izumihara A, 2005, SURG NEUROL, V64, P160, DOI 10.1016/j.surneu.2004.09.010; Johnsen SP, 2003, STROKE, V34, P387, DOI 10.1161/01.STR.0000054057.11892.5B; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kremer PHC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142338; Kuramatsu JB, 2015, JAMA-J AM MED ASSOC, V313, P824, DOI 10.1001/jama.2015.0846; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Majeed A, 2010, STROKE, V41, P2860, DOI 10.1161/STROKEAHA.110.593087; Mendelow AD, 2005, LANCET, V365, P387; Nakamura K, 2008, STROKE, V39, P1694, DOI 10.1161/STROKEAHA.107.496752; Neau JP, 1997, NEUROLOGY, V49, P106, DOI 10.1212/WNL.49.1.106; PASSERO S, 1995, STROKE, V26, P1189, DOI 10.1161/01.STR.26.7.1189; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Rix TA, 2012, SCAND CARDIOVASC J, V46, P149, DOI 10.3109/14017431.2012.673728; Shin D, 2014, J NEUROL, V261, P686, DOI 10.1007/s00415-014-7251-9; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Vermeer SE, 2002, NEUROLOGY, V59, P205, DOI 10.1212/WNL.59.2.205; Viswanathan A, 2006, NEUROLOGY, V66, P206, DOI 10.1212/01.wnl.0000194267.09060.77; Weimar C, 2011, CEREBROVASC DIS, V32, P283, DOI 10.1159/000330643; Yung D, 2012, CAN J CARDIOL, V28, P33, DOI 10.1016/j.cjca.2011.10.002	34	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166223	10.1371/journal.pone.0166223	http://dx.doi.org/10.1371/journal.pone.0166223			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832176	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000077
J	Crewe, C; Schafer, C; Lee, I; Kinter, M; Szweda, LI				Crewe, Clair; Schafer, Christopher; Lee, Irene; Kinter, Michael; Szweda, Luke I.			Regulation of Pyruvate Dehydrogenase Kinase 4 in the Heart through Degradation by the Lon Protease in Response to Mitochondrial Substrate Availability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE KIDNEY; COMPLEX; ACID; MECHANISMS; GLUCOSE; PURIFICATION; EXPRESSION; ISOENZYMES; COMPONENT; DISEASE	Cardiac metabolic inflexibility is driven by robust up-regulation of pyruvate dehydrogenase kinase 4 (PDK4) and phosphorylation-dependent inhibition of pyruvate dehydrogenase (PDH) within a single day of feeding mice a high fat diet. In the current study, we have discovered that PDK4 is a short lived protein (t(1/2) similar to 1 h) and is specifically degraded by the mitochondrial protease Lon. Lon does not rapidly degrade PDK1 and -2, indicating specificity toward the PDK isoform that is a potent modulator of metabolic flexibility. Moreover, PDK4 degradation appears regulated by dissociation from the PDH complex dependent on the respiratory state and energetic substrate availability of mouse heart mitochondria. Finally, we demonstrate that pharmacologic inhibition of PDK4 promotes PDK4 degradation in vitro and in vivo. These findings reveal a novel strategy to manipulate PDH activity by selectively targeting PDK4 content through dissociation and proteolysis.	[Crewe, Clair; Schafer, Christopher; Kinter, Michael; Szweda, Luke I.] Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Crewe, Clair; Szweda, Luke I.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Lee, Irene] Case Western Reserve Univ, Dept Chem, Cleveland, OH 44106 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; Case Western Reserve University	Szweda, LI (corresponding author), Oklahoma Med Res Fdn, Aging & Metab Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Luke-Szweda@omrf.org		Kinter, Michael/0000-0001-7409-8918	Oklahoma Medical Research Foundation	Oklahoma Medical Research Foundation	This work was supported by the Oklahoma Medical Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Bowker-Kinley MM, 1998, BIOCHEM J, V329, P191, DOI 10.1042/bj3290191; COOPER RH, 1974, BIOCHEM J, V143, P625, DOI 10.1042/bj1430625; Crewe C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077280; Grassian AR, 2011, GENE DEV, V25, P1716, DOI 10.1101/gad.16771811; Huang BL, 1998, J BIOL CHEM, V273, P17680, DOI 10.1074/jbc.273.28.17680; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Jeoung NH, 2008, AM J PHYSIOL-ENDOC M, V295, pE46, DOI 10.1152/ajpendo.00536.2007; Kamarajugadda S, 2012, MOL CELL BIOL, V32, P1893, DOI 10.1128/MCB.06248-11; Kim TY, 2012, MOL CELL PROTEOMICS, V11, P1586, DOI 10.1074/mcp.M112.021162; LINN TC, 1972, ARCH BIOCHEM BIOPHYS, V148, P327, DOI 10.1016/0003-9861(72)90151-8; Liu ZM, 2014, INT J ANTENN PROPAG, V2014, DOI 10.1155/2014/959386; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Miller JA, 2013, GENOME MED, V5, DOI 10.1186/gm452; Mori J, 2013, AM J PHYSIOL-HEART C, V304, pH1103, DOI 10.1152/ajpheart.00636.2012; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Rardin MJ, 2009, ANAL BIOCHEM, V389, P157, DOI 10.1016/j.ab.2009.03.040; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; STEPP LR, 1983, J BIOL CHEM, V258, P9454; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sun Y, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-20; Tao RY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071997; Tso SC, 2006, J BIOL CHEM, V281, P27197, DOI 10.1074/jbc.M604339200; Tuganova A, 2002, BIOCHEM J, V366, P129, DOI 10.1042/BJ20020301; Ussher JR, 2012, CARDIOVASC RES, V94, P359, DOI 10.1093/cvr/cvs129; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Wright JJ, 2009, CARDIOVASC RES, V82, P351, DOI 10.1093/cvr/cvp017; Wynn RM, 2008, J BIOL CHEM, V283, P25305, DOI 10.1074/jbc.M802249200	30	28	29	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					305	312		10.1074/jbc.M116.754127	http://dx.doi.org/10.1074/jbc.M116.754127			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27856638	Green Published, hybrid			2022-12-26	WOS:000391578000026
J	Byeon, H; Lee, D; Cho, S				Byeon, Haewon; Lee, Dongwoo; Cho, Sunghyoun			Association between Second-Hand Smoking and Laryngopathy in the General Population of South Korea	PLOS ONE			English	Article							ENVIRONMENTAL TOBACCO-SMOKE; PASSIVE SMOKING; VOICE DISORDERS; LUNG-CANCER; WOMEN; AMERICAN; TEACHERS; DISEASE; RISK	Purpose The relationship between second-hand smoking and laryngopathy has not yet been reported. Thus, this study investigates the relationship between second-hand smoking and laryngopathy and suggests basic empirical data to prevent laryngopathy. Methods This study analyzed 1,905 non-smokers over the age of 19 (269 men and 1,636 women) who completed the health questionnaire, laryngeal endoscope test, and urine cotinine test in the 2008 Korea National Health and Nutrition Examination Survey (KNHANES). Second-hand smoking was defined as a urine cotinine concentration of 50ng/ml and over. Confounding factors included age, gender, education, household income, occupation, alcohol consumption, and coffee consumption. Risk ratios (RR) and 95% confidence intervals (CI) were presented for the relationship between second-hand smoking and laryngopathy by using Poisson regression analysis. Results There was a significant relationship between second-hand smoking and laryngopathy (p<0.05). After all compounding factors were adjusted, non-smokers exposed to second-hand smoking had a 2.5 times (RR = 2.47, 95% CI: 1.19-5.08) significantly higher risk of laryngopathy than non-smokers not exposed to second-hand smoking (p<0.05). Conclusion In this epidemiological study, there was a significant relationship between second-hand smoking and laryngopathy. More effective anti-smoking policies are required to protect the health of both non-smokers and smokers.	[Byeon, Haewon] Nambu Univ, Sch Publ Hlth, Dept Speech Language Pathol & Audiol, Gwangju, South Korea; [Lee, Dongwoo] Honam Univ, Dept Phys Therapy, Sch Publ Hlth, Gwangju, South Korea; [Cho, Sunghyoun] Nambu Univ, Sch Publ Hlth, Dept Phys Therapy, Gwangju, South Korea	Nambu University; Honam University; Nambu University	Cho, S (corresponding author), Nambu Univ, Sch Publ Hlth, Dept Phys Therapy, Gwangju, South Korea.	nambupt@naver.com	Byeon, Haewon/R-2113-2019	Byeon, Haewon/0000-0002-3363-390X				[Anonymous], 2010, KOR NAT HLTH NUTR EX; Byeon H, 2015, PEERJ, V3, DOI 10.7717/peerj.912; CHESEBRO MJ, 1988, AM FAM PHYSICIAN, V37, P212; Cohen SM, 2010, LARYNGOSCOPE, V120, P2022, DOI 10.1002/lary.21058; Cutiva LCC, 2013, J COMMUN DISORD, V46, P143, DOI 10.1016/j.jcomdis.2013.01.001; Duarte Josilene Luciene, 2006, Rev. Bras. Otorrinolaringol., V72, P210, DOI 10.1590/S0034-72992006000200010; HIRAYAMA T, 1981, BRIT MED J, V282, P183, DOI 10.1136/bmj.282.6259.183; Hobbs SD, 2005, J VASC SURG, V41, P451, DOI 10.1016/j.jvs.2004.12.039; International Centre for Alcohol Policies, 2005, ICAP BLUE BOOK PRACT; Iribarren C, 2001, J EPIDEMIOL COMMUN H, V55, P721, DOI 10.1136/jech.55.10.721; Jee SH, 1999, INT J EPIDEMIOL, V28, P824, DOI 10.1093/ije/28.5.824; JINOT J, 1992, RESP HLTH EFFECTS PA; Johns Michael M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P456, DOI 10.1097/00020840-200312000-00009; Kang DH, 2004, TOXICITY SECONDHAND; Kang HG, 2013, ASIAN PAC J CANCER P, V14, P6807, DOI 10.7314/APJCP.2013.14.11.6807; Korea Centers for Disease Control and Prevention, 2011, KOR HLTH STAT 2010; Koufman JA, 2002, OTOLARYNG HEAD NECK, V127, P32, DOI 10.1067/mhn.2002.125760; Leao HZ, 2017, J VOICE, V31, DOI 10.1016/j.jvoice.2015.12.014; Lee PN, 2016, REGUL TOXICOL PHARM, V80, P134, DOI 10.1016/j.yrtph.2016.06.012; MOHTASHAMIPUR E, 1990, J CANCER RES CLIN, V116, P604, DOI 10.1007/BF01637081; Oberg M, 2010, SECONDHAND SMOKE ASS; Park Soon Woo, 2009, J Prev Med Public Health, V42, P223, DOI 10.3961/jpmph.2009.42.4.223; Ramroth H, 2008, EUR ARCH OTO-RHINO-L, V265, P1367, DOI 10.1007/s00405-008-0651-7; Reijula J, 2015, SCAND J PUBLIC HEALT, V43, P204, DOI 10.1177/1403494814565130; ROBBINS AS, 1993, INT J EPIDEMIOL, V22, P809, DOI 10.1093/ije/22.5.809; Roy N, 2005, LARYNGOSCOPE, V115, P1988, DOI 10.1097/01.mlg.0000179174.32345.41; Roy N, 2004, J SPEECH LANG HEAR R, V47, P281, DOI 10.1044/1092-4388(2004/023); Savitz DA, 2001, EPIDEMIOLOGY, V12, P636, DOI 10.1097/00001648-200111000-00010; Signorello LB, 2009, DIS MARKERS, V27, P187, DOI [10.1155/2009/104647, 10.3233/DMA-2009-0661]; U. S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; U. S. Department of Health and Human Services, 1993, RESP HLTH EFF PASS S; U. S Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; World Health Organization, 2009, IMPL SMOK FREE ENV R; Yuan JM, 2000, INT J CANCER, V85, P364, DOI 10.1002/(SICI)1097-0215(20000201)85:3&lt;364::AID-IJC12&gt;3.0.CO;2-C	34	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165337	10.1371/journal.pone.0165337	http://dx.doi.org/10.1371/journal.pone.0165337			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861497	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300006
J	Fan, WG; Zhang, QS; Wang, L; Ye, X; Jiang, TW				Fan, Wenge; Zhang, Qingsong; Wang, Lin; Ye, Xun; Jiang, Tingwang			Risk Factors associated with Paraurethral Duct Dilatation following Gonococcal Paraurethral Duct Infection in Men	PLOS ONE			English	Article							PERIURETHRAL FIBROSIS SECONDARY; EXTERNAL URETHRAL ORIFICE; CHLAMYDIA-TRACHOMATIS; INFLAMMATION; GLANDS; SYMPTOMS; SEQUELAE	No studies have explored the risk factors for paraurethral duct dilatation following paraurethral duct infection by Neisseria gonorrhoeae in men undergoing ceftriaxone therapy. The present study was performed to explore the risk factors for paraurethral duct dilatation following paraurethral duct infection by N. gonorrhoeae in men undergoing ceftriaxone therapy and thus guide clinical interventions. We compared the demographic, behavioral, and clinical data of men with paraurethral duct infection by N. gonorrhoeae with and without dilatation of the paraurethral duct. Univariate analysis showed significant differences in age, disease course of the infected paraurethral duct, Chlamydia trachomatis infection in the paraurethral duct, and a history of paraurethral duct infection by N. gonorrhoeae between the patient and control groups (P<0.05). Multivariate logistic regression analysis showed consistent results (P<0.05). This study that shows delayed treatment may be a major risk factor for paraurethral duct dilatation secondary to paraurethral duct infection by N. gonorrhoeae in men. Age, C. trachomatis infection in the paraurethral duct, and a history of paraurethral duct infection by N. gonorrhoeae are also risk factors. Thus, educating patients to undergo timely therapy and treating the C. trachomatis infection may be effective interventions.	[Fan, Wenge; Wang, Lin] Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Dept Dermatol, Changshu 215500, Jiangsu, Peoples R China; [Zhang, Qingsong] Tradit Chinese Med Hosp Changshu City, Dept Dermatol, Changshu 215500, Jiangsu, Peoples R China; [Ye, Xun] Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Dept Ultrasound, Changshu 215500, Jiangsu, Peoples R China; [Jiang, Tingwang] Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Dept Clin Lab, Changshu 215500, Jiangsu, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Fan, WG (corresponding author), Soochow Univ, Changshu Hosp, Peoples Hosp Changshu City 1, Dept Dermatol, Changshu 215500, Jiangsu, Peoples R China.	csyyfwg@163.com	Jiang, Tingwang/AAW-6431-2021					Ambrose K., 1969, VENEREAL DIS, P161; Beatty Wandy L., 1994, Trends in Microbiology, V2, P94, DOI 10.1016/0966-842X(94)90542-8; Cantiello F, 2014, INT J UROL, V21, P264, DOI 10.1111/iju.12233; Cantiello F, 2013, UROLOGY, V81, P1018, DOI 10.1016/j.urology.2013.01.053; Fan W, 2016, J EUR ACAD DERMATOL, V30, P146, DOI 10.1111/jdv.12638; Fan W, 2013, INT J STD AIDS, V24, P159, DOI 10.1177/0956462413481554; Fan W, 2012, INT J STD AIDS, V23, P400, DOI 10.1258/ijsa.2011.011319; Fan W, 2010, INT J STD AIDS, V21, P225, DOI 10.1258/ijsa.2009.009485; Fan WG, 2015, SEX TRANSM INFECT, V91, P193, DOI 10.1136/sextrans-2014-051773; Fan WG, 2014, SEX TRANSM INFECT, V90, P52, DOI 10.1136/sextrans-2013-051180; Fan WG, 2013, INT J DERMATOL, V52, P1567, DOI 10.1111/j.1365-4632.2011.05160.x; Fan WG, 2012, J DERMATOL TREAT, V23, P184, DOI 10.3109/09546634.2010.519377; Furuya R, 2004, J UROLOGY, V171, P1550, DOI 10.1097/01.ju.0000116288.59223.e9; GILHOOLY P, 1984, UROLOGY, V24, P375, DOI 10.1016/0090-4295(84)90217-6; Haggerty CL, 2010, J INFECT DIS, V201, pS134, DOI 10.1086/652395; HARKNESS A. H., 1948, BRIT JOUR VENEREAL PIS, V24, P137; Itoh M, 1999, INT J ANDROL, V22, P91; Jesus LE, 2014, J UROLOGY, V191, P1856, DOI 10.1016/j.juro.2013.11.098; Lyss SB, 2003, ANN INTERN MED, V139, P178, DOI 10.7326/0003-4819-139-3-200308050-00007; Sherrard J., 2014, MEDICINE, V42, P323, DOI 10.1016/j.mpmed.2014.03.011; Wong L, 2015, PROSTATE, V75, P23, DOI 10.1002/pros.22886; Wong L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100770	22	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166355	10.1371/journal.pone.0166355	http://dx.doi.org/10.1371/journal.pone.0166355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861521	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300050
J	Angkurawaranon, C; Nitsch, D; Larke, N; Rehman, AM; Smeeth, L; Addo, J				Angkurawaranon, C.; Nitsch, D.; Larke, N.; Rehman, A. M.; Smeeth, L.; Addo, J.			Ecological Study of HIV Infection and Hypertension in Sub-Saharan Africa: Is There a Double Burden of Disease?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; NONCOMMUNICABLE DISEASES; INCOME COUNTRIES; BLOOD-PRESSURE; PREVALENCE; ERA; HEALTH; ART	An ecological correlation study of the prevalence of hypertension with human immunodeficiency virus (HIV) prevalence in sub-Saharan Africa was conducted to determine the extent to which these conditions coincide at country level. Methods Data on prevalence of hypertension were derived from a systematic search of literature published between 1975 and 2014 with corresponding national estimates on HIV prevalence and antiretroviral therapy (ART) coverage from the Demographic and Health Surveys and the joint United Nations Programme on HIV/AIDS databases. National estimates on gross national income (GNI) and under-five mortality were obtained from the World Bank database. Linear regression analyses using robust standard errors (allowing for clustering at country level) were carried out for associations of age-standardised hypertension prevalence ratios (standardized to rural Uganda's hypertension prevalence data) with HIV prevalence, adjusted for national indicators, year of study and sex of the study population. Results In total, 140 estimates of prevalence of hypertension representing 25 nations were sex-and area-matched with corresponding HIV prevalence. A two-fold increase in HIV prevalence was associated with a 9.29% increase in age, sex and study year-adjusted prevalence ratio for hypertension (95% CI 2.0 to 16.5, p = 0.01), which increased to 16.3% (95% CI 9.3 to 21.1) after adjusting for under-five mortality, GNI per capita and ART coverage. Conclusions Countries with a pronounced burden of HIV may also have an increased burden of non-communicable diseases such as hypertension with potential economic and health systems implications.	[Angkurawaranon, C.] Chiang Mai Univ, Fac Med, Dept Family Med, Chiang Mai, Thailand; [Nitsch, D.; Smeeth, L.; Addo, J.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England; [Larke, N.; Rehman, A. M.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, Med Res Council,Trop Epidemiol Grp, London, England	Chiang Mai University; University of London; London School of Hygiene & Tropical Medicine; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine	Addo, J (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England.	juliet.addo@lshtm.ac.uk	Rehman, Andrea/AAP-3172-2020; Rehman, Andrea M/H-1351-2015; Angkurawaranon, Chaisiri/I-6140-2015; Smeeth, Liam/X-5862-2018	Rehman, Andrea/0000-0001-9967-5822; Rehman, Andrea M/0000-0001-9967-5822; Angkurawaranon, Chaisiri/0000-0003-4206-9164; Smeeth, Liam/0000-0002-9168-6022; Nitsch, Dorothea/0000-0001-5767-248X	Wellcome Trust; MRC Tropical Epidemiology Group at LSHTM from MRC-UK [MR/K012126/1]; Medical Research Council [MR/K012126/1, MR/K006584/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); MRC Tropical Epidemiology Group at LSHTM from MRC-UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	LS is supported by a senior clinical fellowship from the Wellcome Trust. AR and NL receive funding through the MRC Tropical Epidemiology Group at LSHTM from MRC-UK, grant code MR/K012126/1. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; LS is supported by a senior clinical fellowship from the Wellcome Trust. AMR and NLL receive funding through the MRC Tropical Epidemiology Group at LSHTM from MRC-UK, grant code MR/K012126/1. We thank Professor Helen Weiss for providing useful comments on a draft of this manuscript.	Abrahams Z, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0065-8; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Amico P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012997; Bloomfield GS, 2014, JAIDS-J ACQ IMM DEF, V67, pS40, DOI 10.1097/QAI.0000000000000257; Bloomfield GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022288; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dalal S, 2011, INT J EPIDEMIOL, V40, P885, DOI 10.1093/ije/dyr050; Dillon DG, 2013, INT J EPIDEMIOL, V42, P1754, DOI 10.1093/ije/dyt198; Glass TR, 2006, HIV MED, V7, P404, DOI 10.1111/j.1468-1293.2006.00400.x; Grunfeld C, 2009, AIDS, V23, P1841, DOI 10.1097/QAD.0b013e32832d3b85; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hult M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013582; Nguyen KA, 2015, AIDS REV, V17, P83; Lambert CT, 2016, HIV MED, V17, P411, DOI 10.1111/hiv.12346; Lamptey P, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001086; Lemoine M, 2012, J PUBLIC HEALTH POL, V33, P430, DOI 10.1057/jphp.2012.29; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Maher D, 2012, GLOBALIZATION HEALTH, V8, DOI 10.1186/1744-8603-8-14; Maher D, 2011, J HYPERTENS, V29, P1061, DOI 10.1097/HJH.0b013e3283466e90; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Marquez P FJ, 2012, BMJ-BRIT MED J, V345, pe581; Mateen FJ, 2013, J HYPERTENS, V31, P1372, DOI 10.1097/HJH.0b013e328360de1c; Narayan KMV, 2014, JAIDS-J ACQ IMM DEF, V67, pS2, DOI 10.1097/QAI.0000000000000267; Nugent RA, 2009, LANCET, V374, P784, DOI 10.1016/S0140-6736(09)61589-0; Oni T, 2015, INT HEALTH, V7, P390, DOI 10.1093/inthealth/ihv040; Pacheco AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117461; Peck RN, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0125-2; Ravishankar N, 2009, LANCET, V373, P2113, DOI 10.1016/S0140-6736(09)60881-3; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Thiebaut R, 2005, ANTIVIR THER, V10, P811; Twagirumukiza M, 2011, J HYPERTENS, V29, P1243, DOI 10.1097/HJH.0b013e328346995d; Walker R, 2010, LANCET NEUROL, V9, P786, DOI 10.1016/S1474-4422(10)70144-7; World Health Organization, GLOB HIV AIDS RESP E; World Health Organization, GLOB STAT REP NONC D; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Zatu MC, 1995, SMOKING VASCULAR DYS	36	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166375	10.1371/journal.pone.0166375	http://dx.doi.org/10.1371/journal.pone.0166375			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855194	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000387910200028
J	Cortes-Berrueco, LE; Gershenson, C; Stephens, CR				Cortes-Berrueco, Luis E.; Gershenson, Carlos; Stephens, Christopher R.			Traffic Games: Modeling Freeway Traffic with Game Theory	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; FLOW; EVOLUTION; POLICIES	We apply game theory to a vehicular traffic model to study the effect of driver strategies on traffic flow. The resulting model inherits the realistic dynamics achieved by a two-lane traffic model and aims to incorporate phenomena caused by driver-driver interactions. To achieve this goal, a game-theoretic description of driver interaction was developed. This game-theoretic formalization allows one to model different lane-changing behaviors and to keep track of mobility performance. We simulate the evolution of cooperation, traffic flow, and mobility performance for different modeled behaviors. The analysis of these results indicates a mobility optimization process achieved by drivers' interactions.	[Cortes-Berrueco, Luis E.] Univ Nacl Autonoma Mexico, Posgrad Ciencia & Ingn Comp, Mexico City, DF, Mexico; [Gershenson, Carlos] Univ Nacl Autonoma Mexico, Inst Invest Matemat Aplicadas & Sistemas, Mexico City, DF, Mexico; [Gershenson, Carlos] MIT, SENSEable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Gershenson, Carlos] Northeastern Univ, MoBS Lab, Evanstone, IL USA; [Gershenson, Carlos] ITMO Univ, St Petersburg, Russia; [Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Mexico City, DF, Mexico; [Gershenson, Carlos; Stephens, Christopher R.] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Massachusetts Institute of Technology (MIT); ITMO University; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Cortes-Berrueco, LE (corresponding author), Univ Nacl Autonoma Mexico, Posgrad Ciencia & Ingn Comp, Mexico City, DF, Mexico.	lecortesb@comunicad.unam.mx	Gershenson, Carlos/F-2241-2010	Gershenson, Carlos/0000-0003-0193-3067	Consejo Nacional de Ciencia y Tecnologia, Mexico [CONACYT 212802]	Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors of this paper received research funding from Consejo Nacional de Ciencia y Tecnologia (CONACYT 212802), Mexico. The funders (CONACYT) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUMANN RJ, 1985, J ECON THEORY, V36, P195, DOI 10.1016/0022-0531(85)90102-4; Brams S, 1994, HDB GAME THEORY, V2, P1055, DOI DOI 10.1016/S1574-0005(05)80062-1; Bretherton D., 2006, TRAFFIC ENG CONTROL, V47, P88; Christie R, 2001, ROAD SAF RES POL ED; Cools S. -B., 2013, ADV APPL SELF ORG SY, P45, DOI [10.1007/978-1-4471-5113-5_3, DOI 10.1007/978-1-4471-5113-5_3]; Cortes-Berrueco LE, 2013, SELF ORG PROMOTES EV; DUGATKIN LA, 1992, ANN ZOOL FENN, V29, P233; Dukes RL, 2001, SOC SCI J, V38, P323, DOI 10.1016/S0362-3319(01)00117-3; Cortes-Berrueco LE, 2014, LECT NOTES COMPUT SC, V8221, P145, DOI 10.1007/978-3-642-54140-7_13; Gershenson C, 2015, COMPLEXITY, V21, P9, DOI 10.1002/cplx.21736; Guzman HA, 2015, J CELL AUTOM, V10, P65; Helbing D, 1998, NATURE, V396, P738, DOI 10.1038/25499; Hollander Y, 2006, TRANSPORTATION, V33, P481, DOI 10.1007/s11116-006-0009-1; Ibrahim AH, 2005, APACE: 2005 Asia-Pacific Conference on Applied Electromagnetics, Proceedings, P378; Ichinose G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05104; Jia B, 2005, PHYSICA A, V348, P544, DOI 10.1016/j.physa.2004.09.034; Johnstone RA, 1996, PHILOS T R SOC B, V351, P329, DOI 10.1098/rstb.1996.0026; Katsaros K, 2011, WIREL COMMUN MOB COM, V11, P1657, DOI 10.1002/wcm.1233; Kesting A, 2007, TRANSPORT RES REC, P86, DOI 10.3141/1999-10; Krauss S, 1997, PHYS REV E, V55, P5597, DOI 10.1103/PhysRevE.55.5597; Larraga ME, 2010, PHYSICA A, V389, P5425, DOI 10.1016/j.physa.2010.08.020; Maerivoet S, 2005, PHYS REP, V419, P1, DOI 10.1016/j.physrep.2005.08.005; Nagatani T, 2005, PHYSICA A, V348, P561, DOI 10.1016/j.physa.2004.09.004; NAGEL K, 1992, J PHYS I, V2, P2221, DOI 10.1051/jp1:1992277; Nakata M, 2010, PHYSICA A, V389, P5353, DOI 10.1016/j.physa.2010.08.005; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; ONeill B., 1994, HDB GAME THEORY EC A, V2, P995, DOI DOI 10.1016/S1574-0005(05)80061-X; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Talebpour A, 2015, TRANSP RES PROC, V7, P420, DOI 10.1016/j.trpro.2015.06.022; Toledo BA, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.016107; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Vasconcelos VV, 2014, P NATL ACAD SCI USA, V111, P2212, DOI 10.1073/pnas.1323479111; Wada M, 2005, 2005 IEEE INTELLIGENT VEHICLES SYMPOSIUM PROCEEDINGS, P601; Wang M, 2015, TRANSPORT RES C-EMER, V58, P73, DOI 10.1016/j.trc.2015.07.009; Wastavino LA, 2007, PHYSICA A, V381, P411, DOI 10.1016/j.physa.2007.03.052; Yao D., 2010, 2010 INT C COMP INF, P152, DOI [DOI 10.1109/ICCIA.2010.6141559, 10.1109/ICCIA.2010.6141559]	37	9	9	5	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165381	10.1371/journal.pone.0165381	http://dx.doi.org/10.1371/journal.pone.0165381			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855176	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200010
J	Hong, J				Hong, Jin			Perfect Rainbow Tradeoff with Checkpoints Revisited	PLOS ONE			English	Article							SUCCESS PROBABILITY; OFF CRYPTANALYSIS; MEMORY	The rainbow tradeoff is an algorithm for inverting one-way functions that is widely used in practice to recover passwords from unsalted password hashes. An auxiliary technique referred to as checkpoints can be applied to the rainbow tradeoff to reduce the time taken for these inversions. Working out a rigorous theory that can explain and predict the effects of this technique involves delicate manipulations of the random function and is thus a challenging task. In this work, we compare three existing theoretical analyses of the checkpoint technique. We first demonstrate that the claims made by the three works are incompatible with each other. We then carry out experiments designed to highlight these incompatibilities, obtaining experimental evidences that show just one of the three analyses to be correct. Finally, we discuss the obscure theoretical errors made by the two inadequate analyses.	[Hong, Jin] Seoul Natl Univ, Dept Math Sci, Seoul 08826, South Korea; [Hong, Jin] Seoul Natl Univ, ISaC, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Hong, J (corresponding author), Seoul Natl Univ, Dept Math Sci, Seoul 08826, South Korea.; Hong, J (corresponding author), Seoul Natl Univ, ISaC, Seoul 08826, South Korea.	jinhong@snu.ac.kr	Hong, Jin/A-4879-2009	Hong, Jin/0000-0002-9235-9824	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2012R1A1B4003379]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2012R1A1B4003379). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avoine G, 2005, LECT NOTES COMPUT SC, V3797, P183; Avoine G, 2015, LECT NOTES COMPUT SC, V9144, P356, DOI 10.1007/978-3-319-19962-7_21; Avoine G, 2008, ACM T INFORM SYST SE, V11, DOI 10.1145/1380564.1380565; Babbage S.H., 1995, P EUR CONV SEC DET, V408, P161, DOI DOI 10.1049/CP:19950490; Barkan E, 2006, LECT NOTES COMPUT SC, V4117, P1; Barkan P., 2006, PHD THESIS; Biryukov A, 2006, LECT NOTES COMPUT SC, V3897, P110; Biryukov A, 2000, LECT NOTES COMPUT SC, V1976, P1; Borst J., 1998, S INF THEOR BEN VELD, P111; Borst J., 2001, THESIS; Calik C., 2007, THESIS; Denning D.E.R., 1982, CRYPTOGRAPHY DATA SE; Golic J. D., 1997, Advances in Cryptology - EUROCRYPT '97. International Conference on the Theory and Application of Cryptographic Techniques Proceedings, P239; HELLMAN ME, 1980, IEEE T INFORM THEORY, V26, P401, DOI 10.1109/TIT.1980.1056220; Hong J, 2013, J CRYPTOL, V26, P559, DOI 10.1007/s00145-012-9128-3; Hong J, 2010, DESIGN CODE CRYPTOGR, V57, P293, DOI 10.1007/s10623-010-9368-x; Kim IJ, 1999, IEICE T FUND ELECTR, VE82A, P123; Kim JW, 2015, SOFTWARE PRACT EXPER, V45, P837, DOI 10.1002/spe.2257; Kusuda K, 1996, IEICE T FUND ELECTR, VE79A, P35; Lee GW, 2016, DESIGN CODE CRYPTOGR, V80, P473, DOI 10.1007/s10623-015-0116-0; Ma DG, 2009, INFORM PROCESS LETT, V109, P347, DOI 10.1016/j.ipl.2008.12.002; Nohl K., 2010, BLACK HAT US 2010 LA; Nohl K, 2009, 26 CHAOS COMM C 26C3; Oechslin P, 2003, LECT NOTES COMPUT SC, V2729, P617; Quisquater J.-J., 1998, TIME MEMORY TR UNPUB; Saran AN, 2009, THESIS; Standaert FX, 2002, LECT NOTES COMPUT SC, V2523, P593; Wenhao Wang, 2013, Information and Communications Security. 15th International Conference, ICICS 2013. Proceedings: LNCS 8233, P288, DOI 10.1007/978-3-319-02726-5_21	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166404	10.1371/journal.pone.0166404	http://dx.doi.org/10.1371/journal.pone.0166404			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855190	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200029
J	Jackson, EW; Bistolas, KSI; Button, JB; Hewson, I				Jackson, Elliot W.; Bistolas, Kalia S. I.; Button, Jason B.; Hewson, Ian			Novel Circular Single-Stranded DNA Viruses among an Asteroid, Echinoid and Holothurian (Phylum: Echinodermata)	PLOS ONE			English	Article							MASS MORTALITY; NOVA-SCOTIA; SEA-STAR; DISCOVERY; ALIGNMENT; DISEASE; URCHIN	Echinoderms are prone to large population fluctuations that can be mediated by pervasive disease events. For the majority of echinoderm disease events the causative pathogen is unknown. Viruses have only recently been explored as potential pathogens using culture independent techniques though little information currently exists on echinoderm viruses. In this study, ten circular ssDNA viruses were discovered in tissues among an asteroid (Asterias forbesi), an echinoid (Strongylocentrotus droebachiensis) and a holothurian (Parastichopus californicus) using viral metagenomics. Genome architecture and sequence similarity place these viruses among the rapidly expanding circular rep-encoding single stranded (CRESS) DNA viral group. Multiple genomes from the same tissue were no more similar in sequence identity to each other than when compared to other known CRESS DNA viruses. The results from this study are the first to describe a virus from a holothurian and continue to show the ubiquity of these viruses among aquatic invertebrates.	[Jackson, Elliot W.; Bistolas, Kalia S. I.; Button, Jason B.; Hewson, Ian] Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA; [Button, Jason B.] Univ Delaware, Dept Oceanog, Lewes, DE 19958 USA	Cornell University; University of Delaware	Jackson, EW (corresponding author), Cornell Univ, Dept Microbiol, Ithaca, NY 14850 USA.	ewj34@cornell.edu	Jackson, Elliot/W-2178-2019	Jackson, Elliot/0000-0002-4213-3851	National Science Foundation OCE Division of Ocean Sciences [1537 111, 1356964]; Division Of Ocean Sciences [1537111] Funding Source: National Science Foundation	National Science Foundation OCE Division of Ocean Sciences; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by National Science Foundation OCE Division of Ocean Sciences (award number, 1537 111 and 1356964).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BREITBART M, 2015, FRONT MICROBIOL, V6, DOI DOI 10.3389/FMICB.2015.00006; Dayaram A, 2016, INFECT GENET EVOL, V39, P304, DOI 10.1016/j.meegid.2016.02.011; Dayaram A, 2015, INFECT GENET EVOL, V31, P284, DOI 10.1016/j.meegid.2015.02.010; DUNGAN ML, 1982, SCIENCE, V216, P989, DOI 10.1126/science.216.4549.989; Dunlap DS, 2013, P NATL ACAD SCI USA, V110, P1375, DOI 10.1073/pnas.1216595110; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellis J, 1998, CAN VET J, V39, P44; Fahsbender E, 2015, ARCH VIROL, V160, P2349, DOI 10.1007/s00705-015-2503-2; Feehan CJ, 2013, DIS AQUAT ORGAN, V103, P209, DOI 10.3354/dao02577; Gudenkauf BM, 2014, J GEN VIROL, V95, P652, DOI 10.1099/vir.0.060780-0; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hewson I, 2013, LIMNOL OCEANOGR, V58, P1605, DOI 10.4319/lo.2013.58.5.1605; Hewson I, 2013, J GREAT LAKES RES, V39, P499, DOI 10.1016/j.jglr.2013.06.006; Koonin EV, 2014, MICROBIOL MOL BIOL R, V78, P278, DOI 10.1128/MMBR.00049-13; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; MILLER RJ, 1983, MAR BIOL, V73, P263, DOI 10.1007/BF00392252; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13; Rosario K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00696; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Wang YN, 2013, DEV AQUAC FISH SCI, V38, P179, DOI 10.1016/B978-0-12-396491-5.00012-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	26	10	10	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166093	10.1371/journal.pone.0166093	http://dx.doi.org/10.1371/journal.pone.0166093			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855181	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200019
J	Sato, Y; Mabuchi, Y; Miyamoto, K; Araki, D; Niibe, K; Houlihan, DD; Morikawa, S; Nakagawa, T; Nakajima, T; Akazawa, C; Hori, S; Okano, H; Matsuzaki, Y				Sato, Yukio; Mabuchi, Yo; Miyamoto, Kenichi; Araki, Daisuke; Niibe, Kunimichi; Houlihan, Diarmaid D.; Morikawa, Satoru; Nakagawa, Taneaki; Nakajima, Toshihiro; Akazawa, Chihiro; Hori, Shingo; Okano, Hideyuki; Matsuzaki, Yumi			Notch2 Signaling Regulates the Proliferation of Murine Bone Marrow-Derived Mesenchymal Stem/Stromal Cells via c-Myc Expression	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; DIFFERENTIATION; NEUROGENESIS; GLIOGENESIS; MAINTENANCE; PROGENITORS; ACTIVATION; MUTATIONS; DISORDER; MAINTAIN	Mesenchymal stem/stromal cells (MSCs) reside in the bone marrow and maintain their stemness under hypoxic conditions. However, the mechanism underlying the effects of hypoxia on MSCs remains to be elucidated. This study attempted to uncover the signaling pathway of MSC proliferation. Under low-oxygen culture conditions, MSCs maintained their proliferation and differentiation abilities for a long term. The Notch2 receptor was up-regulated in MSCs under hypoxic conditions. Notch2-knockdown (Notch2-KD) MSCs lost their cellular proliferation ability and showed reduced gene expression of hypoxia-inducible transcription factor (HIF)-1 alpha, HIF-2 alpha, and c-Myc. Overexpression of the c-Myc gene in Notch2-D MSCs allowed the cells to regain their proliferation capacity. These results suggested that Notch2 signaling is linked to c-Myc expression and plays a key role in the regulation of MSC proliferation. Our findings provide important knowledge for elucidating the self-replication competence of MSCs in the bone marrow microenvironment.	[Sato, Yukio; Hori, Shingo] Keio Univ, Sch Med, Dept Emergency & Crit Care Med, Tokyo 1608582, Japan; [Sato, Yukio; Mabuchi, Yo; Okano, Hideyuki; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Sato, Yukio; Nakajima, Toshihiro; Matsuzaki, Yumi] Tokyo Med Univ, Inst Med Sci, Tokyo 1600023, Japan; [Mabuchi, Yo; Akazawa, Chihiro] Tokyo Med & Dent Univ, Grad Sch Hlth Care Sci, Dept Biochem & Biophys, Tokyo 1138510, Japan; [Miyamoto, Kenichi; Matsuzaki, Yumi] Shimane Univ, Fac Med, Dept Life Sci, Matsue, Shimane 6938501, Japan; [Araki, Daisuke; Niibe, Kunimichi; Morikawa, Satoru; Nakagawa, Taneaki] Keio Univ, Sch Med, Dept Dent & Oral Surg, Tokyo 1608582, Japan; [Niibe, Kunimichi] Tohoku Univ, Grad Sch Dent, Div Mol & Regenerat Prosthodont, Sendai, Miyagi 9808575, Japan; [Houlihan, Diarmaid D.] Univ Birmingham, Liver Res Ctr, NIHR Biomed Res Unit, Birmingham B15 2TT, W Midlands, England	Keio University; Keio University; Tokyo Medical University; Tokyo Medical & Dental University (TMDU); Shimane University; Keio University; Tohoku University; University of Birmingham	Matsuzaki, Y (corresponding author), Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan.; Matsuzaki, Y (corresponding author), Tokyo Med Univ, Inst Med Sci, Tokyo 1600023, Japan.; Matsuzaki, Y (corresponding author), Shimane Univ, Fac Med, Dept Life Sci, Matsue, Shimane 6938501, Japan.	matsuzak@med.shimane-u.ac.jp	Okano, Hideyuki/X-9131-2019; Mabuchi, Yo/L-1535-2013; Okano, Hideyuki/I-7584-2019; Morikawa, Satoru/AFL-5621-2022	Okano, Hideyuki/0000-0001-7482-5935; Mabuchi, Yo/0000-0001-8008-3966; Morikawa, Satoru/0000-0001-8859-2888; Matsuzaki, Yumi/0000-0002-3729-2997; Sato, Yukio/0000-0001-5981-7224	Japanese Association for Acute Medicine; Publictrust-Fundation of Marumo ER Research Institute; Ministry of Education, Culture, Sports, Science and Technology of Japan [15K06853]; Grants-in-Aid for Scientific Research [16H05845, 16H05157] Funding Source: KAKEN	Japanese Association for Acute Medicine; Publictrust-Fundation of Marumo ER Research Institute; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Association for Acute Medicine, Publictrust-Fundation of Marumo ER Research Institute (YS), and grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (YM) (15K06853). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asosingh K, 2005, HAEMATOLOGICA, V90, P810; Choi JR, 2014, BIOCHEM BIOPH RES CO, V448, P218, DOI 10.1016/j.bbrc.2014.04.096; Dong YF, 2014, STEM CELL TRANSL MED, V3, P1456, DOI 10.5966/sctm.2014-0034; Forristal CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062507; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Guarnerio J, 2014, STEM CELL REP, V2, P794, DOI 10.1016/j.stemcr.2014.04.002; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Houlihan DD, 2012, NAT PROTOC, V7, P2103, DOI 10.1038/nprot.2012.125; Ikezawa Y, 2017, INT J CLIN ONCOL, V22, P59, DOI 10.1007/s10147-016-1031-8; Isidor B, 2011, NAT GENET, V43, P306, DOI 10.1038/ng.778; Kennedy AS, 1997, INT J RADIAT ONCOL, V37, P897, DOI 10.1016/S0360-3016(96)00539-1; Kim J, 2009, ARCH PHARM RES, V32, P117, DOI 10.1007/s12272-009-1125-1; Kusumbe AP, 2016, NATURE, V532, P380, DOI 10.1038/nature17638; Mabuchi Y, 2016, INT J HEMATOL, V103, P138, DOI 10.1007/s12185-015-1921-y; Mabuchi Y, 2013, STEM CELL REP, V1, P152, DOI 10.1016/j.stemcr.2013.06.001; Mabuchi Y, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/507301; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Min JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147846; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Muto J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033431; Nakano N, 2015, J IMMUNOL, V194, P4535, DOI 10.4049/jimmunol.1301850; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Ogata Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129096; Ong WK, 2014, STEM CELL REP, V2, P171, DOI 10.1016/j.stemcr.2014.01.002; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Petruzzelli R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108309; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Santoyo-Ramos P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112580; Sethi N, 2011, CANCER CELL, V19, P192, DOI 10.1016/j.ccr.2010.12.022; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Valtieri M, 2008, J CELL PHYSIOL, V217, P296, DOI 10.1002/jcp.21521; Yamamoto M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3299; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yasui T, 2016, J DENT RES, V95, P206, DOI 10.1177/0022034515610748; Zanotti S, 2008, ENDOCRINOLOGY, V149, P3890, DOI 10.1210/en.2008-0140; Zhang CP, 2011, ENDOCRINOLOGY, V152, P2437, DOI 10.1210/en.2010-1182; Zhu XY, 2015, STEM CELL REP, V5, P1196, DOI 10.1016/j.stemcr.2015.11.001	46	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165946	10.1371/journal.pone.0165946	http://dx.doi.org/10.1371/journal.pone.0165946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855169	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200013
J	Zhang, SM; Jin, SF; Zhang, H; Fan, W; Tang, FH; Yang, SL				Zhang, Shengmao; Jin, Shaofei; Zhang, Heng; Fan, Wei; Tang, Fenghua; Yang, Shenglong			Distribution of Bottom Trawling Effort in the Yellow Sea and East China Sea	PLOS ONE			English	Article							MONITORING-SYSTEM DATA; BENTHIC BIOMASS; DISTURBANCE; FISHERIES; RECOVERY; SEDIMENT; DENSITY; IMPACT; VMS	Bottom trawling is one of the most efficient fishing activities, but serious and persistent ecological issues have been observed by fishers, scientists and fishery managers. Although China has applied the Beidou fishing vessel position monitoring system (VMS) to manage trawlers since 2006, little is known regarding the impacts of trawling on the sea bottom environments. In this study, continuous VMS data of the 1403 single-rig otter trawlers registered in the Xiangshan Port, 3.9% of the total trawlers in China, were used to map the trawling effort in 2013. We used the accumulated distance (AD), accumulated power distance (APD), and trawling intensity as indexes to express the trawling efforts in the Yellow Sea (YS) and East China Sea (ECS). Our results show that all three indexes had similar patterns in the YS and ECS, and indicated a higher fishing effort of fishing grounds that were near the port. On average, the seabed was trawled 0.73 times in 2013 over the entire fishing region, and 51.38% of the total fishing grounds were with no fishing activities. Because of VMS data from only a small proportion of Chinese trawlers was calculated fishing intensity, more VMS data is required to illustrate the overall trawling effort in China seas. Our results enable fishery managers to identify the distribution of bottom trawling activities in the YS and ECS, and hence to make effective fishery policy.	[Zhang, Shengmao; Zhang, Heng; Fan, Wei; Tang, Fenghua; Yang, Shenglong] Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Key Lab East China Sea & Ocean Fishery Resources, Minist Agr, Shanghai, Peoples R China; [Jin, Shaofei] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China; [Zhang, Shengmao] East China Normal Univ, Minist Educ, Key Lab Geog Informat Sci, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; East China Normal University	Fan, W (corresponding author), Chinese Acad Fishery Sci, East China Sea Fisheries Res Inst, Key Lab East China Sea & Ocean Fishery Resources, Minist Agr, Shanghai, Peoples R China.; Jin, SF (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China.	jinsf@tea.ac.cn; fanwee@126.com			Yangtze River Delta joint research project from the Shanghai Science and Technology Committee [15595811000]; Open Research Funding Program of KLGIS [KLGIS2015A06]; Key Projects in the National Science and Technology Pillar Program during the Thirteen Five-year Plan Period [2013BAD13601]	Yangtze River Delta joint research project from the Shanghai Science and Technology Committee; Open Research Funding Program of KLGIS; Key Projects in the National Science and Technology Pillar Program during the Thirteen Five-year Plan Period	This study was financially supported by the Yangtze River Delta joint research project from the Shanghai Science and Technology Committee (15595811000), the Open Research Funding Program of KLGIS (KLGIS2015A06), and Key Projects in the National Science and Technology Pillar Program during the Thirteen Five-year Plan Period (2013BAD13601). The funders had no role in study design, data collection and analysis,	Buhl-Mortensen L, 2016, ICES J MAR SCI, V73, P98, DOI 10.1093/icesjms/fsv200; Chalmers R, 2014, AFR J MAR SCI, V36, P467, DOI 10.2989/1814232X.2014.979228; Chinese Fishery Bureau, 2013, CHIN FISH YB, P23; de Juan S, 2012, ECOL INDIC, V18, P183, DOI 10.1016/j.ecolind.2011.11.020; Deng R, 2005, CAN J FISH AQUAT SCI, V62, P611, DOI 10.1139/F04-219; Eigaard OR, 2016, ICES J MAR SCI, V73, P27, DOI 10.1093/icesjms/fsv099; Feekings J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036409; Gonzalez-Correa JM, 2005, J EXP MAR BIOL ECOL, V320, P65, DOI 10.1016/j.jembe.2004.12.032; Gonzalez-Mirelis G, 2014, AMBIO, V43, P162, DOI 10.1007/s13280-013-0413-7; Hiddink JG, 2016, J APPL ECOL, V53, P1500, DOI 10.1111/1365-2664.12697; Hiddink JG, 2011, J APPL ECOL, V48, P1441, DOI 10.1111/j.1365-2664.2011.02036.x; Hiddink JG, 2006, CAN J FISH AQUAT SCI, V63, P721, DOI 10.1139/F05-266; Joll L, 1999, INTERNATIONAL CONFERENCE ON INTEGRATED FISHERIES MONITORING, PROCEEDINGS, P317; Jones HP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005653; JONES JB, 1992, NEW ZEAL J MAR FRESH, V26, P59, DOI 10.1080/00288330.1992.9516500; Lambert GI, 2014, J APPL ECOL, V51, P1326, DOI 10.1111/1365-2664.12277; Martin J, 2014, ANTHROPOCENE, V7, P1, DOI 10.1016/j.ancene.2015.01.002; Morton B, 2005, MAR POLLUT BULL, V50, P1031, DOI 10.1016/j.marpolbul.2005.07.008; Morton B, 2011, MAR POLLUT BULL, V62, P1153, DOI 10.1016/j.marpolbul.2010.12.001; Muntadas A, 2015, SCI TOTAL ENVIRON, V506, P594, DOI 10.1016/j.scitotenv.2014.11.042; Natale F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130746; Palanques A, 2014, CONT SHELF RES, V72, P83, DOI 10.1016/j.csr.2013.10.008; Queiros AM, 2006, J EXP MAR BIOL ECOL, V335, P91, DOI 10.1016/j.jembe.2006.03.001; Skaar KL, 2011, ICES J MAR SCI, V68, P1615, DOI 10.1093/icesjms/fsr091; Stiles M.L., 2010, IMPACTS BOTTOM TRAWL; Thrush SF, 2002, ANNU REV ECOL SYST, V33, P449, DOI 10.1146/annurev.ecolsys.33.010802.150515; Valdemarsen J. W., 2007, FAO FISHERIES TECHNI; van Denderen PD, 2015, ICES J MAR SCI, V72, P952, DOI 10.1093/icesjms/fsu183; Wang Y, 2015, J OCEAN U CHINA, V14, P89, DOI 10.1007/s11802-015-2467-6; Watson R, 2001, NATURE, V414, P534, DOI 10.1038/35107050; Zhang SM, 2016, COMM COM INF SC, V569, P159, DOI 10.1007/978-3-662-49155-3_15; Zhang ShengMao, 2014, Journal of Fisheries of China, V38, P1190; [张胜茂 Zhang Shengmao], 2014, [南方水产科学, South China Fisheries Science], V10, P15	33	13	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166640	10.1371/journal.pone.0166640	http://dx.doi.org/10.1371/journal.pone.0166640			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855215	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200040
J	Coetzer, W; Moodley, D; Gerber, A				Coetzer, Willem; Moodley, Deshendran; Gerber, Aurona			Eliciting and Representing High-Level Knowledge Requirements to Discover Ecological Knowledge in Flower-Visiting Data	PLOS ONE			English	Article							BIODIVERSITY; POLLINATORS; ONTOLOGY; NETWORKS	Observations of individual organisms (data) can be combined with expert ecological knowledge of species, especially causal knowledge, to model and extract from flower-visiting data useful information about behavioral interactions between insect and plant organisms, such as nectar foraging and pollen transfer. We describe and evaluate a method to elicit and represent such expert causal knowledge of behavioral ecology, and discuss the potential for wider application of this method to the design of knowledge-based systems for knowledge discovery in biodiversity and ecosystem informatics.	[Coetzer, Willem] SAIAB South African Inst Aquat Biodivers, Private Bag 1015, ZA-6140 Grahamstown, South Africa; [Coetzer, Willem; Moodley, Deshendran; Gerber, Aurona] CSIR Meraka, CAIR Ctr Artificial Intelligence Res, ZA-0001 Pretoria, South Africa; [Gerber, Aurona] Univ Pretoria, Dept Informat, Private Bag X20, ZA-0028 Hatfield, South Africa; [Moodley, Deshendran] Univ Cape Town, Dept Comp Sci, Private Bag X3, ZA-7701 Rondebosch, South Africa; [Coetzer, Willem] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X54001, ZA-4000 Durban, South Africa	National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity; University of Pretoria; University of Cape Town; University of Kwazulu Natal	Coetzer, W (corresponding author), SAIAB South African Inst Aquat Biodivers, Private Bag 1015, ZA-6140 Grahamstown, South Africa.; Coetzer, W (corresponding author), CSIR Meraka, CAIR Ctr Artificial Intelligence Res, ZA-0001 Pretoria, South Africa.; Coetzer, W (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Private Bag X54001, ZA-4000 Durban, South Africa.	w.coetzer@saiab.ac.za	Moodley, Deshendran/N-6228-2013; Gerber, Aurona/AAF-6255-2019	Moodley, Deshendran/0000-0002-4340-9178; Gerber, Aurona/0000-0003-1743-8167; Coetzer, Willem/0000-0003-2214-3910				[Anonymous], 2005, FUNDAMENTALS ECOLOGY; Bartomeus I, 2014, PEERJ, V2, DOI 10.7717/peerj.328; Bosch J, 2009, ECOL LETT, V12, P409, DOI 10.1111/j.1461-0248.2009.01296.x; Brilhante V, 2004, LECT NOTES ARTIF INT, V3171, P144; CHARNIAK E, 1991, AI MAG, V12, P50; Coetzer W, 2014, ECOL INFORM, V24, P47, DOI 10.1016/j.ecoinf.2014.06.008; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Gerber A, 2014, FRONT ART INT APPL 2, P277; Gess S.K., 1996, THE POLLEN WASPS; Gess SK, 2004, J KANSAS ENTOMOL SOC, V77, P602, DOI 10.2317/E7.1; Gess SK, 2010, SANBI BIODIVERS SER, P1; Hardisty A, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-16; Hunter A, 2010, KNOWL ENG REV, V25, P199, DOI 10.1017/S0269888910000019; HUSTON M, 1988, BIOSCIENCE, V38, P682, DOI 10.2307/1310870; Jax K, 2006, Q REV BIOL, V81, P237, DOI 10.1086/506237; Keet CM, 2005, LECT NOTES COMPUT SC, V3615, P46; Kefi S, 2012, ECOL LETT, V15, P291, DOI 10.1111/j.1461-0248.2011.01732.x; KEVAN PG, 1983, ANNU REV ENTOMOL, V28, P407, DOI 10.1146/annurev.en.28.010183.002203; King C, 2013, METHODS ECOL EVOL, V4, P811, DOI 10.1111/2041-210X.12074; Kokar MM, 2009, INFORM FUSION, V10, P83, DOI 10.1016/j.inffus.2007.01.004; Madin J, 2007, ECOL INFORM, V2, P279, DOI 10.1016/j.ecoinf.2007.05.004; Michener WK, 2007, J INTELL INF SYST, V29, P111, DOI 10.1007/s10844-006-0034-8; Michener WK, 2012, TRENDS ECOL EVOL, V27, P85, DOI 10.1016/j.tree.2011.11.016; Neapolitan RE, 2003, MOL BIOL, V6, P674, DOI DOI 10.1145/1327942.1327961; Pauw A, 2006, AM J BOT, V93, P917, DOI 10.3732/ajb.93.6.917; Pauw A, 2011, OIKOS, V120, P344, DOI 10.1111/j.1600-0706.2010.19039.x; Pennington DD, 2008, INT J METADATA SEMAN, P210; Peterson AT, 2010, SYST BIODIVERS, V8, P159, DOI 10.1080/14772001003739369; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Whitehead V. B., 2001, Annals of the South African Museum, V108, P143; Williams RJ, 2006, J WEB SEMANT, V4, P237, DOI 10.1016/j.websem.2006.06.002	31	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166559	10.1371/journal.pone.0166559	http://dx.doi.org/10.1371/journal.pone.0166559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851814	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300067
J	Dai, L; Hu, WW; Xia, L; Xia, M; Yang, Q				Dai, Lei; Hu, Wei Wei; Xia, Lu; Xia, Mi; Yang, Qian			Transmissible Gastroenteritis Virus Infection Enhances SGLT1 and GLUT2 Expression to Increase Glucose Uptake	PLOS ONE			English	Article							BRUSH-BORDER MEMBRANE; EPIDEMIC DIARRHEA VIRUS; COTRANSPORTER SGLT1; CANCER-CELLS; KINASE; ABSORPTION; TRANSPORTERS; INHIBITION; RECEPTOR; REPLICATION	Transmissible gastroenteritis virus (TGEV) is a coronavirus that causes villus atrophy, followed by crypt hyperplasia, reduces the activities of intestinal digestive enzymes, and disrupts the absorption of intestinal nutrients. In vivo, TGEV primarily targets and infects intestinal epithelial cells, which play an important role in glucose absorption via the apical and basolateral transporters Na+-dependent glucose transporter 1 (SGLT1) and facilitative glucose transporter 2 (GLUT2), respectively. In this study, we therefore sought to evaluate the effects of TGEV infection on glucose uptake and SGLT1 and GLUT2 expression. Our data demonstrate that infection with TGEV resulted in increased glucose uptake and augmented expression of EGFR, SGLT1 and GLUT2. Moreover, inhibition studies showed that EGFR modulated glucose uptake in control and TGEV infected cells. Finally, high glucose absorption was subsequently found to promote TGEV replication.	[Dai, Lei; Hu, Wei Wei; Xia, Lu; Xia, Mi; Yang, Qian] Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, Q (corresponding author), Nanjing Agr Univ, Vet Coll, Weigang 1, Nanjing, Jiangsu, Peoples R China.	zxbyq@njau.edu.cn			National Natural Science Foundation of China [31372465]; National Basic Research Program of China (973 program) [2013CB127302]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 program)(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (31372465), National Basic Research Program of China (973 program 2013CB127302) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARDELL D, 1984, MICROBIOS, V39, P95; Boccia MM, 1999, NEUROBIOL LEARN MEM, V71, P104, DOI 10.1006/nlme.1998.3856; Brosnahan AJ, 2012, VET MICROBIOL, V156, P229, DOI 10.1016/j.vetmic.2011.10.017; Chae C, 2000, VET REC, V147, P606, DOI 10.1136/vr.147.21.606; Chambers JW, 2010, J VIROL, V84, P1867, DOI 10.1128/JVI.02123-09; Chen XX, 2015, VET RES, V46, DOI 10.1186/s13567-015-0168-1; Dean P, 2006, P NATL ACAD SCI USA, V103, P1876, DOI 10.1073/pnas.0509451103; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Elfeber K, 2004, HISTOCHEM CELL BIOL, V121, P201, DOI 10.1007/s00418-004-0633-9; ENJUANES L, 2000, VIRUS TAXONOMY CLASS; Fleming SE, 1997, AM J PHYSIOL-GASTR L, V273, pG968, DOI 10.1152/ajpgi.1997.273.4.G968; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Halaihel N, 2000, AM J PHYSIOL-GASTR L, V279, pG587, DOI 10.1152/ajpgi.2000.279.3.G587; Hammer HF, 2012, GASTROENTEROL CLIN N, V41, P611, DOI 10.1016/j.gtc.2012.06.003; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Hu W., 2016, ONCOTARGET; Hu WW, 2014, ARCH VIROL, V159, P2295, DOI 10.1007/s00705-014-2080-9; INMAN WH, 1985, P NATL ACAD SCI USA, V82, P1346, DOI 10.1073/pnas.82.5.1346; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Kasai D, 2009, J HEPATOL, V50, P883, DOI 10.1016/j.jhep.2008.12.029; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Kellett GL, 2001, J PHYSIOL-LONDON, V531, P585, DOI 10.1111/j.1469-7793.2001.0585h.x; Kellett GL, 2005, DIABETES, V54, P3056, DOI 10.2337/diabetes.54.10.3056; KLIP A, 1994, FASEB J, V8, P43, DOI 10.1096/fasebj.8.1.8299889; LANDINI MP, 1984, J GEN VIROL, V65, P1229, DOI 10.1099/0022-1317-65-7-1229; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Loisel-Meyer S, 2012, P NATL ACAD SCI USA, V109, P2549, DOI 10.1073/pnas.1121427109; Manel N, 2003, CELL, V115, P449, DOI 10.1016/S0092-8674(03)00881-X; Melnyk RA, 2001, BIOCHEMISTRY-US, V40, P11106, DOI 10.1021/bi010642e; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Penzes Z, 2001, VIRUS GENES, V23, P105, DOI 10.1023/A:1011147832586; Ren JG, 2013, PROSTATE, V73, P1453, DOI 10.1002/pros.22692; Roder PV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089977; SAITO Y, 1984, NEUROLOGY, V34, P276, DOI 10.1212/WNL.34.3.276; Shin HJ, 2011, J BIOL CHEM, V286, P29872, DOI 10.1074/jbc.M111.259978; SHIRAZIBEECHEY SP, 1994, BIOCHEM SOC T, V22, P655, DOI 10.1042/bst0220655; Siddell S.G., 1995, CORONAVIRIDAE, P141, DOI [DOI 10.1007/978-1-4899-1531-3_7, 10.1007/978-1-4899-1531-3_7]; Takai N, 2010, MOL MED REP, V3, P479, DOI 10.3892/mmr_00000284; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Wesley RD, 2003, VET MICROBIOL, V95, P175, DOI 10.1016/S0378-1135(03)00150-0; Zhao SS, 2014, VIRUS RES, V192, P34, DOI 10.1016/j.virusres.2014.08.014	46	14	14	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165585	10.1371/journal.pone.0165585	http://dx.doi.org/10.1371/journal.pone.0165585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851758	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300021
J	Henkels, KM; Muppani, NR; Gomez-Cambronero, J				Henkels, Karen M.; Muppani, Naveen Reddy; Gomez-Cambronero, Julian			PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases	PLOS ONE			English	Article							PHOSPHOLIPASE-D; INTERLEUKIN-8 SECRETION; CANCER; D2; ACTIVATION; EXPRESSION; MICROENVIRONMENT; INVASION; GROWTH; ANGIOGENESIS	Phospholipase D-2 (PLD2) has a key role in breast cancer formation and metastasis formation with PLD small inhibitors reducing primary tumor growth. This study aimed to evaluate the importance of targeting PLD on the tumor microenvironment. We provide evidence about the beneficial effect of PLD inhibitors [FIPI (dual PLD1/PLD2) or VU0155072-2 (PLD2 inhibitor)] on avoiding infiltration of tumor-helping macrophages and neutrophils. Tumor growth and metastasis within the primary tumors had low (<20% over controls) PLD enzyme activity. Unexpectedly, we found that the inhibitors also affected PLD2 gene expression and protein albeit at a lesser extent. The later could indicate that targeting both the actual PLD enzyme and its activity could be beneficial for potential cancer treatments in vivo. F4/80 and Ly6G staining of macrophages and neutrophils, respectively, and Arg1 staining data were consistent with M2 and N2 polarization. NOS2 staining increased in xenotransplants upon treatment with PLD2 inhibitors suggesting the novel observation that an increased recruitment of M1 macrophages occurred in primary tumors. PLD inhibitor-treated primary tumors had large, fragile, necrotic areas that were Arg1(+) for M2 macrophages. The xenotransplants also caused the formation of large F4/80(+) and Ly6G(+) (>100 mu m) clusters in lungs. However, PLD inhibitors, particularly FIPI, were able to diminish leukocyte presence. Ex vivo chemotaxis and PLD activity of peripheral blood neutrophils (PMN) and peritoneal macrophages was also determined. Whereas PMN had impaired functionality, macrophages did not. This significantly increased ("emboldened") macrophage function was due to PLD inhibition. Since tumor-associated leukocytes in primary tumors and metastases were targeted via PLD inhibition, we posit that these inhibitors have a key role in cancer regression, while still affording an appropriate inflammatory response at least from off-site innate immunity macrophages.	[Gomez-Cambronero, Julian] Brigham & Women Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Gomez-Cambronero, Julian] Harvard Med Sch, Boston, MA 02115 USA; [Henkels, Karen M.; Muppani, Naveen Reddy; Gomez-Cambronero, Julian] Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University System of Ohio; Wright State University Dayton	Gomez-Cambronero, J (corresponding author), Brigham & Women Hosp, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA.; Gomez-Cambronero, J (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Gomez-Cambronero, J (corresponding author), Wright State Univ, Boonshoft Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA.	julian.cambronero@wright.edu		Gomez-Cambronero, Julian/0000-0002-7581-9227	National Institutes of Health (NIH) [HL05665314]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH, HL05665314).	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Arun SN, 2013, J LIPID RES, V54, P581, DOI 10.1194/jlr.M027060; Balkwill FR, 2012, J CELL SCI, V125, P5591, DOI 10.1242/jcs.116392; Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901; BUCANA CD, 1992, AM J PATHOL, V141, P1225; Casbon AJ, 2015, P NATL ACAD SCI USA, V112, pE566, DOI 10.1073/pnas.1424927112; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Cummings RJ, 2002, J BIOL CHEM, V277, P30227, DOI 10.1074/jbc.M111078200; De Larco JE, 2004, CLIN CANCER RES, V10, P4895, DOI 10.1158/1078-0432.CCR-03-0760; De Larco JE, 2003, P NATL ACAD SCI USA, V100, P13988, DOI 10.1073/pnas.2335921100; Fang WY, 2014, CARCINOGENESIS, V35, P1780, DOI 10.1093/carcin/bgu060; Foster DA, 2003, MOL CANCER RES, V1, P789; Fridlender ZG, 2013, BRIT J CANCER, V108, P1288, DOI 10.1038/bjc.2013.93; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Fritz JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00587; Fu X, 2015, INT IMMUNOPHARMACOL, V28, P666, DOI 10.1016/j.intimp.2015.07.033; Galdiero MR, 2013, J CELL PHYSIOL, V228, P1404, DOI 10.1002/jcp.24260; Galdiero MR, 2013, IMMUNOBIOLOGY, V218, P1402, DOI 10.1016/j.imbio.2013.06.003; Ganesan R, 2015, BBA-MOL CELL BIOL L, V1851, P261, DOI 10.1016/j.bbalip.2014.12.007; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Hayes TS, 1999, CELL SIGNAL, V11, P195, DOI 10.1016/S0898-6568(98)00066-7; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hu XL, 2012, CELL MOL IMMUNOL, V9, P464, DOI 10.1038/cmi.2012.47; Joseph T, 2001, BIOCHEM BIOPH RES CO, V289, P1019, DOI 10.1006/bbrc.2001.6118; Kaczmarek M, 2012, WSPOLCZESNA ONKOL, V16, P279, DOI 10.5114/wo.2012.30054; Kim YR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-144; Knoepp SM, 2008, MOL PHARMACOL, V74, P574, DOI 10.1124/mol.107.040105; Leek RD, 1996, CANCER RES, V56, P4625; Liscovitch M, 2000, BIOCHEM J, V345, P401, DOI 10.1042/0264-6021:3450401; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2007, BREAST, V16, pS27, DOI 10.1016/j.breast.2007.07.013; Mantovani A, 2011, NAT MED, V17, P285, DOI 10.1038/nm0311-285; MEATS JE, 1993, AGENTS ACTIONS, V39, pC14, DOI 10.1007/BF01972706; Mishalian I, 2013, CANCER IMMUNOL IMMUN, V62, P1745, DOI 10.1007/s00262-013-1476-9; Mohamed MM, 2014, INT J BIOCHEM CELL B, V46, P138, DOI 10.1016/j.biocel.2013.11.015; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Mukhtar RA, 2011, EXPERT REV MOL DIAGN, V11, P91, DOI 10.1586/ERM.10.97; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Ojalvo LS, 2010, J IMMUNOL, V184, P702, DOI 10.4049/jimmunol.0902360; Oshimoto H, 2003, ONCOL RES, V14, P31, DOI 10.3727/000000003108748586; Park JB, 2012, NAT REV CANCER, V12, P782, DOI 10.1038/nrc3379; PEKAREK LA, 1995, J EXP MED, V181, P435, DOI 10.1084/jem.181.1.435; Peng HJ, 2011, MOL CELL BIOL, V31, P2227, DOI 10.1128/MCB.01348-10; Guerrero AR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-40; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Shabo I, 2011, ADV EXP MED BIOL, V714, P141, DOI 10.1007/978-94-007-0782-5_7; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Uchida H, 1999, ANTICANCER RES, V19, P671; Uchida N, 1997, J CANCER RES CLIN, V123, P280, DOI 10.1007/s004320050060; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Zenger E, 2002, CANCER RES, V62, P5536; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	56	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166553	10.1371/journal.pone.0166553	http://dx.doi.org/10.1371/journal.pone.0166553			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851813	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300066
J	Hertach, T; Puissant, S; Gogala, M; Trilar, T; Hagmann, R; Baur, H; Kunz, G; Wade, EJ; Loader, SP; Simon, C; Nagel, P				Hertach, Thomas; Puissant, Stephane; Gogala, Matija; Trilar, Tomi; Hagmann, Reto; Baur, Hannes; Kunz, Gernot; Wade, Elizabeth J.; Loader, Simon P.; Simon, Chris; Nagel, Peter			Complex within a Complex: Integrative Taxonomy Reveals Hidden Diversity in Cicadetta brevipennis (Hemiptera: Cicadidae) and Unexpected Relationships with a Song Divergent Relative	PLOS ONE			English	Article							NEW-ZEALAND CICADAS; SPECIES DELIMITATION; MITOCHONDRIAL-DNA; GENE FLOW; PHYLOGENETIC UTILITY; CALLING SONGS; SENSU-LATO; PHYLOGEOGRAPHY; HYBRIDIZATION; SPECIATION	Multiple sources of data in combination are essential for species delimitation and classification of difficult taxonomic groups. Here we investigate a cicada taxon with unusual cryptic diversity and we attempt to resolve seemingly contradictory data sets. Cicada songs act as species-specific premating barriers and have been used extensively to reveal hidden taxonomic diversity in morphologically similar species. The Palaearctic Cicadetta montana species complex is an excellent example where distinct song patterns have disclosed multiple recently described species. Indeed, two taxa turned out to be especially diverse in that they form a "complex within the complex" : the Cicadetta cerdaniensis song group (four species studied previously) and Cicadetta brevipennis (examined in details here). Based on acoustic, morphological, molecular, ecological and spatial data sampled throughout their broad European distribution, we find that Cicadetta brevipennis s.l. comprises five lineages. The most distinct lineage is identified as Cicadetta petryi Schumacher, 1924, which we reassign to the species level. Cicadetta brevipennis litoralis Puissant & Hertach ssp. n. and Cicadetta brevipennis hippolaidica Hertach ssp. n. are new to science. The latter hybridizes with Cicadetta brevipennis brevipennis Fieber, 1876 at a zone inferred from intermediate song patterns. The fifth lineage requires additional investigation. The C. cerdaniensis and the C. brevipennis song groups exhibit characteristic, clearly distinct basic song patterns that act as reproductive barriers. However, they remain completely intermixed in the Bayesian and maximum likelihood COI and COII mitochondrial DNA phylogenies. The closest relative of each of the four cerdaniensis group species is a brevipennis group taxon. In our favoured scenario the phylogenetic pairs originated in common Pleistocene glacial refuges where the taxa speciated and experienced sporadic inter-group hybridization leading to extensive introgression and mitochondrial capture.	[Hertach, Thomas; Hagmann, Reto; Loader, Simon P.; Nagel, Peter] Univ Basel, Dept Environm Sci, Biogeog, Basel, Switzerland; [Hertach, Thomas; Hagmann, Reto; Baur, Hannes] Burgergemeinde Bern, Nat Hist Museum, Dept Invertebrates, Bern, Switzerland; [Puissant, Stephane] Museum Jardin Sci, Dijon, France; [Puissant, Stephane] Sorbonne Univ, Museum Natl Hist Nat, Inst Systemat, Evolut,Biodiversite, Paris, France; [Gogala, Matija] Slovenian Acad Sci & Arts, Ljubljana, Slovenia; [Trilar, Tomi] Slovenian Museum Nat Hist, Ljubljana, Slovenia; [Baur, Hannes] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Kunz, Gernot] Karl Franzens Univ Graz, Dept Zool, Graz, Austria; [Wade, Elizabeth J.; Simon, Chris] Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT USA; [Wade, Elizabeth J.] USDA, Ctr Med Agr & Vet Entomol, Gainesville, FL USA; [Loader, Simon P.] Univ Roehampton, Dept Life Sci, London, England	University of Basel; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Slovenian Academy of Sciences & Arts (SASA); University of Bern; University of Graz; University of Connecticut; United States Department of Agriculture (USDA); Roehampton University	Hertach, T (corresponding author), Univ Basel, Dept Environm Sci, Biogeog, Basel, Switzerland.; Hertach, T (corresponding author), Burgergemeinde Bern, Nat Hist Museum, Dept Invertebrates, Bern, Switzerland.	thomas.hertach@unibas.ch	Trilar, Tomi/ABA-6909-2020		Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation; Biedermann-Mantel Foundation; Temperatio Foundation; Otto Gamma Foundation and Pro Natura; Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-0255]; US National Science Foundation [DEB-0955849]	Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation; Biedermann-Mantel Foundation; Temperatio Foundation; Otto Gamma Foundation and Pro Natura; Ministry of Higher Education, Science and Technology of the Republic of Slovenia; US National Science Foundation(National Science Foundation (NSF))	The Swiss cicada project (TH) was financed by the following funders: Wolfermann-Nageli Foundation; Zigerli-Hegi Foundation; Walter Haefner Foundation; Paul Schiller Foundation (http://www.paul-schiller-stiftung.ch); Biedermann-Mantel Foundation; Temperatio Foundation (http://www.temperatio.ch); Otto Gamma Foundation and Pro Natura (http://www.pronatura.ch). The travel expenses in Italy (TH) are covered by the Freiwillige Akademische Gesellschaft Basel (http://www.fag-basel.ch). The research of TT was part of the programme "Communities, relations and communications in the ecosystems" (no. P1-0255), financed by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia. The work of EW and CS was supported by the US National Science Foundation (http:/www.nsf.gov) under grant number DEB-0955849. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Alexander R. D., 1962, Miscellaneous Publications Museum of Zoology University of Michigan, Vno. 121, P1; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barbanera F, 2009, MOL PHYLOGENET EVOL, V52, P103, DOI 10.1016/j.ympev.2009.02.006; Baroni Urbani C, 1977, MEM SOC ENTOMOL ITAL, V56, P35; Bennik RM, 2016, SYST ENTOMOL, V41, P309, DOI 10.1111/syen.12155; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; Boitier E, 2006, ARVERNSIS, V37-38, P7; Boulard M, 1995, POSTURES CYMBALISATI; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Buckley TR, 2006, SYST BIOL, V55, P411, DOI 10.1080/10635150600697283; Buckley TR, 2009, P ROY SOC B-BIOL SCI, V276, P1055, DOI 10.1098/rspb.2008.1552; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Chan KMA, 2005, EVOLUTION, V59, P720; Correggiari AM, 1996, J QUATERNARY SCI, V9, P697; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Delorme Q, 1790, TETTIGETALNA ARGENTA, V71, P31; Den Hollander Jerone, 1995, P440; Drosopoulos S, 2006, CONT T ENT, P219; DUGDALE JS, 1978, NEW ZEAL J ZOOL, V5, P295, DOI 10.1080/03014223.1978.10428319; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feder JL, 2013, J EVOLUTION BIOL, V26, P261, DOI 10.1111/jeb.12009; Fieber FX, 1876, REV MAG ZOOL, V4, P11; Fonseca PJ, 2002, J COMP PHYSIOL A, V187, P971, DOI 10.1007/s00359-001-0267-5; Fritz U, 2005, ZOOL SCR, V34, P351, DOI 10.1111/j.1463-6409.2005.00188.x; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gogala A., 2008, P121; Gogala M, 2004, AN ACAD BRAS CIENC, V76, P316, DOI 10.1590/S0001-37652004000200020; Gogala Matija, 2014, Acta Entomologica Slovenica, V22, P101; Gogala Matija, 1999, Reichenbachia, V33, P91; Gottsberger B, 2007, J COMP PHYSIOL A, V193, P703, DOI 10.1007/s00359-007-0225-y; GRANT PR, 1995, EVOLUTION, V49, P229, DOI 10.1111/j.1558-5646.1995.tb02235.x; Gurcel Kevin, 2015, Entomologiste (Paris), V71, P245; Gvozdik V, 2015, MOL PHYLOGENET EVOL, V83, P143, DOI 10.1016/j.ympev.2014.11.012; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hellrigl K., 1996, TIERWELT SUDTIROLS; Hertach Thomas, 2007, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V80, P37; Hertach T, 2015, ZOOL J LINN SOC-LOND, V173, P320, DOI 10.1111/zoj.12212; Hertach T, 2011, ZOOTAXA, P25, DOI 10.11646/zootaxa.2771.1.3; Hertach T, 2013, REV SUISSE ZOOL, V120, P229; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Hey J, 2006, TRENDS ECOL EVOL, V21, P447, DOI 10.1016/j.tree.2006.05.011; Hey J, 2012, EVOLUTION, V66, P1413, DOI 10.1111/j.1558-5646.2011.01542.x; Hugel Sylvain, 2008, Bulletin de la Societe Entomologique de Mulhouse, V64, P5; International Commission on Zoological Nomenclature, 1999, INT CODE ZOOLOGICAL; Klasa Anna, 2015, Chronmy Przyrode Ojczysta, V71, P108; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lecocq T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-263; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Marshall DC, 2011, SYST BIOL, V60, P482, DOI 10.1093/sysbio/syr017; Marshall DC, 2009, MOL ECOL, V18, P1995, DOI 10.1111/j.1365-294X.2009.04155.x; Martin SH, 2013, GENOME RES, V23, P1817, DOI 10.1101/gr.159426.113; Meineke T., 2012, Entomologische Nachrichten und Berichte, V56, P133; Melo-Ferreira J, 2005, MOL ECOL, V14, P2459, DOI 10.1111/j.1365-294X.2005.02599.x; Minelli A, 2006, ITALIAN FAUNAL PROVI, P37; Moore W, 2014, CURR BIOL, V24, P2435, DOI 10.1016/j.cub.2014.09.022; Moulds MS, 2005, REC AUST MUS, V57, P375, DOI 10.3853/j.0067-1975.57.2005.1447; Nicholls JA, 2012, MOL ECOL, V21, P4051, DOI 10.1111/j.1365-294X.2012.05683.x; Nunes VL, 2014, MOL ECOL RESOUR, V14, P27, DOI 10.1111/1755-0998.12158; Owen CL, 2015, MOL PHYLOGENET EVOL, V83, P258, DOI 10.1016/j.ympev.2014.07.008; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Paterson H.E.H., 1985, Transvaal Museum Monograph, P21; Pfeifer MA, 2015, FAUNA FLORA RHEINL P, V13, P121; Pinho C, 2010, ANNU REV ECOL EVOL S, V41, P215, DOI 10.1146/annurev-ecolsys-102209-144644; Podnar M, 2005, MOL ECOL, V14, P575, DOI 10.1111/j.1365-294X.2005.02427.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Popov AV, 1997, ACTA ENTOMOL SLOV, V5, P89; Popple LW, 2013, ZOOTAXA, V3730, P1; Puissant S., 2001, ECOLE PRAT HAUTES ET, V14, P141; Puissant S., 2006, BE A DEILHAC ET AYNA; Puissant S, 2010, SYST BIODIVERS, V8, P555, DOI 10.1080/14772000.2010.532832; Puissant Stephane, 2000, EPHE Biologie et Evolution des Insectes, V13, P111; Quartau JA, 2006, CONT T ENT, P227; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A, 2007, TRACER V1 5 2007; Schilthuizen M., 2002, FROGS FLIES DANDELIO; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schumacher F., 1924, Deutsche Entomologische Zeitschrift, V1924, P329; SHACKLETON JC, 1984, J FIELD ARCHAEOL, V11, P307, DOI 10.1179/009346984791535476; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Smadja CM, 2011, MOL ECOL, V20, P5123, DOI 10.1111/j.1365-294X.2011.05350.x; Solis-Lemus C, 2015, EVOLUTION, V69, P492, DOI 10.1111/evo.12582; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stebbins G, 1950, VARIATION EVOLUTION, DOI [10.7312/steb94536, DOI 10.7312/STEB94536]; Sueur J, 2003, SYST ENTOMOL, V28, P481, DOI 10.1046/j.1365-3113.2003.00222.x; Sueur Jerome, 2007, Zootaxa, V1442, P55; Sueur J, 2008, BIOACOUSTICS, V18, P213, DOI 10.1080/09524622.2008.9753600; Sullivan J, 2014, HEREDITY, V113, P185, DOI 10.1038/hdy.2014.27; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Trilar T., 2004, Linzer Biologische Beitraege, V36, P1383; Trilar T., 2012, Folia Entomologica Hungarica, V73, P9; Trilar T, 2008, B INSECTOL, V61, P185; Trilar Tomi, 2006, Acta Entomologica Slovenica, V14, P175; Via S, 2012, PHILOS T R SOC B, V367, P451, DOI 10.1098/rstb.2011.0260; Villet Martin, 1995, P422; Wade EJ, 2015, J EVOLUTION BIOL, V28, P2318, DOI 10.1111/jeb.12756; Warren BH, 2012, EVOLUTION, V66, P1490, DOI 10.1111/j.1558-5646.2011.01550.x; Wickham H., 2009, GGPLOF2 ELEGANT GRAP; Wiens JJ, 2007, SYST BIOL, V56, P875, DOI 10.1080/10635150701748506; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zunino M, 2004, BIOGEOGRAFIA DIMENSI	109	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165562	10.1371/journal.pone.0165562	http://dx.doi.org/10.1371/journal.pone.0165562			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851754	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300020
J	Hertzog, LR; Ebeling, A; Meyer, ST; Eisenhauerm, N; Fischer, C; Hildebrandt, A; Wagg, C; Weisser, WW				Hertzog, Lionel R.; Ebeling, Anne; Meyer, Sebastian T.; Eisenhauerm, Nico; Fischer, Christine; Hildebrandt, Anke; Wagg, Cameron; Weisser, Wolfgang W.			High Survival of Lasius niger during Summer Flooding in a European Grassland	PLOS ONE			English	Article							TERRESTRIAL INVERTEBRATES; HYMENOPTERA; INUNDATION; MANGROVE; ANTS; FORMICIDAE; STABILITY	Climate change is projected to increase the frequency of extreme events, such as flooding and droughts, which are anticipated to have negative effects on the biodiversity of primary producers and consequently the associated consumer communities. Here we assessed the effects of an extreme early summer flooding event in 2013 on ant colonies along an experimental gradient of plant species richness in a temperate grassland. We tested the effects of flood duration, plant species richness, plant cover, soil temperature, and soil porosity on ant occurrence and abundance. We found that the ant community was dominated by Lasius niger, whose presence and abundance after the flood was not significantly affected by any of the tested variables, including plant species richness. We found the same level of occupation by L. niger at the field site after the flood (surveyed in 2013) as before the flood (surveyed in 2006). Thus, there were no negative effects of the flood on the presence of L. niger in the plots. We can exclude recolonisation as a possible explanation of ant presence in the field site due to the short time period between the end of the flood and survey as well as to the absence of a spatial pattern in the occupancy data. Thus, the omnipresence of this dominant ant species 1 month after the flood indicates that the colonies were able to survive a 3-week summer flood. The observed ant species proved to be flood resistant despite experiencing such extreme climatic events very rarely.	[Hertzog, Lionel R.; Meyer, Sebastian T.; Weisser, Wolfgang W.] Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, D-85354 Freising Weihenstephan, Germany; [Ebeling, Anne] Friedrich Schiller Univ Jena, Inst Ecol, Dornburger Str 159, D-07745 Jena, Germany; [Eisenhauerm, Nico; Hildebrandt, Anke] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Eisenhauerm, Nico] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Fischer, Christine; Hildebrandt, Anke] Friedrich Schiller Univ Jena, Inst Geosci, Burgweg 11, D-07749 Jena, Germany; [Fischer, Christine; Hildebrandt, Anke] Max Planck Inst Biogeochem, FOB 100164, D-07701 Jena, Germany; [Wagg, Cameron] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Winterthurestr 190, CH-8057 Zurich, Switzerland	Technical University of Munich; Friedrich Schiller University of Jena; Leipzig University; Friedrich Schiller University of Jena; Max Planck Society; University of Zurich	Hertzog, LR (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Dept Ecol & Ecosyst Management, Terr Ecol Res Grp, D-85354 Freising Weihenstephan, Germany.	I.hertzog@tum.de	Wagg, Cameron/O-4318-2019; Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Meyer, Sebastian Tobias/AAH-3856-2021; Hildebrandt, Anke/J-7062-2012	Wagg, Cameron/0000-0002-9738-6901; Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Meyer, Sebastian Tobias/0000-0003-0833-1472; Hildebrandt, Anke/0000-0001-8643-1634; Hertzog, Lionel/0000-0003-0869-9672	German Research Foundation [FOR 456, FOR 1451, FZT 118]; German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation [FZT 118]; Technische Universitat Munchen	German Research Foundation(German Research Foundation (DFG)); German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig - German Research Foundation; Technische Universitat Munchen	All authors received funding from the German Research Foundation (http://www.dfg.de/en/) grant number FOR 456 and FOR 1451. NE received support from the German Research Foundation grant FZT 118. The German Research Foundation and the Technische Universitat Munchen provided support for Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are deeply grateful for the help provided by the gardener team of the Jena Experiment as well as by the student helpers in weeding the field site and helping with the data collection. We are deeply grateful to Viktor Malakhov for providing us with the rights to use his photos of the flood. We thank Lars Clement for providing the data from the 2006 ant survey and Winfried Voigt for the ant dataset of 2005. We also thank Christiane Roscher and Alexandra Weigelt for granting us access to the plant cover data. The Jena Experiment is funded by the German Research Foundation (FOR 456, FOR 1451). Further support came from the German Centre for Integrative Biodiversity Research (iDiv) Halle-Jena-Leipzig, funded by the German Research Foundation (FZT 118). This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding programme Open Access Publishing.	Adis J, 2002, FRESHWATER BIOL, V47, P711, DOI 10.1046/j.1365-2427.2002.00892.x; Anderson C, 2002, INSECT SOC, V49, P99, DOI 10.1007/s00040-002-8286-y; Arndt E, 2011, ENTOMOL GEN, V33, P39; Barros V, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, pIX; Bloschl G, 2013, HYDROL EARTH SYST SC, V17, P5197, DOI 10.5194/hess-17-5197-2013; BOOMSMA JJ, 1982, ECOL ENTOMOL, V7, P121, DOI 10.1111/j.1365-2311.1982.tb00650.x; Devigne C, 2006, INSECT SOC, V53, P46, DOI 10.1007/s00040-005-0834-9; Dietrich Christian O., 1998, Myrmecologische Nachrichten, V2, P35; Ellenberg H., 1996, VEGETATION MITTELEUR, V1095; ELMES GW, 1971, J ANIM ECOL, V40, P495, DOI 10.2307/3258; Fischer C, 2015, PLANT SOIL, V397, P1, DOI 10.1007/s11104-014-2373-5; Folgarait PJ, 2003, BIOL FERT SOILS, V38, P349, DOI 10.1007/s00374-003-0655-9; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Kleineidam C, 2000, INSECT SOC, V47, P241, DOI 10.1007/PL00001710; KLUGE G, 2000, KLIMA AUSGEWAHLTER O; Lipowsky A, 2015, PERSPECT PLANT ECOL, V17, P66, DOI 10.1016/j.ppees.2014.11.003; LONDO G, 1976, VEGETATIO, V33, P61, DOI 10.1007/BF00055300; Maschwitz U, 2000, NATURWISSENSCHAFTEN, V87, P563, DOI 10.1007/s001140050780; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Nielsen MG, 1997, INSECT SOC, V44, P15, DOI 10.1007/s000400050026; Nielsen MG, 2006, PHYSIOL ENTOMOL, V31, P120, DOI 10.1111/j.1365-3032.2005.00492.x; Nielsen MG, 2011, MYRMECOL NEWS, V14, P113; Passera L., 1994, CHARACTERISTICS TRAM, P23; Philpott SM, 2010, ANT ECOLOGY, P137; Plum N, 2005, WETLANDS, V25, P721, DOI 10.1672/0277-5212(2005)025[0721:TIIFGA]2.0.CO;2; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Purcell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089211; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Rust MK, 2000, J AGR URBAN ENTOMOL, V17, P201; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Schroter K, 2015, HYDROL EARTH SYST SC, V19, P309, DOI 10.5194/hess-19-309-2015; SEIFERT B, 2007, AMEISEN MITTEL NORDE; Stein C, 2013, HOCHWASSER ELBE DONA; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; WILSON EDWARD O., 1955, BULL MUS COMP ZOOL HARVARD UNIV, V113, P1; Wright AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7092	37	5	5	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0152777	10.1371/journal.pone.0152777	http://dx.doi.org/10.1371/journal.pone.0152777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851761	Green Published, gold			2022-12-26	WOS:000387909300001
J	Kranzhofer, DK; Gilsbach, R; Gruning, BA; Backofen, R; Nuhrenberg, TG; Hein, L				Kranzhoefer, David K.; Gilsbach, Ralf; Gruening, Bjoern A.; Backofen, Rolf; Nuehrenberg, Thomas G.; Hein, Lutz			5'-Hydroxymethylcytosine Precedes Loss of CpG Methylation in Enhancers and Genes Undergoing Activation in Cardiomyocyte Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; MAMMALIAN DNA; TET PROTEINS; THYMINE DNA; GENOME; DIFFERENTIATION; CHROMATIN; DYNAMICS; REVEALS; 5-CARBOXYLCYTOSINE	Background Cardiomyocytes undergo major changes in DNA methylation during maturation and transition to a non-proliferative state after birth. 5'-hydroxylation of methylated cytosines (5hmC) is not only involved in DNA loss of CpG methylation but is also thought to be an epigenetic mark with unique distribution and functions. Here, we sought to get insight into the dynamics of 5'-hydroxymethylcytosine in newborn and adult cardiomyocytes. Methods Cardiomyocyte nuclei from newborn and adult C57BL/6 mice were purified by flow cytometric sorting. 5hmC-containing DNA was captured by selective chemical labeling, followed by deep sequencing. Sequencing reads of library replicates were mapped independently (n = 3 for newborn, n = 2 for adult mice) and merged for further analysis steps. 5hmC coverage was normalized to read length and the total number of mapped reads (RPKM). MethylC-Seq, ChIP-Seq and RNA-Seq data sets of newborn and adult cardiomyocytes served to elucidate specific features of 5hmC at gene bodies and around low methylated regions (LMRs) representing regulatory genomic regions with enhancer function. Results 163,544 and 315,220 5hmC peaks were identified in P1 and adult cardiomyocytes, respectively. Of these peaks, 66,641 were common between P1 and adult cardiomyocytes with more than 50% reciprocal overlap. P1 and adult 5hmC peaks were overrepresented in genic features such as exons, introns, 3'- and 5'-untranslated regions (UTRs), promotors and transcription end sites (TES). During cardiomyocyte maturation, 5hmC was found to be enriched at sites of subsequent DNA loss of CpG methylation such as gene bodies of upregulated genes (i.e. Atp2a2, Tnni3, Mb, Pdk4). Additionally, centers of postnatally established enhancers were premarked by 5hmC before DNA loss of CpG methylation. Conclusions Simultaneous analysis of 5hmC-Seq, MethylC-Seq, RNA-Seq and ChIP-Seq data at two defined time points of cardiomyocyte maturation demonstrates that 5hmC is positively associated with gene expression and decorates sites of subsequent DNA loss of CpG methylation.	[Kranzhoefer, David K.; Gilsbach, Ralf; Nuehrenberg, Thomas G.; Hein, Lutz] Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Fac Med, Freiburg, Germany; [Gruening, Bjoern A.; Backofen, Rolf] Univ Freiburg, Dept Comp Sci, Bioinformat Grp, Freiburg, Germany; [Nuehrenberg, Thomas G.] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany; [Hein, Lutz] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany	University of Freiburg; University of Freiburg; Universitats Herzzentrum Freiburg; University of Freiburg	Nuhrenberg, TG; Hein, L (corresponding author), Univ Freiburg, Inst Expt & Clin Pharmacol & Toxicol, Fac Med, Freiburg, Germany.; Nuhrenberg, TG (corresponding author), Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol & Angiol 2, Bad Krozingen, Germany.; Hein, L (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signaling Studies, Freiburg, Germany.	thomas.nuehrenberg@universitaets-herzzentrum.de; lutz.hein@pharmakol.uni-freiburg.de	Hein, Lutz/GRJ-8644-2022; Backofen, Rolf/AAC-1569-2021	Gilsbach, Ralf/0000-0002-0895-1535; Gruning, Bjorn/0000-0002-3079-6586	Deutsche Forschungsgemeinschaft [SFB992]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft, SFB992, www.dfg.de.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bergmann O, 2011, EXP CELL RES, V317, P188, DOI 10.1016/j.yexcr.2010.08.017; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bogdanovic O, 2016, NAT GENET, V48, P417, DOI 10.1038/ng.3522; Colquitt BM, 2013, P NATL ACAD SCI USA, V110, P14682, DOI 10.1073/pnas.1302759110; de Laat W, 2013, NATURE, V502, P499, DOI 10.1038/nature12753; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Foglia MJ, 2016, DEVELOPMENT, V143, P729, DOI 10.1242/dev.132910; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Hahn MA, 2013, CELL REP, V3, P291, DOI 10.1016/j.celrep.2013.01.011; He AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5907; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirai M, 2016, CIRC RES, V118, P20, DOI 10.1161/CIRCRESAHA.115.307697; Hon GC, 2014, MOL CELL, V56, P286, DOI 10.1016/j.molcel.2014.08.026; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Iurlaro M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r119; Ivanov M, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r83; Jonker SS, 2016, J ENDOCRINOL, V228, pR1, DOI 10.1530/JOE-15-0309; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lu FL, 2014, GENE DEV, V28, P2103, DOI 10.1101/gad.248005.114; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Mann IK, 2013, GENOME RES, V23, P988, DOI 10.1101/gr.146654.112; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor CEM R.R, 2014, FUNCTIONAL ANAL DNA, Vxv; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Nuhrenberg T, 2014, CELL TISSUE RES, V356, P585, DOI 10.1007/s00441-014-1887-8; Orlanski S, 2016, P NATL ACAD SCI USA, V113, P5018, DOI 10.1073/pnas.1604365113; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Preissl S, 2015, CIRC RES, V117, P413, DOI 10.1161/CIRCRESAHA.115.306337; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Senyo SE, 2013, NATURE, V493, P433, DOI 10.1038/nature11682; Serandour AA, 2012, NUCLEIC ACIDS RES, V40, P8255, DOI 10.1093/nar/gks595; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Soonpaa MH, 2015, CELL, V163, P781, DOI 10.1016/j.cell.2015.10.037; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang LF, 2015, NATURE, V523, P621, DOI 10.1038/nature14482; Wu H, 2014, CELL, V156, P45, DOI 10.1016/j.cell.2013.12.019; Wu H, 2011, CELL CYCLE, V10, P2428, DOI 10.4161/cc.10.15.16930; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	64	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166575	10.1371/journal.pone.0166575	http://dx.doi.org/10.1371/journal.pone.0166575			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851806	Green Submitted, gold, Green Published			2022-12-26	WOS:000387909300069
J	Rebala, K; Rabtsava, AA; Kotova, SA; Kipen, VN; Zhurina, NV; Gandzha, AI; Tsybovsky, IS				Rebala, Krzysztof; Rabtsava, Aline A.; Kotova, Svetlana A.; Kipen, Viachaslau N.; Zhurina, Natalja V.; Gandzha, Alla I.; Tsybovsky, Iosif S.			STR Profiling for Discrimination between Wild and Domestic Swine Specimens and between Main Breeds of Domestic Pigs Reared in Belarus	PLOS ONE			English	Article							GENETIC TRACEABILITY; PARENTAGE CONTROL; IDENTIFICATION; BOARS; PRODUCTS; DIFFERENTIATION; BIODIVERSITY; MARKERS; SCROFA; SYSTEM	A panel comprising 16 short tandem repeats (STRs) and a gender-specific amelogenin marker was worked out and tested for robustness in discrimination between wild and domestic swine subspecies encountered in Europe, between regional populations of wild boars and between main breeds of domestic pigs reared in Belarus. The STR dataset comprised 310 wild boars, inhabiting all administrative regions of Belarus, and 313 domestic pigs, representing three local and three cosmopolitan lines. Additionally, a total of 835 wild boars were genotyped for the presence of melanocortin 1 receptor (MC1R) alleles specific for domestic pigs. Correctness of assignment of STR profiles to appropriate populations was measured by log-likelihood ratios (log-LRs). All samples were correctly identified as wild boars or domestic pigs with average log-LR of 42.4 (LR = 2.6x10(18)). On the other hand, as many as 50 out of 835 (6.0%) genotyped wild boars from Belarus possessed MC1R alleles specific to domestic pigs, demonstrating supremacy of our STR profiling system over traditional differentiation between wild boars and domestic pigs, based on single binary markers. Mean log-LRs for allocation of wild boars to their regions of origin and of domestic pigs to appropriate breeds were 2.3 (LR = 9.7) and 13.4 (LR = 6.6x10(5)), respectively. Our results demonstrate the developed STR profiling system to be a highly efficient tool for differentiation between wild and domestic swine subspecies and between diverse breeds of domestic pigs as well as for verification of genetic identity of porcine specimens for the purpose of forensic investigations of wildlife crimes, assurance of veterinary public health, parentage control in animal husbandry, food safety management and traceability of livestock products.	[Rebala, Krzysztof] Med Univ Gdansk, Dept Forens Med, Gdansk, Poland; [Rabtsava, Aline A.; Kotova, Svetlana A.; Kipen, Viachaslau N.; Tsybovsky, Iosif S.] State Comm Forens Expertises, Sci & Pract Ctr, Minsk, BELARUS; [Zhurina, Natalja V.; Gandzha, Alla I.] Natl Acad Sci Anim Husb, Sci & Pract Ctr, Zhodino, BELARUS	Fahrenheit Universities; Medical University Gdansk; National Academy of Sciences of Belarus (NASB); Scientific & Practical Centre for Animal Husbandry of the National Academy of Sciences of Belarus	Rebala, K (corresponding author), Med Univ Gdansk, Dept Forens Med, Gdansk, Poland.	k.rebala@gumed.edu.pl	Rębała, Krzysztof/U-9856-2018; Kipen, Slava/Y-8813-2019	Rębała, Krzysztof/0000-0003-2236-7455; Kipen, Slava/0000-0002-7822-0746; Svetlana, Kotova/0000-0002-6521-7732				Alves E, 2009, ANIMAL, V3, P1216, DOI 10.1017/S1751731109004819; Aravena P., 2007, Agro-Ciencia, V23, P133; Babicz M, 2013, ANIM GENET, V44, P357, DOI 10.1111/age.12023; Ballin NZ, 2010, MEAT SCI, V86, P577, DOI 10.1016/j.meatsci.2010.06.001; Brodmann PD, 2001, EUR FOOD RES TECHNOL, V212, P491, DOI 10.1007/s002170000284; Buckleton J, 2005, FORENSIC DNA EVIDENCE INTERPRETATION, P27; Buckleton J, 2005, FORENSIC DNA EVIDENCE INTERPRETATION, P65; Caratti S, 2010, FORENSIC SCI INT-GEN, V4, P339, DOI 10.1016/j.fsigen.2010.07.001; Chen KF, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-54; Cherel P, 2011, ANIM GENET, V42, P659, DOI 10.1111/j.1365-2052.2011.02187.x; Conyers CM, 2012, J AGR FOOD CHEM, V60, P3341, DOI 10.1021/jf205109b; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fajardo V, 2010, TRENDS FOOD SCI TECH, V21, P408, DOI 10.1016/j.tifs.2010.06.002; Fontanesi L, 2016, LIVEST SCI, V184, P71, DOI 10.1016/j.livsci.2015.12.007; Fontanesi L, 2014, MEAT SCI, V98, P781, DOI 10.1016/j.meatsci.2014.07.026; Fontanesi L, 2008, MOL REPROD DEV, V75, P1662, DOI 10.1002/mrd.20903; Frantz AC, 2013, BIOL J LINN SOC, V110, P104, DOI 10.1111/bij.12111; Goedbloed DJ, 2013, MOL ECOL, V22, P856, DOI 10.1111/j.1365-294X.2012.05670.x; Groenen MAM, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0204-2; Iyengar A, 2014, J NAT CONSERV, V22, P195, DOI 10.1016/j.jnc.2013.12.001; Khomenko S., 2013, EMPRES WATCH, V28, P1, DOI DOI 10.1016/J.MEATSCI.2007.06.018; Koutsogiannouli EA, 2010, MAMM BIOL, V75, P69, DOI 10.1016/j.mambio.2008.08.001; Lin YC, 2014, FORENSIC SCI INT-GEN, V9, P12, DOI 10.1016/j.fsigen.2013.10.006; Linacre Adrian, 2011, Investig Genet, V2, P2, DOI 10.1186/2041-2223-2-2; Lorenzini R, 2005, FORENSIC SCI INT, V153, P218, DOI 10.1016/j.forsciint.2005.04.032; Megens HJ, 2008, GENET SEL EVOL, V40, P103, DOI 10.1051/gse:2007039; Menendez J, 2015, ARCH TIERZUCHT, V58, P217, DOI 10.5194/aab-58-217-2015; Montiel-Sosa JF, 2000, J AGR FOOD CHEM, V48, P2829, DOI 10.1021/jf9907438; Nechtelberger D, 2001, ANIM BIOTECHNOL, V12, P141, DOI 10.1081/ABIO-100108340; Ogden R, 2015, FORENSIC SCI INT-GEN, V18, P152, DOI 10.1016/j.fsigen.2015.02.008; Oh JD, 2014, ASIAN AUSTRAL J ANIM, V27, P926, DOI 10.5713/ajas.2013.13829; Pigs Porter V., 2016, MASONS WORLD ENCY LI, P517; Putnova L, 2003, CZECH J ANIM SCI, V48, P307; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; Rebala Krzysztof, 2015, Forensic Sci Int Genet, V16, P105, DOI 10.1016/j.fsigen.2014.12.011; Robino C, 2008, FORENS SCI INT-GEN S, V1, P614, DOI 10.1016/j.fsigss.2007.10.202; ROHRER GA, 1994, GENETICS, V136, P231; Tereba A., 1999, PROFILES DNA, V3, P14; Tobe SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014156; Wilkinson S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-580; Yaemmeeklin W, 2009, THAI J VET MED, V39, P259	42	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166563	10.1371/journal.pone.0166563	http://dx.doi.org/10.1371/journal.pone.0166563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851802	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300068
J	Bubak, AN; Yaeger, JDW; Renner, KJ; Swallow, JG; Greene, MJ				Bubak, Andrew N.; Yaeger, Jazmine D. W.; Renner, Kenneth J.; Swallow, John G.; Greene, Michael J.			Neuromodulation of Nestmate Recognition Decisions by Pavement Ants	PLOS ONE			English	Article							HYMENOPTERA-FORMICIDAE; SUPERORGANISM; AGGRESSION; BEHAVIOR	Ant colonies are distributed systems that are regulated in a non-hierarchical manner. Without a central authority, individuals inform their decisions by comparing information in local cues to a set of inherent behavioral rules. Individual behavioral decisions collectively change colony behavior and lead to self-organization capable of solving complex problems such as the decision to engage in aggressive societal conflicts with neighbors. Despite the relevance to colony fitness, the mechanisms that drive individual decisions leading to cooperative behavior are not well understood. Here we show how sensory information, both tactile and chemical, and social context-isolation, nestmate interaction, or fighting non-nestmates-affects brain monoamine levels in pavement ants (Tetramorium caespitum). Our results provide evidence that changes in octopamine and serotonin in the brains of individuals are sufficient to alter the decision by pavement ants to be aggressive towards non-nestmate ants whereas increased brain levels of dopamine correlate to physical fighting. We propose a model in which the changes in brain states of many workers collectively lead to the self-organization of societal aggression between neighboring colonies of pavement ants.	[Bubak, Andrew N.; Swallow, John G.; Greene, Michael J.] Univ Colorado Denver, Dept Integrat Biol, Denver, CO 80204 USA; [Bubak, Andrew N.] Univ Colorado Anschutz Med Campus, Neurosci Program, Denver, CO USA; [Yaeger, Jazmine D. W.; Renner, Kenneth J.] Univ South Dakota, Dept Biol, Vermillion, SD 57069 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of South Dakota	Greene, MJ (corresponding author), Univ Colorado Denver, Dept Integrat Biol, Denver, CO 80204 USA.	michael.greene@ucdenver.edu	Bubak, Andrew/GLR-6501-2022		Center for Brain and Behavioral Research (CBBRe) Pilot grant; University of South Dakota; NSF [IOS 1256898]	Center for Brain and Behavioral Research (CBBRe) Pilot grant; University of South Dakota; NSF(National Science Foundation (NSF))	The research was supported, in part, by a Center for Brain and Behavioral Research (CBBRe) Pilot grant to KJR, University of South Dakota, and NSF grant # IOS 1256898 to JGS.r The research was supported, in part, by a Center for Brain and Behavioral Research (CBBRe) Pilot grant to KJR, University of South Dakota, and NSF grant # IOS 1256898 to JGS. The authors thank Kevin Hoover, William Schuman, Harper Jocque, and Erin Sanders for their comments on the manuscript.	Adams ES, 2016, MYRMECOL NEWS, V23, P101; ADAMS ES, 1990, ANIM BEHAV, V39, P321, DOI 10.1016/S0003-3472(05)80877-2; [Anonymous], 2010, ANT ENCOUNTERS INTER; Arganda S, 2012, P NATL ACAD SCI USA, V109, P20508, DOI 10.1073/pnas.1210664109; Boulay R, 2000, J EXP BIOL, V203, P513; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bubak AN, 2014, BEHAV BRAIN RES, V219, P124; Bubak AN, 2015, BEHAV BRAIN RES, V292, P521, DOI 10.1016/j.bbr.2015.07.028; Bubak AN, 2014, CURR ZOOL, V60, P778, DOI 10.1093/czoolo/60.6.778; Bubak AN, 2013, J NEUROSCI METH, V219, P124, DOI 10.1016/j.jneumeth.2013.07.006; BUGG RL, 1994, AGR ECOSYST ENVIRON, V50, P11, DOI 10.1016/0167-8809(94)90121-X; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Cassidy KA, 2015, BEHAV ECOL, V26, P1352, DOI 10.1093/beheco/arv081; Collignon B, 2010, P ROY SOC B-BIOL SCI, V277, P1267, DOI 10.1098/rspb.2009.1976; Countryman SM, 2015, FRONT ECOL EVOL, V3, DOI 10.3389/fevo.2015.00025; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; Esponda F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2838; Greene MJ, 2007, BEHAV ECOL, V18, P451, DOI 10.1093/beheco/arl105; Greene MJ, 2003, NATURE, V423, P32, DOI 10.1038/423032a; HOLLDOBLER B, 1976, SCIENCE, V192, P912, DOI 10.1126/science.192.4242.912; Hoover KM, 2016, CURR ZOOL, V62, P277, DOI 10.1093/cz/zow041; Kamhi JF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0704; Kamhi JF, 2013, BRAIN BEHAV EVOLUT, V82, P220, DOI 10.1159/000356091; Martin S, 2009, J CHEM ECOL, V35, P1151, DOI 10.1007/s10886-009-9695-4; McGlynn TP, 1999, TRENDS ECOL EVOL, V14, P489, DOI 10.1016/S0169-5347(99)01730-9; Meer RKV, 2008, NATURWISSENSCHAFTEN, V95, P1155, DOI 10.1007/s00114-008-0432-6; Muscedere ML, 2012, J COMP PHYSIOL A, V198, P219, DOI 10.1007/s00359-011-0701-2; Nelson D.R., 1995, WAXES CHEM MOL BIOL, P1; Ozaki M, 2005, SCIENCE, V309, P311, DOI 10.1126/science.1105244; Plowes NJR, 2008, SELF ORG CONFLICTS T; Rillich J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028891; Robinson EJH, 2014, P BIOL SCI ROYAL SOC, P281; Robinson GE, 1999, NATURE, V399, P534, DOI 10.1038/21095; Scharf ME, 2004, J ECON ENTOMOL, V97, P601, DOI 10.1603/0022-0493-97.2.601; Stevenson PA, 2013, CURR OPIN NEUROBIOL, V23, P318, DOI 10.1016/j.conb.2013.03.002; Sturgis SJ, 2012, MYRMECOL NEWS, V16, P101; Wada-Katsumata A, 2011, J EXP BIOL, V214, P1707, DOI 10.1242/jeb.051565; Wilson ML, 2001, ANIM BEHAV, V61, P1203, DOI 10.1006/anbe.2000.1706	38	12	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166417	10.1371/journal.pone.0166417	http://dx.doi.org/10.1371/journal.pone.0166417			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846261	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600059
J	Port, M; Herodin, F; Valente, M; Drouet, M; Ullmann, R; Douche-Senf, S; Lamkowski, A; Majewski, M; Abend, M				Port, Matthias; Herodin, Francis; Valente, Marco; Drouet, Michel; Ullmann, Reinhard; Douche-Senf, Sven; Lamkowski, Andreas; Majewski, Matthaeus; Abend, Michael			MicroRNA Expression for Early Prediction of Late Occurring Hematologic Acute Radiation Syndrome in Baboons	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; CHROMOSOME-ABERRATIONS; CHERNOBYL ACCIDENT; THYROID-CANCER; SIGNATURES; RESIDENTS; EXPOSURE; UNCERTAINTIES; IRRADIATION; PREFECTURE	For effective medical management of radiation-exposed persons after a radiological/nuclear event, blood-based screening measures in the first few days that could predict hematologic acute radiation syndrome (HARS) are needed. For HARS severity prediction, we used microRNA (miRNA) expression changes measured on days one and two after irradiation in a baboon model. Eighteen baboons underwent different patterns of partial or total body irradiation, corresponding to an equivalent dose of 2.5 or 5 Gy. According to changes in blood cell counts (BCC) the surviving baboons (n = 17) exhibited mild (H1-2, n = 4) or more severe (H2-3, n = 13) HARS. In a two Stage study design we screened 667 miRNAs using a quantitative real-time polymerase chain reaction (qRT-PCR) platform. In Stage II we validated candidates where miRNAs had to show a similar regulation (up- or down-regulated) and a significant 2-fold miRNA expression difference over H0. Seventy-two candidate miRNAs (42 for H1-2 and 30 for H2-3) were forwarded for validation. Forty-two of the H1-2 miRNA candidates from the screening phase entered the validation step and 20 of them showed a statistically significant 2-4 fold up-regulation relative to the unexposed reference (H0). Fifteen of the 30 H2-3 miRNAs were validated in Stage II. All miRNAs appeared 2-3 fold down-regulated over H0 and allowed an almost complete separation of HARS categories; the strongest candidate, miR-342-3p, showed a sustained and 10-fold down-regulation on both days 1 and 2. In summary, our data support the medical decision making of the HARS even within the first two days after exposure where diagnostic tools for early medical decision are required but so far missing. The miRNA species identified and in particular miR-342-3p add to the previously identified mRNAs and complete the portfolio of identified mRNA and miRNA transcripts for HARS prediction and medical management.	[Port, Matthias; Ullmann, Reinhard; Douche-Senf, Sven; Lamkowski, Andreas; Majewski, Matthaeus; Abend, Michael] Bundeswehr Inst Radiobiol, Munich, Germany; [Herodin, Francis; Valente, Marco; Drouet, Michel] Inst Rech Biomed Armees, Bretigny Sur Orge, France		Abend, M (corresponding author), Bundeswehr Inst Radiobiol, Munich, Germany.	michaelabend@bundeswehr.org	Valente, Marco/A-8833-2018	Port, Matthias/0000-0002-8496-5883	French Ministry of Defense; German Ministry of Defense	French Ministry of Defense; German Ministry of Defense	This work was supported by both the French and the German Ministry of Defense.	Aavik E, 2004, FASEB J, V18, P130, DOI 10.1096/fj.04-2225fje; Abend M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039103; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Akiba S, 2012, J RADIOL PROT, V32, P1, DOI 10.1088/0952-4746/32/1/1; Beinke C, 2013, RADIAT RES, V180, P129, DOI 10.1667/RR3235.1; Boldt S, 2012, INT J RADIAT BIOL, V88, P267, DOI 10.3109/09553002.2012.638358; Bouville A, 2006, RADIAT RES, V166, P158, DOI 10.1667/RR3370.1; Chaudhry MA, 2008, J BIOMED SCI, V15, P557, DOI 10.1007/s11373-008-9253-z; Cullings HM, 2006, RADIAT RES, V166, P219, DOI 10.1667/RR3546.1; Drozdovitch V, 2007, RADIAT PROT DOSIM, V127, P540, DOI 10.1093/rpd/ncm360; Friesecke I, 2001, BRIT J RADIOL, V74, P121, DOI 10.1259/bjr.74.878.740121; Iaea, 2001, TECH REP SER, V138; Kamada N, 2012, J ENVIRON RADIOACTIV, V110, P84, DOI 10.1016/j.jenvrad.2012.02.007; Koizumi Akio, 2012, Environmental Health and Preventive Medicine, V17, P292, DOI 10.1007/s12199-011-0251-9; Kopecky KJ, 2006, RADIAT RES, V166, P367, DOI 10.1667/RR3596.1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Meadows SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011535; Meadows SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001912; Natarajan AT, 1998, MUTAT RES-FUND MOL M, V400, P299, DOI 10.1016/S0027-5107(98)00021-9; Paul S, 2008, INT J RADIAT ONCOL, V71, P1236, DOI 10.1016/j.ijrobp.2008.03.043; Paul S, 2011, INT J RADIAT BIOL, V87, P791, DOI 10.3109/09553002.2011.568574; Port M, 2016, 1 GENERATION GENE EX, P39, DOI [10.1667/RR14318.1, DOI 10.1667/RR14318.1]; Ramalho AT, 1998, MUTAT RES-FUND MOL M, V404, P97, DOI 10.1016/S0027-5107(98)00099-2; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherwin JRA, 2010, ENDOCRINOLOGY, V151, P4982, DOI 10.1210/en.2010-0275; Shi Q, 2010, CLIN EXP PHARMACOL P, V37, P178, DOI 10.1111/j.1440-1681.2009.05260.x; Singh VK, 2012, RADIAT RES, V177, P781, DOI 10.1667/RR2894.1; Singh VK, 2012, CYTOKINE, V58, P406, DOI 10.1016/j.cyto.2012.03.011; Valente M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132194	29	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165307	10.1371/journal.pone.0165307	http://dx.doi.org/10.1371/journal.pone.0165307			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846229	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600011
J	Shamsi, TN; Parveen, R; Amir, M; Baig, MA; Qureshi, MI; Ali, S; Fatima, S				Shamsi, Tooba Naz; Parveen, Romana; Amir, Mohd.; Baig, Mohd. Affan; Qureshi, M. Irfan; Ali, Sher; Fatima, Sadaf			Allium sativum Protease Inhibitor: A Novel Kunitz Trypsin Inhibitor from Garlic Is a New Comrade of the Serpin Family	PLOS ONE			English	Article							ALPHA-AMYLASE INHIBITOR; PROTEINASE-INHIBITORS; PURIFICATION; CANCER; CHEMOPREVENTION; RESISTANCE; STABILITY; DISEASE	Purpose This study was aimed to purify and characterize the Protease inhibitor (PI) from a plant Allium sativum (garlic) with strong medicinal properties and to explore its phytodrug potentials. Methods Allium sativum Protease Inhibitor (ASPI) was purified using ammonium sulphate fraction-ation and Fast Protein Liquid Chromatography on anion exchanger Hi-Trap DEAE column. The purified protein was analyzed for its purity and molecular weight by SDS PAGE. The confirmation of presence of trypsin inhibiting PI was performed by MALDI TOF-TOF and analyzed by MASCOT database. The ASPI was further investigated for its kinetic properties and stability under extreme conditions of pH, temperature and chemical denaturants. Secondary structure was determined by Circular Dichorism (CD) spectroscopy. Results ASPI of similar to 15 kDa inhibited trypsin and matched "truncated kunitz Trypsin Inhibitor (Glycine max)" in MASCOT database. The purified ASPI showed 30376.1371 U/mg specific activity with a fold purity of 159.92 and yield similar to 93%. ASPI was quite stable in the range of pH 2-12 showing a decline in the activity around pH 4-5 suggesting that the pI value of the protein as ASPI aggregates in this range. ASPI showed stability to a broad range of temperature (10-80 degrees C) but declined beyond 80 degrees C. Further, detergents, oxidizing agents and reducing agents demonstrated change in ASPI activity under varying concentrations. The kinetic analysis revealed sigmoidal relationship of velocity with substrate concentration with Vmax 240.8 (mu M/min) and Km value of 0.12 mu M. ASPI showed uncompetitive inhibition with a Ki of 0.08 +/- 0.01 nM). The Far UV CD depicted 2.0% alpha-helices and 51% beta-sheets at native pH. Conclusions To conclude, purified similar to 15 kDa ASPI exhibited fair stability in wide range of pH and temperature Overall, there was an increase in purification fold with remarkable yield. Chemical modification studies suggested the presence of lysine and tryptophan residues as lead amino acids present in the reactive sites. Therefore, ASPI with trypsin inhibitory property has the potential to be used as a non-cytotoxic clinical agents.	[Shamsi, Tooba Naz; Parveen, Romana; Baig, Mohd. Affan; Qureshi, M. Irfan; Fatima, Sadaf] Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India; [Amir, Mohd.; Ali, Sher] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India	Jamia Millia Islamia; Jamia Millia Islamia	Fatima, S (corresponding author), Jamia Millia Islamia, Dept Biotechnol, New Delhi 110025, India.	amu.jmi@rediffmail.com	Qureshi, M Irfan/CAF-0824-2022; Shamsi, Tooba/ADE-5752-2022; Amir, Mohammad/GOK-1613-2022	Qureshi, M Irfan/0000-0001-9625-0036; Shamsi, Tooba/0000-0001-7164-0791; AMIR, MOHD/0000-0001-9524-0899; Baig, Affan/0000-0002-6203-2097	DST-SERB	DST-SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	TNS, RP, MA and MAB are thankful to Central Instrumentation Facility, Department of Biotechnology, JMI and Cyanobacterial Biotechnology Lab and Microbiology Research Lab, Department of Biosciences, JMI, New Delhi to allow the access to instruments for the research work. SF is thankful to Dr Md Imtaiyaz Hassan, Center for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India for their guidance throughout the research work. SA is grateful to DST-SERB for the award of JC Bose Fellowship.	Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; BHAT AV, 1989, J BIOSCIENCE, V14, P351, DOI 10.1007/BF02703421; Cherqui A, 2001, INSECT BIOCHEM MOLEC, V31, P761, DOI 10.1016/S0965-1748(00)00172-7; Chung JG, 1999, J APPL TOXICOL, V19, P75; Clawson GA, 1996, CANCER INVEST, V14, P597, DOI 10.3109/07357909609076904; Devrim E, 2007, MOL NUTR FOOD RES, V51, P1319, DOI 10.1002/mnfr.200600302; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; FARMER EE, 1990, P NATL ACAD SCI USA, V87, P7713, DOI 10.1073/pnas.87.19.7713; Gorinstein S, 2007, MOL NUTR FOOD RES, V51, P1365, DOI 10.1002/mnfr.200700064; Haq SK, 2005, BIOCHIMIE, V87, P1127, DOI 10.1016/j.biochi.2005.05.007; Haq SK, 2003, J PROTEIN CHEM, V22, P543, DOI 10.1023/B:JOPC.0000005504.57372.5b; Heidtmann HH, 1997, CLIN EXP METASTAS, V15, P368, DOI 10.1023/A:1018494020001; HOCMAN G, 1992, INT J BIOCHEM, V24, P1365, DOI 10.1016/0020-711X(92)90061-5; Huma Habib, 2007, Biotechnology and Molecular Biology Reviews, V2, P068; Ishimoto M, 1996, ENTOMOL EXP APPL, V79, P309, DOI 10.1007/BF00186289; Kidric M, 2002, BIOCHEM BIOPH RES CO, V297, P962, DOI 10.1016/S0006-291X(02)02328-8; Koiwa H, 1997, TRENDS PLANT SCI, V2, P379, DOI 10.1016/S1360-1385(97)90052-2; Krishnan V.M., 2015, FOOD SCI HUM WELL, V4, P97, DOI [10.1016/j.fshw.2015.06.003, DOI 10.1016/J.FSHW.2015.06.003]; Kritchevsky D., 1991, Trends in Food Science & Technology, V2, P141, DOI 10.1016/0924-2244(91)90658-6; Kyo E, 2001, J NUTR, V131, p1075S, DOI 10.1093/jn/131.3.1075S; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lanzotti V, 2006, J CHROMATOGR A, V1112, P3, DOI 10.1016/j.chroma.2005.12.016; Lau BHS, 2001, J NUTR, V131, p985S, DOI 10.1093/jn/131.3.985S; Lawton JM, 1998, BIOCHEM J, V334, P219, DOI 10.1042/bj3340219; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2; MOORE GS, 1977, MYCOLOGIA, V69, P341, DOI 10.2307/3758659; NEURATH H, 1989, TRENDS BIOCHEM SCI, V14, P268, DOI 10.1016/0968-0004(89)90061-3; Ogawa Masahiro, 2003, Journal of Medicinal Food, V6, P317; Oliva MLV, 2010, BIOCHIMIE, V92, P1667, DOI 10.1016/j.biochi.2010.03.021; Pandhare J, 2002, BIORESOURCE TECHNOL, V84, P165, DOI 10.1016/S0960-8524(02)00025-1; Patil DN, 2009, ACTA CRYSTALLOGR F, V65, P736, DOI 10.1107/S1744309109023495; Prathibha S, 1995, PLANT FOOD HUM NUTR, V48, P247, DOI 10.1007/BF01088446; Rahman K, 2006, J NUTR, V136, p736S, DOI 10.1093/jn/136.3.736S; Richardson MJ., 1991, METHODS PLANT BIOCH, P259; RYAN CA, 1990, ANNU REV PHYTOPATHOL, V28, P425, DOI 10.1146/annurev.py.28.090190.002233; SCHROEDER HE, 1995, PLANT PHYSIOL, V107, P1233, DOI 10.1104/pp.107.4.1233; Sever N, 2002, BIOL CHEM, V383, P839, DOI 10.1515/BC.2002.088; SHADE RE, 1994, BIO-TECHNOL, V12, P793, DOI 10.1038/nbt0894-793; Shrivastava B, 2003, INSECT BIOCHEM MOLEC, V33, P1025, DOI 10.1016/S0965-1748(03)00117-6; SUMIYOSHI H, 1990, CANCER RES, V50, P5084; Vogel R., 1968, NATURAL PROTEINASE I	42	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165572	10.1371/journal.pone.0165572	http://dx.doi.org/10.1371/journal.pone.0165572			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846232	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600015
J	So, R; Song, S; Lee, JE; Yoon, HJ				So, Rina; Song, Sihan; Lee, Jung Eun; Yoon, Hyung-Jin			The Association between Renal Hyperfiltration and the Sources of Habitual Protein Intake and Dietary Acid Load in a General Population with Preserved Renal Function: The KoGES Study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR HYPERFILTRATION; HEALTHY; ADULTS; RISK; HYPERTENSION; ALBUMINURIA	Although the differential response of the kidney to the acute load of various sources of dietary protein in subjects with normal renal function is well known, the influence of habitual dietary protein intake and dietary acid load on renal function has not been tested well. The association between renal hyperfiltration (RHF), the earlier and possibly reversible stage of chronic kidney disease, and the sources of habitual dietary protein and dietary acid load was analyzed with the baseline data of 123,169 middle-aged healthy Koreans of a large prospective cohort study, who had a baseline estimated glomerular filtration rate (eGFR) > 60 mL/min/m 2 and no known history of diabetes and/or hypertension. eGFR was calculated with the Chronic Kidney Disease Epidemiology Collaboration equation using serum creatinine and RHF was defined as eGFR > 95 th percentile after adjustment for age, sex, height, and body weight. Dietary acid load was calculated with estimated net endogenous acid production (eNEAP). Although the level of habitual intake of animal protein was positively and vegetable protein was negatively associated with RHF, this association was significant only in women and younger participants (younger than sex-specific median age). The odds for RHF increased as the percentile rank of eNEAP increased until about the 50 th percentile and then leveled off. The positive association between eNEAP and RHF was significant in both sexes and age groups. Dietary acid load was associated with RHF regardless of sex and age and rather than the amount of the total or the individual sources of habitual dietary protein, may be a better target for the dietary intervention of chronic kidney disease.	[So, Rina; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Song, Sihan] Sookmyung Womens Univ, Dept Food & Nutr, Seoul, South Korea; [Lee, Jung Eun] Seoul Natl Univ, Coll Human Ecol, Dept Food & Nutr, Seoul, South Korea	Seoul National University (SNU); Sookmyung Women's University; Seoul National University (SNU)	Yoon, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.	hjyoon@snu.ac.kr	Lee, Jung Eun/AAC-5634-2020; So, Rina/GXM-7545-2022	Lee, Jung Eun/0000-0003-1141-878X; 	Korea Health Industry Development Institute [HI16C0367]	Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	HJY is supported by the Korea Health Industry Development Institute grant HI16C0367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeva MM, 2011, CLIN NUTR, V30, P416, DOI 10.1016/j.clnu.2011.03.008; Ahn Y, 2007, EUR J CLIN NUTR, V61, P1435, DOI 10.1038/sj.ejcn.1602657; Akter S, 2015, NUTRITION, V31, P298, DOI 10.1016/j.nut.2014.07.007; Banerjee T, 2015, J AM SOC NEPHROL, V26, P1693, DOI 10.1681/ASN.2014040332; Banerjee T, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-137; Beasley JM, 2011, J NUTR, V141, P1502, DOI 10.3945/jn.110.135814; BERGSTROM J, 1985, ACTA MED SCAND, V217, P189; Bernstein AM, 2007, J AM DIET ASSOC, V107, P644, DOI 10.1016/j.jada.2007.01.002; Brandle E, 1996, EUR J CLIN NUTR, V50, P734; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Cachat F, 2013, NEPHROL DIAL TRANSPL, V28, P386, DOI 10.1093/ndt/gfs494; CHAN AYM, 1988, J CLIN INVEST, V81, P245, DOI 10.1172/JCI113302; Engberink MF, 2012, AM J CLIN NUTR, V95, P1438, DOI 10.3945/ajcn.111.022343; Halbesma N, 2009, J AM SOC NEPHROL, V20, P1797, DOI 10.1681/ASN.2008060649; Hariharan D, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0529-6; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kim Y, 2016, INT J EPIDEMIOL; KING AJ, 1993, J AM SOC NEPHROL, V3, P1723; KONTESSIS P, 1990, KIDNEY INT, V38, P136, DOI 10.1038/ki.1990.178; Lin CK, 2010, J HEALTH POPUL NUTR, V28, P470; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Maeda I, 2011, CLIN J AM SOC NEPHRO, V6, P2462, DOI 10.2215/CJN.00700111; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Melsom T, 2012, CLIN J AM SOC NEPHRO, V7, P1801, DOI 10.2215/CJN.02980312; Odermatt A, 2011, AM J PHYSIOL-RENAL, V301, pF919, DOI 10.1152/ajprenal.00068.2011; Park M, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-015-0218-y; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Park M, 2013, MED SCI SPORT EXER, V45, P217, DOI 10.1249/MSS.0b013e318271b39f; Pugliese G, 2014, ACTA DIABETOL, V51, P905, DOI 10.1007/s00592-014-0650-7; Rebholz CM, 2015, AM J NEPHROL, V42, P427, DOI 10.1159/000443746; Riccio E, 2015, CLIN EXP NEPHROL, V19, P161, DOI 10.1007/s10157-014-1041-7; Rosolowsky ET, 2008, DIABETES RES CLIN PR, V82, pS46, DOI 10.1016/j.diabres.2008.09.018; Stephenson TJ, 2005, CLIN NEPHROL, V64, P1; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; WISEMAN MJ, 1987, NEPHRON, V46, P37, DOI 10.1159/000184293	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166495	10.1371/journal.pone.0166495	http://dx.doi.org/10.1371/journal.pone.0166495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846266	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600071
J	Tian, CO; Li, ZF; Yang, ZG; Huang, QH; Liu, JM; Hong, B				Tian, Chunou; Li, Zifu; Yang, Zhigang; Huang, Qinghai; Liu, Jianmin; Hong, Bo			Plasma MicroRNA-16 Is a Biomarker for Diagnosis, Stratification, and Prognosis of Hyperacute Cerebral Infarction	PLOS ONE			English	Article							CIRCULATING MICRORNAS; POTENTIAL BIOMARKERS; ISCHEMIC-STROKE; CELL-DEATH; IDENTIFICATION; BRAIN	Indices for the diagnosis of hyperacute cerebral infarction (HACI) and the prediction of prognosis are essential for timely and appropriate management. MicroRNAs (miRNAs) that regulate gene expression following stroke have potential use as prognostic markers of HACI. Here, we explored whether concentrations of circulating miRNAs correlate with clinical outcomes and thus form a system of stroke stratification. Plasma samples from patients with HACI (n = 7) and age-matched healthy volunteers (HVT, n = 4) were screened by microarray to find differentially expressed miRNAs, some of which were further verified by quantitative reverse transcription polymerase chain reaction (qRT-PCR) (HACI: HVT = 33: 23). The target genes of the miRNAs with verified differential expression were investigated by GO and KEEG analyses. Using the TOAST (OCSP) criteria and the 3-month modified Rankin Score (mRS), relationships among the expression patterns of specific miRNAs, stroke stratification, and clinical prognosis were determined. The microarray analysis revealed 12 differentially expressed miRNAs. Among seven selected miRNAs verified with qRT-PCR, miR-16 expression in the HACI group was the most significantly different from the HVT group (P < 0.01). Bioinformatics analysis showed that the potential target genes of miR-16 were mainly involved in programmed cell death and the p53 signaling pathways. Receiver operating characteristic (ROC) analysis showed that the area under the curve (AUC) of miR-16 was 0.775 (sensitivity 69.7% and specificity 87%) and 0.952 (sensitivity 100% and specificity 91.3%) in overall patients and patients with large artery atherosclerosis (LAAS), respectively. Elevated miR-16 expression was associated with the stroke subtype of LAAS, total anterior circulation infarction, partial anterior circulation infarction, and poor prognosis (P < 0.05). A diagnostic method based on rapid measurement of plasma miR-16 has the potential to identify hyperacute cerebral infarction with LAAS with high sensitivity and specificity, which would inform and improve early treatment decisions and disease management.	[Tian, Chunou; Li, Zifu; Yang, Zhigang; Huang, Qinghai; Liu, Jianmin; Hong, Bo] Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China; [Tian, Chunou] 422 Hosp PLA, Dept Neurosurg, Zhanjiang, Guangdong, Peoples R China	Naval Medical University	Hong, B (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Neurosurg, Shanghai, Peoples R China.	hongbosmmu@vip.126.com		Li, Zifu/0000-0002-9332-3786	National Natural Science Foundation of China [31370810]; Shanghai Municipal Commission of Health and Family Planning [201640094]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Commission of Health and Family Planning	This study was funded by grants from the National Natural Science Foundation of China (31370810) (BH) (http://www.mnsfc.gov.cn/). It was also funded by grants from the Shanghai Municipal Commission of Health and Family Planning (201640094) (ZL) (http://www.wsjsw.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2010, MOL NEUROBIOL, V41, P206, DOI 10.1007/s12035-010-8100-1; Barakat W, 2014, EUR J PHARMACOL, V724, P43, DOI 10.1016/j.ejphar.2013.12.032; Bennion DM, 2016, J RENIN-ANGIO-ALDO S, V17, DOI 10.1177/1470320316661060; Cheyuo C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122833; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; Hong LZ, 2010, NEUROSCI BULL, V26, P232, DOI 10.1007/s12264-010-1111-0; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Jahr S, 2001, CANCER RES, V61, P1659; Jiang Z, 2014, NEUROSCI LETT, V566, P298, DOI 10.1016/j.neulet.2014.02.066; Kang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048536; Li PF, 2015, CELL MOL NEUROBIOL, V35, P433, DOI 10.1007/s10571-014-0139-5; Lian TT, 2015, INT J MOL SCI, V16, P13427, DOI 10.3390/ijms160613427; Llombart V, 2016, J NEUROCHEM, V136, P416, DOI 10.1111/jnc.13419; Long GW, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-178; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Peng GP, 2015, TRANSL STROKE RES, V6, P437, DOI 10.1007/s12975-015-0422-x; Picascia A, 2015, J NEUROIMMUNOL, V289, P111, DOI 10.1016/j.jneuroim.2015.10.013; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Sepramaniam S, 2014, INT J MOL SCI, V15, P1418, DOI 10.3390/ijms15011418; Tsai PC, 2013, J VASC RES, V50, P346, DOI 10.1159/000351767; Wang WH, 2014, J STROKE CEREBROVASC, V23, P2607, DOI 10.1016/j.jstrokecerebrovasdis.2014.06.002; Wang Y, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-77; Wang Y, 2014, INT J CLIN EXP PATHO, V7, P4067; Xu ZF, 2005, NEUROSCI LETT, V375, P181, DOI 10.1016/j.neulet.2004.11.039; Yang YL, 2016, THER CLIN RISK MANAG, V12, P1049, DOI 10.2147/TCRM.S107053; Yue JM, 2010, MAMM GENOME, V21, P88, DOI 10.1007/s00335-009-9240-3; Zeng Lili, 2011, Front Biosci (Elite Ed), V3, P1265	29	38	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166688	10.1371/journal.pone.0166688	http://dx.doi.org/10.1371/journal.pone.0166688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846323	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600101
J	Neis, EPJG; Bloemen, JG; Rensen, SS; van der Vorst, JR; van den Broek, MA; Venema, K; Buurman, WA; Dejong, CHC				Neis, Evelien P. J. G.; Bloemen, Johanne G.; Rensen, Sander S.; van der Vorst, Joost R.; van den Broek, Maartje A.; Venema, Koen; Buurman, Wim A.; Dejong, Cornelis H. C.			Effects of Liver Resection on Hepatic Short-Chain Fatty Acid Metabolism in Humans	PLOS ONE			English	Article							GUT MICROBIOTA; ENERGY-METABOLISM; COLONIC FUNCTION; RECEPTOR GPR43; BUTYRATE; PROPIONATE; DIET; ABSORPTION; CITRULLINE; RELEVANCE	Aim To determine whether acute loss of liver tissue affects hepatic short-chain fatty acid (SCFA) clearance. Methods Blood was sampled from the radial artery, portal vein, and hepatic vein before and after hepatic resection in 30 patients undergoing partial liver resection. Plasma SCFA levels were measured by liquid chromatography-mass spectrometry. SCFA exchange across gut and liver was calculated from arteriovenous differences and plasma flow. Liver volume was estimated by CT liver volumetry. Results The gut produced significant amounts of acetate, propionate, and butyrate (39.4 +/- 13.5, 6.2 +/- 1.3, and 9.5 +/- 2.6 mu mol.kgbw(-1).h(-1)), which did not change after partial hepatectomy (p = 0.67, p = 0.59 and p = 0.24). Hepatic propionate uptake did not differ significantly before and after resection (-6.4 +/- 1.4 vs. -8.4 +/- 1.5 mu mol.kgbw(-1).h(-1), p = 0.49). Hepatic acetate and butyrate uptake increased significantly upon partial liver resection (acetate: -35.1 +/- 13.0 vs. -39.6 +/- 9.4 mu mol.kgbw(-1).h(-1), p = 0.0011; butyrate: -9.9 +/- 2.7 vs. -11.5 +/- 2.4 mu mol.kgbw(-1).h(-1), p = 0.0006). Arterial SCFA concentrations were not different before and after partial liver resection (acetate: 176.9 +/- 17.3 vs. 142.3 +/- 12.5 mu mol/L, p = 0.18; propionate: 7.2 +/- 1.4 vs. 5.6 +/- 0.6 mu mol/L, p = 0.38; butyrate: 4.3 +/- 0.7 vs. 3.6 +/- 0.6 mu mol/L, p = 0.73). Conclusion The liver maintains its capacity to clear acetate, propionate, and butyrate from the portal blood upon acute loss of liver tissue.	[Neis, Evelien P. J. G.; Bloemen, Johanne G.; Venema, Koen; Dejong, Cornelis H. C.] TI Food & Nutr, NL-6709 PA Wageningen, Netherlands; [Neis, Evelien P. J. G.; Bloemen, Johanne G.; Rensen, Sander S.; van den Broek, Maartje A.; Buurman, Wim A.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Surg, Med Ctr, NL-6229 HX Maastricht, Netherlands; [van der Vorst, Joost R.; van den Broek, Maartje A.] Leiden Univ, Med Ctr, Dept Surg, NL-2333 ZA Leiden, Netherlands; [Venema, Koen] Wageningen Univ, Beneficial Microbes Consultancy, NL-6708 PB Wageningen, Netherlands	Top Institute Food & Nutrition; Maastricht University; Maastricht University Medical Centre (MUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	Neis, EPJG (corresponding author), TI Food & Nutr, NL-6709 PA Wageningen, Netherlands.; Neis, EPJG (corresponding author), Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Dept Surg, Med Ctr, NL-6229 HX Maastricht, Netherlands.	e.neis@maastrichtuniversity.nl	Rensen, Sander/J-3224-2019; van der Vorst, Joost/ABI-3142-2020	Rensen, Sander/0000-0001-5054-8400; van der Vorst, Joost/0000-0002-0669-4272	TI Food and Nutrition	TI Food and Nutrition	The research was funded by TI Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; BERGMAN EN, 1971, AM J PHYSIOL, V221, P586, DOI 10.1152/ajplegacy.1971.221.2.586; Bloemen JG, 2010, DIS COLON RECTUM, V53, P1069, DOI 10.1007/DCR.0b013e3181d881b7; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Canani RB, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-4; Cavaglieri CR, 2003, LIFE SCI, V73, P1683, DOI 10.1016/S0024-3205(03)00490-9; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06; Eamin EE, 2013, J NUTR, V143, P1872, DOI 10.3945/jn.113.179549; Faerch K, 2015, DIABETES, V64, P2513, DOI 10.2337/db14-1751; Feliz Brady, 2003, Arch Pathol Lab Med, V127, pe325; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hu LI, 2010, MOL MICROBIOL, V77, P15, DOI 10.1111/j.1365-2958.2010.07204.x; Kimura I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00085; Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852; Kristensen NB, 2004, J ANIM SCI, V82, P3549; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; MANNS JG, 1967, AM J PHYSIOL, V212, P747, DOI 10.1152/ajplegacy.1967.212.4.747; Matsumoto N, 2006, KIDNEY INT, V69, P257, DOI 10.1038/sj.ki.5000028; Mckay JA, 2011, ACTA PHYSIOL, V202, P103, DOI 10.1111/j.1748-1716.2011.02278.x; Meijer K, 2010, CURR OPIN CLIN NUTR, V13, P715, DOI 10.1097/MCO.0b013e32833eebe5; Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Roberfroid M, 2007, J NUTR, V137, p830S, DOI 10.1093/jn/137.3.830S; Suzuki T, 2008, BRIT J NUTR, V100, P297, DOI 10.1017/S0007114508888733; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; van de Poll MCG, 2007, AM J PHYSIOL-GASTR L, V293, pG956, DOI 10.1152/ajpgi.00366.2006; van de Poll MCG, 2007, J PHYSIOL-LONDON, V581, P819, DOI 10.1113/jphysiol.2006.126029; van de Poll MCG, 2007, AM J CLIN NUTR, V85, P167, DOI 10.1093/ajcn/85.1.167; van der Vorst JR, 2010, WORLD J SURG, V34, P2426, DOI 10.1007/s00268-010-0663-5; van Eijk HMH, 2009, J CHROMATOGR B, V877, P719, DOI 10.1016/j.jchromb.2009.01.039; VERNAY MY, 1987, GUT, V28, P1077, DOI 10.1136/gut.28.9.1077; Wachtershauser A, 2000, EUR J NUTR, V39, P164, DOI 10.1007/s003940070020; Watzl B, 2005, BRIT J NUTR, V93, pS49, DOI 10.1079/BJN20041357; Welters CFM, 2002, DIS COLON RECTUM, V45, P621, DOI 10.1007/s10350-004-6257-2; Wilson AJ, 1997, GASTROENTEROLOGY, V113, P487, DOI 10.1053/gast.1997.v113.pm9247468	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166161	10.1371/journal.pone.0166161	http://dx.doi.org/10.1371/journal.pone.0166161			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835668	gold, Green Submitted, Green Published			2022-12-26	WOS:000387779200029
J	Rob, D; Marek, J; Dostalova, G; Golan, L; Linhart, A				Rob, Daniel; Marek, Josef; Dostalova, Gabriela; Golan, Lubor; Linhart, Ales			Uric Acid as a Marker of Mortality and Morbidity in Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; XANTHINE-OXIDASE INHIBITION; CHRONIC KIDNEY-DISEASE; LEFT-VENTRICULAR MASS; CARDIAC ENERGY-METABOLISM; ALL-CAUSE MORTALITY; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; HEART-FAILURE; OXIDATIVE STRESS	Background Serum uric acid (UA) elevation is common in patients with cardiovascular, renal and metabolic diseases. However, no study to date has analysed the role of UA in Fabry disease (FD). Objectives To evaluate the association between serum UA levels and mortality and morbidity in FD. Materials and Methods We conducted a post-hoc analysis of a prospectively followed-up cohort of 124 patients with genetically proven FD. Serum UA levels were acquired at baseline; clinical events and mortality were assessed during regular visits every 6 to 12 months. The primary endpoint was a composite of multiple secondary outcomes: all-cause mortality, adverse cardiovascular events, progression of renal dysfunction and stroke or transient ischaemic attack (TIA). Predictive value was assessed using the Cox proportional hazards model and the Kaplan Meyer estimator. Results During follow-up of 7.4 +/- 3.7 years, 64 (52%) patients reached the primary combined endpoint. Overall, UA levels were significantly associated with combined outcome (p < 0.001) and remained independently associated after correcting for age, sex and estimated glomerular filtration rate (hazard ratio [HR] per 20 mu mol/l increase 1.09, 95% confidence interval [95% CI] (1.00-1.19), p = 0.04). UA was associated with overall mortality in univariate analysis (p = 0.021); however, the association did not reach statistical significance after multivariate correction (HR per 20 mu mol/l increase 1.07 95% CI 0.93-1.25, p = 0.32). Higher UA levels were also associated with cardiac adverse outcomes, progression of left ventricular hypertrophy and progression of renal dysfunction (ps < 0.001). No association was observed between UA levels and stroke or TIA (p = 0.323). Conclusion and Implications Increased serum UA levels may represent an independent risk factor for adverse clinical outcomes in Fabry patients and are associated with all-cause mortality. UA is a widely available and cheap biomarker that may improve risk stratification of Fabry patients in clinical practice.	[Linhart, Ales] Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic; Gen Univ Hosp, Prague, Czech Republic	Charles University Prague; General University Hospital Prague	Linhart, A (corresponding author), Charles Univ Prague, Dept Med 2, Dept Cardiovasc Med, Fac Med 1, Prague, Czech Republic.	alinh@lf1.cuni.cz	Rob, Daniel/K-8374-2017; Linhart, Ales/O-2375-2017; Golan, Lubor/O-2359-2017	Rob, Daniel/0000-0002-3927-2674; Linhart, Ales/0000-0002-3372-7850; Golan, Lubor/0000-0003-1705-1157	Charles University in Prague, PRVOUK [P35, LINHART 205035-3]	Charles University in Prague, PRVOUK	This work was supported by the grant of Charles University in Prague, PRVOUK, P35, LINHART 205035-3.	BAKHTIYAROV ZA, 1989, TERAPEVT ARKH, V61, P68; Biancini GB, 2012, BBA-MOL BASIS DIS, V1822, P226, DOI 10.1016/j.bbadis.2011.11.001; Bickel C, 2002, AM J CARDIOL, V89, P12, DOI 10.1016/S0002-9149(01)02155-5; Biegstraaten M, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0253-6; Branton MH, 2002, MEDICINE, V81, P122, DOI 10.1097/00005792-200203000-00003; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Choi YJ, 2014, FASEB J, V28, P3197, DOI 10.1096/fj.13-247148; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; DeGraba T, 2000, ANN NEUROL, V47, P229, DOI 10.1002/1531-8249(200002)47:2<229::AID-ANA13>3.3.CO;2-K; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; Doehner W, 2011, SEMIN NEPHROL, V31, P433, DOI 10.1016/j.semnephrol.2011.08.007; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; George J, 2009, VASC HEALTH RISK MAN, V5, P265, DOI 10.2147/VHRM.S4265; Germain DP, 2015, J MED GENET, V52, P353, DOI 10.1136/jmedgenet-2014-102797; Giordano C, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/382918; Givertz MM, 2015, CIRCULATION, V131, P1763, DOI 10.1161/CIRCULATIONAHA.114.014536; Grayson PC, 2011, ARTHRIT CARE RES, V63, P102, DOI 10.1002/acr.20344; Harrison D, 2003, AM J CARDIOL, V91, p7A; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Higgins P, 2014, HEART, V100, P1085, DOI 10.1136/heartjnl-2014-305683; Higgins P, 2012, CARDIOVASC THER, V30, P217, DOI 10.1111/j.1755-5922.2011.00277.x; Huang H, 2014, EUR J HEART FAIL, V16, P15, DOI 10.1093/eurjhf/hft132; Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14; JARASCH ED, 1981, CELL, V25, P67, DOI 10.1016/0092-8674(81)90232-4; Johnson RJ, 2013, DIABETES, V62, P3307, DOI 10.2337/db12-1814; Johnson RJ, 2013, NEPHROL DIAL TRANSPL, V28, P2221, DOI 10.1093/ndt/gft029; Joly DA, 2014, KIDNEY INT, V86, P5, DOI 10.1038/ki.2014.126; Kanellis J, 2005, SEMIN NEPHROL, V25, P39, DOI 10.1016/j.semnephrol.2004.09.007; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kao MP, 2011, J AM SOC NEPHROL, V22, P1382, DOI 10.1681/ASN.2010111185; Karetova D, 2010, VASA, V39, P123, DOI 10.1024/0301-1526/a000017; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Kim Hyungseop, 2010, Congest Heart Fail, V16, P153, DOI 10.1111/j.1751-7133.2010.00144.x; Kim SY, 2009, ARTHRIT RHEUM-ARTHR, V61, P885, DOI 10.1002/art.24612; Lang RM, 2015, EUR HEART J-CARD IMG, V16, P233, DOI 10.1093/ehjci/jev014; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li JM, 2004, AM J PHYSIOL-REG I, V287, pR1014, DOI 10.1152/ajpregu.00124.2004; Linhart A, 2007, EUR HEART J, V28, P1228, DOI 10.1093/eurheartj/ehm153; Machann W, 2011, EUR J HEART FAIL, V13, P278, DOI 10.1093/eurjhf/hfq211; Moore DF, 2004, J MAGN RESON IMAGING, V20, P674, DOI 10.1002/jmri.20162; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Noman A, 2010, LANCET, V375, P2161, DOI 10.1016/S0140-6736(10)60391-1; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Palecek T, 2010, INT J CARDIOL, V144, P337, DOI 10.1016/j.ijcard.2009.03.045; Riegersperger M, 2011, INT UROL NEPHROL, V43, P441, DOI 10.1007/s11255-011-9929-6; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Sanchez-Lozada LG, 2012, NEPHRON EXP NEPHROL, V121, pE71, DOI 10.1159/000345509; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schiffmann R, 2006, VIRCHOWS ARCH, V448, P337, DOI 10.1007/s00428-005-0089-x; Shen JS, 2008, MOL GENET METAB, V95, P163, DOI 10.1016/j.ymgme.2008.06.016; Soltani Z, 2013, CURR HYPERTENS REP, V15, P175, DOI 10.1007/s11906-013-0344-5; Strasak AM, 2008, INT J CARDIOL, V125, P232, DOI 10.1016/j.ijcard.2007.11.094; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Thanassoulis G, 2010, ARCH INTERN MED, V170, P1358, DOI 10.1001/archinternmed.2010.198; Vitner EB, 2010, J BIOL CHEM, V285, P20423, DOI 10.1074/jbc.R110.134452; WU XW, 1992, J MOL EVOL, V34, P78, DOI 10.1007/BF00163854; Yiginer O, 2008, CLIN RES CARDIOL, V97, P334, DOI 10.1007/s00392-007-0636-3; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhao G, 2013, ATHEROSCLEROSIS, V231, P61, DOI 10.1016/j.atherosclerosis.2013.08.023; Zhu L, 2015, CAN J CARDIOL, V31, P1252, DOI 10.1016/j.cjca.2015.02.018; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949; Zoppini G, 2012, DIABETES CARE, V35, P99, DOI 10.2337/dc11-1346	63	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166290	10.1371/journal.pone.0166290	http://dx.doi.org/10.1371/journal.pone.0166290			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835692	Green Published, gold			2022-12-26	WOS:000387779200035
J	Lenoir-Wijnkoop, I; Gerlier, L; Roy, D; Reid, G				Lenoir-Wijnkoop, Irene; Gerlier, Laetitia; Roy, Denis; Reid, Gregor			The Clinical and Economic Impact of Probiotics Consumption on Respiratory Tract Infections: Projections for Canada	PLOS ONE			English	Article							UNIVERSAL INFLUENZA IMMUNIZATION; ANTIBIOTIC PRESCRIPTIONS; METAANALYSIS; NUTRITION; CHILDREN; ILLNESS; RISK; LACTOBACILLUS; PREVENTION; MORTALITY	Introduction There is accumulating evidence supporting the use of probiotics, which are defined as "live micro-organisms which, when administered in adequate amounts, confer a health benefit on the host", as a preventive measure against respiratory tract infections (RTI). Two recent metaanalyses showed probiotic consumption (daily intake of 10 7 to 10 10 CFU in any form for up to 3 months) significantly reduced RTI duration, frequency, antibiotic use and work absenteeism. Objectives The aim of this study was to assess the impact of probiotic use in terms of number of RTI episodes and days averted, and the number of antibiotic prescriptions and missed workdays averted, in the general population of Canada. In addition, the corresponding economic impact from both a healthcare payer and a productivity perspective was estimated. Methods A microsimulation model was developed to reproduce the Canadian population (sample rate of 1/1000 = 35 540 individuals) employing age and gender. RTI incidence was taken from FluWatch consultation rates for influenza-like illness (2013-14) and StatCan all-cause consultations statistics. The model was calibrated on a 2.1% RTI annual incidence in the general population (5.2 million RTI days) and included known risk factors (smoking status, shared living conditions and vaccination status). RTI-related antibiotic prescriptions and work absenteeism were obtained from the literature. Results The results indicate that probiotic use saved 573 000-2.3 million RTI-days, according to the YHEC-Cochrane scenarios respectively. These reductions were associated with an avoidance of 52 000-84 000 antibiotic courses and 330 000-500 000 sick-leave days. A projection of corresponding costs reductions amounted to Can$ 1.3-8.9 million from the healthcare payer perspective and Can$ 61.2-99.7 million when adding productivity losses. Conclusion The analysis shows that the potential of probiotics to reduce RTI-related events may have a substantial clinical and economic impact in Canada.	[Lenoir-Wijnkoop, Irene] Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands; [Lenoir-Wijnkoop, Irene] Danone Co, Director Publ Hlth & Sci Relat, Paris, France; [Gerlier, Laetitia] QuintilesIMS Real World Evidence, Zaventem, Belgium; [Roy, Denis] Univ Laval, Dept Food Sci, Quebec City, PQ G1K 7P4, Canada; [Reid, Gregor] Univ Western Ontario, Canadian Res & Dev Ctr Probiot, London, ON, Canada	Utrecht University; Danone Nutricia; IQVIA; Laval University; Western University (University of Western Ontario)	Lenoir-Wijnkoop, I (corresponding author), Univ Utrecht, Dept Pharmaceut Sci, Utrecht, Netherlands.; Lenoir-Wijnkoop, I (corresponding author), Danone Co, Director Publ Hlth & Sci Relat, Paris, France.	P.I.Lenoir-Wijnkoop@uu.nl	Reid, Gregor/ABE-8327-2020; Roy, Denis/H-4998-2011	Reid, Gregor/0000-0001-9658-5696; Roy, Denis/0000-0002-4229-9245; Lenoir-Wijnkoop, Irene/0000-0001-9853-8076	Alliance for Education on Probiotics (AEP); Danone; IMS RWES HEOR	Alliance for Education on Probiotics (AEP); Danone(Danone Nutricia); IMS RWES HEOR(Health Economics & Outcomes Research Ltd)	This study was funded by an unrestricted educational grant from the Alliance for Education on Probiotics (AEP, URL: http://wwwaeprobio.com/). AEP had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ILW is employed by Danone and LG is employed by IMS RWES HEOR. Danone and IMS RWES HEOR provided support in the form of salaries for authors ILW and LG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2011, Consum Rep, V76, P12; Bensenor IM, 2001, ANN EPIDEMIOL, V11, P225, DOI 10.1016/S1047-2797(00)00214-3; Caffarelli C, 2015, EXPERT REV ANTI-INFE, V13, P1517, DOI 10.1586/14787210.2015.1096775; Center for Disease Control and Prevention, STOPP SPREAD GERMS H; Centers for Disease Control and Prevention (CDC), FASTSTATS PHYS OFF V; Freijer K, 2015, Eur J Clin Nutr, V69, P539, DOI 10.1038/ejcn.2014.280; Gionet L, FLU VACCINATION RATE; Government of Canada, WEEKL INFL REP; Government of Canada, INFL DEF; Grin PM, 2013, CAN J UROL, V20, P6607; Hao Q, 2015, COCHRANE DATABASE SY, V3; Heneghan CJ, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20420; Hsu J, 2012, ANN INTERN MED, V156, P512, DOI 10.7326/0003-4819-156-7-201204030-00411; Ioannidis JPA, 2016, AM J CLIN NUTR, V103, P1385, DOI 10.3945/ajcn.116.136085; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; Jefferson T, 2014, COCHRANE DATABASE SY, V13; Jefferson T, 2014, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20141324T2, 10.1002/14651858.CD008965.pub4]; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004879.pub5, 10.1002/14651858.CD004879.pub4]; Kang EJ, 2013, KOREAN J FAM MED, V34, P2, DOI 10.4082/kjfm.2013.34.1.2; King S, 2014, BRIT J NUTR, V112, P41, DOI 10.1017/S0007114514000075; Kwong JC, 2008, PLOS MED, V5, P1440, DOI 10.1371/journal.pmed.0050211; Kwong JC, 2009, CLIN INFECT DIS, V49, P750, DOI 10.1086/605087; Lenoir-Wijnkoop I, 2012, BRIT J NUTR, V108, P1714, DOI 10.1017/S0007114512003704; Lenoir-Wijnkoop I, 2011, Br J Nutr, V105, P157, DOI 10.1017/S0007114510003041; Lenoir-Wijnkoop I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122765; Liu S, 2013, INDIAN PEDIATR, V50, P377, DOI 10.1007/s13312-013-0123-z; LOUHIALA PJ, 1995, AM J PUBLIC HEALTH, V85, P1109, DOI 10.2105/AJPH.85.8_Pt_1.1109; Maki KC, 2014, ADV NUTR, V5, P7, DOI 10.3945/an.113.004929; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; Morgan Steve, 2013, CANADIAN RX ATLAS; Olsen R, 2016, NEONATOLOGY, V109, P105, DOI 10.1159/000441274; Ozen M, 2015, EXPERT OPIN BIOL TH, V15, P9, DOI 10.1517/14712598.2015.980233; Palmer LA, 2010, VACCINE, V28, P5049, DOI 10.1016/j.vaccine.2010.05.011; Public Health Agency of Canada, AB FLUWATCH; Public Health Agency of Canada, EC BURD ILLN CAN 200; Public Health Agency of Canada, 2012, VACC COV AD CAN RES; Ritchie ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034938; Saterdal Ingvil, 2012, Glob Adv Health Med, V1, P124, DOI 10.7453/gahmj.2012.1.2.014; Schanzer D, 1992, PLOS ONE; Schanzer DL, 2008, INFLUENZA OTHER RESP, V2, P1, DOI 10.1111/j.1750-2659.2008.00035.x; Statistics Canada, 2014, HLTH IND PROF ANN ES; Statistics Canada, CONT MED DOCT AG GRO; Statistics Canada, POP SEX AG GROUP; Statistics Canada, SMOK SEX PROV TERR; Sun J, 2015, ANN MED, V47, P430, DOI 10.3109/07853890.2015.1071872; van Dijk L, 2011, FAM PRACT, V28, P624, DOI 10.1093/fampra/cmr043; Vervloet M, 2016, NPJ PRIM CARE RESP M, V26, DOI 10.1038/npjpcrm.2015.83; Virk RK, 2016, EXPERT REV ANTI-INFE, V14, P365, DOI 10.1586/14787210.2016.1155450; Vouloumanou EK, 2009, INT J ANTIMICROB AG, V34, DOI 10.1016/j.ijantimicag.2008.11.005; Wang YZ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004509; World Health Organization FaAOotUN, 2002, REP JOINT FAO WHO WO	52	16	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166232	10.1371/journal.pone.0166232	http://dx.doi.org/10.1371/journal.pone.0166232			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832195	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000080
J	Lo, YL; Liou, GG; Lyu, JH; Hsiao, M; Hsu, TL; Wong, CH				Lo, Yen-Lung; Liou, Gunn-Guang; Lyu, Jia-Huei; Hsiao, Michael; Hsu, Tsui-Ling; Wong, Chi-Huey			Dengue Virus Infection Is through a Cooperative Interaction between a Mannose Receptor and CLEC5A on Macrophage as a Multivalent Hetero-Complex	PLOS ONE			English	Article							DC-SIGN; ENTRY; CELLS; COLOCALIZATION; ACTIVATION; BIOSENSOR; IMMUNITY; BINDING; PCR	Dengue fever is a mosquito-borne viral pandemic disease that is widespread in the tropical and subtropical areas. Dengue virus uses human mannose-binding receptor (MR) and DC-SIGN on macrophages as primary receptors, and CLEC5A as signaling receptor to sense the dengue virus invasion and then to signal and stimulate macrophages to secrete cytokines. But the interplay between MR/DC-SIGN and CLEC5A is unknown. Here we demonstrate a plausible mechanism for the interaction, i.e. MR/DC-SIGN first attracts the virus with high avidity, and the virus concurrently interacts with CLEC5A in close proximity to form a multivalent hetero-complex and facilitate CLEC5A-mediated signal transduction. Our study suggests that the cooperation between a high-avidity lectin-virus interaction and a nearby low-avidity signaling receptor provides a necessary connection between binding and signaling. Understanding this mechanism may lead to the development of a new antiviral strategy.	[Lo, Yen-Lung; Lyu, Jia-Huei; Hsiao, Michael; Hsu, Tsui-Ling; Wong, Chi-Huey] Acad Sinica, Genom Res Ctr, Taipei, Taiwan; [Liou, Gunn-Guang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Lo, Yen-Lung; Wong, Chi-Huey] Acad Sinica, Chem Biol & Mol Biophys, Taiwan Int Grad Program, Taipei, Taiwan; [Lo, Yen-Lung; Wong, Chi-Huey] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Wong, CH (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.; Wong, CH (corresponding author), Acad Sinica, Chem Biol & Mol Biophys, Taiwan Int Grad Program, Taipei, Taiwan.; Wong, CH (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	chwong@gate.sinica.edu.tw	Hsu, Tsui-Ling/H-6704-2015; Liou, Gunn‐Guang/AAI-9787-2020; Hsu, Tsui-Ling/AAE-8821-2019; Hsiao, Michael/U-6238-2019	Hsu, Tsui-Ling/0000-0002-2912-3261; Hsiao, Michael/0000-0001-8529-9213; Liou, Gan-Guang/0000-0002-2619-8516	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Academia Sinica. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Academia Sinica, Taiwan. We would like to thank Dr. Yi-Ling Lin, Academia Sinica, for her technical and material support in virus handling. We would also like to thank the confocal image core facility, the EM core facility, the electrophysiology core facility, and the mass spectroscopy core facility of Academia Sinica for making this work possible.	Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; Brocheriou I, 2011, ATHEROSCLEROSIS, V214, P316, DOI 10.1016/j.atherosclerosis.2010.11.023; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013; Chen ST, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002655; Cheung R, 2011, J CLIN INVEST, V121, P4446, DOI 10.1172/JCI57682; Chroneos Z, 1995, AM J PHYSIOL-LUNG C, V269, pL721, DOI 10.1152/ajplung.1995.269.6.L721; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; Dejnirattisai W, 2011, J INFECT DIS, V203, P1775, DOI 10.1093/infdis/jir173; Diamond MS, 2015, CELL, V162, P488, DOI 10.1016/j.cell.2015.07.005; Dubayle J, 2015, VACCINE, V33, P1360, DOI 10.1016/j.vaccine.2015.01.047; Frenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106882; Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023; Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9; Hsu TL, 2009, J BIOL CHEM, V284, P34479, DOI 10.1074/jbc.M109.065961; Knipe D, 2013, FIELDS VIROLOGY; Lagache T, 2015, CYTOM PART A, V87A, P568, DOI 10.1002/cyto.a.22629; Lee RT, 2011, GLYCOBIOLOGY, V21, P512, DOI 10.1093/glycob/cwq193; Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017; Panyi G, 2003, P NATL ACAD SCI USA, V100, P2592, DOI 10.1073/pnas.0438057100; Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069; Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Tung YT, 2014, NANOMED-NANOTECHNOL, V10, P1335, DOI 10.1016/j.nano.2014.03.009; van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07; van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Wang WK, 2000, J CLIN MICROBIOL, V38, P3306, DOI 10.1128/JCM.38.9.3306-3310.2000; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; World Health Organization, 2012, GLOB STRAT DENG PREV, V35; Wu MF, 2013, BLOOD, V121, P95, DOI 10.1182/blood-2012-05-430090	33	26	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166474	10.1371/journal.pone.0166474	http://dx.doi.org/10.1371/journal.pone.0166474			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832191	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000128
J	Carnemolla, R; Villa, CH; Greineder, CF; Zaitsev, S; Patel, KR; Kowalska, MA; Atochin, DN; Cines, DB; Siegel, DL; Esmon, CT; Muzykantov, VR				Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Patel, Kruti R.; Kowalska, M. Anna; Atochin, Dmitriy N.; Cines, Douglas B.; Siegel, Don L.; Esmon, Charles T.; Muzykantov, Vladimir R.			Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury	FASEB JOURNAL			English	Article						sepsis; inflammation; coagulation; pharmacokinetics; drug delivery	ACTIVATED PROTEIN-C; HUMAN SOLUBLE THROMBOMODULIN; DISSEMINATED INTRAVASCULAR COAGULATION; REDUCES INFARCT VOLUME; LECTIN-LIKE DOMAIN; SEVERE SEPSIS; MEMBRANE RIGIDITY; FUSION PROTEIN; IN-VITRO; THROMBOSIS	Endothelial thrombomodulin (TM) regulates coagulation and inflammation via several mechanisms, including production of activated protein C (APC). Recombinant APC and soluble fragments of TM (sTM) have been tested in settings associated with insufficiency of the endogenous TM/APC pathway, such as sepsis. We previously designed a fusion protein of TM [single-chain variable fragment antibody (scFv)/TM] targeted to red blood cells (RBCs) to improve pharmacokinetics and antithrombotic effects without increasing bleeding. Here, scFv/TM was studied in mouse models of systemic inflammation and ischemia-reperfusion injury. Injected concomitantly with or before endotoxin, scFv/TM provided more potent protection against liver injury and release of pathological mediators than sTM, showing similar efficacy at up to 50-fold lower doses. scFv/TM provided protection when injected after endotoxin, whereas sTM did not, and augmented APC production by thrombin similar to 50-fold more than sTM. However, scFv/TM injected after endotoxin did not reduce thrombin/antithrombin complexes; nor did antibodies that block APC anticoagulant activity suppress the prophylactic anti-inflammatory effect of scFv/TM. Therefore, similar to endogenous TM, RBC-anchored scFv/TM activates several protective pathways. Finally, scFv/TM was more effective at reducing cerebral infarct volume and alleviated neurological deficits than sTM after cerebral ischemia/reperfusion injury. These results indicate that RBC-targeted scFv/TM exerts multifaceted cytoprotective effects and may find utility in systemic and focal inflammatory and ischemic disorders.	[Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Esmon, Charles T.; Muzykantov, Vladimir R.] Univ Penn, Ctr Targeted Therapeut & Translat Nanomed, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Villa, Carlos H.; Zaitsev, Sergei; Cines, Douglas B.; Siegel, Don L.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Villa, Carlos H.; Zaitsev, Sergei; Cines, Douglas B.; Siegel, Don L.] Univ Penn, Lab Med, Philadelphia, PA 19104 USA; [Patel, Kruti R.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kowalska, M. Anna] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Kowalska, M. Anna] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Charlestown, MA USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Dept Pathol, Oklahoma City, OK USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Dept Biochem & Mol Biol, Coagulat Biol Lab, Oklahoma City, OK USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Harvard University; Massachusetts General Hospital; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, TRC 10-125,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	Atochin, Dmitriy/Q-3150-2016; Atochin, Dmitriy/AAH-8843-2020	Cines, Douglas/0000-0001-5986-504X; Atochin, Dmitriy/0000-0002-2405-2070; Patel, Kruti/0000-0002-4303-8717; Greineder, Colin/0000-0001-9740-7672	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL121134, R01 HL125462, R01 HL116916-01, R01 HL091950, K08-HL 130430, 7UM1 HL120877-TACTIC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439, R01HL121134, R01HL116916, K08HL130430, T32HL007775, R01HL125462, T32HL007971, R01HL091950, UM1HL120877] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Mortimer Poncz, The Children's Hospital of Philadelphia, for his scientific counsel and support of the study. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01 HL121134, R01 HL125462, R01 HL116916-01, R01 HL091950, K08-HL 130430, and 7UM1 HL120877-TACTIC. The authors declare no conflicts of interest.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; Andreou AP, 2011, J THROMB HAEMOST, V9, P1171, DOI 10.1111/j.1538-7836.2011.04292.x; Angus DC, 2012, CRIT CARE, V16, DOI 10.1186/cc11152; Annane D, 2013, AM J RESP CRIT CARE, V187, P1091, DOI 10.1164/rccm.201211-2020OC; Atochin DN, 2016, NEUROSCI LETT, V618, P45, DOI 10.1016/j.neulet.2016.02.033; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bongoni AK, 2016, TRANSPLANTATION, V100, P1871, DOI 10.1097/TP.0000000000001188; Bouwens EAM, 2013, J THROMB HAEMOST, V11, P242, DOI 10.1111/jth.12247; Carnemolla R, 2013, J PHARMACOL EXP THER, V347, P339, DOI 10.1124/jpet.113.205104; Carnemolla R, 2012, J IMMUNOL METHODS, V384, P21, DOI 10.1016/j.jim.2012.06.012; Chan SH, 2006, INT J CARDIOL, V111, P280, DOI 10.1016/j.ijcard.2005.09.015; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Esmon CT, 2001, CRIT CARE MED, V29, pS48, DOI 10.1097/00003246-200107001-00018; Faust SN, 2001, CRIT CARE MED, V29, pS62, DOI 10.1097/00003246-200107001-00022; Fink MP, 2013, CRIT CARE MED, V41, P2221, DOI 10.1097/CCM.0b013e3182964037; Ganguly K, 2005, J PHARMACOL EXP THER, V312, P1106, DOI 10.1124/jpet.104.075770; Ganguly K, 2007, J PHARMACOL EXP THER, V321, P158, DOI 10.1124/jpet.106.114405; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Hanly AM, 2007, SEMIN THROMB HEMOST, V33, P673, DOI 10.1055/s-2007-991969; Ikezoe T, 2015, BONE MARROW TRANSPL, V50, P113, DOI 10.1038/bmt.2014.208; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Khoory J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141206; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Lattenist L, 2015, THROMB RES, V136, P1325, DOI 10.1016/j.thromres.2015.11.004; Levi M, 2015, J THROMB HAEMOST, V13, P505, DOI 10.1111/jth.12868; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Liaw PCY, 2003, J THROMB HAEMOST, V1, P662, DOI 10.1046/j.1538-7836.2003.00153.x; Ma CY, 2015, J IMMUNOL, V194, P1905, DOI 10.4049/jimmunol.1400923; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub5; Morris GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148503; Morser J, 2012, CURR DRUG TARGETS, V13, P421, DOI 10.2174/138945012799424606; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Moxon CA, 2015, J THROMB HAEMOST, V13, P1653, DOI 10.1111/jth.13060; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; Murciano JC, 2009, J CONTROL RELEASE, V139, P190, DOI 10.1016/j.jconrel.2009.07.003; Opal SM, 2013, AM J RESP CRIT CARE, V187, P1041, DOI 10.1164/rccm.201303-0505ED; PAULITSCHKE M, 1995, BLOOD, V86, P342, DOI 10.1182/blood.V86.1.342.bloodjournal861342; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; Ryang YM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-113; Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x; Schouten M, 2015, THROMB RES, V135, P537, DOI 10.1016/j.thromres.2014.12.020; Shbaklo H, 2009, THROMB HAEMOSTASIS, V101, P505, DOI 10.1160/TH08-08-0511; Shuvaev VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077002; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Sun P, 2013, WORLD J EMERG MED, V4, P210, DOI [10.5847/wjem.j.issn.1920-8642.2013.03.010, 10.5847/wjem.j.1920-8642.2013.03.010]; Suyama K, 2015, NEPHROL DIAL TRANSPL, V30, P969, DOI 10.1093/ndt/gfv004; Tanaka J, 2013, BRIT J PHARMACOL, V170, P1233, DOI 10.1111/bph.12396; Tanemura A, 2014, TRANSPL P, V46, P1107, DOI 10.1016/j.transproceed.2013.11.128; TSIANG M, 1992, J BIOL CHEM, V267, P6164; van Iersel T, 2011, THROMB HAEMOSTASIS, V105, P302, DOI 10.1160/TH10-05-0287; Villa C. H., 2016, ADV DRUG DELIV REV, VS0169-409X; Villa CH, 2016, ISBT SCI SER, V11, P158; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Wei HJ, 2011, CARDIOVASC RES, V92, P317, DOI 10.1093/cvr/cvr220; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x; Yamakawa K, 2015, J THROMB HAEMOST, V13, P508, DOI 10.1111/jth.12841; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149; Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610	68	18	18	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					761	770		10.1096/fj.201600912R	http://dx.doi.org/10.1096/fj.201600912R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836986	Green Published			2022-12-26	WOS:000394235400028
J	Khan, BR; Wherritt, DJ; Huhman, D; Sumner, LW; Chapman, KD; Blancaflor, EB				Khan, Bibi Rafeiza; Wherritt, Daniel J.; Huhman, David; Sumner, Lloyd W.; Chapman, Kent D.; Blancaflor, Elison B.			Malonylation of Glucosylated N-Lauroylethanolamine A NEW PATHWAY THAT DETERMINES N-ACYLETHANOLAMINE METABOLIC FATE IN PLANTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID AMIDE HYDROLASE; ARABIDOPSIS-THALIANA SEEDLINGS; ENDOCANNABINOID SYSTEM; ROOT DEVELOPMENT; GLUTATHIONE; GROWTH; DETOXIFICATION; OVEREXPRESSION; IDENTIFICATION; BIOSYNTHESIS	N-Acylethanolamines (NAEs) are bioactive fatty acid derivatives present in trace amounts in many eukaryotes. Although NAEs have signaling and physiological roles in animals, little is known about their metabolic fate in plants. Our previous microarray analyses showed that inhibition of Arabidopsis thaliana seedling growth by exogenous N-lauroylethanolamine (NAE 12:0) was accompanied by the differential expression of multiple genes encoding small molecule-modifying enzymes. We focused on the gene At5g39050, which encodes a phenolic glucoside malonyltransferase 1 (PMAT1), to better understand the biological significance of NAE12:0-induced gene expression changes. PMAT1 expression was induced 3-5-fold by exogenous NAE 12:0. PMAT1 knockouts (pmat1) had reduced sensitivity to the growth-inhibitory effects of NAE 12:0 compared with wild type leading to the hypothesis that PMAT1 might be a previously uncharacterized regulator of NAE metabolism in plants. To test this hypothesis, metabolic profiling of wildtype and pmat1 seedlings treated with NAE 12:0 was conducted. Wild-type seedlings treated with NAE 12:0 accumulated glucosylated and malonylated forms of this NAE species, and structures were confirmed using nuclear magnetic resonance (NMR) spectroscopy. By contrast, only the peak corresponding to NAE 12:0-glucoside was detected in pmat1. Recombinant PMAT1 catalyzed the reaction converting NAE 12:0-glucoside to NAE 12:0-mono- or -dimalonylglucosides providing direct evidence that this enzyme is involved in NAE 12:0-glucose malonylation. Taken together, our results indicate that glucosylation of NAE 12:0 by a yet to be determined glucosyltransferase and its subsequent malonylation by PMAT1 could represent a mechanism for modulating the biological activities of NAEs in plants.	[Khan, Bibi Rafeiza; Huhman, David; Blancaflor, Elison B.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Wherritt, Daniel J.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Sumner, Lloyd W.] Univ Missouri, Dept Biochem, Bond Life Sci Ctr, Columbia, MO 65211 USA; [Chapman, Kent D.] Univ North Texas, Dept Biol Sci, Div Biochem & Mol Biol, Denton, TX 76203 USA	Noble Research Institute; University of Texas System; University of Texas at San Antonio (UTSA); University of Missouri System; University of Missouri Columbia; University of North Texas System; University of North Texas Denton	Blancaflor, EB (corresponding author), 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	eblancaflor@noble.org	Sumner, Lloyd W/A-3270-2013; Wherritt, Daniel/AAY-6852-2020	Sumner, Lloyd W/0000-0002-4086-663X; Wherritt, Daniel/0000-0002-8616-9864; Huhman, David/0000-0002-3148-7400; Blancaflor, Elison/0000-0001-6115-9670; Khan, Bibi/0000-0002-7661-0142; Chapman, Kent/0000-0003-0489-3072	National Science Foundation under MRI [1126719]	National Science Foundation under MRI	Support for NMR instrumentation was provided by National Science Foundation under MRI Grant 1126719 (to L. W. S.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Blancaflor EB, 2003, PLANTA, V217, P206, DOI 10.1007/s00425-003-0985-8; Blancaflor EB, 2014, PLANT J, V79, P568, DOI 10.1111/tpj.12427; Butler H, 2009, EUR J ENDOCRINOL, V161, P655, DOI 10.1530/EJE-09-0511; Chapman KD, 2004, PROG LIPID RES, V43, P302, DOI 10.1016/j.plipres.2004.03.002; Cotter MQ, 2011, PLANT SIGNAL BEHAV, V6, P671, DOI 10.4161/psb.6.5.14704; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; De Petrocellis L, 2009, BEST PRACT RES CL EN, V23, P1, DOI 10.1016/j.beem.2008.10.013; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Gunning V, 2014, PLANT PHYSIOL, V165, P854, DOI 10.1104/pp.114.237180; Heiling S, 2010, PLANT CELL, V22, P273, DOI 10.1105/tpc.109.071449; Kang L, 2008, PLANT J, V56, P336, DOI 10.1111/j.1365-313X.2008.03603.x; Keereetaweep J, 2015, PLANT J, V82, P315, DOI 10.1111/tpj.12821; Keereetaweep J, 2013, PLANT CELL, V25, P3824, DOI 10.1105/tpc.113.119024; Kilaru A, 2007, CHEM BIODIVERS, V4, P1933, DOI 10.1002/cbdv.200790161; Kim SC, 2010, PLANT SCI, V178, P411, DOI 10.1016/j.plantsci.2010.02.017; Klein M, 2000, PLANT J, V21, P289, DOI 10.1046/j.1365-313x.2000.00684.x; Kreuz K, 1996, PLANT PHYSIOL, V111, P349, DOI 10.1104/pp.111.2.349; Lichtman AH, 2004, PAIN, V109, P319, DOI 10.1016/j.pain.2004.01.022; Ludwig-Muller J, 2011, J EXP BOT, V62, P1757, DOI 10.1093/jxb/erq412; Luo J, 2007, PLANT J, V50, P678, DOI 10.1111/j.1365-313X.2007.03079.x; MATERN U, 1983, EUR J BIOCHEM, V133, P439, DOI 10.1111/j.1432-1033.1983.tb07483.x; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Motes CM, 2005, PROTOPLASMA, V226, P109, DOI 10.1007/s00709-005-0124-4; Neuefeind T, 1997, J MOL BIOL, V274, P446, DOI 10.1006/jmbi.1997.1402; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; SANDERMANN H, 1991, ARCH BIOCHEM BIOPHYS, V287, P341, DOI 10.1016/0003-9861(91)90488-5; Santino A, 2013, PLANT CELL REP, V32, P1085, DOI 10.1007/s00299-013-1441-2; Schmid HHO, 1996, CHEM PHYS LIPIDS, V80, P133, DOI 10.1016/0009-3084(96)02554-6; Shrestha R, 2003, J BIOL CHEM, V278, P34990, DOI 10.1074/jbc.M305613200; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Staswick P, 2009, PLANT SIGNAL BEHAV, V4, P757, DOI 10.1104/pp.109.138529; Suzuki H, 2002, PLANT PHYSIOL, V130, P2142, DOI 10.1104/pp.010447; Taguchi G, 2005, PLANT J, V42, P481, DOI 10.1111/j.1365-313X.2005.02387.x; Taguchi G, 2010, PLANT J, V63, P1031, DOI 10.1111/j.1365-313X.2010.04298.x; Teaster ND, 2007, PLANT CELL, V19, P2454, DOI 10.1105/tpc.106.048702; Teaster ND, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00032; Wang J, 2008, BBA-MOL CELL BIOL L, V1781, P710, DOI 10.1016/j.bbalip.2008.08.004; Wang YS, 2008, NEW PHYTOL, V177, P525, DOI 10.1111/j.1469-8137.2007.02261.x; Wang YS, 2006, P NATL ACAD SCI USA, V103, P12197, DOI 10.1073/pnas.0603571103	41	12	12	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27112	27121		10.1074/jbc.M116.751065	http://dx.doi.org/10.1074/jbc.M116.751065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856641	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000391576300012
J	Izuno, A; Kanzaki, M; Artchawakom, T; Wachrinrat, C; Isagi, Y				Izuno, Ayako; Kanzaki, Mamoru; Artchawakom, Taksin; Wachrinrat, Chongrak; Isagi, Yuji			Vertical Structure of Phyllosphere Fungal Communities in a Tropical Forest in Thailand Uncovered by High-Throughput Sequencing	PLOS ONE			English	Article							RAIN-FOREST; ENDOPHYTIC FUNGI; DIVERSITY; CANOPY; BIODIVERSITY; LEAVES; HOST; ASSEMBLAGES; BIOMASS; REGION	Phyllosphere fungi harbor a tremendous species diversity and play important ecological roles. However, little is known about their distribution patterns within forest ecosystems. We examined how species diversity and community composition of phyllosphere fungi change along a vertical structure in a tropical forest in Thailand. Fungal communities in 144 leaf samples from 19 vertical layers (1.28-34.4 m above ground) of 73 plant individuals (27 species) were investigated by metabarcoding analysis using Ion Torrent sequencing. In total, 1,524 fungal operational taxonomic units (OTUs) were detected among 890,710 reads obtained from the 144 leaf samples. Taxonomically diverse fungi belonging to as many as 24 orders of Ascomycota and 21 orders of Basidiomycota were detected, most of which inhabited limited parts of the lowest layers closest to the forest floor. Species diversity of phyllosphere fungi was the highest in the lowest layers closest to the forest floor, decreased with increasing height, and lowest in the canopy; 742 and 55 fungal OTUs were detected at the lowest and highest layer, respectively. On the layers close to the forest floor, phyllosphere fungal communities were mainly composed of low frequency OTUs and largely differentiated among plant individuals. Conversely, in the canopy, fungal communities consisted of similar OTUs across plant individuals, and as many as 86.1%-92.7% of the OTUs found in the canopy (>= 22 m above ground) were also distributed in the lower layers. Overall, our study showed the variability of phyllosphere fungal communities along the vertical gradient of plant vegetation and environmental conditions, suggesting the significance of biotic and abiotic variation for the species diversity of phyllosphere fungi.	[Izuno, Ayako; Kanzaki, Mamoru; Isagi, Yuji] Kyoto Univ, Grad Sch Agr, Kyoto, Japan; [Artchawakom, Taksin] Sakaerat Environm Res Stn, Nakhon Ratchasima, Thailand; [Wachrinrat, Chongrak] Kasetsart Univ, Fac Forestry, Bangkok, Thailand	Kyoto University; Kasetsart University	Izuno, A (corresponding author), Kyoto Univ, Grad Sch Agr, Kyoto, Japan.	izunoay@gmail.com	Isagi, Yuji/ABA-8678-2020; Izuno, Ayako/AAJ-8099-2020	Isagi, Yuji/0000-0002-9777-076X; Izuno, Ayako/0000-0002-9339-2845	JSPS KAKENHI [24255007]; JSPS; JSPS [13J02516]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by JSPS KAKENHI Grant Number 24255007 to MK (https://www.isps.go.jp/english/e-grants/) and Grant-in-Aid for JSPS Fellows to Al (https://www.jsps.go.jp/english/e-pd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the staffs at the Sakaerat Environmental Research Station for their support on leaf sampling and Akifumi S. Tanabe for his help with bioinformatics analysis. We also thank National Research Council of Thailand for the research permission. This research was supported by JSPS KAKENHI (24255007) and Grant-in-Aid for JSPS Fellows (13J02516).	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acebey A, 2003, J TROP ECOL, V19, P9, DOI 10.1017/S026646740300302X; Adams RI, 2013, ISME J, V7, P1262, DOI 10.1038/ismej.2013.28; Agrios G. N., 2005, PLANT PATHOL; Albrectsen BR, 2010, FUNGAL DIVERS, V41, P17, DOI 10.1007/s13225-009-0011-y; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold A. Elizabeth, 2007, Fungal Biology Reviews, V21, P51, DOI 10.1016/j.fbr.2007.05.003; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Balint M, 2015, MOL ECOL, V24, P235, DOI 10.1111/mec.13018; Bensch K, 2012, STUD MYCOL, P1, DOI 10.3114/sim0003; Birtele D, 2012, ECOL RES, V27, P755, DOI 10.1007/s11284-012-0948-2; Calder IR, 2001, PLANT ECOL, V153, P203, DOI 10.1023/A:1017580311070; Cannon PF, 2007, FUNGAL FAMILIES WORL; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CHAO A, 1984, SCAND J STAT, V11, P265; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Chazdon RL, 2011, ECOLOGY, V92, P1332, DOI 10.1890/10-1345.1; Coince A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100668; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Crous PW, 2014, STUD MYCOL, V64, P17; Davey ML, 2013, MOL ECOL, V22, P368, DOI 10.1111/mec.12122; Davey ML, 2012, NEW PHYTOL, V195, P844, DOI 10.1111/j.1469-8137.2012.04215.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ellwood MDF, 2004, NATURE, V429, P549, DOI 10.1038/nature02560; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishii HT, 2004, FOREST SCI, V50, P342; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Kitajima K, 2005, ANN BOT-LONDON, V95, P535, DOI 10.1093/aob/mci051; Kodsueb R, 2006, MYCOLOGIA, V98, P571, DOI 10.3852/mycologia.98.4.571; Lindow SE, 2003, APPL ENVIRON MICROB, V69, P1875, DOI 10.1128/AEM.69.4.1875-1883.2003; Moffett MW, 2000, BIOTROPICA, V32, P569, DOI 10.1646/0006-3606(2000)032[0569:WSUACL]2.0.CO;2; Murata N, 2011, J FOR RES, V17, P37; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Newton AC, 2010, TRENDS MICROBIOL, V18, P365, DOI 10.1016/j.tim.2010.06.002; Nilsson RH, 2016, MYCOKEYS, P29, DOI 10.3897/mycokeys.12.7553; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Oksanen J, 2011, PACKAGE VEGAN VERSI; Osono T, 2009, FUNGAL DIVERS, V36, P101; Ozanne CMP, 2003, SCIENCE, V301, P183, DOI 10.1126/science.1084507; Perez CA, 2013, FUNGAL BIOL-UK, V117, P94, DOI 10.1016/j.funbio.2012.12.002; Persoh D, 2015, FUNGAL DIVERS, V75, P1, DOI 10.1007/s13225-015-0334-9; Pinto LSRC, 2000, NEW PHYTOL, V147, P609, DOI 10.1046/j.1469-8137.2000.00722.x; Redford AJ, 2010, ENVIRON MICROBIOL, V12, P2885, DOI 10.1111/j.1462-2920.2010.02258.x; Redman RS, 2002, SCIENCE, V298, P1581, DOI 10.1126/science.1072191; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Sakurai K., 1998, TROPICS, V8, P61; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Shaw D.C., 2004, FOREST CANOPIES, P73, DOI DOI 10.1016/B978-012457553-0/50008-3; SMITH AP, 1973, AM NAT, V107, P671, DOI 10.1086/282866; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stone JK, 2000, BOOK SOIL P, P3; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Toju H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086566; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Wacharakitti S, 1980, NATURAL RESOURCES LA; Wagner BL, 2000, APPL ENVIRON MICROB, V66, P3468, DOI 10.1128/AEM.66.8.3468-3473.2000; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; ZAHL S, 1977, ECOLOGY, V58, P907, DOI 10.2307/1936227; Zhang Y, 2009, STUD MYCOL, P85, DOI 10.3114/sim.2009.64.04; Zimmerman NB, 2012, P NATL ACAD SCI USA, V109, P13022, DOI 10.1073/pnas.1209872109	66	19	19	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166669	10.1371/journal.pone.0166669	http://dx.doi.org/10.1371/journal.pone.0166669			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861539	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300086
J	Jensen, MBV; Horsfall, LE; Wardrope, C; Togneri, PD; Marles-Wright, J; Rosser, SJ				Jensen, Mai-Britt V.; Horsfall, Louise E.; Wardrope, Caroline; Togneri, Peter D.; Marles-Wright, Jon; Rosser, Susan J.			Characterisation of a New Family of Carboxyl Esterases with an OsmC Domain	PLOS ONE			English	Article							ENZYMES; SEQUENCE; CLASSIFICATION; ASSIGNMENT; PROTEINS; FEATURES; LIPASE	Proteins in the serine esterase family are widely distributed in bacterial phyla and display activity against a range of biologically produced and chemically synthesized esters. A serine esterase from the psychrophilic bacterium Pseudoalteromonas arctica with a C-terminal OsmC-like domain was recently characterized; here we report on the identification and characterization of further putative esterases with OsmC-like domains constituting a new esterase family that is found in a variety of bacterial species from different environmental niches. All of these proteins contained the Ser-Asp-His motif common to serine esterases and a highly conserved pentapeptide nucleophilic elbow motif. We produced these proteins heterologously in Escherichia coli and demonstrated their activity against a range of esterase substrates. Two of the esterases characterized have activity of over two orders of magnitude higher than other members of the family, and are active over a wide temperature range. We determined the crystal structure of the esterase domain of the protein from Rhodothermus marinus and show that it conforms to the classical alpha/beta hydrolase fold with an extended 'lid' region, which occludes the active site of the protein in the crystal. The expansion of characterized members of the esterase family and demonstration of activity over a wide-range of temperatures could be of use in biotechnological applications such as the pharmaceutical, detergent, bioremediation and dairy industries.	[Jensen, Mai-Britt V.; Horsfall, Louise E.; Wardrope, Caroline; Marles-Wright, Jon; Rosser, Susan J.] Univ Edinburgh, Sch Biol Sci, Inst Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland; [Jensen, Mai-Britt V.; Horsfall, Louise E.; Togneri, Peter D.; Rosser, Susan J.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Glasgow, Lanark, Scotland; [Marles-Wright, Jon] Newcastle Univ, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England	University of Edinburgh; University of Glasgow; Newcastle University - UK	Jensen, MBV; Rosser, SJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Quantitat Biol Biochem & Biotechnol, Edinburgh, Midlothian, Scotland.; Jensen, MBV; Rosser, SJ (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cellular & Syst Biol, Glasgow, Lanark, Scotland.	Mai-Britt.Jensen@ed.ac.uk; Susan.Rosser@ed.ac.uk	Horsfall, Louise/C-7809-2014	Horsfall, Louise/0000-0003-1594-2992; Rosser, Susan/0000-0002-2560-6485; Marles-Wright, Jon/0000-0002-9156-3284	Wellcome Trust; EPSRC UK [EP/H035206/1, EP/H035222/1, EP/H035192/1]; EPSRC [EP/H035206/1, EP/H035192/1, EP/H035222/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H035222/1, EP/H035206/1, EP/H035192/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EPSRC UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Wellcome Trust ISSF funds for the crystallisation facilities at the University of Edinburgh. MVJ, LEH, PDT were supported by EPSRC UK grants EP/H035206/1, EP/H035222/1, and EP/H035192/1 (https://www.epsrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Al Khudary R, 2010, EXTREMOPHILES, V14, P273, DOI 10.1007/s00792-010-0306-7; Arpigny JL, 1999, BIOCHEM J, V343, P177, DOI 10.1042/0264-6021:3430177; Beadle BM, 2002, J MOL BIOL, V321, P285, DOI 10.1016/S0022-2836(02)00599-5; Beeby M, 2005, PLOS BIOL, V3, P1549, DOI 10.1371/journal.pbio.0030309; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Bornscheuer UT, 2002, FEMS MICROBIOL REV, V26, P73, DOI 10.1016/S0168-6445(01)00075-4; Britton HTS, 1931, J CHEM SOC, P1456, DOI 10.1039/jr9310001456; Burg Van Den B, 2002, SELECTION MUTATIONS, P333; Cavicchioli R, 2011, MICROB BIOTECHNOL, V4, P449, DOI 10.1111/j.1751-7915.2011.00258.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CYGLER M, 1993, PROTEIN SCI, V2, P366; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Giuliani SE, 2008, BIOCHEMISTRY-US, V47, P13974, DOI 10.1021/bi801648r; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Goldstone DC, 2010, PROTEINS, V78, P1457, DOI 10.1002/prot.22662; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hahn JS, 2000, J BIOL CHEM, V275, P38254, DOI 10.1074/jbc.M006079200; Hess M, 2008, EXTREMOPHILES, V12, P351, DOI 10.1007/s00792-008-0139-9; JARVINEN KT, 1994, ENVIRON SCI TECHNOL, V28, P2387, DOI 10.1021/es00062a025; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lai KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023269; Lesniak J, 2003, PROTEIN SCI, V12, P2838, DOI 10.1110/ps.03375603; Lucana DOD, 2000, MOL GEN GENET, V264, P341; Margesin R, 1999, J CHEM TECHNOL BIOT, V74, P381; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Panda T, 2005, APPL MICROBIOL BIOT, V67, P160, DOI 10.1007/s00253-004-1840-y; Park SC, 2008, BBA-PROTEINS PROTEOM, V1784, P783, DOI 10.1016/j.bbapap.2008.02.002; PORTER GR, 1958, NATURE, V182, P927, DOI 10.1038/182927a0; Reyes-Duarte D, 2005, ANGEW CHEM INT EDIT, V44, P7553, DOI 10.1002/anie.200502461; Saikolappan S, 2011, TUBERCULOSIS, V91, pS119, DOI 10.1016/j.tube.2011.10.021; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wikmark Y, 2016, CHEMBIOCHEM, V17, P141, DOI 10.1002/cbic.201500471; Wilkins MR, 1999, METH MOL B, V112, P531; WINKLER UK, 1979, J BACTERIOL, V138, P663, DOI 10.1128/JB.138.3.663-670.1979; WOLFF SP, METHODS ENZYMOL, V233, P182; Yang CY, 2006, ACTA CRYSTALLOGR F, V62, P498, DOI 10.1107/S1744309106016265	46	13	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166128	10.1371/journal.pone.0166128	http://dx.doi.org/10.1371/journal.pone.0166128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851780	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000387909300037
J	Fukano, K; Okamatsu-Ogura, Y; Tsubota, A; Nio-Kobayashi, J; Kimura, K				Fukano, Keigo; Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Nio-Kobayashi, Junko; Kimura, Kazuhiro			Cold Exposure Induces Proliferation of Mature Brown Adipocyte in a beta 3-Adrenergic Receptor-Mediated Pathway	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MESSENGER-RNA EXPRESSION; ADIPOSE-TISSUE; UNCOUPLING PROTEIN; PRIMARY CULTURE; MICE; FAT; DIFFERENTIATION; THERMOGENESIS; ANGIOGENESIS	Hyperplasia of brown adipose tissue (BAT) is a fundamental mechanism for adaptation to survive in the cold environment in rodents. To determine which cell types comprising BAT contribute to tissue hyperplasia, immunohistochemical analysis using a proliferative marker Ki67 was performed on the BAT from 6-week-old C57BLJ6J mice housed at 23 degrees C (control) or 10 degrees C (cold) for 5 days. Interestingly, in the control group, the cell proliferative marker Ki67 was detected in the nuclei of uncoupling protein 1-positive mature brown adipocytes (7.2% +/- 0.4% of brown adipocyte), as well as in the non-adipocyte stromal-vascular (SV) cells (19.6% +/- 2.3% of SV cells), which include preadiopocytes. The percentage of Ki67-positive brown adipocytes increased to 25.6% +/- 1.8% at Day 1 after cold exposure and was significantly higher than the non-cold acclimated control until Day 5 (21.8%+/- 1.7%). On the other hand, the percentage of Ki67-positive SV cells gradually increased by a cold exposure and peaked to 42.1%+/- 8.3% at Day 5. Injection of a beta 3-adrenergic receptor (beta 3-AR) agonist for continuous 5 days increased the number of Ki67-positive brown adipocytes even at Day 1 but not that of SV cells. In addition, the beta 3-AR antagonist, but not beta 1-AR antagonist, attenuated the cold exposure-induced increase in the number of Ki67-positive brown adipocytes. These results suggest that mature brown adipocytes proliferate immediately after cold exposure in a beta 3-AR-mediated pathway. Thus, proliferation of mature brown adipocytes as well as preadipocytes in SV cells may contribute to cold exposure-induced BAT hyperplasia.	[Fukano, Keigo; Okamatsu-Ogura, Yuko; Tsubota, Ayumi; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan; [Nio-Kobayashi, Junko] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Sapporo, Hokkaido 0650013, Japan	Hokkaido University; Hokkaido University	Okamatsu-Ogura, Y (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido 0600818, Japan.	y-okamatsu@vetmed.hokudai.ac.jp	Kimura, Kazuhiro/A-5029-2012; Okamatsu-Ogura, Yuko/AAI-5602-2020	NIO-KOBAYASHI, Junko/0000-0003-3019-2923	JSPS KAKENHI [15J02438, 26860684, 15H04545]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported in part by JSPS KAKENHI Grant Number 15J02438 for KF, 26860684 and 15H04545 for YOO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Masayuki Saito (Hokkaido University) for the helpful discussion and Dr. Teruo Kawada (Kyoto University) for the kind gift of the anti-UCP1 antibody. This study is supported in part by JSPS KAKENHI Grant Number 26860684, 15J02438, and 15H04545.	Asano A, 1999, J VET MED SCI, V61, P403, DOI 10.1292/jvms.61.403; Asano A, 1997, BIOCHEM J, V328, P179, DOI 10.1042/bj3280179; Bagchi M, 2013, FASEB J, V27, P3257, DOI 10.1096/fj.12-221812; Bronnikov G, 1999, ENDOCRINOLOGY, V140, P4185, DOI 10.1210/en.140.9.4185; BRONNIKOV G, 1992, J BIOL CHEM, V267, P2006; BUKOWIECKI L, 1982, AM J PHYSIOL, V242, pE353, DOI 10.1152/ajpendo.1982.242.6.E353; BUKOWIECKI LJ, 1986, AM J PHYSIOL, V250, pC880, DOI 10.1152/ajpcell.1986.250.6.C880; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Duchamp C, 1997, AM J PHYSIOL-ENDOC M, V272, pE453, DOI 10.1152/ajpendo.1997.272.3.E453; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Garcia B, 1997, ENDOCRINOLOGY, V138, P4227, DOI 10.1210/en.138.10.4227; GELOEN A, 1992, AM J PHYSIOL, V263, pR1176, DOI 10.1152/ajpregu.1992.263.6.R1176; GELOEN A, 1988, AM J PHYSIOL, V254, pC175, DOI 10.1152/ajpcell.1988.254.1.C175; HIMMSHAGEN J, 1994, AM J PHYSIOL, V266, pR1371, DOI 10.1152/ajpregu.1994.266.4.R1371; Iwanaga T, 2009, BIOMED RES-TOKYO, V30, P217, DOI 10.2220/biomedres.30.217; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Klingenspor M, 2003, EXP PHYSIOL, V88, P141, DOI 10.1113/eph8802508; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; NAGASE I, 1994, JPN J VET RES, V42, P137; NECHAD M, 1994, COMP BIOCHEM PHYS A, V107, P381, DOI 10.1016/0300-9629(94)90396-4; Nisoli E, 1996, ENDOCRINOLOGY, V137, P495, DOI 10.1210/en.137.2.495; Okamatsu-Ogura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084229; Okamatsu-Ogura Y, 2007, OBES RES CLIN PRACT, V1, P233, DOI 10.1016/j.orcp.2007.08.001; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Sun K, 2014, MOL METAB, V3, P474, DOI 10.1016/j.molmet.2014.03.010; Xue Y, 2009, CELL METAB, V9, P99, DOI 10.1016/j.cmet.2008.11.009; YAMASHITA H, 1994, LIFE SCI, V55, P141, DOI 10.1016/0024-3205(94)90105-8; YAMASHITA H, 1995, CELL GROWTH DIFFER, V6, P1457	29	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166579	10.1371/journal.pone.0166579	http://dx.doi.org/10.1371/journal.pone.0166579			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846311	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600086
J	Mishra, PJ; Mishra, PJ; Merlino, G				Mishra, Prasun J.; Mishra, Pravin J.; Merlino, Glenn			Integrated Genomics Identifies miR-32/MCL-1 Pathway as a Critical Driver of Melanomagenesis: Implications for miR-Replacement and Combination Therapy	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; MALIGNANT-MELANOMA; SITE POLYMORPHISM; TUMOR-SUPPRESSOR; RESISTANCE; CELLS; CANCER; MICE; APOPTOSIS; MCL-1	Aims Cutaneous malignant melanoma is among the deadliest human cancers, broadly resistant to most clinical therapies. A majority of patients with BRAF(V600E) melanomas respond well to inhibitors such as vemurafenib, but all ultimately relapse. Moreover, there are no viable treatment options available for other non-BRAF melanoma subtypes in the clinic. A key to improving treatment options lies in a better understanding of mechanisms underlying melanoma progression, which are complex and heterogeneous. Methods In this study we integrated gene and microRNA (miRNA) expression data from genetically engineered mouse models of highly and poorly malignant melanocytic tumors, as well as available human melanoma databases, and discovered an important role for a pathway centered on a tumor suppressor miRNA, miR-32. Results Malignant tumors frequently exhibited poor expression of miR-32, whose targets include NRAS, PI3K and notably, MCL-1. Accordingly, MCL-1 was often highly expressed in melanomas, and when knocked down diminished oncogenic potential. Forced MCL-1 overexpression transformed immortalized primary mouse melanocytes, but only when also expressing activating mutations in BRAF, CRAF or PI3K. Importantly, both miR-32 replacement therapy and the MCL-1-specific antagonist sabutoclax demonstrated single-agent efficacy, and acted synergistically in combination with vemurafenib in preclinical melanoma models. Conclusions We here identify miR-32/ MCL-1 pathway members as key early genetic events driving melanoma progression, and suggest that their inhibition may be an effective anti-melanoma strategy irrespective of NRAS, BRAF, and PTEN status.	[Mishra, Prasun J.] Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA; [Mishra, Prasun J.; Merlino, Glenn] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Mishra, Pravin J.] Dixie Reg Med Ctr, Precis Genom, Intermt Healthcare, St George, UT USA	Roche Holding; Genentech; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Intermountain Healthcare; Intermountain Medical Center	Mishra, PJ (corresponding author), Genentech Inc, Dept Biochem & Cellular Pharmacol, San Francisco, CA 94080 USA.; Mishra, PJ; Merlino, G (corresponding author), NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA.	mishra.prasun@gene.com; gmerlino@helix.nih.gov			Intramural Research Program of the Center of Cancer Research, NCI, NIH; NCI Cancer Research Training Award [C5IL039280]; NCI; Genentech; NATIONAL CANCER INSTITUTE [ZIABC008756] Funding Source: NIH RePORTER	Intramural Research Program of the Center of Cancer Research, NCI, NIH; NCI Cancer Research Training Award; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by the Intramural Research Program of the Center of Cancer Research, NCI, NIH, and in part by NCI Cancer Research Training Award C5IL039280, and NCI Director's Innovation Awards in 2009 and 2011 (to PJM). PJM is employed by Genentech Inc. at present. The funder provided support in the form of salaries to PJM (Genentech), GM (NCI), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The work was supported by the Intramural Research Program of the Center of Cancer Research, NCI, NIH, and in part by NCI Cancer Research Training Award C5IL039280, and NCI Director's Innovation Awards in 2009 and 2011 (to PJM). PJM is employed by Genentech Inc. at present. The funder provided support in the form of salaries to PJM (Genentech), GM (NCI), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Sabutoclax was a generous gift from Dr. Paul B. Fisher, Virginia Commonwealth University, Richmond, VA and was also purchased from APEXBIO. Some of the human melanocytes and melanoma cell lines were obtained from Dr. Meenhard Herlyn, The Wistar Institute Melanoma Research Center, PA and from Cell Culture Core Facility, Yale Skin Diseases Research Center Core, Department of Dermatology, Yale University School of Medicine.	Becker TM, 2014, ONCOGENE, V33, P1158, DOI 10.1038/onc.2013.45; Beillard E, 2012, RNA, V18, P1091, DOI 10.1261/rna.031831.111; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Dash R, 2011, P NATL ACAD SCI USA, V108, P8785, DOI 10.1073/pnas.1100769108; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Freedberg DE, 2008, JNCI-J NATL CANCER I, V100, P784, DOI 10.1093/jnci/djn157; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ha L, 2007, P NATL ACAD SCI USA, V104, P10968, DOI 10.1073/pnas.0611638104; Longo PG, 2008, BLOOD, V111, P846, DOI 10.1182/blood-2007-05-089037; Ma YB, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027935; Magro PG, 2004, CANCER RES, V64, P4338, DOI 10.1158/0008-5472.CAN-03-1045; McKee CS, 2013, EXP DERMATOL, V22, P767, DOI 10.1111/exd.12254; Mishra PJ, 2010, ONCOGENE, V29, P2449, DOI 10.1038/onc.2009.521; Mishra PJ, 2007, P NATL ACAD SCI USA, V104, P13513, DOI 10.1073/pnas.0706217104; Mishra PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008445; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; Placzek WJ, 2011, J BIOL CHEM, V286, P39829, DOI 10.1074/jbc.M111.305326; Recio JA, 2002, CANCER RES, V62, P6724; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Roubelakis MG, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S20; Shao YP, 2010, CANCER RES, V70, P6670, DOI 10.1158/0008-5472.CAN-09-4471; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; SVIDERSKAYA EV, 1995, DEVELOPMENT, V121, P1547; Takayama H, 1997, P NATL ACAD SCI USA, V94, P701, DOI 10.1073/pnas.94.2.701; Tang LR, 1998, CLIN CANCER RES, V4, P1865; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang D, 2007, BBA-MOL CELL RES, V1773, P1248, DOI 10.1016/j.bbamcr.2006.11.009; Wei J, 2010, J MED CHEM, V53, P4166, DOI 10.1021/jm1001265; Wilgenhof S, 2013, J IMMUNOTHER, V36, P215, DOI 10.1097/CJI.0b013e31828eed39; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	37	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165102	10.1371/journal.pone.0165102	http://dx.doi.org/10.1371/journal.pone.0165102			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846237	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600008
J	Protudjer, JLP; Vetander, M; Kull, I; Hedlin, G; van Hage, M; Wickman, M; Bergstrom, A				Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Hedlin, Gunilla; van Hage, Marianne; Wickman, Magnus; Bergstrom, Anna			Food-Related Symptoms and Food Allergy in Swedish Children from Early Life to Adolescence	PLOS ONE			English	Article							COW MILK ALLERGY; QUALITY-OF-LIFE; NATURAL-HISTORY; HYPERSENSITIVITY; PREVALENCE; SENSITIZATION; ANAPHYLAXIS; PARENTS; EPIDEMIOLOGY; ASSOCIATION	Background Risk factors for persistence of food-related symptoms (FRS) and food allergy (FA) from early life to adolescence are incompletely understood. The aim of this study was to identify risk factors for FRS and FA in adolescence amongst children with FRS or FA in the first four years of life (early life). Methods In children enrolled in a Swedish birth cohort and followed to 16 years (n = 2572), we defined children with early life FRS in the absence of FA, and FA. Corresponding phenotypes were defined at 16 years. Associations between potential risk factors at 4 years and FRS and FA at 16 years were investigated using logistic regression. Results Early life FRS and FA prevalences were 12.2% and 6.8%, respectively. Amongst children with early life FRS, 35.7% had FRS or FA at 16 years, whereas 74.3% of the children with early life FA had FA at 16 years. For each of the early life phenotypes, parental allergy, early life allergic multimorbidity, early life reactions to peanuts/tree nuts and IgE reactivity at 4 years were statistically significantly associated with FRS or FA at 16 years. In contrast, male sex was associated with an increased risk of FA at 16 years among children with early life FA only. Conclusions In early life, food-related symptoms are twice as common as food allergy. Unlike food allergy, food-related symptoms often remit by adolescence. Yet, these phenotypes have many common risk factors for persistence to adolescence.	[Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Wickman, Magnus; Bergstrom, Anna] Karolinska Inst, Inst Environm Med, Stockholm, Sweden; [Protudjer, Jennifer L. P.; Vetander, Mirja; Kull, Inger; Hedlin, Gunilla; van Hage, Marianne; Wickman, Magnus; Bergstrom, Anna] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Vetander, Mirja; Kull, Inger; Wickman, Magnus] Sachs Children & Youth Hosp, Sodersjukhuset, Stockholm, Sweden; [Kull, Inger] Karolinska Inst, Dept Clin Sci & Educ, Stockholm, Sweden; [Hedlin, Gunilla] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [van Hage, Marianne] Karolinska Inst, Dept Med Solna, Immunol & Allergy Unit, Stockholm, Sweden; [van Hage, Marianne] Karolinska Univ Hosp, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Protudjer, JLP (corresponding author), Karolinska Inst, Inst Environm Med, Stockholm, Sweden.; Protudjer, JLP (corresponding author), Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden.	jennifer.protudjer@ki.se	van Hage, Marianne/A-9678-2017	van Hage, Marianne/0000-0003-3091-1596; Kull, Inger/0000-0001-6096-3771	Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council; Swedish Research Council; Swedish Research Council for Health Working Life and Welfare, Sweden; European Commission's Seventh Framework 29 Program MeDALL [261357]; Karin and Sten Mortstedt Initiative on Anaphylaxis	Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Health Working Life and Welfare, Sweden; European Commission's Seventh Framework 29 Program MeDALL; Karin and Sten Mortstedt Initiative on Anaphylaxis	The BAMSE study, the cohort on which this study is based has received supported by the Swedish Asthma and Allergy Association's Research Foundation, Centre for Allergy Research (CfA), Karolinska Institutet; Stockholm County Council, the Swedish Research Council and the Swedish Research Council for Health Working Life and Welfare, Sweden. We also acknowledge the European Commission's Seventh Framework 29 Program MeDALL (grant agreement 261357). At the time of data analysis and writing, two of the authors (JP and MV) were postdoctoral researchers funded by the Karin and Sten Mortstedt Initiative on Anaphylaxis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alduraywish SA, 2015, PEDIAT ALLERGY IMMUN; Arshad SH, 2014, J ALLERGY CLIN IMMUN, V134, P1462, DOI 10.1016/j.jaci.2014.09.026; BISHOP JM, 1990, J PEDIATR-US, V116, P862, DOI 10.1016/S0022-3476(05)80641-9; Fox M, 2013, EUR J PUBLIC HEALTH, V23, P757, DOI 10.1093/eurpub/ckt010; Grabenhenrich LB, 2015, J ALLERGY CLIN IMMUN, V136, P932, DOI 10.1016/j.jaci.2015.03.040; Gupta R, 2013, JAMA PEDIATR, V167, P1026, DOI 10.1001/jamapediatrics.2013.2376; Gupta RS, 2013, ANN ALLERG ASTHMA IM, V111, P194, DOI 10.1016/j.anai.2013.06.026; HOST A, 1990, ALLERGY, V45, P587, DOI 10.1111/j.1398-9995.1990.tb00944.x; Keet CA, 2014, ANN ALLERG ASTHMA IM, V112, P222, DOI 10.1016/j.anai.2013.12.007; Kivisto E JE, 2016, J ALLERGY CLIN IMMUN; Kivisto JE, 2016, ALLERGY, V71, P677, DOI 10.1111/all.12837; Koplin JJ, 2014, ALLERGY, V69, P1639, DOI 10.1111/all.12487; Kusunoki T, 2010, PEDIATR ALLERGY IMMU, V21, P60, DOI 10.1111/j.1399-3038.2009.00982.x; Liu AH, 2010, J ALLERGY CLIN IMMUN, V126, P798, DOI 10.1016/j.jaci.2010.07.026; Luccioli S, 2014, PEDIATRICS, V134, pS21, DOI 10.1542/peds.2014-0646E; Mai XM, 2008, ALLERGY, V63, P1499, DOI 10.1111/j.1398-9995.2008.01792.x; Marklund B, 2006, HEALTH QUAL LIFE OUT, V4, DOI 10.1186/1477-7525-4-48; Munoz-Cano R, 2016, J INVEST ALLERG CLIN, V26, P73, DOI 10.18176/jiaci.0046; Neuman-Sunshine DL, 2012, ANN ALLERG ASTHMA IM, V108, P326, DOI 10.1016/j.anai.2011.11.010; Nwaru BI, 2013, J ALLERGY CLIN IMMUN, V131, P78, DOI 10.1016/j.jaci.2012.10.028; Ostblom E, 2008, CLIN EXP ALLERGY, V38, P1325, DOI 10.1111/j.1365-2222.2008.03010.x; Ostblom E, 2008, ALLERGY, V63, P211, DOI 10.1111/j.1398-9995.2007.01559.x; Panesar SS, 2013, ALLERGY, V68, P1353, DOI 10.1111/all.12272; Pereira B, 2005, J ALLERGY CLIN IMMUN, V116, P884, DOI 10.1016/j.jaci.2005.05.047; Protudjer JLP, 2015, J ALLER CL IMM-PRACT, V3, P68, DOI 10.1016/j.jaip.2014.09.021; Protudjer JL, 2016, CLIN TRANSL IN PRESS; Pyrhonen K, 2013, ACTA PAEDIATR, V102, P982, DOI 10.1111/apa.12342; Roehr CC, 2004, CLIN EXP ALLERGY, V34, P1534, DOI 10.1111/j.1365-2222.2004.02080.x; Rona RJ, 2007, J ALLERGY CLIN IMMUN, V120, P638, DOI 10.1016/j.jaci.2007.05.026; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Santos A, 2010, PEDIAT ALLERG IMM-UK, V21, P1127, DOI 10.1111/j.1399-3038.2010.01040.x; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Schnabel E, 2010, CLIN EXP ALLERGY, V40, P450, DOI 10.1111/j.1365-2222.2009.03400.x; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P291, DOI 10.1016/j.jaci.2013.11.020; Sicherer SH, 2014, J ALLERGY CLIN IMMUN, V133, P492, DOI 10.1016/j.jaci.2013.12.1041; Soller L, 2012, J ALLERGY CLIN IMMUN, V130, P986, DOI 10.1016/j.jaci.2012.06.029; Strinnholm A, 2014, ACTA PAEDIATR, V103, P1290, DOI 10.1111/apa.12772; Turnbull JL, 2015, ALIMENT PHARM THER, V41, P3, DOI 10.1111/apt.12984; Vanderhoof J A, 1998, Curr Opin Clin Nutr Metab Care, V1, P419, DOI 10.1097/00075197-199809000-00009; Venter C, 2008, ALLERGY, V63, P354, DOI 10.1111/j.1398-9995.2007.01570.x; Venter C, 2006, PEDIAT ALLERG IMM-UK, V17, P356, DOI 10.1111/j.1399-3038.2006.00428.x; Venter C, 2015, PEDIAT ALLERG IMM-UK, V26, P126, DOI 10.1111/pai.12337; Vetander M, 2014, CLIN EXP ALLERGY, V44, P113, DOI 10.1111/cea.12203; Vetander M, 2012, CLIN EXP ALLERGY, V42, P568, DOI 10.1111/j.1365-2222.2011.03954.x; Westman M, 2015, J ALLERGY CLIN IMMUN, V135, P1199, DOI 10.1016/j.jaci.2014.10.042; Winberg A, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-32; Yavuz ST, 2013, ANN ALLERG ASTHMA IM, V110, P284, DOI 10.1016/j.anai.2013.01.018	47	15	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166347	10.1371/journal.pone.0166347	http://dx.doi.org/10.1371/journal.pone.0166347			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846286	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600048
J	Zheng, YC; Ai, DN; Zhang, P; Gao, YF; Xia, LK; Du, SD; Sang, XT; Yang, J				Zheng, Yongchang; Ai, Danni; Zhang, Pan; Gao, Yefei; Xia, Likun; Du, Shunda; Sang, Xinting; Yang, Jian			Feature Learning Based Random Walk for Liver Segmentation	PLOS ONE			English	Article							SHAPE MODEL	Liver segmentation is a significant processing technique for computer-assisted diagnosis. This method has attracted considerable attention and achieved effective result. However, liver segmentation using computed tomography (CT) images remains a challenging task because of the low contrast between the liver and adjacent organs. This paper proposes a feature-learning-based random walk method for liver segmentation using CT images. Four texture features were extracted and then classified to determine the classification probability corresponding to the test images. Seed points on the original test image were automatically selected and further used in the random walk (RW) algorithm to achieve comparable results to previous segmentation methods.	[Zheng, Yongchang; Du, Shunda; Sang, Xinting] Chinese Acad Med Sci, Dept Liver Surg, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Zheng, Yongchang; Du, Shunda; Sang, Xinting] Peking Union Med Coll, Beijing 100730, Peoples R China; [Ai, Danni; Zhang, Pan; Gao, Yefei; Xia, Likun; Yang, Jian] Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Institute of Technology	Ai, DN (corresponding author), Beijing Inst Technol, Sch Opt & Elect, Beijing Engn Res Ctr Mixed Real & Adv Display, Beijing 100081, Peoples R China.	danni@bit.edu.cn			National Hi-Tech Research and Development Program [2015AA043203]; National Science Foundation Program of China [61501030, 61572076]; China Postdoctoral Science Foundation [2015M570940]	National Hi-Tech Research and Development Program(National High Technology Research and Development Program of China); National Science Foundation Program of China; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Hi-Tech Research and Development Program (2015AA043203), the National Science Foundation Program of China (61501030, 61572076), the China Postdoctoral Science Foundation funded project (2015M570940).	Al-Shaikhli SDS, 2015, COMPUTER VISION PATT; Campadelli P, 2009, ARTIF INTELL MED, V45, P185, DOI 10.1016/j.artmed.2008.07.020; Chi Y, 2007, P MICCAI WORKSH 3D S, P167; Dag I, 2006, J COMPUT APPL MATH, V190, P532, DOI 10.1016/j.cam.2005.04.026; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Furukawa D., 2007, P MICCAI WORKSH 3 D, P117; Gao LM, 1996, RADIOLOGY, V201, P359, DOI 10.1148/radiology.201.2.8888223; Gauriau R, 2013, P 5 WORKSH COMP CLIN, P241; George Linguraru Marius, 2012, COMPUTATIONAL CLIN A, V7029, P198; Grady L, 2006, IEEE T PATTERN ANAL, V28, P1768, DOI 10.1109/TPAMI.2006.233; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Haugen AS, 2015, ANN SURG, V261, P821, DOI 10.1097/SLA.0000000000000716; Haustermans K., 2007, P MICCAI WORKSH 3D S, P197; Heimann T, 2007, LECT NOTES COMPUT SC, V4584, P1; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Huang C, INT C EL COMM CONTR, P126; Hufnagel H, 2007, LECT NOTES COMPUT SC, V4791, P959; Kainmuller D., 2007, P MICCAI WORKSHOP 3D, V109, P116; Li XC, 2008, ENG APPL ARTIF INTEL, V21, P785, DOI 10.1016/j.engappai.2007.07.001; Lienhart R, 2002, IEEE IMAGE PROC, P900; Mahjoub Mohamed Ali, 2011, CANADIAN J IMAGE PRO, V2, P92; Meng B, 2015, IEEE T BIOMEDICAL EN; Meng B., 2014, SPIE DEV XRAY TOMOGR; Mharib AM, 2012, ARTIF INTELL REV, V37, P83, DOI 10.1007/s10462-011-9220-3; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Rikxoort E., 2007, P MICCAI WORKSH 3 D, P101; Saddi M., 2007, P MICCAI WORKSH 3D S, P207; Seghers D., 2007, P MICCAI WORKSH 3 D, P135; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Soh L., 1999, IEEE T GEOSCIENCE RE, V37; Vapnik V., 1998, STAT LEARNING THEORY; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Viola P, 2004, INT J COMPUT VISION, V57, P137, DOI 10.1023/B:VISI.0000013087.49260.fb; Wei YT, 2014, APPL MECH MATER, V513-517, P3115, DOI 10.4028/www.scientific.net/AMM.513-517.3115; Wimmer A, 2009, LECT NOTES COMPUT SC, V5762, P26, DOI 10.1007/978-3-642-04271-3_4	37	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164098	10.1371/journal.pone.0164098	http://dx.doi.org/10.1371/journal.pone.0164098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846217	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600004
J	Ji, XT; Niu, YF; Shen, LC				Ji, Xiaoting; Niu, Yifeng; Shen, Lincheng			Robust Satisficing Decision Making for Unmanned Aerial Vehicle Complex Missions under Severe Uncertainty	PLOS ONE			English	Article							UAV	This paper presents a robust satisficing decision-making method for Unmanned Aerial Vehicles (UAVs) executing complex missions in an uncertain environment. Motivated by the info-gap decision theory, we formulate this problem as a novel robust satisficing optimization problem, of which the objective is to maximize the robustness while satisfying some desired mission requirements. Specifically, a new info-gap based Markov Decision Process (IMDP) is constructed to abstract the uncertain UAV system and specify the complex mission requirements with the Linear Temporal Logic (LTL). A robust satisficing policy is obtained to maximize the robustness to the uncertain IMDP while ensuring a desired probability of satisfying the LTL specifications. To this end, we propose a two-stage robust satisficing solution strategy which consists of the construction of a product IMDP and the generation of a robust satisficing policy. In the first stage, a product IMDP is constructed by combining the IMDP with an automaton representing the LTL specifications. In the second, an algorithm based on robust dynamic programming is proposed to generate a robust satisficing policy, while an associated robustness evaluation algorithm is presented to evaluate the robustness. Finally, through Monte Carlo simulation, the effectiveness of our algorithms is demonstrated on an UAV search mission under severe uncertainty so that the resulting policy can maximize the robustness while reaching the desired performance level. Furthermore, by comparing the proposed method with other robust decision-making methods, it can be concluded that our policy can tolerate higher uncertainty so that the desired performance level can be guaranteed, which indicates that the proposed method is much more effective in real applications.	[Ji, Xiaoting; Niu, Yifeng; Shen, Lincheng] Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China	National University of Defense Technology - China	Niu, YF (corresponding author), Natl Univ Def Technol, Coll Mechatron & Automat, Changsha, Hunan, Peoples R China.	niuyifeng@nudt.edu.cn			National Natural Science Foundation of China [61403410]; National Natural Science Foundation (NNSF) of China [61403410]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation (NNSF) of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China, 61403410, http://www.nsfc.gov.cn/, YN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Natural Science Foundation (NNSF) of China under Grant 61403410.	[Anonymous], 2003, MR1626RPC RAND CORP; Berman ESF, 2012, SENSOR ACTUAT B-CHEM, V169, P128, DOI 10.1016/j.snb.2012.04.036; Bertuccelli LF, 2012, IEEE CONTR SYST MAG, V32, P96, DOI 10.1109/MCS.2012.2205478; Bhatia A, 2011, IEEE ROBOT AUTOM MAG, V18, P55, DOI 10.1109/MRA.2011.942115; Brown CB, 2006, STRUCT SAF, V33, P122; Bulatov D, 2012, INT ARCH PHOTOGRAMME, V3822, P75, DOI [10.5194/isprsarchives-XXXVIII-1-C22-75-2011, DOI 10.5194/ISPRSARCHIVES-XXXVIII-1-C22-75-]; Chang HS, 2005, IEEE T AUTOMAT CONTR, V50, P1804, DOI 10.1109/TAC.2005.858644; Christel Baier, 2008, PRINCIPLES MODEL CHE; Ding X. C., 2011, IFAC, V18, P3515; Ding XC, 2014, IEEE T AUTOMAT CONTR, V59, P1244, DOI 10.1109/TAC.2014.2298143; Farrar C, 2012, SOC PHOT INSTR ENG C, V26; Givan R, 1997, BOUNDED PARAMETER MA, DOI [10.1007/3-540-63912-889, DOI 10.1007/3-540-63912-889]; Goldfarb D, 2003, MATH OPER RES, V28, P1, DOI 10.1287/moor.28.1.1.14260; Goode A, 2001, SOLVING UNCERTAIN MA; Goodrich MA, 2008, J FIELD ROBOT, V25, P89, DOI 10.1002/rob.20226; Hu XX, 2015, J CENT SOUTH UNIV, V22, P4263, DOI 10.1007/s11771-015-2975-y; Iscold P, 2010, IEEE T AERO ELEC SYS, V46, P335, DOI 10.1109/TAES.2010.5417166; Itay S, 2011, IEEE T ROBOTICS, V26, P1032; Iyengar GN, 2005, MATH OPER RES, V30, P257, DOI 10.1287/moor.1040.0129; Ji X, 2015, MATH PROBLEMS ENG, V5; Kalyanasundaram S, 2002, IEEE DECIS CONTR P, P3799; Klein J, 2006, THEOR COMPUT SCI, V363, P182, DOI 10.1016/j.tcs.2006.07.022; Kupferman O, 1998, FORM METHOD SYST DES, V19, P685; Kwiatkowska Marta, 2011, Computer Aided Verification. Proceedings 23rd International Conference, CAV 2011, P585, DOI 10.1007/978-3-642-22110-1_47; Lacerda B, 2014, IEEE INT C INT ROBOT, P1511, DOI 10.1109/IROS.2014.6942756; Lempert RJ, 2006, MANAGE SCI, V52, P514, DOI 10.1287/mnsc.1050.0472; Lempert RJ, 2007, RISK ANAL, V27, P1009, DOI 10.1111/j.1539-6924.2007.00940.x; Loizou S. G., 2005, IEEE C DEC CONTR, P153; Luna R., 2014, WORKSH ALG FDN ROB, P335; MANKTELOW K. I., 1999, REASONING THINKING; McInerney D, 2012, CLIMATIC CHANGE, V112, P547, DOI 10.1007/s10584-011-0377-1; Nilim A, 2005, OPER RES, V53, P780, DOI 10.1287/opre.1050.0216; Pierce SG, 2006, IEEE T NEURAL NETWOR, V17, P1349, DOI 10.1109/TNN.2006.880363; Puterman ML., 1994, WILEY SERIES PROBABI, V37, P353, DOI [10.1002/9780470316887, DOI 10.1002/9780470316887]; Regan HM, 2005, ECOL APPL, V15, P1471, DOI 10.1890/03-5419; SATIA JK, 1973, OPER RES, V21, P728, DOI 10.1287/opre.21.3.728; Semsch E, 2009, 2009 IEEE/WIC/ACM INTERNATIONAL JOINT CONFERENCES ON WEB INTELLIGENCE (WI) AND INTELLIGENT AGENT TECHNOLOGIES (IAT), VOL 2, P82; SIMON HA, 1956, PSYCHOL REV, V63, P129, DOI 10.1037/h0042769; WHITE CC, 1994, OPER RES, V42, P739, DOI 10.1287/opre.42.4.739; Wolff EM, 2012, IEEE DECIS CONTR P, P3372, DOI 10.1109/CDC.2012.6426174; Wongpiromsarn T, 2010, HSSC 10: PROCEEDINGS OF THE 13TH ACM INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P101	42	5	5	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166448	10.1371/journal.pone.0166448	http://dx.doi.org/10.1371/journal.pone.0166448			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835670	Green Submitted, Green Published, gold			2022-12-26	WOS:000387779200051
J	Liu, ZH; Gao, YL; Yang, H; Bao, HY; Qin, LH; Zhu, CT; Chen, YW; Hu, ZY				Liu, Zhonghua; Gao, Yulu; Yang, Hua; Bao, Haiyang; Qin, Lianhua; Zhu, Changtai; Chen, Yawen; Hu, Zhongyi			Impact of Hypoxia on Drug Resistance and Growth Characteristics of Mycobacterium tuberculosis Clinical Isolates	PLOS ONE			English	Article							IN-VITRO; ADAPTATION; BINDING; GENE; EXPRESSION; CULTURE; DOMAIN; SENSOR; VIVO; DEVS	Mycobacterium tuberculosis (MTB) is a specific aerobic bacterium, but can survive under hypoxic conditions, such as those in lung cheese necrosis, granulomas, or macrophages. It is not clear whether the drug sensitivity and growth characteristics of MTB under hypoxic conditions are different from those under aerobic conditions. In this study, we examined the drug resistance and growth characteristics of MTB clinical isolates by a large sample of in vitro drug susceptibility tests, using an automatic growth instrument. Under hypoxic conditions, variance in drug resistance was observed in nearly one-third of the MTB strains and was defined as MTB strains with changed drug sensitivity (MTB-CDS). Among these strains, resistance in a considerable proportion of clinical strains was significantly increased, and some strains emerged as multi-drug resistant. Growth test results revealed a high growth rate and large survival number in macrophages under hypoxia in MTB-CDS. According to the results of fluorescence quantitative PCR, the expression of some genes, including RegX3 (involving RIF resistance), Rv0194 (efflux pump gene), four genes related to transcription regulation (KstR, DosR, Rv0081 and WhiB3) and gene related to translation regulation (DATIN), were upregulated significantly under hypoxic conditions compared to that under aerobic conditions (p < 0.05). Thus, we concluded that some MTB clinical isolates can survive under hypoxic conditions and their resistance could change. As for poor clinical outcomes in patients, based on routine drug susceptibility testing, drug susceptibility tests for tuberculosis under hypoxic conditions should also be recommended. However, the detailed mechanisms of the effect of hypoxia on drug sensitivity and growth characteristics of MTB clinical isolates still requires further study.	[Liu, Zhonghua; Yang, Hua; Bao, Haiyang; Qin, Lianhua; Hu, Zhongyi] Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China; [Gao, Yulu] Nanjing Univ Tradit Chinese Med, Dept Lab Med, Kunshan Hosp, Kunshan, Peoples R China; [Chen, Yawen] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nursing, Shanghai, Peoples R China; [Zhu, Changtai] Shanghai Jiao Tong Univ, Dept Transfus, Affiliated Peoples Hosp 6, Shanghai, Peoples R China	Tongji University; Nanjing University of Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Hu, ZY (corresponding author), Tongji Univ, Shanghai Pulm Hosp, Shanghai Key Lab TB, Sch Med, Shanghai, Peoples R China.; Chen, YW (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Nursing, Shanghai, Peoples R China.; Zhu, CT (corresponding author), Shanghai Jiao Tong Univ, Dept Transfus, Affiliated Peoples Hosp 6, Shanghai, Peoples R China.	zct101@163.com; yawenchen2211@163.com; shhuzy@163.com	zhu, changtai/W-6581-2019; Zhu, Changtai/V-1583-2017	zhu, changtai/0000-0002-5250-1937; Zhu, Changtai/0000-0002-5250-1937	National Basic Research Program of China (973 Program) [2012CB518706]; National Natural Science Foundation of China [81201253]; Research Grant from Shanghai Hospital Development Center [SHDC12015910]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Grant from Shanghai Hospital Development Center	This project was funded by the National Basic Research Program of China (973 Program, no. 2012CB518706), the National Natural Science Foundation of China (no. 81201253), and Research Grant from Shanghai Hospital Development Center (no. SHDC12015910). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Aziz AA, 2013, TROP DOCT, V43, P66, DOI 10.1177/0049475513490421; Abomoelak B, 2009, J BACTERIOL, V191, P5941, DOI 10.1128/JB.00778-09; Andrade BH, 2013, REV SOC BRAS MED TRO, V46, P441, DOI 10.1590/0037-8682-0047-2013; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Bagchi G, 2003, MICROBIOL-SGM, V149, P2303, DOI 10.1099/mic.0.C0120-0; Chen Jian, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P135; Coronel J, 2014, CLIN MICROBIOL INFEC, V20, P536, DOI 10.1111/1469-0691.12401; Devasundaram S, 2016, INFECT GENET EVOL, V40, P21, DOI 10.1016/j.meegid.2016.01.007; Dhingra S, 2012, FEMS MICROBIOL LETT, V330, P66, DOI 10.1111/j.1574-6968.2012.02534.x; Dione N, 2016, CLIN MICROBIOL INFEC, V22, P53, DOI 10.1016/j.cmi.2015.10.032; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; FESENKO LD, 1987, VRACHEBNOE DELO, P57; Fontan PA, 2009, J BACTERIOL, V191, P5628, DOI 10.1128/JB.00510-09; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Gupta AK, 2010, INDIAN J MED RES, V132, P176; He GX, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-166; Hofman S, 2016, EXPERT OPIN EMERG DR, V21, P103, DOI 10.1517/14728214.2016.1151000; Kaur K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-195; Kharatmal S, 2009, J MICROBIOL METH, V78, P161, DOI 10.1016/j.mimet.2009.05.008; Klinkenberg LG, 2013, J INFECT DIS, V207, P1525, DOI 10.1093/infdis/jit049; Kumar A, 2013, CYTOKINE, V64, P258, DOI 10.1016/j.cyto.2013.06.310; Kumar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038709; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Kumar S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004139; Li Jing, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P796; Li Liang, 2004, Zhonghua Yi Xue Za Zhi, V84, P1678; Liu CH, 2011, EPIDEMIOL INFECT, V139, P1909, DOI 10.1017/S0950268810003158; Campos GNL, 2014, INT J IMMUNOGENET, V41, P54, DOI 10.1111/iji.12080; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McGillivray A, 2015, J BIOL CHEM, V290, P2351, DOI 10.1074/jbc.M114.615534; Mesfin YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082235; Nickel D, 2012, J IMMUNOL, V188, P4001, DOI 10.4049/jimmunol.1100976; Phong WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056037; Qualls JE, 2016, SEMIN IMMUNOPATHOL, V38, P139, DOI 10.1007/s00281-015-0534-0; Rustad TR, 2009, CELL MICROBIOL, V11, P1151, DOI 10.1111/j.1462-5822.2009.01325.x; Saini DK, 2004, MICROBIOL-SGM, V150, P865, DOI 10.1099/mic.0.26218-0; Sakuma T, 1995, Kekkaku, V70, P1; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Saxena AK, 2013, INT J ANTIMICROB AG, V42, P27, DOI 10.1016/j.ijantimicag.2013.03.007; Schreuder LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107283; Sharadamma N, 2011, FEBS J, V278, P3447, DOI 10.1111/j.1742-4658.2011.08267.x; Shi L, 2008, TUBERCULOSIS, V88, P1, DOI 10.1016/j.tube.2007.08.007; Stenina MA, 2003, B EXP BIOL MED+, V135, P178, DOI 10.1023/A:1023884201722; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; Xiao He-ping, 2010, Zhonghua Jie He He Hu Xi Za Zhi, V33, P481; Yamamoto T, 1996, Kekkaku, V71, P331; Zenk SF, 2015, MED MICROBIOL IMMUN	50	14	14	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166052	10.1371/journal.pone.0166052	http://dx.doi.org/10.1371/journal.pone.0166052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835653	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200022
J	Fang, L; Yao, ZJ; An, JP; Chen, XJ; Xie, YW; Zhao, H; Mao, JF; Liang, WS; Ma, XX				Fang, Lei; Yao, Zhijun; An, Jianping; Chen, Xuejiao; Xie, Yuanwei; Zhao, Hui; Mao, Junfeng; Liang, Wangsheng; Ma, Xiangxing			Topological Organization of Metabolic Brain Networks in Pre-Chemotherapy Cancer with Depression: A Resting-State PET Study	PLOS ONE			English	Article							BREAST-CANCER; FUNCTIONAL CONNECTIVITY; GLUCOSE-METABOLISM; COGNITIVE FUNCTION; CORTICAL NETWORKS; WORKING-MEMORY; BASAL GANGLIA; SMALL-WORLD; MRI; DYSFUNCTION	This study aimed to investigate the metabolic brain network and its relationship with depression symptoms using F-18-fluorodeoxyglucose positron emission tomography data in 78 pre-chemotherapy cancer patients with depression and 80 matched healthy subjects. Functional and structural imbalance or disruption of brain networks frequently occur following chemotherapy in cancer patients. However, few studies have focused on the topological organization of the metabolic brain network in cancer with depression, especially those without chemotherapy. The nodal and global parameters of the metabolic brain network were computed for cancer patients and healthy subjects. Significant decreases in metabolism were found in the frontal and temporal gyri in cancer patients compared with healthy subjects. Negative correlations between depression and metabolism were found predominantly in the inferior frontal and cuneus regions, whereas positive correlations were observed in several regions, primarily including the insula, hippocampus, amygdala, and middle temporal gyri. Furthermore, a higher clustering efficiency, longer path length, and fewer hubs were found in cancer patients compared with healthy subjects. The topological organization of the whole-brain metabolic networks may be disrupted in cancer. Finally, the present findings may provide a new avenue for exploring the neurobiological mechanism, which plays a key role in lessening the depression effects in pre-chemotherapy cancer patients.	[Fang, Lei; Ma, Xiangxing] Shandong Univ, Affiliated Hosp 1, Dept Radiol, Qilu Hosp, 107 Cultural West Rd, Jinan 250012, Shandong, Peoples R China; [Fang, Lei; Mao, Junfeng; Liang, Wangsheng] Lanzhou Mil Area Command, PET CT Ctr, Affiliated Lanzhou Gen Hosp, 333 South Binhe Rd, Lanzhou 730050, Gansu, Peoples R China; [Yao, Zhijun; Chen, Xuejiao; Xie, Yuanwei] Lanzhou Univ, Sch Informat Sci & Engn, Lanzhou 730000, Gansu, Peoples R China; [An, Jianping; Zhao, Hui] Lanzhou Mil Area Command, Dept Nucl Med, Affiliated Lanzhou Gen Hosp, 333 South Binhe Rd, Lanzhou 730050, Gansu, Peoples R China	Shandong University; Lanzhou University	Ma, XX (corresponding author), Shandong Univ, Affiliated Hosp 1, Dept Radiol, Qilu Hosp, 107 Cultural West Rd, Jinan 250012, Shandong, Peoples R China.	maxiangxing@126.com	ma, xiang/GSE-2438-2022					Ahles TA, 2008, BREAST CANCER RES TR, V110, P143, DOI 10.1007/s10549-007-9686-5; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Ausems MGEM, 2000, AM J HUM GENET, V67, P91; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bruno J, 2012, NEUROBIOL DIS, V48, P329, DOI 10.1016/j.nbd.2012.07.009; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Collins B, 2009, PSYCHO-ONCOLOGY, V18, P134, DOI 10.1002/pon.1379; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Debess J, 2010, BREAST CANCER RES TR, V121, P91, DOI 10.1007/s10549-010-0756-8; Deprez S, 2011, HUM BRAIN MAPP, V32, P480, DOI 10.1002/hbm.21033; Ding SL, 2009, J COMP NEUROL, V514, P595, DOI 10.1002/cne.22053; Douw L, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-103; Eberling JL, 2004, NEUROIMAGE, V21, P364, DOI 10.1016/j.neuroimage.2003.08.037; Fan HGM, 2005, J CLIN ONCOL, V23, P8025, DOI 10.1200/JCO.2005.01.6550; Fujiwara T, 1997, Ann Nucl Med, V11, P307; GILMORE HE, 1988, J AM ACAD CHILD PSY, V27, P145, DOI 10.1097/00004583-198801000-00033; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Gosselin N, 2006, BRAIN, V129, P2585, DOI 10.1093/brain/awl240; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Grahn JA, 2009, BEHAV BRAIN RES, V199, P53, DOI 10.1016/j.bbr.2008.11.020; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; Hemminki K, 2003, CANCER EPIDEM BIOMAR, V12, P796; Hillary FG, 2008, J INT NEUROPSYCH SOC, V14, P526, DOI 10.1017/S1355617708080788; Hirono N, 1998, NEUROLOGY, V50, P380, DOI 10.1212/WNL.50.2.380; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Janelsins MC, 2011, SEMIN ONCOL, V38, P431, DOI 10.1053/j.seminoncol.2011.03.014; Joo EY, 2005, BRAIN, V128, P1802, DOI 10.1093/brain/awh534; Judenhofer MS, 2008, NAT MED, V14, P459, DOI 10.1038/nm1700; Jung MS, 2017, BRAIN IMAGING BEHAV, V11, P86, DOI 10.1007/s11682-016-9507-8; Kesler SR, 2015, NEUROBIOL AGING, V36, P2429, DOI 10.1016/j.neurobiolaging.2015.04.015; Kim LS, 2008, NEUROSCI LETT, V447, P1, DOI 10.1016/j.neulet.2008.09.077; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Li C, 2013, PLOS ONE, V8; Linden W, 2012, J AFFECT DISORDERS, V141, P343, DOI 10.1016/j.jad.2012.03.025; Liu Z, 2014, PLOS ONE, V9; Lynall ME, 2010, J NEUROSCI, V30, P9477, DOI 10.1523/JNEUROSCI.0333-10.2010; McDonald BC, 2013, BRAIN IMAGING BEHAV, V7, P374, DOI 10.1007/s11682-013-9256-x; Meyer-Lindenberg A, 2001, AM J PSYCHIAT, V158, P1809, DOI 10.1176/appi.ajp.158.11.1809; Mitchell Alex J, 2013, Lancet Oncol, V14, P721, DOI 10.1016/S1470-2045(13)70244-4; Mosher CE, 2013, BREAST J, V19, P285, DOI 10.1111/tbj.12107; Muller VI, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00268; Murray EA, 2011, BIOL PSYCHIAT, V69, pE43, DOI 10.1016/j.biopsych.2010.09.041; Perani D, 2014, NEUROIMAGE-CLIN, V6, P445, DOI 10.1016/j.nicl.2014.10.009; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Qiu XZ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00235; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Riedl V, 2014, J NEUROSCI, V34, P6260, DOI 10.1523/JNEUROSCI.0492-14.2014; Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Russo S, 2004, PSYCHOSOM MED, V66, P422, DOI 10.1097/01.psy.0000126204.97565.91; Sanz-Arigita EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013788; Scherling C, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00122; Seo EH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053922, 10.1371/journal.pone.0076875]; Servaes P, 1999, BEHAV MED, V25, P23, DOI 10.1080/08964289909596735; Sheline YI, 2010, P NATL ACAD SCI USA, V107, P11020, DOI 10.1073/pnas.1000446107; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Silverman DHS, 2007, BREAST CANCER RES TR, V103, P303, DOI 10.1007/s10549-006-9380-z; Soloff PH, 2003, PSYCHIAT RES-NEUROIM, V123, P153, DOI 10.1016/S0925-4927(03)00064-7; Stafford L, 2016, BREAST, V26, P100, DOI 10.1016/j.breast.2016.01.008; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Suwa T, 2012, J AFFECT DISORDERS, V136, P1039, DOI 10.1016/j.jad.2011.11.040; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tarapore PE, 2013, J NEUROSURG, V119, pA563; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; VOGELSTEIN B, 1993, TRENDS GENET, V9, P138, DOI 10.1016/0168-9525(93)90209-Z; Votaw JR, 2001, J NUCL MED, V42, P701; Wang JH, 2015, FRONT HUM NEUROSCI, V9; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu K, 2012, HUM BRAIN MAPP, V33, P552, DOI 10.1002/hbm.21232; Yang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125922; Yao ZJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001006; Yu QB, 2013, SCHIZOPHR RES, V143, P165, DOI 10.1016/j.schres.2012.11.001; Zalesky A, 2012, HUM BRAIN MAPP, V33, P2535, DOI 10.1002/hbm.21379; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059	78	12	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							0166049	10.1371/journal.pone.0166049	http://dx.doi.org/10.1371/journal.pone.0166049			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832148	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000059
J	Hu, YZ; Zhao, HY; Ai, XB				Hu, Yanzhu; Zhao, Huiyang; Ai, Xinbo			Inferring Weighted Directed Association Network from Multivariate Time Series with a Synthetic Method of Partial Symbolic Transfer Entropy Spectrum and Granger Causality	PLOS ONE			English	Article							LOCAL SIMILARITY ANALYSIS; DYNAMICS	Complex network methodology is very useful for complex system explorer. However, the relationships among variables in complex system are usually not clear. Therefore, inferring association networks among variables from their observed data has been a popular research topic. We propose a synthetic method, named small-shuffle partial symbolic transfer entropy spectrum (SSPSTES), for inferring association network from multivariate time series. The method synthesizes surrogate data, partial symbolic transfer entropy (PSTE) and Granger causality. A proper threshold selection is crucial for common correlation identification methods and it is not easy for users. The proposed method can not only identify the strong correlation without selecting a threshold but also has the ability of correlation quantification, direction identification and temporal relation identification. The method can be divided into three layers, i.e. data layer, model layer and network layer. In the model layer, the method identifies all the possible pair-wise correlation. In the network layer, we introduce a filter algorithm to remove the indirect weak correlation and retain strong correlation. Finally, we build a weighted adjacency matrix, the value of each entry representing the correlation level between pair-wise variables, and then get the weighted directed association network. Two numerical simulated data from linear system and nonlinear system are illustrated to show the steps and performance of the proposed approach. The ability of the proposed method is approved by an application finally.	[Hu, Yanzhu; Zhao, Huiyang; Ai, Xinbo] Beijing Univ Posts & Telecommun, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing 100876, Peoples R China; [Zhao, Huiyang] Xuchang Univ, Sch Informat Engn, Xuchang 461000, Peoples R China	Beijing University of Posts & Telecommunications; Xuchang University	Zhao, HY (corresponding author), Beijing Univ Posts & Telecommun, Beijing Key Lab Work Safety Intelligent Monitorin, Beijing 100876, Peoples R China.; Zhao, HY (corresponding author), Xuchang Univ, Sch Informat Engn, Xuchang 461000, Peoples R China.	zhyjky@l63.com			National Natural Science Foundation of China [61503034, 61627816]; Beijing Science and Technology Program [D151100004715001]; Key Scientific Research Project of Henan Province Universities [156520031]; Xuchang Science and Technology Program [1502098]; National Key Research and Development Program of China [2016YFC0701309-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Science and Technology Program; Key Scientific Research Project of Henan Province Universities; Xuchang Science and Technology Program; National Key Research and Development Program of China	This work is funded by the National Natural Science Foundation of China (61503034)), by the Beijing Science and Technology Program (D151100004715001), by the Key Scientific Research Project of Henan Province Universities (156520031), by the Xuchang Science and Technology Program (1502098), by the National Key Research and Development Program of China (2016YFC0701309-01) and the National Natural Science Foundation of China (61627816).; We thank all challenge participants for their invaluable contribution. We thank the anonymous reviewers for their valuable comments and suggestions to improve the quality of the paper. This paper is supported by the National Natural Science Foundation of China (61503034), by the Beijing Science and Technology Program (D151100004715001), by the Key Scientific Research Project of Henan Province Universities (15B520031), by the Xuchang Science and Technology Program (1502098), by the National Key Research and Development Program of China (2016YFC0701309-01) and the National Natural Science Foundation of China (61627816). We thank all the fund organizations for offering us the studying conditions.	Ai XB, 2014, ENTROPY-SWITZ, V16, P5753, DOI 10.3390/e16115753; Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; Cecchi GA, 2008, I S BIOMED IMAGING, P604, DOI 10.1109/ISBI.2008.4541068; Chai LE, 2014, CURR BIOINFORM, V9, P531, DOI 10.2174/1574893609666140421210333; Deng LF, 2016, SCI REP-UK, V6, DOI 10.1038/srep26976; Dynamic S., 2012, EUPHYTICA, V183, P361, DOI [10.1007/s10681-011-0538-3, DOI 10.1007/S10681-011-0538-3]; Evans TS, 2012, SCIENTOMETRICS, V93, P473, DOI 10.1007/s11192-012-0694-9; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Fernandez-Rosales IY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126234; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Goldberg SR, 2015, SCIENTOMETRICS, V105, P1577, DOI 10.1007/s11192-015-1737-9; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Guo XB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087446; Han L, 2008, BIOSYSTEMS, V91, P158, DOI 10.1016/j.biosystems.2007.08.008; Hill SM, 2016, NAT METHODS, V13, P310, DOI [10.1038/NMETH.3773, 10.1038/nmeth.3773]; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Ma HF, 2014, SCI REP-UK, V4, DOI 10.1038/srep07464; Mahdevar G, 2013, GENES GENET SYST, V88, P301, DOI 10.1266/ggs.88.301; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Maucher M, 2011, BIOINFORMATICS, V27, P1529, DOI 10.1093/bioinformatics/btr166; Michael S, 2005, APPL NONLINEAR TIME; Nakamura T, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.041114; Nakamura T, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.032323; Papana A, 2013, PARTIAL SYMBOLIC TRA, P13; PRICE DJD, 1965, SCIENCE, V149, P510; Reshef DN, 2011, SCIENCE, V334, P1518, DOI 10.1126/science.1205438; Ruan QS, 2006, BIOINFORMATICS, V22, P2532, DOI 10.1093/bioinformatics/btl417; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schiatti L, 2015, PHYSIOL MEAS, V36, P827, DOI 10.1088/0967-3334/36/4/827; SIMS CA, 1972, AM ECON REV, V62, P540; Staniek M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.158101; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Thomas MC, 2006, ELEMENTS INFORM THEO; Thorniley J., 2011, IMPROVED TRANSFER EN, P797; Tilghman P, 2013, MILCOM 2013 2013 IEE; Villaverde Alejandro F, 2013, Cells, V2, P306, DOI 10.3390/cells2020306; Walker DM, 2010, ANIM BEHAV, V79, P351, DOI 10.1016/j.anbehav.2009.11.011; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wiener N., 1956, THEORY PREDICTION; Xia LC, 2013, BIOINFORMATICS, V29, P230, DOI 10.1093/bioinformatics/bts668; Yuan YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016835; Zoppoli P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-154	46	6	6	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166084	10.1371/journal.pone.0166084	http://dx.doi.org/10.1371/journal.pone.0166084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832153	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000063
J	Seybold, AC; Wharton, DA; Thorne, MAS; Marshall, CJ				Seybold, Anna C.; Wharton, David A.; Thorne, Michael A. S.; Marshall, Craig J.			Establishing RNAi in a Non-Model Organism: The Antarctic Nematode Panagrolaimus sp DAW1	PLOS ONE			English	Article							ELEGANS CHROMOSOME-I; CAENORHABDITIS-ELEGANS; CRYOPROTECTIVE DEHYDRATION; INTERFERENCE; DAVIDI; PROTEINS; EMBRYOGENESIS; DIVERSITY; SURVIVAL; EFFICACY	The Antarctic nematode Panagrolaimus sp. DAW1 is one of the only organisms known to survive extensive intracellular freezing throughout its tissues. Although the physiological mechanisms of this extreme adaptation are partly understood, the molecular mechanisms remain largely unknown. RNAi is a method that allows the examination of gene function in a direct, targeted manner, by knocking out specific mRNAs and revealing the effects on the phenotype. In this study we have explored the viability of RNAi in Panagrolaimus sp. DAW1. In the first trial, nematodes were fed E. coli expressing Panagrolaimus sp. DAW1 dsRNA of the embryonic lethal genes rps-2 and dhc, and the blister gene duox. Pd-rps-2(RNAi)-treated nematodes showed a significant decrease in larval hatching. However, qPCR showed no significant decrease in the amount of rps-2 mRNA in Pd-rps-2(RNAi)-treated animals. Several soaking protocols for dsRNA uptake were investigated using the fluorescent dye FITC. Desiccation-enhanced soaking showed the strongest uptake of FITC and resulted in a significant and consistent decrease of mRNA levels of two of the four tested genes (rps-2 and tps-2a), suggesting effective uptake of dsRNA-containing solution by the nematode. These findings suggest that RNAi by desiccation-enhanced soaking is viable in Panagrolaimus sp. DAW1 and provide the first functional genomic approach to investigate freezing tolerance in this non-model organism. RNAi, in conjunction with qPCR, can be used to screen for candidate genes involved in intracellular freezing tolerance in Panagrolaimus sp. DAW1.	[Seybold, Anna C.; Marshall, Craig J.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Wharton, David A.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Thorne, Michael A. S.] NERC, British Antarctic Survey, Cambridge, England; [Marshall, Craig J.] Univ Otago, Genet Otago, Dunedin, New Zealand	University of Otago; University of Otago; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Otago	Marshall, CJ (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.; Marshall, CJ (corresponding author), Univ Otago, Genet Otago, Dunedin, New Zealand.	craig.marshall@otago.ac.nz	Marshall, Craig J./C-6668-2009	Marshall, Craig J./0000-0003-4186-0368; Thorne, Michael/0000-0001-7759-612X	NERC [bas0100036] Funding Source: UKRI; Natural Environment Research Council [bas0100036] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agrawal N, 2003, MICROBIOL MOL BIOL R, V67, P657, DOI 10.1128/MMBR.67.4.657-685.2003; [Anonymous], 2021, LANG ENV STAT COMP; Barrett J, 2001, INT J BIOCHEM CELL B, V33, P105, DOI 10.1016/S1357-2725(00)00083-2; Bretz F., 2016, MULTIPLE COMP USING; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Dalzell JJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001176; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Flegg JIM, 1970, USDA TECHNICAL B, P5; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Geldhof P, 2006, INT J PARASITOL, V36, P801, DOI 10.1016/j.ijpara.2005.12.004; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kushwaha S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001770; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; Lendner M, 2008, MOL BIOCHEM PARASIT, V161, P21, DOI 10.1016/j.molbiopara.2008.06.003; Lewis SC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-15; Lopez-Martinez G, 2012, J MED ENTOMOL, V49, P215, DOI 10.1603/ME11122; Moens M, 2011, MOL PHYSL BASIS NEMA, DOI [10.1079/9781845936877.0000, DOI 10.1079/9781845936877.0000]; Park JE, 2008, MOL CELLS, V26, P81; Pellerone FI, 2003, INT J PARASITOL, V33, P1195, DOI 10.1016/S0020-7519(03)00173-5; Raymond MR, 2014, ANTARCT SCI, V26, P15, DOI 10.1017/S0954102013000230; Raymond MR, 2013, ANTARCT SCI, V25, P347, DOI 10.1017/S0954102012001162; Shannon AJ, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-58; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Tan JACH, 2013, EXP PARASITOL, V133, P166, DOI 10.1016/j.exppara.2012.11.011; Thorne MAS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104526; Visser A, 2006, PARASITOLOGY, V133, P777, DOI 10.1017/S0031182006001004; WHARTON DA, 1995, J EXP BIOL, V198, P1381; WHARTON DA, 1989, NEW ZEAL J ZOOL, V16, P467, DOI 10.1080/03014223.1989.10422914; Wharton DA, 2005, CRYOBIOLOGY, V51, P198, DOI 10.1016/j.cryobiol.2005.07.001; Wharton DA, 2005, CRYOBIOLOGY, V50, P21, DOI 10.1016/j.cryobiol.2004.09.004; Wharton DA, 2003, J EXP BIOL, V206, P215, DOI 10.1242/jeb.00083; WHARTON DA, 1993, FUND APPL NEMATOL, V16, P17; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Witte H, 2015, DEV GENES EVOL, V225, P55, DOI 10.1007/s00427-014-0486-8; Xie B-Y, 2010, NEMATOLOGY, V12, P225, DOI [10.1163/138855409X12469541205044, DOI 10.1163/138855409X12469541205044]; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	39	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166228	10.1371/journal.pone.0166228	http://dx.doi.org/10.1371/journal.pone.0166228			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832164	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000079
J	Tang, CY; Wang, B				Tang, Chaoying; Wang, Biao			A No-Reference Adaptive Blockiness Measure for JPEG Compressed Images	PLOS ONE			English	Article							QUALITY ASSESSMENT	Digital images have been extensively used in education, research, and entertainment. Many of these images, taken by consumer cameras, are compressed by the JPEG algorithm for effective storage and transmission. Blocking artifact is a well-known problem caused by this algorithm. Effective measurement of blocking artifacts plays an important role in the design, optimization, and evaluation of image compression algorithms. In this paper, we propose a no-reference objective blockiness measure, which is adaptive to high frequency component in an image. Difference of entropies across blocks and variation of block boundary pixel values in edge images are adopted to calculate the blockiness level in areas with low and high frequency component, respectively. Extensive experimental results prove that the proposed measure is effective and stable across a wide variety of images. It is robust to image noise and can be used for real-world image quality monitoring and control. Index Terms-JPEG, no-reference, blockiness measure	[Tang, Chaoying; Wang, Biao] Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China	Nanjing University of Aeronautics & Astronautics	Tang, CY (corresponding author), Nanjing Univ Aeronaut & Astronaut, Coll Automat Engn, Nanjing, Jiangsu, Peoples R China.	cytang@nuaa.edu.cn			National Natural Science Foundation of China [61403196]; Natural Science Foundation of Jiangsu Province [BK20140837]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133218120018]; Fundamental Research Funds for the Central Universities [NS2014030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (61403196), the Natural Science Foundation of Jiangsu Province (BK20140837), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133218120018), and the Fundamental Research Funds for the Central Universities (NS2014030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (61403196), the Natural Science Foundation of Jiangsu Province (BK20140837), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20133218120018), and the Fundamental Research Funds for the Central Universities (NS2014030).	Bovik AC, 2001, INT CONF ACOUST SPEE, P1725, DOI 10.1109/ICASSP.2001.941272; Chandler DM, 2007, IEEE T IMAGE PROCESS, V16, P2284, DOI 10.1109/TIP.2007.901820; Chen CH, 2010, LECT NOTES COMPUT SC, V6297, P112, DOI 10.1007/978-3-642-15702-8_11; Freitas PG, 2016, 2016 EIGHTH INTERNATIONAL CONFERENCE ON QUALITY OF MULTIMEDIA EXPERIENCE (QOMEX); Golestaneh S. Alireza, 2014, IEEE Signal Processing Letters, V21, P155, DOI 10.1109/LSP.2013.2296038; Horita Y., MICT IMAGE QUALITY E; Larson E., CATEGORICAL IMAGE QU; Lee S, 2012, SIGNAL PROCESS-IMAGE, V27, P31, DOI 10.1016/j.image.2011.08.002; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P918, DOI 10.1109/LSP.2014.2320743; Li LD, 2014, IEEE SIGNAL PROC LET, V21, P122, DOI 10.1109/LSP.2013.2294333; Li YM, 2015, NEUROCOMPUTING, V154, P94, DOI 10.1016/j.neucom.2014.12.015; Liu H, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/263540; Liu LX, 2014, SIGNAL PROCESS-IMAGE, V29, P856, DOI 10.1016/j.image.2014.06.006; Liu LX, 2014, SIGNAL PROCESS-IMAGE, V29, P494, DOI 10.1016/j.image.2014.02.004; Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050; Moorthy AK, 2009, IEEE J-STSP, V3, P193, DOI 10.1109/JSTSP.2009.2015374; Ninassi A., SUBJECTIVEJ QUALITY; Pan F, 2007, MULTIDIM SYST SIGN P, V18, P297, DOI 10.1007/s11045-006-0008-6; Perra C., 2005, P IEEE INT C IM PROC, P389, DOI [DOI 10.1109/ICIP.2005.1529769, 10.1109/ICIP.2005.1529769]; Ponomarenko N., 2009, ADV MOD RADIOELECTRO, V10, P30; Ponomarenko N, 2015, SIGNAL PROCESS-IMAGE, V30, P57, DOI 10.1016/j.image.2014.10.009; Ren YL, 2015, LECT NOTES COMPUT SC, V9242, P472, DOI 10.1007/978-3-319-23989-7_48; Sheikh H.R., LIVE IMAGE QUALITY A; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2002, IEEE IMAGE PROC, P477; Wang Z, 2002, IEEE SIGNAL PROC LET, V9, P81, DOI 10.1109/97.995823; Wang Z, 2000, 2000 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL III, PROCEEDINGS, P981, DOI 10.1109/ICIP.2000.899622; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Ye P, 2012, PROC CVPR IEEE, P1098, DOI 10.1109/CVPR.2012.6247789	29	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165664	10.1371/journal.pone.0165664	http://dx.doi.org/10.1371/journal.pone.0165664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832092	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000023
J	Anelone, AJN; Spurgeon, SK				Anelone, Anet J. N.; Spurgeon, Sarah K.			Modelling and Simulation of the Dynamics of the Antigen-Specific T Cell Response Using Variable Structure Control Theory	PLOS ONE			English	Article							INFECTION; PROLIFERATION; CONTRACTION; TOLERANCE	Experimental and mathematical studies in immunology have revealed that the dynamics of the programmed T cell response to vigorous infection can be conveniently modelled using a sigmoidal or a discontinuous immune response function. This paper hypothesizes strong synergies between this existing work and the dynamical behaviour of engineering systems with a variable structure control (VSC) law. These findings motivate the interpretation of the immune system as a variable structure control system. It is shown that dynamical properties as well as conditions to analytically assess the transition from health to disease can be developed for the specific T cell response from the theory of variable structure control. In particular, it is shown that the robustness properties of the specific T cell response as observed in experiments can be explained analytically using a VSC perspective. Further, the predictive capacity of the VSC framework to determine the T cell help required to overcome chronic Lymphocytic Choriomeningitis Virus (LCMV) infection is demonstrated. The findings demonstrate that studying the immune system using variable structure control theory provides a new framework for evaluating immunological dynamics and experimental observations. A modelling and simulation tool results with predictive capacity to determine how to modify the immune response to achieve healthy outcomes which may have application in drug development and vaccine design.	[Anelone, Anet J. N.; Spurgeon, Sarah K.] Univ Kent, Sch Engn & Digital Arts, Canterbury CT2 7NT, Kent, England	University of Kent	Spurgeon, SK (corresponding author), Univ Kent, Sch Engn & Digital Arts, Canterbury CT2 7NT, Kent, England.	S.Spurgeon@ucl.ac.uk	Spurgeon, Sarah/C-3192-2016	Spurgeon, Sarah/0000-0003-3451-0650	Ministry of Higher Education and Scientific Research of the Republic of Cote d'Ivoire; EPSRC [EP/J018295/1]; Engineering and Physical Sciences Research Council [EP/J018295/1] Funding Source: researchfish	Ministry of Higher Education and Scientific Research of the Republic of Cote d'Ivoire; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AJNA was funded by a scholarship from The Ministry of Higher Education and Scientific Research of the Republic of Cote d'Ivoire. This grant contributed to the payment of his PhD tuition fees and living expenses to work on the immune system and this work will be returned as an output of his doctoral research. SKS was funded by an EPSRC (https://www.epsrc.ac.uk/) Research Grant reference number EP/J018295/1 entitled Finite time orbitally stabilizing synthesis of complex dynamic systems with bifurcations with application to biological systems. This grant contributed to the payment of her salary to work on the immune system and this work will be returned as an output of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HK, 2011, B MATH BIOL, V73, P33, DOI 10.1007/s11538-010-9519-2; Althaus CL, 2007, J IMMUNOL, V179, P2944, DOI 10.4049/jimmunol.179.5.2944; Althaus CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016468; Anelone AJN., 2014, P 19 IFAC WORLD C 24; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Badovinac VP, 2003, J IMMUNOL, V170, P4933, DOI 10.4049/jimmunol.170.10.4933; Badovinac VP, 2002, NAT IMMUNOL, V3, P619, DOI 10.1038/ni804; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; BURTON JA, 1986, INT J SYST SCI, V17, P875, DOI 10.1080/00207728608926853; Chang H, 2007, DEC CONTR 2007 46 IE, P3919; De Boer RJ, 2003, J IMMUNOL, V171, P3928, DOI 10.4049/jimmunol.171.8.3928; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Boer RJ, 2013, J THEOR BIOL, V327, P45, DOI 10.1016/j.jtbi.2012.12.025; De Boer RJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002593; DEBOER RJ, 1995, J THEOR BIOL, V175, P567, DOI 10.1006/jtbi.1995.0165; Edwards C., 1998, SLIDING MODE CONTROL; Ganusov VV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015959; Iwami S, 2007, J THEOR BIOL, V246, P646, DOI 10.1016/j.jtbi.2007.01.020; Jones LE, 2005, B MATH BIOL, V67, P1227, DOI 10.1016/j.bulm.2005.01.006; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Khalil H. K., 2002, NONLINEAR SYSTEMS 3, V3rd; Kim PS, 2010, B MATH BIOL, V72, P611, DOI 10.1007/s11538-009-9463-1; Kirschner DE., 1997, J THEORETICAL MED, V1, P25, DOI DOI 10.1080/10273669708833004; Levy D., 2013, MATH METHODS MODELS, V257, P33; Martin MD, 2012, J IMMUNOL, V188, P1255, DOI 10.4049/jimmunol.1101579; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Peet M, 2011, IEEE DECIS CONTR P, P3020, DOI 10.1109/CDC.2011.6161395; Porter BB, 2006, INFECT IMMUN, V74, P1528, DOI 10.1128/IAI.74.3.1528-1536.2006; Ribeiro RM, 2010, J VIROL, V84, P6096, DOI 10.1128/JVI.00127-10; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Utkin V., 1977, IEEE T CONTR SYST T, V10, P780; Veiga-Parga T, 2013, IMMUNOL REV, V255, P182, DOI 10.1111/imr.12085; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wilson S, 2013, B MATH BIOL, V75, P1891, DOI 10.1007/s11538-013-9875-9; Wirth TC, 2011, EUR J IMMUNOL, V41, P1321, DOI 10.1002/eji.201040730; Zurakowski R, 2006, J THEOR BIOL, V238, P368, DOI 10.1016/j.jtbi.2005.05.004	37	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166163	10.1371/journal.pone.0166163	http://dx.doi.org/10.1371/journal.pone.0166163			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861537	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300031
J	Kwok, J; Choi, LCW; Ho, JCY; Chan, GSW; Mok, MMY; Lam, MF; Chak, WL; Cheuk, A; Chau, KF; Tong, M; Chan, KW; Chan, TM				Kwok, Janette; Choi, Leo C. W.; Ho, Jenny C. Y.; Chan, Gavin S. W.; Mok, Maggie M. Y.; Lam, Man-Fei; Chak, Wai-Leung; Cheuk, Au; Chau, Ka-Foon; Tong, Matthew; Chan, Kwok-Wah; Chan, Tak-Mao			A Modified Protocol with Improved Detection Rate for Mis-Matched Donor HLA from Low Quantities of DNA in Urine Samples from Kidney Graft Recipients	PLOS ONE			English	Article							HONG-KONG; TRANSPLANT RECIPIENTS; PERSPECTIVE; MANAGEMENT; TISSUE; TOOL	Background Urine from kidney transplant recipient has proven to be a viable source for donor DNA. However, an optimized protocol would be required to determine mis-matched donor HLA specificities in view of the scarcity of DNA obtained in some cases. Methods In this study, fresh early morning urine specimens were obtained from 155 kidney transplant recipients with known donor HLA phenotype. DNA was extracted and typing of HLA-A, B and DRB1 loci by polymerase chain reaction-specific sequence primers was performed using tailor-made condition according to the concentration of extracted DNA. Results HLA typing of DNA extracted from urine revealed both recipient and donor HLA phenotypes, allowing the deduction of the unknown donor HLA and hence the degree of HLA mis-match. By adopting the modified procedures, mis-matched donor HLA phenotypes were successfully deduced in all of 35 tested urine samples at DNA quantities spanning the range of 620-24,000 ng. Conclusions This urine-based method offers a promising and reliable non-invasive means for the identification of mis-matched donor HLA antigens in kidney transplant recipients with unknown donor HLA phenotype or otherwise inadequate donor information.	[Kwok, Janette; Choi, Leo C. W.; Ho, Jenny C. Y.] Queen Mary Hosp, Dept Pathol, Div Transplantat & Immunogenet, Hong Kong, Hong Kong, Peoples R China; [Chan, Gavin S. W.] Queen Mary Hosp, Dept Pathol, Div Anat Pathol, Hong Kong, Hong Kong, Peoples R China; [Mok, Maggie M. Y.; Lam, Man-Fei; Chan, Tak-Mao] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Chak, Wai-Leung; Chau, Ka-Foon] Queen Elizabeth Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Cheuk, Au; Tong, Matthew] Princess Margaret Hosp, Dept Med & Geriatr, Hong Kong, Hong Kong, Peoples R China; [Chan, Kwok-Wah] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	Kwok, J (corresponding author), Queen Mary Hosp, Dept Pathol, Div Transplantat & Immunogenet, Hong Kong, Hong Kong, Peoples R China.	kwoksy@ha.org.hk	kwok, Janette/K-2485-2019	Chan, Tak Mao/0000-0002-3495-4051	Division of Transplantation and Immunogenetics, Department of Pathology, Queen Mary Hospital, Hong Kong; Division of Anatomical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong; Department of Medicine, The University of Hong Kong, Hong Kong; Department of Medicine, Queen Elizabeth Hospital, Hong Kong; Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong; Department of Pathology, The University of Hong Kong, Hong Kong	Division of Transplantation and Immunogenetics, Department of Pathology, Queen Mary Hospital, Hong Kong; Division of Anatomical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong; Department of Medicine, The University of Hong Kong, Hong Kong; Department of Medicine, Queen Elizabeth Hospital, Hong Kong; Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong; Department of Pathology, The University of Hong Kong, Hong Kong	This work was supported by: 1) Division of Transplantation and Immunogenetics, Department of Pathology, Queen Mary Hospital, Hong Kong; 2) Division of Anatomical Pathology, Department of Pathology, Queen Mary Hospital, Hong Kong; 3) Department of Medicine, The University of Hong Kong, Hong Kong; 4) Department of Medicine, Queen Elizabeth Hospital, Hong Kong; 5) Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong; and 6) Department of Pathology, The University of Hong Kong, Hong Kong.	Chan AKC, 2003, ANN CLIN BIOCHEM, V40, P122, DOI 10.1258/000456303763046030; Chan GSW, 2012, HISTOPATHOLOGY, V60, P1160, DOI 10.1111/j.1365-2559.2012.04215.x; Chan TM, 2002, TRANSPLANT P, V34, P2558, DOI 10.1016/S0041-1345(02)03423-1; Eckels DD, 2008, INT J IMMUNOGENET, V35, P265, DOI 10.1111/j.1744-313X.2008.00768.x; Hernandez-Fuentes MP, 2003, IMMUNOL REV, V196, P247, DOI 10.1046/j.1600-065X.2003.00092.x; Ho YW, 2008, PERITON DIALYSIS INT, V28, pS12; Kwok J, 2010, CLIN TRANSPLANT, V24, pE178, DOI 10.1111/j.1399-0012.2010.01246.x; Leung SSH, 2007, J CLIN NURS, V16, P341, DOI 10.1111/j.1365-2702.2007.02070.x; Mizutani K, 2007, AM J TRANSPLANT, V7; Srikantha M, 2008, KIDNEY INT, V74, P952, DOI 10.1038/ki.2008.340; Su YH, 2004, ANN NY ACAD SCI, V1022, P81, DOI 10.1196/annals.1318.014; Walsh P S, 1992, PCR Methods Appl, V1, P241, DOI 10.1101/gr.1.4.241; Zhang ZH, 2002, CLIN TRANSPLANT, V16, P45, DOI 10.1034/j.1399-0012.16.s8.9.x	13	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166427	10.1371/journal.pone.0166427	http://dx.doi.org/10.1371/journal.pone.0166427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861530	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300055
J	Templeton, EM; Stanton, MV; Zaki, J				Templeton, Emma M.; Stanton, Michael V.; Zaki, Jamil			Social Norms Shift Preferences for Healthy and Unhealthy Foods	PLOS ONE			English	Article							EATING BEHAVIOR; UNITED-STATES; CONFORMITY; OBESITY; ENVIRONMENT; PERSPECTIVE; CONSUMPTION; KNOWLEDGE; REASONS; GENDER	This research investigated whether people change their food preferences and eating behavior in response to health-based social norms. One hundred twenty participants rated a series of healthy and unhealthy food images. After each rating, participants sometimes viewed a rating that ostensibly represented the average rating of previous participants. In fact, these average ratings were manipulated to convey a particular social norm. Participants either saw average ratings that favored healthy foods, favored unhealthy foods, or did not see any average ratings. Participants then re-rated those same food images after approximately ten minutes and again three days later. After the norm manipulation, participants were given the chance to take as many M&Ms as they wanted. Participants exposed to a healthy social norm consistently reported lower preferences for unhealthy foods as compared to participants in the other two conditions. This preference difference persisted three days after the social norm manipulation. However, health-based social norm manipulations did not influence the amount of M&Ms participants took. Although health-based social norm manipulations can influence stated food preferences, in this case they did not influence subsequent eating behavior.	[Templeton, Emma M.] Dartmouth, Dept Psychol & Brain Sci, Hanover, NH USA; [Stanton, Michael V.] Calif State Univ East Bay, Hlth Sci Program, Hayward, CA USA; [Zaki, Jamil] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Dartmouth College; California State University System; California State University East Bay; Stanford University	Zaki, J (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	jzaki@stanford.edu	Templeton, Emma/AAM-7305-2021	Templeton, Emma/0000-0003-1297-6150; Stanton, Michael/0000-0002-8142-6569	United States Army [W911NF-14-1-0001]	United States Army(United States Department of DefenseUnited States Army)	This work was funded in part by the United States Army grant #W911NF-14-1-0001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2003, J PERS SOC PSYCHOL, V84, P18, DOI 10.1037/0022-3514.84.1.18; Ares G, 2008, APPETITE, V51, P663, DOI 10.1016/j.appet.2008.05.061; Bewick BM, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1461; Birnholz Z, 2015, THE STANFORD DAILY; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Carels RA, 2006, APPETITE, V46, P199, DOI 10.1016/j.appet.2005.12.002; Cavallo D A, 2001, Eat Behav, V2, P113, DOI 10.1016/S1471-0153(01)00023-X; CHEADLE A, 1991, PREV MED, V20, P250, DOI 10.1016/0091-7435(91)90024-X; Cialdini R. B., 1998, HDB SOCIAL PSYCHOL, P151; Cialdini RB, 2004, ANNU REV PSYCHOL, V55, P591, DOI 10.1146/annurev.psych.55.090902.142015; Dominguez LJ, 2020, ENCYCLOPEDIA OF BIOMEDICAL GERONTOLOGY, VOL 2, P400, DOI 10.1016/B978-0-12-801238-3.62178-5; Feeney JR, 2011, EAT BEHAV, V12, P75, DOI 10.1016/j.eatbeh.2010.09.007; Fisher BD, 1999, AM J PUBLIC HEALTH, V89, P235, DOI 10.2105/AJPH.89.2.235; Garbinsky EN, 2014, APPETITE, V72, P59, DOI 10.1016/j.appet.2013.09.025; Gerber AS, 2009, J POLIT, V71, P178, DOI 10.1017/S0022381608090117; Harnack L, 1997, J AM DIET ASSOC, V97, P957, DOI 10.1016/S0002-8223(97)00231-9; Hermans RCJ, 2009, APPETITE, V52, P801, DOI 10.1016/j.appet.2009.03.008; Huang Y, 2014, PSYCHOL SCI, V25, P1388, DOI 10.1177/0956797614532104; Jacobson RP, 2011, J PERS SOC PSYCHOL, V100, P433, DOI 10.1037/a0021470; King GA, 1987, FOOD PERCEPTION DIET, P147; Klucharev V, 2009, NEURON, V61, P140, DOI 10.1016/j.neuron.2008.11.027; LAMBERT K G, 1991, Current Psychology, V10, P297, DOI 10.1007/BF02686902; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; MOOK DG, 1992, APPETITE, V18, P69, DOI 10.1016/0195-6663(92)90211-N; MORI D, 1987, J PERS SOC PSYCHOL, V53, P693, DOI 10.1037/0022-3514.53.4.693; Morland KB, 2009, HEALTH PLACE, V15, P491, DOI 10.1016/j.healthplace.2008.09.004; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; Nook EC, 2015, J COGNITIVE NEUROSCI, V27, P1412, DOI 10.1162/jocn_a_00795; Perkins HW, 2002, J STUD ALCOHOL, P164, DOI 10.15288/jsas.2002.s14.164; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; Robinson E, 2015, PHYSIOL BEHAV, V152, P397, DOI 10.1016/j.physbeh.2015.06.010; Robinson E, 2014, J ACAD NUTR DIET, V114, P414, DOI 10.1016/j.jand.2013.11.009; Robinson E, 2013, APPETITE, V65, P20, DOI 10.1016/j.appet.2013.01.010; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Salerno A, 2014, J CONSUM RES, V41, P135, DOI 10.1086/675299; Schnuerch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00669; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; Shestakova A, 2013, SOC COGN AFFECT NEUR, V8, P756, DOI 10.1093/scan/nss064; Smith JR, 2012, J ENVIRON PSYCHOL, V32, P353, DOI 10.1016/j.jenvp.2012.06.001; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Toelch U, 2015, TRENDS COGN SCI, V19, P579, DOI 10.1016/j.tics.2015.07.007; van Strien T, 2012, INT J EAT DISORDER, V45, P257, DOI 10.1002/eat.20940; Vartanian LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079268; Walton GM, 2014, CURR DIR PSYCHOL SCI, V23, P73, DOI 10.1177/0963721413512856; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wardle J, 2000, J NUTR KNOWLEDGE FOO, P269; Wellman NS, 2002, ASIA PAC J CLIN NUTR, V11, pS705, DOI 10.1046/j.1440-6047.11.s8.6.x; Zaki J, 2011, PSYCHOL SCI, V22, P894, DOI 10.1177/0956797611411057; Zylan KD, 1996, APPETITE, V26, P37, DOI 10.1006/appe.1996.0003	50	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166286	10.1371/journal.pone.0166286	http://dx.doi.org/10.1371/journal.pone.0166286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861518	Green Published, gold			2022-12-26	WOS:000388350300042
J	Liao, CC; Day, YJ; Lee, HC; Liou, JT; Chou, AH; Liu, FC				Liao, Chia-Chih; Day, Yuan-Ji; Lee, Hung-Chen; Liou, Jiin-Tarng; Chou, An-Hsun; Liu, Fu-Chao			Baicalin Attenuates IL-17-Mediated Acetaminophen-Induced Liver Injury in a Mouse Model	PLOS ONE			English	Article							GAMMA-DELTA-T; HEPATIC-INJURY; ORGAN INJURY; IN-VITRO; CELLS; INFLAMMATION; HEPATOTOXICITY; MICE; INTERLEUKIN-17; IL-17	Background IL-17 has been shown to be involved in liver inflammatory disorders in both mice and humans. Baicalin (BA), a major compound extracted from traditional herb medicine (Scutellariae radix), has potent hepatoprotective properties. Previous study showed that BA inhibits IL-17-mediated lymphocyte adhesion and downregulates joint inflammation. The aim of this study is to investigate the role of IL-17 in the hepatoprotective effects of BA in an acetaminophen (APAP)-induced liver injury mouse model. Methods Eight weeks male C57BL/6 (B6) mice were used for this study. Mice received intraperitoneal hepatotoxic injection of APAP (300 mg/kg) and after 30 min of injection, the mice were treated with BA at a concentration of 30 mg/kg. After 16 h of treatment, mice were killed. Blood samples and liver tissues were harvested for analysis of liver injury parameters. Results APAP overdose significantly increased the serum alanine transferase (ALT) levels, hepatic activities of myeloperoxidase (MPO), expression of cytokines (TNF-alpha, IL-6, and IL-17), and malondialdehyde (MDA) activity when compared with the control animals. BA treatment after APAP administration significantly attenuated the elevation of these parameters in APAP-induced liver injury mice. Furthermore, BA treatment could also decrease hepatic IL 17 -producing y delta T cells recruitment, which was induced after APAP overdose. Conclusion Our data suggested that baicalin treatment could effectively decrease APAP-induced liver injury in part through attenuation of hepatic IL-17 expression. These results indicate that baicalin is a potential hepatoprotective agent.	[Liao, Chia-Chih; Day, Yuan-Ji; Lee, Hung-Chen; Liou, Jiin-Tarng; Chou, An-Hsun; Liu, Fu-Chao] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Liao, Chia-Chih; Day, Yuan-Ji; Lee, Hung-Chen; Liou, Jiin-Tarng; Chou, An-Hsun; Liu, Fu-Chao] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Liao, Chia-Chih; Day, Yuan-Ji; Lee, Hung-Chen] Chang Gung Univ, Grad Inst Clin Med Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Liu, FC (corresponding author), Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan.; Liu, FC (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.	ana5189@cgmh.org.tw	Liu, Fu-Chao/AAB-3780-2021	Liu, F-C/0000-0003-1712-4053	National Science Council [NSC103-2314-B-182-046-MY2]; Chang Gung Memorial Hospital [CMRPG3E1542, CMRPG3B1391]	National Science Council(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported in part by grants from the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1542) to Fu-Chao Liu and Chang Gung Memorial Hospital (CMRPG3B1391) to Chia-Chih Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants from the National Science Council (NSC103-2314-B-182-046-MY2) and Chang Gung Memorial Hospital (CMRPG3E1542 and CMRPG3F1011) to Fu-Chao Liu and Chang Gung Memorial Hospital (CMRPG3B1391) to Chia-Chih Liao.	Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bunchorntavakul C, 2013, CLIN LIVER DIS, V17, P587, DOI 10.1016/j.cld.2013.07.005; Caldwell CC, 2005, AM J PHYSIOL-GASTR L, V289, pG969, DOI 10.1152/ajpgi.00223.2005; Cao YG, 2011, BRAIN RES BULL, V85, P396, DOI 10.1016/j.brainresbull.2011.05.002; Cui L, 2014, INT IMMUNOPHARMACOL, V23, P294, DOI 10.1016/j.intimp.2014.09.005; Dai SX, 2012, PHYTOTHER RES, V26, P498, DOI 10.1002/ptr.3581; Fouser LA, 2008, IMMUNOL REV, V226, P87, DOI 10.1111/j.1600-065X.2008.00712.x; Hammerich L, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/345803; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; Kim SJ, 2012, TOXICOL APPL PHARM, V258, P43, DOI 10.1016/j.taap.2011.10.005; Kobayashi E, 2009, TOXICOL SCI, V111, P302, DOI 10.1093/toxsci/kfp165; Kono H, 2011, J IMMUNOL, V187, P4818, DOI 10.4049/jimmunol.1100490; Laan M, 2001, BRIT J PHARMACOL, V133, P200, DOI 10.1038/sj.bjp.0704063; Lafdil F, 2010, CELL MOL IMMUNOL, V7, P250, DOI 10.1038/cmi.2010.5; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee W, 2015, INFLAMMATION, V38, P110, DOI 10.1007/s10753-014-0013-0; Lemmers A, 2009, HEPATOLOGY, V49, P646, DOI 10.1002/hep.22680; Li BQ, 2000, IMMUNOPHARMACOLOGY, V49, P295, DOI 10.1016/S0162-3109(00)00244-7; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Lo Re S, 2010, J IMMUNOL, V184, P6367, DOI 10.4049/jimmunol.0900459; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; McGill MR, 2012, J CLIN INVEST, V122, P1574, DOI 10.1172/JCI59755; Mendes-Braz M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/298657; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Park SW, 2008, J PHARMACOL SCI, V106, P136, DOI 10.1254/jphs.FP0071392; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Roark CL, 2007, J IMMUNOL, V179, P5576, DOI 10.4049/jimmunol.179.8.5576; Shibata K, 2007, J IMMUNOL; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Tseng CTK, 2001, HEPATOLOGY, V33, P1312, DOI 10.1053/jhep.2001.24269; Turner JE, 2012, J AM SOC NEPHROL, V23, P1486, DOI 10.1681/ASN.2012010040; Umemura M, 2004, INT IMMUNOL, V16, P1099, DOI 10.1093/intimm/dxh111; Wang HF, 2016, CELL PHYSIOL BIOCHEM, V39, P1129, DOI 10.1159/000447820; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Williams CD, 2010, LIVER INT, V30, P1280, DOI 10.1111/j.1478-3231.2010.02284.x; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Xue YQ, 2015, J PHARM PHARMACOL, V67, P1756, DOI 10.1111/jphp.12484; Yang X, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/268065; Zambon A, 2006, ARTERIOSCL THROM VAS, V26, P977, DOI 10.1161/01.ATV.0000204327.96431.9a; Zhang Y, 2012, EUR J PHARMACOL, V680, P95, DOI 10.1016/j.ejphar.2012.01.010	45	28	31	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166856	10.1371/journal.pone.0166856	http://dx.doi.org/10.1371/journal.pone.0166856			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855209	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200053
J	Taylor, WR; Matthews-Palmer, TRS; Beeby, M				Taylor, William R.; Matthews-Palmer, Teige R. S.; Beeby, Morgan			Molecular Models for the Core Components of the Flagellar Type-III Secretion Complex	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; SYSTEM EXPORT APPARATUS; BASAL BODY; SALMONELLA-ENTERICA; TERTIARY STRUCTURE; CRYSTAL-STRUCTURE; SEQUENCE; TOPOLOGY; ALGORITHM; ALIGNMENT	We show that by using a combination of computational methods, consistent three-dimensional molecular models can be proposed for the core proteins of the type-III secretion system. We employed a variety of approaches to reconcile disparate, and sometimes inconsistent, data sources into a coherent picture that for most of the proteins indicated a unique solution to the constraints. The range of difficulty spanned from the trivial (FliQ) to the difficult (FlhA and FliP). The uncertainties encountered with FlhA were largely the result of the greater number of helix packing possibilities allowed in a large protein, however, for FliP, there remains an uncertainty in how to reconcile the large displacement predicted between its two main helical hairpins and their ability to sit together happily across the bacterial membrane. As there is still no high resolution structural information on any of these proteins, we hope our predicted models may be of some use in aiding the interpretation of electron microscope images and in rationalising mutation data and experiments.	[Taylor, William R.; Matthews-Palmer, Teige R. S.] Francis Crick Inst, Lab Computat Cell & Mol Biol, 1 Midland Rd, London NW1 1AT, England; [Matthews-Palmer, Teige R. S.; Beeby, Morgan] Imperial Coll, Dept Life Sci, London, England	Francis Crick Institute; Imperial College London	Taylor, WR (corresponding author), Francis Crick Inst, Lab Computat Cell & Mol Biol, 1 Midland Rd, London NW1 1AT, England.	william.taylor@crick.ac.uk	Beeby, Morgan/G-2768-2013	Beeby, Morgan/0000-0001-6413-9835; Matthews-Palmer, Teige/0000-0003-1119-0033	Francis Crick Institute (Cancer Research UK) [FC001179]; Francis Crick Institute (UK Medical Research Council) [FC001179]; Francis Crick Institute (Wellcome Trust) [FC001179]; Imperial College London; Marie Curie Career Integration Grant [630988]; The Francis Crick Institute [10179] Funding Source: researchfish	Francis Crick Institute (Cancer Research UK); Francis Crick Institute (UK Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute (Wellcome Trust); Imperial College London(General Electric); Marie Curie Career Integration Grant; The Francis Crick Institute	This work was supported by the Francis Crick Institute (which receives its core funding from Cancer Research UK (FC001179), the UK Medical Research Council (FC001179), and the Wellcome Trust (FC001179)) and Imperial College London, with additional support from the Marie Curie Career Integration Grant 630988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrusci P, 2013, NAT STRUCT MOL BIOL, V20, P99, DOI 10.1038/nsmb.2452; Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992; Aszodi A, 1997, COMPUT CHEM, V21, P13, DOI 10.1016/S0097-8485(96)00011-3; ASZODI A, 1994, BIOPOLYMERS, V34, P489, DOI 10.1002/bip.360340406; Bange G, 2010, P NATL ACAD SCI USA, V107, P11295, DOI 10.1073/pnas.1001383107; Barker CS, 2016, MOL MICROBIOL, V100, P278, DOI 10.1111/mmi.13315; Berger C, 2010, MICROBIOL-SGM, V156, P1963, DOI 10.1099/mic.0.039248-0; Bergeron JRC, 2015, STRUCTURE, V23, P161, DOI 10.1016/j.str.2014.10.021; Brown NP, 1996, COMPUT CHEM, V20, P359, DOI 10.1016/0097-8485(95)00062-3; Brown PN, 2005, J BACTERIOL, V187, P2890, DOI 10.1128/JB.187.8.2890-2902.2005; Chen SY, 2011, EMBO J, V30, P2972, DOI 10.1038/emboj.2011.186; COHEN FE, 1981, J MOL BIOL, V148, P253, DOI 10.1016/0022-2836(81)90538-6; COHEN FE, 1979, J MOL BIOL, V132, P275, DOI 10.1016/0022-2836(79)90260-2; Erhardt M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004800; Erhardt M, 2011, EMBO J, V30, P2948, DOI 10.1038/emboj.2011.185; Fan F, 1997, MOL MICROBIOL, V26, P1035, DOI 10.1046/j.1365-2958.1997.6412010.x; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022417; Hollup SM, 2011, COMPUT BIOL CHEM, V35, P174, DOI 10.1016/j.compbiolchem.2011.04.008; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Hu B, 2015, P NATL ACAD SCI USA, V20, P14116; Ibuki T, 2011, NAT STRUCT MOL BIOL, V18, P277, DOI 10.1038/nsmb.1977; Imada K, 2007, P NATL ACAD SCI USA, V104, P485, DOI 10.1073/pnas.0608090104; Imada K, 2016, P NATL ACAD SCI USA, V113, P3633, DOI 10.1073/pnas.1524025113; Jones DT, 2007, BIOINFORMATICS, V23, P538, DOI 10.1093/bioinformatics/btl677; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; KUNTZ ID, 1976, J MOL BIOL, V106, P983, DOI 10.1016/0022-2836(76)90347-8; Lee LK, 2010, NATURE, V466, P996, DOI 10.1038/nature09300; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Minamino T, 1999, J BACTERIOL, V181, P1388, DOI 10.1128/JB.181.5.1388-1394.1999; Minamino T, 2008, NATURE, V451, P485, DOI 10.1038/nature06449; Morimoto YV, 2014, MOL MICROBIOL, V91, P1214, DOI 10.1111/mmi.12529; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Nugent T, 2011, BIOINFORMATICS, V27, P1438, DOI 10.1093/bioinformatics/btr096; Nugent T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000714; Nugent T, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-159; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Paul K, 2008, NATURE, V451, P489, DOI 10.1038/nature06497; Rippmann F, 1991, J MOL GRAPHICS, V9, P3, DOI 10.1016/0263-7855(91)80005-K; Taylor W.R., 1993, METHOD ENZYMOL, V6, P593, DOI DOI 10.1093/PR0TEIN/6.6.593; Taylor WR, 2016, COMPUT BIOL CHEM, V64, P297, DOI 10.1016/j.compbiolchem.2016.06.007; Taylor WR, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1059-9; Taylor WR, 2016, ALGORITHM MOL BIOL, V11, DOI 10.1186/s13015-016-0080-x; Taylor WR, 2013, CURR OPIN STRUC BIOL, V23, P473, DOI 10.1016/j.sbi.2013.04.001; Taylor WR, 2009, STRUCTURE, V17, P1244, DOI 10.1016/j.str.2009.07.012; Taylor WR, 1999, PROTEIN SCI, V8, P654; TAYLOR WR, 1993, COMPUT CHEM, V17, P117, DOI 10.1016/0097-8485(93)85003-U; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; Taylor WR, 2001, J MOL BIOL, V310, P1135, DOI 10.1006/jmbi.2001.4817; TAYLOR WR, 1994, PROTEINS, V18, P281, DOI 10.1002/prot.340180309; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Worrall LJ, 2010, PROTEIN SCI, V19, P1091, DOI 10.1002/pro.382; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zilkenat S, 2016, MOL CELL PROTEOMICS, V15, P1598, DOI 10.1074/mcp.M115.056598	60	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0164047	10.1371/journal.pone.0164047	http://dx.doi.org/10.1371/journal.pone.0164047			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855178	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200004
J	de Souza, ACC; Moreira, TMM; de Oliveira, ES; de Menezes, AVB; Loureiro, AMO; Silva, CBD; Linard, JG; de Almeida, ILS; Mattos, SM; Borges, JWP				Caetano de Souza, Ana Celia; Magalhaes Moreira, Thereza Maria; de Oliveira, Edmar Souza; Bezerra de Menezes, Anaize Viana; Oliveira Loureiro, Aline Maria; de Araujo Silva, Camila Brasileiro; Linard, Jair Gomes; Sales de Almeida, Italo Lennon; Mattos, Samuel Miranda; Pereira Borges, Jose Wicto			Effectiveness of Educational Technology in Promoting Quality of Life and Treatment Adherence in Hypertensive People	PLOS ONE			English	Article							BLOOD-PRESSURE; OLMESARTAN; VALIDATION	The objective of this study was to test the effectiveness of an educational intervention with use of educational technology (flipchart) to promote quality of life (QOL) and treatment adherence in people with hypertension. It was an intervention study of before-and-after type conducted with 116 hypertensive people registered in Primary Health Care Units. The educational interventions were conducted using the flipchart educational technology. Quality of life was assessed through the MINICHAL (lowest score = better QOL) and the QATSH (higher score = better adherence) was used to assess the adherence to hypertension treatment. Both were measured before and after applying the intervention. In the analysis, we used the Student's t-test for paired data. The average baseline quality of life was 11.66 +/- 7.55, and 7.71 +/- 5.72 two months after the intervention, showing a statistically significant reduction (p < 0.001) and mean of differences of 3.95. The average baseline adherence to treatment was 98.03 +/- 7.08 and 100.71 +/- 6.88 two months after the intervention, which is statistically significant (p < 0.001), and mean of differences of 2.68. The conclusion was that the educational intervention using the flipchart improved the total score of quality of life in the scores of physical and mental domains, and increased adherence to hypertension treatment in people with the disease.	[Caetano de Souza, Ana Celia] Univ Fed Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Univ Estadual Ceara UECE, Unit Clin Pharmacol,Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil; [Magalhaes Moreira, Thereza Maria] Univ Estadual Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Postgrad Program Publ Hlth PPSAC, Fortaleza, Ceara, Brazil; [de Oliveira, Edmar Souza] Hosp Carlos Alberto Studart Gomes, Fortaleza, Ceara, Brazil; [Bezerra de Menezes, Anaize Viana] Univ Estadual Ceara UECE, Fortaleza, Ceara, Brazil; [Oliveira Loureiro, Aline Maria] Hosp Geral Fortaleza, Liver Transplant Unit, Fortaleza, Ceara, Brazil; [Magalhaes Moreira, Thereza Maria; de Araujo Silva, Camila Brasileiro; Linard, Jair Gomes] Univ Estadual Ceara, Postgrad Program Publ Hlth PPSAC, Fortaleza, Ceara, Brazil; [Sales de Almeida, Italo Lennon; Mattos, Samuel Miranda] Univ Estadual Ceara, Scholarship Sci Initiat, Fortaleza, Ceara, Brazil; [Pereira Borges, Jose Wicto] Univ Estadual Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Fortaleza, Ceara, Brazil; [Pereira Borges, Jose Wicto] Univ Fed Piaui, Postgrad Program Hlth & Community PPGSC, Teresina, Brazil; [Caetano de Souza, Ana Celia] Univ Fed Ceara, Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil	Universidade Estadual do Ceara; Universidade Federal do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Estadual do Ceara; Universidade Federal do Piaui; Universidade Federal do Ceara	de Souza, ACC (corresponding author), Univ Fed Ceara, Postgrad Program Clin Care Nursing & Hlth PPCCLIS, Univ Estadual Ceara UECE, Unit Clin Pharmacol,Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil.; de Souza, ACC (corresponding author), Univ Fed Ceara, Ctr Res & Dev Med NPDM, Fortaleza, Ceara, Brazil.	anaceliacs.doc@gmail.com	Mattos, Samuel Miranda/AAB-4099-2019; Borges, José Wicto Pereira/R-2705-2016; MOREIRA, THEREZA MARIA MAGALHÃES/D-1240-2014; de Almeida, Ítalo Lennon Sales/AAF-9559-2021	Mattos, Samuel Miranda/0000-0002-1837-9480; Borges, José Wicto Pereira/0000-0002-3292-1942; MOREIRA, THEREZA MARIA MAGALHÃES/0000-0003-1424-0649; de Almeida, Ítalo Lennon Sales/0000-0002-8013-8565				Bramlage P, 2010, EXPERT OPIN PHARMACO, V11, P2779, DOI 10.1517/14656566.2010.521499; Brasil. Ministerio da Sau A de. Secretaria de Atenc Saude, 2014, MIN SAUD CAD AT BAS, V38; Chin YR, 2014, ASIAN NURS RES, V8, P267, DOI 10.1016/j.anr.2014.10.002; da Silva PM, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0216-6; Doak CC, 1996, TEACHING PATIENTS LO; Houston TK, 2011, ANN INTERN MED, V154, P77, DOI 10.7326/0003-4819-154-2-201101180-00004; Lauziere Therese A, 2013, Can J Cardiovasc Nurs, V23, P12; Mahmoud MIH, 2012, J TAIBAH UNIV MED SC, V7, P92, DOI 10.1016/j.jtumed.2012.11.004; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; MARSHALL IJ, 2012, BMJ-BRIT MED J, V345, DOI DOI 10.1136/BMJ.E3953; Mohammadi Eesa, 2006, Int J Nurs Pract, V12, P153, DOI 10.1111/j.1440-172X.2006.00563.x; Montori VM, 2007, PLOS MED, V4, P1303, DOI 10.1371/journal.pmed.0040233; Rodrigues MTP, 2014, REV SAUDE PUBL, V48, P232, DOI 10.1590/S0034-8910.2014048005044; Parana A, SECRETARIA ESTADO ED; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Schmidt AC, 2008, EXPERT OPIN PHARMACO, V9, P1641, DOI 10.1517/14656566.9.10.1641 ; Schmieder RE, 2013, J HYPERTENS, V31, P610, DOI 10.1097/HJH.0b013e32835d6e53; Schulz Renata Berberi, 2008, Arq. Bras. Cardiol., V90, P139, DOI 10.1590/S0066-782X2008000200010; Schulz Ute, 2008, Psychol Health Med, V13, P423, DOI 10.1080/13548500701660442; Shibuya A, 2011, BLOOD PRESS MONIT, V16, P224, DOI 10.1097/MBP.0b013e32834af7ba; Souza ACC, 2015, THESIS; Souza Ana Célia Caetano de, 2014, Rev. esc. enferm. USP, V48, P944, DOI 10.1590/S0080-6234201400005000023; Talaei M, 2014, J HYPERTENS, V32, P30, DOI 10.1097/HJH.0b013e32836591d4; Radovanovic CAT, 2014, REV LAT-AM ENFERM, V22, P547, DOI 10.1590/0104-1169.3345.2450; Zyoud SH, 2013, INT J CARDIOL, V168, P2981, DOI 10.1016/j.ijcard.2013.04.105	25	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165311	10.1371/journal.pone.0165311	http://dx.doi.org/10.1371/journal.pone.0165311			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851752	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300013
J	Ishige-Wada, M; Kwon, SM; Eguchi, M; Hozumi, K; Iwaguro, H; Matsumoto, T; Fukuda, N; Mugishima, H; Masuda, H; Asahara, T				Ishige-Wada, Mika; Kwon, Sang-Mo; Eguchi, Masamichi; Hozumi, Katsuto; Iwaguro, Hideki; Matsumoto, Taro; Fukuda, Noboru; Mugishima, Hideo; Masuda, Haruchika; Asahara, Takayuki			Jagged-1 Signaling in the Bone Marrow Microenvironment Promotes Endothelial Progenitor Cell Expansion and Commitment of CD133(+) Human Cord Blood Cells for Postnatal Vasculogenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; VASCULAR DEVELOPMENT; EMBRYONIC LETHALITY; IN-VIVO; NOTCH1; LIGAND; EXPRESSION; NEOVASCULARIZATION; DIFFERENTIATION; ANGIOGENESIS	Notch signaling is involved in cell fate decisions during murine vascular development and hematopoiesis in the microenvironment of bone marrow. To investigate the close relationship between hematopoietic stem cells and human endothelial progenitor cells (EPCs) in the bone marrow niche, we examined the effects of Notch signals [Jagged-1 and Delta-like ligand (Dll)-1] on the proliferation and differentiation of human CD133(+) cell-derived EPCs. We established stromal systems using HESS-5 murine bone marrow cells transfected with human Jagged-1 (hJagged-1) or human Dll-1 (hDll-1). CD133(+) cord blood cells were co-cultured with the stromal cells for 7 days, and then their proliferation, differentiation, and EPC colony formation was evaluated. We found that hJagged-1 induced the proliferation and differentiation of CD133(+) cord blood EPCs. In contrast, hDll-1 had little effect. CD133(+) cells stimulated by hJagged-1 differentiated into CD31(+)/KDR+ cells, expressed vascular endothelial growth factor-A, and showed enhanced EPC colony formation compared with CD133(+) cells stimulated by hDll-1. To evaluate the angiogenic properties of hJagged-1-and hDll-1stimulated EPCs in vivo, we transplanted these cells into the ischemic hindlimbs of nude mice. Transplantation of EPCs stimulated by hJagged-1, but not hDll-1, increased regional blood flow and capillary density in ischemic hindlimb muscles. This is the first study to show that human Notch signaling influences EPC proliferation and differentiation in the bone marrow microenvironment. Human Jagged-1 induced the proliferation and differentiation of CD133(+) cord blood progenitors compared with hDll-1. Thus, hJagged-1 signaling in the bone marrow niche may be used to expand EPCs for therapeutic angiogenesis.	[Ishige-Wada, Mika; Kwon, Sang-Mo; Eguchi, Masamichi; Iwaguro, Hideki; Masuda, Haruchika; Asahara, Takayuki] Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan; [Ishige-Wada, Mika; Mugishima, Hideo] Nihon Univ, Sch Med, Dept Pediat & Child Hlth, Tokyo, Japan; [Hozumi, Katsuto] Tokai Univ, Sch Med, Dept Immunol, Isehara, Kanagawa, Japan; [Matsumoto, Taro] Nihon Univ, Sch Med, Div Cell Regenerat & Transplantat, Tokyo, Japan; [Fukuda, Noboru] Nihon Univ, Sch Med, Div Nephrol Hypertens & Endocrinol, Tokyo, Japan	Tokai University; Nihon University; Tokai University; Nihon University; Nihon University	Asahara, T (corresponding author), Tokai Univ, Sch Med, Dept Regenerat Med Sci, Isehara, Kanagawa, Japan.	asa777@is.icc.u-tokai.ac.jp		Fukuda, Noboru/0000-0003-0098-054X	Ministry of Education, Science, Sports, and Culture of Japan [19790542, 15K09603, 25461091]; Japan Agency for Medical Research and Development [15bk0104012h0003]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by a a grant from the Ministry of Education, Science, Sports, and Culture of Japan 19790542 to Dr Mika Ishige-Wada; a grant from the Ministry of Education, Science, Sports, and Culture of Japan 15K09603 to Dr Mika Ishige-Wada; a grant from the Ministry of Education, Science, Sports, and Culture of Japan 25461091 to Dr Haruchika Masada; a grant from Japan Agency for Medical Research and Development 15bk0104012h0003 to Dr Takayuki Asahara. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2000, EXP HEMATOL, V28, P690, DOI 10.1016/S0301-472X(00)00154-5; Aoki M, 2004, STEM CELLS, V22, P994, DOI 10.1634/stemcells.22-6-994; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Choi JH, 2004, J BIOL CHEM, V279, P49430, DOI 10.1074/jbc.M402088200; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hrabe DAM, 1997, NATURE, V386, P717, DOI DOI 10.1038/386717A0; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Iso T, 2003, ARTERIOSCL THROM VAS, V23, P543, DOI 10.1161/01.ATV.0000060892.81529.8F; Iwaguro H, 2002, CIRCULATION, V105, P732, DOI 10.1161/hc0602.103673; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamei N, 2012, J NEUROTRAUM, V29, P1758, DOI 10.1089/neu.2011.2139; Karanu FN, 2001, BLOOD, V97, P1960, DOI 10.1182/blood.V97.7.1960; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lassaletta AD, 2014, CIRC J, V78, P743, DOI 10.1253/circj.CJ-13-0685; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Masuda H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000743; Masuda H, 2011, CIRC RES, V109, P20, DOI 10.1161/CIRCRESAHA.110.231837; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Qian CF, 2009, INT J MOL MED, V24, P445, DOI 10.3892/ijmm_00000251; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Suzuki T, 2005, INT J HEMATOL, V82, P285, DOI 10.1532/IJH97.05115; Takeshita K, 2007, CIRC RES, V100, P70, DOI 10.1161/01.RES.0000254788.47304.6e; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Vercauteren SM, 2004, BLOOD, V104, P2315, DOI 10.1182/blood-2004-01-0204; Wada M, 2003, INT J HEMATOL, V77, P245, DOI 10.1007/BF02983781; Walker L, 2001, STEM CELLS, V19, P543, DOI 10.1634/stemcells.19-6-543	43	15	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166660	10.1371/journal.pone.0166660	http://dx.doi.org/10.1371/journal.pone.0166660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846321	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600100
J	Okano, J; Kojima, H; Katagi, M; Nakagawa, T; Nakae, Y; Terashima, T; Kurakane, T; Kubota, M; Maegawa, H; Udagawa, J				Okano, Junko; Kojima, Hideto; Katagi, Miwako; Nakagawa, Takahiko; Nakae, Yuki; Terashima, Tomoya; Kurakane, Takeshi; Kubota, Mamoru; Maegawa, Hiroshi; Udagawa, Jun			Hyperglycemia Induces Skin Barrier Dysfunctions with Impairment of Epidermal Integrity in Non-Wounded Skin of Type 1 Diabetic Mice	PLOS ONE			English	Article							STRATUM-CORNEUM; IN-VIVO; MELLITUS; CELLS; KERATINOCYTES; MODEL; FOOT; DIFFERENTIATION; SENSITIVITY; HOMEOSTASIS	Diabetes causes skin complications, including xerosis and foot ulcers. Ulcers complicated by infections exacerbate skin conditions, and in severe cases, limb/toe amputations are required to prevent the development of sepsis. Here, we hypothesize that hyperglycemia induces skin barrier dysfunction with alterations of epidermal integrity. The effects of hyperglycemia on the epidermis were examined in streptozotocin-induced diabetic mice with/without insulin therapy. The results showed that dye leakages were prominent, and transepidermal water loss after tape stripping was exacerbated in diabetic mice. These data indicate that hyperglycemia impaired skin barrier functions. Additionally, the distribution of the protein associated with the tight junction structure, tight junction protein-1 (ZO-1), was characterized by diffuse and significantly wider expression in the diabetic mice compared to that in the control mice. In turn, epidermal cell number was significantly reduced and basal cells were irregularly aligned with ultrastructural alterations in diabetic mice. In contrast, the number of corneocytes, namely, denucleated and terminally differentiated keratinocytes significantly increased, while their sensitivity to mechanical stress was enhanced in the diabetic mice. We found that cell proliferation was significantly decreased, while apoptotic cells were comparable in the skin of diabetic mice, compared to those in the control mice. In the epidermis, Keratin 5 and keratin 14 expressions were reduced, while keratin 10 and loricrin were ectopically induced in diabetic mice. These data suggest that hyperglycemia altered keratinocyte proliferation/differentiation. Finally, these phenotypes observed in diabetic mice were mitigated by insulin treatment. Reduction in basal cell number and perturbation of the proliferation/differentiation process could be the underlying mechanisms for impaired skin barrier functions in diabetic mice.	[Okano, Junko; Kurakane, Takeshi; Kubota, Mamoru; Udagawa, Jun] Shiga Univ Med Sci, Dept Anat & Cell Biol, Shiga, Japan; [Kojima, Hideto; Katagi, Miwako; Nakae, Yuki; Terashima, Tomoya] Shiga Univ Med Sci, Dept Stem Cell Biol, Shiga, Japan; [Kojima, Hideto; Katagi, Miwako; Nakae, Yuki; Terashima, Tomoya] Shiga Univ Med Sci, Dept Regenerat Med, Shiga, Japan; [Nakagawa, Takahiko] Nara Med Univ, Ind Acad Govt Collaborat Ctr, Nara, Japan; [Maegawa, Hiroshi] Shiga Univ Med Sci, Internal Med, Shiga, Japan	Shiga University of Medical Science; Shiga University of Medical Science; Shiga University of Medical Science; Nara Medical University; Shiga University of Medical Science	Okano, J (corresponding author), Shiga Univ Med Sci, Dept Anat & Cell Biol, Shiga, Japan.	jokano@belle.shiga-med.ac.jp		Maegawa, Hiroshi/0000-0002-4611-8149	Japanese Ministry of Education, Culture, Sports, Science and Technology [26462730]; Cosmetology Research Foundation; Astrazeneca	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Cosmetology Research Foundation; Astrazeneca(AstraZeneca)	Support was provided by Grant-in-aid from the Japanese Ministry of Education, Culture, Sports Science and Technology (26462730); Grant-in-aid from the Cosmetology Research Foundation; and Grant-in-aid from Astrazeneca.; We thank T. Yamamoto and Y. Mori for their technical assistance. This work was supported by a grant-in aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (no. 26462730 to JO), and grants in-aid from the Cosmetology Research Foundation and Astrazeneca to JO.	Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Alam H, 2011, MOL BIOL CELL, V22, P4068, DOI 10.1091/mbc.E10-08-0703; Bertheim U, 2002, ACTA DERM-VENEREOL, V82, P329, DOI 10.1080/000155502320624041; Bognar P, 2014, J INVEST DERMATOL, V134, P105, DOI 10.1038/jid.2013.307; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Chen XF, 2010, EXP DERMATOL, V19, P1088, DOI 10.1111/j.1600-0625.2010.01137.x; Eaglstein WH, 2009, ARCH DERMATOL, V145, P467, DOI 10.1001/archdermatol.2009.31; Farage M.A., 2017, TXB AGING SKIN, V2nd ed.; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Geerlings SE, 2000, ADV EXP MED BIOL, V485, P309; Geng SM, 2006, J CELL SCI, V119, P4901, DOI 10.1242/jcs.03282; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Hamilton MA, 2013, J AOAC INT, V96, P1138, DOI 10.5740/jaoacint.12-217; Harel A, 2002, BIOCHEM PHARMACOL, V63, P171, DOI 10.1016/S0006-2952(01)00847-4; Holzmann S, 2004, J INVEST DERMATOL, V122, P1165, DOI 10.1111/j.0022-202X.2004.22520.x; Indra AK, 2011, METHODS MOL BIOL, V763, P73, DOI 10.1007/978-1-61779-191-8_4; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Kemeny L, 2002, BRIT J DERMATOL, V146, P764, DOI 10.1046/j.1365-2133.2002.04663.x; Koch PJ, 2000, J CELL BIOL, V151, P389, DOI 10.1083/jcb.151.2.389; Kojima H, 1998, P ASSOC AM PHYSICIAN, V110, P197; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Liu Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-1; LOPEZFRANCO R, 1994, P NATL ACAD SCI USA, V91, P12228, DOI 10.1073/pnas.91.25.12228; Mildner M, 2010, J INVEST DERMATOL, V130, P2286, DOI 10.1038/jid.2010.115; Muller LMAJ, 2005, CLIN INFECT DIS, V41, P281, DOI 10.1086/431587; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Ngo BT, 2005, AM J CLIN DERMATOL, V6, P225, DOI 10.2165/00128071-200506040-00003; Okano J, 2015, BIOCHEM BIOPH RES CO, V461, P695, DOI 10.1016/j.bbrc.2015.04.094; Okano J, 2012, J CELL SCI, V125, P1827, DOI 10.1242/jcs.101550; Papini M, 2013, GIORN ITAL DERMAT V, V148, P603; Park HY, 2011, EXP DERMATOL, V20, P969, DOI 10.1111/j.1600-0625.2011.01364.x; Pavicic Tatjana, 2006, J Dtsch Dermatol Ges, V4, P935, DOI 10.1111/j.1610-0387.2006.06123.x; Pinkus H, 1966, G Ital Dermatol Minerva Dermatol, V107, P1115; Poradzka A, 2013, ACTA POL PHARM, V70, P587; Quondamatteo F, 2014, CELL TISSUE RES, V355, P1, DOI 10.1007/s00441-013-1751-2; Rawlings A.V., 2008, DRUG DISCOV TODAY DI, V5, DOI [10.1016/j.ddmec.2008.03.001, DOI 10.1016/J.DDMEC.2008.03.001]; Rodgers KE, 2006, WOUND REPAIR REGEN, V14, P298, DOI 10.1111/j.1743-6109.2006.00124.x; Sakai S, 2005, BRIT J DERMATOL, V153, P319, DOI 10.1111/j.1365-2133.2005.06756.x; Sakai S, 2003, J INVEST DERMATOL, V120, P79, DOI 10.1046/j.1523-1747.2003.12006.x; Sakurai K, 2002, J DERMATOL SCI, V30, P37, DOI 10.1016/S0923-1811(02)00047-6; Schwindt DA, 1998, J INVEST DERMATOL, V111, P385, DOI 10.1046/j.1523-1747.1998.00321.x; Seirafi H, 2009, J EUR ACAD DERMATOL, V23, P146, DOI 10.1111/j.1468-3083.2008.02950.x; Shah BR, 2003, DIABETES CARE, V26, P510, DOI 10.2337/diacare.26.2.510; Sotiropoulou PA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008383; Spravchikov N, 2001, DIABETES, V50, P1627, DOI 10.2337/diabetes.50.7.1627; Suaya JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060057; Taylor KR, 2011, J INVEST DERMATOL, V131, P2409, DOI 10.1038/jid.2011.241; Tornavaca O, 2015, J CELL BIOL, V208, P821, DOI 10.1083/jcb.201404140; Yu HM, 2016, EXP CELL RES, V342, P11, DOI 10.1016/j.yexcr.2016.02.012; Zakharov P, 2010, PHYSIOL MEAS, V31, P193, DOI 10.1088/0967-3334/31/2/006; Zheng JM, 2008, BRIT J PHARMACOL, V153, P1456, DOI 10.1038/bjp.2008.26; Zipes DP, 2014, CARDIAC ELECTROPHYSI	54	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166215	10.1371/journal.pone.0166215	http://dx.doi.org/10.1371/journal.pone.0166215			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846299	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600041
J	de Assis, DCS; da Silva, GR; Lanza, IP; Ribeiro, ACDR; Lana, AMQ; Lara, LJC; de Figueiredo, TC; Cancado, SD				Sampaio de Assis, Debora Cristina; da Silva, Guilherme Resende; Lanza, Isabela Pereira; dos Santos Rossi Ribeiro, Ana Claudia; Quintao Lana, Angela Maria; Camargos Lara, Leonardo Jose; de Figueiredo, Tadeu Chaves; Cancado, Silvana de Vasconcelos			Evaluation of the Presence and Levels of Enrofloxacin, Ciprofloxacin, Sulfaquinoxaline and Oxytetracycline in Broiler Chickens after Drug Administration	PLOS ONE			English	Article							TISSUE CONCENTRATIONS; ESCHERICHIA-COLI; MUSCLE-TISSUES; LC-MS/MS; RESIDUES; PHARMACOKINETICS; VALIDATION; DEPLETION; METABOLITES; KINETICS	The depletion times of enrofloxacin and its metabolite ciprofloxacin as well as sulfaquinoxaline and oxytetracycline were evaluated in broiler chickens that had been subjected to pharmacological treatment. The presence and residue levels of these drugs in muscle tissue were evaluated using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method that was validated in this work. The results showed the presence of all antimicrobial residues; however, the presence of residues at concentrations higher than the drugs' maximum residue limit (MRL) of 100 mu g kg(-1) was found only during the treatment period for oxytetracycline and until two days after discontinuation of the medication for enrofloxacin, ciprofloxacin and sulfaquinoxaline. It was concluded that the residues of all antimicrobials were rapidly metabolized from the broiler muscles; after four days of withdrawal, the levels were lower than the limit of quantification (LOO) of the method for the studied analytes.	[Sampaio de Assis, Debora Cristina; da Silva, Guilherme Resende; Lanza, Isabela Pereira; Quintao Lana, Angela Maria; Camargos Lara, Leonardo Jose; de Figueiredo, Tadeu Chaves; Cancado, Silvana de Vasconcelos] Univ Fed Minas Gerais, Escola Vet, Dept Tecnol & Inspecao Prod Origem Anim, Belo Horizonte, MG, Brazil; [dos Santos Rossi Ribeiro, Ana Claudia] Minist Agr Pecuaria & Abastecimento, Lab Nacl Agr LANAGRO MG, Pedro Leopoldo, MG, Brazil	Universidade Federal de Minas Gerais	de Assis, DCS (corresponding author), Univ Fed Minas Gerais, Escola Vet, Dept Tecnol & Inspecao Prod Origem Anim, Belo Horizonte, MG, Brazil.	debora@vet.ufmg.br	Assis, Débora/I-2571-2018; Lara, Leonardo/Y-4339-2019; Lana, Angela Maria/ABH-6903-2020; Lara, Leonardo/HGC-9970-2022; Cançado, S. V./E-5307-2017	Assis, Débora/0000-0002-3388-6501; Cançado, S. V./0000-0003-0268-7603; LARA, LEONARDO/0000-0003-1025-4605	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Colegiado de Pos-Graduacao em Ciencia Animal; Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Colegiado de Pos-Graduacao em Ciencia Animal; Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG)	Funding was provided by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), the Colegiado de Pos-Graduacao em Ciencia Animal and the Pro-Reitoria de Pesquisa at the Universidade Federal de Minas Gerais (UFMG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElAziz MI, 1997, BRIT POULTRY SCI, V38, P164, DOI 10.1080/00071669708417963; Anadon A, 2008, FOOD CHEM TOXICOL, V46, P662, DOI 10.1016/j.fct.2007.09.086; Anadon A, 2002, AM J VET RES, V63, P927, DOI 10.2460/ajvr.2002.63.927; Anadon A, 2001, RES VET SCI, V71, P101, DOI 10.1053/rvsc.2001.0494; [Anonymous], 2005, INT C HARM VAL AN PR; Attaie R, 2015, J DAIRY SCI, V98, P4370, DOI 10.3168/jds.2014-8616; Bogialli S, 2009, ANAL BIOANAL CHEM, V395, P947, DOI 10.1007/s00216-009-2930-6; Boison JO, 2015, ANAL BIOANAL CHEM, V407, P4065, DOI 10.1007/s00216-015-8644-z; Bousquet E, 2003, BRIT POULTRY SCI, V44, P822, DOI 10.1080/00071660410001667032; Bugyei K, 1999, CAN J VET RES, V63, P193; Codex Alimentarius Commission, 2009, 18 SESS COD COMM RES; Companyo R, 2009, ANAL BIOANAL CHEM, V395, P877, DOI 10.1007/s00216-009-2969-4; Moreno-Bondi MC, 2009, ANAL BIOANAL CHEM, V395, P921, DOI 10.1007/s00216-009-2920-8; Da Silva RG, 2006, J VET PHARMACOL THER, V29, P365, DOI 10.1111/j.1365-2885.2006.00755.x; de Almeida MP, 2015, TALANTA, V144, P922, DOI 10.1016/j.talanta.2015.07.048; Doyle M. E., 2006, FRI BRIEFINGS; DYER DC, 1989, AM J VET RES, V50, P522; European Medicine Agency (EMA), 2012, BAYTR 10 OR SOL ASS; Fedeniuk RW, 2015, J CHROMATOGR B, V983, P1, DOI 10.1016/j.jchromb.2014.12.035; Fletouris DJ, 2009, J VET PHARMACOL THER, V32, P56, DOI 10.1111/j.1365-2885.2008.01003.x; Gberindyer F. A., 2010, International Journal of Poultry Science, V9, P273; Goetting V, 2011, J VET PHARMACOL THER, V34, P521, DOI 10.1111/j.1365-2885.2011.01287.x; Gustafson RH, 1997, J APPL MICROBIOL, V83, P531, DOI 10.1046/j.1365-2672.1997.00280.x; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Hoff RB, 2015, TALANTA, V134, P768, DOI 10.1016/j.talanta.2014.10.045; de Mendoza JH, 2012, FOOD CHEM, V134, P1149, DOI 10.1016/j.foodchem.2012.02.108; INMETRO-Instituto Nacional de Metrologia Normalizacao e Qualidade Industrial, 2011, DOQCGCRE008 INMETRO, V04, P1; Ito NMK, 2005, FARMACOLOGIA APLICAD, P115; 임종환, 2010, [Journal of Veterinary Clinics, 한국임상수의학회지], V27, P565; Knoll U, 1999, J VET PHARMACOL THER, V22, P239, DOI 10.1046/j.1365-2885.1999.00217.x; Kools SAE, 2008, REGUL TOXICOL PHARM, V50, P59, DOI 10.1016/j.yrtph.2007.06.003; Korolkovas A, FRANC FFAC; Kuhne M, 2000, FOOD CONTROL, V11, P175, DOI 10.1016/S0956-7135(99)00092-4; Landoni MF, 2015, VET J, V205, P21, DOI 10.1016/j.tvjl.2015.04.016; Li RQ, 2015, FISH PHYSIOL BIOCHEM, V41, P803, DOI 10.1007/s10695-015-0047-8; Martinez M, 2006, VET J, V172, P10, DOI 10.1016/j.tvjl.2005.07.010; Miranda JM, 2008, POULTRY SCI, V87, P1643, DOI 10.3382/ps.2007-00485; Odore R, 2015, POULTRY SCI, V94, P1979, DOI 10.3382/ps/pev141; Ovando HG, 1999, J VET PHARMACOL THER, V22, P209, DOI 10.1046/j.1365-2885.1999.00211.x; Palermo-Neto J, 2011, FARMACOLOGIA APLICAD; Paschoal JAR, 2012, J VET PHARMACOL THER, V35, P90, DOI 10.1111/j.1365-2885.2011.01294.x; Perez-Trallero E, 2003, ENFERM INFEC MICR CL, V21, P520, DOI 10.1157/13052338; Petrovic J, 2006, ACTA VET-BEOGRAD, V56, P497, DOI 10.2298/AVB0606497P; Reyes-Herrera I, 2011, POULTRY SCI, V90, P481, DOI 10.3382/ps.2010-01057; Ribani M, 2007, J CHROMATOGR A, V1156, P201, DOI 10.1016/j.chroma.2006.12.080; Serrano JM, 1999, J VET PHARMACOL THER, V22, P148, DOI 10.1046/j.1365-2885.1999.00197.x; Slana M, 2014, J VET PHARMACOL THER, V37, P611, DOI 10.1111/jvp.12130; Soliman GA, 2000, DEUT TIERARZTL WOCH, V107, P23; Spinosa HS, FARMACOLOGIA APLICAD	49	7	7	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166402	10.1371/journal.pone.0166402	http://dx.doi.org/10.1371/journal.pone.0166402			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846314	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600058
J	Duez, M; Giraud, M; Herbert, R; Rocher, T; Salson, M; Thonier, F				Duez, Marc; Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael; Thonier, Florian			Vidjil: A Web Platform for Analysis of High-Throughput Repertoire Sequencing	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SOFTWARE; CHILDHOOD; QUEST; TCR	Background The B and T lymphocytes are white blood cells playing a key role in the adaptive immunity. A part of their DNA, called the V(D) J recombinations, is specific to each lymphocyte, and enables recognition of specific antigenes. Today, with new sequencing techniques, one can get billions of DNA sequences from these regions. With dedicated Repertoire Sequencing (RepSeq) methods, it is now possible to picture population of lymphocytes, and to monitor more accurately the immune response as well as pathologies such as leukemia. Methods and Results Vidjil is an open-source platform for the interactive analysis of high-throughput sequencing data from lymphocyte recombinations. It contains an algorithm gathering reads into clonotypes according to their V(D) J junctions, a web application made of a sample, experiment and patient database and a visualization for the analysis of clonotypes along the time. Vidjil is implemented in C++, Python and Javascript and licensed under the GPLv3 open-source license. Source code, binaries and a public web server are available at http://www.vidjil.org and at http://bioinfo.lille.inria.fr/vidjil. Using the Vidjil web application consists of four steps: 1. uploading a raw sequence file (typically a FASTQ); 2. running RepSeq analysis software; 3. visualizing the results; 4. annotating the results and saving them for future use. For the end-user, the Vidjil web application needs no specific installation and just requires a connection and a modern web browser. Vidjil is used by labs in hematology or immunology for research and clinical applications.	[Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael] Univ Lille, CRIStAL Ctr Rech Informat Signal & Automat Lille, CNRS, UMR 9189, F-59000 Lille, France; [Giraud, Mathieu; Herbert, Ryan; Rocher, Tatiana; Salson, Mikael] Inria Lille, F-59650 Villeneuve Dascq, France; [Duez, Marc] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Duez, Marc] SIRIC ONCOLille, F-59000 Lille, France; [Thonier, Florian] Hop Necker Enfants Malad, INSERM, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Centrale Lille; Universite de Lille; University of Bristol; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Giraud, M (corresponding author), Univ Lille, CRIStAL Ctr Rech Informat Signal & Automat Lille, CNRS, UMR 9189, F-59000 Lille, France.; Giraud, M (corresponding author), Inria Lille, F-59650 Villeneuve Dascq, France.	contact@vidjil.org		Rocher, Tatiana/0000-0002-1220-6335; Giraud, Mathieu/0000-0003-2741-8047	SIRIC ONCOLiIIe [INCa-DGOS-Inserm 6041]	SIRIC ONCOLiIIe	This work was supported by SIRIC ONCOLiIIe, Grant INCa-DGOS-Inserm 6041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022365; Benichou J, 2012, IMMUNOLOGY, V135, P183, DOI 10.1111/j.1365-2567.2011.03527.x; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Bolotin DA, 2013, NAT METHODS, V10, P813, DOI [10.1038/nmeth.2555, 10.1038/NMETH.2555]; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Bystry V, 2017, BIOINFORMATICS, V33, P435, DOI 10.1093/bioinformatics/btw634; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Ferret Y, 2016, BRIT J HAEMATOL, V173, P413, DOI 10.1111/bjh.13981; Finkel R. A., 1974, Acta Informatica, V4, P1, DOI 10.1007/BF00288933; Fischer HJ, 2016, J NEUROIMMUNOL, V290, P26, DOI 10.1016/j.jneuroim.2015.10.020; Giraud M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-409; Giudicelli W, 2005, NUCLEIC ACIDS RES, V33, pD256, DOI 10.1093/nar/gki010; Grardel N, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.1083.1083; Howie B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5624; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Kotrova M, 2015, BLOOD, V126, P1045, DOI 10.1182/blood-2015-07-655159; Kuchenbecker L., 2015, BIOINFORMATICS, V31, DOI DOI 10.1093/BIOINFORMATIONBH309; Lefranc Marie-Paule, 2011, Cold Spring Harb Protoc, V2011, P595, DOI 10.1101/pdb.top115; Linker RA, 2015, EUR J IMMUNOL, V45, P1326, DOI 10.1002/eji.201444985; Moorhouse MJ, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0059-7; Nazarov VI, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0613-1; Salson M, HIGH THROUGHPU UNPUB; Salson M, DATASET SEQUEN UNPUB; Schaller S, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0687-9; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Yang XW, 2014, ADV MATER SCI ENG, V2014, DOI 10.1155/2014/697170; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	32	48	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166126	10.1371/journal.pone.0166126	http://dx.doi.org/10.1371/journal.pone.0166126			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835690	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200027
J	Harris, R; van Kranenburg, P; de Jong, BM				Harris, Robert; van Kranenburg, Peter; de Jong, Bauke M.			Behavioral Quantification of Audiomotor Transformations in Improvising and Score-Dependent Musicians	PLOS ONE			English	Article							AUDITORY-FEEDBACK; PROFESSIONAL PIANISTS; KEYBOARD PERFORMANCE; PERCEPTION; PITCH; PATTERNS; MELODIES; IMPLICIT; SYSTEMS; CORTEX	The historically developed practice of learning to play a music instrument from notes instead of by imitation or improvisation makes it possible to contrast two types of skilled musicians characterized not only by dissimilar performance practices, but also disparate methods of audiomotor learning. In a recent fMRI study comparing these two groups of musicians while they either imagined playing along with a recording or covertly assessed the quality of the performance, we observed activation of a right-hemisphere network of posterior superior parietal and dorsal premotor cortices in improvising musicians, indicating more efficient audiomotor transformation. In the present study, we investigated the detailed performance characteristics underlying the ability of both groups of musicians to replicate music on the basis of aural perception alone. Twenty-two classically-trained improvising and score-dependent musicians listened to short, unfamiliar two-part excerpts presented with headphones. They played along or replicated the excerpts by ear on a digital piano, either with or without aural feedback. In addition, they were asked to harmonize or transpose some of the excerpts either to a different key or to the relative minor. MIDI recordings of their performances were compared with recordings of the aural model. Concordance was expressed in an audiomotor alignment score computed with the help of music information retrieval algorithms. Significantly higher alignment scores were found when contrasting groups, voices, and tasks. The present study demonstrates the superior ability of improvising musicians to replicate both the pitch and rhythm of aurally perceived music at the keyboard, not only in the original key, but also in other tonalities. Taken together with the enhanced activation of the right dorsal frontoparietal network found in our previous fMRI study, these results underscore the conclusion that the practice of improvising music can be associated with enhanced audiomotor transformation in response to aurally perceived music.	[Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Harris, Robert; de Jong, Bauke M.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Harris, Robert] Hanze Univ Appl Sci, Prince Claus Conservatoire, Groningen, Netherlands; [van Kranenburg, Peter] Meertens Inst, Amsterdam, Netherlands	University of Groningen; University of Groningen; Royal Netherlands Academy of Arts & Sciences; Meertens Institute (KNAW)	Harris, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.; Harris, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands.; Harris, R (corresponding author), Hanze Univ Appl Sci, Prince Claus Conservatoire, Groningen, Netherlands.	r.i.harris@pl.hanze.nl		de Jong, Bauke M./0000-0002-6568-5739				[Anonymous], 1998, ADV INFANCY RES; [Anonymous], 1989, MANUAL ADV MEASURES; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Baumann S, 2007, BRAIN RES, V1161, P65, DOI 10.1016/j.brainres.2007.05.045; Brown RM, 2013, J COGNITIVE NEUROSCI, V25, P313, DOI 10.1162/jocn_a_00322; Byrne RW, 2002, ADV STUD BEHAV, V31, P77, DOI 10.1016/S0065-3454(02)80006-7; CLEEREMANS A, 1991, J EXP PSYCHOL GEN, V120, P235, DOI 10.1037/0096-3445.120.3.235; Cleeremans A., 1993, MECH IMPLICIT LEARNI; Drost UC, 2005, Q J EXP PSYCHOL-A, V58, P1376, DOI 10.1080/02724980443000610; Finney SA, 2003, MEM COGNITION, V31, P51, DOI 10.3758/BF03196082; Finney SA, 1997, MUSIC PERCEPT, V15, P153; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Fujioka T, 2005, J COGNITIVE NEUROSCI, V17, P1578, DOI 10.1162/089892905774597263; Fujioka T, 2008, NEUROREPORT, V19, P361, DOI 10.1097/WNR.0b013e3282f51d91; Grachten M, P 6 INT C MUS INF RE; Harris R, 2015, BRAIN RES, V1624, P253, DOI 10.1016/j.brainres.2015.06.050; Haslinger B, 2005, J COGNITIVE NEUROSCI, V17, P282, DOI 10.1162/0898929053124893; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hove MJ, 2014, P NATL ACAD SCI USA, V111, P10383, DOI 10.1073/pnas.1402039111; Kranenburg VP, P INT C MUS INF RETR; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Lemstrom Kjell, 2000, THESIS; Marie C., 2012, PSYCHOMUSICOLOGY, V22, P97, DOI [10.1037/a0030858, DOI 10.1037/A0030858]; Marie C, 2014, NEUROPSYCHOLOGIA, V57, P50, DOI 10.1016/j.neuropsychologia.2014.02.023; Marie C, 2013, CEREB CORTEX, V23, P660, DOI 10.1093/cercor/bhs050; Milner A. D., 1995, VISUAL BRAIN ACTION; MONGEAU M, 1990, COMPUT HUMANITIES, V24, P161, DOI 10.1007/BF00117340; MOORE R, 1992, INT REV AESTHET SOC, V23, P61, DOI 10.2307/836956; Morgan-Short K, 2012, J COGNITIVE NEUROSCI, V24, P933, DOI 10.1162/jocn_a_00119; Mutschler I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000259; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nettl B., 1998, COURSE PERFORMANCE S; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Novembre G, 2011, CONSCIOUS COGN, V20, P1232, DOI 10.1016/j.concog.2011.03.009; Ohnishi T, 2001, CEREB CORTEX, V11, P754, DOI 10.1093/cercor/11.8.754; PALMER C, 1994, PERCEPT PSYCHOPHYS, V56, P301, DOI 10.3758/BF03209764; Pfordresher PQ, 2012, ACTA PSYCHOL, V139, P166, DOI 10.1016/j.actpsy.2011.10.009; REBER PJ, 1994, LEARN MEMORY, V1, P217; Repp BH, 1999, MUSIC PERCEPT, V16, P409; Ruiz M. H., 2009, P INT S PERF SCI, P187; Schon D, 2002, NEUROREPORT, V13, P2285, DOI 10.1097/01.wnr.0000044224.79663.f5; Seppanen M, 2007, NEUROBIOL LEARN MEM, V87, P236, DOI 10.1016/j.nlm.2006.08.011; SERGENT J, 1992, SCIENCE, V257, P106, DOI 10.1126/science.1621084; SHAFFER LH, 1981, COGNITIVE PSYCHOL, V13, P326, DOI 10.1016/0010-0285(81)90013-X; Stewart L, 2003, NEUROIMAGE, V20, P71, DOI 10.1016/S1053-8119(03)00248-9; Stewart L, 2013, Q J EXP PSYCHOL, V66, P37, DOI 10.1080/17470218.2012.687385; Tervaniemi M, 2001, LEARN MEMORY, V8, P295, DOI 10.1101/lm.39501; Trimarchi PD, 2011, PSYCHOL RES-PSYCH FO, V75, P122, DOI 10.1007/s00426-010-0292-5; Ullman M, 2005, MIND CONTEXT ADULT 2, P141; Ullman MT, 2004, COGNITION, V92, P231, DOI 10.1016/j.cognition.2003.10.008; Vuust P, 2012, NEUROPSYCHOLOGIA, V50, P1432, DOI 10.1016/j.neuropsychologia.2012.02.028; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Willingham DB, 1999, PSYCHOL SCI, V10, P531, DOI 10.1111/1467-9280.00201; Wiora W., 1941, JB VOLKSLIEDFORSCHUN, V7, P128, DOI DOI 10.2307/846331; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Woody RH, 2010, J RES MUSIC EDUC, V58, P101, DOI 10.1177/0022429410370785; Zatorre RJ, 2010, J COGNITIVE NEUROSCI, V22, P775, DOI 10.1162/jocn.2009.21239	59	3	3	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166033	10.1371/journal.pone.0166033	http://dx.doi.org/10.1371/journal.pone.0166033			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835631	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200021
J	Kozlov, MV; Skoracka, A; Zverev, V; Lewandowski, M; Zvereva, EL				Kozlov, Mikhail V.; Skoracka, Anna; Zverev, Vitali; Lewandowski, Mariusz; Zvereva, Elena L.			Two Birch Species Demonstrate Opposite Latitudinal Patterns in Infestation by Gall-Making Mites in Northern Europe	PLOS ONE			English	Article							INSECT HERBIVORY; ERIOPHYOID MITE; SPATIAL-DISTRIBUTION; BETULA-PENDULA; B-PUBESCENS; TREES; GRADIENTS; RESPONSES; FOLIAGE; LOSSES	Latitudinal patterns in herbivory, i.e. variations in plant losses to animals with latitude, are generally explained by temperature gradients. However, earlier studies suggest that geographical variation in abundance and diversity of gall-makers may be driven by precipitation rather than by temperature. To test the above hypothesis, we examined communities of eriophyoid mites (Acari: Eriophyoidea) on leaves of Betula pendula and B. pubescens in boreal forests in Northern Europe. We sampled ten sites for each of five latitudinal gradients from 2008-2011, counted galls of six morphological types and identified mites extracted from these galls. DNA analysis revealed cryptic species within two of six morphologically defined mite species, and these cryptic species induced different types of galls. When data from all types of galls and from two birch species were pooled, the percentage of galled leaves did not change with latitude. However, we discovered pronounced variation in latitudinal changes between birch species. Infestation by eriophyoid mites increased towards the north in B. pendula and decreased in B. pubescens, while diversity of galls decreased towards the north in B. pendula and did not change in B. pubescens. The percentage of galled leaves did not differ among geographical gradients and study years, but was 20% lower in late summer relative to early summer, indicating premature abscission of infested leaves. Our data suggest that precipitation has little effect on abundance and diversity of eriophyoid mites, and that climate warming may impose opposite effects on infestation of two birch species by galling mites, favouring B. pendula near the northern tree limit.	[Kozlov, Mikhail V.; Zverev, Vitali; Zvereva, Elena L.] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Skoracka, Anna] Adam Mickiewicz Univ, Populat Ecol Lab, Fac Biol, Poznan, Poland; [Lewandowski, Mariusz] Warsaw Univ Life Sci SGGW, Fac Agr Biotechnol & Landscape Architecture, Dept Appl Entomol, Warsaw, Poland	University of Turku; Adam Mickiewicz University; Warsaw University of Life Sciences	Kozlov, MV (corresponding author), Univ Turku, Sect Ecol, Dept Biol, Turku, Finland.	mikoz@utu.fi	Kozlov, Mikhail V./I-5037-2013; Lewandowski, Mariusz/H-2184-2011; Lewandowski, Mariusz/N-1142-2019; Zvereva, Elena L./M-8490-2016; Skoracka, Anna/E-6002-2011	Kozlov, Mikhail V./0000-0002-9500-4244; Lewandowski, Mariusz/0000-0001-5360-0382; Lewandowski, Mariusz/0000-0001-5360-0382; Zvereva, Elena L./0000-0003-2934-3421; Skoracka, Anna/0000-0002-9485-532X	Academy of Finland [122133, 276671]; University of Turku, Finland; Faculty of Biology, Adam Mickiewicz University, Poland	Academy of Finland(Academy of Finland); University of Turku, Finland; Faculty of Biology, Adam Mickiewicz University, Poland	The study was supported by the Academy of Finland (www.aka.fi; projects 122133, 276671 and researcher exchange grants to M. Kozlov), by a strategic research grant from the University of Turku, Finland (www.utu.fi), and by Faculty of Biology, Adam Mickiewicz University, Poland (https://international.amu.edU.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amrine Jr JW, 2003, REVISED KEYS WORLD G; Amrine JW, 1996, WORLD CROP PESTS ERI, V6, P383, DOI DOI 10.1016/S1572; Amrine JW, 2015, CATALOG ERIOPHYOIDEA; Amrine JW Jr, 1994, CATALOG ERIOPHYOIDEA; ATKINSON MD, 1992, J ECOL, V80, P837, DOI 10.2307/2260870; Bouneb M, 2014, EXP APPL ACAROL, V62, P161, DOI 10.1007/s10493-013-9733-3; Buchta I., 2004, Journal of Forest Science (Prague), V50, P566; Canestrini G, 1891, ATTI SOC VENETO TREN, V12, P40; Castagneyrol B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044247; Castagnoli M, 1996, ERIOPHYOID MITES THE, P543, DOI DOI 10.3791/51738; de Lillo E, 2010, EXP APPL ACAROL, V51, P283, DOI 10.1007/s10493-009-9311-x; Ellis WN, 2015, LEAFMINERS PLANT GAL; Ermakov VI, 1986, MECH BIRCH ADAPTION; FAO, 2006, NEW LOCCLIM LOC CLIM; Fernandes GW, 1994, GALL FORMING INSECTS, P42; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; Ishihara MI, 2007, J APPL ENTOMOL, V131, P585, DOI 10.1111/j.1439-0418.2007.01207.x; Isidorov V, 2014, BIOCHEM SYST ECOL, V52, P41, DOI 10.1016/j.bse.2013.12.008; Junttila O, 2003, SCAND J FOREST RES, V18, P208, DOI 10.1080/02827580308624; Koricheva J, 1996, ENVIRON POLLUT, V93, P345, DOI 10.1016/S0269-7491(96)00039-5; Kotlarski S, 2014, GEOSCI MODEL DEV, V7, P1297, DOI 10.5194/gmd-7-1297-2014; Kozlov MV, 2008, CLIMATIC CHANGE, V87, P107, DOI 10.1007/s10584-007-9348-y; Kozlov MV, 2015, ECOGRAPHY, V38, P1026, DOI 10.1111/ecog.01401; Kozlov MV, 2015, GLOBAL ECOL BIOGEOGR, V24, P1126, DOI 10.1111/geb.12347; Kozlov MV, 2015, POLAR BIOL, V38, P967, DOI 10.1007/s00300-015-1655-6; Kozlov MV, 2015, GLOBAL CHANGE BIOL, V21, P106, DOI 10.1111/gcb.12682; Kozlov MV, 2013, ECOGRAPHY, V36, P1138, DOI 10.1111/j.1600-0587.2013.00272.x; Kuczynski L, 2005, EXP APPL ACAROL, V36, P277, DOI 10.1007/s10493-005-7551-y; Kula E., 2010, Folia Oecologica, V37, P61; Kula E, 2008, INT J ACAROL, V34, P155, DOI 10.1080/01647950808683719; Leckey EH, 2014, ACTA OECOL, V61, P1, DOI 10.1016/j.actao.2014.08.001; Lewandowski M, 2014, EXP APPL ACAROL, V63, P497, DOI 10.1007/s10493-014-9805-z; Lim JY, 2015, GLOBAL ECOL BIOGEOGR, V24, P1106, DOI 10.1111/geb.12336; Lindroth JI, 1899, ACTA SOC PRO FAUNA F, V18, P1; Moles AT, 2011, FUNCT ECOL, V25, P380, DOI 10.1111/j.1365-2435.2010.01814.x; Moreira X, 2015, OIKOS, V124, P1444, DOI 10.1111/oik.02040; Mosbacher JB, 2013, POLAR BIOL, V36, P1735, DOI 10.1007/s00300-013-1393-6; Nalepa A., 1919, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Wien, V69, P25; Nalepa A., 1891, NOVA ACTA LEOP AKAD, V55, P362; Nalepa A, 1892, FEUILLE JEUNES NATUR, V22, P118; Navajas M, 2010, EXP APPL ACAROL, V51, P257, DOI 10.1007/s10493-009-9301-z; NUCKOLS MS, 1995, ECOL ENTOMOL, V20, P253, DOI 10.1111/j.1365-2311.1995.tb00455.x; Palme AE, 2004, MOL ECOL, V13, P167, DOI 10.1046/j.1365-294X.2003.02034.x; Patankar R, 2013, ARCT ANTARCT ALP RES, V45, P99, DOI 10.1657/1938-4246-45.1.99; Petanovic R, 2010, EXP APPL ACAROL, V51, P61, DOI 10.1007/s10493-010-9351-2; Petanovic R, 2010, EXP APPL ACAROL, V51, P81, DOI 10.1007/s10493-009-9328-1; ROIVAENEN H., 1950, ACTA ENT FENNICA, V7., P1; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Schenk MF, 2008, TREE GENET GENOMES, V4, P911, DOI 10.1007/s11295-008-0162-0; Skoracka A, 2014, BIOL J LINN SOC, V111, P421, DOI 10.1111/bij.12213; Soika Grazyna, 2006, Biological Letters, V43, P367; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turcotte MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0555; Valkama E, 2005, OECOLOGIA, V146, P385, DOI 10.1007/s00442-005-0216-z; Vehvilainen H, 2006, BASIC APPL ECOL, V7, P1, DOI 10.1016/j.baae.2005.05.003; VUORISALO T, 1989, OIKOS, V55, P370, DOI 10.2307/3565597; Wang N, 2014, MOL ECOL, V23, P2771, DOI 10.1111/mec.12768; Welter S.C., 1989, P135; Westphal E, 1996, ERIOPHYOID MITES THE, P231, DOI DOI 10.1016/S1572-4379(96)80014-5; WILLSON MF, 1990, AM MIDL NAT, V123, P408, DOI 10.2307/2426571; Zvereva EL, 2012, OECOLOGIA, V169, P441, DOI 10.1007/s00442-011-2210-y	61	7	7	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166641	10.1371/journal.pone.0166641	http://dx.doi.org/10.1371/journal.pone.0166641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835702	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200063
J	Musalek, M; Scharoun, SM; Bryden, PJ				Musalek, Martin; Scharoun, Sara Marie; Bryden, Pamela J.			Using Bishop's Card Reaching Task to Assess Hand Preference in 8-to 10-Year-Old Czech Children	PLOS ONE			English	Article							EDINBURGH HANDEDNESS INVENTORY; CEREBRAL LATERALIZATION; MOTOR CORTEX; PERFORMANCE; LANGUAGE; MODEL; RELIABILITY; MIDLINE; SPEECH; SKILL	Hand preference is one of the most apparent functional asymmetry in humans. Under contralateral control, performance is more proficient with the preferred hand; however, the difference between the two hands is greater in right handers, considering left handers generally display less cerebral lateralization. One method of evaluating hand preference is Bishop's card reaching task; however, information regarding validity and sensitivity with children in limited. This study assessed the relationship between Bishop's card reaching task and five hand preference tasks in 8- to 10-year-old typically-developing children from the Czech Republic (N = 376). Structural equation modelling identified a one factor model as the most suitable, including Bishop's card reaching task and three hand preference tasks (ringing, throwing, and rolling with dice). The factor validity (. 89) and sensitivity of Bishop's card reaching task (90% to 97%) provided a very good identification of hand preference. These results support the suitability of Bishop's card reaching task as a separate test for determining hand preference in children. Accordingly, we suggest that the assessment of handedness, particularly in neurodevelopmental disorders where the proportion of right-handers and left-handers is disrupted (e.g., children with DCD or ADHD), should make use of Bishop's card reaching task alongside other unimanual tasks.	[Musalek, Martin] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic; [Scharoun, Sara Marie] Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada; [Bryden, Pamela J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada	Charles University Prague; Nipissing University; Wilfrid Laurier University	Scharoun, SM (corresponding author), Nipissing Univ, Sch Phys & Hlth Educ, North Bay, ON, Canada.	saras@nipissingu.ca	Bryden, Pam/AAF-6706-2020; Benson, Sara Scharoun/AAG-5946-2020; Musalek, Martin/M-9802-2017	Benson, Sara Scharoun/0000-0002-3329-6392; Musalek, Martin/0000-0003-1070-8304; Bryden, Pamela/0000-0001-8862-3402	Social-Sciences Aspects of Human Movement Studies [PRVOUK P39]; Czech Science Foundation [14-29358P]	Social-Sciences Aspects of Human Movement Studies; Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by project PRVOUK P39, Social-Sciences Aspects of Human Movement Studies and by the Czech Science Foundation, project No. 14-29358P.	Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; ANNETT M, 1981, TRENDS NEUROSCI, V4, P256, DOI 10.1016/0166-2236(81)90080-1; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Annett M., 1981, ANN DYSLEXIA, V31, P103, DOI [10.1007/BF02658604, DOI 10.1007/BF02658604]; Ayres A.J., 1972, SENSORY INTEGRATION; Ayres AJ, 1980, SO CALIFORNIA INTEGR; Baker F.B., 2004, ITEM RESPONSE THEORY; Banerjee M, 1999, CAN J STAT, V27, P3, DOI 10.2307/3315487; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bishop DVM, 1996, BRIT J PSYCHOL, V87, P269, DOI 10.1111/j.2044-8295.1996.tb02590.x; Brown SG, 2006, LATERALITY, V11, P1, DOI 10.1080/1357650054200000440; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Bryden P, 2003, BRAIN COGNITION, V53, P111; Bryden PJ, 2007, DEV NEUROPSYCHOL, V32, P825, DOI 10.1080/87565640701539667; Bryden PJ, 2006, DEV PSYCHOBIOL, V48, P121, DOI 10.1002/dev.20120; Calvert G A, 1998, Laterality, V3, P255, DOI 10.1080/135765098397287; Carlier M, 2006, BRAIN COGNITION, V61, P255, DOI 10.1016/j.bandc.2006.01.007; Cohen J.E., 1988, STAT POWER ANAL BEHA; COREN S, 1977, SCIENCE, V198, P631, DOI 10.1126/science.335510; Cornish KM, 1996, J AUTISM DEV DISORD, V26, P597, DOI 10.1007/BF02172349; DODDS AG, 1978, NEUROPSYCHOLOGIA, V16, P247, DOI 10.1016/0028-3932(78)90115-X; Doyen AL, 2002, LATERALITY, V7, P115, DOI 10.1080/13576500143000140; Doyen AL, 2008, LATERALITY, V13, P179, DOI 10.1080/13576500701764124; Dragovic M, 2004, LATERALITY, V9, P411, DOI 10.1080/13576500342000248; FINLAYSON MAJ, 1976, PERCEPT MOTOR SKILL, V43, P475, DOI 10.2466/pms.1976.43.2.475; Giedd JN, 1996, DEV BRAIN RES, V91, P274; Gut M, 2007, ACTA NEUROBIOL EXP, V67, P43; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; HARRIS LJ, 1993, BRAIN LANG, V45, P108, DOI 10.1006/brln.1993.1037; Hendl J, 2009, PREHLED STAT METOD A; Herron J., 2012, NEUROPSYCHOLOGY LEFT; Hill E L, 1998, Laterality, V3, P295; Hill EL, 2009, BRAIN COGNITION, V71, P99, DOI 10.1016/j.bandc.2009.04.006; Hugdahl K., 2010, 2 HALVES BRAIN INFOR; Ida Y, 1996, CAN J EXP PSYCHOL, V50, P234, DOI 10.1037/1196-1961.50.2.234; Jancke J, 1998, COGNITIVE BRAIN RES, V6, P279; Kerlinger FN, 2000, FDN BEHAV RES, P665; Khedr EM, 2002, EUR J APPL PHYSIOL, V87, P469, DOI 10.1007/s00421-002-0652-y; Kline R., 2011, HDB INNOVATION SOCIA, P562, DOI [10.4135/9781446268261, DOI 10.4135/9781446268261, 10.4135/9781446268261.n31]; Knecht S, 2000, BRAIN, V123, P74, DOI 10.1093/brain/123.1.74; Knecht S, 2000, BRAIN, V123, P2512, DOI 10.1093/brain/123.12.2512; Komarc M, 2012, CZECH KINANTHROPOL, V16, P77; Krippendorff K., 1980, CONTENT ANAL INTRO I; Liederman J., 1983, MANUAL SPECIALIZATIO, P82; McDonald, 1999, TEST THEORY UNIFIED, DOI DOI 10.4324/9781410601087; MCFARLAND K, 1980, BRIT J PSYCHOL, V71, P135, DOI 10.1111/j.2044-8295.1980.tb02739.x; McManus IC, 1992, HDB NEUROPSYCHOLOGY, V6, P115, DOI DOI 10.1037/0894-4105.6.2.115; Michell D., 1999, PHYSIOTHERAPY, V85, P607, DOI [10.1016/S0031-9406(05)66041-5, DOI 10.1016/S0031-9406(05)66041-5]; Milenkovic S, 2013, LATERALITY, V18, P340, DOI 10.1080/1357650X.2012.683196; Musalek M, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01513; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Ocklenburg S, 2014, FRONT PSYCHOL, V5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLEARY DS, 1980, CHILD DEV, V51, P743, DOI 10.2307/1129460; Pool EM, 2015, NEUROIMAGE, V109, P298, DOI 10.1016/j.neuroimage.2015.01.034; PROVINE RR, 1979, CHILD DEV, V50, P437, DOI 10.1111/j.1467-8624.1979.tb04126.x; Provins KA, 1997, PSYCHOL REV, V104, P554, DOI 10.1037/0033-295X.104.3.554; Pujol J, 1999, NEUROLOGY, V52, P1038, DOI 10.1212/WNL.52.5.1038; Scharoun SM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00082; SINGH M, 1994, INT J NEUROSCI, V74, P33, DOI 10.3109/00207459408987227; Springer S. P, 1998, LEFT BRAIN RIGHT BRA; STEENHUIS RE, 1990, J CLIN EXP NEUROPSYC, V12, P921, DOI 10.1080/01688639008401031; STEENHUIS RE, 1989, CORTEX, V25, P289, DOI 10.1016/S0010-9452(89)80044-9; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; TAPLEY SM, 1985, NEUROPSYCHOLOGIA, V23, P215, DOI 10.1016/0028-3932(85)90105-8; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Viviani P, 1998, EXP BRAIN RES, V120, P531, DOI 10.1007/s002210050428; West S. G., 1995, STRUCTURAL EQUATION, P56; Yahagi S, 1999, NEUROSCI LETT, V276, P185, DOI 10.1016/S0304-3940(99)00823-X	71	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166337	10.1371/journal.pone.0166337	http://dx.doi.org/10.1371/journal.pone.0166337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835677	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200041
J	Zwicker, D				Zwicker, David			Normalized Neural Representations of Complex Odors	PLOS ONE			English	Article							OLFACTORY-BULB; LATERAL INHIBITION; MIXTURES; NEURONS; SENSITIVITY; SPARSE; MODEL; TRANSFORMATIONS; ENHANCEMENT; VERTEBRATES	The olfactory system removes correlations in natural odors using a network of inhibitory neurons in the olfactory bulb. It has been proposed that this network integrates the response from all olfactory receptors and inhibits them equally. However, how such global inhibition influences the neural representations of odors is unclear. Here, we study a simple statistical model of the processing in the olfactory bulb, which leads to concentration-invariant, sparse representations of the odor composition. We show that the inhibition strength can be tuned to obtain sparse representations that are still useful to discriminate odors that vary in relative concentration, size, and composition. The model reveals two generic consequences of global inhibition: (i) odors with many molecular species are more difficult to discriminate and (ii) receptor arrays with heterogeneous sensitivities perform badly. Comparing these predictions to experiments will help us to understand the role of global inhibition in shaping normalized odor representations in the olfactory bulb.	[Zwicker, David] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Zwicker, David] Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Harvard University	Zwicker, D (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA.; Zwicker, D (corresponding author), Harvard Univ, Kavli Inst Bionano Sci & Technol, Cambridge, MA 02138 USA.	dzwicker@seas.harvard.edu	Zwicker, David/AAL-8751-2020	Zwicker, David/0000-0002-3909-3334	Simons Foundation; German Science Foundation [ZW 222/1-1]	Simons Foundation; German Science Foundation(German Research Foundation (DFG))	This research was funded by the Simons Foundation (https://www.simonsfoundation.org/) and the German Science Foundation (www.dfg.de/en;) through ZW 222/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I thank Michael P. Brenner, Alexander T. Mathis, Venkatesh N. Murthy, Mikhail Tikhonov, and Christoph A. Weber for helpful discussions and comments on the manuscript. This research was funded by the Simons Foundation and the German Science Foundation through ZW 222/1-1.	Arevian AC, 2008, NAT NEUROSCI, V11, P80, DOI 10.1038/nn2030; Asahina Kenta, 2009, J Biol, V8, P9, DOI 10.1186/jbiol108; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Banerjee A, 2015, NEURON, V87, P193, DOI 10.1016/j.neuron.2015.06.019; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Berck ME, 2016, ELIFE, V5, DOI 10.7554/eLife.14859; Bhandawat V, 2007, NAT NEUROSCI, V10, P1474, DOI 10.1038/nn1976; Blauvelt DG, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00046; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; CAIN WS, 1977, SCIENCE, V195, P796, DOI 10.1126/science.836592; Carandini M, 2012, NAT REV NEUROSCI, V13, P51, DOI 10.1038/nrn3136; Cleland TA, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-7; Cleland TA, 2007, P NATL ACAD SCI USA, V104, P1953, DOI 10.1073/pnas.0608564104; Cleland Thomas A, 2011, Front Neuroeng, V4, P21, DOI 10.3389/fneng.2011.00021; Cleland TA, 2010, TRENDS NEUROSCI, V33, P130, DOI 10.1016/j.tins.2009.12.004; Davison IG, 2007, J NEUROSCI, V27, P2091, DOI 10.1523/JNEUROSCI.3779-06.2007; Demb JB, 2015, ANNU REV VIS SCI, V1, P263, DOI 10.1146/annurev-vision-082114-035334; Ganguli S, 2012, ANNU REV NEUROSCI, V35, P485, DOI 10.1146/annurev-neuro-062111-150410; Geramita MA, 2016, ELIFE, V5, DOI 10.7554/eLife.16039; Getz WM, 1999, CHEM SENSES, V24, P351, DOI 10.1093/chemse/24.4.351; Goyert HF, 2007, BRAIN RES BULL, V72, P1, DOI 10.1016/j.brainresbull.2006.12.010; Gupta P, 2015, NAT NEUROSCI, V18, P272, DOI 10.1038/nn.3913; Haddad R, 2010, J NEUROSCI, V30, P9017, DOI 10.1523/JNEUROSCI.0398-10.2010; HAINER R M, 1954, Ann N Y Acad Sci, V58, P158, DOI 10.1111/j.1749-6632.1954.tb54851.x; Hong EJ, 2015, NEURON, V85, P573, DOI 10.1016/j.neuron.2014.12.040; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Isaacson JS, 2011, NEURON, V72, P231, DOI 10.1016/j.neuron.2011.09.027; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; Kaupp UB, 2010, NAT REV NEUROSCI, V11, P188, DOI 10.1038/nrn2789; Koulakov A, 2007, J NEUROPHYSIOL, V98, P3134, DOI 10.1152/jn.00560.2007; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lazarini F, 2011, TRENDS NEUROSCI, V34, P20, DOI 10.1016/j.tins.2010.09.006; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; LI Z, 1990, BIOL CYBERN, V62, P349, DOI 10.1007/BF00201449; Li Z., 1994, MODELS NEURAL NETWOR, P221, DOI [10.1007/978-1-4612-4320-5_6, DOI 10.1007/978-1-4612-4320-5_6]; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Linster C, 1997, BEHAV BRAIN RES, V84, P117, DOI 10.1016/S0166-4328(97)83331-1; LOWE G, 1995, P NATL ACAD SCI USA, V92, P7864, DOI 10.1073/pnas.92.17.7864; Mainland JD, 2014, TRENDS NEUROSCI, V37, P443, DOI 10.1016/j.tins.2014.05.005; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mathis A, 2016, BIORXIV; Mouret A, 2009, J NEUROSCI, V29, P12302, DOI 10.1523/JNEUROSCI.3383-09.2009; Murthy VN, 2011, ANNU REV NEUROSCI, V34, P233, DOI 10.1146/annurev-neuro-061010-113738; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Nikolova N, 2004, QSAR COMB SCI, V22, P1006, DOI 10.1002/qsar.200330831; Olsen SR, 2010, NEURON, V66, P287, DOI 10.1016/j.neuron.2010.04.009; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Rinberg D, 2006, J NEUROSCI, V26, P8857, DOI 10.1523/JNEUROSCI.0884-06.2006; Roland B, 2016, ELIFE, V5, DOI 10.7554/eLife.16335; Sachse S, 2002, J NEUROPHYSIOL, V87, P1106, DOI 10.1152/jn.00325.2001; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Silbering AF, 2007, J NEUROSCI, V27, P11966, DOI 10.1523/JNEUROSCI.3099-07.2007; Teixeira CSS, 2016, CHEM SENSES, V41, P105, DOI 10.1093/chemse/bjv075; Sirotin YB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0083-15.2015; Soucy ER, 2009, NAT NEUROSCI, V12, P210, DOI 10.1038/nn.2262; Stevens CF, 2016, P NATL ACAD SCI USA, V113, P6737, DOI 10.1073/pnas.1606339113; Stitzel SE, 2011, ANNU REV BIOMED ENG, V13, P1, DOI [10.1146/annurev-bioeng-071910-124633, 10.1146/annurev-bioeng-071910-12463.3]; Su CY, 2009, CELL, V139, P45, DOI 10.1016/j.cell.2009.09.015; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Tikhonov M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150486; Tkacik G, 2016, ANNU REV CONDEN MA P, V7, P89, DOI 10.1146/annurev-conmatphys-031214-014803; Uchida N, 2014, ANNU REV NEUROSCI, V37, P363, DOI 10.1146/annurev-neuro-071013-013941; Uchida N, 2008, FRONT SYST NEUROSCI, V1, DOI 10.3389/neuro.06.003.2007; Ukhanov K, 2010, J NEUROPHYSIOL, V103, P1114, DOI 10.1152/jn.00980.2009; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Verbeurgt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096333; Weiss T, 2012, P NATL ACAD SCI USA, V109, P19959, DOI 10.1073/pnas.1208110109; Wilson RI, 2013, ANNU REV NEUROSCI, V36, P217, DOI 10.1146/annurev-neuro-062111-150533; Wilson RI, 2011, CURR OPIN NEUROBIOL, V21, P254, DOI 10.1016/j.conb.2011.03.002; Wright GA, 2005, RECENT ADV PHYTOCHEM, V39, P191; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yu CR, 2017, EXP NEUROL, V287, P395, DOI 10.1016/j.expneurol.2016.06.001; Yu YQ, 2015, P NATL ACAD SCI USA, V112, P14966, DOI 10.1073/pnas.1517510112; Zhang DK, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/507143; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473; Zwicker D, 2016, P NATL ACAD SCI USA, V113, P5570, DOI 10.1073/pnas.1600357113	84	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166456	10.1371/journal.pone.0166456	http://dx.doi.org/10.1371/journal.pone.0166456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835696	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200052
J	Horii, N; Sato, K; Mesaki, N; Iemitsu, M				Horii, Naoki; Sato, Koji; Mesaki, Noboru; Iemitsu, Motoyuki			Increased Muscular 5 alpha-Dihydrotestosterone in Response to Resistance Training Relates to Skeletal Muscle Mass and Glucose Metabolism in Type 2 Diabetic Rats	PLOS ONE			English	Article							INSULIN-RESISTANCE; EXERCISE; DHEA; TESTOSTERONE; STRENGTH; DEHYDROEPIANDROSTERONE; TRANSLOCATION; ENZYMES	Regular resistance exercise induces skeletal muscle hypertrophy and improvement of glycemic control in type 2 diabetes patients. Administration of dehydroepiandrosterone (DHEA), a sex steroid hormone precursor, increases 5 alpha-dihydrotestosterone (DHT) synthesis and is associated with improvements in fasting blood glucose level and skeletal muscle hypertrophy. Therefore, the aim of this study was to investigate whether increase in muscle DHT levels, induced by chronic resistance exercise, can contribute to skeletal muscle hypertrophy and concomitant improvement of muscular glucose metabolism in type 2 diabetic rats. Male 20-week-old type 2 diabetic rats (OLETF) were randomly divided into 3 groups: sedentary control, resistance training (3 times a week on alternate days for 8 weeks), or resistance training with continuous infusion of a 5 alpha-reductase inhibitor (n = 8 each group). Age-matched, healthy nondiabetic Long-Evans Tokushima Otsuka (LETO) rats (n = 8) were used as controls. The results indicated that OLETF rats showed significant decrease in muscular DHEA, free testosterone, DHT levels, and protein expression of steroidogenic enzymes, with loss of skeletal muscle mass and hyperglycemia, compared to that of LETO rats. However, 8-week resistance training in OLETF rats significantly increased the levels of muscle sex steroid hormones and protein expression of steroidogenic enzymes with a concomitant increase in skeletal muscle mass, improved fasting glucose level, and insulin sensitivity index. Moreover, resistance training accelerated glucose transporter-4 (GLUT-4) translocation and protein kinase B and C-zeta/lambda(IA phosphorylation. Administering the 5a-reductase inhibitor in resistance-trained OLETF rats resulted in suppression of the exercise induced effects on skeletal muscle mass, fasting glucose level, insulin sensitivity index, and GLUT-4 signaling, with a decline in muscular DHT levels. These findings suggest that resistance training-induced elevation of muscular DHT levels may contribute to improvement of hyperglycemia and skeletal muscle hypertrophy in type 2 diabetic rats.	[Horii, Naoki; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport Hlth Sci, Kusatsu, Shiga, Japan; [Sato, Koji] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan; [Mesaki, Noboru] Univ Tsukuba, Tsukuba, Ibaraki, Japan	Ritsumeikan University; Kobe University; University of Tsukuba	Iemitsu, M (corresponding author), Ritsumeikan Univ, Fac Sport Hlth Sci, Kusatsu, Shiga, Japan.	iemitsu@fc.ritsumei.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [26282199, 15H03091]; Grants-in-Aid for Scientific Research [15H03091] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#26282199, M. lemitsu and #15H03091, N. Mesaki). Please show the URL in this grant as follows: https://www.jsps.go.jp/english/ndex.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Therefore, all authors have no conflict of interest.	Aizawa K, 2007, AM J PHYSIOL-ENDOC M, V292, pE577, DOI 10.1152/ajpendo.00367.2006; Almurdhi MM, 2016, DIABETES CARE, V39, P441, DOI 10.2337/dc15-0995; [Anonymous], 2012, GLOBAL STATUS REPORT; Atlantis E, 2009, METABOLISM, V58, P1013, DOI 10.1016/j.metabol.2009.02.027; Bacchi E, 2012, DIABETES CARE, V35, P676, DOI 10.2337/dc11-1655; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Cacho J, 2008, AM J PHYSIOL-ENDOC M, V295, pE1269, DOI 10.1152/ajpendo.90207.2008; Church TS, 2010, JAMA-J AM MED ASSOC, V304, P2253, DOI 10.1001/jama.2010.1710; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; Holten MK, 2004, DIABETES, V53, P294, DOI 10.2337/diabetes.53.2.294; Horii N, 2016, HORM METAB RES, V48, P207, DOI 10.1055/s-0035-1564132; Hornberger TA, 2004, CAN J APPL PHYSIOL, V29, P16, DOI 10.1139/h04-002; Kim JY, 2015, DIABETES METAB J, V39, P424, DOI 10.4093/dmj.2015.39.5.424; Kristiansen S, 2001, AM J PHYSIOL-ENDOC M, V281, pE608, DOI 10.1152/ajpendo.2001.281.3.E608; Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Motamed N, 2016, J DIABETES COMPLICAT, V30, P269, DOI 10.1016/j.jdiacomp.2015.11.019; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000239; Sato K, 2014, FASEB J, V28, P1891, DOI 10.1096/fj.13-245480; Sato K, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-47; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Searls YM, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-8; Sigal RJ, 2007, ANN INTERN MED, V147, P357, DOI 10.7326/0003-4819-147-6-200709180-00005; Srikanthan P, 2011, J CLIN ENDOCR METAB, V96, P2898, DOI 10.1210/jc.2011-0435; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Usui T, 2014, FEBS LETT, V588, P1935, DOI 10.1016/j.febslet.2014.03.051; White JR, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-6; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20; Yamaguchi Y, 1998, CLIN ENDOCRINOL, V49, P377, DOI 10.1046/j.1365-2265.1998.00533.x; Yang ZY, 2014, SPORTS MED, V44, P487, DOI 10.1007/s40279-013-0128-8	32	11	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165689	10.1371/journal.pone.0165689	http://dx.doi.org/10.1371/journal.pone.0165689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832095	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000025
J	Joseph, MB; Stutz, WE; Johnson, PTJ				Joseph, Maxwell B.; Stutz, William E.; Johnson, Pieter T. J.			Multilevel Models for the Distribution of Hosts and Symbionts	PLOS ONE			English	Article							INFECTIOUS-DISEASES; BIOTIC INTERACTIONS; WILDLIFE DISEASE; OCCUPANCY; POPULATION; IMPERFECT; ABUNDANCE; EPIDEMIOLOGY; COOCCURRENCE; PREVALENCE	Symbiont occurrence is influenced by host occurrence and vice versa, which leads to correlations in host-symbiont distributions at multiple levels. Interactions between co-infecting symbionts within host individuals can cause correlations in the abundance of two symbiont species across individual hosts. Similarly, interactions between symbiont transmission and host population dynamics can drive correlations between symbiont and host abundance across habitat patches. If ignored, these interactions can confound estimated responses of hosts and symbionts to other factors. Here, we present a general hierarchical modeling framework for distributions of hosts and symbionts, estimating correlations in host-symbiont distributions at the among-site, within-site, among-species, and among individual levels. We present an empirical example from a multi-host multi-parasite system involving amphibians and their micro- and macroparasites. Amphibian hosts and their parasites were correlated at multiple levels of organization. Macroparasites often co-infected individual hosts, but rarely co-infected with the amphibian chytrid fungus. Such correlations may result from interactions among parasites and hosts, joint responses to environmental factors, or sampling bias. Joint host-symbiont models account for environmental constraints and species interactions while partitioning variance and dependence in abundance at multiple levels. This framework can be adapted to a wide variety of study systems and sampling designs.	[Joseph, Maxwell B.] Univ Colorado, Earth Lab, Boulder, CO 80309 USA; [Stutz, William E.; Johnson, Pieter T. J.] Univ Colorado, Ecol & Evolutionary Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Joseph, MB (corresponding author), Univ Colorado, Earth Lab, Boulder, CO 80309 USA.	maxwell.b.joseph@colorado.edu	Joseph, Maxwell/Z-5422-2019	Joseph, Maxwell/0000-0002-7745-9990; JOHNSON, PIETER/0000-0002-7997-5390	National Institutes of Health, Ecology and Evolution of Infectious Diseases Program [R01GM109499]; National Science Foundation [DEB-1149308]; David and Lucile Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Institutes of Health, Ecology and Evolution of Infectious Diseases Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health, Ecology and Evolution of Infectious Diseases Program (R01GM109499), the National Science Foundation (DEB-1149308), and the David and Lucile Packard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Melina Allahverdian, Dana Calhoun, Kelly DeRolf, Jackie Gregory, Emily Hannon, Jeremy Henderson, Megan Housman, Aaron Klingborg, Bryan LaFonte, Keegan McCaffrey, Travis McDevitt-Galles, Mary Toothman, and Vanessa Wuerthner for assistance with data collection. We also thank Tad Dallas, Helen McCreery, Joseph Mihaljevic, Lauren Shoemaker, Timothy Szewczyk, and Topher Weiss-Lehman for feedback on the manuscript. Finally, we gratefully acknowledge contributions of data and intellectual suggestions from Cheryl Briggs, Jason Hoverman, Jason Rohr, and Andrew Blaustein. This research was supported by funding from the National Institutes of Health, Ecology and Evolution of Infectious Diseases Program (R01GM109499), the National Science Foundation (DEB-1149308), and the David and Lucile Packard Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139; AITCHISON J, 1989, BIOMETRIKA, V76, P643; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; [Anonymous], 2000, CAUSALITY; ASHFORD JR, 1970, BIOMETRICS, V26, P535, DOI 10.2307/2529107; Ashford RW, 2003, EMERG INFECT DIS, V9, P1495; Bailey LL, 2014, METHODS ECOL EVOL, V5, P1269, DOI 10.1111/2041-210X.12100; Bashan Y, 1998, BIOTECHNOL ADV, V16, P729, DOI 10.1016/S0734-9750(98)00003-2; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; Broms KM, 2015, ECOLOGY IN PRESS, DOI [10.1890/15-0416.1, DOI 10.1890/15-0416.1]; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Clark JS, 2014, ECOL APPL, V24, P990, DOI 10.1890/13-1015.1; Dorazio RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094323; Ebert D, 2000, AM NAT, V156, P459, DOI 10.1086/303404; Gelman A., 2007, DATA ANAL USING REGR; He FL, 2003, AM NAT, V162, P366, DOI 10.1086/377190; He FL, 2002, ECOSCIENCE, V9, P119, DOI 10.1080/11956860.2002.11682698; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Holt RD, 2000, ECOL LETT, V3, P41, DOI 10.1046/j.1461-0248.2000.00116.x; Hoverman JT, 2013, OECOLOGIA, V173, P1471, DOI 10.1007/s00442-013-2692-x; Hoverman JT, 2010, DIS AQUAT ORGAN, V89, P97, DOI 10.3354/dao02200; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Johnson PTJ, 2013, NATURE, V494, P230, DOI 10.1038/nature11883; Johnson PTJ, 2012, P NATL ACAD SCI USA, V109, P9006, DOI 10.1073/pnas.1201790109; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 2011, ECOLOGY, V92, P535, DOI 10.1890/10-0570.1; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Joseph MB, 2016, ECOLOGY, V97, P765, DOI 10.1890/15-0833.1; Lachish S, 2012, METHODS ECOL EVOL, V3, P339, DOI 10.1111/j.2041-210X.2011.00156.x; Lewandowski D, 2009, J MULTIVARIATE ANAL, V100, P1989, DOI 10.1016/j.jmva.2009.04.008; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mihaljevic JR, 2012, TRENDS ECOL EVOL, V27, P323, DOI 10.1016/j.tree.2012.01.011; Miller DAW, 2012, METHODS ECOL EVOL, V3, P850, DOI 10.1111/j.2041-210X.2012.00216.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Ovaskainen O, 2010, ECOLOGY, V91, P2514, DOI 10.1890/10-0173.1; Pena D, 2003, J MULTIVARIATE ANAL, V85, P361, DOI 10.1016/S0047-259X(02)00061-1; Pollock LJ, 2014, METHODS ECOL EVOL, V5, P397, DOI 10.1111/2041-210X.12180; Puoti Massimo, 2002, AIDS Reviews, V4, P27; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Royle JA, 2006, ECOLOGY, V87, P835, DOI 10.1890/0012-9658(2006)87[835:GSOMAF]2.0.CO;2; Royle JA, 2005, OIKOS, V110, P353, DOI 10.1111/j.0030-1299.2005.13534.x; SCHRAG SJ, 1995, TRENDS ECOL EVOL, V10, P319, DOI 10.1016/S0169-5347(00)89118-1; Stan Development Team, 2015, STAN C LIB PROB SAMP; Stan Development Team, 2015, RSTAN R INT STAN; Telfer S, 2010, SCIENCE, V330, P243, DOI 10.1126/science.1190333; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x	52	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165768	10.1371/journal.pone.0165768	http://dx.doi.org/10.1371/journal.pone.0165768			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832124	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000033
J	Kanzaki, H; Shinohara, F; Itohiya, K; Yamaguchi, Y; Katsumata, Y; Matsuzawa, M; Fukaya, S; Miyamoto, Y; Wada, S; Nakamura, Y				Kanzaki, Hiroyuki; Shinohara, Fumiaki; Itohiya, Kanako; Yamaguchi, Yuuki; Katsumata, Yuta; Matsuzawa, Masazumi; Fukaya, Sari; Miyamoto, Yutaka; Wada, Satoshi; Nakamura, Yoshiki			RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice	FASEB JOURNAL			English	Article						heme; JNK; bone destruction; NQO1; aminolevulinic acid	TRANSCRIPTIONAL REPRESSOR BACH1; RESISTANT ACID-PHOSPHATASE; HEME OXYGENASE-1; OXIDATIVE STRESS; RESPONSE ELEMENT; GENE-EXPRESSION; BONE-RESORPTION; DIFFERENTIATION; NRF2; INDUCTION	Reactive oxygen species (ROS) play a role in intracellular signaling during osteoclastogenesis. We previously reported that transcriptional factor nuclear factor E2-related factor 2 (Nrf2) was exported from the nucleus to the cytoplasm by receptor activator of nuclear factor-B ligand (RANKL), and that Nrf2 negatively regulated osteoclastogenesis via antioxidant enzyme up-regulation. Knockout mice of BTB and CNC homology 1 (Bach1)the competitor for Nrf2 in transcriptional regulationwas known to attenuate RANKL-mediated osteoclastogenesis, although the mechanism remains unclear. Therefore, we hypothesized that RANKL could be involved in the nuclear translocation of Bach1, which would attenuate Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular ROS signaling in osteoclasts. RANKL induced Bach1 nuclear import and Nrf2 nuclear export. Induction of Bach1 nuclear export increased Nrf2 nuclear import, augmented antioxidant enzyme expression, and, thus, diminished RANKL-mediated osteoclastogenesis via attenuated intracellular ROS signaling. Finally, an in vivo mouse bone destruction model clearly demonstrated that induction of Bach1 nuclear export inhibited bone destruction. In this study, we report that RANKL favors osteoclastogenesis via attenuation of Nrf2-mediated antioxidant enzyme expression by competing with Bach1 nuclear accumulation. Of importance, induction of Bach1 nuclear export activates Nrf2-dependent antioxidant enzyme expression, thereby attenuating osteoclastogenesis. Bach1 nuclear export might be a therapeutic target for such bone destructive diseases as rheumatoid arthritis, osteoporosis, and periodontitis.	[Kanzaki, Hiroyuki] Tohoku Univ Hosp, Maxillooral Disorders, Sendai, Miyagi, Japan; [Kanzaki, Hiroyuki; Itohiya, Kanako; Yamaguchi, Yuuki; Katsumata, Yuta; Matsuzawa, Masazumi; Fukaya, Sari; Miyamoto, Yutaka; Wada, Satoshi; Nakamura, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa, Japan; [Shinohara, Fumiaki] Tohoku Univ, Grad Sch, Oral Microbiol, Sendai, Miyagi, Japan	Tohoku University; Tsurumi University; Tohoku University	Kanzaki, H (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Orthodont, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	kanzaki-h@tsurumi-u.ac.jp	Kanzaki, Hiroyuki/C-7942-2018; Kanzaki, Hiroyuki/M-2764-2019	Kanzaki, Hiroyuki/0000-0003-3473-1218; Kanzaki, Hiroyuki/0000-0003-3473-1218	Japan Society for the Promotion of Science [23689081, 25670841, 15K11376]; Nestle Nutrition Council of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [A-03]; Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency [AS231Z01205G]; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [16K11797] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nestle Nutrition Council of Japan(Nestle SA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23689081, 25670841, and 15K11376); the Nestle Nutrition Council of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (A-03); Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency (AS231Z01205G); and the Astellas Foundation for Research on Metabolic Disorders. The authors thank Eisai Food and Chemical for providing sodium ferrous citrate. Finally, H.K. and F.S. give their heartfelt appreciation to the experimental reagent companies and instrument companies for their various support in the rehabilitation from the damage caused by the Tohoku earthquake on March 11, 2011. The authors declare no conflicts of interest.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Chiurchiu V, 2011, ANTIOXID REDOX SIGN, V15, P2605, DOI 10.1089/ars.2010.3547; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Haro ERA, 2011, J PERIODONTAL RES, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Kanzaki H, 2015, J DENT RES, V94, P787, DOI 10.1177/0022034515577814; Kanzaki H, 2016, REDOX BIOL, V8, P186, DOI 10.1016/j.redox.2016.01.006; Kanzaki H, 2014, FREE RADICAL BIO MED, V77, P239, DOI 10.1016/j.freeradbiomed.2014.09.006; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Kwak HB, 2008, BIOCHEM BIOPH RES CO, V377, P1, DOI 10.1016/j.bbrc.2008.05.048; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamp EC, 2000, LEUKEMIA LYMPHOMA, V39, P477, DOI 10.3109/10428190009113378; Nishio Y, 2014, INT IMMUNOPHARMACOL, V19, P300, DOI 10.1016/j.intimp.2014.02.003; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wild AC, 1998, BIOCHEM J, V332, P373, DOI 10.1042/bj3320373; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Zhao HY, 2015, CYTOKINE, V71, P199, DOI 10.1016/j.cyto.2014.10.007	39	38	39	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					781	792		10.1096/fj.201600826R	http://dx.doi.org/10.1096/fj.201600826R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836987				2022-12-26	WOS:000394235400030
J	Terashima, M; Tange, S; Ishimura, A; Suzuki, T				Terashima, Minoru; Tange, Shoichiro; Ishimura, Akihiko; Suzuki, Takeshi			MEG3 Long Noncoding RNA Contributes to the Epigenetic Regulation of Epithelial-Mesenchymal Transition in Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELLS; TUMOR-SUPPRESSOR; GENE-EXPRESSION; MIR-200 FAMILY; X-CHROMOSOME; E-CADHERIN; TGF-BETA; HISTONE; JARID2; PRC2	Histone methylation is implicated in a number of biological and pathological processes, including cancer development. In this study, we investigated the molecular mechanism for the recruitment of Polycomb repressive complex-2 (PRC2) and its accessory component, JARID2, to chromatin, which regulates methylation of lysine 27 of histone H3 (H3K27), during epithelial-mesenchymal transition (EMT) of cancer cells. The expression of MEG3 long noncoding RNA (lncRNA), which could interact with JARID2, was clearly increased during transforming growth factor-beta (TGF-beta)-induced EMT of human lung cancer cell lines. Knockdown of MEG3 inhibited TGF-beta-mediated changes in cell morphology and cell motility characteristic of EMT and counteracted TGF-beta-dependent changes in the expression of EMT-related genes such as CDH1, ZEB family, and the microRNA-200 family. Overexpression of MEG3 influenced the expression of these genes and enhanced the effects of TGF-beta in their expressions. Chromatin immunoprecipitation (ChIP) revealed that MEG3 regulated the recruitment of JARID2 and EZH2 and histone H3 methylation on the regulatory regions of CDH1 and microRNA-200 family genes for transcriptional repression. RNA immunoprecipitation and chromatin isolation by RNA purification assays indicated that MEG3 could associate with JARID2 and the regulatory regions of target genes to recruit the complex. This study demonstrated a crucial role of MEG3 lncRNA in the epigenetic regulation of the EMT process in lung cancer cells.	[Terashima, Minoru; Tange, Shoichiro; Ishimura, Akihiko; Suzuki, Takeshi] Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University	Suzuki, T (corresponding author), Kanazawa Univ, Canc Res Inst, Div Funct Genom, Kanazawa, Ishikawa 9201192, Japan.	suzuki-t@staff.kanazawa-u.ac.jp	Terashima, Minoru/D-8462-2015	Suzuki, Takeshi/0000-0002-1737-0900	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590346, 15K08263]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research C 24590346 and 15K08263 (to T. S.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bartonicek N, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0530-6; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Chu Ci, 2012, J Vis Exp, DOI 10.3791/3912; da Rocha ST, 2014, MOL CELL, V53, P301, DOI 10.1016/j.molcel.2014.01.002; Davalos V, 2012, ONCOGENE, V31, P2062, DOI 10.1038/onc.2011.383; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Enkhbaatar Z, 2013, CELL CYCLE, V12, P2100, DOI 10.4161/cc.25142; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-669; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lin T, 2010, ONCOGENE, V29, P4896, DOI 10.1038/onc.2010.234; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyazono K, 2012, UPSALA J MED SCI, V117, P143, DOI 10.3109/03009734.2011.638729; Oktyabri D, 2016, BIOCHIMIE, V123, P20, DOI 10.1016/j.biochi.2016.01.005; Oktyabri D, 2014, BIOCHEM BIOPH RES CO, V453, P124, DOI 10.1016/j.bbrc.2014.09.082; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Puda A, 2012, AM J HEMATOL, V87, P245, DOI 10.1002/ajh.22257; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Suzuki T, 2013, CANCER SCI, V104, P795, DOI 10.1111/cas.12169; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tange S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115684; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Walters ZS, 2014, ONCOGENE, V33, P1148, DOI 10.1038/onc.2013.46; Wang Y, 2013, EXP CELL RES, V319, P160, DOI 10.1016/j.yexcr.2012.07.019; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yoshida M, 2011, BIOCHEM J, V437, P555, DOI 10.1042/BJ20110343; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	56	140	151	1	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 6	2017	292	1					82	99		10.1074/jbc.M116.750950	http://dx.doi.org/10.1074/jbc.M116.750950			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2DQ	27852821	Green Published, hybrid			2022-12-26	WOS:000391578000008
J	Karlshoj, S; Amarandi, RM; Larsen, O; Daugvilaite, V; Steen, A; Brvar, M; Pui, A; Frimurer, TM; Ulven, T; Rosenkilde, MM				Karlshoj, Stefanie; Amarandi, Roxana Maria; Larsen, Olav; Daugvilaite, Viktorija; Steen, Anne; Brvar, Matjaz; Pui, Aurel; Frimurer, Thomas Michael; Ulven, Trond; Rosenkilde, Mette Marie			Molecular Mechanism of Action for Allosteric Modulators and Agonists in CC-chemokine Receptor 5 (CCR5)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-ION SITE; 7-TRANSMEMBRANE RECEPTOR; TRANSMEMBRANE HELIX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; HIV-1 INFECTION; BINDING-SITE; ACTIVATION; SWITCH; LIGAND	The small molecule metal ion chelators bipyridine and terpyridine complexed with Zn2+ (ZnBip and ZnTerp) act as CCR5 agonists and strong positive allosteric modulators of CCL3 binding to CCR5, weak modulators of CCL4 binding, and competitors for CCL5 binding. Here we describe their binding site using computational modeling, binding, and functional studies on WT and mutated CCR5. The metal ion Zn2+ is anchored to the chemokine receptor-conserved Glu-283(VII:06/7.39). Both chelators interact with aromatic residues in the transmembrane receptor domain. The additional pyridine ring of ZnTerp binds deeply in the major binding pocket and, in contrast to ZnBip, interacts directly with the Trp-248(VI:13/6.48) microswitch, contributing to its 8-fold higher potency. The impact of Trp-248 was further confirmed by ZnClTerp, a chloro-substituted version of ZnTerp that showed no inherent agonism but maintained positive allosteric modulation of CCL3 binding. Despite a similar overall binding mode of all three metal ion chelator complexes, the pyridine ring of ZnClTerp blocks the conformational switch of Trp-248 required for receptor activation, thereby explaining its lack of activity. Importantly, ZnClTerp becomes agonist to the same extent as ZnTerp upon Ala mutation of Ile-116(III:16/3.40), a residue that constrains the Trp-248 microswitch in its inactive conformation. Binding studies with I-125-CCL3 revealed an allosteric interface between the chemokine and the small molecule binding site, including residues Tyr-37(I:07/1.39), Trp-86(II:20/2.60), and Phe-109(III:09/3.33). The small molecules and CCL3 approach this interface from opposite directions, with some residues being mutually exploited. This study provides new insight into the molecular mechanism of CCR5 activation and paves the way for future allosteric drugs for chemokine receptors.	[Karlshoj, Stefanie; Amarandi, Roxana Maria; Larsen, Olav; Daugvilaite, Viktorija; Steen, Anne; Rosenkilde, Mette Marie] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3,Panum Bldg 18-5, DK-2200 Copenhagen, Denmark; [Amarandi, Roxana Maria; Pui, Aurel] Alexandru Ioan Cuza Univ, Fac Chem, Bd Carol 11, RO-700506 Iasi, Romania; [Frimurer, Thomas Michael] Univ Copenhagen, Sect Metab Receptol & Enteroendocrinol, Novo Nordisk Fdn Ctr Basic Metab Res, Fac Hlth Sci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Brvar, Matjaz; Ulven, Trond] Univ Southern Denmark, Dept Chem & Phys, Campusvej 55, DK-5230 Odense, Denmark	University of Copenhagen; Alexandru Ioan Cuza University; Novo Nordisk Foundation; University of Copenhagen; University of Southern Denmark	Rosenkilde, MM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci & Pharmacol, Mol Pharmacol Lab, Blegdamsvej 3,Panum Bldg 18-5, DK-2200 Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Ulven, Trond/H-5500-2015; Daugvilaite, Viktorija/AAI-1490-2019; Amarandi, Roxana-Maria/AAR-8564-2021; DAUGVILAITE, VIKTORIJA/E-2573-2017	Ulven, Trond/0000-0002-8135-1755; Daugvilaite, Viktorija/0000-0001-8786-348X; DAUGVILAITE, VIKTORIJA/0000-0001-8786-348X; Brvar, Matjaz/0000-0001-7995-7902; Rosenkilde, Mette Marie/0000-0001-9600-3254; Karlshoj, Stefanie/0000-0001-6505-0883; Amarandi, Roxana-Maria/0000-0002-9937-6539; Frimruer, Thomas/0000-0002-9682-8245; Pui, Aurel/0000-0002-0343-5718	AP Moller Maersk Foundation; Aase and Einar Danielsen Foundation; Horslev Foundation; Novo Nordisk Fonden [NNF12OC0001900] Funding Source: researchfish	AP Moller Maersk Foundation; Aase and Einar Danielsen Foundation; Horslev Foundation; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in whole or part by the AP Moller Maersk Foundation, the Aase and Einar Danielsen Foundation, and the Horslev Foundation. The authors declare that they have no conflicts of interest with the contents of this article.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Amarandi RM, 2016, METHOD ENZYMOL, V570, P155, DOI 10.1016/bs.mie.2015.09.001; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanpain C, 2003, J BIOL CHEM, V278, P5179, DOI 10.1074/jbc.M205684200; Brandish PE, 2003, ANAL BIOCHEM, V313, P311, DOI 10.1016/S0003-2697(02)00630-9; Burg JS, 2015, SCIENCE, V347, P1113, DOI 10.1126/science.aaa5026; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Elling CE, 1999, P NATL ACAD SCI USA, V96, P12322, DOI 10.1073/pnas.96.22.12322; ELLING CE, 1995, NATURE, V374, P74, DOI 10.1038/374074a0; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Govaerts C, 2003, J BIOL CHEM, V278, P1892, DOI 10.1074/jbc.M205685200; Govaerts C, 2001, J BIOL CHEM, V276, P13217, DOI 10.1074/jbc.M011670200; Holst B, 2000, MOL PHARMACOL, V58, P263, DOI 10.1124/mol.58.2.263; Ioachim E, 2005, EUR J ORG CHEM, V2005, P3775, DOI 10.1002/ejoc.200500335; Jensen PC, 2008, J BIOL CHEM, V283, P23121, DOI 10.1074/jbc.M803458200; Kissow H, 2012, REGUL PEPTIDES, V179, P91, DOI 10.1016/j.regpep.2012.08.016; Klein A, 2014, J ORGANOMET CHEM, V774, P86, DOI 10.1016/j.jorganchem.2014.10.013; Kufareva I, 2015, IMMUNOL CELL BIOL, V93, P372, DOI 10.1038/icb.2015.15; Liu KM, 2015, CHEM COMMUN, V51, P1124, DOI 10.1039/c4cc08494b; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Maeda K, 2006, J BIOL CHEM, V281, P12688, DOI 10.1074/jbc.M512688200; Maeda K, 2004, J VIROL, V78, P8654, DOI 10.1128/JVI.78.16.8654-8662.2004; Mirzadegan T, 2000, J BIOL CHEM, V275, P25562, DOI 10.1074/jbc.M000692200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Pedretti A, 2004, J COMPUT AID MOL DES, V18, P167, DOI 10.1023/B:JCAM.0000035186.90683.f2; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Proudfoot AEI, 2010, EXPERT OPIN INV DRUG, V19, P345, DOI 10.1517/13543780903535867; Qin L, 2015, SCIENCE, V347, P1117, DOI 10.1126/science.1261064; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenkilde MM, 2007, MOL PHARMACOL, V71, P930, DOI 10.1124/mol.106.030031; Rosenkilde MM, 2006, MOL PHARMACOL, V70, P1892, DOI 10.1124/mol.106.027425; Rosenkilde MM, 2006, CURR TOP MED CHEM, V6, P1319, DOI 10.2174/15680266106061319; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 1998, FEBS LETT, V439, P35, DOI 10.1016/S0014-5793(98)01331-3; ROSENKILDE MM, 1994, J BIOL CHEM, V269, P28160; Rosenkilde MM, 1999, J BIOL CHEM, V274, P956, DOI 10.1074/jbc.274.2.956; Saita Y, 2006, J IMMUNOL, V177, P3116, DOI 10.4049/jimmunol.177.5.3116; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Santos-Martins D, 2014, J CHEM INF MODEL, V54, P2371, DOI 10.1021/ci500209e; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Scholten DJ, 2012, BRIT J PHARMACOL, V165, P1617, DOI 10.1111/j.1476-5381.2011.01551.x; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seibert C, 2006, VIROLOGY, V349, P41, DOI 10.1016/j.virol.2006.01.018; Steen A, 2014, BRIT J PHARMACOL, V171, P1566, DOI 10.1111/bph.12553; Steen A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00277; Steen A, 2013, J BIOL CHEM, V288, P12511, DOI 10.1074/jbc.M112.449587; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thiele S, 2014, BRIT J PHARMACOL, V171, P5313, DOI 10.1111/bph.12842; Thiele S, 2014, CURR MED CHEM, V21, P3594, DOI 10.2174/0929867321666140716093155; Thiele S, 2012, J MED CHEM, V55, P8164, DOI 10.1021/jm301121j; Thiele S, 2011, J BIOL CHEM, V286, P37543, DOI 10.1074/jbc.M111.243808; Thirstrup K, 1996, J BIOL CHEM, V271, P7875, DOI 10.1074/jbc.271.14.7875; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhao LX, 2006, ARCH PHARM RES, V29, P1091, DOI 10.1007/BF02969297	60	9	9	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26860	26874		10.1074/jbc.M116.740183	http://dx.doi.org/10.1074/jbc.M116.740183			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834679	hybrid, Green Published			2022-12-26	WOS:000391571400023
J	Buchhorn, R; Meint, S; Willaschek, C				Buchhorn, Reiner; Meint, Sebastian; Willaschek, Christian			The Impact of Early Life Stress on Growth and Cardiovascular Risk: A Possible Example for Autonomic Imprinting?	PLOS ONE			English	Article							CHILDHOOD SHORT STATURE; HORMONE TREATMENT; PREDICTOR; CHILDREN; SYSTEM	Introduction Early life stress is imprinting regulatory properties with life-long consequences. We investigated heart rate variability in a group of small children with height below the third percentile, who experienced an episode of early life stress due to heart failure or intra uterine growth retardation. These children appear to develop autonomic dysfunction in later life. Results Compared to the healthy control group heart rate variability (HRV) is reduced on average in a group of 101 children with short stature. Low HRV correlates to groups of children born small for gestational age (SGA), children with cardiac growth failure and children with congenital syndromes, but not to those with constitutional growth delay (CGD), who had normal HRV. Reduced HRV indicated by lower RMSSD and High Frequency (HF)-Power is indicating reduced vagal activity as a sign of autonomic imbalance. Conclusion It is not short stature itself, but rather the underlying diseases that are the cause for reduced HRV in children with height below the third percentile. These high risk children-allocated in the groups with an adverse autonomic imprinting in utero or infancy (SGA, congenital heart disease and congenital syndromes)-have the highest risk for 'stress diseases' such as cardiovascular disease in later life. The incidence of attention deficit disorder is remarkably high in our group of short children.	[Buchhorn, Reiner; Meint, Sebastian; Willaschek, Christian] Caritas Krankenhaus, Dept Pediat, Bad Mergentheim, Germany	Caritas Hospital Bad Mergentheim	Willaschek, C (corresponding author), Caritas Krankenhaus, Dept Pediat, Bad Mergentheim, Germany.	christian.willaschek@ckbm.de		Willaschek, Christian/0000-0003-1980-9638	Blaschek foundation	Blaschek foundation	We thank the "Blaschek foundation" who supports us by covering the publication fees for this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DJP, 1989, LANCET, V2, P577; Begum G, 2012, FASEB J, V26, P1694, DOI 10.1096/fj.11-198762; Buchhorn R, 2016, HEART CARDIOL, V1; Buchhorn R, 2016, INT J FOOD NUTR SCI, V3, P1, DOI [10.15436/2377-0619.16.942, DOI 10.15436/2377-0619.16.942]; Buchhorn R, 2012, ADHD-ATTEND DEFICIT, V4, P85, DOI 10.1007/s12402-012-0072-8; Camm AJ, 1996, CIRCULATION, V93, P1043; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Daymont C, 2013, PEDIATRICS, V131, pE236, DOI 10.1542/peds.2012-1157; De Bock F, 2013, INT J CARDIOL, V170, pE30, DOI 10.1016/j.ijcard.2013.10.067; de Bruin C, 2016, CURR OPIN ENDOCRINOL, V23, P51, DOI 10.1097/MED.0000000000000209; Franco MCP, 2008, CLIN SCI, V114, P375, DOI 10.1042/CS20070284; Fujioka K, 2014, J PERINATOL, V34, P6, DOI 10.1038/jp.2013.119; Hess SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122242; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Kapoor A, 2006, J PHYSIOL-LONDON, V572, P31, DOI 10.1113/jphysiol.2006.105254; Manhardt LB, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/983468; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Paul MA, 2009, PEDIATR CARDIOL, V30, P1094, DOI 10.1007/s00246-009-9503-5; Poidvin A, 2014, NEUROLOGY, V83, P780, DOI 10.1212/WNL.0000000000000737; Ravishankar C, 2013, J PEDIATR-US, V162, P250, DOI 10.1016/j.jpeds.2012.07.048; Sandberg DE, 2002, BEST PRACT RES CL EN, V16, P449, DOI 10.1053/beem.2002.0211; Schaffer L, 2008, AM J PHYSIOL-HEART C, V294, pH884, DOI 10.1152/ajpheart.00318.2007; Simeone P, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12047; Waterland RA, 1999, AM J CLIN NUTR, V69, P179; Willaschek C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137643; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wulsin LR, 2015, J CLIN ENDOCR METAB, V100, P2443, DOI 10.1210/jc.2015-1748	27	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166447	10.1371/journal.pone.0166447	http://dx.doi.org/10.1371/journal.pone.0166447			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861527	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300056
J	Zinkstok, SM; Beenen, LF; Luitse, JS; Majoie, CB; Nederkoorn, PJ; Roos, YB				Zinkstok, Sanne M.; Beenen, Ludo F.; Luitse, Jan S.; Majoie, Charles B.; Nederkoorn, Paul J.; Roos, Yvo B.			Thrombolysis in Stroke within 30 Minutes: Results of the Acute Brain Care Intervention Study	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ACUTE ISCHEMIC-STROKE; TO-NEEDLE TIMES; CODE STROKE; INTRAVENOUS THROMBOLYSIS; IMPROVEMENT; TRIALS; PROTOCOL; DELAYS	Background and Purpose Time is brain: benefits of intravenous thrombolysis (IVT) in ischemic stroke last for 4.5 hours but rapidly decrease as time progresses following symptom onset. The goal of the Acute Brain Care (ABC) intervention study was to reduce the door-to-needle time (DNT) to <= 30 minutes by optimizing in-hospital stroke treatment. Methods We performed a single-centre before (pre-intervention period: 2000-2005) versus after (post-intervention period: 2006-2012) comparison in a cohort of consecutive patients treated with IVT. The intervention consisted of the implementation of a multidisciplinary stroke protocol combining simple strategies to reduce the DNT. Primary endpoint was the DNT, presented as proportion <= 30 minutes and median time. Secondary clinical endpoints were symptomatic intracranial hemorrhage (SICH), and favourable outcome defined as a modified Rankin scale (mRs) score of 0-2 at 3 months. Endpoints were additionally adjusted for baseline imbalances between the groups. Results In the pre-intervention period, none (0.0%) of the 100 patients (mean age 63.8 years, median National Institutes of Health Stroke Scale [ NIHSS] score 14) treated with IVT had a DNT <= 30 minutes compared to 234 (62.7%) of the 373 patients (mean age 66.7 years, median NIHSS score 10) in the post-intervention period (p<0.001). The median DNT decreased from 75 (IQR 60-105) to 28 minutes (IQR 20-37, p<0.001). SICH rate remained stable (3.0% versus 4.4%, OR 1.50, 95% CI 0.43-5.25; adjusted OR 5.47, 95% CI 0.69-42.12).The proportion of patients with a favourable outcome increased (38.9% versus 52.3%, OR 1.72, 95% CI 1.09-2.73) but lost statistical significance after adjustment (adjusted OR 1.46, 95% CI 0.82-2.61). Conclusions Important and sustained reduction of the DNT to 30 minutes or less can be safely achieved by optimizing in-hospital stroke treatment. With its simple strategies, the ABC-protocol is a pragmatic framework for increasing the therapeutic yield in time-dependent stroke treatment.	[Zinkstok, Sanne M.; Nederkoorn, Paul J.; Roos, Yvo B.] Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Beenen, Ludo F.; Majoie, Charles B.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Luitse, Jan S.] Univ Amsterdam, Acad Med Ctr, Dept Emergency Med, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Roos, YB (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands.	y.b.roos@amc.uva..nl	Roos, Yvo BWEM/B-9843-2013; Beenen, Ludo F/AAA-3114-2021	Beenen, Ludo F/0000-0001-9204-1026; Majoie, Charles/0000-0002-7600-9568				[Anonymous], 2000, Circulation, V102, pI172; Brandler ES, 2015, J STROKE CEREBROVASC, V24, P2161, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.004; Breuer L, 2010, STROKE, V41, P2867, DOI 10.1161/STROKEAHA.110.578062; Chen CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112228; Committee on Trauma American College of Surgeons, 2004, ADV TRAUMA LIFE SUPP; El Husseini N, 2013, J STROKE CEREBROVASC, V22, P345, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.012; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fonarow GC, 2014, JAMA-J AM MED ASSOC, V311, P1632, DOI 10.1001/jama.2014.3203; Frank B, 2013, STROKE, V44, P727, DOI 10.1161/STROKEAHA.112.674622; Ghrooda E, 2012, CAN J NEUROL SCI, V39, P789, DOI 10.1017/S0317167100015626; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Green TL, 2008, CAN J NEUROL SCI, V35, P348, DOI 10.1017/S0317167100008945; Gumbinger C, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3429; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Harbison J, 1999, LANCET, V353, P1935, DOI 10.1016/S0140-6736(99)00966-6; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kim SK, 2009, EUR J NEUROL, V16, P1331, DOI 10.1111/j.1468-1331.2009.02762.x; Kohrmann M, 2011, INT J STROKE, V6, P493, DOI 10.1111/j.1747-4949.2011.00585.x; Kruyt ND, 2013, STROKE, V44, P3249, DOI 10.1161/STROKEAHA.113.001885; Levine SR, 2013, STROKE, V44, P2500, DOI 10.1161/STROKEAHA.113.000878; Meretoja A, 2012, NEUROLOGY, V79, P306, DOI 10.1212/WNL.0b013e31825d6011; Oostema JA, 2015, STROKE, V46, P1513, DOI 10.1161/STROKEAHA.115.008650; Ruff IM, 2014, STROKE, V45, P504, DOI 10.1161/STROKEAHA.113.004073; Sattin JA, 2006, STROKE, V37, P2935, DOI 10.1161/01.STR.0000249057.44420.4b; Saver JL, 2013, JAMA-J AM MED ASSOC, V309, P2480, DOI 10.1001/jama.2013.6959; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Smith C, 2014, INT J STROKE, V9, P939, DOI 10.1111/j.1747-4949.2012.00924.x; Sohn SW, 2015, J STROKE CEREBROVASC, V24, P465, DOI 10.1016/j.jstrokecerebrovasdis.2014.09.020; Strbian D, 2015, STROKE, V46, P1275, DOI 10.1161/STROKEAHA.114.007170; Studnek JR, 2013, PREHOSP EMERG CARE, V17, P348, DOI 10.3109/10903127.2013.773113; Van de Werf F, 2003, EUR HEART J, V24, P28, DOI 10.1016/S0195-668X(02)00618-8; Van Schaik SM, 2014, J STROKE CEREBROVASC, V23, P2900, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.025; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Zinkstok SM, 2013, STROKE, V44, P1080, DOI 10.1161/STROKEAHA.111.000126	35	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166668	10.1371/journal.pone.0166668	http://dx.doi.org/10.1371/journal.pone.0166668			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861540	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300085
J	Cote-Gravel, J; Brouillette, E; Obradovic, N; Ster, C; Talbot, BG; Malouin, F				Cote-Gravel, Julie; Brouillette, Eric; Obradovic, Natasa; Ster, Celine; Talbot, Brian G.; Malouin, Francois			Characterization of a vraG Mutant in a Genetically Stable Staphylococcus aureus Small-Colony Variant and Preliminary Assessment for Use as a Live-Attenuated Vaccine against Intrammamary Infections	PLOS ONE			English	Article							BOVINE INTRAMAMMARY INFECTIONS; ABC TRANSPORTER; REGULATORY SYSTEM; MOUSE MASTITIS; RESISTANCE; MYELOPEROXIDASE; COLONIZATION; VIRULENCE; PROTEINS; EFFICACY	Staphylococcus aureus is a leading cause of bovine intramammary infections (IMIs) that can evolve into difficult-to-treat chronic mastitis. To date, no vaccine formulation has shown high protective efficacy against S. aureus IMI, partly because this bacterium can efficiently evade the immune system. For instance, S. aureus small colony variants (SCVs) have intracellular abilities and can persist without producing invasive infections. As a first step towards the development of a live vaccine, this study describes the elaboration of a novel attenuated mutant of S. aureus taking advantage of the SCV phenotype. A genetically stable SCV was created through the deletion of the hemB gene, impairing its ability to adapt and revert to the invasive phenotype. Further attenuation was obtained through inactivation of gene vraG (SACOL0720) which we previously showed to be important for full virulence during bovine IMIs. After infection of bovine mammary epithelial cells (MAC-T), the double mutant (Delta vraG Delta hemB) was less internalized and caused less cell destruction than that seen with Delta hemB and Delta vraG, respectively. In a murine IMI model, the Delta vraG Delta hemB mutant was strongly attenuated, with a reduction of viable counts of up to 5-log10 CFU/g of mammary gland when compared to the parental strain. A complete clearance of Delta vraG Delta hemB from glands was observed whereas mortality rapidly (48h) occurred with the wild-type strain. Immunization of mice using subcutaneous injections of live Delta vraG Delta hemB raised a strong immune response as judged by the high total IgG titers measured against bacterial cell extracts and by the high IgG2a/IgG1 ratio observed against the IsdH protein. Also, Delta vraG Delta hemB had sufficient common features with bovine mastitis strains so that the antibody response also strongly recognized strains from a variety of mastitis associated spa types. This double mutant could serve as a live-attenuated component in vaccines to improve cell-mediated immune responses against S. aureus IMIs.	[Cote-Gravel, Julie; Brouillette, Eric; Obradovic, Natasa; Ster, Celine; Talbot, Brian G.; Malouin, Francois] Univ Sherbrooke, CEVDM, Dept Biol, Fac Sci, Sherbrooke, PQ, Canada	University of Sherbrooke	Malouin, F (corresponding author), Univ Sherbrooke, CEVDM, Dept Biol, Fac Sci, Sherbrooke, PQ, Canada.	Francois.Malouin@USherbrooke.ca	Ster, Céline/AAT-2620-2020	Malouin, Francois/0000-0001-5031-345X	discovery grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada [2015-05916]; Canadian Bovine Mastitis and Milk Quality Research Network (Universite de Montreal, St-Hyacinthe, QC, Canada); Op+Lait; Regroupement pour un lait de qualite optimale (Universite de Montreal, St-Hyacinthe, QC, Canada) - Fonds de recherche du Quebec - Nature et technologies (FRONT); NSERC CREATE program	discovery grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Bovine Mastitis and Milk Quality Research Network (Universite de Montreal, St-Hyacinthe, QC, Canada); Op+Lait; Regroupement pour un lait de qualite optimale (Universite de Montreal, St-Hyacinthe, QC, Canada) - Fonds de recherche du Quebec - Nature et technologies (FRONT); NSERC CREATE program	This research was supported by discovery grants from the Natural Sciences and Engineering Research Council (NSERC) of Canada to B. Talbot and to F. Malouin (2015-05916). We also acknowledge support from the Canadian Bovine Mastitis and Milk Quality Research Network (Universite de Montreal, St-Hyacinthe, QC, Canada) as well as from Op+Lait, the Regroupement pour un lait de qualite optimale (Universite de Montreal, St-Hyacinthe, QC, Canada) supported by the Fonds de recherche du Quebec - Nature et technologies (FRONT). JCG received studentships from Op+Lait and the NSERC CREATE program. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Charles Isabelle for technical assistance and Diana-Vanessa Bran-Barrera for performing preliminary and supporting experiments. The authors also want to acknowledge support from the Canadian Bovine Mastitis and Milk Quality Research Network (Universite de Montreal, St-Hyacinthe, QC, Canada) as well as from Op<SUP>+</SUP>Lait, the Regroupement pour un lait de qualite optimale (Universite de Montreal, St-Hyacinthe, QC, Canada). JCG is thankful for receiving studentships from Op+Lait and the NSERC CREATE in milk quality program in support of her doctoral studies. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard M, 2013, VET MICROBIOL, V162, P761, DOI 10.1016/j.vetmic.2012.09.029; Asli A, 2016, ANTIMICROB AGENTS CH, V60, P752, DOI 10.1128/AAC.02102-15; Atalla Heba, 2011, Animal Health Research Reviews, V12, P33, DOI 10.1017/S1466252311000065; Bharathan M, 2011, J MAMMARY GLAND BIOL, V16, P409, DOI 10.1007/s10911-011-9233-1; BRADLEY PP, 1982, BLOOD, V60, P618; Brouillette E, 2005, MICROBES INFECT, V7, P560, DOI 10.1016/j.micinf.2004.11.008; Brouillette E, 2005, VET IMMUNOL IMMUNOP, V104, P163, DOI 10.1016/j.vetimm.2004.11.006; Brouillette E, 2004, FEMS IMMUNOL MED MIC, V41, P35, DOI 10.1016/j.femsim.2003.12.007; Bruckner R, 1997, FEMS MICROBIOL LETT; Buzzola FR, 2007, INFECT IMMUN, V75, P886, DOI 10.1128/IAI.01215-06; Buzzola FR, 2006, INFECT IMMUN, V74, P3498, DOI 10.1128/IAI.01507-05; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Cheung AL, 2014, INFECT IMMUN, V82, P5336, DOI 10.1128/IAI.02480-14; Cui LZ, 2005, ANTIMICROB AGENTS CH, V49, P3404, DOI 10.1128/AAC.49.8.3404-3413.2005; Detmer A, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-23; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Foster TJ, 2009, VET DERMATOL, V20, P456, DOI 10.1111/j.1365-3164.2009.00825.x; Fowler VG, 2014, CLIN MICROBIOL INFEC, V20, P66, DOI 10.1111/1469-0691.12570; Garcia V, 1996, FEMS IMMUNOL MED MIC, V14, P45, DOI 10.1016/0928-8244(96)00020-X; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Gaupp R, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00033; Glaser R, 2014, J INVEST DERMATOL, V134, P2347, DOI 10.1038/jid.2014.176; Gogoi-Tiwari J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148383; Gogoi-Tiwari J, 2015, BIOFOULING, V31, P543, DOI 10.1080/08927014.2015.1074681; Kafala B, 1997, GENE, V199, P231, DOI 10.1016/S0378-1119(97)00372-7; Kawada-Matsuo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069455; Kawada-Matsuo M, 2011, VIRULENCE, V2, P427, DOI 10.4161/viru.2.5.17711; Koo SP, 1996, INFECT IMMUN, V64, P1070, DOI 10.1128/IAI.64.3.1070-1074.1996; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Kuroda M, 2000, BIOCHEM BIOPH RES CO, V269, P485, DOI 10.1006/bbrc.2000.2277; Li M, 2007, MOL MICROBIOL, V66, P1136, DOI 10.1111/j.1365-2958.2007.05986.x; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Loffler B, 2014, INT J MED MICROBIOL, V304, P170, DOI 10.1016/j.ijmm.2013.11.011; Meehl M, 2007, ANTIMICROB AGENTS CH, V51, P2679, DOI 10.1128/AAC.00209-07; Middleton JR, 2008, EXPERT REV VACCINES, V7, P805, DOI 10.1586/14760584.7.6.805; Middleton JR, 2009, VET MICROBIOL, V134, P192, DOI 10.1016/j.vetmic.2008.09.053; Mitchell G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065018; Mitchell G, 2011, INFECT IMMUN, V79, P3541, DOI 10.1128/IAI.00078-11; Mitchell G, 2008, MOL MICROBIOL, V70, P1540, DOI 10.1111/j.1365-2958.2008.06511.x; Mitra SD, 2013, J APPL MICROBIOL, V114, P1604, DOI 10.1111/jam.12186; Moisan FN, 2006, J BACTERIOL, V188, P64, DOI 10.1128/JB.188.1.64-76.2006; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; Otto M, 2013, ANNU REV MED, V64, P175, DOI 10.1146/annurev-med-042711-140023; Overton IM, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-68; Pasetti MF, 2011, IMMUNOL REV, V239, P125, DOI 10.1111/j.1600-065X.2010.00970.x; Pellegrino M, 2010, VACCINE, V28, P4523, DOI 10.1016/j.vaccine.2010.04.056; Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384; Proctor RA, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00099; Proctor RA, 2012, CLIN INFECT DIS, V54, P1179, DOI 10.1093/cid/cis033; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Reyher KK, 2011, J DAIRY SCI, V94, P1616, DOI 10.3168/jds.2010-3180; Sadowska B, 2002, FEMS IMMUNOL MED MIC, V32, P191, DOI 10.1111/j.1574-695X.2002.tb00553.x; Sendi P, 2009, TRENDS MICROBIOL, V17, P54, DOI 10.1016/j.tim.2008.11.004; Senn MM, 2005, J BACTERIOL, V187, P7397, DOI 10.1128/JB.187.21.7397-7406.2005; Barbagelata MS, 2011, MICROBES INFECT, V13, P1081, DOI 10.1016/j.micinf.2011.06.010; Spellberg B, 2012, SEMIN IMMUNOPATHOL, V34, P335, DOI 10.1007/s00281-011-0293-5; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Ster C, 2013, J DAIRY SCI, V96, P1000, DOI 10.3168/jds.2012-5890; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; SUTRA L, 1994, J MED MICROBIOL, V40, P79, DOI 10.1099/00222615-40-2-79; Tuchscherr L, 2011, EMBO MOL MED, V3, P129, DOI 10.1002/emmm.201000115; Tuchscherr L, 2010, J INFECT DIS, V202, P1031, DOI 10.1086/656047; Veh KA, 2015, J DAIRY SCI, V98, P155, DOI 10.3168/jds.2014-8044; von Eiff C, 2006, J BACTERIOL, V188, P687, DOI 10.1128/JB.188.2.687-693.2006; WATSON DL, 1984, J DAIRY SCI, V67, P2608, DOI 10.3168/jds.S0022-0302(84)81620-3; Whist AC, 2009, J DAIRY RES, V76, P24, DOI 10.1017/S0022029908003592; Xia Y, 1997, ANAL BIOCHEM, V245, P93, DOI 10.1006/abio.1996.9940; Yang SJ, 2012, INFECT IMMUN, V80, P74, DOI 10.1128/IAI.05669-11; Zhang CX, 2004, DIABETES, V53, P2950, DOI 10.2337/diabetes.53.11.2950	73	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166621	10.1371/journal.pone.0166621	http://dx.doi.org/10.1371/journal.pone.0166621			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855187	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200039
J	Lee, SH; Tai, CL; Chen, SY; Chang, CH; Chang, YH; Hsieh, PH				Lee, Sheng-Hsun; Tai, Ching-Lung; Chen, Szu-Yuan; Chang, Chih-Hsiang; Chang, Yu-Han; Hsieh, Pang-Hsin			Elution and Mechanical Strength of Vancomycin-Loaded Bone Cement: In Vitro Study of the Influence of Brand Combination	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; TOTAL KNEE ARTHROPLASTY; LIQUID-CHROMATOGRAPHY; METHICILLIN-RESISTANT; GENTAMICIN; INFECTION; PRODUCTS; RELEASE; ANTIBIOTICS; POLYMETHYLMETHACRYLATE	Antibiotic-loaded bone cement (ALBC) is widely used in orthopaedic surgery for both prevention and treatment of infection. Little is known about the effect of different brand combinations of antibiotic and bone cement on the elution profile and mechanical strength of ALBC. Standardized specimens that consisted of one of the 4 brands of bone cement and one of the 3 brands of vancomycin were fashioned, producing 12 combinations of ALBC. Two dosages of vancomycin in 40g bone cement were used to represent the high (4g vancomycin) and low (1g vancomycin) dose groups. Concentrations of vancomycin elution from ALBC was measured for up to 336 hours. The ultimate compression strength was tested at axial compression using a material testing machine before and after elution. In both high-dose and low-dose groups, Lyo-Vancin in PALACOS bone cement resulted in the highest cumulative elution and Vanco in Simplex P bone cement resulted in the lowest elution (458% and 65% higher in high-and low-dose groups, respectively). The mechanical strength was not significantly compromised in all groups with low dose vancomycin (range: 70.31 +/- 2.74 MPa to 87.28 +/- 8.26MPa after elution). However, with the addition of high dose vancomycin, there was a mixed amount of reduction in the ultimate compression strength after cement aging, ranging from 5% (Vanco in Simplex P, 81.10 +/- 0.48 MPa after elution) to 38% (Sterile vancomycin in CMW, 60.94 +/- 5.74 MPa after elution). We concluded that the selection of brands of vancomycin and bone cement has a great impact on the release efficacy and mechanical strength of ALBC.	[Lee, Sheng-Hsun; Tai, Ching-Lung; Chen, Szu-Yuan; Chang, Chih-Hsiang; Chang, Yu-Han; Hsieh, Pang-Hsin] Chang Gung Mem Hosp, Dept Orthopaed Surg, 5,Fuxing St, Taoyuan 333, Taiwan; [Lee, Sheng-Hsun; Chen, Szu-Yuan; Chang, Chih-Hsiang; Chang, Yu-Han; Hsieh, Pang-Hsin] Chang Gung Mem Hosp, Bone & Joint Res Ctr, 5,Fuxing St, Taoyuan 333, Taiwan; [Tai, Ching-Lung] Chang Gung Univ, Grad Inst Med Mechatron, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Hsieh, PH (corresponding author), Chang Gung Mem Hosp, Dept Orthopaed Surg, 5,Fuxing St, Taoyuan 333, Taiwan.; Hsieh, PH (corresponding author), Chang Gung Mem Hosp, Bone & Joint Res Ctr, 5,Fuxing St, Taoyuan 333, Taiwan.	hsieh2634@gmail.com		Tai, Ching-Lung/0000-0002-9084-4885; Lee, Sheng-Hsun/0000-0002-8779-6974				Ayre WN, 2014, J MECH BEHAV BIOMED, V32, P76, DOI 10.1016/j.jmbbm.2013.12.010; Bistolfi Alessandro, 2011, ISRN Orthop, V2011, P290851, DOI 10.5402/2011/290851; Bourne RB, 2004, J ARTHROPLASTY, V19, P69, DOI 10.1016/j.arth.2004.03.005; Bridgens J, 2008, J BONE JOINT SURG BR, V90B, P643, DOI 10.1302/0301-620X.90B5.19803; Cerretani D, 2002, J ARTHROPLASTY, V17, P619, DOI 10.1054/arth.2002.32184; Chang Y, 2013, BONE JOINT RES, V2, P220, DOI 10.1302/2046-3758.210.2000188; Chang YH, 2011, ANTIMICROB AGENTS CH, V55, P5480, DOI 10.1128/AAC.05312-11; CHAPMAN MW, 1976, J BONE JOINT SURG AM, V58, P76, DOI 10.2106/00004623-197658010-00014; Chen Antonia F, 2014, J Long Term Eff Med Implants, V24, P89; Chen DW, 2013, SCI WORLD J, DOI 10.1155/2013/573526; Chiu FY, 2009, J BONE JOINT SURG AM, V91A, P628, DOI 10.2106/JBJS.G.01570; Drexler M, 2015, KNEE SURG SPORTS TRA; Dunne NJ, 2008, J ENG MED, V222, P355; ELSON RA, 1977, J BONE JOINT SURG BR, V59, P200, DOI 10.1302/0301-620X.59B2.873980; Fujimura S, 2008, INT J ANTIMICROB AG, V31, P391, DOI 10.1016/j.ijantimicag.2008.01.002; Hadwiger ME, 2012, ANTIMICROB AGENTS CH, V56, P2824, DOI 10.1128/AAC.00164-12; Hanssen AD, 2005, CLIN ORTHOP RELAT R, P91, DOI 10.1097/01.blo.0000175713.30506.77; He Y, 2002, J BIOMED MATER RES, V63, P800, DOI 10.1002/jbm.10405; Hendriks JGE, 2005, J BONE JOINT SURG BR, V87B, P272, DOI 10.1302/0301-620X.87B2.14781; Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4; Jones RN, 2013, DIAGN MICR INFEC DIS, V76, P237, DOI 10.1016/j.diagmicrobio.2013.01.008; Kanj WW, 2013, ORTHOPEDICS, V36, P138, DOI 10.3928/01477447-20130122-10; Klekamp J, 1999, J ARTHROPLASTY, V14, P339, DOI 10.1016/S0883-5403(99)90061-X; Lee AJC, 2002, J MATER SCI-MATER M, V13, P723, DOI 10.1023/A:1016150403665; Lewis PO, 2014, AM J HEALTH-SYST PH, V71, P1029, DOI 10.2146/ajhp130516; LOONEY MA, 1986, J BIOMED MATER RES, V20, P555, DOI 10.1002/jbm.820200503; MALCHAU H, 1993, ACTA ORTHOP SCAND, V64, P497, DOI 10.3109/17453679308993679; MARKS KE, 1976, J BONE JOINT SURG AM, V58, P358, DOI 10.2106/00004623-197658030-00011; Minelli EB, 2004, J ANTIMICROB CHEMOTH, V53, P329, DOI 10.1093/jac/dkh032; Minelli EB, 2002, J CHEMOTHERAPY, V14, P492, DOI 10.1179/joc.2002.14.5.492; Miola M, 2013, MAT SCI ENG C-MATER, V33, P3025, DOI 10.1016/j.msec.2013.03.032; Moojen DJF, 2008, J ARTHROPLASTY, V23, P1152, DOI 10.1016/j.arth.2007.08.020; Pelletier MH, 2009, J ARTHROPLASTY, V24, P454, DOI 10.1016/j.arth.2007.10.023; Penner MJ, 1996, J ARTHROPLASTY, V11, P939, DOI 10.1016/S0883-5403(96)80135-5; Persson C, 2006, ACTA ORTHOP, V77, P617, DOI 10.1080/17453670610012692; PFALLER MA, 1984, J CLIN MICROBIOL, V20, P311, DOI 10.1128/JCM.20.3.311-316.1984; PICKNELL B, 1977, J BONE JOINT SURG BR, V59, P302, DOI 10.1302/0301-620X.59B3.408356; Powles JW, 1998, J BONE JOINT SURG BR, V80B, P607, DOI 10.1302/0301-620X.80B4.8555; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Somerville AL, 1999, PHARMACOTHERAPY, V19, P702, DOI 10.1592/phco.19.9.702.31548; Stevens CM, 2005, J ORTHOP RES, V23, P27, DOI 10.1016/j.orthres.2004.03.003; Tai CL, 2011, BIO-MED MATER ENG, V21, P341, DOI 10.3233/BME-2012-0681; TOPOLESKI LDT, 1990, J BIOMED MATER RES, V24, P135, DOI 10.1002/jbm.820240202; Torrado S, 2001, INT J PHARM, V217, P57, DOI 10.1016/S0378-5173(01)00587-7; Tsukayama DT, 1996, J BONE JOINT SURG AM, V78A, P512, DOI 10.2106/00004623-199604000-00005; van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557; van de Belt H, 2000, BIOMATERIALS, V21, P1981, DOI 10.1016/S0142-9612(00)00082-X; Vesga O, 2010, ANTIMICROB AGENTS CH, V54, P3271, DOI 10.1128/AAC.01044-09; Zalavras CG, 2004, CLIN ORTHOP RELAT R, P86, DOI 10.1097/01.blo.0000143571.18892.8d	49	32	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166545	10.1371/journal.pone.0166545	http://dx.doi.org/10.1371/journal.pone.0166545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855203	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200034
J	Cao, XY; Guo, XR; Yang, XB; Wang, HQ; Hua, WP; He, YH; Kang, JF; Wang, ZZ				Cao, Xiaoyan; Guo, Xiaorong; Yang, Xinbing; Wang, Huaiqin; Hua, Wenping; He, Yihan; Kang, Jiefang; Wang, Zhezhi			Transcriptional Responses and Gentiopicroside Biosynthesis in Methyl Jasmonate-Treated Gentiana macrophylla Seedlings	PLOS ONE			English	Article							RNA-SEQ; PLANT; TOOL; ATTENUATION; CROSSTALK; DEFENSE; PATHWAY; ACID; GENE	Gentiana macrophylla, a medicinal plant with significant pharmacological properties, contains the bioactive compound gentiopicroside. Methyl jasmonate (MeJA) is an effective elicitor for enhancing the production of such compounds. However, little is known about MeJA-mediated biosynthesis of gentiopicroside. We investigated this phenomenon as well as gene expression profiles to determine the molecular mechanisms for MeJA-mediated gentiopicroside biosynthesis and regulation in G. macrophylla. Our HPLC results showed that Gentiana macrophylla seedlings exposed to MeJA had significantly higher concentrations of gentiopicroside when compared with control plants. We used RNA sequencing to compare transcriptional profiles in seedlings treated for 5 d with either 0 mu mol L-1 MeJA (C) or 250 mu mol L-1 MeJA (M5) and detected differentially expressed genes (DEGs). In total, 77,482 unique sequences were obtained from approximately 34 million reads. Of these, 48,466 (57.46%) sequences were annotated based on BLASTs performed against public databases. We identified 5,206 DEGs between the C and M5 samples, including genes related to the alpha-lenolenic acid degradation pathway, JA signaling pathway, and gentiopicroside biosynthesis. Expression of numerous enzyme genes in the glycolysis pathway was significantly up-regulated. Many genes encoding transcription factors (e.g. ERF, bHLH, MYB, and WRKY) also responded to MeJA elicitation. Rapid acceleration of the glycolysis pathway that supplies precursors for IPP biosynthesis and up-regulates the expression of enzyme genes in that IPP pathway are probably most responsible for MeJA stimulation of gentiopicroside synthesis. Our qRT-PCR results showed that the expression profiles of 12 gentiopicroside biosynthesis genes were consistent with the RNA-Seq data. These results increase our understanding about how the gentiopicroside biosynthesis pathway in G. macrophylla responds to MeJA.	[Cao, Xiaoyan; Guo, Xiaorong; Yang, Xinbing; Wang, Huaiqin; He, Yihan; Kang, Jiefang; Wang, Zhezhi] Shaanxi Normal Univ, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Coll Life Sci, Xian, Peoples R China; [Hua, Wenping] Shaanxi XueQian Normal Univ, Dept Biol Sci & Technol, Xian, Peoples R China	Shaanxi Normal University; Shaanxi Xueqian Normal University	Kang, JF; Wang, ZZ (corresponding author), Shaanxi Normal Univ, Minist Educ Med Resources & Nat Pharmaceut Chem, Natl Engn Lab Resource Dev Endangered Crude Drugs, Key Lab,Coll Life Sci, Xian, Peoples R China.	kangjiefang@snnu.edu.cn; zzwang@snnu.edu.cn		Kang, Jiefang/0000-0002-8082-7256; Hua, wenping/0000-0003-3692-4953; Wang, Zhezhi/0000-0002-6111-1551	Natural Science Foundation of Shaanxi Province, China [2014JQ3107]; Fundamental Research Funds for the Central Universities [GK201302043]	Natural Science Foundation of Shaanxi Province, China(Natural Science Foundation of Shaanxi Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the Natural Science Foundation of Shaanxi Province, China (2014JQ3107) and the Fundamental Research Funds for the Central Universities (GK201302043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Cai Q. S., 2010, J GANSU COLL TRADIT, V27, P55; Cao XY, 2010, PHYTOCHEM ANALYSIS, V21, P348, DOI 10.1002/pca.1206; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chini A, 2009, FEBS J, V276, P4682, DOI 10.1111/j.1742-4658.2009.07194.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; De Luca V, 2011, MONOTERPENOID INDOLE, P263; De Luca V, 2014, CURR OPIN PLANT BIOL, V19, P35, DOI 10.1016/j.pbi.2014.03.006; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Fonseca S, 2009, CURR OPIN PLANT BIOL, V12, P539, DOI 10.1016/j.pbi.2009.07.013; Gantet P, 2002, TRENDS PHARMACOL SCI, V23, P563, DOI 10.1016/S0165-6147(02)02098-9; Givan CV, 1999, BIOL REV, V74, P277, DOI 10.1017/S0006323199005344; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He YH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00945; Hua WP, 2014, MOL BIOL REP, V41, P4817, DOI 10.1007/s11033-014-3352-x; Jaillais Y, 2010, NAT STRUCT MOL BIOL, V17, P642, DOI 10.1038/nsmb0610-642; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Li JiaFeng, 2012, Chinese Journal of Information on Traditional Chinese Medicine, V19, P50; Li ST, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-295; Lichtenthaler HK, 1997, FEBS LETT, V400, P271, DOI 10.1016/S0014-5793(96)01404-4; Liu JP, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2587-4; Liu SB, 2014, NEUROMOL MED, V16, P350, DOI 10.1007/s12017-013-8280-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo HM, 2014, PHYSIOL PLANTARUM, V152, P241, DOI 10.1111/ppl.12193; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miettinen K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4606; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pauwels L, 2008, P NATL ACAD SCI USA, V105, P1380, DOI 10.1073/pnas.0711203105; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Plaxton WC, 1996, ANNU REV PLANT PHYS, V47, P185, DOI 10.1146/annurev.arplant.47.1.185; Ramakrishna A, 2011, PLANT SIGNAL BEHAV, V6, P1720, DOI 10.4161/psb.6.11.17613; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Ren CG, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-128; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Ruan M, 2015, FITOTERAPIA, V103, P265, DOI 10.1016/j.fitote.2015.04.015; Shi J, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0609-z; Sun GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062865; Suttipanta N, 2011, PLANT PHYSIOL, V157, P2081, DOI 10.1104/pp.111.181834; Tai HM, 2003, J CHIN CHEM SOC-TAIP, V50, P441, DOI 10.1002/jccs.200300069; Van Moerkercke A, 2015, P NATL ACAD SCI USA, V112, P8130, DOI 10.1073/pnas.1504951112; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Wang XM, 2015, PHYSIOL PLANTARUM, V153, P30, DOI 10.1111/ppl.12236; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016; Wu Chun, 2016, Zhong Yao Cai, V39, P240; Xu MJ, 2009, PLANT CELL ENVIRON, V32, P960, DOI 10.1111/j.1365-3040.2009.01976.x; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031	53	11	12	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166493	10.1371/journal.pone.0166493	http://dx.doi.org/10.1371/journal.pone.0166493			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851826	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300056
J	Williams, KA; Miles, DB				Williams, Kelly A.; Miles, Donald B.			Demographic Costs Associated with Differences in Habitat Space Occupancy	PLOS ONE			English	Article							NEST-SITE SELECTION; HARDWOOD FORESTS; GRINNELLIAN NICHE; BIRD COMMUNITIES; HOODED WARBLERS; SOUTHERN OHIO; SIBERIAN JAY; PATTERNS; CONSERVATION; LANDSCAPE	Delimiting the habitat characteristics describing the environmental conditions required by a species has become a critical tool for predicting organismal responses to environmental change. Grinnell emphasized the effects of environmental factors on the ability of a population to maintain a positive growth rate, yet few studies have included demographic or reproductive data in analyses of the Grinnellian niche. Identifying differences in habitat exploitation patterns in response to structural variation in the environment presents an incomplete description of the ability of species to adapt to changing habitats if demographic traits are not included. We estimated the vegetation characteristics used by individuals within a population of hooded warblers (Setophaga citrina) across a spatial transect that includes three structurally different forest habitats. We predicted individuals should select similar structural characteristics within each habitat and have similar reproductive success across sample sites. In the two years post burn, adults were present but no young fledged indicating the habitat requirements necessary for reproduction were absent in this habitat. We found significant differences in habitat space occupied by individuals in unaltered and harvested habitats. Nesting habitats used by female warblers differed from available habitat. Fledging success was lower in the harvested habitat 10 to 12 years post-harvest. In the harvested habitat, fledging success was greater on mesic slopes but decreased along a habitat gradient to xeric ridgetops, suggesting compensation in habitat use does not ameliorate fitness costs. In contrast, there was no difference in the number of fledged young along this gradient in the unaltered habitat. Based solely on occupancy data, traditional ecological niche models would incorrectly conclude the environmental characteristics found across the three forested habitats are included in the Grinnellian niche of the hooded warbler. However, examination of demographic and environmental data simultaneously allows differentiation between occupied habitat space and niche space.	[Williams, Kelly A.; Miles, Donald B.] Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA	Ohio University	Williams, KA (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	williak5@ohio.edu	Miles, Donald B./AFW-0480-2022	Miles, Donald/0000-0001-5768-179X	Ohio Center for Ecology and Evolutionary Studies Research Fellowship; Ohio Avian Project Initiative; Midwest Birding Symposium Conservation Fund; Ohio University Graduate Student Senate Original Work Grants; National Fire and Fire Surrogate Project; Scioto Valley Bird and Nature Club	Ohio Center for Ecology and Evolutionary Studies Research Fellowship; Ohio Avian Project Initiative; Midwest Birding Symposium Conservation Fund; Ohio University Graduate Student Senate Original Work Grants; National Fire and Fire Surrogate Project; Scioto Valley Bird and Nature Club	This work was funded by an Ohio Center for Ecology and Evolutionary Studies Research Fellowship, the Ohio Avian Project Initiative, the Midwest Birding Symposium Conservation Fund, Ohio University Graduate Student Senate Original Work Grants, the National Fire and Fire Surrogate Project and the Scioto Valley Bird and Nature Club.	Albrecht MA, 2006, FOREST ECOL MANAG, V226, P88, DOI 10.1016/j.foreco.2005.12.061; Anderson MJ, 2013, ECOL MONOGR, V83, P557, DOI 10.1890/12-2010.1; Artman VL, 2001, CONSERV BIOL, V15, P1423, DOI 10.1046/j.1523-1739.2001.00181.x; Basille M, 2008, ECOL MODEL, V211, P233, DOI 10.1016/j.ecolmodel.2007.09.006; Bayne EM, 2001, AUK, V118, P380, DOI 10.1642/0004-8038(2001)118[0380:EOHFOP]2.0.CO;2; Bedia J, 2013, GLOBAL PLANET CHANGE, V107, P1, DOI 10.1016/j.gloplacha.2013.04.005; Benson TJ, 2010, J WILDLIFE MANAGE, V74, P81, DOI 10.2193/2008-442; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Bisson IA, 2000, CAN J ZOOL, V78, P858, DOI 10.1139/cjz-78-5-858; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Burnham B. A., 2002, MODEL SELECTION MULT; Calcagno V, 2013, GLMULTI MODEL SELECT; Clavero M, 2010, GLOBAL ECOL BIOGEOGR, V19, P684, DOI 10.1111/j.1466-8238.2010.00544.x; Conde DA, 2010, BIOL CONSERV, V143, P1980, DOI 10.1016/j.biocon.2010.04.049; Culbert PD, 2013, AUK, V130, P656, DOI 10.1525/auk.2013.13007; Eggers S, 2006, P ROY SOC B-BIOL SCI, V273, P701, DOI 10.1098/rspb.2005.3373; Eggers S, 2005, BEHAV ECOL, V16, P309, DOI 10.1093/beheco/arh163; Elliott KH, 2010, BEHAV ECOL, V21, P1024, DOI 10.1093/beheco/arq076; Evans Ogden LJ, 1994, BIRDS N AM, DOI [10.2173/bna.110, DOI 10.2173/BNA.110]; Fagan WE, 1999, AM NAT, V153, P165, DOI 10.1086/303162; Grinnell J, 1917, AM NAT, V51, P115, DOI 10.1086/279591; Grinnell J., 1917, Auk Cambridge Mass, V34; Hansen BB, 2009, OIKOS, V118, P859, DOI 10.1111/j.1600-0706.2009.17098.x; Heltzel JM, 2006, J WILDLIFE MANAGE, V70, P1416, DOI 10.2193/0022-541X(2006)70[1416:EOSLOB]2.0.CO;2; Hillen J, 2011, ANN ZOOL FENN, V48, P180, DOI 10.5735/086.048.0306; HOLMES RT, 1986, WILSON BULL, V98, P196; Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106; Hopkins KP, 2011, BIOL J LINN SOC, V102, P878, DOI 10.1111/j.1095-8312.2011.01618.x; Howlett JS, 1996, AUK, V113, P1; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; JAMES FC, 1984, AM NAT, V124, P17, DOI 10.1086/284250; Kaliontzopoulou A, 2010, J EVOLUTION BIOL, V23, P1234, DOI 10.1111/j.1420-9101.2010.01984.x; Legendre P., 2012, NUMERICAL ECOLOGY; LEIBOLD MA, 1995, ECOLOGY, V76, P1371, DOI 10.2307/1938141; LYNCH JF, 1985, AUK, V102, P714; Lyons JE, 2005, CONDOR, V107, P41, DOI 10.1650/7462; Martin T. E., 1997, BBIRD FIELD PROTOCOL; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637; McDermott ME, 2011, FOREST ECOL MANAG, V261, P373, DOI 10.1016/j.foreco.2010.10.020; MORTON ES, 1990, AM NAT, V135, P319, DOI 10.1086/285048; Nagy LR, 2004, J AVIAN BIOL, V35, P487, DOI 10.1111/j.0908-8857.2004.03429.x; Neudorf DL, 1997, BEHAV ECOL, V8, P595, DOI 10.1093/beheco/8.6.595; Oksanen J., **DATA OBJECT**; Oksanen J., 2011, MULTIVARIATE ANAL EC, P1, DOI DOI 10.1016/0169-5347(88)90124-3; ORNAT AL, 1990, AUK, V107, P539; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Saupe EE, 2012, ECOL MODEL, V237, P11, DOI 10.1016/j.ecolmodel.2012.04.001; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Waldrop TA, 2008, FOREST ECOL MANAG, V255, P3117, DOI 10.1016/j.foreco.2007.11.010; Wallendorf MJ, 2007, J WILDLIFE MANAGE, V71, P1899, DOI 10.2193/2006-386; WHITTAKER RH, 1973, AM NAT, V107, P321, DOI 10.1086/282837; Whittam RM, 2002, CAN J ZOOL, V80, P644, DOI 10.1139/Z02-039; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Williams Kate, 2013, THESIS; Yaussy DA, 2003, NE299 USDA FOR SERV, P99; Yaussy DA, 2001, NE4153	61	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165472	10.1371/journal.pone.0165472	http://dx.doi.org/10.1371/journal.pone.0165472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851742	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300018
J	Bledsoe, JW; Peterson, BC; Swanson, KS; Small, BC				Bledsoe, Jacob W.; Peterson, Brian C.; Swanson, Kelly S.; Small, Brian C.			Ontogenetic Characterization of the Intestinal Microbiota of Channel Catfish through 16S rRNA Gene Sequencing Reveals Insights on Temporal Shifts and the Influence of Environmental Microbes	PLOS ONE			English	Article							FRESH-WATER FISH; GUT MICROBIOTA; GASTROINTESTINAL MICROBIOTA; BACTERIAL COMMUNITY; ATLANTIC SALMON; IMMUNE-SYSTEM; DIVERSITY; ZEBRAFISH; BRADYRHIZOBIUM; TILAPIA	Aquaculture recently overtook capture fisheries as the largest producer of food fish, but to continue increasing fish production the industry is in search of better methods of improving fish health and growth. Pre- and probiotic supplementation has gained attention as a means of solving these issues, however, for such approaches to be successful, we must first gain a more holistic understanding of the factors influencing the microbial communities present in the intestines of fish. In this study, we characterize the bacterial communities associated with the digestive tract of a highly valuable U.S. aquaculture species, channel catfish Ictalurus punctatus, over the first 193 days of life to evaluate temporal changes that may occur throughout ontogenetic development of the host. Intestinal microbiota were surveyed with high-throughput DNA sequencing of 16S rRNA V4 gene amplicons derived from fish at 3, 65, 125, and 193 days post hatch (dph), while also characterizing the environmental microbes derived from the water supply and the administered diets. Microbial communities inhabiting the intestines of catfish early in life were dynamic, with significant shifts occurring up to 125 dph when the microbiota somewhat stabilized, as shifts were less apparent between 125 to 193 dph. Bacterial phyla present in the gut of catfish throughout ontogeny include Bacteroidetes, Firmicutes, Fusobacteria, and Proteobacteria; with the species Cetobacterium somerae and Plesiomonas shigelloides showing the highest abundance in the catfish microbiota after 3 dph. Comparisons of the gut microbiota to the environmental microbes reveals that the fish gut is maintained as a niche habitat, separate from the overall microbial communities present in diets and water-supply. Although, there is also evidence that the environmental microbiota serves as an inoculum to the fish gut. Our results have implications for future research related to channel catfish biology and culture, and increase our understanding of ontogenetic effects on the microbiota of teleost fish.	[Bledsoe, Jacob W.] Southern Illinois Univ, Dept Anim Sci, Ctr Fisheries Aquaculture & Aquat Sci, Carbondale, IL 62901 USA; [Peterson, Brian C.] USDA ARS, Warmwater Aquaculture Res Unit, Stoneville, MS 38776 USA; [Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL USA; [Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL USA; [Bledsoe, Jacob W.; Small, Brian C.] Univ Idaho, Dept Fish & Wildlife Sci, Inst Aquaculture Res, Hagerman, ID 83332 USA	Southern Illinois University System; Southern Illinois University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Idaho; University of Idaho	Small, BC (corresponding author), Univ Idaho, Dept Fish & Wildlife Sci, Inst Aquaculture Res, Hagerman, ID 83332 USA.	bcsmail@uidaho.edu	Small, Brian/V-7653-2019	Swanson, Kelly/0000-0001-5518-3076; Bledsoe, Jacob/0000-0003-4819-3326	United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit [6066-31000-013-00]; ARS [ARS-0428104] Funding Source: Federal RePORTER	United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was funded by the United States Department of Agriculture, Agricultural Research Service, Warmwater Aquaculture Research Unit (6066-31000-013-00; http://www.ars.usda/gov/research/protects/projects.htm?acc_no 428191).	American Veterinary Medical Association, 2007, AVMA GUID EUTH; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2015, 2014 US CATFISH DATA; AOAC International, 2000, OFF METH AN 2000; Bakke I, 2015, ENVIRON MICROBIOL, V17, P3914, DOI 10.1111/1462-2920.12888; Bengten E, 2006, DEV COMP IMMUNOL, V30, P77, DOI 10.1016/j.dci.2005.06.016; Bhatt AS, 2013, NEW ENGL J MED, V369, P517, DOI 10.1056/NEJMoa1211115; Bolnick DI, 2014, ECOL LETT, V17, P979, DOI 10.1111/ele.12301; Boutin S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084772; Burr JJ, 2012, DIRECT-FED MICROBIALS AND PREBIOTICS FOR ANIMALS: SCIENCE AND MECHANISMS OF ACTION, P163, DOI 10.1007/978-1-4614-1311-0_11; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; De Schryver P, 2014, ISME J, V8, P2360, DOI 10.1038/ismej.2014.84; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Estruch G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136389; FAO, 2014, STATE WORLD FISHERIE; Giatsis C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103641; Givens CE, 2012, FISH TALE COMPARISON; Gomez D, 2013, FISH SHELLFISH IMMUN, V35, P1729, DOI 10.1016/j.fsi.2013.09.032; Gorley C.K., 2006, GETTING STARTED PRIM; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Hamre K, 2013, REV AQUACULT, V5, pS26, DOI 10.1111/j.1753-5131.2012.01086.x; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Janda JM, 2010, CLIN MICROBIOL REV, V23, P35, DOI 10.1128/CMR.00039-09; Karp NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111239; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Larsen AM, 2014, J APPL MICROBIOL, V116, P1396, DOI 10.1111/jam.12475; Lategan MJ, 2006, AQUACULTURE, V254, P115, DOI 10.1016/j.aquaculture.2005.11.019; Laurence M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097876; Lees H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100916; Li J, 2014, J APPL MICROBIOL, V117, P1750, DOI 10.1111/jam.12663; Li XM, 2012, J MICROBIOL, V50, P29, DOI 10.1007/s12275-012-1340-1; Liu YC, 2012, DIS AQUAT ORGAN, V99, P207, DOI 10.3354/dao02477; Llewellyn MS, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00207; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Merrifield DL, 2014, AQUACULTURE NUTRITION: GUT HEALTH, PROBIOTICS AND PREBIOTICS, P185; Mohammed HH, 2015, VET RES, V46, DOI 10.1186/s13567-015-0215-y; Navarrete P, 2008, J AQUAT ANIM HEALTH, V20, P177, DOI 10.1577/H07-043.1; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, FISH SHELLFISH IMMUN, V29, P2, DOI 10.1016/j.fsi.2010.02.017; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Perez T, 2010, MUCOSAL IMMUNOL, V3, P355, DOI 10.1038/mi.2010.12; Petrie-Hanson L, 2001, VET IMMUNOL IMMUNOP, V81, P113, DOI 10.1016/S0165-2427(01)00331-2; Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Reveco FE, 2014, AQUACULTURE, V420, P262, DOI 10.1016/j.aquaculture.2013.11.007; Ringo E, 2006, AQUACULTURE, V261, P829, DOI 10.1016/j.aquaculture.2006.06.030; Rivas R, 2009, SYST APPL MICROBIOL, V32, P101, DOI 10.1016/j.syapm.2008.12.005; Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Semova I, 2012, CELL HOST MICROBE, V12, P277, DOI 10.1016/j.chom.2012.08.003; Shoemaker CA, 2001, AM J VET RES, V62, P174, DOI 10.2460/ajvr.2001.62.174; Small BC, 2006, MANAGING HATCH RATE; Smith CCR, 2015, ISME J, V9, P2515, DOI 10.1038/ismej.2015.64; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Sugita H, 1996, AQUACULTURE, V145, P195, DOI 10.1016/S0044-8486(96)01319-1; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x; Wang WS, 1997, COMP IMMUNOL MICROB, V20, P261, DOI 10.1016/S0147-9571(96)00035-5; Wong S, 2015, MBIO, V6, DOI 10.1128/mBio.00687-15; Wong SD, 2012, MOL ECOL, V21, P3100, DOI 10.1111/j.1365-294X.2012.05646.x; Xia JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-266; Xing MX, 2013, FEMS MICROBIOL ECOL, V86, P432, DOI 10.1111/1574-6941.12174; Ye L, 2014, ISME J, V8, P541, DOI 10.1038/ismej.2013.181; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	75	64	67	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166379	10.1371/journal.pone.0166379	http://dx.doi.org/10.1371/journal.pone.0166379			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846300	gold, Green Published			2022-12-26	WOS:000387794600054
J	Hu, JL; Li, ZF; Wang, XC; Hong, L; He, H; Chen, WG; Li, LX; Shen, AH; Liu, XJ; Yuan, SG; Zhou, JG; Tan, WW; Zhou, WZ; Tang, FY; Zhu, FC; Bao, CJ				Hu, Jian-li; Li, Zhi-feng; Wang, Xiao-chen; Hong, Lei; He, Hao; Chen, Wei-guo; Li, Lu-xun; Shen, Ai-hua; Liu, Xue-jian; Yuan, Shou-guo; Zhou, Jian-gang; Tan, Wen-wen; Zhou, Wei-zhong; Tang, Fen-yang; Zhu, Feng-cai; Bao, Chang-jun			Risk Factors for Bunyavirus-Associated Severe Fever with Thrombocytopenia Syndrome: A Community-Based Case-Control Study	PLOS ONE			English	Article							SYNDROME VIRUS; TICKS; IDENTIFICATION; PHLEBOVIRUS	Background Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease caused by a novel bunyavirus. Previous studies about risk factors for SFTSV infection have yielded inconsistent results, and behavior factors have not been fully clarified. Methods A community-based, 1: 4 matched case-control study was carried out to investigate the risk factors for SFTS in China. Cases of SFTS were defined as laboratory-confirmed cases that tested positive for real-time PCR (RT-PCR) for severe fever with thrombocytopenia syndrome bunyavirus (SFTSV) or positive for IgM antibodies against SFTSV. Controls of four neighborhood subjects were selected by matching for sex, age, and occupation. Standardized questionnaires were used to collect detailed information about their demographics and risk factors for SFTSV infection. Results A total of 334 subjects participated in the study including 69 cases and 265 controls. The median age of the cases was 59.5 years, 55.1% were male, and 87.0% were farmers. No differences in demographics were observed between cases and controls. In the final multivariate analysis, tick bites two weeks prior to disease onset (OR = 8.04, 95% CI 3.34-19.37) and the presence of weeds and shrubs around the house (OR = 3.46, 95% CI 0.96 +/- 12.46) were found to be risk factors for SFTSV infection; taking preventative measures during outdoor activities (OR = 0.12, 95% CI 0.01-1.01) provided greater protection from SFTSV infection. Conclusions Our results further confirm that SFTSV is transmitted by tick bites and prove that preventative measures that reduce exposure to ticks can prevent SFTSV infection. More efforts should be directed toward health education and behavior change for high-risk populations, especially outdoor workers, in SFTS endemic areas.	[Hu, Jian-li; Li, Zhi-feng; Wang, Xiao-chen; Zhou, Wei-zhong; Tang, Fen-yang; Zhu, Feng-cai; Bao, Chang-jun] Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Zhi-feng] Nanjing Univ, Sch Med, Nanjing, Jiangsu, Peoples R China; [Hong, Lei] Nanjing Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [He, Hao] Gulou Dist Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Chen, Wei-guo] Chuzhou Municipal Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Chuzhou, Anhui, Peoples R China; [Li, Lu-xun; Shen, Ai-hua] Lishui Dist Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Liu, Xue-jian; Yuan, Shou-guo] Xuyi Cty Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Huaian, Jiangsu, Peoples R China; [Zhou, Jian-gang; Tan, Wen-wen] Yixing Cty Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Wuxi, Jiangsu, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Nanjing University	Bao, CJ (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.	bao2000_cn@163.com			Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention [BE2015714]; Natural Science Foundation of China [81373055]; 10th Summit of Six Top Talents of Jiangsu Province [WS-2013-061]	Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 10th Summit of Six Top Talents of Jiangsu Province	This study was financially supported by the Science & Technology Demonstration Project for Emerging Infectious Diseases Control and Prevention (No. BE2015714), and partly supported by Natural Science Foundation of China (No.81373055), and the 10th Summit of Six Top Talents of Jiangsu Province (WS-2013-061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslam S, 2016, BIOMED REP, V4, P15, DOI 10.3892/br.2015.545; Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Bao CJ, 2011, NEW ENGL J MED, V365, P862, DOI 10.1056/NEJMc1106000; Denic S, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/204056; Ding F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003267; Huang Xue-Yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P165; Jiang Xiao-lin, 2012, Chinese Journal of Virology, V28, P252; Jiao YJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004092; Jiao YJ, 2012, J CLIN MICROBIOL, V50, P372, DOI 10.1128/JCM.01319-11; Kang Kai, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P106; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Li DX, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.1; Li Yi-fan, 2011, Journal of Traffic and Transportation Engineering, V11, P36; Li ZF, 2013, J MED VIROL, V85, P370, DOI 10.1002/jmv.23415; Liang SY, 2014, AM J TROP MED HYG, V90, P256, DOI 10.4269/ajtmh.13-0423; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep09679; Liu Li, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P168; Liu Y., 2012, CHIN J PREMED, V46, P500; Marzi A, 2015, EMERG INFECT DIS, V21, P305, DOI 10.3201/eid2102.141649; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Tang XY, 2013, J INFECT DIS, V207, P736, DOI 10.1093/infdis/jis748; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wang SW, 2015, AM J TROP MED HYG, V92, P684, DOI 10.4269/ajtmh.14-0008; Xing XS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002533; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang Yong-Zhen, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P209	27	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166611	10.1371/journal.pone.0166611	http://dx.doi.org/10.1371/journal.pone.0166611			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846273	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600091
J	Labadzhyan, A; Cui, JR; Peterfy, M; Guo, XQ; Chen, YDI; Hsueh, WA; Rotter, JI; Goodarzi, MO				Labadzhyan, Artak; Cui, Jinrui; Peterfy, Miklos; Guo, Xiuqing; Chen, Yii-Der I.; Hsueh, Willa A.; Rotter, Jerome I.; Goodarzi, Mark O.			Insulin Clearance Is Associated with Hepatic Lipase Activity and Lipid and Adiposity Traits in Mexican Americans	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FATTY LIVER-DISEASE; METABOLIC SYNDROME; RESISTANCE ATHEROSCLEROSIS; LIPOPROTEIN-LIPASE; SECRETION; GENE; VARIANTS; PROTEIN; HYPERINSULINEMIA	Reduction in insulin clearance plays an important role in the compensatory response to insulin resistance. Given the importance of this trait to the pathogenesis of diabetes, a deeper understanding of its regulation is warranted. Our goal was to identify metabolic and cardiovascular traits that are independently associated with metabolic clearance rate of insulin (MCRI). We conducted a cross-sectional analysis of metabolic and cardiovascular traits in 765 participants from the Mexican-American Coronary Artery Disease (MACAD) project who had undergone blood sampling, oral glucose tolerance test, euglycemic-hyperinsulinemic clamp, dual-energy X-ray absorptiometry, and carotid ultrasound. We assessed correlations of MCRI with traits from seven domains, including anthropometry, biomarkers, cardiovascular, glucose homeostasis, lipase activity, lipid profile, and liver function tests. We found inverse independent correlations between MCRI and hepatic lipase (P = 0.0004), insulin secretion (P = 0.0002), alanine aminotransferase (P = 0.0045), total fat mass (P = 0.014), and diabetes (P = 0.03). MCRI and apolipoprotein A-I exhibited a positive independent correlation (P = 0.035). These results generate a hypothesis that lipid and adiposity associated traits related to liver function may play a role in insulin clearance.	[Labadzhyan, Artak; Cui, Jinrui; Goodarzi, Mark O.] Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Los Angeles, CA 90048 USA; [Peterfy, Miklos] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Guo, Xiuqing; Chen, Yii-Der I.; Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles BioMed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Hsueh, Willa A.] Ohio State Univ, Dept Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University System of Ohio; Ohio State University	Goodarzi, MO (corresponding author), Cedars Sinai Med Ctr, Div Endocrinol Diabet & Metab, Dept Med, Los Angeles, CA 90048 USA.	mark.goodarzi@cshs.org	Rotter, Jerome/AAY-6598-2021; Goodarzi, Mark/AAH-7106-2021; Labadzhyan, Artak/AAH-6003-2021	Goodarzi, Mark/0000-0001-6364-5103; Labadzhyan, Artak/0000-0002-8288-6698	National Institutes of Health [R01-HL088457, R01-DK079888, P30-DK063491]; National Center for Research Resources [M01-RR00425]; University of California Los Angeles Clinical and Translational Science Institute [UL1TR000124]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK079888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); University of California Los Angeles Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by National Institutes of Health grants R01-HL088457, R01-DK079888, P30-DK063491, M01-RR00425 (General Clinical Research Center Grant from the National Center for Research Resources), and UL1TR000124 (University of California Los Angeles Clinical and Translational Science Institute). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annema W, 2011, CURR ATHEROSCLER REP, V13, P257, DOI 10.1007/s11883-011-0175-2; ANTONIELLO S, 1989, CLIN CHIM ACTA, V183, P343, DOI 10.1016/0009-8981(89)90369-0; Auletta M, 1995, ENZYME PROTEIN, V48, P197, DOI 10.1159/000474989; Bonnet F, 2011, DIABETES, V60, P1660, DOI 10.2337/db10-1806; Bril F, 2014, HEPATOLOGY, V59, P2178, DOI 10.1002/hep.26988; Carr MC, 2001, J CLIN ENDOCR METAB, V86, P2831, DOI 10.1210/jc.86.6.2831; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Fryirs MA, 2010, ARTERIOSCL THROM VAS, V30, P1642, DOI 10.1161/ATVBAHA.110.207373; Gambino R, 2007, HEPATOLOGY, V45, P1097, DOI 10.1002/hep.21631; Goodarzi MO, 2013, DIABETOLOGIA, V56, P1282, DOI 10.1007/s00125-013-2880-6; Goodarzi MO, 2005, J CLIN ENDOCR METAB, V90, P4816, DOI 10.1210/jc.2005-0389; Goodarzi MO, 2005, DIABETES, V54, P1222, DOI 10.2337/diabetes.54.4.1222; Goodarzi MO, 2005, DIABETES, V54, P1228, DOI 10.2337/diabetes.54.4.1228; Goodarzi MO, 2004, DIABETES, V53, P214, DOI 10.2337/diabetes.53.1.214; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karavia EA, 2012, MOL MED, V18, P901, DOI 10.2119/molmed.2012.00113; Kim MK, 2015, OBESITY, V23, P2430, DOI 10.1002/oby.21256; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lee CC, 2013, DIABETES OBES METAB, V15, P441, DOI 10.1111/dom.12049; Lee CC, 2013, DIABETES CARE, V36, P901, DOI 10.2337/dc12-1316; Lewis GF, 2004, DIABETES, V53, P2893, DOI 10.2337/diabetes.53.11.2893; Lichtash CT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065954; Lorenzo C, 2013, DIABETES CARE, V36, P101, DOI 10.2337/dc12-0101; Marini MA, 2014, ACTA DIABETOL, V51, P257, DOI 10.1007/s00592-013-0511-9; Miksztowicz V, 2012, DIABETES-METAB RES, V28, P535, DOI 10.1002/dmrr.2312; Mittelman SD, 2000, DIABETES, V49, P2116, DOI 10.2337/diabetes.49.12.2116; Palmer ND, 2015, DIABETES, V64, P1853, DOI 10.2337/db14-0732; Pascoe L, 2007, DIABETES, V56, P3101, DOI 10.2337/db07-0634; Perret B, 2002, J LIPID RES, V43, P1163, DOI 10.1194/jlr.R100020-JLR200; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Santamarina-Fojo S, 2004, ARTERIOSCL THROM VAS, V24, P1750, DOI 10.1161/01.ATV.0000140818.00570.2d; Selzer RH, 2001, ATHEROSCLEROSIS, V154, P185, DOI 10.1016/S0021-9150(00)00461-5; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Straznicky NE, 2015, J CLIN ENDOCR METAB, V100, P1544, DOI 10.1210/jc.2014-3796; Wang D, 2006, OBESITY SILVER SPRIN, V14, P1192, DOI [10.1038/oby.2006.136, DOI 10.1038/OBY.2006.136]; Wannamethee SG, 2005, DIABETES CARE, V28, P2913, DOI 10.2337/diacare.28.12.2913; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	40	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166263	10.1371/journal.pone.0166263	http://dx.doi.org/10.1371/journal.pone.0166263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846285	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600043
J	van der Fels-Klerx, HJ; Camenzuli, L; van der Lee, MK; Oonincx, DGAB				van der Fels-Klerx, H. J.; Camenzuli, L.; van der Lee, M. K.; Oonincx, D. G. A. B.			Uptake of Cadmium, Lead and Arsenic by Tenebrio molitor and Hermetia illucens from Contaminated Substrates	PLOS ONE			English	Article							FEED PRODUCTION; EDIBLE INSECTS; ACCUMULATION; LARVAE; FOOD; ZINC; COLEOPTERA; DIPTERA; BINDING; SAFETY	Insects have potential as a novel source of protein in feed and food production in Europe, provided they can be used safely. To date, limited information is available on the safety of insects, and toxic elements are one of the potential hazards of concern. Therefore, we aimed to investigate the potential accumulation of cadmium, lead and arsenic in larvae of two insect species, Tenebrio molitor (yellow mealworm) and Hermetia illucens (black soldier fly), which seem to hold potential as a source of food or feed. An experiment was designed with 14 treatments, each in triplicate, per insect species. Twelve treatments used feed that was spiked with cadmium, lead or arsenic at 0.5, 1 and 2 times the respective maximum allowable levels (ML) in complete feed, as established by the European Commission (EC). Two of the 14 treatments consisted of controls, using non-spiked feed. All insects per container (replicate) were harvested when the first larva in that container had completed its larval stage. Development time, survival rates and fresh weights were similar over all treatments, except for development time and total live weight of the half of the maximum limit treatment for cadmium of the black soldier fly. Bioaccumulation (bioaccumulation factor > 1) was seen in all treatments (including two controls) for lead and cadmium in black soldier fly larvae, and for the three arsenic treatments in the yellow mealworm larvae. In the three cadmium treatments, concentrations of cadmium in black soldier fly larvae are higher than the current EC maximum limit for feed materials. The same was seen for the 1.0 and 2.0 ML treatments of arsenic in the yellow mealworm larvae. From this study, it can be concluded that if insects are used as feed materials, the maximum limits of these elements in complete feed should be revised per insect species.	[van der Fels-Klerx, H. J.; Camenzuli, L.; van der Lee, M. K.] RIKILT Wageningen Univ & Res, Akkermaalsbos 2, NL-6708 WB Wageningen, Netherlands; [Oonincx, D. G. A. B.] Wageningen Univ, Dept Entomol, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	van der Fels-Klerx, HJ (corresponding author), RIKILT Wageningen Univ & Res, Akkermaalsbos 2, NL-6708 WB Wageningen, Netherlands.	ine.vanderfels@wur.nl		Camenzuli, Louise/0000-0002-4444-0978	Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food [12638]; Ministry of Economic Affairs, through the STW project In2Food	Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food; Ministry of Economic Affairs, through the STW project In2Food	This work was supported by the Ministry of Economic Affairs, The Netherlands, through the STW programma Novel Proteins, Project In@food (grant No 12638 to HJvdF DO LC MvdL) (http://www.stw.nl/nl/content/onderzoeksprogrammavan-ez-en-stw-voor-eiwitinnovates-van-start). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the financial contribution of the Ministry of Economic Affairs, through the STW project In2Food. Also, the contribution of Ab van Polanen to the chemical analyses at RIKILT is acknowledged, as well as the contribution of Van der Veen in the procedure for the homogeneity testing at RIKILT. Myriem Bouziane is thanked for her contributions to the experiments with BSF, and Pascal van Keulen for his contribution to the experiment with the mealworms.	Belluco S, 2013, COMPR REV FOOD SCI F, V12, P296, DOI 10.1111/1541-4337.12014; Bosch G, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.23; Braeckman B, 1999, ENVIRON RES, V80, P231, DOI 10.1006/enrs.1998.3897; Charlton AJ, 2015, J INSECTS FOOD FEED, V1, P7, DOI 10.3920/JIFF2014.0020; Craig A, 1999, AQUAT TOXICOL, V44, P255, DOI 10.1016/S0166-445X(98)00086-1; Crawford LA, 1996, ENVIRON POLLUT, V92, P241, DOI 10.1016/0269-7491(96)00004-8; CRAWFORD LA, 1995, J APPL ECOL, V32, P528, DOI 10.2307/2404650; DALLINGER R, 1993, SETAC SP P, P245; Devkota B, 1992, P 6 INT C BIOIND DET; Diener S, 2015, J INSECTS FOOD FEED, V1, P261, DOI 10.3920/JIFF2015.0030; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Finke M.D., 2013, MASS PRODUCTION BENE; Gongalsky BK, 2004, B ENV CONTAMINATION, V72, P1115, DOI [10.1007/s00128-004-0359-3, DOI 10.1007/S00128-004-0359-3]; HARE L, 1991, CAN J FISH AQUAT SCI, V48, P39, DOI 10.1139/f91-006; HUNTER BA, 1987, J APPL ECOL, V24, P587, DOI 10.2307/2403895; Kazimirova M, 2000, ENVIRON TOXICOL CHEM, V19, P1822, DOI [10.1897/1551-5028(2000)019&lt;1822:MABCCD&gt;2.3.CO;2, 10.1002/etc.5620190716]; Lauverjat S., 1989, Biology of Metals, V2, P97, DOI 10.1007/BF01129208; LINDQVIST L, 1995, COMP BIOCHEM PHYS C, V111, P325, DOI 10.1016/0742-8413(95)00057-U; LINDQVIST L, 1992, ENVIRON ENTOMOL, V21, P160, DOI 10.1093/ee/21.1.160; LOUDON C, 1988, J INSECT PHYSIOL, V34, P97, DOI 10.1016/0022-1910(88)90160-6; MARONI G, 1985, INSECT BIOCHEM, V15, P55, DOI 10.1016/0020-1790(85)90044-7; Maryanski M, 2002, ECOTOXICOLOGY, V11, P127, DOI 10.1023/A:1014425113481; Miglietta PP, 2015, WATER-SUI, V7, P6190, DOI 10.3390/w7116190; Mireji PO, 2010, ECOTOX ENVIRON SAFE, V73, P46, DOI 10.1016/j.ecoenv.2009.08.004; Moriarty MM, 2009, ENVIRON SCI TECHNOL, V43, P4818, DOI 10.1021/es900086r; Morrissey CA, 2007, ENVIRON SCI TECHNOL, V41, P1494, DOI 10.1021/es061967r; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; Oonincx DGAB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051145; Oonincx DGAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014445; Pedersen SA, 2008, COMP BIOCHEM PHYS C, V148, P217, DOI 10.1016/j.cbpc.2008.05.013; Postma JF, 1996, ENVIRON TOXICOL CHEM, V15, P332, DOI [10.1897/1551-5028(1996)015&lt;0332:ICEIMA&gt;2.3.CO;2, 10.1002/etc.5620150317]; Rahman MM, 2009, ENVIRON GEOCHEM HLTH, V31, P201, DOI 10.1007/s10653-008-9236-z; Rumpold B. A., 2014, Food Chain, V4, P129, DOI 10.3362/2046-1887.2014.013; Rumpold BA, 2013, MOL NUTR FOOD RES, V57, P802, DOI 10.1002/mnfr.201200735; Rumpold BA, 2013, INNOV FOOD SCI EMERG, V17, P1, DOI 10.1016/j.ifset.2012.11.005; SCHMIDT GH, 1994, ECOTOX ENVIRON SAFE, V29, P148, DOI 10.1016/0147-6513(94)90016-7; Tomberlin JK, 2009, ENVIRON ENTOMOL, V38, P930, DOI 10.1603/022.038.0347; van Broekhoven S, 2015, J INSECT PHYSIOL, V73, P1, DOI 10.1016/j.jinsphys.2014.12.005; van der Spiegel M, 2013, COMPR REV FOOD SCI F, V12, P662, DOI 10.1111/1541-4337.12032; Van Huis A., 2013, EDIBLE INSECTS FUTUR; van Zanten HHE, 2015, J CLEAN PROD, V102, P362, DOI 10.1016/j.jclepro.2015.04.106; Veldkamp T., 2012, 638 WAG UR LIV RES; Vijver M, 2003, ECOTOX ENVIRON SAFE, V54, P277, DOI 10.1016/S0147-6513(02)00027-1; WEAVER DK, 1990, J INSECT PHYSIOL, V36, P531, DOI 10.1016/0022-1910(90)90105-O; Wu Guo-Xing, 2006, Insect Science, V13, P31, DOI 10.1111/j.1744-7917.2006.00065.x; Yasunobu A, 1984, COMP BIOCH PHYSL C, V78, P315	46	78	80	10	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166186	10.1371/journal.pone.0166186	http://dx.doi.org/10.1371/journal.pone.0166186			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846238	Green Submitted, gold, Green Published			2022-12-26	WOS:000387794600037
J	Kim, J; Kim, J; Lee, SH; Kepreotis, SV; Yoo, J; Chun, JS; Hajjar, RJ; Jeong, D; Park, WJ				Kim, Jooyeon; Kim, Jihwa; Lee, Seung Hee; Kepreotis, Sacha V.; Yoo, Jimeen; Chun, Jang-Soo; Hajjar, Roger J.; Jeong, Dongtak; Park, Woo Jin			Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-beta Signaling	PLOS ONE			English	Article							FIBROBLAST PRECURSORS; MOLECULAR-CLONING; MYOFIBROBLAST; EXPRESSION; GROWTH	Cytokine-like 1 (Cytl1) is a secreted protein that is involved in diverse biological processes. A comparative modeling study indicated that Cytl1 is structurally and functionally similar to monocyte chemoattractant protein 1 (MCP-1). As MCP-1 plays an important role in cardiac fibrosis (CF) and heart failure (HF), we investigated the role of Cytl1 in a mouse model of CF and HF. Cytl1 was upregulated in the failing mouse heart. Pressure overload-induced CF was significantly attenuated in cytl1 knock-out (KO) mice compared to that from wild-type (WT) mice. By contrast, adeno-associated virus (AAV)-mediated overexpression of cytl1 alone led to the development of CF in vivo. The endothelial-mesenchymal transition (EndMT) and the transdifferentiation of fibroblasts (FBs) to myofibroblasts (MFBs) have been suggested to contribute considerably to CF. Adenovirus-mediated overexpression of cytl1 was sufficient to induce these two critical CF-related processes in vitro, which were completely abrogated by co-treatment with SB-431542, an antagonist of TGF-beta receptor 1. Cytl1 induced the expression of TGF-beta 2 both in vivo and in vitro. Antagonizing the receptor for MCP-1, C-C chemokine receptor type 2 (CCR2), with CAS 445479-97-0 did not block the pro-fibrotic activity of Cytl1 in vitro. Collectively, our data suggest that Cytl1 plays an essential role in CF likely through activating the TGF-beta-SMAD signaling pathway. Although the receptor for Cyt1l remains to be identified, Cytl1 provides a novel platform for the development of anti-CF therapies.	[Kim, Jooyeon; Kim, Jihwa; Lee, Seung Hee; Chun, Jang-Soo; Park, Woo Jin] GIST, Coll Life Sci, Gwangju 61005, South Korea; [Kepreotis, Sacha V.; Yoo, Jimeen; Hajjar, Roger J.; Jeong, Dongtak] Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA	Gwangju Institute of Science & Technology (GIST); Icahn School of Medicine at Mount Sinai	Park, WJ (corresponding author), GIST, Coll Life Sci, Gwangju 61005, South Korea.; Jeong, D (corresponding author), Icahn Sch Med Mt Sinai, Cardiovasc Res Ctr, New York, NY 10029 USA.	dongtak.jeong@mssm.edu; woojinpark@icloud.com	Dongtak, Jeong/AGZ-5435-2022; Jeong, Dongtak/AAK-4194-2020; Jeong, Dongtak/ABA-7745-2020	Jeong, Dongtak/0000-0003-4153-3498; Yoo, Jimeen/0000-0001-9283-3963	Bio & Medical Technology Development Program [2015M3A9E6028951]; Basic Research Laboratory Program of NRF - Korean government [2016R1A4A1009895]; GIST	Bio & Medical Technology Development Program; Basic Research Laboratory Program of NRF - Korean government; GIST	This work was supported by the Bio & Medical Technology Development Program (2015M3A9E6028951) and the Basic Research Laboratory Program (2016R1A4A1009895) of NRF funded by the Korean government and a grant from the Systems Biology Infrastructure Establishment Grant provided by GIST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Cherney RJ, 2008, J MED CHEM, V51, P721, DOI 10.1021/jm701488f; 이성호, 2011, Carbon Letters, V12, P26; COMBADIERE C, 1995, J BIOL CHEM, V270, P29671; deBakker JMT, 1996, J AM COLL CARDIOL, V27, P1071, DOI 10.1016/0735-1097(95)00612-5; Ficker M, 2004, DEV BIOL, V268, P7, DOI 10.1016/j.ydbio.2003.11.023; Frangogiannis NG, 2005, TRENDS CARDIOVAS MED, V15, P163, DOI 10.1016/j.tcm.2005.06.005; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; Haudek SB, 2010, J MOL CELL CARDIOL, V49, P499, DOI 10.1016/j.yjmcc.2010.05.005; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jeon JH, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/271419; Jeong D, 2016, J AM COLL CARDIOL, V67, P1556, DOI 10.1016/j.jacc.2016.01.030; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Kim J, 2014, BIOCHEM BIOPH RES CO, V447, P649, DOI 10.1016/j.bbrc.2014.04.061; Liu X, 2000, GENOMICS, V65, P283, DOI 10.1006/geno.2000.6170; Lu YJ, 2016, INFLAMMATION, V39, P10, DOI 10.1007/s10753-015-0217-y; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Oh JG, 2013, J MOL CELL CARDIOL, V56, P63, DOI 10.1016/j.yjmcc.2012.12.005; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Weber KT, 2000, CURR OPIN CARDIOL, V15, P264, DOI 10.1097/00001573-200007000-00010; Wen MJ, 2012, INT J ONCOL, V41, P1419, DOI 10.3892/ijo.2012.1552; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xu J, 2011, AM J PHYSIOL-HEART C, V301, pH538, DOI 10.1152/ajpheart.01114.2010	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166480	10.1371/journal.pone.0166480	http://dx.doi.org/10.1371/journal.pone.0166480			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835665	Green Submitted, gold, Green Published			2022-12-26	WOS:000387779200053
J	Lee, WD; Wang, KC; Tsai, YF; Chou, PC; Tsai, LK; Chien, CL				Lee, Wen-Di; Wang, Kuo-Chuan; Tsai, Yi-Fen; Chou, Pin-Chun; Tsai, Li-Kai; Chien, Chung-Liang			Subarachnoid Hemorrhage Promotes Proliferation, Differentiation, and Migration of Neural Stem Cells via BDNF Upregulation	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; NITRIC-OXIDE; BRAIN; MICROGLIA; NEURONS; SVZ; INFLAMMATION; REPLACEMENT	Patients who suffer from subarachnoid hemorrhage (SAH) usually have long-term neurological impairments. Endogenous neurogenesis might play a potential role in functional recovery after SAH; however, the underlying neurogenesis mechanism is still unclear. We assessed the extent of neurogenesis in the subventricular zone (SVZ) to better understand the neurogenesis mechanism after SAH. We performed a rat model of SAH to examine the extent of neurogenesis in the SVZ and assessed functional effects of the neurotrophic factors in the cerebrospinal fluid (CSF) on neural stem cells (NSCs) after SAH. In this study, the proliferation, differentiation, and migratory capacities of NSCs in the SVZ were significantly increased on days 5 and 7 post SAH. Furthermore, treatment of cultured rat fetal NSCs with the CSF collected from rats on days 5 and 7 post SAH enhanced their proliferation, differentiation, and migration. Enzyme-linked immunosorbent assay (ELISA) of the CSF detected a marked increase in the concentration of brain-derived neurotrophic factor (BDNF). Treating the cultured NSCs with recombinant BDNF (at the same concentration as that in the CSF) or with CSF from SAH rats, directly, stimulated proliferation, differentiation, and migration to a similar extent. BDNF expression was upregulated in the SVZ of rats on days 5 and 7 post SAH, and BDNF release occurred from NSCs, astrocytes, and microglia in the SVZ. These results indicate that SAH triggers the expression of BDNF, which promotes the proliferation, differentiation, and migration of NSCs in the SVZ after SAH.	[Lee, Wen-Di; Chou, Pin-Chun; Chien, Chung-Liang] Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan; [Wang, Kuo-Chuan; Tsai, Yi-Fen] Natl Taiwan Univ Hosp, Dept Surg, Taipei, Taiwan; [Wang, Kuo-Chuan; Tsai, Yi-Fen; Tsai, Li-Kai] Natl Taiwan Univ, Coll Med, Taipei, Taiwan; [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan; [Tsai, Li-Kai] Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Chien, CL (corresponding author), Natl Taiwan Univ, Grad Inst Anat & Cell Biol, Coll Med, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ, Coll Med, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Dept Neurol, Taipei, Taiwan.; Tsai, LK (corresponding author), Natl Taiwan Univ Hosp, Stroke Ctr, Taipei, Taiwan.	milikai@ntuh.gov.tw; chien@ntu.edu.tw			Ministry of Science and Technology, Taiwan [NSC-100-2320-B-002-085]; National Taiwan University Hospital [104-002608]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the grants to CLC (NSC-100-2320-B-002-085) from the Ministry of Science and Technology, Taiwan, and to LKT (104-002608) from the National Taiwan University Hospital.	Akaneya Y, 1997, J NEUROSCI, V17, P6707; Alagappan D, 2009, ASN NEURO, V1, DOI 10.1042/AN20090002; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bath KG, 2010, DEV NEUROBIOL, V70, P339, DOI 10.1002/dneu.20781; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; Benraiss A, 2001, J NEUROSCI, V21, P6718, DOI 10.1523/JNEUROSCI.21-17-06718.2001; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chen A, 2013, BIOMED REP, V1, P167, DOI 10.3892/br.2012.48; Chen GQ, 1999, J NEUROSCI, V19, P7983; Chen K, 2007, MOL CELL NEUROSCI, V36, P108, DOI 10.1016/j.mcn.2007.06.004; Chiaramello S, 2007, EUR J NEUROSCI, V26, P1780, DOI 10.1111/j.1460-9568.2007.05818.x; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; George PM, 2015, NEURON, V87, P297, DOI 10.1016/j.neuron.2015.05.041; Gratacos E, 2001, J NEUROCHEM, V79, P747, DOI 10.1046/j.1471-4159.2001.00570.x; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; HAYMAN LA, 1989, AM J ROENTGENOL, V153, P135, DOI 10.2214/ajr.153.1.135; Henry RA, 2007, EUR J NEUROSCI, V25, P3513, DOI 10.1111/j.1460-9568.2007.05625.x; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ishikawa Y, 2000, J NEUROCHEM, V75, P494, DOI 10.1046/j.1471-4159.2000.0750494.x; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Johanson C, 2011, J NEURAL TRANSM, V118, P115, DOI 10.1007/s00702-010-0498-0; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KOKAIA M, 1995, EXP NEUROL, V133, P215, DOI 10.1006/exnr.1995.1024; KOKAIA Z, 1995, EXP NEUROL, V136, P73, DOI 10.1006/exnr.1995.1085; Lahteinen S, 2002, EUR J NEUROSCI, V15, P721; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moreno-Lopez B, 2004, J NEUROSCI, V24, P85, DOI 10.1523/JNEUROSCI.1574-03.2004; Morrison ME, 1998, J NEUROSCI, V18, P3563; Numakawa T, 2000, NEUROSCI RES, V37, P59, DOI 10.1016/S0168-0102(00)00103-6; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Rinkel GJE, 2011, LANCET NEUROL, V10, P349, DOI 10.1016/S1474-4422(11)70017-5; Saha RN, 2006, J NEUROIMMUNE PHARM, V1, P212, DOI 10.1007/s11481-006-9020-8; Sgubin D, 2007, J NEUROSCI RES, V85, P1647, DOI 10.1002/jnr.21303; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Sun F, 2012, PLOS ONE, V7, P1; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Whitman MC, 2009, PROG NEUROBIOL, V89, P162, DOI 10.1016/j.pneurobio.2009.07.003; Ying Z, 2008, NEUROSCIENCE, V155, P1070, DOI 10.1016/j.neuroscience.2008.06.057; Zhang RL, 2007, J NEUROSCI, V27, P3157, DOI 10.1523/JNEUROSCI.4969-06.2007; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	54	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165460	10.1371/journal.pone.0165460	http://dx.doi.org/10.1371/journal.pone.0165460			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832087	gold, Green Submitted, Green Published			2022-12-26	WOS:000387725000014
J	Wang, ZH; Fan, C; Myint, SW; Wang, CH				Wang, Zhi-Hua; Fan, Chao; Myint, Soe W.; Wang, Chenghao			Size Matters: What Are the Characteristic Source Areas for Urban Planning Strategies?	PLOS ONE			English	Article							HEAT-ISLAND; ANTHROPOGENIC HEAT; ENERGY; VEGETATION; CLIMATE; IMPACT; PHOENIX; EXCHANGE; SURFACE; ALBEDO	Urban environmental measurements and observational statistics should reflect the properties generated over an adjacent area of adequate length where homogeneity is usually assumed. The determination of this characteristic source area that gives sufficient representation of the horizontal coverage of a sensing instrument or the fetch of transported quantities is of critical importance to guide the design and implementation of urban landscape planning strategies. In this study, we aim to unify two different methods for estimating source areas, viz. the statistical correlation method commonly used by geographers for landscape fragmentation and the mechanistic footprint model by meteorologists for atmospheric measurements. Good agreement was found in the intercomparison of the estimate of source areas by the two methods, based on 2-m air temperature measurement collected using a network of weather stations. The results can be extended to shed new lights on urban planning strategies, such as the use of urban vegetation for heat mitigation. In general, a sizable patch of landscape is required in order to play an effective role in regulating the local environment, proportional to the height at which stakeholders' interest is mainly concerned.	[Wang, Zhi-Hua; Wang, Chenghao] Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA; [Fan, Chao; Myint, Soe W.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Wang, ZH (corresponding author), Arizona State Univ, Sch Sustainable Engn & Built Environm, Tempe, AZ 85287 USA.	zhwang@asu.edu	Wang, Chenghao/O-7961-2017; Wang, Zhi-Hua/A-3391-2008	Wang, Chenghao/0000-0001-8846-4130; Wang, Zhi-Hua/0000-0001-9155-8605	U.S. National Science Foundation [CBET-1435881, CBET-1444758, SES-1462086]; Directorate For Engineering [1435881] Funding Source: National Science Foundation; Div Of Chem, Bioeng, Env, & Transp Sys [1444758] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	ZHW and CW received funding from the U.S. National Science Foundation (http://www.nsf.gov) under grant numbers CBET-1435881, CBET-1444758, and SES-1462086. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the U.S. National Science Foundation under grant numbers: CBET-1435881, CBET-1444758, and SES-1462086 (DCDC III). The authors thank the Academic Editor, Dr. Juergen P. Kropp and the two anonymous reviewers for their constructive feedback.	Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Brazel A, 2000, CLIMATE RES, V15, P123, DOI 10.3354/cr015123; Buyantuyev A, 2010, LANDSCAPE ECOL, V25, P17, DOI 10.1007/s10980-009-9402-4; Chen XL, 2006, REMOTE SENS ENVIRON, V104, P133, DOI 10.1016/j.rse.2005.11.016; Chow WTL, 2014, INT J CLIMATOL, V34, P3863, DOI 10.1002/joc.3947; Dennison P.E., 2000, P 9 JPL AIRB EARTH S, P119; Dvorak B, 2010, LANDSCAPE URBAN PLAN, V96, P197, DOI 10.1016/j.landurbplan.2010.04.009; Dyer A. J., 1974, Boundary-Layer Meteorology, V7, P363, DOI 10.1007/BF00240838; Fan C, 2015, PROG PHYS GEOG, V39, P199, DOI 10.1177/0309133314567583; FISCHER EM, 2007, GEOPHYS RES LETT, V34, DOI DOI 10.1029/2006GL029068; Fouillet A, 2006, INT ARCH OCC ENV HEA, V80, P16, DOI 10.1007/s00420-006-0089-4; Kolokotroni M, 2007, SOL ENERGY, V81, P102, DOI 10.1016/j.solener.2006.06.005; Kormann R, 2001, BOUND-LAY METEOROL, V99, P207, DOI 10.1023/A:1018991015119; Lee TW, 2012, URBAN CLIM, V2, P16, DOI 10.1016/j.uclim.2012.10.005; Myint SW, 2009, INT J REMOTE SENS, V30, P2237, DOI 10.1080/01431160802549328; Myint SW, 2010, GISCI REMOTE SENS, V47, P301, DOI 10.2747/1548-1603.47.3.301; Myint SW, 2004, PHOTOGRAMM ENG REM S, V70, P803, DOI 10.14358/PERS.70.7.803; Narumi D, 2009, ENVIRON RES, V109, P421, DOI 10.1016/j.envres.2009.02.013; Oberndorfer E, 2007, BIOSCIENCE, V57, P823, DOI 10.1641/B571005; OKE TR, 1982, Q J ROY METEOR SOC, V108, P1, DOI 10.1002/qj.49710845502; PASQUILL F, 1972, Q J ROY METEOR SOC, V98, P469, DOI 10.1002/qj.49709841702; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Roberts DA, 1998, REMOTE SENS ENVIRON, V65, P267, DOI 10.1016/S0034-4257(98)00037-6; Sailor DJ, 2011, INT J CLIMATOL, V31, P189, DOI 10.1002/joc.2106; Santamouris M, 2001, SOL ENERGY, V70, P201, DOI 10.1016/S0038-092X(00)00095-5; Schmid HP, 2002, AGR FOREST METEOROL, V113, P159, DOI 10.1016/S0168-1923(02)00107-7; Song JY, 2015, BUILD ENVIRON, V94, P558, DOI 10.1016/j.buildenv.2015.10.016; Stull R.B., 1988, ATMOSPHERIC OCEANOGR; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; United Nations (UN), 2014, STESASERA352 UN DOEA; Wang ZH, 2016, APPL ENERG, V161, P437, DOI 10.1016/j.apenergy.2015.10.047; Wang ZH, 2014, URBAN CLIM, V10, P19, DOI 10.1016/j.uclim.2014.08.004; Wang ZH, 2014, SOL ENERGY, V110, P704, DOI 10.1016/j.solener.2014.10.012; Wang ZH, 2013, Q J ROY METEOR SOC, V139, P1643, DOI 10.1002/qj.2032; Yang JC, 2016, J HYDROMETEOROL, V17, P1031, DOI 10.1175/JHM-D-15-0112.1; Yang JC, 2015, RENEW SUST ENERG REV, V47, P830, DOI 10.1016/j.rser.2015.03.092; Yang JC, 2014, BUILD ENVIRON, V75, P250, DOI 10.1016/j.buildenv.2014.02.006	37	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165726	10.1371/journal.pone.0165726	http://dx.doi.org/10.1371/journal.pone.0165726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832111	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000031
J	Besseling, RMH; Jansen, JFA; de Louw, AJA; Vlooswijk, MCG; Hoeberigs, MC; Aldenkamp, AP; Backes, WH; Hofman, PAM				Besseling, Rene M. H.; Jansen, Jacobus F. A.; de Louw, Anton J. A.; Vlooswijk, Marielle C. G.; Hoeberigs, M. Christianne; Aldenkamp, Albert P.; Backes, Walter H.; Hofman, Paul A. M.			Abnormal Profiles of Local Functional Connectivity Proximal to Focal Cortical Dysplasias	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; BRAIN NETWORKS; EPILEPSY; CLASSIFICATION; LOCALIZATION; FMRI	Introduction Focal cortical dysplasia (FCD) is a congenital malformation of cortical development that often leads to medically refractory epilepsy. Focal resection can be an effective treatment, but is challenging as the surgically relevant abnormality may exceed the MR-visible lesion. The aim of the current study is to develop methodology to characterize the profile of functional connectivity around FCDs using resting-state functional MRI and in the individual patient. The detection of aberrant connectivity may provide a means to more completely delineate the clinically relevant lesion. Materials and Methods Fifteen FCD patients (age, mean +/- SD: 31 +/- 11 years; 11 males) and 16 matched healthy controls (35 +/- 9 years; 7 males) underwent structural and functional imaging at 3 Tesla. The cortical surface was reconstructed from the T1-weighted scan and the registered functional MRI data was spatially normalized to a common anatomical standard space employing the gyral pattern. Seed-based functional connectivity was determined in all subjects for all dysplasia locations. A single patient was excluded based on an aberrant FCD seed time series. Functional connectivity as a function of geodesic distance (along the cortical surface) was compared between the individual patients and the homotopic normative connectivity profiles derived from the controls. Results In 12/14 patients, aberrant profiles of functional connectivity were found, which demonstrated both hyper-and hypoconnectivity as well as combinations. Abnormal functional connectivity was typically found (also) beyond the lesion visible on structural MRI, while functional connectivity profiles not related to a lesion appeared normal in patients. Conclusion This novel functional MRI technique has potential for delineating functionally aberrant from normal cortex beyond the structural lesion in FCD, which remains to be confirmed in future research.	[Besseling, Rene M. H.; de Louw, Anton J. A.; Aldenkamp, Albert P.; Hofman, Paul A. M.] Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands; [Besseling, Rene M. H.; Jansen, Jacobus F. A.; Vlooswijk, Marielle C. G.; Backes, Walter H.; Hofman, Paul A. M.] Maastricht Univ, Res Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [Besseling, Rene M. H.; Jansen, Jacobus F. A.; Hoeberigs, M. Christianne; Backes, Walter H.; Hofman, Paul A. M.] Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands; [Vlooswijk, Marielle C. G.; Aldenkamp, Albert P.] Maastricht Univ, Med Ctr, Dept Neurol, Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University	Hofman, PAM (corresponding author), Epilepsy Ctr Kempenhaeghe, Heeze, Netherlands.; Hofman, PAM (corresponding author), Maastricht Univ, Res Sch Mental Hlth & Neurosci, Maastricht, Netherlands.; Hofman, PAM (corresponding author), Maastricht Univ, Med Ctr, Dept Radiol, Maastricht, Netherlands.	paul.hofman@mumc.nl	Jansen, Jacobus F.A./C-4098-2009; Morden, Frances/AAY-4233-2020	Jansen, Jacobus F.A./0000-0002-5271-8060; 	Dutch Epilepsy Foundation (NEF) [NEF10-08]	Dutch Epilepsy Foundation (NEF)	This work was supported by the Dutch Epilepsy Foundation (NEF), grant NEF10-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge Ester Peeters for data acquisition, Marc Geerlings for continuous soft- and hardware support, and the patients for their time and interest in our research. We would like to thank the Dutch Epilepsy Foundation for funding (grant number NEF10-08).	Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Chassoux F, 2012, EPILEPSIA, V53, P349, DOI 10.1111/j.1528-1167.2011.03363.x; Cocchi L, 2012, J NEUROSCI, V32, P17753, DOI 10.1523/JNEUROSCI.3272-12.2012; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Hauptman JS, 2012, EPILEPSIA, V53, P98, DOI 10.1111/j.1528-1167.2012.03619.x; Hofman PAM, 2011, AM J ROENTGENOL, V196, P881, DOI 10.2214/AJR.10.4423; Hong SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057831; Jager L, 2002, RADIOLOGY, V223, P860, DOI 10.1148/radiol.2233010360; Kassubek J, 2002, EPILEPSIA, V43, P596, DOI 10.1046/j.1528-1157.2002.41401.x; Lee SK, 2004, NEUROIMAGE, V22, P1826, DOI 10.1016/j.neuroimage.2004.04.028; Lopes R, 2012, NEUROIMAGE, V60, P1867, DOI 10.1016/j.neuroimage.2011.12.083; MITCHELL JSB, 1987, SIAM J COMPUT, V16, P647, DOI 10.1137/0216045; O'Rourke J, 1999, INT J COMPUT GEOM AP, V9, P513, DOI 10.1142/S0218195999000297; Palmini A, 2004, NEUROLOGY, V62, pS2, DOI 10.1212/01.WNL.0000114507.30388.7E; Rastogi S, 2008, RADIOGRAPHICS, V28, P1079, DOI 10.1148/rg.284075114; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Sporns O, 2013, NEUROIMAGE, V80, P53, DOI 10.1016/j.neuroimage.2013.03.023; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Thornton R, 2011, ANN NEUROL, V70, P822, DOI 10.1002/ana.22535; Wang DD, 2013, J NEUROSURG, V118, P337, DOI 10.3171/2012.10.JNS12119; Widjaja E, 2007, EPILEPSIA, V48, P1460, DOI 10.1111/j.1528-1167.2007.01105.x; Widjaja E, 2009, RADIOLOGY, V251, P206, DOI 10.1148/radiol.2511081092; Winston GP, 2013, EPILEPSY RES, V105, P349, DOI 10.1016/j.eplepsyres.2013.02.022; Yagishita A, 1997, RADIOLOGY, V203, P553, DOI 10.1148/radiology.203.2.9114120; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041	29	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166022	10.1371/journal.pone.0166022	http://dx.doi.org/10.1371/journal.pone.0166022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861502	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300022
J	Haberfehlner, H; Jaspers, RT; Rutz, E; Becher, JG; Harlaar, J; van der Sluijs, JA; Witbreuk, MM; Romkes, J; Freslier, M; Brunner, R; Maas, H; Buizer, AI				Haberfehlner, Helga; Jaspers, Richard T.; Rutz, Erich; Becher, Jules G.; Harlaar, Jaap; van der Sluijs, Johannes A.; Witbreuk, Melinda M.; Romkes, Jacqueline; Freslier, Marie; Brunner, Reinald; Maas, Huub; Buizer, Annemieke I.			Knee Moment-Angle Characteristics and Semitendinosus Muscle Morphology in Children with Spastic Paresis Selected for Medial Hamstring Lengthening	PLOS ONE			English	Article							MYOFASCIAL FORCE TRANSMISSION; FUNCTION CLASSIFICATION-SYSTEM; EVENT MULTILEVEL SURGERY; CEREBRAL-PALSY; 3-DIMENSIONAL ULTRASOUND; GASTROCNEMIUS-MUSCLE; BOTULINUM TOXIN; SKELETAL-MUSCLE; RECTUS FEMORIS; IMAGE-ANALYSIS	To increase knee range of motion and improve gait in children with spastic paresis (SP), the semitendinosus muscle (ST) amongst other hamstring muscles is frequently lengthened by surgery, but with variable success. Little is known about how the pre-surgical mechanical and morphological characteristics of ST muscle differ between children with SP and typically developing children (TD). The aims of this study were to assess (1) how knee moment-angle characteristics and ST morphology in children with SP selected for medial hamstring lengthening differ from TD children, as well as (2) how knee moment-angle characteristics and ST morphology are related. In nine SP and nine TD children, passive knee moment-angle characteristics and morphology of ST (i.e. fascicle length, muscle belly length, tendon length, physiological cross-sectional area, and volume) were assessed by hand-held dynamometry and freehand 3D ultrasound, respectively. At net knee flexion moments above 0.5 Nm, more flexed knee angles were found for SP compared to TD children. The measured knee angle range between 0 and 4 Nm was 30% smaller in children with SP. Muscle volume, physiological cross-sectional area, and fascicle length normalized to femur length were smaller in SP compared to TD children (62%, 48%, and 18%, respectively). Sixty percent of the variation in knee angles at 4 Nm net knee moment was explained by ST fascicle length. Altered knee moment-angle characteristics indicate an increased ST stiffness in SP children. Morphological observations indicate that in SP children planned for medial hamstring lengthening, the longitudinal and cross-sectional growth of ST muscle fibers is reduced. The reduced fascicle length can partly explain the increased ST stiffness and, hence, a more flexed knee joint in these SP children.	[Haberfehlner, Helga; Jaspers, Richard T.; Maas, Huub] Vrije Univ, Fac Behav & Movement Sci, Dept Human Movement Sci, Lab Myol, Amsterdam, Netherlands; [Haberfehlner, Helga; Becher, Jules G.; Harlaar, Jaap; Buizer, Annemieke I.] Vrije Univ Amsterdam, Med Ctr, Dept Rehabil Med, Amsterdam, Netherlands; [Haberfehlner, Helga; Jaspers, Richard T.; Becher, Jules G.; Harlaar, Jaap; van der Sluijs, Johannes A.; Witbreuk, Melinda M.; Maas, Huub; Buizer, Annemieke I.] MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Rutz, Erich; Brunner, Reinald] Univ Childrens Hosp Basle UKBB, Pediat Orthopaed Dept, Basel, Switzerland; [Rutz, Erich; Romkes, Jacqueline; Freslier, Marie; Brunner, Reinald] Univ Childrens Hosp Basle UKBB, Lab Movement Anal, Basel, Switzerland; [van der Sluijs, Johannes A.; Witbreuk, Melinda M.] Vrije Univ Amsterdam, Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Jaspers, RT (corresponding author), Vrije Univ, Fac Behav & Movement Sci, Dept Human Movement Sci, Lab Myol, Amsterdam, Netherlands.; Jaspers, RT (corresponding author), MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.t.jaspers@vu.nl	Buizer, Annemieke/G-9500-2016; Becher, Jules/AAE-2246-2020	Buizer, Annemieke/0000-0001-5662-2843; Jaspers, Richard/0000-0002-6951-0952; Haberfehlner, Helga/0000-0001-9307-4102; Rutz, Erich/0000-0002-2292-0946; Maas, Huub/0000-0002-2304-2735; Harlaar, Jaap/0000-0003-2889-271X	Phelps Stichting voor Spastici, Bussum, The Netherlands; Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]	Phelps Stichting voor Spastici, Bussum, The Netherlands(Netherlands Government); Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research	This research is financially supported by the Phelps Stichting voor Spastici, Bussum, The Netherlands (http://phelps-stichting.nl/). Huub Maas was supported by the Division for Earth and Life Sciences of the Netherlands Organization for Scientific Research [864-10-011]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MF, 1999, J PEDIATR ORTHOPED, V19, P366; Adolfsen SE, 2007, J PEDIATR ORTHOPED, V27, P658, DOI 10.1097/BPO.0b013e3180dca114; Arnold AS, 2006, GAIT POSTURE, V23, P273, DOI 10.1016/j.gaitpost.2005.03.003; Beals RK, 2001, DEV MED CHILD NEUROL, V43, P802, DOI 10.1017/S0012162201001451; Becher JG., 2002, J PROSTHET ORTHOT, V14, P143, DOI DOI 10.1097/00008526-200212000-00004; Benard MR, 2011, J ANAT, V219, P388, DOI 10.1111/j.1469-7580.2011.01402.x; Booth CM, 2001, DEV MED CHILD NEUROL, V43, P314, DOI 10.1017/S0012162201000597; BRAND RA, 1986, J BIOMECH, V19, P589, DOI 10.1016/0021-9290(86)90164-8; Cans C, 2002, DEV MED CHILD NEUROL, V44, P633; Cave EF, 1936, J BONE JOINT SURG, V18, P455; Chang WN, 2004, GAIT POSTURE, V19, P298, DOI 10.1016/S0966-6362(03)00070-5; CHRISTENSEN E, 1959, Am J Phys Med, V38, P65; Cooney KM, 2006, CLIN BIOMECH, V21, P59, DOI 10.1016/j.clinbiomech.2005.08.014; Dagge B, 2012, ANZ J SURG, V82, P355, DOI 10.1111/j.1445-2197.2012.06030.x; de Bruin M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101038; De Mattos C, 2014, J CHILD ORTHOP, V8, P513, DOI 10.1007/s11832-014-0626-8; DHAWLIKAR SH, 1992, J BONE JOINT SURG AM, V74A, P1385, DOI 10.2106/00004623-199274090-00012; Dreher T, 2012, J BONE JOINT SURG AM, V94A, P121, DOI [10.2106/JBJSJ.00890, 10.2106/JBJS.J.00890]; GAGE JR, 1990, CLIN ORTHOP RELAT R, P45; Gage JR., 2009, IDENTIFICATION TREAT; Gajdosik RL, 2001, CLIN BIOMECH, V16, P87, DOI 10.1016/S0268-0033(00)00061-9; Gough M, 2012, DEV MED CHILD NEUROL, V54, P495, DOI 10.1111/j.1469-8749.2012.04229.x; Haberfehlner H, 2016, J ANAT, V229, P591, DOI 10.1111/joa.12501; Haberfehlner H, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0056-y; Handsfield GG, 2016, MUSCLE NERVE, V53, P933, DOI 10.1002/mus.24972; Hermens H.J., 1999, ROESSINGH RES DEV, V8, P11; Herskind A., 2015, DEV MED CHILD NEUROL; Hicks JL, 2011, GAIT POSTURE, V34, P197, DOI 10.1016/j.gaitpost.2011.04.009; Huijing PA, 2005, SCAND J MED SCI SPOR, V15, P349, DOI 10.1111/j.1600-0838.2005.00457.x; Huijing PA, 2007, J ELECTROMYOGR KINES, V17, P708, DOI 10.1016/j.jelekin.2007.02.003; Johnson DL, 2009, J PEDIATR-US, V154, P715, DOI 10.1016/j.jpeds.2008.10.046; Kay RM, 2002, J PEDIATR ORTHOPED, V22, P169, DOI 10.1097/00004694-200203000-00006; Lampe R, 2006, BRAIN DEV-JPN, V28, P500, DOI 10.1016/j.braindev.2006.02.009; Laracca E, 2014, GAIT POSTURE, V39, P847, DOI 10.1016/j.gaitpost.2013.11.010; Maas H, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/575672; MARKEE JE, 1955, J BONE JOINT SURG AM, V37, P125, DOI 10.2106/00004623-195537010-00015; Mathewson MA, 2015, J ORTHOP RES, V33, P33, DOI 10.1002/jor.22728; McGinley JL, 2012, DEV MED CHILD NEUROL, V54, P117, DOI 10.1111/j.1469-8749.2011.04143.x; Moreau NG, 2009, DEV MED CHILD NEUROL, V51, P800, DOI 10.1111/j.1469-8749.2009.03307.x; Noble JJ, 2014, BRAIN DEV-JPN, V36, P294, DOI 10.1016/j.braindev.2013.05.008; Oberhofer K, 2010, CLIN BIOMECH, V25, P88, DOI 10.1016/j.clinbiomech.2009.09.007; Ounpuu S, 2015, GAIT POSTURE, V42, P365, DOI 10.1016/j.gaitpost.2015.07.003; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pillen S, 2007, NEUROMUSCULAR DISORD, V17, P509, DOI 10.1016/j.nmd.2007.03.008; Pillen S, 2009, ULTRASOUND MED BIOL, V35, P443, DOI 10.1016/j.ultrasmedbio.2008.09.016; Pitcher CA, 2015, MUSCLE NERVE, V52, P397, DOI 10.1002/mus.24549; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Prager RW, 1998, ULTRASOUND MED BIOL, V24, P855, DOI 10.1016/S0301-5629(98)00044-1; Rab M, 1997, SURG RADIOL ANAT, V19, P287, DOI 10.1007/BF01637592; REIMERS J, 1974, J BONE JOINT SURG BR, VB 56, P102; Rodda J, 2001, EUR J NEUROL, V8, P98, DOI 10.1046/j.1468-1331.2001.00042.x; Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028; Rutz E, 2012, DEV MED CHILD NEUROL, V54, P1109, DOI 10.1111/dmcn.12011; Rutz E, 2010, J ORTHOP SCI, V15, P647, DOI 10.1007/s00776-010-1509-6; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidel PMP, 1996, ARCH PHYS MED REHAB, V77, P1157, DOI 10.1016/S0003-9993(96)90140-9; Smeulders MJC, 2007, J ELECTROMYOGR KINES, V17, P644, DOI 10.1016/j.jelekin.2007.02.002; Smeulders MJC, 2004, J ORTHOP RES, V22, P1331, DOI 10.1016/j.orthres.2004.04.006; Smith LR, 2011, J PHYSL; Solberg OV, 2007, ULTRASOUND MED BIOL, V33, P991, DOI 10.1016/j.ultrasmedbio.2007.02.015; Staudenmann D, 2010, J ELECTROMYOGR KINES, V20, P375, DOI 10.1016/j.jelekin.2009.08.005; van Campenhout A, 2011, DEV MED CHILD NEUROL, V53, P108, DOI 10.1111/j.1469-8749.2010.03816.x; Weide G, 2015, J ANAT, V226, P530, DOI 10.1111/joa.12306; Weller R, 2007, ULTRASOUND MED BIOL, V33, P402, DOI 10.1016/j.ultrasmedbio.2006.08.007; Woodley SJ, 2005, CELLS TISSUES ORGANS, V179, P125, DOI 10.1159/000085004; Wu MN, 2012, J BIOMECH, V45, P1728, DOI 10.1016/j.jbiomech.2012.03.017; ZAJAC FE, 1989, CRIT REV BIOMED ENG, V17, P359; Zwick EB, 2002, GAIT POSTURE, V16, P288, DOI 10.1016/S0966-6362(02)00022-X	70	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166401	10.1371/journal.pone.0166401	http://dx.doi.org/10.1371/journal.pone.0166401			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861523	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300054
J	Hills, T; Jakeman, PG; Carlisle, RC; Klenerman, P; Seymour, LW; Cawood, R				Hills, Thomas; Jakeman, Phillip G.; Carlisle, Robert C.; Klenerman, Paul; Seymour, Leonard W.; Cawood, Ryan			A Rapid-Response Humoral Vaccine Platform Exploiting Pre-Existing Non-Cognate Populations of Anti-Vaccine or Anti-Viral CD4+T Helper Cells to Confirm B Cell Activation	PLOS ONE			English	Article							TETRAVALENT DENGUE VACCINE; T-CELLS; HUMAN CYTOMEGALOVIRUS; CD4(+); IMMUNOGENICITY; HEMAGGLUTININ; INFECTION; LATENCY; FUTURE; SAFETY	The need for CD4+ T cell responses to arise de novo following vaccination can limit the speed of B cell responses. Populations of pre-existing vaccine-induced or anti-viral CD4+ T cells recognising distinct antigens could be exploited to overcome this limitation. We hypothesise that liposomal vaccine particles encapsulating epitopes that are recognised, after processing and B cell MHCII presentation, by pre-existing CD4+ T cells will exploit this pre-existing T cell help and result in improved antibody responses to distinct target antigens displayed on the particle surface. Liposomal vaccine particles were engineered to display the malaria circumsporozoite (CSP) antigen on their surface, with helper CD4+ epitopes from distinct vaccine or viral antigens contained within the particle core, ensuring the B cell response is raised but focused against CSP. In vivo vaccination studies were then conducted in C57Bl/6 mice as models of either vaccine-induced pre-existing CD4+ T cell immunity (using ovalbumin-OVA) or virus-induced pre-existing CD4+ T cell immunity (murine cytomegalovirus-MCMV). Following the establishment of pre-existing by vaccination (OVA in the adjuvant TiterMax (R) Gold) or infection with MCMV, mice were administered CSP-coated liposomal vaccines containing the relevant OVA or MCMV core CD4+ T cell epitopes. In mice with pre-existing anti-OVA CD4+ T cell immunity, these vaccine particles elicited rapid, high-titre, isotype-switched CSP-specific antibody responses-consistent with the involvement of anti-OVA T helper cells in confirming activation of anti-CSP B cells. Responses were further improved by entrapping TLR9 agonists, combining humoral vaccination signals 'one', 'two' and 'three' within one particle. Herpes viruses can establish chronic infection and elicit significant, persistent cellular immune responses. We then demonstrate that this principle can be extended to re-purpose pre-existing anti-MCMV immunity to enhance anti-CSP vaccine responses-the first description of a strategy to specifically exploit anti-cytomegalovirus immunity to augment vaccination against a target antigen.	[Hills, Thomas; Jakeman, Phillip G.; Seymour, Leonard W.; Cawood, Ryan] Univ Oxford, Dept Oncol, Oxford, England; [Carlisle, Robert C.] Univ Oxford, Dept Biomed Engn, Oxford, England; [Klenerman, Paul] Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford, England	University of Oxford; University of Oxford; University of Oxford	Seymour, LW (corresponding author), Univ Oxford, Dept Oncol, Oxford, England.	len.seymour@oncology.ox.ac.uk		seymour, len/0000-0003-3825-0841; klenerman, paul/0000-0003-4307-9161; Hills, Thomas/0000-0003-0322-5822	Rhodes Trust; Cancer Research UK [17720] Funding Source: researchfish	Rhodes Trust; Cancer Research UK(Cancer Research UK)	TH was the recipient of a stipend from The Rhodes Trust while he was a doctoral student working on this project. The authors received no other specific funding for this work.	Arens R, 2008, J IMMUNOL, V180, P6472, DOI 10.4049/jimmunol.180.10.6472; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x; Diethelm-Okita BM, 2000, J INFECT DIS, V181, P1001, DOI 10.1086/315324; Dunn HS, 2002, J INFECT DIS, V186, P15, DOI 10.1086/341079; Gompels UA, 2012, CLIN INFECT DIS, V54, P434, DOI 10.1093/cid/cir837; Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555; Gururajan M., 2007, PLOS ONE, V2; Harcourt GC, 2006, CLIN EXP IMMUNOL, V146, P203, DOI 10.1111/j.1365-2249.2006.03193.x; Hovden AO, 2005, SCAND J IMMUNOL, V62, P36, DOI 10.1111/j.1365-3083.2005.01633.x; KRIEG AM, 1995, NATURE, V374, P546, DOI 10.1038/374546a0; Lambert PH, 2005, NAT MED, V11, pS54, DOI 10.1038/nm1216; Lin L, 2004, EUR J IMMUNOL, V34, P1483, DOI 10.1002/eji.200324736; Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mills DM, 2003, SEMIN IMMUNOL, V15, P325, DOI 10.1016/j.smim.2003.09.004; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.iy.11.040193.001555; PEETERS CCAM, 1991, INFECT IMMUN, V59, P3504, DOI 10.1128/IAI.59.10.3504-3510.1991; Plotkin SA, 2005, NAT MED, V11, pS5, DOI 10.1038/nm1209; Pobre K, 2014, VACCINE, V32, P1423, DOI 10.1016/j.vaccine.2014.01.047; Poo J, 2011, PEDIATR INFECT DIS J, V30, pE9, DOI 10.1097/INF.0b013e3181fe05af; PULLEN GR, 1986, J IMMUNOL METHODS, V86, P83, DOI 10.1016/0022-1759(86)90268-1; Qiao M, 2011, AM J TROP MED HYG, V85, P724, DOI 10.4269/ajtmh.2011.10-0436; RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0; SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114; SCHUTZE MP, 1985, J IMMUNOL, V135, P2319; Sester M, 2002, J VIROL, V76, P3748, DOI 10.1128/JVI.76.8.3748-3755.2002; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Sims S., 2014, EUROPEAN J IMMUNOLOG, DOI 10.1038/nature05762; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Vescovini R, 2007, J IMMUNOL, V179, P4283, DOI 10.4049/jimmunol.179.6.4283; Vollmer J, 2009, ADV DRUG DELIVER REV, V61, P195, DOI 10.1016/j.addr.2008.12.008; Weekes MP, 2004, J IMMUNOL, V173, P5843, DOI 10.4049/jimmunol.173.9.5843	37	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166383	10.1371/journal.pone.0166383	http://dx.doi.org/10.1371/journal.pone.0166383			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861512	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300052
J	Jeong, SH; Kim, JK; Park, J; Jeon, HJ; Yoon, MY; Jeong, CW; Ku, JH; Kim, HH; Kwak, C				Jeong, Seung-hwan; Kim, Jung Kwon; Park, Juhyun; Jeon, Ho Joon; Yoon, Min Young; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol			Pathological T3a Upstaging of Clinical T1 Renal Cell Carcinoma: Outcomes According to Surgical Technique and Predictors of Upstaging	PLOS ONE			English	Article							NEPHRON-SPARING SURGERY; PARTIAL NEPHRECTOMY; RADICAL NEPHRECTOMY; TUMORS; GRADE; STAGE; TOMOGRAPHY; SURVIVAL; FEATURES; MASSES	Purpose To evaluate the prognosis of pT3a upstaging from cT1 renal cell carcinoma, and to compare the outcomes of partial or radical nephrectomy in cases of pT3a upstaging. Materials and Methods We reviewed the records of patients who underwent partial or radical nephrectomy for cT1 at our center between January 2001 and October 2013. We compared the 2-year recurrence-free survivals for cases with pT1 or pT3a upstaging, and for partial or radical nephrectomy in cases with pT3a upstaging. Clinicopathological parameters were analyzed in univariate and multivariate analyses to evaluate their associations with upstaging. Results Among the 1,009 eligible patients, 987 patients were included in the analysis. The mean follow-up was 48.5 +/- 27.8 months in whole patients. The 2-year recurrence-free survival was worse in the pT3a upstaging group, compared to the pT1 group (87.3% vs. 98.7%; p < 0.001). Partial nephrectomy and radical nephrectomy had no significant difference in 2-year recurrence-free survivals (91.9% vs. 83.7%; p = 0.251). The multivariate analysis revealed that upstaging was associated with old age, cT1b stage, clinical symptoms, and a high Fuhrman grade. Conclusions Pathological T3a upstaging of cT1 renal cell carcinoma was associated with a poorer prognosis, compared to pT1 disease. However, the surgical technique (radical or partial nephrectomy) did not affect the recurrence rate. Therefore, clinicians should select the treatment method based on the clinical stage, and consider the pathological stage during the follow-up.	[Jeong, Seung-hwan; Kim, Jung Kwon; Jeon, Ho Joon; Yoon, Min Young; Jeong, Chang Wook; Ku, Ja Hyeon; Kim, Hyeon Hoe; Kwak, Cheol] Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea; [Park, Juhyun] Seoul Natl Univ, Coll Med, Seoul Metropolitan Govt, Dept Urol,Boramae Med Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kwak, C (corresponding author), Seoul Natl Univ Hosp, Dept Urol, Seoul, South Korea.	mdrafael@snu.ac.kr						Baccos A, 2013, CLIN GENITOURIN CANC, V11, P451, DOI 10.1016/j.clgc.2013.05.006; Bex Axel, 2015, Am Soc Clin Oncol Educ Book, pe239, DOI 10.14694/EdBook_AM.2015.35.e239; Bradley AJ, 2015, CLIN RADIOL, V70, P822, DOI 10.1016/j.crad.2015.03.013; Breau RH, 2010, J UROLOGY, V183, P903, DOI 10.1016/j.juro.2009.11.037; Chevinsky M, 2015, J UROLOGY, V194, P310, DOI 10.1016/j.juro.2015.02.013; Gorin MA, 2013, J UROLOGY, V190, P1907, DOI 10.1016/j.juro.2013.06.014; Hansen J, 2012, UROLOGY, V80, P347, DOI 10.1016/j.urology.2012.04.043; Kreshover JE, 2013, J ENDOUROL, V27, P1468, DOI 10.1089/end.2013.0197; Leibovich BC, 2010, J UROLOGY, V183, P1309, DOI 10.1016/j.juro.2009.12.035; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Lohse CM, 2002, AM J CLIN PATHOL, V118, P877, DOI 10.1092/5PWP08HKHX0LY56L; Long CJ, 2012, BJU INT, V109, P1450, DOI 10.1111/j.1464-410X.2011.10608.x; Martinez-Salamanca JI, 2011, EUR UROL, V59, P120, DOI DOI 10.1016/J.EURUR0.2010.10.001; Park JY, 2014, HUM PATHOL, V45, P1437, DOI 10.1016/j.humpath.2014.02.019; Porpiglia F, 2016, UROLOGY, V89, P45, DOI 10.1016/j.urology.2015.08.049; Ramaswamy K, 2015, CLIN GENITOURIN CANC, V13, P344, DOI 10.1016/j.clgc.2015.01.001; Roberts WW, 2005, J UROLOGY, V173, P713, DOI 10.1097/01.ju.0000153638.15018.58; Sokhi H K, 2015, Br J Radiol, V88, P20140504, DOI 10.1259/bjr.20140504; Svatek RS, 2006, J UROLOGY, V176, P1321, DOI 10.1016/j.juro.2006.06.008; Tay MHW, 2014, J ENDOUROL, V28, P1138, DOI 10.1089/end.2014.0123; Teloken PE, 2009, J UROLOGY, V182, P2132, DOI 10.1016/j.juro.2009.07.019; Thompson RH, 2009, J UROLOGY, V182, P2601, DOI 10.1016/j.juro.2009.08.087; Tsili AC, 2013, J COMPUT ASSIST TOMO, V37, P450, DOI 10.1097/RCT.0b013e318283bc8e; van Oostenbrugge TJ, 2015, WORLD J UROL, V33, P881, DOI 10.1007/s00345-014-1390-6; Weight CJ, 2011, UROLOGY, V77, P1142, DOI 10.1016/j.urology.2010.11.058	25	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166183	10.1371/journal.pone.0166183	http://dx.doi.org/10.1371/journal.pone.0166183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861519	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300034
J	Matsumura, M; Okudela, K; Kojima, Y; Umeda, S; Tateishi, Y; Sekine, A; Arai, H; Woo, T; Tajiri, M; Ohashi, K				Matsumura, Mai; Okudela, Koji; Kojima, Yoko; Umeda, Shigeaki; Tateishi, Yoko; Sekine, Akimasa; Arai, Hiromasa; Woo, Tetsukan; Tajiri, Michihiko; Ohashi, Kenichi			A Histopathological Feature of EGFR-Mutated Lung Adenocarcinomas with Highly Malignant Potential - An Implication of Micropapillary Element -	PLOS ONE			English	Article							SOCIETY/EUROPEAN RESPIRATORY SOCIETY; SIGNIFICANTLY POOR-PROGNOSIS; DISTINCT PATHOLOGICAL MARKER; FACTOR-RECEPTOR GENE; INTERNATIONAL ASSOCIATION; CANCER; MUTATIONS; CLASSIFICATION; GEFITINIB; PATTERN	The purpose of this study was to define histological features determining the malignant potential of EGFR-mutated lung adenocarcinoma (LADC). Surgically resected tumors (EGFR-mutated LADCs with (21) and without (79) lymph node metastasis and EGFR wildtype LADCs with (26) and without (108) lymph node metastasis) and biopsy samples from inoperably advanced tumors (EGFR-mutated LADCs (78) and EGFR wild-type LADCs (99)) were examined. In surgically resected tumors, the EGFR-mutated LADCs with lymph node metastasis had the micropapillary element in a significantly greater proportion than others (Mann-Whitney tests P <= 0.026). The proportion of micropapillary element was higher in the EGFR-mutated LADC at the advanced stage (stage II, III, or IV) than in the tumor at the early stage (stage I) (Mann-Whitney test, P<0.0001). In the biopsy samples from inoperably advanced LADCs (177), EGFR-mutated tumors also had micropapillary element at a higher frequency than EGFR-wild type tumors (53/78 (68%), versus 30/99 (30%), Pearson x2 test, P<0.0001). In stage I EGFR-mutated LADCs (84), the tumors with the micropapillary element (34) exhibited a significantly higher recurrence rate than tumors without micropapillary element (50) (5-year Recurrence-free survival 64.4% versus 93.3%, log-rank test P = 0.028). The micropapillary element may be an exclusive determinant of malignant potential in EGFR-mutated LADC. It is suggested that EGFR-mutated LADC may develop through a distinct histogenesis, in which the micropapillary element is important for promoting progression.	[Matsumura, Mai; Okudela, Koji; Kojima, Yoko; Umeda, Shigeaki; Tateishi, Yoko; Ohashi, Kenichi] Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan; [Sekine, Akimasa] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Resp Med, Yokohama, Kanagawa, Japan; [Arai, Hiromasa; Tajiri, Michihiko] Kanagawa Prefectural Cardiovasc & Resp Ctr Hosp, Div Surg, Yokohama, Kanagawa, Japan; [Woo, Tetsukan] Saiseikai Yokohamashi Nanbu Hosp, Div Surg, Yokohama, Kanagawa, Japan	Yokohama City University; Kanagawa Cardiovascular & Respiratory Center; Kanagawa Cardiovascular & Respiratory Center	Okudela, K (corresponding author), Yokohama City Univ, Sch Med, Dept Pathol, Yokohama, Kanagawa, Japan.	kojixok@yokoharna-cu.ac.jp			Japanese Ministry of Education, Culture, Sports, and Science (Tokyo, Japan) [15K08365]; Smoking Research Foundation (Tokyo, Japan) [1671890003]	Japanese Ministry of Education, Culture, Sports, and Science (Tokyo, Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Smoking Research Foundation (Tokyo, Japan)	The study received financial support from the Japanese Ministry of Education, Culture, Sports, and Science (Tokyo, Japan, grant number 15K08365 awarded to KOh, URL: https:://www.jsps.go.jp/j.grantsinaid/) and also by the Smoking Research Foundation (Tokyo, Japan, grant number 1671890003 awarded to KOk, URL: http://www.srf. or.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS J, 2014, AM SOC CLIN ONCOL ED, V34, P71; Amin MB, 2002, AM J SURG PATHOL, V26, P358, DOI 10.1097/00000478-200203000-00010; Fukutomi T, 2013, HUM PATHOL, V44, P1849, DOI 10.1016/j.humpath.2013.02.008; Gainor JF, 2013, CLIN CANCER RES, V19, P4273, DOI 10.1158/1078-0432.CCR-13-0318; Gainor JF, 2013, ONCOLOGIST, V18, P865, DOI 10.1634/theoncologist.2013-0095; Goldstraw P, 2011, LANCET, V378, P1727, DOI 10.1016/S0140-6736(10)62101-0; Goto K, 2012, ANN ONCOL, V23, P2914, DOI 10.1093/annonc/mds121; Haneda H, 2006, JPN J CLIN ONCOL, V36, P69, DOI 10.1093/jjco/hyi228; Janjigian YY, 2011, J THORAC ONCOL, V6, P569, DOI 10.1097/JTO.0b013e318202bffe; Johnson ML, 2013, CANCER-AM CANCER SOC, V119, P356, DOI 10.1002/cncr.27730; Kadota K, 2014, AM J SURG PATHOL, V38, P448, DOI 10.1097/PAS.0000000000000134; Kamiya K, 2008, MODERN PATHOL, V21, P992, DOI 10.1038/modpathol.2008.79; Kelly K, 2015, J CLIN ONCOL, V33, P4007, DOI 10.1200/JCO.2015.61.8918; Kimura H, 2006, CLIN CANCER RES, V12, P3915, DOI 10.1158/1078-0432.CCR-05-2324; Kosaka T, 2004, CANCER RES, V64, P8919, DOI 10.1158/0008-5472.CAN-04-2818; Liu C, 2014, LUNG CANCER, V86, P164, DOI 10.1016/j.lungcan.2014.08.018; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Makimoto Y, 2005, HISTOPATHOLOGY, V46, P677, DOI 10.1111/j.1365-2559.2005.02126.x; Miyoshi T, 2003, AM J SURG PATHOL, V27, P101, DOI 10.1097/00000478-200301000-00011; Okudela K, 2009, LUNG CANCER, V66, P287, DOI 10.1016/j.lungcan.2009.02.025; Okudela K, 2010, AM J SURG PATHOL, V34, P243, DOI 10.1097/PAS.0b013e3181c79a6f; Ou SHI, 2011, DRUG DES DEV THER, V5, P471, DOI 10.2147/DDDT.S19045; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Shi Y, 2014, J THORAC ONCOL, V9, P154, DOI 10.1097/JTO.0000000000000033; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Villa C, 2014, ARCH PATHOL LAB MED, V138, P1353, DOI 10.5858/arpa.2013-0376-OA; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Yokose T, 2000, LUNG CANCER, V29, P179, DOI 10.1016/S0169-5002(00)00103-3; Yoshizawa A, 2013, J THORAC ONCOL, V8, P52, DOI 10.1097/JTO.0b013e3182769aa8	35	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166795	10.1371/journal.pone.0166795	http://dx.doi.org/10.1371/journal.pone.0166795			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861549	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300110
J	Tokuda, S; Hirai, T; Furuse, M				Tokuda, Shinsaku; Hirai, Toyohiro; Furuse, Mikio			Effects of Osmolality on Paracellular Transport in MDCK II Cells	PLOS ONE			English	Article							TIGHT JUNCTION STRANDS; CANINE KIDNEY-CELLS; EPITHELIAL-CELLS; ZONULAE-OCCLUDENTES; MEMBRANE-PROTEINS; OSMOTIC-STRESS; ION-TRANSPORT; F-ACTIN; EXPRESSION; CLAUDIN-2	Epithelia separate apical and basal compartments, and movement of substances via the paracellular pathway is regulated by tight junctions. Claudins are major constituents of tight junctions and involved in the regulation of tight junction permeability. On the other hand, the osmolality in the extracellular environment fluctuates in association with life activity. However, effects of osmotic changes on the permeaibility of claudins are poorly understood. Therefore, we investigated the effects of osmotic changes on the paracellular transport in MDCK II cells. Interestingly, apical hyposmolality decreased cation selectivity in the paracellular pathway gradually with time, and the elimination of the osmotic gradient promptly restored the cation selectivity. Apical hyposmolality also induced bleb formation at cell-cell contacts and changed the shape of cell-cell contacts from a jagged pattern to a slightly linear pattern. In claudin-2 knockout MDCK II cells, the decrease of cation selectivity, the bleb formation, nor the changes in the shape of cell-cell contacts was observed under the apical hyposmolality. Our findings in this study indicate that osmotic gradient between apical and basal sides is involved in the acute regulation of the cation selective property of claudin-2 channels.	[Tokuda, Shinsaku; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Furuse, Mikio] Natl Inst Physiol Sci, Div Cell Struct, Okazaki, Aichi, Japan; [Furuse, Mikio] Grad Univ Adv Studies, Dept Physiol Sci, SOKENDAI, Okazaki, Aichi 4448585, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan	Tokuda, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan.	tokku@kuhp.kyoto-u.ac.jp		Furuse, Mikio/0000-0003-2847-8156	Japan Society for the Promotion of Science [16K21101, LS084]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science, 16K21101, http://www.jsps.go.jp/, ST; Funding Program for Next Generation World Leading Researchers from the Japan Society for the Promotion of Science, LS084, http://www.jsps.go.jp/, MF.	Amasheh S, 2002, J CELL SCI, V115, P4969, DOI 10.1242/jcs.00165; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; AndoAkatsuka Y, 1996, J CELL BIOL, V133, P43, DOI 10.1083/jcb.133.1.43; Bagherie-Lachidan M, 2008, AM J PHYSIOL-REG I, V294, pR1638, DOI 10.1152/ajpregu.00039.2008; Capaldo CT, 2015, SEMIN CELL DEV BIOL, V42, P22, DOI 10.1016/j.semcdb.2015.04.003; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Enck AH, 2001, AM J PHYSIOL-RENAL, V281, pF966, DOI 10.1152/ajprenal.0021.2001; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Furuse M, 1999, J CELL BIOL, V147, P891, DOI 10.1083/jcb.147.4.891; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Gorodeski GI, 1996, J SOC GYNECOL INVEST, V3, P267, DOI 10.1016/s1071-5576(96)00028-7; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Ikari A, 2012, J CELL BIOCHEM, V113, P499, DOI 10.1002/jcb.23373; Ikari A, 2011, J CELL PHYSIOL, V226, P1471, DOI 10.1002/jcp.22386; Inokuchi H, 2009, BIOSCI BIOTECH BIOCH, V73, P328, DOI 10.1271/bbb.80538; ITOH M, 1991, J CELL BIOL, V115, P1449, DOI 10.1083/jcb.115.5.1449; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Kiuchi-Saishin Y, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134875; Laghaei R, 2016, PROTEINS, V84, P305, DOI 10.1002/prot.24969; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Long JD, 1997, AM J PHYSIOL-GASTR L, V273, pG647, DOI 10.1152/ajpgi.1997.273.3.G647; MADARA JL, 1983, J CELL BIOL, V97, P125, DOI 10.1083/jcb.97.1.125; Mineta K, 2011, FEBS LETT, V585, P606, DOI 10.1016/j.febslet.2011.01.028; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Nakajima H, 2010, J CELL SCI, V123, P555, DOI 10.1242/jcs.057752; Nilsson H, 2007, CELL TISSUE RES, V330, P257, DOI 10.1007/s00441-007-0482-7; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otani T, 2006, J CELL BIOL, V175, P135, DOI 10.1083/jcb.200605012; Perez M, 1996, J PHYSIOL BIOCHEM, V52, P103; Pihl L, 2008, ACTA PHYSIOL, V193, P67, DOI 10.1111/j.1748-1716.2007.01777.x; POWELL DW, 1981, AM J PHYSIOL, V241, pG275, DOI 10.1152/ajpgi.1981.241.4.G275; Rahner C, 2001, GASTROENTEROLOGY, V120, P411, DOI 10.1053/gast.2001.21736; Reuss L., 2001, TIGHT JUNCTIONS, V2, P61; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenthal R, 2010, J CELL SCI, V123, P1913, DOI 10.1242/jcs.060665; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Samak G, 2010, AM J PHYSIOL-GASTR L, V299, pG572, DOI 10.1152/ajpgi.00265.2010; Sandbichler AM, 2011, J EXP BIOL, V214, P1473, DOI 10.1242/jeb.050062; Sasaki H, 2003, P NATL ACAD SCI USA, V100, P3971, DOI 10.1073/pnas.0630649100; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; STAEHELIN LA, 1973, J CELL SCI, V13, P763; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Tipsmark CK, 2008, COMP BIOCHEM PHYS A, V150, P265, DOI 10.1016/j.cbpa.2008.03.006; Tokuda S, 2008, BIOCHEM BIOPH RES CO, V366, P464, DOI 10.1016/j.bbrc.2007.11.167; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145522; Tokuda S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119869; Tokuda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104994; Tokuda S, 2010, BIOCHEM BIOPH RES CO, V393, P390, DOI 10.1016/j.bbrc.2010.02.002; Van Itallie CM, 2009, MOL BIOL CELL, V20, P3930, DOI 10.1091/mbc.E09-04-0320; Van Itallie CM, 2003, AM J PHYSIOL-RENAL, V285, pF1078, DOI 10.1152/ajprenal.00116.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Weber CR, 2015, ELIFE, V4, DOI 10.7554/eLife.09906; Yu ASL, 2009, J GEN PHYSIOL, V133, P111, DOI 10.1085/jgp.200810154	56	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166904	10.1371/journal.pone.0166904	http://dx.doi.org/10.1371/journal.pone.0166904			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855213	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200054
J	Garg, S; Biju, SD				Garg, Sonali; Biju, S. D.			Molecular and Morphological Study of Leaping Frogs (Anura, Ranixalidae) with Description of Two New Species	PLOS ONE			English	Article							ENDEMIC INDIRANA FROGS; WESTERN-GHATS; MAXIMUM-LIKELIHOOD; AMPHIBIANS; PHYLOGENY; FAMILY; INDIA; DNA; EVOLUTIONARY; DIVERSITY	The monotypic anuran family Ranixalidae is endemic to India, with a predominant distribution in the Western Ghats, a region that is home to several unique amphibian lineages. It is also one of the three ancient anuran families that diversified on the Indian landmass long before several larger radiations of extant frogs in this region. In recent years, ranixalids have been subjected to DNA barcoding and systematic studies. Nearly half of the presently recognized species in this family have been described over the last three years, along with recognition of a new genus to accommodate three previously known members. Our surveys in the Western Ghats further suggest the presence of undescribed diversity in this group, thereby increasing former diversity estimates. Based on rapid genetic identification using a mitochondrial gene, followed by phylogenetic analyses with an additional nuclear gene and detailed morphological studies including examination of museum specimens, new collections, and available literature, here we describe two new species belonging to the genus Indirana from the Western Ghats states of Karnataka and Kerala. We also provide new genetic and morphological data along with confirmed distribution records for all the species known prior to this study. This updated systematic revision of family Ranixalidae will facilitate future studies and provide vital information for conservation assessment of these relic frogs.	[Garg, Sonali; Biju, S. D.] Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India	University of Delhi	Biju, SD (corresponding author), Univ Delhi, Dept Environm Studies, Systemat Lab, Delhi 110007, India.	sdbiju@es.du.ac.in			Department of Science and Technology, Ministry of Science and Technology, Government of India [DU/DST '2009/868', 2014-16]; Ministry of Environment, Forest and Climate Change, Government of India [MoEF '23/3/2007-RE']; Conservation International/Critical Ecosystem Partnership Fund, USA [55918/2009]; University of Delhi Research and Development [2014-15, 2015-16]; University of Delhi under the University Teaching Assistantship Scheme [2010/56562]; Council for Scientific and Industrial Research, India [9/45 (1381)/2015-EMR-I]	Department of Science and Technology, Ministry of Science and Technology, Government of India(Department of Science & Technology (India)); Ministry of Environment, Forest and Climate Change, Government of India; Conservation International/Critical Ecosystem Partnership Fund, USA; University of Delhi Research and Development; University of Delhi under the University Teaching Assistantship Scheme; Council for Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was funded by the following research grants to SDB: DU/DST '2009/868' and '2014-16' (Department of Science and Technology, Ministry of Science and Technology, Government of India); MoEF '23/3/2007-RE' (Ministry of Environment, Forest and Climate Change, Government of India); CEPF 'Project 55918/2009' (Conservation International/Critical Ecosystem Partnership Fund, USA); and University of Delhi Research and Development Grants '2014-15' and '2015-16'. SG was supported by fellowship from University of Delhi under the University Teaching Assistantship Scheme 2010/56562, and Senior Research Fellowship from Council for Scientific and Industrial Research, India (CSIR No. 9/45 (1381)/2015-EMR-I).	AmphibiaWeb, 2016, INF AMPH BIOL CONS W; Biju S.D., 2014, Ceylon Journal of Science Biological Sciences, V43, P37; Biju SD, 2014, CONTRIB ZOOL, V83, P269, DOI 10.1163/18759866-08304004; Biju S.D., 2011, Zootaxa, V3029, P1; Biju S. D., 2001, OCCAS PUBL INDIAN SO, V1, P1; Biju SD, 2003, NATURE, V425, P711, DOI 10.1038/nature02019; Biju Sd, 2009, BMC Res Notes, V2, P241, DOI 10.1186/1756-0500-2-241; BLOMMERSSCHLOSSER RMA, 1993, ETHOL ECOL EVOL, V5, P199, DOI 10.1080/08927014.1993.9523105; Bossuyt F, 2001, SCIENCE, V292, P93, DOI 10.1126/science.1058875; Bossuyt F., 2001, ZEYLANICA, V6, P1; Bossuyt F, 2006, SYST BIOL, V55, P579, DOI 10.1080/10635150600812551; Boulenger G. A., 1918, Annals & Magazine of Natural History Series 9, V1; Boulenger G.A., 1888, ANN MAG NAT HIST, V6, P506; Boulenger GA, 1920, ZOOLOGICAL SURVEY IN, V20, P1; Boulenger GA, 1882, CATALOGUE BATRACHIA; Chanda SK, 2002, HDB INDIAN AMPHIBIAN; Chandra Kailash, 2005, Zoos Print Journal, V20, P1812; Dahanukar Neelesh, 2016, Journal of Threatened Taxa, V8, P9221, DOI 10.11609/jott.2532.8.10.9221-9288; DANIEL J C, 1989, Journal of the Bombay Natural History Society, V86, P194; Daniel JC, 1964, J BOMBAY NATURAL HIS, V60, P737; Daniels RR., 2005, AMPHIBIANS PENINSULA; Dubois A., 1984, Alytes (Paris), V3, P143; Dubois A., 1987, ALYTES, V5, P7; Dubois A., 1986, ALYTES, V4, P113; Dubois A., 1995, ZOOL POLONIAE, V39, P139; Dubois A., 1987, ALYTES, V5, P175; Dubois A, 2006, CR BIOL, V329, P823, DOI 10.1016/j.crvi.2006.07.003; Dubois Alain, 1996, Bulletin du Museum National d'Histoire Naturelle Section A Zoologie Biologie et Ecologie Animales, V18, P297; Dubois Alain, 1992, Bulletin Mensuel de la Societe Linneenne de Lyon, V61, P305; Dutta S.K., 1997, AMPHIBIANS INDIA SRI; Dutta Sushil K., 1992, Hamadryad, V17, P1; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Frost D.R., 2020, AMPHIBIAN SPECIES WO, DOI [10.5531/db.vz.0001, DOI 10.5531/DB.VZ.0001]; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Glaw F, 2010, ZOOTAXA, P1; GUNTHER A., 1876, P ZOOLOGICAL SOC LON, V1875, P567; Hanken J, 1999, TRENDS ECOL EVOL, V14, P7, DOI 10.1016/S0169-5347(98)01534-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; INGER R F, 1984, Journal of the Bombay Natural History Society, V81, P551; Kohler J, 2005, BIOSCIENCE, V55, P693, DOI 10.1641/0006-3568(2005)055[0693:NAAGCA]2.0.CO;2; Laurent R.F., 1986, P594; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Modak Nikhil, 2015, Journal of Threatened Taxa, V7, P7493; Modak N, 2014, ZOOTAXA, V3796, P62, DOI 10.11646/zootaxa.3796.1.3; MYERS C W, 1982, American Museum Novitates, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nair A, 2012, ANIM CONSERV, V15, P489, DOI 10.1111/j.1469-1795.2012.00539.x; Nair A, 2012, ANN ZOOL FENN, V49, P257, DOI 10.5735/086.049.0501; Nair A, 2012, CONSERV GENET, V13, P1459, DOI 10.1007/s10592-012-0389-z; Padhye Anand D., 2014, Journal of Threatened Taxa, V6, P6293; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Rao C R. N., 1937, Proceedings of the Indian Academy of Sciences, V6B, P387; Reddy AH, 2001, HAMADRYAD, V26, P358; Roelants K, 2004, MOL PHYLOGENET EVOL, V31, P730, DOI 10.1016/j.ympev.2003.09.011; Savage J. M., 1967, BEITR NEOTROP FAUNA, V5, P111, DOI DOI 10.1080/01650526709360400; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Srinivasulu C., 2008, Asiatic Herpetological Research, V11, P110; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074; Van Bocxlaer I, 2012, MOL PHYLOGENET EVOL, V62, P839, DOI 10.1016/j.ympev.2011.11.027; van der Meijden A, 2005, MOL PHYLOGENET EVOL, V37, P674, DOI 10.1016/j.ympev.2005.05.001; Vences Miguel, 2000, Hamadryad, V25, P75; Vences Miguel, 2001, Spixiana, V24, P85; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Vitt L. J., 2013, HERPETOLOGY INTRO BI; Wiens JJ, 2009, EVOLUTION, V63, P1217, DOI 10.1111/j.1558-5646.2009.00610.x	70	14	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166326	10.1371/journal.pone.0166326	http://dx.doi.org/10.1371/journal.pone.0166326			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851823	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300042
J	Elwood, PC; Morgan, G; Galante, J; Chia, JWK; Dolwani, S; Graziano, JM; Kelson, M; Lanas, A; Longley, M; Phillips, CJ; Pickering, J; Roberts, SE; Soon, SS; Steward, W; Morris, D; Weightmanm, AL				Elwood, Peter C.; Morgan, Gareth; Galante, Julieta; Chia, John W. K.; Dolwani, Sunil; Graziano, J. Michael; Kelson, Mark; Lanas, Angel; Longley, Marcus; Phillips, Ceri J.; Pickering, Janet; Roberts, Stephen E.; Soon, Swee S.; Steward, Will; Morris, Delyth; Weightmanm, Alison L.			Systematic Review and Meta-Analysis of Randomised Trials to Ascertain Fatal Gastrointestinal Bleeding Events Attributable to Preventive Low-Dose Aspirin: No Evidence of Increased Risk	PLOS ONE			English	Review							COLORECTAL-CANCER; PEPTIC-ULCER; HEMORRHAGIC STROKE; AMERICAN-COLLEGE; MORTALITY; ASSOCIATION; OUTCOMES; ANTICOAGULANTS; IMPROVEMENT; BENEFITS	Background Aspirin has been shown to lower the incidence and the mortality of vascular disease and cancer but its wider adoption appears to be seriously impeded by concerns about gastrointestinal (GI) bleeding. Unlike heart attacks, stroke and cancer, GI bleeding is an acute event, usually followed by complete recovery. We propose therefore that a more appropriate evaluation of the risk-benefit balance would be based on fatal adverse events, rather than on the incidence of bleeding. We therefore present a literature search and meta-analysis to ascertain fatal events attributable to low-dose aspirin. Methods In a systematic literature review we identified reports of randomised controlled trials of aspirin in which both total GI bleeding events and bleeds that led to death had been reported. Principal investigators of studies in which fatal events had not been adequately described were contacted via email and asked for further details. A meta-analyses was then performed to estimate the risk of fatal gastrointestinal bleeding attributable to low-dose aspirin. Results Eleven randomised trials were identified in the literature search. In these the relative risk (RR) of 'major' incident GI bleeding in subjects who had been randomised to low-dose aspirin was 1.55 (95% CI 1.33, 1.83), and the risk of a bleed attributable to aspirin being fatal was 0.45 (95% CI 0.25, 0.80). In all the subjects randomised to aspirin, compared with those randomised not to receive aspirin, there was no significant increase in the risk of a fatal bleed (RR 0.77; 95% CI 0.41, 1.43). Conclusions The majority of the adverse events caused by aspirin are GI bleeds, and there appears to be no valid evidence that the overall frequency of fatal GI bleeds is increased by aspirin. The substantive risk for prophylactic aspirin is therefore cerebral haemorrhage which can be fatal or severely disabling, with an estimated risk of one death and one disabling stroke for every 1,000 people taking aspirin for ten years. These adverse effects of aspirin should be weighed against the reductions in vascular disease and cancer.	[Elwood, Peter C.; Morgan, Gareth; Galante, Julieta; Kelson, Mark; Pickering, Janet; Weightmanm, Alison L.] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales; [Morgan, Gareth] Hywel Dda Univ Hlth Board, Llanelli, Wales; [Galante, Julieta] Univ Cambridge, Dept Psychiat, Cambridge, England; [Chia, John W. K.] Natl Canc Ctr, Div Med Oncol, Singapore, Singapore; [Dolwani, Sunil] Cardiff Univ, Inst Canc & Genet, Cardiff, S Glam, Wales; [Graziano, J. Michael] Harvard Med Sch, Boston, MA USA; [Lanas, Angel] Univ Zaragoza, IIS Aragon, CIBEReshd, Univ Clin Hosp, Zaragoza, Spain; [Longley, Marcus] Univ South Wales, Welsh Inst Hlth & Social Care, Cardiff, S Glam, Wales; [Phillips, Ceri J.] Swansea Univ, Swansea Ctr Hlth Econ, Swansea, W Glam, Wales; [Roberts, Stephen E.] Swansea Univ, Sch Med, Swansea, W Glam, Wales; [Soon, Swee S.] Natl Univ Singapore, Dept Pharm, Singapore, Singapore; [Steward, Will] Univ Leicester, Dept Canc Studies, Leicester, Leics, England; [Morris, Delyth] Cardiff Univ, Univ Lib Serv, Cardiff, S Glam, Wales; [Weightmanm, Alison L.] Cardiff Univ, SURE, Cardiff, S Glam, Wales	Cardiff University; University of Cambridge; National Cancer Centre Singapore (NCCS); Cardiff University; Harvard University; Harvard Medical School; University of Zaragoza; University of South Wales; Swansea University; Swansea University; National University of Singapore; University of Leicester; Cardiff University; Cardiff University	Morgan, G (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff, S Glam, Wales.; Morgan, G (corresponding author), Hywel Dda Univ Hlth Board, Llanelli, Wales.	gareth.morgan5@wales.nhs.uk	Weightman, Alison/A-4680-2010; Kelson, Mark/E-6753-2016	Weightman, Alison/0000-0001-5210-3798; Kelson, Mark/0000-0001-7744-3780; Morris, Delyth/0000-0001-8529-1270; Phillips, Ceri/0000-0003-1076-9289; Elwood, Peter/0000-0003-4352-1570; Galante, Julieta/0000-0002-4108-5341	Universities and Health Services	Universities and Health Services	The funders who were in effect the Universities and Health Services who paid the salaries of the authors - had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Daya H, 2014, J DIGEST DIS, V15, P283, DOI 10.1111/1751-2980.12140; Agra AM, 2012, LANCET ONCOLOGY, V13, P518, DOI [10.1016/S1470-2045(12)70112-2, DOI 10.1016/S1470-2045(12)70112-2]; Ahsberg K, 2010, ALIMENT PHARM THER, V32, P801, DOI 10.1111/j.1365-2036.2010.04399.x; Ahsberg K, 2010, SCAND J GASTROENTERO, V45, P1404, DOI 10.3109/00365521.2010.510567; [Anonymous], 2012, EUR HEART J, V33, P1635, DOI [10.1093/eurheartj/ehs092, DOI 10.1093/EURHEARTJ/EHS092]; [Anonymous], 1998, LANCET, V351, P233; Baigent Colin, 2005, BMJ, V330, P1442, DOI 10.1136/bmj.330.7505.1442; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Battistoni A, 2015, CLIN CARDIOL, DOI [10.1002/cic.22394, DOI 10.1002/CIC.22394]; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Button LA, 2011, ALIMENT PHARM THER, V33, P64, DOI 10.1111/j.1365-2036.2010.04495.x; Calonge N, 2009, ANN INTERN MED, V150, P396; Chubak J, 2015, 1505228EF1 KAIS PERM, V133; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EGGER M, 1995, SYSTEMATIC REV HLTH; Elwood P, 2010, J EPIDEMIOL COMMUN H, V64, P761, DOI 10.1136/jech.2009.087767; Elwood PC, ASPIRIN TREAT MENT C; Feigin FL, 2014, LANCET, V383, P245; Rodriguez LAG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160046; GIOVANNUCCI E, 1995, NEW ENGL J MED, V333, P609, DOI 10.1056/NEJM199509073331001; Gonzalez-Perez A, 2013, NEUROLOGY, V81, P559, DOI 10.1212/WNL.0b013e31829e6eff; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hassan C, 2012, GUT, V61, P1172, DOI 10.1136/gutjnl-2011-300206; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HIGGINS JPT, COCHRANE HANDBOOK FO; Hochholzer W, 2011, CIRCULATION, V123, P2681, DOI 10.1161/CIRCULATIONAHA.110.002683; Hreinsson JP, 2013, EUR J GASTROEN HEPAT, V25, P37, DOI 10.1097/MEG.0b013e32835948e3; Hreinsson JP, 2015, J CLIN GAWSTROENTERO; Ivanusa M, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-26; Janu-Llopis E., GLOBAL EC BURDEN NON; Kang JY, 2006, ALIMENT PHARM THERAP, V24, P65, DOI 10.1111/j.1365-2036.2006.02960.x; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; Kaviani Mohammad J, 2010, Saudi J Gastroenterol, V16, P253, DOI 10.4103/1319-3767.70608; Lanas A, 2005, AM J GASTROENTEROL, V100, P1685, DOI 10.1111/j.1572-0241.2005.41833.x; Lanas A, 2011, CLIN GASTROENTEROL H, V9, P762, DOI 10.1016/j.cgh.2011.05.020; Lanas A, 2009, AM J GASTROENTEROL, V104, P1633, DOI 10.1038/ajg.2009.164; Lieberman D, 2010, GASTROENTEROLOGY, V138, P2115, DOI 10.1053/j.gastro.2010.02.006; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mariotto AB, 2011, J CANC I, DOI [10.1093/jnci/djg495, DOI 10.1093/JNCI/DJG495]; McQuaid KR, 2006, AM J MED, V119, P624, DOI 10.1016/j.amjmed.2005.10.039; Mills EJ, 2012, AM J MED, V125, P560, DOI 10.1016/j.amjmed.2012.01.017; Mose Hanne, 2006, Am J Geriatr Pharmacother, V4, P244, DOI 10.1016/j.amjopharm.2006.09.006; Narum S, 2013, EUR J CLIN PHARMACOL, V69, P1445, DOI 10.1007/s00228-013-1479-7; NORRVING B, 1991, LANCET, V338, P1345; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Peura DA, 1997, AM J GASTROENTEROL, V92, P924; Pignone M, 2013, J GEN INTERN MED MAY; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Roussomoustakaki M, 2000, ANN GASTROENTEROL, V13, P225; Sandercock P, 1997, LANCET, V349, P1569; Soon SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107866; Stegeman I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127194; Sung JJY, 2010, AM J GASTROENTEROL, V105, P84, DOI 10.1038/ajg.2009.507; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Wehbeh A, 2015, DIGEST DIS SCI, V60, P2077, DOI 10.1007/s10620-015-3604-1; Wu C, 2015, THROMB RES, V135, P243, DOI 10.1016/j.thromres.2014.10.033; Zhao Y, 2006, HOSPITALIZATIONS FOR	68	29	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166166	10.1371/journal.pone.0166166	http://dx.doi.org/10.1371/journal.pone.0166166			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846246	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000387794600035
J	Rai, R; Chauhan, SK; Singh, VV; Rai, M; Rai, G				Rai, Richa; Chauhan, Sudhir Kumar; Singh, Vikas Vikram; Rai, Madhukar; Rai, Geeta			RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; EXTRACELLULAR TRAP DEGRADATION; EPSTEIN-BARR-VIRUS; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; T-CELLS; GENE-EXPRESSION; NEUROTROPHIC FACTOR; DNA METHYLATION; MESSENGER-RNA	Systemic lupus erythematosus (SLE) patients exhibit immense heterogeneity which is challenging from the diagnostic perspective. Emerging high throughput sequencing technologies have been proved to be a useful platform to understand the complex and dynamic disease processes. SLE patients categorised based on autoantibody specificities are reported to have differential immuno-regulatory mechanisms. Therefore, we performed RNA-seq analysis to identify transcriptomics of SLE patients with distinguished autoantibody specificities. The SLE patients were segregated into three subsets based on the type of autoantibodies present in their sera (anti-dsDNA(+) group with anti-dsDNA autoantibody alone; anti-ENA(+) group having autoantibodies against extractable nuclear antigens (ENA) only, and anti-dsDNA(+)ENA(+) group having autoantibodies to both dsDNA and ENA). Global transcriptome profiling for each SLE patients subsets was performed using Illumina (R) Hiseq-2000 platform. The biological relevance of dysregulated transcripts in each SLE subsets was assessed by ingenuity pathway analysis (IPA) software. We observed that dysregulation in the transcriptome expression pattern was clearly distinct in each SLE patients subsets. IPA analysis of transcripts uniquely expressed in different SLE groups revealed specific biological pathways to be affected in each SLE subsets. Multiple cytokine signaling pathways were specifically dysregulated in anti-dsDNA(+) patients whereas Interferon signaling was predominantly dysregulated in anti-ENA(+) patients. In anti-dsDNA(+) ENA(+) patients regulation of actin based motility by Rho pathway was significantly affected. The granulocyte gene signature was a common feature to all SLE subsets; however, anti-dsDNA(+) group showed relatively predominant expression of these genes. Dysregulation of Plasma cell related transcripts were higher in anti-dsDNA(+) and anti-ENA(+) patients as compared to antidsDNA (+) ENA(+). Association of specific canonical pathways with the uniquely expressed transcripts in each SLE subgroup indicates that specific immunological disease mechanisms are operative in distinct SLE patients' subsets. This 'sub-grouping' approach could further be useful for clinical evaluation of SLE patients and devising targeted therapeutics.	[Rai, Richa; Chauhan, Sudhir Kumar; Singh, Vikas Vikram; Rai, Geeta] Banaras Hindu Univ, Dept Mol & Human Genet, Inst Sci, Varanasi, Uttar Pradesh, India; [Rai, Madhukar] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India	Banaras Hindu University (BHU); Banaras Hindu University (BHU)	Rai, G (corresponding author), Banaras Hindu Univ, Dept Mol & Human Genet, Inst Sci, Varanasi, Uttar Pradesh, India.	geetarair74@gmail.com	Singh, Vikas Vikram/I-7596-2019; Rai, Richa/GMW-8723-2022	Singh, Vikas Vikram/0000-0001-6304-9942; Rai, Geeta/0000-0001-8162-8964	Department of Biotechnology, Government of India [BT/PR4619/MED/30/834/2012]; Council of Scientific & Industrial Research, New Delhi, India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific & Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was supported by a grant (BT/PR4619/MED/30/834/2012) from the Department of Biotechnology, Government of India (http://dbtindia.nic.in/index.asp) to GR. RR was supported by junior and senior research fellowship from Council of Scientific & Industrial Research (http://www.csirhrdg.resin/), New Delhi, India. The funding agency had no role in study design, data collection, analysis and decision to publish the paper.	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Alegretti AP, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/725684; Banchereau R, 2016, CELL, V165, P551, DOI 10.1016/j.cell.2016.03.008; Becker AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067003; Bengtsson AA, 2000, LUPUS, V9, P664, DOI 10.1191/096120300674499064; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P69; Bezman NA, 2010, J IMMUNOL, V185, P3835, DOI 10.4049/jimmunol.1000980; Cai Z, 2015, LUPUS, V24, P1257, DOI 10.1177/0961203315585815; Cedeno S, 2003, CLIN IMMUNOL, V106, P41, DOI 10.1016/S1521-6616(02)00052-9; Chauhan SK, 2015, IMMUNOL LETT, V168, P254, DOI 10.1016/j.imlet.2015.09.016; Chauhan SK, 2014, J CLIN IMMUNOL, V34, P491, DOI 10.1007/s10875-014-0008-5; Chauhan SK, 2013, J CLIN IMMUNOL, V33, P954, DOI 10.1007/s10875-013-9887-0; Christensen SR, 2005, J EXP MED, V202, P321, DOI 10.1084/jem.20050338; Darrah E, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00428; Davas EM, 1999, CLIN RHEUMATOL, V18, P17, DOI 10.1007/s100670050045; De La Torre M, 2009, LUPUS, V18, P216, DOI 10.1177/0961203308096068; Ellyard JI, 2014, ARTHRITIS RHEUMATOL, V66, P3382, DOI 10.1002/art.38824; FROST P. G., 1968, CLIN EXP IMMUNOL, V3, P447; Gladman DD, 2000, J RHEUMATOL, V29, P288, DOI DOI 10.3899/JRHEUM.110550; Grondal G, 2000, CLIN EXP RHEUMATOL, V18, P565; HADJIYANNAKI K, 1972, CLIN EXP IMMUNOL, V11, P291; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Han GM, 2003, GENES IMMUN, V4, P177, DOI 10.1038/sj.gene.6363966; HARA M, 1987, RHEUMATOL INT, V7, P83, DOI 10.1007/BF00270312; Harley JB, 2006, BULL HOSP JT DIS, V64, P45; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Hrycek A, 2007, AUTOIMMUNITY, V40, P23, DOI 10.1080/08916930601168093; Huang WQ, 2002, ARTHRITIS RHEUM-US, V46, P1554, DOI 10.1002/art.10273; HUBER AR, 1991, SCIENCE, V254, P99, DOI 10.1126/science.1718038; Ikenouchi-Sugita Atsuko, 2008, Neuropsychiatr Dis Treat, V4, P1277; Ivanov VN, 1997, J BIOL CHEM, V272, P8558; Jacob N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3349; Jacobi AM, 2003, ARTHRITIS RHEUM, V48, P1332, DOI 10.1002/art.10949; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jeffries MA, 2011, EPIGENETICS-US, V6, P593, DOI 10.4161/epi.6.5.15374; Jury EC, 2010, EUR J IMMUNOL, V40, P569, DOI 10.1002/eji.200939781; Kakumanu P, 2009, J RHEUMATOL, V36, P2682, DOI 10.3899/jrheum.090338; Karapetyan Armen R, 2013, Cancers (Basel), V5, P462, DOI 10.3390/cancers5020462; Kawano M, 1999, CLIN EXP IMMUNOL, V116, P542; Kawasaki M, 2011, LUPUS, V20, P1231, DOI 10.1177/0961203311409963; Kidani Y, 2014, J CLIN INVEST, V124, P482, DOI 10.1172/JCI74141; Kirou KA, 2005, ARTHRITIS RHEUM-US, V52, P1491, DOI 10.1002/art.21031; Kyttaris VC, 2011, ARTHRITIS RHEUM-US, V63, P2058, DOI 10.1002/art.30353; Leffler J, 2012, J IMMUNOL, V188, P3522, DOI 10.4049/jimmunol.1102404; Li YP, 2010, ARTHRITIS RHEUM-US, V62, P1438, DOI 10.1002/art.27363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lugar PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044362; Maroder M, 1996, J IMMUNOL, V157, P2864; Mohamed AAA, 2015, ARTHRITIS RHEUMATOL, V67; Mosca M, 2011, CLIN EXP RHEUMATOL, V29, pS126; Moulton VR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3251; Nakou M, 2008, ARTHRITIS RHEUM, V58, P3541, DOI 10.1002/art.23961; Niewold TB, 2005, CLIN RHEUMATOL, V24, P178, DOI 10.1007/s10067-004-1024-2; Odendahl M, 2000, J IMMUNOL, V165, P5970, DOI 10.4049/jimmunol.165.10.5970; Park YW, 2009, ARTHRITIS RHEUM-US, V60, P1753, DOI 10.1002/art.24556; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Perl A, 2004, INT REV IMMUNOL, V23, P293, DOI 10.1080/08830180490452576; Perl Andras, 2012, Methods Mol Biol, V900, P61, DOI 10.1007/978-1-60761-720-4_4; Poole BD, 2006, AUTOIMMUNITY, V39, P63, DOI 10.1080/08916930500484849; Rai G, 2016, IMMUNOL RES, V64, P14, DOI 10.1007/s12026-015-8672-y; Rai R, 2015, IMMUNOL LETT, V164, P25, DOI 10.1016/j.imlet.2015.01.007; Ren Y, 2003, ARTHRITIS RHEUM, V48, P2888, DOI 10.1002/art.11237; Rupper A, 2001, J CELL SCI, V114, P2449; Rus V, 2004, CLIN IMMUNOL, V112, P231, DOI 10.1016/j.clim.2004.06.005; Rus V, 2002, CLIN IMMUNOL, V102, P283, DOI 10.1006/clim.2001.5182; Seitz HM, 2010, INT REV IMMUNOL, V29, P184, DOI 10.3109/08830181003602507; Seyednasrollah F, 2015, BRIEF BIOINFORM, V16, P59, DOI 10.1093/bib/bbt086; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Shi LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093846; Sipka S, 2001, ANN RHEUM DIS, V60, P380, DOI 10.1136/ard.60.4.380; Stylianou K, 2011, NEPHROL DIAL TRANSPL, V26, P498, DOI 10.1093/ndt/gfq496; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Sullivan RP, 2012, J IMMUNOL, V188, P3019, DOI 10.4049/jimmunol.1102294; Tamashiro LF, 2014, RHEUMATOLOGY, V53, P2182, DOI 10.1093/rheumatology/keu251; Tang Y, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/826182; Tarte K, 2003, BLOOD, V102, P592, DOI 10.1182/blood-2002-10-3161; Tsumiyama K, 2011, J IMMUNOL, V186, P4424; Van Eyck L, 2015, ARTHRITIS RHEUMATOL, V67, P1592, DOI 10.1002/art.39110; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398; Wu TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037210; Xiong W, 2011, THER ADV MUSCULOSKEL, V3, P255, DOI 10.1177/1759720X11415456; Ye S, 2003, RHEUMATOLOGY, V42, P1155, DOI 10.1093/rheumatology/keg315; Yin XY, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-21; Yu C, 2014, J AUTOIMMUN, V48-49, P10, DOI 10.1016/j.jaut.2014.01.004; Zhang Z, 2015, ARTHRITIS RHEUMATOL, V67, P785, DOI 10.1002/art.38964; Zhang ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103207; Zhao M, 2014, J AUTOIMMUN, V54, P127, DOI 10.1016/j.jaut.2014.07.002	88	27	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166312	10.1371/journal.pone.0166312	http://dx.doi.org/10.1371/journal.pone.0166312			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835693	Green Submitted, Green Published, gold			2022-12-26	WOS:000387779200036
J	Sirotkina, M; Douroudis, K; Papadogiannakis, N; Westgren, M				Sirotkina, Meeli; Douroudis, Konstantinos; Papadogiannakis, Nikos; Westgren, Magnus			Clinical Outcome in Singleton and Multiple Pregnancies with Placental Chorangioma	PLOS ONE			English	Article							TWIN; DISEASE; LESIONS	Introduction Chorangiomas (CAs) are the most common non-trophoblastic tumor-like-lesions of the placenta. Although the clinical significance of small CAs is unknown, the large lesions are often associated with maternal and fetal complications. The aim of our study was to assess the maternal clinical characteristics and neonatal outcome in singleton and multiple pregnancies with placental CA. Materials and Methods Among 15742 selected placentas 170 CAs were diagnosed. Pregnancy and neonatal outcomes were analyzed in singleton (n = 121) and multiple (n = 49) pregnancy groups including 121 and 100 neonates, respectively. Results The frequency of APGAR score < 7 at 5 minutes (p = 0,012), abnormal pulsatility index (p = 0,034), and abnormal blood flow class (p = 0,011) were significantly higher in neonates from singleton compared to multiple pregnancies. Significantly smaller CAs in singleton pregnancies were related to small for gestational age neonates (p = 0,00040) and neonates admitted to the neonatal care unit (p = 0,028). In singleton pregnancies, significantly smaller CAs were associated to maternal preeclampsia (p = 0,039) and larger CAs to multiparity (p = 0,005) and smoking (p = 0,001) groups. The frequency of preeclampsia was high in both singleton and multiple pregnancy groups (41,32% vs 26,53%, respectively), however, the difference did not reach the level of statistical significance. Discussion A high incidence of preeclampsia in cohort of placental CA might lead to a possible recognition of CAs as potential morphologic indicator of placental hypoxia. Conclusion A more favorable pregnancy outcome in multiple gestations compared to the singleton gestations with CAs might reflect an adaptive mechanism for increased demand of oxygen and associated placental tissue hypoxia in this group.	[Sirotkina, Meeli; Papadogiannakis, Nikos] Karolinska Univ, Sect Perinatal Pathol, Dept Pathol, Huddinge Hosp, Stockholm, Sweden; [Sirotkina, Meeli; Papadogiannakis, Nikos] Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden; [Douroudis, Konstantinos] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Douroudis, Konstantinos] Univ Bergen, Dept Clin Med, Bergen, Norway; [Westgren, Magnus] Karolinska Inst, Div Obstet & Gynecol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Westgren, Magnus] Karolinska Univ Hosp, Obstet & Gynecol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; University of Bergen; Haukeland University Hospital; University of Bergen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Sirotkina, M (corresponding author), Karolinska Univ, Sect Perinatal Pathol, Dept Pathol, Huddinge Hosp, Stockholm, Sweden.; Sirotkina, M (corresponding author), Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	meeli.saotkina@ki.se		Douroudis, Konstantinos/0000-0002-6383-7145				Amer HZM, 2010, FETAL PEDIATR PATHOL, V29, P199, DOI 10.3109/15513815.2010.487009; Faupel-Badger JM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.035; GOSLING RG, 1971, ANGIOLOGY, V22, P52, DOI 10.1177/000331977102200109; Krotz S, 2002, TWIN RES, V5, P8; LAURIN J, 1987, BRIT J OBSTET GYNAEC, V94, P940, DOI 10.1111/j.1471-0528.1987.tb02267.x; Ley D, 2000, ACTA PAEDIATR, V89, P1330, DOI 10.1080/080352500300002525; Luo ZC, 2006, OBSTET GYNECOL, V108, P1138, DOI 10.1097/01.AOG.0000238335.61452.89; Maynard SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.042; Ni YY, 2016, INT J GYNECOL OBSTET, V132, P325, DOI 10.1016/j.ijgo.2015.07.029; Ogino S, 2000, HUM PATHOL, V31, P945, DOI 10.1053/hupa.2000.9036; Sibai BM, 2000, AM J OBSTET GYNECOL, V182, P938, DOI 10.1016/S0002-9378(00)70350-4; Sirotkina M, 2016, PLACENTA, V39, P154, DOI 10.1016/j.placenta.2016.01.020; van Gemert MJC, 2016, BIRTH DEFECTS RES A, V106, P733, DOI 10.1002/bdra.23531	13	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166562	10.1371/journal.pone.0166562	http://dx.doi.org/10.1371/journal.pone.0166562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835686	gold, Green Submitted, Green Published			2022-12-26	WOS:000387779200058
J	Bhide, P; Gund, P; Kar, A				Bhide, Prajkta; Gund, Pooja; Kar, Anita			Prevalence of Congenital Anomalies in an Indian Maternal Cohort: Healthcare, Prevention, and Surveillance Implications	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; BIRTH PREVALENCE	Background India lacks a national birth defects surveillance. Data on the prevalence of congenital anomalies are available mostly from hospital-based, cross-sectional studies. This is the first cohort study from India, where 2107 women were followed till pregnancy outcome, in order to measure the prevalence and types of congenital anomalies, their contribution to neonatal mortality, implications for surveillance, and the health service needs for prevention and management. Methods The study followed a cohort of 2107 pregnant women till outcome which was miscarriage, termination of pregnancy, live or stillbirth, neonatal and post-neonatal mortality. Case ascertainment of congenital anomalies was done through visual examination, followed by various investigations. Rates of congenital anomaly affected births were reported per 10 000 births. Health service needs were described through retrospective analysis of events surrounding the diagnosis of a congenital anomaly. Results Among 1822 births, the total prevalence of major congenital anomalies was 230.51 (170.99-310.11) per 10 000 births. Congenital heart defects were the most commonly reported anomalies in the cohort with a prevalence of 65.86 (37.72-114.77) per 10 000 births. Although neural tube defects were two and a half times less as compared to congenital heart defects, they were nevertheless significant at a prevalence of 27.44 (11.73-64.08) per 10 000 births. In this cohort, congenital anomalies were the second largest cause of neonatal deaths. The congenital anomaly prenatal diagnosis prevalence was 10.98 per 1000 births and the congenital anomaly termination of pregnancy rate was 4.39 per 1000 births. Conclusions This first cohort study from India establishes that the congenital anomaly rates were high, affecting one in forty four births in the cohort. The prevalence of congenital anomalies was identical to the stillbirth prevalence in the cohort, highlighting their public health importance. The results of this study identify the need for a well defined national programme with components of prevention, care and surveillance.	[Bhide, Prajkta; Gund, Pooja; Kar, Anita] Savitribai Phule Pune Univ, Sch Hlth Sci, Pune 411007, Maharashtra, India	Savitribai Phule Pune University	Kar, A (corresponding author), Savitribai Phule Pune Univ, Sch Hlth Sci, Pune 411007, Maharashtra, India.	akar@unipune.ac.in			University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children" [UGC-UPE 262 B(2)]; Departmental Research Development Programme Fund of Savitribai Phule Pune University	University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children"; Departmental Research Development Programme Fund of Savitribai Phule Pune University	The study was supported by the University Grant Commission-University with Potential for Excellence (UGC-UPE) Holistic area "Translation research in the health of women and children" grant number UGC-UPE 262 B(2) and the Departmental Research Development Programme Fund of Savitribai Phule Pune University.	AGARWAL SS, 1991, INDIAN J MED RES-B, V94, P413; [Anonymous], 2014, SAMPL REG SYST STAT; [Anonymous], 2006, ETH GUID BIOM RES HU; Baruah J, 2015, INDIAN J PEDIATR, V82, P917, DOI 10.1007/s12098-014-1685-z; Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Bharucha BA., 1998, IND J HUM GENET, V4, P84; Bhide P, 2013, BIRTH DEFECTS RES A, V97, P437, DOI 10.1002/bdra.23153; Christianson A, 2004, ANNU REV GENOM HUM G, V5, P219, DOI 10.1146/annurev.genom.5.061903.175935; Christianson A., 2006, GLOBAL REPORT BIRTH; Doke PP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-543; Gund P., 2016, J WOMENS HEAL CARE, V05, P1, DOI [10.4172/2167-0420.1000296, DOI 10.4172/2167-0420.1000296]; INPI, 2018, NORMATIVE INSTRUCTIO; IOM, 2003, RED BIRTH DEF M CHAL; Kar A., 2015, PUBLIC HLTH DEV INDI, P222; Khoshnood B, 2011, BIRTH DEFECTS RES A, V91, pS16, DOI 10.1002/bdra.20776; Kulshrestha R, 1983, Indian Pediatr, V20, P45; Kyu HH, 2016, JAMA PEDIATR, V170, P267, DOI 10.1001/jamapediatrics.2015.4276; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Penchaszadeh Victor B, 2002, Community Genet, V5, P61, DOI 10.1159/000064632; Sachdeva Sandeep, 2014, Indian J Public Health, V58, P54, DOI 10.4103/0019-557X.128170; Taksande Amar, 2010, Indian J Hum Genet, V16, P159, DOI 10.4103/0971-6866.73412; Thangaratinam S, 2012, LANCET, V379, P2459, DOI 10.1016/S0140-6736(12)60107-X; United Nations Children's Fund, 2014, STAT WORLDS CHILDR 2; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; VERMA M, 1991, Indian Journal of Pediatrics, V58, P245, DOI 10.1007/BF02751129; WHO, 1999, SERV PREV MAN GEN DI; WHO, 2010, INT STAT CLASS DIS R; World Health Organization, 2014, BIRTH DEF SURV MAN P	30	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166408	10.1371/journal.pone.0166408	http://dx.doi.org/10.1371/journal.pone.0166408			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832123	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000121
J	Fabiani, M; Riccardo, F; Di Napoli, A; Gargiulo, L; Declich, S; Petrelli, A				Fabiani, Massimo; Riccardo, Flavia; Di Napoli, Anteo; Gargiulo, Lidia; Declich, Silvia; Petrelli, Alessio			Differences in Influenza Vaccination Coverage between Adult Immigrants and Italian Citizens at Risk for Influenza-Related Complications: A Cross-Sectional Study	PLOS ONE			English	Article							SELF-REPORT; HEALTH; IMMUNIZATION; CHILDREN; MEASLES; DISEASE; AGE	Background Due to their increased vulnerability, immigrants are considered a priority group for communicable disease prevention and control in Europe. This study aims to compare influenza vaccination coverage (IVC) between regular immigrants and Italian citizens at risk for its complications and evaluate factors affecting differences. Methods Based on data collected by the National Institute of Statistics during a population-based cross-sectional survey conducted in Italy in 2012-2013, we analysed information on 42,048 adult residents (>= 18 years) at risk for influenza-related complications and with free access to vaccination (elderly residents >= 65 years and residents with specific chronic diseases). We compared IVC between 885 regular immigrants and 41,163 Italian citizens using log-binomial models and stratifying immigrants by area of origin and length of stay in Italy (recent: < 10 years; long-term: >= 10 years). Results IVC among all immigrants was 16.9% compared to 40.2% among Italian citizens (vaccination coverage ratio (VCR) = 0.42, 95% confidence interval (CI): 0.36-0.49). Adjusting for sex, age and area of residence, this difference was greatly reduced but remained statistically significant (VCR = 0.71, 95 CI: 0.61-0.81). Further adjustment for socio-economic factors (education, occupation, family composition and economic status) and a composite indicator of health-services utilization did not affect the difference (VCR = 0.78, 95% CI: 0.68-0.90). However, after adjustments, only long-term immigrants from Africa (VCR = 0.49, 95% CI: 0.28-0.85) and recent immigrants (VCR = 0.58, 95% CI: 0.43-0.78) showed a significantly different IVC compared to Italian citizens. Conclusions Differences in demographic characteristics, socio-economic conditions and health-services utilization explained the reduced IVC in most long-term immigrants compared to Italian citizens. By contrast, these differences did not explain the reduced IVC in long-term immigrants from Africa and recent immigrants. This suggests that IVC in these sub-groups is affected by other informal barriers (e.g., cultural and linguistic) that need to be investigated to promote effective immunization access strategies.	[Fabiani, Massimo; Riccardo, Flavia; Declich, Silvia] Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy; [Riccardo, Flavia] European Ctr Dis Prevent & Control ECDC, European Programme Intervent Epidemiol Training E, Stockholm, Sweden; [Di Napoli, Anteo; Petrelli, Alessio] Natl Inst Hlth Migrat & Poverty INMP, Rome, Italy; [Gargiulo, Lidia] Natl Inst Stat ISTAT, Rome, Italy	Istituto Superiore di Sanita (ISS); European Centre for Disease Prevention & Control	Fabiani, M (corresponding author), Italian Natl Inst Hlth ISS, Natl Ctr Epidemiol Surveillance & Hlth Promot CNE, Rome, Italy.	massimo.fabiani@iss.it	Di Napoli, Anteo/AAN-1659-2020; Riccardo, Flavia/GRJ-5156-2022; Di Napoli, Anteo/S-6477-2018	Di Napoli, Anteo/0000-0003-3207-8761; Riccardo, Flavia/0000-0002-1582-6329; Di Napoli, Anteo/0000-0003-3207-8761; Fabiani, Massimo/0000-0002-5893-7117; Petrelli, Alessio/0000-0002-7533-7260; Declich, Silvia/0000-0002-5916-3889				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; [Anonymous], 2012, GLOB VACC ACT PLAN 2; Barsanti S, 2013, 042013 I MAN SCUOL S; Bonanni P, 2015, EPIDEMIOL PREV, V39, P146; Borras E, 2007, VACCINE, V25, P3240, DOI 10.1016/j.vaccine.2007.01.026; Centro Studi e Ricerche IDOS, 2015, DOSSIER STAT IMMIGRA; Chiaradia G, 2011, ITAL J PUBLIC HLTH, V8, P268; European Centre for Disease Prevention and Control (ECDC), 2015, TECHN REP SEAS INFL; Eurostat, 2016, MIGR MIGR POP STAT; Flores G, 2005, MED CARE RES REV, V62, P255, DOI 10.1177/1077558705275416; Grimaldi-Bensouda L, 2013, PHARMACOEPIDEM DR S, V22, P278, DOI 10.1002/pds.3401; ISTAT, 2013, MULT SURV HOUS HLTH; Italian Ministry of Health, 2015, PREV CONTR INFL RACC; Italian National Institute of Statistics (ISTAT), 2015, IMM NUOV CITT CONFR; Italian National Institute of Statistics (ISTAT), 2015, DEM FIG; Italian National Statistical System (SISTAN), 2013, PROGR STAT NAZ 2011; Jimenez-Garcia R, 2014, VACCINE, V32, P4386, DOI 10.1016/j.vaccine.2014.06.074; Jimenez-Garcia R, 2014, HUM VACC IMMUNOTHER, V10, P449, DOI 10.4161/hv.27152; Kentikelenis A, 2015, EUR J PUBLIC HEALTH, V25, P937, DOI 10.1093/eurpub/ckv151; Mladovsky P, 2012, CLIN MED, V12, P248, DOI 10.7861/clinmedicine.12-3-248; Norredam M, 2014, TROP MED INT HEALTH, V19, P958, DOI 10.1111/tmi.12340; Pallasch G, 2005, GESUNDHEITSWESEN, V67, P33, DOI 10.1055/s-2004-813912; PAPAVERO G., 2015, SBARCHI RICHIEDENTI; Poethko-Muller C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042867; Poethko-Muller C, 2009, VACCINE, V27, P2563, DOI 10.1016/j.vaccine.2009.02.009; Razum O, 2006, INT J EPIDEMIOL, V35, P919, DOI 10.1093/ije/dyl143; Rechel B, 2013, LANCET, V381, P1235, DOI 10.1016/S0140-6736(12)62086-8; Riccardo F, 2015, INT J ENV RES PUB HE, V12, P11640, DOI 10.3390/ijerph120911640; Riccardo F, 2012, HEALTH POLICY, V105, P17, DOI 10.1016/j.healthpol.2012.02.004; Rizzo C, 2010, EURO SURVEILL; The Council of the European Union, 2009, COUNC REC SEAS INFL; United Nations, 2016, INT MIGR REP 2015 HI; Vandermeulen C, 2008, EUR J PEDIATR, V167, P1161, DOI 10.1007/s00431-007-0652-3; Venturelli F, 2014, 7 EUR PUBL HLTH C GL; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; World Health Organization, 2010, HLTH MIGR WAY FORW R; World Health Organization (WHO), 2015, SUMM WHO SAGE CONCL; Wormann T., 2011, Migration and health in the European Union, P121	38	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166517	10.1371/journal.pone.0166517	http://dx.doi.org/10.1371/journal.pone.0166517			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832186	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000133
J	Kazmi, M; Aziz, A; Akhtar, P; Ikram, N				Kazmi, Majida; Aziz, Arshad; Akhtar, Pervez; Ikram, Nassar			A Low Cost Structurally Optimized Design for Diverse Filter Types	PLOS ONE			English	Article							2-D CONVOLUTION; ARCHITECTURE; EDGE	A wide range of image processing applications deploys two dimensional (2D)-filters for performing diversified tasks such as image enhancement, edge detection, noise suppression, multi scale decomposition and compression etc. All of these tasks require multiple type of 2D-filters simultaneously to acquire the desired results. The resource hungry conventional approach is not a viable option for implementing these computationally intensive 2D-filters especially in a resource constraint environment. Thus it calls for optimized solutions. Mostly the optimization of these filters are based on exploiting structural properties. A common shortcoming of all previously reported optimized approaches is their restricted applicability only for a specific filter type. These narrow scoped solutions completely disregard the versatility attribute of advanced image processing applications and in turn offset their effectiveness while implementing a complete application. This paper presents an efficient framework which exploits the structural properties of 2D-filters for effectually reducing its computational cost along with an added advantage of versatility for supporting diverse filter types. A composite symmetric filter structure is introduced which exploits the identities of quadrant and circular T-symmetries in two distinct filter regions simultaneously. These T-symmetries effectually reduce the number of filter coefficients and consequently its multipliers count. The proposed framework at the same time empowers this composite filter structure with additional capabilities of realizing all of its psi-symmetry based subtypes and also its special asymmetric filters case. The two-fold optimized framework thus reduces filter computational cost up to 75% as compared to the conventional approach as well as its versatility attribute not only supports diverse filter types but also offers further cost reduction via resource sharing for sequential implementation of diversified image processing applications especially in a constraint environment.	[Kazmi, Majida; Aziz, Arshad; Akhtar, Pervez; Ikram, Nassar] Natl Univ Sci & Technol, Dept Elect Engn PNEC, H-12, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Kazmi, M (corresponding author), Natl Univ Sci & Technol, Dept Elect Engn PNEC, H-12, Islamabad, Pakistan.	majida.kazmi@pnec.nust.edu.pk						Aguilar-Gonzalez A, 2019, J REAL-TIME IMAGE PR, V16, P305, DOI 10.1007/s11554-015-0535-1; AlNajjar M, 2014, LECT NOTES ELECTR EN, V114, P1, DOI 10.1007/978-1-4614-1857-3; Amin A, 2015, APPL GEOPHYS, V12, P334, DOI 10.1007/s11770-015-0512-2; Andria G, 2012, MEASUREMENT, V45, P1792, DOI 10.1016/j.measurement.2012.04.005; [Anonymous], 1973, PATTERN CLASSIFICATI; Fiz JA, 2014, BMC MED IMAGING, V14, DOI 10.1186/1471-2342-14-22; Bailey DG., 2011, DESIGN EMBEDDED IMAG, DOI 10.1002/9780470828519; Bashar F, 2014, ADV ELECTR COMPUT EN, V14, P69, DOI 10.4316/AECE.2014.01011; Bosi B, 1999, IEEE T VLSI SYST, V7, P299, DOI 10.1109/92.784091; Chang CH, 2004, IEEE T CIRCUITS-I, V51, P1985, DOI 10.1109/tcsi.2004.835683; Chen Wai-Kai., 2009, FUNDAMENTALS CIRCUIT, VThird; Chen Y. L., 2006, THESIS; Chondronasios A, 2016, INT J ADV MANUF TECH, V83, P33, DOI 10.1007/s00170-015-7514-3; Chu J, 2013, OPT LASER TECHNOL, V45, P756, DOI 10.1016/j.optlastec.2012.04.040; D'Alberto P, 2007, ANN IEEE SYM FIELD P, P173, DOI [10.1109/FCCM.2007.58, 10.1109/FCCM.2007.34]; Di Carlo S, 2015, IEEE T VLSI SYST, V23, P2198, DOI 10.1109/TVLSI.2014.2357181; Fiack L, 2015, J REAL-TIME IMAGE PR, V10, P699, DOI 10.1007/s11554-013-0391-9; Fialka O, 10 INT C INF VIS IV, P609; FREI W, 1977, IEEE T COMPUT, V26, P988, DOI 10.1109/TC.1977.1674733; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; Gu P, 2016, ULTRASONICS, V65, P51, DOI 10.1016/j.ultras.2015.10.023; Haidekker M. A., 2011, ADV BIOMEDICAL IMAGE; Inc X, 2014, ART 7 FPGAS DAT SHEE; Toledo-Moreo FJ, 2012, J SYST ARCHITECT, V58, P277, DOI 10.1016/j.sysarc.2012.06.002; Karabiber F, 2011, J SIGNAL PROCESS SYS, V64, P447, DOI 10.1007/s11265-010-0504-7; Katuri R, 1991, COMPUTER VISION PRIN; Kockanat S, 2015, ARTIF INTELL REV, V44, P265, DOI 10.1007/s10462-014-9427-1; Majurski M, P IEEE C COMP VIS PA, P95; Marr D., 1980, P ROYAL SOC LONDON B; Mccoy SJ., 1999, US Patent, Patent No. [5,926,580, 5926580]; Perri S, 2007, IET CIRC DEVICE SYST, V1, P263, DOI 10.1049/iet-cds:20070056; Rao L, 2016, J SIGNAL PROCESS SYS, V82, P1, DOI 10.1007/s11265-015-0969-5; Reddy H, 2009, CIRCUITS FILTERS HDB; Reddy H. C., 2003, IEEE Circuits and Systems Magazine, V3, P4, DOI 10.1109/MCAS.2003.1263396; Shanbhag S S, 2014, J Med Eng, V2014, P619081, DOI 10.1155/2014/619081; Shirazi N., 1995, Field-Programmable Logic and Applications. 5th International Workshop, FPL '95. Proceedings, P282; Smith SW, 1997, SCI ENG GUIDE DIGITA; Sonka M., 2014, CENGAGE LEARNING, DOI [10.1007/978-1-4899-3216-7, DOI 10.1007/978-1-4899-3216-7]; van Werkhovena B, 2014, FUTURE GENER COMP SY, V30, P14, DOI 10.1016/j.future.2013.09.003; Woods R., 2008, FPGA BASED IMPLEMENT, DOI [10.1002/9780470713785, DOI 10.1002/9780470713785]; Yang WP, 2012, COMPUT ELECTR ENG, V38, P1213, DOI 10.1016/j.compeleceng.2012.05.014; Yasmin J, 2015, INT ARAB J INF TECHN, V12, DOI [10.5120/7779-0865, DOI 10.5120/7779-0865]; Yu CL, 2011, J SIGNAL PROCESS SYS, V64, P109, DOI 10.1007/s11265-010-0500-y; Zhang B, 2013, J IND MICROBIOL BIOT, P1; Zhang MZ, 2007, INTEGRATION, V40, P490, DOI 10.1016/j.vlsi.2006.07.001	45	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166056	10.1371/journal.pone.0166056	http://dx.doi.org/10.1371/journal.pone.0166056			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832133	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000061
J	Ma, B; Marcotte, D; Paramasivam, M; Michelsen, K; Wang, T; Bertolotti-Ciarlet, A; Jones, JH; Moree, B; Butko, M; Salafsky, J; Sun, X; Mckee, T; Silvian, LF				Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Jones, John Howard; Moree, Ben; Butko, Margaret; Salafsky, Joshua; Sun, Xin; McKee, Timothy; Silvian, Laura F.			ATP-Competitive MLKL Binders Have No Functional Impact on Necroptosis	PLOS ONE			English	Article							MOTOR-NEURON DEATH; 2ND-HARMONIC GENERATION; NECROSIS; KINASE; INHIBITOR; MOLECULES; BINDING; PROTEIN; ACTIVATION; DOMAIN	MLKL is a pore forming pseudokinase involved in the final stage of necroptosis, a form of programmed cell death. Its phosphorylation by RIPK3 is necessary for triggering necroptosis but not for triggering apoptosis, which makes it a unique target for pharmacological inhibition to block necroptotic cell death. This mechanism has been described as playing a role in disease progression in neurodegenerative and inflammatory diseases. A type II kinase inhibitor (cpd 1) has been described that reportedly binds to the MLKL pseudokinase domain and prevents necroptosis. Here we describe five compounds that bind to the MLKL ATP-binding site, however the four MLKL-selective compounds have no activity in rescuing cells from necroptosis. We use kinase selectivity panels, crystallography and a new conformationally sensitive method of measuring protein conformational changes (SHG) to confirm that the one previously reported compound that can rescue cells (cpd 1) is a non-selective type II inhibitor that also inhibits the upstream kinase RIPK1. Although this compound can shift the GFE motif of the activation loop to an "out" position, the accessibility of the key residue Ser358 in the MLKL activation loop is not affected by compound binding to the MLKL active site. Our studies indicate that an ATP-pocket inhibitor of the MLKL pseudokinase domain does not have any impact on the necroptosis pathway, which is contrary to a previously reported study.	[Ma, Bin; Marcotte, Doug; Paramasivam, Murugan; Michelsen, Klaus; Wang, Ti; Bertolotti-Ciarlet, Andrea; Jones, John Howard; Sun, Xin; McKee, Timothy; Silvian, Laura F.] Biogen Inc, Drug Discovery, Cambridge, MA 02142 USA; [Moree, Ben; Butko, Margaret; Salafsky, Joshua] Biodesy Inc, San Francisco, CA 94080 USA; [McKee, Timothy] Rodin Therapeut, 400 Technol Sq, Cambridge, MA 02139 USA	Biogen	Silvian, LF (corresponding author), Biogen Inc, Drug Discovery, Cambridge, MA 02142 USA.	laurasilvian@biogen.com	Ma, Bin/AAD-2694-2019	Moree, Ben/0000-0002-8811-7400	Biogen; Biodesy	Biogen(Biogen); Biodesy	Biogen and Biodesy are commercial entities, who have provided financial support in the form of authors' salaries and research materials. Neither funding organization played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials. The specific roles of these authors are articulated in the 'author contributions' section.	Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Dar AC, 2011, EVOLUTION PROTEIN KI, DOI [10.1146/annurev-biochem-090308-173656., DOI 10.1146/ANNUREV-BIOCHEM-090308-173656]; de Almagro MC, 2015, SEMIN CELL DEV BIOL, V39, P56, DOI 10.1016/j.semcdb.2015.02.002; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Harris PA, 2013, ACS MED CHEM LETT, V4, P1238, DOI 10.1021/ml400382p; Hildebrand JM, 2014, P NATL ACAD SCI USA, V111, P15072, DOI 10.1073/pnas.1408987111; Jacobsen AV, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.386; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Lawrence CP, 2005, FEBS LETT, V579, P6465, DOI 10.1016/j.febslet.2005.10.041; Liu S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/290182; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moree B, 2015, J BIOL CHEM, V290, P27582, DOI 10.1074/jbc.M114.636027; Murakami Y, 2014, CELL DEATH DIFFER, V21, P270, DOI 10.1038/cdd.2013.109; Murphy JM, 2014, BIOCHEM J, V457, P369, DOI 10.1042/BJ20131270; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Qu Y, 2016, EXP NEUROL, V279, P223, DOI 10.1016/j.expneurol.2016.03.011; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; Salafsky JS, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218846; Salafsky JS, 2007, PHYS CHEM CHEM PHYS, V9, P5704, DOI 10.1039/b710505c; Salafsky JS, 2001, CHEM PHYS LETT, V342, P485, DOI 10.1016/S0009-2614(01)00623-6; Sato K, 2013, J NEUROSCI, V33, P17458, DOI 10.1523/JNEUROSCI.1380-13.2013; Suda J, 2016, J IMMUNOL, V197, P3120, DOI 10.4049/jimmunol.1600690; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Vanden Berghe T, 2016, CELL MOL LIFE SCI, V73, P2137, DOI 10.1007/s00018-016-2189-y; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wright L, 2004, CHEM BIOL, V11, P775, DOI 10.1016/j.chembiol.2004.03.033	31	20	21	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165983	10.1371/journal.pone.0165983	http://dx.doi.org/10.1371/journal.pone.0165983			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832137	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000052
J	Moraes, AP; Simoes, AO; Alayon, DIO; de Barros, F; Forni-Martins, ER				Moraes, Ana Paula; Simoes, Andre Olmos; Alayon, Dario Isidro Ojeda; de Barros, Fabio; Forni-Martins, Eliana Regina			Detecting Mechanisms of Karyotype Evolution in Heterotaxis (Orchidaceae)	PLOS ONE			English	Article							CHROMOSOME-NUMBER EVOLUTION; 45S RDNA SITES; CENTRIC FISSION; GENOME SIZE; HETEROCHROMATIN; REARRANGEMENTS; INFERENCE; DNA; CYTOTAXONOMY; MAXILLARIA	The karyotype is shaped by different chromosome rearrangements during species evolution. However, determining which rearrangements are responsible for karyotype changes is a challenging task and the combination of a robust phylogeny with refined karyotype characterization, GS measurements and bioinformatic modelling is necessary. Here, this approach was applied in Heterotaxis to determine what chromosome rearrangements were responsible for the dysploidy variation. We used two datasets (nrDNA and cpDNA, both under MP and BI) to infer the phylogenetic relationships among Heterotaxis species and the closely related genera Nitidobulbon and Ornithidium. Such phylogenies were used as framework to infer how karyotype evolution occurred using statistical methods. The nrDNA recovered Ornithidium, Nitidobulbon and Heterotaxis as monophyletic under both MP and BI; while cpDNA could not completely separate the three genera under both methods. Based on the GS, we recovered two groups within Heterotaxis: (1) "small GS", corresponding to the Sessilis grade, composed of plants with smaller genomes and smaller morphological structure, and (2) "large GS", corresponding to the Discolor Glade, composed of plants with large genomes and robust morphological structures. The robust karyotype modeling, using both nrDNA phylogenies, allowed us to infer that the ancestral Heterotaxis karyotype presented 2n = 40, probably with a proximal 45S rDNA on a metacentric chromosome pair. The chromosome number variation was caused by ascending dysploidy (chromosome fission involving the proximal 45S rDNA site resulting in two acrocentric chromosome pairs holding a terminal 45S rDNA), with subsequent descending dysploidy (fusion) in two species, H. maleolens and H. sessilis. However, besides dysploidy, our analysis detected another important chromosome rearrangement in the Orchidaceae: chromosome inversion, that promoted 5S rDNA site duplication and relocation.	[Moraes, Ana Paula; Simoes, Andre Olmos; Forni-Martins, Eliana Regina] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil; [Moraes, Ana Paula] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil; [Moraes, Ana Paula] Univ Fed Sao Paulo UNIFESP, Inst Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil; [Alayon, Dario Isidro Ojeda] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada; [Alayon, Dario Isidro Ojeda] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [de Barros, Fabio] Inst Bot, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); University of British Columbia; University of British Columbia; Instituto de Botanica - Sao Paulo	Moraes, AP (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, Campinas, SP, Brazil.; Moraes, AP (corresponding author), Univ Estadual Paulista UNESP, Inst Biociencias, Dept Genet, Botucatu, SP, Brazil.; Moraes, AP (corresponding author), Univ Fed Sao Paulo UNIFESP, Inst Ciencia & Tecnol, Sao Jose Dos Campos, SP, Brazil.	apaulademoraes@gmail.com	Simoes, Andre O/E-6244-2013; Alayon, Dario Isidro Ojeda/I-2520-2013; Forni-Martins, Eliana/N-1201-2019; Moraes, Ana Paula/C-5105-2016; de Barros, Fábio/D-6412-2015	Simoes, Andre O/0000-0001-6555-8759; Alayon, Dario Isidro Ojeda/0000-0001-8181-4804; Forni-Martins, Eliana/0000-0002-8889-4955; Moraes, Ana Paula/0000-0002-9878-3925; de Barros, Fábio/0000-0002-9943-3417	Sao Paulo Research Foundation [2008/03673-8, 2011/22215-3]; CONACyT; National Council of Scientific and Technological Research [304506/2013-3, 06142/2011-2]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Council of Scientific and Technological Research(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by the Sao Paulo Research Foundation (http://www.fapesp.br/en/; 2008/03673-8 and 2011/22215-3 to APM), CONACyT (http://www.conacyt.mx/; to DIOA), and the National Council of Scientific and Technological Research (http://cnpq.br/CNPq; Research Productivity Grant 304506/2013-3 to FB and 06142/2011-2 to EFM).	Apples R, 1998, CHROMOSOME BIOL; Atwood J. T., 1999, FIELDIANA BOT, V40, P1; Ayres M., 2007, BIOESTAT APLICACOES; Barros F., 2002, HOEHNEA, V29, P109; Beaulieu JM, 2005, NEW PHYTOL, V179, P975; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Biondo Elaine, 2005, Braz. J. Bot., V28, P797, DOI 10.1590/S0100-84042005000400014; BLUMENSCHEIN A, 1963, CIENCIA CULTURA, V15, P255; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; Cabral JS, 2006, GENET MOL BIOL, V29, P659, DOI 10.1590/S1415-47572006000400015; Carnevali G, 1991, THESIS; Christenson EA, 1999, P 16 WORLD ORCH C, P279; Cox AV, 1998, AM J BOT, V85, P681, DOI 10.2307/2446538; Dahmer N, 2011, PLANT SYST EVOL, V291, P211, DOI 10.1007/s00606-010-0382-2; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DOLEZEL J, 1989, BIOL PLANTARUM, V31, P113, DOI 10.1007/BF02907241; Escudero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085266; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Felix LP, 2010, BOT J LINN SOC, V163, P234, DOI 10.1111/j.1095-8339.2010.01059.x; Felix LP, 2000, GENET MOL BIOL, V23, P957, DOI 10.1590/S1415-47572000000400041; Giuseppina B, 2010, CARYOLOGIA, V63, P184, DOI 10.1080/00087114.2010.10589725; Glick L, 2014, MOL BIOL EVOL, V31, P1914, DOI 10.1093/molbev/msu122; Guerra M, 2008, CYTOGENET GENOME RES, V120, P339, DOI 10.1159/000121083; Guerra M, 2012, PLANT BIOSYST, V146, P703, DOI 10.1080/11263504.2012.717973; Hoehne FC, 1947, ARQ BOT EST SAO PAUL; IMAI HT, 1988, JPN J GENET, V63, P159, DOI 10.1266/jjg.63.159; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; Imai HT, 2001, J THEOR BIOL, V210, P475, DOI 10.1006/jtbi.2001.2327; Jones K, 1998, BOT REV, V64, P273, DOI 10.1007/BF02856567; KARASAWA K, 1980, CYTOLOGIA, V45, P97, DOI 10.1508/cytologia.45.97; King M., 1993, SPECIES EVOLUTION; Knight CA, 2008, ANN BOT-LONDON, V101, P759, DOI 10.1093/aob/mcm321; Koehler S, 2008, ANN BOT-LONDON, V102, P491, DOI 10.1093/aob/mcn128; Lan TY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-126; Levin D. A, 2002, OX ECOL EV; Lysak MA, 1998, CARYOLOGIA, V51, P123, DOI 10.1080/00087114.1998.10589127; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Moraes AP, 2015, BOT J LINN SOC, V177, P27, DOI 10.1111/boj.12232; Moraes AP, 2012, BOT J LINN SOC, V170, P29, DOI 10.1111/j.1095-8339.2012.01266.x; Moscone EA, 2007, CHROMOSOME RES, V15, P931, DOI 10.1007/s10577-007-1174-6; Nakata M, 1983, ANN TSUKUBA BOT GARD, V2, P11; Ojeda I, 2005, NOVON, V15, P572; Ojeda I, 2009, GENERA ORCHIDACEAR 2, V5, P147; OJEDA I, 2003, LANKESTERIANA, V7, P45; Pedrosa A, 2002, GENETICS, V161, P1661; Pellicer J, 2013, GENOME, V56, P437, DOI 10.1139/gen-2013-0039; Pellicer J, 2014, NEW PHYTOL, V201, P1484, DOI 10.1111/nph.12617; Pellicer J, 2012, ANN BOT-LONDON, V110, P1185, DOI 10.1093/aob/mcs185; Perry J, 2004, CHROMOSOME RES, V12, P627, DOI 10.1023/B:CHRO.0000036594.38997.59; Peruzzi L, 2013, PLANT BIOSYST, V147, P1238, DOI 10.1080/11263504.2013.861533; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2007, TREEANNOTATOR V1 5 4; Rieseberg LH, 2001, TRENDS ECOL EVOL, V16, P351, DOI 10.1016/S0169-5347(01)02187-5; Roa F, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-225; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Schubert I, 2016, TRENDS PLANT SCI, V21, P749, DOI 10.1016/j.tplants.2016.06.003; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; SCHWARZACHER T, 1982, PLANT SYST EVOL, V141, P91, DOI 10.1007/BF00986411; Severns PM, 2008, CONSERV BIOL, V22, P1641, DOI 10.1111/j.1523-1739.2008.01058.x; Sousa A, 2014, ANN BOT-LONDON, V113, P669, DOI 10.1093/aob/mct302; Souza BCQ, 2011, THESIS; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Wang XY, 2015, NEW PHYTOL, V205, P378, DOI 10.1111/nph.12985; Wanzenbock EM, 1997, PLANT J, V11, P1007, DOI 10.1046/j.1365-313X.1997.11051007.x; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Whitten WM, 2007, AM J BOT, V94, P1860, DOI 10.3732/ajb.94.11.1860; [No title captured]	70	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165960	10.1371/journal.pone.0165960	http://dx.doi.org/10.1371/journal.pone.0165960			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832130	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000047
J	Qi, LF; Liu, Y; Tao, HZ; Xiao, N; Li, JN; Kong, LY; Hou, LT				Qi, Lifang; Liu, Yan; Tao, Huizhu; Xiao, Ning; Li, Jinnian; Kong, Lingyan; Hou, Liting			Screening a Phage Display Library for Two Novel OmpU-Binding Peptides with Adhesion Antagonistic Activity against Vibrio mimicus	PLOS ONE			English	Article							POLYSTYRENE; ANTIBODIES; INFECTION; AFFINITY; CATFISH	Vibrio mimicus is a pathogen that causes ascites disease in fish. We have previously demonstrated that the outer membrane protein U (OmpU) is an important adhesin in V. mimicus. Here eight specific OmpU-binding phage clones, which presented three different OmpU-binding peptides (designated P1, P2, P3), were screened from a commercially available phage displayed 12-mer peptide library using rOmpU protein as target. Then, synthetic OmpU-binding peptides were measured for their adhesion antagonistic activity and binding affinity via adhesion inhibition test and non-competitive ELISA, respectively. The results showed that after co-incubated with the mixture of rOmpU and P3, visible green fluorescence could be observed on the epithelioma papulosum cyprinidi (EPC) cells surface; while the EPC cells co-incubated with the mixture of rOmpU and P1/P2 exhibited little green fluorescence. The average adhesion number of V. mimicus 04-14 isolate before and after treatment with peptide was 21.4 +/- 1.5, 20.8 +/- 0.8 (irrelevant peptide), 20.2 +/- 0.5 (P3), 5.1 +/- 0.7 (P1) and 3.4 +/- 0.8 (P2), respectively. There was a significant decrease in the adhesive level of 04-14 isolate treated with P1/ P2 compared to the untreated isolate (p<0.01). The affinity constants of P1 and P2 were (6.17 +/- 0.19) x 10(8) L/mol and (1.24 +/- 0.56) x 10(9) L/mol, respectively. Furthermore, protective effects of P1 and P2 on grass carps challenged with V. mimicus were preliminary detected. It was found there was delayed death of fish in the groups treated with P1/P2, and the survival rate of challenged fish improved with the increase of the dose of adhesion antagonistic peptide. Taken together, two novel OmpUbinding peptides, which possessed adhesion antagonistic activity, high affinity and a certain degree of antibacterial activity against V. mimicus, were screened and identified.	[Qi, Lifang; Liu, Yan; Tao, Huizhu; Xiao, Ning; Li, Jinnian; Kong, Lingyan; Hou, Liting] Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei 230036, Peoples R China	Anhui Agricultural University	Li, JN (corresponding author), Anhui Agr Univ, Coll Anim Sci & Technol, Key Lab Zoonoses, Hefei 230036, Peoples R China.	lijinnian2000@163.com	li, lijinnian/HDO-3498-2022		China Natural Science Foundation [31272696, 31672698]	China Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This study was supported by the China Natural Science Foundation (No. 31272696 and No.31672698). http://www.nsfc.gov.cn/publish/portal1/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albericio F, 2012, FUTURE MED CHEM, V4, P1527, DOI [10.4155/fmc.12.94, 10.4155/FMC.12.94]; Azimzadeh A, 1990, J Mol Recognit, V3, P108, DOI 10.1002/jmr.300030304; BEATTY JD, 1987, J IMMUNOL METHODS, V100, P173, DOI 10.1016/0022-1759(87)90187-6; [毕仙民 BI Xianmin], 2007, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V32, P232; BOUDET F, 1991, J IMMUNOL METHODS, V142, P73, DOI 10.1016/0022-1759(91)90294-P; Cen JY, 2013, FISH SHELLFISH IMMUN, V34, P291, DOI 10.1016/j.fsi.2012.11.015; Gao HuiHui, 2015, Journal of Fisheries of China, V39, P557; Geng Y, 2014, AQUACULTURE, V433, P82, DOI 10.1016/j.aquaculture.2014.05.053; Hamzeh-Mivehroud M, 2012, CHEM BIOL DRUG DES, V79, P246, DOI 10.1111/j.1747-0285.2011.01282.x; Hoogenboom Hennie R, 2002, Methods Mol Biol, V178, P1; Kim SY, 2010, J DAIRY SCI, V93, P3610, DOI 10.3168/jds.2010-3129; Krumpe LRH, 2006, PROTEOMICS, V6, P4210, DOI 10.1002/pmic.200500606; Loomans EEMG, 1997, ANAL BIOCHEM, V248, P117, DOI 10.1006/abio.1997.2119; LOOMANS EEMG, 1995, J IMMUNOL METHODS, V184, P207, DOI 10.1016/0022-1759(95)00089-S; Pande J, 2010, BIOTECHNOL ADV, V28, P849, DOI 10.1016/j.biotechadv.2010.07.004; Rowley Merrill J, 2004, Biotechnol Annu Rev, V10, P151, DOI 10.1016/S1387-2656(04)10006-9; Sidhu SS, 2000, CURR OPIN BIOTECH, V11, P610, DOI 10.1016/S0958-1669(00)00152-X; Sneha S, 2014, PLOS ONE, V10; STENBERG M, 1988, J IMMUNOL METHODS, V113, P3, DOI 10.1016/0022-1759(88)90376-6; [许元生 Xu Yuansheng], 2014, [免疫学杂志, Immunological Journal], V30, P560; Xueqin L, 2015, PLOS ONE, V10; Yang Q, 2005, VACCINE, V23, P4088, DOI 10.1016/j.vaccine.2004.07.005; Young KN, 2014, PLOS ONE, V10; Zhang X, 2014, AQUACULTURE, V432, P119, DOI 10.1016/j.aquaculture.2014.04.039	24	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165092	10.1371/journal.pone.0165092	http://dx.doi.org/10.1371/journal.pone.0165092			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832083	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000008
J	Sanchez-Barrionuevo, L; Gonzalez-Benjumea, A; Escobar-Nino, A; Garcia, MT; Lopez, O; Maya, I; Fernandez-Bolanos, JG; Canovas, D; Mellado, E				Sanchez-Barrionuevo, Leyre; Gonzalez-Benjumea, Alejandro; Escobar-Nino, Almudena; Teresa Garcia, Maria; Lopez, Oscar; Maya, Ines; Fernandez-Bolanos, Jose G.; Canovas, David; Mellado, Encarnacion			A Straightforward Access to New Families of Lipophilic Polyphenols by Using Lipolytic Bacteria	PLOS ONE			English	Article							ALKYL HYDROXYTYROSYL ETHERS; LIPASE-CATALYZED ESTERIFICATION; OLIVE OIL; PHENOLIC-COMPOUNDS; CONVENIENT SYNTHESIS; OXIDATIVE STRESS; WASTE-WATERS; ANTIOXIDANT; DERIVATIVES; 3,4-DIHYDROXYPHENYLGLYCOL	The chemical synthesis of new lipophilic polyphenols with improved properties presents technical difficulties. Here we describe the selection, isolation and identification of lipolytic bacteria from food-processing industrial wastes, and their use for tailoring a new set of compounds with great interest in the food industry. These bacteria were employed to produce lipolytic supernatants, which were applied without further purification as biocatalysts in the chemoselective and regioselective synthesis of lipophilic partially acetylated phenolic compounds derived from olive polyphenols. The chemoselectivity of polyphenols acylation/deacylation was analyzed, revealing the preference of the lipases for phenolic hydroxyl groups and phenolic esters. In addition, the alcoholysis of peracetylated 3,4-dihydroxyphenylglycol resulted in a series of lipophilic 2-alkoxy-2-(3,4-dihydroxyphenyl) ethyl acetate through an unexpected lipase-mediated etherification at the benzylic position. These new compounds are more lipophilic and retained their antioxidant properties. This approach can provide access to unprecedented derivatives of 3,4-dihydroxyphenylglycol with improved	[Sanchez-Barrionuevo, Leyre; Escobar-Nino, Almudena; Canovas, David] Univ Seville, Fac Biol, Dept Genet, Seville, Spain; [Sanchez-Barrionuevo, Leyre; Escobar-Nino, Almudena; Teresa Garcia, Maria; Mellado, Encarnacion] Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain; [Gonzalez-Benjumea, Alejandro; Lopez, Oscar; Maya, Ines; Fernandez-Bolanos, Jose G.] Univ Seville, Fac Chem, Dept Organ Chem, Seville, Spain	University of Sevilla; University of Sevilla; University of Sevilla	Canovas, D (corresponding author), Univ Seville, Fac Biol, Dept Genet, Seville, Spain.; Mellado, E (corresponding author), Univ Seville, Fac Pharm, Dept Microbiol & Parasitol, Seville, Spain.	davidc@us.es; emellado@us.es	Fernández-Bolaños, José/L-1295-2014; Cánovas, David/L-7628-2014; Benjumea, Alejandro González/K-6666-2014; NIÑO, ALMUDENA ESCOBAR/Y-3315-2019; MELLADO, ENCARNACIÓN/K-8665-2014; López, Óscar/L-2247-2014	Fernández-Bolaños, José/0000-0003-1499-0650; Cánovas, David/0000-0002-7293-7332; Benjumea, Alejandro González/0000-0003-2857-9491; NIÑO, ALMUDENA ESCOBAR/0000-0001-5637-1474; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; López, Óscar/0000-0003-2896-6993; Sanchez, Leyre/0000-0002-9792-5055	Junta de Andalucia [P08-NMR-3515, P11-CVI-7427 MO, FQM134, BIO-213]; European Regional Development Fund (FEDER); Spanish Ministerio de Economia y Competitividad	Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (FEDER)(European Commission); Spanish Ministerio de Economia y Competitividad(Spanish Government)	We thank the Junta de Andalucia (P08-NMR-3515, P11-CVI-7427 MO, FQM134 and BIO-213) and the European Regional Development Fund (FEDER) for financial support. AGB thanks the Spanish Ministerio de Economia y Competitividad for the award of a grant.	Aladedunye F, 2015, LWT-FOOD SCI TECHNOL, V60, P56, DOI 10.1016/j.lwt.2014.08.008; Aparicio-Soto M, 2015, J AGR FOOD CHEM, V63, P836, DOI 10.1021/jf503357s; Barontini M, 2014, NEW J CHEM, V38, P809, DOI 10.1039/c3nj01180a; Bellot JC, 2001, ENZYME MICROB TECH, V28, P362, DOI 10.1016/S0141-0229(00)00326-4; Bernini R, 2008, J AGR FOOD CHEM, V56, P8897, DOI 10.1021/jf801558z; Bernini R, 2015, J MED CHEM, V58, P9089, DOI 10.1021/acs.jmedchem.5b00669; Bernini R, 2012, J AGR FOOD CHEM, V60, P7408, DOI 10.1021/jf301131a; Bernini R, 2012, CURR ORG CHEM, V16, P1051, DOI 10.2174/138527212800194700; Bohn T, 2014, NUTR REV, V72, P429, DOI 10.1111/nure.12114; Brenes M, 1999, J AGR FOOD CHEM, V47, P3535, DOI 10.1021/jf990009o; Capasso R, 2006, J AGR FOOD CHEM, V54, P9063, DOI 10.1021/jf061290r; Castillo E, 1997, J AM OIL CHEM SOC, V74, P77, DOI 10.1007/s11746-997-0148-3; Christophoridou S, 2005, J AGR FOOD CHEM, V53, P4667, DOI 10.1021/jf040466r; Cilla A, 2009, ANN NUTR METAB, V54, P35, DOI 10.1159/000205318; Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006; Deiana M, 2010, FOOD CHEM TOXICOL, V48, P3008, DOI 10.1016/j.fct.2010.07.041; Di Donna L, 2010, FOOD CHEM, V121, P492, DOI 10.1016/j.foodchem.2009.12.070; Du X.-p., 2011, JIMEI DAXUE XUEBAO Z, V16, P424; Escobar-Nino A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104063; Fernandez-Bolanos JG, 2008, CURR ORG CHEM, V12, P442, DOI 10.2174/138527208784083888; Fragopoulou E, 2007, J AGR FOOD CHEM, V55, P80, DOI 10.1021/jf0627221; Guerrero A, 2012, FOOD CHEM, V134, P2176, DOI 10.1016/j.foodchem.2012.04.022; Gupta A, 2009, CRIT REV BIOTECHNOL, V29, P44, DOI 10.1080/07388550802688797; Kalaiselvan I, 2016, PHARM BIOL, V54, P338, DOI 10.3109/13880209.2015.1042980; Kobayashi S, 2010, P JPN ACAD B-PHYS, V86, P338, DOI 10.2183/pjab.86.338; Lorentz C, 2010, BIOTECHNOL LETT, V32, P1955, DOI 10.1007/s10529-010-0386-6; Madrona A, 2009, MOLECULES, V14, P1762, DOI 10.3390/molecules14051762; Caderon-Montano JM, 2013, J AGR FOOD CHEM, V61, P5046, DOI 10.1021/jf400796p; Medina I, 2009, J AGR FOOD CHEM, V57, P9773, DOI 10.1021/jf9023867; Pauwels EKJ, 2010, MED PRIN PRACT, V20, P103, DOI 10.1159/000321197; Pereira-Caro G, 2012, INT J FOOD SCI NUTR, V63, P703, DOI 10.3109/09637486.2011.652943; Pereira-Caro G, 2011, J AGR FOOD CHEM, V59, P5964, DOI 10.1021/jf2002415; Rodriguez G, 2009, LWT-FOOD SCI TECHNOL, V42, P483, DOI 10.1016/j.lwt.2008.08.015; Rodriguez G, 2009, J AGR FOOD CHEM, V57, P6298, DOI 10.1021/jf803512r; Saitta M, 2009, FOOD CHEM, V112, P525, DOI 10.1016/j.foodchem.2008.06.001; Sanchez-Fidalgo S, 2015, J NUTR BIOCHEM, V26, P513, DOI 10.1016/j.jnutbio.2014.12.001; Teixeira A, 2014, INT J MOL SCI, V15, P15638, DOI 10.3390/ijms150915638; Wu HH, 2009, J ASIAN NAT PROD RES, V11, P748, DOI 10.1080/10286020903025783; Wuts P. G., 2006, PROTECTING GROUPS OR; Zhong Y, 2012, FOOD CHEM, V131, P22, DOI 10.1016/j.foodchem.2011.07.089	40	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166561	10.1371/journal.pone.0166561	http://dx.doi.org/10.1371/journal.pone.0166561			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855214	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200035
J	Ahonkhai, V; Martins, SF; Portet, A; Lumpkin, M; Hartman, D				Ahonkhai, Vincent; Martins, Samuel F.; Portet, Alexandre; Lumpkin, Murray; Hartman, Dan			Speeding Access to Vaccines and Medicines in Low- and Middle-Income Countries: A Case for Change and a Framework for Optimized Product Market Authorization	PLOS ONE			English	Article								Background The United Nations Millennium Development Goals galvanized global efforts to alleviate suffering of the world's poorest people through unprecedented public-private partnerships. Donor aid agencies have demonstrably saved millions of lives that might otherwise have been lost to disease through increased access to quality-assured vaccines and medicines. Yet, the introduction of these health interventions in low- and middle-income countries (LMICs) continues to face a time lag due to factors which remain poorly understood. Methods and Findings A recurring theme from our partnership engagements was that an optimized regulatory process would contribute to improved access to quality health products. Therefore, we investigated the current system for medicine and vaccine registration in LMICs as part of our comprehensive regulatory strategy. Here, we report a fact base of the registration timelines for vaccines and drugs used to treat certain communicable diseases in LMICs. We worked with a broad set of stakeholders, including the World Health Organization's prequalification team, national regulatory authorities, manufacturers, procurers, and other experts, and collected data on the timelines between first submission and last approval of applications for product registration sub-Saharan Africa. We focused on countries with the highest burden of communicable disease and the greatest need for the products studied. The data showed a typical lag of 4 to 7 years between the first regulatory submission which was usually to a regulatory agency in a high-income country, and the final approval in Sub-Saharan Africa. Two of the three typical registration steps which products undergo before delivery in the countries involve lengthy timelines. Failure to leverage or rely on the findings from reviews already performed by competent regulatory authorities, disparate requirements for product approval by the countries, and lengthy timelines by manufacturers to respond to regulatory queries were key underlying factors for the delays. Conclusions We propose a series of measures which we developed in close collaboration with key stakeholders that could be taken to reduce registration time and to make safe, effective medicines more quickly available in countries where they are most needed. Many of these recommendations are being implemented by the responsible stakeholders, including the WHO pre-qualification team and the national regulatory authorities in Sub-Saharan Africa. Those efforts will be the focus of subsequent publications by the pertinent groups.	[Ahonkhai, Vincent; Martins, Samuel F.; Portet, Alexandre; Lumpkin, Murray; Hartman, Dan] Bill & Melinda Gates Fdn, Integrated Dev Global Hlth, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Ahonkhai, V (corresponding author), Bill & Melinda Gates Fdn, Integrated Dev Global Hlth, Seattle, WA 98109 USA.	Vincent.ahonkhai@gatesfoundation.org			Bill & Melinda Gates Foundation (BMGF)	Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	Not applicable. See partly related statement above and pasted below: Important background-The Bill & Melinda Gates Foundation (BMGF) is a private non-profit philanthropic organization with a vision for healthy and productive life for the poor through partnerships grant support. This manuscript documents one component of a BMGF partnership work on a strategy to increase access to medical products in low-and middle-income countries. The department responsible for the specific program that we work on is headed by DH. VIA and AP led the project with support from team members. ML contributed to the interpretation of results and SM supported data and issue analyses and both ML and SM contributed to the overall recommendation development for the strategy. Our research was conducted with the services of a management consulting firm. The foundation is currently funding many partnerships in the implementation of a number of the initiatives described in this manuscript.	Bollyky TJ, 2010, CLIN TRIALS, V7, P719, DOI 10.1177/1740774510386390; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Doua JY, 2014, TROP MED INT HEALTH, V19, P23, DOI 10.1111/tmi.12201; GAVI Alliance, 2015, GLOB LEV IND; Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS51, DOI 10.1097/QAI.0b013e31825ca721; Lakkis MM, 2010, DRUG INF J, V44, P289, DOI 10.1177/009286151004400311; Lee LA, 2013, VACCINE, V31, pB61, DOI 10.1016/j.vaccine.2012.11.035; McAuslane N, 2009, DRUG INF J, V43, P349, DOI 10.1177/009286150904300314; Moran M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000411; Rago L, 2014, ANTIVIR THER, V19, P69, DOI 10.3851/IMP2902; Stahl M., 2012, J GENER MED, V9, P63, DOI [10.1177/1741134312448062, DOI 10.1177/1741134312448062]; 't Hoen EFM, 2014, J PUBLIC HEALTH POL, V35, P137, DOI 10.1057/jphp.2013.53; The George Institute for International Health, 2010, REG NEW DRUGS AFR CO; WARDELL WM, 1974, CLIN PHARMACOL THER, V15, P73; WHO, 2013, WHO TECH REP SER, V981, P1; WHO, 2010, ASS MED REG SYST SUB; Zelman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115714	17	33	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166515	10.1371/journal.pone.0166515	http://dx.doi.org/10.1371/journal.pone.0166515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851831	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300059
J	Durrheim, K; Quayle, M; Tredoux, CG; Titlestad, K; Tooke, L				Durrheim, Kevin; Quayle, Michael; Tredoux, Colin G.; Titlestad, Kim; Tooke, Larry			Investigating the Evolution of Ingroup Favoritism Using a Minimal Group Interaction Paradigm: The Effects of Inter- and Intragroup Interdependence	PLOS ONE			English	Article							IN-GROUP FAVORITISM; SOCIAL IDENTITY; GROUP MEMBERSHIP; SELF-CATEGORIZATION; DISCRIMINATION; COOPERATION; IMPACT; RECIPROCITY; ALTRUISM; CRITIQUE	We investigated the effect of structural interdependencies between groups (especially inequality), and interdependencies between individuals on ingroup favoritism in minimal group situations. Previous research has attempted to determine whether ingroup favoritism is produced by categorization or intragroup interdependencies (reciprocation expectations), but recent literature suggests that it is not possible to tease these influences apart. We report two studies that investigate how ingroup favoritism evolves over time in social interaction. The levels of ingroup favoritism were affected by categorization and inequality, and the level of ingroup favoritism changed over time, increasing or decreasing depending on the nature of the initial intergroup structure. We conclude by providing two explanations for this change: emergent norms, and changes to the intergroup situation produced by interaction. Our experiments confirm the value of studying the evolution of minimal group behavior, especially for explaining why low status groups act to preserve intergroup inequalities.	[Durrheim, Kevin; Quayle, Michael; Titlestad, Kim; Tooke, Larry] Univ KwaZulu Natal, Dept Psychol, Pietermaritzburg, Kwazulu Natal, South Africa; [Quayle, Michael] Univ Limerick, Dept Psychol, Limerick, Ireland; [Tredoux, Colin G.] Univ Cape Town, Dept Psychol, Cape Town, Western Cape, South Africa	University of Kwazulu Natal; University of Limerick; University of Cape Town	Durrheim, K (corresponding author), Univ KwaZulu Natal, Dept Psychol, Pietermaritzburg, Kwazulu Natal, South Africa.	durrheim@ukzn.ac.za	Quayle, Michael/N-6414-2017; Tredoux, Colin G/E-7235-2010	Quayle, Michael/0000-0002-7497-0566; Tredoux, Colin G/0000-0002-9653-786X	National Research Foundation of South Africa Grant [BS1203160707]	National Research Foundation of South Africa Grant	Support was provided by National Research Foundation of South Africa Grant (BS1203160707) awarded to Kevin Durrheim [https://nrfsubmission.nrf.ac.za/NrfMklI/Default.aspx].; This research was supported by a National Research Foundation of South Africa Grant (BS1203160707) awarded to Kevin Durrheim.	Balliet D, 2014, PSYCHOL BULL, V140, P1556, DOI 10.1037/a0037737; Bettencourt BA, 2001, PSYCHOL BULL, V127, P520, DOI 10.1037//0033-2909.127.4.520; Billig M, 1976, SOCIAL PSYCHOLOGY AN; Billig M, 2012, BEYOND PREJUDICE; Brewer M.B., 2008, RATIONALITY SOCIAL R, P215, DOI DOI 10.4324/9780203889695; Cacault MP, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00729; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Condor S., 2003, THEORIES CONTROVERSI, P153; De S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17963; Diehl M, 1989, BRIT J SOC PSYCHOL, V28, P227, DOI [10.1111/j.2044-8309.1989.tb00865.x, DOI 10.1111/J.2044-8309.1989.TB00865.X]; Dorrough AR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00476; Everett JAC, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00015; Fu F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00460; Gaertner L, 2000, J PERS SOC PSYCHOL, V79, P77, DOI 10.1037//0022-3514.79.1.77; Gaertner L, 2001, EUR J SOC PSYCHOL, V31, P143, DOI 10.1002/ejsp.28; Gagnon A, 1996, PERS SOC PSYCHOL B, V22, P1289, DOI 10.1177/01461672962212009; Gao SP, 2015, PHYS LETT A, V379, P333, DOI 10.1016/j.physleta.2014.11.035; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, MANAGE SCI, V58, P948, DOI 10.1287/mnsc.1110.1466; Hammond RA, 2006, J CONFLICT RESOLUT, V50, P926, DOI 10.1177/0022002706293470; Hertel G, 2001, J EXP SOC PSYCHOL, V37, P316, DOI 10.1006/jesp.2000.1447; Hertel G, 1994, EUROPEAN J SOCIAL PS, V24, P131; Jetten J, 1996, J PERS SOC PSYCHOL, V71, P1222, DOI 10.1037/0022-3514.71.6.1222; Jost J., 2003, EUROPEAN REV SOCIAL, V13, P111, DOI [DOI 10.1080/10463280240000046, 10.1080/10463280240000046]; JOST JT, 1994, BRIT J SOC PSYCHOL, V33, P1, DOI 10.1111/j.2044-8309.1994.tb01008.x; Karp D., 1993, JAPANESE J EXPT SOCI, V32, P231, DOI [10.2130/jjesp.32.231, DOI 10.2130/JJESP.32.231, https://doi.org/10.2130/jjesp.32.231]; Lei V, 2010, SOUTH ECON J, V76, P1049, DOI 10.4284/sej.2010.76.4.1049; LOCKSLEY A, 1980, J PERS SOC PSYCHOL, V39, P773, DOI 10.1037/0022-3514.39.5.773; Masuda N, 2015, F1000PRIME REPORTS, V7, P1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakamura M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-213; Platow MJ, 2012, SOC PSYCHOL PERS SCI, V3, P5, DOI 10.1177/1948550611407081; Postmes T, 2005, J PERS SOC PSYCHOL, V89, P747, DOI 10.1037/0022-3514.89.5.747; PRUITT DG, 1977, ANNU REV PSYCHOL, V28, P363, DOI 10.1146/annurev.ps.28.020177.002051; RABBIE JM, 1989, EUR J SOC PSYCHOL, V19, P171, DOI 10.1002/ejsp.2420190302; Rubin M, 2014, GROUP PROCESS INTERG, V17, P563, DOI 10.1177/1368430213514122; Saguy T, 2009, PSYCHOL SCI, V20, P114, DOI 10.1111/j.1467-9280.2008.02261.x; SHERIF M, 1958, AM J SOCIOL, V63, P349, DOI 10.1086/222258; Sherif M., 1966, GROUP CONFLICT COOPE; Simpson B, 2006, RATION SOC, V18, P443, DOI 10.1177/1043463106066381; Stroebe K, 2005, PERS SOC PSYCHOL B, V31, P831, DOI 10.1177/0146167204271659; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TAJFEL H, 1970, SCI AM, V223, P96, DOI 10.1038/scientificamerican1170-96; Tajfel H., 1981, HUMAN GROUPS SOCIAL, DOI DOI 10.1002/EJSP.2420120209; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel H., 1972, CONTEXT SOCIAL PSYCH, P69; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tajfel Henri, 1978, SOCIAL PSYCHOL MINOR; Thomas EF, 2016, GROUP PROCESS INTERG, V19, P137, DOI 10.1177/1368430215612217; Turner J.C., 2012, THEORIES SOCIAL PSYC, P399, DOI [10.4135/9781446249222.n46, DOI 10.4135/9781446249222.N46]; Turner J.C., 1996, SOCIAL GROUPS IDENTI, P25; Turner J.C., 1987, REDISCOVERING SOCIAL; Yamagishi T, 1999, ADV GROUP, V16, P161; Yamagishi T, 2000, SOC PSYCHOL QUART, V63, P116, DOI 10.2307/2695887; Yamagishi T, 2008, RATION SOC, V20, P5, DOI 10.1177/1043463107085442	56	5	8	5	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165974	10.1371/journal.pone.0165974	http://dx.doi.org/10.1371/journal.pone.0165974			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851791	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300030
J	Han, TS; Tian, S; Wang, L; Liang, X; Cui, HL; Du, SS; Na, GQ; Na, LX; Sun, CH				Han, Tianshu; Tian, Shuang; Wang, Li; Liang, Xi; Cui, Hongli; Du, Shanshan; Na, Guanqiong; Na, Lixin; Sun, Changhao			Dietary Information Improves Model Performance and Predictive Ability of a Noninvasive Type 2 Diabetes Risk Model	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; SCORE; MELLITUS; CONSUMPTION; REDUCTION	There is no diabetes risk model that includes dietary predictors in Asia. We sought to develop a diet-containing noninvasive diabetes risk model in Northern China and to evaluate whether dietary predictors can improve model performance and predictive ability. Cross-sectional data for 9,734 adults aged 20-74 years old were used as the derivation data, and results obtained for a cohort of 4,515 adults with 4.2 years of follow-up were used as the validation data. We used a logistic regression model to develop a diet-containing noninvasive risk model. Akaike's information criterion (AIC), area under curve (AUC), integrated discrimination improvements (IDI), net classification improvement (NRI) and calibration statistics were calculated to explicitly assess the effect of dietary predictors on a diabetes risk model. A diet-containing type 2 diabetes risk model was developed. The significant dietary predictors including the consumption of staple foods, livestock, eggs, potato, dairy products, fresh fruit and vegetables were included in the risk model. Dietary predictors improved the noninvasive diabetes risk model with a significant increase in the AUC (delta AUC = 0.03, P<0.001), an increase in relative IDI (24.6%, P-value for IDI <0.001), an increase in NRI (category-free NRI = 0.155, P<0.001), an increase in sensitivity of the model with 7.3% and a decrease in AIC (delta AIC = 199.5). The results of the validation data were similar to the derivation data. The calibration of the diet-containing diabetes risk model was better than that of the risk model without dietary predictors in the validation data. Dietary information improves model performance and predictive ability of noninvasive type 2 diabetes risk model based on classic risk factors. Dietary information may be useful for developing a noninvasive diabetes risk model.	[Han, Tianshu; Tian, Shuang; Wang, Li; Liang, Xi; Cui, Hongli; Du, Shanshan; Na, Guanqiong; Na, Lixin; Sun, Changhao] Harbin Med Univ, Natl Key Discipline, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China	Harbin Medical University	Na, LX; Sun, CH (corresponding author), Harbin Med Univ, Natl Key Discipline, Dept Nutr & Food Hyg, Sch Publ Hlth, Harbin, Peoples R China.	nalixin2003@163.com; changhaosun2002@163.com	SUN, CHANG/GXM-3680-2022		National High Technology Research; National 12th five-year Scientific and Technical Support Program of China [2012BAI02B00]; Harbin Medical University [WLD-QN1406]	National High Technology Research(National High Technology Research and Development Program of China); National 12th five-year Scientific and Technical Support Program of China; Harbin Medical University	This work was supported by the National High Technology Research and the National 12th five-year Scientific and Technical Support Program of China (2012BAI02B00) [Sun]; Wu Liande Grant of Harbin Medical University (WLD-QN1406) [Na].	Aekplakorn W, 2006, DIABETES CARE, V29, P1872, DOI 10.2337/dc05-2141; American Diabetes Association, 1998, DIABETES CARE S1, V12, pS20, DOI DOI 10.2337/DIACARE.21.1.S20; Baan CA, 1999, DIABETES CARE, V22, P213, DOI 10.2337/diacare.22.2.213; Baik I, 2013, EUR J CLIN NUTR, V67, P25, DOI 10.1038/ejcn.2012.175; Carter Patrice, 2010, BMJ, V341, pc4229, DOI 10.1136/bmj.c4229; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Doi Y, 2012, DIABETIC MED, V29, P107, DOI 10.1111/j.1464-5491.2011.03376.x; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Gao WG, 2010, DIABETIC MED, V27, P274, DOI 10.1111/j.1464-5491.2010.02943.x; Glumer C, 2006, DIABETES CARE, V29, P410, DOI 10.2337/diacare.29.02.06.dc05-0945; Glumer C, 2004, DIABETES CARE, V27, P727, DOI 10.2337/diacare.27.3.727; Hu EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1454; Huang LN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027703; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koenig W, 2004, CIRCULATION, V109, P1349, DOI 10.1161/01.CIR.0000120707.98922.E3; Lee YH, 2012, DIABETES CARE, V35, P1723, DOI 10.2337/dc11-2347; Li M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005497; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; McGeechan K, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-86; Na LX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122598; Pan A, 2013, JAMA INTERN MED, V173, P1328, DOI 10.1001/jamainternmed.2013.6633; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089; Simmons RK, 2007, DIABETIC MED, V24, P830, DOI 10.1111/j.1464-5491.2007.02173.x; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Sun F, 2009, DIABETES RES CLIN PR, V85, P228, DOI 10.1016/j.diabres.2009.05.005; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhou XH, 2013, DIABETES CARE, V36, P3944, DOI 10.2337/dc13-0593	31	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166206	10.1371/journal.pone.0166206	http://dx.doi.org/10.1371/journal.pone.0166206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851788	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300041
J	Manzoor, S; Bongcam-Rudloff, E; Schnurer, A; Muller, B				Manzoor, Shahid; Bongcam-Rudloff, Erik; Schnurer, Anna; Muller, Bettina			Genome-Guided Analysis and Whole Transcriptome Profiling of the Mesophilic Syntrophic Acetate Oxidising Bacterium Syntrophaceticus schinkii	PLOS ONE			English	Article							DESULFOVIBRIO-VULGARIS HILDENBOROUGH; NON-ACETICLASTIC METHANOGENESIS; ANAEROBIC-DIGESTION PROCESS; ACETYL-COA SYNTHETASE; CITRIC-ACID CYCLE; THERMACETOGENIUM-PHAEUM; SP NOV.; CLOSTRIDIUM ULTUNENSE; ENERGY-CONSERVATION; PYROCOCCUS-FURIOSUS	Syntrophaceticus schinkii is a mesophilic, anaerobic bacterium capable of oxidising acetate to CO2 and H-2 in intimate association with a methanogenic partner, a syntrophic relationship which operates close to the energetic limits of microbial life. Syntrophaceticus schinkii has been identified as a key organism in engineered methane-producing processes relying on syntrophic acetate oxidation as the main methane-producing pathway. However, due to strict cultivation requirements and difficulties in reconstituting the thermodynamically unfavourable acetate oxidation, the physiology of this functional group is poorly understood. Genome-guided and whole transcriptome analyses performed in the present study provide new insights into habitat adaptation, syntrophic acetate oxidation and energy conservation. The working draft genome of Syntrophaceticus schinkii indicates limited metabolic capacities, with lack of organic nutrient uptake systems, chemotactic machineries, carbon catabolite repression and incomplete biosynthesis pathways. Ech hydrogenase, [ FeFe] hydrogenases, [ NiFe] hydrogenases, F1F0-ATP synthase and membrane-bound and cytoplasmic formate dehydrogenases were found clearly expressed, whereas Rnf and a predicted oxidoreductase/heterodisulphide reductase complex, both found encoded in the genome, were not expressed under syntrophic growth condition. A transporter sharing similarities to the high-affinity acetate transporters of aceticlastic methanogens was also found expressed, suggesting that Syntrophaceticus schinkii can potentially compete with methanogens for acetate. Acetate oxidation seems to proceed via the Wood-Ljungdahl pathway as all genes involved in this pathway were highly expressed. This study shows that Syntrophaceticus schinkii is a highly specialised, habitat-adapted organism relying on syntrophic acetate oxidation rather than metabolic versatility. By expanding its complement of respiratory complexes, it might overcome limiting bioenergetic barriers, and drive efficient energy conservation from reactions operating close to the thermodynamic equilibrium, which might enable S. schinkii to occupy the same niche as the aceticlastic methanogens. The knowledge gained here will help specify process conditions supporting efficient and robust biogas production and will help identify mechanisms important for the syntrophic lifestyle.	[Manzoor, Shahid] Univ Punjab, Dept Informat Technol, Lahore, Pakistan; [Bongcam-Rudloff, Erik] Swedish Univ Agr Sci, SLU Global Bioinformat Ctr, Dept Anim Breeding & Genet, SE-75007 Uppsala, Sweden; [Schnurer, Anna; Muller, Bettina] Swedish Univ Agr Sci, BioCtr, Dept Microbiol, SE-75007 Uppsala, Sweden	University of Punjab; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Muller, B (corresponding author), Swedish Univ Agr Sci, BioCtr, Dept Microbiol, SE-75007 Uppsala, Sweden.	Bettina.Muller@slu.se	Müller, Bettina/H-3276-2018	Müller, Bettina/0000-0002-0030-7710; Bongcam-Rudloff, Erik/0000-0002-1947-8288; Schnurer, Anna/0000-0003-0038-553X	Higher Education Commission (HEC), Pakistan; Science for Life Laboratory (Uppsala); Swedish Bioinformatics Infrastructure for the Life Sciences (BILS); SGBC bioinformatics platform at SLU and Uppsala MultidisciplinaryCenter for Advanced Computational Science (UPPMAX), Uppsala, Sweden; EU-COST action [BM1006-SeqAhead]; EU FP7 ALLBIO project [289452]; Swedish Energy Agency [P36651-1]; FORMAS [2015-1008]	Higher Education Commission (HEC), Pakistan(Higher Education Commission of Pakistan); Science for Life Laboratory (Uppsala); Swedish Bioinformatics Infrastructure for the Life Sciences (BILS); SGBC bioinformatics platform at SLU and Uppsala MultidisciplinaryCenter for Advanced Computational Science (UPPMAX), Uppsala, Sweden; EU-COST action(European Cooperation in Science and Technology (COST)European Commission); EU FP7 ALLBIO project; Swedish Energy Agency(Swedish Energy AgencyMaterials & Energy Research Center (MERC)); FORMAS(Swedish Research Council Formas)	This work was supported by the Higher Education Commission (HEC), Pakistan. Uppsala Genome Center performed the sequencing, supported by the Science for Life Laboratory (Uppsala), the Swedish Bioinformatics Infrastructure for the Life Sciences (BILS), the SGBC bioinformatics platform at SLU and Uppsala MultidisciplinaryCenter for Advanced Computational Science (UPPMAX), Uppsala, Sweden. The contribution of SM and EB-R was supported by EU-COST action BM1006-SeqAhead. EB-R was also partially supported by EU FP7 ALLBIO project; grant no. 289452, www.allbioinformatics.eu. AS and BM were supported by the Swedish Energy Agency (project no. P36651-1). BM was also supported by FORMAS (project no. 2015-1008). The funders played no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ACETI DJ, 1988, J BIOL CHEM, V263, P15444; AHRING BK, 1993, APPL ENVIRON MICROB, V59, P2538, DOI 10.1128/AEM.59.8.2538-2545.1993; Ahring BK, 2003, ADV BIOCHEM ENG BIOT, V81, P1; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Aukema KG, 2005, J BACTERIOL, V187, P611, DOI 10.1128/JB.187.2.611-618.2005; Balk M, 2002, INT J SYST EVOL MICR, V52, P1361, DOI [10.1099/ijs.0.02165-0, 10.1099/00207713-52-4-1361]; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Benzie, 2013, BIOENERGY PRODUCTION; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Boone David R., 1993, P35; Brasen C, 2008, J BIOL CHEM, V283, P15409, DOI 10.1074/jbc.M710218200; BUSCHHORN H, 1989, APPL ENVIRON MICROB, V55, P1835, DOI 10.1128/AEM.55.7.1835-1840.1989; Caffrey SA, 2007, J BACTERIOL, V189, P6159, DOI 10.1128/JB.00747-07; Chauhan A, 2006, APPL ENVIRON MICROB, V72, P6837, DOI 10.1128/AEM.01030-06; Chen Y, 2008, BIORESOURCE TECHNOL, V99, P4044, DOI 10.1016/j.biortech.2007.01.057; da Silva SM, 2011, J BACTERIOL, V193, P2909, DOI 10.1128/JB.00042-11; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ferry James G., 1993, P304; FOX DK, 1986, J BIOL CHEM, V261, P3487; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Glasemacher J, 1997, EUR J BIOCHEM, V244, P561, DOI 10.1111/j.1432-1033.1997.00561.x; Gray ND, 2011, ENVIRON MICROBIOL, V13, P2957, DOI 10.1111/j.1462-2920.2011.02570.x; Hao LP, 2011, ENVIRON SCI TECHNOL, V45, P508, DOI 10.1021/es102228v; Hattori S, 2000, INT J SYST EVOL MICR, V50, P1601, DOI 10.1099/00207713-50-4-1601; Hattori S, 2005, J BACTERIOL, V187, P3471, DOI 10.1128/JB.187.10.3471-3476.2005; Hattori S, 2001, J BIOSCI BIOENG, V91, P294, DOI 10.1263/jbb.91.294; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; He K, 2014, TRENDS MICROBIOL, V22, P389, DOI 10.1016/j.tim.2014.04.004; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Ho D, 2014, ENVIRON SCI TECHNOL, V48, P6468, DOI 10.1021/es500074j; Hori T, 2011, MICROBIOL-SGM, V157, P1980, DOI 10.1099/mic.0.049189-0; Horn MA, 2003, APPL ENVIRON MICROB, V69, P74, DOI 10.1128/AEM.69.1.74-83.2003; Hosie AHF, 2002, J BACTERIOL, V184, P5436, DOI 10.1128/JB.184.19.5436-5448.2002; JETTEN MSM, 1992, FEMS MICROBIOL LETT, V88, P181, DOI 10.1111/j.1574-6968.1992.tb04987.x; Jolkver E, 2009, J BACTERIOL, V191, P940, DOI 10.1128/JB.01155-08; Jones DM, 2008, NATURE, V451, P176, DOI 10.1038/nature06484; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Kato S, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00575; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Liu FH, 2010, ENVIRON MICROBIOL, V12, P2341, DOI 10.1111/j.1462-2920.2010.02289.x; Malvankar NS, 2012, CHEMSUSCHEM, V5, P1039, DOI 10.1002/cssc.201100733; Manzoor S, 2013, ION TORRENT SEQUENCI, V19, P60, DOI 10.14806/ej.19.A.665; Manzoor S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0092-z; Manzoor SS, 2015, COMPLETE GENOME SEQU, DOI [10.1186/s40793-016-0199-xSIGS-D-16-00013.3, DOI 10.1186/S40793-016-0199-XSIGS-D-16-00013]; Maus I, 2015, J BIOTECHNOL, V201, P43, DOI 10.1016/j.jbiotec.2014.11.020; Mayumi D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2998; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Merz AJ, 2000, NATURE, V407, P98, DOI 10.1038/35024105; Moestedt J, 2015, AMMONIA THRESHOLD IN; MOLLER D, 1987, ARCH MICROBIOL, V148, P202, DOI 10.1007/BF00414812; Morais-Silva FO, 2013, J BACTERIOL, V195, P4753, DOI 10.1128/JB.00411-13; Muller B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121237; Muller B, 2013, MICROBIOLOGYOPEN, V2, P35, DOI 10.1002/mbo3.50; Musfeldt M, 2002, J BACTERIOL, V184, P636, DOI 10.1128/JB.184.3.636-644.2002; Nobu MK, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01064-13; Nobu MK, 2015, ISME J, V9, P1710, DOI 10.1038/ismej.2014.256; Nobu MK, 2015, ENVIRON MICROBIOL, V17, P4861, DOI 10.1111/1462-2920.12444; Oehler D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-723; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; PETERSEN SP, 1991, FEMS MICROBIOL ECOL, V86, P149, DOI 10.1111/j.1574-6968.1991.tb04804.x; Plugge CM, 2009, ARCH MICROBIOL, V191, P55, DOI 10.1007/s00203-008-0428-9; Rajagopal R, 2013, BIORESOURCE TECHNOL, V143, P632, DOI 10.1016/j.biortech.2013.06.030; Rappert S, 2005, WASTE MANAGE, V25, P940, DOI 10.1016/j.wasman.2005.07.015; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Rui JP, 2011, FEMS MICROBIOL ECOL, V77, P264, DOI 10.1111/j.1574-6941.2011.01104.x; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; SCHAUDER R, 1987, ARCH MICROBIOL, V148, P218, DOI 10.1007/BF00414815; Schnurer A, 2008, WATER SCI TECHNOL, V57, P735, DOI 10.2166/wst.2008.097; SCHNURER A, 1994, ARCH MICROBIOL, V162, P70; Schnurer A, 1996, INT J SYST BACTERIOL, V46, P1145, DOI 10.1099/00207713-46-4-1145; Schnurer A, 1999, FEMS MICROBIOL ECOL, V29, P249; Schnurer A, 1997, FEMS MICROBIOL LETT, V154, P331, DOI 10.1016/S0378-1097(97)00350-9; Schuchmann K, 2014, NAT REV MICROBIOL, V12, P809, DOI 10.1038/nrmicro3365; Schuchmann K, 2012, J BIOL CHEM, V287, P31165, DOI 10.1074/jbc.M112.395038; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Shigematsu T, 2004, APPL ENVIRON MICROB, V70, P4048, DOI 10.1128/AEM.70.7.4048-4052.2004; Sieber JR, 2010, ENVIRON MICROBIOL, V12, P2289, DOI 10.1111/j.1462-2920.2010.02237.x; SPROTT GD, 1986, SYST APPL MICROBIOL, V7, P358; Steinhaus B, 2007, APPL ENVIRON MICROB, V73, P1653, DOI 10.1128/AEM.01827-06; Sun L, 2014, J BIOTECHNOL, V171, P39, DOI 10.1016/j.jbiotec.2013.11.016; Thauer RK, 2010, ANNU REV BIOCHEM, V79, P507, DOI 10.1146/annurev.biochem.030508.152103; THIELE JH, 1988, APPL ENVIRON MICROB, V54, P20, DOI 10.1128/AEM.54.1.20-29.1988; Vallenet D, 2006, NUCLEIC ACIDS RES, V34, P53, DOI 10.1093/nar/gkj406; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Wang SN, 2013, J BACTERIOL, V195, P1267, DOI 10.1128/JB.02158-12; Westerholm M., 2012, BIOGAS PRODUCTION SY; Westerholm M, 2012, APPL ENVIRON MICROB, V78, P7619, DOI 10.1128/AEM.01637-12; Westerholm M, 2011, ENV MICROBIOL REP, V3, P500, DOI 10.1111/j.1758-2229.2011.00249.x; Westerholm M, 2011, SYST APPL MICROBIOL, V34, P260, DOI 10.1016/j.syapm.2010.11.018; Westerholm M, 2010, FEMS MICROBIOL LETT, V309, P100, DOI 10.1111/j.1574-6968.2010.02023.x; Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6; Wu CG, 2007, SYST APPL MICROBIOL, V30, P376, DOI 10.1016/j.syapm.2006.12.001; YANG ST, 1987, APPL ENVIRON MICROB, V53, P823, DOI 10.1128/AEM.53.4.823-827.1987; Zhu JX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036756; ZINDER SH, 1984, ARCH MICROBIOL, V138, P263, DOI 10.1007/BF00402133	98	21	21	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166520	10.1371/journal.pone.0166520	http://dx.doi.org/10.1371/journal.pone.0166520			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851830	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300060
J	Baldo, V; Cocchio, S; Gallo, T; Furlan, P; Romor, P; Bertoncello, C; Buja, A; Baldovin, T				Baldo, Vincenzo; Cocchio, Silvia; Gallo, Tolinda; Furlan, Patrizia; Romor, Pierantonio; Bertoncello, Chiara; Buja, Alessandra; Baldovin, Tatjana			Pneumococcal Conjugated Vaccine Reduces the High Mortality for Community-Acquired Pneumonia in the Elderly: an Italian Regional Experience	PLOS ONE			English	Article							LONG-TERM MORTALITY; RISK-FACTORS; HOSPITALIZATION; ETIOLOGY	Background Community-acquired pneumonia (CAP) is an important cause of illness and death worldwide, particularly among the elderly. Previous studies on the factors associated with mortality in patients hospitalized for CAP revealed a direct association between the type of microorganism involved, the characteristics of the patient and mortality. Vaccination status against pneumococcal disease was not considered. We conducted a retrospective analysis on the mortality rates after a first hospitalization for CAP in north-east Italy with a view to examining especially the role of anti-pneumococcal vaccination as a factor associated with pneumonia-related mortality at one year. Method Between 2012-2013, patients aged 65+ hospitalized with a primary diagnosis of CAP, identified based on International Classification of Diseases, Ninth Revision, Clinical Modification codes 481-486, were enrolled in the study only once. Patients were divided into three groups by pneumococcal vaccination status: 1) 13-valent pneumococcal conjugate vaccine (PCV13) prior to their hospitalization; 2) 23-valent pneumococcal polysaccharide vaccine (PPV23) within 5 years before hospitalization and 3) unvaccinated or PPV23 more than 5 years prior to admission. Gender, age, length of hospital stay and influenza vaccination were considered. Comorbidities were ascertained by means of a properly coded diagnosis. Every patient was followed up for 1 year and the outcome investigated was mortality for any cause and for pneumonia. Results A total of 4,030 patient were included in the study; mean age at the time of admission to hospital was 84.3 +/- 7.7; 50.9% were female. 74.2% of subjects had at least one comorbidity; 73.7% has been vaccinated against influenza. Regard to pneumococcal vaccine, 80.4% of patients were not vaccinated, 14.5% vaccinated with PPV23 and 5.1% with PCV13. The 1year survival rates after hospitalization for pneumonia were 83.6%, 85.9% and 89.3% in the unvaccinated, PPV23 and PCV13 groups, respectively. Regression analysis indicated that the risk of death due to pneumonia increased significantly with age (adjusted OR: 1.073; 1.061-1.085), shorter hospital stay (adjusted OR: 0.981; 0.971-0.990), and male gender (adjusted OR: 1.372; 1.165-1.616). The model also confirmed the pneumococcal 13-valent conjugated vaccine as an independent protective factor for mortality-related pneumonia (adjusted OR: 0.599; 0.390-0.921). Conclusion The main finding of our observational cohort study is a high mortality rate among elderly patients admitted to hospital for pneumonia. The present study suggests a protective role for PCV13 vaccination.	[Baldo, Vincenzo; Cocchio, Silvia; Furlan, Patrizia; Bertoncello, Chiara; Buja, Alessandra; Baldovin, Tatjana] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Hyg & Publ Hlth Unit, Padua, Italy; [Gallo, Tolinda; Romor, Pierantonio] EuroHlth Net, Friuli Venezia Giulia Reg Hlth Directorate, Udine, Italy	University of Padua	Baldo, V (corresponding author), Univ Padua, Dept Cardiac Thorac & Vasc Sci, Hyg & Publ Hlth Unit, Padua, Italy.	vincenzo.baldo@unipd.it	Buja, Alessandra/AAN-8141-2020; Vincenzo, Baldo/D-7822-2018; Cocchio, Silvia/Z-2327-2019; Baldo, Vincenzo/V-4005-2019	Buja, Alessandra/0000-0003-2216-3807; Vincenzo, Baldo/0000-0001-6012-9453; Baldo, Vincenzo/0000-0001-6012-9453; Bertoncello, Chiara/0000-0003-4040-8601; FURLAN, PATRIZIA/0000-0001-5345-7037; BALDOVIN, TATJANA/0000-0002-7375-9187; Cocchio, Silvia/0000-0003-3801-0901				Adamuz J, 2014, J INFECTION, V68, P534, DOI 10.1016/j.jinf.2014.02.006; [Anonymous], 2012, GAZZETTA UFFICIALE R, V72, P47; Baldo V, 2016, JPMH IN PRESS; Baldo V, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-485; Brito V, 2010, THORAX, V65, P944, DOI 10.1136/thx.2010.138131; Bruns AHW, 2011, CLIN MICROBIOL INFEC, V17, P763, DOI 10.1111/j.1469-0691.2010.03296.x; Cangemi R, 2015, AM J CARDIOL, V116, P647, DOI 10.1016/j.amjcard.2015.05.028; Cavallazzi R, 2015, RESP MED, V109, P743, DOI 10.1016/j.rmed.2015.04.007; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Eurich DT, 2015, AM J RESP CRIT CARE, V192, P597, DOI 10.1164/rccm.201501-0140OC; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Griffin MR, 2013, NEW ENGL J MED, V369, P155, DOI 10.1056/NEJMoa1209165; Hebert PL, 2005, MED CARE RES REV, V62, P560, DOI 10.1177/1077558705279310; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Holter JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148741; Kaplan V, 2003, ARCH INTERN MED, V163, P317, DOI 10.1001/archinte.163.3.317; Khawaja A, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-94; Mangen MJJ, 2015, EUR RESPIR J, V46, P1407, DOI 10.1183/13993003.00325-2015; Millett ERC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008737; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Oosterheert J J, 2004, Ned Tijdschr Geneeskd, V148, P1765; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Stupka John E, 2009, Aging health, V5, P763, DOI 10.2217/ahe.09.74; Tan YK, 1998, EUR RESPIR J, V12, P113, DOI 10.1183/09031936.98.12010113; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; van Hoek AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149540; Vila-Corcoles A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-73; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; WHO Pneumococcal vaccines, 2012, WKLY EPIDEMIOL REC, V87, P129; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yende S, 2013, CHEST, V144, P1008, DOI 10.1378/chest.12-2818; Yu H, 2012, J AM GERIATR SOC, V60, P2137, DOI 10.1111/j.1532-5415.2012.04208.x	32	17	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166637	10.1371/journal.pone.0166637	http://dx.doi.org/10.1371/journal.pone.0166637			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846277	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600096
J	Chermak, E; Donato, R; Lensink, MF; Petta, A; Serra, L; Scarano, V; Cavallo, L; Oliva, R				Chermak, Edrisse; De Donato, Renato; Lensink, Marc F.; Petta, Andrea; Serra, Luigi; Scarano, Vittorio; Cavallo, Luigi; Oliva, Romina			Introducing a Clustering Step in a Consensus Approach for the Scoring of Protein-Protein Docking Models	PLOS ONE			English	Article							BLIND PREDICTIONS; RESIDUE CONTACTS; CAPRI; COMPLEXES; RANKING; PRINCIPLES; INTERFACE; ANALYZE	Correctly scoring protein-protein docking models to single out native-like ones is an open challenge. It is also an object of assessment in CAPRI (Critical Assessment of PRedicted Interactions), the community-wide blind docking experiment. We introduced in the field the first pure consensus method, CONSRANK, which ranks models based on their ability to match the most conserved contacts in the ensemble they belong to. In CAPRI, scorers are asked to evaluate a set of available models and select the top ten ones, based on their own scoring approach. Scorers' performance is ranked based on the number of targets/interfaces for which they could provide at least one correct solution. In such terms, blind testing in CAPRI Round 30 (a joint prediction round with CASP11) has shown that critical cases for CONSRANK are represented by targets showing multiple interfaces or for which only a very small number of correct solutions are available. To address these challenging cases, CONSRANK has now been modified to include a contact-based clustering of the models as a preliminary step of the scoring process. We used an agglomerative hierarchical clustering based on the number of common inter-residue contacts within the models. Two criteria, with different thresholds, were explored in the cluster generation, setting either the number of common contacts or of total clusters. For each clustering approach, after selecting the top (most populated) ten clusters, CONSRANK was run on these clusters and the top-ranked model for each cluster was selected, in the limit of 10 models per target. We have applied our modified scoring approach, Clust-CONSRANK, to SCORE_SET, a set of CAPRI scoring models made recently available by CAPRI assessors, and to the subset of homodimeric targets in CAPRI Round 30 for which CONSRANK failed to include a correct solution within the ten selected models. Results show that, for the challenging cases, the clustering step typically enriches the ten top ranked models in native-like solutions. The best performing clustering approaches we tested indeed lead to more than double the number of cases for which at least one correct solution can be included within the top ten ranked models.	[Chermak, Edrisse; De Donato, Renato; Cavallo, Luigi] King Abdullah Univ Sci & Technol, Kaust Catalysis Ctr, Thuwal 239556900, Saudi Arabia; [De Donato, Renato; Petta, Andrea; Serra, Luigi; Scarano, Vittorio] Univ Salerno, Dipartimento Informat& Applicaz, Via Giovanni Paolo II 132, I-84084 Fisciano, SA, Italy; [Lensink, Marc F.] Univ Lille, CNRS, UGSF, UMR8576, F-59000 Lille, France; [Oliva, Romina] Univ Parthenope Naples, Ctr Direz Isola C4, Dept Sci & Technol, I-80143 Naples, Italy	King Abdullah University of Science & Technology; University of Salerno; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Parthenope University Naples	Oliva, R (corresponding author), Univ Parthenope Naples, Ctr Direz Isola C4, Dept Sci & Technol, I-80143 Naples, Italy.	romina.oliva@uniparthenope.it	Oliva, Romina/ABA-6313-2021; Cavallo, Luigi/D-5215-2019; Lensink, Marc F/A-1678-2008; Scarano, Vittorio/B-1353-2010	Oliva, Romina/0000-0002-6156-6249; Cavallo, Luigi/0000-0002-1398-338X; Lensink, Marc F/0000-0003-3957-9470; Scarano, Vittorio/0000-0001-8437-5253	Regione Campania [LR5-AF2008]; Finanziamento peril sostegno della ricerca individuale di Ateneo University Parthenope; King Abdullah University of Science and Technology	Regione Campania(Regione Campania); Finanziamento peril sostegno della ricerca individuale di Ateneo University Parthenope; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	RO has been supported by Regione Campania (LR5-AF2008) and by "Finanziamento peril sostegno della ricerca individuale di Ateneo" 2015-Universita Parthenope. LC thanks the King Abdullah University of Science and Technology for supporting this research.; RO has been supported by Regione Campania (LR5-AF2008) and by "Finanziamento per it sostegno della ricerca individuale di Ateneo" 2015-University Parthenope. LC thanks the King Abdullah University of Science and Technology for supporting this research.	Abdel-Azeim S, 2014, BIOCHEMISTRY-US, V53, P6992, DOI 10.1021/bi500770p; Abdel-Azeim S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S5-S1; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; Aloy P, 2006, NAT REV MOL CELL BIO, V7, P188, DOI 10.1038/nrm1859; Calvanese L, 2016, J STRUCT BIOL; Chermak E, 2015, BIOINFORMATICS, V31, P1481, DOI 10.1093/bioinformatics/btu837; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Huang SY, 2015, DRUG DISCOV TODAY, V20, P969, DOI 10.1016/j.drudis.2015.03.007; Huang SY, 2014, DRUG DISCOV TODAY, V19, P1081, DOI 10.1016/j.drudis.2014.02.005; Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381; Jones E., 2001, SCIPY OPEN SOURCE SC; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lancellotti S, 2016, THROMB HAEMOSTASIS, V115, P51, DOI 10.1160/TH15-02-0119; Lensink MF, 2016, PROTEINS, V84, P323, DOI 10.1002/prot.25007; Lensink MF, 2014, PROTEINS, V82, P3163, DOI 10.1002/prot.24678; Lensink MF, 2013, PROTEINS, V81, P2082, DOI 10.1002/prot.24428; Lensink MF, 2010, PROTEINS, V78, P3085, DOI 10.1002/prot.22850; Lensink MF, 2010, PROTEINS, V78, P3073, DOI 10.1002/prot.22818; Mendez R, 2005, PROTEINS, V60, P150, DOI 10.1002/prot.20551; Mendez R, 2003, PROTEINS, V52, P51, DOI 10.1002/prot.10393; Moal IH, 2013, CURR OPIN STRUC BIOL, V23, P862, DOI 10.1016/j.sbi.2013.06.017; Moal IH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-286; Mullner D, 2013, J STAT SOFTW, V53, P1; Nooren IMA, 2003, EMBO J, V22, P3486, DOI 10.1093/emboj/cdg359; Oliva R, 2015, MOLECULES, V20, P12045, DOI 10.3390/molecules200712045; Oliva R, 2013, PROTEINS, V81, P1571, DOI 10.1002/prot.24314; Rodrigues JPGLM, 2012, PROTEINS, V80, P1810, DOI 10.1002/prot.24078; Vakser IA, 2014, BIOPHYS J, V107, P1785, DOI 10.1016/j.bpj.2014.08.033; Vangone A, 2013, PROTEINS, P2095, DOI [10.1002/prot.24428, DOI 10.1002/PROT.24428]; Vangone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102839; Vangone A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S19; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; WL D, 2002, PYMOL MOL GRAPHICS S	35	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166460	10.1371/journal.pone.0166460	http://dx.doi.org/10.1371/journal.pone.0166460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846259	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600066
J	Kaale, E; Manyanga, V; Chambuso, M; Liana, J; Rutta, E; Embrey, M; Layloff, T; Johnson, K				Kaale, Eliangiringa; Manyanga, Vicky; Chambuso, Mhina; Liana, Jafary; Rutta, Edmund; Embrey, Martha; Layloff, Thomas; Johnson, Keith			The Quality of Selected Essential Medicines Sold in Accredited Drug Dispensing Outlets and Pharmacies in Tanzania	PLOS ONE			English	Article							TROPICAL CONDITIONS; CHEMICAL-STABILITY; ERGOMETRINE; INSTABILITY; COUNTRIES; INJECTION; TABLETS	Introduction The purpose of this study was to investigate the quality of a select group of medicines sold in accredited drug dispensing outlets (ADDOs) and pharmacies in different regions of Tanzania as part of an in-depth cross-sectional assessment of community access to medicines and community use of medicines. Methods We collected 242 samples of amoxicillin trihydrate, artemether-lumefantrine (ALu), co-trimoxazole, ergometrine maleate, paracetamol, and quinine from selected ADDOs and pharmacies in Mbeya, Morogoro, Singida, and Tanga regions. The analysis included physical examination and testing with validated analytical techniques. Assays for eight of nine products were conducted using high-performance thin-layer chromatography (HPTLC). For ALu tablets, we used a two-tiered approach, where tier 1 was a semi-quantitative Global Pharma Health Fund-Minilab (R) method and tier 2 was high-performance liquid chromatography (HPLC) as described in The International Pharmacopoeia's monograph for artemether-lumefantrine. Results and Discussion The physical examination of samples revealed no defects in the solid and oral liquid dosage forms, but unusual discoloration in an injectable solution, ergometrine maleate. For ALu, the results showed that of 38 samples, 31 (81.6%) passed tier 1 testing and 7 (18.4%) gave inconclusive drug content results. The inconclusive ALu samples were submitted for tier 2 testing and all met the quality standards. The pass rate using the HPTLC and TLC/HPLC assays was 93.8%; the failures were the ergometrine maleate samples purchased from both ADDOs and pharmacies. The disintegration testing of the solid dosage forms was conducted in accordance with US Pharmacopeia monographs. Only two samples of paracetamol, 1.2% of the solid dosage forms, failed to comply to standards. The study revealed a high overall rate of 92.6% of samples that met the quality standards. Although the overall failure rate was 7.4%, it is important to note that this was largely limited to one product and likely due to poor distribution and storage rather than poor manufacturing practices. Conclusions Over 90% of the medicines sold in ADDOs and pharmacies met quality standards. Policy makers need to reconsider ergometrine maleate's place on the list of medicines that ADDOs are allowed to dispense, by either substituting a more temperature-stable therapeutically equivalent product or requiring those sites to have refrigerators, which is not a feasible option for rural Tanzania.	[Kaale, Eliangiringa; Manyanga, Vicky; Chambuso, Mhina] Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania; [Liana, Jafary] Pharmaceut & Hlth Technol Grp, Management Sci Hlth, Dar Es Salaam, Tanzania; [Rutta, Edmund; Embrey, Martha; Layloff, Thomas; Johnson, Keith] Pharmaceut & Hlth Technol Grp, Management Sci Hlth, Arlington, VA USA	Muhimbili University of Health & Allied Sciences	Kaale, E (corresponding author), Muhimbili Univ Hlth & Allied Sci, Sch Pharm, Dar Es Salaam, Tanzania.	Elia.kaale@muha.ac.tz	Kaale, Eliangiringa/AAC-8561-2019	Kaale, Eliangiringa/0000-0001-6008-3539	Bill & Melinda Gates Foundation [0PP1017439]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study on which this manuscript is based was funded by the Bill & Melinda Gates Foundation through a grant to Management Sciences for Health (MSH) (URL: http://www.msh.org/), #0PP1017439, that, in turn, subcontracted with MUHAS (#SDSI-2012- 17). MSH employees, Dr. Edmund Rutta, Mr. Keith Johnson, Dr. Suleiman Kimatta, and Mr. Jafary Liana were involved as technical advisors in the design of the study and provided logistics support during data collection and advice during data analysis. The Gates Foundation had no input into the study design, data collection, analysis or the preparation of the manuscript. MSH provided MUHAS unrestricted access to the data.	Al-Abdulla I, 2013, TOXICON, V64, P38, DOI 10.1016/j.toxicon.2012.12.022; Almuzaini T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002923; [Anonymous], 2012, INT PHARM; ASKER AF, 1990, DRUG DEV IND PHARM, V16, P165, DOI 10.3109/03639049009115993; Bate R, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-33; Batty KT, 1996, J PHARM PHARMACOL, V48, P22, DOI 10.1111/j.2042-7158.1996.tb05870.x; DEGROOT ANJA, 1995, J CLIN PHARM THER, V20, P115; Eu/ACP/WHO Renewed Paetnership, 2016, WHOEMPPAU201607 EUAC; HOGERZEIL HV, 1994, BRIT MED J, V308, P59; Hogerzeil HV, 1996, EUR J OBSTET GYN R B, V69, P25, DOI 10.1016/0301-2115(95)02530-8; HOGERZEIL HV, 1991, LANCET, V338, P754, DOI 10.1016/0140-6736(91)91470-F; HOGERZEIL HV, 1994, TROP DOCT, V24, P112, DOI 10.1177/004947559402400305; Jahnke RWO, 2001, DRUG INF J, V35, P941; Jansen FH, 2007, CURR MED CHEM, V14, P3243, DOI 10.2174/092986707782793844; Herrera ASM, 2009, TOXICON, V53, P609, DOI 10.1016/j.toxicon.2009.01.012; Nayyar GML, 2012, LANCET INFECT DIS, V12, P488, DOI 10.1016/S1473-3099(12)70064-6; Risha PG, 2003, EUR J CLIN PHARMACOL, V59, P135, DOI 10.1007/s00228-003-0587-1; Rutta E, 2014, INT J TUBERC LUNG D, V18, P1108, DOI 10.5588/ijtld.14.0020; Rutta Edmund, 2015, J Pharm Policy Pract, V8, P23, DOI 10.1186/s40545-015-0044-4; Rutta E, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-22; WALKER GJA, 1988, LANCET, V2, P393; Zahn M, 2006, J PHARM SCI-US, V95, P946, DOI 10.1002/jps.20584	22	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165785	10.1371/journal.pone.0165785	http://dx.doi.org/10.1371/journal.pone.0165785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846216	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600019
J	Shaharir, SS; Hussein, H; Rajalingham, S; Said, MSM; Gafor, AHA; Mohd, R; Mustafar, R				Shaharir, Syahrul Sazliyana; Hussein, Heselynn; Rajalingham, Sakthiswary; Said, Mohd Shahrir Mohamed; Gafor, Abdul Halim Abdul; Mohd, Rozita; Mustafar, Ruslinda			Damage in the Multiethnic Malaysian Systemic Lupus Erythematosus (SLE) Cohort: Comparison with Other Cohorts Worldwide	PLOS ONE			English	Article							COLLABORATING-CLINICS/AMERICAN-COLLEGE; ORGAN DAMAGE; INCEPTION COHORT; DISEASE EXPRESSION; ETHNIC-GROUPS; ASSOCIATION; PREDICTORS; SURVIVAL; INDEX; HYDROXYCHLOROQUINE	Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease and despite the improvement in the survival in the past few decades, the morbidity due to disease damage remains significant. The objectives of this study were to investigate the disease damagepattern and determine the associated factors of damage in the multi-ethnic Malaysian SLE patients. We consecutively 424SLE patients who attended a consistent follow-up at the National University of Malaysia Medical Centre and Putrajaya Hospital were recruited. Disease damage was assessed using the SLICC/ACR (Systemic Lupus International Collaborating Clinics/American College of Rheumatology) Damage Index (SDI) scores. Information on their demographics and disease characteristicswere obtained from the clinical record. Univariate analysis was performed and the best model of independent predictors of disease damage was determined by multivariate logistic regression analysis. A total of 182 patients (42.9%) had disease damage (SDI >= 1). A significantly higher number of Indian patients had disease/organ damage and they predominantly developed steroid-induced diabetes mellitus (SDM). Patients with corticosteroid-induced osteoporosis (CIOP) were more likely to be Malayswhile majority of patients who developed malignancy were Chinese (p< 0.05). In the univariate and multivariate analyses, disease damage was significantly associated with age, Indian ethnicity, lower mean cumulative C3 level, neuropsychiatry lupus (NPSLE), and antiphospholipid syndrome (APLS). Patients who had ever and early treatment with hydroxychloroquine( HCQ) were less likely to develop disease damage while more patients who had received oral prednisolone >= 1mg/kg daily over 2 weeks had disease damage (p< 0.05). In conclusion, there were inter-ethnic differences in the damage pattern and risks among SLE patients.	[Shaharir, Syahrul Sazliyana; Hussein, Heselynn; Rajalingham, Sakthiswary; Said, Mohd Shahrir Mohamed; Gafor, Abdul Halim Abdul; Mohd, Rozita; Mustafar, Ruslinda] Pusat Perubatan Univ Kebangsaan Malaysia UKMMC, Dept Internal Med, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia; [Hussein, Heselynn] Putrajaya Hosp, Dept Med, Jalan P9,Presint 7, Putrajaya 62250, Malaysia		Shaharir, SS (corresponding author), Pusat Perubatan Univ Kebangsaan Malaysia UKMMC, Dept Internal Med, Jalan Yaacob Latiff, Kuala Lumpur 56000, Malaysia.	ssazliona@gmail.com	Said, Mohd Shahrir Mohamed/AAR-2680-2020; Gafor, Abdul Halim Abdul/L-4405-2017; Sakthiswary, Rajalingham/E-8565-2017	Gafor, Abdul Halim Abdul/0000-0003-3950-2844; 				Akhavan PS, 2013, J RHEUMATOL, V40, P831, DOI 10.3899/jrheum.120572; Alarcon GS, 2011, REUMATOL CLIN, V7, P3, DOI 10.1016/j.reuma.2010.11.001; Alarcon GS, 2001, ARTHRITIS RHEUM, V44, P2797, DOI 10.1002/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO;2-9; [Anonymous], 2016, CURRENTPOPULATION ES; Bernatsky S, 2005, J RHEUMATOL, V32, P820; Bruce IN, 2015, ANN RHEUM DIS, V74, P1706, DOI 10.1136/annrheumdis-2013-205171; Chambers SA, 2009, RHEUMATOLOGY, V48, P673, DOI 10.1093/rheumatology/kep062; Conti F, 2016, LUPUS, V25, P719, DOI 10.1177/0961203315627199; Cooper GS, 2007, ARTHRIT RHEUM-ARTHR, V57, P993, DOI 10.1002/art.22894; del Toro ME, 2010, REUMATOL CLIN, V6, P11, DOI 10.1016/j.reuma.2009.04.007; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2000, J RHEUMATOL, V27, P373; Gladman DD, 2003, J RHEUMATOL, V30, P1955; Golder V, 2013, LUPUS, V22, P1425, DOI 10.1177/0961203313500547; Goncalves MJ, 2015, LUPUS, V24, P256, DOI 10.1177/0961203314555172; Hiramatsu N, 2008, RHEUMATOLOGY, V47, P702, DOI 10.1093/rheumatology/ken019; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jasmin R, 2013, LUPUS, V22, P967, DOI 10.1177/0961203313496299; Jonsen A, 2002, RHEUMATOLOGY, V41, P1308, DOI 10.1093/rheumatology/41.11.1308; Kasitanon N, 2006, MEDICINE, V85, P147, DOI 10.1097/01.md.0000224709.70133.f7; Letchuman G R, 2010, Med J Malaysia, V65, P180; Mok CC, 2013, ANN RHEUM DIS, V71, P545, DOI 10.1136/annrheumdis-2012-eular.3163; Mok CC, 2009, SCAND J RHEUMATOL, V38, P121, DOI 10.1080/03009740802415527; Mok CC, 2003, J RHEUMATOL, V30, P1513; Molad Y, 2002, LUPUS, V11, P356, DOI 10.1191/0961203302lu203ra; Nazaimoon WMW, 2013, DIABETIC MED, V30, P825, DOI 10.1111/dme.12161; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P4021, DOI 10.1002/art.34672; Pons-Estel BA, 2004, MEDICINE, V83, P1, DOI 10.1097/01.md.0000104742.42401.e2; Rabbani MA, 2009, LUPUS, V18, P848, DOI 10.1177/0961203309103410; Ramachandran A, 2001, DIABETOLOGIA, V44, P1094, DOI 10.1007/s001250100627; Rivest C, 2000, J RHEUMATOL, V27, P680; Ruiz-Irastorza G, 2004, ARCH INTERN MED, V164, P77, DOI 10.1001/archinte.164.1.77; Shaharir SS, 2014, LUPUS, V23, P436, DOI 10.1177/0961203313518624; Shaharir SS, 2015, INT J RHEUM DIS, V18, P541, DOI 10.1111/1756-185X.12474; Shahrir M, 2008, INT J RHEUM DIS, V11, P287, DOI 10.1111/j.1756-185X.2008.00379.x; Sung YK, 2007, J RHEUMATOL, V34, P987; Tan VMH, 2015, BRIT J NUTR, V113, P1228, DOI 10.1017/S0007114515000586; Thumboo J, 2000, LUPUS, V9, P702, DOI 10.1191/096120300666529212; Thumboo J., 2006, APLAR J RHEUMATOL, V9, P320, DOI DOI 10.1111/J.1479-8077.2006.00235.X; Toloza SMA, 2004, ARTHRITIS RHEUM-US, V50, P3177, DOI 10.1002/art.20578; Wang F, 1997, LUPUS, V6, P248, DOI 10.1177/096120339700600306; Yee CS, 2015, RHEUMATOLOGY, V54, P836, DOI 10.1093/rheumatology/keu412; Zonana-Nacach A, 1998, LUPUS, V7, P119, DOI 10.1191/096120398678919831; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	44	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166270	10.1371/journal.pone.0166270	http://dx.doi.org/10.1371/journal.pone.0166270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846298	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600045
J	Simmons, KM; Alkanani, AK; McDaniel, KA; Goyne, C; Miao, DM; Zhao, ZY; Yu, LP; Michels, AW				Simmons, Kimber M.; Alkanani, Aimon K.; McDaniel, Kristen A.; Goyne, Christopher; Miao, Dongmei; Zhao, Zhiyuan; Yu, Liping; Michels, Aaron W.			Islet Autoantibody Measurements from Dried Blood Spots on Filter Paper Strongly Correlate to Serum Levels	PLOS ONE			English	Article							RISK; INSULIN; PROGRESSION; APPEARANCE; CHILDREN; PREDICTION; ANTIBODIES; ASSAYS; AGE	Type 1 diabetes (T1D) is increasing in incidence and predictable with measurement of serum islet autoantibodies (iAb) years prior to clinical disease onset. Identifying iAb positive individuals reduces diabetic ketoacidosis and identifies individuals for T1D prevention trials. However, large scale screening for iAb remains challenging as assays have varying sensitivities and specificities, insulin autoantibodies remain difficult to measure and venipuncture is generally required to obtain serum. We developed an approach to reliably measure all four major iAb, including insulin autoantibodies, from dried blood spots (DBS) on filter-paper. By spiking iAb positive serum into iAb negative whole blood in a dose titration, we optimized the conditions for autoantibody elution from filter paper as measured by fluid phase radioimmunoassays. After assessing stability of measuring iAb from DBS over time, we then screened iAb from DBS and the corresponding serum in new-onset T1D (n = 52), and controls (n = 72) which included first-degree relatives of T1D patients. iAb measured from eluted DBS in new-onset T1D strongly correlated with serum measurements (R-2 = 0.96 for mIAA, GADA = 0.94, IA-2A = 0.85, ZnT8A = 0.82, p<0.01 for each autoantibody). There were no false positives in control subjects, and 5/6 with previously unknown iAb positivity in sera were detected using DBS. With further validation, measuring iAb from DBS can be a reliable method to screen for T1D risk.	[Simmons, Kimber M.; Alkanani, Aimon K.; McDaniel, Kristen A.; Miao, Dongmei; Zhao, Zhiyuan; Yu, Liping; Michels, Aaron W.] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Goyne, Christopher] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Indiana University System; Indiana University Bloomington	Simmons, KM (corresponding author), Univ Colorado, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA.	kimber.simmons@childrenscolorado.org			National Institute of Diabetes and Digestive Kidney Diseases [K08 DK095995]; Juvenile Diabetes Research Foundation [2-SRA-2016-202-S-B]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK095995] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive Kidney Diseases (K08 DK095995) and Juvenile Diabetes Research Foundation (2-SRA-2016-202-S-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Bazzigaluppi E, 1999, DIABETES CARE, V22, P275, DOI 10.2337/diacare.22.2.275; Bingley PJ, 2015, DIABETES TECHNOL THE, V17, P867, DOI 10.1089/dia.2015.0133; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Bonifacio E, 2010, J CLIN ENDOCR METAB, V95, P3360, DOI 10.1210/jc.2010-0293; Cameron FJ, 2014, DIABETES CARE, V37, P1554, DOI 10.2337/dc13-1904; DEAN BM, 1986, DIABETOLOGIA, V29, P339, DOI 10.1007/BF00452073; Demirev PA, 2013, ANAL CHEM, V85, P779, DOI 10.1021/ac303205m; GUTHRIE R, 1963, PEDIATRICS, V32, P338; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; Kupila A, 2001, DIABETOLOGIA, V44, P290, DOI 10.1007/s001250051616; Larsson HE, 2011, DIABETES CARE, V34, P2347, DOI 10.2337/dc11-1026; Lin A, 2015, DIABETES CARE, V38, P236, DOI 10.2337/dc14-1385; Rewers A, 2015, JAMA-J AM MED ASSOC, V313, P1570, DOI 10.1001/jama.2015.1414; Schlosser M, 2010, DIABETOLOGIA, V53, P2611, DOI 10.1007/s00125-010-1915-5; Semenkovich K, 2016, PEDIATR DIABETES, V17, P492, DOI 10.1111/pedi.12314; Simell S, 2010, DIABETES CARE, V33, P774, DOI 10.2337/dc09-1217; Siraj ES, 2012, HORM METAB RES, V44, P855, DOI 10.1055/s-0032-1316349; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Steck AK, 2015, DIABETES CARE, V38, P808, DOI 10.2337/dc14-2426; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; Triolo TM, 2009, DIABETES CARE, V32, P769, DOI 10.2337/dc08-1872; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Winkler C, 2012, PEDIATR DIABETES, V13, P301, DOI 10.1111/j.1399-5448.2011.00829.x; Yu LP, 2000, P NATL ACAD SCI USA, V97, P1701, DOI 10.1073/pnas.040556697; Ziegler AG, 1999, DIABETES, V48, P460, DOI 10.2337/diabetes.48.3.460; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; 2002, THE NEW ENGLAND JOUR, V346, P1685, DOI DOI 10.1056/NEJMOA012350	31	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166213	10.1371/journal.pone.0166213	http://dx.doi.org/10.1371/journal.pone.0166213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846247	Green Published, gold			2022-12-26	WOS:000387794600039
J	Xu, MP; Yu, HY; Chen, YY; Xu, JL; Zheng, JW; Yu, XP				Xu, Meiping; Yu, Huanyun; Chen, Yuanyuan; Xu, Jinling; Zheng, Jingwei; Yu, Xinping			Long-Term Quality of Life in Adult Patients with Strabismus after Corrective Surgery Compared to the General Population	PLOS ONE			English	Article							PSYCHOSOCIAL-ASPECTS; INTERMITTENT EXOTROPIA; AS-20 SCORE; EMPLOYMENT; CHILDREN; VISION; IMPACT	Purpose To evaluate the status of and factors associated with long-term health-related quality of life (HROOL) in adult patients with strabismus following corrective surgery. Methods Prospective cross-sectional study. A total of 122 adults who underwent corrective surgery and were followed up for at least 1 year were recruited. Pre- and post-operative HRQOL were evaluated using the Chinese version of the Adult Strabismus 20 (AS-20). Demographics and clinical characteristics were recorded. Eighty-nine age-matched, normal individuals without a history of strabismus were recruited as a control group. Results AS-20 scores improved significantly in the psychosocial subscale and total scale after surgery for a11122 patients, but not in the function subscale. HRQOL was better in the successful cases than in the non-successful cases (p<0.005). Subjects who recovered stereo function had better HRQOL than those who did not (p<0.01). Compared to the control population, the patients had poorer HRQOL post-operatively, with only approximately 30% of the subjects having scores within the normal threshold scores. The self-sense of a lack of ocular deviation and a successful surgical outcome were significant factors associated with postoperative HRQOL status. Conclusions HROOL, as evaluated by AS-20 scores, improved in the patients after surgery but was worse than that in the general population. Successful surgical outcomes and a sense of good alignment were the main factors that correlated with increased post-operative HROOL. Positive assessments of surgical results by patients may benefit post-operative HROOL.	[Xu, Meiping; Yu, Huanyun; Chen, Yuanyuan; Xu, Jinling; Zheng, Jingwei; Yu, Xinping] Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University	Yu, XP (corresponding author), Wenzhou Med Univ, Hosp Eye, Wenzhou, Zhejiang, Peoples R China.	yu-xinping@163.com	Chen, Yuanyuan/GXG-2130-2022					Alpak G, 2014, BRIT J OPHTHALMOL, V98, P876, DOI 10.1136/bjophthalmol-2014-304888; Beauchamp CL, 2006, J AAPOS, V10, P394, DOI 10.1016/j.jaapos.2006.06.004; Beauchamp GR, 2005, J AAPOS, V9, P141, DOI 10.1016/j.jaapos.2004.11.015; Burke JP, 1997, J PEDIAT OPHTH STRAB, V34, P159; Coats DK, 2000, OPHTHALMOLOGY, V107, P402, DOI 10.1016/S0161-6420(99)00035-4; Dickmann A, 2013, J AAPOS, V17, P25, DOI 10.1016/j.jaapos.2012.09.017; Durnian JM, 2010, J AAPOS, V14, P469, DOI 10.1016/j.jaapos.2010.08.013; Durnian JM, 2009, J AAPOS, V13, P477, DOI 10.1016/j.jaapos.2009.06.006; Eustis S, 1987, J Pediatr Ophthalmol Strabismus, V24, P232; Fujiike K, 2011, JPN J OPHTHALMOL, V55, P268, DOI 10.1007/s10384-011-0022-6; Glasman P, 2013, EYE, V27, P1249, DOI 10.1038/eye.2013.174; Granet DB, 2011, BRIT J OPHTHALMOL, V95, P443, DOI 10.1136/bjo.2010.188326; Hatt SR, 2008, ARCH OPHTHALMOL-CHIC, V126, P1525, DOI 10.1001/archopht.126.11.1525; Hatt SR, 2007, AM J OPHTHALMOL, V144, P643, DOI 10.1016/j.ajo.2007.06.032; Hatt SR, 2014, OPHTHALMOLOGY, V121, P2070, DOI 10.1016/j.ophtha.2014.04.031; Hatt SR, 2012, OPHTHALMOLOGY, V119, P1930, DOI 10.1016/j.ophtha.2012.02.035; Hatt SR, 2012, AM J OPHTHALMOL, V153, P614, DOI 10.1016/j.ajo.2011.10.001; Hatt SR, 2010, OPHTHALMOLOGY, V117, P2322, DOI 10.1016/j.ophtha.2010.03.042; Hatt SR, 2010, OPHTHALMOLOGY, V117, P163, DOI 10.1016/j.ophtha.2009.06.038; Hatt SR, 2009, AM J OPHTHALMOL, V148, P558, DOI 10.1016/j.ajo.2009.05.009; Hatt SR, 2009, OPHTHALMOLOGY, V116, P139, DOI 10.1016/j.ophtha.2008.08.043; Jackson S, 2006, BRIT J OPHTHALMOL, V90, P883, DOI 10.1136/bjo.2005.089516; Jackson S, 2013, BRIT J OPHTHALMOL, V97, P419, DOI 10.1136/bjophthalmol-2012-302983; Keech R V, 1987, J Pediatr Ophthalmol Strabismus, V24, P97; Koc F, 2013, BRIT J OPHTHALMOL, V97, P1425, DOI 10.1136/bjophthalmol-2013-303704; Leske DA, 2010, AM J OPHTHALMOL, V149, P672, DOI 10.1016/j.ajo.2009.11.004; McBain HB, 2014, BRIT J OPHTHALMOL, V98, P550, DOI 10.1136/bjophthalmol-2013-304220; McBain HB, 2014, SURV OPHTHALMOL, V59, P185, DOI 10.1016/j.survophthal.2013.04.001; McKenzie JA, 2009, ARCH OPHTHALMOL-CHIC, V127, P743, DOI 10.1001/archophthalmol.2009.68; Menon V, 2002, J PEDIAT OPHTH STRAB, V39, P203, DOI 10.3928/0191-3913-20020701-07; Mojon-Azzi SM, 2009, ACTA OPHTHALMOL, V87, P784, DOI 10.1111/j.1755-3768.2008.01352.x; Mojon-Azzi SM, 2011, BRIT J OPHTHALMOL, V95, P473, DOI 10.1136/bjo.2010.185793; SATTERFIELD D, 1993, ARCH OPHTHALMOL-CHIC, V111, P1100, DOI 10.1001/archopht.1993.01090080096024; Tandon AK, 2014, J AAPOS, V18, P423, DOI 10.1016/j.jaapos.2014.05.009; van de Graaf E S, 2004, Strabismus, V12, P181; Xu JL, 2012, J PEDIAT OPHTH STRAB, V49, P170, DOI 10.3928/01913913-20110920-02; Yu HY, 2013, OPHTHAL EPIDEMIOL, V20, P239, DOI 10.3109/09286586.2013.809771	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166418	10.1371/journal.pone.0166418	http://dx.doi.org/10.1371/journal.pone.0166418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846304	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600060
J	Yeh, WC; Jiang, YZ; Chen, YF; Chen, Z				Yeh, Wei-Chang; Jiang, Yunzhi; Chen, Yee-Fen; Chen, Zhe			A New Soft Computing Method for K-Harmonic Means Clustering	PLOS ONE			English	Article							SIMPLIFIED SWARM OPTIMIZATION; SEARCH; ALGORITHM	The K-harmonic means clustering algorithm (KHM) is a new clustering method used to group data such that the sum of the harmonic averages of the distances between each entity and all cluster centroids is minimized. Because it is less sensitive to initialization than K-means (KM), many researchers have recently been attracted to studying KHM. In this study, the proposed iSSO-KHM is based on an improved simplified swarm optimization (iSSO) and integrates a variable neighborhood search (VNS) for KHM clustering. As evidence of the utility of the proposed iSSO-KHM, we present extensive computational results on eight benchmark problems. From the computational results, the comparison appears to support the superiority of the proposed iSSO-KHM over previously developed algorithms for all experiments in the literature.	[Yeh, Wei-Chang] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Integrat & Collaborat Lab, Hsinchu, Taiwan; [Jiang, Yunzhi] Guangdong Polytech Normal Univ, Sch Automat, Guangzhou, Guangdong, Peoples R China; [Chen, Yee-Fen] Hsiuping Univ Sci & Technol, Dept Ind Engn & Management, Taichung, Taiwan; [Chen, Zhe] Changan Univ, Sch Informat Engn, Xian, Peoples R China	National Tsing Hua University; Guangdong Polytechnic Normal University; Chang'an University	Yeh, WC (corresponding author), Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Integrat & Collaborat Lab, Hsinchu, Taiwan.	yeh@ieee.org	YEH, WEI-CHANG/AAH-4172-2019	YEH, WEI-CHANG/0000-0001-7393-0768	National Science Council of Taiwan, R.O.C. [NSC101-2221- E-007-079- MY3, NSC 102-2221-E-007-086-MY3]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This research was also supported in part by the National Science Council of Taiwan, R.O.C. under grant NSC101-2221- E-007-079- MY3 and NSC 102-2221-E-007-086-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I wish to thank the anonymous editor and the reviewers for their constructive comments and recommendations, which have significantly improved the presentation of this paper. This research was supported in part by the National Science Council of Taiwan, R.O.C. under grant NSC101-2221- E-007-079- MY3 and NSC 102-2221-E-007-086-MY3.	Abshouri Azam Amin, 2012, J COMMUNICATION COMP, V9, P387; Aghdasi T., 2014, INT J MECHATRONICS E, V4, P485; Alguwaizani A, 2011, APPL MATH MODEL, V35, P2688, DOI 10.1016/j.apm.2010.11.032; Anderberg M. R., 1973, CLUSTER ANAL APPL; Ayech MW, 2012, INT C PATT RECOG, P222; Azizipanah-Abarghooee R, 2013, INT J ELEC POWER, V49, P414, DOI 10.1016/j.ijepes.2013.01.013; Chung YY, 2012, APPL SOFT COMPUT, V12, P3014, DOI 10.1016/j.asoc.2012.04.020; Dalli A., EACL 2003; FORGY EW, 1965, BIOMETRICS, V21, P768; Gungor Z, 2008, APPL MATH MODEL, V32, P1115, DOI 10.1016/j.apm.2007.03.011; Gungor Z, 2007, APPL MATH COMPUT, V184, P199, DOI 10.1016/j.amc.2006.05.166; Handl J, 2003, FR ART INT, V104, P204; Huang CL, 2015, RELIAB ENG SYST SAFE, V142, P221, DOI 10.1016/j.ress.2015.06.002; Hung CH, 2013, APPL MATH MODEL, V37, P10123, DOI 10.1016/j.apm.2013.05.052; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jiang H, 2010, EXPERT SYST APPL, V37, P8679, DOI 10.1016/j.eswa.2010.06.061; Lee JH, 2015, APPL MATH COMPUT, V270, P13, DOI 10.1016/j.amc.2015.07.120; Mirkin B., 2005, CLUSTERING DATA MINI; Serapiao ABS, 2016, APPL SOFT COMPUT, V41, P290, DOI 10.1016/j.asoc.2015.12.032; Steinhaus H., 1957, B ACAD POL SCI, V4, P801; Thakare A. D., 2014, INT J COMPUTER APPL, V99, P5; Yang FQ, 2009, EXPERT SYST APPL, V36, P9847, DOI 10.1016/j.eswa.2009.02.003; Yeh W. C., 2008, 972221E007099MY3 NSC; Yeh WC, 2016, NEUROCOMPUTING, V173, P1720, DOI 10.1016/j.neucom.2015.09.045; Yeh WC, 2015, KNOWL-BASED SYST, V82, P60, DOI 10.1016/j.knosys.2015.02.022; Yeh WC, 2014, KNOWL-BASED SYST, V64, P1, DOI 10.1016/j.knosys.2014.03.011; Yeh WC, 2013, IEEE T NEUR NET LEAR, V24, P661, DOI 10.1109/TNNLS.2012.2232678; Yeh WC, 2012, INFORM SCIENCES, V197, P65, DOI 10.1016/j.ins.2012.02.009; Yeh WC, 2012, COMPUT OPER RES, V39, P2168, DOI 10.1016/j.cor.2011.10.027; Yeh WC, 2009, EXPERT SYST APPL, V36, P9192, DOI 10.1016/j.eswa.2008.12.024; Yeh WC, 2009, EXPERT SYST APPL, V36, P8204, DOI 10.1016/j.eswa.2008.10.004; Yin MH, 2011, EXPERT SYST APPL, V38, P9319, DOI 10.1016/j.eswa.2011.01.018; Zhang B., 2000, HPL2000137; Zhang B., 1999, INT WORKSH TEMP SPAT; Zhou ZP, 2015, LECT NOTES COMPUT SC, V9243, P140, DOI 10.1007/978-3-319-23862-3_14	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164754	10.1371/journal.pone.0164754	http://dx.doi.org/10.1371/journal.pone.0164754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846228	Green Published, gold			2022-12-26	WOS:000387794600006
J	Bittencourt, CR; Izar, MCD; Schwerz, VL; Povoa, RMD; Fonseca, HAR; Fonseca, MIH; Bianco, HT; Franca, CN; Ferreira, CED; Fonseca, FAH				de Oliveira Bittencourt, Celia Regina; de Oliveira Izar, Maria Cristina; Schwerz, Valdir Lauro; dos Santos Povoa, Rui Manuel; Rodrigues Fonseca, Henrique Andrade; Helfenstein Fonseca, Marilia Izar; Bianco, Henrique Tria; Franca, Carolina Nunes; dos Santos Ferreira, Carlos Eduardo; Helfenstein Fonseca, Francisco Antonio			Effects of High-Intensity Training of Professional Runners on Myocardial Hypertrophy and Subclinical Atherosclerosis	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; FLOW-MEDIATED DILATION; MALE-ATHLETES HEART; CARDIOVASCULAR-DISEASE; AMERICAN-SOCIETY; BLOOD-PRESSURE; RISK; ECHOCARDIOGRAPHY; CARDIOMYOPATHY; THICKNESS	To evaluate the effects of long-term exposure to high-intensity training among professional runners on cardiac hypertrophy and subclinical atherosclerosis. Prospective study included runners of both sexes (n = 52) and age and gender matched controls (n = 57), without classical cardiovascular risk factors. Ventricular hypertrophy was quantified by echocardiography by linear method and carotid intima-media thickness (cIMT) by 2-D images obtained by ultrasonography. Endothelial function was evaluated by flowmediated dilation (FMD). Steroid hormones were quantified by HPLC followed by LC-MS/MS. Higher left ventricular (LV) mass index was found in male athletes (p< 0.0001 vs. other groups). When adjusted for gender, the degree of left ventricular mass index classified as mildly, moderately or severely abnormal was obtained in 26%, 35%, and 30%, respectively, of female athletes, and in 39%, 14%, and 21%, respectively, of male athletes. Higher ratio of the early (E) to late (A) ventricular filling velocities was found in athletes of both genders. Male athletes presented lower cIMT in the right (p = 0.012 vs. male controls) and left (p< 0.0001 vs. male controls) common carotid arteries, without differences in cIMT between female athletes and controls. FMD results were similar among groups. Higher serum testosterone levels were found in male athletes (p< 0.0001 vs. other groups) and they were correlated with LV mass (r = 0.50, p< 0.0001). The chronic exposure of high-intensity training among professional runners of both genders was associated with increased ventricular mass and adaptive remodeling. Less subclinical atherosclerosis was found in male athletes. Differences in steroid hormones may account in part for these findings.	[de Oliveira Bittencourt, Celia Regina; de Oliveira Izar, Maria Cristina; Schwerz, Valdir Lauro; dos Santos Povoa, Rui Manuel; Rodrigues Fonseca, Henrique Andrade; Helfenstein Fonseca, Marilia Izar; Bianco, Henrique Tria; Franca, Carolina Nunes; dos Santos Ferreira, Carlos Eduardo; Helfenstein Fonseca, Francisco Antonio] Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil; [Franca, Carolina Nunes] Univ Santo Amaro, Sao Paulo, Brazil; [dos Santos Ferreira, Carlos Eduardo] Albert Einstein Israeli Hosp, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Santo Amaro (UNISA); Hospital Israelita Albert Einstein	Fonseca, FAH (corresponding author), Univ Fed Sao Paulo, Div Cardiol, Sao Paulo, Brazil.	fahfonseca@terra.com.br	Izar, Maria/AAG-7499-2020; Fonseca, Henrique A/P-8412-2015; Bianco, Henrique Tria/L-3895-2014; de Oliveira Izar, Maria Cristina/H-6107-2012; França, Carolina Nunes/J-2429-2015	Izar, Maria/0000-0002-5738-2623; Fonseca, Henrique A/0000-0001-8360-8465; Bianco, Henrique Tria/0000-0001-6746-8327; França, Carolina Nunes/0000-0002-4167-4293	Sao Paulo Research Foundation (FAPESP) [2010/50242-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by the The Sao Paulo Research Foundation (FAPESP), grant # 2010/50242-2.; This study was supported by the The Sao Paulo Research Foundation (FAPESP), grant # 2010/50242-2. We thank the Albert Einstein Israeli Hospital for the hormonal analyses.	Achar S, 2010, AM J CARDIOL, V106, P893, DOI 10.1016/j.amjcard.2010.05.013; Augustine JA, 2016, ATHEROSCLEROSIS, V244, P157, DOI 10.1016/j.atherosclerosis.2015.11.011; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; Brandao SA, 2010, AM J HYPERTENS, V23, P208, DOI 10.1038/ajh.2009.214; Caselli S, 2014, AM J CARDIOL, V114, P1383, DOI 10.1016/j.amjcard.2014.07.070; D'Andrea A, 2007, BRIT J SPORT MED, V41, P149, DOI 10.1136/bjsm.2006.030171; da Silva EFR, 2011, AIDS, V25, P1595, DOI 10.1097/QAD.0b013e32834980f4; Green DJ, 2013, MED SCI SPORT EXER, V45, P75, DOI 10.1249/MSS.0b013e318269affe; Grossmann M, 2011, J CLIN ENDOCR METAB, V96, P2341, DOI 10.1210/jc.2011-0118; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hespanhol LC, 2015, SPORTS MED, V45, P1455, DOI 10.1007/s40279-015-0359-y; Howard G, 1993, ARIC INVESTIGATORS S, V24, P1297; Jouffroy R, 2015, AM J CARDIOL, V116, P1284, DOI 10.1016/j.amjcard.2015.07.045; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lauschke J, 2009, CLIN RES CARDIOL, V98, P80, DOI 10.1007/s00392-008-0721-2; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Naylor LH, 2008, SPORTS MED, V38, P69, DOI 10.2165/00007256-200838010-00006; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; Rawlins J, 2009, EUR J ECHOCARDIOGR, V10, P350, DOI 10.1093/ejechocard/jep017; Sato K, 2015, J STEROID BIOCHEM, V145, P200, DOI 10.1016/j.jsbmb.2014.03.009; Scharhag J, 2002, J AM COLL CARDIOL, V40, P1856, DOI 10.1016/S0735-1097(02)02478-6; Shechter M, 2014, AM J CARDIOL, V113, P162, DOI 10.1016/j.amjcard.2013.08.051; Simsek Z, 2013, ECHOCARDIOGR-J CARD, V30, P1202, DOI 10.1111/echo.12263; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Taylor BA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004498; Tzou Wendy S, 2007, Prev Cardiol, V10, P181, DOI 10.1111/j.1520-037X.2007.06450.x; Urhausen A, 1999, SPORTS MED, V28, P237, DOI 10.2165/00007256-199928040-00002; Utomi V, 2014, HEART, V100, P1264, DOI 10.1136/heartjnl-2014-305904; Utomi V, 2013, HEART, V99, P1727, DOI 10.1136/heartjnl-2012-303465; Warren MP, 2001, J ENDOCRINOL, V170, P3, DOI 10.1677/joe.0.1700003; Yang QH, 2015, AM J PREV MED, V48, P58, DOI 10.1016/j.amepre.2014.09.014	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166009	10.1371/journal.pone.0166009	http://dx.doi.org/10.1371/journal.pone.0166009			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835659	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200019
J	Yang, MS; Lee, JY; Kim, J; Kim, GW; Kim, BK; Kim, JY; Park, HW; Cho, SH; Min, KU; Kang, HR				Yang, Min-Suk; Lee, Jin Yong; Kim, Jayeun; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun			Incidence of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Nationwide Population-Based Study Using National Health Insurance Database in Korea	PLOS ONE			English	Article							ERYTHEMA MULTIFORME; EPIDEMIOLOGY; PREVALENCE; FEATURES; DRUGS	Background Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening diseases; however, it is hard to estimate their incidence due to the rarity of these diseases. We evaluated the incidence of SJS and TEN using a nationwide administrative database. Methods We used a national medical insurance review system (Health Insurance Review and Assessment) database which contained the claim data of the entire nation from 2009 to 2013 to estimate the accurate incidence of SJS and TEN in Korea. The diagnostic codes of L511 (SJS) or L512 (TEN) from the International Classification of Diseases-10th revision were used to define the target study population. We also retrospectively followed up a 2011 SJS and TEN cohort for 24 months in order to assess the in-hospital mortality, related complications and total claims cost due to SJS and TEN. Results A total of 1,167 (938 SJS and 229 TEN) cases were newly diagnosed from 2010 to 2013. The age-and sex-standardized annual incidences estimated in this study were 3.96 to 5.03 in SJS and 0.94 to 1.45 in TEN per million. There was no significant change in annual incidence throughout the study periods. When analyzed by 10-year age groups, the annual incidence was the lowest in group 20-29 years and the highest in group 70 for both SJS and TEN. Based on the 2011 cohort analysis, the in-hospital mortality were 5.7 and 15.1% for SJS and TEN, respectively. The mortality increased with age, particularly, after 40 years of age. Among the complications related with SJS or TEN, ocular sequelae was the most common (43.1 and 43.4% of SJS and TEN patients, respectively) followed by urethral sequelae (5.7 and 9.4% of SJS and TEN patients, respectively). Conclusion Overall, our data suggest that SJS, and TEN are infrequent but constantly arise throughout the years.	[Yang, Min-Suk; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Yang, Min-Suk] Seoul Natl Univ, Coll Med, Dept Internal Med, Boramae Med Ctr, Seoul, South Korea; [Yang, Min-Suk; Kim, Gun-Woo; Kim, Byung-Keun; Kim, Ju-Young; Park, Heung-Woo; Cho, Sang-Heon; Min, Kyung-Up; Kang, Hye-Ryun] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Jin Yong] Seoul Natl Univ, Coll Med, Boramae Med Ctr, Publ Hlth Med Serv, Seoul, South Korea; [Kim, Jayeun] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Kim, Ju-Young; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Drug Safety Monitoring Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Kang, HR (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Kang, HR (corresponding author), Seoul Natl Univ Hosp, Drug Safety Monitoring Ctr, Seoul, South Korea.	helenmed@snu.ac.kr	Park, Heung-Woo/AAW-7690-2020	Park, Heung-Woo/0000-0002-6970-3228; Kim, Ju-Young/0000-0003-3841-8122	Seoul National University Hospital [30-2015-0020]	Seoul National University Hospital	This work was supported by a grant from Seoul National University Hospital (#30-2015-0020) URL: http://www.snuh.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastuji-Garin S, 2000, J INVEST DERMATOL, V115, P149, DOI 10.1046/j.1523-1747.2000.00061.x; BASTUJIGARIN S, 1993, ARCH DERMATOL, V129, P92, DOI 10.1001/archderm.129.1.92; CHAN HL, 1990, ARCH DERMATOL, V126, P43, DOI 10.1001/archderm.126.1.43; Chen P, 2011, NEW ENGL J MED, V364, P1126, DOI 10.1056/NEJMoa1009717; Choon SE, 2012, INDIAN J DERMATOL VE, V78, P734, DOI 10.4103/0378-6323.102367; De Rojas MV, 2007, BRIT J OPHTHALMOL, V91, P1048, DOI 10.1136/bjo.2006.109124; Finkelstein Y, 2014, JAMA-J AM MED ASSOC, V311, P2231, DOI 10.1001/jama.2014.839; HUFF JC, 1992, SEMIN DERMATOL, V11, P207; Mockenhaupt M, 2008, J INVEST DERMATOL, V128, P35, DOI 10.1038/sj.jid.5701033; Mockenhaupt M, 2012, CHEM IMMUNOL ALLERGY, V97, P1, DOI 10.1159/000335612; Mockenhaupt M, 2011, EXPERT REV CLIN IMMU, V7, P803, DOI [10.1586/eci.11.66, 10.1586/ECI.11.66]; Oplatek A, 2006, J BURN CARE RES, V27, P26, DOI 10.1097/01.bcr.0000194268.01514.f8; Park SY, 2016, J CLIN NEUROL, V12, P340, DOI 10.3988/jcn.2016.12.3.340; Park SB, 2016, SPINE, V41, P328, DOI 10.1097/BRS.0000000000001291; ROUJEAU JC, 1990, ARCH DERMATOL, V126, P37, DOI 10.1001/archderm.126.1.37; ROUJEAU JC, 1994, NEW ENGL J MED, V331, P1272, DOI 10.1056/NEJM199411103311906; ROUJEAU JC, 1995, NEW ENGL J MED, V333, P1600, DOI 10.1056/NEJM199512143332404; Rzany B, 1996, J CLIN EPIDEMIOL, V49, P769, DOI 10.1016/0895-4356(96)00035-2; SCHOPF E, 1991, ARCH DERMATOL, V127, P839, DOI 10.1001/archderm.127.6.839; Schwartz RA, 2013, J AM ACAD DERMATOL, V69, DOI 10.1016/j.jaad.2013.05.002; Sekula P, 2013, J INVEST DERMATOL, V133, P1197, DOI 10.1038/jid.2012.510; Sekula P, 2011, J BURN CARE RES, V32, P237, DOI 10.1097/BCR.0b013e31820aafbc; Wetter DA, 2010, MAYO CLIN PROC, V85, P131, DOI 10.4065/mcp.2009.0379; Yang MS, 2013, INT ARCH ALLERGY IMM, V162, P346, DOI 10.1159/000354918; Yip LW, 2007, ALLERGY, V62, P527, DOI 10.1111/j.1398-9995.2006.01295.x	25	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165933	10.1371/journal.pone.0165933	http://dx.doi.org/10.1371/journal.pone.0165933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835661	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200017
J	Blom, RM; van Wingen, GA; van der Wal, SJ; Luigjes, J; van Dijk, MT; Scholte, HS; Denys, D				Blom, Rianne M.; van Wingen, Guido A.; van der Wal, Sija J.; Luigjes, Judy; van Dijk, Milenna T.; Scholte, H. Steven; Denys, Damiaan			The Desire for Amputation or Paralyzation: Evidence for Structural Brain Anomalies in Body Integrity Identity Disorder (BIID)	PLOS ONE			English	Article							VENTRAL PREMOTOR CORTEX; ANOREXIA-NERVOSA; INSULAR CORTEX; LIMB OWNERSHIP; RUBBER HAND; XENOMELIA; METAANALYSIS; MOTOR; SOMATOPARAPHRENIA; APOTEMNOPHILIA	Background Body Integrity Identity Disorder (BIID) is a condition in which individuals perceive a mismatch between their internal body scheme and physical body shape, resulting in an absolute desire to be either amputated or paralyzed. The condition is hypothesized to be of congenital nature, but evidence for a neuro-anatomical basis is sparse. Methods We collected T1-weighted structural magnetic resonance imaging scans on a 3T scanner in eight individuals with BIID and 24 matched healthy controls, and analyzed the data using voxel-based morphometry. Results The results showed reduced grey matter volume in the left dorsal and ventral premotor cortices and larger grey matter volume in the cerebellum (lobule Vila) in individuals with BIID compared to controls. Conclusion The premotor cortex and cerebellum are thought to be crucial for the experience of body ownership and the integration of multisensory information. Our results suggest that BIID is associated with structural brain anomalies and might result from a dysfunction in the integration of multisensory information, leading to the feeling of disunity between the mental and physical body shape.	[Blom, Rianne M.; van Wingen, Guido A.; van der Wal, Sija J.; Luigjes, Judy; van Dijk, Milenna T.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands; [van Wingen, Guido A.; Luigjes, Judy; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Brain Imaging Ctr, Amsterdam, Netherlands; [Scholte, H. Steven] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands; [van Dijk, Milenna T.] NYU, Sch Med, Sackler Inst Grad Biomed Sci, New York, NY USA	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); New York University	Blom, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Amsterdam, Netherlands.	riannemb@gmail.com	van Wingen, Guido/AAK-8462-2021; luigjes, judy/P-5161-2014; Scholte, H.Steven/ABD-1737-2020	van Wingen, Guido/0000-0003-3076-5891; Scholte, H.Steven/0000-0002-9839-1788; van der Wal, Sija/0000-0002-3064-3934	Department of Psychiatry of the Academical Medical Center	Department of Psychiatry of the Academical Medical Center	The study was funded by the Department of Psychiatry of the Academical Medical Center. JL, GAvW, RMB and DD received salary from this department.	Amianto F, 2013, PSYCHIAT RES-NEUROIM, V213, P210, DOI 10.1016/j.pscychresns.2013.03.010; Arzy S, 2006, ARCH NEUROL-CHICAGO, V63, P1022, DOI 10.1001/archneur.63.7.1022; Baier B, 2008, STROKE, V39, P486, DOI 10.1161/STROKEAHA.107.495606; Bekrater-Bodmann R, 2012, BRAIN RES, V1452, P130, DOI 10.1016/j.brainres.2012.03.001; Blom R M, 2014, Tijdschr Psychiatr, V56, P54; Blom RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034702; Blom RM, 2014, NED TIJDSCHR GENEES, V158, pA7146; Boghi A, 2011, PSYCHIAT RES-NEUROIM, V192, P154, DOI 10.1016/j.pscychresns.2010.12.008; Bottini G, 2015, NEUROCASE, V21, P394, DOI 10.1080/13554794.2014.902969; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brang D, 2008, NEUROREPORT, V19, P1305, DOI 10.1097/WNR.0b013e32830abc4d; Brugger P, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00204; Bruno RL, 1997, SEX DISABIL, V15, P243, DOI 10.1023/A:1024769330761; Cereda C, 2002, NEUROLOGY, V59, P1950, DOI 10.1212/01.WNL.0000038905.75660.BD; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Everaerd W., AM J PSYCHOTHER, P285; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Fiorio M, 2014, J COGNITIVE NEUROSCI, V26, P712, DOI 10.1162/jocn_a_00522; First MB, 2005, PSYCHOL MED, V35, P919, DOI 10.1017/S0033291704003320; First MB, 2012, PSYCHOPATHOLOGY, V45, P3, DOI 10.1159/000330503; Gentile G, 2015, NEUROIMAGE, V109, P328, DOI 10.1016/j.neuroimage.2015.01.008; GESCHWIND DH, 1995, NEUROLOGY, V45, P802, DOI 10.1212/WNL.45.4.802; Giummarra MJ, 2011, NEUROPSYCHOL REV, V21, P320, DOI 10.1007/s11065-011-9184-8; Giummarra MJ, 2012, PARALYZED DESIRE NEW, P1; Graff-Radford J, 2013, J NEUROL, V260, P1880, DOI 10.1007/s00415-013-6898-y; Hilti LM, 2013, BRAIN, V136, P318, DOI 10.1093/brain/aws316; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Karnath HO, 2005, J NEUROSCI, V25, P7134, DOI 10.1523/JNEUROSCI.1590-05.2005; Kasten E, 2014, PSYCHOL BEHAV SCI, V3, P222, DOI DOI 10.11648/j.pbs.20140306.17; Lenggenhager B, 2015, NEUROPSYCHOLOGY, V29, P205, DOI 10.1037/neu0000143; Lenggenhager B, 2014, CORTEX, V54, P210, DOI 10.1016/j.cortex.2014.02.004; Limanowski J, 2016, SOC COGN AFFECT NEUR, V11, P1130, DOI 10.1093/scan/nsv079; Loetscher T, 2006, J NEUROL NEUROSUR PS, V77, P1099, DOI 10.1136/jnnp.2005.087163; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; MONEY J, 1977, J SEX RES, V13, P115, DOI 10.1080/00224497709550967; Money J., 1984, SEX DISABIL, V7, P43, DOI [10.1007/bf01101829, DOI 10.1007/BF01101829]; Pearce JMS, 2007, EUR NEUROL, V57, P62, DOI 10.1159/000097122; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Romano D, 2015, CONSCIOUS COGN, V34, P140, DOI 10.1016/j.concog.2015.04.008; Scepkowski Lisa A, 2003, Behav Cogn Neurosci Rev, V2, P261, DOI 10.1177/1534582303260119; Sedda A, 2014, NEUROPSYCH DIS TREAT, V10, P1255, DOI 10.2147/NDT.S53385; Soares JC, 1997, BIOL PSYCHIAT, V41, P86, DOI 10.1016/S0006-3223(96)00006-6; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Titova OE, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-110; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; Vallar G, 2009, EXP BRAIN RES, V192, P533, DOI 10.1007/s00221-008-1562-y; van Dijk MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072212; Zeller D, 2011, J NEUROSCI, V31, P4852, DOI 10.1523/JNEUROSCI.5154-10.2011	53	16	16	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165789	10.1371/journal.pone.0165789	http://dx.doi.org/10.1371/journal.pone.0165789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832097	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000034
J	Lee, J; Cho, NW				Lee, Jihwan; Cho, Nam-Wook			Fast Outlier Detection Using a Grid-Based Algorithm	PLOS ONE			English	Article								As one of data mining techniques, outlier detection aims to discover outlying observations that deviate substantially from the reminder of the data. Recently, the Local Outlier Factor (LOF) algorithm has been successfully applied to outlier detection. However, due to the computational complexity of the LOF algorithm, its application to large data with high dimension has been limited. The aim of this paper is to propose grid-based algorithm that reduces the computation time required by the LOF algorithm to determine the k-nearest neighbors. The algorithm divides the data spaces in to a smaller number of regions, called as a "grid", and calculates the LOF value of each grid. To examine the effectiveness of the proposed method, several experiments incorporating different parameters were conducted. The proposed method demonstrated a significant computation time reduction with predictable and acceptable trade-off errors. Then, the proposed methodology was successfully applied to real database transaction logs of Korea Atomic Energy Research Institute. As a result, we show that for a very large dataset, the grid-LOF can be considered as an acceptable approximation for the original LOF. Moreover, it can also be effectively used for real-time outlier detection.	[Lee, Jihwan] Hankuk Univ Foreign Studies, Dept Ind & Management Engn, Gyunggi Do, South Korea; [Cho, Nam-Wook] Seoul Natl Univ Sci & Technol, Dept Ind & Informat Syst Engn, Seoul, South Korea	Hankuk University Foreign Studies; Seoul National University of Science & Technology	Cho, NW (corresponding author), Seoul Natl Univ Sci & Technol, Dept Ind & Informat Syst Engn, Seoul, South Korea.	nwcho@seoultech.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology (MEST) [NRF-2013R1A1A22011169]; Hankuk University of Foreign Studies Research Fund	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science, and Technology (MEST); Hankuk University of Foreign Studies Research Fund	This work was supported by the research program funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (MEST) (NRF-2013R1A1A22011169). This work was also supported by Hankuk University of Foreign Studies Research Fund of 2016.	Aggarwal C. C., 2001, SIGMOD Record, V30, P37, DOI 10.1145/376284.375668; Blake C, UCI REPOSITORY MACHI; Breunig MM, 2000, SIGMOD REC, V29, P93, DOI 10.1145/335191.335388; Faloutsos C., 1995, SIGMOD Record, V24, P163, DOI 10.1145/568271.223812; Fukunaga K., 2013, INTRO STAT PATTERN R; Hawkins D. M, 1980, IDENTIFICATION OUTLI; Kang B, 2012, EXPERT SYST APPL, V39, P6061, DOI 10.1016/j.eswa.2011.12.007; Kim S, 2013, SCI WORLD J, DOI 10.1155/2013/175702; Kim S, 2011, EXPERT SYST APPL, V38, P9587, DOI 10.1016/j.eswa.2011.01.162; Lazarevic A, 2003, SIAM PROC S, P25; Maloof MA, 2006, MACHINE LEARNING DAT; Pokrajac D, P IEEE S COMP INT DA, P504; Strang G., 2006, LINEAR ALGEBRA ITS A; Vetterling W.T., 1988, NUMERICAL RECIPES C	14	4	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165972	10.1371/journal.pone.0165972	http://dx.doi.org/10.1371/journal.pone.0165972			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832163	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000050
J	Chen, DY; Li, JP; Chen, YM; Liao, TL; Chen, HH; Hsieh, CW; Yeh, YW; Lan, JL				Chen, Der-Yuan; Li, Ju-Pi; Chen, Yi-Ming; Liao, Tsai-Ling; Chen, Hsin-Hua; Hsieh, Chia-Wei; Yeh, Yea-Wen; Lan, Joung-Liang			Elevated Neopterin Levels Are Associated with Increased Tuberculosis Risk in Rheumatoid Arthritis Patients with QuantiFERON Conversion during Biologic Therapy	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; HEALTH-CARE WORKERS; ACTIVE TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; DISEASE-ACTIVITY; PREDICTIVE-VALUE; SKIN-TEST; INFECTION; CYTOKINES; EXPRESSION	QuantiFERON-TB-Gold (QFT-G) conversion is frequently observed in rheumatoid arthritis (RA) patients receiving biologic therapy. However, there have not been any known biomarkers available for detecting tuberculosis (TB) in QFT-G converters. We aimed to evaluate clinical utility of cytokines/chemokines for detecting TB in patients with QFT-G conversion. Among a total of 227 RA patients who underwent QFT-G assay, 187 QFT-G-negative patients received biologic therapy without isoniazid prophylaxis. QFT-G assay was repeated at week 52 of biologic therapy or at the time of TB diagnosis. Levels of cytokines/chemokines were determined by magnetic bead array or ELISA in QFT-G converters and 12 non RA patients with TB (non-RA TB). QFT-G conversion was found in 54 (28.9%) of 187 baseline QFT-G-negative patients, of which 7 (13.0%) developed active TB during the one-year follow-up period. Among the examined cytokines/chemokines, non-stimulated and TB-antigen -stimulated neopterin levels were significantly higher in RA patients who developed TB (RA-TB) (median, 24.5pg/ml and 23053pg/ml, respectively) and non-RA TB patients (12.2pg/m1 and 9633pg/ml, respectively) compared with QFT-G converters without TB (3.0pg/ml and 2720pg/ml, respectively, both p<0.001). Rising levels of neopterin relative to baseline (non-stimulated levels, 4.4pg/ml vs. 24.5pg/ml; TB-antigen-stimulated levels, 1801pg/ml vs. 23053pg/ml) were observed in QFT-G converters who developed TB. A high proportion (85.7%) of QFT-G converters with high plasma neopterin levels developed TB during the one-year follow-up period. In conclusion, RA patients with QFT-G conversion during the period of biologic therapy should be carefully monitored for elevation of neopterin levels, which is associated with TB risk in QFT-G converters, particularly in TB-endemic areas.	[Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua; Hsieh, Chia-Wei; Yeh, Yea-Wen] Taichung Vet Gen Hosp, Dept Med Educ & Res, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Hsieh, Chia-Wei] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan; [Chen, Der-Yuan; Liao, Tsai-Ling; Chen, Hsin-Hua] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Liao, Tsai-Ling; Chen, Hsin-Hua] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan; [Li, Ju-Pi; Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Dept Med, Taichung, Taiwan; [Li, Ju-Pi; Lan, Joung-Liang] China Med Univ, Coll Med, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Lan, JL (corresponding author), China Med Univ Hosp, Div Rheumatol & Immunol, Dept Med, Taichung, Taiwan.; Lan, JL (corresponding author), China Med Univ, Coll Med, Taichung, Taiwan.	jounglancmuh@gmail.com	Li, Ju-Pi/AAS-8866-2021; Chen, Yi-Ming/AAV-3806-2021	Li, Ju-Pi/0000-0003-3406-4865; Chen, Yi-Ming/0000-0001-7593-3065	National Science Council, Taiwan [NSC-100-2321-B-075A-001]; Taichung Veterans General Hospital, Taiwan [TCVGH-993804C]; China Medical University Hospital, Taiwan [DMR-C1030224007]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taichung Veterans General Hospital, Taiwan; China Medical University Hospital, Taiwan	This study was supported by a grant (NSC-100-2321-B-075A-001) from the National Science Council, Taiwan, a grant from Taichung Veterans General Hospital, Taiwan (TCVGH-993804C), and by the China Medical University Hospital, Taiwan (DMR-C1030224007, J-LL).; This study was supported by a grant (NSC-100-2321-B-075A-001) from the National Science Council, Taiwan, a grant from Taichung Veterans General Hospital, Taiwan (TCVGH993804C), and by the China Medical University Hospital, Taiwan (DMR-C1030224007, J -LL). We also thank the Biostatistics Task Force of Taichung Veterans General Hospital, and thank the Research Center for Chinese Medicine and Acupuncture, China Medical University (Taiwan) for technical assistance.	Arend SM, 2007, AM J RESP CRIT CARE, V175, P618, DOI 10.1164/rccm.200608-1099OC; Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Barnes PF, 2000, AM J RESP CRIT CARE, V161, P1773, DOI 10.1164/ajrccm.161.6.16167; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Carmona L, 2005, ARTHRITIS RHEUM-US, V52, P1766, DOI 10.1002/art.21043; Centers for Disease Control R. O. C. (Taiwan), 2013, TAIW TUB CONTR REP 2; Cesur S, 2014, INT J MYCOBACT, V3, P5, DOI 10.1016/j.ijmyco.2014.01.002; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen XC, 2010, AM J RESP CRIT CARE, V181, P734, DOI 10.1164/rccm.200909-1463OC; Cooper AM, 2008, IMMUNOL REV, V226, P191, DOI 10.1111/j.1600-065X.2008.00702.x; Diel R, 2011, AM J RESP CRIT CARE, V183, P88, DOI 10.1164/rccm.201006-0974OC; Dlugovitzky D, 1997, FEMS IMMUNOL MED MIC, V18, P203, DOI 10.1016/S0928-8244(97)00040-0; Feng JY, 2013, DIAGN MICR INFEC DIS, V77, P46, DOI 10.1016/j.diagmicrobio.2013.05.020; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; FUCHS D, 1984, LUNG, V162, P337, DOI 10.1007/BF02715666; Hatzara C, 2015, ANN RHEUM DIS, V74, P1848, DOI 10.1136/annrheumdis-2014-205376; Immanuel C, 1997, INT J TUBERC LUNG D, V1, P175; Jeong YH, 2015, J CLIN MICROBIOL, V53, P504, DOI 10.1128/JCM.02758-14; Jung YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141033; Jurado JO, 2012, J LEUKOCYTE BIOL, V91, P991, DOI 10.1189/jlb.1211619; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Ledingham J, 2005, RHEUMATOLOGY, V44, P157, DOI 10.1093/rheumatology/keh464; Lee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119260; Lee K, 2015, INT J TUBERC LUNG D, V19, P191, DOI 10.5588/ijtld.14.0525; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC; Mariette X, 2012, ANN RHEUM DIS, V71, P1783, DOI 10.1136/annrheumdis-2011-200408; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mendy J, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1447-9; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; Ozdemir D, 2006, MED SCI MONITOR, V12, pCR521; Ozkan Y, 2012, CLIN RHEUMATOL, V31, P29, DOI 10.1007/s10067-011-1767-5; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Skogmar S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144292; Suzukawa M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152483; WHO, 2014, GLOB TUB REP 2014; Winthrop KL, 2013, NAT REV RHEUMATOL, V9, P524, DOI 10.1038/nrrheum.2013.82	42	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166301	10.1371/journal.pone.0166301	http://dx.doi.org/10.1371/journal.pone.0166301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861525	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300044
J	Liu, XW; Wang, HY; Zhou, JM; Hu, FQ; Zhu, DJ; Chen, ZM; Liu, YZ				Liu, Xiaowei; Wang, Huoyan; Zhou, Jianmin; Hu, Fengqin; Zhu, Dejin; Chen, Zhaoming; Liu, Yongzhe			Effect of N Fertilization Pattern on Rice Yield, N Use Efficiency and Fertilizer-N Fate in the Yangtze River Basin, China	PLOS ONE			English	Article							NITROGEN-USE EFFICIENCY; DRY-MATTER ACCUMULATION; DEEP PLACEMENT; GRAIN-YIELD; AMMONIA VOLATILIZATION; NUTRIENT-UPTAKE; ROOT-GROWTH; UREA; INCREASES; SYSTEM	High N loss and low N use efficiency (NUE), caused by high N fertilizer inputs and inappropriate fertilization patterns, have become important issues in the rice (Oryza sativa L.) growing regions of southern China. Changing current farmer fertilizer practice (FFP, 225 kg ha(-1) N as three applications, 40% as basal fertilizer, 30% as tillering fertilizer and 30% as jointing fertilizer) to one - time root - zone fertilization (RZF, 225 kg ha(-1) N applied once into 10 cm deep holes positioned 5 cm from the rice root as basal fertilizer) will address this problem. A two - year field experiment covering two rice growing regions was conducted to investigate the effect of urea one - time RZF on rice growth, nutrient uptake, and NUE. The highest NH4+ -N content for RZF at fertilizer point at 30 d and 60 d after fertilization were 861.8 and 369.9 mg kg(-1) higher than FFP, respectively. Rice yield and total N accumulation of RZF increased by 4.3 - 44.9% and 12.7 - 111.2% compared to FFP, respectively. RZF reduced fertilizer - N loss by 56.3 - 81.9% compared to FFP. The NUEs following RZF (mean of 65.8% for the difference method and 43.7% for the labelled method) were significantly higher than FFP (mean of 35.7% for the difference method and 14.4% for the labelled method). In conclusion, RZF maintained substantial levels of fertilizer - N in the root - zone, which led to enhanced rice biomass and N uptake during the early growth stages, increased fertilizer - N residual levels and reduced fertilizer - N loss at harvest. RZF produced a higher yield increment and showed an increased capacity to resist environmental threats than FFP in sandy soils. Therefore, adopting suitable fertilizer patterns plays a key role in enhancing agricultural benefits.	[Liu, Xiaowei; Wang, Huoyan; Zhou, Jianmin; Hu, Fengqin; Chen, Zhaoming] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Liu, Xiaowei; Chen, Zhaoming] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhu, Dejin] Agr Comm Jiangyan City, Taizhou 225599, Peoples R China; [Liu, Yongzhe] Nanjing Agr Univ, Minist Agr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Wang, HY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	hywang@issas.ac.cn			National Basic Research Program of China [2013CB127401]; National Department Public Benefit Research Foundation of China [201203013]; National Natural Science Foundation of China [40971176, 41271309]	National Basic Research Program of China(National Basic Research Program of China); National Department Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was financially supported by National Basic Research Program of China (Grant No. 2013CB127401), National Department Public Benefit Research Foundation of China (Grant No. 201203013) and National Natural Science Foundation of China (Grant Nos. 40971176 and 41271309).	Beek C, 2009, NUTR CYCL AGROECOSYS, V83, P63, DOI 10.1007/s10705-008-9199-6; Cao YS, 2013, FIELD CROP RES, V147, P23, DOI 10.1016/j.fcr.2013.03.015; Chao X, 2005, J ENVIRON SCI-CHINA, V17, P81; Ding CQ, 2014, PLANT CELL REP, V33, P363, DOI 10.1007/s00299-013-1536-9; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; Gaihre YK, 2015, GEODERMA, V259, P370, DOI 10.1016/j.geoderma.2015.06.001; Garnett T, 2009, PLANT CELL ENVIRON, V32, P1272, DOI 10.1111/j.1365-3040.2009.02011.x; Hayashi K, 2008, SCI TOTAL ENVIRON, V390, P485, DOI 10.1016/j.scitotenv.2007.10.037; Hu RF, 2007, AGR SYST, V94, P331, DOI 10.1016/j.agsy.2006.10.002; Jing J, 2012, FIELD CROP RES, V133, P176, DOI 10.1016/j.fcr.2012.04.009; Kapoor V, 2008, AGRON J, V100, P526, DOI 10.2134/agronj2007.0007; Klute A., 1986, METHODS SOIL ANAL PA, P413, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C15; Miah MAM, 2016, AGRON J, V108, P805, DOI 10.2134/agronj2015.0170; Ouk M, 2007, FIELD CROP RES, V101, P145, DOI 10.1016/j.fcr.2006.10.003; Peng SB, 2010, AGRON SUSTAIN DEV, V30, P649, DOI 10.1051/agro/2010002; Rochette P, 2013, J ENVIRON QUAL, V42, P1635, DOI 10.2134/jeq2013.05.0192; SAVANT NK, 1990, FERT RES, V25, P1, DOI 10.1007/BF01063765; Sheehy JE, 1998, FIELD CROP RES, V59, P31, DOI 10.1016/S0378-4290(98)00105-1; Sun L, 2012, POTATO RES, V55, P303, DOI 10.1007/s11540-012-9220-y; Tian GM, 2001, CHEMOSPHERE, V42, P123, DOI 10.1016/S0045-6535(00)00117-X; Wang H-Y, 2014, ACTA PEDOLOGICA SINI, V51, P10, DOI DOI 10.11766/trxb201312110588; Webb J, 1998, J AGR SCI, V130, P271, DOI 10.1017/S0021859698005309; Wen ZH, 2016, PEDOSPHERE, V26, P62, DOI 10.1016/S1002-0160(15)60023-6; Xiang Jing, 2013, Australian Journal of Crop Science, V7, P870; Xiong J, 2013, AGRON J, V105, P1142, DOI 10.2134/agronj2012.0297; Yang M, 2011, PHILIPP J CROP SCI, V36, P1; Yang YC, 2012, SOIL SCI SOC AM J, V76, P2307, DOI 10.2136/sssaj2012.0173; Zhang CF, 2000, J PLANT PHYSIOL, V156, P230, DOI 10.1016/S0176-1617(00)80311-9; Zhang Chao, 2011, Yingyong Shengtai Xuebao, V22, P3236; Zhang QW, 2012, AGR ECOSYST ENVIRON, V158, P118, DOI 10.1016/j.agee.2012.06.003; ZHAO X, 2009, CHINA PLANT SOIL, V319, P225, DOI DOI 10.1007/S11104-008-9865-0; Zhao X, 2012, AGR ECOSYST ENVIRON, V156, P1, DOI 10.1016/j.agee.2012.04.024; Zhou J.M, 2015, SOILS, V45, P785; Zhou S., 2011, AGR WATER MANAGE, V37, P685; Zhu B, 2014, PLANT SOIL, V374, P331, DOI 10.1007/s11104-013-1808-8; Zhu GL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21049	36	49	52	4	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166002	10.1371/journal.pone.0166002	http://dx.doi.org/10.1371/journal.pone.0166002			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861491	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300021
J	Wang, BY; Huang, JY; Hung, WH; Lin, CH; Lin, SH; Liaw, YP; Ko, JL				Wang, Bing-Yen; Huang, Jing-Yang; Hung, Wei-Heng; Lin, Ching-Hsiung; Lin, Sheng-Hao; Liaw, Yung-Po; Ko, Jiunn-Liang			Impact on Survival on Interval between Surgery and Adjuvant Chemotherapy in Completely Resected Stage IB-IIIA Lung Cancer	PLOS ONE			English	Article							RANDOMIZED-TRIAL; COLON; ADENOCARCINOMA; INITIATION; TIME	Background and Objectives Complete surgical resection is recommended for early stage lung cancer, and adjuvant chemotherapy is given for stage IB to IIIA disease. No studies have examined the best timing to administer chemotherapy after surgery in lung cancer. This study was to investigate the optimal timing of adjuvant chemotherapy after surgical resection. Methods Data collected from the Taiwan National Health Insurance Research Database between January, 2004 and December, 2010 were retrospectively analyzed. Patients with stage IB to IIIA lung cancer underwent complete surgical resection and adjuvant chemotherapy were included. A total of 1522 patients were included. The patients were divided into 4 groups according to the interval between surgery and chemotherapy: group 1, <30 days; group 2, 30-45 days; group 3, 46-60 days; group 4 > 60 days. Univariate and multivariate regression analyses were used to identify prognostic factors for overall survival. Results The numbers of patients in groups 1, 2, 3, and 4 were 153, 161, 290, and 818, respectively. The 5-year survival rate was 41% in group 1, 48% in group 2, 50% in group 3, and 35% in group 4 (p<0.001). The median survival time was 44.50 months in group 1, 59.53 months in group 2, 67.33 months in group 3 and 36.33 months in group 4 (p<0.001) Survival rate is the poorest when chemotherapy is delayed beyond 60 days after surgical resection Multivariate analysis also indicated the interval between surgery and first course of chemotherapy more than 60 days after surgery was an independent risk factor for survival. Conclusions Timing of chemotherapy after surgery is associated with poorer survival in lung cancer patients.	[Wang, Bing-Yen; Hung, Wei-Heng] Changhua Christian Hosp, Div Thorac Surg, Dept Surg, Taichung, Taiwan; [Wang, Bing-Yen; Hung, Wei-Heng; Lin, Ching-Hsiung; Lin, Sheng-Hao] Chung Shan Med Univ, Taichung, Taiwan; [Wang, Bing-Yen; Huang, Jing-Yang; Liaw, Yung-Po] Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan; [Wang, Bing-Yen; Huang, Jing-Yang; Liaw, Yung-Po] Chung Shan Med Univ, Inst Publ Hlth, Taichung 40201, Taiwan; [Wang, Bing-Yen] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan; [Wang, Bing-Yen] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung, Taiwan; [Huang, Jing-Yang; Liaw, Yung-Po] Chung Shan Med Univ Hospial, Dept Family & Community Med, Taichung 40201, Taiwan; [Lin, Ching-Hsiung; Lin, Sheng-Hao] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Lin, Ching-Hsiung; Lin, Sheng-Hao] Chang Jung Christian Univ, Dept Resp Care, Coll Hlth Sci, Tainan, Taiwan; [Ko, Jiunn-Liang] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Ko, Jiunn-Liang] Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung, Taiwan	Changhua Christian Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Kaohsiung Medical University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University Hospital; Changhua Christian Hospital; Chang Jung Christian University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital	Liaw, YP (corresponding author), Chung Shan Med Univ, Dept Publ Hlth, Taichung 40201, Taiwan.; Liaw, YP (corresponding author), Chung Shan Med Univ, Inst Publ Hlth, Taichung 40201, Taiwan.; Liaw, YP (corresponding author), Chung Shan Med Univ Hospial, Dept Family & Community Med, Taichung 40201, Taiwan.; Ko, JL (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.; Ko, JL (corresponding author), Chung Shan Med Univ Hosp, Dept Med Oncol & Chest Med, Taichung, Taiwan.	156283@cch.org.tw; jlko@csmu.edu.tw	Liaw, Yung Po/AAV-6746-2021	Huang, Jing-Yang/0000-0002-0794-9388; Ko, Jiunn-Liang/0000-0001-6855-9239; Lin, Ching-Hsiung/0000-0001-9407-8578				Alkis N, 2011, MED ONCOL, V28, P1255, DOI 10.1007/s12032-010-9566-4; Biagi JJ, 2011, JAMA-J AM MED ASSOC, V305, P2335, DOI 10.1001/jama.2011.749; Colleoni M, 2000, J CLIN ONCOL, V18, P584, DOI 10.1200/JCO.2000.18.3.584; Czaykowski PM, 2011, DIS COLON RECTUM, V54, P1082, DOI 10.1097/DCR.0b013e318223c3d6; Kato H, 2004, NEW ENGL J MED, V350, P1713, DOI 10.1056/NEJMoa032792; Keller SM, 2000, NEW ENGL J MED, V343, P1217, DOI 10.1056/NEJM200010263431703; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lima ISF, 2011, CANCER-AM CANCER SOC, V117, P3833, DOI 10.1002/cncr.25954; Lohrisch C, 2006, J CLIN ONCOL, V24, P4888, DOI 10.1200/JCO.2005.01.6089; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Park HS, 2015, ANN SURG ONCOL, V22, P224, DOI 10.1245/s10434-014-3949-2; Park SY, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-151; Peixoto RD, 2015, CLIN COLORECTAL CANC, V14, P25, DOI 10.1016/j.clcc.2014.10.002; PRONZATO P, 1989, AM J CLIN ONCOL-CANC, V12, P481, DOI 10.1097/00000421-198912000-00004; Strauss GM, 2008, J CLIN ONCOL, V26, P5043, DOI 10.1200/JCO.2008.16.4855; Strauss GM, 2004, J CLIN ONCOL, V22, p621S; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang BY, 2013, J THORAC ONCOL, V8, P1128, DOI 10.1097/JTO.0b013e31829ceba4; Winton T, 2005, NEW ENGL J MED, V352, P2589, DOI 10.1056/NEJMoa043623; Yu S, 2013, CLIN COLORECTAL CANC, V12, P275, DOI 10.1016/j.clcc.2013.08.002	20	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0163809	10.1371/journal.pone.0163809	http://dx.doi.org/10.1371/journal.pone.0163809			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861490	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300002
J	Konno, T; Nakano, R; Mamiya, R; Tsuchiya, H; Kitanaka, T; Namba, S; Kitanaka, N; Okabayashi, K; Narita, T; Sugiya, H				Konno, Tadayoshi; Nakano, Rei; Mamiya, Ryo; Tsuchiya, Hisashi; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Okabayashi, Ken; Narita, Takanori; Sugiya, Hiroshi			Expression and Function of Interleukin-1 beta-Induced Neutrophil Gelatinase-Associated Lipocalin in Renal Tubular Cells	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; EPITHELIAL-MESENCHYMAL TRANSITION; EARLY URINARY BIOMARKER; PATHOPHYSIOLOGY; INFLAMMASOMES; REPERFUSION; PATHWAYS; MARKER; NGAL; DISRUPTION	Acute kidney injury (AKI) is characterized by a sudden loss of renal function. Early recognition of AKI, especially in critically ill patients, is essential for adequate therapy. Currently, neutrophil gelatinase-associated lipocalin (NGAL) is considered to be an effective biomarker of AKI; however, the regulation of its expression and function in renal tubular cells remains unclear. In this study, we investigated the regulation of the expression and function of NGAL in IL-1 beta-treated Madin-Darby canine kidney (MDCK) cells as a model of renal tubular cells. IL-1 beta induced a disturbance in the localization of E-cadherin and zonaoccludin-1 (ZO-1). The transepithelial electrical resistance (TER) also decreased 5 days after IL-1 beta treatment. IL-1 beta induced NGAL mRNA expression and protein secretion in a time-and dose- dependent manner, which occurred faster than the decrease in TER. In the presence of ERK1/2 and p38 inhibitors, IL- 1 beta-induced NGAL mRNA expression and protein secretion were significantly attenuated. In the presence of recombinant NGAL, IL-1 beta-induced disturbance in the localization of E-cadherin and ZO-1 was attenuated, and the decrease in TER was partially maintained. These results suggest that NGAL can be used as a biomarker for AKI and that it functions as a protector from AKI.	[Konno, Tadayoshi; Nakano, Rei; Mamiya, Ryo; Tsuchiya, Hisashi; Kitanaka, Taku; Namba, Shinichi; Kitanaka, Nanako; Okabayashi, Ken; Narita, Takanori; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Dept Vet Med, Vet Biochem Lab, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Narita, Takanori/F-1092-2011	Okabayashi, Ken/0000-0003-2525-9265; Nakano, Rei/0000-0003-0255-6347; Narita, Takanori/0000-0003-0295-5014; Namba, Shinichi/0000-0002-9182-3656	Ministry of Education, Science, Sports, and Culture of Japan [15K07728]; Grants-in-Aid for Scientific Research [15K07728] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (#15K07728) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp) (HS). There was no additional external funding received for this study.; This work was supported in part by a Grant-in-Aid for Scientific Research (#15K07728) from the Ministry of Education, Science, Sports, and Culture of Japan. We would like to thank Editage (www.editage.jp) for English language editing.	Anders HJ, 2013, KIDNEY INT, V84, P225, DOI 10.1038/ki.2013.122; Bahmani P, 2010, CELL STRESS CHAPERON, V15, P395, DOI 10.1007/s12192-009-0154-5; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Bennett M, 2008, CLIN J AM SOC NEPHRO, V3, P665, DOI 10.2215/CJN.04010907; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; de Geus HRH, 2012, CLIN KIDNEY J, V5, P102, DOI 10.1093/ckj/sfs008; Edelstein CL, 2008, ADV CHRONIC KIDNEY D, V15, P222, DOI 10.1053/j.ackd.2008.04.003; Fan JM, 2001, AM J KIDNEY DIS, V37, P820, DOI 10.1016/S0272-6386(01)80132-3; Furuse M, 2001, J CELL BIOL, V153, P263, DOI 10.1083/jcb.153.2.263; Gul CB, 2008, CLIN BIOCHEM, V41, P544, DOI 10.1016/j.clinbiochem.2008.01.002; Hanai J, 2005, J BIOL CHEM, V280, P13641, DOI 10.1074/jbc.M413047200; Hutton HL, 2016, NEPHROLOGY, V21, P736, DOI 10.1111/nep.12785; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kelly KJ, 1996, J CLIN INVEST, V97, P1056, DOI 10.1172/JCI118498; KIMIZUKA H, 1964, J THEOR BIOL, V6, P290, DOI 10.1016/0022-5193(64)90035-9; Kimura K, 2009, INVEST OPHTH VIS SCI, V50, P597, DOI 10.1167/iovs.08-2606; Korrapati MC, 2012, J PHARMACOL EXP THER, V341, P126, DOI 10.1124/jpet.111.190249; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee CH, 2015, J CELL PHYSIOL, V230, P875, DOI 10.1002/jcp.24816; Mao SS, 2011, INT J MOL MED, V27, P555, DOI 10.3892/ijmm.2011.613; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Masood H, 2015, KIDNEY DIS-BASEL, V1, P187, DOI 10.1159/000438843; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2004, AM J NEPHROL, V24, P307, DOI 10.1159/000078452; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2007, KIDNEY INT, V71, P967, DOI 10.1038/sj.ki.5002165; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nielsen BS, 1996, GUT, V38, P414, DOI 10.1136/gut.38.3.414; Palenski TL, 2013, MICROVASC RES, V89, P57, DOI 10.1016/j.mvr.2013.06.007; Peerapen P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01041; Sancho-Martinez SM, 2015, CLIN KIDNEY J, V8, P548, DOI 10.1093/ckj/sfv069; Strippoli R, 2010, J CELL SCI, V123, P4321, DOI 10.1242/jcs.071647; Sugiura T, 1999, KIDNEY INT, V56, pS167, DOI 10.1046/j.1523-1755.1999.07143.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong ZM, 2005, BIOCHEM J, V391, P441, DOI 10.1042/BJ20051020; Trachtman H, 2006, PEDIATR NEPHROL, V21, P989, DOI 10.1007/s00467-006-0146-y; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Vinuesa E, 2008, AM J PHYSIOL-RENAL, V295, pF1554, DOI 10.1152/ajprenal.90250.2008; Wagener G, 2006, ANESTHESIOLOGY, V105, P485, DOI 10.1097/00000542-200609000-00011; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Yang JR, 2014, AM J PHYSIOL-RENAL, V306, pF75, DOI 10.1152/ajprenal.00117.2013; Zang XJ, 2014, INT UROL NEPHROL, V46, P1673, DOI 10.1007/s11255-014-0749-3; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513	51	13	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166707	10.1371/journal.pone.0166707	http://dx.doi.org/10.1371/journal.pone.0166707			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851800	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300080
J	Ramaiya, MK; Sullivan, KA; O'Donnell, K; Cunningham, CK; Shayo, AM; Mmbaga, BT; Dow, DE				Ramaiya, Megan K.; Sullivan, Kristen A.; O'Donnell, Karen; Cunningham, Coleen K.; Shayo, Aisa M.; Mmbaga, Blandina T.; Dow, Dorothy E.			A Qualitative Exploration of the Mental Health and Psychosocial Contexts of HIV-Positive Adolescents in Tanzania	PLOS ONE			English	Article							AIDS-ORPHANED CHILDREN; SUB-SAHARAN AFRICA; SOUTH-AFRICA; ANTIRETROVIRAL THERAPY; POSTTRAUMATIC STRESS; INFECTED CHILDREN; YOUNG-ADULTS; CAPE-TOWN; DEPRESSION; HIV/AIDS	Although 85% of HIV-positive adolescents reside in sub-Saharan Africa, little is known about the psychosocial and mental health factors affecting their daily well-being. Identifying these contextual variables is key to development of culturally appropriate and effective interventions for this understudied and high-risk population. The purpose of this study was to identify salient psychosocial and mental health challenges confronted by HIV-positive youth in a resource-poor Tanzanian setting. A total of 24 qualitative interviews were conducted with a convenience sample of adolescents aged 12-24 receiving outpatient HIV care at a medical center in Moshi, Tanzania. All interviews were audio-recorded, transcribed, and coded using thematic analysis. Psychosocial challenges identified included loss of one or more parents, chronic domestic abuse, financial stressors restricting access to medical care and education, and high levels of internalized and community stigma among peers and other social contacts. Over half of youth (56%) reported difficulties coming to terms with their HIV diagnosis and espoused related feelings of self-blame. These findings highlight the urgent need to develop culturally proficient programs aimed at helping adolescents cope with these manifold challenges. Results from this study guided the development of Sauti ya Vijana (The Voice of Youth), a 10-session group mental health intervention designed to address the psychosocial and mental health needs of HIV-positive Tanzanian youth.	[Ramaiya, Megan K.; O'Donnell, Karen] Duke Univ, Duke Global Hlth Inst, Ctr Hlth Policy & Inequal Res, Durham, NC USA; [Ramaiya, Megan K.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Sullivan, Kristen A.] Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27514 USA; [O'Donnell, Karen] Duke Univ, Ctr Child & Family Hlth, Durham, NC USA; [Cunningham, Coleen K.; Dow, Dorothy E.] Duke Univ, Med Ctr, Dept Pediat, Div Pediat Infect Dis, Durham, NC USA; [Shayo, Aisa M.; Mmbaga, Blandina T.; Dow, Dorothy E.] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	Duke University; University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Duke University; Kilimanjaro Christian Medical Centre	Sullivan, KA (corresponding author), Univ North Carolina Chapel Hill, Dept Social Med, Chapel Hill, NC 27514 USA.	ksullivan@med.unc.edu	Dow, Dorothy/H-8164-2019; Mmbaga, Blandina Theophil/AAR-8707-2021	Mmbaga, Blandina Theophil/0000-0002-5550-1916	Duke University Center for AIDS Research (CFAR); NIH [P30 A1064518, R25 TW009337]; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant; Department of Pediatrics, Duke University Medical Center [T32 HD060558]; International Scientist Research Development Award - Fogarty International Center [K01 TW-009985]; National Institute of Mental Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD060558] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW009985, R25TW009337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI064518] Funding Source: NIH RePORTER	Duke University Center for AIDS Research (CFAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant; Department of Pediatrics, Duke University Medical Center; International Scientist Research Development Award - Fogarty International Center; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (P30 A1064518), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558) and by NIH Research Training Grant R25 TW009337 and International Scientist Research Development Award (K01 TW-009985) funded by the Fogarty International Center and the National Institute of Mental Health (to DED). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Duke University Center for AIDS Research (CFAR), an NIH funded program (P30 AI064518), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) training grant to the Division of Infectious Diseases, Department of Pediatrics, Duke University Medical Center (T32 HD060558) and by NIH Research Training Grant R25 TW009337 and International Scientist Research Development Award (K01 TW-009985) funded by the Fogarty International Center and the National Institute of Mental Health (to DED). Authors had control of all primary data.	Akena D, 2013, AIDS CARE, V25, P1245, DOI 10.1080/09540121.2013.764385; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Betancourt T, 2014, PEDIATRICS, V134, pE464, DOI 10.1542/peds.2013-2734; Betancourt TS, 2013, J CHILD PSYCHOL PSYC, V54, P423, DOI 10.1111/j.1469-7610.2012.02613.x; Cholera R, 2014, J AFFECT DISORDERS, V167, P160, DOI [10.1016/j.jad.2014.06.003, 10.1016/]; Cluver L, 2007, AIDS CARE, V19, P318, DOI 10.1080/09540120600986578; Cluver L, 2007, J CHILD PSYCHOL PSYC, V48, P755, DOI 10.1111/j.1469-7610.2007.01757.x; Cluver L, 2013, SOC SCI MED, V87, P185, DOI 10.1016/j.socscimed.2013.03.028; Cluver L, 2011, JAIDS-J ACQ IMM DEF, V58, P336, DOI 10.1097/QAI.0b013e31822f0d82; Cluver L, 2011, NATURE, V474, P27, DOI 10.1038/474027a; Cluver L, 2009, VULNERABLE CHILD YOU, V4, P185, DOI 10.1080/17450120902730196; Cluver L, 2009, SOC SCI MED, V69, P1186, DOI 10.1016/j.socscimed.2009.07.033; Cluver L, 2009, AIDS CARE, V21, P732, DOI 10.1080/09540120802511885; Cluver LD, 2012, J CHILD PSYCHOL PSYC, V53, P363, DOI 10.1111/j.1469-7610.2011.02459.x; Cluver L, 2009, J TRAUMA STRESS, V22, P106, DOI 10.1002/jts.20396; Cohen JA, 2010, CHILD ABUSE NEGLECT, V34, P215, DOI 10.1016/j.chiabu.2009.12.003; DeLaMora Patricia, 2006, Curr HIV/AIDS Rep, V3, P74, DOI 10.1007/s11904-006-0021-2; DiClemente C.C., 2002, MOTIVATIONAL INTERVI, V2nd ed., P201; Dow DE, 2016, AIDS CARE, P1; Dow DE, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0567-3; ENGEL GL, 1980, AM J PSYCHIAT, V137, P535; Gelaye B, 2013, PSYCHIAT RES, V210, P653, DOI 10.1016/j.psychres.2013.07.015; Govender K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-615; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Harder VS, 2012, J TRAUMA STRESS, V25, P64, DOI 10.1002/jts.21660; Joint United Nations Programme on HIV/AIDS, 2013, GLOBAL REPORT UNAIDS; Kahana SY, 2013, AIDS BEHAV, V17, P41, DOI 10.1007/s10461-012-0159-4; Kohn R, 2004, B WORLD HEALTH ORGAN, V82, P858; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mavhu W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070254; Mellins CA, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18593; Menon A, 2007, JAIDS-J ACQ IMM DEF, V46, P349, DOI 10.1097/QAI.0b013e3181565df0; Merzel C, 2008, AIDS PATIENT CARE ST, V22, P977, DOI 10.1089/apc.2008.0048; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Morantz G, 2013, VULNERABLE CHILD YOU, V8, P338, DOI 10.1080/17450128.2013.764476; Murray LK, 2011, INT J MENT HEALTH SY, V5, DOI 10.1186/1752-4458-5-24; Musisi S, 2009, East Afr Med J, V86, P16; Mutumba M, 2015, AIDS PATIENT CARE ST, V29, P86, DOI 10.1089/apc.2014.0222; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; O'Donnell K, 2014, J TRAUMA STRESS, V27, P664, DOI 10.1002/jts.21970; Pao M, 2000, ARCH PEDIAT ADOL MED, V154, P240, DOI 10.1001/archpedi.154.3.240; Petersen I, 2010, AIDS CARE, V22, P970, DOI 10.1080/09540121003623693; Radcliffe J, 2007, AIDS PATIENT CARE ST, V21, P501, DOI 10.1089/apc.2006.0144; Robson E, 2006, POPUL SPACE PLACE, V12, P93, DOI 10.1002/psp.392; Steinberg A, 2008, ENCY PSYCHOL TRAUMA, P673; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Strydom H, 2005, INT SOC WORK, V48, P569, DOI 10.1177/0020872805055321; Stuart S, 2012, INTERPERSONAL PSYCHO; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; Whetten K, 2011, J TRAUMA STRESS, V24, P174, DOI 10.1002/jts.20625; WHO, 2013, HIV AD GUID HIV TEST; World Health Organization, 2011, MENT HLTH ATL UN REP; World Health Organization, 2011, MHGAP INT GUID MENT	54	37	37	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165936	10.1371/journal.pone.0165936	http://dx.doi.org/10.1371/journal.pone.0165936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851797	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300028
J	Bergquist, H; Rocha, CSJ; Alvarez-Asencio, R; Nguyen, CH; Rutland, MW; Smith, CIE; Good, L; Nielsen, PE; Zain, R				Bergquist, Helen; Rocha, Cristina S. J.; Alvarez-Asencio, Ruben; Chi-Hung Nguyen; Rutland, Mark. W.; Smith, C. I. Edvard; Good, Liam; Nielsen, Peter E.; Zain, Rula			Disruption of Higher Order DNA Structures in Friedreich's Ataxia (GAA)(n) Repeats by PNA or LNA Targeting	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INTERSTRAND CROSS-LINKS; DOUBLE-STRANDED DNA; DOT-TTC REPEATS; STICKY DNA; NUCLEIC-ACIDS; DUPLEX DNA; IN-VIVO; (GAA)(N)CENTER-DOT(TTC)(N) REPEATS; BENZOQUINOQUINOXALINE DERIVATIVES	Expansion of (GAA)(n) repeats in the first intron of the Frataxin gene is associated with reduced mRNA and protein levels and the development of Friedreich's ataxia. (GAA)(n) expansions form non-canonical structures, including intramolecular triplex (H-DNA), and Rloops and are associated with epigenetic modifications. With the aim of interfering with higher order H-DNA (like) DNA structures within pathological (GAA)(n) expansions, we examined sequence-specific interaction of peptide nucleic acid (PNA) with (GAA)(n) repeats of different lengths (short: n= 9, medium: n= 75 or long: n= 115) by chemical probing of triple helical and single stranded regions. We found that a triplex structure (H-DNA) forms at GAA repeats of different lengths; however, single stranded regions were not detected within the medium size pathological repeat, suggesting the presence of a more complex structure. Furthermore, (GAA) 4-PNA binding of the repeat abolished all detectable triplex DNA structures, whereas (CTT) 5-PNA did not. We present evidence that (GAA) 4-PNA can invade the DNA at the repeat region by binding the DNA CTT strand, thereby preventing non-canonical-DNA formation, and that triplex invasion complexes by (CTT) 5-PNA form at the GAA repeats. Locked nucleic acid (LNA) oligonucleotides also inhibited triplex formation at GAA repeat expansions, and atomic force microscopy analysis showed significant relaxation of plasmid morphology in the presence of GAA-LNA. Thus, by inhibiting disease related higher order DNA structures in the Frataxin gene, such PNA and LNA oligomers may have potential for discovery of drugs aiming at recovering Frataxin expression.	[Bergquist, Helen] Uppsala Univ, Dept Med Biochem & Microbiol, Microbiol Immunol, Uppsala, Sweden; [Bergquist, Helen; Rocha, Cristina S. J.; Smith, C. I. Edvard; Zain, Rula] Karolinska Inst, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden; [Alvarez-Asencio, Ruben; Rutland, Mark. W.] KTH Royal Inst Technol, Sch Chem Sci & Engn, Dept Chem, Stockholm, Sweden; [Chi-Hung Nguyen] PSL Res Univ, Ctr Univ, Lab Pharmacochim, Inst Curie,INSERM,UMR 9187,U1196,CNRS, Orsay, France; [Good, Liam] Univ London, Dept Pathol & Infect Dis, Royal Vet Coll, London WC1E 7HU, England; [Nielsen, Peter E.] Univ Copenhagen, Panum Inst, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Zain, Rula] Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, SE-17176 Stockholm, Sweden; [Alvarez-Asencio, Ruben] Fdn IMDEA Nanociencia, 9 Campus Univ Cantoblanco, Madrid, Spain	Uppsala University; Karolinska Institutet; Royal Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; University of London; University of London Royal Veterinary College; University of Copenhagen; Karolinska Institutet; Karolinska University Hospital; IMDEA Nanociencia	Zain, R (corresponding author), Karolinska Inst, Dept Lab Med, Clin Res Ctr, SE-14186 Huddinge, Sweden.; Zain, R (corresponding author), Karolinska Univ Hosp, Dept Clin Genet, Ctr Rare Dis, SE-17176 Stockholm, Sweden.	rula.zain@ki.se	Nguyen, Chi/GZG-5146-2022; Rutland, Mark W/F-8890-2012; Nguyen, Chi/GWR-1592-2022; Álvarez-Asencio, Rubén/I-3583-2015	Rutland, Mark W/0000-0002-8935-8070; Álvarez-Asencio, Rubén/0000-0002-0790-194X; Rocha, Cristina/0000-0002-6008-9532; Good, Liam/0000-0002-2798-8640; SMITH, C. I. Edvard/0000-0003-1907-3392; /0000-0001-8771-330X	Knut och Alice Wallenbergs Stiftelse; Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council; Landells stiftelse for neurologisk forskning	Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Magnus Bergvalls Stiftelse; Carl Tryggers Stiftelse for Vetenskaplig Forskning; Swedish Research Council(Swedish Research CouncilEuropean Commission); Landells stiftelse for neurologisk forskning	This work was financially supported by The Knut och Alice Wallenbergs Stiftelse, Magnus Bergvalls Stiftelse, Carl Tryggers Stiftelse for Vetenskaplig Forskning, The Swedish Research Council and Landells stiftelse for neurologisk forskning.	Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Amiri H, 2005, J MOL BIOL, V351, P776, DOI 10.1016/j.jmb.2005.03.044; Bentin T, 2006, NUCLEIC ACIDS RES, V34, P5790, DOI 10.1093/nar/gkl736; Bergquist H, 2009, CHEMBIOCHEM, V10, P2629, DOI 10.1002/cbic.200900263; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Billingsley DJ, 2010, PHYS CHEM CHEM PHYS, V12, P14727, DOI 10.1039/c0cp01347a; Burnett R, 2006, P NATL ACAD SCI USA, V103, P11497, DOI 10.1073/pnas.0604939103; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Carbone GM, 2004, NUCLEIC ACIDS RES, V32, P4358, DOI 10.1093/nar/gkh744; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Datta HJ, 2001, J BIOL CHEM, V276, P18018, DOI 10.1074/jbc.M011646200; DEMIDOV VV, 1995, P NATL ACAD SCI USA, V92, P2637, DOI 10.1073/pnas.92.7.2637; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; EGHOLM M, 1995, NUCLEIC ACIDS RES, V23, P217, DOI 10.1093/nar/23.2.217; Escude C, 1998, P NATL ACAD SCI USA, V95, P3591, DOI 10.1073/pnas.95.7.3591; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Gacy AM, 1998, MOL CELL, V1, P583, DOI 10.1016/S1097-2765(00)80058-1; Grabczyk E, 2000, NUCLEIC ACIDS RES, V28, P2815, DOI 10.1093/nar/28.14.2815; Grant L, 2006, FEBS LETT, V580, P5399, DOI 10.1016/j.febslet.2006.09.006; Greene E, 2007, NUCLEIC ACIDS RES, V35, P3383, DOI 10.1093/nar/gkm271; Groh M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004318; Hansen ME, 2009, NUCLEIC ACIDS RES, V37, P4498, DOI 10.1093/nar/gkp437; HANVEY JC, 1988, P NATL ACAD SCI USA, V85, P6292, DOI 10.1073/pnas.85.17.6292; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Hu JX, 2014, NUCLEIC ACID THER, V24, P199, DOI 10.1089/nat.2013.0476; Jain A, 2002, J BIOMOL STRUCT DYN, V19, P691, DOI 10.1080/07391102.2002.10506775; Jain A, 2010, BIOCHIMIE, V92, P317, DOI 10.1016/j.biochi.2009.12.012; Karkare S, 2006, APPL MICROBIOL BIOT, V71, P575, DOI 10.1007/s00253-006-0434-2; Kosaganov YN, 2000, BIOCHEMISTRY-US, V39, P11742, DOI 10.1021/bi0006417; Krasilnikova MM, 2007, NUCLEIC ACIDS RES, V35, P1075, DOI 10.1093/nar/gkl1140; Krasilnikova MM, 2004, MOL CELL BIOL, V24, P2286, DOI 10.1128/MCB.24.6.2286-2295.2004; Li LD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10606; Liu Y, 2008, NUCLEIC ACIDS RES, V36, P4680, DOI 10.1093/nar/gkn438; Lundin KE, 2013, ADV GENET, V82, P47, DOI 10.1016/B978-0-12-407676-1.00002-0; lvarez-Asencio R, 2016, J MECH BEHAV BIOMED, V54, P185, DOI [10.1016/j.jmbbm.2015.09.014, DOI 10.1016/J.JMBBM.2015.09.014]; Lyubchenko YL, 2011, METHODS, V54, P274, DOI 10.1016/j.ymeth.2011.02.001; Mariappan SVS, 1999, J MOL BIOL, V285, P2035, DOI 10.1006/jmbi.1998.2435; Moreno PMD, 2013, NUCLEIC ACIDS RES, V41, P3257, DOI 10.1093/nar/gkt007; Napierala M, 2004, J BIOL CHEM, V279, P6444, DOI 10.1074/jbc.M309596200; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Nielsen PE, 1996, J AM CHEM SOC, V118, P2287, DOI 10.1021/ja953125q; Nielsen Peter E., 1994, Journal of Molecular Recognition, V7, P165, DOI 10.1002/jmr.300070303; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Pandolfo M, 2002, MITOCHONDRION, V2, P87, DOI 10.1016/S1567-7249(02)00039-9; Pietrement O, 2003, LANGMUIR, V19, P2536, DOI 10.1021/la026942u; Pittenger BB, 2009, BURKER APPL NOTE, V128, P1, DOI 10.13140/RG.2.1.4463.8246; Potaman V N, 1999, Nucleic Acids Res, V27, pe5, DOI 10.1093/nar/27.15.e5; Potaman VN, 2004, NUCLEIC ACIDS RES, V32, P1224, DOI 10.1093/nar/gkh274; Pyne A, 2014, SMALL, V10, P3257, DOI 10.1002/smll.201400265; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Rapireddy S, 2007, J AM CHEM SOC, V129, P15596, DOI 10.1021/ja074886j; Roberts RW, 1996, J MOL BIOL, V260, P135, DOI 10.1006/jmbi.1996.0388; Sakamoto N, 1999, MOL CELL, V3, P465, DOI 10.1016/S1097-2765(00)80474-8; Son LS, 2006, J MOL BIOL, V360, P267, DOI 10.1016/j.jmb.2006.05.025; Suzuki Y, 2011, WIRES NANOMED NANOBI, V3, P574, DOI 10.1002/wnan.150; Vasquez KM, 2002, P NATL ACAD SCI USA, V99, P5848, DOI 10.1073/pnas.082193799; Vetcher AA, 2002, J BIOL CHEM, V277, P39217, DOI 10.1074/jbc.M205209200; Vetcher AA, 2002, J BIOL CHEM, V277, P39228, DOI 10.1074/jbc.M205210200; Wang G, 1996, SCIENCE, V271, P802, DOI 10.1126/science.271.5250.802; Wojciechowska M, 2006, J BIOL CHEM, V281, P24531, DOI 10.1074/jbc.M603888200; Wu Q, 2007, MOL CARCINOGEN, V46, P15, DOI 10.1002/mc.20261; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Zaid A, 2004, CHEMBIOCHEM, V5, P1550, DOI 10.1002/cbic.200400074; Zain R, 2003, CHEMBIOCHEM, V4, P856, DOI 10.1002/cbic.200300621; Zain R, 1999, CHEM BIOL, V6, P771, DOI 10.1016/S1074-5521(99)80124-0; Zhang X, 2000, NUCLEIC ACIDS RES, V28, P3332, DOI 10.1093/nar/28.17.3332; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	69	13	13	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165788	10.1371/journal.pone.0165788	http://dx.doi.org/10.1371/journal.pone.0165788			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846236	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600020
J	Qian, J; Mummalaneni, SK; Alkahtani, RM; Mahavadi, S; Murthy, KS; Grider, JR; Lyall, V				Qian, Jie; Mummalaneni, Shobha K.; Alkahtani, Reem M.; Mahavadi, Sunila; Murthy, Karnam S.; Grider, John R.; Lyall, Vijay			Nicotine-Induced Effects on Nicotinic Acetylcholine Receptors (nAChRs), Ca2+ and Brain-Derived Neurotrophic Factor (BDNF) in STC-1 Cells	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; BITTER TASTE RECEPTORS; GASTROINTESTINAL-TRACT; UP-REGULATION; EXPRESSION; RELEASE; GUT; SECRETION; MOUSE; TRANSDUCTION	In addition to the T2R bitter taste receptors, neuronal nicotinic acetylcholine receptors (nAChRs) have recently been shown to be involved in the bitter taste transduction of nicotine, acetylcholine and ethanol. However, at present it is not clear if nAChRs are expressed in enteroendocrine cells other than beta cells of the pancreas and enterochromaffin cells, and if they play a role in the synthesis and release of neurohumoral peptides. Accordingly, we investigated the expression and functional role of nAChRs in enteroendocrine STC-1 cells. Our studies using RT-PCR, qRT-PCR, immunohistochemical and Western blotting techniques demonstrate that STC-1 cells express several alpha and beta nAChR subunits. Exposing STC-1 cells to nicotine acutely (24h) or chronically (4 days) induced a differential increase in the expression of nAChR subunit mRNA and protein in a dose- and time-dependent fashion. Mecamylamine, a non-selective antagonist of nAChRs, inhibited the nicotine induced increase in mRNA expression of nAChRs. Exposing STC-1 cells to nicotine increased intracellular Ca2+ in a dose-dependent manner that was inhibited in the presence of mecamylamine or dihydro-beta-erythroidine, a alpha 4 beta 2 nAChR antagonist. Brain-derived neurotrophic factor (BDNF) mRNA and protein were detected in STC-1 cells using RT-PCR, specific BDNF antibody, and enzyme-linked immunosorbent assay. Acute nicotine exposure (30 min) decreased the cellular content of BDNF in STC-1 cells. The nicotine-induced decrease in BDNF was inhibited in the presence of mecamylamine. We also detected alpha 3 and beta 4 mRNA in intestinal mucosal cells and alpha 3 protein expression in intestinal enteroendocrine cells. We conclude that STC-1 cells and intestinal enteroendocrine cells express nAChRs. In STC-1 cells nAChR expression is modulated by exposure to nicotine in a dose- and time-dependent manner. Nicotine interacts with nAChRs and inhibits BDNF expression in STC-1 cells.	[Qian, Jie; Mummalaneni, Shobha K.; Alkahtani, Reem M.; Mahavadi, Sunila; Murthy, Karnam S.; Grider, John R.; Lyall, Vijay] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA	Virginia Commonwealth University	Lyall, V (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23219 USA.	vijay.lyall@vcuhelth.org			National Institute on Deafness and Other Communication Disorders [DC11569]; National Institute of Diabetes and Digestive and Kidney Diseases [DK34153, DK28300]; National Cancer Institute [PA30 CM6059]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK028300, R01DK034153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011569] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders, grant DC11569 to VL; National Institute of Diabetes and Digestive and Kidney Diseases, grant DK34153 to JRG; National Institute of Diabetes and Digestive and Kidney Diseases, grant DK28300 to KSM and National Cancer Institute, grant PA30 CM6059-Core Imaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qudah M, 2015, NEUROGASTROENT MOTIL, V27, P1162, DOI 10.1111/nmo.12604; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Arredondo J, 2003, LAB INVEST, V83, P207, DOI 10.1097/01.LAB.0000053917.46614.12; Bala V, 2011, GASTROENTEROLOGY, V140, pS324; Berridge KC, 2009, PHYSIOL BEHAV, V97, P537, DOI 10.1016/j.physbeh.2009.02.044; Bezencon C, 2007, CHEM SENSES, V32, P41, DOI 10.1093/chemse/bjl034; Breslin PAS, 2006, ADV OTO-RHINO-LARYNG, V63, P152, DOI 10.1159/000093760; Brondel L, 1999, INT J OBESITY, V23, P34, DOI 10.1038/sj.ijo.0800754; Brown KC, 2013, J BIOL CHEM, V288, P33049, DOI 10.1074/jbc.M113.501601; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; CHEN MC, 2006, J PHYSICS, V291, pC726, DOI DOI 10.1152/AIPCELL.00003.2006; Cheung AT, 2000, SCIENCE, V290, P1959, DOI 10.1126/science.290.5498.1959; Daly K, 2013, AM J PHYSIOL-GASTR L, V304, pG271, DOI 10.1152/ajpgi.00074.2012; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Dehkordi O, 2010, LIFE SCI, V86, P281, DOI 10.1016/j.lfs.2009.12.016; Depoortere I, 2015, PEPTIDES, V66, P9, DOI 10.1016/j.peptides.2015.01.013; DeSimone J. A., 2015, THESIS, P667; DeSimone JA, 2006, AM J PHYSIOL-GASTR L, V291, pG1005, DOI 10.1152/ajpgi.00235.2006; Dyer J, 2005, BIOCHEM SOC T, V33, P302, DOI 10.1042/BST0330302; Fox AM, 2015, J BIOL CHEM, V290, P24403, DOI 10.1074/jbc.M115.661827; Fujita Y, 2009, AM J PHYSIOL-ENDOC M, V296, pE473, DOI 10.1152/ajpendo.90636.2008; Gallego X, 2012, ALCOHOL, V46, P205, DOI 10.1016/j.alcohol.2011.11.005; Geraedts MCP, 2011, OBES REV, V12, P470, DOI 10.1111/j.1467-789X.2010.00788.x; Govind AP, 2009, BIOCHEM PHARMACOL, V78, P756, DOI 10.1016/j.bcp.2009.06.011; Grider JR, 2006, GASTROENTEROLOGY, V130, P771, DOI 10.1053/j.gastro.2005.12.026; GRITZ E R, 1988, Alimentary Pharmacology and Therapeutics, V2, P173; Hendrickson Linzy M, 2013, Front Psychiatry, V4, P29, DOI 10.3389/fpsyt.2013.00029; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang T, 2015, DEV BIOL, V405, P225, DOI 10.1016/j.ydbio.2015.07.006; Ishida Y, 2002, MOL BRAIN RES, V107, P17, DOI 10.1016/S0169-328X(02)00441-2; Ito A, 2009, CELL TISSUE RES, V337, P349, DOI 10.1007/s00441-009-0833-7; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Jones IW, 2005, TRENDS NEUROSCI, V28, P343, DOI 10.1016/j.tins.2005.04.010; Kido MA, 2003, J DENT RES, V82, P393, DOI 10.1177/154405910308200513; Kim KS, 2014, DIABETOLOGIA, V57, P2117, DOI 10.1007/s00125-014-3326-5; Kokrashvili Z, 2009, AM J CLIN NUTR, V90, p822S, DOI 10.3945/ajcn.2009.27462T; LEE K, 1992, N-S ARCH PHARMACOL, V345, P363; Margolskee RF, 2007, P NATL ACAD SCI USA, V104, P15075, DOI 10.1073/pnas.0706678104; McConnell WM, 1995, DIGEST DIS SCI, V40, P2608, DOI 10.1007/BF02220449; Meng LB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0097-15.2015; Miyata M, 2014, BIOMED RES-TOKYO, V35, P171, DOI 10.2220/biomedres.35.171; Moser N, 2007, J NEUROCHEM, V102, P479, DOI 10.1111/j.1471-4159.2007.04498.x; Mummalaneni S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098049; Oliveira-Maia AJ, 2009, P NATL ACAD SCI USA, V106, P1596, DOI 10.1073/pnas.0810184106; Parker SL, 2004, MOL PHARMACOL, V65, P611, DOI 10.1124/mol.65.3.611; Ren ZJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127936; Richardson CE, 2003, QJM-INT J MED, V96, P57, DOI 10.1093/qjmed/hcg007; Saitoh O, 2007, NEUROREPORT, V18, P1991, DOI 10.1097/WNR.0b013e3282f242d3; Sallette J, 2005, NEURON, V46, P595, DOI 10.1016/j.neuron.2005.03.029; Schneider DA, 2000, J PHARMACOL EXP THER, V294, P363; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Sturz GR, 2011, CHEM SENSES, V36, P375, DOI 10.1093/chemse/bjq146; Sun CS, 2015, J NEUROSCI, V35, P409, DOI 10.1523/JNEUROSCI.2381-14.2015; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Wang XY, 2015, NEUROL SCI, V36, P289, DOI 10.1007/s10072-014-1934-y; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Yee C, 2005, J COMP NEUROL, V490, P371, DOI 10.1002/cne.20670; Yee CL, 2003, J COMP NEUROL, V459, P15, DOI 10.1002/cne.10589; Yeomans MR, 1998, P NUTR SOC, V57, P609, DOI 10.1079/PNS19980089; Zhou XP, 2002, J PHARMACOL EXP THER, V302, P889, DOI 10.1124/jpet.102.033548; Zoli M, 2012, NICOTINE TOB RES, V14, P1270, DOI 10.1093/ntr/nts159	65	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166565	10.1371/journal.pone.0166565	http://dx.doi.org/10.1371/journal.pone.0166565			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846263	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600082
J	Wang, DC; Meng, G; Zheng, MH; Zhang, YH; Chen, AP; Wu, JH; Wei, JW				Wang, Diancheng; Meng, Gang; Zheng, Meihong; Zhang, Yonghui; Chen, Aiping; Wu, Junhua; Wei, Jiwu			The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells	PLOS ONE			English	Article							KIDNEY-TYPE GLUTAMINASE; CANCER-CELLS; IN-VITRO; APOPTOSIS; GROWTH; ARTEMISININ; SUPPRESSION; METABOLISM; EXPRESSION; MECHANISM	Reprogrammed metabolism and redox homeostasis are potential targets of cancer therapy. Our previous study demonstrated that the kidney form of glutaminase (GLS1) is highly expressed in hepatocellular carcinoma (HCC) cells and can be used as a target for effective anticancer therapy. Dihydroartemisinin (DHA) increases intracellular reactive oxygen species (ROS) levels leading to cytotoxicity in cancer cells. However, the heterogeneity of cancer cells often leads to differing responses to oxidative lesions. For instance, cancer cells with high ratio of GSH/GSSG, a critical ROS scavenger, are resistant to ROS-induced cytotoxicity. We postulate that a combinatorial strategy firstly disrupting redox homeostasis followed by DHA might yield a profound antitumor efficacy. In this study, when HCC cells were treated with a GLS1 inhibitor 968, the ROS elimination capacity was significantly reduced in HCC cells, which rendered HCC cells but not normal endothelial cells more sensitive to DHA-mediated cytotoxicity. We further confirmed that this synergistic antitumor efficacy was mediated by excessive ROS generation in HCC cells. NAC, a ROS inhibitor, partly rescued the combinatorial cytotoxic effect of 968 and DHA. Given that GLS1 is a potential antitumor target and DHA has been safely used in clinic, our findings provide new insight into liver cancer therapy targeting glutamine metabolism combined with the ROS generator DHA, which can be readily translated into cancer clinical trials.	[Wang, Diancheng; Meng, Gang; Zheng, Meihong; Zhang, Yonghui; Chen, Aiping; Wu, Junhua; Wei, Jiwu] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China; [Wei, Jiwu] Nanjing Univ Hightech Inst, Suzhou 215123, Peoples R China	Nanjing University	Wu, JH; Wei, JW (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing 210093, Jiangsu, Peoples R China.; Wei, JW (corresponding author), Nanjing Univ Hightech Inst, Suzhou 215123, Peoples R China.	wujunhua@nju.edu.cn; wjw@nju.edu.cn		zhang, yonghui/0000-0001-7542-5183	National Natural Science Foundation of China [81172143, 81472820]; Jiangsu Special Program for Clinical Medical Science and Technology [BL2014054]; Natural Science Foundation of Jiangsu Province [BK20141324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Special Program for Clinical Medical Science and Technology; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Natural Science Foundation of China (81172143 and 81472820, http://www.nsfc.gov.cn/), Jiangsu Special Program for Clinical Medical Science and Technology (BL2014054, http://www.jskjjh.gov.cn/13kjskj2/), and the Natural Science Foundation of Jiangsu Province (no. BK20141324, http://www.jskjjh.gov.cn/13kjskj2/).; This work was supported by the National Natural Science Foundation of China (81172143 and 81472820), Jiangsu Special Program for Clinical Medical Science and Technology (BL2014054) and the Natural Science Foundation of Jiangsu Province (no. BK20141324). We thank Translational Medicine Core facilities of Medical School of Nanjing University for instruments supporting.	Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Disbrow GL, 2005, CANCER RES, V65, P10854, DOI 10.1158/0008-5472.CAN-05-1216; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Emadi A, 2014, EXP HEMATOL, V42, P247, DOI 10.1016/j.exphem.2013.12.001; Erickson JW, 2010, ONCOTARGET, V1, P734, DOI 10.18632/oncotarget.208; Fang J, 2009, ADV DRUG DELIVER REV, V61, P290, DOI 10.1016/j.addr.2009.02.005; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiao Y, 2007, ACTA PHARMACOL SIN, V28, P1045, DOI 10.1111/j.1745-7254.2007.00612.x; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Li Jun, 2005, Yao Xue Xue Bao, V40, P1041; Liem Minh Phan, 2014, Cancer Biology Medicine, V11, P1, DOI 10.7497/j.issn.2095-3941.2014.01.001; Lu JJ, 2011, INVEST NEW DRUG, V29, P1276, DOI 10.1007/s10637-010-9481-8; Lu WQ, 2010, CANCER CELL, V18, P199, DOI 10.1016/j.ccr.2010.08.017; Lu YY, 2010, FEBS LETT, V584, P4019, DOI 10.1016/j.febslet.2010.08.014; Lu YY, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-16; Ma Zhen-qiu, 2007, Zhejiang Da Xue Xue Bao Yi Xue Ban, V36, P267; Meng G, 2014, INT J CANCER, V134, P1958, DOI 10.1002/ijc.28416; Nam W, 2007, HEAD NECK-J SCI SPEC, V29, P335, DOI 10.1002/hed.20524; Robinson MM, 2007, BIOCHEM J, V406, P407, DOI 10.1042/BJ20070039; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sun HJ, 2013, TUMOR BIOL, V34, P3791, DOI 10.1007/s13277-013-0963-0; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tan WF, 2011, PHYTOMEDICINE, V18, P158, DOI 10.1016/j.phymed.2010.07.003; Thangavelu K, 2012, P NATL ACAD SCI USA, V109, P7705, DOI 10.1073/pnas.1116573109; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wang SJ, 2011, CANCER CHEMOTH PHARM, V68, P1421, DOI 10.1007/s00280-011-1643-7; Wang SJ, 2010, CANCER LETT, V293, P99, DOI 10.1016/j.canlet.2010.01.001; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Wu XH, 2006, ANTI-CANCER DRUG, V17, P839, DOI 10.1097/01.cad.0000224443.85834.32; Xiang Y, 2015, J CLIN INVEST, V125, P2293, DOI 10.1172/JCI75836; Yu DC, 2015, ONCOTARGET, V6, P7619, DOI 10.18632/oncotarget.3196; Zhang CZ, 2012, BIOCHEM PHARMACOL, V83, P1278, DOI 10.1016/j.bcp.2012.02.002	42	23	25	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166423	10.1371/journal.pone.0166423	http://dx.doi.org/10.1371/journal.pone.0166423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835669	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200050
J	Hew, J; Solon-Biet, SM; McMahon, AC; Ruohonen, K; Raubenheimer, D; Ballard, JWO; Le Couteur, DG; Nicholls, C; Li, Z; Maitz, PKM; Wang, YW; Simpson, SJ				Hew, Jonathan; Solon-Biet, Samantha M.; McMahon, Aisling C.; Ruohonen, Kari; Raubenheimer, David; Ballard, J. William O.; Le Couteur, David G.; Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.; Wang, Yiwei; Simpson, Stephen J.			The Effects of Dietary Macronutrient Balance on Skin Structure in Aging Male and Female Mice	PLOS ONE			English	Article							PROTEIN-ENERGY MALNUTRITION; GENDER-DIFFERENCES; ADIPOSE-TISSUE; RAT SKIN; NUTRITION; PHYSIOLOGY; HISTOLOGY; AGE; FIBROBLASTS; THICKNESS	Nutrition influences skin structure; however, a systematic investigation into how energy and macronutrients (protein, carbohydrate and fat) affects the skin has yet to be conducted. We evaluated the associations between macronutrients, energy intake and skin structure in mice fed 25 experimental diets and a control diet for 15 months using the Geometric Framework, a novel method of nutritional analysis. Skin structure was associated with the ratio of dietary macronutrients eaten, not energy intake, and the nature of the effect differed between the sexes. In males, skin structure was primarily associated with protein intake, whereas in females carbohydrate intake was the primary correlate. In both sexes, the dermis and subcutaneous fat thicknesses were inversely proportional. Subcutaneous fat thickness varied positively with fat intake, due to enlarged adipocytes rather than increased adipocyte number. We therefore demonstrated clear interactions between skin structure and macronutrient intakes, with the associations being sex-specific and dependent on dietary macronutrient balance.	[Hew, Jonathan; Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.; Wang, Yiwei] Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, Concord Hosp, Ageing & Alzheimers Inst, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; McMahon, Aisling C.; Le Couteur, David G.] Univ Sydney, Concord Hosp, ANZAC Res Inst, Sydney, NSW 2139, Australia; [Solon-Biet, Samantha M.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Solon-Biet, Samantha M.; Raubenheimer, David; Le Couteur, David G.; Simpson, Stephen J.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia; [Ruohonen, Kari] EWOS Innovat, N-4335 Dirdal, Norway; [Raubenheimer, David] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia; [Raubenheimer, David] Univ Sydney, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [Ballard, J. William O.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia; [Nicholls, Caroline; Li, Zhe; Maitz, Peter K. M.] Concord Repatriat Gen Hosp, Burns Unit, Concord, Australia	Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; Concord Repatriation General Hospital; University of Sydney; Concord Repatriation General Hospital; University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney; Concord Repatriation General Hospital	Wang, YW (corresponding author), Univ Sydney, Concord Hosp, ANZAC Res Inst, Burns Res & Reconstruct Surg, Sydney, NSW 2139, Australia.; Simpson, SJ (corresponding author), Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia.; Simpson, SJ (corresponding author), Univ Sydney, Sch Life & Environm Sci, Sydney, NSW, Australia.	yiweiwang@anzac.edu.au; stephen.simpon@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Maitz, Peter/GQI-2475-2022; Ekanayake, Kanchana/P-8817-2016; Ballard, John William O./ABB-2743-2020; Solon-Biet, Samantha/R-6551-2017	Ballard, John William O./0000-0002-2358-6003; Solon-Biet, Samantha/0000-0003-0608-958X; Simpson, Stephen J./0000-0003-0256-7687; Maitz, Peter/0000-0002-8257-7414; Raubenheimer, David/0000-0001-9050-1447	Australian National Health and Medical Research Council (NHMRC) [571328]; Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials; Australian Research Council; NHMRC [GNT 1110098]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials; Australian Research Council(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	Funding was obtained from the Australian National Health and Medical Research Council (NHMRC project grant 571328), the Ageing and Alzheimer's Institute (AAAI) of Concord RG Hospital for research materials. SJS was supported by an Australian Research Council Laureate Fellowship. DR is an Adjunct Professor in the New Zealand Institute for Advanced Study, Massey University, Auckland. SMS-B is supported by a NHMRC Early Career Fellowship (GNT 1110098). KR is employed by EWOS Innovation. EWOS Innovation provided support in the form of salary for author KR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Arnold M, 2006, PLAST RECONSTR SURG, V117, p42S, DOI 10.1097/01.prs.0000225432.17501.6c; Azzi L, 2005, J INVEST DERMATOL, V124, P22, DOI 10.1111/j.0022-202X.2004.23545.x; BARBUL A, 1994, CLIN DERMATOL, V12, P133, DOI 10.1016/0738-081X(94)90264-X; Barker LA, 2011, INT J ENV RES PUB HE, V8, P514, DOI 10.3390/ijerph8020514; Booth A, 2014, HORM MOL BIOL CLIN I, V17, P13, DOI 10.1515/hmbci-2014-0009; Brown KL, 2010, CLIN DERMATOL, V28, P432, DOI 10.1016/j.clindermatol.2010.03.028; Dao H, 2007, GENDER MED, V4, P308; Ezeh AC, 2012, LANCET, V380, P142, DOI 10.1016/S0140-6736(12)60696-5; Ezure T, 2011, J INVEST DERMATOL, V131, P2004, DOI 10.1038/jid.2011.145; Ezure T, 2010, EXP DERMATOL, V19, P878, DOI 10.1111/j.1600-0625.2009.00970.x; Farage M. A., 2008, International Journal of Cosmetic Science, V30, P87, DOI 10.1111/j.1468-2494.2007.00415.x; Gantwerker EA, 2011, FACIAL PLAST SURG CL, V19, P441, DOI 10.1016/j.fsc.2011.06.009; Hwa C, 2011, DERMATOL THER, V24, P464, DOI 10.1111/j.1529-8019.2012.01460.x; Khavkin J, 2011, FACIAL PLAST SURG CL, V19, P229, DOI 10.1016/j.fsc.2011.04.003; Klein J, 2007, EXP DERMATOL, V16, P45, DOI 10.1111/j.1600-0625.2006.00519.x; Lakdawala N, 2013, CLIN DERMATOL, V31, P677, DOI [10.1016/j.clindermatol.2013.05.004, 10.1016/j.clindermato1.2013.05.004]; Le Couteur DG, 2015, J GERONTOL A-BIOL, V70, P1499, DOI 10.1093/gerona/glu196; Leite SN, 2011, AN BRAS DERMATOL, V86, P681, DOI 10.1590/S0365-05962011000400009; LOEWENTHAL LA, 1955, J INVEST DERMATOL, V24, P429, DOI 10.1038/jid.1955.58; Makrantonaki E, 2008, EXP GERONTOL, V43, P939, DOI 10.1016/j.exger.2008.07.005; Makrantonaki E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050393; MCLAREN DS, 1987, ARCH DERMATOL, V123, P1674, DOI 10.1001/archderm.123.12.1674b; Moverare S, 2002, J INVEST DERMATOL, V119, P1053, DOI 10.1046/j.1523-1747.2002.00637.x; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Rivera-Gonzalez G, 2014, COLD SPRING HARB PER, V4, P1; Robert L, 2009, PATHOL BIOL, V57, P336, DOI 10.1016/j.patbio.2008.09.007; Scheinfeld NS, 2004, CLIN DERMATOL, V22, P303, DOI 10.1016/j.clindermatol.2004.01.001; Shu YY, 2011, AM J CLIN DERMATOL, V12, P297, DOI 10.2165/11589180-000000000-00000; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x; Simanainen U, 2015, HORM CANCER-US, V6, P45, DOI 10.1007/s12672-014-0210-1; Simpson SJ, 2012, NATURE NUTR UNIFYING, P248; Simpson SJ, 2015, CELL, V161, P18, DOI 10.1016/j.cell.2015.02.033; SJOSTROM L, 1972, METABOLISM, V21, P1143, DOI 10.1016/0026-0495(72)90109-6; Solon-Biet SM, 2015, P NATL ACAD SCI USA, V112, P3481, DOI 10.1073/pnas.1422041112; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Sorensen A, 2008, OBESITY, V16, P566, DOI 10.1038/oby.2007.58; Stevenson S, 2007, CLIN INTERV AGING, V2, P283; Sugiyama A, 2011, J VET MED SCI, V73, P831, DOI 10.1292/jvms.10-0399; THAVARAJ V, 1989, J TROP PEDIATRICS, V35, P105, DOI 10.1093/tropej/35.3.105; Thomas JR, 2005, LARYNGOSCOPE, V115, P405, DOI 10.1097/01.mlg.0000157845.86154.48; Wild T, 2010, NUTRITION, V26, P862, DOI 10.1016/j.nut.2010.05.008; Williams JZ, 2003, SURG CLIN N AM, V83, P571, DOI 10.1016/S0039-6109(02)00193-7; Yamane T, 2010, MOL NUTR FOOD RES, V54, pS53, DOI 10.1002/mnfr.201000022; Yosipovitch G, 2007, J AM ACAD DERMATOL, V56, P901, DOI 10.1016/j.jaad.2006.12.004	45	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166175	10.1371/journal.pone.0166175	http://dx.doi.org/10.1371/journal.pone.0166175			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832138	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000073
J	Li, WH; Guo, J; Li, FW; Niu, CN				Li, Wenhui; Guo, Jian; Li, Fanwen; Niu, Chune			Evaluation of Crossbreeding of Australian Superfine Merinos with Gansu Alpine Finewool Sheep to Improve Wool Characteristics	PLOS ONE			English	Article							TRAITS; REPRODUCTION; GROWTH	Crossbreeding of Australian Superfine Merinos (ASMs) with Gansu Alpine Finewool (GAF) sheep and an evaluation of the potential benefits of this genetic cross has not been previously conducted. 13 ASMs were crossbred with GAF sheep over a five year period with backcrossing designed to assess heterosis. Data from 11,178 lambs sired by 189 rams were used in the study. Genotype, birth year, birth type, dam age, sex and/or management group, and record age were fitted as fixed effects and within-genotype sire fitted as a random effect. Crossbreeds of 1/2 ASM expressed the most desirable effects for improving average fiber diameter (AFD), clean fleece weight (CFW), yield, coefficient of variation of AFD (CVAFD), yearling staple length (YSL) to AFD ratio (YSUAFD), and CFW to metabolic yearling bodyweight (YWT0.75) ratio (CFWNWT0.75) but showed the least post-weaning average daily gain (powADG) and YWT. Genotype of backcrossing with 1/4 ASM obtained moderate improvements in AFD, CFW, CVAFD, and YSUAFD but the highest YSL, WWT, and prwADG. Except for yield (-1.42%) and CFWNWT0.75 (-1%), heterosis estimates were generally low and positive, and ranged from 0.1% for CVAFD to 4% for powADG, which indicates the potential to improve relevant traits through exploiting heterosis to a varying extent. The ASMs sampled in this study were found to be superior to GAFs for AFD, CFW, yield, and CVAFD by 19.82%, 11.68%, 14.47%, and 6.99%, respectively, but inferior for YSL, PowADG, and YWT by 4.36%, 50.97%, and 16.93%, respectively. ASMs also appeared to be more efficient than GAFs in clean wool production (25.34%) and staple length growth (16.17%). The results of our study strongly suggest that an infusion of ASM genes via crossbreeding is an effective and appropriate approach to improve wool microns and wool production from GAF sheep, and we make recommendations to tackle the undesirable traits of YWT and YSL from ASM introduction.	[Li, Wenhui; Li, Fanwen] Gansu Prov Sheep Breeding Technol Extens Stn, Sunan, Gansu, Peoples R China; [Guo, Jian; Niu, Chune] CAAS, Lanzhou Inst Husb & Pharmaceut Sci, Jiangouyan St, Lanzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Li, WH (corresponding author), Gansu Prov Sheep Breeding Technol Extens Stn, Sunan, Gansu, Peoples R China.	whleee2004@163.com			Fund for Modern China Wool & Cashmere Technology Research System [CARS-40-33]; Fund for Gansu Provincial Science and Technology Supporting Program [1604NKCG046]; fund for Gansu Provincial 10th Five Year Key Science and Technology Project [GS022-A41-052]	Fund for Modern China Wool & Cashmere Technology Research System; Fund for Gansu Provincial Science and Technology Supporting Program; fund for Gansu Provincial 10th Five Year Key Science and Technology Project	This work was supported by the Fund for Modern China Wool & Cashmere Technology Research System (Grant no.CARS-40-33); the Fund for Gansu Provincial Science and Technology Supporting Program (Grant no. 1604NKCG046); the fund for Gansu Provincial 10th Five Year Key Science and Technology Project (Grant no. GS022-A41-052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams NR, 2003, AUST J AGR RES, V54, P1, DOI 10.1071/AR02059; Australian Wool Testing Authority Limited, 2015, MICR PROF DAT AUSTR; BUTLER LG, 1993, AUST J EXP AGR, V33, P397, DOI 10.1071/EA9930397; Chen WD, 1988, WOOL TECH SHEEP BREE, V36, P24; Dickerson GE., 1969, ANIM BREED ABSTR, V37, P191; Elena Ghita, 2007, ARCH ZOOTECH, V10, P102; Fogarty N. M., 2006, Proceedings of the 8th World Congress on Genetics Applied to Livestock Production, Belo Horizonte, Minas Gerais, Brazil, 13-18 August, 2006, P32; GANAI TAS, 1993, INDIAN J ANIM SCI, V63, P783; Gilmour AR, 2009, ASREML USER GUIDE RE; Greeff J, 1995, J ANIM BREED GEN, V11, P595; Hygate L, 1999, P ASS ADV BREED GENE, V13, P50; Kinghorn B. P., 1987, Proceedings of the the Sixth Conference, Australian Association of Animal Breeding and Genetics, University of Western Australia, Perth, WA, Australia, 9-11 February 1987., P112; Kinghorn BP, 1987, MERINO IMPROVEMENT P, P398; Li WH, 2012, ANIM PROD SCI, V52, P321, DOI 10.1071/AN11157; MCGUIRK B, 1988, WOOL TECH SHEEP BREE, V36, P28; MORTIMER SI, 1988, WOOL TECH SHEEP BREE, V35, P208; Purvis I., 1990, P 4 WORLD C GEN APPL, VXV, P220; Rong WH, 1998, WOOL TECH SHEEP BREE, V46, P133; Safari E, 2005, LIVEST PROD SCI, V92, P271, DOI 10.1016/j.livprodsci.2004.09.003; Snowder GD, 1998, SHEEP GOAT RES J, V12, P108; Sun SZ, 1997, CHIN J ANIM SCI, V27, P37; Swan AA, 2005, P 16 C ASS ADV AN BR, P165	22	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166374	10.1371/journal.pone.0166374	http://dx.doi.org/10.1371/journal.pone.0166374			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832155	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000115
J	Melachroinou, K; Leandrou, E; Valkimadi, PE; Memou, A; Hadjigeorgiou, G; Stefanis, L; Rideout, HJ				Melachroinou, Katerina; Leandrou, Emmanouela; Valkimadi, Polytimi-Eleni; Memou, Anna; Hadjigeorgiou, Georgios; Stefanis, Leonidas; Rideout, Hardy J.			Activation of FADD-Dependent Neuronal Death Pathways as a Predictor of Pathogenicity for LRRK2 Mutations	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; 14-3-3 BINDING; PROTEIN; G2019S; DEPHOSPHORYLATION; PHOSPHORYLATION; COMMON; RISK	Background Despite the plethora of sequence variants in LRRK2, only a few clearly segregate with PD. Even within this group of pathogenic mutations, the phenotypic profile can differ widely. Objective We examined multiple properties of LRRK2 behavior in cellular models over-expressing three sequence variants described in Greek PD patients in comparison to several known pathogenic and non-pathogenic LRRK2 mutations, to determine if specific phenotypes associated with pathogenic LRRK2 can be observed in other less-common sequence variants for which pathogenicity is unclear based on clinical and/or genetic data alone. Methods The oligomerization, activity, phosphorylation, and interaction with FADD was assessed in HEK293T cells over-expressing LRRK2; while the induction of neuronal death was determined by quantifying apoptotic nuclei in primary neurons transiently expressing LRRK2. Results One LRRK2 variant, A211V, exhibited a modest increase in kinase activity, whereas only the pathogenic mutants G2019S and I2020T displayed significantly altered auto-phosphorylation. We observed an induction of detergent-insoluble high molecular weight structures upon expression of pathogenic LRRK2 mutants, but not the other LRRK2 variants. In contrast, each of the variants tested induced apoptotic death of cultured neurons similar to pathogenic LRRK2 in a FADD-dependent manner. Conclusions Overall, despite differences in some properties of LRRK2 function such as kinase activity and its oligomerization, each of the LRRK2 variants examined induced neuronal death to a similar extent. Furthermore, our findings further strengthen the notion of a convergence on the extrinsic cell death pathway common to mutations in LRRK2 that are capable of inducing neuronal death.	[Melachroinou, Katerina; Leandrou, Emmanouela; Valkimadi, Polytimi-Eleni; Memou, Anna; Stefanis, Leonidas; Rideout, Hardy J.] Acad Athens, Div Basic Neurosci, Biomed Res Fdn, Athens, Greece; [Hadjigeorgiou, Georgios] Inst Biomed Res & Technol CERETETH, Dept Neurogenet, Larisa, Greece; [Hadjigeorgiou, Georgios] Univ Thessaly, Dept Neurol, Sch Med, Larisa, Greece; [Stefanis, Leonidas] Univ Athens, Sch Med, Dept Neurol 2, Athens, Greece	Academy of Athens; University of Thessaly; Athens Medical School; National & Kapodistrian University of Athens	Rideout, HJ (corresponding author), Acad Athens, Div Basic Neurosci, Biomed Res Fdn, Athens, Greece.	hrideout@bioacademy.gr	Stefanis, Leonidas/AAD-7192-2019	Melachroinou, Katerina/0000-0001-6906-6946; Leandrou, Emmanouela/0000-0001-7364-0445	International Research Grants Program award from the Parkinson's Disease Foundation; Innovation Grant from Parkinson's UK [K-1208]; Michael J Fox Foundation for Parkinson's Research [8418]; Hellenic General Secretariat of Research and Technology ("SINERGASIA") [09SigmaYN-12-876]; Parkinson&quot;s UK [K-1208] Funding Source: researchfish	International Research Grants Program award from the Parkinson's Disease Foundation; Innovation Grant from Parkinson's UK; Michael J Fox Foundation for Parkinson's Research; Hellenic General Secretariat of Research and Technology ("SINERGASIA"); Parkinson&quot;s UK(Parkinson&apos;s UK)	This work was supported by an International Research Grants Program award from the Parkinson's Disease Foundation (HJR), an Innovation Grant from Parkinson's UK (K-1208; HJR), The Michael J Fox Foundation for Parkinson's Research (ID# 8418; HJR); and by the Hellenic General Secretariat of Research and Technology ("SINERGASIA", 09 Sigma YN-12-876; LS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Biosa A, 2013, HUM MOL GENET, V22, P1140, DOI 10.1093/hmg/dds522; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Bozi M, 2014, EUR J NEUROL, V21, P963, DOI 10.1111/ene.12315; Chia R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6827; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Greggio E, 2008, J BIOL CHEM, V283, P16906, DOI 10.1074/jbc.M708718200; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Haugarvoll K, 2008, NEUROLOGY, V70, P1456, DOI 10.1212/01.wnl.0000304044.22253.03; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Ito G, 2012, BIOCHEM J, V441, P987, DOI 10.1042/BJ20111215; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kalinderi K, 2007, EUR J NEUROL, V14, P1088, DOI 10.1111/j.1468-1331.2007.01867.x; Kamikawaji S, 2013, BIOCHEMISTRY-US, V52, P6052, DOI 10.1021/bi400596m; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lobbestael E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33897; Lobbestael E, 2013, BIOCHEM J, V456, P119, DOI 10.1042/BJ20121772; Marder K, 2015, NEUROLOGY, V85, P89, DOI 10.1212/WNL.0000000000001708; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Paisan-Ruiz C, 2013, J PARKINSON DIS, V3, P85, DOI 10.3233/JPD-130192; Papapetropoulos S, 2008, J CLIN NEUROSCI, V15, P1027, DOI 10.1016/j.jocn.2007.08.013; Pungaliya PP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013672; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Reyniers L, 2014, J NEUROCHEM, V131, P239, DOI 10.1111/jnc.12798; Reynolds A, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00054; Rideout HJ, 2014, NEUROCHEM RES, V39, P576, DOI 10.1007/s11064-013-1073-5; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Skibinski G, 2014, J NEUROSCI, V34, P418, DOI 10.1523/JNEUROSCI.2712-13.2014; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Spanaki C, 2006, NEUROLOGY, V67, P1518, DOI 10.1212/01.wnl.0000239829.33936.73; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Steger M, 2016, ELIFE, V5, DOI 10.7554/eLife.12813; Vancraenenbroeck R, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00051; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Xiromerisiou G, 2007, EUR J NEUROL, V14, P7, DOI 10.1111/j.1468-1331.2006.01551.x; Zhao J, 2015, BIOCHEM J, V469, P107, DOI 10.1042/BJ20141305	46	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166053	10.1371/journal.pone.0166053	http://dx.doi.org/10.1371/journal.pone.0166053			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832104	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000060
J	Recek, N; Andjelic, S; Hojnik, N; Filipic, G; Lazovic, S; Vesel, A; Primc, G; Mozetic, M; Hawlina, M; Petrovski, G; Cvelbar, U				Recek, Nina; Andjelic, Sofija; Hojnik, Nataga; Filipic, Gregor; Lazovic, Sasa; Vesel, Alenka; Primc, Gregor; Mozetic, Miran; Hawlina, Marko; Petrovski, Goran; Cvelbar, Uros			Microplasma Induced Cell Morphological Changes and Apoptosis of Ex Vivo Cultured Human Anterior Lens Epithelial Cells - Relevance to Capsular Opacification	PLOS ONE			English	Article							DIELECTRIC BARRIER DISCHARGE; LIPID-PEROXIDATION; GAS-FLOW; PLASMA; DAMAGE; DNA; STERILIZATION; STRESS	Inducing selective or targeted cell apoptosis without affecting large number of neighbouring cells remains a challenge. A plausible method for treatment of posterior capsular opacification (PCO) due to remaining lens epithelial cells (LECs) by reactive chemistry induced by localized single electrode microplasma discharge at top of a needle-like glass electrode with spot size-3 pm is hereby presented. The focused and highly-localized atmospheric pressure microplasma jet with electrode discharge could induce a dose-dependent apoptosis in selected and targeted individual LECs, which could be confirmed by real-time monitoring of the morphological and structural changes at cellular level. Direct cell treatment with micro plasma inside the medium appeared more effective in inducing apoptosis (caspase 8 positivity and DNA fragmentation) at a highly targeted cell level compared to treatment on top of the medium (indirect treatment). Our results show that single cell specific micropipette plasma can be used to selectively induce demise in LECs which remain in the capsular bag after cataract surgery and thus prevent their migration (CXCR4 positivity) to the posterior lens capsule and PCO formation.	[Recek, Nina; Hojnik, Nataga; Filipic, Gregor; Vesel, Alenka; Primc, Gregor; Mozetic, Miran; Cvelbar, Uros] Jozef Stefan Inst, Dept Surface Engn & Optoelect F4, Ljubljana, Slovenia; [Andjelic, Sofija; Hawlina, Marko] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia; [Lazovic, Sasa] Univ Belgrade, Inst Phys Belgrade, Belgrade, Serbia; [Petrovski, Goran] Univ Szeged, Dept Ophthalmol, Stem Cells & Eye Res Lab, Fac Med, Szeged, Hungary; [Petrovski, Goran] Univ Oslo, Oslo Univ Hosp, Dept Ophthalmol, Ctr Eye Res, Oslo, Norway	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University Medical Centre Ljubljana; University of Belgrade; Szeged University; University of Oslo	Andjelic, S (corresponding author), Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia.	sofija.andjelic@kcij.si	Filipič, Gregor/T-4900-2018; Hawlina, Marko/AAZ-8084-2020; Lazovic, Sasa/Q-5056-2016; Cvelbar, Uros/AAE-7916-2019; Vesel, Alenka/I-3934-2014; Primc, Gregor/AAF-6450-2019	Filipič, Gregor/0000-0003-0153-5181; Lazovic, Sasa/0000-0003-1696-9134; Vesel, Alenka/0000-0003-3782-6001; Petrovski, Goran/0000-0003-2905-9252; Cvelbar, Uros/0000-0002-1957-0789; Primc, Gregor/0000-0002-3959-776X	Slovenian Research Agency (ARRS) [P3-0333, P2-0082]; EU COST [MP1101, TP1208]; NATO [SPS 984555]	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia); EU COST(European Cooperation in Science and Technology (COST)); NATO(NATO (North Atlantic Treaty Organisation))	The work has been supported by the Slovenian Research Agency (ARRS) programs P3-0333 & P2-0082, EU COST programs MP1101 & TP1208, and NATO grant SPS 984555.	Andjelic S, 2014, ACTA OPHTHALMOL, V92, DOI 10.1111/j.1755-3768.2014.S078.x; Andjelic S, 2015, ACTA OPHTHALMOL, V93, pE499, DOI 10.1111/aos.12655; Andjelic S, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/232659; Andjelic S, 2011, ACTA OPHTHALMOL, V89, pe645, DOI 10.1111/j.1755-3768.2011.02199.x; [Anonymous], SPECTROCHIMICA ACT B, V103-104, P124; Arjunan KP, 2015, INT J MOL SCI, V16, P2971, DOI 10.3390/ijms16022971; Dobrynin D, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/7/075201; Dobrynin D, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115020; Duncan G, 2007, INVEST OPHTH VIS SCI, V48, P2701, DOI 10.1167/iovs.06-1345; Fridman G, 2007, PLASMA PROCESS POLYM, V4, P370, DOI 10.1002/ppap.200600217; Fridman G, 2007, PLASMA CHEM PLASMA P, V27, P163, DOI 10.1007/s11090-007-9048-4; Georgescu N, 2010, IEEE T PLASMA SCI, V38, P1949, DOI 10.1109/TPS.2010.2041075; Hao PF, 2005, J MICROMECH MICROENG, V15, P2069, DOI 10.1088/0960-1317/15/11/011; Hensel K, 2015, BIOINTERPHASES, V10, DOI 10.1116/1.4919559; Isbary G, 2013, CLIN PLASMA MED, V1, P25, DOI 10.1016/j.cpme.2013.06.001; Joshi RP, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.041920; Joshi RP, 2006, BIOCHEM BIOPH RES CO, V348, P643, DOI 10.1016/j.bbrc.2006.07.144; Kalghatgi SU, 2007, IEEE T PLASMA SCI, V35, P1559, DOI 10.1109/TPS.2007.905953; Kim CH, 2010, J BIOTECHNOL, V150, P530, DOI 10.1016/j.jbiotec.2010.10.003; Kim GC, 2009, J KOREAN PHYS SOC, V54, P628, DOI 10.3938/jkps.54.628; Kim JY, 2010, APPL PHYS LETT, V96; Laurita R, 2015, CLIN PLASMA MED, V3, P53, DOI 10.1016/j.cpme.2015.10.001; Lazovic S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4896626; Lazovic S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083037; Li QT, 2000, BIOCHEM BIOPH RES CO, V273, P72, DOI 10.1006/bbrc.2000.2908; Liu FX, 2010, PLASMA PROCESS POLYM, V7, P231, DOI 10.1002/ppap.200900070; Malovic G, 2010, PLASMA SOURCES SCI T, V19, DOI 10.1088/0963-0252/19/3/034014; Marnett LJ, 1999, MUTAT RES-FUND MOL M, V424, P83, DOI 10.1016/S0027-5107(99)00010-X; Martines E, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115014; Miletic M, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/34/345401; Morfill G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113041; Mukai M, 2009, SUPRAMOL CHEM, V21, P284, DOI 10.1080/10610270802468439; O'Connell D, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3521502; Ohkawa H, 2006, SURF COAT TECH, V200, P5829, DOI 10.1016/j.surfcoat.2005.08.124; Park BJ, 2003, PHYS PLASMAS, V10, P4539, DOI 10.1063/1.1613655; Qu B, 1999, FREE RADICAL BIO MED, V27, P1095, DOI 10.1016/S0891-5849(99)00143-4; RAMANATHAN L, 1994, BIOL TRACE ELEM RES, V40, P59, DOI 10.1007/BF02916821; RILEY PA, 1994, INT J RADIAT BIOL, V65, P27, DOI 10.1080/09553009414550041; Rossi C, 2000, SENSOR ACTUAT A-PHYS, V87, P96, DOI 10.1016/S0924-4247(00)00464-7; Rumbach P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8248; Scholtz V, 2010, PLASMA PROCESS POLYM, V7, P237, DOI 10.1002/ppap.200900072; Selcuk M, 2008, BIORESOURCE TECHNOL, V99, P5104, DOI 10.1016/j.biortech.2007.09.076; Stoffels E, 2006, PLASMA SOURCES SCI T, V15, pS169, DOI 10.1088/0963-0252/15/4/S03; Stoffels E, 2008, IEEE T PLASMA SCI, V36, P1441, DOI 10.1109/TPS.2008.2001084; Takayama M, 2006, THIN SOLID FILMS, V506, P396, DOI 10.1016/j.tsf.2005.08.332; Tan X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101299; Vandamme M, 2012, INT J CANCER, V130, P2185, DOI 10.1002/ijc.26252; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017	48	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165883	10.1371/journal.pone.0165883	http://dx.doi.org/10.1371/journal.pone.0165883			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832099	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000387725000038
J	van Roest, MHG; van der Aa, MA; van der Geest, LGM; de Jong, KP				van Roest, Margijske H. G.; van der Aa, Maaike A.; van der Geest, Lydia G. M.; de Jong, Koert P.			The Impact of Socioeconomic Status, Surgical Resection and Type of Hospital on Survival in Patients with Pancreatic Cancer. A Population-Based Study in The Netherlands	PLOS ONE			English	Article							UNITED-STATES; ADENOCARCINOMA; DISPARITIES; MORTALITY; RISK; CARE; PANCREATICODUODENECTOMY; SURGERY; TRENDS; SOUTH	The influence of socioeconomic inequalities in pancreatic cancer patients and especially its effect in patients who had a resection is not known. Hospital type in which resection is performed might also influence outcome. Patients diagnosed with pancreatic cancer from 1989 to 2011 (n = 34,757) were selected from the population-based Netherlands Cancer Registry. Postal code was used to determine SES. Multivariable survival analyses using Cox regression were conducted to discriminate independent risk factors for death. Patients living in a high SES neighborhood more often underwent resection and more often were operated in a university hospital. After adjustment for clinicopathological factors, risk of dying was increased independently for patients with intermediate and low SES compared to patients with high SES. After resection, no survival difference was found among patients in the three SES groups. However, survival was better for patients treated in university hospitals compared to patients treated in non-university hospitals. Low SES was an independent risk factor for poor survival in patients with pancreatic cancer. SES was not an adverse risk factor after resection. Resection in non-university hospitals was associated with a worse prognosis.	[van Roest, Margijske H. G.; de Jong, Koert P.] Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg Liver Transplant, Groningen, Netherlands; [van der Aa, Maaike A.; van der Geest, Lydia G. M.] Netherlands Comprehens Canc Org IKNL, Dept Res, Utrecht, Netherlands	University of Groningen	de Jong, KP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hepatopancreatobiliary Surg Liver Transplant, Groningen, Netherlands.	k.p.de.jong@umcg.nl						Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; Artinyan A, 2010, CANCER-AM CANCER SOC, V116, P1367, DOI 10.1002/cncr.24817; Aziz Z, 2010, BREAST, V19, P38, DOI 10.1016/j.breast.2009.10.005; Bernards N, 2015, ACTA ONCOL, V54, P403, DOI 10.3109/0284186X.2014.953257; BLOT WJ, 1978, CANCER, V42, P373, DOI 10.1002/1097-0142(197807)42:1<373::AID-CNCR2820420156>3.0.CO;2-L; Bowman KC, 2010, AM SURGEON, V76, P164; Cheung MC, 2010, CANCER-AM CANCER SOC, V116, P723, DOI 10.1002/cncr.24758; Cheung R, 2013, ASIAN PAC J CANCER P, V14, P159, DOI 10.7314/APJCP.2013.14.1.159; Clegg LX, 2009, CANCER CAUSE CONTROL, V20, P417, DOI 10.1007/s10552-008-9256-0; Conway DI, 2010, EUR J CANCER, V46, P588, DOI 10.1016/j.ejca.2009.09.028; Cress RD, 2006, CANCER CAUSE CONTROL, V17, P403, DOI 10.1007/s10552-005-0539-4; de Wilde RF, 2012, BRIT J SURG, V99, P404, DOI 10.1002/bjs.8664; Effenberger KE, 2012, INT J CANCER, V131, pE475, DOI 10.1002/ijc.26439; Enewold Lindsey, 2015, J Gastrointest Cancer, V46, P9, DOI 10.1007/s12029-014-9668-x; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Janes RH, 1996, ANN SURG, V223, P261, DOI 10.1097/00000658-199603000-00006; Knol F, 1998, HIGH LOW LOW HIGH DE; Krzyzanowska MK, 2003, J CLIN ONCOL, V21, P3409, DOI 10.1200/JCO.2003.03.007; Kuhn Y, 2010, EJSO-EUR J SURG ONC, V36, P496, DOI 10.1016/j.ejso.2009.08.006; Le H, 2008, CANCER EPIDEM BIOMAR, V17, P2737, DOI 10.1158/1055-9965.EPI-08-0417; Lim JE, 2003, ANN SURG, V237, P74, DOI 10.1097/00000658-200301000-00011; Louwman WJ, 2010, BRIT J CANCER, V103, P1742, DOI 10.1038/sj.bjc.6605949; Markossian TW, 2015, AUST J RURAL HLTH; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Murphy MM, 2010, SURGERY, V147, P733, DOI 10.1016/j.surg.2009.10.050; Nilsen TIL, 2000, CANCER CAUSE CONTROL, V11, P645, DOI 10.1023/A:1008916123357; Niu XL, 2010, J HEALTH CARE POOR U, V21, P144, DOI 10.1353/hpu.0.0263; Oettle H, 2013, JAMA-J AM MED ASSOC, V310, P1473, DOI 10.1001/jama.2013.279201; SCHOUTEN LJ, 1993, INT J EPIDEMIOL, V22, P369, DOI 10.1093/ije/22.3.369; Seyedin S, 2012, AM SURGEON, V78, P1128; Shahian DM, 2012, ACAD MED, V87, P701, DOI 10.1097/ACM.0b013e318253676a; Shapiro M, 2015, JAMA SURG; Siemerink EJM, 2011, CANCER EPIDEMIOL, V35, P413, DOI 10.1016/j.canep.2011.02.015; SOBIN L, 2002, TNM ATLAS; van Oost FJ, 2006, EJSO, V32, P548, DOI 10.1016/j.ejso.2006.01.019; van Roest MHG, 2008, ANN SURG, V248, P97, DOI 10.1097/SLA.0b013e31817b6609; Vandewalle Laurence, 2015, ASEAN INTERPARLIAMEN, P1; Wittekind C, 2005, INT CLASSIFICATION D; Wolfson JA, 2015, CANCER-AM CANCER SOC, V121, P3885, DOI 10.1002/cncr.29576; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986; Zell JA, 2007, CANCER EPIDEM BIOMAR, V16, P546, DOI 10.1158/1055-9965.EPI-06-0893	41	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166449	10.1371/journal.pone.0166449	http://dx.doi.org/10.1371/journal.pone.0166449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832174	Green Published, gold			2022-12-26	WOS:000387725000127
J	Huang, BX; Cai, J; Xu, X; Guo, S; Wang, ZH				Huang, Bangxing; Cai, Jing; Xu, Xia; Guo, Shuang; Wang, Zehua			High-Grade Tumor Budding Stratifies Early-Stage Cervical Cancer with Recurrence Risk	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL-TRANSITION; SQUAMOUS-CELL CARCINOMA; INDEPENDENT PROGNOSTIC-FACTOR; RADICAL HYSTERECTOMY; COLORECTAL-CANCER; PELVIC LYMPHADENECTOMY; MICROENVIRONMENT; IB	Objectives This study investigated prognostic significance of tumor budding in early-stage cervical cancer (ESCC) following radical surgery and its contribution to improve the stratification of patients with recurrence risk. Methods The archival medical records and H&E-stained slides of 643 patients with IA2-IIA stage cervical cancer who underwent radical surgery were retrospectively reviewed. Clinicopathological parameters were noted, and tumor buds were counted using immunohistochemistry for each case. The prognostic significance of tumor budding was analyzed. Prediction models that comprised tumor budding were established, and the performance was compared between the novel models and classic criteria via log-rank test and receiver operating characteristic analysis. Results Tumors with high-grade tumor budding (HTB) exhibited a substantially increased risk of recurrence (hazard ratio = 4.287, P < 0.001). Nine predictive models for recurrence were established, in which HTB was combined with recognized risk factors. The model using of at least two risk factors of HTB, tumor size >= 4 cm, deep stromal invasion of outer 1/3, and lymphovascular space invasion to stratify patients with an intermediate risk was most predictive of recurrence compared with the classic criteria. Conclusions Tumor budding is an independent, unfavorable, prognostic factor for ESCC patients following radical surgery and holds promise for improved recurrence risk stratification.	[Huang, Bangxing; Cai, Jing; Wang, Zehua] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gynecol & Obstet, Wuhan, Hubei, Peoples R China; [Huang, Bangxing; Xu, Xia; Guo, Shuang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Pathol, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Wang, ZH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Gynecol & Obstet, Wuhan, Hubei, Peoples R China.	zehuavvang@163.net			National Natural Science Foundation of China [81272860, 81472443, 81572572]; Natural Science Foundation of Hubei Province [2015CKB739]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	The work was supported by the following: the National Natural Science Foundation of China (No. 81272860 and 81472443, http://www.nsfc.gov.cn) for ZW; the National Natural Science Foundation of China (No. 81572572, http://www.nsfc.gov.cn) for JC; the Natural Science Foundation of Hubei Province (No. 2015CKB739, http://www.hbstd.gov.cn) for BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Almangush A, 2016, HISTOPATHOLOGY, V68, P173, DOI 10.1111/his.12781; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06; DELGADO G, 1989, GYNECOL ONCOL, V35, P314, DOI 10.1016/0090-8258(89)90070-X; DELGADO G, 1990, GYNECOL ONCOL, V38, P352, DOI 10.1016/0090-8258(90)90072-S; FULLER AF, 1989, GYNECOL ONCOL, V33, P34, DOI 10.1016/0090-8258(89)90598-2; Graham RP, 2015, AM J SURG PATHOL, V39, P1340, DOI 10.1097/PAS.0000000000000504; Gulluoglu M, 2015, INT J SURG PATHOL, V23, P349, DOI 10.1177/1066896915581200; Horn LC, 2006, GYNECOL ONCOL, V103, P906, DOI 10.1016/j.ygyno.2006.05.046; Ito E, 2012, J GASTROENTEROL, V47, P1279, DOI 10.1007/s00535-012-0587-y; Jensen DH, 2015, J PATHOL, V236, P505, DOI 10.1002/path.4550; Kadota K, 2015, CHEST, V148, P711, DOI 10.1378/chest.14-3005; Koyuncuoglu M, 2012, GYNECOL ONCOL, V125, P208, DOI 10.1016/j.ygyno.2011.12.433; Liang FL, 2013, PATHOL RES PRACT, V209, P269, DOI 10.1016/j.prp.2013.01.009; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Masuda R, 2012, MOL MED REP, V6, P937, DOI 10.3892/mmr.2012.1048; Nakamura T, 2008, DIS COLON RECTUM, V51, P568, DOI 10.1007/s10350-008-9192-9; O'Connor K, 2015, AM J SURG PATHOL, V39, P472, DOI 10.1097/PAS.0000000000000333; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Prall F, 2005, HISTOPATHOLOGY, V47, P17, DOI 10.1111/j.1365-2559.2005.02161.x; Prall F, 2007, HISTOPATHOLOGY, V50, P151, DOI 10.1111/j.1365-2559.2006.02551.x; Qureshi R, 2015, CANCER LETT, V356, P321, DOI 10.1016/j.canlet.2014.09.021; Rogers AC, 2014, MODERN PATHOL, V27, P156, DOI 10.1038/modpathol.2013.124; Rogers L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007583.pub3; Ryu SY, 2014, BRIT J CANCER, V110, P278, DOI 10.1038/bjc.2013.716; Ryu SY, 2011, INT J RADIAT ONCOL, V79, P794, DOI 10.1016/j.ijrobp.2009.11.019; Salhia B, 2015, BREAST CANCER RES TR, V150, P363, DOI 10.1007/s10549-015-3333-3; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Taira T, 2012, LUNG CANCER, V76, P423, DOI 10.1016/j.lungcan.2011.11.010; Turner RR, 2007, CLIN CANCER RES, V13, p6871S, DOI 10.1158/1078-0432.CCR-07-1151; van Wyk HC, 2015, CANCER TREAT REV, V41, P151, DOI 10.1016/j.ctrv.2014.12.007; Wartenberg M, 2015, ONCOTARGET, V6, P4190, DOI 10.18632/oncotarget.2775; Yang L, 2015, J MINIM INVAS GYN, V22, P199, DOI 10.1016/j.jmig.2014.09.009; Zlobec I, 2010, ONCOTARGET, V1, P651, DOI 10.18632/oncotarget.199; Zlobec I, 2010, WORLD J GASTROENTERO, V16, P4823, DOI 10.3748/wjg.v16.i38.4823	37	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166311	10.1371/journal.pone.0166311	http://dx.doi.org/10.1371/journal.pone.0166311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861522	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300045
J	Kabwijamu, L; Waiswa, P; Kawooya, V; Nalwadda, CK; Okuga, M; Nabiwemba, EL				Kabwijamu, Lydia; Waiswa, Peter; Kawooya, Vincent; Nalwadda, Christine K.; Okuga, Monica; Nabiwemba, Elizabeth L.			Newborn Care Practices among Adolescent Mothers in Hoima District, Western Uganda	PLOS ONE			English	Article							CHILD HEALTH-CARE; EASTERN UGANDA; RURAL UGANDA; BANGLADESH; OUTCOMES; BABIES	Introduction Adolescent childbearing remains a major challenge to improving neonatal mortality especially in Sub Saharan countries which are still struggling with high neonatal mortality rates. We explored essential newborn care practices and associated factors among adolescent mothers in Western Uganda. Methods Data were collected among 410 adolescent mothers with children aged one to six months in Hoima district. Three composite variables (appropriate neonatal breastfeeding, cord care and thermal protection) were derived by combining related practices from a list of recommended newborn care practices. Logistic regression analysis was conducted to identify factors independently associated with practice of essential newborn care. Results Appropriate newborn feeding, optimal thermal protection and dry cord care were practiced by 60.5%, 67.2% and 31% of adolescent mothers respectively. Independent predictors' of cord care were: knowledge of cord care (AOR 5.34, 95% CI (1.51-18.84) and having delivered twins (AOR 0.04, 95% CI (0.01-0.22). The only predictor of thermal care was knowledge (AOR 25.15, 95% CI (7.01-90.20). Staying in a hospital for more than one day postpartum (AOR 2.45, 95%Cl (1.23-4.86), knowledge of the correct time of breastfeeding initiation (AOR 14.71, 95% CI (5.20-41.58), predicted appropriate neonatal feeding, whereas; adolescent mothers who had had a caesarean delivery (AOR 0.19, 95% CI (I 0.04-0.96) and a male caretaker in the postnatal period (AOR 0.18, 95% CI (0.07-0.49) were less likely to practice the recommended newborn feeding. Conclusion Sub optimal essential newborn care practice was noted especially suboptimal cord care. Adolescent mothers should be a focus of strategies to improve maternal and neonatal health.	[Kabwijamu, Lydia; Waiswa, Peter; Kawooya, Vincent; Nalwadda, Christine K.; Okuga, Monica; Nabiwemba, Elizabeth L.] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda; [Waiswa, Peter; Okuga, Monica] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Ctr Excellence Maternal & Newborn Hlth, Kampala, Uganda; [Waiswa, Peter] Karolinska Inst, Dept Publ Hlth Sci, Global Hlth, Stockholm, Sweden	Makerere University; Makerere University; Karolinska Institutet	Kabwijamu, L (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Kampala, Uganda.	lkabwijamu@gmail.com			Saving Newborn Lives through the Makerere University Centre of Excellence for Maternal and Newborn Health Research; Saving Newborn Lives/ Centre for Maternal and Newborn Health Research at Makerere University School of Public Health; Hoima District Health Office	Saving Newborn Lives through the Makerere University Centre of Excellence for Maternal and Newborn Health Research; Saving Newborn Lives/ Centre for Maternal and Newborn Health Research at Makerere University School of Public Health; Hoima District Health Office	The study was funded by Saving Newborn Lives through the Makerere University Centre of Excellence for Maternal and Newborn Health Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the adolescent mothers, research assistants and the staff of Hoima District Local Government especially the health department for participating in this study. We also acknowledge the Saving Newborn Lives/ Centre for Maternal and Newborn Health Research at Makerere University School of Public Health that financed this study. The field work was supported by the Hoima District Health Office.	Atuyambe Lynn, 2008, Reprod Health, V5, P13, DOI 10.1186/1742-4755-5-13; Ayiasi MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-176; Ayiasi RM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-114; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; Byaruhanga R, 2005, J TROP PEDIATRICS, V51, P212, DOI 10.1093/tropej/fmh098; Byaruhanga RN, 2011, MIDWIFERY, V27, P775, DOI 10.1016/j.midw.2010.02.005; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Hidalgo Luis A., 2005, Archives of Gynecology and Obstetrics, V271, P207, DOI 10.1007/s00404-004-0600-7; Jutte DP, 2010, ACAD PEDIATR, V10, P293, DOI 10.1016/j.acap.2010.06.008; Karas DJ, 2012, J TROP PEDIATRICS, V58, P200, DOI 10.1093/tropej/fmr057; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kongnyuy EJ, 2008, MATERN CHILD HLTH J, V12, P149, DOI 10.1007/s10995-007-0235-y; Kurth F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014367; Mbonye AK, 2012, HEALTH POLICY PLANN, V27, P104, DOI 10.1093/heapol/czs045; MoH, 2011, NAT POL GUID SERV ST; MOH, 2013, REPR MAT NEWB CHILDH; Nankabirwa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019674; Nasreen HE, 2012, REPROD HEALTH, V9, DOI 10.1186/1742-4755-9-18; Okigbo CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129286; Rahman M, 2011, JOGNN-J OBST GYN NEO, V40, P262, DOI 10.1111/j.1552-6909.2011.01240.x; Rahman M, 2011, HEALTH SOC CARE COMM, V19, P138, DOI 10.1111/j.1365-2524.2010.00953.x; Shamba D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-267; Sines E., 2007, POSTNATAL CARE CRITI; Singh L, 2012, J BIOSOC SCI, V44, P1, DOI 10.1017/S0021932011000472; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; Tweheyo R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-53; UBOS I, 2012, UG DEM HLTH SURV 201; Uzun AK, 2013, J MATERN-FETAL NEO M, V26, P454, DOI 10.3109/14767058.2012.733748; Vogel JP, 2015, ARCH DIS CHILD, V100, pS43, DOI 10.1136/archdischild-2013-305514; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; Waiswa Peter, 2008, BMC Pregnancy Childbirth, V8, P21, DOI 10.1186/1471-2393-8-21; World Health Organization, 2011, WHO GUID PREV EARL P; World Health Organization, 2012, EARL MARR AD YOUNG P; World Health Organization, 1996, ESS NEWB CAR; World Health Organization, 2014, EV NEWB ACT PLAN END; World Health Organization Department of Maternal N, 2013, WHO REC POSTN CAR MO	37	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166405	10.1371/journal.pone.0166405	http://dx.doi.org/10.1371/journal.pone.0166405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855186	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200030
J	Mei, WH; Wang, KM; Huang, J; Zheng, XM				Mei, Wenhan; Wang, Kemin; Huang, Jian; Zheng, Xinmin			Cell Transformation by PTP1B Truncated Mutants Found in Human Colon and Thyroid Tumors	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; BREAST-CANCER; SRC; ACTIVATION; 1B; ALPHA; OVEREXPRESSION; MECHANISM; KINASE	Expression of wild-type protein tyrosine phosphatase (PTP) 1B may act either as a tumor suppressor by dysregulation of protein tyrosine kinases or a tumor promoter through Src dephosphorylation at Y527 in human breast cancer cells. To explore whether mutated PTP1B is involved in human carcinogenesis, we have sequenced PTP1B cDNAs from human tumors and found splice mutations in similar to 20% of colon and thyroid tumors. The PTP1B Delta E6 mutant expressed in these two tumor types and another PTP1B Delta E5 mutant expressed in colon tumor were studied in more detail. Although PTP1B Delta E6 revealed no phosphatase activity compared with wild-type PTP1B and the PTP1B Delta E5 mutant, its expression induced oncogenic transformation of rat fibroblasts without Src activation, indicating that it involved signaling pathways independent of Src. The transformed cells were tumourigenic in nude mice, suggesting that the PTP1B Delta E6 affected other molecule(s) in the human tumors. These observations may provide a novel therapeutic target for colon and thyroid cancer.	[Mei, Wenhan; Wang, Kemin; Huang, Jian] SJTU SM, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China; [Zheng, Xinmin] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA	Shanghai Jiao Tong University; Cornell University	Huang, J (corresponding author), SJTU SM, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China.; Zheng, XM (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA.	jyhuanj@shsmu.edu.cn; xz27@cornell.edu	Huang, Jian/ABF-8355-2021		Shanghai Pujiang Talent Fund [2005Z10]; National Natural Science Foundation of China [81302296, 81372190, 81672709]	Shanghai Pujiang Talent Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the grants from Shanghai Pujiang Talent Fund (2005Z10) and the National Natural Science Foundation of China (81302296, 81372190 and 81672709).	Arregui CO, 1998, J CELL BIOL, V143, P861, DOI 10.1083/jcb.143.3.861; BARFORD D, 1994, SCIENCE, V263, P1397, DOI 10.1126/science.8128219; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Burke TR, 1998, BIOPOLYMERS, V47, P225, DOI 10.1002/(SICI)1097-0282(1998)47:3<225::AID-BIP3>3.0.CO;2-O; Chen QT, 2014, J MOL HISTOL, V45, P153, DOI 10.1007/s10735-013-9536-1; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; Fan GF, 2015, J BIOL CHEM, V290, P15934, DOI 10.1074/jbc.M115.651703; Fan GF, 2013, J BIOL CHEM, V288, P24923, DOI 10.1074/jbc.M113.482737; Forsell PKAL, 2000, GENE, V260, P145, DOI 10.1016/S0378-1119(00)00464-9; Gunawardana J, 2014, NAT GENET, V46, P329, DOI 10.1038/ng.2900; He RJ, 2014, ACTA PHARMACOL SIN, V35, P1227, DOI 10.1038/aps.2014.80; Hoekstra E, 2016, ONCOTARGET; Huang J, 2011, EMBO J, V30, P3200, DOI 10.1038/emboj.2011.212; Hunter T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020644; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Lee S.-K., 2007, IEEE INT S ELECTROMA, V1, P1, DOI DOI 10.1002/MED.20079; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; SHIFRIN VI, 1993, J BIOL CHEM, V268, P25376; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; Tonks NK, 2007, CANCER CELL, V11, P214, DOI 10.1016/j.ccr.2007.02.022; Tonks NK, 2013, FEBS J, V280, P346, DOI 10.1111/febs.12077; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2001, EMBO J, V20, P6037, DOI 10.1093/emboj/20.21.6037; ZHENG XM, 1992, NATURE, V359, P336, DOI 10.1038/359336a0; Zhu S, 2007, CANCER RES, V67, P10129, DOI 10.1158/0008-5472.CAN-06-4338	25	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166538	10.1371/journal.pone.0166538	http://dx.doi.org/10.1371/journal.pone.0166538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855221	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200033
J	Canto, CB; Witter, L; De Zeeuw, CI				Canto, Cathrin B.; Witter, Laurens; De Zeeuw, Chris I.			Whole-Cell Properties of Cerebellar Nuclei Neurons In Vivo	PLOS ONE			English	Article							NON-GABAERGIC CELLS; ELECTROPHYSIOLOGICAL PROPERTIES; INFERIOR OLIVE; BRAIN-STEM; FASTIGIAL NUCLEUS; PREFRONTAL CORTEX; ENTORHINAL CORTEX; PYRAMIDAL CELLS; FIRING PATTERNS; FIBER TERMINALS	Cerebellar nuclei neurons integrate sensorimotor information and form the final output of the cerebellum, projecting to premotor brainstem targets. This implies that, in contrast to specialized neurons and interneurons in cortical regions, neurons within the nuclei encode and integrate complex information that is most likely reflected in a large variation of intrinsic membrane properties and integrative capacities of individual neurons. Yet, whether this large variation in properties is reflected in a heterogeneous physiological cell population of cerebellar nuclei neurons with well or poorly defined cell types remains to be determined. Indeed, the cell electrophysiological properties of cerebellar nuclei neurons have been identified in vitro in young rodents, but whether these properties are similar to the in vivo adult situation has not been shown. In this comprehensive study we present and compare the in vivo properties of 144 cerebellar nuclei neurons in adult ketamine-xylazine anesthetized mice. We found regularly firing (N = 88) and spontaneously bursting (N = 56) neurons. Membrane-resistance, capacitance, spike half-width and firing frequency all widely varied as a continuum, ranging from 9.63 to 3352.1 M Omega, from 6.7 to 772.57 pF, from 0.178 to 1.98 ms, and from 0 to 176.6 Hz, respectively. At the same time, several of these parameters were correlated with each other. Capacitance decreased with membrane resistance (R-2 = 0.12, P<0.001), intensity of rebound spiking increased with membrane resistance (for 100 ms duration R-2 = 0.1503, P = 0.0011), membrane resistance decreased with membrane time constant (R-2 = 0.045, P = 0.031) and increased with spike half-width (R-2 = 0.023, P<0.001), while capacitance increased with firing frequency (R-2 = 0.29, P<0.001). However, classes of neuron subtypes could not be identified using merely k-clustering of their intrinsic firing properties and/or integrative properties following activation of their Purkinje cell input. Instead, using whole-cell parameters in combination with morphological criteria revealed by intracellular labelling with Neurobiotin (N = 18) allowed for electrophysiological identification of larger (29.3-50 mu m soma diameter) and smaller (<21.2 mu m) cerebellar nuclei neurons with significant differences in membrane properties. Larger cells had a lower membrane resistance and a shorter spike, with a tendency for higher capacitance. Thus, in general cerebellar nuclei neurons appear to offer a rich and wide continuum of physiological properties that stand in contrast to neurons in most cortical regions such as those of the cerebral and cerebellar cortex, in which different classes of neurons operate in a narrower territory of electrophysiological parameter space. The current dataset will help computational modelers of the cerebellar nuclei to update and improve their cerebellar motor learning and performance models by incorporating the large variation of the in vivo properties of cerebellar nuclei neurons. The cellular complexity of cerebellar nuclei neurons may endow the nuclei to perform the intricate computations required for sensorimotor coordination.	[Canto, Cathrin B.; Witter, Laurens; De Zeeuw, Chris I.] Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [De Zeeuw, Chris I.] Erasmus MC, Dept Neurosci, Rotterdam, Netherlands; [Witter, Laurens] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Integrat Neurophysiol, Amsterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	De Zeeuw, CI (corresponding author), Royal Dutch Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.; De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, Rotterdam, Netherlands.	c.dezeeuw@erasmusmc.nl	Witter, Laurens/AAB-1461-2019	Witter, Laurens/0000-0003-2357-0578	Dutch Organization for Medical Science [ZonMW]; NWO-VENI Fellowship; Life Sciences (NWO-ALW); Senter (Neuro-Bsik); ERC-Advanced Grant; ERC-POC programs of the European Community	Dutch Organization for Medical Science [ZonMW](Netherlands Organization for Health Research and Development); NWO-VENI Fellowship(Netherlands Organization for Scientific Research (NWO)); Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); Senter (Neuro-Bsik); ERC-Advanced Grant(European Research Council (ERC)); ERC-POC programs of the European Community	This work was supported by the Dutch Organization for Medical Science [ZonMW; CIDZ], NWO-VENI Fellowship [CC], Life Sciences (NWO-ALW; CDIZ), Senter (Neuro-Bsik; CIDZ), ERC-Advanced Grant [CIDZ] and ERC-POC [CIDZ] programs of the European Community.	Afshari FS, 2004, J NEUROPHYSIOL, V92, P2831, DOI 10.1152/jn.00261.2004; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Ankri L, 2015, ELIFE, V4, DOI 10.7554/eLife.06262; Arancillo M, 2015, J NEUROPHYSIOL, V113, P578, DOI 10.1152/jn.00586.2014; Aumann TD, 1996, J COMP NEUROL, V376, P420; Aumann TD, 1996, J COMP NEUROL, V368, P608, DOI 10.1002/(SICI)1096-9861(19960513)368:4<608::AID-CNE11>3.0.CO;2-D; Bagnall MW, 2009, J NEUROSCI, V29, P10104, DOI 10.1523/JNEUROSCI.2087-09.2009; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Bengtsson F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018822; Berndt A, 2011, P NATL ACAD SCI USA, V108, P7595, DOI 10.1073/pnas.1017210108; Boudewijns ZSRM, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00099; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; D'Angelo E, 2016, CEREBELLUM, V15, P139, DOI 10.1007/s12311-015-0711-7; De Zeeuw CI, 2011, NAT REV NEUROSCI, V12, P327, DOI 10.1038/nrn3011; Degenetais E, 2002, CEREB CORTEX, V12, P1, DOI 10.1093/cercor/12.1.1; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; DEZEEUW CI, 1988, BRAIN RES, V447, P369, DOI 10.1016/0006-8993(88)91142-0; DeZeeuw CI, 1996, ANN NY ACAD SCI, V781, P607; DEZEEUW CI, 1990, NEUROSCIENCE, V34, P645, DOI 10.1016/0306-4522(90)90171-Y; Dezeeuw CI, 2015, COLD SPRING HARB PER; Engbers JDT, 2011, J PHYSIOL-LONDON, V589, P5391, DOI 10.1113/jphysiol.2011.215632; Funahashi M, 2000, BRAIN RES, V884, P104, DOI 10.1016/S0006-8993(00)02854-7; Gao ZY, 2016, NEURON, V89, P645, DOI 10.1016/j.neuron.2016.01.008; Gauck V, 2000, J NEUROSCI, V20, P3006; Gauck V, 2003, J NEUROSCI, V23, P8109; Hoebeek FE, 2010, P NATL ACAD SCI USA, V107, P8410, DOI 10.1073/pnas.0907118107; Houck BD, 2015, J COMP NEUROL, V523, P2254, DOI 10.1002/cne.23787; Husson Z, 2014, J NEUROSCI, V34, P9418, DOI 10.1523/JNEUROSCI.0401-14.2014; Jaeger D, 2011, CEREBELLUM, V10, P659, DOI 10.1007/s12311-011-0248-3; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Koch Christof, 1999, P1; Kodama T, 2012, J NEUROSCI, V32, P7819, DOI 10.1523/JNEUROSCI.0543-12.2012; Kononenko NL, 2007, CELL TISSUE RES, V330, P179, DOI 10.1007/s00441-007-0425-3; Langston RF, 2010, SCIENCE, V328, P1576, DOI 10.1126/science.1188210; Leto K, 2015, CONSENSUS PAPER CERE, P1; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Luque NR, 2014, FRONT COMPUT NEUROSC, V8, DOI 10.3389/fncom.2014.00097; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Mapelli L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00169; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; Mizuseki K, 2011, NAT NEUROSCI, V14, P1174, DOI 10.1038/nn.2894; Molineux ML, 2008, J NEUROPHYSIOL, V100, P2684, DOI 10.1152/jn.90427.2008; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Najac M, 2015, J NEUROSCI, V35, P544, DOI 10.1523/JNEUROSCI.3583-14.2015; OBERDICK J, 1993, NEURON, V10, P1007, DOI 10.1016/0896-6273(93)90050-2; Pugh JR, 2009, TRENDS NEUROSCI, V32, P170, DOI 10.1016/j.tins.2008.12.001; Quilichini P, 2010, J NEUROSCI, V30, P11128, DOI 10.1523/JNEUROSCI.1327-10.2010; Raman IM, 2000, J NEUROSCI, V20, P9004; Ruigrok TJH, 2011, J NEUROSCI, V31, P712, DOI 10.1523/JNEUROSCI.1959-10.2011; Sangrey T, 2010, EUR J NEUROSCI, V32, P1646, DOI 10.1111/j.1460-9568.2010.07408.x; Schlosser B, 1998, NEUROSCI LETT, V249, P13, DOI 10.1016/S0304-3940(98)00366-8; Sekirnjak C, 2002, J NEUROSCI, V22, P2083, DOI 10.1523/JNEUROSCI.22-06-02083.2002; Shin M, 2011, J NEUROSCI, V31, P10776, DOI 10.1523/JNEUROSCI.0768-11.2011; SIMPSON JI, 1989, PROG BRAIN RES, V80, P213; Sokoloff G, 2015, J NEUROPHYSIOL AM PH; Steuber V, 2013, NEURAL NETWORKS, V47, P112, DOI 10.1016/j.neunet.2012.11.006; Steuber V, 2011, J COMPUT NEUROSCI, V30, P633, DOI 10.1007/s10827-010-0282-z; Sultan F, 2003, J COMP NEUROL, V455, P139, DOI 10.1002/cne.10443; Szilagyi T, 2011, ROM J MORPHOL EMBRYO, V52, P15; Tadayonnejad R, 2010, CEREBELLUM, P13; Teune TM, 1998, J COMP NEUROL, V392, P164, DOI 10.1002/(SICI)1096-9861(19980309)392:2<164::AID-CNE2>3.0.CO;2-0; Teune TM, 2000, PROG BRAIN RES, V124, P141; Uusisaari M, 2008, NEUROSCIENCE, V156, P537, DOI 10.1016/j.neuroscience.2008.07.060; Uusisaari M, 2007, J NEUROPHYSIOL, V97, P901, DOI 10.1152/jn.00974.2006; Uusisaari M, 2011, J PHYSIOL-LONDON, V589, P3441, DOI 10.1113/jphysiol.2010.201582; Uusisaari M, 2011, CEREBELLUM, V10, P637, DOI 10.1007/s12311-010-0240-3; Uusisaari M, 2010, CEREBELLUM, V9, P42, DOI 10.1007/s12311-009-0137-1; Uusisaari MY, 2012, CEREBELLUM, V11, P420, DOI 10.1007/s12311-011-0350-6; VANDERWANT JJL, 1987, J COMP NEUROL, V258, P70, DOI 10.1002/cne.902580105; VANDERWANT JJL, 1989, J COMP NEUROL, V288, P1, DOI 10.1002/cne.902880102; VANDERWANT JJL, 1987, J COMP NEUROL, V258, P81, DOI 10.1002/cne.902580106; Witter L, 2016, NEURON ELSEVIER, P670; Witter L, 2015, CEREBELLUM, V14, P506, DOI 10.1007/s12311-015-0654-z; Witter L, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00133	78	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165887	10.1371/journal.pone.0165887	http://dx.doi.org/10.1371/journal.pone.0165887			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851801	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300026
J	Lampe, N; Biron, DG; Brown, JMC; Incerti, S; Marin, P; Maigne, L; Sarramia, D; Seznec, H; Breton, V				Lampe, Nathanael; Biron, David G.; Brown, Jeremy M. C.; Incerti, Sebastien; Marin, Pierre; Maigne, Lydia; Sarramia, David; Seznec, Herve; Breton, Vincent			Simulating the Impact of the Natural Radiation Background on Bacterial Systems: Implications for Very Low Radiation Biological Experiments	PLOS ONE			English	Article							INDUCED GENOMIC INSTABILITY; ESCHERICHIA-COLI; IONIZING-RADIATION; DEINOCOCCUS-RADIODURANS; MUTATION-RATES; PROTEIN DAMAGE; DNA-DAMAGE; V79 CELLS; MECHANISMS; EVOLUTION	At very low radiation dose rates, the effects of energy depositions in cells by ionizing radiation is best understood stochastically, as ionizing particles deposit energy along tracks separated by distances often much larger than the size of cells. We present a thorough analysis of the stochastic impact of the natural radiative background on cells, focusing our attention on E. coli grown as part of a long term evolution experiment in both underground and surface laboratories. The chance per day that a particle track interacts with a cell in the surface laboratory was found to be 6 x 10(-5) day(-1), 100 times less than the expected daily mutation rate for E. coli under our experimental conditions. In order for the chance cells are hit to approach the mutation rate, a gamma background dose rate of 20 mu Gy hr(-1) is predicted to be required.	[Lampe, Nathanael; Marin, Pierre; Maigne, Lydia; Sarramia, David; Breton, Vincent] Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire, BP 10448, F-63000 Clermont Ferrand, France; [Biron, David G.] Univ Blaise Pascal, Clermont Univ, UMR CNRS 6023, Lab Microorganismes Genome & Environm, BP 10448, F-63000 Clermont Ferrand, France; [Brown, Jeremy M. C.] Queens Univ Belfast, Sch Math & Phys, Belfast, Antrim, North Ireland; [Incerti, Sebastien; Seznec, Herve] Univ Bordeaux, CENBG, UMR 5797, F-33170 Gradignan, France; [Incerti, Sebastien; Seznec, Herve] CNRS, CENBG, IN2P3, UMR 5797, F-33170 Gradignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Queens University Belfast; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux	Lampe, N (corresponding author), Univ Blaise Pascal, Clermont Univ, CNRS IN2P3, Lab Phys Corpusculaire, BP 10448, F-63000 Clermont Ferrand, France.	lampe@clermont.in2p3.fr	SEZNEC, Hervé/ABB-1602-2021; Incerti, Sebastien L/T-3006-2017; Maigne, Lydia/H-3137-2018	SEZNEC, Hervé/0000-0001-6180-8925; Maigne, Lydia/0000-0002-0414-8462; Brown, Jeremy/0000-0001-9508-6190; Breton, Vincent/0000-0001-8197-7080; Incerti, Sebastien/0000-0002-0619-2053; MARIN, Pierre/0000-0002-8304-138X; David, SARRAMIA/0000-0002-7062-9707	Conseil General de l'Allier; Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien"; Electricite de France	Conseil General de l'Allier(Region Auvergne-Rhone-Alpes); Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien"; Electricite de France	The Conseil General de l'Allier funds the PhD scholarship of NL. Funding has been received from the Long Term Ecological Research program "Zone Atelier Territoires Uraniferes dans l'Arc Hercynien" and Electricite de France in support of this project.	Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; Allison J, 2016, NUCL INSTRUM METH A, V835, P186, DOI 10.1016/j.nima.2016.06.125; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Berger M. J., 1998, STOPPING POWER RANGE; Bernal MA, 2015, PHYS MEDICA, P1; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; BOUVILLE A, 1988, RADIAT PROT DOSIM, V24, P293; Calabrese EJ, 2013, CRIT REV TOXICOL, V43, P580, DOI 10.3109/10408444.2013.808172; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Cameron JA, 2004, NUCL DATA SHEETS, V102, P293, DOI 10.1016/j.nds.2004.06.001; Carbone MC, 2009, RADIAT ENVIRON BIOPH, V48, P189, DOI 10.1007/s00411-008-0208-6; Carlton BC, 1981, MANUAL METHODS GENER, P222; Castillo H, 2015, INT J RADIAT BIOL, V91, P749, DOI 10.3109/09553002.2015.1062571; Chirkin D, 2004, FLUXES ATMOSPHERIC L, DOI [10.48550/ARXIV.HEP-PH/0407078, DOI 10.48550/ARXIV.HEP-PH/0407078]; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; de Visser JAGM, 1999, SCIENCE, V283, P404, DOI 10.1126/science.283.5400.404; Douglass M, 2012, MED PHYS, V39, P3509, DOI 10.1118/1.4719963; El Naqa I, 2012, PHYS MED BIOL, V57, pR75, DOI 10.1088/0031-9155/57/11/R75; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fratini E, 2015, RADIAT ENVIRON BIOPH, V54, P183, DOI 10.1007/s00411-015-0587-4; Friedland W, 2011, MUTAT RES-FUND MOL M, V711, P28, DOI 10.1016/j.mrfmmm.2011.01.003; Godin M, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2789694; Gordon MS, 2004, IEEE T NUCL SCI, V51, P3427, DOI 10.1109/TNS.2004.839134; Groom DE, 2001, ATOM DATA NUCL DATA, V78, P183, DOI 10.1006/adnd.2001.0861; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; IRSN, 2015, PELGUIS VERS 1 19 0; Katz JI, 2015, INT J RADIAT BIOL, V2016, P3002; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kudryasheva NS, 2015, J ENVIRON RADIOACTIV, V142, P68, DOI 10.1016/j.jenvrad.2015.01.012; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lampe N, MULTISCALE GEANT4 SI; Lampe N, 2016, EPJ WEB CONF, V124, DOI 10.1051/epjconf/201612400006; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Liang Y, 2016, PHYS MED BIOL, V61, P445, DOI 10.1088/0031-9155/61/1/445; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Malczewski D, 2012, J RADIOANAL NUCL CH, V292, P751, DOI 10.1007/s10967-011-1497-9; McNamara AL, 2012, INT J RADIAT BIOL, V88, P164, DOI 10.3109/09553002.2011.627975; Merrifield Matt, 2013, Frontiers in Genetics, V4, P40, DOI 10.3389/fgene.2013.00040; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Morgan WF, 2003, RADIAT RES, V159, P581, DOI 10.1667/0033-7587(2003)159[0581:NADEOE]2.0.CO;2; MOZUMDER A, 1966, RADIAT RES, V28, P203, DOI 10.2307/3572190; Nikjoo H, 2006, RADIAT MEAS, V41, P1052, DOI 10.1016/j.radmeas.2006.02.001; Olive KA, 2014, CHINESE PHYS C, V38, DOI 10.1088/1674-1137/38/9/090001; Piquemal F, 2012, EUR PHYS J PLUS, V127, DOI 10.1140/epjp/i2012-12110-3; Planel G., 1976, Proceedings of a symposium on Biological Effects of Low-Level Radiation Pertinent to Man and His Environment, P127; PLANEL H, 1987, HEALTH PHYS, V52, P571, DOI 10.1097/00004032-198705000-00007; RADICELLA JP, 1988, P NATL ACAD SCI USA, V85, P9674, DOI 10.1073/pnas.85.24.9674; Reshes G, 2008, BIOPHYS J, V94, P251, DOI 10.1529/biophysj.107.104398; ROSENBERGER RF, 1983, MOL GEN GENET, V191, P207, DOI 10.1007/BF00334815; Ruiz-Gonzalez MX, 2016, SCI REP-UK, V6, DOI 10.1038/srep22969; Satta L, 2002, RADIAT ENVIRON BIOPH, V41, P217, DOI 10.1007/s00411-002-0159-2; SATTA L, 1995, MUTAT RES LETT, V347, P129, DOI 10.1016/0165-7992(95)00031-3; Sears V.F., 1992, NEUTRON NEWS, V3, P29, DOI DOI 10.1080/10448639208218770; Smith Geoffrey Battle, 2011, Health Phys, V100, P263, DOI 10.1097/HP.0b013e318208cd44; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; United Nations Scientific Committee on the Effects of Atomic Radiation UNSCEAR, 2000, ANN B EXP NAT RAD SO; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Zavilgelsky GB, 1998, J PHOTOCH PHOTOBIO B, V43, P152, DOI 10.1016/S1011-1344(98)00099-2	64	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166364	10.1371/journal.pone.0166364	http://dx.doi.org/10.1371/journal.pone.0166364			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851794	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300044
J	Pizarro-Delgado, J; Deeney, JT; Corkey, BE; Tamarit-Rodriguez, J				Pizarro-Delgado, Javier; Deeney, Jude T.; Corkey, Barbara E.; Tamarit-Rodriguez, Jorge			Direct Stimulation of Islet Insulin Secretion by Glycolytic and Mitochondrial Metabolites in KCl-Depolarized Islets	PLOS ONE			English	Article							PANCREATIC-ISLETS; REGULATORY ROLE; GLUCOSE; DEHYDROGENASE; CONTRIBUTES; INHIBITION; ACID	We have previously demonstrated that islet depolarization with 70 mM KCl opens Cx36 hemichannels and allows diffusion of small metabolites and cofactors through the beta-cell plasma membrane. We have investigated in this islet "permeabilized" model whether glycolytic and citric acid cycle intermediates stimulate insulin secretion and how it correlates with ATP production (islet content plus extracellular nucleotide accumulation). Glycolytic intermediates (10 mM) stimulated insulin secretion and ATP production similarly. However, they showed differential sensitivities to respiratory chain or enzyme inhibitors. Pyruvate showed a lower secretory capacity and less ATP production than phosphoenolpyruvate, implicating an important role for glycolytic generation of ATP. ATP production by glucose-6-phosphate was not sensitive to a pyruvate kinase inhibitor that effectively suppressed the phosphoenol-pyruvate-induced secretory response and islet ATP rise. Strong suppression of both insulin secretion and ATP production induced by glucose-6-phosphate was caused by 10 mu M antimycin A, implicating an important role for the glycerophosphate shuttle in transferring reducing equivalents to the mitochondria. Five citric acid cycle intermediates were investigated for their secretory and ATP production capacity (succinate, fumarate, malate, isocitrate and alpha-ketoglutarate at 5 mM, together with ADP and/or NADP(+) to feed the NADPH re-oxidation cycles). The magnitude of the secretory response was very similar among the different mitochondrial metabolites but alpha-ketoglutarate showed a more sustained second phase of secretion. Gabaculine (1 mM, a GABA-transaminase inhibitor) suppressed the second phase of secretion and the ATP-production stimulated by alpha-ketoglutarate, supporting a role for the GABA shuttle in the control of glucose-induced insulin secretion. None of the other citric acid intermediates essayed showed any suppression of both insulin secretion or ATP-production by the presence of gabaculine. We propose that endogenous GABA metabolism in the "GABA-shunt" facilitates ATP production in the citric acid cycle for an optimal insulin secretion.	[Pizarro-Delgado, Javier; Deeney, Jude T.; Corkey, Barbara E.; Tamarit-Rodriguez, Jorge] Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA; [Pizarro-Delgado, Javier; Tamarit-Rodriguez, Jorge] Univ Complutense, Sch Med, Dept Biochem, Madrid, Spain	Boston University; Complutense University of Madrid	Tamarit-Rodriguez, J (corresponding author), Boston Univ, Sch Med, Dept Med, Obes Res Ctr, Boston, MA 02118 USA.	tamarit@med.ucm.es	PIZARRO-DELGADO, JAVIER/E-7268-2012	Deeney, Jude/0000-0003-0988-9419; PIZARRO-DELGADO, JAVIER/0000-0002-3735-844X	National Institutes of Health of the United States of America; Ministerio de Economia y Competitividad	National Institutes of Health of the United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad(Spanish Government)	National Institutes of Health of the United States of America (www.nih.gov) and Ministerio de Economia y Competitividad (www.mineco.gob.es).	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Feksa LR, 2003, BRAIN RES, V968, P199, DOI 10.1016/S0006-8993(03)02239-X; Fernandez-Pascual S, 2004, BIOCHEM J, V379, P721, DOI 10.1042/BJ20031826; Guay C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077097; Heart E, 2007, BIOCHEM J, V403, P197, DOI 10.1042/BJ20061209; HELLMAN B, 1975, DIABETOLOGIA, V11, P495, DOI 10.1007/BF01222098; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Ikemoto A, 2003, J BIOL CHEM, V278, P5929, DOI 10.1074/jbc.M211617200; Ivarsson R, 2005, DIABETES, V54, P2132, DOI 10.2337/diabetes.54.7.2132; Jensen MV, 2008, AM J PHYSIOL-ENDOC M, V295, pE1287, DOI 10.1152/ajpendo.90604.2008; Joseph JW, 2006, J BIOL CHEM, V281, P35624, DOI 10.1074/jbc.M602606200; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MALAISSE WJ, 1988, DIABETES RES CLIN EX, V7, P53; Mukala-Nsengu A, 2004, BIOCHEM PHARMACOL, V67, P981, DOI 10.1016/j.bcp.2003.10.024; Pizarro-Delgado J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140096; Pizarro-Delgado J, 2014, AM J PHYSIOL-ENDOC M, V306, pE1354, DOI 10.1152/ajpendo.00358.2013; Pizarro-Delgado J, 2010, BIOCHEM J, V431, P381, DOI 10.1042/BJ20100714; Pizarro-Delgado J, 2009, BIOCHEM J, V419, P359, DOI 10.1042/BJ20081731; Ronnebaum SM, 2008, J BIOL CHEM, V283, P28909, DOI 10.1074/jbc.M804665200; Ronnebaum SM, 2006, J BIOL CHEM, V281, P30593, DOI 10.1074/jbc.M511908200; SEKINE N, 1994, J BIOL CHEM, V269, P4895; Stark R, 2009, J BIOL CHEM, V284, P26578, DOI 10.1074/jbc.M109.011775; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001	24	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166111	10.1371/journal.pone.0166111	http://dx.doi.org/10.1371/journal.pone.0166111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851770	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300036
J	Remacha, C; Delgado, JA; Bulaic, M; Perez-Tris, J				Remacha, Carolina; Antonio Delgado, Juan; Bulaic, Mateja; Perez-Tris, Javier			Human Disturbance during Early Life Impairs Nestling Growth in Birds Inhabiting a Nature Recreation Area	PLOS ONE			English	Article							BREEDING BLUE TITS; REPRODUCTIVE SUCCESS; PARENTAL CARE; BROOD SIZE; SURVIVAL; WEIGHT; GREAT; CONSEQUENCES; PREDATION; FITNESS	Nature recreation conflicts with conservation, but its impacts on wildlife are not fully understood. Where recreation is not regulated, visitors to natural areas may gather in large numbers on weekends and holidays. This may increase variance in fitness in wild populations, if individuals whose critical life cycle stages coincide with periods of high human disturbance are at a disadvantage. We studied nestling development of blue tits (Cyanistes caeruleus) in a natural area where recreation activities intensify during weekends and other public holidays at picnic and leisure facilities, but not in the surrounding woods. In nests located near recreation facilities, blue tit nestlings that hatched during holidays developed slowly, and fledged with low body mass and poor body condition. However, nestlings that hatched outside of holidays and weekends in these nest boxes developed normally, eventually attaining similar phenotypes as those hatching in the surrounding woods. Within-brood variance in body mass was also higher in broods that began growing during holidays in disturbed areas. Our results show that early disturbance events may have negative consequences for wild birds if they overlap with critical stages of development, unveiling otherwise cryptic impacts of human activities. These new findings may help managers better regulate nature recreation.	[Remacha, Carolina; Bulaic, Mateja; Perez-Tris, Javier] Univ Complutense Madrid, Dept Zool & Phys Anthropol, Madrid, Spain; [Remacha, Carolina; Antonio Delgado, Juan] Univ Complutense Madrid, Dept Ecol, Madrid, Spain	Complutense University of Madrid; Complutense University of Madrid	Remacha, C (corresponding author), Univ Complutense Madrid, Dept Zool & Phys Anthropol, Madrid, Spain.; Remacha, C (corresponding author), Univ Complutense Madrid, Dept Ecol, Madrid, Spain.	cremacha@ucm.es	Pérez-Tris, Javier/D-4087-2012; Delgado, Juan Antonio/P-2398-2019	Pérez-Tris, Javier/0000-0001-5535-3100; Delgado, Juan Antonio/0000-0002-8075-4704; REMACHA SEBASTIAN, CAROLINA/0000-0002-3763-968X	Spanish Ministry of Science and Technology [CGL2007-62937/BOS, CGL2010-15734/BOS, CGL2013-41642-P/BOS]; Community of Madrid; European Union [REMEDINAL-2 52009/AMB-1783, REMEDINAL3-CM (S2013/MAE-2719)]	Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Community of Madrid(Comunidad de Madrid); European Union(European Commission)	This study was funded by the Spanish Ministry of Science and Technology (grants CGL2007-62937/BOS, CGL2010-15734/BOS and CGL2013-41642-P/BOS, to JP), Community of Madrid and European Union (REMEDINAL-2 52009/AMB-1783 and REMEDINAL3-CM (S2013/MAE-2719) to CR and JD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, BEHAV ECOL, V23; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bautista LM, 2004, CONSERV BIOL, V18, P726, DOI 10.1111/j.1523-1739.2004.00499.x; Bogner FX, 1999, INT J SCI EDUC, V21, P1169, DOI 10.1080/095006999290138; Brown Margaret E., 1996, Current Ornithology, V13, P67; Camp MJ, 2012, ETHOLOGY, V118, P1010, DOI 10.1111/eth.12000; Cardoni DA, 2008, BIOL CONSERV, V141, P797, DOI 10.1016/j.biocon.2007.12.024; Caviedes-Vidal E, 2001, PHYSIOL BIOCHEM ZOOL, V74, P769, DOI 10.1086/322966; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; DWYER JF, 1988, LANDSCAPE URBAN PLAN, V15, P127, DOI 10.1016/0169-2046(88)90021-7; Elkins N., 1983, WEATHER BIRD BEHAV; FERNANDEZ C, 1993, J WILDLIFE MANAGE, V57, P602, DOI 10.2307/3809289; Fernandez-Juricic E, 2000, CONDOR, V102, P247, DOI 10.1650/0010-5422(2000)102[0247:LAREOP]2.0.CO;2; Fernandez-Juricic Esteban, 2001, P259; Finney SK, 2005, BIOL CONSERV, V121, P53, DOI 10.1016/j.biocon.2004.04.009; French SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017686; Frid A, 2002, CONSERV ECOL, V6; Giese M, 1996, BIOL CONSERV, V75, P157, DOI 10.1016/0006-3207(95)00060-7; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Guay PJ, 2016, AMBIO, V45, P841, DOI 10.1007/s13280-016-0779-4; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Horak P, 1998, IBIS, V140, P205, DOI 10.1111/j.1474-919X.1998.tb04380.x; Isaksson C, 2007, J AVIAN BIOL, V38, P564, DOI 10.1111/j.2007.0908-8857.04030.x; Krause ET, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005015; Kuznetsova A., 2012, LMERTEST TESTS RANDO; Lambrechts MM, 2010, ACTA ORNITHOL, V45, P1, DOI 10.3161/000164510X516047; Lenth RV, 2015, PACKAGE LSMEANS R PA; Lima SL, 2009, BIOL REV, V84, P485, DOI 10.1111/j.1469-185X.2009.00085.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MAGRATH RD, 1991, J ANIM ECOL, V60, P335, DOI 10.2307/5464; Mallord JW, 2007, J APPL ECOL, V44, P185, DOI 10.1111/j.1365-2664.2006.01242.x; Martinez-Padilla J, 2004, FUNCT ECOL, V18, P426, DOI 10.1111/j.0269-8463.2004.00874.x; McCarty JP, 2001, AUK, V118, P176, DOI 10.1642/0004-8038(2001)118[0176:VIGONT]2.0.CO;2; Mock DW, 2009, ANIM BEHAV, V78, P677, DOI 10.1016/j.anbehav.2009.05.032; Mueller C, 2006, GEN COMP ENDOCR, V148, P163, DOI 10.1016/j.ygcen.2006.02.012; Naef-Daenzer B, 1999, J ANIM ECOL, V68, P708, DOI 10.1046/j.1365-2656.1999.00318.x; Newhouse MJ, 2008, WILSON J ORNITHOL, V120, P99, DOI 10.1676/06-156.1; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; NUR N, 1984, J ANIM ECOL, V53, P497, DOI 10.2307/4530; Oswald SA, 2012, METHODS ECOL EVOL, V3, P1073, DOI 10.1111/j.2041-210X.2012.00231.x; Schew William A., 1998, Oxford Ornithology Series, V8, P288; Stalmaster MV, 1998, WILDLIFE MONOGRAPHS, V137; Stankowich T, 2005, P ROY SOC B-BIOL SCI, V272, P2627, DOI 10.1098/rspb.2005.3251; Svensson L., 1992, IDENTIFICATION GUIDE; Tablado Z., 2015, BIOL REV; Taylor AR, 2003, ECOL APPL, V13, P951, DOI 10.1890/1051-0761(2003)13[951:WRTRAA]2.0.CO;2; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Van de Pol M, 2006, J ANIM ECOL, V75, P616, DOI 10.1111/j.1365-2656.2006.01079.x; Verhulst S, 2001, BIOL CONSERV, V101, P375, DOI 10.1016/S0006-3207(01)00084-2; Watson H, 2014, BIOL CONSERV, V174, P127, DOI 10.1016/j.biocon.2014.03.020; Wolf ID, 2013, J ENVIRON MANAGE, V129, P224, DOI 10.1016/j.jenvman.2013.07.017; Yasue M, 2006, J APPL ECOL, V43, P978, DOI 10.1111/j.1365-2664.2006.01204.x	54	13	14	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166748	10.1371/journal.pone.0166748	http://dx.doi.org/10.1371/journal.pone.0166748			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851816	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000387909300084
J	Mehlhorn, J; Rehkaemper, G				Mehlhorn, Julia; Rehkaemper, Gerd			The Influence of Social Parameters on the Homing Behavior of Pigeons	PLOS ONE			English	Article							LEADERSHIP; ORIENTATION; NAVIGATION; BIRDS	Homing pigeons develop preferred routes when released alone several times from the same site, but they sometimes diverge from their preferred route when subsequently released with another pigeon. Additionally, group flights show a better homing performance than solo flights. But this knowledge is based on studies involving both sexes and lacks analyses of social parameters such as mating or breeding status, even though it is known that such parameters have an influence on behavior and on motivation for specific behavioral patterns. GPS trackers were used to track 24 homing pigeons (9 breeding pairs and 6 unmated females) as they performed a familiar 10km route in various pair and group combinations. Comparisons of efficiency indices (quotient between straight-line distance and pigeon's track) reveal that unmated females show the best efficiency in single flights. Generally, group flights show the best efficiency followed by pair flights with a social partner of the opposite sex. Pair flights with the mated partner exhibit the poorest performance. Additionally, just before squabs hatching, females show a higher efficiency index when released at 8 am, compared to releases at 2 pm. Our results indicate that homing flight efficiency can provide insight into individual motivation and that social parameters have an influence on homing performance on a familiar route.	[Mehlhorn, Julia; Rehkaemper, Gerd] Univ Duesseldorf, Inst Anat 1, Res Grp Comparat Neurobiol & Evolutionary Res, Dusseldorf, Germany		Mehlhorn, J (corresponding author), Univ Duesseldorf, Inst Anat 1, Res Grp Comparat Neurobiol & Evolutionary Res, Dusseldorf, Germany.	julia.mehlhom@uni-duesseldorf.de						Bell A, 2013, BEHAV ECOL, V24, P16, DOI 10.1093/beheco/ars148; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; CLAUSEN DM, 1958, EXPERIENTIA, V14, P386, DOI 10.1007/BF02159172; Dell'Ariccia G, 2008, ANIM BEHAV, V76, P1165, DOI 10.1016/j.anbehav.2008.05.022; DelSeppia C, 1996, ANIM BEHAV, V52, P33, DOI 10.1006/anbe.1996.0150; Flack A, 2013, J EXP BIOL, V216, P1434, DOI 10.1242/jeb.082800; Flack A, 2012, ANIM BEHAV, V83, P703, DOI 10.1016/j.anbehav.2011.12.018; Gould JL, 2006, CURR BIOL, V16, pR920, DOI 10.1016/j.cub.2006.09.051; Guilford T, 2014, J EXP BIOL, V217, P169, DOI 10.1242/jeb.092908; Johnston RF, 1995, FERAL PIGEONS; Jorge PE, 2012, J EXP BIOL, V215, P2414, DOI 10.1242/jeb.070375; Lipp H.-P., 1996, ACTA BIOL BENRODIS S, V3, P85; LIPP HP, 1983, COMP BIOCHEM PHYS A, V76, P743, DOI 10.1016/0300-9629(83)90136-6; Lipp HP, 2004, CURR BIOL, V14, P1239, DOI 10.1016/j.cub.2004.07.024; Meade J, 2005, P ROY SOC B-BIOL SCI, V272, P17, DOI 10.1098/rspb.2004.2873; Mehlhorn J, 2009, NATURWISSENSCHAFTEN, V96, P1011, DOI 10.1007/s00114-009-0560-7; MICHENER MC, 1967, J EXP BIOL, V47, P99; PAPI F, 1974, J COMP PHYSIOL, V94, P187, DOI 10.1007/BF00611866; PARKER GA, 1972, J THEOR BIOL, V36, P529, DOI 10.1016/0022-5193(72)90007-0; Pettit B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2160; Rosler G, 1998, DIE BRIEFTAUBE; Santos CD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147497; Schiffner I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112439; Schiffner I, 2009, NATURWISSENSCHAFTEN, V96, P251, DOI 10.1007/s00114-008-0476-7; SCHMIDTKOENIG K, 1990, EXPERIENTIA, V46, P336, DOI 10.1007/BF01952166; Simons AM, 2004, TRENDS ECOL EVOL, V19, P453, DOI 10.1016/j.tree.2004.07.001; Steiner I, 2000, PHYSIOL BEHAV, V71, P589, DOI 10.1016/S0031-9384(00)00409-1; VISALBERGHI E, 1979, BIOL BULL, V125, P246; von Hunerbein K, 2000, NATURWISSENSCHAFTEN, V87, P278, DOI 10.1007/s001140050721; WALLRAFF HG, 1978, OIKOS, V30, P401, DOI 10.2307/3543490; Wallraff HG., 2005, AVIAN NAVIGATION PIG; Wiltschko R, 2007, ANIM BEHAV, V74, P1229, DOI 10.1016/j.anbehav.2007.01.028	32	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166572	10.1371/journal.pone.0166572	http://dx.doi.org/10.1371/journal.pone.0166572			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846262	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600084
J	Yu, P; Pan, YS; Wang, YJ; Wang, XW; Liu, LP; Ji, RJ; Meng, X; Jing, J; Tong, X; Guo, L; Wang, YL				Yu, Ping; Pan, Yuesong; Wang, Yongjun; Wang, Xianwei; Liu, Liping; Ji, Ruijun; Meng, Xia; Jing, Jing; Tong, Xu; Guo, Li; Wang, Yilong			External Validation of a Case-Mix Adjustment Model for the Standardized Reporting of 30-Day Stroke Mortality Rates in China	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; INTRACEREBRAL HEMORRHAGE; PROGNOSTIC MODELS; SCORE; PREDICTORS; DISABILITY; SURVIVAL; SCALE; RISK; AGE	Background and Purpose A case-mix adjustment model has been developed and externally validated, demonstrating promise. However, the model has not been thoroughly tested among populations in China. In our study, we evaluated the performance of the model in Chinese patients with acute stroke. Methods The case-mix adjustment model A includes items on age, presence of atrial fibrillation on admission, National Institutes of Health Stroke Severity Scale (NIHSS) score on admission, and stroke type. Model B is similar to Model A but includes only the consciousness component of the NIHSS score. Both model A and B were evaluated to predict 30-day mortality rates in 13,948 patients with acute stroke from the China National Stroke Registry. The discrimination of the models was quantified by c-statistic. Calibration was assessed using Pearson's correlation coefficient. Results The c-statistic of model A in our external validation cohort was 0.80 (95% confidence interval, 0.79-0.82), and the c-statistic of model B was 0.82 (95% confidence interval, 0.81-0.84). Excellent calibration was reported in the two models with Pearson's correlation coefficient (0.892 for model A, p<0.001; 0.927 for model B, p=0.008). Conclusions The case-mix adjustment model could be used to effectively predict 30-day mortality rates in Chinese patients with acute stroke.	[Yu, Ping; Guo, Li] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Peoples R China; [Pan, Yuesong; Wang, Yongjun; Wang, Xianwei; Meng, Xia; Jing, Jing; Wang, Yilong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Tiantan Clin Trial & Res Ctr Stroke, Beijing, Peoples R China; [Pan, Yuesong] Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China; [Wang, Yongjun; Liu, Liping; Ji, Ruijun; Wang, Yilong] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China; [Wang, Yongjun; Ji, Ruijun; Wang, Yilong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China; [Liu, Liping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Neurointens Care Unit, Beijing, Peoples R China; [Tong, Xu] Hebei Med Univ, Tangshan Gongren Hosp, Dept Neurol, Tangshan, Hebei, Peoples R China; [Yu, Ping] Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Hebei Province, Peoples R China; [Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Hebei Medical University; Capital Medical University; Capital Medical University; Capital Medical University; Hebei Medical University; Hebei Medical University; Capital Medical University	Guo, L (corresponding author), Hebei Med Univ, Hosp 2, Dept Neurol, Shijiazhuang, Peoples R China.; Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Tiantan Clin Trial & Res Ctr Stroke, Beijing, Peoples R China.; Wang, YL (corresponding author), China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China.; Wang, YL (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Vasc Neurol, Beijing, Peoples R China.	guoli6hb@163.com; yilong528@gmail.com	Pan, Yuesong/AAI-6303-2020	Pan, Yuesong/0000-0003-3082-6789	Ministry of Science and Technology; Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China [2008ZX09312_008]; State Key Development Program of (for) Basic Research of China [2009CB521905]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China; State Key Development Program of (for) Basic Research of China(National Basic Research Program of ChinaState Key Development Program for Basic Research of China)	This study was funded by the Ministry of Science and Technology and the Ministry of Health of the People's Republic of China: National Science and Technology Major Project of China (2008ZX09312_008) and State Key Development Program of (for) Basic Research of China (2009CB521905).	Abdul-Rahim AH, 2016, STROKE, V47, P74, DOI 10.1161/STROKEAHA.115.009898; ALLEN CMC, 1984, J NEUROL NEUROSUR PS, V47, P475, DOI 10.1136/jnnp.47.5.475; Bray BD, 2014, STROKE, V45, P3374, DOI 10.1161/STROKEAHA.114.006451; Carandang R, 2006, JAMA-J AM MED ASSOC, V296, P2939, DOI 10.1001/jama.296.24.2939; Cheung RTF, 2003, STROKE, V34, P1717, DOI 10.1161/01.STR.0000078657.22835.B9; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; FRITHZ G, 1976, ACTA MED SCAND, V199, P133; FULLERTON KJ, 1988, Q J MED, V66, P147; GOMPERTZ P, 1994, J NEUROL NEUROSUR PS, V57, P932, DOI 10.1136/jnnp.57.8.932; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Liu LP, 2011, STROKE, V42, P3651, DOI 10.1161/STROKEAHA.111.635755; Myint PK, 2014, INT J STROKE, V9, P278, DOI 10.1111/ijs.12088; Papavasileiou V, 2013, STROKE, V44, P1616, DOI 10.1161/STROKEAHA.113.001047; Saposnik G, 2011, CIRCULATION, V123, P739, DOI 10.1161/CIRCULATIONAHA.110.983353; SHEIKH K, 1983, J EPIDEMIOL COMMUN H, V37, P70, DOI 10.1136/jech.37.1.70; Smith EE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005207; Teale EA, 2012, CLIN REHABIL, V26, P771, DOI 10.1177/0269215511433068; TUHRIM S, 1991, ANN NEUROL, V29, P658, DOI 10.1002/ana.410290614; Wang XG, 2015, CNS NEUROSCI THER, V21, P657, DOI 10.1111/cns.12421; Wang Y, 2003, ARCH PHYS MED REHAB, V84, P1006, DOI 10.1016/S0003-9993(03)00032-7; Wang Y, 2001, J CLIN EPIDEMIOL, V54, P766, DOI 10.1016/S0895-4356(01)00338-9; Wang YJ, 2011, INT J STROKE, V6, P355, DOI 10.1111/j.1747-4949.2011.00584.x; Weimar C, 2004, STROKE, V35, P158, DOI 10.1161/01.STR.0000106761.94985.8B; Weimar C, 2002, J NEUROL, V249, P888, DOI 10.1007/s00415-002-0755-8; Zhang N, 2013, STROKE, V44, P1924, DOI 10.1161/STROKEAHA.111.000172; Zhang N, 2012, STROKE, V43, P3108, DOI 10.1161/STROKEAHA.112.669085	28	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166069	10.1371/journal.pone.0166069	http://dx.doi.org/10.1371/journal.pone.0166069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846282	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600030
J	Okamoto, K; Yamasaki, M; Takao, K; Soya, S; Iwasaki, M; Sasaki, K; Magoori, K; Sakakibara, I; Miyakawa, T; Mieda, M; Watanabe, M; Sakai, J; Yanagisawa, M; Sakurai, T				Okamoto, Kitaro; Yamasaki, Miwako; Takao, Keizo; Soya, Shingo; Iwasaki, Monica; Sasaki, Koh; Magoori, Kenta; Sakakibara, Iori; Miyakawa, Tsuyoshi; Mieda, Michihiro; Watanabe, Masahiko; Sakai, Juro; Yanagisawa, Masashi; Sakurai, Takeshi			QRFP-Deficient Mice Are Hypophagic, Lean, Hypoactive and Exhibit Increased Anxiety-Like Behavior	PLOS ONE			English	Article							MELANIN-CONCENTRATING HORMONE; FAT FOOD-INTAKE; OREXIN NEURONS; ENERGY-BALANCE; FEMALE RATS; RECEPTOR; OBESITY; LIGAND; GPR103; SLEEP	How the hypothalamus transmits hunger information to other brain regions to govern whole brain function to orchestrate feeding behavior has remained largely unknown. Our present study suggests the importance of a recently found lateral hypothalamic neuropeptide, QRFP, in this signaling. Qrfp(-/-) mice were hypophagic and lean, and exhibited increased anxiety-like behavior, and were hypoactive in novel circumstances as compared with wild type littermates. They also showed decreased wakefulness time in the early hours of the dark period. Histological studies suggested that QRFP neurons receive rich innervations from neurons in the arcuate nucleus which is a primary region for sensing the body's metabolic state by detecting levels of leptin, ghrelin and glucose. These observations suggest that QRFP is an important mediator that acts as a downstream mediator of the arcuate nucleus and regulates feeding behavior, mood, wakefulness and activity.	[Okamoto, Kitaro; Soya, Shingo; Iwasaki, Monica; Sasaki, Koh; Mieda, Michihiro; Sakurai, Takeshi] Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan; [Yamasaki, Miwako; Watanabe, Masahiko] Hokkaido Univ, Grad Sch Med, Dept Anat, Sapporo, Hokkaido 0608638, Japan; [Takao, Keizo; Miyakawa, Tsuyoshi] Natl Inst Physiol Sci, Ctr Genet Anal Behav, Sect Behav Patterns, 38 Nishigonaka Myodaiji, Okazaki, Aichi 4448585, Japan; [Takao, Keizo] Toyama Univ, Div Anim Resources & Dev, Life Sci Res Ctr, Toyama 9308555, Japan; [Magoori, Kenta; Sakakibara, Iori; Sakai, Juro] Univ Tokyo, Div Metab Med, RCAST, Tokyo 1538904, Japan; [Sakakibara, Iori; Sakai, Juro; Yanagisawa, Masashi; Sakurai, Takeshi] Japan Sci & Technol Agcy, ERATO Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan; [Miyakawa, Tsuyoshi] Fujita Hlth Univ, Div Syst Med Sci, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; [Yanagisawa, Masashi; Sakurai, Takeshi] Univ Tsukuba, Fac Med, Int Inst Integrat Sleep Med IIIS, Tsukuba, Ibaraki 3058575, Japan	Kanazawa University; Hokkaido University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Toyama; University of Tokyo; Japan Science & Technology Agency (JST); Fujita Health University; University of Tsukuba	Sakurai, T (corresponding author), Kanazawa Univ, Fac Med, Dept Mol Neurosci & Integrat Physiol, Kanazawa, Ishikawa 9208640, Japan.; Sakurai, T (corresponding author), Japan Sci & Technol Agcy, ERATO Yanagisawa Orphan Receptor Project, Tokyo 1350064, Japan.; Sakurai, T (corresponding author), Univ Tsukuba, Fac Med, Int Inst Integrat Sleep Med IIIS, Tsukuba, Ibaraki 3058575, Japan.	sakurai.takeshi.gf@u.tsukuba.ac.jp	Takao, Keizo/B-9527-2008; Yamasaki, Miwako/I-8053-2014; Watanabe, Masahiko/S-3614-2019; WATANABE, Masahiko/A-4055-2012; Miyakawa, Tsuyoshi/A-7741-2008	Takao, Keizo/0000-0002-4734-3583; Yamasaki, Miwako/0000-0003-4974-9349; Watanabe, Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138; Mieda, Michihiro/0000-0002-2451-7034; Soya, Shingo/0000-0001-7222-5012; Sakai, Juro/0000-0003-4043-1035; Miyakawa, Tsuyoshi/0000-0003-0137-8200	Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [16H06401]; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [16K01946, 16H06462, 16H05120] Funding Source: KAKEN	Cabinet Office, Government of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers." This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas Integrative Brain Research (IBR-shien) and a Grant-in-Aid for Scientific Research on Innovative Areas (16H06401) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; The authors thank Ms. Satsuki Sawada and Yuki C. Saito for their excellent technical assistance. This research was funded by the Cabinet Office, Government of Japan through its "Funding Program for Next Generation World-Leading Researchers." This work was also supported by a Grant-in-Aid for Scientific Research on Priority Areas-Integrative Brain Research (IBR-shien)-and a Grant-in-Aid for Scientific Research on Innovative Areas (Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Allerton TD, 2015, PEPTIDES, V69, P77, DOI 10.1016/j.peptides.2015.04.006; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Atasoy D, 2012, NATURE; Beck B, 2009, BIOCHEM BIOPH RES CO, V383, P78, DOI 10.1016/j.bbrc.2009.03.132; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Friedman JM, 2009, AM J CLIN NUTR, V89, p973S, DOI 10.3945/ajcn.2008.26788B; Friedman JM, 1997, NATURE, V385, P119, DOI 10.1038/385119a0; Fukusumi S, 2003, J BIOL CHEM, V278, P46387, DOI 10.1074/jbc.M305270200; Georgsson J, 2014, J MED CHEM, V57, P5935, DOI 10.1021/jm401951t; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Jiang Y, 2003, J BIOL CHEM, V278, P27652, DOI 10.1074/jbc.M302945200; Lectez B, 2009, ENDOCRINOLOGY, V150, P2342, DOI 10.1210/en.2008-1432; Moriya R, 2006, ENDOCRINOLOGY, V147, P2916, DOI 10.1210/en.2005-1580; Mulumba M, 2010, MOL ENDOCRINOL, V24, P1615, DOI 10.1210/me.2010-0010; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Primeaux SD, 2013, HORM METAB RES, V45, P967, DOI 10.1055/s-0033-1353181; Primeaux SD, 2008, PEPTIDES, V29, P1994, DOI 10.1016/j.peptides.2008.07.024; Primeaux SD, 2011, PEPTIDES, V32, P1270, DOI 10.1016/j.peptides.2011.03.022; Ramanjaneya M, 2013, AM J PHYSIOL-ENDOC M, V305, pE1049, DOI 10.1152/ajpendo.00191.2013; Ramos A, 1997, BEHAV BRAIN RES, V85, P57, DOI 10.1016/S0166-4328(96)00164-7; Sakurai T, 2007, NAT REV NEUROSCI, V8, P171, DOI 10.1038/nrn2092; Sakurai T, 2014, NAT REV NEUROSCI, V15, P719, DOI 10.1038/nrn3837; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schreiber AL, 2016, NEUROPEPTIDES, V58, P103, DOI 10.1016/j.npep.2016.01.004; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Takasaki C, 2010, EUR J NEUROSCI, V32, P1326, DOI 10.1111/j.1460-9568.2010.07377.x; Takayasu S, 2006, P NATL ACAD SCI USA, V103, P7438, DOI 10.1073/pnas.0602371103; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Tsunematsu T, 2014, J NEUROSCI, V34, P6896, DOI 10.1523/JNEUROSCI.5344-13.2014; Ukena K, 2010, ENDOCRINOLOGY, V151, P2255, DOI 10.1210/en.2009-1478; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zagoracz O, 2015, BRAIN RES BULL, V118, P58, DOI 10.1016/j.brainresbull.2015.09.004	38	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164716	10.1371/journal.pone.0164716	http://dx.doi.org/10.1371/journal.pone.0164716			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835635	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200002
J	Pace, E; Luo, H; Bobian, M; Panekkad, A; Zhang, XG; Zhang, HM; Zhang, JS				Pace, Edward; Luo, Hao; Bobian, Michael; Panekkad, Ajay; Zhang, Xueguo; Zhang, Huiming; Zhang, Jinsheng			A Conditioned Behavioral Paradigm for Assessing Onset and Lasting Tinnitus in Rats	PLOS ONE			English	Article							SALICYLATE-INDUCED TINNITUS; INDUCED HEARING-LOSS; TRAUMA-INDUCED TINNITUS; GAP DETECTION DEFICITS; ANIMAL-MODEL; ACOUSTIC TRAUMA; RECEPTOR AGONISTS; NEURAL ACTIVITY; NOISE; HYPERACUSIS	Numerous behavioral paradigms have been developed to assess tinnitus-like behavior in animals. Nevertheless, they are often limited by prolonged training requirements, as well as an inability to simultaneously assess onset and lasting tinnitus behavior, tinnitus pitch or duration, or tinnitus presence without grouping data from multiple animals or testing sessions. To enhance behavioral testing of tinnitus, we developed a conditioned licking suppression paradigm to determine the pitch(s) of both onset and lasting tinnitus-like behavior within individual animals. Rats learned to lick water during broadband or narrowband noises, and to suppress licking to avoid footshocks during silence. After noise exposure, rats significantly increased licking during silent trials, suggesting onset tinnitus-like behavior. Lasting tinnitus-behavior, however, was exhibited in about half of noise-exposed rats through 7 weeks post-exposure tested. Licking activity during narrowband sound trials remained unchanged following noise exposure, while ABR hearing thresholds fully recovered and were comparable between tinnitus((+)) and tinnitus((-)) rats. To assess another tinnitus inducer, rats were injected with sodium salicylate. They demonstrated high pitch tinnitus-like behavior, but later recovered by 5 days post-injection. Further control studies showed that 1): sham noise-exposed rats tested with footshock did not exhibit tinnitus-like behavior, and 2): noise-exposed or sham rats tested without footshocks showed no fundamental changes in behavior compared to those tested with shocks. Together, these results demonstrate that this paradigm can efficiently test the development of noise-and salicylate-induced tinnitus behavior. The ability to assess tinnitus individually, over time, and without averaging data enables us to realistically address tinnitus in a clinically relevant way. Thus, we believe that this optimized behavioral paradigm will facilitate investigations into the mechanisms of tinnitus and development of effective treatments.	[Pace, Edward; Luo, Hao; Bobian, Michael; Zhang, Xueguo; Zhang, Jinsheng] Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA; [Panekkad, Ajay] Wayne State Coll Engn, Dept Elect Engn, 5050 Anthony Wayne Dr, Detroit, MI 48202 USA; [Zhang, Huiming] Univ Windsor, Dept Biol Sci, 401 Sunset Ave, Windsor, ON, Canada; [Zhang, Jinsheng] Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, 60 Farnsworth St, Detroit, MI 48202 USA	Wayne State University; University of Windsor; Wayne State University	Zhang, JS (corresponding author), Wayne State Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 4201 St Antoine, Detroit, MI 48201 USA.; Zhang, JS (corresponding author), Wayne State Univ, Dept Commun Sci & Disorders, Coll Liberal Arts & Sci, 60 Farnsworth St, Detroit, MI 48202 USA.	jinzhang@med.wayne.edu	张, 锦胜/GXF-8167-2022; Zhang, Hui/HHN-8494-2022		Wayne State University Research funds;  [NIH5R21DC014335-02];  [NIH1R21DC014335-01]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC014335] Funding Source: NIH RePORTER	Wayne State University Research funds; ; ; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was partially supported by Wayne State University Research funds and NIH5R21DC014335-02.; The authors would like to thank Evan Hill for his valuable feedback during the early stages of developing this behavioral paradigm, and Nafi Yassar for helping us to develop the software used for behavioral testing. We would also like to thank Yiwen Zheng for her helpful comments on a previous version of this manuscript. This work was partially supported by Wayne State University Research funds and NIH1R21DC014335-01.	Adams P F, 1995, Vital Health Stat 10, P1; ATHERLEY GR, 1968, J ACOUST SOC AM, V44, P1503, DOI 10.1121/1.1911288; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2001, JARO-J ASSOC RES OTO, V2, P54, DOI 10.1007/s101620010030; Bauer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064726; Berger JI, 2013, J NEUROSCI METH, V213, P188, DOI 10.1016/j.jneumeth.2012.12.023; Boyen K, 2015, EAR HEARING, V36, pe138, DOI 10.1097/AUD.0000000000000156; Brennan JF, 1991, ACTA NEUROBIOL EXP W, P12; Brozoski TJ, 2007, JARO-J ASSOC RES OTO, V8, P105, DOI 10.1007/s10162-006-0067-2; Campolo J, 2013, NOISE HEALTH, V15, P398, DOI 10.4103/1463-1741.121232; Chung JW, 2007, ANESTH ANALG, V104, P1404, DOI 10.1213/01.ane.0000261508.24083.6c; Dauman Nicolas, 2012, Int J Qual Stud Health Well-being, V7, P1, DOI 10.3402/qhw.v7i0.19540; Dauman R, 2005, ACTA OTO-LARYNGOL, V125, P503, DOI 10.1080/00016480510027565; Fournier P, 2013, HEARING RES, V295, P16, DOI 10.1016/j.heares.2012.05.011; Galazyuk A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00088; Granjeiro RC, 2013, OTOLARYNG HEAD NECK, V148, P658, DOI 10.1177/0194599812473554; Guitton Matthieu J., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/80904; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HALLBERG LRM, 1993, BRIT J AUDIOL, V27, P19, DOI 10.3109/03005369309077885; Hayes SH, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00179; Heffner HE, 2005, BEHAV NEUROSCI, V119, P734, DOI 10.1037/0735-7044.119.3.734; Heffner HE, 2002, HEARING RES, V170, P83, DOI 10.1016/S0378-5955(02)00343-X; Heffner HE, 2012, BEHAV TESTS TINNITUS; Heffner HE, 2011, BEHAV RES METHODS, V43, P577, DOI 10.3758/s13428-011-0061-4; Heffner LE, 2012, BEHAV TESTS TINNITUS; Hickox AE, 2014, J NEUROPHYSIOL, V111, P552, DOI 10.1152/jn.00184.2013; Hu SS, 2014, INFLAMMATION, V37, P365, DOI 10.1007/s10753-013-9748-2; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; Kim JU, 2005, LARYNGOSCOPE, V115, P1996, DOI 10.1097/01.mlg.0000180173.81034.4d; Kim YH, 2016, LARYNGOSCOPE, V126, P447, DOI 10.1002/lary.25446; Kizawa K, 2010, NEUROSCIENCE, V165, P1323, DOI 10.1016/j.neuroscience.2009.11.048; Kraus KS, 2010, NEUROSCIENCE, V167, P1216, DOI 10.1016/j.neuroscience.2010.02.071; Lewis J E, 2002, J Am Acad Audiol, V13, P339; Liu XP, 2015, HEARING RES, V323, P51, DOI 10.1016/j.heares.2015.01.013; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lobarinas E, 2015, JARO-J ASSOC RES OTO, V16, P263, DOI 10.1007/s10162-014-0500-x; Lobarinas E, 2013, HEARING RES, V295, P150, DOI 10.1016/j.heares.2012.06.001; LOEB M, 1967, J ACOUST SOC AM, V42, P453, DOI 10.1121/1.1910600; Longenecker RJ, 2011, JARO-J ASSOC RES OTO, V12, P647, DOI 10.1007/s10162-011-0276-1; Mahmoudian S, 2012, J RES MED SCI, V17, P242; McFadden D., 1982, TINNITUS FACTS THEOR; Norman M, 2012, HEARING RES, V290, P64, DOI 10.1016/j.heares.2012.03.015; Oishi N, 2010, AUDIOL NEURO-OTOL, V15, P187, DOI 10.1159/000251916; Pace E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075011; Radziwon KE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00031; Ruttiger L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057247; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; Stolzberg D, 2013, J NEUROSCI METH, V219, P224, DOI 10.1016/j.jneumeth.2013.07.021; Stolzberg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00028; Tan J, 2007, NEUROSCIENCE, V145, P715, DOI 10.1016/j.neuroscience.2006.11.067; Turner JG, 2008, AM J AUDIOL, V17, pS185, DOI 10.1044/1059-0889(2008/08-0006); Turner JG, 2006, BEHAV NEUROSCI, V120, P188, DOI 10.1037/0735-7044.120.1.188; USDoV Affairs, ANN BEN REP VET BEN; Wang H, 2009, NEUROSCIENCE, V164, P747, DOI 10.1016/j.neuroscience.2009.08.026; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Zheng YW, 2015, EUR J PHARMACOL, V761, P206, DOI 10.1016/j.ejphar.2015.05.007; Zheng YW, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00060; Zheng YW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/724195; Zheng Yiwen, 2012, Front Neurol, V3, P127; Zheng YW, 2010, HEARING RES, V268, P145, DOI 10.1016/j.heares.2010.05.015; Zheng Y, 2011, ACM T WEB, V5, DOI 10.1145/1921591.1921596	63	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166346	10.1371/journal.pone.0166346	http://dx.doi.org/10.1371/journal.pone.0166346			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835697	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200042
J	Anton-Sanchez, L; Bielza, C; Larranaga, P; DeFelipe, J				Anton-Sanchez, Laura; Bielza, Concha; Larranaga, Pedro; DeFelipe, Javier			Wiring Economy of Pyramidal Cells in the Juvenile Rat Somatosensory Cortex	PLOS ONE			English	Article							DENDRITIC STRUCTURE; NEURONS	Ever since Cajal hypothesized that the structure of neurons is designed in such a way as to save space, time and matter, numerous researchers have analyzed wiring properties at different scales of brain organization. Here we test the hypothesis that individual pyramidal cells, the most abundant type of neuron in the cerebral cortex, optimize brain connectivity in terms of wiring length. In this study, we analyze the neuronal wiring of complete basal arborizations of pyramidal neurons in layer II, Ill, IV, Va, Vb and VI of the hindlimb somatosensory cortical region of postnatal day 14 rats. For each cell, we search for the optimal basal arborization and compare its length with the length of the real dendritic structure. Here the optimal arborization is defined as the arborization that has the shortest total wiring length provided that all neuron bifurcations are respected and the extent of the dendritic arborizations remain unchanged. We use graph theory and evolutionary computation techniques to search for the minimal wiring arborizations. Despite morphological differences between pyramidal neurons located in different cortical layers, we found that the neuronal wiring is near-optimal in all cases (the biggest difference between the shortest synthetic wiring found for a dendritic arborization and the length of its real wiring was less than 5%). We found, however, that the real neuronal wiring was significantly closer to the best solution found in layers II, Ill and IV. Our studies show that the wiring economy of cortical neurons is related not to the type of neurons or their morphological complexities but to general wiring economy principles.	[Anton-Sanchez, Laura; Bielza, Concha; Larranaga, Pedro] Univ Politecn Madrid, Dept Inteligencia Artificial, Escuela Tecn Super Ingenieros Informat, Madrid, Spain; [DeFelipe, Javier] Univ Politecn Madrid, Lab Cajal Circuitos Corticales, Ctr Tecnol Biomed, Madrid, Spain; [DeFelipe, Javier] CSIC, Inst Cajal, Madrid, Spain	Universidad Politecnica de Madrid; Universidad Politecnica de Madrid; Centro de Tecnologia Biomedica (CTB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Anton-Sanchez, L (corresponding author), Univ Politecn Madrid, Dept Inteligencia Artificial, Escuela Tecn Super Ingenieros Informat, Madrid, Spain.	l.anton-sanchez@upm.es	DEFELIPE, JAVIER/D-1195-2014; Bielza, Concha/F-9277-2013; Larranaga, Pedro/F-9293-2013	DEFELIPE, JAVIER/0000-0001-5484-0660; Bielza, Concha/0000-0001-7109-2668; Larranaga, Pedro/0000-0003-0652-9872; Anton-Sanchez, Laura/0000-0002-5556-1759	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain [C080020-09, TIN2013-41592-P]; Regional Government of Madrid [S2013/ICE-2845-CASI-CAM-CM]; European Union's Horizon 2020 research and innovation programme [720270]; Spanish MINECO scholarship at the Residencia de Estudiantes	Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain(Spanish Government); Regional Government of Madrid; European Union's Horizon 2020 research and innovation programme; Spanish MINECO scholarship at the Residencia de Estudiantes	This work has been partially supported by the Spanish Ministry of Economy and Competitiveness through the Cajal Blue Brain (C080020-09; the Spanish partner of the EPFL's Blue Brain initiative) and TIN2013-41592-P projects, by the Regional Government of Madrid through the S2013/ICE-2845-CASI-CAM-CM project, and by the European Union's Horizon 2020 research and innovation programme under grant agreement No. 720270. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thankfully acknowledge the computer resources, technical expertise and assistance provided by the Supercomputing and Visualization Center of Madrid (CeSViMa). The authors would like to thank Isabel Fernaud-Espinosa for her technical assistance. LA-S acknowledges support from the Spanish MINECO scholarship at the Residencia de Estudiantes.	Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anton-Sanchez L, 2016, NEUROINFORMATICS, V14, P453, DOI 10.1007/s12021-016-9309-6; Cajal SR, 1904, TEXTURA SISTEMA NERV, V2, P903; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Cuntz H, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-21; Cuntz H, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000877; Cuntz H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000251; DEFELIPE J, 1992, PROG NEUROBIOL, V39, P563, DOI 10.1016/0301-0082(92)90015-7; DEFELIPE J, 1993, CEREB CORTEX, V3, P273, DOI 10.1093/cercor/3.4.273; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; Elston G.N., 2007, P191; Fishell G, 2011, ANNU REV NEUROSCI, V34, P535, DOI 10.1146/annurev-neuro-061010-113717; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Holland J.H., 1975, ADAPTATION NATURAL A; Markram H, 2015, CELL, V163, P456, DOI 10.1016/j.cell.2015.09.029; Rojo C, 2015, EVOLUTIONARY COMPUTA; Rojo C, 2016, CEREB CORTEX, V26, P2811, DOI 10.1093/cercor/bhv316; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Syswerda G., 1991, FDN GENETIC ALGORITH, V1, P94, DOI DOI 10.1016/B978-0-08-050684-5.50009-4; Wen Q, 2008, J NEUROPHYSIOL, V99, P2320, DOI 10.1152/jn.00280.2007; Wen Q, 2009, P NATL ACAD SCI USA, V106, P12536, DOI 10.1073/pnas.0901530106	22	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165915	10.1371/journal.pone.0165915	http://dx.doi.org/10.1371/journal.pone.0165915			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832100	Green Published, gold, Green Accepted			2022-12-26	WOS:000387725000040
J	Heidmann, I; Schade-Kampmann, G; Lambalk, J; Ottiger, M; Di Berardino, M				Heidmann, Iris; Schade-Kampmann, Grit; Lambalk, Joep; Ottiger, Marcel; Di Berardino, Marco			Impedance Flow Cytometry: A Novel Technique in Pollen Analysis	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; HEAT-STRESS; CARBOHYDRATE CONCENTRATION; TOMATO POLLEN; VIABILITY; GERMINATION; EXPRESSION; FERTILITY; RESERVES; CALCIUM	Introduction An efficient and reliable method to estimate plant cell viability, especially of pollen, is important for plant breeding research and plant production processes. Pollen quality is determined by classical methods, like staining techniques or in vitro pollen germination, each having disadvantages with respect to reliability, analysis speed, and species dependency. Analysing single cells based on their dielectric properties by impedance flow cytometry (IFC) has developed into a common method for cellular characterisation in microbiology and medicine during the last decade. The aim of this study is to demonstrate the potential of IFC in plant cell analysis with the focus on pollen. Method Developing and mature pollen grains were analysed during their passage through a microfluidic chip to which radio frequencies of 0.5 to 12 MHz were applied. The acquired data provided information about the developmental stage, viability, and germination capacity. The biological relevance of the acquired IFC data was confirmed by classical staining methods, inactivation controls, as well as pollen germination assays. Results Different stages of developing pollen, dead, viable and germinating pollen populations could be detected and quantified by IFC. Pollen viability analysis by classical FDA staining showed a high correlation with IFC data. In parallel, pollen with active germination potential could be discriminated from the dead and the viable but non-germinating population. Conclusion The presented data demonstrate that IFC is an efficient, label-free, reliable and non-destructive technique to analyse pollen quality in a species-independent manner.	[Heidmann, Iris; Lambalk, Joep] Enza Zaden, Res & Dev BV, POB 7, NL-1600 AA Enkhuizen, Netherlands; [Schade-Kampmann, Grit; Ottiger, Marcel; Di Berardino, Marco] Amphasys AG, Technopk Lucerne, CH-6039 Root D4, Switzerland		Heidmann, I (corresponding author), Enza Zaden, Res & Dev BV, POB 7, NL-1600 AA Enkhuizen, Netherlands.	i.heidmann@enzazaden.nl	Heidmann, Iris/AAL-1293-2021	Heidmann, Iris/0000-0002-4389-2120	Enza Zaden; Amphasys	Enza Zaden; Amphasys	This study was jointly financed and conducted by Enza Zaden and Amphasys to develop a method to analyse pollen quality in a reliable and efficient way. Enza Zaden R&D B.V funded the project by providing the salaries for IH and JL and Amphasys funded its part by providing the salaries for GSK, MO, MDB. The companies approve the wish of the authors to publish but did not have any additional role in the study design,	Azzarello E., 2012, PLANT ELECTROPHYSIOL, P205, DOI [10.1007/978-3-642-29119-7_9, DOI 10.1007/978-3-642-29119-7_9]; Berger F, 2011, ANNU REV PLANT BIOL, V62, P461, DOI 10.1146/annurev-arplant-042110-103824; BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; Cheung KC, 2010, CYTOM PART A, V77A, P648, DOI 10.1002/cyto.a.20910; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Dafni A, 2000, PLANT SYST EVOL, V222, P113, DOI 10.1007/BF00984098; David F, 2012, BIOTECHNOL BIOENG, V109, P483, DOI 10.1002/bit.23345; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; De Storme N, 2013, PLANT REPROD, V26, P65, DOI 10.1007/s00497-012-0209-0; DEBLOIS RW, 1970, REV SCI INSTRUM, V41, P909, DOI 10.1063/1.1684724; Demidov D, 2014, PLANT J, V80, P449, DOI 10.1111/tpj.12647; Fila J, 2016, MOL CELL PROTEOMICS, V15, P1338, DOI 10.1074/mcp.M115.051672; Firon N, 2006, SCI HORTIC-AMSTERDAM, V109, P212, DOI 10.1016/j.scienta.2006.03.007; Firon N, 2012, ANN BOT-LONDON, V109, P1201, DOI 10.1093/aob/mcs070; Franchi GG, 1996, FLORA, V191, P143; Garcia CC, 2007, GRANA, V46, P13, DOI 10.1080/00173130601179217; Garcia-Pardo C., 2016, PROC IEEE 27 ANN INT, P1, DOI DOI 10.1109/PIMRC.2016.7794780; Gawad S, 2001, LAB CHIP, V1, P76, DOI 10.1039/b103933b; Geng XM, 2013, GRANA, V52, P202, DOI 10.1080/00173134.2013.819033; Hansson J, 2011, INERTIAL PARTICLE FO, P1777; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; HECKER RJ, 1986, EUPHYTICA, V35, P777, DOI 10.1007/BF00028585; HERRERO MP, 1980, CROP SCI, V20, P796, DOI 10.2135/cropsci1980.0011183X002000060030x; Heslop-Harrison J. S., 1992, Sexual plant reproduction. Lectures presented on a course, University of Siena, Italy, 15 November to 2 December 1991., P41; HESLOPHARRISON J, 1979, AM J BOT, V66, P737, DOI 10.2307/2442418; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Ischebeck T, 2014, MOL CELL PROTEOMICS, V13, P295, DOI 10.1074/mcp.M113.028100; ISSARAKRAISILA M, 1994, ANN BOT-LONDON, V73, P231, DOI 10.1006/anbo.1994.1028; Johnson SA, 2001, PLANT PHYSIOL, V126, P685, DOI 10.1104/pp.126.2.685; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kelly JK, 2002, AM J BOT, V89, P1021, DOI 10.3732/ajb.89.6.1021; Khan MMR, 2013, SCI HORTIC-AMSTERDAM, V157, P39, DOI 10.1016/j.scienta.2013.04.010; Lang V, 2014, PROTOPLASMA, V251, P477, DOI 10.1007/s00709-013-0555-2; Maluszynski M., 2003, DOUBLED HAPLOID PROD; Maraschin SF, 2005, J EXP BOT, V56, P1711, DOI 10.1093/jxb/eri190; MATTON DP, 1994, P NATL ACAD SCI USA, V91, P1992, DOI 10.1073/pnas.91.6.1992; Muller F, 2016, PLANT REPROD, V29, P107, DOI 10.1007/s00497-016-0282-x; Orczyk W, 2003, PLANT CELL TISS ORG, V74, P1, DOI 10.1023/A:1023396405655; Otto F, 1990, Methods Cell Biol, V33, P105; Pacini E, 2006, PROTOPLASMA, V228, P73, DOI 10.1007/s00709-006-0169-z; Parrotta L, 2016, PLANTA, V243, P43, DOI 10.1007/s00425-015-2394-1; Pierzchalski A, 2012, LAB CHIP, V12, P4533, DOI 10.1039/c2lc40408g; Pressman E, 2002, ANN BOT-LONDON, V90, P631, DOI 10.1093/aob/mcf240; Rodriguez-Riano T, 2000, SEX PLANT REPROD, V12, P241, DOI 10.1007/s004970050008; Rutley N, 2015, PLANT REPROD, V28, P73, DOI 10.1007/s00497-015-0261-7; Sabuncu AC, 2011, MICROFLUIDIC DEVICE; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Sharma KD, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00402; Shen YH, 2014, PHYSIOL PLANTARUM, V150, P425, DOI 10.1111/ppl.12085; Shivanna K. R., 1989, Sexual Plant Reproduction, V2, P137, DOI 10.1007/BF00192759; Song J, 2007, J EXP BOT, V58, P4235, DOI 10.1093/jxb/erm280; Song JJ, 2002, PLANT CELL PHYSIOL, V43, P619, DOI 10.1093/pcp/pcf078; Spencer D, 2016, LAB CHIP, V16, P2467, DOI 10.1039/c6lc00339g; Steinhorst L, 2013, BBA-MOL CELL RES, V1833, P1573, DOI 10.1016/j.bbamcr.2012.10.009; Towil L. E., 2010, PLANT BREED REV, V13, P179; Twell D, 2011, SEX PLANT REPROD, V24, P149, DOI 10.1007/s00497-010-0157-5; Vizintin L, 2004, ACTA BIOL CRACOV BOT, V46, P177; Volkov AG, 2012, PLANT ELECTROPHYSIOL; Wei DM, 2015, J AM SOC HORTIC SCI, V140, P356, DOI 10.21273/JASHS.140.4.356; Yafouz B, 2013, SENSORS-BASEL, V13, P9029, DOI 10.3390/s130709029; Zechmann B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-54; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	63	40	41	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165531	10.1371/journal.pone.0165531	http://dx.doi.org/10.1371/journal.pone.0165531			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832091	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000017
J	Kienitz, MC; Vladimirova, D; Muller, C; Pott, L; Rinne, A				Kienitz, Marie-Cecile; Vladimirova, Dilyana; Mueller, Christian; Pott, Lutz; Rinne, Andreas			Receptor Species-dependent Desensitization Controls KCNQ1/KCNE1 K+ Channels as Downstream Effectors of G(q) Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C; MEDIATED DESENSITIZATION; QUANTITATIVE PROPERTIES; PHOSPHOLIPASE-C; PHOSPHORYLATION; PKC; ACTIVATION; INTERNALIZATION; MODULATION; MECHANISMS	Activation of G(q) protein-coupled receptors (G(q)PCRs) might induce divergent cellular responses, related to receptor-specific activation of different branches of the G(q) signaling pathway. Receptor-specific desensitization provides a mechanism of effector modulation by restricting the spatiotemporal activation of signaling components downstream of G(q). We quantified signaling events downstream of G(q)PCR activation with FRET-based biosensors in CHO and HEK 293 cells. KCNQ1/KCNE1 channels (I-Ks) were measured as a functional readout of receptor-specific activation. Activation of muscarinic M-1 receptors (M-1-Rs) caused robust and reversible inhibition of I-Ks. In contrast, activation of alpha(1B)-adrenergic receptors (alpha(1B)-ARs) induced transient inhibition of I-Ks, which turned into delayed facilitation after agonist withdrawal. As a novel finding, we demonstrate that G(q)PCR-specific kinetics of I-Ks modulation are determined by receptor-specific desensitization, evident at the level of G alpha(q) activation, phosphatidylinositol 4,5-bisphosphate (PIP2) depletion, and diacylglycerol production. Sustained I-Ks inhibition during M-1-R stimulation is attributed to robust membrane PIP2 depletion, whereas the rapid desensitization of alpha(1B)-AR delimits PIP2 reduction and augments current activation by protein kinase C(PKC). Overexpression of Ca2+-independent PKC delta did not affect the time course of alpha(1B)-AR-induced diacylglycerol formation, excluding a contribution of PKC delta to alpha(1B)-AR desensitization. Pharmacological inhibition of Ca2+-dependent PKC isoforms abolished fast alpha(1B) receptor desensitization and augmented I-Ks reduction, but did not affect I-Ks facilitation. These data indicate a contribution of Ca2+-dependent PKCs to alpha(1B)-AR desensitization, whereas I-Ks facilitation is induced by Ca2+-independent PKC isoforms. In contrast, neither inhibition of Ca2+-dependent/Ca2+-independent isoforms nor overexpression of PKC delta induced M-1 receptor desensitization, excluding a contribution of PKC to M-1-R-induced I-Ks modulation.	[Kienitz, Marie-Cecile; Vladimirova, Dilyana; Mueller, Christian; Pott, Lutz; Rinne, Andreas] Ruhr Univ Bochum, Inst Physiol, Univ Str 150, D-44780 Bochum, Germany	Ruhr University Bochum	Kienitz, MC (corresponding author), Ruhr Univ Bochum, Inst Physiol, Univ Str 150, D-44780 Bochum, Germany.	cecile.kienitz@rub.de	Rinne, Andreas/AAO-1685-2020; Rinne, Andreas/G-7986-2017	Rinne, Andreas/0000-0003-3535-2498; Rinne, Andreas/0000-0003-3535-2498; Pott, Lutz/0000-0002-4000-4132				Garcia-Sainz JA, 2011, IUBMB LIFE, V63, P811, DOI 10.1002/iub.519; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; Bodmann EL, 2015, EUR J CELL BIOL, V94, P415, DOI 10.1016/j.ejcb.2015.06.004; Castillo-Badillo JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121165; Chen XJ, 2014, CELLS-BASEL, V3, P247, DOI 10.3390/cells3020247; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Dickson EJ, 2013, J GEN PHYSIOL, V141, P521, DOI 10.1085/jgp.201210886; Diviani D, 1997, J BIOL CHEM, V272, P28712, DOI 10.1074/jbc.272.45.28712; Diviani D, 1996, J BIOL CHEM, V271, P5049; Falkenburger BH, 2013, J GEN PHYSIOL, V141, P537, DOI 10.1085/jgp.201210887; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Garcia-Sainz JA, 2000, EUR J PHARMACOL, V389, P1, DOI 10.1016/S0014-2999(99)00896-1; Hertel F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020855; Hogue M, 2014, CELL SIGNAL, V26, P1213, DOI 10.1016/j.cellsig.2014.02.012; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Hui X, 2014, MOL CELL BIOL, V34, P2370, DOI 10.1128/MCB.00040-14; Iacovelli L, 1999, MOL PHARMACOL, V56, P316, DOI 10.1124/mol.56.2.316; Kienitz MC, 2015, CELL SIGNAL, V27, P1457, DOI 10.1016/j.cellsig.2015.04.002; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LATTION AL, 1994, J BIOL CHEM, V269, P22887; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Masuho I, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab4068; Matavel A, 2010, CHANNELS, V4, P3, DOI 10.4161/chan.4.1.10227; Matavel A, 2009, J MOL CELL CARDIOL, V46, P704, DOI 10.1016/j.yjmcc.2009.02.006; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; O-Uchi J, 2015, BIOCHEM BIOPH RES CO, V465, P464, DOI 10.1016/j.bbrc.2015.08.040; O-Uchi J, 2015, J MOL CELL CARDIOL, V79, P203, DOI 10.1016/j.yjmcc.2014.11.020; Perez-Aso M, 2013, BBA-MOL CELL RES, V1833, P2322, DOI 10.1016/j.bbamcr.2013.06.013; Shirai Y, 2002, J BIOCHEM, V132, P663, DOI 10.1093/oxfordjournals.jbchem.a003271; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Stanasila L, 2008, MOL PHARMACOL, V74, P562, DOI 10.1124/mol.107.043422; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Toews M. L., 2003, REGULATION ALPHAIB A; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; van Koppen CJ, 2003, PHARMACOL THERAPEUT, V98, P197, DOI 10.1016/S0163-7258(03)00032-9; Vazquez-Prado J, 2000, J BIOL CHEM, V275, P6553, DOI 10.1074/jbc.275.9.6553; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Violin JD, 2006, J BIOL CHEM, V281, P36411, DOI 10.1074/jbc.M607956200; Willets JM, 2007, J NEUROCHEM, V103, P2268, DOI 10.1111/j.1471-4159.2007.04931.x; Yeatman HR, 2014, J BIOL CHEM, V289, P15856, DOI 10.1074/jbc.M113.536672; Zhong HY, 1999, EUR J PHARMACOL, V375, P261, DOI 10.1016/S0014-2999(99)00222-8	45	6	6	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26410	26426		10.1074/jbc.M116.746974	http://dx.doi.org/10.1074/jbc.M116.746974			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27834678	Green Published, hybrid			2022-12-26	WOS:000391568200015
J	Amadatsu, T; Morinaga, J; Kawano, T; Terada, K; Kadomatsu, T; Miyata, K; Endo, M; Kasamo, D; Kuratsu, J; Oikel, Y				Amadatsu, Toshihiro; Morinaga, Jun; Kawano, Takayuki; Terada, Kazutoyo; Kadomatsu, Tsuyoshi; Miyata, Keishi; Endo, Motoyoshi; Kasamo, Daiki; Kuratsu, Jun-ichi; Oikel, Yuichi			Macrophage-Derived Angiopoietin-Like Protein 2 Exacerbates Brain Damage by Accelerating Acute Inflammation after Ischemia-Reperfusion	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; FOCAL CEREBRAL-ISCHEMIA; ANGPTL2; CELLS; EXPRESSION; STROKE; DEATH; MICE	lschemic stroke is a leading cause of death and disability worldwide. Several reports suggest that acute inflammation after ischemia-reperfusion exacerbates brain damage; however, molecular mechanisms underlying this effect remain unclear. Here, we report that MAC-3-positive immune cells, including infiltrating bone marrow-derived macrophages and activated microglia, express abundant angiopoietin-like protein (ANGPTL) 2 in ischemic mouse brain in a transient middle cerebral artery occlusion (MCAO) model. Both neurological deficits and infarct volume decreased in transient MCAO model mice established in Angptl2 knockout (KO) relative to wild-type mice. Acute brain inflammation after ischemia-reperfusion, as estimated by expression levels of pro-inflammatory cytokines such as interleukin (IL)-1 beta and tumor necrosis factor alpha (TNF)-alpha, was significantly suppressed in Angptl2 KO compared to control mice. Moreover, analysis employing bone marrow chimeric models using Angptl2 KO and wild-type mice revealed that infiltrated bone marrow-derived macrophages secreting ANGPTL2 significantly contribute to acute brain injury seen after ischemia-reperfusion. These studies demonstrate that infiltrating bone marrow-derived macrophages promote inflammation and injury in affected brain areas after ischemia-reperfusion, likely via ANGPTL2 secretion in the acute phase of ischemic stroke.	[Amadatsu, Toshihiro; Morinaga, Jun; Terada, Kazutoyo; Kadomatsu, Tsuyoshi; Miyata, Keishi; Endo, Motoyoshi; Kasamo, Daiki; Oikel, Yuichi] Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan; [Amadatsu, Toshihiro; Kawano, Takayuki; Kasamo, Daiki; Kuratsu, Jun-ichi] Kumamoto Univ, Grad Sch Med Sci, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan	Kumamoto University; Kumamoto University	Oikel, Y (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Mol Genet, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.	oike@gpo.kumamoto-u.ac.jp	Endo, Motoyoshi/T-5840-2019; Miyata, Keishi/HGF-1876-2022	Miyata, Keishi/0000-0003-0336-1859	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) [13417915]; Japan Agency for Medical Research and Development (AMED) [15gm0610007h0003]; JSPS KAKENHI [25462224]	Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (13417915), Japan Agency for Medical Research and Development (AMED) (15gm0610007h0003) and by JSPS KAKENHI Grant (25462224).; This work was supported by the Core Research for Evolutional Science and Technology (CREST) program of the Japan Science and Technology Agency (JST) (13417915), Japan Agency for Medical Research and Development (AMED) (15gm0610007h0003) and by JSPS KAKENHI Grant (25462224).	Benakis C, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00461; Boutin H, 2001, J NEUROSCI, V21, P5528, DOI 10.1523/JNEUROSCI.21-15-05528.2001; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Endo M, 2012, CANCER RES, V72, P1784, DOI 10.1158/0008-5472.CAN-11-3878; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Horio E, 2014, ARTERIOSCL THROM VAS, V34, P790, DOI 10.1161/ATVBAHA.113.303116; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Kadomatsu T, 2014, TRENDS ENDOCRIN MET, V25, P245, DOI 10.1016/j.tem.2014.03.012; Kanda A, 2012, LAB INVEST, V92, P1553, DOI 10.1038/labinvest.2012.111; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; KOBAYASHI T, 1991, MICROBIOL IMMUNOL, V35, P315, DOI 10.1111/j.1348-0421.1991.tb01560.x; Konsman JP, 2007, CLIN SCI, V112, P1, DOI 10.1042/CS20060043; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Nishijima Y, 2015, J NEUROSURG, V123, P243, DOI 10.3171/2014.9.JNS14778; Odagiri H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004612; Okada T, 2010, AM J PATHOL, V176, P2309, DOI 10.2353/ajpath.2010.090865; PARUMS DV, 1990, J CLIN PATHOL, V43, P752, DOI 10.1136/jcp.43.9.752; Recognition and Alleviation of Pain in Laboratory Animals, 2009, NAT AC COLL REP FUND; Ritzel RM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0329-1; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Stevens SL, 2002, BRAIN RES, V932, P110, DOI 10.1016/S0006-8993(02)02292-8; Tabata M, 2009, CELL METAB, V10, P178, DOI 10.1016/j.cmet.2009.08.003; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Tobin MK, 2014, J CEREBR BLOOD F MET, V34, P1573, DOI 10.1038/jcbfm.2014.130; Wang Y., 2014, INT J DISTRIB SENS N, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0110024; YAMASAKI Y, 1995, STROKE, V26, P676, DOI 10.1161/01.STR.26.4.676; Yamasaki Y, 1995, STROKE, V26; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041	32	19	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166285	10.1371/journal.pone.0166285	http://dx.doi.org/10.1371/journal.pone.0166285			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861531	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300041
J	Shiota, T; Miyasato, Y; Ohnishi, K; Yamamoto-Ibusuki, M; Yamamoto, Y; Iwase, H; Takeya, M; Komohara, Y				Shiota, Takuya; Miyasato, Yuko; Ohnishi, Koji; Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Iwase, Hirotaka; Takeya, Motohiro; Komohara, Yoshihiro			The Clinical Significance of CD169-Positive Lymph Node Macrophage in Patients with Breast Cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; CD169(+) MACROPHAGES; PREDICTIVE-VALUE; T-CELLS; SIALOADHESIN; ACTIVATION; EXPRESSION; SURVIVAL; RECEPTOR; CD8	The immune status of patients can impact on the clinical course of cancer. Lymph node (LN) macrophages play critical roles in anti- cancer immunity via the activation of cytotoxic T-lym-phocytes (CTLs). In this study, the prognostic significance of CD169(+) LN macrophages was examined in patients with breast cancer. For this purpose the number of CD169(+) cells and their ratio relative to total macrophages (CD68(+)) in regional LNs (RLNs), as well as the number of CD8(+) CTLs in tumor tissues, were investigated using immunohistochemistry of paraffin-embedded tissue samples from 146 patients with breast cancer. The association of these data with clinicopathological factors was then analyzed. The number of cells positive for the pan-macrophage marker CD68 remained relatively uniform, while the number of CD169(+) cells varied across all cases. Moreover, a high density of CD169(+) cells correlated with early clinical stage and no LN metastasis, while a higher CD169(+) to CD68(+) ratio was significantly associated with small tumor size and a low Ki-67(+) rate. There was also a significant correlation between the number of CD8(+) CTLs and that of CD169(+) macrophages in high grade breast cancer cases with a Ki-67 index greater than 40%. However, neither the density nor the ratio of CD169(+) cells, nor the density of CD8(+) CTLs, were associated with relapse-free survival, distant relapse-free survival, or breast cancer-specific survival. These findings suggest that CD169(+) macrophages in RLNs might be a useful marker for assessing clinical stage, including LN states, in patients with breast cancer.	[Shiota, Takuya; Miyasato, Yuko; Ohnishi, Koji; Takeya, Motohiro; Komohara, Yoshihiro] Kumamoto Univ, Dept Cell Pathol, Grad Sch Med Sci, Kumamoto, Japan; [Yamamoto-Ibusuki, Mutsuko] Kumamoto Univ Hosp, Dept Mol Targeting Therapy Breast Canc, Kumamoto, Japan; [Yamamoto, Yutaka; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Komohara, Y (corresponding author), Kumamoto Univ, Dept Cell Pathol, Grad Sch Med Sci, Kumamoto, Japan.	ycomo@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26460454]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by Grants-in-Aid for Scientific Research (26460454) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely thank Ms. Yui Hayashida, Mr. Osamu Nakamura, and Mr. Takenobu Nakagawa for providing valuable technical assistance. This study was supported in part by Grants-in-Aid for Scientific Research (26460454) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Anz D, 2011, HISTOPATHOLOGY, V59, P965, DOI 10.1111/j.1365-2559.2011.04040.x; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Barral P, 2010, NAT IMMUNOL, V11, P303, DOI 10.1038/ni.1853; Bernhard CA, 2015, P NATL ACAD SCI USA, V112, P5461, DOI 10.1073/pnas.1423356112; Brown JR, 2014, CLIN CANCER RES, V20, P5995, DOI 10.1158/1078-0432.CCR-14-1622; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grotz TE, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1026504; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Kim ST, 2013, AM J CLIN ONCOL-CANC, V36, P224, DOI 10.1097/COC.0b013e3182467d90; Kohrt HE, 2005, PLOS MED, V2, P904, DOI 10.1371/journal.pmed.0020284; Kuka M, 2014, ANN NY ACAD SCI, V1319, P38, DOI 10.1111/nyas.12387; Liu SZ, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3148; Liu Y, 2012, CANCER IMMUNOL IMMUN, V61, P789, DOI 10.1007/s00262-011-1137-9; Martinez-Pomares L, 2012, TRENDS IMMUNOL, V33, P66, DOI 10.1016/j.it.2011.11.001; Menard S, 1997, CLIN CANCER RES, V3, P817; Mills CD, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00212; Miyashita M, 2014, BREAST CANCER RES TR, V148, P525, DOI 10.1007/s10549-014-3197-y; Naito Y, 1998, CANCER RES, V58, P3491; Ohnishi K, 2013, CANCER SCI, V104, P1236, DOI 10.1111/cas.12212; Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12; Ravishankar B, 2014, P NATL ACAD SCI USA, V111, P4215, DOI 10.1073/pnas.1320924111; Rose BS, 2015, BREAST CANCER RES TR, V152, P209, DOI 10.1007/s10549-015-3451-y; Sabatier R, 2015, ONCOTARGET, V6, P5449, DOI 10.18632/oncotarget.3216; Saito Y, 2015, CANCER IMMUNOL RES, V3, P1356, DOI 10.1158/2326-6066.CIR-14-0180; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Takahashi R, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3685; Conesa MAV, 2012, BREAST, V21, P468, DOI 10.1016/j.breast.2011.11.002; Wu C, 2009, J IMMUNOL, V182, P6508, DOI 10.4049/jimmunol.0804247; Xu CS, 2014, BREAST CANCER-TOKYO, V21, P482, DOI 10.1007/s12282-012-0403-9; Yamamoto-Ibusuki M, 2013, MODERN PATHOL, V26, P79, DOI 10.1038/modpathol.2012.151	32	36	38	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166680	10.1371/journal.pone.0166680	http://dx.doi.org/10.1371/journal.pone.0166680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861544	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300087
J	Kim, CS; Bae, EH; Ma, SK; Han, SH; Choi, KH; Lee, J; Chae, DW; Oh, KH; Ahn, C; Kim, SW				Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Han, Seung Hyeok; Choi, Kyu Hun; Lee, Joongyub; Chae, Dong Wan; Oh, Kook-Hwan; Ahn, Curie; Kim, Soo Wan		KNOW-CKD Investigator Grp	Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study	PLOS ONE			English	Article							KAPPA-B-LIGAND; MINERAL DENSITY; VASCULAR CALCIFICATION; RECEPTOR-ACTIVATOR; OLDER-ADULTS; FRACTURE; OSTEOPOROSIS; EXPRESSION; ESTROGEN; RANKL	Osteoprotegerin, a potent osteoclast activation inhibitor, decreases bone resorption and positively affects bone mineral density. This study examined the association between serum osteoprotegerin levels and bone loss in patients with chronic kidney disease, a condition associated with increased risk of mineral and bone disorders. The bone mineral densities of the lumbar spine, total hip, and femur neck were assessed by dual-energy X-ray absorptiometry; serum osteoprotegerin levels were measured at baseline for 1,423 patients enrolled in the prospective KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). Patients aged >= 50 years and with a T-score <=-2.5 were diagnosed as having osteoporosis. Multivariable linear regression analysis indicated independent association between serum osteoprotegerin levels and decreased bone mineral density in the lumbar spine (B: 0.489, 95% confidence interval [CI]: 0.883 to 0.095, P= 0.015), and total hip (B: 0.349, 95% CI: 0.672 to 0.027, P= 0.027). However, bone mineral density of the femur neck was not associated with serum osteoprotegerin levels in women. After adjustments, no independent association was found between serum osteoprotegerin levels and bone mineral density in men. In multivariable logistic regression analysis, serum osteoprotegerin levels were associated with increased risk of osteoporosis in women (odds ratio [OR]: 4.72, 95% CI: 1.35 to 16.52, P= 0.015), but not in men (OR: 0.21; 95% CI: 0.04 to 1.31, P= 0.095). To summarize, in female patients with chronic kidney disease, increased serum osteoprotegerin levels were independently associated with decreased bone mineral density in the lumbar spine and total hip, and with increased risk of osteoporosis. Therefore, the measurement of serum osteoprotegerin concentration might be useful as a surrogate marker for determining bone loss in patients with chronic kidney disease, especially for women, although not so much for men.	[Kim, Chang Seong; Bae, Eun Hui; Ma, Seong Kwon; Kim, Soo Wan] Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea; [Han, Seung Hyeok; Choi, Kyu Hun] Yonsei Univ, Coll Med, Depatment Internal Med, Seoul, South Korea; [Lee, Joongyub] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea; [Lee, Joongyub] Seoul Natl Univ, Coll Med, Seoul, South Korea; [Chae, Dong Wan; Oh, Kook-Hwan; Ahn, Curie] Seoul Natl Univ, Dept Internal Med, Seoul, South Korea	Chonnam National University; Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Internal Med, Sch Med, Gwangju, South Korea.	skimw@chonnam.ac.kr	Han, Seung Hyeok/W-8825-2019; Han, Seung Hyeok/K-4559-2018	Han, Seung Hyeok/0000-0001-7923-5635; Han, Seung Hyeok/0000-0001-7923-5635	Research of Korea Centers for Disease Control and Prevention [2011E3300300, 2012E3301100, 2013E3301600]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C2084]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning [2016R1A2B4007870]; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2015R1C1A1A01051769]; Chonnam National University Hospital Institute for Biomedical Science [CRI14008-1]	Research of Korea Centers for Disease Control and Prevention; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and future Planning; National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Chonnam National University Hospital Institute for Biomedical Science	This research was supported by grants 2011E3300300, 2012E3301100 and 2013E3301600 from Research of Korea Centers for Disease Control and Prevention, by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C2084), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and future Planning (2016R1A2B4007870) and by the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2015R1C1A1A01051769), Chonnam National University Hospital Institute for Biomedical Science (CRI14008-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bord S, 2003, BONE, V32, P136, DOI 10.1016/S8756-3282(02)00953-5; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bucur RC, 2015, OSTEOPOROSIS INT, V26, P449, DOI 10.1007/s00198-014-2813-3; Chen Q, 2004, HORM METAB RES, V36, P674, DOI 10.1055/s-2004-826013; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Crisafulli A, 2005, CLIN SCI, V109, P389, DOI 10.1042/CS20050058; Edwards MH, 2015, BONE, V80, P126, DOI 10.1016/j.bone.2015.04.016; Fahrleitner A, 2003, BONE, V32, P96, DOI 10.1016/S8756-3282(02)00926-2; Fahrleitner-Pammer A, 2003, WIEN KLIN WOCHENSCHR, V115, P291, DOI 10.1007/BF03040334; Fahrleitner-Pammer A, 2009, CLIN NEPHROL, V71, P652; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Ho LT, 2013, ADV CHRONIC KIDNEY D, V20, P423, DOI 10.1053/j.ackd.2013.06.007; Hofbauer LC, 2002, EUR J ENDOCRINOL, V147, P269, DOI 10.1530/eje.0.1470269; Hofbauer LC, 1999, ENDOCRINOLOGY, V140, P4367, DOI 10.1210/en.140.9.4367; Jabbar S, 2011, J CLIN PATHOL, V64, P354, DOI 10.1136/jcp.2010.086595; Jassal SK, 2007, J BONE MINER RES, V22, P203, DOI 10.1359/JBMR.061014; Jiang JQ, 2011, NEPHROLOGY, V16, P588, DOI 10.1111/j.1440-1797.2011.01481.x; Khosla S, 2002, OSTEOPOROSIS INT, V13, P394, DOI 10.1007/s001980200045; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kim Jung Ha, 2016, Chonnam Med J, V52, P12, DOI 10.4068/cmj.2016.52.1.12; Kudlacek S, 2003, BONE, V32, P681, DOI 10.1016/S8756-3282(03)00090-5; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; LINDERGARD B, 1985, NEPHRON, V39, P122, DOI 10.1159/000183355; Mikami S, 2008, HYPERTENS RES, V31, P1163, DOI 10.1291/hypres.31.1163; Min H, 2000, J EXP MED, V192, P463, DOI 10.1084/jem.192.4.463; Morony S, 2008, CIRCULATION, V117, P411, DOI 10.1161/CIRCULATIONAHA.107.707380; NOTTESTAD SY, 1987, J BONE MINER RES, V2, P221; Oh KH, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-80; Oh KW, 2005, CLIN ENDOCRINOL, V62, P92, DOI 10.1111/j.1365-2265.2004.02179.x; Saika M, 2001, ENDOCRINOLOGY, V142, P2205, DOI 10.1210/en.142.6.2205; Shimamura M, 2014, P NATL ACAD SCI USA, V111, P8191, DOI 10.1073/pnas.1400544111; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Stern A, 2007, EUR J ENDOCRINOL, V156, P555, DOI 10.1530/EJE-06-0753; Szulc P, 2001, J CLIN ENDOCR METAB, V86, P3162, DOI 10.1210/jc.86.7.3162; Ueland T, 2005, CIRCULATION, V111, P2461, DOI 10.1161/01.CIR.0000165119.62099.14; Uemura H, 2008, J ENDOCRINOL INVEST, V31, P163, DOI 10.1007/BF03345584; Wade SW, 2014, ARCH OSTEOPOROS, V9, DOI 10.1007/s11657-014-0182-3; West SL, 2015, J BONE MINER RES, V30, P913, DOI 10.1002/jbmr.2406; Yenchek RH, 2012, CLIN J AM SOC NEPHRO, V7, P1130, DOI 10.2215/CJN.12871211; Yun BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123665; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	44	16	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166792	10.1371/journal.pone.0166792	http://dx.doi.org/10.1371/journal.pone.0166792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855207	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200052
J	Hou, Y; Hossain, GS; Li, JH; Shin, HD; Liu, L; Du, GC; Chen, J				Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Shin, Hyun-dong; Liu, Long; Du, Guocheng; Chen, Jian			Two-Step Production of Phenylpyruvic Acid from L-Phenylalanine by Growing and Resting Cells of Engineered Escherichia coli: Process Optimization and Kinetics Modeling	PLOS ONE			English	Article							ALPHA-KETO ACIDS; SUBSTRATE-INHIBITION; PROTEUS-MIRABILIS; AMINO-ACIDS; BIOTRANSFORMATION; DEAMINASE; OXIDASE; FERMENTATION; TRANSFORMATION; DEHYDROGENASE	Phenylpyruvic acid (PPA) is widely used in the pharmaceutical, food, and chemical industries. Here, a two-step bioconversion process, involving growing and resting cells, was established to produce PPA from L-phenylalanine using the engineered Escherichia coli constructed previously. First, the biotransformation conditions for growing cells were optimized (L-phenylalanine concentration 20.0 g.L-1, temperature 35 degrees C) and a two-stage temperature control strategy (keep 20 degrees C for 12 h and increase the temperature to 35 degrees C until the end of biotransformation) was performed. The biotransformation conditions for resting cells were then optimized in 3-L bioreactor and the optimized conditions were as follows: agitation speed 500 rpm, aeration rate 1.5 vvm, and L-phenylalanine concentration 30 g.L-1. The total maximal production (mass conversion rate) reached 29.8 +/- 2.1 g.L-1 (99.3%) and 75.1 +/- 2.5 g.L-1 (93.9%) in the flask and 3-L bioreactor, respectively. Finally, a kinetic model was established, and it was revealed that the substrate and product inhibition were the main limiting factors for resting cell biotransformation.	[Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China; [Hou, Ying; Hossain, Gazi Sakir; Li, Jianghua; Liu, Long; Du, Guocheng; Chen, Jian] Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China; [Shin, Hyun-dong] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA	Jiangnan University; Jiangnan University; University System of Georgia; Georgia Institute of Technology	Liu, L; Du, GC (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi 214122, Peoples R China.; Liu, L; Du, GC (corresponding author), Jiangnan Univ, Synerget Innovat Ctr Food Safety & Nutr, Wuxi 214122, Peoples R China.	longliu@jiangnan.edu.cn; gcdu@jiangnan.edu.cn	Hossain, Gazi Sakir/AAE-5391-2020; li, jianghua/GXG-4735-2022		863 Program [2014AA021200, 2014AA021201]; 111 project [11-2-06]; Fundamental Research Funds for the Central Universities [JUSRP51612A]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA021201] Funding Source: NIH RePORTER	863 Program(National High Technology Research and Development Program of China); 111 project(Ministry of Education, China - 111 Project); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work is financially supported by the 863 Program (2014AA021200, 2014AA021201), 111 project (11-2-06) and the Fundamental Research Funds for the Central Universities (JUSRP51612A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by the 863 Program (2014AA021200, 2014AA021201).	ALVAREZ-COHEN L, 1991, APPL ENVIRON MICROB, V57, P1031, DOI 10.1128/AEM.57.4.1031-1037.1991; Aymard C, 2000, ENZYME MICROB TECH, V27, P612, DOI 10.1016/S0141-0229(00)00258-1; Binay B, 2007, APPL BIOCHEM BIOTECH, V141, P265, DOI 10.1007/BF02729067; Canovas M, 2002, BIOTECHNOL BIOENG, V77, P764, DOI 10.1002/bit.10157; Carballeira JD, 2009, BIOTECHNOL ADV, V27, P686, DOI 10.1016/j.biotechadv.2009.05.001; Chen C, 2014, APPL ENVIRON MICROB, V80, P3992, DOI 10.1128/AEM.00215-14; CHITNIS A, 1989, BIOTECHNOL BIOENG, V34, P804, DOI 10.1002/bit.260340610; Coban HB, 2016, ACTA ALIMENT HUNG, V45, P1, DOI 10.1556/066.2016.45.1.1; Coban HB, 2016, PREP BIOCHEM BIOTECH, V46, P157, DOI 10.1080/10826068.2014.995813; Coban HB, 2014, BIOPROC BIOSYST ENG, V37, P2343, DOI 10.1007/s00449-014-1212-7; de Carvalho CCCR, 2011, BIOTECHNOL ADV, V29, P75, DOI 10.1016/j.biotechadv.2010.09.001; des Abbayes H, 2003, DALTON T, P1041, DOI 10.1039/b209103h; Fernandez-Lafuente R, 1998, ENZYME MICROB TECH, V23, P28, DOI 10.1016/S0141-0229(98)00028-3; Geueke B, 2002, ENZYME MICROB TECH, V31, P77, DOI 10.1016/S0141-0229(02)00072-8; Grishko VV, 2013, PROCESS BIOCHEM, V48, P1640, DOI 10.1016/j.procbio.2013.08.012; Hossain GS, 2014, APPL MICROBIOL BIOT, V98, P1507, DOI 10.1007/s00253-013-5444-2; Hou Y, 2016, APPL MICROBIOL BIOT, V100, P2183, DOI 10.1007/s00253-015-7048-5; Hou Y, 2015, APPL MICROBIOL BIOT, V99, P8391, DOI 10.1007/s00253-015-6757-0; Huang WC, 2006, BIOCHEM ENG J, V32, P239, DOI 10.1016/j.bej.2006.10.011; Lang YJ, 2011, EXTREMOPHILES, V15, P303, DOI 10.1007/s00792-011-0360-9; Leese C, 2013, J MOL CATAL B-ENZYM, V85-86, P17, DOI 10.1016/j.molcatb.2012.07.008; Li XF, 2007, BIOTECHNOL LETT, V29, P593, DOI 10.1007/s10529-006-9275-4; Liu L, 2013, J BIOTECHNOL, V164, P97, DOI 10.1016/j.jbiotec.2013.01.005; Liu T, 2013, PROCESS BIOCHEM, V48, P103, DOI 10.1016/j.procbio.2012.11.018; MASSAD G, 1995, J BACTERIOL, V177, P5878, DOI 10.1128/jb.177.20.5878-5883.1995; Pantaleone DP, 2001, J MOL CATAL B-ENZYM, V11, P795, DOI 10.1016/S1381-1177(00)00155-7; Silberbach M, 2003, APPL MICROBIOL BIOT, V62, P92, DOI 10.1007/s00253-003-1222-x; Tobajas M, 2007, BIOCHEM ENG J, V35, P218, DOI 10.1016/j.bej.2007.01.017; Tsuge Y, 2014, APPL MICROBIOL BIOT, V98, P4911, DOI 10.1007/s00253-014-5594-x; Upadhya R, 1999, PROCESS BIOCHEM, V35, P7, DOI 10.1016/S0032-9592(99)00025-4; VILLABLANCA M, 1987, BIOCHIM BIOPHYS ACTA, V926, P224, DOI 10.1016/0304-4165(87)90207-8; Xudong S, 2009, CHINESE J CHEM ENG, V17, P822; Zhang CZ, 2014, FEMS MICROBIOL LETT, V353, P11, DOI 10.1111/1574-6968.12397; Zhang Y, 2012, APPL MICROBIOL BIOT, V94, P1619, DOI 10.1007/s00253-012-3868-8	34	5	6	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166457	10.1371/journal.pone.0166457	http://dx.doi.org/10.1371/journal.pone.0166457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851793	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300052
J	Cho, Y; Sinn, DH; Yu, SJ; Gwak, GY; Kim, JH; Yoo, YJ; Jun, DW; Kim, TY; Lee, HY; Cho, EJ; Lee, JH; Kim, YJ; Yoon, JH				Cho, Yuri; Sinn, Dong Hyun; Yu, Su Jong; Gwak, Geum Youn; Kim, Ji Hoon; Yoo, Yang Jae; Jun, Dae Won; Kim, Tae Yeob; Lee, Hyo Young; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan			Survival Analysis of Single Large (> 5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B	PLOS ONE			English	Article							7 STAGING SYSTEMS; HEPATIC RESECTION; LIVER-TRANSPLANTATION; TRANSARTERIAL CHEMOEMBOLIZATION; SURGICAL-TREATMENT; PROGNOSIS; CIRRHOSIS; INVASION; TUMOR	Background & Aims Single large (>5 cm) hepatocellular carcinoma (HCC) is classified as Barcelona Liver Clinic (BCLC) stage early stage (A). Yet, controversies exist whether single large HCC can be considered as early stage. We have analyzed long-term outcome to see which stage is appropriate for these patients. Methods From 2005 to 2006, 1,546 consecutive patients who were newly diagnosed as HCC (BCLC A or B) at four tertiary hospitals in Korea were analyzed. BCLC A was sub-classified into A1 (single 2-5 cm), A2 (2-3 nodules <= 3 cm), and A3 (single >5 cm). BCLC B1 included patients beyond-Milan criteria, and within up-to-7 criterion. Survival prediction between subgroupings (1: A1 + A2 + A3 vs. B1 and 2: A1 + A2 vs. A3 + B1) was compared based on c-index and Akaike information criterion (AIC). Results The 5-year overall survival (OS) rate was 62.3, 58.6, 36.8, and 42.0% for A1, A2, A3 and B1, respectively. In multivariate Cox-regression analysis, OS was significantly different between A3 + B1 vs. A1 + A2 (hazard ratio [HR] 1.85; P < 0.001), but not between A1 + A2 + A3 vs. B1 (HR 1.19; P = 0.258). For A3, surgical resection showed superior OS over transarterial chemoembolization. Survival prediction was superior in subgrouping 2 (AIC 5727.2; cindex 0.652) than subgrouping 1 (AIC 5766.3; c-index 0.619) even after inverse probability weighting. Conclusions This large scale long-term follow-up data shows that single large tumor should be considered as intermediate stage in terms of prognosis. However, in terms of treatment, resection might be the first line treatment option.	[Cho, Yuri; Yu, Su Jong; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Cho, Yuri; Yu, Su Jong; Cho, Eun Ju; Lee, Jeong-Hoon; Kim, Yoon Jun; Yoon, Jung-Hwan] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea; [Cho, Yuri] CHA Univ, Dept Internal Med, CHA Gangnam Med Ctr, Seoul, South Korea; [Sinn, Dong Hyun; Gwak, Geum Youn] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul, South Korea; [Kim, Ji Hoon; Yoo, Yang Jae] Korea Univ, Coll Med, Guro Hosp, Dept Internal Med, Seoul, South Korea; [Jun, Dae Won; Lee, Hyo Young] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Tae Yeob] Hanyang Univ, Inst Med Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pochon Cha University; Sungkyunkwan University (SKKU); Samsung Medical Center; Korea University; Korea University Medicine (KU Medicine); Hanyang University; Hanyang University	Yu, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Yu, SJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea.	ydoctor2@hanmail.net		KIM, JI HOON/0000-0003-3924-0434; Kim, Yoon Jun/0000-0001-9141-7773; Cho, Eun Ju/0000-0002-2677-3189; Yu, Su Jong/0000-0001-8888-7977; Yoon, Jung-Hwan/0000-0002-9128-3610	Scientific Research Fund of the Korean Liver Cancer Study Group; Seoul National University Hospital Research Fund [04-2013-0830]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [1420050]	Scientific Research Fund of the Korean Liver Cancer Study Group; Seoul National University Hospital Research Fund; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea	This work was supported by the Scientific Research Fund of the Korean Liver Cancer Study Group 2015, by grant No. 04-2013-0830 from the Seoul National University Hospital Research Fund, and by the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (1420050).	BELGHITI J, 1991, ANN SURG, V214, P114, DOI 10.1097/00000658-199108000-00004; Bolondi L, 2012, SEMIN LIVER DIS, V32, P348, DOI 10.1055/s-0032-1329906; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Cho YB, 2007, WORLD J SURG, V31, P795, DOI 10.1007/s00268-006-0359-z; Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Cole SR, 2004, COMPUT METH PROG BIO, V75, P45, DOI 10.1016/j.cmpb.2003.10.004; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Esnaola NF, 2002, J GASTROINTEST SURG, V6, P224, DOI 10.1016/S1091-255X(01)00015-4; European Assoc Study Liver, 2012, EUR J CANCER, V48, P599, DOI 10.1016/j.ejca.2011.12.021; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fong YM, 1999, ANN SURG, V229, P790, DOI 10.1097/00000658-199906000-00005; Fuster J, 1996, ANN SURG, V223, P297, DOI 10.1097/00000658-199603000-00011; Guglielmi A, 2008, AM J GASTROENTEROL, V103, P597, DOI 10.1111/j.1572-0241.2007.01604.x; Hanazaki K, 2001, AM J SURG, V181, P347, DOI 10.1016/S0002-9610(01)00584-0; Jung YK, 2016, J GASTROEN HEPATOL, V31, P467, DOI 10.1111/jgh.13152; Kim JY, 2016, CLIN MOL HEPATOL, V22, P250, DOI 10.3350/cmh.2016.0015; Lee YB, 2015, J VASC INTERV RADIOL, V26, P651, DOI 10.1016/j.jvir.2015.02.004; Liu PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155588; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2008, ANN SURG ONCOL, V15, P1001, DOI 10.1245/s10434-007-9559-5; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; National Cancer Institute: About Cancer, CANC DIAGN STAG; Nonami T, 1997, AM J SURG, V173, P288, DOI 10.1016/S0002-9610(96)00399-6; O'Neil BH, 2007, ONCOLOGIST, V12, P1425, DOI 10.1634/theoncologist.12-12-1425; Pawlik TM, 2005, LIVER TRANSPLANT, V11, P1086, DOI 10.1002/lt.20472; Roayaie S, 2002, ANN SURG, V235, P533, DOI 10.1097/00000658-200204000-00012; Shuto T, 1999, HEPATO-GASTROENTEROL, V46, P413; Sinn DH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112184; Vauthey JN, 2002, J CLIN ONCOL, V20, P1527, DOI 10.1200/JCO.20.6.1527; Yang JD, 2011, CLIN GASTROENTEROL H, V9, P64, DOI 10.1016/j.cgh.2010.08.019; Yu SJ, 2016, CLIN MOL HEPATOL, V22, P7, DOI 10.3350/cmh.2016.22.1.7; Zhong JH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000396; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	36	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165722	10.1371/journal.pone.0165722	http://dx.doi.org/10.1371/journal.pone.0165722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846227	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600018
J	Chuang, PH; Wu, MH; Fan, SY; Lin, KY; Jou, R				Chuang, Pei-Hua; Wu, Mei-Hua; Fan, Shin-Yuan; Lin, Keng-Yu; Jou, Ruwen			Population-Based Drug Resistance Surveillance of Multidrug-Resistant Tuberculosis in Taiwan, 2007-2014	PLOS ONE			English	Article								Objective To determine the extent of drug resistance in multidrug-resistant tuberculosis (MDR-TB) cases, we conducted a retrospective, population-based analysis using drug susceptibility testing (DST) results of MDR Mycobacterium tuberculosis complex isolates obtained from 2007-2014 in Taiwan. Methods M. tuberculosis isolates collected from 1,331 MDR-TB cases were included in this survey. Treatment histories, age, sex, chest radiograph and bacteriological results of patients were analyzed. Standard DST was performed to assess resistance to the following drugs: isoniazid (INH), rifampicin (RIF), streptomycin (SM), ethambutol (EMB), amikacin (AM), kanamycin (KM), capreomycin (CAP), ofloxacin (OFX), moxifloxacin (MOX), levofloxacin (LVX), gatifloxacin (GAT), para-aminosalicylate (PAS), ethionamide (EA), and pyrazinamide (PZA). The Cochran-Armitage trend test was used for statistical analysis. Results We observed a significant increasing trend in portion of new MDR-TB cases, from 59.5% to 80.2% (p < 0.0001), and significant decreasing trend of portion in the 15-44-year-old age group (p < 0.05). Of the MDR M. tuberculosis isolates tested, 6.2% were resistant to AM, 8.6% were resistant to KM, 4.6% were resistant to CAP, 19.5% were resistant to OFX, 17.1% were resistant to MOX, 16.0% were resistant to LVX, 5.8% were resistant to GAT, 9.5% were resistant to PAS, 28.5% were resistant to EA and 33.3% were resistant to PZA. Fifty (3.8%) extensively drug-resistant TB cases were identified. No significant differences were found in drug resistance frequencies between new and previously treated MDR cases. However, we observed significant decreases in the rates of AM resistance (p < 0.05), OFX resistance (p < 0.00001), PAS resistance (p < 0.00001), EA resistance (p < 0.05) and PZA resistance (p < 0.05). Moreover, younger age groups had higher rates of resistance to fluoroquinolones. Conclusion A policy implemented in 2007 to restrict the prescription of fluoroquinolones was shown to be effective. Our survey revealed a decreasing trend of resistance to PZA, OFX and AM, which suggests the feasibility of adopting a short- course regimen and demonstrates the effectiveness of our management program for MDR-TB.	[Chuang, Pei-Hua; Wu, Mei-Hua; Fan, Shin-Yuan; Lin, Keng-Yu; Jou, Ruwen] Ctr Dis Control, TB Res Ctr, Taipei, Taiwan; [Jou, Ruwen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan	Centers For Disease Control - Taiwan; National Yang Ming Chiao Tung University	Jou, R (corresponding author), Ctr Dis Control, TB Res Ctr, Taipei, Taiwan.; Jou, R (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei, Taiwan.	rwj@cdc.gov.tw			Centers for Disease Control, Ministry of Health and Welfare [MOHW103-CDC-C-315-000405]	Centers for Disease Control, Ministry of Health and Welfare	This study was supported by the Centers for Disease Control, Ministry of Health and Welfare, under the grant number MOHW103-CDC-C-315-000405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Centers for Disease Control, Ministry of Health and Welfare under the grant number MOHW103-CDC-C-315-000405. The authors would like to thank Yu-Ming Deng for his technical assistance and Hsien-Ho Lin for his comments.	[Anonymous], 2010, MULTIDRUG EXTENSIVEL; CDC, 2014, TUB CONTR REP 2013; Centers for Disease Control and Prevention (CDC), 2015, ANN REPORT; Chang KC, 2013, ANTIMICROB AGENTS CH, V57, P4097, DOI 10.1128/AAC.00120-13; Cohen T, 2014, DRUG RESIST UPDATE, V17, P105, DOI 10.1016/j.drup.2014.10.001; Fitzpatrick LK, 2001, CLIN INFECT DIS, V33, P1801, DOI 10.1086/323671; Gopal M, 2013, INT J TUBERC LUNG D, V17, P1001, DOI 10.5588/ijtld.12.0144; Mitarai S, 2015, INT J TUBERC LUNG D, V19, P157, DOI 10.5588/ijtld.13.0905; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; Stagg HR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142425; Whitfield MG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133869; WHO-World Health Organisation, 2016, TUB FACT SHEET; Winters N, 2015, EUR RESPIR J, V46, P1461, DOI 10.1183/13993003.00649-2015; World Health Organization, 2011, GUID PROGR MAN DRUG; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2015, GUID SURV DRUG RES T; World Health Organization, 2014, MULT RES TUB; World Health organization, 2008, POL GUID DRUG SUSC T; Yu MC, 2008, EMERG INFECT DIS, V14, P849, DOI 10.3201/eid1405.071398; Yu MC, 2015, EUR RESPIR J, V45, P272, DOI 10.1183/09031936.00080614	20	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165222	10.1371/journal.pone.0165222	http://dx.doi.org/10.1371/journal.pone.0165222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846235	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600009
J	Del Rio-Ospina, L; Soto-De Leon, SC; Camargo, M; Sanchez, R; Mancilla, CL; Patarroyo, ME; Patarroyo, MA				Del Rio-Ospina, Luisa; Cecilia Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Lizeth Mancilla, Cindy; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel			The Prevalence of High-Risk HPV Types and Factors Determining Infection in Female Colombian Adolescents	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL-CANCER PREVENTION; YOUNG-WOMEN; AGE; VARIANTS; COHORT; ASSOCIATION; INTERCOURSE; NEOPLASIA; MY09/11	This study reports six HR-HPV types' infection prevalence discriminated by species and multiple infection in unvaccinated Colombian female adolescents, as well as some factors modulating the risk of infection. HPV DNA for six high-risk viral types was identified in cervical samples taken from 2,134 12-19 year-old females using conventional generic and typespecific PCR. Binomial logistical regression analysis was used for modelling HR-HPV infection and multiple infection risk. The interaction between variables in a stepwise model was also included in such analysis. Viral DNA was detected in 48.97% of the females; 28.52% of them had multiple infections, HPV-16 being the most frequently occurring type (37.44%). Cytological abnormality prevalence was 15.61%. Being over 16 years-old (1.66: 1.01-2.71 95% CI), white ethnicity (4.40: 1.16-16.73 95% CI), having had 3 or more sexual partners (1.77: 1.11-2.81 95% CI) and prior sexually-transmitted infections (STI) (1.65: 1.17-2.32 95% CI) were associated with a greater risk of HPV infection. Having given birth was related to a higher risk of infection by A7 species and antecedent of abortion to less risk of coinfection. Where the females in this study came from also influenced the risk of infection by A7 species as female adolescents from the Andean region had a lower risk of infection (0.42: 0.18-0.99 95% CI). The presence of factors related to risky sexual behaviour in the study population indicated that public health services should pay special attention to female adolescents to modify the risk of infection by high-risk HPV types and decrease their impact on this age group.	[Del Rio-Ospina, Luisa; Cecilia Soto-De Leon, Sara; Camargo, Milena; Sanchez, Ricardo; Lizeth Mancilla, Cindy; Elkin Patarroyo, Manuel; Alfonso Patarroyo, Manuel] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Del Rio-Ospina, Luisa; Sanchez, Ricardo; Elkin Patarroyo, Manuel] Univ Nacl Colombia, Sch Med, Bogota, Colombia; [Cecilia Soto-De Leon, Sara] Univ Ciencias Aplicadas & Ambientales UDCA, Bogota, Colombia; [Camargo, Milena] Univ Rosario, PhD Programme Biomed & Biol Sci, Bogota, Colombia; [Alfonso Patarroyo, Manuel] Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario; Universidad del Rosario	Patarroyo, MA (corresponding author), Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia.; Patarroyo, MA (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Bogota, Colombia.	mapatarr.fidic@gmail.com	Patarroyo, Manuel A/I-8046-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Leon, Sara Cecilia Soto-De/ABD-3186-2020; De León, Sara Cecilia Soto/AAF-6301-2021; Sanchez, Ricardo/K-8254-2015	Patarroyo, Manuel A/0000-0002-4751-2500; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; De León, Sara Cecilia Soto/0000-0003-4515-6749; Camargo, Milena/0000-0003-0246-0716; Sanchez, Ricardo/0000-0002-7540-4734	Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID) [10-CAP1-0197]; Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) [617]	Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID); Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This project was funded by the Basque Development Cooperation Agency at the Spanish International Development Cooperation Agency (AECID) (Project 10-CAP1-0197). The Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS) supported MC through PhD training in Colombia within the framework of the Colombian Programme for Promoting Research Training (Convocatoria 617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Kalbani Moza, 2015, Asian Pac J Cancer Prev, V16, P6557; Caixeta RCA, 2015, DIAGN CYTOPATHOL, V43, P780, DOI 10.1002/dc.23301; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Camargo M, 2011, J VIROL METHODS, V178, P68, DOI 10.1016/j.jviromet.2011.08.014; Camargo M, 2011, ANN EPIDEMIOL, V21, P204, DOI 10.1016/j.annepidem.2010.11.003; Castellsague X, 2003, SALUD PUBLICA MEXICO, V45, pS345; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Chattopadhyay Koushik, 2011, Indian J Hum Genet, V17, P132, DOI 10.4103/0971-6866.92087; Cuschieri KS, 2004, J CLIN PATHOL, V57, P68, DOI 10.1136/jcp.57.1.68; Ferlay J, 2013, CANC INCIDENCE MORTA; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Franco EL, 2003, CANCER J, V9, P348, DOI 10.1097/00130404-200309000-00004; Ghosh I, 2016, J CLIN DIAGN RES, V10, pXE1, DOI 10.7860/JCDR/2016/15305.7173; Gonzalez-Losa MD, 2004, J CLIN VIROL, V29, P95, DOI 10.1016/S1386-6532(03)00094-5; Guan P, 2012, INT J CANCER, V131, P2349, DOI 10.1002/ijc.27485; HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057; Hwang LY, 2009, J ADOLESCENT HEALTH, V44, P103, DOI 10.1016/j.jadohealth.2008.10.006; Jayasinghe YL, 2016, J LOW GENIT TRACT DI, V20, P224, DOI 10.1097/LGT.0000000000000217; Lizano M, 2009, ARCH MED RES, V40, P428, DOI 10.1016/j.arcmed.2009.06.001; Lopera EA, 2014, INFECT GENET EVOL, V28, P339, DOI 10.1016/j.meegid.2014.10.014; Lopez-Hernandez D, 2016, MED CLIN BARC; Louie KS, 2009, BRIT J CANCER, V100, P1191, DOI 10.1038/sj.bjc.6604974; Marek E, 2016, EUR J CANCER CARE, V25, P57, DOI 10.1111/ecc.12332; Molano M, 2002, BRIT J CANCER, V87, P324, DOI 10.1038/sj.bjc.6600442; Nonato DR, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.07.003; Pelkofski E, 2016, CLIN THER, V38, P459, DOI 10.1016/j.clinthera.2016.01.024; Remmerbach TW, 2004, J CLIN VIROL, V30, P302, DOI 10.1016/j.jcv.2003.12.011; Remschmidt C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1248; Salazar KL, 2015, ACTA CYTOL, V59, P391, DOI 10.1159/000442512; Schiffman M, 2011, CANCER EPIDEM BIOMAR, V20, P1398, DOI 10.1158/1055-9965.EPI-11-0206; Shew ML, 2015, J MED VIROL, V87, P2122, DOI 10.1002/jmv.24284; Smith MA, 2014, CANCER EPIDEM BIOMAR, V23, P812, DOI 10.1158/1055-9965.EPI-13-1255; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Soto-De Leon S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014705; Tanton C, 2015, CANCER EPIDEM BIOMAR, V24, P842, DOI 10.1158/1055-9965.EPI-14-1333; Vinodhini K, 2012, ARCH GYNECOL OBSTET, V285, P771, DOI 10.1007/s00404-011-2155-8; Wang Sophia S, 2003, J Natl Cancer Inst Monogr, P35; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297	39	11	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166502	10.1371/journal.pone.0166502	http://dx.doi.org/10.1371/journal.pone.0166502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846258	gold, Green Published			2022-12-26	WOS:000387794600072
J	Lindblom, A; Wallmenius, K; Sjowall, J; Fryland, L; Wilhelmsson, P; Lindgren, PE; Forsberg, P; Nilsson, K				Lindblom, Anders; Wallmenius, Katarina; Sjowall, Johanna; Fryland, Linda; Wilhelmsson, Peter; Lindgren, Per-Eric; Forsberg, Pia; Nilsson, Kenneth			Prevalence of Rickettsia spp. in Ticks and Serological and Clinical Outcomes in Tick-Bitten Individuals in Sweden and on the Aland Island	PLOS ONE			English	Article							IXODES-RICINUS TICKS; SPOTTED-FEVER; ANAPLASMA-PHAGOCYTOPHILUM; ERYTHEMA MIGRANS; SOUTHERN SWEDEN; HELVETICA; EUROPE; COINFECTIONS; INFECTION; PATIENT	Tick-transmitted diseases are an emerging health problem, and the hard tick Ixodes ricinus is the main vector for Borrelia spp., tick-borne encephalitis virus and most of the spotted fever Rickettsiae in Europe. The aim of the present study was to examine the incidence of rickettsial infection in the southernmost and south central parts of Sweden and the Aland Islands in Finland the risk of infection in humans and its correlation with a bite of a Rickettsia-infected tick, the self-reported symptoms of rickettsial disease, and the prevalence of co-infection between Rickettsia spp. and Borrelia spp. Persons with a recent tick bite were enrolled through public media and asked to answer a questionnaire, provide a blood sample and bring detached ticks at enlistment and at follow-up three months later. Blood samples were previously analysed for Borrelia spp. antibodies and, for this report, analysed for antibodies to Rickettsia spp. by immunofluorescence and in 16 cases also using Western Blot. Ninety-six (44.0%) of the 218 participants were seropositive for IgG antibodies to Rickettsia spp. Forty (18.3%) of the seropositive participants had increased titres at the follow-up, indicating recent/current infection, while four (1.8%) had titres indicating probable recent/current infection (>= 1: 256). Of 472 ticks, 39 (8.3%) were Rickettsia sp. positive. Five (31.3%) of 16 participants bitten by a Rickettsia-infected tick seroconverted. Experience of the selfreported symptoms nausea (p = 0.006) and radiating pain (p = 0.041) was more common among those with recent, current or probable infection compared to those who did not seroconvert. Participants who showed seroreactivity or seroconversion to Rickettsia spp. had more symptoms than those who were seronegative. Seven (3.2%) participants showed seroconversion to Borrelia spp., and three (1.4%) of these showed seroconversion to both Rickettsia spp. and Borrelia spp., in accordance with previous studies in Sweden. Symptoms of rickettsial disease were in most of the cases vague and general that were difficult to differentiate from other tick-borne diseases.	[Lindblom, Anders; Nilsson, Kenneth] Uppsala Univ, Dept Med Sci, Infect Dis Unit, Uppsala, Sweden; [Wallmenius, Katarina; Nilsson, Kenneth] Uppsala Univ, Dept Med Sci, Unit Clin Bacteriol, Uppsala, Sweden; [Sjowall, Johanna] Linkoping Univ, Dept Infect Dis, Linkoping, Sweden; [Fryland, Linda] Linkoping Univ, Dept Clin & Expt Med, Clin Immunol, Linkoping, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Linkoping Univ, Dept Clin & Expt Med, Med Microbiol, Linkoping, Sweden; [Wilhelmsson, Peter; Lindgren, Per-Eric] Cty Hosp Ryhov, Med Serv, Jonkoping, Sweden; [Forsberg, Pia] Linkoping Univ, Dept Infect Dis, Linkoping, Sweden; [Forsberg, Pia] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Lindblom, Anders; Nilsson, Kenneth] Clin Res Ctr, Dalarna, Falun, Sweden	Uppsala University; Uppsala University; Linkoping University; Linkoping University; Linkoping University; Linkoping University; Linkoping University	Nilsson, K (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Unit, Uppsala, Sweden.; Nilsson, K (corresponding author), Uppsala Univ, Dept Med Sci, Unit Clin Bacteriol, Uppsala, Sweden.; Nilsson, K (corresponding author), Clin Res Ctr, Dalarna, Falun, Sweden.	kenneth.nilsson@medsci.uu.se		Sjowall, Johanna/0000-0001-5622-866X; Wilhelmsson, Peter/0000-0002-9200-2964	Swedish Research Council Branch of Medicine [K2008-58X-14631-06-3]; EU Interreg IV A project ScandTick [167226]; County Council of Ostergotland [L10-56191]; Stiftelsen Olle Engqvist Byggmastare [11877]; Uppsala-Orebro-Regional Research 324 Council [25021]; Center for Clinical Research Dalarna [9028]	Swedish Research Council Branch of Medicine(Swedish Research Council); EU Interreg IV A project ScandTick; County Council of Ostergotland; Stiftelsen Olle Engqvist Byggmastare; Uppsala-Orebro-Regional Research 324 Council; Center for Clinical Research Dalarna	The study was financially supported by grants from the Swedish Research Council Branch of Medicine (grant no. K2008-58X-14631-06-3) (PF); the EU Interreg IV A project ScandTick (grant no. 167226)(PEL); the County Council of Ostergotland (grant no. L10-56191)(PF); Stiftelsen Olle Engqvist Byggmastare (11877)(KN); Uppsala-Orebro-Regional Research 324 Council (25021) (KN); the Center for Clinical Research Dalarna (9028)(KN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brouqui P, 2004, CLIN MICROBIOL INFEC, V10, P1108, DOI 10.1111/j.1469-0691.2004.01019.x; CLEMENTS ML, 1983, J INFECT DIS, V148, P876, DOI 10.1093/infdis/148.5.876; Dubourg G, 2014, EUR J CLIN MICROBIOL, V33, P1449, DOI 10.1007/s10096-014-2090-2; Fournier PE, 2004, J CLIN MICROBIOL, V42, P816, DOI 10.1128/JCM.42.2.816-818.2004; Fryland L, 2011, INT J INFECT DIS, V15, pE174, DOI 10.1016/j.ijid.2010.10.006; Gray J, 2005, INT J MED MICROBIOL, V295, P567, DOI 10.1016/j.ijmm.2005.05.008; HAMMERSBERGGREN S, 1994, J CLIN MICROBIOL, V32, P1519, DOI 10.1128/JCM.32.6.1519-1525.1994; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Koetsveld J, 2016, TICKS TICK-BORNE DIS, V7, P371, DOI 10.1016/j.ttbdis.2015.12.010; Lindblom A, 2013, EUR J CLIN MICROBIOL, V32, P317, DOI 10.1007/s10096-012-1742-3; Lindblom A, 2010, SCAND J INFECT DIS, V42, P906, DOI 10.3109/00365548.2010.508466; Mancini F, 2014, ANN AGR ENV MED, V21, P723, DOI 10.5604/12321966.1129922; May K, 2014, PARASITOL RES, V113, P2169, DOI 10.1007/s00436-014-3869-x; Nogueras MM, 2015, J CLIN MICROBIOL, V53, P3057, DOI 10.1128/JCM.00457-15; Milhano N, 2010, TICKS TICK-BORNE DIS, V1, P172, DOI 10.1016/j.ttbdis.2010.09.003; Nilsson K, 1999, LANCET, V354, P1169, DOI 10.1016/S0140-6736(99)04093-3; Nilsson K, 2005, APMIS, V113, P126, DOI 10.1111/j.1600-0463.2005.apm1130206.x; Nilsson K, 2014, EUR J NEUROL, V21, P206, DOI 10.1111/ene.12218; Nilsson K, 2009, J INFECTION, V58, P79, DOI 10.1016/j.jinf.2008.06.005; Nilsson K, 2011, CASE REP INFECT DIS, V2011, DOI 10.1155/2011/469194; Nilsson K, 2010, EMERG INFECT DIS, V16, P490, DOI 10.3201/eid1603.090184; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Portillo A, 2015, MICROBES INFECT, V17, P834, DOI 10.1016/j.micinf.2015.09.009; RAOULT D, 1995, FEMS IMMUNOL MED MIC, V11, P13, DOI 10.1111/j.1574-695X.1995.tb00073.x; Saraiva DG, 2014, EMERG INFECT DIS, V20, P1504, DOI 10.3201/eid2009.140189; Severinsson K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-66; Swanson SJ, 2006, CLIN MICROBIOL REV, V19, P708, DOI 10.1128/CMR.00011-06; Tijsse-Klasen E, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-347; Wallmenius K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-318; Wallmenius K, 2012, TICKS TICK-BORNE DIS, V3, P100, DOI 10.1016/j.ttbdis.2011.11.003; Wilhelmsson P, 2016, TICKS TICK-BORNE DIS, V7, P71, DOI 10.1016/j.ttbdis.2015.08.009; Wilhelmsson P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-362; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433	34	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166653	10.1371/journal.pone.0166653	http://dx.doi.org/10.1371/journal.pone.0166653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846275	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600098
J	Gronewold, J; Todica, O; Seidel, UK; Volsek, M; Kribben, A; Bruck, H; Hermann, DM				Gronewold, Janine; Todica, Olga; Seidel, Ulla K.; Volsek, Michaels; Kribben, Andreas; Bruck, Heike; Hermann, Dirk M.			Cognitive Performance Is Highly Stable over a 2-Year-Follow-Up in Chronic Kidney Disease Patients in a Dedicated Medical Environment	PLOS ONE			English	Article							MEMORY COMPLAINTS; DECLINE; IMPAIRMENT; ASSOCIATION; PREVALENCE; DEMENTIA; ALBUMINURIA; DYSFUNCTION; ADULTS; HEALTH	BACKGROUND As kidney and brain functions decline with aging, chronic kidney disease (CKD) and dementia are becoming increasing health burdens worldwide. Among the risk factors for cognitive impairment, CKD is increasingly recognized. The precise impact of CKD on the development of cognitive impairment is poorly understood. METHODS In the New Tools for the Prevention of Cardiovascular Disease in Chronic Kidney Disease (NTCVD) cohort, which was recruited in a dedicated nephrology department, we examined the 2-year course of cognitive performance in 120 patients (73 patients with CKD stages 3-5D, 47 control patients without CKD with similar vascular risk profile) using a comprehensive battery of 10 neuropsychological tests. RESULTS Kidney function, vascular risk factors and cognitive performance were highly stable both in CKD and control patients. The summary score of cognitive performance in CKD patients was very similar at baseline (z = -0.63 +/- 0.76) and follow-up (z = -0.54 +/- 0.79, p = 0.113), as was cognitive performance in control patients (z = -0.01 +/- 0.59 and 0.01 +/- 0.70, p = 0.862, at baseline and follow-up, respectively). Total serum cholesterol (199.6 +/- 36.0 and 186.0 +/- 32.9, p = 0.005 in controls; 194.4 +/- 46.1 and 181.2 +/- 41.2, p = 0.008 in CKD) and common carotid intima-media thickness (0.87 +/- 0.18 and 0.84 +/- 0.17, p = 0.351 in controls; 0.88 +/- 0.21 and 0.82 +/- 0.16, p = 0.002 in CKD) moderately but significantly decreased during the follow-up. In multivariable regression analyses, high age (beta = -0.28, 95%CI = -0.48 to 0.08, p = 0.007) predicted decrease in cognitive performance. CONCLUSIONS In this well-defined cohort receiving state-of-the-art therapy, cognitive performance did not decrease over 2 years. Our data emphasize the aspect of risk factor control, suggesting that dedicated medical care might prevent cognitive decline in CKD patients.	[Gronewold, Janine; Todica, Olga; Seidel, Ulla K.; Hermann, Dirk M.] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany; [Volsek, Michaels; Kribben, Andreas; Bruck, Heike] Univ Duisburg Essen, Univ Hosp Essen, Dept Nephrol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Hermann, DM (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany.	dirk.hermann@uk-essen.de	Hermann, Dirk M./AAT-3652-2021; Hermann, Dirk/GZB-9350-2022; Hermann, Dirk M/AAP-5538-2020	Hermann, Dirk M./0000-0003-0198-3152; 	Federal Ministry of Education and Research (BMBF/NGFN) [01GR0807]; Heinz Nixdorf Foundation; Dr Werner Jackstadt Foundation	Federal Ministry of Education and Research (BMBF/NGFN); Heinz Nixdorf Foundation; Dr Werner Jackstadt Foundation	This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation and Dr Werner Jackstadt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Federal Ministry of Education and Research (BMBF/NGFN 01GR0807), the Heinz Nixdorf Foundation and Dr Werner Jackstadt Foundation. We thank Gisela Behrendt for administrative and technical support.	Abdel-Kader K, 2010, CLIN J AM SOC NEPHRO, V5, P1566, DOI 10.2215/CJN.08121109; [Anonymous], 2003, AM J KIDNEY DIS, V41, pS7; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Barzilay JI, 2011, ARCH INTERN MED, V171, P142, DOI 10.1001/archinternmed.2010.502; Baumler G., 1985, FARB WORT INTERFEREN; Buchman AS, 2009, NEUROLOGY, V73, P920, DOI 10.1212/WNL.0b013e3181b72629; Darsie B, 2014, AM J EPIDEMIOL, V180, P68, DOI 10.1093/aje/kwu102; Davey A, 2013, NEPHROL DIAL TRANSPL, V28, P1810, DOI 10.1093/ndt/gfs470; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Etgen T, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0115-4; Etgen T, 2009, NEPHROL DIAL TRANSPL, V24, P3144, DOI 10.1093/ndt/gfp230; Feng L, 2012, J AM GERIATR SOC, V60, P1208, DOI 10.1111/j.1532-5415.2012.04043.x; Geerlings MI, 1999, AM J PSYCHIAT, V156, P531; Gronewold J, 2016, MOL NEUROBIOL, V53, P3136, DOI 10.1007/s12035-015-9218-y; Harting C, 2000, WECHSLER MEMORY SCAL; Helmer C, 2011, NEUROLOGY, V77, P2043, DOI 10.1212/WNL.0b013e31823b4765; Herrmann-Lingen C., 2005, HADS D HOSP ANXIETY; Jassal SK, 2010, AM J EPIDEMIOL, V171, P277, DOI 10.1093/aje/kwp426; Khatri M, 2009, J AM SOC NEPHROL, V20, P2427, DOI 10.1681/ASN.2008101090; Kurella M, 2005, J AM SOC NEPHROL, V16, P2127, DOI 10.1681/ASN.2005010005; Kurella M, 2004, J AM GERIATR SOC, V52, P1863, DOI 10.1111/j.1532-5415.2004.52508.x; Miwa K, 2014, NEUROLOGY, V82, P1051, DOI 10.1212/WNL.0000000000000251; Nulsen RS, 2008, J REN CARE, V34, P121, DOI 10.1111/j.1755-6686.2008.00028.x; Reitan R, 1992, TRAIL MAKING TEST; Russ M, REY COMPLEX FIGURE T; Sajjad I, 2012, CLIN J AM SOC NEPHRO, V7, P437, DOI 10.2215/CJN.05330611; Salem S, 2012, AM J NEPHROL, V35, P31, DOI 10.1159/000334742; Sasaki Y, 2011, J AM GERIATR SOC, V59, P1175, DOI 10.1111/j.1532-5415.2011.03477.x; Schofield PW, 1997, AM J PSYCHIAT, V154, P609; Seidel UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091176; Seidel UK, 2014, KIDNEY INT, V85, P693, DOI 10.1038/ki.2013.366; Slinin Y, 2008, J AM GERIATR SOC, V56, P2082, DOI 10.1111/j.1532-5415.2008.01936.x; Tamura MK, 2011, AM J KIDNEY DIS, V58, P756, DOI 10.1053/j.ajkd.2011.05.027; Thornton WL, 2007, J INT NEUROPSYCH SOC, V13, P344, DOI 10.1017/S1355617707070361; Wang F, 2010, AM J NEPHROL, V32, P117, DOI 10.1159/000315618; Weng SC, 2012, INTERNAL MED, V51, P29, DOI 10.2169/internalmedicine.51.5975; Zehnder Antoinette E, 2007, Am J Alzheimers Dis Other Demen, V22, P416, DOI 10.1177/1533317507302448; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166530	10.1371/journal.pone.0166530	http://dx.doi.org/10.1371/journal.pone.0166530			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835681	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200056
J	Le, TQ; Bukkapatnam, STS				Le, Trung Q.; Bukkapatnam, Satish T. S.			Nonlinear Dynamics Forecasting of Obstructive Sleep Apnea Onsets	PLOS ONE			English	Article							PREDICTION; SIGNALS	Recent advances in sensor technologies and predictive analytics are fueling the growth in point-of-care (POC) therapies for obstructive sleep apnea (OSA) and other sleep disorders. The effectiveness of POC therapies can be enhanced by providing personalized and real-time prediction of OSA episode onsets. Previous attempts at OSA prediction are limited to capturing the nonlinear, nonstationary dynamics of the underlying physiological processes. This paper reports an investigation into heart rate dynamics aiming to predict in real time the onsets of OSA episode before the clinical symptoms appear. A prognosis method based on a nonparametric statistical Dirichlet-Process Mixture-Gaussian-Process (DPMG) model to estimate the transition from normal states to an anomalous (apnea) state is utilized to estimate the remaining time until the onset of an impending OSA episode. The approach was tested using three datasets including (1) 20 records from 14 OSA subjects in benchmark ECG apnea databases (Physionet. org), (2) records of 10 OSA patients from the University of Dublin OSA database and (3) records of eight subjects from previous work. Validation tests suggest that the model can be used to track the time until the onset of an OSA episode with the likelihood of correctly predicting apnea onset in 1 min to 5 mins ahead is 83.6 +/- 9.3%, 80 +/- 8.1%, 76.2 +/- 13.3%, 66.9 +/- 15.4%, and 61.1 +/- 16.7%, respectively. The present prognosis approach can be integrated with wearable devices, enhancing proactive treatment of OSA and real-time wearable sensor-based of sleep disorders.	[Le, Trung Q.] Int Univ Vietnam Natl Univ, Dept Biomed Engn, Ho Chi Minh, Vietnam; [Bukkapatnam, Satish T. S.] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Bukkapatnam, Satish T. S.] Texas A&M Univ, Ctr Remote Hlth Technol, College Stn, TX USA	Vietnam National University Hochiminh City; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Le, TQ (corresponding author), Int Univ Vietnam Natl Univ, Dept Biomed Engn, Ho Chi Minh, Vietnam.	trung.le@hcmiu.edu.vn		Bukkapatnam, Satish/0000-0003-3312-8222	US National Science Foundation [CM MI: 1543226, 1432914]; Vietnam National University HCM City [1161/QD-DHQG-KHCN]	US National Science Foundation(National Science Foundation (NSF)); Vietnam National University HCM City	This work was supported by US National Science Foundation under grants CM MI: 1543226 and 1432914 and Vietnam National University HCM City under the grant No. 1161/QD-DHQG-KHCN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock J, 1998, IEEE T BIO-MED ENG, V45, P1332, DOI 10.1109/10.725330; Bregas SE, 2012, J SLEEP RES, V21, P221, DOI [10.1111/j.1365-2869.2011.00944.x, DOI 10.1111/J.1365-2869.2011.00944.X]; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dingli K, 2003, EUR RESPIR J, V22, P943, DOI 10.1183/09031936.03.00098002; Faure P, 1997, P NATL ACAD SCI USA, V94, P6506, DOI 10.1073/pnas.94.12.6506; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GRONE R, 1990, SIAM J MATRIX ANAL A, V11, P218, DOI 10.1137/0611016; Hirata Y, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.026202; Horner RL, 1996, SLEEP, V19, P827, DOI 10.1093/sleep/19.10.827; Jo JA, 2007, ANN BIOMED ENG, V35, P1425, DOI 10.1007/s10439-007-9299-5; Kantz H., 2004, NONLINEAR TIME SERIE; Karandikar K, 2013, ENG MED BIO SOC EMBC; KENNEL MB, 1992, PHYS REV A, V45, P3403, DOI 10.1103/PhysRevA.45.3403; Kim JW, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.178104; Le T., 2013, NONLINEAR STOCHASTIC; Le TQ, 2013, IEEE J TRANSL ENG HE, V1, DOI 10.1109/JTEHM.2013.2273354; Marwan N, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026702; Morselli LL, 2012, PFLUG ARCH EUR J PHY, V463, P139, DOI 10.1007/s00424-011-1053-z; Patil SP, 2007, J APPL PHYSIOL, V102, P547, DOI 10.1152/japplphysiol.00282.2006; Penzel T, 2003, NEUROPSYCHOPHARMACOL, V28, pS48, DOI 10.1038/sj.npp.1300146; Penzel T, 2010, ANN INT C IEEE ENG M; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; So P, 1998, BIOPHYS J, V74, P2776, DOI 10.1016/S0006-3495(98)77985-8; Waxman JA, 2010, AM J RESP CRIT CARE, V181, P727, DOI 10.1164/rccm.200907-1146OC	24	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164406	10.1371/journal.pone.0164406	http://dx.doi.org/10.1371/journal.pone.0164406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835632	Green Submitted, gold, Green Published			2022-12-26	WOS:000387779200001
J	Boete, C; Morand, S				Boete, Christophe; Morand, Serge			Bats and Academics: How Do Scientists Perceive Their Object of Study?	PLOS ONE			English	Article							DIVERSITY	Bats are associated with conflicting perceptions among humans, ranging from affection to disgust. If these attitudes can be associated with various factors among the general public (e.g. social norms, lack of knowledge), it is also important to understand the attitude of scientists who study bats. Such reflexive information on the researchers community itself could indeed help designing adequate mixed communication tools aimed at protecting bats and their ecosystems, as well as humans living in their vicinity that could be exposed to their pathogens. Thus, we conducted an online survey targeting researchers who spend a part of their research activity studying bats. Our aim was to determine (1) how they perceive their object of study, (2) how they perceive the representation of bats in the media and by the general population, (3) how they protect themselves against pathogen infections during their research practices, and (4) their perceptions of the causes underlying the decline in bat populations worldwide. From the 587 completed responses (response rate of 28%) having a worldwide distribution, the heterogeneity of the scientists' perception of their own object of study was highlighted. In the majority of cases, this depended on the type of research they conducted (i.e. laboratory versus field studies) as well as their research speciality. Our study revealed a high level of personal protection equipment being utilised against pathogens during scientific practices, although the role bats play as reservoirs for a number of emerging pathogens remains poorly known. Our results also disclosed the unanimity among specialists in attributing a direct role for humans in the global decline of bat populations, mainly via environmental change, deforestation, and agriculture intensification. Overall, the present study suggests the need for better communication regarding bats and their biology, their role within the scientific community, as well as in the general public population. As a consequence, increased knowledge regarding scientists' perceptions of bats should improve the role scientists play in influencing the perception of bats by the general public.	[Boete, Christophe] Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, 27,Bd Jean Moulin, F-13385 Marseille 5, France; [Morand, Serge] CNRS ISEM CIRAD AGIRs, Ctr Infectiol Christophe Merieux Laos, Viangchan, Laos; [Morand, Serge] Mahidol Univ, Fac Trop Med, Dept Helminthol, Bangkok, Thailand	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Mahidol University	Boete, C (corresponding author), Aix Marseille Univ, UMR Emergence Pathol Virales, IRD 190, EHESP,INSERM 1207, 27,Bd Jean Moulin, F-13385 Marseille 5, France.	cboete@gmail.com	Morand, Serge/M-5433-2018; BOETE, Christophe/A-7926-2010	Morand, Serge/0000-0003-3986-7659; BOETE, Christophe/0000-0001-9043-8652	French ANR CPAMP;ES BiodivHealthSEA project [ANR 11 CPEL 002]	French ANR CPAMP;ES BiodivHealthSEA project(French National Research Agency (ANR))	This study is supported by the French ANR CP&ES BiodivHealthSEA project (grant ANR 11 CPEL 002; Local impacts and perceptions of global changes: Biodiversity, health and zoonoses in Southeast Asia).r We are really grateful to Ben Holt for allowing us to use the map with the zoogeographic regions that was presented in Holt et al. 2012. An Update of Wallace's Zoogeographic Regions of the World Science 339 (6115), p74-78 (10.1126/science.1228282). We wish to thank Julien Cappelle, Boripat Siriaroonrat, Kevin Olival for helpful comments on the questionnaire. We are extremely grateful to Neil Furey for his many useful suggestions on the design of the survey and insightful comments on a previous version of this manuscript. This study is supported by the French ANR CP&ES BiodivHealthSEA project (grant ANR 11 CPEL 002; Local impacts and perceptions of global changes: Biodiversity, health and zoonoses in Southeast Asia).	Bjerke T, 2004, ANTHROZOOS, P109; Boyles JG, 2011, SCIENCE, V332, P41, DOI 10.1126/science.1201366; Buttke DE, 2015, J WILDLIFE DIS, V51, P1, DOI 10.7589/2014-01-004; Calcagno V, 2010, J STAT SOFTW, V34, P1; Cunningham AA, 2005, BRIT MED J, V331, P1214, DOI 10.1136/bmj.331.7527.1214; Davey GCL, 1998, BEHAV RES THER, V36, P735, DOI 10.1016/S0005-7967(98)00059-X; Davis C. E., 2012, THESIS; Furey Neil M., 2016, P463; Furey NM, 2010, BIODIVERS CONSERV, V19, P1821, DOI 10.1007/s10531-010-9806-0; Gay Noellie, 2014, International Journal for Parasitology Parasites and Wildlife, V3, P161, DOI 10.1016/j.ijppaw.2014.06.003; Hayes MA, 2012, BIOSCIENCE, V62, P819, DOI 10.1525/bio.2012.62.9.7; Hoffmaster E, 2016, ANIMALS, V6, DOI 10.3390/ani6010006; Kane B, 1939, DETECTIVE COMICS, V1939; Kingston Tigga, 2016, P571; Kuzmin Ivan V, 2011, Emerg Health Threats J, V4, P7159, DOI 10.3402/ehtj.v4i0.7159; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; Olival KJ, 2016, ECOHEALTH, V13, P6, DOI 10.1007/s10393-015-1075-7; Prokop P, 2009, ANTHROZOOS, V22, P19, DOI 10.2752/175303708X390446; Robins L.N., 1991, PSYCHIAT DISORDERS A; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Soderbergh S., 2011, CONTAGION, P106; Team RDC, 2019, R LANG ENV STAT COMP; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Voigt C.C., 2016, BATS ANTHROPOCENE CO; Word Medical Association, 1964, BRIT MED J, P177	25	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165969	10.1371/journal.pone.0165969	http://dx.doi.org/10.1371/journal.pone.0165969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832185	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000048
J	Borisev, M; Borisev, I; Zupunski, M; Arsenov, D; Pajevic, S; Curcic, Z; Vasin, J; Djordjevic, A				Borisev, Milan; Borisev, Ivana; Zupunski, Milan; Arsenov, Danijela; Pajevic, Slobodanka; Curcic, Zivko; Vasin, Jovica; Djordjevic, Aleksandar			Drought Impact Is Alleviated in Sugar Beets (Beta vulgaris L.) by Foliar Application of Fullerenol Nanoparticles	PLOS ONE			English	Article							WALLED CARBON NANOTUBES; OXIDATIVE STRESS; LIPID-PEROXIDATION; PLANT; EXPRESSION; C-60(OH)(24); ARABIDOPSIS; INDUCTION; ENZYMES; PROTEIN	Over the past few years, significant efforts have been made to decrease the effects of drought stress on plant productivity and quality. We propose that fullerenol nanoparticles (FNPs, molecular formula C-60(OH)(24)) may help alleviate drought stress by serving as an additional intercellular water supply. Specifically, FNPs are able to penetrate plant leaf and root tissues, where they bind water in various cell compartments. This hydroscopic activity suggests that FNPs could be beneficial in plants. The aim of the present study was to analyse the influence of FNPs on sugar beet plants exposed to drought stress. Our results indicate that intracellular water metabolism can be modified by foliar application of FNPs in drought exposed plants. Drought stress induced a significant increase in the compatible osmolyte proline in both the leaves and roots of control plants, but not in FNP treated plants. These results indicate that FNPs could act as intracellular binders of water, creating an additional water reserve, and enabling adaptation to drought stress. Moreover, analysis of plant antioxidant enzyme activities (CAT, APx and GPx), MDA and GSH content indicate that fullerenol foliar application could have some beneficial effect on alleviating oxidative effects of drought stress, depending on the concentration of nanoparticles applied. Although further studies are necessary to elucidate the biochemical impact of FNPs on plants; the present results could directly impact agricultural practice, where available water supplies are often a limiting factor in plant bioproductivity.	[Borisev, Milan; Zupunski, Milan; Arsenov, Danijela; Pajevic, Slobodanka] Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia; [Borisev, Ivana; Djordjevic, Aleksandar] Univ Novi Sad, Dept Chem Biochem & Environm Protect, Fac Sci, Novi Sad, Serbia; [Curcic, Zivko; Vasin, Jovica] Inst Field & Vegetable Crops, Novi Sad, Serbia	University of Novi Sad; University of Novi Sad	Borisev, M (corresponding author), Univ Novi Sad, Dept Biol & Ecol, Fac Sci, Novi Sad, Serbia.	milan.borisev@dbe.uns.ac.rs	Župunski, Milan/U-1696-2017; Arsenov, Danijela D/E-5508-2013; Curcic, Zivko/Y-1459-2019; Arsenov, Danijela/P-5868-2019; Borišev, Ivana/AAK-8961-2020; Borisev, Milan/ABG-7493-2020	Župunski, Milan/0000-0002-8576-1292; Curcic, Zivko/0000-0001-6029-0175; Arsenov, Danijela/0000-0002-1200-5023; Borisev, Milan/0000-0002-1833-002X; , Aleksandar/0000-0003-4120-7318	Ministry of Education, Science and Technological Development of the Republic of Serbia [III 045005]	Ministry of Education, Science and Technological Development of the Republic of Serbia	The authors acknowledge financial support of the Ministry of Education, Science and Technological Development of the Republic of Serbia (grant number III 045005).; Authors acknowledge financial support of the Ministry of Education, Science and Technological Development of the Republic of Serbia (Grant number III 045005). We thank dr Edward T. Petri, University of Novi Sad, for editing this manuscript for English language and content. This research was kindly supported by Sanja Muzikravic, chief laboratory technician and Milos I Bokorov, head of the Electron Microscopy Center at the University of Novi Sad, Serbia.	Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Bakry R, 2007, INT J NANOMED, V2, P639; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUMONT F, 1990, PLANT SCI, V72, P19, DOI 10.1016/0168-9452(90)90182-N; Bogdanovic V, 2008, J RADIAT RES, V49, P321, DOI 10.1269/jrr.07092; Borsani O, 2001, PLANT SCI, V161, P757, DOI 10.1016/S0168-9452(01)00467-8; Bouwmeester H, 2009, REGUL TOXICOL PHARM, V53, P52, DOI 10.1016/j.yrtph.2008.10.008; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brant JA, 2006, LANGMUIR, V22, P3878, DOI 10.1021/la053293o; Canas JE, 2008, ENVIRON TOXICOL CHEM, V27, P1922, DOI 10.1897/08-117.1; Arruda SCC, 2015, TALANTA, V131, P693, DOI 10.1016/j.talanta.2014.08.050; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen R, 2010, SMALL, V6, P612, DOI 10.1002/smll.200901911; Clogston JD, 2011, METHODS MOL BIOL, V697, P63, DOI 10.1007/978-1-60327-198-1_6; Da Ros T, 2008, CARBON MATER-CHEM PH, V1, P1; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; Delfine S, 1998, AUST J PLANT PHYSIOL, V25, P395, DOI 10.1071/PP97161; Devasagayam TPA, 2003, INDIAN J BIOCHEM BIO, V40, P300; Djordjevic A, 1998, FULLERENE SCI TECHN, V6, P689, DOI 10.1080/10641229809350229; Djordjevic A, 2015, J NANOMATER, V2015, DOI 10.1155/2015/567073; Dugan LL, 2001, PARKINSONISM RELAT D, V7, P243, DOI 10.1016/S1353-8020(00)00064-X; Faisal M, 2013, J HAZARD MATER, V250, P318, DOI 10.1016/j.jhazmat.2013.01.063; Farmer EE, 2013, ANNU REV PLANT BIOL, V64, P429, DOI 10.1146/annurev-arplant-050312-120132; Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X; Foyer CH, 2005, PLANT CELL ENVIRON, V28, P1056, DOI 10.1111/j.1365-3040.2005.01327.x; Ghorbanpour M, 2015, CARBON, V94, P749, DOI 10.1016/j.carbon.2015.07.056; Ghormade V, 2011, BIOTECHNOL ADV, V29, P792, DOI 10.1016/j.biotechadv.2011.06.007; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hossain MA, 2014, OXIDATIVE DAMAGE TO PLANTS: ANTIOXIDANT NETWORKS AND SIGNALING, P477, DOI 10.1016/B978-0-12-799963-0.00016-2; Husebo LO, 2004, J AM CHEM SOC, V126, P12055, DOI 10.1021/ja047593o; Husen A, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/1477-3155-12-16; ICUMSA, 1994, ICUMSA METH BOOK; Inagaki S, 2013, METHODS, V59, P287, DOI 10.1016/j.ymeth.2012.11.006; Injac R, 2009, BIOMATERIALS, V30, P1184, DOI 10.1016/j.biomaterials.2008.10.060; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; KAPETANOVIC IM, 1979, J PHARMACOL EXP THER, V209, P25; Kertesz A, 2014, INT SOIL WATER CONSE, V2, P91, DOI 10.1016/S2095-6339(15)30016-2; Khodakovskaya M, 2009, ACS NANO, V3, P3221, DOI 10.1021/nn900887m; Khot LR, 2012, CROP PROT, V35, P64, DOI 10.1016/j.cropro.2012.01.007; Kole C, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-37; Letenko DG, 2011, RUSS J APPL CHEM+, V84, P50, DOI 10.1134/S1070427211010083; Lin SJ, 2009, SMALL, V5, P1128, DOI 10.1002/smll.200801556; Lobatto ME, 2011, NAT REV DRUG DISCOV, V10, P835, DOI 10.1038/nrd3578; Ma HL, 2010, SCI CHINA CHEM, V53, P2233, DOI 10.1007/s11426-010-4118-5; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Miralles P, 2014, J R SOC, V9, P3514; Mirkov SM, 2004, NITRIC OXIDE-BIOL CH, V11, P201, DOI 10.1016/j.niox.2004.08.003; Mondal A, 2011, J NANOPART RES, V13, P4519, DOI 10.1007/s11051-011-0406-z; Nair R, 2010, PLANT SCI, V179, P154, DOI 10.1016/j.plantsci.2010.04.012; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nielsen GD, 2008, BASIC CLIN PHARMACOL, V103, P197, DOI 10.1111/j.1742-7843.2008.00266.x; Nikolic N, 2008, ACTA BIOL CRACOV BOT, V50, P95; Nikravesh F, 2012, RUSS J PLANT PHYSL+, V59, P648, DOI 10.1134/S1021443712030132; Noctor G, 2015, PHYTOCHEMISTRY, V112, P33, DOI 10.1016/j.phytochem.2014.09.002; Noctor G, 2014, PLANT PHYSIOL, V164, P1636, DOI 10.1104/pp.113.233478; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; Oberdorster G, 2010, J INTERN MED, V267, P89, DOI 10.1111/j.1365-2796.2009.02187.x; ordevic A., 2008, ARCH ONCOL, V16, P42, DOI [10.2298/AOO0804042D, DOI 10.2298/AOO0804042D, DOI 10.2298/AOO0804042]; Partha R, 2009, INT J NANOMED, V4, P261; Parthasarathy A., 2007, BIOMED ENG, V2, P1; Pitkethly MJ, 2004, MATER TODAY, V7, P20, DOI 10.1016/S1369-7021(04)00627-3; Prylutska S, 2012, J BIOMED NANOTECHNOL, V8, P522, DOI 10.1166/jbn.2012.1404; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Queval G, 2011, PLANT CELL ENVIRON, V34, P21, DOI 10.1111/j.1365-3040.2010.02222.x; Sapsford KE, 2011, ANAL CHEM, V83, P4453, DOI 10.1021/ac200853a; Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Semenov KN, 2011, J CHEM ENG DATA, V56, P230, DOI 10.1021/je100755v; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; SIMON LM, 1974, BIOCHEM PHYSIOL PFL, V166, P387; Singh B., 2012, TXB ANIMAL BIOTECHNO; Song U, 2013, BIOL TRACE ELEM RES, V155, P93, DOI 10.1007/s12011-013-9765-x; Spinoni J, 2015, GLOBAL PLANET CHANGE, V127, P50, DOI 10.1016/j.gloplacha.2015.01.012; Stankov K, 2013, J NANOSCI NANOTECHNO, V13, P105, DOI 10.1166/jnn.2013.6847; Tiwari DK, 2014, APPL NANOSCI, V4, P577, DOI 10.1007/s13204-013-0236-7; Tommerup E.C., 1934, FIELD DESCRIPTION PH, P155; Trpkovic A, 2012, ARCH TOXICOL, V86, P1809, DOI 10.1007/s00204-012-0859-6; Vileno B, 2006, ADV FUNCT MATER, V16, P120, DOI 10.1002/adfm.200500425; Villagarcia H, 2012, SMALL, V8, P2328, DOI 10.1002/smll.201102661; Weng MY, 2015, PAK J BOT, V47, P49; Yoshimura K, 2000, PLANT PHYSIOL, V123, P223, DOI 10.1104/pp.123.1.223; YSSS-Yugoslav Soil Science Society, 1966, ISP ZEMLJ, P124; YSSS-Yugoslav Soil Science Society, 1997, PRIR ISP ZEMLJ, P17; Zhao LJ, 2012, ACS NANO, V6, P9615, DOI 10.1021/nn302975u	88	49	49	5	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166248	10.1371/journal.pone.0166248	http://dx.doi.org/10.1371/journal.pone.0166248			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832171	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000084
J	Hsu, CY; Chen, BS				Hsu, Chih-Yuan; Chen, Bor-Sen			Systematic Design of a Metal Ion Biosensor: A Multi-Objective Optimization Approach	PLOS ONE			English	Article							COMBINATORIAL PROMOTER DESIGN; NONLINEAR DYNAMIC-SYSTEMS; TRACKING CONTROL DESIGN; S-ADENOSYLMETHIONINE; WASTE-WATER; GENE; NOISE; IDENTIFICATION; REMOVAL	With the recent industrial expansion, heavy metals and other pollutants have increasingly contaminated our living surroundings. Heavy metals, being non-degradable, tend to accumulate in the food chain, resulting in potentially damaging toxicity to organisms. Thus, techniques to detect metal ions have gradually begun to receive attention. Recent progress in research on synthetic biology offers an alternative means for metal ion detection via the help of promoter elements derived from microorganisms. To make the design easier, it is necessary to develop a systemic design method for evaluating and selecting adequate components to achieve a desired detection performance. A multi-objective (MO) H-2/H-infinity performance criterion is derived here for design specifications of a metal ion biosensor to achieve the H-2 optimal matching of a desired input/output (I/O) response and simultaneous H-infinity optimal filtering of intrinsic parameter fluctuations and external cellular noise. According to the two design specifications, a Takagi-Sugeno (T-S) fuzzy model is employed to interpolate several local linear stochastic systems to approximate the nonlinear stochastic metal ion biosensor system so that the multi-objective H-2/H-infinity design of the metal ion biosensor can be solved by an associated linear matrix inequality (LMI)-constrained multi-objective (MO) design problem. The analysis and design of a metal ion biosensor with optimal I/O response matching and optimal noise filtering ability then can be achieved by solving the multi-objective problem under a set of LMIs. Moreover, a multi-objective evolutionary algorithm (MOEA)-based library search method is employed to find adequate components from corresponding libraries to solve LMI-constrained MO H-2/H-infinity design problems. It is a useful tool for the design of metal ion biosensors, particularly regarding the tradeoffs between the design factors under consideration.	[Hsu, Chih-Yuan; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu 30013, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu 30013, Taiwan.	bsehen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017	Chen, Bor-Sen/0000-0003-1644-6106	Ministry of Science and Technology, Taiwan [MOST-103-2745-E-007-001-ASP]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan through grant no. MOST-103-2745-E-007-001-ASP.; The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan through grant no. MOST 103-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Ayala FJ, 2007, P NATL ACAD SCI USA, V104, P8567, DOI 10.1073/pnas.0701072104; Back T., 1997, IEEE Transactions on Evolutionary Computation, V1, P3, DOI 10.1109/4235.585888; Bajic D., 2012, BMC GENOMICS, P13; Balazsi G, 2007, FEBS J, V274, P258; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Cameron DE, 2014, NAT REV MICROBIOL, V12, P381, DOI 10.1038/nrmicro3239; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Chen B.S., 2008, BMC SYSTEMS BIOL, V2; Chen B.S., 2006, BMC BIOINFORMATICS, V7; Chen BS, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/304236; Chen BS, 2004, IEEE T AUTOMAT CONTR, V49, P45, DOI 10.1109/TAC.2003.821400; Chen BS, 1999, IEEE T FUZZY SYST, V7, P571, DOI 10.1109/91.797980; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Hanzelka BL, 1996, J BACTERIOL, V178, P5291, DOI 10.1128/jb.178.17.5291-5294.1996; HARTWIG A, 1995, BIOMETALS, V8, P3; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hobman J.L., 2012, BMC MICROBIOL, P12; Hooshangi S, 2006, CHAOS, V16, DOI 10.1063/1.2208927; Kaern M, 2003, ANNU REV BIOMED ENG, V5, P179, DOI 10.1146/annurev.bioeng.5.040202.121553; Munson GP, 2000, J BACTERIOL, V182, P5864, DOI 10.1128/JB.182.20.5864-5871.2000; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; NEALSON KH, 1979, MICROBIOL REV, V43, P496, DOI 10.1128/MMBR.43.4.496-518.1979; Ngah WSW, 2008, BIORESOURCE TECHNOL, V99, P3935, DOI 10.1016/j.biortech.2007.06.011; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Pedraza JM, 2005, SCIENCE, V307, P1965, DOI 10.1126/science.1109090; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Rezvani-Boroujeni A, 2015, IND ENG CHEM RES, V54, P502, DOI 10.1021/ie504106y; Singha AS, 2014, INT J BIOL MACROMOL, V67, P409, DOI 10.1016/j.ijbiomac.2014.03.046; Taghavi S, 1997, RES MICROBIOL, V148, P536, DOI 10.1016/S0923-2508(97)88361-1; TAKAGI T, 1985, IEEE T SYST MAN CYB, V15, P116, DOI 10.1109/TSMC.1985.6313399; Teodosiu C, 2014, REV CHEM ENG, V30, P403, DOI 10.1515/revce-2013-0036; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Tseng CS, 2001, IEEE T FUZZY SYST, V9, P381, DOI 10.1109/91.928735; Tseng CS, 2001, IEEE T FUZZY SYST, V9, P795, DOI 10.1109/91.971729; Val DL, 1998, J BACTERIOL, V180, P2644, DOI 10.1128/JB.180.10.2644-2651.1998; Zhang HG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038111; Zhang WH, 2005, IEEE T SIGNAL PROCES, V53, P589, DOI 10.1109/TSP.2004.840724	43	3	3	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165911	10.1371/journal.pone.0165911	http://dx.doi.org/10.1371/journal.pone.0165911			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832110	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000039
J	Janiszewska, J; Posadas, I; Jativa, P; Bugaj-Zarebska, M; Urbanczyk-Lipkowska, Z; Cena, V				Janiszewska, Jolanta; Posadas, Inmaculada; Jativa, Pablo; Bugaj-Zarebska, Marta; Urbanczyk-Lipkowska, Zofia; Cena, Valentin			Second Generation Amphiphilic Poly-Lysine Dendrons Inhibit Glioblastoma Cell Proliferation without Toxicity for Neurons or Astrocytes	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; SIRNA DELIVERY; DENDRIMERS; PEPTIDE; ACTIVATION; MEMBRANE; POLY(L-LYSINE); TRANSFECTION; HIF-1-ALPHA; APOPTOSIS	Glioblastomas are the most common malignant primary brain tumours in adults and one of the most aggressive and difficult-to-treat cancers. No effective treatment exits actually for this tumour and new therapeutic approaches are needed for this disease. One possible innovative approach involves the nanoparticle-mediated specific delivery of drugs and/or genetic material to glioblastoma cells where they can provide therapeutic benefits. In the present work, we have synthesised and characterised several second generation amphiphilic polylysine dendrons to be used as siRNA carriers. We have found that, in addition to their siRNA binding properties, these new compounds inhibit the proliferation of two glioblastoma cell lines while being nontoxic for non-tumoural central nervous system cells like neurons and glia, cell types that share the anatomical space with glioblastoma cells during the course of the disease. The selective toxicity of these nanoparticles to glioblastoma cells, as compared to neurons and glial cells, involves mitochondrial depolarisation and reactive oxygen species production. This selective toxicity, together with the ability to complex and release siRNA, suggests that these new polylysine dendrons might offer a scaffold in the development of future nanoparticles designed to restrict the proliferation of glioblastoma cells.	[Janiszewska, Jolanta] Inst Ind Res, Warsaw, Poland; [Posadas, Inmaculada; Jativa, Pablo; Cena, Valentin] Inst Salud Carlos III, CIBERNED, Madrid, Spain; [Bugaj-Zarebska, Marta; Urbanczyk-Lipkowska, Zofia] PAS, Inst Organ Chem, Warsaw, Poland; [Posadas, Inmaculada; Jativa, Pablo; Cena, Valentin] Univ Castilla La Mancha, Unidad Asociada Neurodeath, Fac Med, Albacete, Spain	CIBERNED; Instituto de Salud Carlos III; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Universidad de Castilla-La Mancha	Cena, V (corresponding author), Inst Salud Carlos III, CIBERNED, Madrid, Spain.; Cena, V (corresponding author), Univ Castilla La Mancha, Unidad Asociada Neurodeath, Fac Med, Albacete, Spain.	valentin.cena@gmail.com	Janiszewska, Jolanta/W-4148-2018; Cena, Valentin/L-1751-2017; Posadas, Inmaculada/M-1124-2014	Janiszewska, Jolanta/0000-0003-0958-8018; Cena, Valentin/0000-0001-8928-3681; Posadas, Inmaculada/0000-0003-1854-3372; Jativa Carbajal, Pablo/0000-0003-0288-9416; Urbanczyk-Lipkowska, Zofia/0000-0003-2043-487X; Bugaj-Zarebska, Marta/0000-0002-8308-0450	MINECO [BFU2014-59009-P]; CYTED [214RT0482]; NCN [UMO-2012/07/B/ST5/01941]	MINECO(Spanish Government); CYTED; NCN	Support was provided by: MINECO Grant no. BFU2014-59009-P to VC; CYTED grant no. 214RT0482 to VC; and NCN grant no UMO-2012/07/B/ST5/01941 to ZU-L.	Agrawal A, 2009, ACS NANO, V3, P2495, DOI 10.1021/nn900201e; Al-Jamal KT, 2010, P NATL ACAD SCI USA, V107, P3966, DOI 10.1073/pnas.0908401107; [Anonymous], 2016, NANOMEDICINE-UK, V11, P833; [Anonymous], 2010, NANOMEDICINE-UK, V5, P1219; Battigelli A, 2013, SMALL, V9, P3610, DOI 10.1002/smll.201300264; BONFOCO E, 1995, P NATL ACAD SCI USA, V92, P7162, DOI 10.1073/pnas.92.16.7162; Celardo I, 2014, BRIT J PHARMACOL, V171, P1943, DOI 10.1111/bph.12433; Cho KC, 2005, MACROMOL BIOSCI, V5, P512, DOI 10.1002/mabi.200500018; Coantic S, 2008, INT J PEPT RES THER, V14, P143, DOI 10.1007/s10989-008-9123-6; Cookson MR, 1998, J NEUROCHEM, V70, P501; Curtis Carol D., 2009, V505, P187, DOI 10.1007/978-1-60327-575-0_11; Fruchon S, 2009, J LEUKOCYTE BIOL, V85, P553, DOI 10.1189/jlb.0608371; Ghosh PS, 2008, ACS NANO, V2, P2213, DOI 10.1021/nn800507t; Guerra J, 2012, CARBON, V50, P2832, DOI 10.1016/j.carbon.2012.02.050; Inoue Y, 2008, J CONTROL RELEASE, V126, P59, DOI 10.1016/j.jconrel.2007.10.022; Janiszewska J, 2012, BIOORG MED CHEM LETT, V22, P1388, DOI 10.1016/j.bmcl.2011.12.051; Jobin ML, 2013, BBA-BIOMEMBRANES, V1828, P1457, DOI 10.1016/j.bbamem.2013.02.008; Jordan J, 2004, J NEUROCHEM, V89, P124, DOI 10.1046/j.1471-4159.2003.02299.x; Kaneshiro TL, 2007, MOL PHARMACEUT, V4, P759, DOI 10.1021/mp070036z; Kim WJ, 2009, PHARM RES-DORDR, V26, P657, DOI 10.1007/s11095-008-9774-1; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kwok A, 2013, ACS NANO, V7, P4668, DOI 10.1021/nn400343z; Lipton SA, 1998, CELL CALCIUM, V23, P165, DOI 10.1016/S0143-4160(98)90115-4; Liu XX, 2015, NANOSCALE, V7, P3867, DOI 10.1039/c4nr04759a; Lopez-Hernandez B, 2012, EXP NEUROL, V233, P543, DOI 10.1016/j.expneurol.2011.11.040; Ma D, 2013, J COLLOID INTERF SCI, V405, P305, DOI 10.1016/j.jcis.2013.05.017; Mader JS, 2007, EXP CELL RES, V313, P2634, DOI 10.1016/j.yexcr.2007.05.015; Malhotra S, 2012, BIOMACROMOLECULES, V13, P3087, DOI 10.1021/bm300892v; Malkoch M, 2002, MACROMOLECULES, V35, P8307, DOI 10.1021/ma0205360; Monteagudo S, 2012, NANOMEDICINE-UK, V7, P493, DOI [10.2217/NNM.11.61, 10.2217/nnm.11.61]; Olson JJ, 2014, J NEURO-ONCOL, V118, P427, DOI 10.1007/s11060-014-1431-4; Papadopoulos A, 2012, MOL PHARMACEUT, V9, P394, DOI 10.1021/mp200490b; Parat A, 2015, NANOMEDICINE-UK, V10, P977, DOI [10.2217/NNM.14.196, 10.2217/nnm.14.196]; Perez-Carrion MD, 2013, PHARM RES-DORDR, V30, P2584, DOI 10.1007/s11095-013-1049-9; Perez-Carrion MD, 2012, J NEUROCHEM, V120, P259, DOI 10.1111/j.1471-4159.2011.07556.x; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Polcyn P, 2013, MOLECULES, V18, P7120, DOI 10.3390/molecules18067120; Posadas I, 2012, J NEUROCHEM, V120, P515, DOI 10.1111/j.1471-4159.2011.07599.x; Posadas I, 2009, PHARM RES-DORDR, V26, P1181, DOI 10.1007/s11095-009-9839-9; Rekdal O, 2012, J BIOL CHEM, V287, P233, DOI 10.1074/jbc.M111.279281; Rodrigo AC, 2011, BIOMACROMOLECULES, V12, P1205, DOI 10.1021/bm1014987; Sadler Kristen, 2002, J Biotechnol, V90, P195; Sahay G, 2013, NAT BIOTECHNOL, V31, P653, DOI 10.1038/nbt.2614; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shcharbin D, 2014, J CONTROL RELEASE, V181, P40, DOI 10.1016/j.jconrel.2014.02.021; Venur VA, 2015, CANCER TREAT RES, V163, P103, DOI 10.1007/978-3-319-12048-5_7; Weller M, 2014, INT J CANCER, V134, P2437, DOI 10.1002/ijc.28576; Woehrer A, 2014, CURR OPIN NEUROL, V27, P666, DOI 10.1097/WCO.0000000000000144; Wong HL, 2010, ADV DRUG DELIVER REV, V62, P503, DOI 10.1016/j.addr.2009.11.020; Zhao J, 2014, ARCH PHARM, V347, P469, DOI 10.1002/ardp.201300415	50	25	26	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165704	10.1371/journal.pone.0165704	http://dx.doi.org/10.1371/journal.pone.0165704			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832093	gold, Green Submitted, Green Published			2022-12-26	WOS:000387725000028
J	Rienstra, M; Geelhoed, B; Yin, XY; Siland, JE; Vermond, RA; Mulder, BA; Van Der Harst, P; Hillege, HL; Benjamin, EJ; Van Gelder, IC				Rienstra, Michiel; Geelhoed, Bastiaan; Yin, Xiaoyan; Siland, Joylene E.; Vermond, Rob A.; Mulder, Bart A.; Van Der Harst, Pim; Hillege, Hans L.; Benjamin, Emelia J.; Van Gelder, Isabelle C.			Cluster Individuals Based on Phenotype and Determine the Risk for Atrial Fibrillation in the PREVEND and Framingham Heart Study Populations	PLOS ONE			English	Article							ASSOCIATION CONSENSUS CONFERENCE; LATENT CLASS ANALYSIS; PROGNOSIS; COHORT	Background Risk prediction of atrial fibrillation (AF) is of importance to improve the early diagnosis and treatment of AF. Latent class analysis takes into account the possible existence of classes of individuals each with shared risk factors, and maybe a better method of incorporating the phenotypic heterogeneity underlying AF. Methods and findings Two prospective community-based cohort studies from Netherlands and United States were used. Prevention of Renal and Vascular End-stage Disease (PREVEND) study, started in 1997, and the Framingham Heart Study (FHS) Offspring cohort started in 1971, both with 10-years follow-up. The main objective was to determine the risk of AF using a latent class analysis, and compare the discrimination and reclassification performance with traditional regression analysis. Mean age in PREVEND was 49 13 years, 49.8% were men. During follow-up, 250(3%) individuals developed AF. We built a latent class model based on 18 risk factors. A model with 7 distinct classes (ranging from 341 to 1517 individuals) gave the optimum tradeoff between a high statistical model-likelihood and a low number of model parameters. All classes had a specific profile. The incidence of AF varied; class 1 0.0%, class 2 0.3%, class 3 7.5%, class 4 0.2%, class 5 1.3%, class 6 4.2%, class 7 21.7% (p<0.001). The discrimination (C-statistic 0.830 vs. 0.842, delta-C -0.013, p = 0.22) and reclassification (IDI-0.028, p<0.001, NRI-0.090, p = 0.049, and category-less-NRI -0.049, p = 0.495) performance of both models was comparable. The results were successfully replicated in a sample of the FHS study (n = 3162; mean age 58 9 years, 46.3% men). Conclusions Latent class analysis to build an AF risk model is feasible. Despite the heterogeneity in number and severity of risk factors between individuals at risk for AF, latent class analysis produces distinguishable groups.	[Rienstra, Michiel; Geelhoed, Bastiaan; Siland, Joylene E.; Vermond, Rob A.; Mulder, Bart A.; Van Der Harst, Pim; Hillege, Hans L.; Van Gelder, Isabelle C.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Yin, Xiaoyan; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Yin, Xiaoyan; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Cardiovasc Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Sect Prevent Med, Boston, MA 02118 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Groningen; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; Boston University; Boston University; Boston University	Rienstra, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands.	m.rienstra@umcg.nl	Benjamin, Emelia/E-7103-2011; Mulder, Bart/AAU-3871-2020	Benjamin, Emelia/0000-0003-4076-2336; Mulder, Bart/0000-0002-4411-3918; Rienstra, Michiel/0000-0002-2581-070X; Siland, Joylene/0000-0003-4404-1245	Dutch Kidney Foundation [E0.13]; Netherlands Heart Foundation [NHS2010B280]; Netherlands Organization for Scientific Research (Veni) [016.136.055]; EHRA Academic Fellowship program;  [HHSN268201500001I];  [N01-HC 25195];  [2R01HL092577];  [1R01HL128914]	Dutch Kidney Foundation; Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research (Veni)(Netherlands Organization for Scientific Research (NWO)); EHRA Academic Fellowship program; ; ; ; 	The PREVEND study is supported by the Dutch Kidney Foundation (grant E0.13) and the Netherlands Heart Foundation (grant NHS2010B280). Dr. M. Rienstra is supported by grants from the Netherlands Organization for Scientific Research (Veni grant 016.136.055) and from the EHRA Academic Fellowship program. The FHS is supported by HHSN268201500001I, N01-HC 25195, 2R01HL092577, and 1R01HL128914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Altman RB, 2015, CIRCULATION, V131, P232, DOI 10.1161/CIRCULATIONAHA.114.014106; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Calfee CS, 2014, LANCET RESP MED, V2, P611, DOI 10.1016/S2213-2600(14)70097-9; Chugh SS, 2014, CIRCULATION, V129, P837, DOI 10.1161/CIRCULATIONAHA.113.005119; Collins GS, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.g7594; Elia J, 2009, PSYCHIAT RES, V170, P192, DOI 10.1016/j.psychres.2008.10.008; Frost L, 2005, AM J MED, V118, P489, DOI 10.1016/j.amjmed.2005.01.031; Ganesalingam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007107; Hagenaars J., 2002, APPL LATENT CLASS AN, DOI DOI 10.1017/CBO9780511499531; KANNEL WB, 1979, AM J EPIDEMIOL, V110, P281, DOI 10.1093/oxfordjournals.aje.a112813; Kannel WB, 1998, AM J CARDIOL, V82, p2N, DOI 10.1016/S0002-9149(98)00583-9; Kao DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048184; Kirchhof P, 2013, EUROPACE, V15, P1540, DOI 10.1093/europace/eut232; Kirchhof P, 2012, EUROPACE, V14, P8, DOI 10.1093/europace/eur241; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lanza ST, 2013, STRUCT EQU MODELING, V20, P1, DOI 10.1080/10705511.2013.742377; Lazarsfeld P.F., 1968, LATENT STRUCTURE ANA; Linzer DA, 2011, J STAT SOFTW, V42, P1, DOI 10.18637/jss.v042.i10; Lloyd-Jones DM, 2010, CIRCULATION, V121, P1768, DOI 10.1161/CIRCULATIONAHA.109.849166; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Siroux V, 2011, EUR RESPIR J, V38, P310, DOI 10.1183/09031936.00120810; Vermond RA, 2015, J AM COLL CARDIOL, V66, P1000, DOI 10.1016/j.jacc.2015.06.1314; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	26	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165828	10.1371/journal.pone.0165828	http://dx.doi.org/10.1371/journal.pone.0165828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832125	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000036
J	van't Boveneind-Vrubleuskaya, N; Daskapan, A; Kosterink, JGW; van der Wert, TS; van den Hof, S; Alffenaar, JWC				van't Boveneind-Vrubleuskaya, Natasha; Daskapan, Alper; Kosterink, Jos G. W.; van der Wert, Tjip S.; van den Hof, Susan; Alffenaar, Jan-Willem C.			Predictors of Prolonged TB Treatment in a Dutch Outpatient Setting	PLOS ONE			English	Article							INDUCED LIVER-INJURY; DRUG-INDUCED HEPATOTOXICITY; TUBERCULOSIS TREATMENT; SPUTUM SMEAR; PULMONARY TUBERCULOSIS; ANTITUBERCULOSIS TREATMENT; CULTURE CONVERSION; TREATMENT OUTCOMES; FOLLOW-UP; PHARMACOGENETICS	Introduction Standard treatment duration for drug-susceptible tuberculosis (TB) treatment is 6 months. Treatment duration is often extended-and for various different reasons. The aim of this study was to determine the prevalence and to assess risk factors associated with extended TB treatment. Methods A cross-sectional study was conducted. Data including demographic, clinical, radiological and microbiological information from the Netherlands TB Register (NTR) of 90 patients with smear and culture positive pulmonary TB of the region Haaglanden, The Netherlands, was eligible for analysis. Results Treatment was extended to >= 200 days by 46 (51%) patients. Extended TB treatment was associated with a higher frequency of symptoms, presumed to be due to adverse drug reactions (ADR; OR 2.39 95% CI: 1.01-5.69), drug-induced liver injury (DILI) (OR: 13.51; 95% CI: 1.66-109.82) and longer than 2 month smear and culture conversion rate (OR: 11.00; 95% CI: 1.24-97.96 and OR: 8.56; 95% CI: 1.53-47.96). In the multivariable logistic analysis, development of DILI emerged as the single statistically strong risk factor necessitating extension of TB treatment. Conclusion This finding will need further confirmation in a prospective study, exploring the possible mutual role of pharmacokinetic and pharmacogenetic determinants of DILI among TB patients.	[van't Boveneind-Vrubleuskaya, Natasha] Metropolitan Publ Hlth Serv, Dept Publ Hlth TB Control, The Hague, Netherlands; [van't Boveneind-Vrubleuskaya, Natasha; Daskapan, Alper; Kosterink, Jos G. W.; Alffenaar, Jan-Willem C.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [van den Hof, Susan] KNCV TB Fdn, The Hague, Netherlands; [van den Hof, Susan] Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [van der Wert, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis & TB, Groningen, Netherlands	University of Groningen; KNCV Tuberculosis Foundation; University of Groningen	van't Boveneind-Vrubleuskaya, N (corresponding author), Metropolitan Publ Hlth Serv, Dept Publ Hlth TB Control, The Hague, Netherlands.; van't Boveneind-Vrubleuskaya, N (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands.	natasha.boveneind@ggdhaaglanden.nl		Daskapan, Alper/0000-0003-4744-6619; van der Werf, Tjip/0000-0002-4824-1642; Kosterink, Jos/0000-0001-8358-765X				Azuma J, 2013, EUR J CLIN PHARMACOL, V69, P1091, DOI 10.1007/s00228-012-1429-9; Ben Fredj N, 2017, PHARMACOGENOMICS J, V17, P372, DOI 10.1038/tpj.2016.26; Mota PC, 2012, REV PORT PNEUMOL, V18, P72, DOI 10.1016/j.rppneu.2011.12.005; Chang KC, 2007, EUR RESPIR J, V29, P347, DOI 10.1183/09031936.00090306; Choi H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-360; Clancy L., 1990, LUNG DIS, V65, P70; Cojutti P, 2016, J ANTIMICROB CHEMOTH, V71, P1323, DOI 10.1093/jac/dkv490; Gomes NMDF, 2015, PULM MED, V2015, DOI 10.1155/2015/546106; De Vries G, 2014, EURO SURVEILL, V19; Dossing M, 1996, TUBERCLE LUNG DIS, V77, P335, DOI 10.1016/S0962-8479(96)90098-2; Finney L, 2013, EUR RESP J S57, V42, pP4684; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Heysell SK, 2010, EMERG INFECT DIS, V16, P1546, DOI 10.3201/eid1610.100374; Jeong I, 2015, J KOREAN MED SCI, V30, P167, DOI 10.3346/jkms.2015.30.2.167; Kimerling ME, 1998, CHEST, V113, P1178, DOI 10.1378/chest.113.5.1178; Lange C, 2014, EUR RESPIR J, V44, P23, DOI 10.1183/09031936.00188313; Lee J, 2012, INT J TUBERC LUNG D, V16, P1344, DOI 10.5588/ijtld.12.0113; Lienhardt C, 1998, INT J TUBERC LUNG D, V2, P712; Lonnroth K, 2015, EUR RESPIR J, V45, P928, DOI 10.1183/09031936.00214014; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Magis-Escurra C, 2014, INT J ANTIMICROB AG, V44, P229, DOI 10.1016/j.ijantimicag.2014.04.019; Matsumoto T, 2014, PHARMACOGENOMICS, V15, P601, DOI 10.2217/pgs.14.38; Mehta JB, 2001, CHEST, V120, P1520, DOI 10.1378/chest.120.5.1520; Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; National Collaborating Centre for Chronic Conditions (UK), 2006, TUB CLIN DIAGN MAN T; Nijland HMJ, 2006, CLIN INFECT DIS, V43, P848, DOI 10.1086/507543; Pasipanodya JG, 2013, J INFECT DIS, V208, P1464, DOI 10.1093/infdis/jit352; Pasipanodya JG, 2013, CLIN INFECT DIS, V57, P21, DOI 10.1093/cid/cit167; Pasipanodya JG, 2012, INT J TUBERC LUNG D, V16, P706, DOI 10.5588/ijtld.11.0850; Peloquin CA, 2002, DRUGS, V62, P2169, DOI 10.2165/00003495-200262150-00001; Ramarokoto H, 2002, INT J TUBERC LUNG D, V6, P909; Rieder HL, 1996, TUBERCLE LUNG DIS, V77, P124, DOI 10.1016/S0962-8479(96)90026-X; Salaniponi FML, 1999, INT J TUBERC LUNG D, V3, P1047; Satyaraddi A, 2014, INT J TUBERC LUNG D, V18, P188, DOI 10.5588/ijtld.13.0128; Saukkonen JJ, 2006, AM J RESP CRIT CARE, V174, P935, DOI 10.1164/rccm.200510-1666ST; Singla R, 2003, INT J TUBERC LUNG D, V7, P58; Society AT, 2003, REC REP AM THOR SOC, V52, P1; Sotsuka T, 2011, IN VIVO, V25, P803; Su WJ, 2011, EUR RESPIR J, V37, P376, DOI 10.1183/09031936.00007410; Sun F, 2008, INT J TUBERC LUNG D, V12, P994; Tostmann A, 2008, J GASTROEN HEPATOL, V23, P192, DOI 10.1111/j.1440-1746.2007.05207.x; TSAGAROPOULOUSTINGA H, 1985, PEDIATR INFECT DIS J, V4, P270, DOI 10.1097/00006454-198505000-00013; Valin N, 2009, INT J TUBERC LUNG D, V13, P881; Wang JY, 2009, RESPIROLOGY, V14, P1012, DOI 10.1111/j.1440-1843.2009.01598.x; Wang PY, 2012, INT J TUBERC LUNG D, V16, P589, DOI 10.5588/ijtld.11.0377; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2014, GLOB TUB REP; Yew WW, 2011, EUR RESPIR J, V37, P441, DOI 10.1183/09031936.00033010; Zhang HY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147744; Zumla A, 2013, NEW ENGL J MED, V368, P745, DOI 10.1056/NEJMra1200894	51	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166030	10.1371/journal.pone.0166030	http://dx.doi.org/10.1371/journal.pone.0166030			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832142	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000055
J	Bowman, L; Zeden, MS; Schuster, CF; Kaever, V; Grundling, A				Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Kaever, Volkhard; Grundling, Angelika			New Insights into the Cyclic Di-adenosine Monophosphate (c-di-AMP) Degradation Pathway and the Requirement of the Cyclic Dinucleotide for Acid Stress Resistance in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIME TRANSCRIPTION INITIATION; AFFECT BACTERIAL-GROWTH; BACILLUS-SUBTILIS; MYCOBACTERIUM-TUBERCULOSIS; ABC TRANSPORTER; GENE-EXPRESSION; PHOSPHODIESTERASE; NUCLEOTIDE; PROTEIN; OLIGORIBONUCLEASE	Nucleotide signaling networks are key to facilitate alterations in gene expression, protein function, and enzyme activity in response to diverse stimuli. Cyclic di-adenosine monophosphate (c-di-AMP) is an important secondary messenger molecule produced by the human pathogen Staphylococcus aureus and is involved in regulating a number of physiological processes including potassium transport. S. aureus must ensure tight control over its cellular levels as both high levels of the dinucleotide and its absence result in a number of detrimental phenotypes. Here we show that in addition to the membrane-bound Asp-His-His and Asp-His-His-associated (DHH/DHHA1) domain-containing phosphodiesterase (PDE) GdpP, S. aureus produces a second cytoplasmic DHH/DHHA1 PDE Pde2. Although capable of hydrolyzing c-di-AMP, Pde2 preferentially converts linear 5'-phosphadenylyl-adenosine (pApA) to AMP. Using a pde2 mutant strain, pApA was detected for the first time in S. aureus, leading us to speculate that this dinucleotide may have a regulatory role under certain conditions. Moreover, pApA is involved in a feedback inhibition loop that limits GdpP-dependent c-di-AMP hydrolysis. Another protein linked to the regulation of c-di-AMP levels in bacteria is the predicted regulator protein YbbR. Here, it is shown that a ybbR mutant S. aureus strain has increased acid sensitivity that can be bypassed by the acquisition of mutations in a number of genes, including the gene coding for the diadenylate cyclase DacA. We further show that c-di-AMP levels are slightly elevated in the ybbR suppressor strains tested as compared with the wild-type strain. With this, we not only identified a new role for YbbR in acid stress resistance in S. aureus but also provide further insight into how c-di-AMP levels impact acid tolerance in this organism.	[Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Grundling, Angelika] Imperial Coll London, Microbiol Sect, Flowers Bldg,Rm 3-21, London SW7 2AZ, England; [Bowman, Lisa; Zeden, Merve S.; Schuster, Christopher F.; Grundling, Angelika] Imperial Coll London, Med Res Council Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-306625 Hannover, Germany	Imperial College London; Imperial College London; Hannover Medical School	Grundling, A (corresponding author), Imperial Coll London, Microbiol Sect, Flowers Bldg,Rm 3-21, London SW7 2AZ, England.	a.grundling@imperial.ac.uk	Zeden, Merve/GXF-9824-2022; Schuster, Christopher/J-9904-2015; Kaever, Volkhard/G-3280-2013	Schuster, Christopher/0000-0002-4566-7226; Zeden, Merve Suzan/0000-0003-3636-700X; Grundling, Angelika/0000-0002-6235-8687	Biotechnology and Biological Sciences Research Council [BB/L024209/1]; BBSRC [BB/L024209/1] Funding Source: UKRI; MRC [MR/J006874/1] Funding Source: UKRI; Medical Research Council [MR/J006874/1, MR/J006874/1B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Andrew Ulijasz for providing the S. pneumoniae D39 DNA and Thomas Bernhardt and Jackson Buss for help with the Illumina sequencing of the S. aureus LAC*Delta ybbR mutant and suppressor strains as well as help with the genome sequence analysis. The Illumina sequencing of the LAC* strain was performed by MicrobesNG, which is supported by the Biotechnology and Biological Sciences Research Council Grant BB/L024209/1). We also thank Sanika Hakim for optimization of bacterial growth conditions for MIC determinations, Charlie Millership for purification of the DisA<INF>BT</INF> protein, Mikaila Jayaweera Bandara for construction of the E. coli YbbR overexpression strain, and Annette Garbe for the nucleotide analysis by mass spectrometry. Finally, we thank Manal AbuQun for the phenotype microarray experiments of the LAC* and LAC*Delta ybbR strains on Biolog plates.	Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Barker JR, 2013, MBIO, V4, DOI 10.1128/mBio.00018-13; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Campeotto I, 2015, J BIOL CHEM, V290, P2888, DOI 10.1074/jbc.M114.621789; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chan KX, 2013, TRENDS PLANT SCI, V18, P18, DOI 10.1016/j.tplants.2012.07.005; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Cohen D, 2015, P NATL ACAD SCI USA, V112, P11359, DOI 10.1073/pnas.1421450112; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2015, J BIOL CHEM, V290, P5826, DOI 10.1074/jbc.M114.598300; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Glanzmann P, 1999, ANTIMICROB AGENTS CH, V43, P240, DOI 10.1128/AAC.43.2.240; Goldman SR, 2011, MOL CELL, V42, P817, DOI 10.1016/j.molcel.2011.06.005; Griffiths JM, 2012, ANTIMICROB AGENTS CH, V56, P579, DOI 10.1128/AAC.05148-11; Grundling A, 2007, J BACTERIOL, V189, P2521, DOI 10.1128/JB.01683-06; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Hauryliuk V, 2015, NAT REV MICROBIOL, V13, P298, DOI 10.1038/nrmicro3448; He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]; Heinrich J, 2008, MICROBIOL-SGM, V154, P1989, DOI 10.1099/mic.0.2008/018648-0; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Jolly L, 1997, J BACTERIOL, V179, P5321, DOI 10.1128/jb.179.17.5321-5325.1997; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kitko RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010078; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Kuipers K, 2016, MOL MICROBIOL, V101, P12, DOI 10.1111/mmi.13312; LEE CY, 1991, GENE, V103, P101, DOI 10.1016/0378-1119(91)90399-V; Leskela S, 1999, MOL MICROBIOL, V31, P533, DOI 10.1046/j.1365-2958.1999.01194.x; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mechold U, 2007, NUCLEIC ACIDS RES, V35, P4552, DOI 10.1093/nar/gkm462; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; MenginLecreulx D, 1996, J BIOL CHEM, V271, P32, DOI 10.1074/jbc.271.1.32; Monk IR, 2015, MBIO, V6, DOI 10.1128/mBio.00308-15; Monk IR, 2012, MBIO, V3, DOI 10.1128/mBio.00277-11; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; Moses S, 2012, J BACTERIOL, V194, P745, DOI 10.1128/JB.06380-11; Nickels BE, 2011, J MOL BIOL, V412, P772, DOI 10.1016/j.jmb.2011.06.015; Orr MW, 2015, P NATL ACAD SCI USA, V112, pE5048, DOI 10.1073/pnas.1507245112; Pilonieta MC, 2012, MOL MICROBIOL, V84, P296, DOI 10.1111/j.1365-2958.2012.08022.x; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Pozzi C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002626; Rallu F, 2000, MOL MICROBIOL, V35, P517, DOI 10.1046/j.1365-2958.2000.01711.x; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Rismondo J, 2016, J BACTERIOL, V198, P416, DOI 10.1128/JB.00845-15; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Schuster CF, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7279; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Huynh TN, 2016, MOL MICROBIOL, V102, P233, DOI 10.1111/mmi.13456; Huynh TN, 2016, CURR OPIN MICROBIOL, V30, P22, DOI 10.1016/j.mib.2015.12.007; Underwood AJ, 2014, J MICROBIOL METH, V107, P58, DOI 10.1016/j.mimet.2014.08.026; van Belkum A, 2009, INFECT GENET EVOL, V9, P32, DOI 10.1016/j.meegid.2008.09.012; Weinrick B, 2004, J BACTERIOL, V186, P8407, DOI 10.1128/JB.186.24.8407-8423.2004; Whiteley AT, 2015, CELL HOST MICROBE, V17, P788, DOI 10.1016/j.chom.2015.05.006; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14	67	53	57	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					26970	26986		10.1074/jbc.M116.747709	http://dx.doi.org/10.1074/jbc.M116.747709			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27834680	hybrid, Green Published			2022-12-26	WOS:000391576300003
J	Nigdelioglu, R; Hamanaka, RB; Meliton, AY; O'Leary, E; Witt, LJ; Cho, T; Sun, K; Bonham, C; Wu, D; Woods, PS; Husain, AN; Wolfgeher, D; Dulin, NO; Chandel, NS; Mutlu, GM				Nigdelioglu, Recep; Hamanaka, Robert B.; Meliton, Angelo Y.; O'Leary, Erin; Witt, Leah J.; Cho, Takugo; Sun, Kaitlyn; Bonham, Catherine; Wu, David; Woods, Parker S.; Husain, Aliya N.; Wolfgeher, Don; Dulin, Nickolai O.; Chandel, Navdeep S.; Mutlu, Gokhan M.			Transforming Growth Factor (TGF)-beta Promotes de Novo Serine Synthesis for Collagen Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOFIBROBLAST DIFFERENTIATION; PULMONARY; METABOLISM; MECHANISMS; INHIBITOR; SUPPORTS; FIBROSIS; GLYCINE	TGF-beta promotes excessive collagen deposition in fibrotic diseases such as idiopathic pulmonary fibrosis (IPF). The amino acid composition of collagen is unique due to its high (33%) glycine content. Here, we report that TGF-beta induces expression of glycolytic genes and increases glycolytic flux. TGF-beta also induces the expression of the enzymes of the de novo serine synthesis pathway (phosphoglycerate dehydrogenase (PHGDH), phosphoserine aminotransferase 1 (PSAT1), and phosphoserine phosphatase (PSPH)) and de novo glycine synthesis (serine hydroxymethyltransferase 2 (SHMT2)). Studies in fibroblasts with genetic attenuation of PHGDH or SHMT2 and pharmacologic inhibition of PHGDH showed that these enzymes are required for collagen synthesis. Furthermore, metabolic labeling experiments demonstrated carbon from glucose incorporated into collagen. Lungs from humans with IPF demonstrated increased expression of PHGDH and SHMT2. These results indicate that the de novo serine synthesis pathway is necessary for TGF-beta induced collagen production and suggest that this pathway may be a therapeutic target for treatment of fibrotic diseases including IPF.	[Nigdelioglu, Recep; Hamanaka, Robert B.; Meliton, Angelo Y.; O'Leary, Erin; Witt, Leah J.; Cho, Takugo; Sun, Kaitlyn; Bonham, Catherine; Wu, David; Woods, Parker S.; Dulin, Nickolai O.; Mutlu, Gokhan M.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Husain, Aliya N.] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Wolfgeher, Don] Univ Chicago, Prote Core Facil, Chicago, IL 60637 USA; [Chandel, Navdeep S.] Northeastern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	University of Chicago; University of Chicago; University of Chicago	Mutlu, GM (corresponding author), Univ Chicago, Sect Pulm & Crit Care Med, 5841 S Maryland Ave,MC6026, Chicago, IL 60637 USA.	gmutlu@medicine.bsd.uchicago.edu	Mutlu, Gokhan/HIR-2545-2022	Bonham, Catherine/0000-0001-9132-4083; Wu, David/0000-0003-3162-3238; O'Leary, Erin/0000-0003-2220-2757	National Institutes of Health [R01 ES015024, R21 ES025644, K01 AR066579, R56 HL127395, F32 HL134288]; American Heart Association [15POST255900003]; NATIONAL CANCER INSTITUTE [T32CA070085, P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL119995, R56HL127395, F32HL134288] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR066579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES025644, R01ES015024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES015024 and R21 ES025644 (to G. M. M.), K01 AR066579 (to R. B. H.), R56 HL127395 (to N. O. D.), and F32 HL134288 (to D. Wu) and American Heart Association Grant 15POST255900003 (to R. N.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Bernard K, 2015, J BIOL CHEM, V290, P25427, DOI 10.1074/jbc.M115.646984; Budinger GRS, 2006, P NATL ACAD SCI USA, V103, P4604, DOI 10.1073/pnas.0507604103; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Ducker GS, 2016, CELL METAB, V24, P640, DOI 10.1016/j.cmet.2016.09.011; FULMER JD, 1980, AM REV RESPIR DIS, V122, P289; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; La J, 2016, AM J PHYSIOL-LUNG C, V310, pL815, DOI 10.1152/ajplung.00322.2015; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; Maddocks ODK, 2016, MOL CELL, V61, P210, DOI 10.1016/j.molcel.2015.12.014; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mullarky E, 2016, P NATL ACAD SCI USA, V113, P1778, DOI 10.1073/pnas.1521548113; Mutlu GM, 2012, THORAX, V67, P139, DOI 10.1136/thoraxjnl-2011-200717; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rockey DC, 2015, NEW ENGL J MED, V373, P96, DOI 10.1056/NEJMc1504848; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Zeisberg M, 2013, AM J PHYSIOL-CELL PH, V304, pC216, DOI 10.1152/ajpcell.00328.2012	27	69	72	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27239	27251		10.1074/jbc.M116.756247	http://dx.doi.org/10.1074/jbc.M116.756247			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836973	hybrid, Green Published			2022-12-26	WOS:000391576300022
J	Lagerlof, JH; Bernhardt, P				Lagerlof, Jakob H.; Bernhardt, Peter			Oxygen Distributions-Evaluation of Computational Methods, Using a Stochastic Model for Large Tumour Vasculature, to Elucidate the Importance of Considering a Complete Vascular Network	PLOS ONE			English	Article							SIMULATION; HYPOXIA; TISSUE; TRANSPORT; CANCER	Purpose To develop a general model that utilises a stochastic method to generate a vessel tree based on experimental data, and an associated irregular, macroscopic tumour. These will be used to evaluate two different methods for computing oxygen distribution. Methods A vessel tree structure, and an associated tumour of 127 cm(3), were generated, using a stochastic method and Bresenham's line algorithm to develop trees on two different scales and fusing them together. The vessel dimensions were adjusted through convolution and thresholding and each vessel voxel was assigned an oxygen value. Diffusion and consumption were modelled using a Green's function approach together with Michaelis-Menten kinetics. The computations were performed using a combined tree method (CTM) and an individual tree method (ITM). Five tumour sub-sections were compared, to evaluate the methods. Results The oxygen distributions of the same tissue samples, using different methods of computation, were considerably less similar (root mean square deviation, RMSD approximate to 0.02) than the distributions of different samples using CTM (0.001< RMSD<0.01). The deviations of ITM from CTM increase with lower oxygen values, resulting in ITM severely underestimating the level of hypoxia in the tumour. Kolmogorov Smirnov (KS) tests showed that millimetre-scale samples may not represent the whole. Conclusions The stochastic model managed to capture the heterogeneous nature of hypoxic fractions and, even though the simplified computation did not considerably alter the oxygen distribution, it leads to an evident underestimation of tumour hypoxia, and thereby radioresistance. For a trustworthy computation of tumour oxygenation, the interaction between adjacent microvessel trees must not be neglected, why evaluation should be made using high resolution and the CTM, applied to the entire tumour.	[Lagerlof, Jakob H.; Bernhardt, Peter] Univ Gothenburg, Dept Radiat Phys, Gothenburg, Sweden	University of Gothenburg	Lagerlof, JH (corresponding author), Univ Gothenburg, Dept Radiat Phys, Gothenburg, Sweden.	jakob@radfys.gu.se	Lagerlöf, Jakob/AAZ-3483-2020	Lagerlöf, Jakob/0000-0001-6389-7773	Swedish National Cancer Society; Swedish radiation safety authority; King Gustaf V Jubilee Clinic Cancer Research Foundation	Swedish National Cancer Society; Swedish radiation safety authority; King Gustaf V Jubilee Clinic Cancer Research Foundation	This work was supported by grants from the Swedish National Cancer Society (https://www.cancerforden.se/), Swedish radiation safety authority (http//www.stralsakerhetsmyndigheten.se/Forsknuig/), and King Gustaf V Jubilee Clinic Cancer Research Foundation (http://www.rahfo.se/Om-oss/Konung-Gustaf-Vs-Jubileumsford/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikarla V, 2012, PHYS MED BIOL, V57, P6103, DOI 10.1088/0031-9155/57/19/6103; BRESENHAM JE, 1965, IBM SYST J, V4, P25, DOI 10.1147/sj.41.0025; Brizel DM, 1996, CANCER RES, V56, P941; Dasu A, 2003, PHYS MED BIOL, V48, P2829, DOI 10.1088/0031-9155/48/17/307; Debbaut C, 2014, J ANAT, V224, P509, DOI 10.1111/joa.12156; Den Buijs JO, 2006, ANN BIOMED ENG, V34, P1420, DOI 10.1007/s10439-006-9150-4; Espinoza I, 2013, MED PHYS, V40, DOI 10.1118/1.4812431; Gaussian T., 2003, FRONT END VISION MUL, P37, DOI 10.1007/978-1-4020-8840-7_3; Guyton AC., 2006, TXB MED PHYSL, V11th Ed.; Harting C, 2007, PHYS MED BIOL, V52, P4775, DOI 10.1088/0031-9155/52/16/005; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Hockel M, 1996, CANCER RES, V56, P4509; Klabunde R, 2011, CARDIOVASCULAR PHYSL; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Lagerlof J, 2014, TUMOUR VASCULATURE O; Lagerlof JH, 2014, MED PHYS, V41, DOI 10.1118/1.4866887; Lagerlof JH, 2013, MED PHYS, V40, DOI 10.1118/1.4773886; Lagerlof JH, 2011, MED PHYS, V38, P4888, DOI 10.1118/1.3615164; Lee CT, 2014, ANTIOXID REDOX SIGN, V21, P313, DOI 10.1089/ars.2013.5759; Peplow DE, 1999, NUCL SCI ENG, V131, P132, DOI 10.13182/NSE99-A2024; Pittman RN, 2013, MICROCIRCULATION, V20, P117, DOI 10.1111/micc.12017; SECOMB TW, 1993, INT J RADIAT ONCOL, V25, P481, DOI 10.1016/0360-3016(93)90070-C; Varlotto J, 2005, INT J RADIAT ONCOL, V63, P25, DOI 10.1016/j.ijrobp.2005.04.049; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009	25	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166251	10.1371/journal.pone.0166251	http://dx.doi.org/10.1371/journal.pone.0166251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861529	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300039
J	Palocz, O; Paszti-Gere, E; Galfi, P; Farkas, O				Palocz, Orsolya; Paszti-Gere, Erzsebet; Galfi, Peter; Farkas, Orsolya			Chlorogenic Acid Combined with Lactobacillus plantarum 2142 Reduced LPS-Induced Intestinal Inflammation and Oxidative Stress in IPEC-J2 Cells	PLOS ONE			English	Article							IN-VITRO; EXPRESSION; IL-8; ASSAY; LINE	This study was carried out to investigate protective effect of chlorogenic acid against lipopolysaccharide-induced inflammation and oxidative stress in intestinal epithelial cells. As a marker of inflammatory response, IL-6, IL-8, TNF-alpha mRNA and protein levels, furthermore, COX-2 mRNA level were followed up. Intracellular redox status and extracellular H2O2 level were also monitored by two fluorescent assays (DCFH-DA, Amplex Red). Moreover, the effect of gut microbiota metabolites in the above mentioned processes was taken into account in our model using Lactobacillus plantarum 2142 bacterial strain. Our data revealed that chlorogenic acid had significant lowering effect on the inflammatory response. Treatment with chlorogenic acid (25-50 mu M) significantly decreased gene expression and concentration of proinflammatory cytokines IL-6 and IL-8 compared to LPS-treated cells. COX-2 and TNF-a mRNA levels were also reduced. Furthermore, chlorogenic acid reduced the level of reactive oxygen species in IPEC-J2 cells. Simultaneous application of chlorogenic acid and Lactobacillus plantarum 2142 supernatant resulted protective effect against LPS-induced inflammation and oxidative stress as well.	[Palocz, Orsolya; Paszti-Gere, Erzsebet; Galfi, Peter; Farkas, Orsolya] Univ Vet Med, Dept Pharmacol & Toxicol, Budapest, Hungary	University of Veterinary Medicine Budapest	Farkas, O (corresponding author), Univ Vet Med, Dept Pharmacol & Toxicol, Budapest, Hungary.	farkas.orsolya@aotk.szie.hu	Palócz, Orsolya/J-4116-2017	Palócz, Orsolya/0000-0003-3925-8773; Farkas, Orsolya/0000-0002-0828-7902	Hungarian Scientific Research Fund [105718]; Hungarian Ministry of Human Resources [11475-4/2016/FEKUT]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Ministry of Human Resources	The research described here was supported by the Hungarian Scientific Research Fund (OTKA 105718) and the 11475-4/2016/FEKUT grant of the Hungarian Ministry of Human Resources.; The research described here was supported by the Hungarian Scientific Research Fund (OTKA 105718) and the 11475-4/2016/FEKUT grant of the Hungarian Ministry of Human Resources. We are indebted to Dr. Jody Gookin (Department of Clinical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, NC, USA) for providing the IPEC-J2 cells. The excellent assistance of Andrea Anna Szabo (Faculty of Veterinary Science, Szent Istvan University, Budapest, Hungary) is also gratefully acknowledged.	Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI [10.1002/(SICI)1097-0010(19990301)79:3&lt;362::AID-JSFA256&gt;3.0.CO;2-D, 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D]; de Magalhaes PM, 2012, FOOD CHEM, V134, P864, DOI 10.1016/j.foodchem.2012.02.195; Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042; Farkas O, 2014, J ANIM SCI, V92, P3835, DOI 10.2527/jas.2013-7453; Farkas O, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/673847; Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077; Frontela C, 2011, J SCI FOOD AGR, V91, P286, DOI 10.1002/jsfa.4183; Gao RF, 2014, EUR J PHARMACOL, V729, P54, DOI 10.1016/j.ejphar.2014.01.015; Garbetta A, 2014, J FUNCT FOODS, V10, P456, DOI 10.1016/j.jff.2014.07.019; Gonthier MP, 2003, J NUTR, V133, P1853, DOI 10.1093/jn/133.6.1853; Haller D, 2000, GUT, V47, P79, DOI 10.1136/gut.47.1.79; Hwang SJ, 2014, INFLAMM RES, V63, P81, DOI 10.1007/s00011-013-0674-4; Hyland KA, 2006, VET IMMUNOL IMMUNOP, V109, P1, DOI 10.1016/j.vetimm.2005.06.016; Langerholc T, 2011, TRENDS FOOD SCI TECH, V22, pS11, DOI 10.1016/j.tifs.2011.03.010; Lopez-Nicolas R, 2014, FOOD CHEM, V157, P14, DOI 10.1016/j.foodchem.2014.01.126; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Mohanty JG, 1997, J IMMUNOL METHODS, V202, P133, DOI 10.1016/S0022-1759(96)00244-X; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Paszti-Gere E, 2012, INFLAMMATION, V35, P1487, DOI 10.1007/s10753-012-9462-5; Paszti-Gere E, 2012, INFLAMMATION, V35, P994, DOI 10.1007/s10753-011-9403-8; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Repetto G, 2008, NAT PROTOC, V3, P1125, DOI 10.1038/nprot.2008.75; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Sakumoto R, 2006, DOMEST ANIM ENDOCRIN, V31, P246, DOI 10.1016/j.domaniend.2005.11.001; Sato Y, 2011, INT J PHARMACEUT, V403, P136, DOI 10.1016/j.ijpharm.2010.09.035; Schierack P, 2006, HISTOCHEM CELL BIOL, V125, P293, DOI 10.1007/s00418-005-0067-z; Sergent T, 2010, CHEM-BIOL INTERACT, V188, P659, DOI 10.1016/j.cbi.2010.08.007; Shan JH, 2009, INT IMMUNOPHARMACOL, V9, P1042, DOI 10.1016/j.intimp.2009.04.011; Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100; Soh N, 2006, ANAL BIOANAL CHEM, V386, P532, DOI 10.1007/s00216-006-0366-9; Sonier B, 2009, INT REV IMMUNOL, V28, P414, DOI 10.3109/08830180903208329; Tsai CM, 2013, MOL PHARMACEUT, V10, P1890, DOI 10.1021/mp3006648; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Wang DZ, 2009, CURR OPIN PHARMACOL, V9, P688, DOI 10.1016/j.coph.2009.08.003; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Xu YX, 2010, INFLAMM RES, V59, P871, DOI 10.1007/s00011-010-0199-z	36	60	63	7	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166642	10.1371/journal.pone.0166642	http://dx.doi.org/10.1371/journal.pone.0166642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861533	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300082
J	Garcia, ES; Swann, ALS; Villegas, JC; Breshears, DD; Law, DJ; Saleska, SR; Stark, SC				Garcia, Elizabeth S.; Swann, Abigail L. S.; Villegas, Juan C.; Breshears, David D.; Law, Darin J.; Saleska, Scott R.; Stark, Scott C.			Synergistic Ecoclimate Teleconnections from Forest Loss in Different Regions Structure Global Ecological Responses	PLOS ONE			English	Article							SCALE DEFORESTATION; BOREAL FOREST; CLIMATE; VEGETATION; DROUGHT; IMPACT; FEEDBACKS; DYNAMICS; MONSOON; FLUXES	Forest loss in hotspots around the world impacts not only local climate where loss occurs, but also influences climate and vegetation in remote parts of the globe through ecoclimate teleconnections. The magnitude and mechanism of remote impacts likely depends on the location and distribution of forest loss hotspots, but the nature of these dependencies has not been investigated. We use global climate model simulations to estimate the distribution of ecologically-relevant climate changes resulting from forest loss in two hotspot regions: western North America (wNA), which is experiencing accelerated dieoff, and the Amazon basin, which is subject to high rates of deforestation. The remote climatic and ecological net effects of simultaneous forest loss in both regions differed from the combined effects of loss from the two regions simulated separately, as evident in three impacted areas. Eastern South American Gross Primary Productivity (GPP) increased due to changes in seasonal rainfall associated with Amazon forest loss and changes in temperature related to wNA forest loss. Eurasia's GPP declined with wNA forest loss due to cooling temperatures increasing soil ice volume. Southeastern North American productivity increased with simultaneous forest loss, but declined with only wNA forest loss due to changes in VPD. Our results illustrate the need for a new generation of local-to-global scale analyses to identify potential ecoclimate teleconnections, their underlying mechanisms, and most importantly, their synergistic interactions, to predict the responses to increasing forest loss under future land use change and climate change.	[Garcia, Elizabeth S.; Swann, Abigail L. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Swann, Abigail L. S.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Villegas, Juan C.] Univ Antioquia, Escuela Ambiental, Calle 67 53-108, Medellin, Colombia; [Villegas, Juan C.; Breshears, David D.; Law, Darin J.] Univ Arizona, Sch Nat Resources & Environm, ENRII, 1064 E Lowell St,N227, Tucson, AZ 85721 USA; [Breshears, David D.; Saleska, Scott R.] Univ Arizona, Dept Ecol & Evolutionary Biol, 1064 E Lowell St,N227, Tucson, AZ 85721 USA; [Stark, Scott C.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universidad de Antioquia; University of Arizona; University of Arizona; Michigan State University	Garcia, ES (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	esgarcia@uw.edu	Breshears, David D/GSN-3920-2022; Breshears, David D./B-9318-2009; Saleska, Scott R/K-1733-2016	Breshears, David D./0000-0001-6601-0058; Saleska, Scott R/0000-0002-4974-3628; Stark, Scott C/0000-0002-1579-1648; Villegas, Juan Camilo/0000-0001-5048-921X; Swann, Abigail/0000-0001-8513-1074	National Science Foundation [EF-1340649, EF-1340624, EF-1340604, EF-1550641, EF-1550686, EF-1550756]; Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; Estrategia de Sostenibilidad at the Universidad de Antioquia; Direct For Biological Sciences [1340649] Funding Source: National Science Foundation; Division Of Environmental Biology [1550686, 1340624] Funding Source: National Science Foundation; Emerging Frontiers [1550641] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona; Estrategia de Sostenibilidad at the Universidad de Antioquia; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported primarily through the National Science Foundation EF-1340649 to the University of Washington, EF-1340624 to the University of Arizona, and EF-1340604 to Michigan State University (www.nsf.gov). Additional support was provided through the National Science foundation EF-1550641 to the University of Washington, EF-1550686 to Michigan State University, EF-1550756 to the University of Arizona, to S.R.S. by the Agnese Nelms Haury Program in Environment and Social Justice at the University of Arizona (haury.arizona.edu), and to J.C.V. by the Estrategia de Sostenibilidad 2014-2015 at the Universidad de Antioquia (http./Avww.udea.edu.co/). The Community Earth System Model project is supported by the National Science Foundation and the Office of Science (BER) of the U.S. Department of Energy. Computing resources were provided by the Climate Simulation Laboratory at National Center for Atmospheric Research's Computational and Information Systems Laboratory, sponsored by the National Science Foundation and other agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkama R, 2016, SCIENCE, V351, P600, DOI 10.1126/science.aac8083; Allen CD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00203.1; Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Asner GP, 2016, P NATL ACAD SCI USA, V113, pE249, DOI 10.1073/pnas.1523397113; Avissar R, 2005, J HYDROMETEOROL, V6, P134, DOI 10.1175/JHM406.1; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Betts R, 2008, PHILOS T R SOC B, V363, P1873, DOI 10.1098/rstb.2007.0027; BONAN GB, 1992, NATURE, V359, P716, DOI 10.1038/359716a0; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Cayan DR, 2001, B AM METEOROL SOC, V82, P399, DOI 10.1175/1520-0477(2001)082<0399:CITOOS>2.3.CO;2; Chen GS, 2012, J CLIMATE, V25, P4511, DOI 10.1175/JCLI-D-11-00317.1; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Cohen J, 1999, GEOPHYS RES LETT, V26, P345, DOI 10.1029/1998GL900321; COLLATZ GJ, 1991, AGR FOREST METEOROL, V54, P107, DOI 10.1016/0168-1923(91)90002-8; Davin EL, 2010, J CLIMATE, V23, P97, DOI 10.1175/2009JCLI3102.1; Devaraju N, 2015, P NATL ACAD SCI USA, V112, P3257, DOI 10.1073/pnas.1423439112; DICKINSON RE, 1992, GEOPHYS RES LETT, V19, P1947, DOI 10.1029/92GL01905; Donohoe A, 2014, P NATL ACAD SCI USA, V111, P16700, DOI 10.1073/pnas.1412190111; Doughty CE, 2015, NATURE, V519, P78, DOI 10.1038/nature14213; Fisher RA, 2015, GEOSCI MODEL DEV, V8, P3593, DOI 10.5194/gmd-8-3593-2015; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; Frierson DMW, 2012, J CLIMATE, V25, P720, DOI 10.1175/JCLI-D-11-00116.1; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Hartmann D. L., 1994, GLOBAL PHYS CLIMATOL; Hunke EC, 2012, CICE LOS ALAMOS SEA; Koven CD, 2015, P NATL ACAD SCI USA, V112, P3752, DOI 10.1073/pnas.1415123112; Lawrence, 2013, TECHNICAL DESCRIPTIO, P434, DOI DOI 10.5065/D6RR1W7M; Ma D, 2013, CLIM DYNAM, V41, P2439, DOI 10.1007/s00382-012-1592-9; McCarthy MP, 2012, EARTH SYST DYNAM, V3, P87, DOI 10.5194/esd-3-87-2012; McDowell NG, 2016, NAT CLIM CHANGE, V6, P295, DOI [10.1038/nclimate2873, 10.1038/NCLIMATE2873]; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Medvigy D, 2013, J CLIMATE, V26, P9115, DOI 10.1175/JCLI-D-12-00775.1; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Neale R.B, 2012, TN486STR NCAR; Nepstad D, 2002, SCIENCE, V295, P629, DOI 10.1126/science.1067053; Notaro M, 2007, J CLIMATE, V20, P981, DOI 10.1175/JCLI4052.1; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Soares BS, 2006, NATURE, V440, P520, DOI 10.1038/nature04389; Soja AJ, 2007, GLOBAL PLANET CHANGE, V56, P274, DOI 10.1016/j.gloplacha.2006.07.028; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stark SC, 2016, LANDSCAPE ECOL, V31, P181, DOI 10.1007/s10980-015-0282-5; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Swann ALS, 2014, J CLIMATE, V27, P4857, DOI 10.1175/JCLI-D-13-00690.1; Swann ALS, 2012, P NATL ACAD SCI USA, V109, P712, DOI 10.1073/pnas.1116706108; Trumbore S, 2015, SCIENCE, V349, P814, DOI 10.1126/science.aac6759; United Nations, 2016, C PART ITS 21 SESS H; Voigt A, 2014, J CLIMATE, V27, P1029, DOI 10.1175/JCLI-D-13-00205.1	48	31	31	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165042	10.1371/journal.pone.0165042	http://dx.doi.org/10.1371/journal.pone.0165042			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851740	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300008
J	Grider, JF; Larsen, AL; Homyack, JA; Kalcounis-Rueppell, MC				Grider, John F.; Larsen, Angela L.; Homyack, Jessica A.; Kalcounis-Rueppell, Matina C.			Winter Activity of Coastal Plain Populations of Bat Species Affected by White-Nose Syndrome and Wind Energy Facilities	PLOS ONE			English	Article							GREAT DISMAL SWAMP; LASIURUS-BOREALIS; NORTH-CAROLINA; VIRGINIA; BEHAVIOR; AMERICA; DISEASE; FOREST	Across the entire distribution of a species, populations may have variable responses to environmental perturbations. Many bat species experience mortality in large portions of their range during hibernation and along migratory paths to and from wintering grounds, from White-nose syndrome (WNS) and wind energy development, respectively. In some areas, warm temperatures may allow bats to remain active through winter, thus decreasing their susceptibility to WNS and/or mortality associated with migration to wintering grounds. These areas could act as a refugia and be important for the persistence of local populations. To determine if warmer temperatures affect bat activity, we compared year-round activity of bat populations in the Coastal Plain and Piedmont of North Carolina, USA, two regions that differ in winter temperature. We established six recording stations, four along a 295-kilometer north-south transect in the Coastal Plain, and two in the Piedmont of North Carolina. We recorded bat activity over two years. We supplemented our recordings with mist-net data. Although bat activity was lower during winter at all sites, the odds of recording a bat during winter were higher at Coastal Plain sites when compared with Piedmont sites. Further, bats in the Piedmont had a lower level of winter activity compared to summer activity than bats in the Coastal Plain that had more similar levels of activity in the winter and summer. We found high bat species richness on the Coastal Plain in winter, with winter-active species including those known to hibernate throughout most of their range and others known to be long distance migrants. In particular, two species impacted by WNS, the northern long-eared bat (Myotis septentrionalis) and tricolored bat (Perimyotis subflavus), were present year round in the Coastal Plain. The tricolored bat was also present year-round in the Piedmont. In the Coastal Plain, the long distance migratory hoary bat (Lasiurus cinereus) was active in the winter but not present during the other seasons, and the long distance migratory silver-haired bat (Lasionycteris noctivagans) was active primarily in the winter, suggesting the Coastal Plain may be an overwintering ground for these two species. We suggest that the winter activity exhibited by populations of bats on the North Carolina Coastal Plain has important conservation implications and these populations should be carefully monitored and afforded protection.	[Grider, John F.] Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Grider, John F.; Larsen, Angela L.; Kalcounis-Rueppell, Matina C.] Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27402 USA; [Homyack, Jessica A.] Weyerhaeuser Co, 505 North Pearl St, Centralia, WA 98531 USA	University System of Georgia; University of Georgia; University of North Carolina; University of North Carolina Greensboro	Grider, JF (corresponding author), Univ Georgia, Warne Sch Forestry & Nat Resources, Athens, GA 30602 USA.; Grider, JF (corresponding author), Univ North Carolina Greensboro, Dept Biol, Greensboro, NC 27402 USA.	john.grider26@uga.edu		Grider, John/0000-0002-0268-8772; Larsen-Gray, Angela/0000-0002-7222-4201	North Carolina Wildlife Resources Commission [WM-0229]; University of North Carolina at Greensboro; North Carolina Wildlife Resources Commission; Southeastern Bat Diversity Network; University of North Carolina at Greensboro Biology Department	North Carolina Wildlife Resources Commission; University of North Carolina at Greensboro; North Carolina Wildlife Resources Commission; Southeastern Bat Diversity Network; University of North Carolina at Greensboro Biology Department	This study was primarily funded by the North Carolina Wildlife Resources Commission (Grant Number WM-0229). Supplemental funding came through small grants from the University of North Carolina at Greensboro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Weyerhaeuser provided access and logistical support to collect empirical data and provided support in the form of salary for our middle author, Jessica Homyack. Weyerhaeuser did not, however, have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are articulated in the 'author contributions' section.; The North Carolina Wildlife Resources Commission, Southeastern Bat Diversity Network and University of North Carolina at Greensboro Biology Department provided funding. A. Matteson and H. Li assisted with figures. Appreciation to K. Caldwell, K. King, C. Redd, U. Moura and C. Anderson for help in the field and M. Smith, C. Anderson, J. Anderson, L. Pittaway, L. Randall, J. Cash, B. Khan, L. Cooper, C. Anderson, T. Heckman, and K. Corson for help in the lab. C. Tyson, G. Ridgeway, D. Davis, J. Bland, V. French, D. Allen, E. Beverly, and G. Queen facilitated field logistics. We would like to thank M.K. Clark and D. Lee for access to and help with the South River site. S. Faeth and two amazing and dedicated anonymous reviewers improved earlier versions of this manuscript.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; [Anonymous], 2005, N CAR 50M WIND RES M; [Anonymous], 2016, N CAR TURB MAP; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; Arnett Edward B., 2013, P435; AVERY MI, 1985, J ANIM ECOL, V54, P721, DOI 10.2307/4374; Baerwald EF, 2009, J MAMMAL, V90, P1341, DOI 10.1644/09-MAMM-S-104R.1; Berner EK, 1995, GLOBAL ENV WATER AIR; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Bolker B., 2012, GETTING STARTED GLMM; Caceres MC, 2000, MAMM SPECIES; CHAHINE MT, 1992, NATURE, V359, P373, DOI 10.1038/359373a0; Cryan PM, 2014, P NATL ACAD SCI USA, V111, P15126, DOI 10.1073/pnas.1406672111; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Fleming TH, 2003, BAT ECOLOGY, P156; Foufopoulos J, 1999, AM NAT, V153, P1, DOI 10.1086/303149; Fournier DA, 2012, OPTIM METHOD SOFTW, V27, P233, DOI 10.1080/10556788.2011.597854; Fraser EE, 2012, PLOS ONE, P7; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Furmankiewicz J, 2009, J MAMMAL, V90, P1310, DOI 10.1644/09-MAMM-S-099R1.1; Giraudoux P., 2015, PACKAGE PGIRMESS DAT; Griffin D. R., 1960, Animal Behaviour, V8, P141, DOI 10.1016/0003-3472(60)90022-1; Hayes JP, 1997, J MAMMAL, V78, P514, DOI 10.2307/1382902; Johnson JB, 2011, ENVIRON MONIT ASSESS, V173, P685, DOI 10.1007/s10661-010-1415-6; Kalcounis MC, 1999, J MAMMAL, V80, P673, DOI 10.2307/1383311; Kunz T.H., 1988, P1; KUNZ TH, 1973, J MAMMAL, V54, P14, DOI 10.2307/1378869; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Kurta A, 1995, BATS FORESTS S, P102; Lacki M.J., 2007, BATS IN FORESTS; Lacki MJ, 1984, OHIO J SCI, P84; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Maher SP, 2012, NAT COMMUN, P3; Morris AD, 2010, J WILDLIFE MANAGE, V74, P26, DOI 10.2193/2008-471; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; PADGETT TM, 1991, BRIMLEYANA, P17; R Core Team, 2016, LANG ENV STAT COMP; Reed DH, 2003, BIOL CONSERV, V113, P23, DOI 10.1016/S0006-3207(02)00346-4; Reeder DM, 2012, PLOS ONE, P7; Reichard JD, 2009, ACTA CHIROPTEROL, V11, P457, DOI 10.3161/150811009X485684; RICE DALE W., 1957, JOUR MAMMAL, V38, P15, DOI 10.2307/1376471; ROWLEY WA, 1968, J INSECT PHYSIOL, V14, P1251, DOI 10.1016/0022-1910(68)90018-8; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Sinclair ARE, 2006, WILDLIFE ECOLOGY CON; Skaug H. J., 2014, GEN LINEAR MIXED MOD; Speakman JR, 2003, BAT ECOLOGY, P430; Taylor PD, 2011, PROPERTY RIGHTS AND, P6; U.S. Fish and Wildlife Service, 2014, WHIT NOS SYNDR DEV D; Warnecke L, 2013, ECOL LETT; Whitaker JO, 1997, AM MIDL NAT, V137, P408, DOI 10.2307/2426862	50	22	23	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166512	10.1371/journal.pone.0166512	http://dx.doi.org/10.1371/journal.pone.0166512			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851832	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300058
J	Chen, C; Geng, ZM; Shen, HX; Song, HW; Zhao, YL; Zhang, GJ; Li, WZ; Ma, L; Wang, L				Chen, Chen; Geng, Zhimin; Shen, Haoxin; Song, Huwei; Zhao, Yaling; Zhang, Guanjun; Li, Wenzhi; Ma, Li; Wang, Lin			Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage	PLOS ONE			English	Article							LYMPH-NODE INVOLVEMENT; SURGICAL RESECTION; BILE-DUCT; AGGRESSIVE SURGERY; ADVANCED-CARCINOMA; RADICAL SURGERY; JAUNDICE; MANAGEMENT; SURVIVAL; IMPACT	Background Radical resection is an effective therapeutic method to increase the survival rate of patients with gallbladder cancer (GBC). In addition to the surgical approach, the relationships between various clinicopathologic factors and the outcome of patients with GBC remain controversial. Methods Clinical and laboratory examination characteristics, pathological and surgical data, and post-operative survival time of 338 patients with advanced GBC who received treatment at the First Affiliated Hospital of Xi'an Jiaotong University, China from January 2008 to December 2012 were analyzed retrospectively. Factors influencing the prognosis of GBC after surgery were analyzed by univariate and multivariate analysis. Results The overall survival rates for curative resection patients were significantly greater than those for non-curative resection patients (1-, 3-, 5-year survival rate and mean-survival time: 59.0%, 47.3%, 44.3% and 22.0 months vs. 12.7%, 8.3%, 7.7% and 3.0 months) (P < 0.001). For the curative resection patients, positive margin, lymph node metastasis, poorly pathological differentiation and the presence of ascites were all independent risk factors for poor prognosis. For patients with T3 stage, neither segmentectomy of IVb and V nor common bile duct resection improved the prognosis (P = 0.867 and P = 0.948). For patients with T4 stage, aggressive curative resection improved the prognosis (P = 0.007). Conclusions An advanced T stage does not preclude curative resection. Positive margin, lymph node metastasis, poorly pathological differentiation and the presence of ascites are all independent risk factors for poor prognosis in the curative intent resection patients. The range of liver resection and whether common bile duct resection is performed do not influence the prognosis as long as R0 resection is achieved.	[Chen, Chen; Geng, Zhimin; Shen, Haoxin; Song, Huwei; Li, Wenzhi; Ma, Li; Wang, Lin] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China; [Zhao, Yaling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Xian, Shaanxi, Peoples R China; [Zhang, Guanjun] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Pathol, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, L (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China.	jiaodawanglin@163.com			National Natural Science Foundation of China [81572420]; Key Science and Technology Program of Shaanxi Province [2014K11-03-03-12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Program of Shaanxi Province	This work was supported by National Natural Science Foundation of China (81572420, ZG) and Key Science and Technology Program of Shaanxi Province (2014K11-03-03-12, LW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal AK, 2007, J GASTROINTEST SURG, V11, P1722, DOI 10.1007/s11605-007-0320-y; Akyurek N, 2004, J HEPATO-BILIARY-PAN, V11, P357, DOI 10.1007/s00534-004-0910-y; Aloia TA, 2015, HPB, V17, P681, DOI 10.1111/hpb.12444; Andren-Sandberg A, 2014, CURR OPIN GASTROEN, V30, P326, DOI 10.1097/MOG.0000000000000068; Araida T, 2009, J HEPATO-BILIARY-PAN, V16, P204, DOI 10.1007/s00534-009-0044-3; Birnbaum DJ, 2014, EJSO-EUR J SURG ONC, V40, P1008, DOI 10.1016/j.ejso.2013.10.014; Birnbaum DJ, 2015, ANN SURG ONCOL, V22, P811, DOI 10.1245/s10434-014-4044-4; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chan KM, 2006, SURG ENDOSC, V20, P1867, DOI 10.1007/s00464-005-0195-5; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gani F, 2016, J SURG ONCOL, V114, P176, DOI 10.1002/jso.24283; Gourgiotis S, 2008, AM J SURG, V196, P252, DOI 10.1016/j.amjsurg.2007.11.011; Hawkins WG, 2004, ANN SURG ONCOL, V11, P310, DOI 10.1245/ASO.2004.03.011; Higuchi R, 2014, ANN SURG ONCOL, V21, P4308, DOI 10.1245/s10434-014-3885-1; Hirono S, 2006, WORLD J SURG, V30, P567, DOI 10.1007/s00268-005-0380-7; Hundal R, 2014, CLIN EPIDEMIOL, V6, P99, DOI 10.2147/CLEP.S37357; Kai M, 2007, J GASTROINTEST SURG, V11, P1025, DOI 10.1007/s11605-007-0181-4; Kim Y, 2016, ANN SURG ONCOL, V23, P2998, DOI 10.1245/s10434-016-5262-8; Koerkamp BG, 2014, J SURG ONCOL, V110, P585, DOI 10.1002/jso.23762; Kondo S, 2000, BRIT J SURG, V87, P418, DOI 10.1046/j.1365-2168.2000.01384.x; Kondo S, 2001, J Hepatobiliary Pancreat Surg, V8, P511, DOI 10.1007/s005340100018; Lee SE, 2014, J KOREAN MED SCI, V29, P1333, DOI 10.3346/jkms.2014.29.10.1333; Lim CS, 2012, J GASTROINTEST SURG, V16, P1012, DOI 10.1007/s11605-012-1826-5; Lim H, 2013, J CLIN GASTROENTEROL, V47, P443, DOI 10.1097/MCG.0b013e3182703409; Liu BZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157401; Ma N, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1617-y; Mekeel KL, 2007, J GASTROINTEST SURG, V11, P1188, DOI 10.1007/s11605-007-0115-1; Miller G, 2008, EJSO-EUR J SURG ONC, V34, P306, DOI 10.1016/j.ejso.2007.07.206; Misra S, 2003, LANCET ONCOL, V4, P167, DOI 10.1016/S1470-2045(03)01021-0; Miyazaki M, 2015, J HEPATO-BIL-PAN SCI, V22, P249, DOI 10.1002/jhbp.233; Murakami Y, 2011, J GASTROINTEST SURG, V15, P1007, DOI 10.1007/s11605-011-1479-9; Muratore A, 2000, EUR J SURG ONCOL, V26, P438, DOI 10.1053/ejso.1999.0918; Nasu Y, 2016, DIGEST SURG, V33, P213, DOI 10.1159/000443842; Nishio H, 2007, J HEPATO-BILIARY-PAN, V14, P351, DOI 10.1007/s00534-006-1187-0; Nishio H, 2011, ANN SURG, V253, P953, DOI 10.1097/SLA.0b013e318216f5f3; Regimbeau JM, 2011, EJSO-EUR J SURG ONC, V37, P505, DOI 10.1016/j.ejso.2011.03.135; Sakamoto Y, 2013, SURGERY, V153, P794, DOI 10.1016/j.surg.2012.11.024; Sasaki R, 2006, WORLD J SURG, V30, P36, DOI 10.1007/s00268-005-0181-z; Sasaki R, 2002, HEPATO-GASTROENTEROL, V49, P912; Shimizu Tetsuya, 2006, J Nippon Med Sch, V73, P136, DOI 10.1272/jnms.73.136; Shirai Y, 2012, WORLD J GASTROENTERO, V18, P2775, DOI 10.3748/wjg.v18.i22.2775; Sikora SS, 2006, J SURG ONCOL, V93, P670, DOI 10.1002/jso.20535; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Taner CB, 2004, J GASTROINTEST SURG, V8, P83, DOI 10.1016/j.gassur.2003.09.022; Vernerey D, 2016, BRIT J CANCER, V115, P281, DOI 10.1038/bjc.2016.212; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429; Xu Xie-qun, 2013, Chinese Medical Sciences Journal, V28, P102; Yamamoto Y, 2016, SURGERY, V159, P810, DOI 10.1016/j.surg.2015.09.009; Yang XW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-652; Yang XW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051513; Zaydfudim V, 2008, HPB, V10, P420, DOI 10.1080/13651820802320057; Zhang WJ, 2015, INT J CLIN EXP MED, V8, P869	53	46	49	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166361	10.1371/journal.pone.0166361	http://dx.doi.org/10.1371/journal.pone.0166361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846279	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600049
J	Giraldo, P; Royo, C; Gonzalez, M; Carrillo, JM; Ruiz, M				Giraldo, Patricia; Royo, Conxita; Gonzalez, Mirvana; Carrillo, Jose M.; Ruiz, Magdalena			Genetic Diversity and Association Mapping for Agromorphological and Grain Quality Traits of a Structured Collection of Durum Wheat Landraces Including subsp durum, turgidum and diccocon	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; CARBON-ISOTOPE DISCRIMINATION; WIDE LINKAGE DISEQUILIBRIUM; BREAD-MAKING QUALITY; QTL ANALYSIS; AGRONOMIC PERFORMANCE; TETRAPLOID WHEAT; MAIZE GENOME; KERNEL SIZE; EMMER WHEAT	Association mapping was performed for 18 agromorphological and grain quality traits in a set of 183 Spanish landraces, including subspecies durum, turgidum and dicoccon, genotyped with 749 DArT (Diversity Array Technology) markers. Large genetic and phenotypic variability was detected, being the level of diversity among the chromosomes and genomes heterogeneous, and sometimes complementary, among subspecies. Overall, 356 were monomorphic in at least one subspecies, mainly in dicoccon, and some of them coincidental between subspecies, especially between turgidum and dicoccon. Several of those fixed markers were associated to plant responses to environmental stresses or linked to genes subjected to selection during tetraploid wheat domestication process. A total of 85 stable MTAs (marker trait associations) have been identified for the agromorphological and quality parameters, some of them common among subspecies and others subspecies-specific. For all the traits, we have found MTAs explaining more than 10% of the phenotypic variation in any of the three subspecies. The number of MTAs on the B genome exceeded that on the A genome in subsp. durum, equalled in turgidum and was below in dicoccon. The validation of several adaptive and quality trait MTAs by combining the association mapping with an analysis of the signature of selection, identifying the putative gene function of the marker, or by coincidences with previous reports, showed that our approach was successful for the detection of MTAs and the high potential of the collection to identify marker trait associations. Novel MTAs not previously reported, some of them subspecies specific, have been described and provide new information about the genetic control of complex traits.	[Giraldo, Patricia; Carrillo, Jose M.] Tech Univ Madrid, Sch Agr Engn, Dept Biotechnol Plant Biol, Madrid, Spain; [Royo, Conxita] Inst Food & Agr Res & Technol, Field Crops Program, Lleida, Spain; [Gonzalez, Mirvana] Autonomous Univ Baja California, Engn Inst, Lab Bioinformat & Biofonot, Mexicali, Baja California, Mexico; [Ruiz, Magdalena] Natl Inst Agr & Food Res & Technol, Plant Genet Resources Ctr, Alcala De Henares, Spain	Universidad Politecnica de Madrid; IRTA; Universidad Autonoma de Baja California	Ruiz, M (corresponding author), Natl Inst Agr & Food Res & Technol, Plant Genet Resources Ctr, Alcala De Henares, Spain.	mruiz@inia.es	Royo, Conxita/J-3362-2017; Giraldo, Patricia/AAA-2825-2019; , Mirvana/K-3727-2019; Ruiz, Magdalena/G-1214-2014	Royo, Conxita/0000-0001-7939-1451; Ruiz, Magdalena/0000-0003-3901-703X	Ministerio de Economia y Competitividad, Gobierno de Espana [AGL2012-38345]; Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana [RF2006-00020]	Ministerio de Economia y Competitividad, Gobierno de Espana; Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana	Support was provided by AGL2012-38345: Ministerio de Economia y Competitividad, Gobierno de Espana (to PG, JMC, MR); RF2006-00020: Institute nacional de Investigacion y tecnologia Agraria y Alimentaria, Gobierno de Espana (PG, CR, JMC, MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiriano E, 2008, SPAN J AGRIC RES, V6, P599, DOI 10.5424/sjar/2008064-353; Aguiriano E, 2006, GENET RESOUR CROP EV, V53, P1543, DOI 10.1007/s10722-005-7767-z; [Anonymous], REV DESCR LIST WHEAT; AXFORD DWE, 1978, MILL FEED FERTIL, V161, P18; Blanco A, 1998, THEOR APPL GENET, V97, P721, DOI 10.1007/s001220050948; Blanco A, 1998, PLANT BREEDING, V117, P413, DOI 10.1111/j.1439-0523.1998.tb01965.x; Bordes J, 2014, MOL BREEDING, V33, P755, DOI 10.1007/s11032-013-0004-0; Borner A, 2002, THEOR APPL GENET, V105, P921, DOI 10.1007/s00122-002-0994-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, CROP SCI, V46, P1323, DOI 10.2135/cropsci2005.09-0305; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chao SM, 2007, CROP SCI, V47, P1018, DOI 10.2135/cropsci2006.06.0434; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Condon AG, 2002, CROP SCI, V42, P122, DOI 10.2135/cropsci2002.0122; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; Di Rienzo J.A., 2011, INFOSTAT VERSION 201; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1989, SOC EXP BIOL SEM SER, V39, P47, DOI 10.1017/CBO9780511661587.005; Federer WT, 2001, AGRON J, V93, P389, DOI 10.2134/agronj2001.932389x; Ficco DBM, 2014, CROP PASTURE SCI, V65, P1, DOI 10.1071/CP13293; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Frankel O, 1984, PLANT GENETIC RESOUR; Furtado A, 2015, SCI REP-UK, V5, DOI 10.1038/srep10446; Gadea M., 1954, TRIGOS ESPANOLES; Graziani M, 2014, CROP PASTURE SCI, V65, P80, DOI 10.1071/CP13349; He HY, 2014, ACTA PHYSIOL PLANT, V36, P581, DOI 10.1007/s11738-013-1444-1; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Kaan F., 1993, Journal of Genetics and Breeding, V47, P151; KATO K, 1992, THEOR APPL GENET, V84, P259, DOI 10.1007/BF00229480; Kosuge K, 2011, EUPHYTICA, V179, P257, DOI 10.1007/s10681-010-0302-0; Kumar V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065535; Laido G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095211; Laido G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067280; Li Y, 2009, PLANT BREEDING, V128, P235, DOI 10.1111/j.1439-0523.2008.01578.x; Littel RC, 1996, SAS SYSTEM MIXED MOD; Longin CFH, 2016, CROP SCI, V56, P302, DOI 10.2135/cropsci2015.04.0242; Lopes MS, 2015, J EXP BOT, V66, P3477, DOI 10.1093/jxb/erv122; Luo W, 2016, GENET RESOUR CROP EV, V63, P763, DOI 10.1007/s10722-016-0393-0; Maccaferri M, 2005, MOL BREEDING, V15, P271, DOI 10.1007/s11032-004-7012-z; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2015, PLANT BIOTECHNOL J, V13, P648, DOI 10.1111/pbi.12288; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Marone D, 2012, THEOR APPL GENET, V125, P1619, DOI 10.1007/s00122-012-1939-y; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; McCartney CA, 2005, GENOME, V48, P870, DOI 10.1139/g05-055; McIntosh R. A., 1978, Cereal Research Communications, V6, P9; McIntosh RA, 1998, 9 INT WHEAT GEN S; Mora F, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0264-y; Moragues M, 2006, GENET RESOUR CROP EV, V53, P993, DOI 10.1007/s10722-004-7367-3; Nalam VJ, 2006, THEOR APPL GENET, V112, P373, DOI 10.1007/s00122-005-0140-y; Narasimhamoorthy B, 2006, THEOR APPL GENET, V112, P787, DOI 10.1007/s00122-005-0159-0; Nazco R, 2012, EUPHYTICA, V185, P1, DOI 10.1007/s10681-011-0588-6; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Oliveira HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037063; Peleg Z, 2011, J EXP BOT, V62, P5051, DOI 10.1093/jxb/err206; Peng JH, 2003, P NATL ACAD SCI USA, V100, P2489, DOI 10.1073/pnas.252763199; Peng JH, 2011, AUST J CROP SCI, V5, P1127; Pfluger LA, 2001, THEOR APPL GENET, V102, P767, DOI 10.1007/s001220051708; Thanh PT, 2013, BIOTECHNOL BIOTEC EQ, V27, P3627, DOI 10.5504/BBEQ.2013.0008; Rebetzke GJ, 2006, EUPHYTICA, V150, P97, DOI 10.1007/s10681-006-9097-4; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rossi M, 2009, EVOL APPL, V2, P504, DOI 10.1111/j.1752-4571.2009.00082.x; Royo C, 2016, J AGR SCI-CAMBRIDGE, V154, P612, DOI 10.1017/S0021859615000507; Royo C, 2014, GENET RESOUR CROP EV, V61, P1345, DOI 10.1007/s10722-014-0116-3; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; Ruiz M, 2008, PLANT BREEDING, V127, P20, DOI 10.1111/j.1439-0523.2007.01406.x; RUIZ M, 1995, PLANT BREEDING, V114, P40, DOI 10.1111/j.1439-0523.1995.tb00756.x; Ruiz M, 2012, CROP SCI, V52, P2262, DOI 10.2135/cropsci2012.02.0081; *SAS I INC, 2000, SAS STAT GUID PERS C; Shukla S, 2015, EUPHYTICA, V203, P449, DOI 10.1007/s10681-014-1314-y; Somers DJ, 2007, GENOME, V50, P557, DOI 10.1139/G07-031; Sukumaran S, WHEAT MAPPING POPULA; Team R. D. C, 2011, R LANG ENV STAT COMP; Tian Jichun, 2015, GENETIC ANAL WHEAT M; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; UNRAU JOHN, 1950, SCI AGRIC [OTTOWA], V30, P66; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Wang MH, 2012, THEOR APPL GENET, V124, P233, DOI 10.1007/s00122-011-1697-2; Worland AJ, 1998, EUPHYTICA, V100, P385, DOI 10.1023/A:1018327700985; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zapotoczny P, 2010, INT J FOOD PROP, V13, P75, DOI 10.1080/10942910802180174; Zeven AC, 1998, EUPHYTICA, V104, P127, DOI 10.1023/A:1018683119237; Zhang J, 2012, THEOR APPL GENET, V125, P1697, DOI 10.1007/s00122-012-1946-z; Zheng GJ, 2014, J INTEGR AGR, V13, P2608, DOI 10.1016/S2095-3119(13)60738-8; Zohary D., 1994, DOMESTICATION OF PLA	88	21	21	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166577	10.1371/journal.pone.0166577	http://dx.doi.org/10.1371/journal.pone.0166577			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846306	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000387794600085
J	Hwong, WY; Bots, ML; Selvarajah, S; Aziz, ZA; Sidek, NN; Spiering, W; Kappelle, LJ; Vaartjes, I				Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Aziz, Zariah Abdul; Sidek, Norsima Nazifah; Spiering, Wilko; Kappelle, L. Jaap; Vaartjes, Ilonca			Use of Antihypertensive Drugs and Ischemic Stroke Severity - Is There a Role for Angiotensin-II?	PLOS ONE			English	Article							ACUTE CEREBRAL INFARCTION; SCALE; INHIBITORS; RECEPTORS	Background The increase in angiotensin II (Ang II) formation by selected antihypertensive drugs is said to exhibit neuroprotective properties, but this translation into improvement in clinical outcomes has been inconclusive. We undertook a study to investigate the relationship between types of antihypertensive drugs used prior to a stroke event and ischemic stroke severity. We hypothesized that use of antihypertensive drugs that increase Ang II formation (Ang II increasers) would reduce ischemic stroke severity when compared to antihypertensive drugs that suppress Ang II formation (Ang II suppressors). Methods From the Malaysian National Neurology Registry, we included hypertensive patients with first ischemic stroke who presented within 48 hours from ictus. Antihypertensive drugs were divided into Ang II increasers (angiotensin-I receptor blockers (ARBs), calcium channel blockers (CCBs) and diuretics) and Ang II suppressors (angiotensin-converting-enzyme inhibitors (ACEIs) and beta blockers). We evaluated stroke severity during admission with the National Institute of Health Stroke Scale (NIHSS). We performed a multivariable logistic regression with the score being dichotomized at 15. Scores of less than 15 were categorized as less severe stroke. Results A total of 710 patients were included. ACEIs was the most commonly prescribed antihypertensive drug in patients using Ang II suppressors (74%) and CCBs, in patients prescribed with Ang II increasers at 77%. There was no significant difference in the severity of ischemic stroke between patients who were using Ang II increasers in comparison to patients with Ang II suppressors (OR: 1.32, 95% CI: 0.83-2.10, p = 0.24). Conclusion In our study, we found that use of antihypertensive drugs that increase Ang II formation was not associated with less severe ischemic stroke as compared to use of antihypertensive drugs that suppress Ang II formation.	[Hwong, Wen Yea] Kuala Lumpur Gen Hosp, Natl Clin Res Ctr, Kuala Lumpur, Malaysia; [Hwong, Wen Yea; Bots, Michiel L.; Selvarajah, Sharmini; Vaartjes, Ilonca] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Aziz, Zariah Abdul] Hosp Sultanah Nur Zahirah, Dept Neurol, Terengganu, Malaysia; [Sidek, Norsima Nazifah] Hosp Sultanah Nur Zahirah, Dept Pharm, Terengganu, Malaysia; [Spiering, Wilko] Univ Med Ctr Utrecht, Dept Vasc Med, Utrecht, Netherlands; [Kappelle, L. Jaap] Univ Med Ctr Utrecht, Dept Neurol & Neurosurg, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Vaartjes, I (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	c.h.vaartjes@umcutrecht.nl	SIDEK, NORSIMA NAZIFAH/AAG-4416-2021	SIDEK, NORSIMA NAZIFAH/0000-0003-1269-7661	Julius Center for Health Sciences and Primary Care under the Honors Track Programme; Dutch Heart Foundation; Ministry of Health Malaysia [NMRR 08-1631-3189]	Julius Center for Health Sciences and Primary Care under the Honors Track Programme; Dutch Heart Foundation(Netherlands Heart Foundation); Ministry of Health Malaysia	WYH is funded by Julius Center for Health Sciences and Primary Care under the Honors Track Programme. IV is funded by the Dutch Heart Foundation for project Facts and Figures. The Honors Track Committee and the Dutch Heart Foundation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The registry is funded by Ministry of Health Malaysia (ID: NMRR 08-1631-3189). Ministry of Health Malaysia had no role in the study design, analysis and preparation of the manuscript.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; [Anonymous], 2014, R LANG ENV STAT COMP; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; BROWN MJ, 1986, LANCET, V2, P427; Chitravas N, 2007, NEUROLOGY, V68, P1687, DOI 10.1212/01.wnl.0000261914.18101.60; Chrysant SG, 2012, CURR HYPERTENS REP, V14, P202, DOI 10.1007/s11906-012-0257-8; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; Dienert HC, 2008, LANCET NEUROL, V7, P875, DOI 10.1016/S1474-4422(08)70198-4; Fournier A, 2004, CURR HYPERTENS REP, V6, P182, DOI 10.1007/s11906-004-0067-8; Fournier A, 2004, J AM COLL CARDIOL, V43, P1343, DOI 10.1016/j.jacc.2003.10.060; Fuentes B, 2010, J HYPERTENS, V28, P575, DOI 10.1097/HJH.0b013e3283350f50; Klungel OH, 2004, J CLIN EPIDEMIOL, V57, P1223, DOI 10.1016/j.jclinepi.2004.03.011; McCarthy CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095762; McCarthy CA, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0440-1; McCleary L, 2002, NURS RES, V51, P339, DOI 10.1097/00006199-200209000-00012; Miyamoto N, 2012, J STROKE CEREBROVASC, V21, P363, DOI 10.1016/j.jstrokecerebrovasdis.2010.09.011; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Nazifah S Norsima, 2012, Med J Malaysia, V67, P302; Ovbiagele B, 2005, NEUROLOGY, V65, P851, DOI 10.1212/01.wnl.0000175984.29283.6d; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Sato S, 2008, NEUROLOGY, V70, P2371, DOI 10.1212/01.wnl.0000304346.14354.0b; Selim M, 2005, BMC NEUROL, V5, P1, DOI 10.1186/1471-2377-5-10; Stata Corp, 2013, STATA STAT SOFTW REL; Tziomalos K, 2015, J CLIN HYPERTENS, V17, P275, DOI 10.1111/jch.12498	24	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166524	10.1371/journal.pone.0166524	http://dx.doi.org/10.1371/journal.pone.0166524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846309	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600076
J	Kwon, RJ; Han, ME; Kim, JY; Liu, L; Kim, YH; Jung, JS; Oh, SO				Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Jung, Jin-Sup; Oh, Sae-Ock			ZHX1 Promotes the Proliferation, Migration and Invasion of Cholangiocarcinoma Cells	PLOS ONE			English	Article							ZINC-FINGERS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; PROSTATE-CANCER; TARGETS; GROWTH; EGR1	Zinc-fingers and homeoboxes 1 (ZHX1) is a transcription repressor that has been associated with the progressions of hepatocellular carcinoma, gastric cancer, and breast cancer. However, the functional roles of ZHX1 in cholangiocarcinoma (CCA) have not been determined. We investigated the expression and roles of ZHX1 during the proliferation, migration, and invasion of CCA cells. In silico analysis and immunohistochemical studies showed amplification and overexpression of ZHX1 in CCA tissues. Furthermore, ZHX1 knockdown using specific siRNAs decreased CCA cell proliferation, migration, and invasion, whereas ZHX1 overexpression promoted all three characteristics. In addition, results suggested EGR1 might partially mediate the effect of ZHX1 on the proliferation of CCA cells. Taken together, these results show ZHX1 promotes CCA cell proliferation, migration, and invasion, and present ZHX1 as a potential target for the treatment of CCA.	[Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Oh, Sae-Ock] Pusan Natl Univ, Sch Med, Dept Anat, Busandaehak Ro 49, Yangsan 50612, South Korea; [Kwon, Ryuk-Jun; Han, Myoung-Eun; Kim, Ji-young; Liu, Liangwen; Kim, Yun-Hak; Oh, Sae-Ock] Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Busandaehak Ro 49, Yangsan 50612, South Korea; [Jung, Jin-Sup] Pusan Natl Univ, Dept Physiol, Sch Med, Busandaehak Ro 49, Yangsan 50612, South Korea	Pusan National University; Pusan National University; Pusan National University	Oh, SO (corresponding author), Pusan Natl Univ, Sch Med, Dept Anat, Busandaehak Ro 49, Yangsan 50612, South Korea.; Oh, SO (corresponding author), Pusan Natl Univ, Gene & Therapy Res Ctr Vessel Associated Dis, Busandaehak Ro 49, Yangsan 50612, South Korea.	hedgehog@pusan.ac.kr		Liu, Liangwen/0000-0003-2918-8142; Kim, Yun Hak/0000-0002-9796-8266	Medical Research Center (MRC) Program [NRF-2015R1A5A2009656]; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST) [NRF-2015R1A1A3A04001322]; National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea [0920050]	Medical Research Center (MRC) Program; Basic Science Research Foundation of the National Research Foundation (NRF) - Korean government (MEST); National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Medical Research Center (MRC) Program (#NRF-2015R1A5A2009656) and Basic Science Research Foundation (#NRF-2015R1A1A3A04001322) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050). We would like to thank TCGA group providing Cancer Genome Atlas (TCGA) database and tools for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Medical Research Center (MRC) Program (#NRF-2015R1A5A2009656) and Basic Science Research Foundation (#NRF-2015R1A1A3A04001322) of the National Research Foundation (NRF) funded by the Korean government (MEST), and by a grant from the National R&D Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea (#0920050). We would like to thank TCGA group providing Cancer Genome Atlas (TCGA) database and tools for data analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank the Korea Biobank Network. The biospecimens used for this study were provided by the Biobank of Pusan National University Hospital, a member of the Korea Biobank Network.	Adamson E, 2003, CANCER BIOL THER, V2, P617; Armellini A, 2008, BRIT J HAEMATOL, V141, P212, DOI 10.1111/j.1365-2141.2007.06956.x; Barthelemy I, 1996, BIOCHEM BIOPH RES CO, V224, P870, DOI 10.1006/bbrc.1996.1114; Chen SL, 2013, J CELL BIOCHEM, V114, P2323, DOI 10.1002/jcb.24579; Chen Y, 2015, ONCOTARGET, V6, P20419, DOI 10.18632/oncotarget.3983; Cheng JC, 2013, ONCOGENE, V32, P1041, DOI 10.1038/onc.2012.127; de Jong MC, 2011, J CLIN ONCOL, V29, P3140, DOI 10.1200/JCO.2011.35.6519; Dokduang H, 2013, TUMOR BIOL, V34, P3519, DOI 10.1007/s13277-013-0930-9; Firlej V, 2008, J CELL SCI, V121, P3393, DOI 10.1242/jcs.027201; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gitenay D, 2009, FUTURE ONCOL, V5, P993, DOI 10.2217/FON.09.67; Han ME, 2013, ANAT CELL BIOL, V46, P8, DOI 10.5115/acb.2013.46.1.8; Kabbach G, 2015, J CLIN TRANSL HEPATO, V3, P169, DOI 10.14218/JCTH.2015.00012; Kim KS, 2012, ANAT CELL BIOL, V45, P17, DOI 10.5115/acb.2012.45.1.17; Kim S. S., 2007, J CHROMATOGR, P1, DOI DOI 10.6133/APJ; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Liu Y, 2015, CANCER GENE THER, V22, P223, DOI 10.1038/cgt.2015.16; Ma XJ, 2016, J CANCER, V7, P60, DOI 10.7150/jca.12973; Maroni L, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.10.04; Meng LQ, 2014, TUMOR BIOL, V35, P12497, DOI 10.1007/s13277-014-2568-7; Nagel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138416; Nagel S, 2011, GENE CHROMOSOME CANC, V50, P996, DOI 10.1002/gcc.20920; Ogata-Kawata H, 2007, FRONT BIOSCI-LANDMRK, V12, P1911, DOI 10.2741/2197; Olnes MJ, 2004, ONCOLOGY-BASEL, V66, P167, DOI 10.1159/000077991; Segura-Lopez FK, 2015, HELICOBACTER, V20, P223, DOI 10.1111/hel.12195; Shou ZF, 2004, BIOCHEM BIOPH RES CO, V314, P885, DOI 10.1016/j.bbrc.2003.12.162; Sribenja S, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-430; Thomas Charles R., 2008, PATHOLOGIC STAGING G, P77; Wang JJ, 2013, INT J MODEL SIMUL SC, V4, DOI 10.1142/S1793962313500098; Yamada K, 2002, BIOCHEM BIOPH RES CO, V297, P368, DOI 10.1016/S0006-291X(02)02203-9; Yamada K, 1999, BIOCHEM BIOPH RES CO, V261, P614, DOI 10.1006/bbrc.1999.1087; Yue XT, 2012, GASTROENTEROLOGY, V142, P1559, DOI 10.1053/j.gastro.2012.02.049; Zhao HL, 2016, J CO2 UTIL, V15, P15, DOI 10.1016/j.jcou.2016.04.004	33	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165516	10.1371/journal.pone.0165516	http://dx.doi.org/10.1371/journal.pone.0165516			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835650	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200007
J	Miguchi, M; Hinoi, T; Shimomura, M; Adachi, T; Saito, Y; Niitsu, H; Kochi, M; Sada, H; Sotomaru, Y; Ikenoue, T; Shigeyasu, K; Tanakaya, K; Kitadai, Y; Sentani, K; Oue, N; Yasui, W; Ohdan, H				Miguchi, Masashi; Hinoi, Takao; Shimomura, Manabu; Adachi, Tomohiro; Saito, Yasufumi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Sotomaru, Yusuke; Ikenoue, Tsuneo; Shigeyasu, Kunitoshi; Tanakaya, Kohji; Kitadai, Yasuhiko; Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru; Ohdan, Hideki			Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor beta Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation	PLOS ONE			English	Article							TGF-BETA; MICROSATELLITE INSTABILITY; GASTROINTESTINAL-TRACT; GASTRIC-CANCER; COLON-CANCER; MUTATIONS; EXPRESSION; CARCINOMA; GENE; FAMILY	Mutations in TGFBR2, a component of the transforming growth factor (TGF)-beta signaling pathway, occur in high-frequency microsatellite instability (MSI-H) colorectal cancer (CRC). In mouse models, Tgfbr2 inactivation in the intestinal epithelium accelerates the development of malignant intestinal tumors in combination with disruption of the Wnt-beta-catenin pathway. However, no studies have further identified the genes influenced by TGFBR2 inactivation following disruption of the Wnt-beta-catenin pathway. We previously described CDX2P-G19Cre; Apc(flox/flox) mice, which is stochastically null for Apc in the colon epithelium. In this study, we generated CDX2P-G19Cre; Apc(flox/flox); Tgfbr2(flox/flox) mice, with simultaneous loss of Apc and Tgfbr2. These mice developed tumors, including adenocarcinoma in the proximal colon. We compared gene expression profiles between tumors of the two types of mice using microarray analysis. Our results showed that the expression of the murine homolog of GSDMC was significantly upregulated by 9.25-fold in tumors of CDX2P-G19Cre; Apc(flox/flox); Tgfbr2(flox/flox) mice compared with those of CDX2P-G19Cre; Apc(flox/flox) mice. We then investigated the role of GSDMC in regulating CRC tumorigenesis. The silencing of GSDMC led to a significant reduction in the proliferation and tumorigenesis of CRC cell lines, whereas the overexpression of GSDMC enhanced cell proliferation. These results suggested that GSDMC functioned as an oncogene, promoting cell proliferation in colorectal carcinogenesis. In conclusion, combined inactivation of both Apc and Tgfbr2 in the colon epithelium of a CRC mouse model promoted development of adenocarcinoma in the proximal colon. Moreover, GSDMC was upregulated by TGFBR2 mutation in CRC and promoted tumor cell proliferation in CRC carcinogenesis, suggesting that GSDMC may be a promising therapeutic target.	[Miguchi, Masashi; Hinoi, Takao; Shimomura, Manabu; Adachi, Tomohiro; Saito, Yasufumi; Niitsu, Hiroaki; Kochi, Masatoshi; Sada, Haruki; Ohdan, Hideki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan; [Hinoi, Takao] Natl Hosp Org Kure Med Ctr, Dept Surg, Inst Clin Res, Hiroshima, Japan; [Hinoi, Takao] Chugoku Canc Ctr, Hiroshima, Japan; [Sotomaru, Yusuke] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Ikenoue, Tsuneo] Univ Tokyo, Inst Med Sci, Div Clin Genome Res, Tokyo, Japan; [Shigeyasu, Kunitoshi; Tanakaya, Kohji] Natl Hosp Org Iwakuni Clin Ctr, Dept Surg, Yamaguchi, Japan; [Kitadai, Yasuhiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Gastroenterol, Hiroshima, Japan; [Kitadai, Yasuhiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Appl Life Sci, Dept Metab, Hiroshima, Japan; [Kitadai, Yasuhiko] Prefectural Univ Hiroshima, Dept Hlth Sci, Program Human Culture & Sci, Hiroshima, Japan; [Sentani, Kazuhiro; Oue, Naohide; Yasui, Wataru] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Mol Pathol, Appl Life Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University; University of Tokyo; Hiroshima University; Hiroshima University; Hiroshima University	Hinoi, T (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Transplant Surg, Appl Life Sci, Hiroshima, Japan.; Hinoi, T (corresponding author), Natl Hosp Org Kure Med Ctr, Dept Surg, Inst Clin Res, Hiroshima, Japan.; Hinoi, T (corresponding author), Chugoku Canc Ctr, Hiroshima, Japan.	thinoi@hiroshima-u.ac.jp	Niitsu, Hiroaki/HHZ-1925-2022; Sotomaru, Yusuke/G-5508-2019; Tanakaya, Kohji/AAF-5219-2019; 北台, 靖彦/AAH-1678-2021; Kitadai, Yasuhiko/AAG-4389-2021; Hinoi, Takao/AAI-1443-2020; Ohdan, Hideki/G-4719-2019	北台, 靖彦/0000-0002-8743-3815; Hinoi, Takao/0000-0003-0462-6177; Ohdan, Hideki/0000-0002-9066-1288	Japan Society for the Promotion of Science (JSPS) KAKENHI [22390257, 25293284, 25861190, 15K19892]; Japanese Society of Gastroenterology; Nakayama Cancer Research Institute	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society of Gastroenterology(Japanese Society of Gastroenterology); Nakayama Cancer Research Institute	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (http://www.jsps.go.jp/j-grantsinaid/) (Grant Numbers 22390257 and 25293284) to TH, the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for young Scientists Research (http://www.jsps.go.jp/j-grantsinaid/) (Grant Numbers 25861190 and 15K19892) to MS, the Japanese Society of Gastroenterology Grant-in-Aid 2010, and the Nakayama Cancer Research Institute Grant-in-Aid 2009 for Gastrointestinal Disease. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol A, 2008, NAT METHODS, V5, P231, DOI 10.1038/NMETH.1182; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Fernandez-Peralta AM, 2005, CANCER GENET CYTOGEN, V157, P18, DOI 10.1016/j.cancergencyto.2004.05.008; Freshney RI, 1994, CULTURE ANIMAL CELLS; Grady WM, 1998, CANCER RES, V58, P3101; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hatch SB, 2005, CLIN CANCER RES, V11, P2180, DOI 10.1158/1078-0432.CCR-04-0234; Hinoi T, 2003, J BIOL CHEM, V278, P44608, DOI 10.1074/jbc.M307435200; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Hinoi T, 2007, CANCER RES, V67, P9721, DOI 10.1158/0008-5472.CAN-07-2735; Kawaguchi Y, 2016, J GASTROENTEROL, V51, P447, DOI 10.1007/s00535-015-1121-9; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kubiczkova L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-183; Lawes DA, 2005, BRIT J CANCER, V93, P472, DOI 10.1038/sj.bjc.6602708; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Long XC, 2007, J BIOL CHEM, V282, P15941, DOI 10.1074/jbc.R700010200; Markowitz Sanford D., 1996, Cytokine and Growth Factor Reviews, V7, P93, DOI 10.1016/1359-6101(96)00001-9; Mori Y, 2001, CANCER RES, V61, P6046; MOSES HL, 1990, CELL, V63, P245, DOI 10.1016/0092-8674(90)90155-8; Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890; PARSONS R, 1995, CANCER RES, V55, P5548; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Rigau V, 2003, ARCH PATHOL LAB MED, V127, P694; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2000, MAMM GENOME, V11, P718, DOI 10.1007/s003350010138; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Samowitz WS, 2002, GENE CHROMOSOME CANC, V35, P368, DOI 10.1002/gcc.10125; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sasada T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132435; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sumida T, 2011, INT J CANCER, V128, P2050, DOI 10.1002/ijc.25812; Takami H, 2012, PATHOBIOLOGY, V79, P154, DOI 10.1159/000335694; Takayama T, 2006, J GASTROENTEROL, V41, P185, DOI 10.1007/s00535-006-1801-6; Tamura M, 2007, GENOMICS, V89, P618, DOI 10.1016/j.ygeno.2007.01.003; Trobridge P, 2009, GASTROENTEROLOGY, V136, P1680, DOI 10.1053/j.gastro.2009.01.066; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Watabe E, 2001, JPN J CANCER RES, V92, P140, DOI 10.1111/j.1349-7006.2001.tb01076.x; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yu M, 2014, ONCOGENE, V33, P1538, DOI 10.1038/onc.2013.102	46	100	104	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166422	10.1371/journal.pone.0166422	http://dx.doi.org/10.1371/journal.pone.0166422			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835699	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200049
J	Xiao, R; Jiang, DW; Christakos, G; Fei, XF; Wu, JP				Xiao, Rui; Jiang, Diwei; Christakos, George; Fei, Xufeng; Wu, Jiaping			Soil Landscape Pattern Changes in Response to Rural Anthropogenic Activity across Tiaoxi Watershed, China	PLOS ONE			English	Article							URBAN SPRAWL; URBANIZATION; IMPACT; CITIES; RIVER; CITY	Soil sealing (loss of soil resources due to extensive land covering for the purpose of house building, road construction etc.) and subsequent soil landscape pattern changes constitute typical environmental problems in many places worldwide. Previous studies concentrated on soil sealing in urbanized regions, whereas rural areas have not been given sufficient attention. Accordingly, this paper studies soil landscape pattern dynamics (i.e., landscape pattern changes in response to rural anthropogenic activities) in the Tiaoxi watershed (Zhejiang province, eastern China), in which surface sealing is by far the predominant component of human forcing with respect to environmental change. A novel approach of quantifying the impacts of rural anthropogenic activities on soil resources is presented. Specifically, quantitative relationships were derived between five soil landscape pattern metrics (patch density, edge density, shape index, Shannon's diversity index and aggregation index) and three rural anthropogenic activity indicators (anthropogenic activity intensity, distance to towns, and distance to roads) at two landscape block scales (3 and 5 km) between 1985 and 2010. The results showed that the Tiaoxi watershed experienced extensive rural settlement expansion and high rates of soil sealing. Soil landscapes became more fragmented, more irregular, more isolated, and less diverse. Relationships between soil landscape pattern changes and rural anthropogenic activities differed with the scale (spatial and temporal) and variable considered. In particular, the anthropogenic activity intensity was found to be the most important indicator explaining social development intensity, whereas the other two proximity indicators had a significant impact at certain temporal interval. In combination with scale effects, spatial dependency (correlation) was shown to play a key role that should be carefully taken into consideration in any relevant environmental study. Overall, the findings of this work suggest that soil sealing can be a critical human forcing issue with considerable consequences deserving serious attention by the experts, the public and the government alike.	[Xiao, Rui; Jiang, Diwei; Christakos, George; Fei, Xufeng; Wu, Jiaping] Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China; [Xiao, Rui] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Peoples R China	Zhejiang University; Wuhan University	Wu, JP (corresponding author), Zhejiang Univ, Inst Isl & Coastal Ecosyst, Zhoushan, Peoples R China.	jw67@zju.edu.cn	Wu, Jiaping/AAD-8800-2022		Ministry of Science and Technology, China [2015DFA01410]	Ministry of Science and Technology, China(Ministry of Science and Technology, China)	This work was supported partially by the Ministry of Science and Technology, China (2015DFA01410).; We are very grateful to the PLoS ONE Editor (Dr. Iratxe Puebla) and the two reviewers for their constructive comments and suggestions, which have substantially improved this paper. Professor Stephen DeGloria of Cornell University (USA) provided valuable comments. This work was supported partially by the Ministry of Science and Technology, China (2015DFA01410).	Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Clarke KC, 1998, INT J GEOGR INF SCI, V12, P699, DOI 10.1080/136588198241617; Couch C., 2007, URBAN SPRAWL EUROPE; DARMODY RG, 1982, SOIL SCI SOC AM J, V46, P588, DOI 10.2136/sssaj1982.03615995004600030029x; Donnelly S, 2011, REG ENVIRON CHANGE, V11, P97, DOI 10.1007/s10113-010-0124-6; Jiang ZL, 2012, STOCH ENV RES RISK A, V26, P751, DOI 10.1007/s00477-012-0590-0; Johnson MP, 2001, ENVIRON PLANN A, V33, P717, DOI 10.1068/a3327; Karim Z, 2014, ECOL INDIC, V42, P20, DOI 10.1016/j.ecolind.2013.07.020; Lacombe D, 2004, PUBLIC FINANC REV, V35, P480; Li TH, 2010, ECOL ECON, V69, P1427, DOI 10.1016/j.ecolecon.2008.05.018; Li X, 2004, LANDSCAPE URBAN PLAN, V69, P335, DOI 10.1016/j.landurbplan.2003.10.033; Liu SL, 2008, ECOL ENG, V34, P91, DOI 10.1016/j.ecoleng.2008.07.006; Long HL, 2009, LAND USE POLICY, V26, P322, DOI 10.1016/j.landusepol.2008.04.001; Luo J, 2009, LANDSCAPE URBAN PLAN, V91, P51, DOI 10.1016/j.landurbplan.2008.11.010; McGarigal K, 2002, COMPUTER SOFTWARE PR; McMahon G, 2000, J AM WATER RESOUR AS, V36, P1247, DOI 10.1111/j.1752-1688.2000.tb05724.x; Munsi M, 2010, REG ENVIRON CHANGE, V10, P145, DOI 10.1007/s10113-009-0101-0; Napton DE, 2010, REG ENVIRON CHANGE, V10, P37, DOI 10.1007/s10113-009-0084-x; Nazemi A, 2012, STOCH ENV RES RISK A, V26, P189, DOI 10.1007/s00477-011-0467-7; Pan XZ, 2007, CATENA, V69, P65, DOI 10.1016/j.catena.2006.04.016; Piotrowska-Dlugosz A, 2015, J SOIL SEDIMENT, V15, P47, DOI 10.1007/s11368-014-0963-8; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rempel R, 2008, PATCH ANAL; Saura S, 2007, ISPRS J PHOTOGRAMM, V62, P201, DOI 10.1016/j.isprsjprs.2007.03.004; Scalenghe R, 2009, LANDSCAPE URBAN PLAN, V90, P1, DOI 10.1016/j.landurbplan.2008.10.011; Schaldach R, 2007, REG ENVIRON CHANGE, V7, P137, DOI 10.1007/s10113-007-0034-4; Seto KC, 2005, LANDSCAPE ECOL, V20, P871, DOI 10.1007/s10980-005-5238-8; Su SL, 2013, ECOL INDIC, V24, P375, DOI 10.1016/j.ecolind.2012.07.015; Su SL, 2011, PHYS CHEM EARTH, V36, P379, DOI 10.1016/j.pce.2010.03.021; Su SL, 2011, REG ENVIRON CHANGE, V11, P651, DOI 10.1007/s10113-010-0197-2; Tan MH, 2005, LAND USE POLICY, V22, P187, DOI 10.1016/j.landusepol.2004.03.003; Tate CM, 2005, AM FISH S S, V47, P291; Wang XW, 2016, STOCH ENV RES RISK A, V30, P137, DOI 10.1007/s00477-015-1043-3; Wei ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109380; Wu JG, 2002, LANDSCAPE ECOL, V17, P761, DOI 10.1023/A:1022995922992; Wu JG, 2002, LANDSCAPE ECOL, V17, P355, DOI 10.1023/A:1020561630963; Wu JiaPing, 2013, Acta Pedologica Sinica, V50, P30; Wu JX, 2009, AGR ECOSYST ENVIRON, V129, P523, DOI 10.1016/j.agee.2008.11.008; Xiao R, 2013, CATENA, V109, P1, DOI 10.1016/j.catena.2013.05.004; Xiao R, 2013, APPL GEOGR, V39, P158, DOI 10.1016/j.apgeog.2013.01.002; Yaalon DH, 2000, NATURE, V407, P301, DOI 10.1038/35030260; Zhang XL, 2007, CATENA, V69, P16, DOI 10.1016/j.catena.2006.04.020	43	5	5	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166224	10.1371/journal.pone.0166224	http://dx.doi.org/10.1371/journal.pone.0166224			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832167	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000078
J	Hadjistylli, M; Roderick, GK; Brown, JK				Hadjistylli, Margarita; Roderick, George K.; Brown, Judith K.			Global Population Structure of a Worldwide Pest and Virus Vector: Genetic Diversity and Population History of the Bemisia tabaci Sibling Species Group	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; EXOTIC Q-BIOTYPE; MICROSATELLITE-LOCI; MITOCHONDRIAL-DNA; HEMIPTERA ALEYRODIDAE; GENNADIUS HEMIPTERA; 1ST REPORT; PHYLOGENETIC-RELATIONSHIPS; INSECTICIDE RESISTANCE; SWEET-POTATO	The whitefly Bemisia tabaci sibling species (sibsp.) group comprises morphologically indiscernible lineages of well-known exemplars referred to as biotypes. It is distributed throughout tropical and subtropical latitudes and includes the contemporary invasive haplotypes, termed B and Q. Several well-studied B. tabaci biotypes exhibit ecological and biological diversity, however, most members are poorly studied or completely uncharacterized. Genetic studies have revealed substantial diversity within the group based on a fragment of the mitochondrial cytochrome oxidase I (mtCOI) sequence (haplotypes), with other tested markers being less useful for deep phylogenetic comparisons. The view of global relationships within the B. tabaci sibsp. group is largely derived from this single marker, making assessment of gene flow and genetic structure difficult at the population level. Here, the population structure was explored for B. tabaci in a global context using nuclear data from variable microsatellite markers. Worldwide collections were examined representing most of the available diversity, including known monophagous, polyphagous, invasive, and indigenous haplotypes. Well-characterized biotypes and other related geographic lineages discovered represented highly differentiated genetic clusters with little or no evidence of gene flow. The invasive B and Q biotypes exhibited moderate to high levels of genetic diversity, suggesting that they stemmed from large founding populations that have maintained ancestral variation, despite homogenizing effects, possibly due to human-mediated among-population gene flow. Results of the microsatellite analyses are in general agreement with published mtCOI phylogenies; however, notable conflicts exist between the nuclear and mitochondrial relationships, highlighting the need for a multifaceted approach to delineate the evolutionary history of the group. This study supports the hypothesis that the extant B. tabaci sibsp. group contains ancient genetic entities and highlights the vast cryptic diversity throughout the genome in the group.	[Hadjistylli, Margarita; Roderick, George K.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Hadjistylli, Margarita] Minist Agr Rural Dev & Environm, Dept Environm, Nicosia, Cyprus	University of California System; University of California Berkeley; University of Arizona	Hadjistylli, M (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.; Hadjistylli, M (corresponding author), Minist Agr Rural Dev & Environm, Dept Environm, Nicosia, Cyprus.	mhadjistylli@environment.moa.gov.cy		Roderick, George/0000-0001-7557-2415	United States Department of Agriculture (National Institute of Food and Agriculture [2005-35302-16188]; University of California Agricultural Experiment Station grant; A.G. Leventis Foundation (Cyprus) Scholarship for Doctorate Studies; UC Berkeley; Margaret C. Walker Fund award for Systematic Entomology, Department of Environmental Science, Policy, and Management; France-Berkeley Fund (Invasive Insects and Mites of Mediterranean Climates); National Science Foundation Research Coordination Networks grant [Invasive Insects: 0342279]	United States Department of Agriculture (National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); University of California Agricultural Experiment Station grant; A.G. Leventis Foundation (Cyprus) Scholarship for Doctorate Studies; UC Berkeley; Margaret C. Walker Fund award for Systematic Entomology, Department of Environmental Science, Policy, and Management; France-Berkeley Fund (Invasive Insects and Mites of Mediterranean Climates); National Science Foundation Research Coordination Networks grant(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by: 1. United States Department of Agriculture (National Institute of Food and Agriculture, http://nifa.usda.gov) grant (2005-35302-16188) (Discrimination of whiteflies in the genus Bemisia) to GKR and JKB; 2. University of California Agricultural Experiment Station grant to GKR (http://ucanr.edu/); 3. An A.G. Leventis Foundation (Cyprus) Scholarship for Doctorate Studies to MH (http://www.leventisfoundation.org/en/); 4. Research grants and doctorate fellowships from UC Berkeley to MH, including a Margaret C. Walker Fund award for Systematic Entomology, Department of Environmental Science, Policy, and Management (https://ourenvironment.berkeley.edu/current-graduate-students/funding); 5. The France-Berkeley Fund (Invasive Insects and Mites of Mediterranean Climates) to GKR (http://live-fbf.pantheon.berkeley.edu/); and 6. National Science Foundation Research Coordination Networks grant (Invasive Insects: 0342279) to GKR (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=11691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi I, 2003, B ENTOMOL RES, V93, P97, DOI 10.1079/BER2003223; Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; ANTHONY NM, 1995, PESTIC BIOCHEM PHYS, V51, P220, DOI 10.1006/pest.1995.1022; Ballard JWO, 2004, MOL ECOL, V13, P729, DOI 10.1046/j.1365-294X.2003.02063.x; Banks G, 1998, 2 INT WORKSH BERN GE; Banks G K, 1999, Plant Dis, V83, P486, DOI 10.1094/PDIS.1999.83.5.486B; Beheregaray Luciano B, 2007, J Biol, V6, P9, DOI 10.1186/jbiol60; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bosco D, 2006, PHYTOPARASITICA, V34, P243, DOI 10.1007/BF02980951; Boykin LM, 2007, MOL PHYLOGENET EVOL, V44, P1306, DOI 10.1016/j.ympev.2007.04.020; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Brown DM, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-57; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK., 2007, PLANT DIS FEATURE; Brown Judith K., 2010, P31; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bush GL, 2004, CAMBRIDGE STUDIES AD, V3, P229; Byrne FJ, 1996, BIOCHEM GENET, V34, P93, DOI 10.1007/BF02396243; Caballero R., 2006, SYSTEMATICS BEMISIA; CALLEN DF, 1993, AM J HUM GENET, V52, P922; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cervera MT, 2000, B ENTOMOL RES, V90, P391, DOI 10.1017/S0007485300000523; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; CHARLESWORTH B, 1982, EVOLUTION, V36, P474, DOI 10.1111/j.1558-5646.1982.tb05068.x; Chu D, 2008, INSECT SCI, V15, P115, DOI 10.1111/j.1744-7917.2008.00191.x; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2012, INSECT SCI, V19, P595, DOI 10.1111/j.1744-7917.2011.01500.x; COATS SA, 1994, INSECT BIOCHEM MOLEC, V24, P723, DOI 10.1016/0965-1748(94)90060-4; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; COSTA HS, 1991, ENTOMOL EXP APPL, V61, P211, DOI 10.1007/BF00187724; COSTA HS, 1993, INSECT SCI APPL, V14, P255, DOI 10.1017/S1742758400014703; Coyne J.A., 2004, SPECIATION; Dalmon A, 2008, HEREDITY, V100, P316, DOI 10.1038/sj.hdy.6801080; Dalton R, 2006, NATURE, V443, P898, DOI 10.1038/443898a; De Barro PJ, 2008, BIOL INVASIONS, V10, P411, DOI 10.1007/s10530-007-9141-x; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Barro PJ, 2000, MOL PHYLOGENET EVOL, V16, P29, DOI 10.1006/mpev.1999.0768; De Barro PJ, 2005, B ENTOMOL RES, V95, P193, DOI 10.1079/BER2004351; De Barro PJ, 2003, MOL ECOL NOTES, V3, P40, DOI 10.1046/j.1471-8286.2003.00344.x; De la Rua P, 2006, J ZOOL SYST EVOL RES, V44, P25, DOI 10.1111/j.1439-0469.2005.00336.x; Delatte H, 2006, GENET RES, V87, P109, DOI 10.1017/S0016672306008135; Demichelis S, 2005, PHYTOPARASITICA, V33, P196, DOI 10.1007/BF03029979; Dennehy TJ, 2010, J ECON ENTOMOL, V103, P2174, DOI 10.1603/EC10239; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dolman G, 2006, EVOLUTION, V60, P573, DOI 10.1554/05-487.1; Drayton G. M., 2009, New Zealand Plant Protection, V62, P310; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edwards SV, 2000, EVOLUTION, V54, P1839; ELLEGREN H, 1995, NAT GENET, V11, P360, DOI 10.1038/ng1295-360; Elmer KR, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-247; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; FEDER JL, 1994, P NATL ACAD SCI USA, V91, P7990, DOI 10.1073/pnas.91.17.7990; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Frohlich D., 1999, MOL ECOL, V8, P1593, DOI DOI 10.1046/J.1365-294X.1999.00754.X; Funk DJ, 2002, GENETICA, V116, P251, DOI 10.1023/A:1021236510453; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gauthier N, 2008, MOL ECOL RESOUR, V8, P1004, DOI 10.1111/j.1755-0998.2008.02163.x; Gauthier N, 2014, PEST MANAG SCI, V70, P1477, DOI 10.1002/ps.3733; Gawel N.J., 1993, Insect Molecular Biology, V2, P33, DOI 10.1111/j.1365-2583.1993.tb00123.x; Gill Raymond J., 2010, P5; Gnankine O, 2013, INSECT CONSERV DIVER, V6, P411, DOI 10.1111/j.1752-4598.2012.00206.x; Gompert Z, 2008, MOL ECOL, V17, P5231, DOI 10.1111/j.1365-294X.2008.03988.x; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hadjistylli M, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu010; Hadjistylli M., 2010, USITC PUBL; Hadjistylli M, 2010, TOOLS RECENT PROGR S, P69; Hadjistylli M, 2015, PHYTOPARASITICA, V43, P679, DOI 10.1007/s12600-015-0480-3; Himler AG, 2011, SCIENCE, V332, P254, DOI 10.1126/science.1199410; Hoffmann AA, 1997, INFLUENTIAL PASSENGERS, P42; Horowitz AR, 2005, ARCH INSECT BIOCHEM, V58, P216, DOI 10.1002/arch.20044; Horowitz AR, 2003, PHYTOPARASITICA, V31, P94, DOI 10.1007/BF02979772; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Hutter CM, 1998, MOL BIOL EVOL, V15, P1620, DOI 10.1093/oxfordjournals.molbev.a025890; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Langella O., 1999, POPULATIONS 1 2 30 P; Lee W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063817; Legg JP, 1996, J APPL ENTOMOL, V120, P523, DOI 10.1111/j.1439-0418.1996.tb01646.x; Letunic I., 2011, NUCLEIC ACIDS RES; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Martinez-Carrillo JL, 2007, PHYTOPARASITICA, V35, P282, DOI 10.1007/BF02981162; Michalakis Y, 1996, GENETICS, V142, P1061; NEI M, 1978, GENETICS, V89, P583; Nirgianaki A, 2003, CURR MICROBIOL, V47, P93, DOI 10.1007/s00284-002-3969-1; Paetkau D, 1997, GENETICS, V147, P1943; Parrella G, 2012, J PEST SCI, V85, P227, DOI 10.1007/s10340-012-0417-2; Parrella G, 2014, PEST MANAG SCI, V70, P1514, DOI 10.1002/ps.3686; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; PEMBERTON JM, 1995, MOL ECOL, V4, P249, DOI 10.1111/j.1365-294X.1995.tb00214.x; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Pfenninger M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-121; Pritchard JK, 2000, GENETICS, V155, P945; Qiu BL, 2007, PROG NAT SCI-MATER, V17, P645; R Core Team, 2012, LANG ENV STTA COMP C; Rauch N, 2003, ARCH INSECT BIOCHEM, V54, P165, DOI 10.1002/arch.10114; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosell RC, 1997, ANN ENTOMOL SOC AM, V90, P575, DOI 10.1093/aesa/90.5.575; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Saleh D, 2012, POPUL ECOL, V54, P261, DOI 10.1007/s10144-012-0303-z; Schlotterer C, 2001, GENET RES, V78, P209, DOI 10.1017/S0016672301005444; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Scott I. A. W., 2007, New Zealand Plant Protection, V60, P264; Simon B, 2003, B ENTOMOL RES, V93, P259, DOI 10.1079/BER2003233; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Smouse PE, 1999, HEREDITY, V82, P561, DOI 10.1038/sj.hdy.6885180; Sseruwagi P, 2006, ENTOMOL EXP APPL, V119, P145, DOI 10.1111/j.1570-7458.2006.00402.x; Sseruwagi P, 2005, ANN APPL BIOL, V147, P253, DOI 10.1111/j.1744-7348.2005.00026.x; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tsagkarakou A, 2007, B ENTOMOL RES, V97, P29, DOI 10.1017/S000748530700466X; Tsagkarakou A, 2012, B ENTOMOL RES, V102, P353, DOI 10.1017/S0007485311000757; Tsagkarakou A, 2003, MOL ECOL NOTES, V3, P196, DOI 10.1046/j.1471-8286.2003.00393.x; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Ueda S, 2006, PHYTOPARASITICA, V34, P405, DOI 10.1007/BF02981027; WAKE DB, 1983, J THEOR BIOL, V101, P211, DOI 10.1016/0022-5193(83)90335-1; Weeks AR, 2003, CONT T ENT, P165; Weir B. S., 1996, GENETIC DATA ANAL; Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587; WOOL D, 1989, J APPL ENTOMOL, V107, P344, DOI 10.1111/j.1439-0418.1989.tb00267.x; Zchori-Fein E, 2002, ANN ENTOMOL SOC AM, V95, P711, DOI 10.1603/0013-8746(2002)095[0711:DOPAWB]2.0.CO;2; Zhang LP, 2005, J APPL ENTOMOL, V129, P121, DOI 10.1111/j.1439-0418.2005.00950.x	132	44	45	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165105	10.1371/journal.pone.0165105	http://dx.doi.org/10.1371/journal.pone.0165105			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855173	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200007
J	Reyes, LF; Restrepo, MI; Hinojosa, CA; Soni, NJ; Shenoy, AT; Gilley, RP; Gonzalez-Juarbe, N; Noda, JR; Winter, VT; de la Garza, MA; Shade, RE; Coalson, JJ; Giavedoni, LD; Anzueto, A; Orihuela, CJ				Reyes, Luis F.; Restrepo, Marcos I.; Hinojosa, Cecilia A.; Soni, Nilam J.; Shenoy, Anukul T.; Gilley, Ryan P.; Gonzalez-Juarbe, Norberto; Noda, Julio R.; Winter, Vicki T.; de la Garza, Melissa A.; Shade, Robert E.; Coalson, Jacqueline J.; Giavedoni, Luis D.; Anzueto, Antonio; Orihuela, Carlos J.			A Non-Human Primate Model of Severe Pneumococcal Pneumonia	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; STREPTOCOCCUS-PNEUMONIAE; INFLAMMATORY MARKERS; LUNG ULTRASOUND; HOSPITALIZATION; DIAGNOSIS; MOUSE; CORTICOSTEROIDS; RESPONSES; SEQUENCE	Rationale Streptococcus pneumoniae is the leading cause of community-acquired pneumonia and infectious death in adults worldwide. A non-human primate model is needed to study the molecular mechanisms that underlie the development of severe pneumonia, identify diagnostic tools, explore potential therapeutic targets, and test clinical interventions during pneumococcal pneumonia. Objective To develop a non-human primate model of pneumococcal pneumonia. Methods Seven adult baboons (Papio cynocephalus) were surgically tethered to a continuous monitoring system that recorded heart rate, temperature, and electrocardiography. Animals were inoculated with 10(9) colony-forming units of S. pneumoniae using bronchoscopy. Three baboons were rescued with intravenous ampicillin therapy. Pneumonia was diagnosed using lung ultrasonography and ex vivo confirmation by histopathology and immunodetection of pneumococcal capsule. Organ failure, using serum biomarkers and quantification of bacteremia, was assessed daily. Results Challenged animals developed signs and symptoms of pneumonia 4 days after infection. Infection was characterized by the presence of cough, tachypnea, dyspnea, tachycardia and fever. All animals developed leukocytosis and bacteremia 24 hours after infection. A severe inflammatory reaction was detected by elevation of serum cytokines, including Interleukin (IL)1Ra, IL-6, and IL-8, after infection. Lung ultrasonography precisely detected the lobes with pneumonia that were later confirmed by pathological analysis. Lung pathology positively correlated with disease severity. Antimicrobial therapy rapidly reversed symptomology and reduced serum cytokines. Conclusions We have developed a novel animal model for severe pneumococcal pneumonia that mimics the clinical presentation, inflammatory response, and infection kinetics seen in humans. This is a novel model to test vaccines and treatments, measure biomarkers to diagnose pneumonia, and predict outcomes.	[Reyes, Luis F.; Restrepo, Marcos I.; Hinojosa, Cecilia A.; Soni, Nilam J.; Noda, Julio R.; Anzueto, Antonio] Univ Texas Hlth Sci Ctr San Antonio, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA; [Reyes, Luis F.; Restrepo, Marcos I.; Hinojosa, Cecilia A.; Soni, Nilam J.; Noda, Julio R.; Anzueto, Antonio] South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, San Antonio, TX USA; [Gilley, Ryan P.; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Shenoy, Anukul T.; Gonzalez-Juarbe, Norberto; Orihuela, Carlos J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Winter, Vicki T.; Coalson, Jacqueline J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [de la Garza, Melissa A.; Shade, Robert E.; Giavedoni, Luis D.] Texas Biomed Res Inst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio; University of Alabama System; University of Alabama Birmingham; University of Texas System; University of Texas Health San Antonio; Texas Biomedical Research Institute	Restrepo, MI (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Pulm Dis & Crit Care Med, San Antonio, TX 78229 USA.; Restrepo, MI (corresponding author), South Texas Vet Hlth Care Syst, Div Pulm Dis & Crit Care Med, San Antonio, TX USA.	restrepom@uthscsa.edu	Shenoy, Anukul/AAD-9552-2021; Nilam Soni, Nilam J Soni/AAU-4098-2021; Reyes, Luis Felipe/ACX-9822-2022; Reyes, Luis/AAR-8202-2020	Nilam Soni, Nilam J Soni/0000-0002-8460-0323; Shenoy, Anukul/0000-0001-8861-2295; Reyes, Luis Felipe/0000-0003-1172-6539	National Heart, Lung, and Blood Institute [K23HL096054]; NIH [AI114800]; Southwest National Primate Research Center grant from the Office of Research Infrastructure Programs, NIH [P51 OD011133]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120, TL1TR001119] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI114800, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM088010] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011133] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Southwest National Primate Research Center grant from the Office of Research Infrastructure Programs, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MIR's time is partially protected by Award Number K23HL096054 from the National Heart, Lung, and Blood Institute. CJO receives support from NIH grant AI114800. This investigation used resources that were supported by the Southwest National Primate Research Center grant P51 0D011133 from the Office of Research Infrastructure Programs, NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of any of the funding agencies or sources of support received during this specific study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram AR, 2010, CHEST, V138, P825, DOI 10.1378/chest.09-3071; BERENDT RF, 1975, J INFECT DIS, V132, P689, DOI 10.1093/infdis/132.6.689; Berlet T, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0248-9; Bordon JM, 2015, INFECTION, V43, P729, DOI 10.1007/s15010-015-0837-z; Brown AO, 2015, JOVE-J VIS EXP, DOI 10.3791/52590; Brown AO, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004383; Chiavolini D, 2008, CLIN MICROBIOL REV, V21, P666, DOI 10.1128/CMR.00012-08; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Faverio P, 2014, EUR J INTERN MED, V25, P312, DOI 10.1016/j.ejim.2013.12.001; Fernandez-Botran R, 2014, INFLAMMATION, V37, P1158, DOI 10.1007/s10753-014-9840-2; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; Gilley RP, 2016, INFECT IMMUN, V84, P1457, DOI 10.1128/IAI.00007-16; Hew Mark, 2015, BMJ Open, V5, pe007838, DOI 10.1136/bmjopen-2015-007838; Jain S, 2015, NEW ENGL J MED, V373, P415, DOI [10.1056/NEJMoa1500245, 10.1056/NEJMc1511751]; Kean LS, 2012, AM J TRANSPLANT, V12, P812, DOI 10.1111/j.1600-6143.2011.03873.x; Koch R, 1890, Br Med J, V2, P380; Kraft BD, 2014, AM J RESP CELL MOL, V50, P995, DOI 10.1165/rcmb.2013-0340OC; Lichtenstein DA, 2004, INTENS CARE MED, V30, P276, DOI 10.1007/s00134-003-2075-6; Lichtenstein DA, 2008, CHEST, V134, P117, DOI 10.1378/chest.07-2800; Lichtenstein DA, 2015, CHEST, V147, P1659, DOI 10.1378/chest.14-1313; Nuermberger E, 2005, INT J ANTIMICROB AG, V26, P497, DOI 10.1016/j.ijantimicag.2005.08.022; Nuermberger E, 2005, PHARMACOTHERAPY, V25, p134S, DOI 10.1592/phco.2005.25.12part2.134S; Philipp MT, 2006, J MED PRIMATOL, V35, P113, DOI 10.1111/j.1600-0684.2006.00164.x; Prina E, 2015, LANCET, V386, P1097, DOI 10.1016/S0140-6736(15)60733-4; Rae N, 2016, CURR OPIN PULM MED, V22, P212, DOI 10.1097/MCP.0000000000000261; Restrepo MI, 2015, ANN INTERN MED, V163, P560, DOI 10.7326/M15-1805; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Restrepo MI, 2009, INFECT DIS CLIN N AM, V23, P503, DOI 10.1016/j.idc.2009.04.003; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; SHADE RE, 1990, AM J PHYSIOL, V258, pR930, DOI 10.1152/ajpregu.1990.258.4.R930; Strouse S, 1909, J EXP MED, V11, P743, DOI 10.1084/jem.11.5.743; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Tilghman RC, 1936, J CLIN INVEST, V15, P493, DOI 10.1172/JCI100799; Torres A, 2015, JAMA-J AM MED ASSOC, V313, P677, DOI 10.1001/jama.2015.88; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wade KR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004353; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Ye X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130066; Yende S, 2005, AM J RESP CRIT CARE, V172, P1440, DOI 10.1164/rccm.200506-888OC; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	42	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166092	10.1371/journal.pone.0166092	http://dx.doi.org/10.1371/journal.pone.0166092			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855182	Green Submitted, gold, Green Published			2022-12-26	WOS:000387910200018
J	Gonzalez-Betancor, SM; Lopez-Puig, AJ				Gonzalez-Betancor, Sara M.; Lopez-Puig, Alexis J.			Grade Retention in Primary Education Is Associated with Quarter of Birth and Socioeconomic Status	PLOS ONE			English	Article							CHILD-CARE PREDICTORS; KINDERGARTEN RETENTION; PRESCHOOL EDUCATION; PRE-K; ACHIEVEMENT; STUDENTS; 1ST-GRADE; FAMILY; REPETITION; PROGRAM	Grade retention is still common practice in some countries though longstanding experience tells us that it is a highly criticised practice for its unclear benefits, its important costs for the educational systems and its relation with school dropout. Therefore, the aim of the present study is to analyse which variables increase the probability of being retained in primary education differentiating between being retained in second or in fourth grade, and paying special attention to the role of the socioeconomic status of the families. By knowing which analysed variables are related to grade retention, and how, we may offer some suggestions to reduce it. We use a national dataset with more observations for Spain than any other international ones, called 'Evaluacion General de Diagnostico', conducted in Spain in 2009 with the participation of 28708 students of fourth grade of primary education from 874 schools, considered to be representative for every Spanish autonomous region. This assessment focused on four competences and includes information about the learning context collected through questionnaires for students, families, school management and teachers. Estimating different multilevel random-intercept logistic regressions we obtain the following three main findings: 1) the existence of a 'quarter of birth' effect, that nearly doubles the probability of grade retention in second grade of primary compared to the probability of grade retention in fourth grade, for the youngest students of their same age cohort (OR = 1.93 vs. OR = 1.53, both p<0.001); 2) that the mothers' education level influences more than the fathers' one especially in second grade (OR = 0.20 vs. OR = 0.45, both p<0.001); and 3) that having an unemployed father increases the probability of grade retention much more than having an unemployed mother especially in second grade (OR = 1.48, p<0.005 vs. OR =1.18, p>0.05).	[Gonzalez-Betancor, Sara M.] Univ Las Palmas Gran Canaria, Dept Metodos Cuantitat Econ & Gest, Econ Salud & Polit Publ, Las Palmas Gran Canaria, Spain; [Lopez-Puig, Alexis J.] Univ Las Palmas Gran Canaria, Dept Ingn Elect & Automat, Las Palmas Gran Canaria, Spain; [Lopez-Puig, Alexis J.] ACCUEE, Gobierno De Canarias, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Gonzalez-Betancor, SM (corresponding author), Univ Las Palmas Gran Canaria, Dept Metodos Cuantitat Econ & Gest, Econ Salud & Polit Publ, Las Palmas Gran Canaria, Spain.	sara.gonzalez@ulpgc.es	González-Betancor, Sara M./P-8315-2015	González-Betancor, Sara M./0000-0002-2209-1922; Lopez-Puig, Alexis J./0000-0002-8254-3513				Alivernini F, 2013, EDUC STUD-UK, V39, P399, DOI 10.1080/03055698.2013.767187; Almond D, 2011, HBK ECON, V4, P1315, DOI 10.1016/S0169-7218(11)02413-0; Ammermueller A, 2009, J LABOR ECON, V27, P315, DOI 10.1086/603650; [Anonymous], APPL MEAS ED, DOI [10.1080/08957340902754635, DOI 10.1080/08957340902754635]; Barbetta G.P., 2003, ANN PUBLIC COOP ECON, V74, P529, DOI [https://doi.org/10.1111/j.1467-8292.2003.00234.x, DOI 10.1111/J.1467-8292.2003.00234.X, 10.1111/j.1467-8292.2003.00234.x]; Bedard K, 2006, Q J ECON, V121, P1437, DOI 10.1162/qjec.121.4.1437; Borodankova O, 2011, GRADE RETENTION COMP; Bowman-Perrott LJ, 2010, READ WRIT Q, V26, P91, DOI 10.1080/10573560903397064; Brown CA, 2011, EDUC POLICY, V25, P115, DOI 10.1177/0895904810386601; BYRD RS, 1994, PEDIATRICS, V93, P481; Calero J, 2010, REV EDUC-MADRID, P225; Carabaha J., 2015, REV ASOC SOCIOLOGIA, V8, P7; Carabana Morales J, 2011, REV ASOCIACI N SOCIO, V4, P283; Cham HN, 2015, J SCHOOL PSYCHOL, V53, P7, DOI 10.1016/j.jsp.2014.10.001; de Mendizabal AC, 2013, REV EDUC-MADRID, P562, DOI 10.4438/1988-592X-RE-2013-362-242; Conboy J, 2011, INT C ED ED PSYCH 20; Ferrera JMC, 2014, REV EDUC-MADRID, P12, DOI 10.4438/1988-592X-RE-2014-365-263; Ferrera JMC, 2011, REV ECON APL-SPAIN, V19, P117; Corman H, 2003, ECON EDUC REV, V22, P409, DOI 10.1016/S0272-7757(02)00070-5; COSDEN M, 1995, J SCHOOL PSYCHOL, V33, P123, DOI 10.1016/0022-4405(95)00002-4; DANIELS S, 1995, OXFORD REV EDUC, V21, P163, DOI 10.1080/0305498950210203; Downer JT, 2006, SCHOOL PSYCHOL REV, V35, P11; Ehmke T, 2008, Z ERZIEHWISS, V11, P368, DOI 10.1007/s11618-008-0033-3; El-Hassan K, 1998, J EDUC RES, V91, P279, DOI 10.1080/00220679809597555; Elder TE, 2009, J HUM RESOUR, V44, P641; Garcia Montalvo J., 2013, PIRLS TIMSS 2011 EST, VII, P55; Gil-Flores J, 2011, CULT EDUC, V23, P141, DOI 10.1174/113564011794728597; Gonzalez-Betancor SM, 2015, CULT EDUC, V27, P237, DOI 10.1080/11356405.2015.1034533; Gonzalez-Betancor SM, 2015, REV EDUC, V369, P151; Goos M, 2013, J SCHOOL PSYCHOL, V51, P323, DOI 10.1016/j.jsp.2013.03.002; Gormley WT, 2008, SOC SCI QUART, V89, P916, DOI 10.1111/j.1540-6237.2008.00591.x; Guzel CI, 2010, EGIT ARAST, V10, P93; Halpern R., 2013, TEACH COLL REC, V115, P1; Hillmert S, 2013, RES SOC STRAT MOBIL, V32, P7, DOI 10.1016/j.rssm.2013.02.002; Huerta Cuervo MR, 2010, GEST POLIT PUBLICA, V19, P420; Hughes JN, 2013, AM EDUC RES J, V50, P1336, DOI 10.3102/0002831213490784; Hughes JN, 2010, EDUC EVAL POLICY AN, V32, P166, DOI 10.3102/0162373710367682; Hurd S, 2008, BRIT EDUC RES J, V34, P19, DOI 10.1080/01411920701492035; Garcia-Perez JI, 2014, APPL ECON, V46, P1373, DOI 10.1080/00036846.2013.872761; Klapproth F, 2015, EUR J PSYCHOL EDUC, V30, P119, DOI 10.1007/s10212-014-0232-7; Ladd HF, 2012, J POLICY ANAL MANAG, V31, P203, DOI 10.1002/pam.21615; Magnuson KA, 2004, AM EDUC RES J, V41, P115, DOI 10.3102/00028312041001115; Magnuson KA, 2007, EARLY CHILD RES Q, V22, P18, DOI 10.1016/j.ecresq.2006.10.002; MANTZICOPOULOS P, 1992, AM EDUC RES J, V29, P182, DOI 10.2307/1162907; Martin M, PIRLS 20062008; Martin RP, 2004, J LEARN DISABIL-US, V37, P307, DOI 10.1177/00222194040370040301; MCLESKEY J, 1992, EXCEPT CHILDREN, V58, P548, DOI 10.1177/001440299205800609; MECD, 2015, SIST EST IND ED 2015; MECD, 2012, SIST EST IND ED; Ministerio de Educacion, 2010, EV GEN DIAGN 2009 ED; Mwaura PAM, 2008, INT J EARLY YEARS ED, V16, P237, DOI 10.1080/09669760802357121; Pedraja-Chaparro F, 2016, APPL ECON, V48, P1978, DOI 10.1080/00036846.2015.1111989; Pedraja-Chaparro F, 2015, J POLICY MODEL, V37, P820, DOI 10.1016/j.jpolmod.2015.04.004; Rabe-Hesketh S.S.A., 2005, MULTILEVEL LONGITUDI; Rao N, 2012, EARLY CHILD RES Q, V27, P66, DOI 10.1016/j.ecresq.2011.07.001; REYNOLDS AJ, 1992, EDUC EVAL POLICY AN, V14, P101, DOI 10.3102/01623737014002101; Robertson E, 2011, ECON EDUC REV, V30, P300, DOI 10.1016/j.econedurev.2010.10.005; Roman M, 2011, CEPAL REV, P37; Seyda S, 2009, Z ERZIEHWISS, V12, P233, DOI 10.1007/s11618-009-0073-3; Silberglitt B, 2006, SCHOOL PSYCHOL REV, V35, P134; Stinebrickner R, 2003, J HUM RESOUR, V38, P591, DOI 10.2307/1558769; Stull JC, 2013, RES EDUC, V90, P53, DOI 10.7227/RIE.90.1.4; Verachtert P, 2010, OXFORD REV EDUC, V36, P285, DOI 10.1080/03054981003629896; Winsler A, 2012, DEV PSYCHOL, V48, P1299, DOI 10.1037/a0026985; Wossmann L, 2010, APPL ECON, V42, P2645, DOI 10.1080/00036840801964617	65	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166431	10.1371/journal.pone.0166431	http://dx.doi.org/10.1371/journal.pone.0166431			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851779	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300048
J	Kobayashi, Y; Ikeda, K; Nakamura, T; Yamagata, M; Nakazawa, T; Tanaka, S; Furuta, S; Umibe, T; Nakajima, H				Kobayashi, Yoshihisa; Ikeda, Kei; Nakamura, Takayuki; Yamagata, Mieko; Nakazawa, Takuya; Tanaka, Shigeru; Furuta, Shunsuke; Umibe, Takeshi; Nakajima, Hiroshi			Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis	PLOS ONE			English	Article							ERYTHROCYTE SEDIMENTATION-RATE; DISEASE-ACTIVITY SCORE; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; FLEXOR TENOSYNOVITIS; PROGRESSION; TRIALS; JOINTS	Background and objectives Although morning stiffness has long been recognized as a characteristic feature of rheumatoid arthritis (RA), it is no more included in the 2010 ACR/EULAR Classification Criteria or in the current major instruments for evaluating disease activity of RA. In this cross-sectional study, we aimed to determine the independent value and the optimal measurement of morning stiffness by clarifying the associations between morning stiffness and synovial inflammation. Patients and methods We enrolled 76 consecutive RA patients who underwent musculoskeletal ultrasound examination and agreed to participate in the study. In addition to asking the duration of morning stiffness, we asked patients to complete a diagram which represents the time course of their morning stiffness in the dominant hand. Based on this diagram, we calculated the severity and the diurnal improvement of morning stiffness. We also determined the activity of intraarticular synovitis in 11 joints and tenosynovitis in 8 tendons/tendon compartments in the same hand by using power Doppler (PD) ultrasound with a semiquantitative score (0-3). Results For intra-articular synovitis, swollen/tender joint counts more strongly correlated with total PD scores (rho= 0.379-0.561, p <= 0.001) than did any parameters of morning stiffness (rho = 0.217-0.314, p = 0.006-0.021). For tenosynovitis, however, the severity on awakening and the improvement of morning stiffness more strongly correlated with total PD scores (rho =0.503 - 0.561, p < 0.001) than did swollen/ tender joint counts (rho = 0.276-0.388, p = 0.001-0.016). Multivariate analyses identified the severity on awakening and the improvement but not the duration of morning stiffness as factors that independently associate with the total tenosynovial PD score. Conclusions Our data demonstrate a pathophysiological link between morning stiffness and tenosynovitis and also give an insight into the optimal measurement of morning stiffness. Our data support an independent value of evaluating morning stiffness in the management of RA.	[Kobayashi, Yoshihisa; Ikeda, Kei; Nakamura, Takayuki; Yamagata, Mieko; Nakazawa, Takuya; Tanaka, Shigeru; Furuta, Shunsuke; Nakajima, Hiroshi] Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan; [Kobayashi, Yoshihisa; Umibe, Takeshi] Matsudo City Hosp, Ctr Rheumatol, Matsudo, Chiba, Japan; [Kobayashi, Yoshihisa] Chiba Aoba Municipal Hosp, Dept Internal Med, Chiba, Japan; [Nakamura, Takayuki] Asahi Gen Hosp, Res Ctr Allergy & Clin Immunol, Asahi Ku, Chiba, Japan; [Yamagata, Mieko] Natl Hosp Org, Shimoshizu Hosp, Dept Rheumatol, Yotsukaido, Chiba, Japan; [Nakazawa, Takuya] Natl Hosp Org, Chiba East Hosp, Dept Rheumatol Allergy & Clin Immunol, Chiba, Japan	Chiba University; Chiba University	Ikeda, K (corresponding author), Chiba Univ Hosp, Dept Allergy & Clin Immunol, Chiba, Japan.	K.Ikeda@faculty.chiba-u.jp	Nakajima, Hiroshi/AFU-9313-2022	Nakajima, Hiroshi/0000-0001-8595-9381; Tanaka, Shigeru/0000-0002-8466-110X				Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burgers LE, 2016, RHEUMATOLOGY OXFORD; Buttgereit F, 2008, LANCET, V371, P205, DOI 10.1016/S0140-6736(08)60132-4; Cash J, 2015, HARRISONS PRINCIPLES, P2216; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Cutolo M, 2011, SCAND J RHEUMATOL, V40, P17, DOI 10.3109/03009742.2011.566436; da Silva JAP, 2011, SCAND J RHEUMATOL, V40, P6, DOI 10.3109/03009742.2011.566434; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; FELSON DT, 1993, ARTHRITIS RHEUM-US, V36, P729, DOI 10.1002/art.1780360601; Funovits J, 2010, ANN RHEUM DIS, V69, P1589, DOI 10.1136/ard.2010.130310; Haavardsholm EA, 2009, ANN RHEUM DIS, V68, P1572, DOI 10.1136/ard.2008.091801; Hammer HB, 2011, SCAND J RHEUMATOL, V40, P178, DOI 10.3109/03009742.2010.517549; HAZES JMW, 1993, J RHEUMATOL, V20, P1138; HUG C, 1991, J RHEUMATOL, V18, P1055; Ikeda K, 2013, J RHEUMATOL, V40, P1967, DOI 10.3899/jrheum.130556; Iwamoto T, 2014, ARTHRIT CARE RES, V66, P1576, DOI 10.1002/acr.22303; Kalyoncu U, 2009, ANN RHEUM DIS, V68, P183, DOI 10.1136/ard.2007.084848; KIRWAN JR, 1984, ANN RHEUM DIS, V43, P686, DOI 10.1136/ard.43.5.686; Lillegraven S, 2011, ANN RHEUM DIS, V70, P2049, DOI 10.1136/ard.2011.151316; MILLIS MB, 1976, J BONE JOINT SURG AM, V58, P801, DOI 10.2106/00004623-197658060-00010; Nakagomi D, 2013, ARTHRITIS RHEUM, V65, P890, DOI DOI 10.1002/ART.37848; Orbai AM, 2015, J RHEUMATOL, V42, P2182, DOI 10.3899/jrheum.141172; Orbai AM, 2014, ARTHRIT CARE RES, V66, P1662, DOI 10.1002/acr.22374; PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308, DOI 10.1002/art.1780241012; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; SCOTT JT, 1960, ANN RHEUM DIS, V19, P361, DOI 10.1136/ard.19.4.361; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Soubrier M, 2006, J RHEUMATOL, V33, P1243; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; Wells G, 2009, ANN RHEUM DIS, V68, P954, DOI 10.1136/ard.2007.084459; Westhoff G, 2008, RHEUMATOLOGY, V47, P980, DOI 10.1093/rheumatology/ken137; Yazici Y, 2004, J RHEUMATOL, V31, P1723	34	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166616	10.1371/journal.pone.0166616	http://dx.doi.org/10.1371/journal.pone.0166616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851825	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300074
J	Saito, M; Kim, HS; Ito, A; Yokota, T; Maksyutov, S				Saito, Makoto; Kim, Heon-Sook; Ito, Akihiko; Yokota, Tatsuya; Maksyutov, Shamil			Enhanced Methane Emissions during Amazonian Drought by Biomass Burning	PLOS ONE			English	Article							RETRIEVAL ALGORITHM; ERROR-STATISTICS; CO2; INVERSIONS; VALIDATION; SATELLITE; AIRCRAFT; SIBERIA; SURFACE; MODEL	The Amazon is a significant source of atmospheric methane, but little is known about the source response to increasing drought severity and frequency. We investigated satellite observations of atmospheric column-averaged methane for the 2010 drought and subsequent 2011 wet year in the Amazon using an atmospheric inversion scheme. Our analysis indicates an increase in atmospheric methane over the southern Amazon region during the drought, representing an increase in annual emissions relative to the wet year. We attribute the increase to emissions from biomass burning driven by intense drought, combined with carbon monoxide showing seasonal variations corresponding to methane variations. We show that there is probably a strong correspondence between drought and methane emissions in the Amazon.	[Saito, Makoto; Kim, Heon-Sook; Ito, Akihiko; Yokota, Tatsuya; Maksyutov, Shamil] Natl Inst Environm Studies, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan	National Institute for Environmental Studies - Japan	Saito, M (corresponding author), Natl Inst Environm Studies, Ctr Global Environm Res, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.	saito.makoto@nies.go.jp	Ito, Akihiko/P-2624-2017; Saito, Makoto/AAL-4510-2021; Maksyutov, Shamil S/G-6494-2011	Ito, Akihiko/0000-0001-5265-0791; Maksyutov, Shamil S/0000-0002-1200-9577	Environment Research and Technology Development Fund, Ministry of Environment Japan [A-1202]	Environment Research and Technology Development Fund, Ministry of Environment Japan	This study was supported by Grant A-1202 of Environment Research and Technology Development Fund, Ministry of Environment Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This study was supported by Grant A-1202 of Environment Research and Technology Development Fund, Ministry of Environment Japan. We thank I. Morino, O. Uchino, Y. Yoshida, T. Machida, M. Sasakawa, the GOSAT project by NIES, CarbonTracker-CH<INF>4</INF>, CRU, EDGAR, GFED, GLOBALVIEW, JCDAS, MOPITT, and WDGCC for providing data. GOSAT data was obtained from the GOSAT User Interface Gateway at http://www.gosat.nies.go.jp/en/. Maptool uses the Generic Mapping Tools, version 5.2.1 (http://gmt.soest.hawaii.edu/).	Arnesen AS, 2013, REMOTE SENS ENVIRON, V130, P51, DOI 10.1016/j.rse.2012.10.035; Berchet A, 2013, ATMOS CHEM PHYS, V13, P7115, DOI 10.5194/acp-13-7115-2013; Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bruhwiler L, 2014, ATMOS CHEM PHYS, V14, P8269, DOI 10.5194/acp-14-8269-2014; Bruhwiler LMP, 2005, ATMOS CHEM PHYS, V5, P2691, DOI 10.5194/acp-5-2691-2005; Chapnik B, 2004, Q J ROY METEOR SOC, V130, P2253, DOI 10.1256/qj.03.26; Christensen T. R., 2010, METHANE CLIMATE CHAN, P27; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; CRUTZEN PJ, 1990, SCIENCE, V250, P1669, DOI 10.1126/science.250.4988.1669; Deeter MN, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003186; Dils B, 2014, ATMOS MEAS TECH, V7, P1723, DOI 10.5194/amt-7-1723-2014; Environmental Protection Agency (EPA), 2012, GLOBAL ANTHROPOGENIC; European Commission Joint Research Centre Netherlands Environmental Assessment Agency, 2010, EM DAT GLOB ATM RES; FEARNSIDE PM, 1990, ECOL STU AN, V84, P106; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; Fraser A, 2013, ATMOS CHEM PHYS, V13, P5697, DOI 10.5194/acp-13-5697-2013; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Ganesan AL, 2014, ATMOS CHEM PHYS, V14, P3855, DOI 10.5194/acp-14-3855-2014; Gatti LV, 2014, NATURE, V506, P76, DOI 10.1038/nature12957; GLOBALVIEW-CH4, 2009, COOP ATM DAT INT PRO; Guild LS, 2004, ECOL APPL, V14, pS232; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Ito A, 2012, BIOGEOSCIENCES, V9, P759, DOI 10.5194/bg-9-759-2012; Kim HS, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/035201; Kirschke S, 2013, NAT GEOSCI, V6, P813, DOI [10.1038/ngeo1955, 10.1038/NGEO1955]; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Law RM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001593; Liu JJ, 2014, TELLUS B, V66, DOI 10.3402/tellusb.v66.22486; Maksyutov S, 2013, ATMOS CHEM PHYS, V13, P9351, DOI 10.5194/acp-13-9351-2013; Malhi Y, 2006, GLOBAL CHANGE BIOL, V12, P1107, DOI 10.1111/j.1365-2486.2006.01120.x; Marengo JA, 2004, J CLIMATE, V17, P2261, DOI 10.1175/1520-0442(2004)017<2261:COTLJE>2.0.CO;2; Marengo JA, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047436; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Miller JB, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029213; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; Patra PK, 2011, ATMOS CHEM PHYS, V11, P4163, DOI [10.5194/acp-11-4163-2011, 10.5194/acp-11-12813-2011]; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Potter C, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000250; Saeki T, 2013, J GEOPHYS RES-ATMOS, V118, P1100, DOI 10.1002/jgrd.50127; Saleska SR, 2007, SCIENCE, V318, P612, DOI 10.1126/science.1146663; Sasakawa M, 2013, J GEOPHYS RES-ATMOS, V118, P9489, DOI 10.1002/jgrd.50755; Tsakiris G, 2007, WATER RESOUR MANAG, V21, P821, DOI 10.1007/s11269-006-9105-4; Tsutsumi Y, 2009, TECHNICAL REPORT GLO; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Wilson C, 2016, GLOBAL BIOGEOCHEM CY; Wood TE, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB004014; Yokota T, 2009, SOLA, V5, P160, DOI 10.2151/sola.2009-041; Yoshida Y, 2013, ATMOS MEAS TECH, V6, P1533, DOI 10.5194/amt-6-1533-2013	49	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166039	10.1371/journal.pone.0166039	http://dx.doi.org/10.1371/journal.pone.0166039			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851783	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300032
J	Davey, L; Halperin, SA; Lee, SF				Davey, Lauren; Halperin, Scott A.; Lee, Song F.			Mutation of the Streptococcus gordonii Thiol-Disulfide Oxidoreductase SdbA Leads to Enhanced Biofilm Formation Mediated by the CiaRH Two-Component Signaling System	PLOS ONE			English	Article							BINDING-PROTEIN-B; REGULATORY SYSTEM; RESPONSE REGULATOR; ORAL COLONIZATION; IMMUNE-RESPONSES; STRESS TOLERANCE; PNEUMONIAE R6; A ABPA; COMPETENCE; MUTANS	Streptococcus gordonii is a commensal inhabitant of human oral biofilms. Previously, we identified an enzyme called SdbA that played an important role in biofilm formation by S. gordonii. SdbA is thiol-disulfide oxidoreductase that catalyzes disulfide bonds in secreted proteins. Surprisingly, inactivation of SdbA results in enhanced biofilm formation. In this study we investigated the basis for biofilm formation by the Delta sdbA mutant. The results revealed that biofilm formation was mediated by the interaction between the CiaRH and ComDE twocomponent signalling systems. Although it did not affect biofilm formation by the S. gordonii parent strain, CiaRH was upregulated in the Delta sdbA mutant and it was essential for the enhanced biofilm phenotype. The biofilm phenotype was reversed by inactivation of CiaRH or by the addition of competence stimulating peptide, the production of which is blocked by CiaRH activity. Competition assays showed that the enhanced biofilm phenotype also corresponded to increased oral colonization in mice. Thus, the interaction between SdbA, CiaRH and ComDE affects biofilm formation both in vitro and in vivo.	[Davey, Lauren; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada; [Davey, Lauren; Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada; [Davey, Lauren; Halperin, Scott A.; Lee, Song F.] IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada; [Halperin, Scott A.; Lee, Song F.] Dalhousie Univ, Dept Pediat, Fac Med, Halifax, NS B3K 6R8, Canada; [Lee, Song F.] Dalhousie Univ, Dept Appl Oral Sci, Fac Med, Halifax, NS B3H 4R2, Canada	Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University; Dalhousie University	Lee, SF (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Canadian Ctr Vaccinol, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), IWK Hlth Ctr, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Dept Pediat, Fac Med, Halifax, NS B3K 6R8, Canada.; Lee, SF (corresponding author), Dalhousie Univ, Dept Appl Oral Sci, Fac Med, Halifax, NS B3H 4R2, Canada.	Song.Lee@Dal.Ca		Halperin, Scott/0000-0003-0525-589X; Davey, Lauren/0000-0002-9541-485X	Natural Sciences and Engineering Research Council of Canada [183712]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was funded by Natural Sciences and Engineering Research Council of Canada, grant #183712, to SL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2006, INFECT IMMUN, V74, P1631, DOI 10.1128/IAI.74.3.1631-1642.2006; Anwar N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106095; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Batoni G, 2016, BBA-BIOMEMBRANES, V1858, P1044, DOI 10.1016/j.bbamem.2015.10.013; Blanchette-Cain K, 2013, MBIO, V4, DOI 10.1128/mBio.00745-13; Burne RA, 1999, J BACTERIOL, V181, P2863, DOI 10.1128/JB.181.9.2863-2871.1999; Chaudhuri B, 2008, INFECT IMMUN, V76, P4530, DOI 10.1128/IAI.00186-08; Chaudhuri B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-60; Dagkessamanskaia A, 2004, MOL MICROBIOL, V51, P1071, DOI 10.1111/j.1365-2958.2003.03892.x; Davey L, 2016, MOL MICROBIOL, V99, P236, DOI 10.1111/mmi.13227; Davey L, 2016, J BACTERIOL, V198, P321, DOI 10.1128/JB.00800-15; Davey L, 2013, J BIOL CHEM, V288, P16416, DOI 10.1074/jbc.M113.464578; Davis E, 2011, APPL ENVIRON MICROB, V77, P1660, DOI 10.1128/AEM.02178-10; Du LD, 2000, INFECT IMMUN, V68, P4834, DOI 10.1128/IAI.68.8.4834-4837.2000; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUNNY GM, 1991, APPL ENVIRON MICROB, V57, P1194, DOI 10.1128/AEM.57.4.1194-1201.1991; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Halfmann A, 2011, J MOL MICROB BIOTECH, V20, P96, DOI 10.1159/000324893; Hendrickson EL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-211; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Huang R, 2014, APPL ENVIRON MICROB, V80, P7212, DOI 10.1128/AEM.02395-14; Jack AA, 2015, MICROBIOL-SGM, V161, P411, DOI 10.1099/mic.0.000010; Jakubovics NS, 2008, FEMS MICROBIOL ECOL, V66, P637, DOI 10.1111/j.1574-6941.2008.00585.x; Jakubovics NS, 2015, MOL MICROBIOL, V97, P281, DOI 10.1111/mmi.13023; Jakubovics NS, 2009, MICROBIOL-SGM, V155, P3572, DOI 10.1099/mic.0.032078-0; Knight JB, 2008, CLIN VACCINE IMMUNOL, V15, P925, DOI 10.1128/CVI.00500-07; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Lee SF, 2003, CURR OPIN INFECT DIS, V16, P231, DOI 10.1097/00001432-200306000-00008; Lee SF, 2002, FEMS MICROBIOL LETT, V208, P175, DOI 10.1016/S0378-1097(02)00457-3; Lee Y, 2008, FEMS MICROBIOL LETT, V278, P213, DOI 10.1111/j.1574-6968.2007.00993.x; Lee Y, 2009, FEMS MICROBIOL LETT, V297, P38, DOI 10.1111/j.1574-6968.2009.01650.x; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Liu YL, 2011, J BACTERIOL, V193, P2826, DOI 10.1128/JB.00056-11; Liu YL, 2009, J BACTERIOL, V191, P7353, DOI 10.1128/JB.01053-09; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Love RM, 1997, INFECT IMMUN, V65, P5157, DOI 10.1128/IAI.65.12.5157-5164.1997; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; Mascher T, 2006, J BACTERIOL, V188, P1959, DOI 10.1128/JB.188.5.1959-1968.2006; Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Pirias GE, 2008, MICROBIOLOGY, V154, P1300, DOI [10.1099/m5.0.2007/015925-0, DOI 10.1099/M5.0.2007/015925-0]; Prudhomme M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006113; Quach D, 2009, J BACTERIOL, V191, P2023, DOI 10.1128/JB.01216-08; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schnorpfeil A, 2013, MOL MICROBIOL, V89, P334, DOI 10.1111/mmi.12277; Sebert ME, 2002, INFECT IMMUN, V70, P4059, DOI 10.1128/IAI.70.8.4059-4067.2002; Tanzer JM, 2003, MICROBIOL-SGM, V149, P2653, DOI 10.1099/mic.0.26022-0; Throup JP, 2000, MOL MICROBIOL, V35, P566, DOI 10.1046/j.1365-2958.2000.01725.x; Trappetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019844; Tremblay YDN, 2009, MICROBIOL-SGM, V155, P2856, DOI 10.1099/mic.0.028456-0; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Wang BY, 2011, J DENT RES, V90, P501, DOI 10.1177/0022034510388808; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; Zhang Y, 2005, INFECT IMMUN, V73, P3351, DOI 10.1128/IAI.73.6.3351-3357.2005; Zhang YS, 2009, MICROBIOL-SGM, V155, P165, DOI 10.1099/mic.0.023168-0	60	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166656	10.1371/journal.pone.0166656	http://dx.doi.org/10.1371/journal.pone.0166656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846284	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600099
J	Butler, JM; Hirshberg, EL; Hopkins, RO; Wilson, EL; Orme, JF; Beesley, SJ; Kuttler, K; Brown, SM				Butler, Jorie M.; Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.			Preliminary Identification of Coping Profiles Relevant to Surrogate Decision Making in the ICU	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; PATIENT-REPORTED MEASURE; OF-LIFE CARE; POSTTRAUMATIC-STRESS; FAMILY-MEMBERS; SYMPTOMS; COLLABORATE; DEPRESSION; INVENTORY; DISCHARGE	Objective The Intensive Care Unit (ICU) is a stressful environment for families of critically ill patients and these individuals are at risk to develop persistent psychological morbidity. Our study objective was to identify individual differences in coping with stress and information presentation preferences of respondents exposed to a simulated ICU experience. Methods Participants were recruited from a university and two community populations. Participants completed questionnaires that measured demographic information and characteristics that may be relevant to an individual's ICU experience. Quality of life was measured by the EQ5D, personality dimensions were examined with the abbreviated Big Five inventory, coping with stress was assessed with Brief COPE. Shared decision making preferences were assessed by the Degner Control Preferences Scale (CPS) and information seeking style was assessed with the Miller Behavioral Style Scale (MBSS). Social support was examined using an abbreviated version of the Social Relationship Index. Participants also completed a vignette-based simulated ICU experience, in which they made a surrogate decision on behalf of a loved one in the ICU. Results Three hundred forty-three participants completed the study. Three distinct coping profiles were identified: adaptive copers, maladaptive copers, and disengaged copers. Profiles differed primarily on coping styles, personality, quality of their closest social relationship, and history of anxiety and depression. Responses to the simulated ICU decision making experience differed across profiles. Disengaged copers (15%) were more likely to elect to refuse dialysis on behalf of an adult sibling compared to adaptive copers (7%) or maladaptive copers (5%) (p = 0.03). Notably, the MBSS and the CPS did not differ by coping profile. Conclusion Distinct coping profiles are associated with differences in responses to a simulated ICU experience. Tailoring communication and support to specific coping profiles may represent an important pathway to improving ICU experience for patients and families.	[Butler, Jorie M.] George E Wahlen Dept Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA; [Butler, Jorie M.] Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA; [Butler, Jorie M.; Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.] Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA; [Hirshberg, Eliotte L.; Hopkins, Ramona O.; Wilson, Emily L.; Orme, James F.; Beesley, Sarah J.; Kuttler, Kathryn; Brown, Samuel M.] Intermt Med Ctr, Pulm & Crit Care Div, Dept Med, Murray, UT USA; [Hirshberg, Eliotte L.; Orme, James F.; Beesley, Sarah J.; Brown, Samuel M.] Univ Utah, Dept Internal Med, Div Pulm Med, Salt Lake City, UT 84112 USA; [Hirshberg, Eliotte L.] Univ Utah, Dept Pediat, Div Crit Care, Salt Lake City, UT USA; [Hopkins, Ramona O.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Hopkins, Ramona O.] Brigham Young Univ, Ctr Neurosci, Provo, UT 84602 USA; [Kuttler, Kathryn] Homer Warner Ctr Informat Res, Murray, UT USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Intermountain Healthcare; Intermountain Medical Center; Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Brigham Young University; Brigham Young University	Butler, JM (corresponding author), George E Wahlen Dept Vet Affairs Med Ctr, GRECC, Salt Lake City, UT 84148 USA.; Butler, JM (corresponding author), Univ Utah, Dept Internal Med, Div Geriatr, Salt Lake City, UT 84112 USA.; Butler, JM (corresponding author), Intermt Healthcare, Ctr Humanizing Crit Care, Murray, UT USA.	jorie.butler@hsc.utah.edu	Brown, Samuel/E-6846-2015	Brown, Samuel/0000-0003-1206-6261	Intermountain Research and Medical Foundation	Intermountain Research and Medical Foundation	Intermountain Research and Medical Foundation. https://intermountainhealthcare.org/giving-volunteering/intermountain-foundation/what-we-support/intermountain-research-medical-foundation/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Community Faces of Utah, including Pastor France A. Davis, Doriena Lee, Edwin Napia, Valentine Mukundente, Ana Sanchez-Birkhead, Jeannette Villata, Fahina Tavake-Pasi, Heather Coulter and Louisa Stark, as well as Cathy House at the Osher Lifelong Learning Center for their collaboration and assistance with obtaining survey data. We also thank Jonathan Butner, Jason Watson, and Nathan Story at the Department of Psychology at the University of Utah for assistance in data collection. Heather Gallo at Intermountain Healthcare provided superb support for the REDCAP online survey platform. Thank you to Jacqueline Telonidis for her invaluable assistance with manuscript preparation. Funding for this project was provided by the Intermountain Research and Medical Foundation. The authors declare no competing interests. License is granted to PLOSONE for publication. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	Anderson WG, 2008, J GEN INTERN MED, V23, P1871, DOI 10.1007/s11606-008-0770-2; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Azoulay E, 2014, ANN INTENSIVE CARE, V4, DOI 10.1186/s13613-014-0037-5; Barr PJ, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3085; Braun UK, 2014, PATIENT EDUC COUNS, V94, P334, DOI 10.1016/j.pec.2013.10.013; Brooks R, 2003, MEASUREMENT VALIDATI; Campo RA, 2009, J COMMUNITY PSYCHOL, V37, P471, DOI 10.1002/jcop.20308; Carlson EB, 2015, J CRIT CARE, V30, P557, DOI 10.1016/j.jcrc.2015.01.012; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cassell EJ, 2001, ANN INTERN MED, V134, P1120, DOI 10.7326/0003-4819-134-12-200106190-00012; Curtis JR, 2008, CHEST, V134, P835, DOI 10.1378/chest.08-0235; Curtis JR, 2016, AM J RESP CRIT CARE, V193, P154, DOI 10.1164/rccm.201505-0900OC; Curtis JR, 2012, CONTEMP CLIN TRIALS, V33, P1245, DOI 10.1016/j.cct.2012.06.010; Degner L F, 1997, Can J Nurs Res, V29, P21; DiGangi JA, 2013, CLIN PSYCHOL REV, V33, P728, DOI 10.1016/j.cpr.2013.05.002; Elwyn G, 2013, PATIENT EDUC COUNS, V93, P102, DOI 10.1016/j.pec.2013.05.009; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hickman RL, 2010, AM J CRIT CARE, V19, P410, DOI 10.4037/ajcc2010354; Jamerson PA, 1996, HEART LUNG, V25, P467, DOI 10.1016/S0147-9563(96)80049-5; Jox RJ, 2012, INT J GERIATR PSYCH, V27, P1045, DOI 10.1002/gps.2820; Khalaila R, 2013, J ADV NURS, V69, P1172, DOI 10.1111/j.1365-2648.2012.06109.x; Kleiber C, 1994, Am J Crit Care, V3, P70; Lautrette A, 2007, NEW ENGL J MED, V356, P469, DOI 10.1056/NEJMoa063446; McKiernan Margaret, 2010, Intensive Crit Care Nurs, V26, P254, DOI 10.1016/j.iccn.2010.06.004; Miller S. M., 1980, COPING HLTH, P145, DOI DOI 10.1007/978-1-4684-1042-6_8; Myhren H, 2011, PATIENT EDUC COUNS, V85, P237, DOI 10.1016/j.pec.2010.11.005; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Netzer Giora, 2014, Ann Am Thorac Soc, V11, P435, DOI 10.1513/AnnalsATS.201309-308OT; Parslow RA, 2006, PSYCHOL MED, V36, P387, DOI 10.1017/S0033291705006306; Patel SS, 2008, CLIN J AM SOC NEPHRO, V3, P587, DOI 10.2215/CJN.04040907; Pochard F, 2005, J CRIT CARE, V20, P90, DOI 10.1016/j.jcrc.2004.11.004; Pomey MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122499; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Shaller D., 2007, PATIENT CTR CARE WHA; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Sokol DK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7351; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Team RC, 2014, R LANG ENV STAT COMP; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Turan B, 2011, HEALTH PSYCHOL, V30, P814, DOI 10.1037/a0025664; Turnbull AE, 2016, CRIT CARE MED, V44, P1267, DOI 10.1097/CCM.0000000000001651; Watson D, 2005, J RES PERS, V39, P46, DOI 10.1016/j.jrp.2004.09.006; Wendler D, 2011, ANN INTERN MED, V154, P336, DOI 10.7326/0003-4819-154-5-201103010-00008; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams-Piehota P, 2005, HEALTH PSYCHOL, V24, P58, DOI 10.1037/0278-6133.24.1.58; Zaki M.J., 2014, DATA MINING ANAL FUN; Zoellner LA, 2009, J BEHAV THER EXP PSY, V40, P455, DOI 10.1016/j.jbtep.2009.06.001	47	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166542	10.1371/journal.pone.0166542	http://dx.doi.org/10.1371/journal.pone.0166542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835704	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200057
J	Guldner, D; Hwang, JK; Cardieri, MCD; Eren, M; Ziaei, P; Norton, MG; Souza, CD				Guldner, Delphine; Hwang, Julianne K.; Cardieri, Maria Clara D.; Eren, Meaghan; Ziaei, Parissa; Norton, M. Grant; Souza, Cleverson D.			In Vitro Evaluation of the Biological Responses of Canine Macrophages Challenged with PLGA Nanoparticles Containing Monophosphoryl Lipid A	PLOS ONE			English	Article							DENDRITIC CELLS; VACCINE DELIVERY; T-CELLS; NANOTECHNOLOGY; TECHNOLOGY; ENHANCE	Poly (lactic-co-glycolic acid) nanoparticles (PLGA NPs) have been considerably studied as a promising biodegradable delivery system to induce effective immune responses and to improve stability, safety, and cost effectiveness of vaccines. The study aimed at evaluating early inflammatory effects and cellular safety of PLGA NPs, co-encapsulating ovalbumin (PLGA/OVA NPs), as a model antigen and the adjuvant monophosphoryl lipid A (PLGA/MPLA NPs) as an adjuvant, on primary canine macrophages. The PLGA NPs constructs were prepared following the emulsion-solvent evaporation technique and further physicchemically characterized. Peripheral blood mononuclear cells were isolated from canine whole blood by magnetic sorting and further cultured to generate macrophages. The uptake of PLGA NP constructs by macrophages was demonstrated by flow cytometry, transmission electron microscopy and confocal microscopy. Macrophage viability and morphology were evaluated by trypan blue exclusion and light microscopy. Macrophages were immunophenotyped for the expression of MHC-I and MHC-II and gene expression of Interleukin-10 (IL-10), Interleukin-12 (IL-12p40), and tumor necrosis factor alpha (TNF-alpha) were measured. The results showed that incubation of PLGA NP constructs with macrophages revealed effective early uptake of the PLGA NPs without altering the viability of macrophages. PLGA/OVA/MPLA NPs strongly induced TNF-alpha and IL-12p40 expression by macrophages as well as increase relative expression of MHC-I but not MHC-II molecules. Taken together, these results indicated that PLGA NPs with addition of MPLA represent a good model, when used as antigen carrier, for further, in vivo, work aiming to evaluate their potential to induce strong, specific, immune responses in dogs.	[Guldner, Delphine; Hwang, Julianne K.; Cardieri, Maria Clara D.; Eren, Meaghan; Souza, Cleverson D.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Ziaei, Parissa; Norton, M. Grant] Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA	Washington State University; Washington State University	Souza, CD (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	souza@vetmed.wsu.edu		Hwang, Julianne/0000-0002-9222-1729	WSU - College of Veterinary Medicine	WSU - College of Veterinary Medicine	Most of this work was supported by WSU - College of Veterinary Medicine, intramural grants.; The authors would like to thank Elizabeth Laws for technical help. This work was supported by WSU-College of Veterinary Medicine, intramural grants.	Balogh L, 2007, NANOMED-NANOTECHNOL, V3, P281, DOI 10.1016/j.nano.2007.09.001; Bergman PJ, 2007, VET CLIN N AM-SMALL, V37, P1111, DOI 10.1016/j.cvsm.2007.06.005; Brewer JM, 2006, IMMUNOL LETT, V102, P10, DOI 10.1016/j.imlet.2005.08.002; Cooper DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113558; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Elamanchili P, 2007, J IMMUNOTHER, V30, P378, DOI 10.1097/CJI.0b013e31802cf3e3; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Joshi VB, 2013, HUM VACC IMMUNOTHER, V9, P2584, DOI 10.4161/hv.26136; Keijzer C, 2013, J CONTROL RELEASE, V168, P35, DOI 10.1016/j.jconrel.2013.02.027; Keijzer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026684; Kim H, 2016, CLIN EXP VACCINE RES, V5, P12, DOI 10.7774/cevr.2016.5.1.12; Li WD, 2014, VACCINES-BASEL, V2, P515, DOI 10.3390/vaccines2030515; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; Ma WX, 2012, INT J NANOMED, V7, P1475, DOI 10.2147/IJN.S29506; McVey S, 2010, VET CLIN N AM-SMALL, V40, P381, DOI 10.1016/j.cvsm.2010.02.001; Minigo G, 2007, VACCINE, V25, P1316, DOI 10.1016/j.vaccine.2006.09.086; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Peek LJ, 2008, ADV DRUG DELIVER REV, V60, P915, DOI 10.1016/j.addr.2007.05.017; Petrizzo A, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0231-9; Poteet E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136862; Proudfoot AG, 2014, IMMUNOL CELL BIOL, V92, P739, DOI 10.1038/icb.2014.73; Romagnani S, 1995, RES IMMUNOL, V146, P457, DOI 10.1016/0923-2494(96)83015-X; Sarti F, 2011, BIOMATERIALS, V32, P4052, DOI 10.1016/j.biomaterials.2011.02.011; Shurety W, 2000, J INTERF CYTOK RES, V20, P427, DOI 10.1089/107999000312379; Silva AL, 2015, VACCINE, V33, P847, DOI 10.1016/j.vaccine.2014.12.059; Valle I., 2015, J PREVENTIVE MED HYG, V56, P21; Wagner JL, 2002, TISSUE ANTIGENS, V59, P205, DOI 10.1034/j.1399-0039.2002.590304.x; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Wijewardana V, 2006, VET IMMUNOL IMMUNOP, V114, P37, DOI 10.1016/j.vetimm.2006.07.002; Wu F, 2009, MOL PHARMACEUT, V6, P1506, DOI 10.1021/mp900081y; Zhang N, 2008, BIOCONJUGATE CHEM, V19, P145, DOI 10.1021/bc700227z	34	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165477	10.1371/journal.pone.0165477	http://dx.doi.org/10.1371/journal.pone.0165477			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835636	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200006
J	Morese, R; Rabellino, D; Sambataro, F; Perussia, F; Valentini, MC; Bare, BG; Bosco, FM				Morese, Rosalba; Rabellino, Daniela; Sambataro, Fabio; Perussia, Felice; Valentini, Maria Consuelo; Bare, Bruno G.; Bosco, Francesca M.			Group Membership Modulates the Neural Circuitry Underlying Third Party Punishment	PLOS ONE			English	Article							MEASURING INDIVIDUAL-DIFFERENCES; VENTROMEDIAL PREFRONTAL DAMAGE; ECONOMIC DECISION-MAKING; ALTRUISTIC PUNISHMENT; PAROCHIAL ALTRUISM; COSTLY PUNISHMENT; INTERGROUP CONFLICT; GENDER-DIFFERENCES; STRONG RECIPROCITY; NORM ENFORCEMENT	This research aims to explore the neural correlates involved in altruistic punishment, parochial altruism and anti-social punishment, using the Third-Party Punishment (TPP) game. In particular, this study considered these punishment behaviors in in-group vs. out-group game settings, to compare how people behave with members of their own national group and with members of another national group. The results showed that participants act altruistically to protect in-group members. This study indicates that norm violation in in-group (but not in out-group) settings results in increased activity in the medial prefrontal cortex and temporo-parietal junction, brain regions involved in the mentalizing network, as the third-party attempts to understand or justify in-group members' behavior. Finally, exploratory analysis during anti-social punishment behavior showed brain activation recruitment of the ventromedial prefrontal cortex, an area associated with altered regulation of emotions.	[Morese, Rosalba; Perussia, Felice; Bare, Bruno G.; Bosco, Francesca M.] Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy; [Morese, Rosalba] Univ Svizzera Italiana, Fac Commun Sci, Lugano, Switzerland; [Rabellino, Daniela] Univ Western Ontario, Schulich Sch Med & Dent, Dept Psychiat, London, ON, Canada; [Sambataro, Fabio] Univ Udine, Dept Expt & Clin Med Sci DISM, Udine, Italy; [Valentini, Maria Consuelo] Hosp Citta Salute & Sci Torino, Dept Neuroradiol, Turin, Italy; [Bare, Bruno G.; Bosco, Francesca M.] Univ Turin, Neurosci Inst Turin, Turin, Italy	University of Turin; Universita della Svizzera Italiana; Western University (University of Western Ontario); University of Udine; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin	Morese, R (corresponding author), Univ Turin, Dept Psychol, Ctr Cognit Sci, Turin, Italy.; Morese, R (corresponding author), Univ Svizzera Italiana, Fac Commun Sci, Lugano, Switzerland.	rosalba.morese@unito.it	Morese, Rosalba/AAI-1008-2019; Morese, Rosalba/B-5444-2014; BOSCO, Francesca Marina/B-6746-2013	Morese, Rosalba/0000-0003-4939-6539; BOSCO, Francesca Marina/0000-0001-6101-8587	University of Turin	University of Turin	This research was supported by the University of Turin through project 2015 Action B "Neural correlates involved in punishment and reward behavior. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Balleine BW, 2007, J NEUROSCI, V27, P8161, DOI 10.1523/JNEUROSCI.1554-07.2007; Barraza JA, 2009, ANN NY ACAD SCI, V1167, P182, DOI 10.1111/j.1749-6632.2009.04504.x; Batson CD, 1999, EUR J SOC PSYCHOL, V29, P909, DOI 10.1002/(SICI)1099-0992(199911)29:7<909::AID-EJSP965>3.0.CO;2-L; Baumgartner T, 2012, HUM BRAIN MAPP, V33, P1452, DOI 10.1002/hbm.21298; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bortolotti S, 2015, ECON INQ, V53, P1207, DOI 10.1111/ecin.12187; Bosco FM, 2009, CONSCIOUS COGN, V18, P323, DOI 10.1016/j.concog.2008.12.007; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Bruneau EG, 2012, NEUROPSYCHOLOGIA, V50, P219, DOI 10.1016/j.neuropsychologia.2011.11.008; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Croson R, 2009, J ECON LIT, V47, P448, DOI 10.1257/jel.47.2.448; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Durham WH., 1991, COEVOLUTION GENES CU; Ellingsen T, 2013, ECON LETT, V118, P470, DOI 10.1016/j.econlet.2012.12.010; Enzi B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119150; Fehr E, 2000, J ECON PERSPECT, V14, P159, DOI 10.1257/jep.14.3.159; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fershtman C, 2001, Q J ECON, V116, P351, DOI 10.1162/003355301556338; Flavell J.H., 1998, HDB CHILD PSYCHOL, P851; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Goette L, 2012, MANAGE SCI, V58, P948, DOI 10.1287/mnsc.1110.1466; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Halevy N, 2012, J BEHAV DECIS MAKING, V25, P188, DOI 10.1002/bdm.726; Hassin RR, 2007, P NATL ACAD SCI USA, V104, P19757, DOI 10.1073/pnas.0704679104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Jensen K, 2010, PHILOS T R SOC B, V365, P2635, DOI 10.1098/rstb.2010.0146; Kirman A, 2010, PHILOS T R SOC B, V365, P303, DOI 10.1098/rstb.2009.0192; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Knoch D, 2010, PSYCHOL SCI, V21, P337, DOI 10.1177/0956797609360750; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Knutson B, 2007, ANN NY ACAD SCI, V1104, P54, DOI 10.1196/annals.1390.020; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Levine M, 2005, PERS SOC PSYCHOL B, V31, P443, DOI 10.1177/0146167204271651; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Moretti L, 2009, J COGNITIVE NEUROSCI, V21, P128, DOI 10.1162/jocn.2009.21011; Nosek BA, 2006, PROJECT IMPLICIT ADV; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PREMACK D, 1979, SCIENCE, V206, P1202, DOI 10.1126/science.206.4423.1202; Rabellino D, 2016, J COGN PSYCHOL, V28, P1, DOI [10.1060/204459112016.1136981, DOI 10.1060/204459112016.1136981]; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Robinson JL, 2012, NEUROIMAGE, V60, P117, DOI 10.1016/j.neuroimage.2011.12.010; Saaksvuori L, 2011, P ROY SOC B-BIOL SCI, V278, P3428, DOI 10.1098/rspb.2011.0252; Sambataro F, 2006, EUR J NEUROSCI, V24, P2355, DOI 10.1111/j.1460-9568.2006.05120.x; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Schnall S, 2008, PERS SOC PSYCHOL B, V34, P1096, DOI 10.1177/0146167208317771; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Seymour B, 2007, NAT REV NEUROSCI, V8, P300, DOI 10.1038/nrn2119; Shinada M, 2004, EVOL HUM BEHAV, V25, P379, DOI 10.1016/j.evolhumbehav.2004.08.001; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; TAJFEL H., 1986, DIFFERENTIATION SOCI, P7, DOI [10.4324/9780203505984-16, DOI 10.4324/9780203505984-16]; Tajfel J, 1971, EUROPEAN J SOCIAL PS, V1, P149; Tomasello M, 2009, WHY WE COOPERATE, P1; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789	76	21	22	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166357	10.1371/journal.pone.0166357	http://dx.doi.org/10.1371/journal.pone.0166357			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835675	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200043
J	Guillot, R; Muriach, B; Rocha, A; Rotllant, J; Kelsh, RN; Cerda-Reverter, JM				Guillot, Raul; Muriach, Borja; Rocha, Ana; Rotllant, Josep; Kelsh, Robert N.; Miguel Cerda-Reverter, Jose			Thyroid Hormones Regulate Zebrafish Melanogenesis in a Gender-Specific Manner	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; NEURAL CREST; CELL; EXPRESSION; PATTERN; FOXD3; MITF	Zebrafish embryos are treated with anti-thyroidal compounds, such as phenylthiourea, to inhibit melanogenesis. However, the mechanism whereby the thyroidal system controls melanin synthesis has not been assessed in detail. In this work, we tested the effect of the administration of diets supplemented with T3 (500 mu g/g food) on the pigment pattern of adult zebrafish. Oral T3 induced a pronounced skin paling in both adult female and male zebrafish that was reversible upon cessation of treatment. The number of visible melanophores was significantly reduced in treated fish. Accordingly, treatment down-regulated expression of tyrosinase-related protein 1 in both sexes. We also found sexually dimorphic regulation of some melanogenic genes, such as Dct/Tyrp2 that was dramatically up-regulated in females after T3 treatment. Thus, we demonstrated that melanogenesis is reversibly inhibited by thyroid hormones in adult zebrafish and make the discovery of gender-specific differences in the response of melanogenic gene expression. Thus, fish gender is now shown to be an important variable that should be controlled in future studies of fish melanogenesis.	[Guillot, Raul; Rocha, Ana; Miguel Cerda-Reverter, Jose] IATS CSIC, Dept Fish Physiol & Biotechnol, Ribera De Cabanes 12595, Castellon, Spain; [Muriach, Borja] Univ CEU Cardenal Herrera, Fac Ciencias Salud, Castellon de La Plana 12006, Spain; [Rotllant, Josep] IIM CSIC, Aquat Mol Pathobiol Grp, Vigo 36208, Spain; [Kelsh, Robert N.] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Kelsh, Robert N.] Univ Bath, Dev Biol Programme, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); Universidad CEU Cardenal Herrera; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Bath; University of Bath	Cerda-Reverter, JM (corresponding author), IATS CSIC, Dept Fish Physiol & Biotechnol, Ribera De Cabanes 12595, Castellon, Spain.	jm.cerda.reverter@csic.es	Cerda-Reverter, Jose Miguel/K-4934-2014; Guillot, Raúl/Z-1884-2019; Rocha, Ana/J-3658-2012; Kelsh, Robert/B-6445-2008; Rotllant, Josep/K-1146-2014	Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Rocha, Ana/0000-0003-2165-5519; Kelsh, Robert/0000-0002-9381-0066; Guillot, Raul/0000-0001-9248-7263; Rotllant, Josep/0000-0001-5331-807X	Ministerio de Economia y Competitividad [AGL2013-46448-C3-3-R, AGL2014-52473R]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L00769X/1]; Medical Research Council (MRC) [MR/J001457/1]; MRC [MR/J001457/1] Funding Source: UKRI; Medical Research Council [MR/J001457/1] Funding Source: researchfish	Ministerio de Economia y Competitividad(Spanish Government); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Ministerio de Economia y Competitividad grant numbers AGL2013-46448-C3-3-R and AGL2014-52473R (http//www.mineco.gob.es), Biotechnology and Biological Sciences Research Council (BBSRC) grant number BB/L00769X/1 (http://www.bbsrc.ac.uk), and Medical Research Council (MRC) grant number MR/J001457/1 (http/www.mrc.ac.uk).	Budi EH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002044; Curran K, 2010, DEV BIOL, V344, P107, DOI 10.1016/j.ydbio.2010.04.023; Curran K, 2009, DEV BIOL, V332, P408, DOI 10.1016/j.ydbio.2009.06.010; Darias MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068844; Dong W., 2014, ENDOCR DISRUPTORS, V2, pe969072, DOI [10.4161/23273739.2014.969072, DOI 10.4161/23273739.2014.969072]; Dooley CM, 2013, DEVELOPMENT, V140, P1003, DOI 10.1242/dev.087007; Hirata M, 2005, DEV DYNAM, V234, P293, DOI 10.1002/dvdy.20513; Hirata M, 2003, DEV DYNAM, V227, P497, DOI 10.1002/dvdy.10334; Ito S, 2008, PHOTOCHEM PHOTOBIOL, V84, P582, DOI 10.1111/j.1751-1097.2007.00238.x; Agulleiro MJ, 2013, MOL ENDOCRINOL, V27, P1934, DOI 10.1210/me.2013-1099; Karlsson J, 2001, MAR BIOTECHNOL, V3, P522, DOI 10.1007/s1012601-0053-4; Kelsh RN, 2000, MECH DEVELOP, V93, P161, DOI 10.1016/S0925-4773(00)00250-1; Krauss J, 2014, PIGM CELL MELANOMA R, V27, P827, DOI 10.1111/pcmr.12272; McMenamin SK, 2014, SCIENCE, V345, P1358, DOI 10.1126/science.1256251; Mukhi S, 2007, GEN COMP ENDOCR, V150, P486, DOI 10.1016/j.ygcen.2006.11.013; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Robinson KC, 2009, SEMIN CELL DEV BIOL, V20, P111, DOI 10.1016/j.semcdb.2008.11.016; Sarangarajan R, 2001, PIGMENT CELL RES; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; Walpita CN, 2007, GEN COMP ENDOCR, V152, P206, DOI 10.1016/j.ygcen.2007.02.020; Walpita CN, 2009, ENDOCRINOLOGY, V150, P530, DOI 10.1210/en.2008-0457	21	19	21	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166152	10.1371/journal.pone.0166152	http://dx.doi.org/10.1371/journal.pone.0166152			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832141	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000069
J	Karlsson, T; Lundholm, M; Widmark, A; Persson, E				Karlsson, Terese; Lundholm, Marie; Widmark, Anders; Persson, Emma			Tumor Cell-Derived Exosomes from the Prostate Cancer Cell Line TRAMP-C1 Impair Osteoclast Formation and Differentiation	PLOS ONE			English	Article							DOWN-MODULATE; MICRORNA	Skeletal metastatic disease is a deleterious consequence of dissemination of tumor cells from numerous primary sites, such as prostate, lung and breast. Skeletal metastases are still incurable, resulting in development of clinical complications and decreased survival for cancer patients with metastatic disease. During the last decade, tumor cell-derived microvesicles have been identified and suggested to be involved in cancer disease progression. Whether cancer exosomes are involved in tumor and bone cell interactions in the metastatic site is still, however, a rather unexplored field. Here we show that exosomes isolated from the murine prostate cancer cell line TRAMP-C1 dramatically decrease fusion and differentiation of monocytic osteoclast precursors to mature, multinucleated osteoclasts. The presence of tumor cell-derived exosomes also clearly decreased the expression of established markers for osteoclast fusion and differentiation, including DC-STAMP, TRAP, cathepsin K, and MMP-9. In contrast, exosomes derived from murine fibroblastic cells did not affect osteoclast formation. Our findings suggest that exosomes released from tumor cells in the tumor-bone interface are involved in pathological regulation of bone cell formation in the metastatic site. This further strengthens the role of tumor cell-derived microvesicles in cancer progression and disease aggressiveness.	[Karlsson, Terese; Widmark, Anders; Persson, Emma] Umea Univ, Div Oncol, Dept Radiat Sci, Umea, Sweden; [Lundholm, Marie] Umea Univ, Div Pathol, Dept Med Biosci, Umea, Sweden	Umea University; Umea University	Persson, E (corresponding author), Umea Univ, Div Oncol, Dept Radiat Sci, Umea, Sweden.	emma.e.persson@umu.se		Persson, Emma/0000-0003-4020-1694	AFA Insurance Sweden [120338]; Swedish Cancer Foundation [CAN 2012/743]; Cancer Research Foundation in Northern Sweden [AMP 10-647]; Percy Falk Foundation	AFA Insurance Sweden; Swedish Cancer Foundation; Cancer Research Foundation in Northern Sweden; Percy Falk Foundation	This work received financial support from AFA Insurance Sweden, www.afaforsakring.se (grant no. 120338, EP), The Swedish Cancer Foundation, www.cancerfonden.se (CAN 2012/743, AW), The Cancer Research Foundation in Northern Sweden, www.cancerforskningsfonden.se (AMP 10-647, EP), and The Percy Falk Foundation for research in prostate cancer and breast cancer (EP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Deng XY, 2014, CANCER TREAT REV, V40, P730, DOI 10.1016/j.ctrv.2014.04.003; Di Vizio D, 2012, AM J PATHOL, V181, P1573, DOI 10.1016/j.ajpath.2012.07.030; EL Andaloussi S, 2013, NAT REV DRUG DISCOV, V12, P348, DOI 10.1038/nrd3978; Fang J, 2015, CLIN TRANSL ONCOL, V17, P173, DOI 10.1007/s12094-014-1247-x; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Franzen CA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/619829; Gingrich JR, 1996, CANCER RES, V56, P4096; Hedlund M, 2009, J IMMUNOL, V183, P340, DOI 10.4049/jimmunol.0803477; Hensel J, 2016, UROLOGY IN PRESS; Lundholm M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108925; Melo SA, 2014, CANCER CELL, V26, P707, DOI 10.1016/j.ccell.2014.09.005; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Ohno S, 2013, ADV DRUG DELIVER REV, V65, P398, DOI 10.1016/j.addr.2012.07.019; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raimondi L, 2015, ONCOTARGET, V6, P13772, DOI 10.18632/oncotarget.3830; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Silva J, 2012, GENE CHROMOSOME CANC, V51, P409, DOI 10.1002/gcc.21926; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2012, PHARMACOL REV, V64, P676, DOI 10.1124/pr.112.005983; Webber J P, 2015, Oncogene, V34, P290, DOI 10.1038/onc.2013.560; Zhang HG, 2014, AM J PATHOL, V184, P28, DOI 10.1016/j.ajpath.2013.09.027; Zhao L, 2015, CANCER LETT, V356, P339, DOI 10.1016/j.canlet.2014.10.027	24	49	52	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166284	10.1371/journal.pone.0166284	http://dx.doi.org/10.1371/journal.pone.0166284			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832183	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000090
J	Soteriades, AD; Stott, AW; Moreau, S; Charroin, T; Blanchard, M; Liu, JY; Faverdin, P				Soteriades, Andreas Diomedes; Stott, Alistair William; Moreau, Sindy; Charroin, Thierry; Blanchard, Melanie; Liu, Jiayi; Faverdin, Philippe			The Relationship of Dairy Farm Eco-Efficiency with Intensification and Self-Sufficiency. Evidence from the French Dairy Sector Using Life Cycle Analysis, Data Envelopment Analysis and Partial Least Squares Structural Equation Modelling	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; ENVIRONMENTAL-IMPACT; MILK-PRODUCTION; TECHNICAL EFFICIENCY; ECONOMIC-PERFORMANCE; SUSTAINABILITY; MANAGEMENT; PLS; SYSTEMS; AGROECOLOGY	We aimed at quantifying the extent to which agricultural management practices linked to animal production and land use affect environmental outcomes at a larger scale. Two practices closely linked to farm environmental performance at a larger scale are farming intensity, often resulting in greater off-farm environmental impacts (land, non-renewable energy use etc.) associated with the production of imported inputs (e.g. concentrates, fertilizer); and the degree of self-sufficiency, i.e. the farm's capacity to produce goods from its own resources, with higher control over nutrient recycling and thus minimization of losses to the environment, often resulting in greater on-farm impacts (eutrophication, acidification etc.). We explored the relationship of these practices with farm environmental performance for 185 French specialized dairy farms. We used Partial Least Squares Structural Equation Modelling to build, and relate, latent variables of environmental performance, intensification and self-sufficiency. Proxy indicators reflected the latent variables for intensification (milk yield/cow, use of maize silage etc.) and self-sufficiency (home-grown feed/total feed use, on-farm energy/total energy use etc.). Environmental performance was represented by an aggregate 'eco-efficiency' score per farm derived from a Data Envelopment Analysis model fed with LCA and farm output data. The dataset was split into two spatially heterogeneous (biophysical conditions, production patterns) regions. For both regions, eco-efficiency was significantly negatively related with milk yield/cow and the use of maize silage and imported concentrates. However, these results might not necessarily hold for intensive yet more self-sufficient farms. This requires further investigation with latent variables for intensification and self-sufficiency that do not largely overlap-a modelling challenge that occurred here. We conclude that the environmental 'sustainability' of intensive dairy farming depends on particular farming systems and circumstances, although we note that more self-sufficient farms may be preferable when they may benefit from relatively low land prices and agri-environment schemes aimed at maintaining grasslands.	[Soteriades, Andreas Diomedes; Stott, Alistair William] Scotlands Rural Coll, Future Farming Syst Grp, Edinburgh, Midlothian, Scotland; [Moreau, Sindy; Charroin, Thierry] Inst Elevage, F-75000 Paris, France; [Blanchard, Melanie] CIRAD INRA Montpellier SupAgro, UMR, SELMET Syst Elevage Mediterraneens & Trop 0868, F-34000 Montpellier, France; [Liu, Jiayi] Biomath & Stat Scotland, Edinburgh, Midlothian, Scotland; [Faverdin, Philippe] INRA, UMR PEGASE 1348, F-35590 St Gilles, France; [Faverdin, Philippe] Agrocampus Ouest, UMR PEGASE 1348, F-35000 Rennes, France	Scotland's Rural College; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; James Hutton Institute; INRAE; Institut Agro; Agrocampus Ouest	Soteriades, AD (corresponding author), Scotlands Rural Coll, Future Farming Syst Grp, Edinburgh, Midlothian, Scotland.	andreas.soteriades@sruc.ac.uk	LIU, JIAYI/I-7242-2013	LIU, JIAYI/0000-0002-9194-5338; Soteriades, Andreas Diomedes/0000-0002-5992-9602; Blanchard, Melanie/0000-0002-5166-8719	Scotland's Rural College; Scottish Government Strategic Research Programme; Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research); Project "Efficience Environnementale et productions animales pour le developpement durable, Agence Nationale de la Recherche (French National Research Agency) [ANR-09-STRA-01-01]	Scotland's Rural College; Scottish Government Strategic Research Programme; Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research); Project "Efficience Environnementale et productions animales pour le developpement durable, Agence Nationale de la Recherche (French National Research Agency)(French National Research Agency (ANR))	Funding was obtained from the following sources: 1. Scotland's Rural College (http://www.sruc.ac.uk/) (ADS); 2. Scottish Government Strategic Research Programme 2011-16 (http://www.gov.scot/Topics/Resear/About/EBAR/StrategicResearchStutute-research-strategy) (ADS); 3. Physiologie Animale et Systeme d'Elevage division of the Institut National de la Recherche Agronomique (French National Institute for Agricultural Research; http:/www.inra.fr/en) (ADS); 4. Project "Efficience Environnementale et productions animales pour le developpement durable, ANR-09-STRA-01-01, Agence Nationale de la Recherche (French National Research Agency; http://www.agence-nationale-recherche.fr/en/project-based-funding-to-advance-french-research/) (MB); 5. Scottish Government Strategic Research Programme 2011-16 (http://www.gov.scot/Topics/Research/About/EBAR/StrategicResearch/future-research-strategy) Consultancy for Theme 4 WP4.1 Adaptation to change in land-based and other rural industries (JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Alba I, 2012, RENEW AGR FOOD SYST, V27, P217, DOI 10.1017/S1742170511000329; Acosta-Alba I, 2012, J CLEAN PROD, V28, P160, DOI 10.1016/j.jclepro.2011.11.061; [Anonymous], 2013, R PACKAGE NOTES; Arsenault N, 2009, INT J AGR SUSTAIN, V7, P19, DOI 10.3763/ijas.2009.0356; Barnes AP, 2006, J ENVIRON MANAGE, V80, P287, DOI 10.1016/j.jenvman.2005.09.020; Barnes AP, 2014, ECOL INDIC, V36, P213, DOI 10.1016/j.ecolind.2013.07.001; Basset-Mens C, 2009, ECOL ECON, V68, P1615, DOI 10.1016/j.ecolecon.2007.11.017; Bava L, 2014, J DAIRY SCI, V97, P4579, DOI 10.3168/jds.2013-7530; Ben Arfa N, 2009, 3 JOURN RECH SCI SOC; Berre D, 2014, J ENVIRON MANAGE, V146, P235, DOI 10.1016/j.jenvman.2014.07.008; Berre D, 2013, EUR J OPER RES, V226, P325, DOI 10.1016/j.ejor.2012.11.017; Bickel U., 2003, IMPACTS SOYBEAN CULT; Casey JW, 2005, J ENVIRON QUAL, V34, P429, DOI 10.2134/jeq2005.0429; CHARNES A, 1978, EUR J OPER RES, V2, P429, DOI 10.1016/0377-2217(78)90138-8; Charroin T., 2005, Rencontres Autour des Recherches sur les Ruminants, V12, P335; Chatellier V, 2006, P FIN SEM GREEN DAIR; Chin W.W., 2010, HDB PARTIAL LEAST SQ, P171; Cooper WW, 2005, J MULTI-CRITERIA DEC, V13, P3, DOI 10.1002/mcda.370; Cooper WW, 1999, J PROD ANAL, V11, P5, DOI 10.1023/A:1007701304281; Cooper WW., 2007, DATA ENVELOPMENT ANA, V2nd; de Boer IJM, 2003, LIVEST PROD SCI, V80, P69, DOI 10.1016/S0301-6226(02)00322-6; de los Campos G, 2006, J ANIM SCI, V84, P2934, DOI 10.2527/jas.2006-016; Del Prado A, 2008, J AGR SCI-CAMBRIDGE, V146, P195, DOI 10.1017/S0021859608007727; Detilleux J, 2012, PREV VET MED, V107, P170, DOI 10.1016/j.prevetmed.2012.06.005; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Dumont B, 2013, ANIMAL, V7, P1028, DOI 10.1017/S1751731112002418; Eisler MC, 2014, NATURE, V507, P32, DOI 10.1038/507032a; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; Gac A., 2010, Rencontres Autour des Recherches sur les Ruminants, V17, P335; Godfray HCJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0273; Goodhue DL, 2012, MIS QUART, V36, P981; Government Office for Science, 2011, FOR FUT FOOD FARM; Guerci M, 2013, J DAIRY RES, V80, P300, DOI 10.1017/S0022029913000277; Gyau A, 2011, BRIT FOOD J, V113, P838, DOI 10.1108/00070701111148388; Hair J. F., 2017, ADV ISSUES PARTIAL L; Hair JF, 2012, J ACAD MARKET SCI, V40, P414, DOI 10.1007/s11747-011-0261-6; Hansson H, 2011, LIVEST SCI, V135, P110, DOI 10.1016/j.livsci.2010.06.157; Henseler J, 2016, INT MARKET REV, V33, P405, DOI 10.1108/IMR-09-2014-0304; Henseler J, 2015, J ACAD MARKET SCI, V43, P115, DOI 10.1007/s11747-014-0403-8; Henseler J, 2013, COMPUTATION STAT, V28, P565, DOI 10.1007/s00180-012-0317-1; HOCH I, 1962, ECONOMETRICA, V30, P34, DOI 10.2307/1911286; Hulland J, 1999, STRATEGIC MANAGE J, V20, P195, DOI 10.1002/(SICI)1097-0266(199902)20:2<195::AID-SMJ13>3.3.CO;2-Z; Iribarren D, 2011, SCI TOTAL ENVIRON, V409, P1786, DOI 10.1016/j.scitotenv.2011.02.013; Jan P, 2012, INT J LIFE CYCLE ASS, V17, P706, DOI 10.1007/s11367-012-0405-z; Kuosmanen T, 2005, J IND ECOL, V9, P59, DOI 10.1162/108819805775247846; Lebacq T, 2015, ANIMAL, V9, P544, DOI 10.1017/S1751731114002845; Lehuger S, 2009, J CLEAN PROD, V17, P616, DOI 10.1016/j.jclepro.2008.10.005; Lohmoller J.B., 1989, PHYSICA, DOI DOI 10.1007/978-3-642-52512-4; Matthews A, 2013, BIO-BASED APPL ECON, V2, P1; Maulfair D, 2011, FEED EFFICIENCY LACT; Meul M, 2008, AGRON SUSTAIN DEV, V28, P321, DOI 10.1051/agro:2008001; Novo AM, 2013, AGR SYST, V121, P63, DOI 10.1016/j.agsy.2013.06.007; Olesen JE, 2006, AGR ECOSYST ENVIRON, V112, P207, DOI 10.1016/j.agee.2005.08.022; Ondersteijn CJM, 2003, AGR SYST, V78, P31, DOI 10.1016/S0308-521X(03)00031-3; Urdiales MP, 2016, ENVIRON RESOUR ECON, V64, P559, DOI 10.1007/s10640-015-9885-1; Puillet L, 2014, LIVEST SCI, V165, P167, DOI 10.1016/j.livsci.2014.04.001; R Core Team, 2013, R LANG ENV STAT COMP; Reig-Martinez E, 2011, AGR ECON-BLACKWELL, V42, P561, DOI 10.1111/j.1574-0862.2011.00536.x; Richards TJ, 2000, J AGR RESOUR ECON, V25, P232; Ringle CM, 2011, J MARKET THEORY PRAC, V19, P459, DOI 10.2753/MTP1069-6679190407; Rodriguez-Entrena M, 2013, FOOD POLICY, V40, P44, DOI 10.1016/j.foodpol.2013.02.001; Saam H, 2005, AGR SYST, V84, P343, DOI 10.1016/j.agsy.2004.06.020; Salou T, 2017, J CLEAN PROD, V140, P445, DOI 10.1016/j.jclepro.2016.05.019; Santarossa JM, 2004, ANIM SCI, V79, P315, DOI 10.1017/S1357729800090172; Sarstedt M, 2014, J FAM BUS STRATEG, V5, P105, DOI 10.1016/j.jfbs.2014.01.002; Shortall OK, 2013, ECOL INDIC, V29, P478, DOI 10.1016/j.ecolind.2013.01.022; Soteriades AD, 2016, ANIMAL, V10, P1899, DOI 10.1017/S1751731116000707; Soteriades AD, 2015, AGR FOOD SCI, V24, P235, DOI 10.23986/afsci.49446; Tenenhaus M, 2005, COMPUT STAT DATA AN, V48, P159, DOI 10.1016/j.csda.2004.03.005; Nguyen TTH, 2013, INT J LIFE CYCLE ASS, V18, P1470, DOI 10.1007/s11367-013-0605-1; Tomich TP, 2011, ANNU REV ENV RESOUR, V36, P193, DOI 10.1146/annurev-environ-012110-121302; Torna L, 2013, J DAIRY SCI, V96, P7014, DOI 10.3168/jds.2013-6911; Van Berkum S, 2006, EUROPEAN DAIRY POLIC; van Calker KJ, 2008, ECOL ECON, V65, P407, DOI 10.1016/j.ecolecon.2007.07.010; Voorhees CM, 2016, J ACAD MARKET SCI, V44, P119, DOI 10.1007/s11747-015-0455-4; Wold H., 1975, PATH MODELS LATENT V, P307, DOI [10.1016/B978-0-12-103950-9.50017-4, DOI 10.1016/B978-0-12-103950-9.50017-4]; Wu, 2007, ED MEASUREMENT ISSUE, V26, P33, DOI DOI 10.1111/J.1745-3992.2007.00099.X; Zehetmeier M, 2012, ANIMAL, V6, P154, DOI 10.1017/S1751731111001467; Zimmermann A, 2008, J SUSTAIN AGR, V32, P77, DOI 10.1080/10440040802121411	79	22	22	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166445	10.1371/journal.pone.0166445	http://dx.doi.org/10.1371/journal.pone.0166445			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832199	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000126
J	Tachikawa, S; Nakayama, K; Nakamura, S; Mochizuki, A; Iijima, T; Inoue, T				Tachikawa, Satoshi; Nakayama, Kiyomi; Nakamura, Shiro; Mochizuki, Ayako; Iijima, Takehiko; Inoue, Tomio			Coordinated Respiratory Motor Activity in Nerves Innervating the Upper Airway Muscles in Rats	PLOS ONE			English	Article							BRAIN-STEM PREPARATION; IN-SITU; ELECTROMYOGRAPHIC ACTIVITY; GENIOGLOSSUS MUSCLE; EXPIRATORY ACTIVITY; RHYTHM GENERATION; HYOID MUSCLES; HYPOXIA; HYPOGLOSSAL; HYPERCAPNIA	Maintaining the patency of the upper airway during breathing is of vital importance. The activity of various muscles is related to the patency of the upper airway. In the present study, we examined the respiratory motor activity in the efferent nerves innervating the upper airway muscles to determine the movements of the upper airway during respiration under normocapnic conditions (pH = 7.4) and in hypercapnic acidosis (pH = 7.2). Experiments were performed on arterially perfused decerebrate rats aged between postnatal days 21-35. We recorded the efferent nerve activity in a branch of the cervical spinal nerve innervating the infrahyoid muscles (CN), the hypoglossal nerve (HGN), the external branch of the superior laryngeal nerve (SLN), and the recurrent laryngeal nerve (RLN) with the phrenic nerve (PN). Inspiratory nerve discharges were observed in all these nerves under normocapnic conditions. The onset of inspiratory discharges in the CN and HGN was slightly prior to those in the SLN and RLN. When the CO2 concentration in the perfusate was increased from 5% to 8% to prepare for hypercapnic acidosis, the peak amplitudes of the inspiratory discharges in all the recorded nerves were increased. Moreover, hypercapnic acidosis induced pre-inspiratory discharges in the CN, HGN, SLN, and RLN. The onset of pre-inspiratory discharges in the CN, HGN, and SLN was prior to that of discharges in the RLN. These results suggest that the securing of the airway that occurs a certain time before dilation of the glottis may facilitate ventilation and improve hypercapnic acidosis.	[Tachikawa, Satoshi; Nakayama, Kiyomi; Nakamura, Shiro; Mochizuki, Ayako; Inoue, Tomio] Showa Univ, Dept Oral Physiol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan; [Tachikawa, Satoshi; Iijima, Takehiko] Showa Univ, Div Anesthesiol, Dept Perioperat Med, Sch Dent,Oota Ku, Tokyo 1458515, Japan	Showa University; Showa University	Nakayama, K (corresponding author), Showa Univ, Dept Oral Physiol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan.	nakayamak@dent.showa-u.ac.jp			MEXT/JSPS KAKENHI [25350622, 26293397, 15K15687]; Grants-in-Aid for Scientific Research [26293397, 15K15687, 16K11489, 15H05050, 16K11488] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by MEXT/JSPS KAKENHI (www.jsps.go.jp) Grant number 25350622 (KN), 26293397 (T. Inoue), and 15K15687 (T. Inoue). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala APL, 2009, J PHYSIOL-LONDON, V587, P3539, DOI 10.1113/jphysiol.2008.167502; Adachi T, 1998, OTOLARYNG HEAD NECK, V118, P537, DOI 10.1016/S0194-5998(98)70215-3; Bautista TG, 2016, RESP PHYSIOL NEUROBI, V226, P102, DOI 10.1016/j.resp.2015.07.012; BROUILLETTE RT, 1980, J APPL PHYSIOL, V49, P801, DOI 10.1152/jappl.1980.49.5.801; Chhetri DK, 2014, LARYNGOSCOPE, V124, P2363, DOI 10.1002/lary.24742; COHEN MI, 1979, PHYSIOL REV, V59, P1105, DOI 10.1152/physrev.1979.59.4.1105; Corcoran AE, 2013, RESP PHYSIOL NEUROBI, V186, P214, DOI 10.1016/j.resp.2013.02.015; Curran AK, 2000, EUR RESPIR J, V15, P902, DOI 10.1034/j.1399-3003.2000.15e15.x; Day TA, 2007, J PHYSIOL-LONDON, V578, P843, DOI 10.1113/jphysiol.2006.119594; Dutschmann M, 2000, AUTON NEUROSCI-BASIC, V84, P19, DOI 10.1016/S1566-0702(00)00177-6; FUKUDA Y, 1982, JPN J PHYSIOL, V32, P387; Ghali MGZ, 2015, RESP PHYSIOL NEUROBI, V215, P47, DOI 10.1016/j.resp.2015.05.002; Harris MB, 2001, RESP PHYSIOL, V125, P199, DOI 10.1016/S0034-5687(00)00220-6; Holley HS, 2012, RESP PHYSIOL NEUROBI, V180, P79, DOI 10.1016/j.resp.2011.10.012; Iizuka M, 2007, RESP PHYSIOL NEUROBI, V157, P196, DOI 10.1016/j.resp.2007.01.004; Janczewski WA, 2013, J NEUROSCI, V33, P5454, DOI 10.1523/JNEUROSCI.1595-12.2013; KOBLER JB, 1994, J COMP NEUROL, V349, P129, DOI 10.1002/cne.903490109; Levitt ES, 2015, J PHYSIOL-LONDON, V593, P4453, DOI 10.1113/JP270822; Massey CA, 2015, J NEUROPHYSIOL, V113, P2879, DOI 10.1152/jn.01073.2014; Molkov YI, 2011, J NEUROPHYSIOL, V105, P3080, DOI 10.1152/jn.00070.2011; Molkov YI, 2010, J NEUROPHYSIOL, V104, P2713, DOI 10.1152/jn.00334.2010; MUNTENER M, 1980, ANAT EMBRYOL, V159, P49, DOI 10.1007/BF00299254; OHalloran KD, 1996, EUR RESPIR J, V9, P2323, DOI 10.1183/09031936.96.09112323; Paton JFR, 2006, NAT NEUROSCI, V9, P311, DOI 10.1038/nn1650; Paton JFR, 2005, J NEUROSCI METH, V147, P138, DOI 10.1016/j.jneumeth.2005.04.003; Paton JFR, 1996, J PHYSIOL-LONDON, V493, P819, DOI 10.1113/jphysiol.1996.sp021425; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Poliacek I, 2003, PHYSIOL RES, V52, P749; Rubin JE, 2011, J COMPUT NEUROSCI, V30, P607, DOI 10.1007/s10827-010-0281-0; SAUERLAND EK, 1976, EXP NEUROL, V51, P160, DOI 10.1016/0014-4886(76)90061-3; SHERREY JH, 1977, ELECTROEN CLIN NEURO, V43, P218, DOI 10.1016/0013-4694(77)90129-8; St-John WM, 2000, RESP PHYSIOL, V123, P201, DOI 10.1016/S0034-5687(00)00177-8; St-John WM, 2004, EXP PHYSIOL, V89, P727, DOI 10.1113/expphysiol.2004.028829; St-John WM, 1998, PROG NEUROBIOL, V56, P97, DOI 10.1016/S0301-0082(98)00031-8; Stipica I, 2016, PHYSIOL RES, V65, P133, DOI 10.33549/physiolres.933012; STROHL KP, 1980, J APPL PHYSIOL, V49, P638, DOI 10.1152/jappl.1980.49.4.638; SURATT PM, 1985, J APPL PHYSIOL, V58, P1252, DOI 10.1152/jappl.1985.58.4.1252; UEYAMA T, 1988, ANAT EMBRYOL, V177, P445, DOI 10.1007/BF00304742; VANDEGRAAFF WB, 1984, J APPL PHYSIOL, V57, P197, DOI 10.1152/jappl.1984.57.1.197; VANLUNTEREN E, 1987, J APPL PHYSIOL, V62, P582, DOI 10.1152/jappl.1987.62.2.582; Wakai J, 2015, RESP PHYSIOL NEUROBI, V215, P64, DOI 10.1016/j.resp.2015.05.008; WIEGAND DA, 1990, J APPL PHYSIOL, V69, P1262, DOI 10.1152/jappl.1990.69.4.1262; Wilson RJA, 2001, AM J PHYSIOL-REG I, V281, pR528, DOI 10.1152/ajpregu.2001.281.2.R528; Yokoba M, 2003, J APPL PHYSIOL, V95, P810, DOI 10.1152/japplphysiol.00332.2002; ZHOU D, 1989, J APPL PHYSIOL, V67, P1171, DOI 10.1152/jappl.1989.67.3.1171	45	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166436	10.1371/journal.pone.0166436	http://dx.doi.org/10.1371/journal.pone.0166436			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832132	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000124
J	Kim, HR; Lee, JE; Oqani, RK; Kim, SY; Wakayama, T; Li, C; Sa, SJ; Woo, JS; Jin, DI				Kim, Hong Rye; Lee, Jae Eun; Oqani, Reza Kheirkhahi; Kim, So Yeon; Wakayama, Teruhiko; Li, Chong; Sa, Su Jin; Woo, Je Seok; Jin, Dong Ii			Aberrant Expression of TIMP-2 and PBEF Genes in the Placentae of Cloned Mice Due to Epigenetic Reprogramming Error	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; METHYLATION; EMBRYOS; CELLS; REGIONS	Cloned mice derived from somatic or ES cells show placental overgrowth (placentomegaly) at term. We had previously analyzed cloned and normal mouse placentae by using two-dimensional gel electrophoresis and mass spectrometry to identify differential protein expression patterns. Cloned placentae showed upregulation of tissue inhibitor of metalloproteinase-2 (TIMP-2), which is involved in extracellular matrix degradation and tissue remodeling, and downregulation of pre-B cell colony enhancing factor 1 (PBEF), which inhibits apoptosis and induces spontaneous labor. Here, we used Western blotting to further analyze the protein expression levels of TIMP-2 and PBEF in cloned placentae derived from cumulus cells, TSA-treated cumulus cells, intracytoplasmic sperm injection (ICSI), and natural mating (NM control). Cloned and TSA-treated cloned placentae had higher expression levels of TIMP-2 compared with NM control and ICSI-derived placentae, and there was a positive association between TIMP-2 expression and the placental weight of cloned mouse concepti. Conversely, PBEF protein expression was significantly lower in cloned and ICSI placentae compared to NM controls. To examine whether the observed differences were due to abnormal gene expression caused by faulty epigenetic reprogramming in clones, we investigated DNA methylation and histone modification in the promoter regions of the genes encoding TIMP-2 and PBEF. Sodium bisulfite sequencing did not reveal any difference in DNA methylation between cloned and NM control placentae. However, ChIP assays revealed that the level of H3-K9/K14 acetylation at the TIMP-2 locus was higher in cloned placentae than in NM controls, whereas acetylation of the PBEF promoter was lower in cloned and ICSI placenta versus NM controls. These results suggest that cloned placentae appear to suffer from failure of histone modification-based reprogramming in these (and potentially other) developmentally important genes, leading to aberrant expression of their protein products. These changes are likely to be involved in generating the abnormalities seen in cloned mouse placentae, including enlargement and/or a lack of proper placental function.	[Kim, Hong Rye; Lee, Jae Eun; Oqani, Reza Kheirkhahi; Kim, So Yeon; Jin, Dong Ii] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Daejeon, South Korea; [Wakayama, Teruhiko] Univ Yamanashi, Fac Life & Environm Sci, Yamanashi, Japan; [Li, Chong] Tongi Univ, Sch Med, Shanghai, Peoples R China; [Sa, Su Jin; Woo, Je Seok] Natl Inst Anim Sci, Dept Anim Resource Dev, Cheonan, South Korea	Chungnam National University; University of Yamanashi; National Institute of Animal Science, Republic of Korea	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Daejeon, South Korea.	dijin@.ac.kr			BioGreen 21 Program [PJ01119601]; Cooperative Research Program for Agriculture Science & Technology Development in Rural Development Administration, Republic of Korea [PJ0118512016]; Grants-in-Aid for Scientific Research [16H02593] Funding Source: KAKEN	BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science & Technology Development in Rural Development Administration, Republic of Korea; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the BioGreen 21 Program (grant no. PJ01119601) and the Cooperative Research Program for Agriculture Science & Technology Development (grant no. PJ0118512016) in Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the BioGreen 21 Program (grant no. PJ01119601) and the Cooperative Research Program for Agriculture Science & Technology Development (grant no. PJ0118512016) in Rural Development Administration, Republic of Korea.	Alexander CM, 1996, DEVELOPMENT, V122, P1723; CALZONETTI T, 1995, DEV BIOL, V171, P615, DOI 10.1006/dbio.1995.1309; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Han Rong Xun, 2007, Reproductive & Developmental biology, V31, P253; Hill J R, 2001, Cloning, V3, P83, DOI 10.1089/15204550152475581; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Isaka K, 2003, PLACENTA, V24, P53, DOI 10.1053/plac.2002.0867; Kang YK, 2001, NAT GENET, V28, P173, DOI 10.1038/88903; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kang YK, 2001, J BIOL CHEM, V276, P39980, DOI 10.1074/jbc.M106516200; Kim HR, 2009, REPROD DOMEST ANIM, V44, P714, DOI 10.1111/j.1439-0531.2007.01058.x; Kim HR, 2010, PLACENTA, V31, P853, DOI 10.1016/j.placenta.2010.07.006; Kim HR, 2011, BMB REP, V44, P535, DOI 10.5483/BMBRep.2011.44.8.535; Kim HR, 2005, PROTEOMICS, V5, P4264, DOI 10.1002/pmic.200401297; Kishigami Satoshi, 2009, V518, P207, DOI 10.1007/978-1-59745-202-1_15; Kohda T, 2005, BIOL REPROD, V73, P1302, DOI 10.1095/biolreprod.105.044958; Kono T, 1997, Rev Reprod, V2, P74; Lederberg J, 2001, SCIENTIST, V15, P6; Li T, 2004, HUM MOL GENET, V13, P741, DOI 10.1093/hmg/ddh081; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Millar LK, 1998, AM J OBSTET GYNECOL, V179, P126, DOI 10.1016/S0002-9378(98)70262-5; Nemeth E, 2000, AM J OBSTET GYNECOL, V182, P50, DOI 10.1016/S0002-9378(00)70490-X; Niemann H., 2002, Cloning and Stem Cells, V4, P29, DOI 10.1089/153623002753632020; Niemann H, 2000, THERIOGENOLOGY, V53, P21, DOI 10.1016/S0093-691X(99)00237-X; Ognjanovic S, 2003, AM J OBSTET GYNECOL, V189, P1187, DOI 10.1067/S0002-9378(03)00591-X; Ognjanovic S, 2002, AM J OBSTET GYNECOL, V187, P1051, DOI 10.1067/mob.2002.126295; Ogura A, 2000, BIOL REPROD, V62, P1579, DOI 10.1095/biolreprod62.6.1579; Ohgane J, 2004, GENES CELLS, V9, P253, DOI 10.1111/j.1356-9597.2004.00720.x; Ohta H, 2005, BIOL REPROD, V73, P390, DOI 10.1095/biolreprod.105.041673; OSMERS RGW, 1995, OBSTET GYNECOL, V86, P223, DOI 10.1016/0029-7844(95)93704-4; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Stice SL, 2002, J ANIM SCI, V79, P285; Tanaka S, 2001, BIOL REPROD, V65, P1813, DOI 10.1095/biolreprod65.6.1813; Tanaka SS, 1998, PLACENTA, V19, P41, DOI 10.1016/S0143-4004(98)90097-2; Thibault C, 2003, REPROD NUTR DEV, V43, P303, DOI 10.1051/rnd:2003027; Van Thuan N, 2010, J REPROD DEVELOP, V56, P20, DOI 10.1262/jrd.09-221A; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wakayama T, 1999, NAT GENET, V22, P127, DOI 10.1038/9632; Walter I, 2001, PLACENTA, V22, P473, DOI 10.1053/plac.2001.0633; WOODING FBP, 1994, CELL TISSUE RES, V276, P387, DOI 10.1007/BF00306124	43	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166241	10.1371/journal.pone.0166241	http://dx.doi.org/10.1371/journal.pone.0166241			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855185	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200023
J	van Meulen, FB; Weenk, D; van Asseldonk, EHF; Schepers, HM; Veltink, PH; Buurke, JH				van Meulen, Fokke B.; Weenk, Dirk; van Asseldonk, Edwin H. F.; Schepers, H. Martin; Veltink, Peter H.; Buurke, Jaap H.			Analysis of Balance during Functional Walking in Stroke Survivors	PLOS ONE			English	Article							GO TEST; TURNING STRATEGIES; MOBILITY; FALLS; ASSOCIATION; IMPAIRMENTS; RECOVERY; PEOPLE	Background An important objective of rehabilitation care is to regain adequate balance function to safely ambulate in community. However, in rehabilitation practice, it remains unclear if a stroke survivor functionally recovers by restitution or by learning to compensate for the lack of restoration of body function. Aim of this study is to propose and evaluate methods for the objective evaluation of balance during functional walking in stroke survivors. Methods Stroke survivors performed twice a Timed "Up & Go" (TUG) test. Ground reaction forces and position changes of both feet were measured using instrumented shoes and used to estimate the position of the center of mass (CoM). Balance control and efficiency metrics were defined to evaluate functional walking under variable conditions. Metrics were corrected based on the instantaneous velocity direction of CoM. Intra-and inter-participant variations for different phases of the TUG test were examined. Metrics were related to the Berg balance scale (BBS). Results Participants with higher BBS scores show a more efficient walking pattern. Their walking velocity and walking direction is less variable and they are more frequently unstable when walking in a straight line or when turning. Furthermore, the less affected participants are able to move their CoM more towards their affected side. Discussion We developed and demonstrated a method to assess walking balance of stroke survivors. System design and evaluation methods allow balance evaluation during functional walking in daily life. Some presented metrics show correlations with BBS scores. Clear inter-and intra-patient variations in metric values are present that cannot be explained by BBS scores, which supports the additional value of the presented system. Presented methods may be used for objective evaluation of restitution and compensation of walking balance and have a potential application in individual evidence-based therapy.	[van Meulen, Fokke B.; Weenk, Dirk; Veltink, Peter H.; Buurke, Jaap H.] Univ Twente, Biomed Signals & Syst, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands; [van Asseldonk, Edwin H. F.] Univ Twente, Biomech Engn, MIRA Inst Biomed Technol & Tech Med, POB 217, NL-7500 AE Enschede, Netherlands; [Schepers, H. Martin] Xsens Technol BV, Enschede, Netherlands; [Buurke, Jaap H.] Roessingh Rehabil Ctr, Roessingh Res & Dev, Enschede, Netherlands	University of Twente; University of Twente	Buurke, JH (corresponding author), Univ Twente, Biomed Signals & Syst, MIRA Inst Biomed Technol & Tech Med, Enschede, Netherlands.; Buurke, JH (corresponding author), Roessingh Rehabil Ctr, Roessingh Res & Dev, Enschede, Netherlands.	j.h.buurke@utwente.nl	van Meulen, Fokke B/L-2537-2016	van Meulen, Fokke B/0000-0002-5486-9663; van Asseldonk, Edwin/0000-0003-1534-2348	European Commission [FP7-ICT-2011-7-287351]; PIDON; Dutch ministry of economic affairs; Province Overijssel; Province Gelderland; Xsens Technologies B.V.	European Commission(European CommissionEuropean Commission Joint Research Centre); PIDON; Dutch ministry of economic affairs(Ministry of Economic Affairs, Netherlands); Province Overijssel; Province Gelderland; Xsens Technologies B.V.	This study was part of the INTERACTION project, which was partially funded by the European Commission under the Seventh Framework Programme (FP7-ICT-2011-7-287351) and the FUSION project financed by PIDON, the Dutch ministry of economic affairs and the Provinces Overijssel and Gelderland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xsens Technologies B.V. provided support in the form of salary for author HMS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	BERG K, 1989, Physiotherapy Canada, V41, P304; Bergmann JHM, 2011, ANN BIOMED ENG, V39, P2299, DOI 10.1007/s10439-011-0339-9; Faria CDCD, 2009, TOP STROKE REHABIL, V16, P196, DOI 10.1310/tsr1603-196; FORSTER A, 1995, BRIT MED J, V311, P83, DOI 10.1136/bmj.311.6997.83; Geyh S, 2004, J REHABIL MED, V36, P135, DOI 10.1080/16501960410016776; Glaister BC, 2007, GAIT POSTURE, V25, P289, DOI 10.1016/j.gaitpost.2006.04.003; Hase K, 1999, J NEUROPHYSIOL, V81, P2914, DOI 10.1152/jn.1999.81.6.2914; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hollands KL, 2009, NEUROREHABILITATION, V24, P358; Hsu AL, 2003, ARCH PHYS MED REHAB, V84, P1185, DOI 10.1016/S0003-9993(03)00030-3; Kollen B, 2006, REV RECENT CLIN TRIA, V1, P75, DOI 10.2174/157488706775246111; Kwakkel G, 2004, RESTOR NEUROL NEUROS, V22, P281; Lugade V, 2011, GAIT POSTURE, V33, P406, DOI 10.1016/j.gaitpost.2010.12.013; Mackintosh SFH, 2005, CLIN REHABIL, V19, P441, DOI 10.1191/0269215505cr796oa; Manaf H, 2012, ISRN REHABILITATION, V2012, P1, DOI 10.5402/2012/284924; Ng SS, 2005, ARCH PHYS MED REHAB, V86, P1641, DOI 10.1016/j.apmr.2005.01.011; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Persson CU, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-83; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schepers HM, 2009, IEEE T BIO-MED ENG, V56, P1189, DOI 10.1109/TBME.2008.2011059; Segal AD, 2008, J BIOMECH, V41, P1486, DOI 10.1016/j.jbiomech.2008.02.012; Simpson LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019431; Smith MT, 1999, ARCH PHYS MED REHAB, V80, P442, DOI 10.1016/S0003-9993(99)90283-6; Taylor MJD, 2005, HUM MOVEMENT SCI, V24, P558, DOI 10.1016/j.humov.2005.07.005; Tyson SF, 2006, PHYS THER, V86, P30, DOI 10.1093/ptj/86.1.30; van Meulen FB, 2016, J NEUROENGI IN PRESS; van Meulen FB, 2016, FRONTIERS BIOENGINEE, V3, P1; van Meulen FB, 2015, ANN BIOMED ENG, V43, P478, DOI 10.1007/s10439-014-1198-y; Waters RL, 1999, GAIT POSTURE, V9, P207, DOI 10.1016/S0966-6362(99)00009-0; Weenk D, 2015, IEEE T NEUR SYS REH, V23, P817, DOI 10.1109/TNSRE.2014.2357686; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; WHO, 2001, WHO INT CLASS FUNCT; Zamparo P., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P348	35	25	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166789	10.1371/journal.pone.0166789	http://dx.doi.org/10.1371/journal.pone.0166789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855211	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200051
J	Wang, YX; Liu, ZW; Wu, ZJ; Li, H; Zhuang, J				Wang, Yong-Xin; Liu, Zhi-Wei; Wu, Zhi-Jun; Li, Hui; Zhuang, Jing			Transcriptome-Wide Identification and Expression Analysis of the NAC Gene Family in Tea Plant [Camellia sinensis (L.) O. Kuntze]	PLOS ONE			English	Article							COMPREHENSIVE ANALYSIS; FUNCTIONAL-ANALYSIS; STRESS TOLERANCE; CELL-DEATH; ARABIDOPSIS; DOMAIN; DEHYDRATION; RESPONSES; COLD; SENESCENCE	In plants, the NAC (NAM-ATAF1/2-CUC) family of proteins constitutes several transcription factors and plays vital roles in diverse biological processes, such as growth, development, and adaption to adverse factors. Tea, as a non-alcoholic drink, is known for its bioactive ingredients and health efficacy. Currently, knowledge about NAC gene family in tea plant remains very limited. In this study, a total of 45 CsNAC genes encoding NAC proteins including three membrane-bound members were identified in tea plant through transcriptome analysis. CsNAC factors and Arabidopsis counterparts were clustered into 17 subgroups after phylogenetic analysis. Conserved motif analysis revealed that CsNAC proteins with a close evolutionary relationship possessed uniform or similar motif compositions. The distribution of NAC family MTFs (membrane-associated transcription factors) among higher plants of whose genome-wide has been completed revealed that the existence of doubled TMs (transmembrane motifs) may be specific to fabids. Transcriptome analysis exhibited the expression profiles of CsNAC genes in different tea plant cultivars under non-stress conditions. Nine CsNAC genes, including the predicted stress-related and membrane-bound genes, were examined through qRT-PCR (quantitative real time polymerase chain reaction) in two tea plant cultivars, namely, 'Huangjinya' and 'Yingshuang'. The expression patterns of these genes were investigated in different tissues (root, stem, mature leaf, young leaf and bud) and under diverse environmental stresses (drought, salt, heat, cold and abscisic acid). Several CsNAC genes, including CsNAC17 and CsNAC30 that are highly orthologous to known stress-responsive ANAC072/RD26 were identified as highly responsive to abiotic stress. This study provides a global survey of tea plant NAC proteins, and would be helpful for the improvement of stress resistance in tea plant via genetic engineering.	[Wang, Yong-Xin; Liu, Zhi-Wei; Wu, Zhi-Jun; Li, Hui; Zhuang, Jing] Nanjing Agr Univ, Coll Hort, Tea Sci Res Inst, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhuang, J (corresponding author), Nanjing Agr Univ, Coll Hort, Tea Sci Res Inst, Nanjing 210095, Jiangsu, Peoples R China.	zhuangjing@niau.edu.cn	wu, zhi/GXH-3041-2022		National Natural Science Foundation of China [31570691]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Natural Science Foundation of China (31570691). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by the National Natural Science Foundation of China (31570691). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balazadeh S, 2011, MOL PLANT, V4, P346, DOI 10.1093/mp/ssq080; Cao HL, 2015, PLANT PHYSIOL BIOCH, V97, P432, DOI 10.1016/j.plaphy.2015.10.030; Cenci A, 2014, PLANT MOL BIOL, V85, P63, DOI 10.1007/s11103-013-0169-2; Chen QF, 2011, PROTEIN CELL, V2, P55, DOI 10.1007/s13238-011-1010-9; Chen YX, 2009, J SCI FOOD AGR, V89, P2350, DOI 10.1002/jsfa.3716; Christianson JA, 2010, PLANT SIGNAL BEHAV, V5, P428, DOI 10.4161/psb.5.4.10847; Das A, 2012, PLANT MOL BIOL REP, V30, P1088, DOI 10.1007/s11105-012-0422-x; Le DT, 2011, DNA RES, V18, P263, DOI 10.1093/dnares/dsr015; Duval M, 2002, PLANT MOL BIOL, V50, P237, DOI 10.1023/A:1016028530943; Elbling L, 2005, FASEB J, V19, P807, DOI 10.1096/fj.04-2915fje; Elofsson JHA, 1999, HIDDEN MARKOV MODELS; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Greve K, 2003, BIOCHEM J, V371, P97, DOI 10.1042/BJ20021123; Guo YF, 2006, PLANT J, V46, P601, DOI 10.1111/j.1365-313X.2006.02723.x; Hao YJ, 2011, PLANT J, V68, P302, DOI 10.1111/j.1365-313X.2011.04687.x; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hu HH, 2008, PLANT MOL BIOL, V67, P169, DOI 10.1007/s11103-008-9309-5; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Hu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136993; Huang H, 2012, PLANT SCI, V193, P18, DOI 10.1016/j.plantsci.2012.05.004; Jensen MK, 2010, BIOCHEM J, V426, P183, DOI 10.1042/BJ20091234; Jeong JS, 2013, PLANT BIOTECHNOL J, V11, P101, DOI 10.1111/pbi.12011; Kato H, 2010, J PLANT PHYSIOL, V167, P571, DOI 10.1016/j.jplph.2009.11.004; Kim SG, 2010, PLANT SCI, V178, P239, DOI 10.1016/j.plantsci.2009.12.007; Kim SG, 2010, GENOMICS, V95, P56, DOI 10.1016/j.ygeno.2009.09.003; Kjaersgaard T, 2011, J BIOL CHEM, V286, P35418, DOI 10.1074/jbc.M111.247221; Lee S, 2014, PLANT SCI, V227, P76, DOI 10.1016/j.plantsci.2014.07.003; Li NN, 2016, PLANT GROWTH REGUL, V78, P253, DOI 10.1007/s10725-015-0090-6; Liu TK, 2014, PLANT MOL BIOL REP, V32, P1041, DOI 10.1007/s11105-014-0712-6; Liu ZW, 2016, GENE, V576, P52, DOI 10.1016/j.gene.2015.09.076; Ma J, 2014, SCI HORTIC-AMSTERDAM, V165, P82, DOI 10.1016/j.scienta.2013.11.005; Mittler R, 2015, PLANT CELL, V27, P64, DOI 10.1105/tpc.114.133090; Morishita T, 2014, PLANT CELL PHYSL, V50, P2210; Nakashima K, 2007, PLANT J, V51, P617, DOI 10.1111/j.1365-313X.2007.03168.x; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nuruzzaman M, 2010, GENE, V465, P30, DOI 10.1016/j.gene.2010.06.008; Olsen AN, 2005, TRENDS PLANT SCI, V10, P79, DOI 10.1016/j.tplants.2004.12.010; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Patzold M., 2009, WIREL SENSOR NETW, V1, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000520; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Puranik S, 2011, MOL BIOTECHNOL, V49, P138, DOI 10.1007/s12033-011-9385-7; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Sanghera GS, 2011, CURR GENOMICS, V12, P30, DOI 10.2174/138920211794520178; Seo PJ, 2008, TRENDS PLANT SCI, V13, P550, DOI 10.1016/j.tplants.2008.06.008; Shang HH, 2013, J INTEGR PLANT BIOL, V55, P663, DOI 10.1111/jipb.12085; Shiriga K, 2014, META GENE, V2, P407, DOI 10.1016/j.mgene.2014.05.001; Singh AK, 2013, DNA RES, V20, P403, DOI 10.1093/dnares/dst019; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Sperotto RA, 2009, PLANTA, V230, P985, DOI 10.1007/s00425-009-1000-9; Su HY, 2015, J PLANT BIOCHEM BIOT, V24, P176, DOI 10.1007/s13562-014-0255-9; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tran LSP, 2004, PLANT CELL, V16, P2481, DOI 10.1105/tpc.104.022699; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Vyas D, 2005, PLANT PHYSIOL BIOCH, V43, P383, DOI 10.1016/j.plaphy.2005.02.016; Wang N, 2013, PLANT CELL REP, V32, P61, DOI 10.1007/s00299-012-1340-y; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wu K, 2014, BMC PLANT BIOL, V14, DOI [10.1186/s12870-014-0274-7, 10.1186/s12870-014-0277-4]; Wu ZY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131890; Wu ZJ, 2016, MOL GENET GENOMICS, V291, P255, DOI 10.1007/s00438-015-1107-6; Wu ZJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19748; Wu ZJ, 2015, FUNCT INTEGR GENOMIC, V15, P741, DOI 10.1007/s10142-015-0457-9; Xie Q, 2000, GENE DEV, V14, P3024, DOI 10.1101/gad.852200; Xu ZY, 2013, PLANT CELL, V25, P4708, DOI 10.1105/tpc.113.119099; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang SD, 2011, PLANT CELL, V23, P2155, DOI 10.1105/tpc.111.084913; You J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122027; Zeller G, 2009, PLANT J, V58, P1068, DOI 10.1111/j.1365-313X.2009.03835.x; Zhang H, 2013, PLANT ANIMAL GENOME; Zhong RQ, 2010, PLANT PHYSIOL, V152, P1044, DOI 10.1104/pp.109.148270	72	31	39	8	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166727	10.1371/journal.pone.0166727	http://dx.doi.org/10.1371/journal.pone.0166727			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855193	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200047
J	Huang, GH; Chu, C; Huang, T; Kong, XY; Zhang, YH; Zhang, N; Cai, YD				Huang, Guohua; Chu, Chen; Huang, Tao; Kong, Xiangyin; Zhang, Yunhua; Zhang, Ning; Cai, Yu-Dong			Exploring Mouse Protein Function via Multiple Approaches	PLOS ONE			English	Article							AUTOMATED PREDICTION; KISS1 EXPRESSION; ESSENTIAL ROLES; ANNOTATION; ALIGNMENT; BINDING; PHOSPHORYLATION; REGULATOR; KINASE; INTEGRATION	Although the number of available protein sequences is growing exponentially, functional protein annotations lag far behind. Therefore, accurate identification of protein functions remains one of the major challenges in molecular biology. In this study, we presented a novel approach to predict mouse protein functions. The approach was a sequential combination of a similarity-based approach, an interaction-based approach and a pseudo amino acid composition-based approach. The method achieved an accuracy of about 0.8450 for the 1st-order predictions in the leave-one-out and ten-fold cross-validations. For the results yielded by the leave-one-out cross-validation, although the similarity-based approach alone achieved an accuracy of 0.8756, it was unable to predict the functions of proteins with no homologues. Comparatively, the pseudo amino acid composition-based approach alone reached an accuracy of 0.6786. Although the accuracy was lower than that of the previous approach, it could predict the functions of almost all proteins, even proteins with no homologues. Therefore, the combined method balanced the advantages and disadvantages of both approaches to achieve efficient performance. Furthermore, the results yielded by the ten-fold cross-validation indicate that the combined method is still effective and stable when there are no close homologs are available. However, the accuracy of the predicted functions can only be determined according to known protein functions based on current knowledge. Many protein functions remain unknown. By exploring the functions of proteins for which the 1st-order predicted functions are wrong but the 2nd-order predicted functions are correct, the 1st-order wrongly predicted functions were shown to be closely associated with the genes encoding the proteins. The so-called wrongly predicted functions could also potentially be correct upon future experimental verification. Therefore, the accuracy of the presented method may be much higher in reality.	[Huang, Guohua] Shaoyang Univ, Dept Math, Shaoyang 422000, Hunan, Peoples R China; [Cai, Yu-Dong] Shanghai Univ, Sch Life Sci, 99 Shangda Rd, Shanghai 200444, Peoples R China; [Chu, Chen] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Huang, Tao; Kong, Xiangyin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200031, Peoples R China; [Zhang, Yunhua] Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China; [Zhang, Ning] Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin, Peoples R China	Shaoyang University; Shanghai University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Anhui Agricultural University; Tianjin University	Cai, YD (corresponding author), Shanghai Univ, Sch Life Sci, 99 Shangda Rd, Shanghai 200444, Peoples R China.; Zhang, N (corresponding author), Tianjin Univ, Dept Biomed Engn, Tianjin Key Lab Biomed Engn Measurement, Tianjin, Peoples R China.	zhni@tju.edu.cn; cai_yud@126.com	Zhang, Yu-Hang/AAQ-9012-2021; Zhang, Yu-Hang/O-9774-2015; Chu, Chen/J-6527-2019; Huang, Guohua/A-2215-2019	Zhang, Yu-Hang/0000-0003-3825-0796; Zhang, Yu-Hang/0000-0003-3825-0796; Chu, Chen/0000-0001-8084-0867; Huang, Guohua/0000-0001-6954-3933; cai, yudong/0000-0001-5664-7979; Zhang, Ning/0000-0002-1559-111X	National Natural Science Foundation of China [61401302, 31371335, 81171342, 81201148]; Tianjin Research Program of the Application Foundation and Advanced Technology [14JCQNJC09500]; Innovation Program of the Shanghai Municipal Education Commission [12ZZ087]; National Research Foundation for the Doctoral Program of Higher Education of China [20130032120070, 20120032120073]; Scientific Research Fund of Hunan Provincial Education Department [15B216]; Science and Technology Program of Hunan [2015JC3099]; Seed Foundation of Tianjin University [60302064, 60302069]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of the Application Foundation and Advanced Technology; Innovation Program of the Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); National Research Foundation for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Fund of Hunan Provincial Education Department(Hunan Provincial Education Department); Science and Technology Program of Hunan; Seed Foundation of Tianjin University	Funded by National Natural Science Foundation of China (61401302, 31371335, 81171342, 81201148), the Tianjin Research Program of the Application Foundation and Advanced Technology (14JCQNJC09500), the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Scientific Research Fund of Hunan Provincial Education Department (15B216), the Science and Technology Program of Hunan (2015JC3099), and the Seed Foundation of Tianjin University (60302064, 60302069).; This work was supported by grants from the National Natural Science Foundation of China (61401302, 31371335, 81171342, 81201148), the Tianjin Research Program of the Application Foundation and Advanced Technology (14JCQNJC09500), the Innovation Program of the Shanghai Municipal Education Commission (12ZZ087), the National Research Foundation for the Doctoral Program of Higher Education of China (20130032120070, 20120032120073), the Scientific Research Fund of Hunan Provincial Education Department (15B216), the Science and Technology Program of Hunan (2015JC3099), and the Seed Foundation of Tianjin University (60302064, 60302069).	Agrawal PB, 2014, AM J HUM GENET, V95, P218, DOI 10.1016/j.ajhg.2014.07.004; Altaf-Ul-Amin M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-207; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An JY, 2016, PROTEIN SCI, V25, P1825, DOI 10.1002/pro.2991; Arnau V, 2005, BIOINFORMATICS, V21, P364, DOI 10.1093/bioinformatics/bti021; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Aumais JP, 2003, J CELL SCI, V116, P1991, DOI 10.1242/jcs.00412; AWATA H, 1994, GENOMICS, V23, P534, DOI 10.1006/geno.1994.1540; Chen L, 2014, MOL BIOSYST, V10, P868, DOI 10.1039/c3mb70490d; Chen L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035254; Chen YK, 2013, J THEOR BIOL, V318, P1, DOI 10.1016/j.jtbi.2012.10.033; Chi XX, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-437; Chitale M, 2009, BIOINFORMATICS, V25, P1739, DOI 10.1093/bioinformatics/btp309; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chua HN, 2006, BIOINFORMATICS, V22, P1623, DOI 10.1093/bioinformatics/btl145; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Cozzetto D, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S3-S1; DEMICHEL P, 1993, PEPTIDES, V14, P1005, DOI 10.1016/0196-9781(93)90078-U; Deng MH, 2003, J COMPUT BIOL, V10, P947, DOI 10.1089/106652703322756168; Di Pietro SM, 2004, TRAFFIC, V5, P276, DOI 10.1111/j.1600-0854.2004.0171.x; Diaz-Martinez LA, 2007, CELL CYCLE, V6, P714, DOI 10.4161/cc.6.6.3935; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Eggers CT, 2009, J BIOL CHEM, V284, P32869, DOI 10.1074/jbc.M109.022582; Erdin S, 2011, CURR OPIN STRUC BIOL, V21, P180, DOI 10.1016/j.sbi.2011.02.001; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Fukuda MN, 2008, CELL MOL LIFE SCI, V65, P92, DOI 10.1007/s00018-007-7302-9; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gudmundsdottir K, 2007, ONCOGENE, V26, P7601, DOI 10.1038/sj.onc.1210579; Hawkins T, 2009, PROTEINS, V74, P566, DOI 10.1002/prot.22172; Hayat M, 2011, J THEOR BIOL, V271, P10, DOI 10.1016/j.jtbi.2010.11.017; Hishigaki H, 2001, YEAST, V18, P523, DOI 10.1002/yea.706; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hu LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014556; Huang T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010972; Huang YA, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1035-4; Jia CZ, 2014, INT J MOL SCI, V15, P10410, DOI 10.3390/ijms150610410; Jin Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030419, 10.1371/journal.pone.0032155]; Khan S, 2003, BIOINFORMATICS, V19, P2484, DOI 10.1093/bioinformatics/btg338; Kikuchi Y, 2015, GENES CELLS, V20, P191, DOI 10.1111/gtc.12210; Kolodny R, 2004, P NATL ACAD SCI USA, V101, P12201, DOI 10.1073/pnas.0404383101; Kostakis ID, 2013, APMIS, V121, P1004, DOI 10.1111/apm.12161; Kourmpetis YAI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009293; Kroll H, 2011, NEUROENDOCRINOLOGY, V93, P114, DOI 10.1159/000321678; Kurasawa Y, 2004, EMBO J, V23, P3237, DOI 10.1038/sj.emboj.7600347; Lai SK, 2011, CELL DEATH DIFFER, V18, P996, DOI 10.1038/cdd.2010.165; Landry DM, 2009, GENE DEV, V23, P2753, DOI 10.1101/gad.1832209; Letovsky S, 2003, BIOINFORMATICS, V19, pi197, DOI 10.1093/bioinformatics/btg1026; Li DL, 2009, PEPTIDES, V30, P130, DOI 10.1016/j.peptides.2008.09.025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu JAJ, 2013, P NATL ACAD SCI USA, V110, P2882, DOI 10.1073/pnas.1211747110; Lizama AJ, 2015, INNATE IMMUN-LONDON, V21, P575, DOI 10.1177/1753425914566083; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mollereau C, 2001, BRIT J PHARMACOL, V133, P1, DOI 10.1038/sj.bjp.0704049; Morrison KB, 2002, ONCOGENE, V21, P5684, DOI 10.1038/sj.onc.1205669; Nabieva E, 2005, BIOINFORMATICS, V21, pI302, DOI 10.1093/bioinformatics/bti1054; Nishizawa M, 2005, J CELL SCI, V118, P1081, DOI 10.1242/jcs.01667; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Olety B, 2010, FEBS LETT, V584, P493, DOI 10.1016/j.febslet.2009.11.096; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Onuma TA, 2012, FASEB J, V26, P2941, DOI 10.1096/fj.11-201095; Pandey G, 2006, COMPUTATIONAL APPROA; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Pegg SCH, 2006, BIOCHEMISTRY-US, V45, P2545, DOI 10.1021/bi052101l; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Qiu W, 2014, SCI WORLD J, DOI 10.1155/2014/406154; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Rubinstein ND, 2009, MOL IMMUNOL, V46, P840, DOI 10.1016/j.molimm.2008.09.009; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Ruepp A, 2006, NUCLEIC ACIDS RES, V34, pD568, DOI 10.1093/nar/gkj074; Saini HK, 2007, NUCLEIC ACIDS RES, V35, pW499, DOI 10.1093/nar/gkm367; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shatsky M, 2004, NUCLEIC ACIDS RES, V32, pW503, DOI 10.1093/nar/gkh413; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Singh R, 2008, P NATL ACAD SCI USA, V105, P12763, DOI 10.1073/pnas.0806627105; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Stefansson K, 2006, BIOL CHEM, V387, P761, DOI 10.1515/BC.2006.095; Sugimoto M, 2008, J CELL BIOL, V183, P19, DOI 10.1083/jcb.200803133; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V288, pE1055, DOI 10.1152/ajpendo.00516.2004; Tersteeg C, 2014, CIRCULATION, V129, P1320, DOI 10.1161/CIRCULATIONAHA.113.006727; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Wang HH, 2012, AM J PATHOL, V180, P1170, DOI 10.1016/j.ajpath.2011.11.020; Wass MN, 2008, BIOINFORMATICS, V24, P798, DOI 10.1093/bioinformatics/btn037; Wong L, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010021; Xu LF, 2004, J CELL BIOL, V167, P819, DOI 10.1083/jcb.200408181; Xu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055844; Yu J, 2009, INT J ONCOL, V35, P175, DOI 10.3892/ijo_00000326; Yuan J, 2008, J CELL BIOCHEM, V103, P648, DOI 10.1002/jcb.21439; Zehetner G, 2003, NUCLEIC ACIDS RES, V31, P3799, DOI 10.1093/nar/gkg555	93	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166580	10.1371/journal.pone.0166580	http://dx.doi.org/10.1371/journal.pone.0166580			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846315	gold, Green Submitted, Green Published			2022-12-26	WOS:000387794600087
J	Yu, JM; Hua, H; Liu, Y; Liu, Y				Yu, Jiaming; Hua, Hui; Liu, Yan; Liu, Yang			Distributions of Direct, Reflected, and Diffuse Irradiance for Ocular UV Exposure at Different Solar Elevation Angles	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; ANATOMICAL DISTRIBUTION; SURFACE; BODY	To analyze intensities of ocular exposure to direct (E-o,(dir)), reflected (E-o,(refl)), and diffuse (E-o,E-diff) ultraviolet (UV) irradiance at different solar elevation angles (SEAs), a rotating manikin and dual-detector spectrometer were used to monitor the intensity of ocular exposure to UV irradiation (E-o) and ambient UV radiation (UVR) under clear skies in Sanya, China. E-o,E-dir was derived as the difference between maximum and minimum measured Eo values. E-o,E-refl was converted from the value measured at a height of 160 cm. E-o,E-diff was calculated as the minimum measured E-o value minus E-o,E-refl. Regression curves were fitted to determine distributions of intensities and growth rates at different wavelengths and SEAs. E-o,E-dir differed from ambient UVR exposure. Linear, quadratic, and linear E-o,E-dir distributions were obtained in SEA ranges of 14 degrees-30 degrees, 30 degrees-50 degrees, and 50 degrees-90 degrees, respectively, with maximum E-o,E-dir at 32 degrees-38 degrees SEA. Growth rates of E-o,E-dir with increasing wavelength were fitted with quadratic functions in all SEA ranges. Distributions and growth rate of E-o,(refl) values were fitted with quadratic functions. Maximum E-o,E-diff was achieved at the same SEA for all fitted quadratic functions. Growth rate of E-o,E-diff with increasing wavelength was fitted with a linear function. E-o,E-dir distributions were fitted with linear or quadratic functions in different SEA ranges. All E-o,E-refl and E-o,E-diff distributions were fitted with quadratic functions. As SEA increased, the E-o,E-dir portion of E-o increased and then decreased; the E-o,E-refl portion increased from an initial minimum; and the E-o,E-diff portion first decreased and then increased. The findings may provide data supporting on construction of a mathematical model of ocular UV exposure.	[Yu, Jiaming] China Med Univ, Affiliated Hosp 4, Dept Ophthalmol, Shenyang, Liaoning, Peoples R China; [Hua, Hui; Liu, Yang] China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China; [Liu, Yan] China Med Univ, Dept Biomed Engn, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Liu, Y (corresponding author), China Med Univ, Sch Publ Hlth, Shenyang, Liaoning, Peoples R China.	yangliu@cmu.edu.cn			National Natural Science Foundation of China [81273034]; Natural Science Foundation of Liaoning Province, China [2014021009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province, China(Natural Science Foundation of Liaoning Province)	This work was supported by the National Natural Science Foundation of China, Grant NO:81273034 (https:/isisn.nsfc.gov.cn/egrantindextfuncindex/prisearch-list) to YL and the Natural Science Foundation of Liaoning Province, China, Grant No: 2014021009 (http://kjjh.ininfo.gov.cn/) to JMY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baczynska KA, 2013, RADIAT PROT DOSIM, V154, P497, DOI 10.1093/rpd/ncs261; Boulton M, 2001, J PHOTOCH PHOTOBIO B, V64, P144, DOI 10.1016/S1011-1344(01)00227-5; Cullen AP, 2002, INT J TOXICOL, V21, P455, DOI 10.1080/10915810290169882; Fleming DP, 2006, RADIAT PROT DOSIM, V118, P265, DOI 10.1093/rpd/nci346; Gao N, 2012, PHOTOCHEM PHOTOBIOL, V88, P736, DOI 10.1111/j.1751-1097.2012.01094.x; GARRISON LM, 1978, APPL OPTICS, V17, P827, DOI 10.1364/AO.17.000827; Hoeppe P, 2004, INT J BIOMETEOROL, V49, P18, DOI 10.1007/s00484-004-0211-9; Hu LW, 2014, PHOTOCHEM PHOTOBIOL, V90, P925, DOI 10.1111/php.12267; Hu LW, 2013, J OCCUP ENVIRON HYG, V10, P17, DOI 10.1080/15459624.2012.737700; Kim J, 2013, J PHOTOCH PHOTOBIO B, V119, P46, DOI 10.1016/j.jphotobiol.2012.11.007; Kimlin MG, 2003, PHOTOCH PHOTOBIO SCI, V2, P365, DOI 10.1039/b207953d; Liou JC, 2015, MOL VIS, V21; Liu GC, 2014, J PHOTOCH PHOTOBIO B, V141, P106, DOI 10.1016/j.jphotobiol.2014.09.009; Mesa R, 2013, INVEST OPHTH VIS SCI, V54, P6789, DOI 10.1167/iovs.13-12644; Newkirk KM, 2007, TOXICOL PATHOL, V35, P817, DOI 10.1080/01926230701584197; Oppenrieder A, 2004, J PHOTOCH PHOTOBIO B, V74, P85, DOI 10.1016/j.jphotobiol.2003.11.008; Parisi AV, 2003, J PHOTOCH PHOTOBIO B, V69, P1, DOI 10.1016/S1011-1344(02)00385-8; Pope SJ, 2010, PHOTOCHEM PHOTOBIOL, V86, P457, DOI 10.1111/j.1751-1097.2009.00679.x; Roberts JE, 2001, J PHOTOCH PHOTOBIO B, V64, P136, DOI 10.1016/S1011-1344(01)00196-8; ROSENTHAL FS, 1988, INVEST OPHTH VIS SCI, V29, P649; Serrano D, 2010, TETHYS-J MEDITERR ME, P57, DOI 10.3369/tethys.2010.7.05; Streicher JJ, 2004, PHOTOCHEM PHOTOBIOL, V79, P40, DOI 10.1562/0031-8655(2004)79&lt;40:MTADOS&gt;2.0.CO;2; Sydenham MM, 1997, INVEST OPHTH VIS SCI, V38, P1485; Turner J, 2008, J PHOTOCH PHOTOBIO B, V92, P29, DOI 10.1016/j.jphotobiol.2008.03.006; Turner J, 2009, PHOTOCH PHOTOBIO SCI, V8, P62, DOI 10.1039/b814006e; Vernez D, 2012, BRIT J DERMATOL, V167, P383, DOI 10.1111/j.1365-2133.2012.10898.x; Vernez D, 2011, PHOTOCHEM PHOTOBIOL, V87, P721, DOI 10.1111/j.1751-1097.2011.00895.x; Wang F, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050177, 10.1371/journal.pone.0052259]; Weihs P, 2002, INT J BIOMETEOROL, V46, P95, DOI 10.1007/s00484-002-0124-4; Weihs P, 2013, PHOTOCHEM PHOTOBIOL, V89, P1004, DOI 10.1111/php.12085	30	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166729	10.1371/journal.pone.0166729	http://dx.doi.org/10.1371/journal.pone.0166729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846278	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600103
J	Ahmed, A; Haider, SH; Parveen, S; Arshad, M; Alsenaidy, HA; Baaboud, AO; Mobaireek, KF; AlSaadi, MM; Alsenaidy, AM; Sullender, W				Ahmed, Anwar; Haider, Shakir H.; Parveen, Shama; Arshad, Mohammed; Alsenaidy, Hytham A.; Baaboud, Alawi Omar; Mobaireek, Khalid Fahad; AlSaadi, Muslim Mohammed; Alsenaidy, Abdulrahman M.; Sullender, Wayne			Co-Circulation of 72bp Duplication Group A and 60bp Duplication Group B Respiratory Syncytial Virus (RSV) Strains in Riyadh, Saudi Arabia during 2014	PLOS ONE			English	Article							GLYCOPROTEIN G GENE; G-PROTEIN GENE; MOLECULAR EPIDEMIOLOGY; GENOTYPE ON1; 60-NUCLEOTIDE DUPLICATION; PHYLOGENETIC ANALYSIS; NOSOCOMIAL OUTBREAK; CONSECUTIVE SEASONS; RAPID REPLACEMENT; TRACT INFECTION	Respiratory syncytial virus (RSV) is an important viral pathogen of acute respiratory tract infection (ARI). Limited data are available on molecular epidemiology of RSV from Saudi Arabia. A total of 130 nasopharyngeal aspirates were collected from children less than 5 years of age with ARI symptoms attending the Emergency Department at King Khalid University Hospital and King Fahad Medical City, Riyadh, Saudi Arabia between October and December, 2014. RSV was identified in the 26% of the hospitalized children by reverse transcriptase PCR. Group A RSV (77%) predominated during the study as compared to group B RSV (23%). The phylogenetic analysis of 28 study strains clustered group A RSV in NA1 and ON1 genotypes and group B viruses in BA (BA9) genotype. Interestingly, 26% of the positive samples clustered in genotypes with duplication in the G protein gene (ON1 for group A and BA for group B). Both the genotypes showed enhanced O-linked glycosylation in the duplicated region, with 10 and 2 additional sites in ON1 and BA respectively. Selection pressure analysis revealed purifying selection in both the ON1 and BA genotypes. One codon each in the ON1 (position 274) and BA genotypes (position 219) were positively selected and had high entropy values indicating variations at these amino acid positions. This is the first report describing the presence of ON1 genotype and the first report on co-circulation of two different genotypes of RSV with duplication in the G protein gene from Saudi Arabia. The clinical implications of the simultaneous occurrence of genotypes with duplication in G protein gene in a given population especially in the concurrent infections should be investigated in future. Further, the ongoing surveillance of RSV in this region will reveal the evolutionary trajectory of these two genotypes with duplication in G protein gene from largest country in the Middle East.	[Ahmed, Anwar; Arshad, Mohammed; Alsenaidy, Abdulrahman M.] King Saud Univ, Dept Biochem, Coll Sci, Prot Res Chair, Riyadh, Saudi Arabia; [Ahmed, Anwar] King Saud Univ, Dept Biochem, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia; [Haider, Shakir H.; Parveen, Shama] Jamia Millie Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi, India; [Alsenaidy, Hytham A.] Shaqra Univ, Coll Med, Shaqra, Saudi Arabia; [Baaboud, Alawi Omar; Mobaireek, Khalid Fahad] King Fahad Med City, Pediat Emergency Dept, Childrens Hosp, King, WI USA; [AlSaadi, Muslim Mohammed] King Saud Univ, King Khalid Univ Hosp, Dept Pediat, Coll Med, Riyadh, Saudi Arabia; [Sullender, Wayne] Colorado Sch Publ Hlth, Sch Med, Ctr Global Hlth, Aurora, CO USA	King Saud University; King Saud University; Jamia Millia Islamia; Shaqra University; Children's Hospital of Wisconsin; King Saud University; King Khalid University Hospital; Colorado School of Public Health	Ahmed, A (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Prot Res Chair, Riyadh, Saudi Arabia.; Ahmed, A (corresponding author), King Saud Univ, Dept Biochem, Coll Sci, Ctr Excellence Biotechnol Res, Riyadh, Saudi Arabia.	anahmed@ksu.edu.sa	Ahmed, Anwar/AAL-7789-2021; Ahmed, Anwar/ADH-1445-2022	Ahmed, Anwar/0000-0001-8147-714X	National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia [12MED-2886-02]	National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia	The project was funded by the National Plan for Science, Technology and Innovation (MAARIFA), King Abdulaziz City for Science and Technology, Kingdom of Saudi Arabia, URL: http//maanfah.kacst.edu.sa/NSTIPWCPortal/faces/NSTIPHomePage; Award Number 12MED-2886-02, to AA.	Aamir UB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074018; Agoti CN, 2014, EMERG INFECT DIS, V20, P950, DOI 10.3201/eid2006.131438; Agoti CN, 2013, INFLUENZA OTHER RESP, V7, P1008, DOI 10.1111/irv.12131; Agrawal AS, 2009, J CLIN VIROL, V45, P358, DOI 10.1016/j.jcv.2009.05.013; Akhter J., 2009, Saudi Pharmaceutical Journal, V17, P177; Al-Ayed MS, 2014, SAUDI MED J, V35, P1348; Al-Hajjar S, 1998, ANN TROP PAEDIATR, V18, P87, DOI 10.1080/02724936.1998.11747933; Al-Majhdi F. N., 2009, International Journal of Virology, V5, P154, DOI 10.3923/ijv.2009.154.163; Al-Shehri Mohammed A, 2005, West Afr J Med, V24, P299; Almajhdi FN, 2014, VIRUS GENES, V48, P252, DOI 10.1007/s11262-013-1030-z; Almajhdi FN, 2014, ARCH VIROL, V159, P73, DOI 10.1007/s00705-013-1792-6; Amer HM, 2015, J MED VIROL; Auksornkitti V, 2014, ARCH VIROL, V159, P499, DOI 10.1007/s00705-013-1773-9; Avadhanula V, 2015, J INFECT DIS, V211, P582, DOI 10.1093/infdis/jiu473; Baek YH, 2012, ARCH VIROL, V157, P1039, DOI 10.1007/s00705-012-1267-1; Bakir TMF, 1998, J TROP PEDIATRICS, V44, P100, DOI 10.1093/tropej/44.2.100; Balmaks R, 2014, J MED VIROL, V86, P1971, DOI 10.1002/jmv.23855; Ramirez JB, 2014, REV PANAM SALUD PUBL, V36, P101; Bose ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120098; Botosso VF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000254; CANE PA, 1991, J GEN VIROL, V72, P2091, DOI 10.1099/0022-1317-72-9-2091; Choudhary ML, 2013, INFECT GENET EVOL, V20, P369, DOI 10.1016/j.meegid.2013.09.025; Choudhary ML, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00165-13; Cui Bin, 2013, Zhongguo Xuexichongbing Fangzhi Zazhi, V25, P598; Cui GL, 2015, INFECT GENET EVOL, V33, P163, DOI 10.1016/j.meegid.2015.04.025; Cui GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075020; De-Paris F, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-36; Duvvuri VR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14268; Eshaghi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032807; Esposito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129369; Galiano MC, 2005, J CLIN MICROBIOL, V43, P2266, DOI 10.1128/JCM.43.5.2266-2273.2005; Gimferrer L, 2015, J CLIN VIROL, V66, P27, DOI 10.1016/j.jcv.2015.02.018; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hirano E, 2014, INFECT GENET EVOL, V28, P183, DOI 10.1016/j.meegid.2014.09.030; JAMJOOM GA, 1993, J TROP PEDIATRICS, V39, P346, DOI 10.1093/tropej/39.6.346; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Khor CS, 2013, INFECT GENET EVOL, V14, P357, DOI 10.1016/j.meegid.2012.12.017; Kim YJ, 2014, INFECT GENET EVOL, V26, P103, DOI 10.1016/j.meegid.2014.05.007; Kouni S, 2013, CLIN MICROBIOL INFEC, V19, P772, DOI 10.1111/1469-0691.12015; Lee WJ, 2012, J VIROL, V86, P13810, DOI 10.1128/JVI.02571-12; Malasao R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142192; Martinez-Roig A, 2015, ARCH BRONCONEUMOL, V51, P5, DOI 10.1016/j.arbres.2014.01.018; Meqdam MM, 2006, FEMS IMMUNOL MED MIC, V47, P129, DOI 10.1111/j.1574-695X.2006.00073.x; Nagai K, 2004, J MED VIROL, V74, P161, DOI 10.1002/jmv.20160; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ohno A, 2013, J CLIN VIROL, V57, P59, DOI 10.1016/j.jcv.2013.01.001; Panayiotou C, 2014, EPIDEMIOL INFECT, V142, P2406, DOI 10.1017/S0950268814000028; Parveen S, 2006, J MED VIROL, V78, P659, DOI 10.1002/jmv.20590; Parveen S, 2006, J CLIN MICROBIOL, V44, P3055, DOI 10.1128/JCM.00187-06; Pierangeli A, 2014, EURO SURVEILL, V19; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Pretorius MA, 2013, J INFECT DIS, V208, pS227, DOI 10.1093/infdis/jit477; Raghuram V. L. N. S., 2015, VirusDisease, V26, P276, DOI 10.1007/s13337-015-0283-7; Reiche J, 2009, J CLIN MICROBIOL, V47, P1800, DOI 10.1128/JCM.02286-08; Ren L, 2014, INFECT GENET EVOL, V27, P339, DOI 10.1016/j.meegid.2014.07.030; Roca A, 2001, J GEN VIROL, V82, P103, DOI 10.1099/0022-1317-82-1-103; RUEDA P, 1991, J VIROL, V65, P3374, DOI 10.1128/JVI.65.6.3374-3378.1991; Sato M, 2005, J CLIN MICROBIOL, V43, P36, DOI 10.1128/JCM.43.1.36-40.2005; Scott PD, 2004, J MED VIROL, V74, P344, DOI 10.1002/jmv.20183; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shier MK, 2005, MINOUFIA MED J, V18, P11; Tabatabai J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109191; Taha MK, 2013, EMERG INFECT DIS, V19, P1030, DOI 10.3201/eid1906.120515; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trento A, 2006, J VIROL, V80, P975, DOI 10.1128/JVI.80.2.975-984.2006; Trento A, 2003, J GEN VIROL, V84, P3115, DOI 10.1099/vir.0.19357-0; Trento A, 2010, J VIROL, V84, P7500, DOI 10.1128/JVI.00345-10; Tsukagoshi H, 2013, MICROBIOL IMMUNOL, V57, P655, DOI 10.1111/1348-0421.12075; Valley-Omar Z, 2013, EMERG INFECT DIS, V19, P668, DOI 10.3201/eid1904.121465; Viegas M, 2005, J MED VIROL, V77, P302, DOI 10.1002/jmv.20457; Visser A, 2008, J MED VIROL, V80, P724, DOI 10.1002/jmv.21128; Who, 2005, WHOFCHCAH0012; Yamaguchi M, 2011, J CLIN MICROBIOL, V49, P1034, DOI 10.1128/JCM.02132-10; Yu X., 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1016/J.JCV.2015.05.015; Zhang Y, 2007, ARCH VIROL, V152, P1425, DOI 10.1007/s00705-007-0984-3; Zlateva KT, 2007, J CLIN MICROBIOL, V45, P3022, DOI 10.1128/JCM.00339-07; Zlateva KT, 2005, J VIROL, V79, P9157, DOI 10.1128/JVI.79.14.9157-9167.2005	77	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166145	10.1371/journal.pone.0166145	http://dx.doi.org/10.1371/journal.pone.0166145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835664	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200028
J	Tsitoura, MEI; Stavrou, EF; Maraziotis, LA; Sarafidis, K; Athanassiadou, A; Dimitriou, G				Tsitoura, Maria-Eleni I.; Stavrou, Eleana F.; Maraziotis, Loannis A.; Sarafidis, Kosmas; Athanassiadou, Aglaia; Dimitriou, Gabriel			Surfactant Protein A and B Gene Polymorphisms and Risk of Respiratory Distress Syndrome in Late-Preterm Neonates	PLOS ONE			English	Article							ASSOCIATION; VARIANTS; DISEQUILIBRIUM; POPULATION; MORBIDITY; INFANTS; LOCUS	Background and Objectives Newborns delivered late-preterm (between 34(0/7) and 36(6/7) weeks of gestation) are at increased risk of respiratory distress syndrome (RDS). Polymorphisms within the surfactant protein (SP) A and B gene have been shown to predispose to RDS in preterm neonates. The aim of this study was to investigate whether specific SP-A and/or SP-B genetic variants are also associated with RDS in infants born late-preterm. Methods This prospective cross-sectional study included 56 late-preterm infants with and 60 without RDS. Specific SP-A1/SP-A2 haplotypes and SP-B Ile131Thr polymorphic alleles were determined in blood specimens using polymerase-chain-reaction and DNA sequencing. Results The SP-A1 6A(4) and the SP-A2 1A(5) haplotypes were significantly overrepresented in new-borns with RDS compared to controls (OR 2.86, 95% CI 1.20-6.83 and OR 4.68, 95% CI 1.28-17.1, respectively). The distribution of the SP-B Ile131Thr genotypes was similar between the two late-preterm groups. Overall, the SP-A1 6A(4) or/and SP-A2 1A(5) haplotype was present in 20 newborns with RDS (35.7%), resulting in a 4.2-fold (1.60-11.0) higher probability of RDS in carriers. Multivariable regression analysis revealed that the effect of SP-A1 6A(4) and SP-A2 1A(5) haplotypes was preserved when adjusting for known risk or protective factors, such as male gender, smaller gestational age, smaller weight, complications of pregnancy, and administration of antenatal corticosteroids. Conclusions Specific SP-A genetic variants may influence the susceptibility to RDS in late-preterm infants, independently of the effect of other perinatal factors.	[Tsitoura, Maria-Eleni I.; Maraziotis, Loannis A.; Dimitriou, Gabriel] Univ Patras, Dept Pediat, Neonatal Intens Care Unit, Fac Med, Patras, Greece; [Tsitoura, Maria-Eleni I.; Stavrou, Eleana F.; Athanassiadou, Aglaia] Univ Patras, Dept Gen Biol, Fac Med, Patras, Greece; [Sarafidis, Kosmas] Aristotle Univ Thessaloniki, Ippokrat Gen Hosp, Dept Neonatol 1, Thessaloniki, Greece	University of Patras; University of Patras; Aristotle University of Thessaloniki	Dimitriou, G (corresponding author), Univ Patras, Dept Pediat, Neonatal Intens Care Unit, Fac Med, Patras, Greece.	gdimitriou@med.upatras.gr	Dimitriou, Gabriel/AAJ-1946-2020; Sarafidis, Kosmas/R-1266-2019	Sarafidis, Kosmas/0000-0002-6806-6343	European Union (European Social Fund ESF); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	European Union (European Social Fund ESF)(European Social Fund (ESF)); Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund	This research has been co-financed by the European Union (European Social Fund ESF) and Greek national funds through the Operational Program "Education and Lifelong Learning" of the National Strategic Reference Framework (NSRF) Research Funding Program: Heracleitus II. Investing in knowledge society through the European Social Fund.	Altman M, 2013, PAEDIATR PERINAT EP, V27, P172, DOI 10.1111/ppe.12035; Ariki S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/532071; DiAngelo S, 1999, DIS MARKERS, V15, P269, DOI 10.1155/1999/961430; Dimitriou G, 2010, EARLY HUM DEV, V86, P587, DOI 10.1016/j.earlhumdev.2010.07.011; Dudell GG, 2006, CLIN PERINATOL, V33, P803, DOI 10.1016/j.clp.2006.09.006; Engle WA, 2007, PEDIATRICS, V120, P1390, DOI 10.1542/peds.2007-2952; Floros J, 2001, PEDIATR INT, V43, P567, DOI 10.1046/j.1442-200X.2001.01474.x; Floros J, 2001, CLIN GENET, V60, P178, DOI 10.1034/j.1399-0004.2001.600303.x; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; Haataja R, 2000, HUM MOL GENET, V9, P2751, DOI 10.1093/hmg/9.18.2751; Hawgood S, 2004, BIOL NEONATE, V85, P285, DOI 10.1159/000078169; Hibbard JU, 2010, JAMA-J AM MED ASSOC, V304, P419, DOI 10.1001/jama.2010.1015; Hoover RR, 1999, AM J PHYSIOL-LUNG C, V276, pL917, DOI 10.1152/ajplung.1999.276.6.L917; Hoover RR, 1998, AM J RESP CELL MOL, V18, P353, DOI 10.1165/ajrcmb.18.3.3035; Jo HS, 2013, NEONATOLOGY, V103, P44, DOI 10.1159/000342498; KARINCH AM, 1995, AM J RESP CELL MOL, V12, P77, DOI 10.1165/ajrcmb.12.1.7811473; Liu WL, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-13; Marttila R, 2003, AM J RESP CRIT CARE, V168, P1216, DOI 10.1164/rccm.200304-524OC; Marttila R, 2003, HUM GENET, V112, P18, DOI 10.1007/s00439-002-0835-y; NOGEE LM, 1994, J CLIN INVEST, V93, P1860, DOI 10.1172/JCI117173; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raju TNK, 2012, SEMIN FETAL NEONAT M, V17, P126, DOI 10.1016/j.siny.2012.01.010; Ramet M, 2000, AM J HUM GENET, V66, P1569, DOI 10.1086/302906; Ramet M, 2000, DIS MARKERS, V16, P119; Selman M, 2003, HUM GENET, V113, P542, DOI 10.1007/s00439-003-1015-4; Silveyra P, 2012, FRONT BIOSCI-LANDMRK, V17, P407, DOI 10.2741/3935	27	7	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166516	10.1371/journal.pone.0166516	http://dx.doi.org/10.1371/journal.pone.0166516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835691	Green Submitted, Green Published, gold			2022-12-26	WOS:000387779200054
J	Baron, K; Neumayer, B; Amerstorfer, E; Scheurer, E; Diwoky, C; Stollberger, R; Sprenger, H; Weinberg, AM				Baron, Katharina; Neumayer, Bernhard; Amerstorfer, Eva; Scheurer, Eva; Diwoky, Clemens; Stollberger, Rudolf; Sprenger, Hanna; Weinberg, Annelie M.			Time-Dependent Changes in T1 during Fracture Healing in Juvenile Rats: A Quantitative MR Approach	PLOS ONE			English	Article							MUSCULOSKELETAL MRI; RELAXATION-TIMES; BONE; AGE	Quantitative magnetic resonance imaging (qMRI) offers several advantages in imaging and determination of soft tissue alterations when compared to qualitative imaging techniques. Although applications in brain and muscle tissues are well studied, its suitability to quantify relaxation times of intact and injured bone tissue, especially in children, is widely unknown. The objective observation of a fracture including its age determination can become of legal interest in cases of child abuse or maltreatment. Therefore, the aim of this study is the determination of time dependent changes in intact and corresponding injured bones in immature rats via qMRI, to provide the basis for an objective and radiation-free approach for fracture dating. Thirty-five MR scans of 7 Sprague-Dawley rats (male, 4 weeks old, 100 5 g) were acquired on a 3T MRI scanner (TimTrio, Siemens AG, Erlangen, Germany) after the surgical infliction of an epiphyseal fracture in the tibia. The images were taken at days 1, 3, 7, 14, 28, 42 and 82 post-surgery. A proton density-weighted and a T1-weighted 3D FLASH sequence were acquired to calculate the longitudinal relaxation time T1 of the fractured region and the surrounding tissues. The calculation of T1 in intact and injured bone resulted in a quantitative observation of bone development in intact juvenile tibiae as well as the bone healing process in the injured tibiae. In both areas, T1 decreased overtime. To evaluate the differences in T1 behaviour between the intact and injured bone, the relative T1 values (bone-fracture) were calculated, showing clear detectable alterations of T1 after fracture occurrence. These results indicate that qMRI has a high potential not only for clinically relevant applications to detect growth defects or developmental alterations in juvenile bones, but also for forensically relevant applications such as the dating of fractures in cases of child abuse or maltreatment.	[Baron, Katharina; Neumayer, Bernhard; Scheurer, Eva; Sprenger, Hanna] LBI CFI, Graz, Austria; [Amerstorfer, Eva] Med Univ Graz, Dept Paediat & Adolescent Surg, Graz, Austria; [Scheurer, Eva] Univ Basel, Hlth Dept Basel, Inst Forens Med, Basel, Switzerland; [Diwoky, Clemens] Graz Univ, Inst Mol Biosci, Graz, Austria; [Stollberger, Rudolf] Graz Univ Technol, Inst Med Engn, Graz, Austria; [Weinberg, Annelie M.] Med Univ Graz, Dept Orthoped & Orthoped Surg, Graz, Austria; [Baron, Katharina; Neumayer, Bernhard; Diwoky, Clemens; Stollberger, Rudolf; Sprenger, Hanna; Weinberg, Annelie M.] BioTechMed Graz, Graz, Austria	Medical University of Graz; University of Basel; University of Graz; Graz University of Technology; Medical University of Graz	Baron, K (corresponding author), LBI CFI, Graz, Austria.; Baron, K (corresponding author), BioTechMed Graz, Graz, Austria.	Katharina.Baron@cfi.lbg.ac.at	Stollberger, Rudolf/AAB-9957-2019; Scheurer, Eva/AAE-6161-2019	Scheurer, Eva/0000-0002-2742-0422; Neumayer, Bernhard/0000-0002-4439-4799; Stollberger, Rudolf/0000-0002-4969-3878	Austrian Science Fund FWF [F3209-18]; AO Research Fund of the AO Research Foundation [S-06-96W]	Austrian Science Fund FWF(Austrian Science Fund (FWF)); AO Research Fund of the AO Research Foundation	This work was funded by the Austrian Science Fund FWF (SFB grant F3209-18, https://www.fwf.ac.at, with RS as Vice-Coordinator) and the AO Research Fund of the AO Research Foundation (project number S-06-96W, https://www.aofoundation.org, to AMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron K, 2016, FORENSIC SCI INT, V261, P61, DOI 10.1016/j.forsciint.2016.01.020; BRADLEY WG, 1993, RADIOLOGY, V189, P15, DOI 10.1148/radiology.189.1.8372185; Cheng S, 1994, BONE MINERAL DENSITY; del Rio Barquero L, 1992, Bone Miner, V18, P159; Einhorn TA, 2015, NAT REV RHEUMATOL, V11, P45, DOI 10.1038/nrrheum.2014.164; Fischerauer E, 2011, J MOL HISTOL, V42, P513, DOI 10.1007/s10735-011-9359-x; FUTAMURA Y, 1993, EXP ANIM TOKYO, V42, P643, DOI 10.1538/expanim1978.42.4_643; Gold GE, 2004, AM J ROENTGENOL, V183, P343, DOI 10.2214/ajr.183.2.1830343; Histing T, 2011, BONE, V49, P591, DOI 10.1016/j.bone.2011.07.007; HITTMAIR K, 1994, MAGNET RESON MED, V31, P567, DOI 10.1002/mrm.1910310516; Jordan CD, 2013, EUR J RADIOL, V82, P734, DOI 10.1016/j.ejrad.2011.09.021; Kalfas I H, 2001, Neurosurg Focus, V10, pE1; Kruger K, 1999, ROFO-FORTSCHR RONTG, V170, P262; Lai PH, 1999, AM J ROENTGENOL, V172, P1109, DOI 10.2214/ajr.172.4.10587157; Lu CY, 2005, J ORTHOP RES, V23, P1300, DOI 10.1016/j.orthres.2005.04.003; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; Merwa R, 2009, P INT SOC MAG RESON, P4661; Morrow JM, 2014, EUR RADIOL, V24, P1610, DOI 10.1007/s00330-014-3145-6; Nunes JS, 2016, ATLAS HISTOLOGY JUVE, P29; Parker GA, 2016, ATLAS HISTOLOGY JUVE, pxi; Piney A, 1922, BRIT MED J, V1922, P792; Pountos I, 2012, SCI WORLD J, DOI 10.1100/2012/606404; Prosser I, 2005, AM J ROENTGENOL, V184, P1282, DOI 10.2214/ajr.184.4.01841282; Prosser I, 2012, AM J ROENTGENOL, V198, P1014, DOI 10.2214/AJR.11.6734; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Schoenfeld BJ, 2012, SPORTS MED, V42, P1017, DOI 10.2165/11635190-000000000-00000; Silva JR, 2013, DIAGN INTERV RADIOL, V19, P393, DOI 10.5152/dir.2013.067; Snow-Harter C, 1991, Exerc Sport Sci Rev, V19, P351; Stanisz GJ, 2005, MAGNET RESON MED, V54, P507, DOI 10.1002/mrm.20605; Taha MA, 2013, J MAGN RESON IMAGING, V38, P231, DOI 10.1002/jmri.23876; Wang DT, 2012, J AM OSTEOPATH COLL, V1, P2; Zollinger TJ, 2011, J AVIAN MED SURG, V25, P173, DOI 10.1647/2010-023.1	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164284	10.1371/journal.pone.0164284	http://dx.doi.org/10.1371/journal.pone.0164284			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832068	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000003
J	Vigoder, FM; Parker, DJ; Cook, N; Tourniere, O; Sneddon, T; Ritchie, MG				Vigoder, Felipe M.; Parker, Darren J.; Cook, Nicola; Tourniere, Oceane; Sneddon, Tanya; Ritchie, Michael G.			Inducing Cold-Sensitivity in the Frigophilic Fly Drosophila montana by RNAi	PLOS ONE			English	Article							THERMAL ADAPTATION; GENE-EXPRESSION; TOLERANCE; ACCLIMATION; TEMPERATURE; MYOINOSITOL; SELECTION; DRIVES; TOOLS; FLIES	Cold acclimation is a critical physiological adaptation for coping with seasonal cold. By increasing their cold tolerance individuals can remain active for longer at the onset of winter and can recover more quickly from a cold shock. In insects, despite many physiological studies, little is known about the genetic basis of cold acclimation. Recently, transcriptomic analyses in Drosophila virilis and D. montana revealed candidate genes for cold acclimation by identifying genes upregulated during exposure to cold. Here, we test the role of myo-inositol-1-phosphate synthase (Inos), in cold tolerance in D. montana using an RNAi approach. D. montana has a circumpolar distribution and overwinters as an adult in northern latitudes with extreme cold. We assessed cold tolerance of dsRNA knock-down flies using two metrics: chill-coma recovery time (CCRT) and mortality rate after cold acclimation. Injection of dsRNA/nos did not alter CCRT, either overall or in interaction with the cold treatment, however it did induced cold-specific mortality, with high levels of mortality observed in injected flies acclimated at 5 degrees C but not at 19 degrees C. Overall, injection with dsRNA/nos induced a temperature-sensitive mortality rate of over 60% in this normally cold-tolerant species. qPCR analysis confirmed that dsRNA injection successfully reduced gene expression of Inos. Thus, our results demonstrate the involvement of Inos in increasing cold tolerance in D. montana. The potential mechanisms involved by which Inos increases cold tolerance are also discussed.	[Vigoder, Felipe M.; Parker, Darren J.; Cook, Nicola; Tourniere, Oceane; Sneddon, Tanya; Ritchie, Michael G.] Univ St Andrews, Ctr Biol Divers, Sch Biol, St Andrews, Fife, Scotland; [Vigoder, Felipe M.] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil; [Parker, Darren J.] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Tourniere, Oceane] Sars Int Ctr Marine Mol Biol, Bergen, Norway	University of St Andrews; Universidade Federal do Rio de Janeiro; University of Jyvaskyla	Vigoder, FM (corresponding author), Univ St Andrews, Ctr Biol Divers, Sch Biol, St Andrews, Fife, Scotland.; Vigoder, FM (corresponding author), Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, Brazil.	fvigoder@gmail.com	Cook, Nicola/AGU-9057-2022; Ritchie, Michael G/F-7055-2013	Cook, Nicola/0000-0003-4462-0116; Ritchie, Michael G/0000-0001-7913-8675; Vigoder, Felipe/0000-0003-1037-8851; Parker, Darren James/0000-0003-4027-7779; Tourniere, Oceane/0000-0002-1125-7747	Natural Environment Research Council [NE/J020818/1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq; CNPq; NERC Studentship; NERC [NE/J020818/1, NE/P000592/1] Funding Source: UKRI; Natural Environment Research Council [NE/P000592/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NERC Studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council-NE/J020818/1 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Venera Tyukmaeva, Liam Dougherty, Emily Burdfield-Steel, Claire Stewart, Jade Green, Jonti Siva-Jothy and Lauren Halliwell for help with CCRT observations. We would also like to thank Dr. Rafaela Bruno for providing a plasmid containing a fragment of lacZ. The work was supported by CNPq (Fellowship to FMV) and a NERC Studentship to DJP. Maaria Kankare, Anneli Hoikkala and Paris Veltsos have contributed help and advice.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; [Anonymous], 2010, LOW TEMPERATURE BIOL; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BLOCK W, 1983, POLAR BIOL, V2, P109, DOI 10.1007/BF00303176; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Colinet H, 2012, FUNCT ECOL, V26, P84, DOI 10.1111/j.1365-2435.2011.01898.x; Fassbinder-Orth CA, 2014, INTEGR COMP BIOL, V54, P396, DOI 10.1093/icb/icu023; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Keller I, 2012, MOL ECOL, V21, P782, DOI 10.1111/j.1365-294X.2011.05397.x; Kellermann V, 2012, EVOLUTION, V66, P3377, DOI 10.1111/j.1558-5646.2012.01685.x; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Kostal V, 1996, CRYO-LETT, V17, P267; Kostal V, 2003, COMP BIOCHEM PHYS B, V135, P407, DOI 10.1016/S1096-4959(03)00117-9; Kristensen TN, 2008, P NATL ACAD SCI USA, V105, P216, DOI 10.1073/pnas.0708074105; Majumder AL, 1997, BBA-LIPID LIPID MET, V1348, P245, DOI 10.1016/S0005-2760(97)00122-7; Miller SC, 2008, DEV GENES EVOL, V218, P505, DOI 10.1007/s00427-008-0238-8; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Overgaard J, 2008, LOW TEMPERATURE BIOL, P276; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; Parker DJ, 2015, HEREDITY, V115, P13, DOI 10.1038/hdy.2015.6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Port F, 2014, P NATL ACAD SCI USA, V111, pE2967, DOI 10.1073/pnas.1405500111; Qvarnstrom A, 2016, EVOL APPL, V9, P119, DOI 10.1111/eva.12276; R Core Team, 2021, R LANGUAGE ENV STAT; Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049; Roignant JY, 2003, RNA, V9, P299, DOI 10.1261/rna.2154103; Scott JG, 2013, J INSECT PHYSIOL, V59, P1212, DOI 10.1016/j.jinsphys.2013.08.014; Teets NM, 2012, PHYSIOL GENOMICS, V44, P764, DOI 10.1152/physiolgenomics.00042.2012; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Throckmorton L.H., 1982, Genetics and Biology of Drosophila, V3b, P227; Veltsos P, 2012, ECOL EVOL, V2, P80, DOI 10.1002/ece3.75; Vesala L, 2012, INSECT MOL BIOL, V21, P107, DOI 10.1111/j.1365-2583.2011.01119.x; Vesala L, 2012, J EXP BIOL, V215, P2891, DOI 10.1242/jeb.069948	39	8	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165724	10.1371/journal.pone.0165724	http://dx.doi.org/10.1371/journal.pone.0165724			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832122	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000030
J	Hatherley, R; Brown, DK; Glenister, M; Bishop, OT				Hatherley, Rowan; Brown, David K.; Glenister, Michael; Bishop, Oezlem Tastan			PRIMO: An Interactive Homology Modeling Pipeline	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PROTEIN-STRUCTURE; SCORING FUNCTION; BIOINFORMATICS; GENERATION; PREDICTION; DATABASE; SERVER; WEB	The development of automated servers to predict the three-dimensional structure of proteins has seen much progress over the years. These servers make calculations simpler, but largely exclude users from the process. In this study, we present the PRotein Interactive MOdeling (PRIMO) pipeline for homology modeling of protein monomers. The pipeline eases the multi-step modeling process, and reduces the workload required by the user, while still allowing engagement from the user during every step. Default parameters are given for each step, which can either be modified or supplemented with additional external input. PRIMO has been designed for users of varying levels of experience with homology modeling. The pipeline incorporates a user-friendly interface that makes it easy to alter parameters used during modeling. During each stage of the modeling process, the site provides suggestions for novice users to improve the quality of their models. PRIMO provides functionality that allows users to also model ligands and ions in complex with their protein targets. Herein, we assess the accuracy of the fully automated capabilities of the server, including a comparative analysis of the available alignment programs, as well as of the refinement levels used during modeling. The tests presented here demonstrate the reliability of the PRIMO server when producing a large number of protein models. While PRIMO does focus on user involvement in the homology modeling process, the results indicate that in the presence of suitable templates, good quality models can be produced even without user intervention. This gives an idea of the base level accuracy of PRIMO, which users can improve upon by adjusting parameters in their modeling runs. The accuracy of PRIMO's automated scripts is being continuously evaluated by the CAMEO (Continuous Automated Model EvaluatiOn) project. The PRIMO site is free for non-commercial use and can be accessed at https://primo.rubi.ru.ac.za/.	[Hatherley, Rowan; Brown, David K.; Glenister, Michael; Bishop, Oezlem Tastan] Rhodes Univ, Dept Biochem & Microbiol, Res Unit Bioinformat RUBi, ZA-6140 Grahamstown, South Africa	Rhodes University	Bishop, OT (corresponding author), Rhodes Univ, Dept Biochem & Microbiol, Res Unit Bioinformat RUBi, ZA-6140 Grahamstown, South Africa.	o.tastanbishop@ru.ac.za	Bishop, Ozlem Tastan/J-3084-2016	Bishop, Ozlem Tastan/0000-0001-6861-7849	National Institutes of Health Common Fund [U41HG006941]; National Research Foundation (NRF), South Africa [79765, 93690]; Rhodes University, Postdoctoral Fellowship	National Institutes of Health Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); Rhodes University, Postdoctoral Fellowship	This work was supported by the National Institutes of Health Common Fund (grant number U41HG006941) to H3ABioNet, the National Research Foundation (NRF), South Africa (grant numbers 79765, 93690) and Rhodes University, Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092; Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Binshtein E, 2015, BIOCHEMISTRY-US, V54, P3133, DOI 10.1021/acs.biochem.5b00114; Bishop AOT, 2008, S AFR J SCI, V104, P2; Bishop OT, 2011, J MOL MODEL, V17, P3163, DOI 10.1007/s00894-011-0990-y; Brown DK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134273; di Luccio E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-48; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Haas Juergen, 2013, Database (Oxford), V2013, pbat031, DOI 10.1093/database/bat031; Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jefferys BR, 2010, J MOL BIOL, V397, P1329, DOI 10.1016/j.jmb.2010.01.074; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Mariani V, 2013, BIOINFORMATICS, V29, P2722, DOI 10.1093/bioinformatics/btt473; Mulder NJ, 2016, GENOME RES, V26, P271, DOI 10.1101/gr.196295.115; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Petrey D, 2014, ANNU REV BIOPHYS, V43, P193, DOI 10.1146/annurev-biophys-051013-022726; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Rotimi C, 2014, SCIENCE, V344, P1346, DOI 10.1126/science.1251546; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sali Andrej, 2015, MODELLER PROGRAM PRO, P293; Schwede T, 2013, STRUCTURE, V21, P1531, DOI 10.1016/j.str.2013.08.007; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Szilagyi A, 2014, CURR OPIN STRUC BIOL, V24, P10, DOI 10.1016/j.sbi.2013.11.005; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang Y, 2009, CURR OPIN STRUC BIOL, V19, P145, DOI 10.1016/j.sbi.2009.02.005	41	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166698	10.1371/journal.pone.0166698	http://dx.doi.org/10.1371/journal.pone.0166698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855192	gold, Green Published, Green Submitted			2022-12-26	WOS:000387910200045
J	Howe, A; Yang, F; Williams, RJ; Meyer, F; Hofmockel, KS				Howe, Adina; Yang, Fan; Williams, Ryan J.; Meyer, Folker; Hofmockel, Kirsten S.			Identification of the Core Set of Carbon-Associated Genes in a Bioenergy Grassland Soil	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; FUNCTIONAL REDUNDANCY; ORGANIC-MATTER; CD-HIT; DIVERSITY; RESPONSES; DECOMPOSITION; PHOSPHORUS; INPUTS; TOOLS	Despite the central role of soil microbial communities in global carbon (C) cycling, little is known about soil microbial community structure and even less about their metabolic pathways. Efforts to characterize soil communities often focus on identifying differences in gene content across environmental gradients, but an alternative question is what genes are similar in soils. These genes may indicate critical species or potential functions that are required in all soils. Here we identified the "core" set of C cycling sequences widely present in multiple soil metagenomes from a fertilized prairie (FP). Of 226,887 sequences associated with known enzymes involved in the synthesis, metabolism, and transport of carbohydrates, 843 were identified to be consistently prevalent across four replicate soil metagenomes. This core metagenome was functionally and taxonomically diverse, representing five enzyme classes and 99 enzyme families within the CAZy database. Though it only comprised 0.4% of all CAZy-associated genes identified in FP metagenomes, the core was found to be comprised of functions similar to those within cumulative soils. The FP CAZy-associated core sequences were present in multiple publicly available soil metagenomes and most similar to soils sharing geographic proximity. In soil ecosystems, where high diversity remains a key challenge for metagenomic investigations, these core genes represent a subset of critical functions necessary for carbohydrate metabolism, which can be targeted to evaluate important C fluxes in these and other similar soils.	[Howe, Adina; Yang, Fan; Williams, Ryan J.] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Meyer, Folker] Argonne Natl Lab, Math & Comp Sci Div, Argonne, IL 60439 USA; [Hofmockel, Kirsten S.] Iowa State Univ, Dept Ecol & Evolutionary Biol, Ames, IA 50011 USA; [Hofmockel, Kirsten S.] Pacific Northwest Natl Lab, Richland, WA 99352 USA	Iowa State University; United States Department of Energy (DOE); Argonne National Laboratory; Iowa State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory	Hofmockel, KS (corresponding author), Iowa State Univ, Dept Ecol & Evolutionary Biol, Ames, IA 50011 USA.; Hofmockel, KS (corresponding author), Pacific Northwest Natl Lab, Richland, WA 99352 USA.	khof@iastate.edu		Hofmockel, Kirsten/0000-0003-1586-2167; Meyer, Folker/0000-0003-1112-2284	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research [SC0010775]; USDA National Institute of Food and Agriculture Carbon Cycle Science Program [2011-01033]	U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); USDA National Institute of Food and Agriculture Carbon Cycle Science Program	This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under Award Number SC0010775. Fieldwork was supported by the USDA National Institute of Food and Agriculture Carbon Cycle Science Program grant number 2011-01033. We thank Elizabeth Bach for sample collection, Sarah Hargreaves for DNA extraction, and Stephanie Moorman and Sarah Owens for preparing sequencing libraries. This material is based upon work supported by the U.S. Department of Energy, Office of Science, Office of Biological and Environmental Research, under Award Number SC0010775. Fieldwork was supported by the USDA National Institute of Food and Agriculture Carbon Cycle Science Program grant number 2011-01033. We acknowledge the support and infrastructure of Magellan, the Argonne Cloud Computing Platform, and their team, especially Ryan Aydelott and Scott Devoid. We are also grateful to the late Dave Sundberg, whose attentive site management made this research possible.	Abdi D, 2014, J ENVIRON QUAL, V43, P1431, DOI 10.2134/jeq2013.10.0424; Bach EM, 2016, GCB BIOENERGY, V8, P588, DOI 10.1111/gcbb.12267; Bach EM, 2015, ECOSYSTEMS, V18, P417, DOI 10.1007/s10021-014-9835-8; Bach EM, 2014, SOIL BIOL BIOCHEM, V69, P54, DOI 10.1016/j.soilbio.2013.10.033; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barns SM, 2007, APPL ENVIRON MICROB, V73, P3113, DOI 10.1128/AEM.02012-06; Biely P, 2012, BIOTECHNOL ADV, V30, P1575, DOI 10.1016/j.biotechadv.2012.04.010; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown C. T., 2012, ARXIV12034802QBICOGN, V1203, P4802; Cardenas E, 2015, ISME J, V9, P2465, DOI 10.1038/ismej.2015.57; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Correa-Galeote D, 2013, FEMS MICROBIOL ECOL, V83, P340, DOI 10.1111/j.1574-6941.2012.01479.x; Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1; Doolette AL, 2011, ORG GEOCHEM, V42, P955, DOI 10.1016/j.orggeochem.2011.04.004; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Franklin RB, 2003, FEMS MICROBIOL ECOL, V44, P335, DOI 10.1016/S0168-6496(03)00074-6; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gaby JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042149; Gittel A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00541; Glass EM, 2011, METAGENOMICS COMPLEM, V8, P325, DOI [10.1002/9781118010518.CH37, DOI 10.1002/9781118010518.CH37, 10.1002/9781118010518.ch37]; He ZQ, 2011, SOIL SCI SOC AM J, V75, P1712, DOI 10.2136/sssaj2010.0355; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Jesus ED, 2010, BIOENERG RES, V3, P20, DOI 10.1007/s12155-009-9073-7; Keenleyside WJ, 2001, J BACTERIOL, V183, P77, DOI 10.1128/JB.183.1.77-85.2001; Keil D, 2011, FEMS MICROBIOL ECOL, V77, P95, DOI 10.1111/j.1574-6941.2011.01091.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luo CW, 2014, APPL ENVIRON MICROB, V80, P1777, DOI 10.1128/AEM.03712-13; Miltner A, 2012, BIOGEOCHEMISTRY, V111, P41, DOI 10.1007/s10533-011-9658-z; Morales SE, 2011, FEMS MICROBIOL ECOL, V75, P2, DOI 10.1111/j.1574-6941.2010.00938.x; Pell J, 2012, P NATL ACAD SCI USA, V109, P13272, DOI 10.1073/pnas.1121464109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rodriguez-R LM, 2014, BIOINFORMATICS, V30, P629, DOI 10.1093/bioinformatics/btt584; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Schellenberger S, 2010, ENVIRON MICROBIOL, V12, P845, DOI 10.1111/j.1462-2920.2009.02128.x; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Simpson AJ, 2007, ENVIRON SCI TECHNOL, V41, P876, DOI 10.1021/es061576c; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Treseder KK, 2012, BIOGEOCHEMISTRY, V109, P7, DOI 10.1007/s10533-011-9636-5; Tveit A, 2013, ISME J, V7, P299, DOI 10.1038/ismej.2012.99; Xue K, 2016, NAT CLIM CHANGE, V6, P595, DOI [10.1038/NCLIMATE2940, 10.1038/nclimate2940]; Yin B, 2000, APPL ENVIRON MICROB, V66, P4361, DOI 10.1128/AEM.66.10.4361-4365.2000; Young EO, 2013, SOIL SCI SOC AM J, V77, P1636, DOI 10.2136/sssaj2012.0313; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang QP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101271	52	10	10	9	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166578	10.1371/journal.pone.0166578	http://dx.doi.org/10.1371/journal.pone.0166578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855202	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200036
J	Xu, GY; Cui, YX; Jia, ZH; Yue, YA; Yang, SX				Xu, Guiyu; Cui, Yuxia; Jia, Zhenghua; Yue, Yunan; Yang, Shuixiang			The Values of Coronary Circulating miRNAs in Patients with Atrial Fibrillation	PLOS ONE			English	Article							CATHETER ABLATION; MICRORNAS; POLYMORPHISMS; MUTATIONS; CHINESE; KCNE1	The mechanism of miRNA regulation in atrial fibrillation (AF) occurrence and development is still unclear, especially, the regulating values of coronary circulating miRNAs has not been reported. Based on our AF radiofrequency ablation clinical practice and previous miRNA study, we proposed a hypothesis that the coronary circulating miRNA might much better reflect the regulating state and metabolic level of myocardial miRNA in AF patient. To investigate the regulating values of coronary circulation miRNA, 90 AF patients were selected and compared with 90 healthy subjects, the changes of coronary circulating miRNA differential expression profile in the whole genome were observed in this study. We found out that compared with autologous peripheral blood (PB), 6 miRNAs were upregulated and 8 miRNA downregulated in AF patients' coronary sinus blood (CSB) significantly, especially, the expression of miR-1266, miR-4279 and miR-4666a-3p were obviously increased. Compared with normal donors' peripheral blood, 16 miRNAs were upregulated and 24 miRNAs downregulated dramatically in patients' peripheral blood, among them, the miR-3171 decreased, but miR-892a and miR-3149 increased significantly from the early to end stages of AF. Our results indicated that the coronary circulating miRNA can really reflect the regulating values of miRNA in AF patient; the level of miRNA change in 3 types of AF may reflect the severity of AF clinical and pathophysiological advance; The miR-892a, miR-3171 and miR-3149 may be used as biomarkers for earlier diagnosis, while miR-1266, miR-4279 and miR-4666a-3p may serve as potential intervening targets for AF patient in future.	[Xu, Guiyu; Cui, Yuxia; Yue, Yunan; Yang, Shuixiang] Capital Med Univ, Affiliated Beijing Shijitan Hosp, Dept Cardiol, Beijing, Peoples R China; [Jia, Zhenghua; Yang, Shuixiang] Hebei Med Univ, Affiliated Yiling Hosp, Dept Cardiol, Shijiazhuang Shi, Hebei, Peoples R China	Capital Medical University; Hebei Medical University	Yang, SX (corresponding author), Capital Med Univ, Affiliated Beijing Shijitan Hosp, Dept Cardiol, Beijing, Peoples R China.; Yang, SX (corresponding author), Hebei Med Univ, Affiliated Yiling Hosp, Dept Cardiol, Shijiazhuang Shi, Hebei, Peoples R China.	dryangsx@163.com			Beijing Natural Science Foundation [7083108]; Chinese National 863 High Technological Foundation [2006AA02Z4Z3]; Scientific Developing Foundation of Shijitan Hospital [2011003]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Chinese National 863 High Technological Foundation; Scientific Developing Foundation of Shijitan Hospital	This research was supported in part by Beijing Natural Science Foundation (No. 7083108); by Chinese National 863 High Technological Foundation (2006AA02Z4Z3); and by Scientific Developing Foundation of Shijitan Hospital (No. 2011003).	Anselmino M, 2016, EUROPACE, V18, P638, DOI 10.1093/europace/euv368; Bellew SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002984; Burkowitz J, 2016, EUR J PREV CARDIOL, V23, P1261, DOI 10.1177/2047487316632628; Chan PJ, 2012, J GEN PHYSIOL, V139, P135, DOI 10.1085/jgp.201110672; Choi YM, 2012, INT J ONCOL, V41, P331, DOI 10.3892/ijo.2012.1418; Clauss S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148599; Clauss S, 2015, ARRHYTH ELECTROPHYSI, V4, P146, DOI 10.15420/aer.2015.4.3.146; Copley DJ, 2016, AACN ADV CRIT CARE, V27, P120, DOI 10.4037/aacnacc2016281; Cui Yuxia, 2015, Zhonghua Xin Xue Guan Bing Za Zhi, V43, P1051; Ichihara A, 2012, EUR J DERMATOL, V22, P68, DOI 10.1684/ejd.2011.1600; Jabbari J, 2011, CARDIOLOGY, V118, P116, DOI 10.1159/000323840; Jalife J, 2015, TRENDS CARDIOVAS MED, V25, P475, DOI 10.1016/j.tcm.2014.12.015; Koektuerk B, 2016, WORLD J DIABETES, V7, P45, DOI 10.4239/wjd.v7.i3.45; Lappe Jason M, 2016, Curr Treat Options Cardiovasc Med, V18, P15, DOI 10.1007/s11936-016-0437-y; Li L, 2015, CHIN J GERIA HEART B, V17, P1257, DOI [10.3969/j.issn.1009-0126.2015.12.008, DOI 10.3969/J.ISSN.1009-0126.2015.12.008]; Li M, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/730535; Liu Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044906; Lu TZ, 2012, MOL NEUROBIOL, V45, P415, DOI 10.1007/s12035-012-8260-2; Lu YJ, 2010, CIRCULATION, V122, P2378, DOI 10.1161/CIRCULATIONAHA.110.958967; Lu ZJ, 2004, CELL PHYSIOL BIOCHEM, V14, P11, DOI 10.1159/000076922; McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101; McManus DD, 2015, HEART RHYTHM, V12, P3, DOI 10.1016/j.hrthm.2014.09.050; Nan J, 2015, CHIN J GERIA HEART B, V17, P1236, DOI [10.3969/j.issn.1009-0126.2015.12.002, DOI 10.3969/J.ISSN.1009-0126.2015.12.002]; Olesen MS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-24; Orenes-Pinero E, 2015, ARCH CARDIOL MEX, V85, P225, DOI 10.1016/j.acmx.2015.01.005; Poudel P, 2015, CARDIOLOGY, V131, P58, DOI 10.1159/000375403; Rosenheck S, 2015, CARDIOLOGY, V131, P55, DOI 10.1159/000381282; Sardu C, 2015, PHARMACOGENOMICS, V16, P1863, DOI 10.2217/pgs.15.117; Su Y, 2015, CHIN J GERIA HEART B, V17, P511, DOI [10.3969/j.issn.1009-0126.2015.05.020, DOI 10.3969/J.ISSN.1009-0126.2015.05.020]; Waldmann V, 2016, REV MED INTERNE, V37, P608, DOI 10.1016/j.revmed.2015.12.032; Wang QS, 2009, J CARDIOVASC ELECTR, V20, P1158, DOI 10.1111/j.1540-8167.2009.01494.x; Weckbach LT, 2016, CURR OPIN PHARMACOL, V27, P24, DOI 10.1016/j.coph.2016.01.001; Zhang C, 2009, HEART LUNG CIRC, V18, P257, DOI 10.1016/j.hlc.2008.12.002; Zhang XD, 2013, CARDIOVASC RES; [张瑜 Zhang Yu], 2012, [解放军医学杂志, Medical Journal of Chinese People's Liberation Army], V37, P195	35	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166235	10.1371/journal.pone.0166235	http://dx.doi.org/10.1371/journal.pone.0166235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855199	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200022
J	Agnvall, B; Jensen, P				Agnvall, Beatrix; Jensen, Per			Effects of Divergent Selection for Fear of Humans on Behaviour in Red Junglefowl	PLOS ONE			English	Article							ANIMAL DOMESTICATION; FEATHER PECKING; GALLUS-GALLUS; ANTIPREDATOR BEHAVIOR; FORAGING STRATEGIES; CHICKENS; MODEL; FOWL; PIGS; EVOLUTION	Domestication has caused a range of similar phenotypic changes across taxa, relating to physiology, morphology and behaviour. It has been suggested that this recurring domesticated phenotype may be a result of correlated responses to a central trait, namely increased tameness. We selected Red Junglefowl, the ancestors of domesticated chickens, during five generations for reduced fear of humans. This caused a marked and significant response in tameness, and previous studies have found correlated effects on growth, metabolism, reproduction, and some behaviour not directly selected for. Here, we report the results from a series of behavioural tests carried out on the initial parental generation (P0) and the fifth selected generation (S5), focusing on behaviour not functionally related to tameness, in order to study any correlated effects. Birds were tested for fear of humans, social reinstatement tendency, open field behaviour at two different ages, foraging/exploration, response to a simulated aerial predator attack and tonic immobility. In S5, there were no effects of selection on foraging/ exploration or tonic immobility, while in the social reinstatement and open field tests there were significant interactions between selection and sex. In the aerial predator test, there were significant main effects of selection, indicating that fear of humans may represent a general wariness towards predators. In conclusion, we found only small correlated effects on behaviours not related to the tameness trait selected for, in spite of them showing high genetic correlations to fear of humans in a previous study on the same population. This suggests that species- specific behaviour is generally resilient to changes during domestication.	[Agnvall, Beatrix; Jensen, Per] Linkoping Univ, IFM Biol, Avian Behav Genom & Physiol Grp, SE-58183 Linkoping, Sweden	Linkoping University	Jensen, P (corresponding author), Linkoping Univ, IFM Biol, Avian Behav Genom & Physiol Grp, SE-58183 Linkoping, Sweden.	perje@ifm.liu.se			European Research Council [322206]; FORMAS [221-2007-838]; Vetenskapsradet [621-2008-5437]	European Research Council(European Research Council (ERC)European Commission); FORMAS(Swedish Research Council Formas); Vetenskapsradet(Swedish Research Council)	This work is supported by European Research Council 322206 http://erc.europa.eu, FORMAS 221-2007-838 http://www.formas.se/en/ Vetenskapsradet 621-2008-5437 http://www.vr.se. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agnvall B, 2014, ANIMAL, V8, P1498, DOI 10.1017/S1751731114001426; Agnvall B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0509; Agnvall B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035162; Albert FW, 2008, HORM BEHAV, V53, P413, DOI 10.1016/j.yhbeh.2007.11.010; Albert FW, 2009, GENETICS, V182, P541, DOI 10.1534/genetics.109.102186; Andersson M, 2001, APPL ANIM BEHAV SCI, V72, P51, DOI 10.1016/S0168-1591(00)00195-7; Belteky J, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160033; BELYAEV DK, 1979, J HERED, V70, P301, DOI 10.1093/oxfordjournals.jhered.a109263; Buitenhuis AJ, 2004, BEHAV GENET, V34, P325, DOI 10.1023/B:BEGE.0000017876.82142.73; Campler M, 2009, BEHAV PROCESS, V81, P39, DOI 10.1016/j.beproc.2008.12.018; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DUNCAN IJH, 1978, APPL ANIM ETHOL, V4, P29, DOI 10.1016/0304-3762(78)90091-3; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Francois N, 2000, BEHAV PROCESS, V48, P171, DOI 10.1016/S0376-6357(99)00081-9; Ghareeb K., 2008, International Journal of Poultry Science, V7, P843; Gogoleva SS, 2009, BEHAV PROCESS, V81, P369, DOI 10.1016/j.beproc.2009.03.012; GROMKO MH, 1995, EVOLUTION, V49, P685, DOI 10.1111/j.1558-5646.1995.tb02305.x; Gustafsson M, 1999, APPL ANIM BEHAV SCI, V62, P305, DOI 10.1016/S0168-1591(98)00236-6; Hakansson J, 2008, APPL ANIM BEHAV SCI, V114, P409, DOI 10.1016/j.applanim.2008.04.003; Jensen P, 2005, PHYSIOL BEHAV, V86, P52, DOI 10.1016/j.physbeh.2005.06.029; JENSEN P, 1993, ANIM BEHAV, V45, P351, DOI 10.1006/anbe.1993.1040; JENSEN P, 1991, APPL ANIM BEHAV SCI, V31, P195, DOI 10.1016/0168-1591(91)90005-I; Jensen P, 2015, J EXP BIOL, V218, P32, DOI 10.1242/jeb.106799; Johnsson JI, 1996, CAN J FISH AQUAT SCI, V53, P1546, DOI 10.1139/cjfas-53-7-1546; Kagawa H, 2014, BEHAV PROCESS, V106, P91, DOI 10.1016/j.beproc.2014.04.011; Kjaer JB, 2001, APPL ANIM BEHAV SCI, V71, P229, DOI 10.1016/S0168-1591(00)00184-2; Kjaer JB, 2009, BEHAV GENET, V39, P564, DOI 10.1007/s10519-009-9280-1; Malmkvist J, 2001, WELFARE FARMED MINK; Miklosi A, 2004, ANIM BEHAV, V67, P995, DOI 10.1016/j.anbehav.2003.10.008; Miklosi A., 2008, DOG BEHAV EVOLUTION; Natt D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-59; Nicol CJ, BEHAV BIOL CHICKENS; Price EO, 2003, ANIMAL DOMESTICATION; Schutz KE, 2001, ETHOLOGY, V107, P753, DOI 10.1046/j.1439-0310.2001.00703.x; STOLBA A, 1989, ANIM PROD, V48, P419, DOI 10.1017/S0003356100040411; Stryjek R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040642; Tixier-Boichard M, 2011, CR BIOL, V334, P197, DOI 10.1016/j.crvi.2010.12.012; Trut L, 2009, BIOESSAYS, V31, P349, DOI 10.1002/bies.200800070	38	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166075	10.1371/journal.pone.0166075	http://dx.doi.org/10.1371/journal.pone.0166075			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851792	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300035
J	Bonneaud, C; Wilson, RS; Seebacher, F				Bonneaud, Camille; Wilson, Robbie S.; Seebacher, Frank			Immune-Challenged Fish Up-Regulate Their Metabolic Scope to Support Locomotion	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; WINTERING GREAT TITS; RAINBOW-TROUT; SICKNESS BEHAVIOR; TRADE-OFFS; LIPOPOLYSACCHARIDE ENDOTOXIN; TERMINAL INVESTMENT; ENERGY-EXPENDITURE; HOUSE SPARROW; SALMO-TRUTTA	Energy-based trade-offs occur when investment in one fitness-related trait diverts energy away from other traits. The extent to which such trade-offs are shaped by limits on the rate of conversion of energy ingested in food (e.g. carbohydrates) into chemical energy (ATP) by oxidative metabolism rather than by the amount of food ingested in the first place is, however, unclear. Here we tested whether the ATP required for mounting an immune response will lead to a trade-off with ATP available for physical activity in mosquitofish (Gambusia hol-brooki). To this end, we challenged fish either with lipopolysaccharide (LPS) from E. coli or with Sheep Red Blood Cells (SRBC), and measured oxygen consumption at rest and during swimming at maximum speed 24h, 48h and 7 days post-challenge in order to estimate metabolic rates. Relative to saline-injected controls, only LPS-injected fish showed a significantly greater resting metabolic rate two days post-challenge and significantly higher maximal metabolic rates two and seven days post-challenge. This resulted in a significantly greater metabolic scope two days post-challenge, with LPS-fish transiently overcompensating by increasing maximal ATP production more than would be required for swimming in the absence of an immune challenge. LPS-challenged fish therefore increased their production of ATP to compensate physiologically for the energetic requirements of immune functioning. This response would avoid ATP shortages and allow fish to engage in an aerobically-challenging activity (swimming) even when simultaneously mounting an immune response. Nevertheless, relative to controls, both LPS- and SRBC-fish displayed reduced body mass gain one week post-injection, and LPS-fish actually lost mass. The concomitant increase in metabolic scope and reduced body mass gain of LPS-challenged fish indicates that immuneassociated trade-offs are not likely to be shaped by limited oxidative metabolic capacities, but may instead result from limitations in the acquisition, assimilation or efficient use of resources.	[Bonneaud, Camille] Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR10 9FE, Cornwall, England; [Bonneaud, Camille] CNRS, Stn Ecol Expt, USR 2936, F-09200 Moulis, France; [Wilson, Robbie S.] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Seebacher, Frank] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Exeter; Centre National de la Recherche Scientifique (CNRS); University of Queensland; University of Sydney	Bonneaud, C (corresponding author), Univ Exeter, Ctr Ecol & Conservat, Penryn Campus, Penryn TR10 9FE, Cornwall, England.; Bonneaud, C (corresponding author), CNRS, Stn Ecol Expt, USR 2936, F-09200 Moulis, France.	c.bonneaud@exeter.ac.uk		Wilson, Robbie/0000-0002-0116-5427; Seebacher, Frank/0000-0002-2281-9311	Marie Curie Reintegration Grant (FP7-PEOPLE-IRG) [239257]; Natural Environment Research Council [NE/M00256X]; Australian Research Council [DP120101215]; Natural Environment Research Council [NE/M00256X/1] Funding Source: researchfish; NERC [NE/M00256X/1] Funding Source: UKRI	Marie Curie Reintegration Grant (FP7-PEOPLE-IRG); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by a Marie Curie Reintegration Grant (FP7-PEOPLE-IRG-2008 #239257) to Dr Camille Bonneaud; Natural Environment Research Council (NE/M00256X) to Dr Camille Bonneaud; Australian Research Council Discovery Projects (DP120101215) to Prof Frank Seebacher and Prof Robbie Wilson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman PA, 2000, J AQUAT ANIM HEALTH, V12, P157, DOI 10.1577/1548-8667(200006)012&lt;0157:PAIEOA&gt;2.0.CO;2; Altringham JD, 1999, J EXP BIOL, V202, P3397; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Ardia DR, 2012, FUNCT ECOL, V26, P732, DOI 10.1111/j.1365-2435.2012.01989.x; Barbosa A, 2004, ECOSCIENCE, V11, P305, DOI 10.1080/11956860.2004.11682837; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; BERCZI I, 1966, CAN J MICROBIOL, V12, P1070, DOI 10.1139/m66-143; Binuramesh C, 2006, BRAIN BEHAV IMMUN, V20, P300, DOI 10.1016/j.bbi.2005.09.002; Bonneaud C, 2004, EVOLUTION, V58, P2823, DOI 10.1111/j.0014-3820.2004.tb01633.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Bonneaud C, 2012, MOL ECOL, V21, P4787, DOI 10.1111/j.1365-294X.2012.05736.x; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; Burness G, 2010, J EXP BIOL, V213, P1386, DOI 10.1242/jeb.027011; Cherry AD, 2015, ANTIOXID REDOX SIGN, V22, P965, DOI 10.1089/ars.2014.6200; Claireaux G, 2007, PHILOS T R SOC B, V362, P2031, DOI 10.1098/rstb.2007.2099; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cooney RN, 1997, SHOCK, V7, P1, DOI 10.1097/00024382-199701000-00001; Cutrera AP, 2010, J EXP BIOL, V213, P715, DOI 10.1242/jeb.037887; DERIJK RH, 1993, AM J PHYSIOL, V265, pR1179, DOI 10.1152/ajpregu.1993.265.5.R1179; Einarsdottir IE, 2000, AQUAC RES, V31, P923, DOI 10.1046/j.1365-2109.2000.00506.x; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; Frost R A, 2008, J Anim Sci, V86, pE84, DOI 10.2527/jas.2007-0483; FRY FEJ, 1948, BIOL BULL, V94, P66, DOI 10.2307/1538211; Fumagalli M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002355; Goetz FW, 2004, MOL IMMUNOL, V41, P1199, DOI 10.1016/j.molimm.2004.06.005; GRONDEL JL, 1987, J FISH DIS, V10, P35, DOI 10.1111/j.1365-2761.1987.tb00716.x; Horak P, 2003, CAN J ZOOL, V81, P371, DOI [10.1139/z03-020, 10.1139/Z03-020]; Hulbert AJ, 2000, ANNU REV PHYSIOL, V62, P207, DOI 10.1146/annurev.physiol.62.1.207; Iliev DB, 2005, MOL IMMUNOL, V42, P1215, DOI 10.1016/j.molimm.2004.11.023; INGRAM GA, 1980, J FISH BIOL, V16, P181, DOI 10.1111/j.1095-8649.1980.tb03698.x; INGRAM GA, 1981, ACTA BIOL MED GER, V40, P317; Janeway C., 2005, IMMUNOBIOLOGY IMMUNE; Jovanovic B, 2011, J FISH BIOL, V78, P1054, DOI 10.1111/j.1095-8649.2011.02919.x; Kaitetzidou E, 2012, MAR BIOTECHNOL, V14, P605, DOI 10.1007/s10126-012-9469-9; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; KLASING KC, 1984, P SOC EXP BIOL MED, V176, P285; Klasing Kirk C., 2004, Acta Zoologica Sinica, V50, P961; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; MacKenzie S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-141; MacKenzie S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-46; Magnoni Leonardo J., 2015, Biology-Basel, V4, P67, DOI 10.3390/biology4010067; Martin LB, 2003, P ROY SOC B-BIOL SCI, V270, P153, DOI 10.1098/rspb.2002.2185; Martin LB, 2008, FUNCT ECOL, V22, P68, DOI 10.1111/j.1365-2435.2007.01347.x; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Nayak SK, 2008, FISH SHELLFISH IMMUN, V24, P394, DOI 10.1016/j.fsi.2007.09.005; Nilsson JA, 2007, J AVIAN BIOL, V38, P488, DOI 10.1111/j.2007.0908-8857.03919.x; Novoa B, 2009, FISH SHELLFISH IMMUN, V26, P326, DOI 10.1016/j.fsi.2008.12.004; Ots I, 2001, P ROY SOC B-BIOL SCI, V268, P1175, DOI 10.1098/rspb.2001.1636; Owen-Ashley NT, 2008, BRAIN BEHAV IMMUN, V22, P614, DOI 10.1016/j.bbi.2007.12.005; Owen-Ashley NT, 2007, J ORNITHOL, V148, pS583, DOI 10.1007/s10336-007-0197-2; Owen-Ashley NT, 2006, J EXP BIOL, V209, P3062, DOI 10.1242/jeb.02371; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Povey S, 2009, J ANIM ECOL, V78, P437, DOI 10.1111/j.1365-2656.2008.01499.x; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Seebacher F, 2013, J EXP BIOL, V216, P771, DOI 10.1242/jeb.079756; Seebacher F, 2014, FUNCT ECOL, V28, P137, DOI 10.1111/1365-2435.12156; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Skinner LA, 2010, FISH SHELLFISH IMMUN, V28, P387, DOI 10.1016/j.fsi.2009.11.026; Smith IJ, 2010, INT J BIOCHEM CELL B, V42, P701, DOI 10.1016/j.biocel.2010.01.006; Snoeijs T, 2007, ANIM BIOL, V57, P79, DOI 10.1163/157075607780002041; Swain P, 2008, FISH SHELLFISH IMMUN, V25, P191, DOI 10.1016/j.fsi.2008.04.009; Uller T, 2006, FUNCT ECOL, V20, P873, DOI 10.1111/j.1365-2435.2006.01163.x; van der Most PJ, 2011, FUNCT ECOL, V25, P74, DOI 10.1111/j.1365-2435.2010.01800.x; VLECK D, 1987, J APPL PHYSIOL, V62, P2103, DOI 10.1152/jappl.1987.62.5.2103; Volkoff H, 2004, BRAIN RES, V998, P139, DOI 10.1016/j.brainres.2003.11.011; WEDEMEYER G, 1969, J FISH RES BOARD CAN, V26, P115, DOI 10.1139/f69-010; Wedemeyer G., 1968, J FISH RES BOARD CAN, V26; Zamora-Camacho F. J., BEHAV ECOLOGY, V26, P115	69	22	22	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166028	10.1371/journal.pone.0166028	http://dx.doi.org/10.1371/journal.pone.0166028			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851769	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300031
J	Thomsen, PF; Moller, PR; Sigsgaard, EE; Knudsen, SW; Jorgensen, OA; Willerslev, E				Thomsen, Philip Francis; Moller, Peter Rask; Sigsgaard, Eva Egelyng; Knudsen, Steen Wilhelm; Jorgensen, Ole Ankjaer; Willerslev, Eske			Environmental DNA from Seawater Samples Correlate with Trawl Catches of Subarctic, Deepwater Fishes	PLOS ONE			English	Article							GREENLAND; EDNA; CATCHABILITY; BIODIVERSITY; UNCERTAINTIES; COMMUNITIES; COLLAPSE; HALIBUT; IMPACT	Remote polar and deepwater fish faunas are under pressure from ongoing climate change and increasing fishing effort. However, these fish communities are difficult to monitor for logistic and financial reasons. Currently, monitoring of marine fishes largely relies on invasive techniques such as bottom trawling, and on official reporting of global catches, which can be unreliable. Thus, there is need for alternative and non-invasive techniques for qualitative and quantitative oceanic fish surveys. Here we report environmental DNA (eDNA) metabarcoding of seawater samples from continental slope depths in Southwest Greenland. We collected seawater samples at depths of 188-918 m and compared seawater eDNA to catch data from trawling. We used Illumina sequencing of PCR products to demonstrate that eDNA reads show equivalence to fishing catch data obtained from trawling. Twenty-six families were found with both trawling and eDNA, while three families were found only with eDNA and two families were found only with trawling. Key commercial fish species for Greenland were the most abundant species in both eDNA reads and biomass catch, and interpolation of eDNA abundances between sampling sites showed good correspondence with catch sizes. Environmental DNA sequence reads from the fish assemblages correlated with biomass and abundance data obtained from trawling. Interestingly, the Greenland shark (Somniosus microcephalus) showed high abundance of eDNA reads despite only a single specimen being caught, demonstrating the relevance of the eDNA approach for large species that can probably avoid bottom trawls in most cases. Quantitative detection of marine fish using eDNA remains to be tested further to ascertain whether this technique is able to yield credible results for routine application in fisheries. Nevertheless, our study demonstrates that eDNA reads can be used as a qualitative and quantitative proxy for marine fish assemblages in deepwater oceanic habitats. This relates directly to applied fisheries as well as to monitoring effects of ongoing climate change on marine biodiversity-especially in polar ecosystems.	[Thomsen, Philip Francis; Willerslev, Eske] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark; [Moller, Peter Rask; Sigsgaard, Eva Egelyng; Knudsen, Steen Wilhelm] Univ Copenhagen, Nat Hist Museum Denmark, Sect EvoGen, Copenhagen, Denmark; [Jorgensen, Ole Ankjaer] Tech Univ Denmark, Natl Inst Aquat Resources, Charlottenlund, Denmark; [Jorgensen, Ole Ankjaer] Greenland Inst Nat Resources, Nuuk, Greenland; [Willerslev, Eske] Univ Cambridge, Dept Zool, Cambridge, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England	University of Copenhagen; University of Copenhagen; Technical University of Denmark; Greenland Institute of Natural Resources; University of Cambridge; Wellcome Trust Sanger Institute	Thomsen, PF; Willerslev, E (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.; Willerslev, E (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge, England.	pfthomsen@snm.ku.dk; ewillerslev@snm.ku.dk	Knudsen, Steen W/C-1072-2015; Thomsen, Philip Francis/AAE-9354-2019; Willerslev, Eske/A-9619-2011; Willerslev, Eske/AAA-5686-2019; Sigsgaard, Eva Egelyng/ABB-6275-2021; Knudsen, Steen/X-7948-2019	Knudsen, Steen W/0000-0003-0428-9940; Thomsen, Philip Francis/0000-0002-9867-4366; Willerslev, Eske/0000-0002-7081-6748; Sigsgaard, Eva Egelyng/0000-0002-9396-1550; Knudsen, Steen/0000-0003-0428-9940	Danish National Research Foundation; Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research; Natural History Museum of Denmark and the Danish National Sequencing Centre	Danish National Research Foundation(Danmarks Grundforskningsfond); Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research; Natural History Museum of Denmark and the Danish National Sequencing Centre	Danish National Research Foundation funded the work. Greenland Institute of Natural Resources, Greenland Self-government, Department for education and research funded the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the crew on R/V Paamiut for their support during the cruises. Peter Frandsen is thanked for a valuable and heroic effort on board. We thank the Natural History Museum of Denmark and the Danish National Sequencing Centre for support in carrying out the work. Pernille Selmer Olsen is thanked for help with the lab work. Marcus Anders Krag is thanked for help with tissue samples. We thank Prof. Pierre Taberlet for design of and permission to use the primer V05F_898. We would like to thank Greenland Institute of Natural Resources, Greenland Self-government, Department for Education and Research for financial support. We thank the Danish National Research Foundation for funding.	Amante C., 2009, NOAA TECHNICAL MEMOR, V1, P1, DOI 10.7289/V5C8276M; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; [Anonymous], 1942, SAMMENDRAG STAT OPLY, V1, P647; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Biggs J, 2015, BIOL CONSERV, V183, P19, DOI 10.1016/j.biocon.2014.11.029; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Buch E., 2000, MONOGRAPH PHYS OCEAN; Christiansen JS, 2016, SCI NAT-HEIDELBERG, V103, DOI 10.1007/s00114-016-1332-9; Coissac Eric, 2012, Methods Mol Biol, V888, P13, DOI 10.1007/978-1-61779-870-2_2; Coissac E, 2012, MOL ECOL, V21, P1834, DOI 10.1111/j.1365-294X.2012.05550.x; Daan N., 2001, ICES CM, V3, P1; Darling JA, 2011, ENVIRON RES, V111, P978, DOI 10.1016/j.envres.2011.02.001; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2016, NAT COMMUN, V7, P1, DOI 10.1038/ncomms12544; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dejean T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023398; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Foote AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041781; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Fraser HM, 2007, ICES J MAR SCI, V64, P1800, DOI 10.1093/icesjms/fsm145; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harley SJ, 2001, CAN J FISH AQUAT SCI, V58, P1569, DOI 10.1139/cjfas-58-8-1569; Hutchings JA, 2000, NATURE, V406, P882, DOI 10.1038/35022565; Ingvaldsen RB, 2015, NAT CLIM CHANGE, V5, P788, DOI 10.1038/nclimate2761; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Jerde CL, 2016, ENVIRON SCI TECHNOL, V50, P8770, DOI 10.1021/acs.est.6b01761; Jorgensen O.A., 2015, J NW ATLANTIC FISHER, V47, P37, DOI DOI 10.2960/J.V47.M706; Jorgensen OA, 2005, CAN J FISH AQUAT SCI, V62, P1833, DOI 10.1139/F05-101; Jorgensen OA, 1998, 25 NAFO; Jorgensen OA, 2015, SURVEY FOR GREENLAND; Jorgensen OA, 2014, ICES J MAR SCI, V71, P845, DOI 10.1093/icesjms/fst191; Kelly RP, 2016, MOL ECOL RESOUR, V16, P10, DOI 10.1111/1755-0998.12455; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; Kenchington E, 2017, POLAR BIOL, V40, P321, DOI 10.1007/s00300-016-1957-3; Leonard JA, 2007, J ARCHAEOL SCI, V34, P1361, DOI 10.1016/j.jas.2006.10.023; Lorance P, 2015, IUCN RED LIST THREAT; MacKenzie BR, 2014, GLOBAL CHANGE BIOL, V20, P2484, DOI 10.1111/gcb.12597; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Moller PR, 2010, ZOOTAXA, P1; Moller PR, 2005, COPEIA, P374; Murphy HM, 2010, MAR FRESHWATER RES, V61, P236, DOI 10.1071/MF09068; Murray DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124671; Nielsen J, 2014, POLAR BIOL, V37, P37, DOI 10.1007/s00300-013-1408-3; Nygaard R, 2015, BIOMASS ABUNDANCE DE; Olds BP, 2016, ECOL EVOL, V6, P4214, DOI 10.1002/ece3.2186; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10244; PEDERSEN SA, 1994, POLAR RES, V13, P183, DOI 10.1111/j.1751-8369.1994.tb00448.x; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; Shelton AO, 2016, ECOL APPL, V26, P1645, DOI 10.1890/15-1733.1; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Watanabe YY, 2012, J EXP MAR BIOL ECOL, V426, P5, DOI 10.1016/j.jembe.2012.04.021; Wisz MS, 2015, NAT CLIM CHANGE, V5, P790, DOI 10.1038/nclimate2762; Wisz MS, 2015, NAT CLIM CHANGE, V5, P261, DOI [10.1038/nclimate2500, 10.1038/NCLIMATE2500]; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x	71	156	166	7	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165252	10.1371/journal.pone.0165252	http://dx.doi.org/10.1371/journal.pone.0165252			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851757	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300012
J	de Miguel-Diez, J; Lopez-de-Andres, A; Jimenez-Garcia, R; Puente-Maestu, L; Jimenez-Trujillo, I; Hernandez-Barrera, V; Resino, S; Alvaro-Meca, A				de Miguel-Diez, Javier; Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Puente-Maestu, Luis; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; Resino, Salvador; Alvaro-Meca, Alejandro			Trends in Epidemiology of COPD in HIV-Infected Patients in Spain (1997-2012)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; RISK-FACTORS; PREVALENCE; MORTALITY; ABNORMALITIES; COMORBIDITY	Purpose The aim of this study was to estimate trends of incidence of hospital admissions and in-hospital mortality (IHM) in HIV-infected patients with COPD in the combination antiretroviral therapy (cART) era in Spain (1997-2012). Methods A retrospective study with data from nationwide population-based COPD diagnoses in the Spanish Minimum Basic Data Set (MBDS) was performed. We established groups according to their HIV and HCV infections: 1) HIV-uninfected patients; 2) HIV-infected patients (with or without HCV coinfection). Results 1,580,207 patients discharge with a COPD diagnosis were included in the study, 8902 of them were HIV-infected patients (5000 HIV-monoinfected patients and 3902 HIV/HCVcoinfected patients). The HIV-infected patients had higher incidence rates of hospital admissions for COPD than the HIV-uninfected patients during the study period. The HIV-monoinfected patients had higher rates of hospitalizations for COPD than the HIV/HCV-coinfected patients in the early-period cART (1997-1999), but these rates decreased in the first group and increased in the second, being even similar in both groups in the late-period cART (2004-2011). On the other hand, the HIV-infected patients with COPD had higher IHM than the HIV-uninfected patients with COPD. The mortality rates were higher in the HIV-monoinfected patients with COPD than in the HIV/HCV-coinfected patients with COPD in the earlyperiod cART; however, in the late-period cART, the mortality rates trends seems higher in the HIV/HCV group. The likelihood of death in HIV/HCV-coinfected patients with COPD was similar to than in HIV-monoinfected patients with COPD. Conclusions Incidence of hospital admissions for COPD and IHM have decreased among HIV-monoinfected individuals but have increased steadily among HIV/HCV-coinfected individuals in the cART era.	[de Miguel-Diez, Javier; Puente-Maestu, Luis] Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Fac Med, Inst Invest Sanitaria Gregorio Maranon IiSGM,Pneu, Madrid, Spain; [Lopez-de-Andres, Ana; Jimenez-Garcia, Rodrigo; Jimenez-Trujillo, Isabel; Hernandez-Barrera, Valentin; Alvaro-Meca, Alejandro] Univ Rey Juan Carlos, Dept Hlth Sci, Prevent Med & Publ Hlth Teaching & Res Unit, Madrid, Spain; [Resino, Salvador] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain	Complutense University of Madrid; General University Gregorio Maranon Hospital; Universidad Rey Juan Carlos; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	de Miguel-Diez, J (corresponding author), Univ Complutense Madrid, Hosp Gen Univ Gregorio Maranon, Fac Med, Inst Invest Sanitaria Gregorio Maranon IiSGM,Pneu, Madrid, Spain.	javier.miguel@saluci.madrid.org	Jimenez-Trujillo, Isabel/AAP-7746-2021; Resino, Salvador/B-2430-2008; Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Resino, Salvador/0000-0001-8783-0450; Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Alvaro-Meca, Alejandro/0000-0003-1315-4386; de Miguel-Diez, Javier/0000-0003-4543-573X; Hernandez-Barrera, Valentin/0000-0001-5790-1959; Puente-Maestu, Luis/0000-0001-8501-0117	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III) [PI11/00245, PI12/00019, PI12/02734]; European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE) [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III); European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa"); Grupo de Excelencia Investigadora URJC-Banco: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE)	This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, Institute de Salud Carlos III grants no. PI11/00245 to SR, PI12/00019 to MM and PI12/02734 to LPM) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URJC-Banco Santander No 30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE) to RJG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study forms part of research funded by the FIS (Fondo de Investigaciones Sanitarias- Health Research Fund, Instituto de Salud Carlos III grants no. PI11/00245 to SR, PI12/00019 to AAM and PI12/02734 to LPM) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URIC-Banco Santander No 30VCPIGI03: Investigacion traslacional en el proceso de salud-enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akanbi MO, 2015, J AIDS CLIN RES, V6; Akgun KM, 2013, JAIDS-J ACQ IMM DEF, V62, P52, DOI 10.1097/QAI.0b013e318278f3fa; Alkaline Software Inc, WEBS FREE 2014 MED C; Alvaro-Meca A, 2014, J INFECTION, V68, P355, DOI 10.1016/j.jinf.2013.12.003; [Anonymous], 2001, SUBD GEN DES; Bednasz CJ, 2015, FUTURE VIROL, V10, P981, DOI 10.2217/FVL.15.64; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Diez M, 2014, EURO SURVEILL, V19; Drummond MB, 2012, THORAX, V67, P309, DOI 10.1136/thoraxjnl-2011-200702; Erol S, 2009, HEPAT MON, V9, P39; Estebanez-Munoz M, 2012, ARCH BRONCONEUMOL, V48, P126, DOI 10.1016/j.arbres.2011.12.001; Fischer WA, 2014, COPD, V11, P10, DOI 10.3109/15412555.2013.800854; George MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006328; Gingo MR, 2010, AM J RESP CRIT CARE, V182, P790, DOI 10.1164/rccm.200912-1858OC; Gonzalez-Garcia J, 2012, 19 C RETR OPP INF CR; Kanazawa H, 2003, CHEST, V123, P596, DOI 10.1378/chest.123.2.596; Kristoffersen US, 2012, CLIN PHYSIOL FUNCT I, V32, P288, DOI 10.1111/j.1475-097X.2012.01124.x; Madeddu G, 2013, INFECTION, V41, P347, DOI 10.1007/s15010-012-0330-x; Magalhaes MG, 2007, J AM DENT ASSOC, V138, P1468, DOI 10.14219/jada.archive.2007.0083; Makinson A, 2015, EUR RESPIR J, V45, P828, DOI 10.1183/09031936.00154914; Moorman J, 2005, CHEST, V128, P2882, DOI 10.1378/chest.128.4.2882; Morris Alison, 2011, Proc Am Thorac Soc, V8, P320, DOI 10.1513/pats.201006-045WR; Norris KA, 2011, IMMUNOL RES, V50, P175, DOI 10.1007/s12026-011-8218-x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Petrache I, 2008, THORAX, V63, P463, DOI 10.1136/thx.2007.079111; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rahmanian Shiva, 2011, Proc Am Thorac Soc, V8, P313, DOI 10.1513/pats.201009-058WR; Raynaud C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-117; Roca B, 2003, J INFECTION, V47, P117, DOI 10.1016/S0163-4453(03)00067-7; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Samperiz G, 2014, HIV MED, V15, P321, DOI 10.1111/hiv.12117; Schwarcz SK, 2014, AIDS PATIENT CARE ST, V28, P517, DOI 10.1089/apc.2014.0079; Silva DR, 2010, EPIDEMIOL INFECT, V138, P167, DOI 10.1017/S0950268809990276; Simmons RD, 2013, HIV MED, V14, P596, DOI 10.1111/hiv.12045; Simonetti JA, 2014, J AIDS CLIN RES, V5; Soriano V, 2015, CURR OPIN HIV AIDS, V10, P309, DOI 10.1097/COH.0000000000000175; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; UN Joint Programme on HIV/AIDS, 2010, GLOB REP UN REP GLOB; Vallecillo G, 2010, CURR HIV RES, V8, P641, DOI 10.2174/157016210794088272; Yearsley MM, 2005, DIAGN MOL PATHOL, V14, P48, DOI 10.1097/01.pas.0000142168.72253.11	43	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166421	10.1371/journal.pone.0166421	http://dx.doi.org/10.1371/journal.pone.0166421			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846297	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600062
J	Penizek, V; Zadorova, T; Kodesova, R; Vanek, A				Penizek, Vit; Zadorova, Tereza; Kodesova, Radka; Vanek, Ales			Influence of Elevation Data Resolution on Spatial Prediction of Colluvial Soils in a Luvisol Region	PLOS ONE			English	Article							YOUNG MORAINIC LANDSCAPES; DEM RESOLUTION; TERRAIN ANALYSIS; ORGANIC-CARBON; MODELS; SCALE; IDENTIFICATION; ATTRIBUTES; TOPOGRAPHY; TRUNCATION	The development of a soil cover is a dynamic process. Soil cover can be altered within a few decades, which requires updating of the legacy soil maps. Soil erosion is one of the most important processes quickly altering soil cover on agriculture land. Colluvial soils develop in concave parts of the landscape as a consequence of sedimentation of eroded material. Colluvial soils are recognised as important soil units because they are a vast sink of soil organic carbon. Terrain derivatives became an important tool in digital soil mapping and are among the most popular auxiliary data used for quantitative spatial prediction. Prediction success rates are often directly dependent on raster resolution. In our study, we tested how raster resolution (1, 2, 3, 5, 10, 20 and 30 meters) influences spatial prediction of colluvial soils. Terrain derivatives (altitude, slope, plane curvature, topographic position index, LS factor and convergence index) were calculated for the given raster resolutions. Four models were applied (boosted tree, neural network, random forest and Classification/Regression Tree) to spatially predict the soil cover over a 77 ha large study plot. Models training and validation was based on 111 soil profiles surveyed on a regular sampling grid. Moreover, the predicted real extent and shape of the colluvial soil area was examined. In general, no clear trend in the accuracy prediction was found without the given raster resolution range. Higher maximum prediction accuracy for colluvial soil, compared to prediction accuracy of total soil cover of the study plot, can be explained by the choice of terrain derivatives that were best for Colluvial soils differentiation from other soil units. Regarding the character of the predicted Colluvial soils area, maps of 2 to 10 m resolution provided reasonable delineation of the colluvial soil as part of the cover over the study area.	[Penizek, Vit; Zadorova, Tereza; Kodesova, Radka; Vanek, Ales] Czech Univ Life Sci Prague, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic	Czech University of Life Sciences Prague	Penizek, V (corresponding author), Czech Univ Life Sci Prague, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.	penizek@af.czu.cz	Kodešová, Radka/F-5671-2019; Penížek, Vít/O-6418-2019; Zádorová, Tereza/Z-1202-2019; Vanek, Ales/M-7058-2013	Kodešová, Radka/0000-0001-7236-8064; Penížek, Vít/0000-0001-6131-7608; Zádorová, Tereza/0000-0002-5541-2155; Vanek, Ales/0000-0002-6156-3419	Czech Science Foundation [13-07516P]	Czech Science Foundation(Grant Agency of the Czech Republic)	The study was funded by Czech Science Foundation by grant nr. 13-07516P.	Adhikari K, 2014, GEODERMA, V214, P101, DOI 10.1016/j.geoderma.2013.09.023; Ariza-Villaverde AB, 2015, GEOMORPHOLOGY, V241, P243, DOI 10.1016/j.geomorph.2015.03.040; Cavazzi S, 2013, GEODERMA, V195, P111, DOI 10.1016/j.geoderma.2012.11.020; Chaplot V, 2005, J HYDROL, V312, P207, DOI 10.1016/j.jhydrol.2005.02.017; Chaplot V, 2000, GEODERMA, V97, P405, DOI 10.1016/S0016-7061(00)00048-3; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; de Forges A.R., 2014, GLOBALSOILMAP BASIS; Debella-Gilo M, 2009, CATENA, V77, P8, DOI 10.1016/j.catena.2008.12.001; Feder F, 2013, CATENA, V110, P215, DOI 10.1016/j.catena.2013.06.019; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; FRIDLAND VM, 1972, PATTERN SOIL COVER; Gallant JC, 1997, MATH COMPUT SIMULAT, V43, P313, DOI 10.1016/S0378-4754(97)00015-3; Gillin CP, 2015, PHOTOGRAMM ENG REM S, V81, P387, DOI 10.14358/PERS.81.5.387; Greve MH, 2012, SOIL SCI SOC AM J, V76, P2116, DOI 10.2136/sssaj2010.0354; Guth J., 1964, KOMPLEXNI PRUZKUM ZE; Hengl T, 2006, COMPUT GEOSCI-UK, V32, P1283, DOI 10.1016/j.cageo.2005.11.008; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heung B, 2016, GEODERMA, V265, P62, DOI 10.1016/j.geoderma.2015.11.014; Heung B, 2014, GEODERMA, V214, P141, DOI 10.1016/j.geoderma.2013.09.016; Jenny H., 1941, FACTORS SOIL FORMATI; Kempen B, 2012, SOIL SCI SOC AM J, V76, P2097, DOI 10.2136/sssaj2011.0424; Kempen B, 2009, GEODERMA, V151, P311, DOI 10.1016/j.geoderma.2009.04.023; Kerry R, 2012, GEODERMA, V170, P347, DOI 10.1016/j.geoderma.2011.10.007; Laamrani A, 2014, FOREST ECOL MANAG, V330, P144, DOI 10.1016/j.foreco.2014.07.013; Lacoste M, 2011, GEOMORPHOLOGY, V133, P90, DOI 10.1016/j.geomorph.2011.06.026; Lassueur T, 2006, ECOL MODEL, V198, P139, DOI 10.1016/j.ecolmodel.2006.04.004; Lemercier B, 2012, GEODERMA, V171, P75, DOI 10.1016/j.geoderma.2011.03.010; Mashimbye ZE, 2014, GEODERMA, V213, P312, DOI 10.1016/j.geoderma.2013.08.023; Maynard JJ, 2014, GEODERMA, V230, P29, DOI 10.1016/j.geoderma.2014.03.021; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; Mukherjee S, 2013, INT J APPL EARTH OBS, V21, P205, DOI 10.1016/j.jag.2012.09.004; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; Napieralski J, 2010, COMPUT GEOSCI-UK, V36, P222, DOI 10.1016/j.cageo.2009.06.003; Park SJ, 2001, GEODERMA, V103, P249, DOI 10.1016/S0016-7061(01)00042-8; Shi X, 2012, GEODERMA, V170, P217, DOI 10.1016/j.geoderma.2011.11.020; Smith MP, 2006, GEODERMA, V137, P58, DOI 10.1016/j.geoderma.2006.07.002; Sorensen R, 2007, J HYDROL, V347, P79, DOI 10.1016/j.jhydrol.2007.09.001; StatSoftInc, 2015, STATISTICA; Sulaeman Y, 2013, GEODERMA, V192, P77, DOI 10.1016/j.geoderma.2012.08.005; Sun XL, 2015, EUR J SOIL SCI, V66, P1012, DOI 10.1111/ejss.12295; Switoniak M, 2016, CATENA, V137, P583, DOI 10.1016/j.catena.2014.09.005; Switoniak M, 2014, CATENA, V116, P173, DOI 10.1016/j.catena.2013.12.015; Tarolli P, 2009, GEOMORPHOLOGY, V113, P47, DOI 10.1016/j.geomorph.2009.02.006; Taylor JA, 2013, GEODERMA, V193, P83, DOI 10.1016/j.geoderma.2012.09.009; Thompson JA, 2001, GEODERMA, V100, P67, DOI 10.1016/S0016-7061(00)00081-1; Vaze J, 2010, ENVIRON MODELL SOFTW, V25, P1086, DOI 10.1016/j.envsoft.2010.03.014; Vianello A, 2009, CATENA, V76, P97, DOI 10.1016/j.catena.2008.09.012; Wilson J.P., 2000, TERRAIN ANAL PRINCIP, P133; Wu S, 2008, APPL GEOGR, V28, P210, DOI 10.1016/j.apgeog.2008.02.006; Wu S, 2007, ENVIRON MODELL SOFTW, V22, P1250, DOI 10.1016/j.envsoft.2006.08.001; Wu W, 2008, AGR ECOSYST ENVIRON, V126, P209, DOI 10.1016/j.agee.2008.01.026; Zadorova T, 2015, GEODERMA, V253, P122, DOI 10.1016/j.geoderma.2015.04.012; Zadorova T, 2013, GEODERMA, V195, P56, DOI 10.1016/j.geoderma.2012.11.012; Zadorova T, 2011, CATENA, V85, P22, DOI 10.1016/j.catena.2010.11.006	54	17	17	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165699	10.1371/journal.pone.0165699	http://dx.doi.org/10.1371/journal.pone.0165699			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846230	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600017
J	Zuo, HY; Zhang, JF; Zhang, LG; Ren, XX; Chen, XL; Hao, HS; Zhao, XM; Wang, D				Zuo, Haiyang; Zhang, Junfang; Zhang, Liuguang; Ren, Xiaoxia; Chen, Xiaoli; Hao, Haisheng; Zhao, Xueming; Wang, Dong			Transcriptomic Variation during Spermiogenesis in Mouse Germ Cells	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; SPERMATOGENESIS; NUCLEAR; RNA; TESTIS; GENE; OVEREXPRESSION	To explore variations in the transcription activity during spermiogenesis, round and elongated spermatids were collected from ICR/CD1 model mice using laser capture microdissection (LCM) and cauda epididymal sperm samples. The transcripts were sequenced using RNA-seq, and the reads were mapped to mm9. The majority of the reads (70%) in the round and elongated spermatids were mappable to known and predicted exons, but that in sperm was only 9%. The results of the distribution of reads suggested that alternative splicing was more complicated in sperm than in round and elongated spermatids. In the 19,127 genes, we detected the expression of 5,104 de novo genes and 91,112 alternative splicing events, and 12,105 were differentially expressed. Gene ontology (GO), InterPro domains, and KEGG revealed changes in gene transcription, mitochondrial protein translation, cellular components, and energy metabolism during spermiogenesis. The results provided considerable information about alternative splicing events, differentiallly expressed genes (DEGs), and novel transcriptions during spermiogenesis in mice.	[Zuo, Haiyang; Zhang, Junfang; Zhang, Liuguang; Ren, Xiaoxia; Chen, Xiaoli; Hao, Haisheng; Zhao, Xueming; Wang, Dong] Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing 100193, Peoples R China; [Zuo, Haiyang] JiLin Agr Univ Anim Sci & Technol, Changchun 130118, Peoples R China; [Zhang, Liuguang] HaiKou Mary Hosp, Reprod Med Ctr, Haikou 570100, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Ministry of Agriculture & Rural Affairs	Wang, D (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Minist Agr China, Key Lab Farm Anim Genet & Utilizat, Beijing 100193, Peoples R China.	dwangcn2002@vip.sina.com			National Natural Science Foundation of China [31372296]; Beijing Innovation Team of Technology System in Dairy Industry; National Science and Technology Support Program of China [2011BAD19B02]; Agricultural Science and Technology Innovation Program (ASTIP) [cxgc-ias-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Innovation Team of Technology System in Dairy Industry; National Science and Technology Support Program of China; Agricultural Science and Technology Innovation Program (ASTIP)	This work was supported by grants from the National Natural Science Foundation of China (No. 31372296), Beijing Innovation Team of Technology System in Dairy Industry, the National Science and Technology Support Program of China (No. 2011BAD19B02) and the Agricultural Science and Technology Innovation Program (ASTIP) (cxgc-ias-06).	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Dadoune JP, 1995, MICRON, V26, P323, DOI 10.1016/0968-4328(95)00007-0; DAOUST R, 1955, AM J ANAT, V96, P255, DOI 10.1002/aja.1000960204; Ecsedy JA, 2003, MOL CELL BIOL, V23, P950, DOI 10.1128/MCB.23.3.950-960.2003; Erkek S, 2013, NAT STRUCT MOL BIOL, V20, P868, DOI 10.1038/nsmb.2599; Escalier D, 2003, MOL REPROD DEV, V65, P298, DOI 10.1002/mrd.10290; Gannon JR, 2014, ADV EXP MED BIOL, V791, P53, DOI 10.1007/978-1-4614-7783-9_4; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; HENDRIKSEN PJM, 1995, DEV BIOL, V170, P730, DOI 10.1006/dbio.1995.1252; HINRICHSENKOHANE AC, 1984, ANDROLOGIA, V16, P321; Hokari M, 2010, NEUROPATHOLOGY, V30, P401, DOI 10.1111/j.1440-1789.2009.01086.x; Hosken DJ, 2014, TRENDS ECOL EVOL, V29, P451, DOI 10.1016/j.tree.2014.05.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Johnson GD, 2011, REPRODUCTION, V141, P21, DOI 10.1530/REP-10-0322; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Lassalle B, 1999, HUM REPROD, V14, P388, DOI 10.1093/humrep/14.2.388; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; Phillips BT, 2010, PHILOS T R SOC B, V365, P1663, DOI 10.1098/rstb.2010.0026; Schmidt EE, 1997, J BIOL CHEM, V272, P5326, DOI 10.1074/jbc.272.8.5326; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Sutovsky P, 2000, INT REV CYTOL, V195, P1; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Woop M, 2015, BIOPHYS J, V108, p393A, DOI 10.1016/j.bpj.2014.11.2156; Wouters-Tyrou D, 1998, BIOCHIMIE, V80, P117, DOI 10.1016/S0300-9084(98)80018-7	31	8	8	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0164874	10.1371/journal.pone.0164874	http://dx.doi.org/10.1371/journal.pone.0164874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835637	Green Submitted, gold, Green Published			2022-12-26	WOS:000387779200003
J	Kim, HJ; Kim, SY; Kwon, JY; Kim, YJ; Kang, SH; Jang, WH; Lee, JH; Seo, MW; Song, JJ; Seo, YR; Park, MK				Kim, Hyo Jeong; Kim, So Young; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Jang, Won-Hee; Lee, Jun Ho; Seo, Myung-Whan; Song, Jae -Jun; Seo, Young Rok; Park, Moo Kyun			Identification of Potential Novel Biomarkers and Signaling Pathways Related to Otitis Media Induced by Diesel Exhaust Particles Using Transcriptomic Analysis in an In Vivo System	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; MIDDLE-EAR; INFLAMMATION; ACETYLCHOLINE; EXPRESSION; AIRWAY; APOPTOSIS; CHILDREN; SOS1	Introduction Air pollutants are associated with inflammatory diseases such as otitis media (OM). Significantly higher incidence rates of OM are reported in regions with air pollution. Diesel exhaust particles (DEPs) comprise a major class of contaminants among numerous air pollutants, and they are characterized by a carbonic mixture of polycyclic aromatic hydrocarbons (PAHs), nitro-PAHs, and small amounts of sulfate, nitrate, metals and other trace elements. DEP exposure is a risk factor for inflammatory diseases. Our previous study identified potential biomarkers using gene expression microarray and pathway analyses in an in vitro system. Although in vitro investigations have been conducted to elucidate plausible biomarkers and molecular mechanisms related to DEP exposure, in vivo studies are necessary to identify the exact biological relevance regarding the incidence of OM caused by DEP exposure. In this study, we identified potential molecular biomarkers and pathways triggered by DEP exposure in a rodent model. Methods Transcriptomic analysis was employed to identify novel potential biomarkers in the middle ear of DEP-exposed mice. Results A total of 697 genes were differentially expressed in the DEP-exposed mice; 424 genes were upregulated and 273 downregulated. In addition, signaling pathways among the differentially expressed genes mediated by DEP exposure were predicted. Several key molecular biomarkers were identified including cholinergic receptor muscarinic 1 (CHRM1), erythropoietin (EPO), son of sevenless homolog 1 (SOS1), estrogen receptor 1 (ESR1), cluster of differentiation 4 (CD4) and interferon alpha-1 (IFNA1). Conclusions Our results shed light on the related cell processes and gene signaling pathways affected by DEP exposure. The identified biomarkers might be potential candidates for determining early diagnoses and effective treatment strategies for DEP-mediated disorders.	[Kim, Hyo Jeong; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Jang, Won-Hee; Seo, Young Rok; Park, Moo Kyun] Dongguk Univ, Dept Life Sci, Biomedi Campus,32 Dongguk Ro, Goyang Si 410820, Gyeonggi Do, South Korea; [Kim, Hyo Jeong; Kwon, Jee Young; Kim, Yeo Jin; Kang, Seung Hun; Seo, Young Rok; Park, Moo Kyun] Dongguk Univ, Inst Environm Med, Seoul, South Korea; [Kim, So Young] CHA Univ, Dept Otorhinolaryngol Head & Neck Surg, Bundang CHA Med Ctr, Songnam, South Korea; [Lee, Jun Ho; Seo, Myung-Whan; Park, Moo Kyun] Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Song, Jae -Jun] Korea Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea	Dongguk University; Dongguk University; Pochon Cha University; Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Seo, YR; Park, MK (corresponding author), Dongguk Univ, Dept Life Sci, Biomedi Campus,32 Dongguk Ro, Goyang Si 410820, Gyeonggi Do, South Korea.; Seo, YR; Park, MK (corresponding author), Dongguk Univ, Inst Environm Med, Seoul, South Korea.; Park, MK (corresponding author), Seoul Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	seoyr1@naver.com; aseptic@snu.ac.kr		Jang, Wonhee/0000-0003-2470-8137; Park, Moo Kyun/0000-0002-8635-797X; Kim, Yeo Jin/0000-0001-9122-914X	Korea Ministry of the Environment under 'Environmental Health Action Program' [2016001360009]; Research Resettlement Fund for the new faculty of Seoul National University	Korea Ministry of the Environment under 'Environmental Health Action Program'; Research Resettlement Fund for the new faculty of Seoul National University	This work was supported by the Korea Ministry of the Environment (grant no. 2016001360009) under the auspices of the 'Environmental Health Action Program.' This work was supported by Research Resettlement Fund for the new faculty of Seoul National University.	Amin K, 1999, INFLAMM RES, V48, P626, DOI 10.1007/s000110050513; Boland S, 1999, AM J PHYSIOL-LUNG C, V276, pL604, DOI 10.1152/ajplung.1999.276.4.L604; BONNER TI, 1987, SCIENCE, V237, P527, DOI 10.1126/science.3037705; Cao DS, 2007, AM J RESP CELL MOL, V37, P232, DOI 10.1165/rcmb.2006-0449OC; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; Churg A, 1997, AM J RESP CRIT CARE, V155, P2109, DOI 10.1164/ajrccm.155.6.9196123; GENDELMAN HE, 1991, J EXP MED, V173, P277, DOI 10.1084/jem.173.1.277; Guittard G, 2015, EUR J IMMUNOL, V45, P2389, DOI 10.1002/eji.201445226; KOYAMA S, 1992, AM J PHYSIOL, V262, pL466, DOI 10.1152/ajplung.1992.262.4.L466; Landvik NE, 2007, TOXICOLOGY, V231, P159, DOI 10.1016/j.tox.2006.12.009; Li N, 2006, EUR RESPIR J, V27, P667, DOI 10.1183/09031936.06.00025006; Li N, 2002, J IMMUNOL, V169, P4531, DOI 10.4049/jimmunol.169.8.4531; Malley R, 2005, P NATL ACAD SCI USA, V102, P4848, DOI 10.1073/pnas.0501254102; Mazzarella G, 2007, RESP MED, V101, P1155, DOI 10.1016/j.rmed.2006.11.011; Metzen J, 2003, LIFE SCI, V72, P2075, DOI 10.1016/S0024-3205(03)00086-9; Nemmar A, 2010, TOXICOL LETT, V194, P58, DOI 10.1016/j.toxlet.2010.02.001; Nguyen LHP, 2004, J ALLERGY CLIN IMMUN, V114, P1110, DOI 10.1016/j.jaci.2004.07.061; Park EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026749; Polanczyk M, 2004, AM J PATHOL, V164, P1915, DOI 10.1016/S0002-9440(10)63752-2; Polosa R, 2002, ARCH ENVIRON HEALTH, V57, P188, DOI 10.1080/00039890209602935; Poltorak M, 2014, EUR J IMMUNOL, V44, P1535, DOI 10.1002/eji.201344046; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Riedl M, 2005, J ALLERGY CLIN IMMUN, V115, P221, DOI 10.1016/j.jaci.2004.11.047; SAGAI M, 1993, FREE RADICAL BIO MED, V14, P37, DOI 10.1016/0891-5849(93)90507-Q; Salvi S, 1999, AM J RESP CRIT CARE, V159, P702, DOI 10.1164/ajrccm.159.3.9709083; Scariano JK, 2008, J RECEPT SIG TRANSD, V28, P285, DOI [10.1080/10799890802084614, 10.1080/10799890802084614 ]; Sharma SK, 2011, J INFECT DIS, V204, P645, DOI 10.1093/infdis/jir340; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Song JJ, 2013, INT J PEDIATR OTORHI, V77, P1760, DOI 10.1016/j.ijporl.2013.08.012; Song JJ, 2012, INT J PEDIATR OTORHI, V76, P334, DOI 10.1016/j.ijporl.2011.12.003; Sydbom A, 2001, EUR RESPIR J, V17, P733, DOI 10.1183/09031936.01.17407330; Takano H, 1997, AM J RESP CRIT CARE, V156, P36, DOI 10.1164/ajrccm.156.1.9610054; Takizawa H, 2000, Respirology, V5, P197, DOI 10.1046/j.1440-1843.2000.00245.x; Wan JX, 2007, INHAL TOXICOL, V19, P177, DOI 10.1080/08958370701496145; WEBB GC, 1993, GENOMICS, V18, P14, DOI 10.1006/geno.1993.1421	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166044	10.1371/journal.pone.0166044	http://dx.doi.org/10.1371/journal.pone.0166044			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832168	Green Published, gold			2022-12-26	WOS:000387725000058
J	de Leon-Bautista, MP; Cardenas-Aguayo, MD; Casique-Aguirre, D; Almaraz-Salinas, M; Parraguirre-Martinez, S; Olivo-Diaz, A; Thompson-Bonilla, MD; Vargas, M				Piedad de Leon-Bautista, Mercedes; del Carmen Cardenas-Aguayo, Maria; Casique-Aguirre, Diana; Almaraz-Salinas, Manuel; Parraguirre-Martinez, Sara; Olivo-Diaz, Angelica; del Rocio Thompson-Bonilla, Maria; Vargas, Miguel			Immunological and Functional Characterization of RhoGDI3 and Its Molecular Targets RhoG and RhoB in Human Pancreatic Cancerous and Normal Cells	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; EPIDERMAL-GROWTH-FACTOR; GTP-BINDING PROTEINS; FACTOR RECEPTOR; EXPRESSION; GTPASES; CARCINOMA; RAS; METASTASIS; INVASION	RhoGDI proteins have been implicated in several human cancers; changes in their expression levels have shown pro-or anti-tumorigenic effects. Pancreatic Ductal Adenocarcinoma (PDAC) is a complex pathology, with poor prognosis, and most patients die shortly after diagnosis. Efforts have been focused on understanding the role of RhoGDI's in PDAC, specially, RhoGDI1 and RhoGDI2. However, the role of RhoGDI3 has not been studied in relation to cancer or to PDAC. Here, we characterized the expression and functionality of RhoGDI3 and its target GTPases, RhoG and RhoB in pancreatic cell lines from both normal pancreatic tissue and tissue in late stages of PDAC, and compared them to human biopsies. Through immunofluorescences, pulldown assays and subcellular fractionation, we found a reduction in RhoGDI3 expression in the late stages of PDAC, and this reduction correlates with tumor progression and aggressiveness. Despite the reduction in the expression of RhoGDI3 in PDAC, we found that RhoB was underexpressed while RhoG was overexpressed, suggesting that cancerous cells preserve their capacity to activate this pathway, thus these cells may be more eager to response to the stimuli needed to proliferate and become invasive unlike normal cells. Surprisingly, we found nuclear localization of RhoGDI3 in non -cancerous pancreatic cell line and normal pancreatic tissue biopsies, which could open the possibility of novel nuclear functions for this protein, impacting gene expression regulation and cellular homeostasis.	[Piedad de Leon-Bautista, Mercedes; Casique-Aguirre, Diana; Vargas, Miguel] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico; [del Carmen Cardenas-Aguayo, Maria] Univ Nacl Autonoma Mexico, Fac Med, Dept Fisiol, Ave Univ 3000, Delegacion Coyoacan 04510, Mexico; [Almaraz-Salinas, Manuel] Inst Tecnol Milpa Alta, Fac Bioquim, Independencia 36, Mexico City 12300, DF, Mexico; [Parraguirre-Martinez, Sara] Hosp Gen Doctor Manuel Gea Gonzalez, Dept Anat Patol, Av Calzada Tlalpan 4800,Sect 16, Mexico City 14080, DF, Mexico; [Olivo-Diaz, Angelica] Hosp Doctor Manuel Gea Gonzalez, Dept Biol Mol & Histocompatibilidad, Av Calzada Tlalpan 4800,Sect 16, Mexico City 14080, DF, Mexico; [del Rocio Thompson-Bonilla, Maria] Hosp 1 Octubre, ISSSTE, Lab Med Genom, Invest Biomed Traslac, Av Inst Politecn Nacl 1669, Mexico City 07760, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico	Vargas, M (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Ave Inst Politecn Nacl 2508, Mexico City 07360, DF, Mexico.	mavargas@cinvestav.mx	Casique Aguirre, Diana/E-8650-2019; del Carmen Cardenas-Aguayo, Maria/AAH-5073-2020	Casique Aguirre, Diana/0000-0001-5580-2551; del Carmen Cardenas-Aguayo, Maria/0000-0001-9156-2161; VARGAS, MIGUEL/0000-0002-3031-9798	CONACyT Mexico Grant ANR-CONAGyT [140364]; CONACYT [153334]; ISSSTE [002.2015]	CONACyT Mexico Grant ANR-CONAGyT(French National Research Agency (ANR)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ISSSTE	This work was supported by CONACyT Mexico Grant ANR-CONAGyT 140364, CONACYT 153334 and ISSSTE 002.2015.	Abiatari I, 2009, MOL CANCER THER, V8, P1494, DOI 10.1158/1535-7163.MCT-08-0755; Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Adnane J, 2002, CLIN CANCER RES, V8, P2225; Adra CN, 1998, GENOMICS, V53, P104, DOI 10.1006/geno.1998.5482; ADRA CN, 1993, GENE CHROMOSOME CANC, V8, P253, DOI 10.1002/gcc.2870080408; Adra CN, 1997, P NATL ACAD SCI USA, V94, P4279, DOI 10.1073/pnas.94.9.4279; Ali S, 2005, MOL CANCER THER, V4, P1943, DOI 10.1158/1535-7163.MCT-05-0065; Aznar S, 2001, MOL BIOL CELL, V12, P3282, DOI 10.1091/mbc.12.10.3282; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bousquet E, 2016, ONCOGENE, V35, P1760, DOI 10.1038/onc.2015.240; Brunet N, 2002, TRAFFIC, V3, P342, DOI 10.1034/j.1600-0854.2002.30504.x; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fritz G, 2002, BRIT J CANCER, V87, P635, DOI 10.1038/sj.bjc.6600510; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FUKUMOTO Y, 1990, ONCOGENE, V5, P1321; Gampel A, 1999, CURR BIOL, V9, P955, DOI 10.1016/S0960-9822(99)80422-9; Gildea JJ, 2002, CANCER RES, V62, P6418; Golovanov AP, 2001, J MOL BIOL, V305, P121, DOI 10.1006/jmbi.2000.4262; Guillemot JC, 1996, BLOOD, V88, P2722, DOI 10.1182/blood.V88.7.2722.bloodjournal8872722; Hu LD, 2007, ONCOL REP, V17, P1383; JAHNER D, 1991, MOL CELL BIOL, V11, P3682; Jiang K, 2004, ONCOGENE, V23, P1136, DOI 10.1038/sj.onc.1207236; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Jones MB, 2002, PROTEOMICS, V2, P76, DOI 10.1002/1615-9861(200201)2:1<76::AID-PROT76>3.3.CO;2-F; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Keep NH, 1997, STRUCTURE, V5, P623, DOI 10.1016/S0969-2126(97)00218-9; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krieser RJ, 1999, CELL DEATH DIFFER, V6, P412, DOI 10.1038/sj.cdd.4400515; Li WD, 2013, INT J CLIN EXP PATHO, V6, P2535; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Lu W, 2008, CHINA FRONTIERS ENV, V2, P15, DOI [10.1007/s11783-008-006-z, DOI 10.1007/S11010-008-9713-9]; Morin A, 2011, SMALL GTPASES, V1, P142, DOI DOI 10.4161/SGTP.1.3.15112; OHGA N, 1989, BIOCHEM BIOPH RES CO, V163, P1523, DOI 10.1016/0006-291X(89)91153-4; Paulo JA, 2013, BBA-PROTEINS PROTEOM, V1834, P791, DOI 10.1016/j.bbapap.2013.01.011; REGAZZI R, 1992, J BIOL CHEM, V267, P17512; Reimer J, 2007, ANTI-CANCER DRUG, V18, P333, DOI 10.1097/CAD.0b013e328011fd7f; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Vega FM, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120076; [王世和 Wang Shihe], 2003, [中国给水排水, China Water & Wastewater], V19, P9; Wherlock M, 2004, J CELL SCI, V117, P3221, DOI 10.1242/jcs.01193; Wu YM, 2009, P NATL ACAD SCI USA, V106, P5807, DOI 10.1073/pnas.0810094106; Yi B, 2014, INT J MOL MED, V34, P205, DOI 10.3892/ijmm.2014.1765; Yu JX, 2012, J BIOL CHEM, V287, P13752, DOI 10.1074/jbc.M111.337469; Zhang Y-Y, 2006, PROG MODERN BIOMED, V6, P8, DOI DOI 10.1158/0008-5472.CAN-05-; Zhang YQ, 2009, J BIOL CHEM, V284, P12956, DOI 10.1074/jbc.M807845200; Zheng Z, 2013, ONCOL LETT, V5, P255, DOI 10.3892/ol.2012.949	57	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166370	10.1371/journal.pone.0166370	http://dx.doi.org/10.1371/journal.pone.0166370			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832197	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000112
J	Teilmann, AC; Rozell, B; Kalliokoski, O; Hau, J; Abelson, KSP				Teilmann, Anne Charlotte; Rozell, Bjorn; Kalliokoski, Otto; Hau, Jann; Abelson, Klas S. P.			Carotid Catheterization and Automated Blood Sampling Induce Systemic IL-6 Secretion and Local Tissue Damage and Inflammation in the Heart, Kidneys, Liver and Salivary Glands in NMRI Mice	PLOS ONE			English	Article							VOLUNTARILY-INGESTED BUPRENORPHINE; CHRONIC VASCULAR CATHETERIZATION; CORTICOSTERONE LEVELS; PERMANENT CATHETERIZATION; PLASMA INTERLEUKIN-6; BODY-WEIGHT; STRESS; CYTOKINES; RAT; ACTIVATION	Automated blood sampling through a vascular catheter is a frequently utilized technique in laboratory mice. The potential immunological and physiological implications associated with this technique have, however, not been investigated in detail. The present study compared plasma levels of the cytokines IL-1 beta, IL-2, IL-6, IL-10, IL-17A, GM-CSF, IFN-gamma and TNF-alpha in male NMRI mice that had been subjected to carotid artery catheterization and subsequent automated blood sampling with age-matched control mice. Body weight and histopathological changes in the surgical area, including the salivary glands, the heart, brain, spleen, liver, kidneys and lungs were compared. Catheterized mice had higher levels of IL-6 than did control mice, but other cytokine levels did not differ between the groups. No significant difference in body weight was found. The histology revealed inflammatory and regenerative ( healing) changes at surgical sites of all catheterized mice, with mild inflammatory changes extending into the salivary glands. Several catheterized mice had multifocal degenerative to necrotic changes with inflammation in the heart, kidneys and livers, suggesting that thrombi had detached from the catheter tip and embolized to distant sites. Thus, catheterization and subsequent automated blood sampling may have physiological impact. Possible confounding effects of visceral damage should be assessed and considered, when using catheterized mouse models.	[Teilmann, Anne Charlotte; Kalliokoski, Otto; Hau, Jann; Abelson, Klas S. P.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark; [Rozell, Bjorn] Karolinska Inst, Dept Comparat Med, SE-17177 Stockholm, Sweden	University of Copenhagen; Karolinska Institutet	Teilmann, AC (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Expt Med, Blegdamsvej 3b, DK-2200 Copenhagen N, Denmark.	annete@sund.ku.dk	Kalliokoski, Otto/I-3828-2019; Hau, Jann/C-8692-2012	Kalliokoski, Otto/0000-0001-6531-3487; Hau, Jann/0000-0001-8586-5705; Abelson, Klas/0000-0002-4986-7882				Abelson KSP, 2012, LAB ANIM-UK, V46, P349, DOI 10.1258/la.2012.012028; Anderson G, 2002, THEORY PRACTICE HIST, P85; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BLAHA MD, 2008, J AM ASSOC LAB ANIM, V47, P8; Blanchard AA, 2015, PROTEOME SCI, V13, DOI 10.1186/s12953-015-0068-3; Chappell MG, 2011, J AM ASSOC LAB ANIM, V50, P227; Desborough JP, 2000, BRIT J ANAESTH, V85, P109, DOI 10.1093/bja/85.1.109; Fonseca UNK, 2010, LAB ANIM-UK, V44, P46, DOI 10.1258/la.2009.008122; Frazier KS, 2012, TOXICOL PATHOL, V40, P14, DOI 10.1177/0192623312438736; Goldkuhl R, 2010, IN VIVO, V24, P131; Grouzmann E, 2003, PFLUG ARCH EUR J PHY, V447, P254, DOI 10.1007/s00424-003-1140-x; Hagan CE, 2012, COMP ANATOMY HISTOLO, P339; Harada T., 1999, PATHOLOGY MOUSE, P119; Haschek WM, 2010, FUNDAMENTALS OF TOXICOLOGIC PATHOLOGY, 2ND EDITION, P197, DOI 10.1016/B978-0-12-370469-6.00009-X; Hayes KE, 2000, CONTEMP TOP LAB ANIM, V39, P18; Hovard AMB, 2015, LAB ANIM-UK, V49, P40, DOI 10.1177/0023677214551108; Hsing Chung-Hsi, 2015, Acta Anaesthesiol Taiwan, V53, P23, DOI 10.1016/j.aat.2015.03.002; Jacobsen KR, 2011, ANIM WELFARE, V20, P591; Jacobsen KR, 2013, COMPARATIVE MED, V63, P105; Jokinen MP, 2005, CARDIOVASC TOXICOL, V5, P227, DOI 10.1385/CT:5:2:227; Kalliokoski O, 2010, IN VIVO, V24, P641; Kaplan H. M., 1983, MOUSE BIOMEDICAL RES, V111, P248; Lin E, 2000, SURGERY, V127, P117, DOI 10.1067/msy.2000.101584; Mahler M, 2014, LAB ANIM-UK, V48, P178, DOI 10.1177/0023677213516312; McInnes E.F., 2011, BACKGROUND LESIONS L; Mirantes C, 2014, EXP CELL RES; MOKHTARIAN A, 1993, PHYSIOL BEHAV, V54, P895, DOI 10.1016/0031-9384(93)90298-T; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Nukina K, 2001, J NEUROIMMUNOL, V115, P46, DOI 10.1016/S0165-5728(01)00260-0; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Shabgah AG, 2014, POSTEP DERM ALERGOL, V31, P256, DOI 10.5114/pdia.2014.40954; Shebusky RJ, 2001, J PHARMACOL EXP THER, V300, P729; Sheeran P, 1997, BRIT J ANAESTH, V78, P201, DOI 10.1093/bja/78.2.201; Sinno MCN, 2012, ECHOCARDIOGR-J CARD, V29, pE56, DOI 10.1111/j.1540-8175.2011.01582.x; Siswanto H, 2008, IN VIVO, V22, P435; Sundbom R, 2011, IN VIVO, V25, P335; Tan RHH, 2003, AUST VET J, V81, P136, DOI 10.1111/j.1751-0813.2003.tb11074.x; Teilmann AC, 2014, LAB ANIM-UK, V48, P278, DOI 10.1177/0023677214541438; Teilmann AC, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-33; Teilmann AC, 2014, LAB ANIMAL, V43, P397, DOI 10.1038/laban.570; Teilmann AC, 2012, IN VIVO, V26, P577; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Watkins LR, 1995, PAIN, V63, P289, DOI 10.1016/0304-3959(95)00186-7; Yang J, 2005, LAB ANIM-UK, V39, P259, DOI 10.1258/0023677054307033; YOBURN BC, 1984, PHYSIOL BEHAV, V33, P89, DOI 10.1016/0031-9384(84)90018-0; Zhong Q., 2015, J APPL STAT, V1, P1, DOI DOI 10.1007/S00500-015-1789-Z; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	48	4	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166353	10.1371/journal.pone.0166353	http://dx.doi.org/10.1371/journal.pone.0166353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832170	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000108
J	Deflorio, C; Blanchard, S; Carisi, MC; Bohl, D; Maskos, U				Deflorio, Cristina; Blanchard, Stephane; Carisi, Maria Carla; Bohl, Delphine; Maskos, Uwe			Human polymorphisms in nicotinic receptors: a functional analysis in iPS-derived dopaminergic neurons	FASEB JOURNAL			English	Article						electrophysiology; stem cells; GWAS; smoking; screening system	PLURIPOTENT STEM-CELLS; GENOME-WIDE ASSOCIATION; ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; HUMAN ES; PHYSIOLOGICAL DIVERSITY; SUSCEPTIBILITY LOCUS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOTOR-NEURONS	Tobacco smoking is a public health problem, with similar to 5 million deaths per year, representing a heavy burden for many countries. No effective therapeutic strategies are currently available for nicotine addiction, and it is therefore crucial to understand the etiological and pathophysiological factors contributing to this addiction. The neuronal 5 nicotinic acetylcholine receptor (nAChR) subunit is critically involved in nicotine dependence. In particular, the human polymorphism 5D398N corresponds to the strongest correlation with nicotine dependence risk found to date in occidental populations, according to meta-analysis of genome-wide association studies. To understand the specific contribution of this subunit in the context of nicotine addiction, an efficient screening system for native human nAChRs is needed. We have differentiated human induced pluripotent stem (iPS) cells into midbrain dopaminergic (DA) neurons and obtained a comprehensive characterization of these neurons by quantitative RT-PCR. The functional properties of nAChRs expressed in these human DA neurons, with or without the polymorphism in the 5 subunit, were studied with the patch-clamp electrophysiological technique. Our results in human DA neurons carrying the polymorphism in the 5 subunit showed an increase in EC50, indicating that, in the presence of the polymorphism, more nicotine or acetylcholine chloride is necessary to obtain the same effect. This human cell culturing system can now be used in drug discovery approaches to screen for compounds that interact specifically with human native and polymorphic nAChRs.	[Deflorio, Cristina; Blanchard, Stephane; Carisi, Maria Carla; Bohl, Delphine; Maskos, Uwe] Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France; [Maskos, Uwe] CNRS, Inst Pasteur, UMR 3731, Paris, France; [Bohl, Delphine] Univ Paris 06, CNRS, INSERM, Inst Cerveau & La Moelle Epiniere,Unite 1127,UMR, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Maskos, U (corresponding author), Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France.	umaskos@pasteur.fr	Bohl, Delphine/L-8709-2016	Bohl, Delphine/0000-0001-8262-5642	PasteurInnov; Fondation de la Recherche Medicale (FRM) [SPF20140129365, DPA20140629803]; French National Cancer Institute [CANCEROPOLE IDF 2016-1-TABAC-01-IP-1]; Centre National de la Recherche Scientifique, Unite Mixte de Recherche [3571]	PasteurInnov; Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Cancer Institute(Institut National du Cancer (INCA) France); Centre National de la Recherche Scientifique, Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS))	The authors thank Thomas Lemonnier and Matthias Groszer (Sorbonne Universites, Paris, France) for constant support, and Stephanie Pons, Stefania Tolu and Martine Soudant (all from Institut Pasteur) for the Th-eGFP lentiviral vector. U.M. is a member of the Laboratory of Excellence, LabEx Bio-Psy. This work was supported by PasteurInnov 2013, Fondation de la Recherche Medicale (FRM; Grants SPF20140129365 and DPA20140629803), the French National Cancer Institute Grant CANCEROPOLE IDF 2016-1-TABAC-01-IP-1 (to U.M.), and Centre National de la Recherche Scientifique, Unite Mixte de Recherche 3571. The laboratory of U.M. is part of the Ecole des Neurosciences de Paris Ile-de-France Thematic Network for Advanced Research (RTRA). The authors declare no conflicts of interest.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Chatzidaki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125116; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Fallon James H., 1995, P215; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fucile S, 1997, NEUROREPORT, V8, P2433, DOI 10.1097/00001756-199707280-00005; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Gundisch D, 2011, EXPERT OPIN THER PAT, V21, P1867, DOI 10.1517/13543776.2011.637919; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hartfield EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087388; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lemonnier T, 2011, HUM MOL GENET, V20, P3653, DOI 10.1093/hmg/ddr285; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sanchez-Danes A, 2012, HUM GENE THER, V23, P56, DOI 10.1089/hum.2011.054; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Sciaccaluga M, 2015, FASEB J, V29, P3389, DOI 10.1096/fj.14-268102; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; STROMBERG I, 1991, EXP NEUROL, V112, P140, DOI 10.1016/0014-4886(91)90064-J; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Toli D, 2015, NEUROBIOL DIS, V82, P269, DOI 10.1016/j.nbd.2015.06.011; Tolu S, 2013, MOL PSYCHIATR, V18, P382, DOI 10.1038/mp.2012.83; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zhang PB, 2014, JOVE-J VIS EXP, DOI 10.3791/51737	69	14	14	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					828	839		10.1096/fj.201600932R	http://dx.doi.org/10.1096/fj.201600932R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27856558				2022-12-26	WOS:000394235400034
J	Wang, GY; Zhu, ZM; Cui, S; Wang, JH				Wang, Guang-Yan; Zhu, Zhao-Ming; Cui, Shan; Wang, Jin-Hui			Glucocorticoid Induces Incoordination between Glutamatergic and GABAergic Neurons in the Amygdala	PLOS ONE			English	Article							CORTICAL PYRAMIDAL NEURONS; GAMMA-AMINOBUTYRIC-ACID; ANXIETY-LIKE BEHAVIOR; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; INHIBITORY NEURONS; SEQUENTIAL SPIKES; CEREBRAL-CORTEX; UP-REGULATION; STRESS	Background Stressful life leads to mood disorders. Chronic mild stress is presumably major etiology for depression, and acute severe stress leads to anxiety. These stressful situations may impair hypothalamus-pituitary-adrenal axis and in turn induce synapse dysfunction. However, it remains elusive how the stress hormones mess up subcellular compartments and interactions between excitatory and inhibitory neurons, which we have investigated in mouse amygdala, a structure related to emotional states. Methods and Results Dexamethasone was chronically given by intraperitoneal injection once a day for one week or was acutely washed into the brain slices. The neuronal spikes and synaptic transmission were recorded by whole-cell patching in amygdala neurons of brain slices. The chronic or acute administration of dexamethasone downregulates glutamate release as well as upregulates GABA release and GABAergic neuron spiking. The chronic administration of dexamethasone also enhances the responsiveness of GABA receptors. Conclusion The upregulation of GABAergic neurons and the downregulation of glutamatergic neurons by glucocorticoid impair their balance in the amygdala, which leads to emotional disorders during stress.	[Wang, Guang-Yan; Zhu, Zhao-Ming; Wang, Jin-Hui] Qingdao Univ, Sch Pharm, 38 Dengzhou, Qingdao, Shandong, Peoples R China; [Cui, Shan; Wang, Jin-Hui] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China; [Wang, Jin-Hui] Univ Chinese Acad Sci, Beijing, Peoples R China	Qingdao University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, JH (corresponding author), Qingdao Univ, Sch Pharm, 38 Dengzhou, Qingdao, Shandong, Peoples R China.; Wang, JH (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing, Peoples R China.; Wang, JH (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	jhw@sun5.ibp.ac.cn			National Basic Research Program [2013CB531304, 2016YFC1307100]; Natural Science Foundation China [81671071, 81471123]	National Basic Research Program(National Basic Research Program of China); Natural Science Foundation China(National Natural Science Foundation of China (NSFC))	This study is granted by the National Basic Research Program (2013CB531304 and 2016YFC1307100) and Natural Science Foundation China (81671071 and 81471123) to JHW.	Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Banasr M, 2011, CURR OPIN CELL BIOL, V23, P730, DOI 10.1016/j.ceb.2011.09.002; Bennett Paul, 2008, J Genet Couns, V17, P234, DOI 10.1007/s10897-007-9136-x; Berton O, 2012, SCIENCE, V338, P75, DOI 10.1126/science.1222940; Bishop SJ, 2007, TRENDS COGN SCI, V11, P307, DOI 10.1016/j.tics.2007.05.008; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Capogna M, 2014, CURR OPIN NEUROBIOL, V26, P110, DOI 10.1016/j.conb.2014.01.006; Chen N, 2006, BIOCHEM BIOPH RES CO, V340, P151, DOI 10.1016/j.bbrc.2005.11.170; Chen N, 2008, J CELL SCI, V121, P2961, DOI 10.1242/jcs.022368; Craske MG, 2009, DEPRESS ANXIETY, V26, P1066, DOI 10.1002/da.20633; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; Duman CH, 2010, VITAM HORM, V82, P1, DOI 10.1016/S0083-6729(10)82001-1; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Elhwuegi AS, 2004, PROG NEURO-PSYCHOPH, V28, P435, DOI 10.1016/j.pnpbp.2003.11.018; Elizalde N, 2008, PSYCHOPHARMACOLOGY, V199, P1, DOI 10.1007/s00213-007-1035-1; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gallagher M, 1996, CURR OPIN NEUROBIOL, V6, P221, DOI 10.1016/S0959-4388(96)80076-6; Ge RJ, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-26; Ge RJ, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-19; Gong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117503; Grundemann J, 2015, CURR OPIN NEUROBIOL, V35, P200, DOI 10.1016/j.conb.2015.10.005; Guilloux JP, 2012, MOL PSYCHIATR, V17, P1130, DOI 10.1038/mp.2011.113; Gunn BG, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00131; Hasler G, 2007, ARCH GEN PSYCHIAT, V64, P193, DOI 10.1001/archpsyc.64.2.193; Hu W, 2010, NEUROPSYCHOPHARMACOL, V35, P1693, DOI 10.1038/npp.2010.31; Johnson LR, 2005, NEUROSCIENCE, V136, P289, DOI 10.1016/j.neuroscience.2005.06.050; Karolewicz B, 2009, INT J NEUROPSYCHOPH, V12, P143, DOI 10.1017/S1461145708008985; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Li HB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2932; Lin LC, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00110; Lu W, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-38; Ma K, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.181; Ma K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159093; MacKenzie G, 2015, EPILEPSY RES, V109, P13, DOI 10.1016/j.eplepsyres.2014.10.003; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Quintero L, 2011, PAIN, V152, P1909, DOI 10.1016/j.pain.2011.04.017; Rickels K, 2001, PSYCHIAT CLIN N AM, V24, P1, DOI 10.1016/S0193-953X(05)70203-3; Rohleder N, 2010, NEUROSCI BIOBEHAV R, V35, P104, DOI 10.1016/j.neubiorev.2009.12.003; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sandi C, 2015, NAT REV NEUROSCI, V16, P290, DOI 10.1038/nrn3918; Seney ML, 2015, NEUROBIOL DIS, V73, P213, DOI 10.1016/j.nbd.2014.10.005; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Skilbeck KJ, 2010, J NEUROCHEM, V112, P1115, DOI 10.1111/j.1471-4159.2009.06539.x; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Strekalova T, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-9; Suwanjang W, 2013, CELL CALCIUM, V53, P256, DOI 10.1016/j.ceca.2012.12.006; Swanson LW, 2003, ANN NY ACAD SCI, V985, P174; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Uchida T, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.13; Wang DG, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00320; Wang J-H, 2015, BRAIN DISORDERS THER, V4, P1, DOI [10.4172/2168-975X.1000200, DOI 10.4172/2168-975X.1000200]; Wang JH, 2003, BRAIN RES BULL, V60, P53, DOI 10.1016/S0361-9230(03)00026-1; Wang JH, 2001, J PHYSIOL-LONDON, V533, P407, DOI 10.1111/j.1469-7793.2001.0407a.x; Wang JH, 2008, J CELL SCI, V121, P2951, DOI 10.1242/jcs.025684; Wei J, 2004, NEUROSCIENCE, V127, P637, DOI 10.1016/j.neuroscience.2004.05.056; Wen B, 2015, CNS NEUROSCI THER, V21, P204, DOI 10.1111/cns.12336; Wislowska-Stanek A, 2013, BEHAV BRAIN RES, V253, P337, DOI 10.1016/j.bbr.2013.07.042; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Wu LJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000167; Xu AP, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv122; Yang ZL, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-1; Yau SY, 2014, CELL TRANSPLANT, V23, P471, DOI 10.3727/096368914X678283; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Yu IT, 2004, BIOCHEM BIOPH RES CO, V317, P484, DOI 10.1016/j.bbrc.2004.03.071; Yu JD, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-26; Zhang FY, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-20; Zhang GJ, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-2; Zhu M, 2006, NEUROSCIENCE, V141, P2019, DOI 10.1016/j.neuroscience.2006.05.011; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	77	20	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166535	10.1371/journal.pone.0166535	http://dx.doi.org/10.1371/journal.pone.0166535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861545	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300071
J	Xiao, YH; Wang, QY; Liu, LH				Xiao, Yunhai; Wang, Qiuyu; Liu, Lihong			Applications of Spectral Gradient Algorithm for Solving Matrix l(2,1)-Norm Minimization Problems in Machine Learning	PLOS ONE			English	Article							NONMONOTONE LINE SEARCH; MULTIPLE TASKS; BARZILAI	The main purpose of this study is to propose, then analyze, and later test a spectral gradient algorithm for solving a convex minimization problem. The considered problem covers the matrix l(2,1)-norm regularized least squares which is widely used in multi-task learning for capturing the joint feature among each task. To solve the problem, we firstly minimize a quadratic approximated model of the objective function to derive a search direction at current iteration. We show that this direction descends automatically and reduces to the original spectral gradient direction if the regularized term is removed. Secondly, we incorporate a nonmonotone line search along this direction to improve the algorithm's numerical performance. Furthermore, we show that the proposed algorithm converges to a critical point under some mild conditions. The attractive feature of the proposed algorithm is that it is easily performable and only requires the gradient of the smooth function and the objective function's values at each and every step. Finally, we operate some experiments on synthetic data, which verifies that the proposed algorithm works quite well and performs better than the compared ones.	[Xiao, Yunhai] Henan Univ, Sch Math & Stat, Inst Appl Math, Kaifeng, Henan Province, Peoples R China; [Wang, Qiuyu; Liu, Lihong] Henan Univ, Sch Math & Stat, Kaifeng, Henan Province, Peoples R China	Henan University; Henan University	Xiao, YH (corresponding author), Henan Univ, Sch Math & Stat, Inst Appl Math, Kaifeng, Henan Province, Peoples R China.	yhxiao@henu.edu.cn	liu, li/HGC-0900-2022; Xiao, Yunhai/AAB-9140-2019	Xiao, Yunhai/0000-0002-7503-4585	Major State Basic Research Development Program of China (973 Program) [2015CB856003]; National Natural Science Foundation of China [11471101]; Program for Science and Technology Innovation Talents in Universities of Henan Province [13HASTIT050]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Science and Technology Innovation Talents in Universities of Henan Province	The research is supported by the Major State Basic Research Development Program of China (973 Program) (Grant No. 2015CB856003), the National Natural Science Foundation of China (Grant No. 11471101), and the Program for Science and Technology Innovation Talents in Universities of Henan Province (Grant No. 13HASTIT050).; The research of Y. Xiao was supported by the Major State Basic Research Development Program of China (973 Program) (Grant No. 2015CB856003), the National Natural Science Foundation of China (Grant No. 11471101), and the Program for Science and Technology Innovation Talents in Universities of Henan Province (Grant No. 13HASTIT050).	Ando RK, 2005, J MACH LEARN RES, V6, P1817; Argyriou A, 2008, MACH LEARN, V73, P243, DOI 10.1007/s10994-007-5040-8; Bakker B, 2004, J MACH LEARN RES, V4, P83, DOI 10.1162/153244304322765658; BARZILAI J, 1988, IMA J NUMER ANAL, V8, P141, DOI 10.1093/imanum/8.1.141; Bi J., 2008, EUR C MACH LEARN; Birgin EG, 2000, SIAM J OPTIMIZ, V10, P1196, DOI 10.1137/S1052623497330963; Chen BJ, 2015, J MATH IMAGING VIS, V51, P124, DOI 10.1007/s10851-014-0511-6; Cheng WY, 2009, IMA J NUMER ANAL, V29, P814, DOI 10.1093/imanum/drn019; Deng W, 2011, TR1106 RIC U TR1106 RIC U; Evgeniou T, 2005, J MACH LEARN RES, V6, P615; Fu Z., 2016, IEEE T INF FOREN SEC, DOI [10.1109/TIFS.2016.2596138, DOI 10.1109/TIFS.2016.2596138]; Fu Z.J., 2015, IEEE T PARALLEL DIST, DOI [10.1109/TPDS.2015.2506573, DOI :10.1109/TPDS.2015.2506573]; GRIPPO L, 1986, SIAM J NUMER ANAL, V23, P707, DOI 10.1137/0723046; Gu B, 2016, IEEE T NEURAL NETWOR, DOI [10.1109/TNNLS.2016.2527796, DOI 10.1109/TNNLS.2016.2527796PMID]; Hu Y, 2014, STAT OPTIMIZATION IN, V2, P352, DOI 10.19139/soic.v2i4.106; Liu J, 2009, COMFERENCE UNCERTAIN; Obozinski G., 2007, TECHNICAL REPORT; Obozinski G, 2010, STAT COMPUT, V20, P231, DOI 10.1007/s11222-008-9111-x; Obozinski Guillaume, 2006, MULTITASK FEATURE SE; Raydan M, 1997, SIAM J OPTIMIZ, V7, P26, DOI 10.1137/S1052623494266365; RAYDAN M, 1993, IMA J NUMER ANAL, V13, P321, DOI 10.1093/imanum/13.3.321; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Xia Z, 2016, IEEE T INF FOREN SEC, DOI [10.1109/TIFS.2016.2590944, DOI 10.1109/TIFS.2016.2590944]; Xia ZH, 2014, SECUR COMMUN NETW, V7, P1283, DOI 10.1002/sec.864; Xiao YH, 2014, J SCI COMPUT, V61, P17, DOI 10.1007/s10915-013-9815-8; Xiao YH, 2012, J IND MANAG OPTIM, V8, P1057, DOI 10.3934/jimo.2012.8.1057; Zhang J, 2008, MACH LEARN, V73, P221, DOI 10.1007/s10994-008-5050-1; Zheng YH, 2015, J INTELL FUZZY SYST, V28, P961, DOI 10.3233/IFS-141378	28	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166169	10.1371/journal.pone.0166169	http://dx.doi.org/10.1371/journal.pone.0166169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861526	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300032
J	Wagner, TC; Hane, S; Joubert, DF; Fischer, C				Wagner, Thomas C.; Hane, Susanne; Joubert, Dave F.; Fischer, Christina			Herbaceous Legume Encroachment Reduces Grass Productivity and Density in Arid Rangelands	PLOS ONE			English	Article							WOODY PLANT ENCROACHMENT; SHRUB ENCROACHMENT; AFRICAN SAVANNA; RAINFALL; COMPETITION; NITROGEN; ESTABLISHMENT; LANDSCAPE; DIVERSITY; DYNAMICS	Worldwide savannas and arid grasslands are mainly used for livestock grazing, providing livelihood to over a billion people. While normally dominated by perennial C-4 grasses, these rangelands are increasingly affected by the massive spread of native, mainly woody legumes. The consequences are often a repression of grass cover and productivity, leading to a reduced carrying capacity. While such encroachment by woody plants has been extensively researched, studies on similar processes involving herbaceous species are rare. We studied the impact of a sustained and massive spread of the native herbaceous legume Crotalaria podocarpa in Namibia's escarpment region on the locally dominant fodder grasses Stipagrostis ciliata and Stipagrostis uniplumis. We measured tussock densities, biomass production of individual tussocks and tussock dormancy state of Stipagrostis on ten 10 m x 10 m plots affected and ten similarly-sized plots unaffected by C. podocarpa over eight consecutive years and under different seasonal rainfalls and estimated the potential relative productivity of the land. We found the percentage of active Stipagrostis tussocks and the biomass production of individual tussocks to increase asymptotically with higher seasonal rainfall reaching a maximum around 300 mm while the land's relative productivity under average local rainfall conditions reached only 40% of its potential. Crotalaria podocarpa encroachment had no effect on the proportion of productive grass tussocks, but reduced he productivity of individual Stipagrostis tussocks by a third. This effect of C. podocarpa on grass productivity was immediate and direct and was not compensated for by above-average rainfall. Besides this immediate effect, over time, the density of grass tussocks declined by more than 50% in areas encroached by C. podocarpa further and lastingly reducing the lands carrying capacity. The effects of C. podocarpa on grass productivity hereby resemble those of woody encroachers. Therefore, against the background of global change, the spread of herbaceous legumes and the underlying patterns needs to be further investigated to develop adequate counter measures for a sustainable land use.	[Wagner, Thomas C.; Fischer, Christina] Tech Univ Munich, Dept Ecol & Ecosyst Management, Restorat Ecol, Freising Weihenstephan, Germany; [Hane, Susanne] Leibniz Univ Hannover, Inst Phys Geog & Landscape Ecol, Hannover, Germany; [Joubert, Dave F.] Namibia Univ Sci & Technol, Nat Resources & Spatial Sci, Windhoek, Namibia	Technical University of Munich; Leibniz University Hannover; Namibia University of Science & Technology	Wagner, TC (corresponding author), Tech Univ Munich, Dept Ecol & Ecosyst Management, Restorat Ecol, Freising Weihenstephan, Germany.	wagner@tum.de	Fischer, Christina/B-5568-2011	Fischer, Christina/0000-0001-7784-1105; Wagner, Thomas/0000-0002-0457-367X	German Research Foundation (DFG); Technische Universitat Munchen	German Research Foundation (DFG)(German Research Foundation (DFG)); Technische Universitat Munchen	This work was supported by the German Research Foundation (DFG) and the Technische Universitat Munchen within the funding program Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams MM, 1997, J ARID ENVIRON, V35, P29, DOI 10.1006/jare.1995.0139; Baudena M, 2015, BIOGEOSCIENCES, V12, P1833, DOI 10.5194/bg-12-1833-2015; BELSKY AJ, 1994, ECOLOGY, V75, P922, DOI 10.2307/1939416; Beyer U., 2001, THESIS; Blaum N, 2009, BIODIVERS CONSERV, V18, P1187, DOI 10.1007/s10531-008-9498-x; Bond WJ, 2000, GLOBAL CHANGE BIOL, V6, P865, DOI 10.1046/j.1365-2486.2000.00365.x; Botha CJ, 2008, J ETHNOPHARMACOL, V119, P549, DOI 10.1016/j.jep.2008.07.022; Carlyle C, 2014, OECOLOGIA, V174, P1065, DOI 10.1007/s00442-013-2833-2; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; D'Onofrio D, 2015, WATER RESOUR RES, V51, P169, DOI 10.1002/2014WR015515; Dalle G, 2006, AFR J ECOL, V44, P237, DOI 10.1111/j.1365-2028.2006.00638.x; Danin A, 1996, J ARID ENVIRON, V34, P297, DOI 10.1006/jare.1996.0111; de Klerk J.N., 2004, FUNCT ECOL; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Dohn J, 2013, J ECOL, V101, P202, DOI 10.1111/1365-2745.12010; Donzelli D, 2013, J THEOR BIOL, V332, P181, DOI 10.1016/j.jtbi.2013.04.003; Eldridge DJ, 2011, ECOL LETT, V14, P709, DOI 10.1111/j.1461-0248.2011.01630.x; Fischer C, 2015, PERSPECT PLANT ECOL, V17, P405, DOI 10.1016/j.ppees.2015.07.002; Galindez G, 2013, PLANT ECOL, V214, P75, DOI 10.1007/s11258-012-0147-9; Grice AC, 2004, AUSTRAL ECOL, V29, P51, DOI 10.1111/j.1442-9993.2004.01364.x; Henschel J.R., 2005, AFR STUDY MONOGR, V30, P43; Hodgkinson KC, 2005, RANGELAND J, V27, P105, DOI 10.1071/RJ05009; Hudak AT, 1999, HUM ECOL, V27, P55, DOI 10.1023/A:1018705300730; Joubert DF, 2013, J ARID ENVIRON, V91, P7, DOI 10.1016/j.jaridenv.2012.11.001; Jourand P, 2005, MOL PLANT MICROBE IN, V18, P1061, DOI 10.1094/MPMI-18-1061; Juergens N, 2013, J ARID ENVIRON, V93, P59, DOI 10.1016/j.jaridenv.2012.09.009; Kraaij T, 2006, PLANT ECOL, V186, P235, DOI 10.1007/s11258-006-9125-4; Lange G. M., 1998, Development Southern Africa, V15, P555, DOI 10.1080/03768359808440031; Lett MS, 2004, CAN J BOT, V82, P1363, DOI [10.1139/B04-088, 10.1139/b04-088]; Mendelsohn J., 2009, ATLAS NAMIBIA PORTRA; Milton SJ, 2004, S AFR J SCI, V100, P69; Milton SJ, 2000, PLANT ECOL, V150, P37, DOI 10.1023/A:1026585211708; Milton SJ, 2010, BIOL INVASIONS, V12, P3935, DOI 10.1007/s10530-010-9820-x; Mugasi S. K., 2000, African Journal of Range and Forage Science, V17, P64, DOI 10.2989/10220110009485741; Muller M.A.N., 2007, GRASSES OF NAMIBIA; Mworia JK, 2011, INVASIVE PLANT SPECI; O'Connor TG, 2014, AFR J RANGE FOR SCI, V31, P67, DOI 10.2989/10220119.2014.939996; Pellegrini AFA, 2016, ECOLOGY, V97, P2177, DOI 10.1002/ecy.1504; Pinheiro J, R PACKAGE VERSION; Pinheiro J.C., 2000, MIXED EFFECTS MODELS, DOI [10.1007/0-387-22747-4_1, DOI 10.1007/B98882]; POLHILL R M, 1968, Kew Bulletin, V22, P169, DOI 10.2307/4107767; R Core Team, 2013, R LANG ENV STAT COMP; Richter C. G. F., 2001, African Journal of Range and Forage Science, V18, P103, DOI 10.2989/10220110109485762; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; Safriel U., 2005, ECOSYSTEMS HUMAN WEL, P623; Sankaran M, 2013, NEW MODELS ECOSYSTEM, P136; Scanlon TM, 2005, ADV WATER RESOUR, V28, P291, DOI 10.1016/j.advwatres.2004.10.014; Schleicher J, 2011, J ARID ENVIRON, V75, P270, DOI 10.1016/j.jaridenv.2010.10.003; Scholes RJ, 1997, ANNU REV ECOL SYST, V28, P517, DOI 10.1146/annurev.ecolsys.28.1.517; SEELY M K, 1978, Madoqua, V11, P61; Seymour CL, 2010, J APPL ECOL, V47, P859, DOI 10.1111/j.1365-2664.2010.01833.x; Van Auken OW, 2009, J ENVIRON MANAGE, V90, P2931, DOI 10.1016/j.jenvman.2009.04.023; Wanjala CCW, 1999, PHYTOCHEMISTRY, V51, P705, DOI 10.1016/S0031-9422(99)00065-5; Ward D, 2014, AFR J RANGE FOR SCI, V31, P107, DOI 10.2989/10220119.2014.914974; Ward D, 2010, PLANT ECOL, V209, P147, DOI 10.1007/s11258-010-9731-z; Wiegand T, 1996, VEGETATIO, V125, P169, DOI 10.1007/BF00044649; Wigley BJ, 2010, GLOBAL CHANGE BIOL, V16, P964, DOI 10.1111/j.1365-2486.2009.02030.x; Zhu ZC, 2016, NAT CLIM CHANGE, V6, P791, DOI [10.1038/nclimate3004, 10.1038/NCLIMATE3004]; Zimmermann J, 2010, PERSPECT PLANT ECOL, V12, P1, DOI 10.1016/j.ppees.2009.09.003	59	8	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166743	10.1371/journal.pone.0166743	http://dx.doi.org/10.1371/journal.pone.0166743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855205	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200050
J	Wyss, AB; Jones, AC; Bolling, AK; Kissling, GE; Chartier, R; Dahlman, HJ; Rodes, CE; Archer, J; Thornburg, J; Schwarze, PE; London, SJ				Wyss, Annah B.; Jones, Anna Ciesielski; Bolling, Anette K.; Kissling, Grace E.; Chartier, Ryan; Dahlman, Hans Jorgen; Rodes, Charles E.; Archer, Janet; Thornburg, Jonathan; Schwarze, Per E.; London, Stephanie J.			Particulate Matter 2.5 Exposure and Self-Reported Use of Wood Stoves and Other Indoor Combustion Sources in Urban Nonsmoking Homes in Norway	PLOS ONE			English	Article							AIR-QUALITY; OUTDOOR; PM2.5; CHANGEOUT; PROGRAM	Few studies have examined particulate matter (PM) exposure from self-reported use of wood stoves and other indoor combustion sources in urban settings in developed countries. We measured concentrations of indoor PM < 2.5 microns (PM2.5) for one week with the MicroPEM (TM) nephelometer in 36 households in the greater Oslo, Norway metropolitan area. We examined indoor PM2.5 levels in relation to use of wood stoves and other combustion sources during a 7 day monitoring period using mixed effects linear models with adjustment for ambient PM2.5 levels. Mean hourly indoor PM2.5 concentrations were higher (p = 0.04) for the 14 homes with wood stove use (15.6 mu g/m(3)) than for the 22 homes without (12.6 mu g/m(3)). Moreover, mean hourly PM2.5 was higher (p = 0.001) for use of wood stoves made before 1997 (6 homes, 20.2 mu g/m(3)), when wood stove emission limits were instituted in Norway, compared to newer wood stoves (8 homes, 11.9 mu g/m(3)) which had mean hourly values similar to control homes. Increased PM2.5 levels during diary-reported burning of candles was detected independently of concomitant wood stove use. These results suggest that self-reported use of wood stoves, particularly older stoves, and other combustion sources, such as candles, are associated with indoor PM2.5 measurements in an urban population from a high income country.	[Wyss, Annah B.; Kissling, Grace E.; London, Stephanie J.] NIEHS, Div Intramural Res, NIH, US Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA; [Jones, Anna Ciesielski; Archer, Janet] Social & Sci Syst Inc, Durham, NC USA; [Bolling, Anette K.; Dahlman, Hans Jorgen; Schwarze, Per E.] Norwegian Inst Publ Hlth, Domain Infect Control & Environm Hlth, Dept Air Pollut & Noise, Oslo, Norway; [Chartier, Ryan; Rodes, Charles E.; Thornburg, Jonathan] Res Triangle Inst Int, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Social & Scientific Systems; Norwegian Institute of Public Health (NIPH); Research Triangle Institute	London, SJ (corresponding author), NIEHS, Div Intramural Res, NIH, US Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	london2@niehs.nih.gov	London, Stephanie/C-3734-2019	London, Stephanie/0000-0003-4911-5290; Chartier, Ryan/0000-0002-5663-8201; Thornburg, Jonathan/0000-0002-6740-2149; Bolling, Anette Kocbach/0000-0003-4209-7448	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences [ZIA ES049019]; NIEHS; RTI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES049019, ZIAES103106] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); RTI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (ZIA ES049019). Anna Ciesielski Jones and Janet Archer are employed by Social & Scientific Systems, Inc., which serves as a contractor to the National Institutes of Health. The support for their effort on this project is provided via contract with NIEHS. Ryan Chartier and Jonathan Thornburg are employed by Research Triangle Institute International, a non-profit organization. RTI provided support in the form of salaries for these authors. Neither RTI nor SSS had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Lawless PA, 1999, J AIR WASTE MANAGE, V49, P1039, DOI 10.1080/10473289.1999.10463877; McNamara M, 2013, INDOOR AIR, V23, P498, DOI 10.1111/ina.12043; Molnar P, 2005, ATMOS ENVIRON, V39, P2643, DOI 10.1016/j.atmosenv.2005.01.016; Noonan C., 2011, RES REP HLTH EFF I, P39; Noonan CW, 2012, INDOOR AIR, V22, P492, DOI 10.1111/j.1600-0668.2012.00789.x; Noonan Curtis W, 2011, Res Rep Health Eff Inst, P3; Noonan CW, 2012, OCCUP ENVIRON MED, V69, P354, DOI 10.1136/oemed-2011-100394; Norwegian Directorate of Health, 2014, PHYS ACT AD ELD RES; Research Triangle Institute, 2013, CHILDR HLTH STORMS F; Research Triangle Institute, 2013, MILLSB INH EXP BIOM; Rodes CE, 2010, ATMOS ENVIRON, V44, P1386, DOI 10.1016/j.atmosenv.2010.02.002; Salthammer T, 2014, CHEMOSPHERE, V103, P205, DOI 10.1016/j.chemosphere.2013.11.067; Semmens EO, 2015, ENVIRON RES, V138, P93, DOI 10.1016/j.envres.2015.02.005; Semple S, 2012, INDOOR AIR, V22, P212, DOI 10.1111/j.1600-0668.2011.00755.x; Statistics Norway, 2014, EN CONS HOUS 2012 EN CONS HOUS 2012; Thornburg J, 2009, ATMOS ENVIRON, V43, P4251, DOI 10.1016/j.atmosenv.2009.06.026; Ward T, 2008, INDOOR AIR, V18, P408, DOI 10.1111/j.1600-0668.2008.00541.x; Ward T, 2011, SCI TOTAL ENVIRON, V409, P664, DOI 10.1016/j.scitotenv.2010.11.006; WHO, 2005, AIR QUAL GUID GLOB U; Wolrd Health Organization, 2010, WHO GUID IND AIR QUA	20	15	15	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166440	10.1371/journal.pone.0166440	http://dx.doi.org/10.1371/journal.pone.0166440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855223	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000387910200032
J	Cortini, M; Massa, A; Avnet, S; Bonuccelli, G; Baldini, N				Cortini, Margherita; Massa, Annamaria; Avnet, Sofia; Bonuccelli, Gloria; Baldini, Nicola			Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion	PLOS ONE			English	Article							GROWTH-FACTOR; BREAST-CANCER; KAPPA-B; DOWN-REGULATION; LUNG-CANCER; EXPRESSION; INTERLEUKIN-6; PATHWAY; METASTASIS; MICROENVIRONMENT	Osteosarcoma (OS) is an aggressive bone malignancy with a high relapse rate despite combined treatment with surgery and multiagent chemotherapy. As for other cancers, OS-associated microenvironment may contribute to tumor initiation, growth, and metastasis. We consider mesenchymal stromal cells (MSC) as a relevant cellular component of OS microenvironment, and have previously found that the interaction between MSC and tumor cells is bidirectional: tumor cells can modulate their peripheral environment that in turn becomes more favorable to tumor growth through metabolic reprogramming. Here, we determined the effects of MSC on OS stemness and migration, two major features associated with recurrence and chemoresistance. The presence of stromal cells enhanced the number of floating spheres enriched in cancer stem cells (CSC) of the OS cell population. Furthermore, the co-culturing with MSC stimulated the migratory capacity of OS via TGF beta 1 and IL-6 secretion, and the neutralizing antibody anti-IL-6 impaired this effect. Thus, stromal cells in combination with OS spheres exploit a vicious cycle where the presence of CSC stimulates mesenchymal cytokine secretion, which in turn increases stemness, proliferation, migration, and metastatic potential of CSC, also through the increase of expression of adhesion molecules like ICAM-1. Altogether, our data corroborate the concept that a comprehensive knowledge of the interplay between tumor and stroma that also includes the stem-like fraction of tumor cells is needed to develop novel and effective anti-cancer therapies.	[Cortini, Margherita; Massa, Annamaria; Avnet, Sofia; Bonuccelli, Gloria; Baldini, Nicola] IOR, Orthopaed Pathophysiol & Regenerat Med Unit, I-40136 Bologna, Italy; [Cortini, Margherita; Baldini, Nicola] Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy	University of Bologna	Baldini, N (corresponding author), IOR, Orthopaed Pathophysiol & Regenerat Med Unit, I-40136 Bologna, Italy.; Baldini, N (corresponding author), Univ Bologna, Dept Biomed & Neuromotor Sci, I-40126 Bologna, Italy.	nicola.baldini@ior.it	Avnet, Sofia/B-3220-2018; Cortini, Margherita/J-7325-2018; Massa, Annamaria/AAB-9872-2019; Baldini, Nicola/J-4806-2016	Avnet, Sofia/0000-0002-7843-0591; Massa, Annamaria/0000-0002-8156-3037; Baldini, Nicola/0000-0003-2228-3833; Bonuccelli, Gloria/0000-0001-7576-5508; Cortini, Margherita/0000-0002-8151-8105	Associazione Italiana Ricerca sul Cancro (AIRC) [15608]; Ministry of Instruction and Education (FIRB) [RBAP10447J]; 5xMille; PRrU Oncologia "Programma di ricerca Regione-Universita"	Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministry of Instruction and Education (FIRB); 5xMille; PRrU Oncologia "Programma di ricerca Regione-Universita"	This study was supported by Associazione Italiana Ricerca sul Cancro (AIRC to NB, no: 15608), by Ministry of Instruction and Education (FIRB to NB, no RBAP10447J), 5xMille 2012 to NB and PRrU Oncologia "Programma di ricerca Regione-Universita 2010-2012" to NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avnet S, 2008, INT J ONCOL, V33, P1231, DOI 10.3892/ijo_00000113; Bergfeld SA, 2010, CANCER METAST REV, V29, P249, DOI 10.1007/s10555-010-9222-7; Bian ZY, 2010, CANCER SCI, V101, P2554, DOI 10.1111/j.1349-7006.2010.01731.x; Bonuccelli G, 2014, ONCOTARGET, V5, P7575, DOI 10.18632/oncotarget.2243; Broadhead Matthew L., 2011, Sarcoma, V2011, P959248, DOI 10.1155/2011/959248; Cormier JN, 2004, CA-CANCER J CLIN, V54, P94, DOI 10.3322/canjclin.54.2.94; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Desiderio V, 2013, J CARCINOGENE MUTAGE, V5; Di DL, 2016, ONCOL REP, V35, P1541, DOI 10.3892/or.2016.4543; Duan Z, 2002, CYTOKINE, V17, P234, DOI 10.1006/cyto.2001.1008; Duperray A, 1997, J BIOL CHEM, V272, P435; FERRACINI R, 1995, ONCOGENE, V10, P739; Fessler E, 2013, CANCER LETT, V341, P97, DOI 10.1016/j.canlet.2012.10.015; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hou CH, 2014, BIOCHEM PHARMACOL, V89, P453, DOI 10.1016/j.bcp.2014.03.010; Hov H, 2009, EUR J HAEMATOL, V82, P277, DOI 10.1111/j.1600-0609.2009.01212.x; Huang WH, 2013, ONCOGENE, V32, P4343, DOI 10.1038/onc.2012.458; Isakoff MS, 2015, J CLIN ONCOL, V33, P3029, DOI 10.1200/JCO.2014.59.4895; Khakoo AY, 2006, J EXP MED, V203, P1235, DOI 10.1084/jem.20051921; Kim SY, 2013, CELL SIGNAL, V25, P961, DOI 10.1016/j.cellsig.2013.01.007; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Korkaya H, 2011, J CLIN INVEST, V121, P3804, DOI 10.1172/JCI57099; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Lemma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149481; Lewis VO, 2007, J BONE JOINT SURG AM, V89A, P1399, DOI 10.2106/JBJS.G.00075; Lim YC, 2014, ORAL ONCOL, V50, P633, DOI 10.1016/j.oraloncology.2014.04.004; Lin YM, 2013, CANCER LETT, V328, P135, DOI 10.1016/j.canlet.2012.08.029; Lo CW, 2011, CANCER RES, V71, P424, DOI 10.1158/0008-5472.CAN-10-1496; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Miekus K, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.199; Patane S, 2006, CANCER RES, V66, P4750, DOI 10.1158/0008-5472.CAN-05-4422; Park GB, 2015, INT J ONCOL, V46, P185, DOI 10.3892/ijo.2014.2721; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Park Tea Soon, 2014, Curr Pathobiol Rep, V2, P41; Perrot P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010999; Postiglione L, 2005, INT J ONCOL, V26, P1193; Salerno M, 2013, INT J ONCOL, V43, P95, DOI 10.3892/ijo.2013.1927; Salvatore V, 2015, ONCOTARGET, V6, P28988, DOI 10.18632/oncotarget.4902; Scotlandi K, 1996, AM J PATHOL, V149, P1209; Skrzypek K, 2015, ONCOTARGET, V6, P31378, DOI 10.18632/oncotarget.5145; Song LB, 2012, J CLIN INVEST, V122, P3563, DOI 10.1172/JCI62339; Szewczyk B, 2017, CURR DRUG TARGETS, V18, P98, DOI 10.2174/1389450117666151209124123; Tang CH, 2011, J BIOL CHEM, V286, P11056, DOI 10.1074/jbc.M110.204081; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; To Y, 2002, AM J RESP CELL MOL, V27, P220, DOI 10.1165/ajrcmb.27.2.4804; Tsou HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053974; Tsukamoto S, 2012, INT J ONCOL, V40, P163, DOI 10.3892/ijo.2011.1220; Tu B, 2014, EXP CELL RES, V320, P164, DOI 10.1016/j.yexcr.2013.10.013; Tu B, 2012, CANCER LETT, V325, P80, DOI 10.1016/j.canlet.2012.06.006; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Walter M, 2009, ONCOGENE, V28, P2745, DOI 10.1038/onc.2009.130; Xiao W, 2013, CLIN SARCOMA RES, V3, DOI 10.1186/2045-3329-3-10; Xu SG, 2014, DNA CELL BIOL, V33, P802, DOI 10.1089/dna.2014.2527; Xu WT, 2009, CANCER LETT, V281, P32, DOI 10.1016/j.canlet.2009.02.022; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Zhang Y, 2015, ONCOTARGET, V7, P446	62	61	62	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166500	10.1371/journal.pone.0166500	http://dx.doi.org/10.1371/journal.pone.0166500			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851822	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300057
J	Machado, DE; Rodrigues-Baptista, KC; Alessandra-Perini, J; de Moura, RS; dos Santos, TA; Pereira, KG; da Silva, YM; Souza, PJC; Nasciutti, LE; Perini, JA				Machado, Daniel Escorsim; Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; de Moura, Roberto Soares; dos Santos, Thiago Alves; Pereira, Kariny Gomes; da Silva, Yasmin Marinho; Cunha Souza, Pergentino Jose; Nasciutti, Luiz Eurico; Perini, Jamila Alessandra			Euterpe oleracea Extract (Acai) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; AMAZONIAN PALM BERRY; MART. ACAI; PHYTOCHEMICAL COMPOSITION; ECTOPIC ENDOMETRIUM; DOWN-REGULATION; IN-VITRO; ANGIOGENESIS; EXPRESSION; CYCLOOXYGENASE-2	This study investigated the therapeutic potential of Euterpe oleracea extract (acai) on the growth and survival of endometriotic lesions using an experimental model. Twenty female Sprague-Dawley rats were randomized into two groups after the implantation and establishment of autologous endometrium onto the peritoneum abdominal wall and treated with 200 mg/kg hydroalcoholic solution extract from acai stone or vehicle via gastric tube for 30 consecutive days. Body weight, lesion surface areas, histological and immunohistochemistry analyses of vascular endothelial growth factor (VEGF), VEGF receptor-2 (VEGFR-2), metalloproteinase-9 (MMP-9), cyclooxygenase-2 (COX-2) and F4-80 were performed. Levels of VEGF, VEGFR-2, MMP-9 and COX-2 mRNA were measured. Flow cytometry of F4-80 was performed, and ELISA immunoassays measured prostaglandin E2 (PGE2), VEGF and nitric oxide (NO) and concentrations. Macrophage cell line J774. G8 was treated with 10, 20, and 40 mu g/mL of acai for 24, 48 and 72 h, and cell viability was measured using 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. Acai treatment significantly decreased the implant size, and histological examination indicated atrophy and regression. A reduction in immunostaining and mRNA expression of VEGF, MMP-9 and COX-2 was observed, and F4-80 was lower in the treated group than the control group. The treated group also exhibited lower concentrations of PGE2, VEGF and NO compared to the control group. Macrophages cells treated with 20 and 40 mu g/ml of Acai reduced cell viability in about 50% after 24, 48 and 72 h. Our results suggest that Acai effectively suppressed the establishment and growth of endometriotic lesions, and this agent is a promising novel pharmacological therapeutic treatment for endometriosis.	[Machado, Daniel Escorsim; Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; dos Santos, Thiago Alves; Pereira, Kariny Gomes; da Silva, Yasmin Marinho; Perini, Jamila Alessandra] Ctr Univ Estadual Zona Oeste, Unidade Farm, Rio De Janeiro, RJ, Brazil; [Rodrigues-Baptista, Karina Cristina; Alessandra-Perini, Jessica; Perini, Jamila Alessandra] Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil; [de Moura, Roberto Soares] Univ Estado Rio De Janeiro, Dept Farmacol & Psicobiol, Rio De Janeiro, RJ, Brazil; [dos Santos, Thiago Alves] Univ Estadual Norte Fluminense, Programa Posgrad Biociencias & Biotecnol, Campos Dos Goytacazes, RJ, Brazil; [Cunha Souza, Pergentino Jose] Fed Univ Para, Dept Farm, Belem, PA, Brazil; [Nasciutti, Luiz Eurico] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, RJ, Brazil	Centro Universitario Estadual da Zona Oeste; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Universidade Estadual do Norte Fluminense; Universidade Federal do Para; Universidade Federal do Rio de Janeiro	Perini, JA (corresponding author), Ctr Univ Estadual Zona Oeste, Unidade Farm, Rio De Janeiro, RJ, Brazil.; Perini, JA (corresponding author), Fundacao Osvaldo Cruz, Escola Nacl Saude Publ, Programa Posgrad Saude Publ & Meio Ambiente, Rio De Janeiro, RJ, Brazil.	jamilaperini@yahoo.com.br		Machado, Daniel/0000-0002-2640-8579	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil [E-26/010.002619/2014, E-26/010.002644/2014]; Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil [E-26/010.002619/2014, E-26/010.002644/2014]	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil	This work was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Riode Janeiro - FAPERJ, Brazil (E-26/010.002619/2014 and E-26/010.002644/2014).; This study was supported by the Brazilian agency Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro-FAPERJ, Brazil (E-26/010.002619/2014 and E-26/010.002644/2014).	Becker CM, 2007, MICROVASC RES, V74, P121, DOI 10.1016/j.mvr.2007.04.008; Becker CM, 2011, AM J PATHOL, V178, P1782, DOI 10.1016/j.ajpath.2010.12.037; Castro MM, 2009, FREE RADICAL BIO MED, V46, P1298, DOI 10.1016/j.freeradbiomed.2009.02.011; Chishima F, 2002, AM J REPROD IMMUNOL, V48, P50, DOI 10.1034/j.1600-0897.2002.01101.x; da Costa CA, 2012, N-S ARCH PHARMACOL, V385, P1199, DOI 10.1007/s00210-012-0798-z; de Moura RS, 2012, PHYTOMEDICINE, V19, P262, DOI 10.1016/j.phymed.2011.11.004; de Moura RS, 2011, FOOD CHEM TOXICOL, V49, P855, DOI 10.1016/j.fct.2010.12.007; de Souza MO, 2012, NUTR RES, V32, P976, DOI 10.1016/j.nutres.2012.10.001; Del Pozo-Insfran D, 2006, J AGR FOOD CHEM, V54, P1222, DOI 10.1021/jf052132n; Del Pozo-Insfran D, 2004, J AGR FOOD CHEM, V52, P1539, DOI 10.1021/jf035189n; Di Carlo C, 2009, FERTIL STERIL, V91, P2315, DOI 10.1016/j.fertnstert.2008.03.079; Ergenoglu AM, 2013, REPROD SCI, V20, P1230, DOI 10.1177/1933719113483014; Fang XX, 2015, EUR J CANCER, V51, P2820, DOI 10.1016/j.ejca.2015.09.010; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Fragoso MF, 2013, FOOD CHEM TOXICOL, V58, P68, DOI 10.1016/j.fct.2013.04.011; GALLE PC, 1989, OBSTET GYN CLIN N AM, V16, P29; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; Gilabert-Estelles J, 2007, HUM REPROD, V22, P2120, DOI 10.1093/humrep/dem149; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Guo SW, 2007, GYNECOL OBSTET INVES, V64, P24, DOI 10.1159/000098413; Heinrich M, 2011, PHYTOCHEM LETT, V4, P10, DOI 10.1016/j.phytol.2010.11.005; Jackson LW, 2005, HUM REPROD, V20, P2014, DOI 10.1093/humrep/dei001; Jana S, 2012, BIOCHEM PHARMACOL, V83, P797, DOI 10.1016/j.bcp.2011.12.030; Jeon SH, 2007, J LEUKOCYTE BIOL, V81, P557, DOI 10.1189/jlb.0806517; Kang J, 2010, FOOD CHEM, V122, P610, DOI 10.1016/j.foodchem.2010.03.020; Kong Sai, 2014, Evid Based Complement Alternat Med, V2014, P146383, DOI 10.1155/2014/146383; Kumar S, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.08.017; Laschke MW, 2008, HUM REPROD, V23, P2308, DOI 10.1093/humrep/den245; Laschke MW, 2007, FERTIL STERIL, V87, P163, DOI 10.1016/j.fertnstert.2006.05.068; Laschke MW, 2007, HUM REPROD UPDATE, V13, P331, DOI 10.1093/humupd/dmm006; Lichtenthaler R, 2005, INT J FOOD SCI NUTR, V56, P53, DOI 10.1080/09637480500082082; Lin YJ, 2006, ENDOCRINOLOGY, V147, P1278, DOI 10.1210/en.2005-0790; Machado DE, 2008, FERTIL STERIL, V90, P148, DOI 10.1016/j.fertnstert.2007.05.076; Machado DE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/751460; Machado DE, 2014, HISTOL HISTOPATHOL, V29, P903, DOI 10.14670/HH-29.903; Machado DE, 2010, FERTIL STERIL, V93, P2674, DOI 10.1016/j.fertnstert.2009.11.037; Marques ES, 2016, FOOD CHEM TOXICOL, V93, P13, DOI 10.1016/j.fct.2016.04.018; Matsuzaki S, 2004, FERTIL STERIL, V82, P1309, DOI 10.1016/j.fertnstert.2004.03.059; McLaren J, 2000, HUM REPROD UPDATE, V6, P45, DOI 10.1093/humupd/6.1.45; Melin A, 2006, HUM REPROD, V21, P1237, DOI 10.1093/humrep/dei462; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Olivares C, 2008, HUM REPROD, V23, P2701, DOI 10.1093/humrep/den315; Ota H, 2001, HUM REPROD, V16, P561, DOI 10.1093/humrep/16.3.561; Pacheco-Palencia LA, 2009, FOOD CHEM, V115, P1199, DOI 10.1016/j.foodchem.2009.01.034; Perini JA, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0745-x; Perini JA, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-117; Podgaec S, 2007, HUM REPROD, V22, P1373, DOI 10.1093/humrep/del516; Poulose SM, 2012, J AGR FOOD CHEM, V60, P1084, DOI 10.1021/jf203989k; Ribeiro JC, 2010, MUTAT RES-GEN TOX EN, V695, P22, DOI 10.1016/j.mrgentox.2009.10.009; Rocha APM, 2007, VASC PHARMACOL, V46, P97, DOI 10.1016/j.vph.2006.08.411; Rodrigues RB, 2006, J AGR FOOD CHEM, V54, P4162, DOI 10.1021/jf058169p; Ruhland B, 2011, Minerva Ginecol, V63, P247; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8604, DOI 10.1021/jf0609779; Schauss AG, 2006, J AGR FOOD CHEM, V54, P8598, DOI 10.1021/jf060976g; Silva DF, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-175; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Stoner GD, 2009, CANCER PREV RES, V2, P187, DOI 10.1158/1940-6207.CAPR-08-0226; Sudo RT, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0724-2; Swarnakar S, 2009, INDIAN J BIOCHEM BIO, V46, P59; Taylor RN, 2004, GYNECOL OBSTET INVES, V57, P54; Tekin YB, 2015, EUR J OBSTET GYN R B, V184, P1, DOI 10.1016/j.ejogrb.2014.10.041; Tosti C, 2015, REPROD SCI, V22, P1053, DOI 10.1177/1933719115592713; VERNON MW, 1985, FERTIL STERIL, V44, P684; Wang CC, 2013, ANGIOGENESIS, V16, P59, DOI 10.1007/s10456-012-9299-4; Wu Meng-Hsing, 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S146239940700021X; Xu H, 2009, HUM REPROD, V24, P608, DOI 10.1093/humrep/den417; Xu H, 2011, FERTIL STERIL, V96, P1021, DOI 10.1016/j.fertnstert.2011.07.008; Zanini S, 2015, CRIT REV FOOD SCI, V55, P1870, DOI 10.1080/10408398.2012.732126; Zhang Y, 2011, INT J MOL MED, V27, P87, DOI 10.3892/ijmm.2010.552	70	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166059	10.1371/journal.pone.0166059	http://dx.doi.org/10.1371/journal.pone.0166059			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851787	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300033
J	Mazzuoli, S; Tricarico, D; Demma, F; Furneri, G; Guglielmi, FW				Mazzuoli, S.; Tricarico, D.; Demma, F.; Furneri, G.; Guglielmi, F. W.			Accelerated Infliximab Infusion: Safety, Factors Predicting Adverse Events, Patients' Satisfaction and Cost Analysis. A Cohort Study in IBD Patients	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; CROHNS-DISEASE; MAINTENANCE THERAPY; TOLERABILITY; DRUG	Background Standard Infliximab infusion consists of a 2-hour intravenous administration. Recently, Infliximab shortened infusion has been included in the Infliximab label as possible maintenance regimen for patients tolerating Infliximab induction therapy. Aim To verify if accelerated 1-hour Infliximab infusions are as safe as standard administrations, in patients with Inflammatory Bowel Disease. Methods Seventy-four patients treated between September 2008 and November 2014 were evaluated. Patients were eligible for 1-hour infusion if they had no history of infusion reactions during the previous 2-hour infusions. Results Twenty-three patients received 2-hour infusions, 16 patients received 1-hour infusions, 35 patients received 2-hour infusions followed by 1-hour infusions. A total of 1,123 Infliximab infusions were administered. The proportion of patients experiencing infusion reaction was: 4% over the 1-hour infusions and 9% over the 2-hour (P = 0.318). Adverse reaction/infusion rate was 0.55% over the 1-hour infusions and 0.66% over the 2-hour (P = 0.835). In the logistic model, accelerated infusion was the only statistically significant predictor of infusion reaction risk reduction (-90%; P = 0.024). Mean satisfaction was 8/10 (0.84) with 1-hour regimen and 6/10 (0.56) with 2-hour infusions (P = 0.000). The mean total cost was reduced by 47% with the 1-hour regimen (133.54 and 250.86 for 1-hour and 2-hour infusions, respectively). Conclusions Accelerated Infliximab infusion does not increase the acute infusion reaction incidence. In patients with inflammatory bowel disease, the 1-hour regimen should be preferred to 2-hour protocol also due to positive effects on indirect costs and patient's satisfaction.	[Mazzuoli, S.; Guglielmi, F. W.] San Nicola Pellegrino Hosp, Gastroenterol & Artificial Dept, Trani, BT, Italy; [Tricarico, D.] Univ Bari Aldo Moro, Dept Pharmacol & Pharmaceut Sci, Bari, Italy; [Demma, F.; Furneri, G.] EBMA Consulting, Hlth Econ & Outcome Res Dept, Milan, Italy	Universita degli Studi di Bari Aldo Moro	Guglielmi, FW (corresponding author), San Nicola Pellegrino Hosp, Gastroenterol & Artificial Dept, Trani, BT, Italy.	guglielmifw@libero.it			Merck	Merck(Merck & Company)	Merck provided funding for the editorial support of this article and to EBMA. The funder provided support in the form of salaries for authors GF and FD but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, REM INFL FULL PRESCR; Babouri A, 2013, J CROHNS COLITIS, V7, P129, DOI 10.1016/j.crohns.2012.03.007; Belhassan M, 2013, CLIN RES HEPATOL GAS, V37, P189, DOI 10.1016/j.clinre.2012.07.004; Breynaert C, 2011, AM J GASTROENTEROL, V106, P778, DOI 10.1038/ajg.2011.61; Cheifetz A, 2003, AM J GASTROENTEROL, V98, P1315, DOI 10.1016/S0002-9270(03)00231-4; Colombo GL, 2003, FARMECONOMIA PERCORS, V4; Doessegger L, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.14; European Medicine Agency, 2015, INFL SUMM PROD CHAR; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; ISTAT, 2015, REV CALC; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Lee TW, 2011, ALIMENT PHARM THER, V34, P181, DOI 10.1111/j.1365-2036.2011.04699.x; Lichtenstein L, 2015, J CROHNS COLITIS, V9, P806, DOI 10.1093/ecco-jcc/jjv096; Urbano PCM, 2014, BIOL-TARGETS THER, V8, P211, DOI 10.2147/BTT.S57253; Mazzuoli S, 2013, DIGEST LIVER DIS, V45, P969, DOI 10.1016/j.dld.2013.06.010; National Coordination of chronic patients Associations, 2014, DIAGN MED ASS PATW C; Neef HC, 2013, ALIMENT PHARM THER, V38, P365, DOI 10.1111/apt.12389; OECD, 2014, AV SAL; Ollendorf Daniel A, 2006, Am J Ther, V13, P502, DOI 10.1097/01.mjt.0000245223.43783.45; Rutgeerts P, 2005, NEW ENGL J MED, V353, P2462, DOI 10.1056/NEJMoa050516; Saxena P, 2014, EXPERT OPIN BIOL TH, V14, P277, DOI 10.1517/14712598.2014.866649; Van Assche G, 2010, J CROHNS COLITIS, V4, P329, DOI 10.1016/j.crohns.2009.12.012; Vermeire S, 2007, GUT, V56, P1226, DOI 10.1136/gut.2006.099978; Wong BJ, 2011, J MANAGE CARE PHARM, V17, P313	25	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166443	10.1371/journal.pone.0166443	http://dx.doi.org/10.1371/journal.pone.0166443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851772	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300049
J	Jebena, MG; Lindstrom, D; Belachew, T; Hadley, C; Lachat, C; Verstraeten, R; De Cock, N; Kolsteren, P				Jebena, Mulusew G.; Lindstrom, David; Belachew, Tefera; Hadley, Craig; Lachat, Carl; Verstraeten, Roos; De Cock, Nathalie; Kolsteren, Patrick			Food Insecurity and Common Mental Disorders among Ethiopian Youth: Structural Equation Modeling	PLOS ONE			English	Article							SELF-REPORTING QUESTIONNAIRE; FREQUENCY QUESTIONNAIRE; MEDIATION ANALYSIS; FAMILY INCOME; JIMMA ZONE; HEALTH; INSUFFICIENCY; VALIDATION; DEPRESSION; VALIDITY	Background Although the consequences of food insecurity on physical health and nutritional status of youth living have been reported, its effect on their mental health remains less investigated in developing countries. The aim of this study was to examine the pathways through which food insecurity is associated with poor mental health status among youth living in Ethiopia. Methods We used data from Jimma Longitudinal Family Survey of Youth (JLFSY) collected in 2009/ 10. A total of 1,521 youth were included in the analysis. We measured food insecurity using a 5-items scale and common mental disorders using the 20-item Self-Reporting Questionnaire (SRQ-20). Structural and generalized equation modeling using maximum likelihood estimation method was used to analyze the data. Results The prevalence of common mental disorders was 30.8% (95% CI: 28.6, 33.2). Food insecurity was independently associated with common mental disorders (beta = 0.323, P<0.05). Most (91.8%) of the effect of food insecurity on common mental disorders was direct and only 8.2% of their relationship was partially mediated by physical health. In addition, poor self-rated health (beta = 0.285, P< 0.05), high socioeconomic status (beta = -0.076, P< 0.05), parental education (beta = 0.183, P< 0.05), living in urban area (beta=0.139, P< 0.05), and female-headed household (beta = 0.192, P< 0.05) were associated with common mental disorders. Conclusions Food insecurity is directly associated with common mental disorders among youth in Ethiopia. Interventions that aim to improve mental health status of youth should consider strategies to improve access to sufficient, safe and nutritious food.	[Jebena, Mulusew G.; Belachew, Tefera] Jimma Univ, Populat & Family Hlth, Jimma, Ethiopia; [Lindstrom, David] Brown Univ, Dept Sociol, Providence, RI 02912 USA; [Hadley, Craig] Emory Univ, Dept Anthropol, Atlanta, GA 30322 USA; [Jebena, Mulusew G.; Lachat, Carl; De Cock, Nathalie; Kolsteren, Patrick] Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium; [Verstraeten, Roos] Inst Trop Med, Dept Publ Hlth, Nutr & Child Hlth Unit, Antwerp, Belgium	Jimma University; Brown University; Emory University; Ghent University; Institute of Tropical Medicine (ITM)	Jebena, MG (corresponding author), Jimma Univ, Populat & Family Hlth, Jimma, Ethiopia.; Jebena, MG (corresponding author), Univ Ghent, Dept Food Safety & Food Qual, Ghent, Belgium.	mulusew.gerbaba@gmail.com	lachat, carl/AAH-9764-2020; Belachew, Tefera/AAO-5877-2020	lachat, carl/0000-0002-1389-8855; Gerbaba, Mulusew/0000-0002-0383-7012	Packard Foundation; Campton Foundation; National Institutes of Health; National Science Foundation (NSF Grant) [0717608]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD041020] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); Campton Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF Grant)(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Packard Foundation, Campton Foundation, the National Institutes of Health, and the National Science Foundation (NSF Grant #0717608). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidoo M, 2001, HEALTH POLICY PLANN, V16, P206, DOI 10.1093/heapol/16.2.206; Alaimo K, 2002, J NUTR, V132, P719, DOI 10.1093/jn/132.4.719; Alaimo K, 2001, PEDIATRICS, V108, P44; Alaimo K, 2001, AM J PUBLIC HEALTH, V91, P781, DOI 10.2105/AJPH.91.5.781; Alemu WG, 2013, PREVALENCE ASS FACTO, V2, P43; Allen J, 2014, INT REV PSYCHIATR, V26, P392, DOI 10.3109/09540261.2014.928270; Almeida Alessandro de Moura, 2007, J. bras. psiquiatr., V56, P245, DOI 10.1590/S0047-20852007000400002; Ashiabi GS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000940; Ashiabi GS, 2007, IS HOUSEHOLD FOOD IN, V5, P76; Belachew T, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-55; Belachew T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057643; Belachew T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-604; Belachew T, 2011, PEDIATRICS, V127, pE398, DOI 10.1542/peds.2010-0944; Belachew T, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-29; Beusenberg M, 1994, USERS GUIDE SELF REP; Bhattacharya J, 2004, J HEALTH ECON, V23, P839, DOI 10.1016/j.jhealeco.2003.12.008; Bronte-Tinkew J, 2007, J NUTR, V137, P2160, DOI 10.1093/jn/137.9.2160; CAMPBELL CC, 1991, J NUTR, V121, P408, DOI 10.1093/jn/121.3.408; Carta MG, 2000, PSYCHOPATHOLOGY, V33, P240, DOI 10.1159/000029152; Carter KN, 2009, J EPIDEMIOL COMMUN H, V63, P221, DOI 10.1136/jech.2008.079483; Cheng Y, 2008, ASIA PAC J CLIN NUTR, V17, P166; Chilton M, 2009, AM J PUBLIC HEALTH, V99, P556, DOI 10.2105/AJPH.2008.144394; Coates J, 2006, J NUTR, V136, P1438, DOI 10.1093/jn/136.5.1438S; Cole SM, 2011, SOC SCI MED, V73, P1071, DOI 10.1016/j.socscimed.2011.07.012; Collins L., 2009, J ASS RES MOTHERING, V11, P251; Cook JT, 2004, J NUTR, V134, P1432; Dachew BA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119464; Damena T, 2011, ETHIOP J HEALTH SCI, V21, P37; Dessie Y, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.95.2173; Fao, STAT FOOD INS WORLD2; Fekadu A, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-194; Fernandes AC, 2013, SOC PSYCH PSYCH EPID, V48, P515, DOI 10.1007/s00127-012-0614-6; Gelaye Bizu, 2012, Clin Pract Epidemiol Ment Health, V8, P126, DOI 10.2174/1745017901208010126; Giang KB, 2006, INT J SOC PSYCHIATR, V52, P175, DOI 10.1177/0020764006061251; Gunzler Douglas, 2013, Shanghai Arch Psychiatry, V25, P390, DOI 10.3969/j.issn.1002-0829.2013.06.009; Hackett M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-175; Hadley C, 2008, J EPIDEMIOL COMMUN H, V62, P980, DOI 10.1136/jech.2007.068460; Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025; Hadley C, 2007, PUBLIC HEALTH NUTR, V10, P544, DOI 10.1017/S1368980007246725; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Harpham T, 2005, BRIT J PSYCHIAT, V187, P161, DOI 10.1192/bjp.187.2.161; Harpham T, 2003, HEALTH POLICY PLANN, V18, P344, DOI 10.1093/heapol/czg041; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heflin CM, 2005, SOC SCI MED, V61, P1971, DOI 10.1016/j.socscimed.2005.04.014; Huang J, 2010, SOC SERV REV, V84, P381, DOI 10.1086/655821; Jacka FN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024805; Jackson MD, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-28; Jacob KS, 2014, LANCET, V383, P1433, DOI 10.1016/S0140-6736(13)62382-X; Johnson JG, 1999, J ABNORM PSYCHOL, V108, P490, DOI 10.1037/0021-843X.108.3.490; Jyoti DF, 2005, J NUTR, V135, P2831, DOI 10.1093/jn/135.12.2831; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Kulkarni AA, 2015, EUR J CLIN NUTR, V69, P79, DOI 10.1038/ejcn.2014.130; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Liu L, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-49; Lund C, 2014, SOC SCI MED, V111, P134, DOI 10.1016/j.socscimed.2014.04.010; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Marques-Vidal P, 2011, FOOD NUTR RES, V55, DOI 10.3402/fnr.v55i0.5905; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Oddy WH, 2009, PREV MED, V49, P39, DOI 10.1016/j.ypmed.2009.05.009; Olson CM, 1999, J NUTR, V129, p504S, DOI 10.1093/jn/129.2.504S; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2008, J CHILD PSYCHOL PSYC, V49, P313, DOI 10.1111/j.1469-7610.2007.01824.x; Psid ID, 2010, DOES HOUSEHOLD FOOD; Quizan T, 2007, FASEB J, V21, pA312; Rose D, 1997, AM J PUBLIC HEALTH, V87, P1956, DOI 10.2105/AJPH.87.12.1956; Roustit C, 2010, EUR CHILD ADOLES PSY, V19, P597, DOI 10.1007/s00787-010-0094-8; Rucker DD, 2011, SOC PERSONAL PSYCHOL, V5, P359, DOI 10.1111/j.1751-9004.2011.00355.x; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-208; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573; Siefert K, 2004, J HEALTH SOC BEHAV, V45, P171, DOI 10.1177/002214650404500204; Solar O, 2010, CONCEPTUAL FRAMEWORK, P79; Sorsdahl K, 2011, J EPIDEMIOL COMMUN H, V65, P426, DOI 10.1136/jech.2009.091462; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Tampubolon G, 2014, SOC SCI MED, V106, P20, DOI 10.1016/j.socscimed.2014.01.012; Tarasuk V, 2007, J NUTR, V137, P1980, DOI 10.1093/jn/137.8.1980; Tarasuk V, 2013, J NUTR, V143, P1785, DOI 10.3945/jn.113.178483; Tesfaye A, 2009, PREVALENCE CORRELATE, P85; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Vozoris NT, 2003, J NUTR, V133, P120, DOI 10.1093/jn/133.1.120; Weaver LJ, 2009, ECOL FOOD NUTR, V48, P263, DOI 10.1080/03670240903001167; Webb Patrick, 2006, J Nutr, V136, p1404S; Weinreb L, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e41; World Health Organization N, 2008, GLOB BURD DIS 2004 U, V2010, P146	84	23	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165931	10.1371/journal.pone.0165931	http://dx.doi.org/10.1371/journal.pone.0165931			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0MG	27846283	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600023
J	Sonderegger, K; Tschopp, M; Taube, W				Sonderegger, Karin; Tschopp, Markus; Taube, Wolfgang			The Challenge of Evaluating the Intensity of Short Actions in Soccer: A New Methodological Approach Using Percentage Acceleration	PLOS ONE			English	Article							LOCAL POSITION MEASUREMENT; SPEED; PLAYERS; SYSTEM; LPM; PROFILES; ACCURACY	Purpose There are several approaches to quantifying physical load in team sports using positional data. Distances in different speed zones are most commonly used. Recent studies have used acceleration data in addition in order to take short intense actions into account. However, the fact that acceleration decreases with increasing initial running speed is ignored and therefore introduces a bias. The aim of our study was to develop a new methodological approach that removes this bias. For this purpose, percentage acceleration was calculated as the ratio of the maximal acceleration of the action (a(max, action)) and the maximal voluntary acceleration (a(max)) that can be achieved for a particular initial running speed (percentage acceleration [%] = a(max, action) /a(max) * 100). Methods To define a(max), seventy-two highly trained junior male soccer players (17.1 +/- 0.6 years) completed maximal sprints from standing and three different constant initial running speeds (vinit; trotting: similar to 6.0 km .h(-1); jogging: similar to 10.8 km.h(-1); running: similar to 15.0 km.h(-1)). Results The a(max) was 6.01 +/- 0.55 from a standing start, 4.33 +/- 0.40 from trotting, 3.20 +/- 0.49 from jogging and 2.29 +/- 0.34 m.s(-2) from running. The amax correlated significantly with v(init) (r = -0.98) and the linear regression equation of highly-trained junior soccer players was: a(max) = -0.23 * v(init) + 5.99. Conclusion Using linear regression analysis, we propose to classify high-intensity actions as accelerations > 75% of the a(max), corresponding to acceleration values for our population of > 4.51 initiated from standing, > 3.25 from trotting, > 2.40 from jogging, and > 1.72 m.s(-2) from running. The use of percentage acceleration avoids the bias of underestimating actions with high and overestimating actions with low initial running speed. Furthermore, percentage acceleration allows determining individual intensity thresholds that are specific for one population or one single player.	[Sonderegger, Karin; Tschopp, Markus] SFISM, Sect Elite Sport, Magglingen, Switzerland; [Sonderegger, Karin; Taube, Wolfgang] Univ Fribourg, Dept Med Movement & Sport Sci, Fribourg, Switzerland	University of Fribourg	Sonderegger, K (corresponding author), SFISM, Sect Elite Sport, Magglingen, Switzerland.; Sonderegger, K (corresponding author), Univ Fribourg, Dept Med Movement & Sport Sci, Fribourg, Switzerland.	karin.sonderegger@baspo.admin.ch	Taube, Wolfgang/E-4018-2012	Taube, Wolfgang/0000-0002-8802-2065				Akenhead R, 2013, J SCI MED SPORT, V16, P556, DOI 10.1016/j.jsams.2012.12.005; Arsac LM, 2002, J APPL PHYSIOL, V92, P1781, DOI 10.1152/japplphysiol.00754.2001; Aughey RJ, 2011, INT J SPORT PHYSIOL, V6, P367, DOI 10.1123/ijspp.6.3.367; Aughey RJ, 2010, INT J SPORT PHYSIOL, V5, P394, DOI 10.1123/ijspp.5.3.394; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Buchheit M, 2014, J SPORT SCI, V32, P1271, DOI 10.1080/02640414.2014.884721; Buchheit M, 2012, INT J SPORT PHYSIOL, V7, P76, DOI 10.1123/ijspp.7.1.76; Cohen J.E., 1988, STAT POWER ANAL BEHA; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Duthie GM, 2006, J STRENGTH COND RES, V20, P208, DOI 10.1519/R-16784.1; Dwyer DB, 2012, J STRENGTH COND RES, V26, P818, DOI 10.1519/JSC.0b013e3182276555; Frencken WGP, 2010, J SCI MED SPORT, V13, P641, DOI 10.1016/j.jsams.2010.04.003; Gaudino P, 2013, INT J SPORTS MED, V34, P963, DOI 10.1055/s-0033-1337943; Haugen TA, 2014, INT J SPORT PHYSIOL, V9, P432, DOI [10.1123/IJSPP.2013-0121, 10.1123/ijspp.2013-0121]; Hodgson C, 2014, HUM MOVEMENT SCI, V33, P25, DOI 10.1016/j.humov.2013.12.002; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; McFarlane B. A, 1993, NATL STR COND ASS J, V15, P57; Ogris G, 2012, J SPORT SCI, V30, P1503, DOI 10.1080/02640414.2012.712712; Osgnach C, 2010, MED SCI SPORT EXER, V42, P170, DOI 10.1249/MSS.0b013e3181ae5cfd; Stelzer A, 2004, IEEE T MICROW THEORY, V52, P2664, DOI 10.1109/TMTT.2004.838281; Stevens TGA, 2014, INT J SPORT PHYSIOL, V9, P446, DOI [10.1123/IJSPP.2013-0340, 10.1123/ijspp.2013-0340]; Varley MC, 2013, INT J SPORTS MED, V34, P34, DOI 10.1055/s-0032-1316315; Young W, 2001, STRENGTH COND J, V23, P7, DOI 10.1519/1533-4295(2001)023<0007:RTFSSA>2.0.CO;2	24	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166534	10.1371/journal.pone.0166534	http://dx.doi.org/10.1371/journal.pone.0166534			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846308	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600079
J	Heo, SK; Noh, EK; Gwon, GD; Kim, JY; Joe, JC; Choi, Y; Kohl, S; Baek, JH; Min, YJ; Kim, H				Heo, Sook-Kyoung; Noh, Eui-Kyu; Gwon, Gi-Dong; Kim, Jeong Yi; Joe, Jae-Cheol; Choi, Yunsuk; Kohl, SuJin; Baek, Jin Ho; Min, Young Joo; Kim, Hawk			LIGHT (TNFSF14) Increases the Survival and Proliferation of Human Bone Marrow-Derived Mesenchymal Stem Cells	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; AMYOTROPHIC-LATERAL-SCLEROSIS; SOLUBLE DECOY RECEPTOR-3; VIRUS ENTRY MEDIATOR; STROMAL CELLS; METHODOLOGICAL APPROACH; CO-STIMULATION; TRANSPLANTATION; LYMPHOTOXIN/LIGHT; THERAPY	LIGHT (HVEM-L, TNFSF14, or CD258), an entity homologous to lymphotoxins, with inducible nature and the ability to compete with herpes simplex virus glycoprotein D for herpes virus entry mediator (HVEM)/tumor necrosis factor (TNF)-related 2, is a member of the TNF superfamily. It is expressed as a homotrimer on activated T cells and dendritic cells (DCs), and has three receptors: HVEM, LT-beta receptor (LT beta R), and decoy receptor 3 (DcR3). So far, three receptors with distinct cellular expression patterns are known to interact with LIGHT. Follicular DCs and stromal cells bind LIGHT through LT beta R. We monitored the effects of LIGHT on human bone marrow-derived mesenchymal stem cells (BM-MSCs). At first, we checked the negative and positive differentiation markers of BM-MSCs. And we confirmed the quality of MSCs by staining cells undergoing adipogenesis (Oil Red O staining), chondrogenesis (Alcian blue staining), and osteogenesis (Alizarin red staining). After rhLIGHT treatment, we monitored the count, viability, and proliferation of cells and cell cycle distribution. PDGF and TGF beta production by rhLIGHT was examined by ELISA, and the underlying biological mechanisms were studied by immunoblotting by rhLIGHT treatment. LT beta R was constitutively expressed on the surface of human BM-MSCs. Cell number and viability increased after rhLIGHT treatment. BM-MSC proliferation was induced by an increase in the S/G2/M phase. The expression of not only diverse cyclins such as cyclin B1, D1, D3, and E, but also CDK1 and CDK2, increased, while that of p27 decreased, after rhLIGHT treatment. RhLIGHT-induced PDGF and TGF beta production mediated by STAT3 and Smad3 activation accelerated BM-MSC proliferation. Thus, LIGHT and LT beta R interaction increases the survival and proliferation of human BM-MSCs, and therefore, LIGHT might play an important role in stem cell therapy.	[Heo, Sook-Kyoung; Gwon, Gi-Dong; Kim, Jeong Yi; Kim, Hawk] Univ Ulsan, Coll Med, Biomed Res Ctr, Ulsan Univ Hosp, Ulsan 682060, South Korea; [Noh, Eui-Kyu; Joe, Jae-Cheol; Choi, Yunsuk; Kohl, SuJin; Baek, Jin Ho; Min, Young Joo; Kim, Hawk] Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan 682714, South Korea	University of Ulsan; Ulsan University Hospital; University of Ulsan; Ulsan University Hospital	Kim, H (corresponding author), Univ Ulsan, Coll Med, Biomed Res Ctr, Ulsan Univ Hosp, Ulsan 682060, South Korea.; Kim, H (corresponding author), Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan 682714, South Korea.	kimhawkmd@gmail.com		Choi, Yunsuk/0000-0002-7983-8089	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2009-0094050]; Basic Science Research Program through the NRF - Ministry of Education [NRF-2014R1A1A3051393]; Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital [UUHBRC-2016-001]	Priority Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Basic Science Research Program through the NRF - Ministry of Education; Basic Science Research Program through the Biomedical Research Center - Ulsan University Hospital	This work was supported by the Priority Research Center Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education, Science and Technology (2009-0094050), and by the Basic Science Research Program through the NRF, funded by the Ministry of Education (NRF-2014R1A1A3051393). This research was supported by Basic Science Research Program through the Biomedical Research Center, funded by the Ulsan University Hospital (UUHBRC-2016-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; Bamias G, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/2637010; Brunetti G, 2014, ONCOTARGET, V5, P12950, DOI 10.18632/oncotarget.2633; Chang PMH, 2008, INT J ONCOL, V33, P549, DOI 10.3892/ijo_00000039; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Colucci S, 2009, LEUKEMIA, V23, P2139, DOI 10.1038/leu.2009.136; De Miguel MP, 2012, CURR MOL MED, V12, P574; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Heo SK, 2006, J LEUKOCYTE BIOL, V79, P330, DOI 10.1189/jlb.1104694; Heo SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129853; Heo SK, 2012, EXP MOL MED, V44, P149, DOI 10.3858/emm.2012.44.2.010; Hikita A, 2009, BIOCHEM CELL BIOL, V87, P581, DOI [10.1139/O09-015, 10.1139/o09-015]; Horwitz EM, 2002, P NATL ACAD SCI USA, V99, P8932, DOI 10.1073/pnas.132252399; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jung HW, 2003, EXP MOL MED, V35, P501, DOI 10.1038/emm.2003.65; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lin WW, 2011, BIOCHEM PHARMACOL, V81, P838, DOI 10.1016/j.bcp.2011.01.011; Liu CX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-114; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lu TT, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00047; Martinez HR, 2012, CELL TRANSPLANT, V21, P1899, DOI 10.3727/096368911X582769; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Mazzini L, 2003, AMYOTROPH LATERAL SC, V4, P158, DOI 10.1080/14660820310014653; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Najar M, 2016, J IMMUNOTHER, V39, P45, DOI 10.1097/CJI.0000000000000108; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Nicolay NH, 2015, CANCER LETT, V366, P133, DOI 10.1016/j.canlet.2015.06.012; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Si YL, 2011, AGEING RES REV, V10, P93, DOI 10.1016/j.arr.2010.08.005; Song H, 2010, EXPERT OPIN BIOL TH, V10, P309, DOI 10.1517/14712590903455997; Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1; Suk KT, 2016, HEPATOLOGY; Tamada K, 2000, NAT MED, V6, P283; van der Garde M, 2015, STEM CELLS DEV, V24, P2649, DOI 10.1089/scd.2015.0138; Wang J, 2004, IMMUNOL RES, V30, P201, DOI 10.1385/IR:30:2:201; WONG ST, 1989, CELL, V56, P495, DOI 10.1016/0092-8674(89)90252-3	43	15	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166589	10.1371/journal.pone.0166589	http://dx.doi.org/10.1371/journal.pone.0166589			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835685	gold, Green Submitted, Green Published			2022-12-26	WOS:000387779200062
J	Nora, S; Aparicio, A; Albaladejo, RG				Nora, Sofia; Aparicio, Abelardo; Albaladejo, Rafael G.			High Correlated Paternity Leads to Negative Effects on Progeny Performance in Two Mediterranean Shrub Species	PLOS ONE			English	Article							ECOLOGICAL MATERNAL NEIGHBORHOOD; LIFE-HISTORY TRAITS; PISTACIA-LENTISCUS; MATING PATTERNS; MYRTUS-COMMUNIS; FRAGMENTED LANDSCAPES; HABITAT FRAGMENTATION; GENETIC DIVERSITY; POLLEN LIMITATION; DISPERSAL	Anthropogenic habitat deterioration can promote changes in plant mating systems that subsequently may affect progeny performance, thereby conditioning plant recruitment for the next generation. However, very few studies yet tested mating system parameters other than outcrossing rates; and the direct effects of the genetic diversity of the pollen received by maternal plants (i.e. correlated paternity) has often been overlooked. In this study, we investigated the relation between correlated paternity and progeny performance in two common Mediterranean shrubs, Myrtus communis and Pistacia lentiscus. To do so, we collected open-pollinated progeny from selected maternal plants, calculated mating system parameters using microsatellite genotyping and conducted sowing experiments under greenhouse and field conditions. Our results showed that some progeny fitness components were negatively affected by the high correlated paternity of maternal plants. In Myrtus communis, high correlated paternity had a negative effect on the proportion and timing of seedling emergence in the natural field conditions and in the greenhouse sowing experiment, respectively. In Pistacia lentiscus, seedling emergence time under field conditions was also negatively influenced by high correlated paternity and a progeny survival analysis in the field experiment showed greater mortality of seedlings from maternal plants with high correlated paternity. Overall, we found effects of correlated paternity on the progeny performance of Myrtus communis, a self-compatible species. Further, we also detected effects of correlated paternity on the progeny emergence time and survival in Pistacia lentiscus, an obligate out-crossed species. This study represents one of the few existing empirical examples which highlight the influence that correlated paternity may exert on progeny performance in multiple stages during early seedling growth.	[Nora, Sofia; Aparicio, Abelardo; Albaladejo, Rafael G.] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	University of Sevilla	Nora, S (corresponding author), Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain.	sofianora@us.es	Albaladejo, Rafael G/K-2204-2014	Albaladejo, Rafael G/0000-0003-2101-5204	Spanish Ministerio de Ciencia en Innovacion [CGL2008-00938, CGL2011-23721]; pre-doctoral FPI studentship [BES-2009-026244]	Spanish Ministerio de Ciencia en Innovacion; pre-doctoral FPI studentship	This study was funded by projects from the Spanish Ministerio de Ciencia en Innovacion (CGL2008-00938 and CGL2011-23721) and by a pre-doctoral FPI studentship for S.N. (BES-2009-026244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo RG, 2008, MOL ECOL RESOUR, V8, P904, DOI 10.1111/j.1755-0998.2008.02110.x; Albaladejo RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049012; Albaladejo RG, 2010, AM J BOT, V97, pE23, DOI 10.3732/ajb.1000060; Albaladejo RG, 2009, MOL ECOL, V18, P5195, DOI 10.1111/j.1365-294X.2009.04415.x; Aparicio A, 2008, BIODIVERS CONSERV, V17, P2219, DOI 10.1007/s10531-007-9295-y; Aparicio JM, 2006, MOL ECOL, V15, P4659, DOI 10.1111/j.1365-294X.2006.03111.x; Armbruster WS, 2004, AM J BOT, V91, P1939, DOI 10.3732/ajb.91.11.1939; Breed MF, 2015, HEREDITY, V115, P100, DOI 10.1038/hdy.2012.72; Breed MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090478; Breed MF, 2012, MOL ECOL, V21, P5955, DOI 10.1111/mec.12056; Breed MF, 2012, ECOL LETT, V15, P444, DOI 10.1111/j.1461-0248.2012.01752.x; Byrne M, 2007, MOL ECOL, V16, P1303, DOI 10.1111/j.1365-294X.2006.03204.x; Coates DJ, 2007, AUST J BOT, V55, P239, DOI 10.1071/BT06142; Coulon A, 2010, MOL ECOL RESOUR, V10, P167, DOI 10.1111/j.1755-0998.2009.02731.x; COX DR, 1972, J R STAT SOC B, V34, P187; De-Lucas AI, 2008, HEREDITY, V100, P390, DOI 10.1038/sj.hdy.6801090; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Eckert CG, 2010, TRENDS ECOL EVOL, V25, P35, DOI 10.1016/j.tree.2009.06.013; Franceschinelli EV, 2000, HEREDITY, V84, P116, DOI 10.1046/j.1365-2540.2000.00636.x; Garcia C, 2005, MOL ECOL, V14, P1821, DOI 10.1111/j.1365-294X.2005.02542.x; Garcia-Fayos P, 1998, ACTA OECOL, V19, P357, DOI 10.1016/S1146-609X(98)80040-4; Ghazoul J, 2005, BIOL REV, V80, P413, DOI 10.1017/S1464793105006731; Gomez-Aparicio L, 2008, J ECOL, V96, P1128, DOI 10.1111/j.1365-2745.2008.01431.x; Gonzalez-Varo JP, 2012, PERSPECT PLANT ECOL, V14, P111, DOI 10.1016/j.ppees.2011.11.002; Gonzalez-Varo JP, 2010, ANN BOT-LONDON, V106, P999, DOI 10.1093/aob/mcq200; Gonzalez-Varo JP, 2010, J APPL ECOL, V47, P1242, DOI 10.1111/j.1365-2664.2010.01879.x; Gonzalez-Varo JP, 2010, ECOGRAPHY, V33, P185, DOI 10.1111/j.1600-0587.2009.06021.x; Gonzalez-Varo JP, 2009, PLANT ECOL, V203, P207, DOI 10.1007/s11258-008-9534-7; Gonzalez-Varo JP, 2009, BIOL CONSERV, V142, P1058, DOI 10.1016/j.biocon.2009.01.017; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hardy OJ, 2004, GENETICS, V168, P1601, DOI 10.1534/genetics.104.027714; HERRERA CM, 1994, ECOL MONOGR, V64, P315, DOI 10.2307/2937165; IZHAKI I, 1991, J ECOL, V79, P575, DOI 10.2307/2260654; JORDANO P, 1989, OIKOS, V55, P375, DOI 10.2307/3565598; JORDANO P, 1988, Anales del Jardin Botanico de Madrid, V45, P213; Kleinbaum DG, 1996, SURVIVAL ANAL SELF L; Llorens TM, 2013, MOL ECOL, V164, P129, DOI 10.1016/ j. biocon. 2013.05.011; Lowe AJ, 2005, HEREDITY, V95, P255, DOI 10.1038/sj.hdy.6800725; Mimura M, 2009, MOL ECOL, V18, P4180, DOI 10.1111/j.1365-294X.2009.04350.x; Neal PR, 2005, PLANT SYST EVOL, V250, P173, DOI 10.1007/s00606-004-0229-9; Nora S, 2015, PLANT BIOLOGY, V17, P311, DOI 10.1111/plb.12242; Oddou-Muratorio S, 2006, AM J BOT, V93, P1650, DOI 10.3732/ajb.93.11.1650; Pannell JR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0051; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Rocha OJ, 2001, AM J BOT, V88, P1600, DOI 10.2307/3558404; Skogsmyr I, 2002, BIOL REV, V77, P537, DOI 10.1017/S1464793102005973; Traveset A, 2003, J ECOL, V91, P427, DOI 10.1046/j.1365-2745.2003.00780.x; Valbuena-Carabana M, 2010, REV PALAEOBOT PALYNO, V162, P492, DOI 10.1016/j.revpalbo.2009.11.003; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Verdu M, 2005, ECOLOGY, V86, P1385, DOI 10.1890/04-1647; Verdu M, 2002, REV CHIL HIST NAT, V75, P57; Verdu M, 2006, EVOLUTION, V60, P2056, DOI 10.1111/j.0014-3820.2006.tb01843.x; Yasui Y, 1998, TRENDS ECOL EVOL, V13, P246, DOI 10.1016/S0169-5347(98)01383-4	54	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166023	10.1371/journal.pone.0166023	http://dx.doi.org/10.1371/journal.pone.0166023			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835658	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200020
J	de Beer, M; Vrijkotte, TGM; Fall, CHD; van Eijsden, M; Osmond, C; Gemke, RJBJ				de Beer, Marieke; Vrijkotte, Tanja G. M.; Fall, Caroline H. D.; van Eijsden, Manon; Osmond, Clive; Gemke, Reinoud J. B. J.			Associations of Infant Feeding and Timing of Weight Gain and Linear Growth during Early Life with Childhood Blood Pressure: Findings from a Prospective Population Based Cohort Study	PLOS ONE			English	Article							POSTNATAL-GROWTH; YOUNG ADULTHOOD; BIRTH-WEIGHT; RISK-FACTORS; CHILDREN; HEIGHT; HEALTH; INCOME; AGE; HYPERTENSION	Objective Small birth size and rapid postnatal growth have been associated with higher future blood pressure. The timing of these effects, the relative importance of weight gain and linear growth and the role of infant feeding need to be clarified. Methods We assessed how blood pressure relates to birth weight, infant and childhood growth and infant feeding (duration of exclusive breastfeeding and timing of introduction of complementary feeding) in 2227 children aged 5 years from a prospective cohort study (Amsterdam Born Children and their Development). Postnatal growth was represented by statistically independent measures of relative weight gain (weight gain independent of height) and linear growth in four age periods during infancy (0-1 month; 1-3 months; 3-6 months; 6-12 months) and from 12 months to 5 years. Results Lower birth weight was associated with higher childhood diastolic blood pressure (-0.38 mm Hg.SD-1; P = 0.007). Faster relative weight gain and linear growth after 1 month were positively associated with systolic and diastolic blood pressure. Associations of linear growth with systolic blood pressure ranged from 0.47 to 1.49 mm Hg.SD-1; P< 0.01 for all. Coefficients were similar for different periods of infancy and also for relative weight gain and linear growth. Compared to breastfeeding < 1 month, breastfeeding > 1 month was associated with lower blood pressure (e.g. > 6 months -1.56 mm Hg systolic blood pressure; P<0.001). Compared to > 6 months, introduction of complementary feeding < 6 months was associated with higher blood pressure (e.g. 4-6 months 0.91 mm Hg systolic blood pressure; P = 0.004). Conclusions After the age of one month faster growth in either weight or height is associated with higher childhood blood pressure. It is unknown whether faster weight gain and linear growth carry the same risk for adult hypertension and cardiovascular morbidity. Longer breastfeeding and delayed introduction of complementary feeding may be associated with lower adult blood pressure.	[de Beer, Marieke; Gemke, Reinoud J. B. J.] Vrije Univ Amsterdam, Dept Pediat, Med Ctr, Amsterdam, Netherlands; [Vrijkotte, Tanja G. M.] Univ Amsterdam, Acad Med Ctr, Dept Social Med, Amsterdam, Netherlands; [Fall, Caroline H. D.; Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [van Eijsden, Manon] Publ Hlth Serv, Dept Epidemiol Documentat & Hlth Promot, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Southampton; Public Health Service Amsterdam	de Beer, M (corresponding author), Vrije Univ Amsterdam, Dept Pediat, Med Ctr, Amsterdam, Netherlands.	m.debeer@vumc.nl		Vrijkotte, Tanja/0000-0003-3641-4048	Netherlands Organisation for Health Research and Development [92003489]; Medical Research Council [MC_UU_12011/3, MC_UP_A620_1016, U1475000003] Funding Source: researchfish; MRC [MC_UU_12011/3, MC_UP_A620_1016] Funding Source: UKRI	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Netherlands Organisation for Health Research and Development (http://www.zonmw.nl), Grand nr: 92003489, MDB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adair LS, 2009, AM J CLIN NUTR, V89, P1383, DOI 10.3945/ajcn.2008.27139; Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; Ben-Shlomo Y, 2008, HYPERTENSION, V52, P638, DOI 10.1161/HYPERTENSIONAHA.108.114256; Brion MJA, 2011, INT J EPIDEMIOL, V40, P670, DOI 10.1093/ije/dyr020; Chen XL, 2008, CIRCULATION, V117, P3171, DOI 10.1161/CIRCULATIONAHA.107.730366; Chiolero A, 2014, AM J EPIDEMIOL, V179, P4, DOI 10.1093/aje/kwt228; de Beer M, 2015, INT J OBESITY, V39, P586, DOI 10.1038/ijo.2014.200; de Beer M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-23; de Jonge LL, 2013, J NUTR, V143, P1959, DOI 10.3945/jn.113.174326; de Onis M, 2003, ACTA PAEDIATR, V92, P413, DOI 10.1111/j.1651-2227.2003.tb00570.x; Dotsch J, 2009, HYPERTENS RES, V32, P238, DOI 10.1038/hr.2009.4; Eriksson JG, 2007, HYPERTENSION, V49, P1415, DOI 10.1161/HYPERTENSIONAHA.106.085597; Erlingsdottir A, 2010, PEDIATR NEPHROL, V25, P323, DOI 10.1007/s00467-009-1350-3; Fall CHD, 2011, INT J EPIDEMIOL, V40, P47, DOI 10.1093/ije/dyq155; HEBERT PR, 1993, CIRCULATION, V88, P1437, DOI 10.1161/01.CIR.88.4.1437; HEINIG MJ, 1993, ACTA PAEDIATR, V82, P999, DOI 10.1111/j.1651-2227.1993.tb12798.x; Heys M, 2013, PEDIATRICS, V131, pE62, DOI 10.1542/peds.2012-0574; Jones A, 2012, HYPERTENSION, V59, P919, DOI 10.1161/HYPERTENSIONAHA.111.187716; Kaakinen M, 2014, J EPIDEMIOL COMMUN H, V68, P1161, DOI 10.1136/jech-2013-203661; Kark M, 2009, PAEDIATR PERINAT EP, V23, P245, DOI 10.1111/j.1365-3016.2008.01007.x; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Kotsis V, 2010, HYPERTENS RES, V33, P386, DOI 10.1038/hr.2010.9; Kramer MS, 2007, AM J CLIN NUTR, V86, P1717; Kwok MK, 2013, AM J EPIDEMIOL, V178, P928, DOI 10.1093/aje/kwt076; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; LAW CM, 1993, BRIT MED J, V306, P24, DOI 10.1136/bmj.306.6869.24; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Martin RM, 2005, AM J EPIDEMIOL, V161, P15, DOI 10.1093/aje/kwh338; Martin RM, 2004, CIRCULATION, V109, P1259, DOI 10.1161/01.CIR.0000118468.76447.CE; Menezes AMB, 2012, J EPIDEMIOL COMMUN H, V66, P149, DOI 10.1136/jech.2010.124842; Organization WH, 2009, GLOB HLTH RISKS MORT; Paajanen TA, 2010, EUR HEART J, V31, P1802, DOI 10.1093/eurheartj/ehq155; Pomeranz A, 2002, J HYPERTENS, V20, P203, DOI 10.1097/00004872-200202000-00009; Regnault N, 2014, INT J EPIDEMIOL, V43, P149, DOI 10.1093/ije/dyt248; Robinson S, 2012, NUTRIENTS, V4, P859, DOI 10.3390/nu4080859; Singhal A, 2001, LANCET, V357, P413, DOI 10.1016/S0140-6736(00)04004-6; Tu YK, 2013, INT J EPIDEMIOL, V42, P1327, DOI 10.1093/ije/dyt157; van Eijsden M, 2011, INT J EPIDEMIOL, V40, P1176, DOI 10.1093/ije/dyq128; Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153; Verduci E, 2014, NUTRIENTS, V6, P1711, DOI 10.3390/nu6041711; Visser GHA, 2009, EARLY HUM DEV, V85, P737, DOI 10.1016/j.earlhumdev.2009.09.008; Wilson AC, 1998, BMJ-BRIT MED J, V316, P21, DOI 10.1136/bmj.316.7124.21; Wuhl E, 2002, J HYPERTENS, V20, P1995, DOI 10.1097/00004872-200210000-00019	44	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166281	10.1371/journal.pone.0166281	http://dx.doi.org/10.1371/journal.pone.0166281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832113	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000089
J	Moreno, CL; Yang, LD; Decks, PA; Soda, F; van Deursen, JMA; Mobbs, CV				Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; van Deursen, Jan M. A.; Mobbs, Charles V.			Role of Hypothalamic Creb-Binding Protein in Obesity and Molecular Reprogramming of Metabolic Substrates	PLOS ONE			English	Article							INDIRECT CALORIMETRY; MESSENGER-RNA; FOOD-INTAKE; GLUCOSE; CBP; EXPRESSION; NEURONS; INHIBITION; HORMONE; NUCLEUS	We have reported a correlation between hypothalamic expression of Creb-binding protein (Cbp) and lifespan, and that inhibition of Cbp prevents protective effects of dietary restriction during aging, suggesting that hypothalamic Cbp plays a role in responses to nutritional status and energy balance. Recent GWAS and network analyses have also implicated Cbp as the most connected gene in protein-protein interactions in human Type 2 diabetes. The present studies address mechanisms mediating the role of Cbp in diabetes by inhibiting hypothalamic Cbp using a Cre-lox strategy. Inhibition of hypothalamic Cbp results in profound obesity and impaired glucose homeostasis, increased food intake, and decreased body temperature. In addition, these changes are accompanied by molecular evidence in the hypothalamus for impaired leptin and insulin signaling, a shift from glucose to lipid metabolism, and decreased Pomc mRNA, with no effect on locomotion. Further assessment of the significance of the metabolic switch demonstrated that enhanced expression of hypothalamic Cptl a, which promotes lipid metabolism, similarly resulted in increased body weight and reduced Pomc mRNA.	[Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; Mobbs, Charles V.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Moreno, Cesar L.; Yang, Linda; Decks, Penny A.; Soda, Fumiko; Mobbs, Charles V.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [van Deursen, Jan M. A.] Mayo Clin, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Mayo Clinic	Mobbs, CV (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Mobbs, CV (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	Charles.mobbs@mssm.edu	Moreno, Cesar/Q-4822-2017	Moreno, Cesar/0000-0002-0876-0341; Dacks, Penny/0000-0003-1149-4192	National Institute of Aging of the National Institute of Health [FAG042299A, R01 AG019934]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH087004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F31AG042299] Funding Source: NIH RePORTER	National Institute of Aging of the National Institute of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute of Aging of the National Institute of Health under award number FAG042299A, and R01 AG019934. The funder in the study had no role in the study design, data collection, analysis, or preparation of this manuscript.	Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Aschauer DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076310; Barrett RM, 2011, NEUROPSYCHOPHARMACOL, V36, P1545, DOI 10.1038/npp.2011.61; Belgardt BF, 2009, J PHYSIOL-LONDON, V587, P5305, DOI 10.1113/jphysiol.2009.179192; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Caccamo A, 2010, P NATL ACAD SCI USA, V107, P22687, DOI 10.1073/pnas.1012851108; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Even PC, 2012, AM J PHYSIOL-REG I, V303, pR459, DOI 10.1152/ajpregu.00137.2012; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Huo L, 2009, CELL METAB, V9, P537, DOI 10.1016/j.cmet.2009.05.003; James WPT, 2008, INT J OBESITY, V32, pS120, DOI 10.1038/ijo.2008.247; Jordan SD, 2010, CELL MOL LIFE SCI, V67, P3255, DOI 10.1007/s00018-010-0414-7; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kang L, 2006, DIABETES, V55, P412, DOI 10.2337/diabetes.55.02.06.db05-1229; Kang-Decker N, 2004, CANCER CELL, V5, P177, DOI 10.1016/S1535-6108(04)00022-4; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lavrentyev EN, 2004, BIOCHEM BIOPH RES CO, V315, P174, DOI 10.1016/j.bbrc.2004.01.040; Liao GY, 2012, NAT MED, V18, P564, DOI 10.1038/nm.2687; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MAYER J, 1953, NEW ENGL J MED, V249, P13, DOI 10.1056/NEJM195307022490104; Mera P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097195; Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294; Mizuno TM, 2003, DIABETES, V52, P2675, DOI 10.2337/diabetes.52.11.2675; Moreno C, 2013, ENDOCRIN METAB CLIN, V42, P67, DOI 10.1016/j.ecl.2012.11.007; Moreno CL, 2016, NEUROBIOL DIS, V85, P25, DOI 10.1016/j.nbd.2015.09.012; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Perdomo G, 2010, J LIPID RES, V51, P1298, DOI 10.1194/jlr.M001206; Poplawski MM, 2010, ENDOCRINOLOGY, V151, P5206, DOI 10.1210/en.2010-0702; Shu I-W, 2002, KEYSTONE S J, VJ3/J4, P98; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Stromberg H, 1999, BRAIN RES, V818, P510, DOI 10.1016/S0006-8993(98)01219-0; Tanaka Y, 1997, P NATL ACAD SCI USA, V94, P10215, DOI 10.1073/pnas.94.19.10215; Vincent M, 2014, J NEUROSCI METH, V235, P189, DOI 10.1016/j.jneumeth.2014.07.005; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; Yang XJ, 2004, DIABETES, V53, P67, DOI 10.2337/diabetes.53.1.67; Zhang MH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000245	46	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166381	10.1371/journal.pone.0166381	http://dx.doi.org/10.1371/journal.pone.0166381			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832201	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000116
J	Shen, J; Xia, JB; Dong, SF; Zhang, XY; Fu, K				Shen, Jian; Xia, Jingbo; Dong, Shufu; Zhang, Xiaoyan; Fu, Kai			Universal Feature Extraction for Traffic Identification of the Target Category	PLOS ONE			English	Article							REGRESSION; FRAMEWORK	Traffic identification of the target category is currently a significant challenge for network monitoring and management. To identify the target category with pertinence, a feature extraction algorithm based on the subset with highest proportion is presented in this paper. The method is proposed to be applied to the identification of any category that is assigned as the target one, but not restricted to certain specific category. We divide the process of feature extraction into two stages. In the stage of primary feature extraction, the feature subset is extracted from the dataset which has the highest proportion of the target category. In the stage of secondary feature extraction, the features that can distinguish the target and interfering categories are added to the feature subset. Our theoretical analysis and experimental observations reveal that the proposed algorithm is able to extract fewer features with greater identification ability of the target category. Moreover, the universality of the proposed algorithm proves to be available with the experiment that every category is set to be the target one.	[Shen, Jian; Dong, Shufu; Zhang, Xiaoyan; Fu, Kai] Air Force Engn Univ, Inst Informat & Nav, Xian, Shaanxi, Peoples R China; [Xia, Jingbo] Xiamen Univ, Tan KahKee Coll, Xiamen, Fujian, Peoples R China	Air Force Engineering University; Xiamen University	Shen, J (corresponding author), Air Force Engn Univ, Inst Informat & Nav, Xian, Shaanxi, Peoples R China.	shenjian2018@126.com			Shaanxi Province Natural Science Foundation [2012JZ8005]; Aero-Science Foundation [20141996018]	Shaanxi Province Natural Science Foundation(Natural Science Foundation of Shaanxi Province); Aero-Science Foundation	Project supported by the Shaanxi Province Natural Science Foundation (Grant No. 2012JZ8005), Aero-Science Foundation (Grant No. 20141996018).	Alibeigi M, 2012, DATA KNOWL ENG, V81-82, P67, DOI 10.1016/j.datak.2012.08.001; [Anonymous], 1999, CORRELATION BASED FE; Bonfiglio D, 2006, ACM SIGCOMM COMPUTER; Bonfiglio D, 2009, IEEE T MULTIMEDIA, V11, P117, DOI 10.1109/TMM.2008.2008927; Cai X., 2013, PROC 23 INT JOINT C, P1; Callado A, 2010, J NETW COMPUT APPL, V33, P433, DOI 10.1016/j.jnca.2010.02.002; Callado A, 2009, IEEE COMMUN SURV TUT, V11, P37, DOI 10.1109/SURV.2009.090304; Chen H X, 2009, ELECTROOPTIC TECHNOL; Elkan C., 2008, PROC ACM SIGKDD INT, P213, DOI DOI 10.1145/1401890.1401920; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Gui J, 2014, IEEE T IMAGE PROCESS, V23, P3126, DOI 10.1109/TIP.2014.2326001; Gui J, 2014, IEEE T CIRC SYST VID, V24, P211, DOI 10.1109/TCSVT.2013.2273652; Gui J, 2012, PATTERN RECOGN, V45, P2884, DOI 10.1016/j.patcog.2012.02.005; Gui J, 2010, ARTIF INTELL MED, V50, P181, DOI 10.1016/j.artmed.2010.05.004; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; He HT, 2008, LECT NOTES COMPUT SC, V5227, P449; He HB, 2010, IMBALANCED LEARNING, VVII; Hou C, 2016, DISCRIMINATIVE VANIS, P1666; Hou CP, 2014, IEEE T CYBERNETICS, V44, P793, DOI 10.1109/TCYB.2013.2272642; Huang KZ, 2004, PROC CVPR IEEE, P558; Jeffrey C M, 1992, ACM T COMPUT SYST, V10, P81; Jin Y, 2012, ACM T KNOWL DISCOV D, V6, DOI 10.1145/2133360.2133364; Kalfut A, 2006, P 6 ACM SIGCOMM C IN; Liu T, 2003, P INT C MACH LEARN A; Manevitz LM, 2002, J MACH LEARN RES, V2, P139, DOI 10.1162/15324430260185574; Masnadi-Shirazi H, 2007, MACH LEARN P 24 INT, P609; Nie F., 2008, P 23 NAT C ART INT, P671; Nie F., 2010, ADV NEURAL INFORM PR, V23, DOI DOI 10.1007/978-3-319-10690-8_12; Padmaja TM., 2008, IEEE REG 10 ANN INT; Sen S, 2004, IEEE ACM T NETWORK, V12, P219, DOI 10.1109/TNET.2004.826277; Stefanowski J, 2008, LECT NOTES COMPUT SC, V5182, P283, DOI 10.1007/978-3-540-85836-2_27; Street W N, 2001, ACM SIGKDD INT C KNO, P1152; Trang DD, 2000, THESIS; Wald R, 2013, STABILITY FILTER WRA, P374; Wang D, 2015, IEEE T KNOWL DATA EN, V27, P2743, DOI 10.1109/TKDE.2015.2426703; Wang H., 2003, P 9 ACM SIGKDD INT C, P226, DOI DOI 10.1145/956750.956778; Wasikowski M, 2010, IEEE T KNOWL DATA EN, V22, P1388, DOI 10.1109/TKDE.2009.187; Weicai Zhong, 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P3548, DOI 10.1109/IJCNN.2009.5178804; Williamson C, 2001, IEEE INTERNET COMPUT, V5, P70, DOI 10.1109/4236.968834; Witten IH, 2011, MOR KAUF D, P61, DOI 10.1016/B978-0-12-374856-0.00003-1; Zhang HL, 2010, SKYPE TRAFFIC IDENTI, V12, P149	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165993	10.1371/journal.pone.0165993	http://dx.doi.org/10.1371/journal.pone.0165993			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832103	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000053
J	Zhang, D; Goldberg, MV; Chiu, ML				Zhang, Di; Goldberg, Monica V.; Chiu, Mark L.			Fc Engineering Approaches to Enhance the Agonism and Effector Functions of an Anti-OX40 Antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA RECEPTOR ENGAGEMENT; MONOCLONAL-ANTIBODY; CANCER-IMMUNOTHERAPY; ANTITUMOR ACTIVITIES; TUMOR-IMMUNITY; TNF RECEPTOR; KAPPA-B; CELLS; OX40; ACTIVATION	Agonistic antibodies directed against immunostimulatory receptors belonging to the tumor necrosis factor receptor (TNFR) superfamily are emerging as promising cancer immunotherapies. Several Fc engineering approaches discovered recently can augment the anti-tumor activities of TNFR antibodies by enhancing their agonistic activities and/or effector functions. In this study, we compared these approaches for their effects on an anti-OX40 antibody. Both S267E/L328F and V12 mutations facilitated enhanced binding to Fc gamma RIIB and thus increased Fc gamma RIIB cross-linking mediated agonist activity. However, both mutations abrogated the binding to Fc gamma RIIIA and thereby decreasing the antibody-dependent cellular cytotoxicity activities. In contrast, the E345R mutation, which can promote antibody multimerization upon receptor binding, facilitated anti-OX40 antibody to have increased agonism by promoting the clustering of OX40 receptors without the dependence on Fc gamma RIIB cross-linking. Nonetheless, cross-linking to Fc gamma RIIB can lead to a further boost of the agonism of the anti-OX40 antibody with IgG1 Fc but not with the silent IgG2 sigma Fc. The antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity activities of the anti-OX40 antibody with the E345R mutation were affected by the choice of IgG subtypes. However, there was little change in the antibody-dependent cellular phagocytosis activity. In summary, different Fc engineering approaches can guide the design of engineered antibodies to OX40 and other TNFR with improved anti-tumor activity.	[Zhang, Di; Goldberg, Monica V.; Chiu, Mark L.] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Goldberg, Monica V.] Bristol Myers Squibb, Lawrence, NJ 08648 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc; Bristol-Myers Squibb	Zhang, D (corresponding author), Janssen R&D LLC, Dept Biol Res, 1400 McKean Rd,POB 776, Spring House, PA 19477 USA.	dzhang53@its.jnj.com	chiu, mark/AAK-2756-2021	Chiu, Mark/0000-0001-6300-404X				Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Bulliard Y, 2014, IMMUNOL CELL BIOL, V92, P475, DOI 10.1038/icb.2014.26; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; de Jong RN, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002344; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; He LZ, 2013, J IMMUNOL, V191, P4174, DOI 10.4049/jimmunol.1300409; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kanamaru F, 2004, J IMMUNOL, V172, P7306, DOI 10.4049/jimmunol.172.12.7306; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Khalil Magi, 2007, Update Cancer Ther, V2, P61, DOI 10.1016/j.uct.2007.06.001; Li FB, 2012, CELL CYCLE, V11, P3343, DOI 10.4161/cc.21842; Li FB, 2012, P NATL ACAD SCI USA, V109, P10966, DOI 10.1073/pnas.1208698109; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Luo Y, 2009, MABS-AUSTIN, V1, P491, DOI 10.4161/mabs.1.5.9631; Mangsbo SM, 2015, CLIN CANCER RES, V21, P1115, DOI 10.1158/1078-0432.CCR-14-0913; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mimoto F, 2013, PROTEIN ENG DES SEL, V26, P589, DOI 10.1093/protein/gzt022; Moran AE, 2013, CURR OPIN IMMUNOL, V25, P230, DOI 10.1016/j.coi.2013.01.004; Morris NP, 2007, MOL IMMUNOL, V44, P3112, DOI 10.1016/j.molimm.2007.02.004; POLLOK KE, 1993, J IMMUNOL, V150, P771; Ramakrishna V, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0080-2; Rankin CT, 2006, BLOOD, V108, P2384, DOI 10.1182/blood-2006-05-020602; Schaer DA, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-7; Simons PJ, 2014, Patent US, Patent No. [20140377284 A1, WO 2014/ 148895 A1, 20140377284]; Veri MC, 2007, IMMUNOLOGY, V121, P392, DOI 10.1111/j.1365-2567.2007.02588.x; White AL, 2015, CANCER CELL, V27, P138, DOI 10.1016/j.ccell.2014.11.001; White AL, 2011, J IMMUNOL, V187, P1754, DOI 10.4049/jimmunol.1101135; Wilson NS, 2011, CANCER CELL, V19, P101, DOI 10.1016/j.ccr.2010.11.012; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Xu YY, 2003, J IMMUNOL, V171, P562, DOI 10.4049/jimmunol.171.2.562	34	38	45	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27134	27146		10.1074/jbc.M116.757773	http://dx.doi.org/10.1074/jbc.M116.757773			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856634	hybrid, Green Published			2022-12-26	WOS:000391576300014
J	Kabinejadian, F; McElroy, M; Ruiz-Soler, A; Leo, HL; Slevin, MA; Badimon, L; Keshmiri, A				Kabinejadian, Foad; McElroy, Michael; Ruiz-Soler, Andres; Leo, Hwa Liang; Slevin, Mark A.; Badimon, Lina; Keshmiri, Amir			Numerical Assessment of Novel Helical/Spiral Grafts with Improved Hemodynamics for Distal Graft Anastomoses	PLOS ONE			English	Article							TO-SIDE ANASTOMOSIS; SPIRAL LAMINAR-FLOW; OF-PLANE GEOMETRY; SHEAR-STRESS; PULSATILE FLOW; WALL SHEAR; CAROTID BIFURCATION; ABDOMINAL-AORTA; SWIRLING FLOW; BLOOD-FLOW	In the present work, numerical simulations were conducted for a typical end-to-side distal graft anastomosis to assess the effects of inducing secondary flow, which is believed to remove unfavourable flow environment. Simulations were carried out for four models, generated based on two main features of 'out-of-plane helicity' and 'spiral ridge' in the grafts as well as their combination. Following a qualitative comparison against in vitro data, various mean flow and hemodynamic parameters were compared and the results showed that helicity is significantly more effective in inducing swirling flow in comparison to a spiral ridge, while their combination could be even more effective. In addition, the induced swirling flow was generally found to be increasing the wall shear stress and reducing the flow stagnation and particle residence time within the anastomotic region and the host artery, which may be beneficial to the graft longevity and patency rates. Finally, a parametric study on the spiral ridge geometrical features was conducted, which showed that the ridge height and the number of spiral ridges have significant effects on inducing swirling flow, and revealed the potential of improving the efficiency of such designs.	[Kabinejadian, Foad] Univ Michigan, Dept Biomed Engn, 1107 Carl A Gerstacker Bldg,2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA; [McElroy, Michael; Ruiz-Soler, Andres; Keshmiri, Amir] Manchester Metropolitan Univ, Engn & Mat Res Ctr, Manchester M1 5GD, Lancs, England; [Leo, Hwa Liang] Natl Univ Singapore, Dept Biomed Engn, 4 Engn Dr 3,Block E4 04-08, Singapore 117583, Singapore; [Slevin, Mark A.] Manchester Metropolitan Univ, Healthcare Sci Res Ctr, Manchester M1 5GD, Lancs, England; [Badimon, Lina] Hosp Santa Creu & St Pau UAB, CSIC ICCC, Cardiovasc Res Ctr, C St Antoni Maria Claret 167, Barcelona 08025, Spain; [Keshmiri, Amir] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester M13 9PL, Lancs, England	University of Michigan System; University of Michigan; Manchester Metropolitan University; National University of Singapore; Manchester Metropolitan University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); University of Manchester	Keshmiri, A (corresponding author), Manchester Metropolitan Univ, Engn & Mat Res Ctr, Manchester M1 5GD, Lancs, England.; Keshmiri, A (corresponding author), Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester M13 9PL, Lancs, England.	a.keshmiri@manchester.ac.uk	Slevin, Mark/AFT-1420-2022; slevin, mark a/A-1593-2008; BADIMON, LINA/S-2950-2019; Kabinejadian, Foad/A-9829-2015; Badimon, Lina/O-4711-2014	Kabinejadian, Foad/0000-0002-4125-5064; slevin, mark/0000-0003-3767-4861; McElroy, Michael/0000-0002-4320-2628; Keshmiri, Amir/0000-0003-4747-277X; Badimon, Lina/0000-0002-9162-2459	UK Engineering and Physical Sciences Research Council (EPSRC) [EP/M015599/1]; EPSRC [EP/M015599/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M015599/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors would like to acknowledge the support from the UK Engineering and Physical Sciences Research Council (EPSRC) under grant EP/M015599/1.	Archie JP, 2001, CRITICAL REV BIOMEDI, P1; Bechara, 2014, VASC DIS MANAG, V11, pE54; BIRD R.B., 1987, FLUID MECH-SOV RES, V1; Bryan AJ, 1994, CURRENT OPINION CARD, P641; Buchanan JR, 2003, J BIOMECH, V36, P1185, DOI 10.1016/S0021-9290(03)00088-5; Caro CG, 2005, J ROY SOC INTERFACE, V2, P261, DOI 10.1098/rsif.2005.0044; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; Cookson AN, 2010, J COMPUT APPL MATH, V234, P2069, DOI 10.1016/j.cam.2009.08.065; Cookson AN, 2009, ANN BIOMED ENG, V37, P710, DOI 10.1007/s10439-009-9636-y; Coppola G, 2009, J R SOC INTERFACE, V6, P519, DOI 10.1098/rsif.2008.0417; DEPAOLA N, 1992, ARTERIOSCLER THROMB, V12, P1254, DOI 10.1161/01.ATV.12.11.1254; DONOVAN FM, 1994, J FLUID ENG-T ASME, V116, P516, DOI 10.1115/1.2910307; Gallo D, 2012, J BIOMECH, V45, P2398, DOI 10.1016/j.jbiomech.2012.07.007; Ghista DN, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-129; Ha H, 2015, MED ENG PHYS, V37, P272, DOI 10.1016/j.medengphy.2015.01.007; Ha H, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1861-y; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Hellums JD, 1993, ANN BIOMEDICAL ENG A, V22, P445; Himburg HA, 2004, AM J PHYSIOL-HEART C, V286, pH1916, DOI 10.1152/ajpheart.00897.2003; JEONG J, 1995, J FLUID MECH, V285, P69, DOI 10.1017/S0022112095000462; Jung B, 2006, EUR J CARDIO-THORAC, V29, pS150, DOI 10.1016/j.ejcts.2006.02.066; Kabinejadian F, 2015, MED BIOL ENG COMPUT, V53, P165, DOI 10.1007/s11517-014-1222-2; Kabinejadian F, 2012, MED ENG PHYS, V34, P860, DOI 10.1016/j.medengphy.2011.10.001; Kabinejadian F, 2010, J MECH MED BIOL, V10, P593, DOI 10.1142/S0219519410003587; Kabinejadian F, 2010, ANN BIOMED ENG, V38, P3135, DOI 10.1007/s10439-010-0068-5; Keshmiri A, 2015, HDB METHODS VASCULAR, P343; Keshmiri A, 2016, PROC CIRP, V49, P147, DOI 10.1016/j.procir.2015.11.005; Klein WM, 2003, J VASC SURG, V38, P1060, DOI 10.1016/S0741-5214(03)00706-7; Kokkalis E, 2013, ULTRASOUND MED BIOL, V39, P2295, DOI 10.1016/j.ultrasmedbio.2013.07.014; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Ku JP, 2005, ANN BIOMED ENG, V33, P257, DOI 10.1007/s10439-005-1729-7; Lee KE, 2011, MED ENG PHYS, V33, P38, DOI 10.1016/j.medengphy.2010.09.005; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Liu X, 2015, ANN BIOMED ENG, V43, P3, DOI 10.1007/s10439-014-1097-2; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; MOFFATT HK, 1992, ANNU REV FLUID MECH, V24, P281, DOI 10.1146/annurev.fl.24.010192.001433; MOORE JE, 1994, J APPL PHYSIOL, V76, P1520, DOI 10.1152/jappl.1994.76.4.1520; Papaharilaou Y, 2002, J BIOMECH, V35, P1225, DOI 10.1016/S0021-9290(02)00072-6; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; PERKTOLD K, 1995, J BIOMECH, V28, P845, DOI 10.1016/0021-9290(95)95273-8; RAMSTACK JM, 1979, J BIOMECH, V12, P113, DOI 10.1016/0021-9290(79)90150-7; Sherwin SJ, 2000, J BIOMECH ENG-T ASME, V122, P86, DOI 10.1115/1.429630; Steinman David A., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P183, DOI 10.2174/1568006043336302; STONEBRIDGE PA, 1991, LANCET, V338, P1360, DOI 10.1016/0140-6736(91)92238-W; Stonebridge PA, 1996, CLIN SCI, V91, P17, DOI 10.1042/cs0910017; Stonebridge PA, 2012, ANN VASC SURG, V26, P1093, DOI 10.1016/j.avsg.2012.02.001; Stonebridge Peter A, 2011, Methodist Debakey Cardiovasc J, V7, P21; Sun AQ, 2010, ARTIF ORGANS, V34, P22, DOI 10.1111/j.1525-1594.2009.00797.x; Sunamura M, 2007, SURGERY, V141, P764, DOI 10.1016/j.surg.2006.12.019; WHITE SS, 1993, J BIOMECH ENG-T ASME, V115, P104, DOI 10.1115/1.2895456; WHITTEMORE AD, 1981, ANN SURG, V193, P35, DOI 10.1097/00000658-198101000-00006; Wurzinger L. J., 1986, ANGIOLOGIE, V38, P81; WURZINGER LJ, 1985, BIORHEOLOGY, V22, P399; Zhan F, 2010, THROMB RES, V125, P413, DOI 10.1016/j.thromres.2009.02.011; Zheng TH, 2009, ASAIO J, V55, P192, DOI 10.1097/MAT.0b013e31819b34f2	55	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165892	10.1371/journal.pone.0165892	http://dx.doi.org/10.1371/journal.pone.0165892			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861485	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000388350300015
J	Sugai, T; Suzuki, Y; Yamazaki, M; Shimoda, K; Mori, T; Ozeki, Y; Matsuda, H; Sugawara, N; Yasui-Furukori, N; Minami, Y; Okamoto, K; Sagae, T; Someya, T				Sugai, Takuro; Suzuki, Yutaro; Yamazaki, Manabu; Shimoda, Kazutaka; Mori, Takao; Ozeki, Yuji; Matsuda, Hiroshi; Sugawara, Norio; Yasui-Furukori, Norio; Minami, Yoshitake; Okamoto, Kurefu; Sagae, Toyoaki; Someya, Toshiyuki			High Prevalence of Obesity, Hypertension, Hyperlipidemia, and Diabetes Mellitus in Japanese Outpatients with Schizophrenia: A Nationwide Survey	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; DYSLIPIDEMIA; POPULATION; PEOPLE; CHOLESTEROL; MORTALITY; DISEASE; ADULTS; TRIAL	Background Patients with schizophrenia have significantly shorter life expectancy than the general population, and a problem they commonly face is an unhealthy lifestyle, which can lead to obesity and metabolic syndrome. There is a very clear need to determine the prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus which are components of metabolic syndrome in patients with schizophrenia, but there has been a paucity of large-scale studies examining this situation in Japan. The aim of our study was to address this need. Setting & Participants We conducted a large-scale investigation of the prevalence of obesity, hypertension, hyperlipidemia, and diabetes mellitus using a questionnaire in 520 outpatient facilities and 247 inpatient facilities of the Japan Psychiatric Hospitals Association between January 2012 and July 2013. There were 7,655 outpatients and 15,461 inpatients with schizophrenia. Results The outpatients had significantly higher prevalence of obesity, hypertension, hypertriglyceridemia, hyper-LDL cholesterolemia, and diabetes mellitus than the inpatients. The prevalence of hypo-HDL cholesterolemia was higher in inpatients than outpatients. Age-specific analysis showed the prevalence of obesity, hypertension, hypertriglyceridemia, hyper-LDL cholesterolemia, and diabetes mellitus among outpatients to be 2- to 3-fold higher than among inpatients. In individuals aged >= 60 years, the prevalence of obesity and DM among outpatients was about 3-fold higher than among inpatients. Conclusion Japanese outpatients with schizophrenia were more likely to have physical risk such as obesity, hypertension, hyperlipidemia, and diabetes mellitus than inpatients. The physical risk to patients with schizophrenia may be affected by environmental parameters, such as type of care. The physical risk to Japanese patients with schizophrenia demands greater attention.	[Sugai, Takuro; Suzuki, Yutaro; Someya, Toshiyuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan; [Sugai, Takuro; Suzuki, Yutaro; Shimoda, Kazutaka; Ozeki, Yuji; Sugawara, Norio; Yasui-Furukori, Norio; Someya, Toshiyuki] Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan; [Yamazaki, Manabu; Mori, Takao; Matsuda, Hiroshi; Minami, Yoshitake; Okamoto, Kurefu] Japan Psychiat Hosp Assoc, Tokyo, Japan; [Shimoda, Kazutaka; Ozeki, Yuji] Dokkyo Med Univ, Sch Med, Dept Psychiat, Mibu, Tochigi, Japan; [Sugawara, Norio; Yasui-Furukori, Norio] Hirosaki Univ, Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Sagae, Toyoaki] Yamagata Prefectural Yonezawa Univ Nutr Sci, Fac Hlth & Nutr, Dept Hlth & Nutr, Yonezawa, Yamagata, Japan	Niigata University; Dokkyo Medical University; Hirosaki University	Someya, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Psychiat, Niigata, Japan.; Someya, T (corresponding author), Japanese Soc Clin Neuropsychopharmacol, Tokyo, Japan.	psy@med.niigata-u.ac.jp	Someya, Toshiyuki/ABD-1878-2021		Eisai Co., Ltd.; Yoshitomi Pharmaceutical Industries; Dainippon Sumitomo Pharma Co., Ltd.; Astellas Pharma Inc.; Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.; Otsuka Pharmaceutical Co., Ltd.; GlaxoSmithKline K.K.; Janssen Pharmaceutical K.K.; MSD K.K.; Shionogi Co., Ltd.; Asahi Kasei Pharma Corp.; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; Ono Pharmaceutical Co., Ltd.; Tsumura Co.	Eisai Co., Ltd.(Eisai Co Ltd); Yoshitomi Pharmaceutical Industries; Dainippon Sumitomo Pharma Co., Ltd.(Dainippon Sumitomo Pharma Co., Ltd.); Astellas Pharma Inc.(Astellas Pharmaceuticals); Meiji Seika Pharma Co., Ltd.; Eli Lilly Japan, K.K.(Eli Lilly); Otsuka Pharmaceutical Co., Ltd.(Otsuka Pharmaceutical); GlaxoSmithKline K.K.(GlaxoSmithKline); Janssen Pharmaceutical K.K.; MSD K.K.(Merck & Company); Shionogi Co., Ltd.; Asahi Kasei Pharma Corp.; Novartis Pharma Co., Ltd.; Takeda Pharmaceutical Co., Ltd.(Takeda Pharmaceutical Company Ltd); Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); Tsumura Co.(Tsumura & Company)	This work was partially supported by Eisai Co., Ltd., Yoshitomi Pharmaceutical Industries, Dainippon Sumitomo Pharma Co., Ltd., Astellas Pharma Inc., Meiji Seika Pharma Co., Ltd., Eli Lilly Japan, K.K., Otsuka Pharmaceutical Co., Ltd., GlaxoSmithKline K.K., Janssen Pharmaceutical K.K., MSD K.K., Shionogi & Co., Ltd., Asahi Kasei Pharma Corp., Novartis Pharma Co., Ltd., Takeda Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., and Tsumura & Co. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birkenaes AB, 2008, J CLIN PSYCHOPHARM, V28, P132, DOI 10.1097/JCP.0b013e318166c4f7; Bobes J, 2007, SCHIZOPHR RES, V90, P162, DOI 10.1016/j.schres.2006.09.025; Bresee LC, 2010, SCHIZOPHR RES, V117, P75, DOI 10.1016/j.schres.2009.12.016; Chien IC, 2009, SCHIZOPHR RES, V111, P17, DOI 10.1016/j.schres.2009.04.003; Chu N F, 1996, J Cardiovasc Risk, V3, P205, DOI 10.1097/00043798-199604000-00012; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; De Hert MA, 2006, SCHIZOPHR RES, V83, P87, DOI 10.1016/j.schres.2005.12.855; De Hert M, 2009, WORLD PSYCHIATRY, V8, P15; Dixon L, 2000, SCHIZOPHRENIA BULL, V26, P903, DOI 10.1093/oxfordjournals.schbul.a033504; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Frontini MG, 2003, PREV MED, V36, P398, DOI 10.1016/S0091-7435(02)00045-2; Goff DC, 2005, J CLIN PSYCHIAT, V66, P183, DOI 10.4088/JCP.v66n0205; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hippisley-Cox J, 2007, HEART, V93, P1256, DOI 10.1136/hrt.2006.110171; Huang MC, 2009, ACTA PSYCHIAT SCAND, V120, P274, DOI 10.1111/j.1600-0447.2009.01401.x; Huang TL, 2005, SCHIZOPHR RES, V80, P55, DOI 10.1016/j.schres.2005.05.001; Kato Martha M, 2005, Prim Care Companion J Clin Psychiatry, V7, P115; Mann S, 2014, SPORTS MED, V44, P211, DOI 10.1007/s40279-013-0110-5; McEvoy JP, 2005, SCHIZOPHR RES, V80, P19, DOI 10.1016/j.schres.2005.07.014; Ministry of Health Labour and Welfare, 2009, PAT SURV; Ministry of Health Labour and Welfare, 2011, NAT HLTH NUTR EX SUR; Ministry of Health Labour and Welfare Japan. Patient Survey, 2008, PAT SURV; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401; Oh SW, 2011, DIABETES METAB J, V35, P561, DOI 10.4093/dmj.2011.35.6.561; Osborn DPJ, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-84; Pilote L, 2007, CAN MED ASSOC J, V176, pS1, DOI 10.1503/cmaj.051455; Ridker PM, 2001, JAMA-J AM MED ASSOC, V285, P2481, DOI 10.1001/jama.285.19.2481; Suvisaari JM, 2007, J CLIN PSYCHIAT, V68, P1045, DOI 10.4088/JCP.v68n0711; Thakore JH, 2002, INT J OBESITY, V26, P137, DOI 10.1038/sj.ijo.0801840	30	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166429	10.1371/journal.pone.0166429	http://dx.doi.org/10.1371/journal.pone.0166429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855222	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200031
J	Chiang, MH; Chen, PH; Chen, YK; Chen, CH; Ho, ML; Wang, YH				Chiang, Min-Hsuan; Chen, Ping-Ho; Chen, Yuk-Kwan; Chen, Chia-Hsin; Ho, Mei-Ling; Wang, Yan-Hsiung			Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; COLLAGEN-SYNTHESIS; IN-VITRO; FIBROBLASTS; STIMULATION; BLEOMYCIN; MECHANISM; CYTOTOXICITY; INHIBITION; ACTIVATION	Oral submucous fibrosis (OSF) is an oral potentially malignant disorder and areca quid chewing is the main etiological factor. However, the molecular mechanism underlying OSF remains unclear, partly due to the lack of an appropriate animal model. The present study aimed to establish and characterize an animal model of areca nut extract (ANE)-induced skin fibrosis that mimics OSF. Mice were divided into 4 groups: the control group; the bleomycin group; and the ANE10 and ANE20 groups, which received 10mg/ml and 20mg/ml subcutaneous (SC) injection of ANE, respectively. Skin fibrosis was evaluated by histological analyses. Additionally, the expression levels of the fibrotic marker genes were determined by immunohistochemical staining and immunoblotting. ANE administration significantly increased dermal thickness and collagen deposition compared with the control group. Moreover, ANE induced the expression of the fibrotic marker genes alpha smooth muscle actin (alpha-SMA) and connective tissue growth factor (CTGF) in the skin lesions. The SC injection of ANE successfully induced skin fibrosis, exhibiting characteristics similar to those of OSF. This model may facilitate future studies of the mechanism underlying OSF.	[Chiang, Min-Hsuan; Chen, Ping-Ho; Chen, Yuk-Kwan; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan; [Chiang, Min-Hsuan; Chen, Chia-Hsin; Ho, Mei-Ling; Wang, Yan-Hsiung] Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan; [Chen, Ping-Ho] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan; [Chen, Ping-Ho] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res CICAR, Kaohsiung, Taiwan; [Chen, Yuk-Kwan] Kaohsiung Med Univ, Oral & Maxillofacial Imaging Ctr, Kaohsiung, Taiwan; [Chen, Yuk-Kwan] Kaohsiung Med Univ Hosp, Dept Dent, Div Oral Pathol & Maxillofacial Radiol, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Chen, Chia-Hsin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Phys Med & Rehabil, Kaohsiung, Taiwan; [Ho, Mei-Ling] Kaohsiung Med Univ, Coll Med, Dept Physiol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Wang, YH (corresponding author), Kaohsiung Med Univ, Coll Dent Med, Sch Dent, Kaohsiung, Taiwan.; Wang, YH (corresponding author), Kaohsiung Med Univ, Coll Med, Orthopaed Res Ctr, Kaohsiung, Taiwan.	yhwang@kmu.edu.tw	Chen, Yuk-Kwan/C-8773-2009; Wang, Yan-Hsiung/ABD-4004-2020	Wang, Yan-Hsiung/0000-0001-8161-7472; Chen, Chia-Hsin/0000-0002-6557-9848; Ho, Mei-Ling/0000-0001-8064-8488	Ministry of Science and Technology [MOST-104-2314-B-037-059-]; Kaohsiung Medical University Aim for the Top Universities Grants [KMU-TP103B08, KM U-TP104B11]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Aim for the Top Universities Grants	The authors gratefully acknowledge the support of research grant from the Ministry of Science and Technology (MOST-104-2314-B-037-059-) and Kaohsiung Medical University Aim for the Top Universities Grants (KMU-TP103B08 and KM U-TP104B11).	ADAMSON IYR, 1984, ENVIRON HEALTH PERSP, V55, P25, DOI 10.1289/ehp.845525; Angadi PV, 2011, ORAL MAXILLOFAC SURG, V15, P1, DOI 10.1007/s10006-010-0219-8; ASO Y, 1976, LAB INVEST, V35, P558; CANNIFF JP, 1981, INT J ORAL MAXILLOF, V10, P163; CHANDLER DB, 1990, CLIN CHEST MED, V11, P21; Chang MC, 2004, J BIOL CHEM, V279, P50676, DOI 10.1074/jbc.M404465200; Chang YC, 2014, J CELL MOL MED, V18, P698, DOI 10.1111/jcmm.12219; Dai JP, 2015, MOLECULES, V20, P6794, DOI 10.3390/molecules20046794; Dai JP, 2014, J ORAL PATHOL MED, V43, P464, DOI 10.1111/jop.12158; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; Ham SA, 2015, J DERMATOL SCI, V80, P186, DOI 10.1016/j.jdermsci.2015.10.005; Jeng JH, 1999, J ORAL PATHOL MED, V28, P64; Khan I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051806; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; MA RH, 1995, J ORAL PATHOL MED, V24, P407, DOI 10.1111/j.1600-0714.1995.tb01210.x; MAHER R, 1994, J ORAL PATHOL MED, V23, P65, DOI 10.1111/j.1600-0714.1994.tb00258.x; MEGHJI S, 1987, ARCH ORAL BIOL, V32, P213, DOI 10.1016/0003-9969(87)90138-5; Meier JKH, 2011, INFLAMM BOWEL DIS, V17, P202, DOI 10.1002/ibd.21344; Mukherjee S, 2012, ORAL ONCOL, V48, pE27, DOI 10.1016/j.oraloncology.2012.05.018; Mukherjee S, 2012, J ORAL PATHOL MED, V41, P292, DOI 10.1111/j.1600-0714.2011.01097.x; MURTI PR, 1985, COMMUNITY DENT ORAL, V13, P340, DOI 10.1111/j.1600-0528.1985.tb00468.x; Perera MWS, 2007, J ORAL PATHOL MED, V36, P273, DOI 10.1111/j.1600-0714.2007.00523.x; PINDBORG JJ, 1984, SCAND J DENT RES, V92, P224; Samuel CS, 2007, ADV EXP MED BIOL, V612, P88; Satish L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-113; SCUTT A, 1987, EXPERIENTIA, V43, P391, DOI 10.1007/BF01940422; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Swaney JS, 2005, P NATL ACAD SCI USA, V102, P437, DOI 10.1073/pnas.0408704102; Tilakaratne WM, 2006, ORAL ONCOL, V42, P561, DOI 10.1016/j.oraloncology.2005.08.005; Tsai CC, 1999, J ORAL PATHOL MED, V28, P59; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Yamamoto T, 1999, J INVEST DERMATOL, V112, P456, DOI 10.1046/j.1523-1747.1999.00528.x; Yang SC, 2003, J ORAL PATHOL MED, V32, P600, DOI 10.1034/j.1600-0714.2003.00199.x	33	11	12	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166454	10.1371/journal.pone.0166454	http://dx.doi.org/10.1371/journal.pone.0166454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851781	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300051
J	Costanzo, A; Panseri, S; Giorgi, A; Romano, A; Caprioli, M; Saino, N				Costanzo, Alessandra; Panseri, Sara; Giorgi, Annamaria; Romano, Andrea; Caprioli, Manuela; Saino, Nicola			The Odour of Sex: Sex-Related Differences in Volatile Compound Composition among Barn Swallow Eggs Carrying Embryos of Either Sex	PLOS ONE			English	Article							UROPYGIAL GLAND SECRETION; PLUMAGE COLOR; DOSAGE COMPENSATION; YOLK ANDROGENS; BEGGING CALLS; RATIO; RECOGNITION; ALLOCATION; GROWTH; BIRDS	Avian communication has been traditionally believed to be mainly mediated by visual and auditory channels. However, an increasing number of studies are disclosing the role of olfaction in the interaction of birds with their social environment and with other species, as well as in other behaviors such as nest recognition, food location and navigation. Olfaction has also been suggested to play a role in parent-offspring communication not only in the post-but also in the pre-hatching period. Volatile compounds produced during embryogenesis and passively released through the eggshell pores may indeed represent the only cue at parents' disposal to assess offspring quality, including the sex composition of their clutch before hatching. In turn, sex identification before hatching may mediate adaptive strategies of allocation to either sex. In the present study, we analyzed odour composition of barn swallow eggs incubated in their nest in order to identify any sex-related differences in volatile compounds emitted. For the first time in any bird species, we also investigated whether odour composition is associated with relatedness. The evidence of differences in odour composition among eggs containing embryos of either sex indicates that parents have a cue to identify their brood sex composition even before hatching which can be used to modulate their behavior accordingly. Moreover, odour similarity within nests may represent the prerequisite for kin recognition in this species.	[Costanzo, Alessandra; Romano, Andrea; Caprioli, Manuela; Saino, Nicola] Univ Milan, Dept Biosci, Milan, Italy; [Panseri, Sara] Univ Milan, Dept Vet Sci & Publ Hlth, Milan, Italy; [Giorgi, Annamaria] Univ Milan, Ctr Appl Studies Sustainable Management & Protect, Ge S Di Mt, Brescia, Italy	University of Milan; University of Milan; University of Milan	Costanzo, A (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	alessandra.costanzo@unimi.it	costanzo, alessandra/AAF-8987-2020; Romano, Andrea/A-2780-2017; Romano, Andrea/B-3930-2012	costanzo, alessandra/0000-0003-3781-0798; Romano, Andrea/0000-0002-0945-6018; giorgi, annamaria/0000-0001-5386-7378; Panseri, Sara/0000-0001-6970-2009; Saino, Nicola/0000-0002-0230-3967				Amo L, 2012, J ANIM ECOL, V81, P605, DOI 10.1111/j.1365-2656.2011.01940.x; Appleby BM, 1997, P ROY SOC B-BIOL SCI, V264, P1111, DOI 10.1098/rspb.1997.0153; Badyaev AV, 2006, J EVOLUTION BIOL, V19, P1044, DOI 10.1111/j.1420-9101.2006.01106.x; Balbontin J, 2009, BEHAV ECOL SOCIOBIOL, V63, P1197, DOI 10.1007/s00265-009-0752-3; BALTHAZART J, 1979, NATURWISSENSCHAFTEN, V66, P55, DOI 10.1007/BF00369365; Bang B.G., 1985, P195; BANG BG, 1968, AUK, V85, P55; BANG BG, 1960, NATURE, V188, P547, DOI 10.1038/188547a0; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bernardi ML, 1996, HUM REPROD, V11, P621, DOI 10.1093/HUMREP/11.3.621; Bonadonna F, 2003, J EXP BIOL, V206, P3719, DOI 10.1242/jeb.00610; Bonadonna F, 2012, ANIM BEHAV, V84, P509, DOI 10.1016/j.anbehav.2012.06.014; Boncoraglio G, 2008, BEHAV ECOL SOCIOBIOL, V62, P729, DOI 10.1007/s00265-007-0498-8; Bonisoli-Alquati A, 2011, P ROY SOC B-BIOL SCI, V278, P1273, DOI 10.1098/rspb.2010.1741; Booksmythe I, 2017, BIOL REV, V92, P108, DOI 10.1111/brv.12220; CAREY C, 1980, BIOSCIENCE, V30, P819, DOI 10.2307/1308374; Caro SP, 2010, J COMP PHYSIOL A, V196, P751, DOI 10.1007/s00359-010-0534-4; CHARNOV E L, 1982; COHEN J, 1981, BIOCHEM SYST ECOL, V9, P351, DOI 10.1016/0305-1978(81)90022-3; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cordero PJ, 2001, J EVOLUTION BIOL, V14, P829, DOI 10.1046/j.1420-9101.2001.00320.x; Costanzo A, 2017, BEHAV ECOL, V28, P204, DOI 10.1093/beheco/arw147; Cramp S, 1998, COMPLETE BIRDS W PAL; Deeming DC, 2002, OX ORN SER, V13, P63; Dijkstra C, 1998, BEHAV ECOL, V9, P287, DOI 10.1093/beheco/9.3.287; DuRant SE, 2010, J EXP BIOL, V213, P45, DOI 10.1242/jeb.034488; Fisher, 1930, GENETICAL THEORY NAT; FRANK SA, 1990, ANNU REV ECOL SYST, V21, P13, DOI 10.1146/annurev.es.21.110190.000305; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Gil D, 2006, J EVOLUTION BIOL, V19, P123, DOI 10.1111/j.1420-9101.2005.00981.x; Gilbert L, 2005, NATURWISSENSCHAFTEN, V92, P178, DOI 10.1007/s00114-004-0603-z; Goluke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155513; GRUBB TC, 1972, NATURE, V237, P404, DOI 10.1038/237404a0; Hagelin JC, 2007, AUK, V124, P741, DOI 10.1642/0004-8038(2007)124[741:BOAOCS]2.0.CO;2; Hirao A, 2009, BEHAV PROCESS, V80, P115, DOI 10.1016/j.beproc.2008.10.006; Hubbard JK, 2015, ECOL EVOL, V5, P3436, DOI 10.1002/ece3.1602; JACOB J, 1978, J LIPID RES, V19, P148; Jacob J., 1982, AVIAN BIOL, DOI [10.1016/B978-0-12-249406-2.50013-7, DOI 10.1016/B978-0-12-249406-2.50013-7]; Jacob S, 2002, NAT GENET, V30, P175, DOI 10.1038/ng830; Johnsen A, 2003, P ROY SOC B-BIOL SCI, V270, P1263, DOI 10.1098/rspb.2003.2375; Komdeur J, 1997, NATURE, V385, P522, DOI 10.1038/385522a0; Komdeur J, 2012, EVOLUTION OF PARENTAL CARE, P171; Krause ET, 2014, BEHAV ECOL SOCIOBIOL, V68, P1819, DOI 10.1007/s00265-014-1791-y; Mainwaring MC, 2012, J ORNITHOL, V153, P1011, DOI 10.1007/s10336-012-0828-0; Mank JE, 2009, HEREDITY, V102, P312, DOI 10.1038/hdy.2008.116; Manzo A, 2014, MOLECULES, V19, P7913, DOI 10.3390/molecules19067913; Menezo YJR, 1999, FERTIL STERIL, V72, P221, DOI 10.1016/S0015-0282(99)00256-3; Moller AP., 1994, SEXUAL SELECTION BAR; Monk DS, 1997, WILSON BULL, V109, P328; Nager RG, 1999, P NATL ACAD SCI USA, V96, P570, DOI 10.1073/pnas.96.2.570; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nord A, 2011, AM NAT, V178, P639, DOI 10.1086/662172; Otte D., 1974, Annual Rev Ecol Syst, V5, P385, DOI 10.1146/annurev.es.05.110174.002125; PAGANELLI CV, 1980, AM ZOOL, V20, P329; Panseri S, 2011, FOOD CHEM, V127, P886, DOI 10.1016/j.foodchem.2010.12.150; Parejo D, 2012, BIOL LETTERS, V8, P502, DOI 10.1098/rsbl.2012.0124; PEIPPO J, 1995, MOL REPROD DEV, V40, P56, DOI 10.1002/mrd.1080400108; Romano A, 2015, J EVOLUTION BIOL, V28, P1234, DOI 10.1111/jeb.12650; Romano A, 2016, BEHAV ECOL, V27, P1198, DOI 10.1093/beheco/arw040; Romano A, 2012, EVOL ECOL, V26, P1041, DOI 10.1007/s10682-011-9543-1; Rosenberg MS, 2000, METAWIN STAT SOFTWAR; Roulin A, 1998, EVOLUTION, V52, P1451, DOI 10.1111/j.1558-5646.1998.tb02026.x; Saino N, 2003, ANIM BEHAV, V66, P1003, DOI 10.1006/anbe.2003.2295; Saino N, 2003, J EVOLUTION BIOL, V16, P516, DOI 10.1046/j.1420-9101.2003.00534.x; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2008, ANIM BEHAV, V75, P1375, DOI 10.1016/j.anbehav.2007.09.011; Soler JJ, 2014, J EVOLUTION BIOL, V27, P1265, DOI 10.1111/jeb.12377; Spurr E. B., 1999, Science for Conservation, P1; Stager KE, 1964, LOS ANGELES COUNTY M, V81, P1; Steiger SS, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-117; STREHL CE, 1986, OECOLOGIA, V70, P178, DOI 10.1007/BF00379237; Surai P. F., 2002, NATURAL ANTIOXIDANTS; Tagirov M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114625; Tillmann H, 2002, GENE, V291, P57, DOI 10.1016/S0378-1119(02)00627-3; Tinbergen JM, 2002, OX ORN SER, V13, P299; TRIVERS RL, 1973, SCIENCE, V179, P90, DOI 10.1126/science.179.4068.90; Tschirren B, 2012, P ROY SOC B-BIOL SCI, V279, P1233, DOI 10.1098/rspb.2011.1543; Turner A., 2006, BARN SWALLOW; Uller T, 2006, BIOL REV, V81, P207, DOI 10.1017/S1464793105006962; van Kerkhof P, 2007, J BIOL CHEM, V282, P20475, DOI 10.1074/jbc.M702610200; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vleck CM, 1998, AVIAN GROWTH DEV EVO, P89; Webster B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116345; Wenzel B.M., 1973, P389; WENZEL BM, 1968, NATURE, V220, P1133, DOI 10.1038/2201133a0; West SA, 2009, MONOGR POPUL BIOL, V44, P162; Whittaker DJ, 2011, BEHAV ECOL, DOI [10.1093/beheco/, DOI 10.1093/BEHECO/]; Williams Joseph B., 1996, P375; Yamazaki K, 2000, P NATL ACAD SCI USA, V97, P10500, DOI 10.1073/pnas.180320997; Zhang SBO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-13; Zhao D, 2010, NATURE, V464, P237, DOI 10.1038/nature08852	93	9	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165055	10.1371/journal.pone.0165055	http://dx.doi.org/10.1371/journal.pone.0165055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851741	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300009
J	Martinez, LM; Estebaranz-Sanchez, F; Galbany, J; Perez-Perez, A				Monica Martinez, Laura; Estebaranz-Sanchez, Ferran; Galbany, Jordi; Perez-Perez, Alejandro			Testing Dietary Hypotheses of East African Hominines Using Buccal Dental Microwear Data	PLOS ONE			English	Article							UNDERGROUND-STORAGE ORGANS; FLK 22 ZINJANTHROPUS; LATE PLIOCENE HOMO; OLDUVAI GORGE; FALLBACK FOODS; QUANTITATIVE-ANALYSIS; PARANTHROPUS-BOISEI; EARLY PLEISTOCENE; ISOTOPIC EVIDENCE; MOLAR MICROWEAR	There is much debate on the dietary adaptations of the robust hominin lineages during the Pliocene-Pleistocene transition. It has been argued that the shift from C3 to C4 ecosystems in Africa was the main factor responsible for the robust dental and facial anatomical adaptations of Paranthropus taxa, which might be indicative of the consumption of fibrous, abrasive plant foods in open environments. However, occlusal dental microwear data fail to provide evidence of such dietary adaptations and are not consistent with isotopic evidence that supports greater C4 food intake for the robust clades than for the gracile australopithecines. We provide evidence from buccal dental microwear data that supports softer dietary habits than expected for P. aethiopicus and P. boisei based both on masticatory apomorphies and isotopic analyses. On one hand, striation densities on the buccal enamel surfaces of paranthropines teeth are low, resembling those of H. habilis and clearly differing from those observed on H. ergaster, which display higher scratch densities indicative of the consumption of a wide assortment of highly abrasive foodstuffs. Buccal dental microwear patterns are consistent with those previously described for occlusal enamel surfaces, suggesting that Paranthropus consumed much softer diets than previously presumed and thus calling into question a strict interpretation of isotopic evidence. On the other hand, the significantly high buccal scratch densities observed in the H. ergaster specimens are not consistent with a highly specialized, mostly carnivorous diet; instead, they support the consumption of a wide range of highly abrasive food items.	[Monica Martinez, Laura; Estebaranz-Sanchez, Ferran; Perez-Perez, Alejandro] Univ Barcelona, Seccio Zool & Antropol, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Barcelona, Spain; [Galbany, Jordi] George Washington Univ, Dept Anthropol, Ctr Adv Study Human Paleobiol, Washington, DC USA	University of Barcelona; George Washington University	Perez-Perez, A (corresponding author), Univ Barcelona, Seccio Zool & Antropol, Dept Biol Evolut Ecol & Ciencies Ambientals, Fac Biol, Barcelona, Spain.	martinez.perez-perez@ub.edu	Martínez, Laura Mónica/J-7148-2017; Sánchez, Ferran Estebaranz/K-7434-2017; Pérez-Pérez, Alejandro/K-6715-2014; Galbany, Jordi/K-8609-2017	Martínez, Laura Mónica/0000-0002-1166-4799; Sánchez, Ferran Estebaranz/0000-0002-9736-3953; Pérez-Pérez, Alejandro/0000-0002-1442-1397; Galbany, Jordi/0000-0001-6724-3451	Spanish "Ministerio de Ciencia e Innovacion" [CGL2011-22999, CGL2014-52611-C2-1-P]	Spanish "Ministerio de Ciencia e Innovacion"(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This research was funded by the Spanish "Ministerio de Ciencia e Innovacion" (http://www.id.mineco.gob.es/portal/site/MICINN/), grant numbers CGL2011-22999 and CGL2014-52611-C2-1-P, both to APP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; Bauchop T, 1978, ECOLOGY ARBOREAL FOL, P195; Behrensmeyer AK, 1997, SCIENCE, V278, P1589, DOI 10.1126/science.278.5343.1589; BERNSTEIN PL, 1978, Z TIERPSYCHOL, V46, P268; Berthaume M, 2010, ANAT REC, V293, P594, DOI 10.1002/ar.21130; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 2003, SCIENCE, V299, P1217, DOI 10.1126/science.1075374; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe R, 2002, J HUM EVOL, V42, P475, DOI 10.1006/jhev.2001.0535; Brown F. H., 1991, KOOBI FORA RES PROJE, V3, P1; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10507, DOI 10.1073/pnas.1222571110; Cerling TE, 2013, P NATL ACAD SCI USA, V110, P10501, DOI 10.1073/pnas.1222568110; Cerling TE, 2011, P NATL ACAD SCI USA, V108, P9337, DOI 10.1073/pnas.1104627108; CHISHOLM BS, 1983, J ARCHAEOL SCI, V10, P355, DOI 10.1016/0305-4403(83)90073-0; Constantino PJ, 2011, J HUM EVOL, V61, P89, DOI 10.1016/j.jhevol.2011.02.009; Constantino PJ, 2010, BIOL LETTERS, V6, P826, DOI 10.1098/rsbl.2010.0304; Constantino PJ, 2009, AM J PHYS ANTHROPOL, V140, P599, DOI 10.1002/ajpa.20978; Copeland SR, 2007, J HUM EVOL, V53, P146, DOI 10.1016/j.jhevol.2007.03.002; Curnoe D, 2006, J HUM EVOL, V50, P36, DOI 10.1016/j.jhevol.2005.07.008; Cuthbert MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107358; Daegling DJ, 2013, AM J PHYS ANTHROPOL, V151, P356, DOI 10.1002/ajpa.22281; DASILVA GL, 1994, INT J PRIMATOL, V15, P655, DOI 10.1007/BF02737426; Davis M, 2016, ECOL EVOL, V6, P1883, DOI 10.1002/ece3.2054; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Deocampo DM, 2009, AM J SCI, V309, P834, DOI 10.2475/09.2009.03; Dominguez-Rodrigo M, 1997, J HUM EVOL, V33, P669, DOI 10.1006/jhev.1997.0161; Dominy NJ, 2008, EVOL BIOL, V35, P159, DOI 10.1007/s11692-008-9026-7; Estebaranz F, 2009, J HUM EVOL, V57, P739, DOI 10.1016/j.jhevol.2009.07.007; Estebaranz F, 2012, J ANTHROPOL SCI, V90, P163, DOI [10.4436/JASS.90006, 10.4436/jass.90006]; Finlayson C., 2014, IMPROBABLE PRIMATE W; FOX CL, 1994, J ARCHAEOL SCI, V21, P29, DOI 10.1006/jasc.1994.1005; FOX CL, 1993, J HUM EVOL, V24, P29, DOI 10.1006/jhev.1993.1004; Galbany J, 2006, MICROSC RES TECHNIQ, V69, P246, DOI 10.1002/jemt.20296; Galbany J, 2005, FOLIA PRIMATOL, V76, P325, DOI 10.1159/000089531; Galbany J, 2005, SCANNING, V27, P23; Galbany J., 2004, ANTHROPOLOGIE, V42, P5; Galbany J., 2004, ANTHROPOLOGIE, V42, P13; Galbany J, 2009, PRIMATES, V50, P221, DOI 10.1007/s10329-009-0139-0; GORDON KD, 1983, AM J PHYS ANTHROPOL, V60, P109, DOI 10.1002/ajpa.1330600115; GORDON KD, 1982, AM J PHYS ANTHROPOL, V59, P195, DOI 10.1002/ajpa.1330590208; Grine F. E., 1988, AUSTRALOPITHECUS PAR, P3; GRINE FE, 1986, J HUM EVOL, V15, P783, DOI 10.1016/S0047-2484(86)80010-0; Grine FE, 2006, J HUM EVOL, V51, P297, DOI 10.1016/j.jhevol.2006.04.004; Grine FE, 2012, AM J PHYS ANTHROPOL, V148, P285, DOI 10.1002/ajpa.22086; Grine FE, 2010, J HUM EVOL, V58, P293, DOI 10.1016/j.jhevol.2009.12.001; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOSHINO J, 1985, Primates, V26, P248, DOI 10.1007/BF02382401; Hylander W.L., 1988, P55; IWAMOTO T, 1983, J ANIM ECOL, V52, P357, DOI 10.2307/4559; Kimbel WH, 1997, AM J PHYS ANTHROPOL, V103, P235, DOI 10.1002/(SICI)1096-8644(199706)103:2<235::AID-AJPA8>3.3.CO;2-V; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; King T, 1999, AM J PHYS ANTHROPOL, V108, P359, DOI 10.1002/(SICI)1096-8644(199903)108:3<359::AID-AJPA10>3.0.CO;2-9; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; LAHM SA, 1986, AM J PRIMATOL, V11, P9, DOI 10.1002/ajp.1350110103; Lalueza C, 1996, AM J PHYS ANTHROPOL, V101, P101; Lalueza C, 1996, AM J PHYS ANTHROPOL, V100, P367, DOI 10.1002/(SICI)1096-8644(199607)100:3<367::AID-AJPA5>3.0.CO;2-R; Lambert JE, 2007, EVOLUTION HUMAN DIET, P324; Lee JJW, 2011, BIOL REV, V86, P959, DOI 10.1111/j.1469-185X.2011.00181.x; LEONARD WR, 1994, AM J HUM BIOL, V6, P77, DOI 10.1002/ajhb.1310060111; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; LUCAS PW, 1995, FOLIA PRIMATOL, V64, P30, DOI 10.1159/000156829; MAAS MC, 1991, AM J PHYS ANTHROPOL, V85, P31, DOI 10.1002/ajpa.1330850106; Macho GA, 1999, AM J PHYS ANTHROPOL, V109, P211, DOI 10.1002/(SICI)1096-8644(199906)109:2<211::AID-AJPA6>3.3.CO;2-2; Macho GA, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0084942, 10.1371/journal.pone.0102794]; Mahoney P, 2006, J HUM EVOL, V50, P452, DOI 10.1016/j.jhevol.2005.11.003; Marlowe FW, 2009, AM J PHYS ANTHROPOL, V140, P751, DOI 10.1002/ajpa.21040; Martinez L. M., 2004, ANTHROPOLOGY, VXLII, P37; McGraw WS, 2016, J HUM EVOL, V98, P90, DOI 10.1016/j.jhevol.2015.06.001; McGraw WS, 2012, AM J PHYS ANTHROPOL, V147, P326, DOI 10.1002/ajpa.21634; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mirazon-Lahr M, 2010, OUT OF AFRICA; MITANI M, 1989, PRIMATES, V30, P307, DOI 10.1007/BF02381257; O'Connell JF, 1999, J HUM EVOL, V36, P461, DOI 10.1006/jhev.1998.0285; Oates John F., 1994, P45; Pazol K, 2005, BEHAV ECOL SOCIOBIOL, V58, P566, DOI 10.1007/s00265-005-0953-3; Perez-Perez A, 2003, J HUM EVOL, V44, P497, DOI 10.1016/S0047-2484(03)00030-7; Perez-Perez A, 1999, AM J PHYS ANTHROPOL, V108, P433, DOI 10.1002/(SICI)1096-8644(199904)108:4<433::AID-AJPA5>3.0.CO;2-5; Perez-Perez A, 1990, EVOLUCION DIETA BALE; Perez-Perez A, 2004, ANTHROPOLOGIE, V42, P1; PEREZPEREZ A, 1994, AM J PHYS ANTHROPOL, V94, P175, DOI 10.1002/ajpa.1330940203; PETERS CR, 1995, J HUM EVOL, V29, P321, DOI 10.1006/jhev.1995.1062; Pinilla Perez B, 2011, ANTHR REV, V74, P25, DOI DOI 10.2478/V10044-010-0005-0; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R, 2012, CURR ANTHROPOL, V53, pS299, DOI 10.1086/667704; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; PUECH PF, 1985, CR ACAD SCI II, V301, P59; PUECH PF, 1984, CURR ANTHROPOL, V25, P349, DOI 10.1086/203146; PUECH PF, 1983, J HUM EVOL, V12, P721, DOI 10.1016/S0047-2484(83)80127-4; Purnell MA, 2006, J ANIM ECOL, V75, P967, DOI 10.1111/j.1365-2656.2006.01116.x; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Remis MJ, 2001, INT J PRIMATOL, V22, P807, DOI 10.1023/A:1012021617737; Romero A, 2009, AM J PHYS ANTHROPOL, P223; Romero A, 2007, NEW PERSPECTIVES PRO; Romero A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084804; Romero A, 2012, AM J PHYS ANTHROPOL, V148, P467, DOI 10.1002/ajpa.22054; Shabel A, 2009, CRANIODENTAL MORPHOL; Shabel A.B., 2010, HUMAN BRAIN EVOL INF, P173, DOI 10.1002/9780470609880.ch9; Shultz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076750; SPETH JD, 1989, J HUM EVOL, V18, P329, DOI 10.1016/0047-2484(89)90035-3; Sponheimer M, 2013, P NATL ACAD SCI USA, V110, P10513, DOI 10.1073/pnas.1222579110; Sponheimer M, 2009, AM J PHYS ANTHROPOL, V140, P661, DOI 10.1002/ajpa.21111; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; Stewart K.M., 2010, HUMAN BRAIN EVOLUTIO, P137, DOI [10.1002/9780470609880.ch8, DOI 10.1002/9780470609880.CH8]; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; TEAFORD MF, 1988, SCANNING MICROSCOPY, V2, P1167; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P73, DOI 10.1002/ajpa.1330800109; TEAFORD MF, 1984, AM J PHYS ANTHROPOL, V64, P191, DOI 10.1002/ajpa.1330640213; Tobias P, 1991, O GORGE SKULLS ENDOC, V4; Tobias PV, 2010, HUMAN BRAIN EVOLUTIO, pvii; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Tutin CEG, 1997, AM J PRIMATOL, V42, P1, DOI 10.1002/(SICI)1098-2345(1997)42:1<1::AID-AJP1>3.0.CO;2-0; Ungar P, 2004, J HUM EVOL, V46, P605, DOI 10.1016/j.jhevol.2004.03.004; Ungar PS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002044; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Ungar PS, 2012, J HUM EVOL, V63, P429, DOI 10.1016/j.jhevol.2011.04.006; Ungar PS, 2010, PHILOS T R SOC B, V365, P3345, DOI 10.1098/rstb.2010.0033; Ungar Peter S., 2009, P121, DOI 10.1007/978-1-4020-9980-9_11; Ungar PS, 1996, J HUM EVOL, V31, P335, DOI 10.1006/jhev.1996.0065; Ungar PS, 2006, J HUM EVOL, V50, P78, DOI 10.1016/j.jhevol.2005.08.007; Ungar PS, 1996, AM J PHYS ANTHROPOL, V100, P101; Ungar PS, 1999, AM J PHYS ANTHROPOL, V109, P387, DOI 10.1002/(SICI)1096-8644(199907)109:3&lt;387::AID-AJPA7&gt;3.0.CO;2-F; van der Merwe NJ, 2008, S AFR J SCI, V104, P153; Vaneechoutte Mario, 2000, Human Evolution, V15, P243, DOI 10.1007/BF02437448; WALKER A, 1981, PHILOS T ROY SOC B, V292, P57, DOI 10.1098/rstb.1981.0013; Waters N E, 1980, Symp Soc Exp Biol, V34, P99; White EC, 2010, INT J PRIMATOL, V31, P627, DOI 10.1007/s10764-010-9417-3; WHITEN A, 1991, PHILOS T ROY SOC B, V334, P187, DOI 10.1098/rstb.1991.0108; Wood B, 2001, AM J PHYS ANTHROPOL, V116, P13, DOI 10.1002/ajpa.1097; Wood B, 1999, SCIENCE, V284, P65, DOI 10.1126/science.284.5411.65; Wood B, 2004, J HUM EVOL, V46, P119, DOI 10.1016/j.jhevol.2003.11.004; WOOD B, 1992, NATURE, V355, P783, DOI 10.1038/355783a0; Wood B, 1998, AM J PHYS ANTHROPOL, V105, P523, DOI 10.1002/(SICI)1096-8644(199804)105:4<523::AID-AJPA9>3.0.CO;2-O; Wood B. A., 1991, HOMINID CRANIAL REMA, V4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732; Wood Bernard, 1993, P485; Wood Bernard A., 2009, P17, DOI 10.1007/978-1-4020-9980-9_3; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; XHONGA FA, 1977, J ORAL REHABIL, V4, P65, DOI 10.1111/j.1365-2842.1977.tb00967.x; Yamagiwa Juichi, 2012, P385	146	13	13	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165447	10.1371/journal.pone.0165447	http://dx.doi.org/10.1371/journal.pone.0165447			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851745	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300016
J	Poremski, D; Vathsala; Wang, P; Lum, A; Subramaniam, M; Ann, CS				Poremski, Daniel; Vathsala; Wang, Peizhi; Lum, Alvin; Subramaniam, Mythily; Ann, Chong Siow			The Impact of Stakeholder Preferences on Service User Adherence to Treatments for Schizophrenia and Metabolic Comorbidities	PLOS ONE			English	Article							ILLNESS; SAMPLE; HEALTH; FOCUS; PEOPLE; RATES	Objective To determine how stakeholder opinions of treatments influence service user decisions to adhere to courses of actions necessary to treat metabolic conditions. Methods Qualitative open-ended interviews were conducted with 20 service providers, 25 service users, and 9 caregivers. Grounded theory was used to generate an understanding that linked preferences of care with adherence to follow-up treatments. Results Participants spoke about several considerations when discussing adherence: Resource limitations were the predominant consideration. Social considerations such as stigma and support surfaced in caregiver and service-user interviews. The influence of symptoms, especially their absence could reduce adherence, and organizational considerations related to the opinions they had about the qualifications of professionals. Discussion A rational patient model partially organizes our findings, but emotional components related to stigma and the opinion of service providers do not fit well into such a model. If service providers do not consider components of the decision making process which fall outside of the rational patient model, they may incorrectly be leveraging suboptimal values to bring about adherence to treatment plans. Being sensitive to the values of service users and their caregivers may allow service providers to better act on points that may bring about change in non-compliant service users with schizophrenia and metabolic comorbidities.	[Poremski, Daniel; Vathsala; Wang, Peizhi; Lum, Alvin; Subramaniam, Mythily; Ann, Chong Siow] Inst Mental Hlth, Div Res, Singapore, Singapore		Poremski, D (corresponding author), Inst Mental Hlth, Div Res, Singapore, Singapore.	daniel_poremski@imh.com.sg			Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme [NMRC/CG/004/2013]	Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme	This research was supported by the Singapore Ministry of Health's National Medical Research Council under the Centre Grant Programme (Grant No.: NMRC/CG/004/2013) awarded to the Institute of Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Almeida OP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111882; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; Barnes TRE, 2011, J PSYCHOPHARMACOL, V25, P567, DOI 10.1177/0269881110391123; Broadbent E, 2011, DIABETES CARE, V34, P338, DOI 10.2337/dc10-1779; Carr VJ, 2004, SOC PSYCH PSYCH EPID, V39, P78, DOI 10.1007/s00127-004-0703-2; Chang CK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019590; Citrome Leslie, 2008, J Psychopharmacol, V22, P90, DOI 10.1177/0269881107087373; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Corrigan PW, 2014, REHABIL PSYCHOL, V59, P85, DOI 10.1037/a0034935; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; DiBonaventura M, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-20; Eiring O, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007848; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gorczynski P, 2014, CLIN SCHIZOPHR RELAT, V4, P1; Greene JA, 2016, PSYCHIAT SERV, V67, P485, DOI 10.1176/appi.ps.201400591; Hewitt J, 2005, J ADV NURS, V52, P561, DOI 10.1111/j.1365-2648.2005.03623.x; Hysong SJ, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-125; MacDougall C, 2001, QUAL HEALTH RES, V11, P117, DOI 10.1177/104973201129118975; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Nasrallah HA, 2006, SCHIZOPHR RES, V86, P15, DOI 10.1016/j.schres.2006.06.026; Domecq JP, 2015, J CLIN ENDOCR METAB, V100, P363, DOI 10.1210/jc.2014-3421; Polednak AP, 2014, SOC PSYCH PSYCH EPID, V49, P1083, DOI 10.1007/s00127-014-0846-8; Raney LE, 2015, AM J PSYCHIAT, V172, P721, DOI 10.1176/appi.ajp.2015.15010017; Rich A, 2015, J BEHAV MED, V38, P673, DOI 10.1007/s10865-015-9644-3; Rojo LE., 2015, PHARM RES; Stahl S.M., 2021, ESSENTIAL PSYCHOPHAR; Stubbs B., 2015, ACTA PSYCHIAT SCAND; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Weiss KA, 2002, SCHIZOPHRENIA BULL, V28, P341, DOI 10.1093/oxfordjournals.schbul.a006943; Werner FM, 2014, EXPERT OPIN DRUG SAF, V13, P1031, DOI 10.1517/14740338.2014.935761; Young SL, 2015, J PSYCHOPHARMACOL, V29, P353, DOI 10.1177/0269881114562090	32	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166171	10.1371/journal.pone.0166171	http://dx.doi.org/10.1371/journal.pone.0166171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851771	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300039
J	Uceyler, N; Schroter, N; Kafke, W; Kramer, D; Wanner, C; Weidemann, F; Sommer, C				Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Wanner, Christoph; Weidemann, Frank; Sommer, Claudia			Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; PAIN SYMPTOM INVENTORY; SMALL FIBER NEUROPATHY; AGALSIDASE-BETA; DIAGNOSIS; NEPHROPATHY; BIOPSIES; EFFICACY; SAFETY; TRIAL	Background The X-chromosomally linked life-limiting Fabry disease (FD) is associated with deposits of the sphingolipid globotriaosylceramide 3 (Gb3) in various tissues. Skin is easily accessible and may be used as an additional diagnostic and follow-up medium. Our aims were to visualize skin Gb3 deposits in FD patients applying immunofluorescence and to determine if cutaneous Gb3 load correlates with disease severity. Methods At our Fabry Center for Interdisciplinary Therapy we enrolled 84 patients with FD and 27 healthy controls. All subjects underwent 5-mm skin punch biopsy at the lateral lower leg and the back. Skin samples were processed for immunohistochemistry using antibodies against CD77 (i.e. Gb3). Cutaneous Gb3 deposition was quantified in a blinded manner and correlated to clinical data. Results We found that Gb3 load was higher in distal skin of male FD patients compared to healthy controls (p<0.05). Men (p<0.01) and women (p<0.05) with a classic FD phenotype had higher distal skin Gb3 load than healthy controls. Men with advanced disease as reflected by impaired renal function, and men and women with small fiber neuropathy had more Gb3 deposits in distal skin samples than males with normal renal function (p<0.05) and without small fiber neuropathy. Gb3 deposits were not different between patients with and without enzyme replacement therapy. Conclusions Immunofluorescence on minimally invasive skin punch biopsies may be useful as a tool for assessment and follow-up in FD patients.	[Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Sommer, Claudia] Univ Wurzburg, Dept Neurol, Wurzburg, Germany; [Wanner, Christoph; Weidemann, Frank] Univ Wurzburg, Dept Internal Med, Wurzburg, Germany; [Ueceyler, Nurcan; Schroeter, Nils; Kafke, Waldemar; Kramer, Daniela; Wanner, Christoph; Weidemann, Frank; Sommer, Claudia] Univ Wurzburg, Wurzburg Fabry Ctr Interdisciplinary Therapy FAZI, Wurzburg, Germany; [Weidemann, Frank] Katharinen Hosp Unna, Innere Klin 2, Obere Husemannstr 2, D-59423 Unna, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Uceyler, N (corresponding author), Univ Wurzburg, Dept Neurol, Wurzburg, Germany.; Uceyler, N (corresponding author), Univ Wurzburg, Wurzburg Fabry Ctr Interdisciplinary Therapy FAZI, Wurzburg, Germany.	ueceyler_n@ukw.de	Schröter, Nils/ABE-4090-2020; Sommer, Claudia/A-9820-2010	Schröter, Nils/0000-0002-3833-9822; Sommer, Claudia/0000-0002-7064-5002; Uceyler, Nurcan/0000-0001-6973-6428	intramural research funds of the University of Wurzburg; European Union's Seventh Framework Programme ("ncRNAPain") [602133]; German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [Sonderforschungsbereich 581]	intramural research funds of the University of Wurzburg; European Union's Seventh Framework Programme ("ncRNAPain"); German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG))	The study was supported by intramural research funds of the University of Wurzburg and by an unrestricted grant to the University of Wurzburg by Genzyme Corp. The sponsor had no knowledge of the study design and the results and also had no influence on the conductance of the project. Claudia Sommer and Nurcan Uceyler received funding by the European Union's Seventh Framework Programme ("ncRNAPain", grant agreement number 602133). This work was part of the doctoral theses of Nils Schroter, who received a six-months scholarship form the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG; Sonderforschungsbereich 581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askari H, 2007, VIRCHOWS ARCH, V451, P823, DOI 10.1007/s00428-007-0468-6; Bouhassira D, 2004, PAIN, V108, P248, DOI 10.1016/j.pain.2003.12.024; Devigili G, 2008, BRAIN, V131, P1912, DOI 10.1093/brain/awn093; Eng CM, 2001, AM J HUM GENET, V68, P711, DOI 10.1086/318809; Kanekura T, 2005, BRIT J DERMATOL, V153, P544, DOI 10.1111/j.1365-2133.2005.06732.x; KAYE EM, 1988, ANN NEUROL, V23, P505, DOI 10.1002/ana.410230513; Lakoma J, 2016, J CELL PHYSIOL, V231, P192, DOI 10.1002/jcp.25072; Lao LM, 1998, J DERMATOL SCI, V18, P109, DOI 10.1016/S0923-1811(98)00032-2; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; MCCARTHY BG, 1995, NEUROLOGY, V45, P1848, DOI 10.1212/WNL.45.10.1848; Navarro C, 2006, ACTA NEUROPATHOL, V111, P178, DOI 10.1007/s00401-005-0026-8; Palungwachira Piti, 2002, J Med Assoc Thai, V85, P842; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rozenfeld PA, 2006, CLIN EXP OPHTHALMOL, V34, P689, DOI 10.1111/j.1442-9071.2006.01318.x; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Schiffmann R, 2009, PHARMACOL THERAPEUT, V122, P65, DOI 10.1016/j.pharmthera.2009.01.003; Sommer C, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-104; Tahir H, 2007, J AM SOC NEPHROL, V18, P2609, DOI 10.1681/ASN.2006121400; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Thurberg BL, 2004, J INVEST DERMATOL, V122, P900, DOI 10.1111/j.0022-202X.2004.22425.x; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; Uceyler N, 2010, NEUROLOGY, V74, P1806, DOI 10.1212/WNL.0b013e3181e0f7b3; Uceyler N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087054; Uceyler N, 2012, J ULTRAS MED, V31, P463; Uceyler N, 2011, J PERIPHER NERV SYST, V16, P304, DOI 10.1111/j.1529-8027.2011.00365.x; Valbuena C, 2012, VIRCHOWS ARCH, V460, P211, DOI 10.1007/s00428-011-1182-y; van der Tol L, 2016, BRIT J OPHTHALMOL, V100, P3, DOI 10.1136/bjophthalmol-2014-306433; van der Tol L, 2015, MOL GENET METAB, V114, P242, DOI 10.1016/j.ymgme.2014.08.007; van Mullem P J, 1972, Arch Belg Dermatol Syphiligr, V28, P41; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Wijburg FA, 2015, PLOS ONE, V10, DOI [DOI 10.1371/journal.pone.0124987, 10.1371/JOUMALPONE.0124987]; Wraith JE, 2008, J PEDIATR-US, V152, P563, DOI 10.1016/j.jpeds.2007.09.007	32	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166484	10.1371/journal.pone.0166484	http://dx.doi.org/10.1371/journal.pone.0166484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851774	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300055
J	Amaya, R; Cancel, LM; Tarbell, JM				Amaya, Ronny; Cancel, Limary M.; Tarbell, John M.			Interaction between the Stress Phase Angle (SPA) and the Oscillatory Shear Index (OSI) Affects Endothelial Cell Gene Expression	PLOS ONE			English	Article							WALL SHEAR; ATHEROSCLEROTIC PLAQUE; CAROTID BIFURCATION; CORONARY-ARTERY; PULSATILE FLOW; SIMULATION; RECEPTOR	Hemodynamic forces play an important role in the non-uniform distribution of atherosclerotic lesions. Endothelial cells are exposed simultaneously to fluid wall shear stress (WSS) and solid circumferential stress (CS). Due to variations in impedance (global factors) and geometric complexities (local factors) in the arterial circulation a time lag arises between these two forces that can be characterized by the temporal phase angle between CS and WSS (stress phase angle-SPA). Asynchronous flows (SPA close to -180 degrees) that are most prominent in coronary arteries have been associated with localization of atherosclerosis. Reversing oscillatory flows characterized by an oscillatory shear index (OSI) that is great than zero are also associated with atherosclerosis localization. In this study we examined the relationship between asynchronous flows and reversing flows in altering the expression of 37 genes relevant to atherosclerosis development. In the case of reversing oscillatory flow, we observed that the asynchronous condition upregulated 8 genes compared to synchronous hemodynamics, most of them proatherogenic. Upregulation of the pro-inflammatory transcription factor NF kappa B p65 was confirmed by western blot, and nuclear translocation of NF kappa B p65 was confirmed by immunofluorescence staining. A comparative study between non reversing flow and reversing flow found that in the case of synchronous hemodynamics, reversing flow altered the expression of 11 genes, while in the case of asynchronous hemodynamics, reversing flow altered the expression of 17 genes. Reversing flow significantly upregulated protein expression of NFKB p65 for both synchronous and asynchronous conditions. Nuclear translocation of NF kappa B p65 was confirmed for synchronous and asynchronous conditions in the presence of flow reversal. These data suggest that asynchronous hemodynamics and reversing flow can elicit proatherogenic responses in endothelial cells compared to synchronous hemodynamics without shear stress reversal, indicating that SPA as well as reversal flow (OSI) are important parameters characterizing arterial susceptibility to disease.	[Amaya, Ronny; Cancel, Limary M.; Tarbell, John M.] CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA	City University of New York (CUNY) System; City College of New York (CUNY)	Tarbell, JM (corresponding author), CUNY City Coll, Dept Biomed Engn, New York, NY 10031 USA.	tarbell@ccny.cuny.edu			National Institutes of Health [HL 086543]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant HL 086543. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129952; Bradley MT, 2016, PSYCHOL REP, V119, P487, DOI 10.1177/0033294116662659; CARO CG, 1971, PROC R SOC SER B-BIO, V177, P109, DOI 10.1098/rspb.1971.0019; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Galkina E, 2007, ARTERIOSCL THROM VAS, V27, P2292, DOI 10.1161/ATVBAHA.107.149179; Ishino S, 2007, ATHEROSCLEROSIS, V195, P48, DOI 10.1016/j.atherosclerosis.2006.11.031; Joshi AK, 2004, ARTERIOSCL THROM VAS, V24, P2408, DOI 10.1161/01.ATV.0000147118.97474.4b; KU DN, 1985, ARTERIOSCLEROSIS, V5, P293, DOI 10.1161/01.ATV.5.3.293; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Levonen AL, 2008, CIRCULATION, V117, P2142, DOI 10.1161/CIRCULATIONAHA.107.718585; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Malek AM, 1999, JAMA-J AM MED ASSOC, V282, P2035, DOI 10.1001/jama.282.21.2035; Murphy JE, 2008, J CELL SCI, V121, P2136, DOI 10.1242/jcs.020917; Nam D., 2010, J VIS EXP, V2010, P1861, DOI DOI 10.3791/1861; Park JG, 2011, CIRC RES, V109, P739, DOI 10.1161/CIRCRESAHA.111.245530; Qiu YC, 2000, J BIOMECH ENG-T ASME, V122, P77, DOI 10.1115/1.429629; Qiu YC, 1996, ASAIO J, V42, pM702, DOI 10.1097/00002480-199609000-00078; Qiu YC, 2000, J VASC RES, V37, P147, DOI 10.1159/000025726; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Tada S, 2005, ANN BIOMED ENG, V33, P1202, DOI 10.1007/s10439-005-5630-1; Tada S, 2007, BIOPHYS J, V93, P3026, DOI 10.1529/biophysj.106.100685; Torii R, 2009, AM J PHYSIOL-HEART C, V296, pH765, DOI 10.1152/ajpheart.01166.2007; van der Giessen AG, 2010, INT J CARDIOVAS IMAG, V26, P781, DOI 10.1007/s10554-009-9546-y; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217	24	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166569	10.1371/journal.pone.0166569	http://dx.doi.org/10.1371/journal.pone.0166569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846267	Green Published, gold			2022-12-26	WOS:000387794600083
J	Gucyetmez, B; Atalan, HK; Cakar, N				Gucyetmez, Bulent; Atalan, Hakan Korkut; Cakar, Nahit		Turkish Tracheotomy Survey Grp	Elective Tracheotomy Practices in Turkey	PLOS ONE			English	Article							PERCUTANEOUS DILATATIONAL TRACHEOSTOMY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; SURGICAL TRACHEOSTOMY; ICU PATIENTS; NATIONWIDE SURVEY; POSTAL SURVEY; METAANALYSIS; TRIALS; INTUBATION	Objectives Elective tracheotomy (ET) procedures in intensive care units (ICU) might be different in accordance with countries and ICUs' features. The aim of the present study was to search the epidemiology of ET procedures in Turkey. Methods A questionnaire which consists of 43 questions was sent by e-mail to 238 ICUs which were officially recognized by The Turkish Ministry of Health. All answers were obtained between August 1, 2015 and August 31, 2015. Results Two hundred and three ICUs (85.3%) participated in this study. 177 (87.2%) and 169 (83.4%) of ICU's were level III and mixed ICUs respectively. Anesthesiologists were the director of 189 (93.0%) ICUs. Estimated total count of admitted, mechanically ventilated and tracheotomized patients in 2014 were 126282, 80569 (63.8%) and 8989 (7.1%) respectively. Most common indication for ET was prolonged mechanical ventilation (76.9%). The first choice for ET procedure was percutaneous in 162 (79.8%) ICUs. Griggs guide wire dilatational forceps (GWDF) technique was used as the first choice for elective percutaneous tracheotomy (EPT) by 143 (70.4%) ICUs. Most common early EPT complication was bleeding (68.0%) and late EPT complication was stenosis (35.0%). While facilitation of weaning was most important advantage (26.1%), bleeding and tracheal complications were most important disadvantages for EPT (29.1%). Conclusions Most common indications for ET are prolonged MV and coma in Turkish ICUs. EPT is the preferred procedure for ET and GWDF is the most common technique. Bronchoscopy and USG are rarely used as a guide.	[Gucyetmez, Bulent; Cakar, Nahit] Acibadem Univ, Dept Anesthesiol, Sch Med, Istanbul, Turkey; [Atalan, Hakan Korkut] Atasehir Mem Hosp, Dept Anesthesiol, Istanbul, Turkey	Acibadem University; Memorial Healthcare Group	Gucyetmez, B (corresponding author), Acibadem Univ, Dept Anesthesiol, Sch Med, Istanbul, Turkey.	bulentgucyetmez@gmail.com	Kavrut Ozturk, Nilgun/P-3404-2016; YAPICI, Nihan/A-9114-2018; Atalan, Hakan Korkut/I-1384-2018; Mutlu, Nevzat Mehmet/AIB-3959-2022; Gucyetmez, Bulent/D-1033-2016	Kavrut Ozturk, Nilgun/0000-0002-9320-0778; YAPICI, Nihan/0000-0002-7684-8177; Atalan, Hakan Korkut/0000-0001-9306-3657; Mutlu, Nevzat Mehmet/0000-0001-7981-3060; Gucyetmez, Bulent/0000-0002-4464-4591; Cakar, Nahit/0000-0002-1302-9596				Angel LF, 2003, CLIN CHEST MED, V24, P423, DOI 10.1016/S0272-5231(03)00053-4; Anon JM, 2004, INTENS CARE MED, V30, P1212, DOI 10.1007/s00134-004-2276-7; Blot F, 2005, CHEST, V127, P1347, DOI 10.1378/chest.127.4.1347; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Byhahn C, 2000, ANAESTHESIST, V49, P202, DOI 10.1007/s001010050815; Cabrini L, 2014, ACTA ANAESTH SCAND, V58, P135, DOI 10.1111/aas.12213; CIAGLIA P, 1985, CHEST, V87, P715, DOI 10.1378/chest.87.6.715; Delaney A, 2006, CRIT CARE, V10, DOI 10.1186/cc4887; Dosemeci L, 2002, INTENS CARE MED, V28, P63, DOI 10.1007/s00134-001-1161-x; Dulguerov P, 1999, CRIT CARE MED, V27, P1617, DOI 10.1097/00003246-199908000-00041; Fantoni A, 1997, INTENS CARE MED, V23, P386, DOI 10.1007/s001340050345; Fikkers BG, 2003, INTENS CARE MED, V29, P1390, DOI 10.1007/s00134-003-1824-x; Fischler L, 2000, INTENS CARE MED, V26, P1428, DOI 10.1007/s001340000634; Freeman BD, 2000, CHEST, V118, P1412, DOI 10.1378/chest.118.5.1412; Frova G, 2002, INTENS CARE MED, V28, P299, DOI 10.1007/s00134-002-1218-5; GRIGGS WM, 1990, SURG GYNECOL OBSTET, V170, P543; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Jackson LM, 2011, J TRAUMA, V71, P1553, DOI 10.1097/TA.0b013e31823ba29e; Kluge S, 2008, ANESTH ANALG, V107, P1639, DOI 10.1213/ane.0b013e318188b818; Krishnan K, 2005, ANAESTHESIA, V60, P360, DOI 10.1111/j.1365-2044.2004.04106.x; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; Maziak DE, 1998, CHEST, V114, P605, DOI 10.1378/chest.114.2.605; Nates JL, 2000, CRIT CARE MED, V28, P3734, DOI 10.1097/00003246-200011000-00034; Oliver ER, 2007, LARYNGOSCOPE, V117, P1570, DOI 10.1097/MLG.0b013e318093edae; Putensen C, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0544-7; Rudas M, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0514-0; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Sollid SJM, 2008, EUR J ANAESTH, V25, P925, DOI 10.1017/S0265021508004791; Van Heurn LWE, 2001, INTENS CARE MED, V27, P292, DOI 10.1007/s001340000743; vanHeurn LWE, 1996, J LARYNGOL OTOL, V110, P723; Vargas M, 2013, MINERVA ANESTESIOL, V79, P156; Walz MK, 1998, INTENS CARE MED, V24, P685, DOI 10.1007/s001340050645	32	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166097	10.1371/journal.pone.0166097	http://dx.doi.org/10.1371/journal.pone.0166097			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846248	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600032
J	Li, L; Zhang, JY; Deng, QS; Li, JM; Li, ZF; Xiao, Y; Hu, SW; Li, TT; Tan, QX; Li, XF; Luo, BS; Mo, H				Li, Li; Zhang, Jiangyu; Deng, Qingshan; Li, Jieming; Li, Zhengfen; Xiao, Yao; Hu, Shuiwang; Li, Tiantian; Tan, Qiuxiao; Li, Xiaofang; Luo, Bingshu; Mo, Hui			Proteomic Profiling for Identification of Novel Biomarkers Differentially Expressed in Human Ovaries from Polycystic Ovary Syndrome Patients	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; CELL-SURVIVAL; ANDROGEN EXCESS; GRANULOSA-CELLS; HSP90; PHOSPHORYLATION; DIAGNOSIS; MECHANISM; CANCER; PREVALENCE	Objectives To identify differential protein expression pattern associated with polycystic ovary syndrome (PCOS). Methods Twenty women were recruited for the study, ten with PCOS as a test group and ten without PCOS as a control group. Differential in-gel electrophoresis (DIGE) analysis and mass spectroscopy were employed to identify proteins that were differentially expressed between the PCOS and normal ovaries. The differentially expressed proteins were further validated by western blot (WB) and immunohistochemistry (IHC). Results DIGE analysis revealed eighteen differentially expressed proteins in the PCOS ovaries of which thirteen were upregulated, and five downregulated. WB and IHC confirmed the differential expression of membrane-associated progesterone receptor component 1 (PGRMC1), retinol-binding protein 1 (RBP1), heat shock protein 90B1, calmodulin 1, annexin A6, and tropomyosin 2. Also, WB analysis revealed significantly (P<0.05) higher expression of PGRMC1 and RBP1 in PCOS ovaries as compared to the normal ovaries. The differential expression of the proteins was also validated by IHC. Conclusions The present study identified novel differentially expressed proteins in the ovarian tissues of women with PCOS that can serve as potential biomarkers for the diagnosis and development of novel therapeutics for the treatment of PCOS using molecular interventions.	[Li, Li; Deng, Qingshan; Li, Jieming; Li, Tiantian; Tan, Qiuxiao; Li, Xiaofang; Luo, Bingshu] Guangdong Women & Children Hosp, Dept Obstet & Gynecol, Guangzhou 510010, Guangdong, Peoples R China; [Zhang, Jiangyu] Guangdong Women & Children Hosp, Dept Pathol, Guangzhou 510010, Guangdong, Peoples R China; [Li, Zhengfen] Southern Med Univ, Affiliated Hosp 3, Guangzhou 510515, Guangdong, Peoples R China; [Xiao, Yao; Mo, Hui] Macau Univ Sci & Technol, Lab Chinese Med Qual Res, Macau 00853, Peoples R China; [Hu, Shuiwang] Southern Med Univ, Dept Pathophysiol, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Macau University of Science & Technology; Southern Medical University - China	Mo, H (corresponding author), Macau Univ Sci & Technol, Lab Chinese Med Qual Res, Macau 00853, Peoples R China.	lili-1406@163.com			Science and Technology Planning Project of Guangdong Province [2014A020212237]; Guangdong Natural Science Foundation [S2013010011984]; Guangdong provincial population and family planning commission [20133071]; Guangzhou Municipal Science and Technology Innovation Council [201510010290]	Science and Technology Planning Project of Guangdong Province; Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong provincial population and family planning commission; Guangzhou Municipal Science and Technology Innovation Council	The study was supported by Science and Technology Planning Project of Guangdong Province (2014A020212237); Guangdong Natural Science Foundation (S2013010011984); Guangdong provincial population and family planning commission (20133071); and Guangzhou Municipal Science and Technology Innovation Council (201510010290).	Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chehab M, 2015, ONCOTARGET, V6, P8454, DOI 10.18632/oncotarget.3502; Chittenden BG, 2009, REPROD BIOMED ONLINE, V19, P398, DOI 10.1016/S1472-6483(10)60175-7; Choi DH, 2010, J PROTEOME RES, V9, P4329, DOI 10.1021/pr100008e; DeUgarte CM, 2005, FERTIL STERIL, V83, P1454, DOI 10.1016/j.fertnstert.2004.11.070; Engmann L, 2006, J CLIN ENDOCR METAB, V91, P4962, DOI 10.1210/jc.2006-1128; Ernst A, 2015, CANCER LETT, V365, P211, DOI 10.1016/j.canlet.2015.05.024; Escobar-Morreale HF, 2007, TRENDS ENDOCRIN MET, V18, P266, DOI 10.1016/j.tem.2007.07.003; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Gao M, 2015, ASIAN PAC J TROP MED, V8, P305, DOI 10.1016/S1995-7645(14)60335-7; Gerdes D, 1998, BIOL CHEM, V379, P907; Gerst F, 2015, DIABETOLOGIA, V58, P2819, DOI 10.1007/s00125-015-3744-z; Ghosh S, 2015, ACS CHEM BIOL, V10, P577, DOI 10.1021/cb5008713; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Haoula Z, 2012, HUM REPROD, V27, P1327, DOI 10.1093/humrep/des042; Hart R, 2006, BEST PRACT RES CL OB, V20, P751, DOI 10.1016/j.bpobgyn.2006.04.006; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Hickey M, 2011, HUM REPROD, V26, P1469, DOI 10.1093/humrep/der102; Hughes AL, 2007, CELL METAB, V5, P143, DOI 10.1016/j.cmet.2006.12.009; Insenser M, 2013, MOL CELL ENDOCRINOL, V370, P65, DOI 10.1016/j.mce.2013.02.009; Lee KH, 2015, AM J RESP CELL MOL, V53, P412, DOI 10.1165/rcmb.2014-0186OC; Li L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152837; Li R, 2013, HUM REPROD, V28, P2562, DOI 10.1093/humrep/det262; Lim GE, 2013, DIABETOLOGIA, V56, P825, DOI 10.1007/s00125-012-2820-x; Ma X, 2007, MOL HUM REPROD, V13, P527, DOI 10.1093/molehr/gam036; Matharoo-Ball B, 2007, J PROTEOME RES, V6, P3321, DOI 10.1021/pr070124b; Min L, 2005, FEBS J, V272, P5832, DOI 10.1111/j.1742-4658.2005.04977.x; Misiti S, 2010, J ENDOCRINOL INVEST, V33, P156, DOI [10.1007/BF03346575, 10.3275/6544]; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Mori M, 2015, INT J ONCOL, V46, P47, DOI 10.3892/ijo.2014.2727; Neukamm SS, 2013, J BIOL CHEM, V288, P16403, DOI 10.1074/jbc.M113.474593; Park JK, 2008, PLACENTA, V29, P584, DOI 10.1016/j.placenta.2008.03.007; Peluso JJ, 2004, BIOL REPROD, V71, P1870, DOI 10.1095/biolreprod.104.031716; Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050; Peluso JJ, 2006, BIOL REPROD, V75, P2, DOI 10.1095/biolreprod.105.049924; Peluso JJ, 2009, J CLIN ENDOCR METAB, V94, P2644, DOI 10.1210/jc.2009-0147; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Sanchon R, 2012, HUM REPROD, V27, P1209, DOI 10.1093/humrep/des028; Sun YF, 2015, ACTA BIOCH BIOPH SIN, V47, P451, DOI 10.1093/abbs/gmv034; Teede HJ, 2007, TRENDS ENDOCRIN MET, V18, P273, DOI 10.1016/j.tem.2007.08.001; Wang HX, 2006, J PROTEOME RES, V5, P361, DOI 10.1021/pr0503681; Wickenheisser JK, 2006, TRENDS ENDOCRIN MET, V17, P63, DOI 10.1016/j.tem.2006.01.003; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450	46	13	14	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0164538	10.1371/journal.pone.0164538	http://dx.doi.org/10.1371/journal.pone.0164538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846214	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600005
J	Powner, MB; Salt, TE; Hogg, C; Jeffery, G				Powner, Michael B.; Salt, Thomas E.; Hogg, Chris; Jeffery, Glen			Improving Mitochondrial Function Protects Bumblebees from Neonicotinoid Pesticides	PLOS ONE			English	Article							NEAR-INFRARED LIGHT; THERAPY; SYSTEM; EYE	Global pollination is threatened by declining insect pollinator populations that may be linked to neonicotinoid pesticide use. Neonicotinoids over stimulate neurons and depolarize their mitochondria, producing immobility and death. However, mitochondrial function can be improved by near infrared light absorbed by cytochrome c oxidase in mitochondrial respiration. In flies, daily exposure to 670nm light throughout life increases average lifespan and aged mobility, and reduces systemic inflammation. Here we treat bumble bees with Imidacloprid a common neonicotinoid. This undermined ATP and rapidly induced immobility and reduced visual function and survival. Bees exposed to insecticide and daily to 670nm light showed corrected ATP levels and significantly improved mobility allowing them to feed. Physiological recordings from eyes revealed that light exposure corrected deficits induced by the pesticide. Overall, death rates in bees exposed to insecticide but also given 670nm light were indistinguishable from controls. When Imidacloprid and light exposure were withdrawn, survival was maintained. Bees and insects generally cannot see deep red light so it does not disturb their behaviour. Hence, we show that deep red light exposure that improves mitochondrial function, reverses the sensory and motor deficits induced by Imidacloprid. These results may have important implications as light delivery is economic and can be placed in hives/colonies.	[Salt, Thomas E.; Hogg, Chris; Jeffery, Glen] UCL, London, England; [Powner, Michael B.] City Univ London, London, England; [Salt, Thomas E.] Neurexpert Ltd, London, England	University of London; University College London; City University London	Jeffery, G (corresponding author), UCL, London, England.	g.jeffery@ucl.ac.uk	Salt, Thomas E/A-6405-2009; Powner, Michael/CAG-7455-2022	Powner, Michael/0000-0003-4913-1004	Biotechnology and Biological Sciences Research Council, UK [BB/N000250/1]; Biotechnology and Biological Sciences Research Council [BB/N000250/1] Funding Source: researchfish; BBSRC [BB/N000250/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Biotechnology and Biological Sciences Research Council, UK, BB/N000250/1.; This research was supported by the BBSRC BB/N000250/1.	Begum R, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0073; Begum R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057828; Darlot F, 2016, ANN NEUROL, V79, P59, DOI 10.1002/ana.24542; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Ferguson M, 2005, BIOCHEM J, V390, P501, DOI 10.1042/BJ20042130; Fitzgerald M, 2013, REV NEUROSCIENCE, V24, P205, DOI 10.1515/revneuro-2012-0086; Gkotsi D, 2014, EXP EYE RES, V122, P50, DOI 10.1016/j.exer.2014.02.023; GOLDSMITH TH, 1960, J GEN PHYSIOL, V43, P775, DOI 10.1085/jgp.43.4.775; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Kokkinopoulos I, 2013, NEUROBIOL AGING, V34, P602, DOI 10.1016/j.neurobiolaging.2012.04.014; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Moffat C, 2016, SCI REP-UK, V6, DOI 10.1038/srep24764; Moffat C, 2015, FASEB J, V29, P2112, DOI 10.1096/fj.14-267179; Rojas JC, 2011, EYE BRAIN, V3, P49, DOI 10.2147/EB.S21391; Rojas JC, 2008, J NEUROSCI, V28, P13511, DOI 10.1523/JNEUROSCI.3457-08.2008; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Vernace VA, 2007, FASEB J, V21, P2672, DOI 10.1096/fj.06-6751com; Vos M, 2013, PLOS ONE; Wilson M, 1970, BIOCHEM J, V116, P17	20	20	20	2	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166531	10.1371/journal.pone.0166531	http://dx.doi.org/10.1371/journal.pone.0166531			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846310	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000387794600077
J	Bonfrer, I; Breebaart, L; Van de Poel, E				Bonfrer, Igna; Breebaart, Lyn; Van de Poel, Ellen			The Effects of Ghana's National Health Insurance Scheme on Maternal and Infant Health Care Utilization	PLOS ONE			English	Article							PROPENSITY SCORE; IMPLEMENTATION; PERCEPTIONS	Increasing equitable access to health care is a main challenge African policy makers are facing. The Ghanaian government implemented the National Health Insurance Scheme in 2004 and the aim of this study is to evaluate its early effects on maternal and infant healthcare use. We exploit data on births before and after the intervention and apply propensity score matching to limit the bias arising from self-selection into the health insurance. About forty percent of children had a mother who is enrolled in this insurance. The scheme significantly increased the proportion of pregnancies with at least four antenatal care visits with 7 percentage points and had a significant effect on attended deliveries (10 percentage points). Caesarean sections increased (6 percentage points) and the number of children born from an unwanted pregnancy decreased (7 percentage points). Insurance enrollment had almost no effect on child vaccinations. Among the poorest forty percent of the sample, the effects of the scheme on antenatal care and attended deliveries were similar. However, the effects of the scheme on caesarean sections were about half the size (3 percentage points) and the reduction in unwanted pregnancies was larger (10 percentage points) compared to the effects in the full sample. We conclude that in the first years of operation, the National Health Insurance Scheme had a modest impact on the use of antenatal and delivery care. This is important for other African countries currently introducing or considering a national health insurance as a means towards universal health coverage.	[Bonfrer, Igna; Breebaart, Lyn; Van de Poel, Ellen] Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, South Holland, Netherlands; [Bonfrer, Igna] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA	Erasmus University Rotterdam; Harvard University; Harvard T.H. Chan School of Public Health	Bonfrer, I (corresponding author), Erasmus Univ, Inst Hlth Policy & Management, Rotterdam, South Holland, Netherlands.; Bonfrer, I (corresponding author), Harvard Univ, Harvard TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.	bonfrer@bmg.eur.nl		Bonfrer, Igna/0000-0002-8570-0393	Netherland Organization for Scientific Research, Rubicon fellowship; Beleid en Management van de Gezondheidszorg Innovationfund; Netherlands Organization for Scientific Research [451-11-031]	Netherland Organization for Scientific Research, Rubicon fellowship; Beleid en Management van de Gezondheidszorg Innovationfund; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Support was provided by: Netherland Organization for Scientific Research, Rubicon fellowship (to IB); Beleid en Management van de Gezondheidszorg Innovationfund, [www.bmg.eurnl] (to IB); and Netherlands Organization for Scientific Research, Veni project 451-11-031 [http://www.nwo.nl/actueel/nieuws//2011/Toekenningen+Verrieuwingsimpuls+Veri+bij+MaGW.html] (to EVdP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agyepong IA, 2008, HEALTH POLICY PLANN, V23, P150, DOI 10.1093/heapol/czn002; Amporfu E, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-4; Arhin A. A., 2013, Developing Country Studies, V3, P151; Arthur E., 2012, HLTH EC REV, V2, P214; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Blanchet N J, 2012, Ghana Med J, V46, P76; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; De Allegri M, 2009, TROP MED INT HEALTH, V14, P586, DOI 10.1111/j.1365-3156.2009.02262.x; Dionne K. Y., 2013, GLOB HLTH, V4, P1; Dixon J., 2011, AFRICANPORTAL BACKGR, V8, P1; Dixon J, 2013, BMC INT HEALTH HUM R, V13, DOI 10.1186/1472-698X-13-35; Escobar ML, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P1; Fenenga C., 2015, A MATTER OF TRUST; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gajate-Garrido G, 2013, EFFECT PARENTS INSUR; Gajate-Garrido G, 2013, NATL HLTH INSURANCE, P1; Ghana Statistical Service, 2009, DEM HLTH SURV 2008 R; Giedion U, 2010, IMPACT OF HEALTH INSURANCE IN LOW- AND MIDDLE-INCOME COUNTRIES, P13; Global Alliance for Vaccines and Immunization, 2005, PROGR REP GAVI VACC; Gobah FF., 2011, GLOBAL J HLTH SCI, V3, P90, DOI [10.5539/gjhs.v3n2p90, DOI 10.5539/GJHS.V3N2P90]; Jehu-Appiah C, 2011, SOC SCI MED, V72, P157, DOI 10.1016/j.socscimed.2010.10.025; Khandker S.R., 2010, HDB IMPACT EVALUATIO; Koch S, 2010, SOC SCI MED, V70, P175, DOI 10.1016/j.socscimed.2009.10.015; Leuven E, 2014, PSMATCH2 STATA MODUL; Mensah J, 2010, HEALTH ECON, V19, P95, DOI 10.1002/hec.1633; Ministry of Health Ghana, 2009, IND REV HLTH SECT PR; National Health Insurance Authority, 2009, NAT HLTH INS AUTH 20; National Health Insurance Authority, 2013, NAT HLTH INS AUTH 20; National Health Insurance Authority, 2008, PROV FREE MAT NEON H; National Health Insurance Scheme, 2014, PREM REG FEE; Ofori-Adjei David, 2007, Ghana Med J, V41, P94; Oxfam, 2014, ACH SHAR GOAL FREE U; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Saleh K., 2012, HLTH SECTOR TRANSITI; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; WHO, 2010, GLOB NUMB COSTS ADD; Witter S, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-16; Witter S, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-20	40	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165623	10.1371/journal.pone.0165623	http://dx.doi.org/10.1371/journal.pone.0165623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC0HG	27835639	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200009
J	Carreras-Sureda, A; Rubio-Moscardo, F; Olvera, A; Argilaguet, J; Kiefer, K; Mothe, B; Meyerhans, A; Brander, C; Vicente, R				Carreras-Sureda, Amado; Rubio-Moscardo, Fanny; Olvera, Alex; Argilaguet, Jordi; Kiefer, Kerstin; Mothe, Beatriz; Meyerhans, Andreas; Brander, Christian; Vicente, Ruben			Lymphocyte Activation Dynamics Is Shaped by Hereditary Components at Chromosome Region 17q12-q21	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; CELL-DIFFERENTIATION; ORMDL3; EXPRESSION; ASTHMA; SUSCEPTIBILITY; RISK; LOCI; IDENTIFICATION	Single nucleotide polymorphisms (SNPs) located in the chromosome region 17q12-q21 are risk factors for asthma. Particularly, there are cis-regulatory haplotypes within this region that regulate differentially the expression levels of ORMDL3, GSDMB and ZPBP2 genes. Remarkably, ORMDL3 has been shown to modulate lymphocyte activation parameters in a heterologous expression system. In this context, it has been shown that Th2 and Th17 cytokine production is affected by SNPs in this region. Therefore, we aim to assess the impact of hereditary components within region 17q12-q21 on the activation profile of human T lymphocytes, focusing on the haplotype formed by allelic variants of SNPs rs7216389 and rs12936231. We measured calcium influx and activation markers, as well as the proliferation rate upon T cell activation. Haplotype-dependent differences in mRNA expression levels of IL-2 and INF-gamma were observed at early times after activation. In addition, the allelic variants of these SNPs impacted on the extent of calcium influx in resting lymphocytes and altered proliferation rates in a dose dependent manner. As a result, the asthma risk haplotype carriers showed a lower threshold of saturation during activation. Finally, we confirmed differences in activation marker expression by flow cytometry using phytohemagglutinin, a strong polyclonal stimulus. Altogether, our data suggest that the genetic component of pro-inflammatory pathologies present in this chromosome region could be explained by different T lymphocyte activation dynamics depending on individual allelic heredity.	[Carreras-Sureda, Amado; Rubio-Moscardo, Fanny; Kiefer, Kerstin; Vicente, Ruben] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona, Spain; [Carreras-Sureda, Amado] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Carreras-Sureda, Amado] Univ Chile, Inst Biomed Sci, Program Cellular & Mol Biol, Ctr Mol Studies Cell, Santiago, Chile; [Olvera, Alex; Mothe, Beatriz; Brander, Christian] Hosp Germans Trias i Pujol, AIDS Res Inst, IrsiCaixa HIVACAT, Badalona, Spain; [Argilaguet, Jordi; Meyerhans, Andreas] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Infect Biol Grp, Barcelona, Spain; [Mothe, Beatriz; Brander, Christian] Univ Vic Univ Cent Catalunya UVic UCC, Vic, Spain; [Meyerhans, Andreas; Brander, Christian] Inst Catalana Recerca & Estudis Avancats, Barcelona, Spain	Pompeu Fabra University; Universidad de Chile; Universidad de Chile; Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Pompeu Fabra University; Universitat de Vic - Universitat Central de Catalunya (UVic-UCC); ICREA	Vicente, R (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona, Spain.	ruben.vicente@upf.edu	Argilaguet, Jordi/E-5109-2016; García, Rubén Vicente/L-1097-2014; Rubio-Moscardó, Francisca/L-6247-2014	Argilaguet, Jordi/0000-0001-5924-2774; García, Rubén Vicente/0000-0003-0401-4808; Rubio-Moscardó, Francisca/0000-0002-3609-9992; Carreras Sureda, Amado/0000-0002-9032-5639; Mothe, Beatriz/0000-0001-9975-407X; Olvera, Alex/0000-0002-9934-5759	Spanish Ministry of Economy and Competitiveness [SAF2010-16725, SAF2013-46077-R, SAF2014-52228-R, BES-2011-043839]; Fondo de Investigacion Sanitaria [Red HERACLES RD12/0042/0014]; Fundacio la Marato de TV3 [20134030]; Fondo Nacional de Desarrollo Cientifico y Tecnologico [FONDECYT 3150113]; ICREA Funding Source: Custom	Spanish Ministry of Economy and Competitiveness(Spanish Government); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacio la Marato de TV3; Fondo Nacional de Desarrollo Cientifico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ICREA(ICREA)	This work was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2010-16725, SAF2013-46077-R, SAF2014-52228-R, BES-2011-043839), Fondo de Investigacion Sanitaria (Red HERACLES RD12/0042/0014), Fundacio la Marato de TV3 (20134030) and Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT 3150113). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Berlivet S, 2012, HUM GENET, V131, P1161, DOI 10.1007/s00439-012-1142-x; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Ferreiros-Vidal I, 2013, BLOOD, V121, P1769, DOI 10.1182/blood-2012-08-450114; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Frauwirth KA, 2002, J CLIN INVEST, V109, P295, DOI 10.1172/JCI200214941; Ha SG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3479; Hamalainen HK, 2001, ANAL BIOCHEM, V299, P63, DOI 10.1006/abio.2001.5369; Kalies K, 2006, J IMMUNOL, V176, P741, DOI 10.4049/jimmunol.176.2.741; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lluis A, 2011, J ALLERGY CLIN IMMUN, V127, P1587, DOI 10.1016/j.jaci.2011.03.015; Mcgovern DPB, 2011, GENOME WIDE ASS IDEN, V42, P332; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Orban C, 2014, CYTOM PART A, V85A, P636, DOI 10.1002/cyto.a.22479; Qiu R, 2013, SCAND J RHEUMATOL, V42, P469, DOI 10.3109/03009742.2013.786755; Quah BJC, 2007, NAT PROTOC, V2, P2049, DOI 10.1038/nprot.2007.296; Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363; Rebollo A, 2001, J IMMUNOL, V167, P6366, DOI 10.4049/jimmunol.167.11.6366; Schedel M, 2015, J ALLERGY CLIN IMMUN, V136, P893, DOI 10.1016/j.jaci.2015.03.014; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stamm C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067746; Tkach KE, 2014, ELIFE, V3, DOI 10.7554/eLife.01944; Toldi G, 2012, IMMUNOBIOLOGY, V217, P37, DOI 10.1016/j.imbio.2011.08.007; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Waysbort N, 2013, J IMMUNOL, V191, P5822, DOI 10.4049/jimmunol.1301575	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166414	10.1371/journal.pone.0166414	http://dx.doi.org/10.1371/journal.pone.0166414			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835674	Green Published, gold			2022-12-26	WOS:000387779200046
J	Fujiwara, M; Zhou, C; Acres, C; Martinez-Andrade, F				Fujiwara, Masami; Zhou, Can; Acres, Chelsea; Martinez-Andrade, Fernando			Interaction between Penaeid Shrimp and Fish Populations in the Gulf of Mexico: Importance of Shrimp as Forage Species	PLOS ONE			English	Article							BROWN SHRIMP; RED DRUM; SCIAENOPS-OCELLATA; GALVESTON BAY; TIME-SERIES; AZTECUS; SALINITY; GROWTH; TEXAS; PREY	This study investigated the contribution of shrimp stocks in supporting the production of valuable predator species. Fishery-independent data on white shrimp, brown shrimp, and selected fish species (spotted seatrout, red drum, and southern flounder) were collected from 1986 to 2014 by the Texas Parks and Wildlife Department, and converted to catch-perunit effort (CPUE). Here, the associations between the CPUEs of fish species as predators and those of shrimp species as prey in each sampled bay and sampling season were analyzed using co-integration analysis and Partial Least Squares Regression (PLSR). Co-integration analysis revealed significant associations between 31 of 70 possible fish/shrimp pairings. The analysis also revealed discernible seasonal and spatial patterns. White shrimp in August and brown shrimp in May were associated with fish CPUEs in bays located along the lower coast of Texas, whereas white shrimp in November was more strongly associated with fish CPUEs in bays located on the upper coast. This suggests the possible influence of latitudinal environmental gradient. The results of the PLSR, on the other hand, were not conclusive. This may reflect the high statistical error rates inherent to the analysis of short non-stationary time series. Co-integration is a robust method when analyzing non-stationary time series, and a majority of time series in this study was non-stationary. Based on our co-integration results, we conclude that the CPUE data show significant associations between shrimp abundance and the three predator fish species in the tested regions.	[Fujiwara, Masami; Acres, Chelsea] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Zhou, Can] Chinese Acad Fisheries Sci, East China Sea Fisheries Res Inst, Shanghai, Peoples R China; [Zhou, Can] Virginia Polytech Inst & State Univ, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA; [Martinez-Andrade, Fernando] Texas Parks & Wildlife Dept, Coastal Fisheries Div, Corpus Christi, TX USA	Texas A&M University System; Texas A&M University College Station; Chinese Academy of Fishery Sciences; East China Sea Fisheries Research Institute, CAFS; Virginia Polytechnic Institute & State University	Fujiwara, M (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	fujiwara@tamu.edu	Fujiwara, Masami/C-3115-2012; Zhou, Can/AAZ-9771-2020	Fujiwara, Masami/0000-0002-9255-6043; Zhou, Can/0000-0003-4533-5333	Institutional Grant from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce [NA140AR4170102]	Institutional Grant from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce	This work was supported by an Institutional Grant (NA140AR4170102) to the Texas Sea Grant College Program from the National Sea Grant Office, National Oceanic and Atmospheric Administration, U.S. Department of Commerce.	Adamack AT, 2012, MAR ECOL PROG SER, V444, P155, DOI 10.3354/meps09431; Alder J, 2008, ANNU REV ENV RESOUR, V33, P153, DOI 10.1146/annurev.environ.33.020807.143204; [Anonymous], 2015, MATLAB VER 8 5; BOOTHBY RN, 1971, T AM FISH SOC, V100, P290, DOI 10.1577/1548-8659(1971)100<290:FHLRAC>2.0.CO;2; ENGLE RF, 1987, ECONOMETRICA, V55, P251, DOI 10.2307/1913236; Fujiwara M, 2008, ECOLOGY, V89, P4, DOI 10.1890/07-1270.1; Fujiwara M, 2009, OIKOS, V118, P1712, DOI 10.1111/j.1600-0706.2009.17570.x; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; Green LM, 2010, MANAGEMENT DATA SERI, V57; Haas HL, 2001, CAN J FISH AQUAT SCI, V58, P2258, DOI 10.1139/cjfas-58-11-2258; Hart R. A., 2012, NMFSSEFSC638 NOAA; Hart RA, 2012, NOAA TECHNICAL MEMOR, P36; Hart Rick A., 2013, U S National Marine Fisheries Service Marine Fisheries Review, V75, P43; KLIMA EF, 1982, MAR FISH REV, V44, P16; Lassuy D.R., 1983, FWSOBS8211 US ARM CO; Martinez-Andrade F., 2015, MARINE RESOURCE MONI; MINELLO TJ, 1984, CONTRIB MAR SCI, V27, P159; MINELLO TJ, 1989, T AM FISH SOC, V118, P693, DOI 10.1577/1548-8659(1989)118<0693:MOYBSP>2.3.CO;2; MINELLO TJ, 1985, ESTUAR COAST SHELF S, V20, P707, DOI 10.1016/0272-7714(85)90027-7; Muncy R. J., 1984, FWSOBS821120 US ARM; MURDOCH WW, 1970, ECOLOGY, V51, P497, DOI 10.2307/1935385; Nance JM, 1993, NMFSSEFSC323 NOAA; National Marine Fisheries Service, 2016, NMFSFSPO163 NOAA US; OVERSTREET RM, 1978, GULF RES REP, V6, P131; Rosas C, 1999, J CRUSTACEAN BIOL, V19, P244, DOI 10.2307/1549230; Rozas LP, 2007, MAR ECOL PROG SER, V344, P119, DOI 10.3354/meps06945; Rozas LP, 2011, J EXP MAR BIOL ECOL, V397, P196, DOI 10.1016/j.jembe.2010.12.003; Rozas LP, 2001, WETLANDS, V21, P327, DOI 10.1672/0277-5212(2001)021[0327:MTAAWR]2.0.CO;2; Saoud IP, 2003, ESTUARIES, V26, P970, DOI 10.1007/BF02803355; Scharf FS, 2000, ESTUARIES, V23, P128, DOI 10.2307/1353230; Simonsen KA, 2013, B MAR SCI, V89, P657, DOI 10.5343/bms.2012.1013; SOLOW AR, 1994, BIOMETRICS, V50, P556, DOI 10.2307/2533401; Stokes GM, 1977, LIFE HIST STUDIES SO; TPWD, 2002, TEX SHRIMP FISH REP; VanderKooy S, 2001, GULF STATES MARINE F, V87; VanderKooy S, 2000, GULF STATES MARINE F, V83; ZEINELDIN ZP, 1965, BIOL BULL-US, V129, P199, DOI 10.2307/1539778; Zhou C, 2016, ENVIRON ECOL STAT, V23, P181, DOI 10.1007/s10651-015-0334-7; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293; Zimmerman RJ, 2002, SALT MARSH LINKAGES, P293	40	12	13	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166479	10.1371/journal.pone.0166479	http://dx.doi.org/10.1371/journal.pone.0166479			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832213	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000129
J	Huang, CH; Wang, CH; Tsai, MS; Hsu, NT; Chiang, CY; Wang, TD; Chang, WT; Chen, HW; Chen, WJ				Huang, Chien-Hua; Wang, Chih-Hung; Tsai, Min-Shan; Hsu, Nai-Tan; Chiang, Chih-Yen; Wang, Tzung-Dau; Chang, Wei-Tien; Chen, Huei-Wen; Chen, Wen-Jone			Urocortin Treatment Improves Acute Hemodynamic Instability and Reduces Myocardial Damage in Post-Cardiac Arrest Myocardial Dysfunction	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; AMERICAN-HEART-ASSOCIATION; RESUSCITATION; CARDIOPULMONARY; ACTIVATION; MODEL; DOBUTAMINE; MANAGEMENT; COMMITTEE; SURVIVAL	Aims Hemodynamic instability occurs following cardiac arrest and is associated with high mortality during the post-cardiac period. Urocortin is a novel peptide and a member of the corticotrophin-releasing factor family. Urocortin has the potential to improve acute cardiac dysfunction, as well as to reduce the myocardial damage sustained after ischemia reperfusion injury. The effects of urocortin in post-cardiac arrest myocardial dysfunction remain unclear. Methods and Results We developed a preclinical cardiac arrest model and investigated the effects of urocortin. After cardiac arrest induced by 6.5 min asphyxia, male Wistar rats were resuscitated and randomized to either the urocortin treatment group or the control group. Urocortin (10 mu g/kg) was administrated intravenously upon onset of resuscitation in the experimental group. The rate of return of spontaneous circulation (ROSC) was similar between the urocortin group (76%) and the control group (72%) after resuscitation. The left ventricular systolic (dP/dt(40)) and diastolic (maximal negative dP/dt) functions, and cardiac output, were ameliorated within 4 h after ROSC in the urocortin-treated group compared to the control group (P<0.01). The neurological function of surviving animals was better at 6 h after ROSC in the urocortin-treated group (p = 0.023). The 72-h survival rate was greater in the urocortintreated group compared to the control group (p = 0.044 by log-rank test). Cardiomyocyte apoptosis was lower in the urocortin-treated group (39.9 +/- 8.6 vs. 17.5 +/- 4.6% of TUNEL positive nuclei, P<0.05) with significantly increased Akt, ERK and STAT-3 activation and phosphorylation in the myocardium (P<0.05). Conclusions Urocortin treatment can improve acute hemodynamic instability as well as reducing myocardial damage in post-cardiac arrest myocardial dysfunction.	[Huang, Chien-Hua; Wang, Chih-Hung; Tsai, Min-Shan; Hsu, Nai-Tan; Chang, Wei-Tien; Chen, Wen-Jone] Natl Taiwan Univ, Med Coll & Hosp, Dept Emergency Med, Taipei, Taiwan; [Huang, Chien-Hua; Wang, Tzung-Dau] Natl Taiwan Univ, Med Coll & Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Chiang, Chih-Yen] Cardinal Tien Hosp, Yunghe Branch, Dept Internal Med, Div Cardiol, New Taipei, Taiwan; [Chen, Huei-Wen] Natl Taiwan Univ, Grad Inst Toxicol, Coll Med, Taipei, Taiwan; [Chen, Wen-Jone] Lotung Poh Ai Hosp, Dept Internal Med, Div Cardiol, Luodong Township, Yilan County, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University	Chen, WJ (corresponding author), Natl Taiwan Univ, Med Coll & Hosp, Dept Emergency Med, Taipei, Taiwan.; Chen, WJ (corresponding author), Lotung Poh Ai Hosp, Dept Internal Med, Div Cardiol, Luodong Township, Yilan County, Taiwan.	wjchen1955@ntu.edu.tw	TSAI, MIN-SHAN/AHE-3825-2022	TSAI, MIN-SHAN/0000-0002-2862-7572; CHANG, WEI-TIEN/0000-0002-1880-7932; HUANG, CHIEN-HUA/0000-0003-2981-4537; CHEN, HUEI-WEN/0000-0001-5051-9896; CHEN, WEN-JONE/0000-0002-2098-5922; WANG, TZUNG-DAU/0000-0002-7180-3607; WANG, CHIH-HUNG/0000-0003-0802-7825	National Science Council [101-2628-B-002-004-MY3]; National Taiwan University Hospital [101MSN04]	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University)	This work was supported by the National Science Council, 101-2628-B-002-004-MY3, and the National Taiwan University Hospital, 101MSN04.	Adao R, 2015, DRUG DISCOV TODAY, V20, P906, DOI 10.1016/j.drudis.2015.02.012; Bale TL, 2004, P NATL ACAD SCI USA, V101, P3697, DOI 10.1073/pnas.0307324101; Barry SP, 2010, J MOL ENDOCRINOL, V45, P69, DOI 10.1677/JME-09-0148; Bigham BL, 2011, RESUSCITATION, V82, P979, DOI 10.1016/j.resuscitation.2011.03.024; Brar BK, 2004, ENDOCRINOLOGY, V145, P24, DOI 10.1210/en.2003-0689; Chanalaris A, 2005, BIOCHEM BIOPH RES CO, V328, P442, DOI 10.1016/j.bbrc.2005.01.001; Davis ME, 2007, EUR HEART J, V28, P2589, DOI 10.1093/eurheartj/ehm340; Hausenloy DJ, 2013, J CLIN INVEST, V123, P92, DOI 10.1172/JCI62874; Hsuchou H, 2010, ENDOCRINOLOGY, V151, P1221, DOI 10.1210/en.2009-1039; Huang C., 2007, TEXT RES J, V28, P53, DOI DOI 10.1097/SHK.0B013E31802F0218; Huang CH, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0516-3; Huang Chien-Hua, 2011, Resuscitation, V82 Suppl 2, pS41, DOI 10.1016/S0300-9572(11)70150-2; Huang HY, 2011, NEUROBIOL AGING, V32, P1662, DOI 10.1016/j.neurobiolaging.2009.09.010; Huang L, 2005, CRIT CARE MED, V33, P487, DOI 10.1097/01.ccm.0000156241.55872.15; Kakavas S, 2011, EUR J PHARMACOL, V667, P32, DOI 10.1016/j.ejphar.2011.06.002; Kern KB, 1996, J AM COLL CARDIOL, V28, P232, DOI 10.1016/0735-1097(96)00130-1; Kimura Y, 2002, J CLIN ENDOCR METAB, V87, P340, DOI 10.1210/jc.87.1.340; Kuizon E, 2009, INT J CARDIOL, V137, P189, DOI 10.1016/j.ijcard.2009.03.112; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Leary S, 2013, AVMA GUIDELINES EUTH; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Madathil RJ, 2016, RESUSCITATION, V105, P85, DOI 10.1016/j.resuscitation.2016.04.009; Meili-Butz S, 2010, EUR J HEART FAIL, V12, P797, DOI 10.1093/eurjhf/hfq054; Morimura N, 2011, RESUSCITATION, V82, P10, DOI 10.1016/j.resuscitation.2010.08.032; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Nielsen N, 2013, NEW ENGL J MED, V369, P2197, DOI 10.1056/NEJMoa1310519; Overgaard CB, 2008, CIRCULATION, V118, P1047, DOI 10.1161/CIRCULATIONAHA.107.728840; Perrin MH, 1999, ANN NY ACAD SCI, V885, P312, DOI 10.1111/j.1749-6632.1999.tb08687.x; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Rademaker MT, 2015, INT J CARDIOL, V197, P56, DOI 10.1016/j.ijcard.2015.06.011; Rademaker MT, 2002, J AM COLL CARDIOL, V40, P1495, DOI 10.1016/S0735-1097(02)02170-8; Smani T, 2011, CLIN EXP PHARMACOL P, V38, P71, DOI 10.1111/j.1440-1681.2010.05466.x; Suleman N, 2008, CARDIOVASC RES, V79, P127, DOI 10.1093/cvr/cvn067; Tsai MS, 2015, AM J EMERG MED, V33, P1374, DOI 10.1016/j.ajem.2015.07.030; Vasquez A, 2004, RESUSCITATION, V61, P199, DOI 10.1016/j.resuscitation.2004.01.002; Walther S, 2014, AM J PHYSIOL-HEART C, V307, pH689, DOI 10.1152/ajpheart.00694.2013; Weihong P, 2007, J MOL NEUROSCI, V33, P232, DOI 10.1007/s12031-007-0071-y; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Wenzel V, 2004, NEW ENGL J MED, V350, P105, DOI 10.1056/NEJMoa025431; Yang LZ, 2011, BRIT J PHARMACOL, V162, P544, DOI 10.1111/j.1476-5381.2010.01067.x; Zhou Y, 2016, J CARDIOVASC PHARM T, V21, P296, DOI 10.1177/1074248415604463	41	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166324	10.1371/journal.pone.0166324	http://dx.doi.org/10.1371/journal.pone.0166324			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832152	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000098
J	Lee, SY; Ro, HJ; Chung, SG; Kang, SH; Seo, KM; Kim, DK				Lee, Sang Yoon; Ro, Hee Joon; Chung, Sun G.; Kang, Si Hyun; Seo, Kyung Mook; Kim, Don-Kyu			Low Skeletal Muscle Mass in the Lower Limbs Is Independently Associated to Knee Osteoarthritis	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; VITAMIN-D DEFICIENCY; LEAN BODY-MASS; SARCOPENIC OBESITY; HIP OSTEOARTHRITIS; PROSPECTIVE COHORT; CARTILAGE LOSS; OLDER PERSONS; RISK-FACTORS; BONE LOSS	Objectives It has been reported that low skeletal muscle mass correlates with knee osteoarthritis in obese individuals. This study aimed to investigate whether lower limb skeletal muscle mass is independently associated with knee osteoarthritis in the general population. Materials and Methods This cross-sectional study used public data from the Fourth and Fifth Korean National Health and Nutrition Examination Survey. Subjects included 4924 community-dwelling adults aged >= 50 years (821 subjects with knee osteoarthritis and 4,103 controls). Skeletal muscle mass index (SMI) was calculated from the appendicular skeletal muscle mass measured by dual energy X-ray absorptiometry. Independent effects of total and lower limb SMI values on knee osteoarthritis were determined using odds ratios (OR) adjusted for age, sex, obesity, total femur bone mineral density, serum vitamin D level, diabetes mellitus status, and physical activity on multivariate logistic regression analysis. Results The adjusted logistic regression model revealed that older age, female sex, and obesity were significantly associated with knee osteoarthritis. A higher serum vitamin D level was also positively correlated with knee osteoarthritis (OR, 1.015; 95% CI, 1.003-1.027; P = 0.010). Although total SMI was not significantly associated with knee osteoarthritis (OR, 0.976; 95% CI, 0.946-1.007; P = 0.127), a low lower limb SMI had an independent effect on knee osteoarthritis (OR, 0.941; 95% CI, 0.900-0.983; P = 0.006). Conclusions Low skeletal muscle mass in the lower limbs but not in the whole body was independently associated with knee osteoarthritis.	[Lee, Sang Yoon; Ro, Hee Joon; Kang, Si Hyun; Seo, Kyung Mook; Kim, Don-Kyu] Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, 102 Heukseok Ro, Seoul 156755, South Korea; [Chung, Sun G.] Seoul Natl Univ, Coll Med, Dept Rehabil Med, 101 Daehang Ro, Seoul 110744, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU)	Kim, DK (corresponding author), Chung Ang Univ, Coll Med, Dept Phys Med & Rehabil, 102 Heukseok Ro, Seoul 156755, South Korea.	donkim21@gmail.com			National Research Foundation of Korea [2011-0030135]; Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MEST) [2011-0030135]	National Research Foundation of Korea(National Research Foundation of Korea); Bio & Medical Technology Development Program of the National Research Foundation - Korean government (MEST)	This work was supported by the National Research Foundation of Korea, 2011-0030135, to Sun G. Chung.; This work was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Korean government (MEST) (No. 2011-0030135).	Annweiler C, 2010, NEUROPSYCHOBIOLOGY, V62, P139, DOI 10.1159/000318570; [Anonymous], 1988, STAT POWER ANAL BEHA; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Baert IAC, 2013, CLIN BIOMECH, V28, P40, DOI 10.1016/j.clinbiomech.2012.10.007; Becker R, 2004, J ORTHOPAED RES, V22, P768, DOI 10.1016/j.orthres.2003.11.004; Burger H, 1996, ARTHRITIS RHEUM, V39, P81, DOI 10.1002/art.1780390111; Candow DG, 2005, J GERONTOL A-BIOL, V60, P148, DOI 10.1093/gerona/60.2.148; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.0.CO;2-M; Chun MY, 2012, KOREAN J FAM MED, V33, P144, DOI 10.4082/kjfm.2012.33.3.144; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dannhauer T, 2014, MAGN RESON MATER PHY, V27, P339, DOI 10.1007/s10334-013-0418-z; Ding C, 2009, ARTHRITIS RHEUM-US, V60, P1381, DOI 10.1002/art.24486; Felson DT, 2007, ARTHRITIS RHEUM-US, V56, P129, DOI 10.1002/art.22292; Fogelholm M, 2006, MED SCI SPORT EXER, V38, P753, DOI 10.1249/01.mss.0000194075.16960.20; Frediani B, 2003, BONE, V33, P575, DOI 10.1016/S8756-3282(03)00208-4; Glass NA, 2013, OSTEOARTHR CARTILAGE, V21, P1154, DOI 10.1016/j.joca.2013.05.016; Grineva EN, 2013, AGING-US, V5, P575; Harding GT, 2012, OSTEOARTHR CARTILAGE, V20, P1234, DOI 10.1016/j.joca.2012.08.004; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; HEIM G, 1990, Z ERNAHRUNGSWISS, V29, P178, DOI 10.1007/BF02021556; Holick MF, 2012, J CLIN ENDOCR METAB, V97, P1153, DOI 10.1210/jc.2011-2601; Hu PF, 2011, MOL BIOL REP, V38, P873, DOI 10.1007/s11033-010-0179-y; Hunter DJ, 2008, ANN RHEUM DIS, V67, P1545, DOI 10.1136/ard.2007.076810; Hwang B, 2012, J KOREAN MED SCI, V27, P748, DOI 10.3346/jkms.2012.27.7.748; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karlsson MK, 2015, CLIN ORTHOP RELAT R, V473, P258, DOI 10.1007/s11999-014-3973-3; Laiguillon MC, 2015, OSTEOARTHR CARTILAGE, V23, P1513, DOI 10.1016/j.joca.2015.04.026; Lane NE, 1999, ARTHRITIS RHEUM-US, V42, P854, DOI 10.1002/1529-0131(199905)42:5&lt;854::AID-ANR3&gt;3.0.CO;2-I; Lang T, 2010, OSTEOPOROSIS INT, V21, P543, DOI 10.1007/s00198-009-1059-y; Le Graverand MPH, 2009, ANN RHEUM DIS, V68, P1734, DOI 10.1136/ard.2007.085530; Lee S, 2012, ARTHRITIS RHEUM-US, V64, P3947, DOI 10.1002/art.37696; Liikavainio T, 2010, KNEE, V17, P69, DOI 10.1016/j.knee.2009.05.003; Lohmander LS, 2009, ANN RHEUM DIS, V68, P490, DOI 10.1136/ard.2008.089748; Maly MR, 2013, ARTHRIT CARE RES, V65, P44, DOI 10.1002/acr.21868; McAlindon T, 2013, JAMA-J AM MED ASSOC, V309, P155, DOI 10.1001/jama.2012.164487; O'Reilly Sheila, 1997, Current Opinion in Rheumatology, V9, P259, DOI 10.1097/00002281-199705000-00014; Papalia R, 2014, Musculoskelet Surg, V98, P9, DOI 10.1007/s12306-014-0311-6; Powell A, 2005, BRIT J SPORT MED, V39, P4, DOI 10.1136/bjsm.2004.011841; Roberson JR, 2000, J AM VET MED ASSOC, V216, P1115, DOI 10.2460/javma.2000.216.1115; Roberson JR, 2000, J AM VET MED ASSOC, V216, P1075; Sanghi D, 2013, CLIN ORTHOP RELAT R, V471, P3556, DOI 10.1007/s11999-013-3201-6; Segal NA, 2012, OSTEOARTHR CARTILAGE, V20, P1534, DOI 10.1016/j.joca.2012.08.019; Toda Y, 2000, J RHEUMATOL, V27, P2449; Visser M, 2005, J GERONTOL A-BIOL, V60, P324, DOI 10.1093/gerona/60.3.324; Wang YY, 2012, ARTHRITIS RHEUM-US, V64, P3917, DOI 10.1002/art.34681; Wilder FV, 2003, OSTEOARTHR CARTILAGE, V11, P29, DOI 10.1053/joca.2002.0857; Zhang YQ, 2001, ARTHRITIS RHEUM, V44, P2065, DOI 10.1002/1529-0131(200109)44:9<2065::AID-ART356>3.0.CO;2-Z; Zheng W, 2011, NEW ENGL J MED, V364, P719, DOI 10.1056/NEJMoa1010679	50	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166385	10.1371/journal.pone.0166385	http://dx.doi.org/10.1371/journal.pone.0166385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832208	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000118
J	Shenoy, VK; Beaver, KM; Fisher, FM; Singhal, G; Dushay, JR; Maratos-Flier, E; Flier, SN				Shenoy, Vivek K.; Beaver, Kristin M.; Fisher, Ffolliott M.; Singhal, Garima; Dushay, Jody R.; Maratos-Flier, Eleftheria; Flier, Sarah N.			Elevated Serum Fibroblast Growth Factor 21 in Humans with Acute Pancreatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; METABOLIC REGULATOR; CIRCULATING FGF21; FGF-21; FIBROBLAST-GROWTH-FACTOR-21; MICE	Background The metabolic regulator Fibroblast Growth Factor 21 (FGF21) is highly expressed in the acinar pancreas, but its role in pancreatic function is obscure. It appears to play a protective role in acute experimental pancreatitis in mice. The aim of this study was to define an association between FGF21 and the course and resolution of acute pancreatitis in humans. Methods and Principal Findings Twenty five subjects with acute pancreatitis admitted from May to September 2012 to the Beth Israel Deaconess Medical Center (BIDMC) were analyzed. Serial serum samples were collected throughout hospitalization and analyzed for FGF21 levels by ELISA. Twenty healthy subjects sampled three times over a four week period were used as controls. We found that, in patients with pancreatitis, serum FGF21 rises significantly and peaks four to six days after the maximum lipase level, before slowly declining. Maximum FGF21 levels were significantly greater than baseline levels for acute pancreatitis subjects (1733 vs. 638 pg/mL, P = 0.003). This maximum value was significantly greater than the highest value observed for our control subjects (1733 vs. 322 pg/mL, P = 0.0002). The ratio of active to total FGF21 did not change during the course of the disease (42.5% vs. 44.4%, P = 0.58). Fold increases in FGF21 were significantly greater in acute pancreatitis subjects than the fold difference seen in healthy subjects (4.7 vs. 2.0, P = 0.01). Higher fold changes were also seen in severe compared to mild pancreatitis (18.2 vs. 4.4, P = 0.01). The timing of maximum FGF21 levels correlated with day of successful return to oral intake (R-2 = 0.21, P = 0.04). Conclusions Our results demonstrate that serum FGF21 rises significantly in humans with acute pancreatitis. The pancreas may be contributing to increased FGF21 levels following injury and FGF21 may play a role in the recovery process.	[Shenoy, Vivek K.; Beaver, Kristin M.; Fisher, Ffolliott M.; Singhal, Garima; Dushay, Jody R.; Maratos-Flier, Eleftheria; Flier, Sarah N.] Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Beaver, Kristin M.] Stanford Univ, Med Ctr, Dept Med, Stanford, CA 94305 USA; [Shenoy, Vivek K.] Univ Calif San Francisco, Sch Med, Dept Pediat, San Francisco, CA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Stanford University; University of California System; University of California San Francisco	Flier, SN (corresponding author), Harvard Med Sch, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	Sflier1@bidmc.harvarvd.edu			NCATS NIH HHS [UL1 TR001102] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Banks PA, 2013, GUT, V62, P102, DOI 10.1136/gutjnl-2012-302779; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Christodoulides C, 2009, J CLIN ENDOCR METAB, V94, P3594, DOI 10.1210/jc.2009-0111; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Feingold KR, 2012, ENDOCRINOLOGY, V153, P2689, DOI 10.1210/en.2011-1496; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2016, ANNU REV PHYSIOL, V78, P223, DOI 10.1146/annurev-physiol-021115-105339; Hansen JS, 2015, MOL METAB, V4, P551, DOI 10.1016/j.molmet.2015.06.001; Johnson CL, 2014, AM J PHYSIOL-ENDOC M, V306, pE916, DOI 10.1152/ajpendo.00559.2013; Johnson CL, 2009, GASTROENTEROLOGY, V137, P1795, DOI 10.1053/j.gastro.2009.07.064; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim KH, 2013, NAT MED, V19, P83, DOI 10.1038/nm.3014; Li HT, 2010, J HEPATOL, V53, P934, DOI 10.1016/j.jhep.2010.05.018; Li HT, 2009, J CLIN ENDOCR METAB, V94, P2151, DOI 10.1210/jc.2008-2331; Markan KR, 2014, DIABETES, V63, P4057, DOI 10.2337/db14-0595; Nishimura T, 2000, BBA-GENE STRUCT EXPR, V1492, P203, DOI 10.1016/S0167-4781(00)00067-1; Novotny D, 2015, CLIN LAB, V61, P1119, DOI 10.7754/Clin.Lab.2015.141251; Singhal G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148252; Suomalainen Anu, 2013, Expert Opin Med Diagn, V7, P313, DOI 10.1517/17530059.2013.812070; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Woo YC, 2013, CLIN ENDOCRINOL, V78, P489, DOI 10.1111/cen.12095; Yilmaz Y, 2010, EUR J CLIN INVEST, V40, P887, DOI 10.1111/j.1365-2362.2010.02338.x; Zhang W, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/417432	25	22	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0164351	10.1371/journal.pone.0164351	http://dx.doi.org/10.1371/journal.pone.0164351			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832059	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000005
J	Xu, Z; Yang, F; Wei, D; Liu, B; Chen, C; Bao, Y; Wu, Z; Wu, D; Tan, H; Li, J; Wang, J; Liu, J; Sun, S; Qu, L; Wang, L				Xu, Z.; Yang, F.; Wei, D.; Liu, B.; Chen, C.; Bao, Y.; Wu, Z.; Wu, D.; Tan, H.; Li, J.; Wang, J.; Liu, J.; Sun, S.; Qu, L.; Wang, L.			Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma	ONCOGENE			English	Article							NF-KAPPA-B; ANTITUMOR-ACTIVITY; CANCER; PROSTATE; INHIBITION; STAT3	Although the use of sorafenib appears to increase the survival rate of renal cell carcinoma (RCC) patients, there is also a proportion of patients who exhibit a poor primary response to sorafenib therapy. It is therefore critical to elucidate the mechanisms underlying sorafenib resistance and find representative biomarkers for sorafenib treatment in RCC patients. Herein, we identified a long non-coding RNA referred to as lncRNA-SRLR (sorafenib resistance-associated lncRNA in RCC) that is upregulated in intrinsically sorafenib-resistant RCCs. lncRNA-SRLR knockdown sensitized nonresponsive RCC cells to sorafenib treatment, whereas the overexpression of lncRNA-SRLR conferred sorafenib resistance to responsive RCC cells. Mechanistically, lncRNA-SRLR directly binds to NF-kappa B and promotes IL-6 transcription, leading to the activation of STAT3 and the development of sorafenib tolerance. A STAT3 inhibitor and IL-6-receptor antagonist both restored the response to sorafenib treatment. Moreover, a clinical investigation demonstrated that high levels of lncRNA-SRLR correlated with poor responses to sorafenib therapy in RCC patients. Collectively, lncRNA-SRLR may serve as not only a predictive biomarker for inherent sorafenib resistance but also as a therapeutic target to enhance responses to sorafenib in RCC patients.	[Xu, Z.; Liu, B.; Bao, Y.; Wu, Z.; Wu, D.; Tan, H.; Li, J.; Wang, J.; Liu, J.; Qu, L.; Wang, L.] Second Mil Med Univ, Changzheng Hosp, Dept Urol, 415 Fengyang Rd, Shanghai 200003, Peoples R China; [Yang, F.; Sun, S.] Second Mil Med Univ, Dept Med Genet, 800 Xiangyin Rd, Shanghai 200433, Peoples R China; [Wei, D.] Shandong Univ, Shandong Prov Qianfoshan Hosp, Div Endocrinol, Dept Internal Med, Jinan, Peoples R China; [Chen, C.] Nanjing Univ, Jinling Hosp, Dept Med Oncol, Clin Sch Med, Nanjing, Jiangsu, Peoples R China; [Qu, L.] Nanjing Univ, Jinling Hosp, Dept Urol, Clin Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China	Naval Medical University; Naval Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Nanjing University; Nanjing University	Wang, L (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Urol, 415 Fengyang Rd, Shanghai 200003, Peoples R China.; Sun, S (corresponding author), Second Mil Med Univ, Dept Med Genet, 800 Xiangyin Rd, Shanghai 200433, Peoples R China.; Qu, L (corresponding author), Nanjing Univ, Jinling Hosp, Dept Urol, Clin Sch Med, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	shsun@vip.sina.com; septsoul@hotmail.com; wanglinhuicz@163.com	Yang, Fu/C-3786-2008; Yang, Fu/L-8441-2019	Yang, Fu/0000-0003-2459-3923; Qu, Le/0000-0001-9499-4277	National Natural Science Foundation of China [81272817, 81472691, 81572521]; Leading Talent Project of Shanghai [2013046]; Youth Talent Sailing Program of Shanghai Science and Technology Committee [16YF1403600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Leading Talent Project of Shanghai; Youth Talent Sailing Program of Shanghai Science and Technology Committee	We thank Dr Feng Liu and Qifei Tao for editing this manuscript. This study was supported by grants from the National Natural Science Foundation of China (81272817, 81472691 and 81572521), the Leading Talent Project of Shanghai (2013046) and Youth Talent Sailing Program of Shanghai Science and Technology Committee (16YF1403600).	Abe H, 2013, INT J UROL, V20, P944, DOI 10.1111/iju.12187; Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Chandarlapaty S, 2012, CANCER DISCOV, V2, P311, DOI 10.1158/2159-8290.CD-12-0018; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Grivennikov S, 2008, CANCER CELL, V13, P7, DOI 10.1016/j.ccr.2007.12.020; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Heng DY, 2012, ANN ONCOL, V23, P1549, DOI 10.1093/annonc/mdr533; Hirata H, 2015, CANCER RES, V75, P1322, DOI 10.1158/0008-5472.CAN-14-2931; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kharaziha P, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.1; Kong J, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-7; Liang YJ, 2013, HEPATOLOGY, V57, P1847, DOI 10.1002/hep.26224; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114586; Ljungberg B, 2015, EUR UROL, V67, P913, DOI 10.1016/j.eururo.2015.01.005; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Martens-Uzunova ES, 2014, EUR UROL, V65, P1140, DOI 10.1016/j.eururo.2013.12.003; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Motzer RJ, 1996, NEW ENGL J MED, V335, P865, DOI 10.1056/NEJM199609193351207; Ozturk G, 2012, EUR REV MED PHARMACO, V16, P2064; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Patil S, 2012, J UROLOGY, V188, P2095, DOI 10.1016/j.juro.2012.08.026; Powles T, 2016, EUR UROL, V69, P4, DOI 10.1016/j.eururo.2015.10.017; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Shi SJ, 2015, ONCOTARGET, V6, P11652, DOI 10.18632/oncotarget.3457; Sotillo E, 2011, NAT GENET, V43, P616, DOI 10.1038/ng.870; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Ye DW, 2014, ONCOTARGETS THER, V7, P925, DOI 10.2147/OTT.S41828; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	37	75	80	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					1965	1977		10.1038/onc.2016.356	http://dx.doi.org/10.1038/onc.2016.356			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27841868				2022-12-26	WOS:000398898500007
J	Geng, QD; Xhabija, B; Knuckle, C; Bonham, CA; Vacratsis, PO				Geng, Qiudi; Xhabija, Besa; Knuckle, Colleen; Bonham, Christopher A.; Vacratsis, Panayiotis O.			The Atypical Dual Specificity Phosphatase hYVH1 Associates with Multiple Ribonucleoprotein Particles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MENTAL-RETARDATION PROTEIN; STRESS GRANULES; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; YVH1; TRANSLATION; PHOSPHORYLATION; IDENTIFICATION; REPRESSION; REGULATORS	Human YVH1 (hYVH1), also known as dual specificity phosphatase 12 (DUSP12), is a poorly characterized atypical dual specificity phosphatase widely conserved throughout evolution. Recent findings have demonstrated that hYVH1 expression affects cellular DNA content and is a novel cell survival phosphatase preventing both thermal and oxidative stress-induced cell death, whereas studies in yeast have established YVH1 as a novel 60S ribosome biogenesis factor. In this study, we have isolated novel hYVH1-associating proteins from human U2OS osteosarcoma cells using affinity chromatography coupled to mass spectrometry employing ion mobility separation. Numerous ribosomal proteins were identified, confirming the work done in yeast. Furthermore, proteins known to be present on additional RNP particles were identified, including Y box-binding protein 1 (YB-1) and fragile X mental retardation protein, proteins that function in translational repression and stress granule regulation. Follow-up studies demonstrated that hYVH1 co-localizes with YB-1 and fragile X mental retardation protein on stress granules in response to arsenic treatment. Interestingly, hYVH1-positive stress granules were significantly smaller, whereas knocking down hYVH1 expression attenuated stress granule breakdown during recovery from arsenite stress, indicating a possible role for hYVH1 in stress granule disassembly. These results propagate a role for dual specificity phosphatases at RNP particles and suggest that hYVH1 may affect a variety of fundamental cellular processes by regulating messenger ribonucleoprotein (mRNP) dynamics.	[Geng, Qiudi; Xhabija, Besa; Knuckle, Colleen; Bonham, Christopher A.; Vacratsis, Panayiotis O.] Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada	University of Windsor	Vacratsis, PO (corresponding author), Univ Windsor, Dept Chem & Biochem, 401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	vacratsi@uwindsor.ca	Xhabija, Besa/GOP-2447-2022	Xhabija, Besa/0000-0002-4784-2454	Natural Sciences and Engineering Research Council of Canada (NSERC) [298468]; Seeds4Hope grant; NSERC CGS; Ontario Trillium award; Ontario Graduate Scholarship program	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Seeds4Hope grant; NSERC CGS(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Trillium award; Ontario Graduate Scholarship program(Ontario Graduate Scholarship)	This work was supported by a Discovery Grant (298468) from the Natural Sciences and Engineering Research Council of Canada (NSERC) (to P. O. V.), a Seeds4Hope grant (to P. O. V.), and an NSERC CGS (to C. A. B. and C. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an Ontario Trillium award.; Supported by the Ontario Graduate Scholarship program.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Alonso A., 2003, PROTEIN PHOSPHATASES, P333; Antrobus R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018218; Beeser AE, 2000, J BACTERIOL, V182, P3517, DOI 10.1128/JB.182.12.3517-3528.2000; Biernacki MA, 2010, CANCER RES, V70, P906, DOI 10.1158/0008-5472.CAN-09-2303; Bonham CA, 2009, J BIOL CHEM, V284, P22853, DOI 10.1074/jbc.M109.038612; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cain EL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018677; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Franklin NE, 2013, J CELL SCI, V126, P1333, DOI 10.1242/jcs.113928; Franklin NE, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209122; Fritzsche R, 2013, CELL REP, V5, P1749, DOI 10.1016/j.celrep.2013.11.023; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; Harada M, 2014, GENES CELLS, V19, P504, DOI 10.1111/gtc.12150; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kemmler S, 2009, J CELL BIOL, V186, P863, DOI 10.1083/jcb.200904111; Kim M, 2009, MOL CELL BIOL, V29, P214, DOI 10.1128/MCB.01377-08; Kozarova A, 2011, CELL CYCLE, V10, P1669, DOI 10.4161/cc.10.10.15641; Kresse SH, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-39; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; LIN A, 1990, P NATL ACAD SCI USA, V87, P8565, DOI 10.1073/pnas.87.21.8565; Liu W, 2012, HUM MOL GENET, V21, P4655, DOI 10.1093/hmg/dds307; Liu Y, 2009, GENETICS, V181, P907, DOI 10.1534/genetics.108.100099; Lo KY, 2009, J CELL BIOL, V186, P849, DOI 10.1083/jcb.200904110; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mendrzyk F, 2006, CLIN CANCER RES, V12, P2070, DOI 10.1158/1078-0432.CCR-05-2363; Muda M, 1999, J BIOL CHEM, V274, P23991, DOI 10.1074/jbc.274.34.23991; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Ray D, 2013, NATURE, V499, P172, DOI 10.1038/nature12311; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Sadatomi D, 2013, INT J MOL SCI, V14, P4596, DOI 10.3390/ijms14034596; Sharda PR, 2009, BIOCHEM J, V418, P391, DOI 10.1042/BJ20081484; Somasekharan SP, 2015, J CELL BIOL, V208, P913, DOI 10.1083/jcb.201411047; Walters RW, 2015, RNA, V21, P1660, DOI 10.1261/rna.053116.115; Warner JR, 2009, MOL CELL, V34, P3, DOI 10.1016/j.molcel.2009.03.006; Yuvaniyama J, 1996, SCIENCE, V272, P1328, DOI 10.1126/science.272.5266.1328; Zhou B, 1999, J BIOL CHEM, V274, P35526, DOI 10.1074/jbc.274.50.35526	42	9	9	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 13	2017	292	2					539	550		10.1074/jbc.M116.715607	http://dx.doi.org/10.1074/jbc.M116.715607			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI2KN	27856639	hybrid, Green Published			2022-12-26	WOS:000392316100011
J	McCarthy, AJ; Negus, D; Martin, P; Pechincha, C; Oswald, E; Stabler, RA; Taylor, PW				McCarthy, Alex J.; Negus, David; Martin, Patricia; Pechincha, Catarina; Oswald, Eric; Stabler, Richard A.; Taylor, Peter W.			Pathoadaptive Mutations of Escherichia coli K1 in Experimental Neonatal Systemic Infection	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; GASTROINTESTINAL-TRACT; FORMATE-LYASE; VIRULENCE; SEQUENCE; COLONIZATION; EPIDEMIOLOGY; BACTEREMIA; MENINGITIS; INDUCTION	Although Escherichia coli K1 strains are benign commensals in adults, their acquisition at birth by the newborn may result in life-threatening systemic infections, most commonly sepsis and meningitis. Key features of these infections, including stable gastrointestinal (GI) colonization and age-dependent invasion of the bloodstream, can be replicated in the neonatal rat. We previously increased the capacity of a septicemia isolate of E. coli K1 to elicit systemic infection following colonization of the small intestine by serial passage through two-day-old (P2) rat pups. The passaged strain, A192PP (belonging to sequence type 95), induces lethal infection in all pups fed 2-6 x 10(6) CFU. Here we use whole-genome sequencing to identify mutations responsible for the threefold increase in lethality between the initial clinical isolate and the passaged derivative. Only four single nucleotide polymorphisms (SNPs), in genes (gloB, yjgV, tdcE) or promoters (thrA) involved in metabolic functions, were found: no changes were detected in genes encoding virulence determinants associated with the invasive potential of E. coli K1. The passaged strain differed in carbon source utilization in comparison to the clinical isolate, most notably its inability to metabolize glucose for growth. Deletion of each of the four genes from the E. coli A192PP chromosome altered the proteome, reduced the number of colonizing bacteria in the small intestine and increased the number of P2 survivors. This work indicates that changes in metabolic potential lead to increased colonization of the neonatal GI tract, increasing the potential for translocation across the GI epithelium into the systemic circulation.	[McCarthy, Alex J.; Negus, David; Pechincha, Catarina; Taylor, Peter W.] UCL, Sch Pharm, London, England; [Martin, Patricia; Oswald, Eric] INSERM, UMR1220, Toulouse, France; [Martin, Patricia; Oswald, Eric] INRA, UMR 1416, Toulouse, France; [Martin, Patricia; Oswald, Eric] Univ Toulouse, UPS, Inst Rech Sante Digest, Toulouse, France; [Oswald, Eric] CHU Toulouse, Hop Purpan, Serv Bacteriol Hyg, Toulouse, France; [Stabler, Richard A.] London Sch Hyg & Trop Med, London, England	University of London; University College London; University of London School of Pharmacy; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; University of London; London School of Hygiene & Tropical Medicine	Taylor, PW (corresponding author), UCL, Sch Pharm, London, England.	peter.taylor@ucl.ac.uk		Negus, David/0000-0001-9047-4565; McCarthy, Alex/0000-0002-4105-3737; Oswald, Eric/0000-0002-3017-0081; Stabler, Richard/0000-0002-2402-6630	Medical Research Council [MR/K018396/1]; Agence Nationale de la Recherch [ANR-13-BSV1-0028-01]; platform Aninfimip, an EquipEx ('Equipement d'Excellence') - French government through the Investments for the Future program [ANR-11-EQPX-0003]; MRC [MR/K018396/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Agence Nationale de la Recherch(French National Research Agency (ANR)); platform Aninfimip, an EquipEx ('Equipement d'Excellence') - French government through the Investments for the Future program(French National Research Agency (ANR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by research grant MR/K018396/1 from the Medical Research Council (http://www.mrc.ac.uk/). This work was also supported by research grant ANR-13-BSV1-0028-01 from the Agence Nationale de la Recherch (http://www. agence-natonale-recherche.fr/) and the platform Aninfimip, an EquipEx ('Equipement d'Excellence') supported by the French government through the Investments for the Future program (ANR-11-EQPX-0003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research grant MR/K018396/1 from the Medical Research Council. This work was also supported by research grant ANR-13-BSV1-0028-01 from the Agence Nationale de la Recherche and the platform Aninfimip, an EquipEx (`Equipement d'Excellence') supported by the French government through the Investments for the Future program (ANR-11-EQPX-0003). The National Institute for Health Research University College London Hospitals Biomedical Research Centre provided infrastructural support.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; BERG RD, 1980, INFECT IMMUN, V29, P1073; Birchenough GMH, 2013, INFECT IMMUN, V81, P3264, DOI 10.1128/IAI.00268-13; Blanco J, 2011, J ANTIMICROB CHEMOTH, V66, P2011, DOI 10.1093/jac/dkr235; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; CONWAY T, 1992, FEMS MICROBIOL LETT, V103, P1; Croxall G, 2011, J ANTIMICROB CHEMOTH, V66, P2501, DOI 10.1093/jac/dkr349; Dalgakiran F, 2014, JOVE-J VIS EXP, DOI 10.3791/52018; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong XY, 2011, BIOTECHNOL ADV, V29, P11, DOI 10.1016/j.biotechadv.2010.07.009; Fabich AJ, 2011, INFECT IMMUN, V79, P2430, DOI 10.1128/IAI.01199-10; GLODE MP, 1977, INFECT IMMUN, V16, P75, DOI 10.1128/IAI.16.1.75-80.1977; Harvey D, 1999, SEMIN PERINATOL, V23, P218, DOI 10.1016/S0146-0005(99)80066-4; Hesslinger C, 1998, MOL MICROBIOL, V27, P477, DOI 10.1046/j.1365-2958.1998.00696.x; KASPER DL, 1973, J IMMUNOL, V110, P262; Kim I, 2004, J BACTERIOL, V186, P7229, DOI 10.1128/JB.186.21.7229-7235.2004; KORHONEN TK, 1985, INFECT IMMUN, V48, P486, DOI 10.1128/IAI.48.2.486-491.1985; Leatham MP, 2005, INFECT IMMUN, V73, P8039, DOI 10.1128/IAI.73.12.8039-8049.2005; Li H, 2011, BIOINFORMATICS, V27, P1157, DOI 10.1093/bioinformatics/btr076; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McCarthy AJ, 2015, INFECT IMMUN, V83, P3704, DOI 10.1128/IAI.00716-15; Mushtaq N, 2005, J ANTIMICROB CHEMOTH, V56, P160, DOI 10.1093/jac/dki177; Mushtaq N, 2004, ANTIMICROB AGENTS CH, V48, P1503, DOI 10.1128/AAC.48.5.1503-1508.2004; Obata-Yasuoka M, 2002, MICROBIOL-SGM, V148, P2745, DOI 10.1099/00221287-148-9-2745; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Ozyamak E, 2010, MOL MICROBIOL, V78, P1577, DOI 10.1111/j.1365-2958.2010.07426.x; Peekhaus N, 1998, J BACTERIOL, V180, P1777, DOI 10.1128/JB.180.7.1777-1785.1998; PLUSCHKE G, 1983, INFECT IMMUN, V39, P599, DOI 10.1128/IAI.39.2.599-608.1983; Polin R A, 2001, Semin Neonatol, V6, P157, DOI 10.1053/siny.2001.0045; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; ROBBINS JB, 1974, NEW ENGL J MED, V290, P1216, DOI 10.1056/NEJM197405302902202; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SAINTGIRONS I, 1985, J BACTERIOL, V161, P461, DOI 10.1128/JB.161.1.461-462.1985; SARFF LD, 1975, LANCET, V1, P1099; Sawers G, 1998, J BACTERIOL, V180, P3509, DOI 10.1128/JB.180.14.3509-3516.1998; SCHIFFER MS, 1976, PEDIATR RES, V10, P82, DOI 10.1203/00006450-197602000-00002; Simonsen KA, 2014, CLIN MICROBIOL REV, V27, P21, DOI 10.1128/CMR.00031-13; Soares SC, 2015, J BIOTECHNOL; TOMLINSON S, 1985, J VIROL, V55, P374, DOI 10.1128/JVI.55.2.374-378.1985; Witcomb LA, 2015, INFECT IMMUN, V83, P4528, DOI 10.1128/IAI.00953-15; Zelmer A, 2008, MICROBIOL-SGM, V154, P2522, DOI 10.1099/mic.0.2008/017988-0; Zerbino DR, 2010, CURR PROTOC BIOINFOR, V11, P11	47	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166793	10.1371/journal.pone.0166793	http://dx.doi.org/10.1371/journal.pone.0166793			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861552	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000388350300108
J	Xu, D; Hou, Y; Zheng, YF; Zheng, Y; Li, MT; Zeng, XF				Xu, Dong; Hou, Yong; Zheng, Yuanfang; Zheng, Yue; Li, Mengtao; Zeng, Xiaofeng			The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center	PLOS ONE			English	Article							PERFORMANCE	Objectives To evaluate the performance of the 2013 ACR/EULAR classification criteria for systemic sclerosis (SSc) in clinical practice in a Chinese patient cohort, and to compare outcomes with the 1980 ACR criteria. Methods Patients clinically diagnosed with SSc between September 2013 and May 2015 were prospectively recruited from the EUSTAR database of the Peking Union Medical College Hospital. Diagnosis of SSc was based on the evaluation of three experienced rheumatologists. Patients diagnosed with other connective tissue diseases were recruited as disease controls. The 1980 ACR and 2013 ACR/EULAR criteria were applied to the cohort, and patients who fulfilled the criteria were classified as definite SSc patients. Sensitivity and specificity were analyzed for the 2013 and 1980 criteria. Results A total of 143 SSc patients and 87 patients with other connective diseases were recruited. 41 (28.7%) and 102 (71.3%) cases were diffuse cutaneous SSc and limited cutaneous SSc, respectively. Although the sensitivity of the 2013 criteria (94.4%) exceeded the 1980 criteria (72.7%) (P<0.001), the 1980 and 2013 criteria sets showed no significant difference in specificity (97.7% and 93.1%, respectively, P = 0.278). The sensitivity of the 2013 criteria was significantly higher than the 1980 criteria in some SSc subgroups (e.g., lcSSc, abnormal pattern of nailfold videocapillaroscopy [NVC] and presence of Raynaud's phenomenon [RP]) compared to others. Conclusions Relative to the 1980 ACR criteria, in Chinese SSc patients the new 2013 ACR/EULAR criteria had similar specificity and higher sensitivity, especially for patients with mild skin thickening or prominent microvascular diseases.	[Li, Mengtao; Zeng, Xiaofeng] Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China; Chinese Acad Med Sci, Key Lab Rheumatol & Clin Immunol, Minist Educ, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College	Li, MT; Zeng, XF (corresponding author), Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Rheumatol & Clin Immunol, Beijing 100730, Peoples R China.	mengtao.li@cstar.org.cn; xiaofeng.zeng@cstar.org.cn	meng, li/GVT-2063-2022		EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China [81571597]; Funding scientific research special clinical medicine of the Chinese medical association [12040740374]	EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding scientific research special clinical medicine of the Chinese medical association	This work was supported by the EULAR Scleroderma Trial & Research group (EUSTAR); National Natural Science Foundation of China [81571597]; and Funding scientific research special clinical medicine of the Chinese medical association [12040740374]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhajeri H, 2015, ARTHRIT CARE RES, V67, P582; [Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Hoffmann-Vold AM, 2015, J RHEUMATOL, V42, P60, DOI 10.3899/jrheum.140047; Jordan S, 2015, RHEUMATOLOGY, V54, P1454, DOI 10.1093/rheumatology/keu530; LeRoy EC, 2001, J RHEUMATOL, V28, P1573; LEROY EC, 1992, CLIN EXP RHEUMATOL, V10, P485; Melchor S, 2016, SEMIN ARTHRITIS RHEU; Pamuk ON, 2016, CLIN RHEUMATOL, V35, P357, DOI 10.1007/s10067-015-3138-0; van den Hoogen F, 2013, ANN RHEUM DIS, V72, P1747, DOI [10.1136/annrheumdis-2013-204424, 10.1002/art.38098]; Zhang X, 1999, CHINESE J RHEUMATOLO, V1, P5; Zhang X, 1999, CHINESE RHEUMATOLOGY, V3, P247	11	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166629	10.1371/journal.pone.0166629	http://dx.doi.org/10.1371/journal.pone.0166629			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851803	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300075
J	Pan, YZ; Wang, XQ; Sun, GL; Lie, FS; Gong, X				Pan, Yuezhi; Wang, Xueqin; Sun, Guiling; Lie, Fusheng; Gong, Xun			Application of RAD Sequencing for Evaluating the Genetic Diversity of Domesticated Panax notoginseng (Araliaceae)	PLOS ONE			English	Article							POPULATION-STRUCTURE; NATURAL-POPULATIONS; SNP DISCOVERY; DE-NOVO; HISTORY; EVOLUTIONARY; LOCI; POLYMORPHISM; INFERENCE; PHYLOGENY	Panax notoginseng, a traditional Chinese medicinal plant, has been cultivated and domesticated for approximately 400 years, mainly in Yunnan and Guangxi, two provinces in southwest China. This species was named according to cultivated rather than wild individuals, and no wild populations had been found until now. The genetic resources available on farms are important for both breeding practices and resource conservation. In the present study, the recently developed technology RADseq, which is based on next-generation sequencing, was used to analyze the genetic variation and differentiation of P. notoginseng. The nucleotide diversity and heterozygosity results indicated that P. notoginseng had low genetic diversity at both the species and population levels. Almost no genetic differentiation has been detected, and all populations were genetically similar due to strong gene flow and insufficient splitting time. Although the genetic diversity of P. notoginseng was low at both species and population levels, several traditional plantations had relatively high genetic diversity, as revealed by the He and p values and by the private allele numbers. These valuable genetic resources should be protected as soon as possible to facilitate future breeding projects. The possible geographical origin of Sanqi domestication was discussed based on the results of the genetic diversity analysis.	[Pan, Yuezhi; Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China; [Pan, Yuezhi; Lie, Fusheng] Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Peoples R China; [Wang, Xueqin] Zhoukou Normal Univ, Coll Life Sci & Agron, Zhoukou, Peoples R China; [Sun, Guiling] Yunnan Key Lab Wild Plant Resources, Kunming, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Yunnan Agricultural University; Zhoukou Normal University	Gong, X (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Peoples R China.; Lie, FS (corresponding author), Yunnan Agr Univ, Coll Agron & Biotechnol, Kunming, Peoples R China.	Ifs810@sina.com; gongxun@mail.kib.ac.cn			National Natural Science Foundation of China [31570339]; Natural Science Foundation of Yunnna province, China [2011FZ207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnna province, China	This project was supported by grant 31570339 from the National Natural Science Foundation of China and grant 2011FZ207 from Natural Science Foundation of Yunnna province, China (YP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artyukova EV, 2004, RUSS J GENET+, V40, P178, DOI 10.1023/B:RUGE.0000016992.55458.3f; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Bolibok-Bragoszewska H, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-184; Bruneaux M, 2013, MOL ECOL, V22, P565, DOI 10.1111/j.1365-294X.2012.05749.x; Catchen J, 2013, MOL ECOL, V22, P2864, DOI 10.1111/mec.12330; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105064; Chen Z, 2001, CHINESE TRADITIONAL, V32, P357; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; DaCosta JM, 2016, MOL PHYLOGENET EVOL, V94, P122, DOI 10.1016/j.ympev.2015.07.026; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Emanuelli F, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-39; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Falush D, 2003, GENETICS, V164, P1567; Frankel OH, 1995, CONSERVATION PLANT D; FRANKEL OH, 1975, CROP GENETIC RESOURC; Frankham R., 2002, INTRO CONSERVATION G, DOI 10.1017/CBO9780511808999; Freeland J. R., 2011, MOL ECOLOGY; Grubbs HJ, 2004, CONSERV GENET, V5, P13, DOI 10.1023/B:COGE.0000014064.44592.bc; Guo HB, 2010, GENET RESOUR CROP EV, V57, P453, DOI 10.1007/s10722-010-9531-2; Guo YM, 2014, J HERED, V105, P555, DOI 10.1093/jhered/esu021; Hamilton M.B., 2009, POPULATION GENETICS; Han YP, 2016, NEW PHYTOL, V209, P871, DOI 10.1111/nph.13626; Hartl Daniel L., 1997; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hohenlohe PA, 2012, PHILOS T R SOC B, V367, P395, DOI 10.1098/rstb.2011.0245; Hohenlohe PA, 2011, MOL ECOL RESOUR, V11, P117, DOI 10.1111/j.1755-0998.2010.02967.x; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Huang RS, 2007, LISHIZHEN MED MAT ME, V18, P1610; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; Jakob SS, 2014, GENOME BIOL EVOL, V6, P685, DOI 10.1093/gbe/evu047; Lee C, 2004, MOL PHYLOGENET EVOL, V31, P894, DOI 10.1016/j.ympev.2003.10.009; Liu W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135390; Lozier JD, 2014, MOL ECOL, V23, P788, DOI 10.1111/mec.12636; Meegahakumbura MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155369; Miao ZuoQing, 2006, Scientia Agricultura Sinica, V39, P1371; Migicovsky Z, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2834-8; Miller MR, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r105; Mutegi E, 2011, THEOR APPL GENET, V122, P989, DOI 10.1007/s00122-010-1504-5; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Ogden R, 2013, MOL ECOL, V22, P3112, DOI 10.1111/mec.12234; Pan Yue-Zhi, 2014, Plant Diversity and Resources, V36, P233, DOI 10.7677/ynzwyj201413084; Pritchard JK, 2000, GENETICS, V155, P945; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Shi FX, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0669-0; SLATKIN M, 1985, ANNU REV ECOL SYST, V16, P393, DOI 10.1146/annurev.ecolsys.16.1.393; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Sun XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058700; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tiwari G, 2016, IND CROP PROD, V86, P1, DOI 10.1016/j.indcrop.2016.03.031; Wang D, 2013, PHYTOCHEMISTRY, V93, P88, DOI 10.1016/j.phytochem.2013.03.007; Wen J, 1996, MOL PHYLOGENET EVOL, V6, P167, DOI 10.1006/mpev.1996.0069; Wen J., 2001, UTILIZATION BIOTECHN, P67; WRIGHT S, 1951, ANN EUGENIC, V15, P323; WRIGHT S, 1978, P580; Wright SI, 2003, MOL ECOL, V12, P1247, DOI 10.1046/j.1365-294X.2003.01743.x; Wu GA, 2014, NAT BIOTECHNOL, V32, P656, DOI 10.1038/nbt.2906; Xiao Hui, 2008, Southwest China Journal of Agricultural Sciences, V21, P147; Xiao JH, 2015, THESIS; Xu P, 2014, PLANT J, V77, P430, DOI 10.1111/tpj.12370; Yao XH, 2012, CONSERV GENET, V13, P1499, DOI 10.1007/s10592-012-0393-3; Yi TS, 2004, TAXON, V53, P987, DOI 10.2307/4135565; Zhang JJ, 2013, BOT J LINN SOC, V173, P775, DOI 10.1111/boj.12116; Zheng GZ, 1994, BIOL PANAX NOTOGINSE; Zhou SL, 2005, J INTEGR PLANT BIOL, V47, P107, DOI 10.1111/j.1744-7909.2005.00013.x; Zhuravlev YN, 2008, ACTA PHARMACOL SIN, V29, P1127, DOI 10.1111/j.1745-7254.2008.00866.x	78	15	23	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166419	10.1371/journal.pone.0166419	http://dx.doi.org/10.1371/journal.pone.0166419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846268	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600061
J	Schnurr, TM; Gjesing, AP; Sandholt, CH; Jonsson, A; Mahendran, Y; Have, CT; Ekstrom, CT; Bjerregaard, AL; Brage, S; Witte, DR; Jorgensen, ME; Aadahl, M; Thuesen, BH; Linneberg, A; Eiberg, H; Pedersen, O; Grarup, N; Kilpelainen, TO; Hansen, T				Schnurr, Theresia M.; Gjesing, Anette P.; Sandholt, Camilla H.; Jonsson, Anna; Mahendran, Yuvaraj; Have, Christian T.; Ekstrom, Claus T.; Bjerregaard, Anne-Louise; Brage, Soren; Witte, Daniel R.; Jorgensen, Marit E.; Aadahl, Mette; Thuesen, Betina H.; Linneberg, Allan; Eiberg, Hans; Pedersen, Oluf; Grarup, Niels; Kilpelainen, Tuomas O.; Hansen, Torben			Genetic Correlation between Body Fat Percentage and Cardiorespiratory Fitness Suggests Common Genetic Etiology	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEART-RATE; OBESITY; EXERCISE; COHORT; MASS	Objectives It has long been discussed whether fitness or fatness is a more important determinant of health status. If the same genetic factors that promote body fat percentage (body fat%) are related to cardiorespiratory fitness (CRF), part of the concurrent associations with health outcomes could reflect a common genetic origin. In this study we aimed to 1) examine genetic correlations between body fat% and CRF; 2) determine whether CRF can be attributed to a genetic risk score (GRS) based on known body fat% increasing loci; and 3) examine whether the fat mass and obesity associated (FTO) locus associates with CRF. Methods Genetic correlations based on pedigree information were examined in a family based cohort (n = 230 from 55 families). For the genetic association analyses, we examined two Danish population-based cohorts (n(total) = 3206). The body fat% GRS was created by summing the alleles of twelve independent risk variants known to associate with body fat%. We assessed CRF as maximal oxygen uptake expressed in millilitres of oxygen uptake per kg of body mass (VO(2)max), per kg fat-free mass (VO(2)max(FFM)), or per kg fat mass (VO(2)max(FM)). All analyses were adjusted for age and sex, and when relevant, for body composition. Results We found a significant negative genetic correlation between VO(2)max and body fat% (rho G = -0.72 (SE +/- 0.13)). The body fat% GRS associated with decreased VO(2)max (beta = -0.15 mL/kg/min per allele, p = 0.0034, age and sex adjusted). The body fat%-increasing FTO allele was associated with a 0.42 mL/kg/min unit decrease in VO(2)max per allele (p = 0.0092, age and sex adjusted). Both associations were abolished after additional adjustment for body fat %. The fat% increasing GRS and FTO risk allele were associated with decreased VO(2)max(FM) but not with VO(2)max(FFM). Conclusions Our findings suggest a shared genetic etiology between whole body fat% and CRF.	[Schnurr, Theresia M.; Gjesing, Anette P.; Sandholt, Camilla H.; Jonsson, Anna; Mahendran, Yuvaraj; Have, Christian T.; Pedersen, Oluf; Grarup, Niels; Kilpelainen, Tuomas O.; Hansen, Torben] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark; [Ekstrom, Claus T.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Biostat Sect, Copenhagen, Denmark; [Aadahl, Mette; Thuesen, Betina H.; Linneberg, Allan] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Copenhagen, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Eiberg, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Cellular & Mol Med, Copenhagen, Denmark; [Bjerregaard, Anne-Louise; Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Brage, Soren] Univ Cambridge, Med Res Council Epidemiol Unit, Cambridge, England; [Jorgensen, Marit E.] Univ Southern Denmark, Natl Inst Publ Hlth, Odense, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, Gentofte, Denmark	Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aarhus University; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; University of Southern Denmark; Steno Diabetes Center	Schnurr, TM (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Copenhagen, Denmark.	tmschnurr@sund.ku.dk	Brage, Soren/C-6415-2013; Pedersen, Oluf/Z-1731-2019; Grarup, Niels/K-2807-2015; Gjesing, Anette/ACC-7521-2022; Witte, Daniel/AAF-9535-2019; Pedersen, Oluf/AAG-8015-2020; Kilpeläinen, Tuomas/F-8569-2012; Schnurr, Theresia M./AAY-9287-2020	Brage, Soren/0000-0002-1265-7355; Pedersen, Oluf/0000-0002-3321-3972; Grarup, Niels/0000-0001-5526-1070; Gjesing, Anette/0000-0003-4580-1576; Witte, Daniel/0000-0002-0769-2922; Kilpeläinen, Tuomas/0000-0002-8349-3028; Schnurr, Theresia M./0000-0002-6573-4959; Thuesen, Betina/0000-0001-9772-4344; Jorgensen, Marit Eika/0000-0001-8356-5565; Aadahl, Mette/0000-0001-5904-9747; Linneberg, Allan/0000-0002-0994-0184; Jonsson, Anna/0000-0003-1252-8673; Ekstrom, Claus Thorn/0000-0003-1191-373X; Bjerregaard, Anne-Louise/0000-0001-9844-5531; Hansen, Torben/0000-0001-8748-3831	Danish Diabetes Academy - Novo Nordisk Foundation; University of Copenhagen Excellence Programme for Interdisciplinary Research; Danish Medical Research Council; European Foundation [74550801]; Danish Council for Strategic Research; Steno Diabetes Center; UK Medical Research Council [MC_UU_12015/3]; Velux Foundation; Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health; Capital Region of Denmark; Novo Nordisk Foundation; MRC [MC_UU_12015/3] Funding Source: UKRI; Lundbeck Foundation [R140-2013-13313] Funding Source: researchfish; Medical Research Council [MC_UU_12015/3] Funding Source: researchfish	Danish Diabetes Academy - Novo Nordisk Foundation; University of Copenhagen Excellence Programme for Interdisciplinary Research; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Foundation(European Science Foundation (ESF)); Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Steno Diabetes Center; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Velux Foundation(Velux Fonden); Danish Agency for Science, Technology and Innovation; Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark); Timber Merchant Vilhelm Bangs Foundation; MEKOS Laboratories (Denmark); Research Centre for Prevention and Health; Capital Region of Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The project was supported by the Danish Diabetes Academy supported by the Novo Nordisk Foundation, the research programme "Governing Obesity" funded by the University of Copenhagen Excellence Programme for Interdisciplinary Research (www.go.ku.dk) as well as the Danish Medical Research Council. The ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801), by the Danish Council for Strategic Research and by internal research and equipment funds from Steno Diabetes Center. The work of SB was funded by the UK Medical Research Council (MC_UU_12015/3). The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark) and Research Centre for Prevention and Health, the Capital Region of Denmark. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.kudk).; The authors thank A. Forman, B. Andersen and G.J. Klaysen from the Novo Nordisk Foundation Center for Basic Metabolic Research for their dedicated and careful technical assistance and G. Lademann for secretarial support. The project was supported by the Danish Diabetes Academy supported by the Novo Nordisk Foundation, the research programme "Governing Obesity" funded by the University of Copenhagen Excellence Programme for Interdisciplinary Research (www.go.ku.dk) as well as the Danish Medical Research Council. The ADDITION PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801), by the Danish Council for Strategic Research and by internal research and equipment funds from Steno Diabetes Center. The work of SB was funded by the UK Medical Research Council (MC_UU_12015/3). The Health2006 study was financially supported by grants from the Velux Foundation; the Danish Medical Research Council, Danish Agency for Science, Technology and Innovation; the Aase and Ejner Danielsens Foundation; ALK-Abello A/S (Horsholm, Denmark), Timber Merchant Vilhelm Bangs Foundation, MEKOS Laboratories (Denmark) and Research Centre for Prevention and Health, the Capital Region of Denmark. The Novo Nordisk Foundation Center for Basic Metabolic Research is an independent research center at the University of Copenhagen partially funded by an unrestricted donation from the Novo Nordisk Foundation (www.metabol.ku.dk).	Aadahl M, 2013, EUR J PREV CARDIOL, V20, P1088, DOI 10.1177/2047487312462825; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreasen CH, 2008, DIABETES, V57, P95, DOI 10.2337/db07-0910; ASTRAND PO, 1954, J APPL PHYSIOL, V7, P218, DOI 10.1152/jappl.1954.7.2.218; Blair SN, 2001, MED SCI SPORT EXER, V33, pS379, DOI 10.1097/00005768-200106001-00007; Blair SN, 1999, MED SCI SPORT EXER, V31, pS646, DOI 10.1097/00005768-199911001-00025; Blair SN, 2004, JAMA-J AM MED ASSOC, V292, P1232, DOI 10.1001/jama.292.10.1232; BOUCHARD C, 1988, INT J OBESITY, V12, P205; Bouchard C, 1998, MED SCI SPORT EXER, V30, P252, DOI 10.1097/00005768-199802000-00013; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2007, J APPL PHYSIOL, V103, P682, DOI 10.1152/japplphysiol.00092.2006; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gjesing AP, 2015, DIABETOLOGIA, V58, P1006, DOI 10.1007/s00125-015-3516-9; Gjesing AP, 2014, DIABETOLOGIA, V57, P1173, DOI 10.1007/s00125-014-3207-y; Goran M, 2000, INT J OBESITY, V24, P841, DOI 10.1038/sj.ijo.0801241; Hamer M, 2007, PREV MED, V44, P3, DOI 10.1016/j.ypmed.2006.09.005; Hinriksdottir G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130597; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Johnson W, 2015, BEHAV GENET, V45, P84, DOI 10.1007/s10519-014-9690-6; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Knab AM, 2010, INT J BIOL SCI, V6, P133; Knab AM, 2009, BEHAV BRAIN RES, V204, P147, DOI 10.1016/j.bbr.2009.05.034; Laukkanen JA, 2009, AM J CARDIOL, V103, P1598, DOI 10.1016/j.amjcard.2009.01.371; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227; Maes HHM, 1997, BEHAV GENET, V27, P325, DOI 10.1023/A:1025635913927; Rankinen T, 2010, OBESITY, V18, P322, DOI 10.1038/oby.2009.205; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Tanaka H, 2001, J AM COLL CARDIOL, V37, P153, DOI 10.1016/S0735-1097(00)01054-8; Thuesen BH, 2014, INT J EPIDEMIOL, V43, P568, DOI 10.1093/ije/dyt009	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166738	10.1371/journal.pone.0166738	http://dx.doi.org/10.1371/journal.pone.0166738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846319	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600105
J	Castro-Castro, A; Muriel, O; del Pozo, MA; Bustelo, XR				Castro-Castro, Antonio; Muriel, Olivia; del Pozo, Miguel A.; Bustelo, Xose R.			Characterization of Novel Molecular Mechanisms Favoring Rac1 Membrane Translocation	PLOS ONE			English	Article							INTEGRIN-ASSOCIATED PROTEIN; SMALL GTPASE RAC; G-BETA-GAMMA; CELL-MIGRATION; PLASMA-MEMBRANE; CORONIN 1A; SIGNAL-TRANSDUCTION; LIPID RAFTS; ACTIVATION; DISSOCIATION	The Rac1 GTPase plays key roles in cytoskeletal organization, cell motility and a variety of physiological and disease-linked responses. Wild type Rac1 signaling entails dissociation of the GTPase from cytosolic Rac1-Rho GDP dissociation inhibitor (GDI) complexes, translocation to membranes, activation by exchange factors, effector binding, and activation of downstream signaling cascades. Out of those steps, membrane translocation is the less understood. Using transfections of a expression cDNA library in cells expressing a Rac1 bioreporter, we previously identified a cytoskeletal feedback loop nucleated by the F-actin binding protein coronin 1A (Coro1A) that promotes Rac1 translocation to the plasma membrane by facilitating the Pak-dependent dissociation of Rac1-Rho GDI complexes. This screening identified other potential regulators of this process, including WDR26, basigin, and TMEM8A. Here, we show that WDR26 promotes Rac1 translocation following a Coro1A-like and Coro1A-dependent mechanism. By contrast, basigin and TMEM8A stabilize Rac1 at the plasma membrane by inhibiting the internalization of caveolin-rich membrane subdomains. This latter pathway is F-actin-dependent but Coro1A-, Pak- and Rho GDI-independent.	[Castro-Castro, Antonio; Bustelo, Xose R.] Ctr Invest Canc, Salamanca, Spain; [Castro-Castro, Antonio; Bustelo, Xose R.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain; [Muriel, Olivia; del Pozo, Miguel A.] Ctr Nacl Invest Cardiovasc, Vasc Pathophysiol Dept, Madrid, Spain; [Bustelo, Xose R.] Carlos III Hlth Inst, Ctr Invest Biorned Red Oncol, Madrid, Spain; [Castro-Castro, Antonio] Inst Pasteur, Cell Polar Migrat & Invas Unit, Paris, France; [Muriel, Olivia] Univ Geneva, Dept Biochem, Geneva, Switzerland	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Geneva	Castro-Castro, A; Bustelo, XR (corresponding author), Ctr Invest Canc, Salamanca, Spain.; Castro-Castro, A; Bustelo, XR (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, Salamanca, Spain.; Bustelo, XR (corresponding author), Carlos III Hlth Inst, Ctr Invest Biorned Red Oncol, Madrid, Spain.; Castro-Castro, A (corresponding author), Inst Pasteur, Cell Polar Migrat & Invas Unit, Paris, France.	antonio.castro@pasteur.fr; xbustelo@usal.es	del Pozo, Miguel Angel/L-2861-2014; Bustelo, Xose R./A-9526-2010; Bustelo, Xose R./AAD-2081-2022	del Pozo, Miguel Angel/0000-0001-9077-391X; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072; Muriel, Olivia/0000-0003-2640-2342	Spanish Ministry of Economy and Competitiveness [RD12/0036/0002, SAF2015-64556-R]; Worldwide Cancer Research [14-1248]; Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon [CSI049U16]; Fundacion Cientifica Asociacion Espanola contra el Cancer [GD16173472GARC]; Junta de Castilla y Leon	Spanish Ministry of Economy and Competitiveness(Spanish Government); Worldwide Cancer Research; Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon; Fundacion Cientifica Asociacion Espanola contra el Cancer; Junta de Castilla y Leon(Junta de Castilla y Leon)	XRB has been supported by grants from the Spanish Ministry of Economy and Competitiveness (RD12/0036/0002, SAF2015-64556-R), Worldwide Cancer Research (14-1248), Ramon Areces Foundation, Consejeria de Educacion of the Junta de Castilla y Leon (CSI049U16), and Fundacion Cientifica Asociacion Espanola contra el Cancer (GD16173472GARC). Funding from both the Spanish Ministry of Economy and Competitiveness and Junta de Castilla y Leon is partially contributed by the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovici H, 2009, MOL BIOL CELL, V20, P2049, DOI 10.1091/mbc.E07-12-1248; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BROWN E, 1990, J CELL BIOL, V111, P2785, DOI 10.1083/jcb.111.6.2785; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2012, BIOESSAYS, V34, P748, DOI 10.1002/bies.201200041; Bustelo XR, 2012, SMALL GTPASES, V3, P1; Castillo-Lluva S, 2010, NAT CELL BIOL, V12, P1078, DOI 10.1038/ncb2112; Castro-Castro A, 2011, EMBO J, V30, P3913, DOI 10.1038/emboj.2011.310; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Chao WT, 2010, J CELL BIOL, V190, P247, DOI 10.1083/jcb.200911110; Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Chuang HW, 2015, PLANT SCI, V241, P23, DOI 10.1016/j.plantsci.2015.09.024; CHUANG TH, 1993, J BIOL CHEM, V268, P26206; Cordova-Palomera A, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.49; de Kreu BJ, 2011, J CELL SCI, V124, P2375, DOI 10.1242/jcs.080630; de la Vega M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1243; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Fei F, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-48; Feng YS, 2012, FREE RADICAL RES, V46, P777, DOI 10.3109/10715762.2012.678840; Francis O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075217; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Gandhi Meghal, 2008, V48, P72, DOI 10.1007/978-0-387-09595-0_7; Gandhi PN, 2004, BIOCHEM J, V378, P409, DOI 10.1042/BJ20030979; Gosser YQ, 1997, NATURE, V387, P814, DOI 10.1038/42961; Goto T, 2016, FEBS LETT, V590, P1291, DOI 10.1002/1873-3468.12180; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Maruta Hiroshi, 2002, Methods Mol Biol, V189, P75; MAWBY WJ, 1994, BIOCHEM J, V304, P525, DOI 10.1042/bj3040525; Miyashita M, 2004, MOL BIOL CELL, V15, P3950, DOI 10.1091/mbc.E04-01-0019; Muramatsu T, 2016, J BIOCHEM, V159, P481, DOI 10.1093/jb/mvv127; Murata T, 2006, J NEUROSCI, V26, P12397, DOI 10.1523/JNEUROSCI.3981-06.2006; Muriel O, 2011, J CELL SCI, V124, P2763, DOI 10.1242/jcs.080804; Nethe M, 2010, J CELL SCI, V123, P1948, DOI 10.1242/jcs.062919; Norambuena A, 2011, MOL BIOL CELL, V22, P3456, DOI 10.1091/mbc.E11-04-0361; Ojeda V, 2015, MOL BIOL CELL, V26, P2895, DOI 10.1091/mbc.E15-01-0052; Ojeda V, 2014, MOL CELL BIOL, V34, P3388, DOI 10.1128/MCB.00347-14; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Porter Andrew P, 2016, Small GTPases, V7, P123, DOI 10.1080/21541248.2016.1173767; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Rebres RA, 2005, J CELL PHYSIOL, V205, P182, DOI 10.1002/jcp.20379; Rosenberger G, 2006, EUR J CELL BIOL, V85, P265, DOI 10.1016/j.ejcb.2005.10.007; Runne C, 2013, CELL ADHES MIGR, V7, P214, DOI 10.4161/cam.22940; Saci A, 2011, MOL CELL, V42, P50, DOI 10.1016/j.molcel.2011.03.017; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SCHLIWA M, 1982, J CELL BIOL, V92, P79, DOI 10.1083/jcb.92.1.79; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sun ZZ, 2013, J BIOL CHEM, V288, P16715, DOI 10.1074/jbc.M113.462564; Sun ZZ, 2011, J BIOL CHEM, V286, P43902, DOI 10.1074/jbc.M111.301382; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Tolias KF, 1998, MOL CELL BIOL, V18, P762, DOI 10.1128/MCB.18.2.762; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Wang XQ, 1998, MOL BIOL CELL, V9, P865, DOI 10.1091/mbc.9.4.865; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Ye Y, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7439; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yoshida H, 2000, BLOOD, V96, P234, DOI 10.1182/blood.V96.1.234.013k06_234_241; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232; Zhao J, 2009, NEUROSCI LETT, V460, P66, DOI 10.1016/j.neulet.2009.05.024; Zhu Y, 2004, J CELL BIOCHEM, V93, P579, DOI 10.1002/jcb.20175	72	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166715	10.1371/journal.pone.0166715	http://dx.doi.org/10.1371/journal.pone.0166715			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835684	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200065
J	Liu, X; Han, Q; Wang, J; Wang, X; Xu, JH; Shi, JR				Liu, Xin; Han, Qi; Wang, Jian; Wang, Xin; Xu, Jianhong; Shi, Jianrong			Two FgLEU2 Genes with Different Roles in Leucine Biosynthesis and Infection-Related Morphogenesis in Fusarium graminearum	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; RESISTANCE; VIRULENCE; SYNTHASE; TRANSFORMATION; PATHOGENESIS; METABOLISM; MUTATIONS; SURVIVAL; MUTANTS	3-isopropylmalate dehydrogenase (IPMD) encoded by LEU2 is a key enzyme in leucine (Leu) biosynthetic pathway. Analysis of the genome sequence of Fusarium graminearum revealed two paralogous LEU2 genes (designated as FgLEU2A and FgLEU2B) in this fungus and the deduced amino acid sequences of FgLeu2A and FgLeu2B share 45% identity. Targeted disruption of individual FgLEU2A/B gene in F. graminearum assigned a more crucial role of FgLeu2A in Leu biosynthesis as disruption of FgLEU2A resulted in mutant (Delta FgLeu2A-10) that was Leu-auxotrophic and could not grow in minimal medium limited for amino acids, whereas FgLEU2B deletion mutant Delta FgLeu2B-2 was morphologically indistinguishable from the wild type strain PH-1. The growth defects of Delta FgLeu2A-10 could be overcome by exogenous addition of Leu at 0.25 mM. Double deletion of FgLEU2A and FgLEU2B (Delta FgLeu2AB-8) caused a more severe Leu-auxotrophic phenotype as the concentration of Leu exogenously added to medium to rescue the growth defect of Delta FgLeu2AB-8 should be raised to 1.25 mM, indicating a less important but nonnegligible role of FgLeu2B in Leu biosynthesis. Disturb of Leu biosynthesis caused by FgLEU2A deletion leads to slower growth rate, reduced aerial hyphal formation and red pigmentation on PDA plates and completely blocked conidial production and germination. All of the defects above could be overcome by Leu addition or complementation of the full-length FgLEU2A gene. Delta FgLeu2A-10 also showed significantly increased sensitivity to osmotic and oxidative stresses. Pathogenicity assay results showed that virulence of mutants lacking FgLEU2A were dramatically impaired on wheat heads and non-host cherry tomatoes. Additionally, a low level of deoxynivalenol (DON) production of Delta FgLeu2A-10 and Delta FgLeu2AB-8 in wheat kernels was also detected. Taken together, results of this study indicated a crucial role of FgLeu2A and a less important role of FgLeu2B in Leu biosynthesis and fungal infection-related morphogenesis in F. graminearum and FgLeu2A may serve as a potential target for novel antifungal development.	[Liu, Xin; Han, Qi; Wang, Jian; Wang, Xin; Xu, Jianhong; Shi, Jianrong] Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Minist Agr, Key Lab Agroprod Safety Risk Evaluat Nanjing, Nanjing, Jiangsu, Peoples R China; [Liu, Xin; Xu, Jianhong; Shi, Jianrong] Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Ministry of Agriculture & Rural Affairs	Xu, JH; Shi, JR (corresponding author), Jiangsu Acad Agr Sci, Inst Food Qual & Safety, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Prov, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Minist Agr, Key Lab Control Technol & Stand Agroprod Safety &, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Minist Agr, Key Lab Agroprod Safety Risk Evaluat Nanjing, Nanjing, Jiangsu, Peoples R China.; Xu, JH; Shi, JR (corresponding author), Collaborat Innovat Ctr Modern Grain Circulat & Sa, Nanjing, Jiangsu, Peoples R China.	xujianhongnj@126.com; shiji@jaas.ac.cn	Shi, Jianrong/AAQ-1805-2020; xu, jianhong/AAQ-4773-2021	shi, jianrong/0000-0001-8650-248X	National Natural Science Foundation of China [31301623, 31300128]; Jiangsu Provincial Natural Science Foundation [BK20130704]; Jiangsu Agricultural Science and Technology Innovation Fund [CX(13)5050]; Special Fund for Agro-scientific Research in the Public Interest [201303016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Agricultural Science and Technology Innovation Fund; Special Fund for Agro-scientific Research in the Public Interest	The research was supported by National Natural Science Foundation of China (31301623 and 31300128), Jiangsu Provincial Natural Science Foundation (BK20130704) and Jiangsu Agricultural Science and Technology Innovation Fund (CX(13)5050) to Xin Liu; and Special Fund for Agro-scientific Research in the Public Interest (201303016) to Jianrong Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The research was supported by National Natural Science Foundation of China (31301623 and 31300128), Jiangsu Provincial Natural Science Foundation (BK20130704) and Jiangsu Agricultural Science and Technology Innovation Fund (CX(13)5050) to Xin Liu, Special Fund for Agro-scientific Research in the Public Interest (201303016) to Jianrong Shi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthy D, 2009, MICROBIOL-SGM, V155, P2978, DOI 10.1099/mic.0.029884-0; Bluhm BH, 2007, MOL PLANT MICROBE IN, V20, P627, DOI 10.1094/MPMI-20-6-0627; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Cuomo CA, 2007, SCIENCE, V317, P1400, DOI 10.1126/science.1143708; Davey ML, 2009, MYCOL RES, V113, P1254, DOI 10.1016/j.mycres.2009.08.001; Du Y, 2014, FUNGAL GENET BIOL, V73, P53, DOI 10.1016/j.fgb.2014.10.001; Du Y, 2013, MOL PLANT PATHOL, V14, P870, DOI 10.1111/mpp.12053; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Ilgen P, 2008, CEREAL RES COMMUN, V36, P421, DOI 10.1556/CRC.36.2008.Suppl.B.35; Jansen C, 2005, P NATL ACAD SCI USA, V102, P16892, DOI 10.1073/pnas.0508467102; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kingsbury JM, 2004, MICROBIOL-SGM, V150, P1547, DOI 10.1099/mic.0.26928-0; Kingsbury JM, 2006, EUKARYOT CELL, V5, P816, DOI 10.1128/EC.5.5.816-824.2006; Kingsbury JM, 2010, MICROBIOL-SGM, V156, P929, DOI 10.1099/mic.0.034348-0; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leslie JF, WILEY INTERSCIENCE O, Vxii; Liu HJ, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/324502; Liu XR, 2014, TRANSL STROKE RES, V5, P692, DOI 10.1007/s12975-014-0359-5; Liu X, 2015, CURR GENET, V61, P55, DOI 10.1007/s00294-014-0444-z; Liu X, 2011, MICROBIOL-SGM, V157, P1665, DOI 10.1099/mic.0.045690-0; Liu X, 2011, FUNGAL GENET BIOL, V48, P113, DOI 10.1016/j.fgb.2010.10.004; Liu ZH, 2012, METHODS MOL BIOL, V835, P365, DOI 10.1007/978-1-61779-501-5_21; McCourt JA, 2006, AMINO ACIDS, V31, P173, DOI 10.1007/s00726-005-0297-3; MCCUSKER JH, 1990, MOL CELL BIOL, V10, P2941, DOI 10.1128/MCB.10.6.2941; Oliver JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043559; PROCTOR RH, 1995, MOL PLANT MICROBE IN, V8, P593, DOI 10.1094/MPMI-8-0593; Rep M, 2010, CURR OPIN PLANT BIOL, V13, P420, DOI 10.1016/j.pbi.2010.04.004; Sasanya JJ, 2008, J FOOD PROTECT, V71, P1205, DOI 10.4315/0362-028X-71.6.1205; SIMON JR, 1990, MOL GEN GENET, V223, P241, DOI 10.1007/BF00265060; Soleimany F, 2012, FOOD CHEM, V130, P1055, DOI 10.1016/j.foodchem.2011.07.131; Swinnen S, 2015, EUKARYOT CELL, V14, P884, DOI 10.1128/EC.00053-15; Williams BA, 1996, CURR GENET, V30, P305, DOI 10.1007/s002940050137; Wu AB, 2005, MYCOPATHOLOGIA, V160, P75, DOI 10.1007/s11046-005-1153-4; Yoshizawa F, 2004, BIOCHEM BIOPH RES CO, V313, P417, DOI 10.1016/j.bbrc.2003.07.013; Zhan J, 2001, PHYTOPATHOLOGY, V91, P1011, DOI 10.1094/PHYTO.2001.91.10.1011	37	7	10	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165927	10.1371/journal.pone.0165927	http://dx.doi.org/10.1371/journal.pone.0165927			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835660	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200016
J	Paege, N; Jung, S; Schape, P; Muller-Hagen, D; Ouedraogo, JP; Heiderich, C; Jedamzick, J; Nitsche, BM; van den Hondel, CA; Ram, AF; Meyer, V				Paege, Norman; Jung, Sascha; Schape, Paul; Muller-Hagen, Dirk; Ouedraogo, Jean-Paul; Heiderich, Caroline; Jedamzick, Johanna; Nitsche, Benjamin M.; van den Hondel, Cees A.; Ram, Arthur F.; Meyer, Vera			A Transcriptome Meta-Analysis Proposes Novel Biological Roles for the Antifungal Protein AnAFP in Aspergillus niger	PLOS ONE			English	Article							GUILT-BY-ASSOCIATION; FILAMENTOUS FUNGI; PENICILLIUM-CHRYSOGENUM; GENOME DATABASE; MULTISPECIES CURATION; STRESS-RESPONSE; PYRG-GENE; CELL-WALL; EXPRESSION; REVEALS	Understanding the genetic, molecular and evolutionary basis of cysteine-stabilized antifungal proteins (AFPs) from fungi is important for understanding whether their function is mainly defensive or associated with fungal growth and development. In the current study, a transcriptome meta-analysis of the Aspergillus niger.-core protein AnAFP was performed to explore co-expressed genes and pathways, based on independent expression profiling microarrays covering 155 distinct cultivation conditions. This analysis uncovered that anafp displays a highly coordinated temporal and spatial transcriptional profile which is concomitant with key nutritional and developmental processes. Its expression profile coincides with early starvation response and parallels with genes involved in nutrient mobilization and autophagy. Using fluorescence-and luciferase reporter strains we demonstrated that the anafp promoter is active in highly vacuolated compartments and foraging hyphal cells during carbon starvation with CreA and FlbA, but not BrlA, as most likely regulators of anafp. A co-expression network analysis supported by luciferase-based reporter assays uncovered that anafp expression is embedded in several cellular processes including allorecognition, osmotic and oxidative stress survival, development, secondary metabolism and autophagy, and predicted StuA and VelC as additional regulators. The transcriptomic resources available for A. niger provide unparalleled resources to investigate the function of proteins. Our work illustrates how transcriptomic meta-analyses can lead to hypotheses regarding protein function and predict a role for AnAFP during slow growth, allorecognition, asexual development and nutrient recycling of A. niger and propose that it interacts with the autophagic machinery to enable these processes.	[Paege, Norman; Jung, Sascha; Schape, Paul; Muller-Hagen, Dirk; Ouedraogo, Jean-Paul; Nitsche, Benjamin M.; Meyer, Vera] Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Berlin, Germany; [Ouedraogo, Jean-Paul; Heiderich, Caroline; Jedamzick, Johanna; van den Hondel, Cees A.; Ram, Arthur F.] Leiden Univ, Inst Biol Leiden, Dept Mol Microbiol & Biotechnol, Leiden, Netherlands; [van den Hondel, Cees A.; Ram, Arthur F.; Meyer, Vera] HiTexaCoat, Gouda, Netherlands	Technical University of Berlin; Leiden University; Leiden University - Excl LUMC	Meyer, V (corresponding author), Berlin Univ Technol, Inst Biotechnol, Dept Appl & Mol Microbiol, Berlin, Germany.; Meyer, V (corresponding author), HiTexaCoat, Gouda, Netherlands.	vera.meyer@tu-berlin.de	Ram, Arthur FJ/S-4648-2017	Ram, Arthur FJ/0000-0002-2487-8016; Jung, Sascha/0000-0003-4970-6904; Meyer, Vera/0000-0002-2298-2258; Ouedraogo, Jean-Paul/0000-0002-9735-6235; Van den Hondel, Kees/0000-0003-4782-2725	Marie Curie Integration grant [CIG 303684]; Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research	Marie Curie Integration grant; Kluyver Centre for Genomics of Industrial Fermentation, Netherlands Genomics Initiative/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was partly funded by the Marie Curie Integration grant to VM (CIG 303684) and supported by the Kluyver Centre for Genomics of Industrial Fermentation which is part of the Netherlands Genomics Initiative/Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AFF, 2002, AFF MICR SUIT 5 0 US; Allen A, 2008, PLANTA, V227, P331, DOI 10.1007/s00425-007-0620-1; Arentshorst M., 2014, FUNGAL BIOL, V1, P263, DOI DOI 10.1007/978-3-319-10142-2_; Arnaud MB, 2012, NUCLEIC ACIDS RES, V40, pD653, DOI 10.1093/nar/gkr875; Baroni A, 2009, PEPTIDES, V30, P267, DOI 10.1016/j.peptides.2008.11.001; Batta G, 2009, FEBS J, V276, P2875, DOI 10.1111/j.1742-4658.2009.07011.x; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; Bennett JW, 1991, MORE GENE MANIPULATI; Benoit I, 2015, ENVIRON MICROBIOL, V17, P2099, DOI 10.1111/1462-2920.12564; Bleichrodt R, 2013, STUD MYCOL, P31, DOI 10.3114/sim0007; Braaksma M, 2009, MICROBIOL-SGM, V155, P3430, DOI 10.1099/mic.0.031062-0; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cairns TC, 2016, TRENDS MICROBIOL, V24, P35, DOI 10.1016/j.tim.2015.09.008; CAMPOSOLIVAS R, 1995, BIOCHEMISTRY-US, V34, P3009, DOI 10.1021/bi00009a032; Carvalho NDSP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-350; Carvalho NDSP, 2010, APPL MICROBIOL BIOT, V87, P1463, DOI 10.1007/s00253-010-2588-1; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Choudhary M, 2015, PHYSIOL MOL BIOL PLA, V21, P187, DOI 10.1007/s12298-015-0287-1; CLUTTERBUCK AJ, 1969, GENETICS, V63, P317; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; de Bekker C, 2011, APPL ENVIRON MICROB, V77, P1263, DOI 10.1128/AEM.02134-10; DERUITERJACOBS YMJT, 1989, CURR GENET, V16, P159, DOI 10.1007/BF00391472; Fiedler Markus Rm, 2014, Fungal Biol Biotechnol, V1, P5, DOI 10.1186/s40694-014-0005-8; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Girgi M, 2006, TRANSGENIC RES, V15, P313, DOI 10.1007/s11248-006-0001-8; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; Gruben BS, 2014, APPL MICROBIOL BIOT, V98, P5531, DOI 10.1007/s00253-014-5607-9; Gruben BS, 2012, FEBS LETT, V586, P3980, DOI 10.1016/j.febslet.2012.09.029; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Han SJ, 2011, PROTEIN CELL, V2, P784, DOI 10.1007/s13238-011-1104-4; Hegedus N, 2013, FUNGAL BIOL REV, V26, P132, DOI 10.1016/j.fbr.2012.07.002; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Hu PJ, 2015, FUNGAL GENET BIOL, V83, P26, DOI 10.1016/j.fgb.2015.08.003; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jorgensen TR, 2010, APPL ENVIRON MICROB, V76, P5344, DOI 10.1128/AEM.00450-10; Jorgensen TR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-44; Jung S, 2012, J BIOL CHEM, V287, P14246, DOI 10.1074/jbc.M111.336495; Kaiserer L, 2003, ARCH MICROBIOL, V180, P204, DOI 10.1007/s00203-003-0578-8; Klomp Jeff A, 2012, BMC Res Notes, V5, P370, DOI 10.1186/1756-0500-5-370; Kovacs B, 2014, ACTA MICROBIOL IMM H, V61, P379, DOI 10.1556/AMicr.61.2014.3.10; Kovacs L, 2011, PEPTIDES, V32, P1724, DOI 10.1016/j.peptides.2011.06.022; Krijgsheld P, 2013, STUD MYCOL, P1, DOI 10.3114/sim0006; Krijgsheld P, 2013, FUNGAL GENOM BIOL, V3; Krijgsheld P, 2013, J PROTEOME RES, V12, P1808, DOI 10.1021/pr301154w; Krijgsheld P, 2012, J PROTEOME RES, V11, P2807, DOI 10.1021/pr201157b; Kwon MJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-701; Lee DG, 1999, BIOCHEM BIOPH RES CO, V263, P646, DOI 10.1006/bbrc.1999.1428; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Liu YM, 2009, AUTOPHAGY, V5, P954, DOI 10.4161/auto.5.7.9290; Martens-Uzunova ES, 2008, FUNGAL GENET BIOL, V45, P1449, DOI 10.1016/j.fgb.2008.08.002; Meyer V, 2008, FUNGAL GENET BIOL, V45, P152, DOI 10.1016/j.fgb.2007.07.006; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Meyer V, 2007, J BIOL CHEM, V282, P32935, DOI 10.1074/jbc.M705856200; Meyer V, 2007, J BIOTECHNOL, V128, P770, DOI 10.1016/j.jbiotec.2006.12.021; Meyer V, 2015, ADV BIOCHEM ENG BIOT, V149, P91, DOI 10.1007/10_2014_297; Meyer V, 2010, MANUAL OF INDUSTRIAL MICROBIOLOGY AND BIOTECHNOLOGY, THIRD EDITION, P318; Meyer V, 2009, EUKARYOT CELL, V8, P1677, DOI 10.1128/EC.00050-09; Nitsche BM, 2013, APPL MICROBIOL BIOT, V97, P8205, DOI 10.1007/s00253-013-4971-1; Nitsche BM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-380; Nitsche BM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-486; Nitsche BM, 2014, FUNGAL GENOMICS, V13, P209, DOI DOI 10.1007/978-3-642-45218-5_; Normile D, 2010, SCIENCE, V327, P807, DOI 10.1126/science.327.5967.807; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; OLSON BH, 1965, APPL MICROBIOL, V13, P314, DOI 10.1128/AEM.13.3.314-321.1965; Ouedraogo JP, 2011, J BIOL CHEM, V286, P13859, DOI 10.1074/jbc.M110.203588; Paramythiotou E, 2014, MOLECULES, V19, P1085, DOI 10.3390/molecules19011085; Park BC, 2014, J MICROBIOL, V52, P940, DOI 10.1007/s12275-014-4517-y; Park HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep10199; Park HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089883; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; PUNT PJ, 1987, GENE, V56, P117, DOI 10.1016/0378-1119(87)90164-8; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J, 2001, MOL CLONING LAB MANU, P2588; Schachtschabel D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078102; SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sheppard DC, 2005, MOL BIOL CELL, V16, P5866, DOI 10.1091/mbc.E05-07-0617; Sigl C, 2011, APPL ENVIRON MICROB, V77, P972, DOI 10.1128/AEM.01557-10; Skouri-Gargouri H, 2008, PEPTIDES, V29, P1871, DOI 10.1016/j.peptides.2008.07.005; SPEARMAN C, 1987, AM J PSYCHOL, V100, P441, DOI 10.2307/1422689; Subramanian H, 2013, J IMMUNOL, V191, P345, DOI 10.4049/jimmunol.1300023; Theis T, 2003, ANTIMICROB AGENTS CH, V47, P588, DOI 10.1128/AAC.47.2.588-593.2003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; van der Veen D, 2009, APPL ENVIRON MICROB, V75, P2414, DOI 10.1128/AEM.02270-08; Van Diepeningen AD, 2009, MYCOL RES, V113, P222, DOI 10.1016/j.mycres.2008.10.003; van Leeuwen MR, 2013, STUD MYCOL, P71, DOI 10.3114/sim0013; van Munster JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116269; van Munster JM, 2013, MICROBIOL-SGM, V159, P1853, DOI 10.1099/mic.0.067967-0; VANHARTINGSVELDT W, 1987, MOL GEN GENET, V206, P71, DOI 10.1007/BF00326538; Wanka F, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0543-2; Wolfe CJ, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-227; Xiong Y, 2005, PLANT J, V42, P535, DOI 10.1111/j.1365-313X.2005.02397.x; Yeaman MR, 2007, NAT REV MICROBIOL, V5, P727, DOI 10.1038/nrmicro1744; Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Yuan XL, 2008, MOL GENET GENOMICS, V279, P11, DOI 10.1007/s00438-007-0290-5	102	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165755	10.1371/journal.pone.0165755	http://dx.doi.org/10.1371/journal.pone.0165755			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835655	Green Published, gold			2022-12-26	WOS:000387779200010
J	Calegario, G; Pollier, J; Arendt, P; de Oliveira, LS; Thompson, C; Soares, AR; Pereira, RC; Goossens, A; Thompson, FL				Calegario, Gabriela; Pollier, Jacob; Arendt, Philipp; de Oliveira, Louisi Souza; Thompson, Cristiane; Soares, Angelica Ribeiro; Pereira, Renato Crespo; Goossens, Alain; Thompson, Fabiano L.			Cloning and Functional Characterization of Cycloartenol Synthase from the Red Seaweed Laurencia dendroidea	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; OXIDOSQUALENE CYCLASES; HALOGENATED COMPOUNDS; TRITERPENOIDS; PATHWAY; PLANTS; ALGAE; EXPRESSION; BIOLOGY; GENES	The red seaweed Laurencia dendroidea belongs to the Rhodophyta, a phylum of eukaryotic algae that is widely distributed across the oceans and that constitute an important source of bioactive specialized metabolites. Laurencia species have been studied since 1950 and were found to contain a plethora of specialized metabolites, mainly halogenated sesquiterpenes, diterpenes and triterpenes that possess a broad spectrum of pharmacological and ecological activities. The first committed step in the biosynthesis of triterpenes is the cyclization of 2,3-oxidosqualene, an enzymatic reaction carried out by oxidosqualene cyclases (OSCs), giving rise to a broad range of different compounds, such as the sterol precursors cycloartenol and lanosterol, or triterpene precursors such as cucurbitadienol and beta-amyrin. Here, we cloned and characterized the first OSC from a red seaweed. The OSC gene was identified through mining of a L. dendroidea transcriptome dataset and subsequently cloned and heterologously expressed in yeast for functional characterization, which indicated that the corresponding enzyme cyclizes 2,3-oxidosqualene to the sterol precursor cycloartenol. Accordingly, the gene was named L. dendroidea cycloartenol synthase (LdCAS). A phylogenetic analysis using OSCs genes from plants, fungi and algae revealed that LdCAS grouped together with OSCs from other red algae, suggesting that cycloartenol could be the common product of the OSC in red seaweeds. Furthermore, profiling of L. dendroidea revealed cholesterol as the major sterol accumulating in this species, implicating red seaweeds contain a 'hybrid' sterol synthesis pathway in which the phytosterol precursor cycloartenol is converted into the major animal sterol cholesterol.	[Calegario, Gabriela; Pereira, Renato Crespo] Univ Fed Fluminense, Dept Marine Biol, Niteroi, RJ, Brazil; [Calegario, Gabriela; de Oliveira, Louisi Souza; Thompson, Cristiane; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio de Janeiro, Brazil; [Calegario, Gabriela; de Oliveira, Louisi Souza; Thompson, Cristiane; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, Brazil; [Pollier, Jacob; Arendt, Philipp; Goossens, Alain] VIB, Dept Plant Syst Biol, Ghent, Belgium; [Pollier, Jacob; Arendt, Philipp; Goossens, Alain] Univ Ghent, Dept Plant Biotechnol & Bioinformat, Ghent, Belgium; [Soares, Angelica Ribeiro] UFRJ, Nucleo Estudos Ecol & Desenvolvimento Socioambien, GPNOA, Macae, Brazil	Universidade Federal Fluminense; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Flanders Institute for Biotechnology (VIB); Ghent University; Universidade Federal do Rio de Janeiro	Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Rio de Janeiro, Brazil.; Thompson, FL (corresponding author), Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, Brazil.	fabianothompson1@gmail.com	Pollier, Jacob/B-3091-2012; Soares, Angelica/AAW-6611-2021; Van Breusegem, Frank/AAJ-2647-2020; Pereira, Renato Crespo/AAA-7832-2020	Pollier, Jacob/0000-0002-1134-9238; Soares, Angelica/0000-0001-9126-3778; Van Breusegem, Frank/0000-0002-3147-0860; Calegario, Gabriela/0000-0002-3772-8447; Thompson, Fabiano/0000-0002-7562-1683	CNPq; CAPES; FAPERJ; CAPES scholarship; VIB International Fellowship Program	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CAPES scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); VIB International Fellowship Program	We thank CNPq, CAPES and FAPERJ for financial support. This work is part of GC's PhD thesis in the graduate course of Dinamica dos Oceanos e da Terra, supported by CAPES scholarship. JP is postdoctoral fellow of the Research Foundation Flanders. PA is indebted to the VIB International Fellowship Program for a predoctoral fellowship. RCP and FLT thank CNPq by Productivity Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank CNPq, CAPES and FAPERJ for financial support. This work is part of G.C. PhD thesis in the graduate course of Dinamica dos Oceanos e da Terra, supported by CAPES scholarship. J.P. is postdoctoral fellow of the Research Foundation Flanders. P.A. is indebted to the VIB International Fellowship Program for a predoctoral fellowship. RCP and FLT thank CNPq by Productivity Fellowships.	Abe I, 1996, J AM CHEM SOC, V118, P9180, DOI 10.1021/ja961643a; ABE I, 1995, P NATL ACAD SCI USA, V92, P9274, DOI 10.1073/pnas.92.20.9274; Acimovic J, 2013, MOLECULES, V18, P4002, DOI 10.3390/molecules18044002; Andre CM, 2016, NEW PHYTOL, V211, P1279, DOI 10.1111/nph.13996; Arendt P, 2016, PLANT J, V87, P16, DOI 10.1111/tpj.13138; Babiychuk E, 2008, P NATL ACAD SCI USA, V105, P3163, DOI 10.1073/pnas.0712190105; Cabrita MT, 2010, MAR DRUGS, V8, P2301, DOI 10.3390/md8082301; Cardenas PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10654; CATTEL L, 1986, LIPIDS, V21, P31, DOI 10.1007/BF02534300; Chen F, 2011, PLANT J, V66, P212, DOI 10.1111/j.1365-313X.2011.04520.x; Cock PJA, 2013, PEERJ, V1, DOI 10.7717/peerj.167; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COREY EJ, 1993, P NATL ACAD SCI USA, V90, P11628, DOI 10.1073/pnas.90.24.11628; Davidovich-Rikanati R, 2015, YEAST, V32, P103, DOI 10.1002/yea.3049; de Oliveira LS, 2015, MAR DRUGS, V13, P879, DOI 10.3390/md13020879; Dhar N, 2014, J BIOL CHEM, V289, P17249, DOI 10.1074/jbc.M114.571919; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dong YZ, 2011, NAT PROD REP, V28, P529, DOI 10.1039/c0np00035c; Fabris M, 2014, NEW PHYTOL, V204, P521, DOI 10.1111/nph.12917; Fernandez JJ, 1998, BIOORGAN MED CHEM, V6, P2237, DOI 10.1016/S0968-0896(98)80004-7; Fiallos-Jurado J, 2016, PLANT SCI, V250, P188, DOI 10.1016/j.plantsci.2016.05.015; Gas-Pascual E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109156; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Iliopoulou D, 2002, TETRAHEDRON, V58, P6749, DOI 10.1016/S0040-4020(02)00687-7; IRIE T, 1965, TETRAHEDRON LETT, P1091; IRIE T, 1970, TETRAHEDRON, V26, P3271, DOI 10.1016/S0040-4020(01)92906-0; Ji NY, 2008, HELV CHIM ACTA, V91, P1940, DOI 10.1002/hlca.200890207; Ji NY, 2014, PHYTOCHEM REV, V13, P653, DOI 10.1007/s11101-013-9326-0; Khakimov B, 2015, PLANT J, V84, P478, DOI 10.1111/tpj.13012; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirby J, 2008, NAT PROD REP, V25, P656, DOI 10.1039/b802939c; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Li YX, 2013, MOLECULES, V18, P7886, DOI 10.3390/molecules18077886; Lin YL, 2015, J NAT PROD, V78, P1556, DOI 10.1021/acs.jnatprod.5b00020; Lohr M, 2012, PLANT SCI, V185, P9, DOI 10.1016/j.plantsci.2011.07.018; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Masse G, 2004, P NATL ACAD SCI USA, V101, P4413, DOI 10.1073/pnas.0400902101; Moses T, 2015, PLANT CELL, V27, P286, DOI 10.1105/tpc.114.134486; Moses T, 2014, P NATL ACAD SCI USA, V111, P1634, DOI 10.1073/pnas.1323369111; Nasir M, 2011, PHARMACOGN MAG, V7, P97, DOI 10.4103/0973-1296.80663; Pereira R. C., 2003, Braz. J. Biol., V63, P665, DOI 10.1590/S1519-69842003000400013; Sambamurty AVSS, 2005, A TXB ALGAE; Sawai S, 2014, PLANT CELL, V26, P3763, DOI 10.1105/tpc.114.130096; Schwender J, 2001, PLANTA, V212, P416, DOI 10.1007/s004250000409; Schwender J, 1997, FEBS LETT, V414, P129, DOI 10.1016/S0014-5793(97)01002-8; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Singh P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058833; Summons RE, 2006, PHILOS T R SOC B, V361, P951, DOI 10.1098/rstb.2006.1837; Thimmappa R, 2014, ANNU REV PLANT BIOL, V65, P225, DOI 10.1146/annurev-arplant-050312-120229; Vairappan CS, 2010, J APPL PHYCOL, V22, P305, DOI 10.1007/s10811-009-9460-7; Vairappan CS, 2004, PLANTA MED, V70, P1087, DOI 10.1055/s-2004-832653; Vairappan CS, 2001, PHYTOCHEMISTRY, V58, P291, DOI 10.1016/S0031-9422(01)00243-6; Wang BG, 2013, CHEM REV, V113, P3632, DOI 10.1021/cr9002215; Wendt KU, 2000, ANGEW CHEM INT EDIT, V39, P2812, DOI 10.1002/1521-3773(20000818)39:16<2812::AID-ANIE2812>3.0.CO;2-#; Xu R, 2004, PHYTOCHEMISTRY, V65, P261, DOI 10.1016/j.phytochem.2003.11.014; Xue ZY, 2012, NEW PHYTOL, V193, P1022, DOI 10.1111/j.1469-8137.2011.03997.x; Yang DC, 2012, IEEE PES TRANSM DIST, V2012, P7, DOI [DOI 10.1371/J0URNAL.P0NE.0042076, DOI 10.1371/J0URNAL.P0NE.0033596]	58	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165954	10.1371/journal.pone.0165954	http://dx.doi.org/10.1371/journal.pone.0165954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832119	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000046
J	Fortuna, TM; Snirc, A; Badouin, H; Gouzy, J; Siguenza, S; Esquerre, D; Le Prieur, S; Shykoff, JA; Giraud, T				Fortuna, Taiadjana M.; Snirc, Alodie; Badouin, Helene; Gouzy, Jerome; Siguenza, Sophie; Esquerre, Diane; Le Prieur, Stephanie; Shykoff, Jacqui A.; Giraud, Tatiana			Polymorphic Microsatellite Markers for the Tetrapolar Anther-Smut Fungus Microbotryum saponariae Based on Genome Sequencing	PLOS ONE			English	Article							MATING-TYPE CHROMOSOMES; VIOLACEUM USTILAGO-VIOLACEA; WITHIN-HOST COMPETITION; SILENE-LATIFOLIA; POPULATION-STRUCTURE; LYCHNIDIS-DIOICAE; PATHOGEN; PLANT; DIVERGENCE; LOCI	Background Anther-smut fungi belonging to the genus Microbotryum sterilize their host plants by aborting ovaries and replacing pollen by fungal spores. Sibling Microbotryum species are highly specialized on their host plants and they have been widely used as models for studies of ecology and evolution of plant pathogenic fungi. However, most studies have focused, so far, on M. lychnidis-dioicae that parasitizes the white campion Silene latifolia. Microbotryum saponariae, parasitizing mainly Saponaria officinalis, is an interesting anther-smut fungus, since it belongs to a tetrapolar lineage (i.e., with two independently segregating mating-type loci), while most of the anther-smut Microbotryum fungi are bipolar (i.e., with a single mating-type locus). Saponaria officinalis is a widespread long-lived perennial plant species with multiple flowering stems, which makes its anther-smut pathogen a good model for studying phylogeography and within-host multiple infections. Principal Findings Here, based on a generated genome sequence of M. saponariae we developed 6 multiplexes with a total of 22 polymorphic microsatellite markers using an inexpensive and efficient method. We scored these markers in fungal individuals collected from 97 populations across Europe, and found that the number of their alleles ranged from 2 to 11, and their expected heterozygosity from 0.01 to 0.58. Cross-species amplification was examined using nine other Microbotryum species parasitizing hosts belonging to Silene, Dianthus and Knautia genera. All loci were successfully amplified in at least two other Microbotryum species. Significance These newly developed markers will provide insights into the population genetic structure and the occurrence of within-host multiple infections of M. saponariae. In addition, the draft genome of M. saponariae, as well as one of the described markers will be useful resources for studying the evolution of the breeding systems in the genus Microbotryum and the evolution of specialization onto different plant species.	[Fortuna, Taiadjana M.; Snirc, Alodie; Badouin, Helene; Le Prieur, Stephanie; Shykoff, Jacqui A.; Giraud, Tatiana] Univ Paris Saclay, Lab Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, F-91400 Orsay, France; [Gouzy, Jerome; Siguenza, Sophie] INRA, LIPM, UMR441, F-31326 Castanet Tolosan, France; [Gouzy, Jerome; Siguenza, Sophie] CNRS, LIPM, UMR2594, F-31326 Castanet Tolosan, France; [Esquerre, Diane] Univ Toulouse, INRA, INPT, GenPhySE,ENVT, F-31326 Castanet Tolosan, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National des Sciences Appliquees de Toulouse; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Fortuna, TM (corresponding author), Univ Paris Saclay, Lab Ecol Systemat Evolut, Univ Paris Sud, CNRS,AgroParisTech, F-91400 Orsay, France.	taadjanafortuna@gmail.com	Gouzy, Jerome/AAH-4977-2020	Gouzy, Jerome/0000-0001-5695-4557; Giraud, Tatiana/0000-0002-2685-6478; Badouin, Helene/0000-0002-2456-5968	MULTIVIR [ANR-13-BSV7-0008]; Agence Nationale de Recherche; GenomeFun [309403]; European Reserach Council	MULTIVIR; Agence Nationale de Recherche(French National Research Agency (ANR)); GenomeFun; European Reserach Council	Funded by MULTIVIR ANR-13-BSV7-0008, Agence Nationale de Recherche, (JAS) and GenomeFun 309403, European Reserach Council, (TG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovics J, 2002, AM NAT, V160, pS40, DOI 10.1086/342143; Badouin H, 2015, GENETICS, V200, P1275, DOI 10.1534/genetics.115.177709; Bucheli E, 2000, J EVOLUTION BIOL, V13, P188, DOI 10.1046/j.1420-9101.2000.00160.x; Bucheli E, 2001, MOL ECOL, V10, P285, DOI 10.1046/j.1365-294x.2001.01146.x; Bueker B, 2016, MOL ECOL, V25, P811, DOI 10.1111/mec.13512; Cryer NC, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-3; DAY AW, 1968, GENET RES, V11, P63, DOI 10.1017/S0016672300011204; Devier B, 2009, GENETICS, V181, P209, DOI 10.1534/genetics.108.093708; Dutech C, 2007, FUNGAL GENET BIOL, V44, P933, DOI 10.1016/j.fgb.2007.05.003; Fontaine MC, 2013, NEW PHYTOL, V198, P946, DOI 10.1111/nph.12177; Fontanillas E, 2015, MOL BIOL EVOL, V32, P928, DOI 10.1093/molbev/msu396; Garber ED, 2002, ADV APPL MICROBIOL, V51, P107, DOI 10.1016/S0065-2164(02)51003-0; Giraud T, 2008, MOL ECOL RESOUR, V8, P387, DOI 10.1111/j.1471-8286.2007.01967.x; Giraud T, 2004, HEREDITY, V93, P559, DOI 10.1038/sj.hdy.6800554; Giraud T, 2005, INT J PLANT SCI, V166, P649, DOI 10.1086/430098; Giraud T, 2002, MOL ECOL NOTES, V2, P142, DOI 10.1046/j.1471-8286.2002.00172.x; Gladieux P, 2015, MOL ECOL, V24, P1969, DOI 10.1111/mec.13028; Gladieux P, 2014, MOL ECOL, V23, P753, DOI 10.1111/mec.12631; Gladieux P, 2011, GENETICS AND EVOLUTION OF INFECTIOUS DISEASES, P59, DOI 10.1016/B978-0-12-384890-1.00004-2; Gladieux P, 2011, MOL BIOL EVOL, V28, P459, DOI 10.1093/molbev/msq235; Holleley CE, 2009, BIOTECHNIQUES, V46, P511, DOI 10.2144/000113156; Hood ME, 2003, AM NAT, V162, P122, DOI 10.1086/375539; Hood ME, 2000, HEREDITY, V85, P231, DOI 10.1046/j.1365-2540.2000.00748.x; Hood ME, 2002, GENETICS, V160, P457; Hood ME, 2015, EVOLUTION, V69, P2561, DOI 10.1111/evo.12765; Hood ME, 2013, GENETICS, V193, P309, DOI 10.1534/genetics.112.146266; Hood ME, 2010, NEW PHYTOL, V187, P217, DOI 10.1111/j.1469-8137.2010.03268.x; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kemler M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-35; Kemler M, 2009, SYST BIODIVERS, V7, P297, DOI 10.1017/S1477200009990028; Kniep H, 1919, Z BOT, V11, P257; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; Le Gac M, 2007, EVOLUTION, V61, P15, DOI 10.1111/j.1558-5646.2007.00002.x; Lopez-Villavicencio M, 2007, PLOS PATHOG, V3, P1710, DOI 10.1371/journal.ppat.0030176; Lopez-Villavicencio M, 2011, EVOLUTION, V65, P1357, DOI 10.1111/j.1558-5646.2010.01207.x; Lutz Matthias, 2005, Mycological Progress, V4, P225, DOI 10.1007/s11557-006-0126-4; Lutz M, 2008, MYCOL RES, V112, P1280, DOI 10.1016/j.mycres.2008.04.010; Murray J., 1910, REPORTS SCI EXPEDITI, P17; Nieuwenhuis BPS, 2013, HEREDITY, V111, P445, DOI 10.1038/hdy.2013.67; Perlin MH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1660-8; POON NH, 1976, CAN J MICROBIOL, V22, P495, DOI 10.1139/m76-076; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Refregier G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-100; Smit A.F.A., 2015, REPEATMASKER OPEN 4; Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; Thrall PH, 1995, AM NAT, V73, pS1249; Tollenaere C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052492; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Xu L, 2016, HEREDITY, V116, P44, DOI 10.1038/hdy.2015.68	51	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165656	10.1371/journal.pone.0165656	http://dx.doi.org/10.1371/journal.pone.0165656			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832131	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000022
J	Jonkers, ART; Sharkey, KJ				Jonkers, Art R. T.; Sharkey, Kieran J.			The Differential Warming Response of Britain's Rivers (1982-2011)	PLOS ONE			English	Article							SALMON SALMO-SALAR; CLIMATE-CHANGE; WATER TEMPERATURE; CHINOOK SALMON; FRESH-WATER; STREAM; FISH; VARIABILITY; POPULATIONS; IMPACTS	River water temperature is a hydrological feature primarily controlled by topographical, meteorological, climatological, and anthropogenic factors. For Britain, the study of freshwater temperatures has focussed mainly on observations made in England and Wales; similar comprehensive data sets for Scotland are currently unavailable. Here we present a model for the whole of mainland Britain over three recent decades (1982-2011) that incorporates geographical extrapolation to Scotland. The model estimates daily mean freshwater temperature for every river segment and for any day in the studied period, based upon physico-geographical features, daily mean air and sea temperatures, and available freshwater temperature measurements. We also extrapolate the model temporally to predict future warming of Britain's rivers given current observed trends. Our results highlight the spatial and temporal diversity of British freshwater temperatures and warming rates. Over the studied period, Britain's rivers had a mean temperature of 9.84 degrees C and experienced a mean warming of +0.22 degrees C per decade, with lower rates for segments near lakes and in coastal regions. Model results indicate April as the fastest-warming month (+0.63 degrees C per decade on average), and show that most rivers spend on average ever more days of the year at temperatures exceeding 10 degrees C, a critical threshold for several fish pathogens. Our results also identify exceptional warming in parts of the Scottish Highlands (in April and September) and pervasive cooling episodes, in December throughout Britain and in July in the southwest of England (in Wales, Cornwall, Devon, and Dorset). This regional heterogeneity in rates of change has ramifications for current and future water quality, aquatic ecosystems, as well as for the spread of waterborne diseases.	[Jonkers, Art R. T.; Sharkey, Kieran J.] Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England; [Jonkers, Art R. T.] Westfalische Wilhelms Univ, Inst Geophys, Munster, Germany	University of Liverpool; University of Munster	Jonkers, ART (corresponding author), Univ Liverpool, Dept Math Sci, Liverpool, Merseyside, England.; Jonkers, ART (corresponding author), Westfalische Wilhelms Univ, Inst Geophys, Munster, Germany.	jonkers@earth.uni-muenster.de		Sharkey, Kieran/0000-0002-7210-9246	BBSRC/NERC [BB/M026434/1]; Biotechnology and Biological Sciences Research Council [BB/M026434/1] Funding Source: researchfish; BBSRC [BB/M026434/1] Funding Source: UKRI	BBSRC/NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by BBSRC/NERC grant reference BB/M026434/1. URL: http://www.bbsrc.ac.uk/innovation/collaboration/collaborative-programmes/uk-aquaculture-initiative/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell A, 2014, ENERG ECON, V46, P510, DOI 10.1016/j.eneco.2013.12.016; Broadmeadow SB, 2011, RIVER RES APPL, V27, DOI 10.1002/rra.1354; Brown LE, 2008, HYDROL PROCESS, V22, P954, DOI 10.1002/hyp.6982; Buchan J, 2014, MON WEATHER REV, V142, P922, DOI 10.1175/MWR-D-13-00104.1; Caissie D, 2006, FRESHWATER BIOL, V51, P1389, DOI 10.1111/j.1365-2427.2006.01597.x; Chen Z, 2013, CAN J ZOOL, V91, P265, DOI 10.1139/cjz-2012-0300; Cianfrani C, 2015, ECOL MODEL, V313, P1, DOI 10.1016/j.ecolmodel.2015.06.023; Des Clers S, 2010, SR070035 UK ENV AG; Durance I, 2007, GLOBAL CHANGE BIOL, V13, P942, DOI 10.1111/j.1365-2486.2007.01340.x; Elliott JM, 2010, J FISH BIOL, V77, P1793, DOI 10.1111/j.1095-8649.2010.02762.x; Garner G, 2014, HYDROL PROCESS, V28, P5583, DOI 10.1002/hyp.9992; Graham DA, 2008, J FISH DIS, V31, P859, DOI 10.1111/j.1365-2761.2008.00946.x; Gurney WSC, 2008, CAN J FISH AQUAT SCI, V65, P2606, DOI 10.1139/F08-149; Hammond D, 2007, SC060017SR UK ENV AG; Hari RE, 2006, GLOBAL CHANGE BIOL, V12, P10, DOI 10.1111/j.1365-2486.2005.001051.x; Hawley LM, 2008, DIS AQUAT ORGAN, V82, P171, DOI 10.3354/dao01998; Hrachowitz M, 2010, HYDROL PROCESS, V24, P3374, DOI 10.1002/hyp.7756; Jenkins GJ, 2008, UKCP09 MET OFF HADL; Jeppesen E, 2012, HYDROBIOLOGIA, V694, P1, DOI 10.1007/s10750-012-1182-1; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kaushal SS, 2010, FRONT ECOL ENVIRON, V8, P461, DOI 10.1890/090037; Keery J, 2007, J HYDROL, V336, P1, DOI 10.1016/j.jhydrol.2006.12.003; Lisi PJ, 2015, GEOPHYS RES LETT, V42, P3380, DOI 10.1002/2015GL064083; Malcolm IA, 2008, HYDROL PROCESS, V22, P968, DOI 10.1002/hyp.6996; Mantua NJ, 2015, NAT CLIM CHANGE, V5, P613, DOI 10.1038/nclimate2670; Marcos-Lopez M, 2010, TRANSBOUND EMERG DIS, V57, P293, DOI 10.1111/j.1865-1682.2010.01150.x; Moore A, 2012, FISHERIES MANAG ECOL, V19, P518, DOI 10.1111/j.1365-2400.2011.00833.x; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P615, DOI 10.1038/nclimate2671; Munoz NJ, 2015, NAT CLIM CHANGE, V5, P163, DOI 10.1038/NCLIMATE2473; O'Reilly CM, 2015, GEOPHYS RES LETT, V42, P10773, DOI 10.1002/2015GL066235; Okamura B, 2011, FRESHWATER BIOL, V56, P735, DOI 10.1111/j.1365-2427.2010.02465.x; Orr H. G., 2010, ROLE HYDROLOGY MANAG; Orr HG, 2015, HYDROL PROCESS, V29, P752, DOI 10.1002/hyp.10181; Pletterbauer F, 2015, HYDROBIOLOGIA, V744, P235, DOI 10.1007/s10750-014-2079-y; Quigley JT, 2006, J THERM BIOL, V31, P429, DOI 10.1016/j.jtherbio.2006.02.003; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Salama NKG, 2013, AQUACULT ENV INTERAC, V4, P91, DOI 10.3354/aei00077; Segura C, 2015, HYDROL PROCESS, V29, P2178, DOI 10.1002/hyp.10357; Solomon DJ, 2008, SCHO0808BOLVEP UK EN; Thrush MA, 2013, TRANSBOUND EMERG DIS, V60, P460, DOI 10.1111/j.1865-1682.2012.01368.x; van Vliet MTH, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009198; van Vliet MTH, 2013, GLOBAL ENVIRON CHANG, V23, P450, DOI 10.1016/j.gloenvcha.2012.11.002; VHSV Expert Panel & Working Grp, 2010, PREV VET MED, V94, P128, DOI 10.1016/j.prevetmed.2009.11.020; Webb BW, 2008, HYDROL PROCESS, V22, P902, DOI 10.1002/hyp.6994; Webb BW, 2007, HYDROLOG SCI J, V52, P74, DOI 10.1623/hysj.52.1.74; Webb BW, 1996, HYDROL PROCESS, V10, P205, DOI 10.1002/(SICI)1099-1085(199602)10:2&lt;205::AID-HYP358&gt;3.0.CO;2-1; Wehrly KE, 2007, T AM FISH SOC, V136, P365, DOI 10.1577/T06-163.1; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Whitehead PG, 2009, HYDROLOG SCI J, V54, P101, DOI 10.1623/hysj.54.1.101	49	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166247	10.1371/journal.pone.0166247	http://dx.doi.org/10.1371/journal.pone.0166247			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832108	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000083
J	Kim, N; Choi, J; Kim, S; Gwon, YD; Cho, Y; Yang, JM; Oh, YK; Kim, YB				Kim, Nayoung; Choi, Jiwon; Kim, Sehyun; Gwon, Yong-Dae; Cho, Yeondong; Yang, Jae Myung; Oh, Yu-Kyoung; Kim, Young Bong			Transmission of Porcine Endogenous Retrovirus Produced from Different Recipient Cells In Vivo	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; ISLET XENOTRANSPLANTATION; INFECTION; EXPRESSION; VIRUS; PERV; VITRO; PIGS	Humanized pigs have been developed to reduce the incidence of immune rejection in xeno-transplantation, but significant concerns remain, such as transmission of viral zoonosis. Porcine endogenous retroviruses (PERV), which exist in the genome of pigs, are produced as infectious virions from all porcine cells and cause zoonosis. Here, we examined the possibility of zoonosis of hosts under conditions of immune suppression or xenotransplantation of cells producing host-adapted viruses. Upon transplantation of PERV-producing porcine cells into mice, no transmission of PERV was detected, whereas, transmission of PERV from mice transplanted with mouse-adapted PERV-producing cells was detected. In addition, the frequency of PERV transmission was increased in CsA treated mice transplanted with PERV-producing murine cells, compared with PERV-producing porcine cells. Transmission of PERV to host animals did not affect weight but immune responses, in particular, the number of T cells from PERV-transmitted mice, were notably reduced. The observed risk of PERV zoonosis highlights the requirement for thorough evaluation of viral zoonosis under particular host conditions, such as immunosuppressive treatment and transplantation with host-adapted virus-producing cells.	[Kim, Nayoung; Yang, Jae Myung] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Choi, Jiwon; Kim, Sehyun; Gwon, Yong-Dae; Cho, Yeondong; Kim, Young Bong] Konkuk Univ, Dept Bioind Technol, Seoul, South Korea; [Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Oh, Yu-Kyoung] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Sogang University; Konkuk University; Seoul National University (SNU); Seoul National University (SNU)	Kim, YB (corresponding author), Konkuk Univ, Dept Bioind Technol, Seoul, South Korea.	kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Gwon, Yong-Dae/0000-0002-0703-4188; Oh, Yu-Kyoung/0000-0002-0969-3339	Konkuk University	Konkuk University	This work was supported by the Konkuk University in 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Konkuk University in 2015.	Atluri VSR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00212; Bach FH, 1998, ANNU REV MED, V49, P301; BACH FH, 1995, NAT MED, V1, P869, DOI 10.1038/nm0995-869; Bertera S, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/856386; Bertin J, 2014, VIROLOGY, V454, P128, DOI 10.1016/j.virol.2014.02.007; Blusch JH, 2002, XENOTRANSPLANTATION, V9, P242, DOI 10.1034/j.1399-3089.2002.01110.x; Boneva RS, 2001, CLIN MICROBIOL REV, V14, P1, DOI 10.1128/CMR.14.1.1-14.2001; Cooper DKC, 2000, J HEART LUNG TRANSPL, V19, P1125, DOI 10.1016/S1053-2498(00)00224-2; Deng YM, 2000, TRANSPLANTATION, V70, P1010, DOI 10.1097/00007890-200010150-00004; Di Nicuolo G, 2005, XENOTRANSPLANTATION, V12, P286, DOI 10.1111/j.1399-3089.2005.00226.x; Dorling A, 1997, LANCET, V349, P867, DOI 10.1016/S0140-6736(96)09404-4; Dufrane D, 2012, TRANSPLANT REV-ORLAN, V26, P183, DOI 10.1016/j.trre.2011.07.004; Gunzburg WH, 2000, MOL MED TODAY, V6, P199, DOI 10.1016/S1357-4310(00)01708-1; Hermida-Prieto M, 2007, TRANSPLANTATION, V84, P548, DOI 10.1097/01.tp.0000275203.91841.23; Karlas A, 2010, ANN TRANSPL, V15, P45; Kim NY, 2009, VIRUS GENES, V39, P210, DOI 10.1007/s11262-009-0377-7; Koch KS, 2006, IMMUNOLOGY, V119, P98, DOI 10.1111/j.1365-2567.2006.02412.x; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Lee Jung Eun, 2009, Journal of Bacteriology and Virology, V39, P137; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Martin U, 1998, LANCET, V352, P692, DOI 10.1016/S0140-6736(98)07144-X; Martina Y, 2006, J VIROL, V80, P3135, DOI 10.1128/JVI.80.7.3135-3146.2006; Martina Y, 2005, AM J TRANSPLANT, V5, P1837, DOI 10.1111/j.1600-6143.2005.00978.x; Mendoza R, 2011, J VIROL, V85, P9247, DOI 10.1128/JVI.05137-11; Pal N, 2011, TRANSBOUND EMERG DIS, V58, P344, DOI 10.1111/j.1865-1682.2011.01210.x; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Popp SK, 2007, IMMUNOL CELL BIOL, V85, P238, DOI 10.1038/sj.icb.7100028; Sakuma K, 2005, ACTA NEUROPATHOL, V110, P269, DOI 10.1007/s00401-005-1049-x; Samstein B, 2001, J AM SOC NEPHROL, V12, P182, DOI 10.1681/ASN.V121182; Scheef G, 2001, J VIROL, V75, P6933, DOI 10.1128/JVI.75.15.6933-6940.2001; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; van der Laan LJW, 2000, NATURE, V407, P90, DOI 10.1038/35024089; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Yang YG, 2004, J CLIN INVEST, V114, P695, DOI 10.1172/JCI200421946; Zmuda EJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2096	35	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165156	10.1371/journal.pone.0165156	http://dx.doi.org/10.1371/journal.pone.0165156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832080	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000011
J	Daivadanam, M; Ravindran, TKS; Thankappan, KR; Sarma, PS; Wahlstrom, R				Daivadanam, Meena; Ravindran, T. K. Sundari; Thankappan, K. R.; Sarma, P. S.; Wahlstrom, Rolf			Development of a Tool to Stage Households' Readiness to Change Dietary Behaviours in Kerala, India	PLOS ONE			English	Article							TRANSTHEORETICAL MODEL; PHYSICAL-ACTIVITY; RURAL KERALA; FOOD CHOICE; INTERVENTIONS; TRIAL; FAT	Dietary interventions and existing health behaviour theories are centred on individuals; therefore, none of the available tools are applicable to households for changing dietary behaviour. The objective of this pilot study was to develop a practical tool that could be administered by community volunteers to stage households in rural Kerala based on readiness to change dietary behaviour. Such a staging tool, comprising a questionnaire and its algorithm, focusing five dietary components (fruits, vegetables, salt, sugar and oil) and households (rather than individuals), was finalised through three consecutive pilot validation sessions, conducted over a four-month period. Each revised version was tested with a total of 80 households (n = 30, 35 and 15 respectively in the three sessions). The tool and its comparator, Motivational Interviewing (MI), assessed the stage-of-change for a household pertaining to their: 1) fruit and vegetable consumption behaviour; 2) salt, sugar and oil consumption behaviour; 3) overall readiness to change. The level of agreement between the two was tested using Kappa statistics to assess concurrent validity. A value of 0.7 or above was considered as good agreement. The final version was found to have good face and content validity, and also a high level of agreement with MI (87%; weighted kappa statistic: 0.85). Internal consistency testing was performed using Cronbach's Alpha, with a value between 0.80 and 0.90 considered to be good. The instrument had good correlation between the items in each section (Cronbach's Alpha: 0.84 (fruit and vegetables), 0.85 (salt, sugar and oil) and 0.83 (Overall)). Pre-contemplation was the most difficult stage to identify; for which efficacy and perceived cooperation at the household level were important. To the best of our knowledge, this is the first staging tool for households. This tool represents a new concept in community-based dietary interventions. The tool can be easily administered by lay community workers and can therefore be used in large population-based studies. A more robust validation process with a larger sample is needed before it can be widely used.	[Daivadanam, Meena; Ravindran, T. K. Sundari; Thankappan, K. R.; Sarma, P. S.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram 695011, Kerala, India; [Daivadanam, Meena; Wahlstrom, Rolf] Karolinska Inst, Dept Publ Hlth Sci Global Hlth, Tomtebodavagen 18A, S-17177 Stockholm, Sweden; [Daivadanam, Meena] Uppsala Univ, Dept Food Nutr & Dietet, Box 560, SE-75122 Uppsala, Sweden; [Wahlstrom, Rolf] Uppsala Univ, Family Med & Prevent Med, Dept Publ Hlth & Caring Sci, Uppsala, Sweden	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Karolinska Institutet; Uppsala University; Uppsala University	Daivadanam, M (corresponding author), Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Thiruvananthapuram 695011, Kerala, India.; Daivadanam, M (corresponding author), Karolinska Inst, Dept Publ Hlth Sci Global Hlth, Tomtebodavagen 18A, S-17177 Stockholm, Sweden.; Daivadanam, M (corresponding author), Uppsala Univ, Dept Food Nutr & Dietet, Box 560, SE-75122 Uppsala, Sweden.	meena.daivadanam@ikv.uu.se	Thankappan, Kr/ABC-9551-2021; Daivadanam, Meena/F-1747-2018	Daivadanam, Meena/0000-0002-9532-6059; , KR/0000-0002-4536-2684	Erasmus Mundus Scholarship [13]	Erasmus Mundus Scholarship	The authors acknowledge funding for doctoral studies received by the first author (MD) from Erasmus Mundus Scholarship (external cooperation window, lot 13).	[Anonymous], 2004, JOINT FAO WHO WORKSH; [Anonymous], 2003, DIET NUTR PREV CHRON; Babicz-Zielinska Ewa, 2006, Polish Journal of Food and Nutrition Sciences, V15, P379; Ball K, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-33; Berg-Smith SM, 1999, HEALTH EDUC RES, V14, P399, DOI 10.1093/her/14.3.399; Blissmer B, 2002, ANN BEHAV MED, V24, P181, DOI 10.1207/S15324796ABM2403_03; Brett JM, 2000, INT J PSYCHOL, V35, P97, DOI 10.1080/002075900399385; Conner M, 2005, PREDICTING HLTH BEHA; Daivadanam M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1880-5; Daivadanam M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-574; Daivadanam M, 2013, GLOBAL HEALTH ACTION, V6, DOI 10.3402/gha.v6i0.20993; Daivadanam M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-95; DeVellis R. F., 2012, SCALE DEV THEORY APP; Greene GW, 1998, J AM DIET ASSOC, V98, P529, DOI 10.1016/S0002-8223(98)00120-5; Hargreaves MK, 1999, J AM DIET ASSOC, V99, P1392, DOI 10.1016/S0002-8223(99)00338-7; Hildebrand DA, 2009, J NUTR EDUC BEHAV, V41, P110, DOI 10.1016/j.jneb.2008.09.007; Horwath CC, 1999, NUTR RES REV, V12, P281, DOI 10.1079/095442299108728965; Kristal AR, 1999, J AM DIET ASSOC, V99, P679, DOI 10.1016/S0002-8223(99)00165-0; LAFORGE RG, 1994, J BEHAV MED, V17, P361, DOI 10.1007/BF01858008; Lavrakes P, 2008, ENCY SURVEY RES METH; Lewis-Beck MichaelS., 2011, SAGE ENCY SOCIAL SCI, P1193; Littell JH, 2002, BEHAV MODIF, V26, P223, DOI 10.1177/0145445502026002006; Mehta P, 2010, INT Q COMMUNITY HEAL, V30, P257, DOI 10.2190/IQ.30.3.f; Miller R, 1991, MOTIVATIONAL INTERVI; Miller WR, 1996, ADDICT BEHAV, V21, P835, DOI 10.1016/0306-4603(96)00044-5; MILLER WR, 1983, BEHAV PSYCHOTHER, V11, P147, DOI 10.1017/S0141347300006583; NIN, 2010, DIET GUID IND; Noar SM, 2005, HEALTH EDUC RES, V20, P275, DOI 10.1093/her/cyg113; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Rollnick S, 1992, J MENT HEALTH, V1, P25, DOI DOI 10.3109/09638239209034509; Shepherd R, 2005, FORUM NUTR, V57, P36, DOI 10.1159/000083752; Shepherd R, 1999, P NUTR SOC, V58, P807, DOI 10.1017/S0029665199001093; Shirazi M, 2007, J EVAL CLIN PRACT, V13, P298, DOI 10.1111/j.1365-2753.2006.00735.x; Spencer L, 2007, NUTR RES REV, V20, P46, DOI 10.1017/S0954422407747881; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; Varatharajan D, 2004, HEALTH POLICY PLANN, V19, P41, DOI 10.1093/heapol/czh005; Warrens MJ, 2013, J PROBAB STAT, V2013, DOI 10.1155/2013/325831; Wilson Caroline, 2010, Anthropol Med, V17, P261, DOI 10.1080/13648470.2010.526699; World Health Organization, 2007, RED SALT INT POP REP, P109; World Health Organization, 2005, WHO STEPS SURV MAN W; World Health Organization, 2013, POP NUTR INT GOALS P	41	1	1	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165599	10.1371/journal.pone.0165599	http://dx.doi.org/10.1371/journal.pone.0165599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861500	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300010
J	Menten-Dedoyart, C; Navacerrada, MES; Bartholome, O; Gill, JS; Neirinckx, V; Wislet, S; Becker, G; Plenevaux, A; Van den Ackerveken, P; Rogister, B				Menten-Dedoyart, Catherine; Navacerrada, Maria Elise Serrano; Bartholome, Odile; Gill, Judit Sanchez; Neirinckx, Virginie; Wislet, Sabine; Becker, Guillaume; Plenevaux, Alain; Van den Ackerveken, Priscilla; Rogister, Bernard			Development and Validation of a New Mouse Model to Investigate the Role of SV2A in Epilepsy	PLOS ONE			English	Article							SYNAPTIC VESICLE PROTEIN; NEUROTRANSMITTER RELEASE; ENDOCRINE-CELLS; MICE; BRAIN; 2A; SV2A-DEFICIENT; LEVETIRACETAM; EXPRESSION; ISOFORMS	SV2A is a glycoprotein present in the membranes of most synaptic vesicles. Although it has been highly conserved throughout evolution, its physiological role remains largely unknown. Nevertheless, Levetiracetam, a very effective anti-epileptic drug, has been recently demonstrated to bind to SV2A. At present, our understanding of the normal function of SV2A and its possible involvement in diseases like epilepsy is limited. With this study, we sought to develop a relevant model enabling analysis of SV2A's role in the occurrence or progression of epilepsy. For this purpose, we generated a floxed SV2A mouse model with conditional alleles carrying LoxP sites around exon 3 by means of a gene-targeting strategy. The SV2A lox/lox mouse line is indistinguishable from wild-type mice. When the recombination was observed in all cells, a model of mice with both SV2A alleles floxed around exon 3 recapitulated the phenotype of SV2A KO mice, including seizures. However, the specific invalidation of SV2A in the CA3 hippocampal region was not followed by epileptic seizures or decrease in the epileptic threshold on pentylenetetrazol (PTZ) test. These results demonstrate that the floxed SV2A mouse line has been successfully established. This transgenic mouse model will be useful for investigating SV2A functions related to cell types and developmental stages.	[Menten-Dedoyart, Catherine; Bartholome, Odile; Gill, Judit Sanchez; Neirinckx, Virginie; Wislet, Sabine; Van den Ackerveken, Priscilla; Rogister, Bernard] Univ Liege, GIGA Neurosci, Liege, Belgium; [Navacerrada, Maria Elise Serrano; Becker, Guillaume; Plenevaux, Alain] Univ Liege, Cyclotron Res Ctr, Liege, Belgium; [Rogister, Bernard] Univ Liege, Acad Hosp, CHU, Dept Neurol, Liege, Belgium	University of Liege; University of Liege; University of Liege	Rogister, B (corresponding author), Univ Liege, GIGA Neurosci, Liege, Belgium.; Rogister, B (corresponding author), Univ Liege, Acad Hosp, CHU, Dept Neurol, Liege, Belgium.	Bernard.Rogister@ulg.ac.be	Rogister, Bernard/AAJ-9591-2020; Becker, Guillaume/AAC-4792-2019	Becker, Guillaume/0000-0002-1714-0267; Serrano Navacerrada, Maria Elisa/0000-0003-0880-6183; Van Den Ackerveken, Priscilla/0000-0001-5913-6293; wislet, sabine/0000-0003-4279-9669	FRS-FNRS; Fonds Leon Fredericq; ARC; UCB Pharma; Belgian National Funds for Scientific Research (FRS-FNRS)	FRS-FNRS(Fonds de la Recherche Scientifique - FNRS); Fonds Leon Fredericq; ARC(Australian Research Council); UCB Pharma(UCB Pharma SA); Belgian National Funds for Scientific Research (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS)	Funded by FRS-FNRS, the Fonds Leon Fredericq and ARC. The funders had no role in study design, data collection and analysis, decision to publish. This work was funded too with UCB Pharma as partners.; The authors wish to thank A. Colige for sharing the Ubc: cre-mouse lines and L. Nguyen for the RosaEYFP mice. We thank the GIGA-Imaging for their technical support. B.R. and A.P are Senior Research Associates from the Belgian National Funds for Scientific Research (FRS-FNRS). B.R. is funded by grants from the FRS-FNRS, the Fonds Leon Fredericq, and ARC. This work was funded with UCB Pharma as partners.	BAJJALIEH SM, 1994, J NEUROSCI, V14, P5223, DOI 10.1523/jneurosci.14-09-05223.1994; BINDRA PS, 1993, GENE, V137, P299, DOI 10.1016/0378-1119(93)90024-W; Bretin F, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-35; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; Crevecoeur J, 2014, NEUROPATH APPL NEURO, V40, P191, DOI 10.1111/nan.12054; Crevecoeur J, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-87; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; Dong M, 2006, SCIENCE, V312, P592, DOI 10.1126/science.1123654; Mendoza-Torreblanca JG, 2013, EUR J NEUROSCI, V38, P3529, DOI 10.1111/ejn.12360; Haws ME, 2012, GENES BRAIN BEHAV, V11, P201, DOI 10.1111/j.1601-183X.2011.00755.x; Janz R, 1999, NEUROSCIENCE, V94, P1279, DOI 10.1016/S0306-4522(99)00370-X; Janz R, 1999, NEURON, V24, P1003, DOI 10.1016/S0896-6273(00)81046-6; Kaminski RM, 2009, EPILEPSIA, V50, P1729, DOI 10.1111/j.1528-1167.2009.02089.x; Lamberty Y, 2009, BEHAV BRAIN RES, V198, P329, DOI 10.1016/j.bbr.2008.11.005; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; Suzuki T, 2009, HUM MOL GENET, V18, P1099, DOI 10.1093/hmg/ddp006; Venkatesan K, 2012, J NEUROSCI RES, V90, P2317, DOI 10.1002/jnr.23111; Wan QF, 2010, NEURON, V66, P884, DOI 10.1016/j.neuron.2010.05.010; Warnock GI, 2014, J NUCL MED, V55, P1336, DOI 10.2967/jnumed.113.136143	21	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166525	10.1371/journal.pone.0166525	http://dx.doi.org/10.1371/journal.pone.0166525			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861538	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300068
J	Sagong, HY; Son, HF; Kim, S; Kim, YH; Kim, IK; Kim, KJ				Sagong, Hye-Young; Son, Hyeoncheol Francis; Kim, Sunghwan; Kim, Yong-Hwan; Kim, Il-Kwon; Kim, Kyung-Jin			Crystal Structure and Pyridoxal 5-Phosphate Binding Property of Lysine Decarboxylase from Selenomonas ruminantium	PLOS ONE			English	Article							ESCHERICHIA-COLI; CORYNEBACTERIUM-GLUTAMICUM; ORNITHINE-DECARBOXYLASE; ACID RESISTANCE; INTERNAL PH; CADAVERINE; PUTRESCINE; POLYAMINES	Lysine decarboxylase (LDC) is a crucial enzyme for acid stress resistance and is also utilized for the biosynthesis of cadaverine, a promising building block for bio-based polyamides. We determined the crystal structure of LDC from Selenomonas ruminantium (SrLDC). SrLDC functions as a dimer and each monomer consists of two distinct domains; a PLP-binding barrel domain and a sheet domain. We also determined the structure of SrLDC in complex with PLP and cadaverine and elucidated the binding mode of cofactor and substrate. Interestingly, compared with the apo-form of SrLDC, the SrLDC in complex with PLP and cadaverine showed a remarkable structural change at the PLP binding site. The PLP binding site of SrLDC contains the highly flexible loops with high b-factors and showed an open-closed conformational change upon the binding of PLP. In fact, SrLDC showed no LDC activity without PLP supplement, and we suggest that highly flexible PLP binding site results in low PLP affinity of SrLDC. In addition, other structurally homologous enzymes contain the flexible PLP binding site, which indicates that high flexibility at the PLP binding site and low PLP affinity seems to be a common feature of these enzyme family.	[Sagong, Hye-Young; Son, Hyeoncheol Francis; Kim, Kyung-Jin] Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Daegu 702701, South Korea; [Kim, Sunghwan] Daegu Gyungpook Med Innovat Fdn, New Drug Dev Ctr, Daegu 701310, South Korea; [Kim, Yong-Hwan] UNIST, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Kim, Il-Kwon] DAESANG Corp, Biopoecess Res Dept, R&D Ctr, Icheon Si 17384, Gyeonggi Do, South Korea	Kyungpook National University; Ulsan National Institute of Science & Technology (UNIST)	Kim, KJ (corresponding author), Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Daegu 702701, South Korea.	kkim@knu.ac.kr		Sagong, Hye-Young/0000-0003-1823-4991; Kim, Il-Kwon/0000-0002-6946-3375; Kim, Sunghwan/0000-0002-1927-9617	National Research Foundation of Korea (NRF) [NRF-2014M1A2A2033626]; C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2016M3D3A1A01913269]; New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP); Ministry of Trade, Industry & Energy, Republic of Korea [20153030091360]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning(National Research Foundation of Korea); New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP); Ministry of Trade, Industry & Energy, Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626) and by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3D3A1A01913269), and was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (20153030091360).; This work was supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626) and by C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3D3A1A01913269), and was also supported by the New & Renewable Energy Core Technology Program of the Korea Institute of Energy Technology Evaluation and Planning (KETEP) granted financial resource from the Ministry of Trade, Industry & Energy, Republic of Korea (20153030091360).	Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; BALK H, 1981, BIOCHEMISTRY-US, V20, P6391, DOI 10.1021/bi00525a017; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; BOEKER EA, 1972, ENZYMES, V6, P217; Brickman TJ, 1996, J BACTERIOL, V178, P54, DOI 10.1128/jb.178.1.54-60.1996; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flieger M, 2003, FOLIA MICROBIOL, V48, P27, DOI 10.1007/BF02931273; Kim HJ, 2015, J MICROBIOL BIOTECHN, V25, P1108, DOI 10.4014/jmb.1412.12052; Kind S, 2010, METAB ENG, V12, P341, DOI 10.1016/j.ymben.2010.03.005; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JW, 2011, CURR OPIN BIOTECH, V22, P758, DOI 10.1016/j.copbio.2011.02.011; Lee SG, 2006, FEBS J, V273, P5564, DOI 10.1111/j.1742-4658.2006.05546.x; Ma W, 2015, SCI REPORTS, V5; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mimitsuka T, 2007, BIOSCI BIOTECH BIOCH, V71, P2130, DOI 10.1271/bbb.60699; Mimizuka T, 2002, INVENTORSHOST METHOD; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neely MN, 1996, J BACTERIOL, V178, P5522, DOI 10.1128/jb.178.18.5522-5528.1996; Nishi K., 2006, Eur. Pat, Patent No. [EP1482055 (B1), 1482055]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park YK, 1996, MOL MICROBIOL, V20, P605, DOI 10.1046/j.1365-2958.1996.5441070.x; Patel CN, 2006, J BACTERIOL, V188, P2355, DOI 10.1128/JB.188.7.2355-2363.2006; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Platt DK, 2003, ENG HIGH PERFORMANCE; Qian ZG, 2011, BIOTECHNOL BIOENG, V108, P93, DOI 10.1002/bit.22918; Richard H, 2004, J BACTERIOL, V186, P6032, DOI 10.1128/jb.186.18.6032-6041.2004; Schneider J, 2011, APPL MICROBIOL BIOT, V91, P17, DOI 10.1007/s00253-011-3252-0; Shah R, 2007, BIOCHEMISTRY-US, V46, P2831, DOI 10.1021/bi6023447; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; Tateno T, 2009, APPL MICROBIOL BIOT, V82, P115, DOI 10.1007/s00253-008-1751-4; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Willke T, 2004, APPL MICROBIOL BIOT, V66, P131, DOI 10.1007/s00253-004-1733-0	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166667	10.1371/journal.pone.0166667	http://dx.doi.org/10.1371/journal.pone.0166667			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861532	gold, Green Published			2022-12-26	WOS:000388350300084
J	Tian, Q; Zhao, WJ; Lu, SY; Zhu, SF; Li, SD				Tian, Qian; Zhao, Wenjun; Lu, Songyu; Zhu, Shuifang; Li, Shidong			DNA Barcoding for Efficient Species- and Pathovar-Level Identification of the Quarantine Plant Pathogen Xanthomonas	PLOS ONE			English	Article							HSP60 GENE; SEQUENCES; TAXONOMY	Genus Xanthomonas comprises many economically important plant pathogens that affect a wide range of hosts. Indeed, fourteen Xanthomonas species/pathovars have been regarded as official quarantine bacteria for imports in China. To date, however, a rapid and accurate method capable of identifying all of the quarantine species/pathovars has yet to be developed. In this study, we therefore evaluated the capacity of DNA barcoding as a digital identification method for discriminating quarantine species/pathovars of Xanthomonas. For these analyses, 327 isolates, representing 45 Xanthomonas species/pathovars, as well as five additional species/pathovars from GenBank (50 species/pathovars total), were utilized to test the efficacy of four DNA barcode candidate genes (16S rRNA gene, cpn60, gyrB, and avrBs2). Of these candidate genes, cpn60 displayed the highest rate of PCR amplification and sequencing success. The tree-building (Neighbor-joining), 'best close match', and barcode gap methods were subsequently employed to assess the species-and pathovar-level resolution of each gene. Notably, all isolates of each quarantine species/pathovars formed a monophyletic group in the neighbor-joining tree constructed using the cpn60 sequences. Moreover, cpn60 also demonstrated the most satisfactory results in both barcoding gap analysis and the 'best close match' test. Thus, compared with the other markers tested, cpn60 proved to be a powerful DNA barcode, providing a reliable and effective means for the species-and pathovar-level identification of the quarantine plant pathogen Xanthomonas.	[Tian, Qian; Li, Shidong] Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China; [Tian, Qian; Zhao, Wenjun; Zhu, Shuifang] Chinese Acad Inspect & Quarantine, Inst Plant Quarantine Res, Beijing, Peoples R China; [Lu, Songyu] Nanjing Agr Univ, Coll Plant Protect, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Inspection & Quarantine; Nanjing Agricultural University	Li, SD (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, Beijing, Peoples R China.; Zhao, WJ (corresponding author), Chinese Acad Inspect & Quarantine, Inst Plant Quarantine Res, Beijing, Peoples R China.	wenjunzhao@188.com; sdli@ippcaas.cn			National Science and Technology Ministry [2012BAK11602]	National Science and Technology Ministry	This work is financially supported by National Science and Technology Ministry (2012BAK11602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brousseau R, 2001, APPL ENVIRON MICROB, V67, P4828, DOI 10.1128/AEM.67.10.4828-4833.2001; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Chaban B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-73; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Dumonceaux TJ, 2006, J MICROBIOL METH, V64, P46, DOI 10.1016/j.mimet.2005.04.006; Dye D. W., 1980, Review of Plant Pathology, V59, P153; Goh SH, 2000, J CLIN MICROBIOL, V38, P3953, DOI 10.1128/JCM.38.11.3953-3959.2000; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajri A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006632; Hauben L, 1997, INT J SYST BACTERIOL, V47, P328, DOI 10.1099/00207713-47-2-328; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hill JE, 2006, J MED MICROBIOL, V55, P393, DOI 10.1099/jmm.0.46282-0; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kwok AYC, 2003, INT J SYST EVOL MICR, V53, P87, DOI 10.1099/ijs.0.02210-0; Links MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049755; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Minana-Galbis D, 2009, INT J SYST EVOL MICR, V59, P1976, DOI 10.1099/ijs.0.005413-0; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paramel JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043009 PMID: 22900080, DOI :10.1371/JOURNAL.PONE.]; Parkinson N, 2008, INT J SYST EVOL MICR, V57, P2881; Parkinson N, 2009, INT J SYST EVOL MICR, V59, P264, DOI 10.1099/ijs.0.65825-0; Sahin N, 2010, FEMS MICROBIOL LETT, V307, P25, DOI 10.1111/j.1574-6968.2010.01954.x; Sakamoto M, 2010, J MED MICROBIOL, V59, P1293, DOI 10.1099/jmm.0.020420-0; STEAD D E, 1989, Bulletin OEPP, V19, P57, DOI 10.1111/j.1365-2338.1989.tb00129.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VAUTERIN L, 1990, INT J SYST BACTERIOL, V40, P312, DOI 10.1099/00207713-40-3-312; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Young JM, 2008, SYST APPL MICROBIOL, V31, P366, DOI 10.1016/j.syapm.2008.06.004; Zeigler DR, 2003, INT J SYST EVOL MICR, V53, P1893, DOI 10.1099/ijs.0.02713-0	30	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165995	10.1371/journal.pone.0165995	http://dx.doi.org/10.1371/journal.pone.0165995			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861494	Green Submitted, gold, Green Published			2022-12-26	WOS:000388350300020
J	Toju, H; Kishida, O; Katayama, N; Takagi, K				Toju, Hirokazu; Kishida, Osamu; Katayama, Noboru; Takagi, Kentaro			Networks Depicting the Fine-Scale Co-Occurrences of Fungi in Soil Horizons	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; ROOT-ASSOCIATED FUNGI; COMMUNITY COMPOSITION; PLANT; DIVERSITY; IDENTIFICATION; BIODIVERSITY; ARCHITECTURE; SPECIFICITY; VARIABILITY	Fungi in soil play pivotal roles in nutrient cycling, pest controls, and plant community succession in terrestrial ecosystems. Despite the ecosystem functions provided by soil fungi, our knowledge of the assembly processes of belowground fungi has been limited. In particular, we still have limited knowledge of how diverse functional groups of fungi interact with each other in facilitative and competitive ways in soil. Based on the high-throughput sequencing data of fungi in a cool-temperate forest in northern Japan, we analyzed how taxonomically and functionally diverse fungi showed correlated fine-scale distributions in soil. By uncovering pairs of fungi that frequently co-occurred in the same soil samples, networks depicting fine-scale co-occurrences of fungi were inferred at the O (organic matter) and A (surface soil) horizons. The results then led to the working hypothesis that mycorrhizal, endophytic, saprotrophic, and pathogenic fungi could form compartmentalized (modular) networks of facilitative, antagonistic, and/or competitive interactions in belowground ecosystems. Overall, this study provides a research basis for further understanding how interspecific interactions, along with sharing of niches among fungi, drive the dynamics of poorly explored biospheres in soil.	[Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Kishida, Osamu] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Expt Forest, Tomakomai, Hokkaido, Japan; [Katayama, Noboru] Kyoto Univ, Ctr Ecol Res, 2 Chome, Otsu, Shiga, Japan; [Takagi, Kentaro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Teshio Expt Forest, Aza Toikanbetsu 131, Horonobe, Hokkaido, Japan	Kyoto University; Hokkaido University; Kyoto University; Hokkaido University	Toju, H (corresponding author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan.	toju.hirokazu.4c@kyoto-u.ac.jp	Kishida, Osamu/B-7970-2011; Takagi, Kentaro/C-2222-2012; Toju, Hirokazu/T-7355-2019; Toju, Hirokazu/S-7307-2017	Toju, Hirokazu/0000-0002-3362-3285	Japan Society for the Promotion of Science JSPS KAKENHI [26711026]; Supporting Program for Interaction-based Initiative Team Studies (SPIRITS) by Kyoto University; PRESTO by JST [11118]; Funding Program for Next Generation World Leading Researchers of Cabinet Office, the Government of Japan [GS014]	Japan Society for the Promotion of Science JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Supporting Program for Interaction-based Initiative Team Studies (SPIRITS) by Kyoto University; PRESTO by JST; Funding Program for Next Generation World Leading Researchers of Cabinet Office, the Government of Japan	This work was financially supported by Japan Society for the Promotion of Science JSPS KAKENHI Grant (No. 26711026) [https://www.jsps.go.jp/english/index.html] to HT; the Supporting Program for Interaction-based Initiative Team Studies (SPIRITS) by Kyoto University [http://research.kyoto-u.ac.jp/service/topic/spirits/lists/h27list_e/] to HT; [http://www.jst.go.jp/kisoken/presto/en/index.html] of "PRESTO by JST (No.11118); and the Funding Program for Next Generation World Leading Researchers of Cabinet Office, the Government of Japan (GS014) to HT [http://www.jsps.go.jp/english/e.jisedai/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bakker MG, 2014, MOL ECOL, V23, P1571, DOI 10.1111/mec.12571; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Beiler KJ, 2010, NEW PHYTOL, V185, P543, DOI 10.1111/j.1469-8137.2009.03069.x; Bridge PD, 2009, FUNGAL ECOL, V2, P66, DOI 10.1016/j.funeco.2008.10.008; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caruso T, 2012, NEW PHYTOL, V194, P891, DOI 10.1111/j.1469-8137.2012.04163.x; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Cuthbertson AGS, 2008, INSECT SCI, V15, P355, DOI 10.1111/j.1744-7917.2008.00221.x; Darwin C, 1859, ORIGIN SPECIES MEANS; Dickie IA, 2007, NEW PHYTOL, V174, P230, DOI 10.1111/j.1469-8137.2007.02055.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fukami T, 2015, ANNU REV ECOL EVOL S, V46, P1, DOI 10.1146/annurev-ecolsys-110411-160340; Ginns James, 2003, Mycological Progress, V2, P137, DOI 10.1007/s11557-006-0051-6; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Kennedy P, 2014, PEERJ, V2, DOI 10.7717/peerj.686; Kennedy PG, 2005, NEW PHYTOL, V166, P631, DOI 10.1111/j.1469-8137.2005.01355.x; Kiers ET, 2011, SCIENCE, V333, P880, DOI 10.1126/science.1208473; Koide RT, 2005, NEW PHYTOL, V165, P305, DOI 10.1111/j.1469-8137.2004.01216.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226; Letten AD, 2015, J ECOL, V103, P1264, DOI 10.1111/1365-2745.12428; Li W, 2012, BRIEF BIOINFORM; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Ma B, 2016, ISME J, V10, P1891, DOI 10.1038/ismej.2015.261; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Meyling NV, 2007, BIOL CONTROL, V43, P145, DOI 10.1016/j.biocontrol.2007.07.007; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Miura T, 2015, MICROB ECOL, V70, P646, DOI 10.1007/s00248-015-0620-9; Mujic AB, 2016, NEW PHYTOL, V209, P1174, DOI 10.1111/nph.13677; Nara K, 2006, NEW PHYTOL, V169, P169, DOI 10.1111/j.1469-8137.2005.01545.x; Newman M, 2010, NETWORKS INTRO; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; O'Donnell JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148698; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ovaskainen O, 2016, METHODS ECOL EVOL, V7, P549, DOI 10.1111/2041-210X.12501; Peay KG, 2015, ECOL LETT, V18, P807, DOI 10.1111/ele.12459; Peay KG, 2014, NEW PHYTOL, V204, P180, DOI 10.1111/nph.12906; R-Core-Team, 2015, R 3 2 0 LANG ENV STA; READ DJ, 1991, EXPERIENTIA, V47, P376, DOI 10.1007/BF01972080; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Smith S.E., 2010, MYCORRHIZAL SYMBIOSI, V3rd, DOI DOI 10.1097/00010694-198403000-00011; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stevens JL, 2013, J MICROBIOL METH, V93, P203, DOI 10.1016/j.mimet.2013.03.013; Talbot JM, 2014, P NATL ACAD SCI USA, V111, P6341, DOI 10.1073/pnas.1402584111; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Toju H, 2016, MOL ECOL, V25, P3242, DOI 10.1111/mec.13680; Toju H, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500291; Toju H, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1097; Toju H, 2015, POPUL ECOL, V57, P37, DOI 10.1007/s10144-014-0472-z; Toju H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6273; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Wagg C, 2014, P NATL ACAD SCI USA, V111, P5266, DOI 10.1073/pnas.1320054111; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Warton DI, 2015, TRENDS ECOL EVOL, V30, P766, DOI 10.1016/j.tree.2015.09.007; Werner GDA, 2015, NEW PHYTOL, V205, P1515, DOI 10.1111/nph.13092; Yamamoto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096363; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhang YH, 2016, SCI REP-UK, V6, DOI 10.1038/srep22399	82	53	61	20	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165987	10.1371/journal.pone.0165987	http://dx.doi.org/10.1371/journal.pone.0165987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861486	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300017
J	Cruz, MJ; Menezes, G; Machete, M; Silva, MA				Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.			Predicting Interactions between Common Dolphins and the Pole-and-Line Tuna Fishery in the Azores	PLOS ONE			English	Article							PELAGIC LONGLINE FISHERIES; TROPICAL PACIFIC-OCEAN; BOTTLE-NOSED DOLPHINS; NORTHEAST ATLANTIC; DELPHINUS-DELPHIS; NE ATLANTIC; SPATIAL-DISTRIBUTION; MITIGATION DEVICE; CATCH RATES; DEPREDATION	Common dolphins (Delphinus delphis) are responsible for the large majority of interactions with the pole-and-line tuna fishery in the Azores but the underlying drivers remain poorly understood. In this study we investigate the influence of various environmental and fisheries-related factors in promoting the interaction of common dolphins with this fishery and estimate the resultant catch losses. We analysed 15 years of fishery and cetacean interaction data (1998-2012) collected by observers placed aboard tuna fishing vessels. Dolphins interacted in less than 3% of the fishing events observed during the study period. The probability of dolphin interaction varied significantly between years with no evident trend over time. Generalized additive modeling results suggest that fishing duration, sea surface temperature and prey abundance in the region were the most important factors explaining common dolphin interaction. Dolphin interaction had no impact on the catches of albacore, skipjack and yellowfin tuna but resulted in significantly lower catches of bigeye tuna, with a predicted median annual loss of 13.5% in the number of fish captured. However, impact on bigeye catches varied considerably both by year and fishing area. Our work shows that rates of common dolphin interaction with the pole-and-line tuna fishery in the Azores are low and showed no signs of increase over the study period. Although overall economic impact was low, the interaction may lead to significant losses in some years. These findings emphasize the need for continued monitoring and for further research into the consequences and economic viability of potential mitigation measures.	[Cruz, Maria Joao; Menezes, Gui] Univ Acores, Dept Oceanog & Pescas, P-9901862 Horta, Portugal; [Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.] Univ Azores, MARE Marine & Environm Sci Ctr, P-9901862 Horta, Portugal; [Cruz, Maria Joao; Menezes, Gui; Machete, Miguel; Silva, Monica A.] Univ Azores, Ctr Inst Marine Res IMAR, P-9901862 Horta, Portugal; [Silva, Monica A.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Universidade dos Acores; Universidade dos Acores; Universidade dos Acores; Woods Hole Oceanographic Institution	Cruz, MJ (corresponding author), Univ Acores, Dept Oceanog & Pescas, P-9901862 Horta, Portugal.; Cruz, MJ (corresponding author), Univ Azores, MARE Marine & Environm Sci Ctr, P-9901862 Horta, Portugal.; Cruz, MJ (corresponding author), Univ Azores, Ctr Inst Marine Res IMAR, P-9901862 Horta, Portugal.	mjoaocruz@uac.pt	Silva, Mónica/D-1893-2012; Menezes, Gui M./A-3956-2009	Silva, Mónica/0000-0002-2683-309X; Menezes, Gui M./0000-0003-0781-4579	Fundacao para a Ciencia e a Tecnologia (FCT) though FEDER; DRCT/SRCTE, though FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Portuguese Ministry for Science and Education [PTDC/MAR/74071/2006, IF/00943/2013/CP1199/CT0001, M2.1.2/F/012/2011]; Fundacao para a Ciencia e Tecnologia (FCT) [UID/MAR/04292/2013]; Azorean Regional Government; Shipowners Association; Association of the Tuna Canning Industries; DRCT [M3.1.2/F/008/2009]; POPH; QREN; European Social Fund; Portuguese Ministry for Science and Education, through an FCT [IF/00943/2013]; FCT [IF/00943/2013/CP1199/CT0001]; SMRCT/DRCT	Fundacao para a Ciencia e a Tecnologia (FCT) though FEDER; DRCT/SRCTE, though FEDER; Competitiveness Factors Operational (COMPETE); QREN European Social Fund; Portuguese Ministry for Science and Education(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Azorean Regional Government; Shipowners Association; Association of the Tuna Canning Industries; DRCT; POPH; QREN; European Social Fund(European Social Fund (ESF)); Portuguese Ministry for Science and Education, through an FCT; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); SMRCT/DRCT	This work was funded by Fundacao para a Ciencia e a Tecnologia (FCT) and DRCT/SRCTE, though FEDER, the Competitiveness Factors Operational (COMPETE), QREN European Social Fund, the Portuguese Ministry for Science and Education, under research projects TRACE (PTDC/MAR/74071/2006), FCT Exploratory Project (IF/00943/2013/CP1199/CT0001), and MAPCET (M2.1.2/F/012/2011). We acknowledge the support of Fundacao para a Ciencia e Tecnologia (FCT), through the strategic project UID/MAR/04292/2013 granted to MARE. We thank the Azorean Regional Government for funding POPA, the Shipowners Association and the Association of the Tuna Canning Industries for their support to the program. MJC was supported by a DRCT doctoral grant (M3.1.2/F/008/2009). MAS was supported by POPH, QREN, European Social Fund and Portuguese Ministry for Science and Education, through an FCT Investigator grant (IF/00943/2013). Publication fees for this open access publication were supported the FCT Exploratory Project (IF/00943/2013/CP1199/CT0001) and by SMRCT/DRCT.	[Anonymous], 2014, 2 IPNLF; Ansmann IC, 2012, ANIM BEHAV, V84, P575, DOI 10.1016/j.anbehav.2012.06.009; AU DWK, 1986, CONDOR, V88, P304, DOI 10.2307/1368877; Auge AA, 2012, FISHERIES MANAG ECOL, V19, P426, DOI 10.1111/j.1365-2400.2012.00861.x; Bonizzoni S, 2014, AQUAT CONSERV, V24, P696, DOI 10.1002/aqc.2401; Brill RW, 2001, AM FISH S S, V25, P179; Brotons JM, 2008, MAR MAMMAL SCI, V24, P112, DOI 10.1111/j.1748-7692.2007.00164.x; Brown S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104468; Carretta JV, 2011, MAR TECHNOL SOC J, V45, P7, DOI 10.4031/MTSJ.45.5.3; Chilvers BL, 2003, CAN J ZOOL, V81, P1947, DOI 10.1139/Z03-195; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Correia AM, 2015, J MARINE SYST, V143, P73, DOI 10.1016/j.jmarsys.2014.10.016; Cruz MJ, 2014, ICES J MAR SCI, V71, P2608, DOI 10.1093/icesjms/fsu073; Dalla Rosa L, 2007, J MAR BIOL ASSOC UK, V87, P135, DOI 10.1017/S0025315407054306; Damaso C, 2007, THESIS; Das K, 2000, MAR POLLUT BULL, V40, P102, DOI 10.1016/S0025-326X(99)00178-2; Edwards E.F., 2007, INT J COMP PSYCHOL, V20, P217; EDWARDS EF, 1992, FISH B-NOAA, V90, P678; Erzini K, 2005, FISH OCEANOGR, V14, P195, DOI 10.1111/j.1365-2419.2005.00332.x; FAO. Fisheries and Aquaculture Department, 2015, GLOB TUN CATCH STOCK; Fertl D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P219; Food and Agriculture Organization, 2015, STAT WORLD FISH AQ 2; Forney KA, 2011, MAR ECOL-EVOL PERSP, V32, P380, DOI 10.1111/j.1439-0485.2011.00454.x; Gerrodette T, 2005, MAR ECOL PROG SER, V291, P1, DOI 10.3354/meps291001; Gilman E, 2012, AQUAT CONSERV, V22, P446, DOI 10.1002/aqc.2237; Gosliner Michael L., 1999, P120; Hall MA, 1998, REV FISH BIOL FISHER, V8, P1, DOI 10.1023/A:1008854816580; Hamer DJ, 2015, ICES J MAR SCI, V72, P1691, DOI 10.1093/icesjms/fsv013; Hassani Sami, 1997, Journal of Northwest Atlantic Fishery Science, V22, P119; Hastie GD, 2005, ICES J MAR SCI, V62, P760, DOI 10.1016/j.icesjms.2005.02.004; ICES, 2012, ICES CM 2012 ACOM; ISSF, 2015, 201503 ISSF; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; Lopez BD, 2012, MAR BIOL, V159, P2161, DOI 10.1007/s00227-012-2002-x; Lotacor, 2014, PESC DESC NA RAA; Lourenco N, 1998, MAR GEOPHYS RES, V20, P141, DOI 10.1023/A:1004505401547; Machete M, 2007, P 5 INT FISH OBS C V, P114; Majkowski J, 2007, FAO FISHERIES TECHNI; Meynier L, 2008, MAR ECOL PROG SER, V354, P277, DOI 10.3354/meps07246; Miyake M.P., 2010, 543 FAO, P125; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Neumann Dirk R., 2001, Aquatic Mammals, V27, P121; O'Connell V, 2015, ICES J MAR SCI, V72, P1667, DOI 10.1093/icesjms/fsv014; Peterson MJ, 2013, ICES J MAR SCI, V70, P1220, DOI 10.1093/icesjms/fst045; Pham CK, 2013, ICES J MAR SCI, V70, P564, DOI 10.1093/icesjms/fst024; Pusineri C, 2007, MAR MAMMAL SCI, V23, P30, DOI 10.1111/j.1748-7692.2006.00088.x; Rabearisoa N, 2015, ICES J MAR SCI, V72, P1682, DOI 10.1093/icesjms/fsu252; Rabearisoa N, 2012, J EXP MAR BIOL ECOL, V432, P55, DOI 10.1016/j.jembe.2012.07.004; Read AJ, 2008, J MAMMAL, V89, P541, DOI 10.1644/07-MAMM-S-315R1.1; Rogan E, 2007, FISH RES, V86, P6, DOI 10.1016/j.fishres.2007.02.013; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Scott MD, 2012, MAR ECOL PROG SER, V458, P283, DOI 10.3354/meps09740; Silva MA, 2002, MAR MAMMAL SCI, V18, P893, DOI 10.1111/j.1748-7692.2002.tb01080.x; Silva Monica A., 2003, Aquatic Mammals, V29, P77, DOI 10.1578/016754203101024095; Silva MA, 2014, MAR BIOL RES, V10, P123, DOI 10.1080/17451000.2013.793814; Silva MA, 2011, AQUAT CONSERV, V21, P17, DOI 10.1002/aqc.1158; Tixier P, 2010, CCAMLR SCI, V17, P179; Tixier P, 2015, ICES J MAR SCI, V72, P1673, DOI 10.1093/icesjms/fsu166; YOUNG DD, 1994, J ZOOL, V234, P41, DOI 10.1111/j.1469-7998.1994.tb06055.x; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	60	5	5	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164107	10.1371/journal.pone.0164107	http://dx.doi.org/10.1371/journal.pone.0164107			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851763	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300004
J	Greibe, E; Nexo, E				Greibe, Eva; Nexo, Ebba			Forms and Amounts of Vitamin B12 in Infant Formula: A Pilot Study	PLOS ONE			English	Article							BREAST-FED INFANTS; HUMAN-MILK; HAPTOCORRIN; COBALAMINS; PROTEINS; SERUM	Purpose Infant formula is based on cow's milk and designed to mimic breast milk for substitution. Vitamin B12 (B12) is bound to proteins in both breast milk and cow's milk, and in milk from both species the vitamin occurs mainly in its natural form such as hydroxo-B12 with little or no synthetic B12 (cyano-B12). Here we test commercially available infant formulas. Methods Eleven commercially available infant formulas were measured for content of B12 and analyzed for the presence of B12-binding proteins and forms of B12 using size exclusion chromatography and HPLC. Results All infant formulas contained B12 by and large in accord with the informations given on the package inserts. None of the formulas contained protein-bound B12, and cyano-B12 accounted for 19-78% of the total amount of B12 present, while hydroxo-B12 constituted more or less the rest. Conclusions This pilot study shows that infant formula differs from breast milk in providing the infant with free B12, rather than protein-bound B12, and by a relative high content of cyano-B12. The consequence of supplying the infant with synthetic cyano-B12 remains to be elucidated.	[Greibe, Eva; Nexo, Ebba] Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark	Aarhus University	Greibe, E (corresponding author), Aarhus Univ Hosp, Dept Clin Biochem, Aarhus, Denmark.	greibe@clin.au.dk	Greibe, Eva/E-3375-2018	Greibe, Eva/0000-0002-0417-1195; Nexo, Ebba/0000-0001-9406-9081	Innovation Fund Denmark [12-132437]	Innovation Fund Denmark	The work is part of the TRIM project (www.trirm-project.dk), headed by Associate Professor Christian Heegaard and financed by Innovation Fund Denmark (http://innovationsfonden.dkten) (Grant No. 12-132437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2002, J PEDIATR GASTR NUTR, V35, P192, DOI 10.1097/00005176-200208000-00016; CRAFT IL, 1971, J CLIN PATHOL, V24, P449, DOI 10.1136/jcp.24.5.449; DIPALMA J, 1991, GASTROENTEROLOGY, V101, P116, DOI 10.1016/0016-5085(91)90467-Y; FARQUHARSON J, 1976, BRIT J NUTR, V36, P127, DOI 10.1079/BJN19760063; Fedosov SN, 1996, BBA-PROTEIN STRUCT M, V1292, P113, DOI 10.1016/0167-4838(95)00173-5; FORD JE, 1974, BRIT J NUTR, V31, P243, DOI 10.1079/BJN19740030; Froese DS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001651; Greibe E, 2013, AM J CLIN NUTR, V98, P389, DOI 10.3945/ajcn.113.058479; GULLBERG R, 1973, SCAND J GASTROENTERO, V8, P497; Hardlei TF, 2010, CLIN CHEM, V56, P432, DOI 10.1373/clinchem.2009.131524; Hardlei TF, 2009, CLIN CHEM, V55, P1002, DOI 10.1373/clinchem.2008.114132; Institue of Medicine Food and Nutrition Board, 1998, DIET REF INT THIAM R; KELLY EJ, 1992, EARLY HUM DEV, V31, P163, DOI 10.1016/0378-3782(92)90043-G; Kornerup LS, 2016, BIOCHIMIE, V126, P57, DOI 10.1016/j.biochi.2015.11.024; Lildballe DL, 2009, CLIN CHEM LAB MED, V47, P182, DOI 10.1515/CCLM.2009.047; Matte JJ, 2012, BRIT J NUTR, V107, P61, DOI 10.1017/S0007114511002364; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Russell RM, 2001, J NUTR, V131, P291, DOI 10.1093/jn/131.2.291; SPECKER BL, 1990, AM J CLIN NUTR, V51, P209, DOI 10.1093/ajcn/51.2.209; Vogiatzoglou A, 2009, AM J CLIN NUTR, V89, P1078, DOI 10.3945/ajcn.2008.26598	20	8	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165458	10.1371/journal.pone.0165458	http://dx.doi.org/10.1371/journal.pone.0165458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851744	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300017
J	Kwan, JM; Hajjiri, Z; Metwally, A; Finn, PW; Perkins, DL				Kwan, Jennifer M.; Hajjiri, Zahraa; Metwally, Ahmed; Finn, Patricia W.; Perkins, David L.			Effect of the Obesity Epidemic on Kidney Transplantation: Obesity Is Independent of Diabetes as a Risk Factor for Adverse Renal Transplant Outcomes	PLOS ONE			English	Article							BODY-MASS INDEX; ADIPOSE-TISSUE; WEIGHT-LOSS; INFLAMMATION; SURVIVAL; CELLS; OVERWEIGHT	Background Obesity is a growing epidemic in most developed countries including the United States resulting in an increased number of obese patients with end-stage renal disease. A previous study has shown that obese patients with end-stage renal disease have a survival benefit with transplantation compared with dialysis. However, due to serious comorbidities, many centers place restrictions on the selection of obese patients for transplantation. Further, due to obese patients having an increased risk of diabetes, it is unclear whether obesity can be an independent risk, independent of diabetes for increasing adverse renal transplant outcomes. Methods To investigate the role of obesity in kidney transplantation, we used the Scientific Registry of Transplant Recipients database. After filtering for subjects that had the full set of covariates including age, gender, graft type, ethnicity, diabetes, peripheral vascular disease, dialysis time and time period of transplantation for our analysis, 191,091 subjects were included in the analyses. Using multivariate logistic regression analyses adjusted for covariates we determined whether obesity is an independent risk factor for adverse outcomes such as delayed graft function, acute rejection, urine protein and graft failure. Cox regression modeling was used to determine hazard ratios of graft failure. Results Using multivariate model analyses, we found that obese patients have significantly increased risk of adverse transplant outcomes, including delayed graft function, graft failure, urine protein and acute rejection. Cox regression modeling hazard ratios showed that obesity also increased risk of graft failure. Life-table survival curves showed that obesity may be a risk factor independent of diabetes mellitus for a shorter time to graft failure. Conclusions A key observation in our study is that the risks for adverse outcome of obesity are progressive with increasing body mass index. Furthermore, pre-obese overweight recipients compared with normal weight recipients also had increased risks of adverse outcomes related to kidney transplantation.	[Kwan, Jennifer M.; Hajjiri, Zahraa; Finn, Patricia W.; Perkins, David L.] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Metwally, Ahmed; Perkins, David L.] Univ Illinois, Dept Bioengn, Chicago, IL USA; [Perkins, David L.] Univ Illinois, Dept Surg, Chicago, IL 60680 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Finn, PW (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	pwfinn@uic.edu		Abdelhadi Metwally, Ahmed/0000-0002-0155-7412				[Anonymous], 1995, SURV AN US SAS; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blackburn GL, 2010, AM J CLIN NUTR, V91, p289S, DOI 10.3945/ajcn.2009.28473D; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; CDC, AD OB FACTS 2014; Chicago UoIa, 2012, SCIENCEDAILYCOM; de las Fuentes L, 2009, J AM COLL CARDIOL, V54, P2376, DOI 10.1016/j.jacc.2009.07.054; Ditonno P, 2011, TRANSPL P, V43, P367, DOI 10.1016/j.transproceed.2010.12.022; Fontana L, 2007, DIABETES, V56, P1010, DOI 10.2337/db06-1656; Friedman AN, 2003, AM J KIDNEY DIS, V41, P480, DOI 10.1053/ajkd.2003.50059; Fujioka K, 2010, DIABETES OBES METAB, V12, P186, DOI 10.1111/j.1463-1326.2009.01155.x; Gerriets VA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00379; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Gill JS, 2013, AM J TRANSPLANT, V13, P2083, DOI 10.1111/ajt.12331; Gore JL, 2006, AM J TRANSPLANT, V6, P357, DOI 10.1111/j.1600-6143.2005.01198.x; Hariharan S, 2000, NEW ENGL J MED, V342, P605, DOI 10.1056/NEJM200003023420901; Hill CJ, 2015, NEPHROL DIAL TRANSPL, V30, P1403, DOI 10.1093/ndt/gfv214; Kalantar-Zadeh K, 2006, ANN INTERN MED, V144, P701, DOI 10.7326/0003-4819-144-9-200605020-00021; Kawasaki N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00799; Kucharska AM, 2015, ADV EXP MED BIOL, V866, P35, DOI 10.1007/5584_2015_147; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Liu LL, 2010, PEDIATR DIABETES, V11, P4, DOI 10.1111/j.1399-5448.2009.00519.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Nicoletto F N, 2014, TRANSPLANTATION; Ortiz J, 2012, CLIN TRANSPLANT, V26, pE284, DOI 10.1111/j.1399-0012.2012.01649.x; Port FK, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341061; Segev DL, 2008, J AM SOC NEPHROL, V19, P349, DOI 10.1681/ASN.2007050610; Seijkens T, 2014, DIABETES, V63, P3982, DOI 10.2337/db14-0272; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Vicenti F, 2002, TRANSPLANTATION, V73, P775, DOI 10.1097/00007890-200203150-00021; Zoccali C, 2005, J RENAL NUTR, V15, P125, DOI 10.1053/j.jrn.2004.09.036	31	42	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165712	10.1371/journal.pone.0165712	http://dx.doi.org/10.1371/journal.pone.0165712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851743	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300023
J	Guo, BS; Lei, C; Ito, T; Jiang, YY; Ozeki, Y; Goda, K				Guo, Baoshan; Lei, Cheng; Ito, Takuro; Jiang, Yiyue; Ozeki, Yasuyuki; Goda, Keisuke			High-Throughput Accurate Single-Cell Screening of Euglena gracilis with Fluorescence-Assisted Optofluidic Time-Stretch Microscopy	PLOS ONE			English	Article							NITROGEN STARVATION; BIOFUEL PRODUCTION; MICROALGAE; CLASSIFICATION; ACCUMULATION; RICH	The development of reliable, sustainable, and economical sources of alternative fuels is an important, but challenging goal for the world. As an alternative to liquid fossil fuels, algal biofuel is expected to play a key role in alleviating global warming since algae absorb atmospheric CO2 via photosynthesis. Among various algae for fuel production, Euglena gracilis is an attractive microalgal species as it is known to produce wax ester (good for biodiesel and aviation fuel) within lipid droplets. To date, while there exist many techniques for inducing microalgal cells to produce and accumulate lipid with high efficiency, few analytical methods are available for characterizing a population of such lipid-accumulated microalgae including E. gracilis with high throughout, high accuracy, and single-cell resolution simultaneously. Here we demonstrate high-throughput, high-accuracy, single-cell screening of E. gracilis with fluorescence-assisted optofluidic time-stretch microscopy-a method that combines the strengths of microfluidic cell focusing, optical time-stretch microscopy, and fluorescence detection used in conventional flow cytometry. Specifically, our fluorescence-assisted optofluidic time-stretch microscope consists of an optical time-stretch microscope and a fluorescence analyzer on top of a hydrodynamically focusing microfluidic device and can detect fluorescence from every E. gracilis cell in a population and simultaneously obtain its image with a high throughput of 10,000 cells/s. With the multi-dimensional information acquired by the system, we classify nitrogen-sufficient (ordinary) and nitrogen-deficient (lipid-accumulated) E. gracilis cells with a low false positive rate of 1.0%. This method holds promise for evaluating cultivation techniques and selective breeding for microalgae-based biofuel production.	[Guo, Baoshan; Lei, Cheng; Jiang, Yiyue; Goda, Keisuke] Univ Tokyo, Dept Chem, Tokyo 1130033, Japan; [Lei, Cheng] Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China; [Ito, Takuro; Goda, Keisuke] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Ozeki, Yasuyuki] Univ Tokyo, Dept Elect Engn & Informat Syst, Tokyo 1138656, Japan; [Goda, Keisuke] Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA	University of Tokyo; Tsinghua University; Japan Science & Technology Agency (JST); University of Tokyo; University of California System; University of California Los Angeles	Lei, C; Goda, K (corresponding author), Univ Tokyo, Dept Chem, Tokyo 1130033, Japan.; Lei, C (corresponding author), Tsinghua Univ, Dept Elect Engn, Beijing 100084, Peoples R China.; Goda, K (corresponding author), Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.; Goda, K (corresponding author), Univ Calif Los Angeles, Dept Elect Engn, Los Angeles, CA 90095 USA.	leicheng@chem.s.u-tokyo.ac.jp; goda@chems.s.u-tokyo.ac.jp	GODA, KEISUKE/G-4997-2014; Guo, Baoshan/AAM-9544-2020	Guo, Baoshan/0000-0003-2508-7424; Goda, Keisuke/0000-0001-6302-6038; Ito, Takuro/0000-0001-5043-1886	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Postdoctoral Exchange Fellowship Program of the Office of the China Postdoctoral Council; Burroughs Wellcome Fund; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan); International Postdoctoral Exchange Fellowship Program of the Office of the China Postdoctoral Council; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). CL and KG were partly supported by the International Postdoctoral Exchange Fellowship Program 2014 of the Office of the China Postdoctoral Council and Burroughs Wellcome Fund, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by the ImPACT Program of the Council for Science, Technology and Innovation (Cabinet Office, Government of Japan). C. Lei and K. Goda were partly supported by the International Postdoctoral Exchange Fellowship Program 2014 of the Office of the China Postdoctoral Council and Burroughs Wellcome Fund, respectively. The fabrication of the microfluidic device was conducted at the Centre for Nano Lithography & Analysis, The University of Tokyo, supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Andersen R. A., 2005, ALGAL CULTURING TECH; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chen CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21471; Christenson L, 2011, BIOTECHNOL ADV, V29, P686, DOI 10.1016/j.biotechadv.2011.05.015; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Georgianna DR, 2012, NATURE, V488, P329, DOI 10.1038/nature11479; Goda K, 2013, NAT PHOTONICS, V7, P102, DOI [10.1038/NPHOTON.2012.359, 10.1038/nphoton.2012.359]; Goda K, 2009, NATURE, V458, P1145, DOI 10.1038/nature07980; Goda K, 2012, P NATL ACAD SCI USA, V109, P11630, DOI 10.1073/pnas.1204718109; Hessen DO, 1997, FRESHWATER BIOL, V38, P513, DOI 10.1046/j.1365-2427.1997.00223.x; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Lamers PP, 2012, J BIOTECHNOL, V162, P21, DOI 10.1016/j.jbiotec.2012.04.018; LATASA M, 1994, J PLANKTON RES, V16, P83, DOI 10.1093/plankt/16.1.83; Lau AKS, 2016, LAB CHIP, V16, P1743, DOI 10.1039/c5lc01458a; Lei C, 2016, BIOMED OPT EXPRESS, V7, P2703, DOI 10.1364/BOE.7.002703; Lei C, 2016, APPL PHYS REV, V3, DOI 10.1063/1.4941050; Li YQ, 2008, APPL MICROBIOL BIOT, V81, P629, DOI 10.1007/s00253-008-1681-1; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mujtaba G, 2012, BIORESOURCE TECHNOL, V123, P279, DOI 10.1016/j.biortech.2012.07.057; Narayanan A, 2006, LECT NOTES COMPUT SC, V3852, P335; Ogawa T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0264-5; Ooka H, 2014, RSC ADV, V4, P20693, DOI 10.1039/c4ra02101k; Shapiro HM, 2005, PRACTICAL FLOW CYTOM; Sharma KK, 2012, ENERGIES, V5, P1532, DOI 10.3390/en5051532; Thoroddsen ST, 2008, ANNU REV FLUID MECH, V40, P257, DOI 10.1146/annurev.fluid.40.111406.102215; Ugawa M, 2015, OPT LETT, V40, P4803, DOI 10.1364/OL.40.004803; Watson J., 1991, FLUID FLOW DYNAMICS; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yamada K, 2016, SCI REP-UK, V6, DOI 10.1038/srep26327	30	21	21	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166214	10.1371/journal.pone.0166214	http://dx.doi.org/10.1371/journal.pone.0166214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846239	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600040
J	Zhang, YL; Li, ZF; Feng, ZL; Feng, HJ; Shi, YQ; Zhao, LH; Zhang, XL; Zhu, HQ				Zhang, Ya-Lin; Li, Zhi-Fang; Feng, Zi-Li; Feng, Hong-Jie; Shi, Yong-Qiang; Zhao, Li-Hong; Zhang, Xi-Ling; Zhu, He-Qin			Functional Analysis of the Pathogenicity-Related Gene VdPR1 in the Vascular Wilt Fungus Verticillium dahliae	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; PROTEIN-KINASE GENE; MOLECULAR CHARACTERIZATION; MICROSCLEROTIA FORMATION; FUSARIUM-OXYSPORUM; HYDROPHOBIN GENE; V-DAHLIAE; EXPRESSION; VIRULENCE; TOOL	Verticillium dahliae Kleb., the causal agent of vascular wilt, can seriously diminish the yield and quality of many crops, including cotton. The pathogenic mechanism to cotton is complicated and unclear now. To screen pathogencity related genes and identify their function is the reliable way to explain the mechanism. In this study, we obtained a low-pathogenicity mutant vdpr1 from a T-DNA insertional library of the highly virulent isolate of V. dahliae Vd080, isolated from cotton. The tagged gene was named pathogenicity-related gene (VdPR1). The deletion mutant Delta VdPR1 did not form microsclerotia and showed a drastic reduction in spore yield and mycelial growth, compared to wild type. Also, Delta VdPR1 showed significantly lower protease and cellulase activities than those of wild type. Complementation of the mutant strain with VdPR1 (strain Delta VdPR1-C) almost completely rescued the attributes described above to wild-type levels. The knockout mutant Delta VdPR1 showed delayed infection, caused mild disease symptoms, formed a smaller biomass in roots of the host, and showed compromised systemic invasive growth in the xylem. These results suggest that VdPR1 is a multifaceted gene involved in regulating the growth development, early infection and pathogenicity of V. dahliae.	[Zhang, Ya-Lin; Li, Zhi-Fang; Feng, Zi-Li; Feng, Hong-Jie; Shi, Yong-Qiang; Zhao, Li-Hong; Zhang, Xi-Ling; Zhu, He-Qin] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhang, XL; Zhu, HQ (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Inst Cotton Res, Anyang 455000, Henan, Peoples R China.	hainan1571@163.com; heqinanyang@163.com		Zhang, Yalin/0000-0002-3296-0239	Special Fund for Agro-scientific Research in the Public Interest [201503109]	Special Fund for Agro-scientific Research in the Public Interest	The Special Fund for Agro-scientific Research in the Public Interest (201503109). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank The Special Fund for Agro-scientific Research in the Public Interest (201503109) for the financial support.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Briesemeister S, 2010, NUCLEIC ACIDS RES, V38, pW497, DOI 10.1093/nar/gkq477; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; [邓晟 Deng Sheng], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3382; Dobinson KF, 1997, CAN J MICROBIOL, V43, P227, DOI 10.1139/m97-031; Eisenhaber B, 2004, J MOL BIOL, V337, P243, DOI 10.1016/j.jmb.2004.01.025; Eynck C, 2007, EUR J PLANT PATHOL, V118, P259, DOI 10.1007/s10658-007-9144-6; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Gao F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015319; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Khang CH, 2005, FUNGAL GENET BIOL, V42, P483, DOI 10.1016/j.fgb.2005.03.004; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Linder T, 2008, FUNGAL GENET BIOL, V45, P485, DOI 10.1016/j.fgb.2007.08.002; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; [刘义杰 Liu Yijie], 2015, [植物病理学报, Acta Phytopathologica Sinica], V45, P258; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XM, 2014, APPL MICROBIOL BIOT, V98, P6921, DOI 10.1007/s00253-014-5863-8; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; ODonnell K, 1997, MYCOLOGIA, V89, P48, DOI 10.2307/3761172; Ospina-Giraldo MD, 2003, CURR GENET, V44, P49, DOI 10.1007/s00294-003-0419-y; Pataky NR, 1997, REPORT PLANT DIS VER, P1010; Pegg GF, 2002, VERTICILLUM WILTS, DOI [DOI 10.1079/9780851995298.0000, 10.1079/9780851995298.0000]; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; Sambrook J, 2001, MOL CLONING LAB MANU, V999; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P278, DOI 10.1094/MPMI-09-12-0222-R; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Tian LL, 2014, GENE, V550, P238, DOI 10.1016/j.gene.2014.08.035; Tjamos EC, 1989, VASCULAR WILT DIS PL, P51; Tonukari NJ, 2000, PLANT CELL, V12, P237, DOI 10.1105/tpc.12.2.237; Tzima A, 2010, FUNGAL GENET BIOL, V47, P406, DOI 10.1016/j.fgb.2010.01.007; Tzima AK, 2012, FUNGAL GENET BIOL, V49, P271, DOI 10.1016/j.fgb.2012.02.005; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Tran VT, 2014, NEW PHYTOL, V202, P565, DOI 10.1111/nph.12671; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Yajima W, 2006, PROTEOMICS, V6, P5995, DOI 10.1002/pmic.200600424; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Zhang YL, 2015, CURR GENET, V61, P555, DOI 10.1007/s00294-015-0476-z; Zhou BJ, 2012, MOL PLANT MICROBE IN, V25, P964, DOI 10.1094/MPMI-12-11-0319; Zhou FF, 2012, ACTA AGR BOREALI OCC, V8, P004; Zhou L, 2013, J GENET GENOMICS, V40, P421, DOI 10.1016/j.jgg.2013.04.006; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402; Zhu HQ, 2013, J PHYTOPATHOL, V161, P70, DOI 10.1111/jph.12027	50	12	18	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166000	10.1371/journal.pone.0166000	http://dx.doi.org/10.1371/journal.pone.0166000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846253	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600027
J	Lima, L; Gaiteiro, C; Peixoto, A; Soares, J; Neves, M; Santos, LL; Ferreira, JA				Lima, Luis; Gaiteiro, Cristiana; Peixoto, Andreia; Soares, Janine; Neves, Manuel; Santos, Lucio Lara; Ferreira, Jose Alexandre			Reference Genes for Addressing Gene Expression of Bladder Cancer Cell Models under Hypoxia: A Step Towards Transcriptomic Studies	PLOS ONE			English	Article							HOUSEKEEPING GENES; INDUCIBLE FACTOR-1-ALPHA; PROSTATE-CANCER; QRT-PCR; RT-PCR; VALIDATION; SELECTION; IDENTIFICATION; NORMALIZATION; HIF-1	Highly aggressive, rapidly growing tumors contain significant areas of hypoxia or anoxia as a consequence of inadequate and/or irregular blood supply. During oxygen deprivation, tumor cells withstand a panoply of adaptive responses, including a shift towards anaerobic metabolism and the reprogramming of the transcriptome. One of the major mediators of the transcriptional hypoxic response is the hypoxia-inducible factor 1 (HIF-1), whose stabilization under hypoxia acts as an oncogenic stimulus contributing to chemotherapy resistance, invasion and metastasis. Gene expression analysis by qRT-PCR is a powerful tool for cancer cells phenotypic characterization. Nevertheless, as cells undergo a severe transcriptome remodeling. in response to oxygen deficit, the precise identification of reference genes poses a significant challenge for hypoxic studies. Herein, we aim to establish the best reference genes for studying the effects of hypoxia on bladder cancer cells. Accordingly, three bladder cancer cell lines (T24, 5637, and HT1376) representative of two distinct carcinogenesis pathways to invasive cancer (FGFR3/CCND1 and E2F3/RB1) were used. Additionally, we have explored the most suitable control gene when addressing the influence of Deferoxamine Mesilate salt (DFX), an iron chelator often used to avoid the proteasomal degradation of HIF-1 alpha, acting as an hypoxia-mimetic agent. Using bioinformatics tools (GeNorm and NormFinder), we have elected B2M and HPRT as the most stable genes for all cell lines and experimental conditions out of a panel of seven putative candidates (HPRT, ACTB, 18S, GAPDH, TBP, B2M, and SDHA). These observations set the molecular basis for future studies addressing the effect of hypoxia and particularly HIF-1 alpha in bladder cancer cells.	[Lima, Luis; Gaiteiro, Cristiana; Peixoto, Andreia; Soares, Janine; Neves, Manuel; Santos, Lucio Lara; Ferreira, Jose Alexandre] Portuguese Inst Oncol Porto IPO Porto, Expt Pathol & Therapeut Grp, Res Ctr, P-4200072 Oporto, Portugal; [Lima, Luis; Peixoto, Andreia; Ferreira, Jose Alexandre] Univ Porto, I3S, Oporto, Portugal; [Lima, Luis; Ferreira, Jose Alexandre] Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200135 Oporto, Portugal; [Peixoto, Andreia; Neves, Manuel; Ferreira, Jose Alexandre] Univ Porto, Inst Biomed Sci Abel Salazar ICBAS, P-4050313 Oporto, Portugal; [Santos, Lucio Lara] Hlth Sch Univ Fernando Pessoa, P-4249004 Oporto, Portugal; [Santos, Lucio Lara] Portuguese Inst Oncol Porto IPO Porto, Dept Surg Oncol, P-4200072 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto	Lima, L (corresponding author), Portuguese Inst Oncol Porto IPO Porto, Expt Pathol & Therapeut Grp, Res Ctr, P-4200072 Oporto, Portugal.; Lima, L (corresponding author), Univ Porto, I3S, Oporto, Portugal.; Lima, L (corresponding author), Univ Porto IPATIMUP, Inst Mol Pathol & Immunol, P-4200135 Oporto, Portugal.	luis.carlos.lima@ipoporto.min-saude.pt	Santos, Lúcio Lara/AAE-2822-2021; Ferreira, José Alexandre/ABM-1695-2022; Peixoto, Andreia/AAG-4757-2021; Gaiteiro, Cristiana/M-1544-2014	Santos, Lúcio Lara/0000-0002-0521-5655; Ferreira, José Alexandre/0000-0002-0097-6148; Peixoto, Andreia/0000-0001-9514-0775; Lima, Luis/0000-0001-8152-9237; Soares, Eliana/0000-0002-1586-7120; Gaiteiro, Cristiana/0000-0001-5438-1679	Portuguese Foundation for Science and Technology [SFRH/BPD/66288/2009, SFRH/BPD/101827/2014, SFRH/BD/111242/2015]; European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF)	Some authors have postdoctoral grants SFRH/BPD/66288/2009 (JAF), SFRH/BPD/101827/2014 (LL), and PhD grants SFRH/BD/111242/2015 (AP) supported by Portuguese Foundation for Science and Technology (FCT - www.fct.pt). FCT is co-financed by European Social Fund (ESF) under Human Potential Operation Programme (POPH) from National Strategic Reference Framework (NSRF).	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Azevedo R, 2015, J CONTROL RELEASE, V214, P40, DOI 10.1016/j.jconrel.2015.07.002; Caradec J, 2010, BRIT J CANCER, V102, P1037, DOI 10.1038/sj.bjc.6605573; Chouaib S, 2017, ONCOGENE, V36, P439, DOI 10.1038/onc.2016.225; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Die JV, 2010, PLANTA, V232, P145, DOI 10.1007/s00425-010-1158-1; Ferguson RE, 2005, PROTEOMICS, V5, P566, DOI 10.1002/pmic.200400941; Ferreira JA, 2016, DRUG RESIST UPDATE, V24, P34, DOI 10.1016/j.drup.2015.11.003; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Gadkar VJ, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0952-4; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Higashimura Y, 2011, ARCH BIOCHEM BIOPHYS, V509, P1, DOI 10.1016/j.abb.2011.02.011; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jiang JA, 2011, CANCER BIOL THER, V11, P714, DOI 10.4161/cbt.11.8.15274; Kuwai T, 2003, INT J CANCER, V105, P176, DOI 10.1002/ijc.11068; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2013.05.009; Lima L, 2014, UROL ONCOL-SEMIN ORI, V32, P449, DOI 10.1016/j.urolonc.2013.10.012; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Maltseva Diana V, 2013, J Clin Bioinforma, V3, P13, DOI 10.1186/2043-9113-3-13; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Marxsen JH, 2004, BIOCHEM J, V381, P761, DOI 10.1042/BJ20040620; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; Nascimento CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127935; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Pinto-Leite R, 2014, TUMOR BIOL, V35, P4599, DOI 10.1007/s13277-013-1604-3; Riemer AB, 2012, EXP DERMATOL, V21, P625, DOI 10.1111/j.1600-0625.2012.01537.x; Rohwer N, 2011, DRUG RESIST UPDATE, V14, P191, DOI 10.1016/j.drup.2011.03.001; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; Said Harun M, 2009, BMC Res Notes, V2, P8, DOI 10.1186/1756-0500-2-8; Schmid T, 2004, J CELL MOL MED, V8, P423, DOI 10.1111/j.1582-4934.2004.tb00467.x; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Strube C, 2008, GENE, V425, P36, DOI 10.1016/j.gene.2008.08.001; Sun Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041659; Tan SC, 2012, MOL BIOL REP, V39, P4857, DOI 10.1007/s11033-011-1281-5; Theodoropoulos VE, 2005, BJU INT, V95, P425, DOI 10.1111/j.1464-410X.2005.05314.x; Theodoropoulos VE, 2004, EUR UROL, V46, P200, DOI 10.1016/j.eururo.2004.04.008; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Unruh A, 2003, ONCOGENE, V22, P3213, DOI 10.1038/sj.onc.1206385; Vajda A, 2013, PROSTATE, V73, P382, DOI 10.1002/pros.22578; Van Hiel MB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-56; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang HJ, 2015, EXP MOL PATHOL, V98, P375, DOI 10.1016/j.yexmp.2014.10.014; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V343, P8, DOI 10.1016/j.bbrc.2006.02.116; Wu C, 2013, ACTA BIOCH BIOPH SIN, V45, P780, DOI 10.1093/abbs/gmt072; Yao L, 2012, MOL BIOL REP, V39, P569, DOI 10.1007/s11033-011-0772-8; Zhao JD, 2015, CANCER TREAT REV, V41, P623, DOI 10.1016/j.ctrv.2015.05.004; Zhong H, 1999, BIOCHEM BIOPH RES CO, V259, P523, DOI 10.1006/bbrc.1999.0815	54	18	19	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166120	10.1371/journal.pone.0166120	http://dx.doi.org/10.1371/journal.pone.0166120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835695	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200025
J	Das, A; Mahapatra, S; Mala, GS; Chaudhuri, I; Mahapatra, T				Das, Aritra; Mahapatra, Sanchita; Mala, Guntur Sai; Chaudhuri, Indrajit; Mahapatra, Tanmay			Association of Frontline Worker-Provided Services with Change in Block-Level Complementary Feeding Indicators: An Ecological Analysis from Bihar, India	PLOS ONE			English	Article							YOUNG-CHILDREN; DETERMINANTS; URBAN; NUTRITION; GROWTH	Background Insufficiencies in complementary feeding put infants and young children at increased risk of undernutrition. Till now, most Indian studies have looked at the individual level determinants of complementary feeding practices. We aimed to evaluate the association of frontline worker (FLW) provided nutritional counselling services, with change in community level indicators of complementary feeding practices among 9-11 month old children over time. Methods The study data was obtained from five rounds of 'Lot Quality Assurance Sampling' survey in eight districts of Bihar, an impoverished Indian state. The surveys were conducted as evaluation exercises for the 'Integrated Family Health Initiative (IFHI)'-a multi-faceted program aimed at improving the maternal and child health outcomes in Bihar. The main outcome indicators were-current breastfeeding, age-appropriate minimum frequency of semi-solid food, age-appropriate minimum quantity of semi-solid food, initiation of complementary feeding at the right age, and dietary diversity. Repeated measures analysis was performed to determine the association of changes in the outcome indicators with coverage of FLW-provided counselling services. Results Visits by FLW, advices on age-appropriate frequency and handwashing were significant predictors of receiving age-appropriate frequency of feeding. The determinants of receiving age-appropriate quantity were-advices on age appropriate frequency and advices on handwashing. Receiving food support from AWC and FLW visits were significantly associated with initiating complementary feeding at the right age. Conclusions The present study identified the critical elements among the different types of FLW-provided services. The study findings, from an economically and socially underdeveloped region of India, would inform the relevant programs about the nutritional counselling services that need to be emphasized upon for reducing the burden of childhood malnutrition.	[Das, Aritra; Mala, Guntur Sai; Chaudhuri, Indrajit; Mahapatra, Tanmay] CARE India Solut Sustainable Dev, H 14,Patliputra Colony, Patna, Bihar 800013, India; [Mahapatra, Sanchita] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, 650 Charles Young Dr South,Box 951772, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mahapatra, T (corresponding author), CARE India Solut Sustainable Dev, H 14,Patliputra Colony, Patna, Bihar 800013, India.	drtanmaymahapatra@yahoo.com	Das, Aritra/C-9076-2014	Das, Aritra/0000-0002-7033-1441; Chaudhuri, Indrajit/0000-0002-8248-4402	Bill and Melinda Gates Foundation [OPP1016872CARE]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study, under Integrated Family Health Initiative (IFHI) project, was financially supported by a grant from the Bill and Melinda Gates Foundation (Grant ID# OPP1016872CARE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostoni C, 2008, J PEDIATR GASTR NUTR, V46, P99, DOI 10.1097/01.mpg.0000304464.60788.bd; [Anonymous], 2010, HINDU; [Anonymous], 2001, DESCR COMP METH CLUS; [Anonymous], 2013, CAT CHANG HLTH COMM; Bhandari N, 2004, J NUTR, V134, P2342; Black MM, 2015, ADV NUTR, V6, P852, DOI 10.3945/an.115.010348; BROWN KH, 1998, COMPLEMENTARY FEEDIN; Das A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161186; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Dewey KG., 2003, GUIDING PRINCIPLES C; Dodge H.F., 1959, SAMPLING INSPECTION; Hawkes C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0383-7; Huff-Rousselle M, 2007, ASSESSMENT DECENTRAL; International Institute for Population Sciences (IIPS), 2007, NAT FAM HLTH SURV NF; Kapur D, 2005, INDIAN PEDIATR, V42, P351; Khan M E, 1990, Asia Pac Popul J, V5, P71; Kimani-Murage EW, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-396; Kristiansen AL, 2010, PUBLIC HEALTH NUTR, V13, P2087, DOI 10.1017/S1368980010002156; Kumar Sanjiv, 2016, Indian J Community Med, V41, P1, DOI 10.4103/0970-0218.170955; LANATA C F, 1991, World Health Statistics Quarterly, V44, P133; MARTORELL R, 1994, EUR J CLIN NUTR, V48, pS45; Myatt M, 2003, B WORLD HEALTH ORGAN, V81, P877; National Guidelines on Infant and Young Child Feeding, 2004, NAT GUID INF YOUNG C; Oommen A, 2009, INDIAN PEDIATR, V46, P891; PAHO, 2003, GUID PRINC COMPL FEE; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Patel A, 2010, FOOD NUTR BULL, V31, P314, DOI 10.1177/156482651003100221; Pezzoli L, 2013, GLOBAL HEALTH ACTION, V6, P1, DOI 10.3402/gha.v6i0.21921; Reinke WA, 1988, IND SAMPLING PLANS P; Robertson Susan E., 1997, World Health Statistics Quarterly, V50, P199; Roig AO, 2010, REV LAT-AM ENFERM, V18, P373, DOI 10.1590/S0104-11692010000300012; Sethi Vani, 2003, Indian Journal of Pediatrics, V70, P463; Steinmann P, 2015, J WATER SANIT HYG DE, V5, P474, DOI 10.2166/washdev.2015.101; UNICEF Uzbekistan, 2020, YOUTH UZB CHALL PROS; VALADEZ JJ, 1995, AM J PUBLIC HEALTH, V85, P1165, DOI 10.2105/AJPH.85.8_Pt_1.1165-a; Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WHO, 1996, WHOVRDTRAM9601; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166511	10.1371/journal.pone.0166511	http://dx.doi.org/10.1371/journal.pone.0166511			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832211	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000132
J	Dolezal, AG; Hendrix, SD; Scavo, NA; Carrillo-Tripp, J; Harris, MA; Wheelock, MJ; O'Neal, ME; Toth, AL				Dolezal, Adam G.; Hendrix, Stephen D.; Scavo, Nicole A.; Carrillo-Tripp, Jimena; Harris, Mary A.; Wheelock, M. Joseph; O'Neal, Matthew E.; Toth, Amy L.			Honey Bee Viruses in Wild Bees: Viral Prevalence, Loads, and Experimental Inoculation	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; ACUTE PARALYSIS VIRUS; BOMBUS-TERRESTRIS; POLLINATORS; INFECTION; PATHOGEN; BUMBLEBEES; DECLINE; TRENDS	Evidence of inter-species pathogen transmission from managed to wild bees has sparked concern that emerging diseases could be causing or exacerbating wild bee declines. While some pathogens, like RNA viruses, have been found in pollen and wild bees, the threat these viruses pose to wild bees is largely unknown. Here, we tested 169 bees, representing 4 families and 8 genera, for five common honey bee (Apis mellifera) viruses, finding that more than 80% of wild bees harbored at least one virus. We also quantified virus titers in these bees, providing, for the first time, an assessment of viral load in a broad spectrum of wild bees. Although virus detection was very common, virus levels in the wild bees were minimal D similar to or lower than foraging honey bees and substantially lower than honey bees collected from hives. Furthermore, when we experimentally inoculated adults of two different bee species (Megachile rotundata and Colletes inaequalis) with a mixture of common viruses that is lethal to honey bees, we saw no effect on short term survival. Overall, we found that honey bee RNA viruses can be commonly detected at low levels in many wild bee species, but we found no evidence that these pathogens cause elevated short-term mortality effects. However, more work on these viruses is greatly needed to assess effects on additional bee species and life stages.	[Dolezal, Adam G.; Scavo, Nicole A.; Carrillo-Tripp, Jimena; Toth, Amy L.] Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA; [Hendrix, Stephen D.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Carrillo-Tripp, Jimena] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Harris, Mary A.] Iowa State Univ, Dept Nat Resource Ecol & Management, Ames, IA USA; [Wheelock, M. Joseph; O'Neal, Matthew E.; Toth, Amy L.] Iowa State Univ, Dept Entomol, Ames, IA USA	Iowa State University; University of Iowa; Iowa State University; Iowa State University; Iowa State University	Dolezal, AG (corresponding author), Iowa State Univ, Dept Ecol Evolut & Organismal Biol, Ames, IA 50011 USA.	adolezal@gmail.com			USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, Iowa State University Center for Virus-Insect Interactions) [2011-04894]; USDA-AFRI [2011-04894]; Iowa State University Center for Virus-Insect Interactions	USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, Iowa State University Center for Virus-Insect Interactions); USDA-AFRI(United States Department of Agriculture (USDA)); Iowa State University Center for Virus-Insect Interactions	Funded by USDA-AFRI (United States Department of Agriculture, Agriculture and Food Research Initiative, 2011-04894 Iowa State University Center for Virus-Insect Interactions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like the Iowa Lakeside Laboratory and the Friends of Lakeside Lab, the Iowa State University Horticulture Research Station, and the Iowa Agriculture and Home Economics Experiment Station. We also thank Steve J. Hanlin and the USDA-ARS North Central Region Plant Introduction Station for providing M. rotundata and advisement on their care and the Toth laboratory for comments on the manuscript. Amy Geffre provided bee illustrations for the figures. This work was supported by USDA-AFRI 2011-04894 and the Iowa State University Center for Virus-Insect Interactions.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Burkle LA, 2013, SCIENCE, V339, P1611, DOI 10.1126/science.1232728; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caron DM, 2009, HONEY BEE BIOL BEEKE; Carrillo-Tripp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22265; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Yanping, 2011, P105; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Database TPC, 2011, DAT TPC; Daughenbaugh KF, 2015, VIRUSES-BASEL, V7, P3285, DOI 10.3390/v7062772; de Miranda JR, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.22; Droege S, VERY HANDY MANUAL CA; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Gill KA, 2015, ENVIRON ENTOMOL, V44, P488, DOI 10.1093/ee/nvv001; Gisder S, 2015, VIRUSES-BASEL, V7, P5603, DOI 10.3390/v7102885; Goulson D, 2003, J FOOD AGRIC ENVIRON, V1, P142; Graystock P, INT J PARASITOLOGY P; Graystock P, 2016, INT J PARASITOL-PAR, V5, P64, DOI 10.1016/j.ijppaw.2015.10.001; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hedtke SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130560; Hendrix SD, 2010, BIODIVERS CONSERV, V19, P1699, DOI 10.1007/s10531-010-9797-x; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Locke B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099998; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Meeus I, 2014, J INVERTEBR PATHOL, V121, P64, DOI 10.1016/j.jip.2014.06.011; Michener CD, 2000, BEES WORLD, Vxiv; Michener CD, 1994, BEE GENERA N CENTRAL, Vviii; Mitchell T.B., 1960, BEES E US; Mitchell T.B., 1962, BEES E US; Plischuk S, 2009, ENV MICROBIOL REP, V1, P131, DOI 10.1111/j.1758-2229.2009.00018.x; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sachman-Ruiz B, 2015, BIOL INVASIONS, V17, P2043, DOI 10.1007/s10530-015-0859-6; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Tehel A, 2016, CURR OPIN VIROL, V19, P16, DOI 10.1016/j.coviro.2016.06.006; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Woolhouse MEJ, 2005, TRENDS ECOL EVOL, V20, P238, DOI 10.1016/j.tree.2005.02.009; Yanez O, 2012, APIDOLOGIE, V43, P587, DOI 10.1007/s13592-012-0128-y; Zhang X, 2012, J INVERTEBR PATHOL, V109, P156, DOI 10.1016/j.jip.2011.09.010	53	54	54	6	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166190	10.1371/journal.pone.0166190	http://dx.doi.org/10.1371/journal.pone.0166190			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832169	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000074
J	Ma, JP; Sun, Y; Yuan, XM; Kurths, J; Zhan, M				Ma, Jinpeng; Sun, Yong; Yuan, Xiaoming; Kurths, Juergen; Zhan, Meng			Dynamics and Collapse in a Power System Model with Voltage Variation: The Damping Effect	PLOS ONE			English	Article							STABILITY; SYNCHRONIZATION; BIFURCATIONS; ATTRACTORS; CRISES; CHAOS; GRIDS	Complex nonlinear phenomena are investigated in a basic power system model of the single-machine-infinite-bus (SMIB) with a synchronous generator modeled by a classical third order differential equation including both angle dynamics and voltage dynamics, the so-called flux decay equation. In contrast, for the second-order differential equation considering the angle dynamics only, it is the classical swing equation. Similarities and differences of the dynamics generated between the third-order model and the second-order one are studied. We mainly find that, for positive damping, these two models show quite similar behavior, namely, stable fixed point, stable limit cycle, and their coexistence for different parameters. However, for negative damping, the second-order system can only collapse, whereas for the third-order model, more complicated behavior may happen, such as stable fixed point, limit cycle, quasi-periodicity, and chaos. Interesting partial collapse phenomena for angle instability only and not for voltage instability are also found here, including collapse from quasi-periodicity and from chaos etc. These findings not only provide a basic physical picture for power system dynamics in the third-order model incorporating voltage dynamics, but also enable us a deeper understanding of the complex dynamical behavior and even leading to a design of oscillation damping in electric power systems.	[Ma, Jinpeng; Sun, Yong] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Ma, Jinpeng; Sun, Yong] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yuan, Xiaoming; Zhan, Meng] Huazhong Univ Sci & Technol, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China; [Kurths, Juergen] Potsdam Inst Climate Impact Res PIK, Potsdam, Germany; [Kurths, Juergen] Humboldt Univ, Dept Phys, Berlin, Germany; [Kurths, Juergen] Univ Aberdeen, Inst Complex Syst & Math Biol, Aberdeen, Scotland	Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Huazhong University of Science & Technology; Potsdam Institut fur Klimafolgenforschung; Humboldt University of Berlin; University of Aberdeen	Zhan, M (corresponding author), Huazhong Univ Sci & Technol, Sch Elect & Elect Engn, State Key Lab Adv Electromagnet Engn & Technol, Wuhan, Peoples R China.	zhanmeng@hust.edu.cn	Zhan, Meng/A-9926-2008	Zhan, Meng/0000-0002-2331-2002	National Natural Science Foundation of China [11475253]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant No. 11475253. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABED EH, 1984, INT J ELEC POWER, V6, P37, DOI 10.1016/0142-0615(84)90034-6; Anderson PM, 2012, POWER SYSTEM CONTROL; ARAPOSTATHIS A, 1982, IEEE T CIRCUITS SYST, V29, P673, DOI 10.1109/TCS.1982.1085086; Bergen A R, 1986, POWER SYSTEMS ANAL; Caliskan SY, 2015, IEEE DECIS CONTR P, P6662, DOI 10.1109/CDC.2015.7403268; Carareto R, 2013, COMMUN NONLINEAR SCI, V18, P1035, DOI 10.1016/j.cnsns.2012.08.030; Carter G. K., 1941, T AM I ELECT ENG, V60, P116, DOI [10.1109/T-AIEE1941.5058292, DOI 10.1109/T-AIEE1941.5058292]; Chen HK, 2005, CHAOS SOLITON FRACT, V24, P1307, DOI 10.1016/j.chaos.2004.09.081; Chiang H. D., 2011, DIRECT METHODS STABI; CHUA LO, 1986, IEEE T CIRCUITS SYST, V33, P1072, DOI 10.1109/TCS.1986.1085869; DEMELLO FP, 1969, IEEE T POWER AP SYST, VPA88, P316, DOI 10.1109/TPAS.1969.292452; Dhooge A., 2011, MATCONT 150 MATCONT; DOBSON I, 1989, SYST CONTROL LETT, V13, P253, DOI 10.1016/0167-6911(89)90072-8; Dobson I., 2001, CIRCUITS SYSTEMS 1 F, V48, P349; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Du-Qu Wei, 2011, Proceedings of the Fourth International Workshop on Chaos-Fractals Theories and Applications (IWCFTA 2011), P295, DOI 10.1109/IWCFTA.2011.8; Gajduk A, 2014, EUR PHYS J-SPEC TOP, V223, P2387, DOI 10.1140/epjst/e2014-02212-1; GREBOGI C, 1983, PHYSICA D, V7, P181, DOI 10.1016/0167-2789(83)90126-4; Ji W, 1996, INT J ELEC POWER, V18, P279, DOI 10.1016/0142-0615(95)00066-6; Ji WJ, 1995, PROCEEDINGS OF THE 34TH IEEE CONFERENCE ON DECISION AND CONTROL, VOLS 1-4, P3465, DOI 10.1109/CDC.1995.479121; Kundur P., 2007, POWER SYSTEM STABILI, V10; Liwschitz M M, 1941, ELECTRON ENG, V60, P210, DOI [10.1109/T-AIEE.1941.5058316, DOI 10.1109/T-AIEE.1941.5058316]; Lu JH, 2006, INT J BIFURCAT CHAOS, V16, P775, DOI 10.1142/S0218127406015179; Lu Q, 1982, OPTIMAL CONTROL TRAN; Ma ML, 2015, CHINESE PHYS B, V24, DOI 10.1088/1674-1056/24/3/030501; Machowski J., 2008, POWER SYSTEM DYNAMIC, V2nd; Mahmud MA, 2012, INT J ELEC POWER, V41, P54, DOI 10.1016/j.ijepes.2012.03.007; Manjarekar NS, 2010, INT J ELEC POWER, V32, P63, DOI 10.1016/j.ijepes.2009.06.010; Menck PJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4969; Monshizadeh P, 2016, ARXIV160307440; Motter AE, 2013, NAT PHYS, V9, P191, DOI 10.1038/nphys2535; Ni Y.X., 2002, DYNAMIC THEORY ANAL; Nishikawa T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/1/015012; Paganini F, 2002, IEEE T CIRCUITS SYST, V46, P760; Quattrociocchi W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087986; Rohden M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.064101; Rongxiang Yuan, 2012, Journal of Control Theory and Applications, V10, P554, DOI 10.1007/s11768-012-0168-x; Schmietendorf K, 2014, EUR PHYS J-SPEC TOP, V223, P2577, DOI 10.1140/epjst/e2014-02209-8; Sen Gupta D. P., 1985, IEE Proceedings C (Generation, Transmission and Distribution), V132, P109, DOI 10.1049/ip-c.1985.0023; Simpson-Porco JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10790; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Subbarao D, 2004, IEEE T POWER SYST, V19, P1918, DOI 10.1109/TPWRS.2004.836203; Sun YZ, 2001, ELECTR POW SYST RES, V57, P123, DOI 10.1016/S0378-7796(01)00085-2; Susuki Y, 2011, J NONLINEAR SCI, V21, P403, DOI 10.1007/s00332-010-9087-5; van der Schaft A, 2016, ANNU REV CONTROL, V41, P119, DOI 10.1016/j.arcontrol.2016.04.017; VARAIYA P, 1985, P IEEE, V73, P1703, DOI 10.1109/PROC.1985.13366; Venkatasubramanian V, 1999, IEEE T CIRCUITS-I, V46, P405, DOI 10.1109/81.751316; WANG HO, 1994, IEEE T CIRCUITS-I, V41, P294, DOI 10.1109/81.285684; Wang X., 2014, B PATIENTS RHEUM ART, V2014, P1; Wang XD, 2015, APPL MATH MODEL, V39, P2951, DOI 10.1016/j.apm.2014.11.018; Wei DQ, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/50008; Wei DQ, 2010, NONLINEAR DYNAM, V61, P477, DOI 10.1007/s11071-010-9663-0	52	12	12	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165943	10.1371/journal.pone.0165943	http://dx.doi.org/10.1371/journal.pone.0165943			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832098	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000044
J	Szigeti, A; Ecsedy, M; Schneider, M; Lenart, L; Lesch, B; Nagy, ZZ; Fekete, A; Recsan, Z				Szigeti, Andrea; Ecsedy, Monika; Schneider, Miklos; Lenart, Lilla; Lesch, Balazs; Nagy, Zoltan Zsolt; Fekete, Andrea; Recsan, Zsuzsanna			Stromal Cell-Derived Factor 1 Polymorphism in Retinal Vein Occlusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CHEMOKINE GENE VARIANT; FACTOR-I; OCULAR NEOVASCULARIZATION; EXPRESSION; CELLS; ADHESION; CXCR4; RETINOPATHY; MIGRATION	Background Stromal cell-derived factor 1 (SDF1) has crucial role in the regulation of angiogenesis and ocular neovascularisation (NV). The purpose of this study was to evaluate the association Methods 130 patients with RVO (median age: 69.0, range 35-93 years; male/female-58/72; 55 patients had central RVO, 75 patients had branch RVO) were enrolled in this study. In the RVO group, 40 (30.8%) patients were diagnosed with NV complications of RVO and 90 (69.2%) patients without NVs. The median follow up period was 40.3 months (range: 18-57 months). The SDF1-3'G(801) A polymorphism was detected by PCR-RFLP. Allelic prevalence was related to reference values obtained in the control group consisted of 125 randomly selected, age and gender matched, unrelated volunteers (median age: 68.0, range 36-95 years; male/female -53/72). Statistical analysis of the allele and genotype differences between groups (RVO patients vs controls; RVO patients with NV vs RVO patients without NV) was determined by chi-squared test. P value of <0.05 was considered statistically significant. Results Hardy-Weinberg criteria was fulfilled in all groups. The SDF1-3'G(801) A allele and genotype frequencies of RVO patients were similar to controls (SDF1-3'A allele: 22.3% vs 20.8%; SDF1-3'(801) AA: 5.4% vs 4.8%, SDF1-3'(801) GG: 60.8% vs 63.2%). The frequency of SDF1-3'(801) AA and SDF1-3'(801) GA genotypes, as well as the SDF1-3'(801) A allele frequency were higher in RVO patients with NV versus in patients without NV complication (SDF1-3'(801) AA+AG genotypes: 57.5% vs 31.1%, p = 0.008; SDF1-3'(801) A allele: 35.0% vs 16.7%, p = 0.002) or versus controls (SDF1-3'(801) AA+AG genotypes 57.5% vs 36.8%, p = 0.021; SDF1-3'(801) A allele: 35.0% vs 20.8% p = 0.01). Carrying of SDF1-3'(801) A allele increased the risk of neovascularisation complications of RVO by 2.69 ( OR, 95% CI = 1.47-4.93). Conclusion These findings suggest that carrying SDF1-3'( 801) A allele plays a role in the development of neovascular complications in retinal vein occlusion.	[Szigeti, Andrea; Ecsedy, Monika; Schneider, Miklos; Lesch, Balazs; Nagy, Zoltan Zsolt; Recsan, Zsuzsanna] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary; [Lenart, Lilla; Fekete, Andrea] Hungarian Acad Sci, MTA SE Lendulet Diabet Res Grp, Res Lab Pediat & Nephrol, Budapest, Hungary; [Lenart, Lilla; Fekete, Andrea] Semmelweis Univ, Budapest, Hungary	Semmelweis University; Hungarian Academy of Sciences; Semmelweis University	Recsan, Z (corresponding author), Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.	zsrecsan@gmail.com	Schneider, Miklos/E-7128-2018; Nagy, Zoltan Zsolt/T-6180-2017	Schneider, Miklos/0000-0003-1488-4743; 	OTKA [K112629]; MTA-SE Lendulet Diabetes Research Grant [LP-008/2015]; BELSZEM MED Kft	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); MTA-SE Lendulet Diabetes Research Grant; BELSZEM MED Kft	This study was founded by grants of OTKA K112629- and MTA-SE Lendulet Diabetes Research Grant (LP-008/2015) and BELSZEM MED Kft. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors have no financial or proprietary interest in any material or method mentioned.; This study was founded by grants of OTKA K112629- and MTA-SE Lendulet Diabetes Research Grant (LP-008/2015) and BELSZEMMED Kft.	Abu El-Asrar AM, 2006, EUR CYTOKINE NETW, V17, P155, DOI 10.1684/ecn.2006.0033; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Browning DJ., 2012, RETINAL VEIN OCCLUSI; Burger M, 2003, ONCOGENE, V22, P8093, DOI 10.1038/sj.onc.1207097; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Butler JM., 2006, THESIS U FLORIDA; Cardones AR, 2003, CANCER RES, V63, P6751; Chen LY, 2010, CHINESE MED J-PEKING, V123, P984, DOI 10.3760/cma.j.issn.0366-6999.2010.08.002; Colobran R, 2007, CLIN EXP IMMUNOL, V150, P1, DOI 10.1111/j.1365-2249.2007.03489.x; Djuric Z, 2010, ACTA DIABETOL, V47, P79, DOI 10.1007/s00592-009-0119-2; Dubois-Laforgue D, 2001, DIABETES, V50, P1211, DOI 10.2337/diabetes.50.5.1211; FUNDERBURK RL, 1989, ANN OPHTHALMOL, V21, P65; Glass TJ, 2011, BLOOD, V118, P766, DOI 10.1182/blood-2011-01-328476; Gu XL, 2014, BIOCHEM BIOPH RES CO, V443, P932, DOI 10.1016/j.bbrc.2013.12.065; Hayreh SS, 2007, PROG RETIN EYE RES, V26, P470, DOI 10.1016/j.preteyeres.2007.06.001; Hayreh SS, 2012, RETINA-J RET VIT DIS, V32, P1553, DOI 10.1097/IAE.0b013e318246912c; HAYREH SS, 1983, OPHTHALMOLOGY, V90, P488; Ide A, 2003, HUM IMMUNOL, V64, P973, DOI 10.1016/S0198-8859(03)00176-9; Joussen A. M., 2007, RETINAL VASCULAR DIS; Ki-I Y, 2007, CURR EYE RES, V32, P1065, DOI 10.1080/02713680701758727; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Lam FC, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008732.pub2; Luan B, 2010, MOL BIOL REP, V37, P399, DOI 10.1007/s11033-009-9845-3; Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj.gt.3301723; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Rogers SL, 2010, OPHTHALMOLOGY, V117, P1094, DOI 10.1016/j.ophtha.2010.01.058; ROSENBERG N, 1986, ARCH OPHTHALMOL-CHIC, V104, P34; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Santiago JG, 2009, INVEST OPHTHALMOL, V50, P3720; SHILLING JS, 1976, BRIT J OPHTHALMOL, V60, P810, DOI 10.1136/bjo.60.12.810; Silva RLE, 2007, FASEB J, V21, P3219, DOI 10.1096/fj.06-7359com; Sonmez K, 2008, OPHTHALMOLOGY, V115, P1065, DOI 10.1016/j.ophtha.2007.08.050; Warchol T, 2010, MOL BIOL REP, V37, P3121, DOI 10.1007/s11033-009-9890-y; Yannuzzi LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P545	35	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166544	10.1371/journal.pone.0166544	http://dx.doi.org/10.1371/journal.pone.0166544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832196	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000387725000134
J	Zhou, W; Zhang, X; Zhu, CL; He, ZY; Liang, JP; Song, ZC				Zhou, Wei; Zhang, Xuan; Zhu, Cai-Lian; He, Zhi-Yan; Liang, Jing-Ping; Song, Zhong-Chen			Melatonin Receptor Agonists as the "Perioceutics" Agents for Periodontal Disease through Modulation of Porphyromonas gingivalis Virulence and Inflammatory Response	PLOS ONE			English	Article							OXIDATIVE STRESS; IL-8 PRODUCTION; P. GINGIVALIS; FIBROBLASTS; BACTERIAL; LIPOPOLYSACCHARIDE; ANTIOXIDANT; EXPRESSION; BIOFILMS; GENES	Aim "Perioceutics" including antimicrobial therapy and host modulatory therapy has emerged as a vital adjunctive treatment of periodontal disease. Melatonin level was significantly reduced in patients with periodontal diseases suggesting melatonin could be applied as a potential "perioceutics" treatment of periodontal diseases. This study aims to investigate the effects of melatonin receptor agonists (melatonin and ramelteon) on Porphyromonas gingivalis virulence and Porphyromonas gingivalis-derived lipopolysaccharide (Pg-LPS)-induced inflammation. Methods Effects of melatonin receptor agonists on Porphyromonas gingivalis planktonic cultures were determined by microplate dilution assays. Formation, reduction, and viability of Porphyromonas gingivalis biofilms were detected by crystal violet staining and MTT assays, respectively. Meanwhile, biofilms formation was also observed by confocal laser scanning microscopy (CLSM). The effects on gingipains and hemolytic activities of Porphyromonas gingivalis were evaluated using chromogenic peptides and sheep erythrocytes. The mRNA expression of virulence and iron/heme utilization was assessed using RT-PCR. In addition, cell viability of melatonin receptor agonists on human gingival fibroblasts (HGFs) was evaluated by MTT assays. After pretreatment of melatonin receptor agonists, HGFs were stimulated with Pg-LPS and then release of cytokines (IL-6 and lL-8) was measured by enzyme-linked immunosorbent assay (ELISA). Results Melatonin and ramelteon did exhibit antimicrobial effects against planktonic culture. Importantly, they inhibited biofilm formation, reduced the established biofilms, and decreased biofilm viability of Porphyromonas gingivalis. Furthermore, they at sub-minimum inhibitory concentration (sub-MIC) concentrations markedly inhibited the proteinase activities of gingipains and hemolysis in a dose-dependent manner. They at sub-MIC concentrations significantly inhibited the mRNA expression of virulence factors (kgp, rgpA, rgpB, hagA, and ragA), while increasing the mRNA expression of ferritin (ftn) or hemolysin (hem). They did not show obvious cytotoxicity toward HGFs. They inhibited Pg-LPS-induced IL-6 and IL-8 secretion, which was reversed by luzindole, the melatonin receptor antagonist. Conclusion Melatonin receptor agonists can inhibit planktonic and biofilm growth of Porphyromonas gingivalis by affecting the virulent properties, as well as Pg-LPS-induced inflammatory response. Our study provides new evidence that melatonin receptor agonists might be useful as novel "perioceutics" agents to prevent and treat Porphyromonas gingivalis-associated periodontal diseases.	[Zhou, Wei; Song, Zhong-Chen] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Periodontol,Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China; [Zhou, Wei; Zhu, Cai-Lian; He, Zhi-Yan; Liang, Jing-Ping] Shanghai Jiao Tong Univ, Shanghai Res Inst Stomatol, Peoples Hosp 9, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 1, Peoples R China; [Zhang, Xuan] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Pharm, Sch Med, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Song, ZC (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Dept Periodontol,Shanghai Key Lab Stomatol, 639 Zhi Zao Ju Rd, Shanghai 200011, Peoples R China.; Liang, JP (corresponding author), Shanghai Jiao Tong Univ, Shanghai Res Inst Stomatol, Peoples Hosp 9, Shanghai Key Lab Stomatol,Sch Med, 639 Zhi Zao Ju Rd, Shanghai 1, Peoples R China.	liangjpdentist@126.com; szhongchen@sina.com			National Natural Science Foundation of China [81271156, 81670992]; Shanghai Municipal Education Commission - Summit & Plateau Disciplines [20152523]; Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering [YG2015007, YG2015M504]; Chinese Stomatological Association Grant [CSA-Y2015-01]; Shanghai Cooperation of Industry, University and Research Institute; Shanghai Education Commission	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission - Summit & Plateau Disciplines; Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering; Chinese Stomatological Association Grant; Shanghai Cooperation of Industry, University and Research Institute; Shanghai Education Commission	This work was supported by the National Natural Science Foundation of China (No.81271156, No.81670992), Shanghai Municipal Education Commission - Summit & Plateau Disciplines (No.20152523), Shanghai Jiao Tong University Cooperation Grant of Medicine, Science, Engineering (YG2015007, YG2015M504), Chinese Stomatological Association Grant (CSA-Y2015-01), Shanghai Cooperation of Industry, University and Research Institute by Shanghai Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdolsamadi Hamidreza, 2014, J Dent Res Dent Clin Dent Prospects, V8, P160, DOI 10.5681/joddd.2014.029; Belanger M, 2012, ANAEROBE, V18, P128, DOI 10.1016/j.anaerobe.2011.10.005; Bodet C, 2006, J ANTIMICROB CHEMOTH, V57, P685, DOI 10.1093/jac/dkl031; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Carocci A, 2014, CLIN PHARMACOL-ADV A, V6, P127, DOI 10.2147/CPAA.S36600; Chava VK, 2012, INT J DENT, V2012, DOI 10.1155/2012/720185; Choi EY, 2011, J PINEAL RES, V50, P197, DOI 10.1111/j.1600-079X.2010.00829.x; CHU L, 1991, INFECT IMMUN, V59, P1932, DOI 10.1128/IAI.59.6.1932-1940.1991; Cogo K, 2012, J PERIODONTAL RES, V47, P766, DOI 10.1111/j.1600-0765.2012.01494.x; CURTIS MA, 1991, ORAL MICROBIOL IMMUN, V6, P321, DOI 10.1111/j.1399-302X.1991.tb00502.x; Curtis MA, 2011, CELL HOST MICROBE, V10, P302, DOI 10.1016/j.chom.2011.09.008; Cutando A, 2014, ODONTOLOGY, V102, P290, DOI 10.1007/s10266-013-0122-5; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Elias S, 2012, FEMS MICROBIOL REV, V36, P990, DOI 10.1111/j.1574-6976.2012.00325.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Ghallab NA, 2016, AUST DENT J, V61, P53, DOI 10.1111/adj.12294; Gomez-Florit M, 2013, BIOCHEM PHARMACOL, V86, P1784, DOI 10.1016/j.bcp.2013.10.009; Graziano TS, 2014, J PERIODONTAL RES, V49, P660, DOI 10.1111/jre.12148; Gulati Minkle, 2014, J Indian Soc Periodontol, V18, P282, DOI 10.4103/0972-124X.134559; Gulle K, 2014, J PERIODONTAL RES, V49, P736, DOI 10.1111/jre.12156; Haffajee A D, 1994, Periodontol 2000, V5, P78, DOI 10.1111/j.1600-0757.1994.tb00020.x; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hiratsuka K, 2010, MICROB PATHOGENESIS, V48, P116, DOI 10.1016/j.micpath.2010.01.001; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Jain S, 2010, PERIODONTOL 2000, V54, P53, DOI 10.1111/j.1600-0757.2009.00333.x; James CE, 2006, INFECT IMMUN, V74, P3834, DOI 10.1128/IAI.01768-05; Kadowaki T, 2003, CURR PROTEIN PEPT SC, V4, P451, DOI 10.2174/1389203033486992; Kara A, 2013, FREE RADICAL BIO MED, V55, P21, DOI 10.1016/j.freeradbiomed.2012.11.002; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Konar V, 2000, BIOORG CHEM, V28, P214, DOI 10.1006/bioo.2000.1173; Kong LX, 2015, ARCH ORAL BIOL, V60, P12, DOI 10.1016/j.archoralbio.2014.08.019; Elmahallawy EK, 2014, CHEM-BIOL INTERACT, V220, P84, DOI 10.1016/j.cbi.2014.06.016; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lepine G, 1996, INFECT IMMUN, V64, P1467; Li JY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/909870; Limson J, 1998, J PINEAL RES, V24, P15, DOI 10.1111/j.1600-079X.1998.tb00361.x; Liu JZ, 2009, J BIOL CHEM, V284, P12512, DOI 10.1074/jbc.M809789200; Lo A, 2010, J BACTERIOL, V192, P1332, DOI 10.1128/JB.01211-09; Mahanonda R, 2007, J IMMUNOL, V178, P1151, DOI 10.4049/jimmunol.178.2.1151; Mathes AM, 2008, CRIT CARE MED, V36, P2863, DOI 10.1097/CCM.0b013e318187b863; Murakami Yukio, 2012, ISRN Dent, V2012, P350859, DOI 10.5402/2012/350859; Nakayama K, 2003, CURR PROTEIN PEPT SC, V4, P389, DOI 10.2174/1389203033486983; Olsen I, 2014, J ORAL MICROBIOL, V6, DOI 10.3402/jom.v6.24800; Ozturk AI, 2000, CELL BIOCHEM FUNCT, V18, P117; Pandi-Perumal SR, 2009, ADV THER, V26, P613, DOI 10.1007/s12325-009-0041-6; Patel M., 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/624089; Potempa J, 2000, PERIODONTOL 2000, V24, P153, DOI 10.1034/j.1600-0757.2000.2240108.x; Reiter RJ, 2015, J PERIODONTAL RES, V50, P9, DOI 10.1111/jre.12176; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Ryan Maria Emanuel, 2005, Dent Clin North Am, V49, P611, DOI 10.1016/j.cden.2005.03.010; Saito T, 2011, ARCH ORAL BIOL, V56, P244, DOI 10.1016/j.archoralbio.2010.09.014; Sakoda K, 2006, J DENT RES, V85, P520, DOI 10.1177/154405910608500608; Schuck DC, 2014, EUR J MED CHEM, V78, P375, DOI 10.1016/j.ejmech.2014.03.055; Slots J, 2000, PERIODONTOL 2000, V22, P7; Smith AW, 2005, ADV DRUG DELIVER REV, V57, P1539, DOI 10.1016/j.addr.2005.04.007; Tabeta K, 2000, INFECT IMMUN, V68, P3731, DOI 10.1128/IAI.68.6.3731-3735.2000; Tang HJ, 2012, J ANTIMICROB CHEMOTH, V67, P944, DOI 10.1093/jac/dkr535; Tekbas OF, 2008, J PINEAL RES, V44, P222, DOI 10.1111/j.1600-079X.2007.00516.x; Thurnheer T, 2014, ARCH ORAL BIOL, V59, P977, DOI 10.1016/j.archoralbio.2014.05.023; Tomas-Zapico C, 2005, J PINEAL RES, V39, P99, DOI 10.1111/j.1600-079X.2005.00248.x; Vanterpool E, 2004, INFECT IMMUN, V72, P5555, DOI 10.1128/IAI.72.10.5555-5564.2004; Wang HX, 2001, COMP BIOCHEM PHYS C, V130, P379, DOI 10.1016/S1532-0456(01)00264-2; Wang Q, 2016, ARCH ORAL BIOL, V62, P28, DOI 10.1016/j.archoralbio.2015.11.007; Wei GX, 2006, J ANTIMICROB CHEMOTH, V57, P1100, DOI 10.1093/jac/dkl120; Wendell KJ, 2001, J PERIODONTOL, V72, P1038, DOI 10.1902/jop.2001.72.8.1038; Wilson M, 1996, J MED MICROBIOL, V44, P79, DOI 10.1099/00222615-44-2-79; Zhang D., 2013, THESIS	68	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166442	10.1371/journal.pone.0166442	http://dx.doi.org/10.1371/journal.pone.0166442			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832188	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000125
J	Kato, M; Sugiyama, T; Sakai, K; Yamashita, T; Fujita, H; Sato, K; Tomonari, S; Shichida, Y; Ohuchi, H				Kato, Mutsuko; Sugiyama, Takashi; Sakai, Kazumi; Yamashita, Takahiro; Fujita, Hirofumi; Sato, Keita; Tomonari, Sayuri; Shichida, Yoshinori; Ohuchi, Hideyo			Two Opsin 3-Related Proteins in the Chicken Retina and Brain: A TMT-Type Opsin 3 Is a Blue-Light Sensor in Retinal Horizontal Cells, Hypothalamus, and Cerebellum	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; SCHIFF-BASE COUNTERION; ANCIENT-LONG OPSIN; GANGLION-CELLS; NEURAL TISSUE; DEEP BRAIN; EXPRESSION; MELANOPSIN; IDENTIFICATION; VERTEBRATE	Opsin family genes encode G protein-coupled seven-transmembrane proteins that bind a retinaldehyde chromophore in photoreception. Here, we sought potential as yet undescribed avian retinal photoreceptors, focusing on Opsin 3 homologs in the chicken. We found two Opsin 3-related genes in the chicken genome: one corresponding to encephalopsin/panopsin (Opn3) in mammals, and the other belonging to the teleost multiple tissue opsin (TMT) 2 group. Bioluminescence imaging and G protein activation assays demonstrated that the chicken TMT opsin (cTMT) functions as a blue light sensor when forced-expressed in mammalian cultured cells. We did not detect evidence of light sensitivity for the chicken Opn3 (cOpn3). In situ hybridization demonstrated expression of cTMT in subsets of differentiating cells in the inner retina and, as development progressed, predominant localization to retinal horizontal cells (HCs). Immunohistochemistry (IHC) revealed cTMT in HCs as well as in small numbers of cells in the ganglion and inner nuclear layers of the post-hatch chicken retina. In contrast, cOpn3-IR cells were found in distinct subsets of cells in the inner nuclear layer. cTMT-IR cells were also found in subsets of cells in the hypothalamus. Finally, we found differential distribution of cOpn3 and cTMT proteins in specific cells of the cerebellum. The present results suggest that a novel TMT-type opsin 3 may function as a photoreceptor in the chicken retina and brain.	[Kato, Mutsuko; Fujita, Hirofumi; Sato, Keita; Ohuchi, Hideyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama, Japan; [Sugiyama, Takashi] Olympus Corp, R&D Grp, Tokyo, Japan; [Sakai, Kazumi; Yamashita, Takahiro; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan; [Tomonari, Sayuri] Univ Tokushima, Grad Sch, Dept Life Syst, Inst Sci & Technol, Tokushima, Japan	Okayama University; Olympus Corporation; Kyoto University; Tokushima University	Ohuchi, H (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cytol & Histol, Okayama, Japan.	hohuchi@okayama-u.ac.jp			KAKENHI [15H00812, 16H02515, 24500382, 22657057]; Pfizer Japan Inc.; NICHD	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Pfizer Japan Inc.(Pfizer); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Olympus Corporation is not a funder in this study. This commercial affiliation provided support in the form of salaries for an author [TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section. The funders, KAKENHI (grant numbers 15H00812 to Takahiro Yamashita; 16H02515 to Yoshinori Shichida; 24500382 and 22657057 to Hideyo Ohuchi) and Pfizer Japan Inc. (to Hideyo Ohuchi), as stated previous and revised versions, had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript, either.; We thank Dr. F. Lefcort (Montana State University, MT, USA) and Dr. L. F. Reichardt (University of California at San Francisco, CA, USA) for providing anti-TrkA antibody, and Dr. D. V. Pow (University of Newcastle, Callaghan, Australia) for providing anti-serotonin antibody. Antibodies to Lhxl (Lim1+Lim2) and Isletl, developed by Drs. T. Jessell/S. Brenner-Morton and T. Jessell, respectively, were obtained from the Developmental Studies Hybridoma Bank, which was developed under the auspices of the NICHD and is maintained by the University of Iowa Department of Biological Sciences (Iowa City, IA, USA). We thank Akira Takagi, Mizue Yamanaka, Naoki Murao, and Shuang Song for their contributions in the initial phase of this study. We thank Hadley Horch and Sumihare Noji for their critical reading of the manuscript.	Bailey MJ, 2005, MOL BRAIN RES, V134, P345, DOI 10.1016/j.molbrainres.2004.11.003; Barmack NH, 2008, J NEUROSCI, V28, P1140, DOI 10.1523/JNEUROSCI.3942-07.2008; Bastianelli E, 2003, CEREBELLUM, V2, P242, DOI 10.1080/14734220310022289; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blackshaw S, 1999, J NEUROSCI, V19, P3681; Borges R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1924-3; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Do MTH, 2010, PHYSIOL REV, V90, P1547, DOI 10.1152/physrev.00013.2010; Edqvist PHD, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-46; Fischer RM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001585; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Jiao JH, 2012, CANCER LETT, V320, P96, DOI 10.1016/j.canlet.2012.01.035; KATADA T, 1994, METHOD ENZYMOL, V237, P131; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kojima D, 2000, J NEUROSCI, V20, P2845; Koyanagi M, 2013, P NATL ACAD SCI USA, V110, P4998, DOI 10.1073/pnas.1219416110; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; MARIANI AP, 1977, J COMP NEUROL, V175, P13, DOI 10.1002/cne.901750103; Matos-Cruz V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025111; Moutsaki P, 2003, MOL BRAIN RES, V112, P135, DOI 10.1016/S0169-328X(03)00059-7; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; NATHANS J, 1990, BIOCHEMISTRY-US, V29, P9746, DOI 10.1021/bi00493a034; Nissila J, 2012, J COMP PHYSIOL A, V198, P833, DOI 10.1007/s00359-012-0754-x; Perlman I., 2007, WEBVISION ORG RETINA; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; ROGERS JH, 1989, NEUROSCIENCE, V31, P711, DOI 10.1016/0306-4522(89)90435-1; Sakai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141238; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; Sato K, 2011, BIOCHEMISTRY-US, V50, P10484, DOI 10.1021/bi201212z; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sugihara T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161215; Sugiyama T, 2014, SCI REP-UK, V4, DOI 10.1038/srep05352; Surbhi, 2015, GEN COMP ENDOCR, V220, P13, DOI 10.1016/j.ygcen.2014.06.001; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Tomonari S, 2005, DEV DYNAM, V234, P783, DOI 10.1002/dvdy.20600; Tomonari S, 2008, DEV DYNAM, V237, P1910, DOI 10.1002/dvdy.21611; Torii M, 2007, FEBS LETT, V581, P5327, DOI 10.1016/j.febslet.2007.10.019; Verra DM, 2011, INVEST OPHTH VIS SCI, V52, P5111, DOI 10.1167/iovs.11-75301; Welsh David K, 2012, Cold Spring Harb Protoc, V2012, DOI 10.1101/pdb.top070607; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107	48	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0163925	10.1371/journal.pone.0163925	http://dx.doi.org/10.1371/journal.pone.0163925			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861495	gold, Green Submitted, Green Published			2022-12-26	WOS:000388350300003
J	Strifler, G; Tuboly, E; Gorbe, A; Boros, M; Pecz, D; Hartmann, P				Strifler, Gerda; Tuboly, Eszter; Gorbe, Aniko; Boros, Mihaly; Pecz, Danielle; Hartmann, Petra			Targeting Mitochondrial Dysfunction with L-Alpha Glycerylphosphorylcholine	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; CELL-LINES; RAT-LIVER; CHOLINE; TISSUE; PHOSPHATIDYLCHOLINE; PEROXYNITRITE; MEMBRANE; RELEASE; OXIDASE	Background We hypothesized that L-alpha-glycerylphosphorylcholine (GPC), a deacylatedphosphatidylcholine derivative, can influence the mitochondrial respiratory activity and in this way, may exert tissue protective effects. Methods Rat liver mitochondria were examined with high-resolution respirometry to analyze the effects of GPC on the electron transport chain in normoxic and anoxic conditions. Besides, Sprague-Dawley rats were subjected to sham operation or standardized liver ischemiareperfusion (IR), with or without GPC administration. The reduced glutathione (GSH) and oxidized glutathione disulfide (GSSG), the tissue myeloperoxidase, xanthine oxidoreductase and NADPH oxidases activities were measured. Tissue malondialdehyde and nitrite/nitrate formation, together with blood superoxide and hydrogen-peroxide production were assessed. Results GPC increased the efficacy of complex I-linked mitochondrial oxygen consumption, with significantly lower in vitro leak respiration. Mechanistically, liver IR injury was accompanied by deteriorated mitochondrial respiration and enhanced ROS production and, as a consequence, by significantly increased inflammatory enzyme activities. GPC administration decreased the inflammatory activation in line with the reduced oxidative and nitrosative stress markers. Conclusion GPC, by preserving the mitochondrial complex I function respiration, reduced the biochemical signs of oxidative stress after an IR episode. This suggests that GPC is a mitochondriatargeted compound that indirectly suppresses the activity of major intracellular superoxidegenerating enzymes.	[Strifler, Gerda; Tuboly, Eszter; Boros, Mihaly; Pecz, Danielle; Hartmann, Petra] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Gorbe, Aniko] Univ Szeged, Dept Biochem, Szeged, Hungary	Szeged University; Szeged University	Hartmann, P (corresponding author), Univ Szeged, Inst Surg Res, Szeged, Hungary.	hartmann.petra@med.u-szeged.hu	Hartmann, Petra/AAZ-7881-2021	Hartmann, Petra/0000-0002-4746-9792; Boros, Mihaly/0000-0003-1410-1999	Hungarian Science Research Fund (OTKA) [K104656, NKFI K120232, GINOP-2.3.2-15-2016-00015]	Hungarian Science Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	The study was supported by Hungarian Science Research Fund (OTKA) K104656, NKFI K120232 grants and GINOP-2.3.2-15-2016-00015. MB was the principle investigator, ET, and AG were associated researchers of the grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The technical help of Louise Dugue and NejlaJounaidi (University of Angers, France) is greatly acknowledged. The study was supported by Hungarian Science Research Fund (OTKA) K104656,NKFI K120232 and GINOP-2.3.2-15-2016-00015 grants.	Anderson EJ, 2012, CLIN EXP PHARMACOL P, V39, P179, DOI 10.1111/j.1440-1681.2011.05641.x; Aon MA, 2010, BBA-BIOENERGETICS, V1797, P865, DOI 10.1016/j.bbabio.2010.02.016; Ascenzi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102811; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Bencsik P, 2010, AM J PHYSIOL-HEART C, V299, pH512, DOI 10.1152/ajpheart.00052.2010; BEVAN C, 1990, PFLUG ARCH EUR J PHY, V417, P324, DOI 10.1007/BF00370999; Brownawell AM, 2011, FOOD CHEM TOXICOL, V49, P1303, DOI 10.1016/j.fct.2011.03.012; Bruhl A, 2004, LIFE SCI, V75, P1609, DOI 10.1016/j.lfs.2004.03.019; Chattopadhyay P, 2007, Indian J Gastroenterol, V26, P95; Chen C, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/452891; Corda D, 2014, FEBS J, V281, P998, DOI 10.1111/febs.12699; Enriquez JA, 2014, MOL SYNDROMOL, V5, P119, DOI 10.1159/000363364; Farber SA, 2000, FASEB J, V14, P2198, DOI 10.1096/fj.99-0853; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Ferdinandy P, 2000, CIRC RES, V87, P241, DOI 10.1161/01.RES.87.3.241; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Gibellini F, 2010, IUBMB LIFE, V62, P414, DOI 10.1002/iub.337; Goetz M, 2011, AM J PHYSIOL-GASTR L, V301, pG764, DOI 10.1152/ajpgi.00175.2011; Habersetzer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075429; Hartmann P, 2014, J SURG RES, V189, P32, DOI 10.1016/j.jss.2013.12.025; Hines IN, 2003, AM J PHYSIOL-GASTR L, V284, pG536, DOI 10.1152/ajpgi.00400.2002; Hirakawa A, 2003, J SURG RES, V111, P240, DOI 10.1016/S0022-4804(03)00091-X; Kalashnyk OM, 2012, LIFE SCI, V91, P1033, DOI 10.1016/j.lfs.2012.02.005; Kawamura T, 2012, NUTRITION, V28, P1122, DOI 10.1016/j.nut.2012.02.011; Kenneth B.S, 2005, FUNCTIONAL METABOLIS; Komary Z, 2010, BBA-BIOENERGETICS, V1797, P922, DOI 10.1016/j.bbabio.2010.03.010; Kuebler WM, 1996, INT J MICROCIRC, V16, P89, DOI 10.1159/000179155; Magalon A, 2016, BBA-BIOENERGETICS, V1857, P198, DOI 10.1016/j.bbabio.2015.10.015; Patel RP, 2014, WORLD J HEPATOL, V6, P1, DOI 10.4254/wjh.v6.i1.1; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; PLACER ZA, 1966, ANAL BIOCHEM, V16, P359, DOI 10.1016/0003-2697(66)90167-9; Plangar I, 2014, J NEURO-ONCOL, V119, P253, DOI 10.1007/s11060-014-1489-z; Purnak T, 2012, CLIN BIOCHEM, V45, P1450, DOI 10.1016/j.clinbiochem.2012.07.091; Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15; Scapicchio PL, 2013, INT J NEUROSCI, V123, P444, DOI 10.3109/00207454.2013.765870; Strifler G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146363; Taniguchi M, 2007, J SURG RES, V137, P69, DOI 10.1016/j.jss.2006.06.033; Tokes T, 2015, EUR J NUTR, V54, P109, DOI 10.1007/s00394-014-0691-2; Tokes T, 2011, SHOCK, V36, P458, DOI 10.1097/SHK.0b013e31822f36b0; Traini E, 2013, CURR ALZHEIMER RES, V10, P1070, DOI 10.2174/15672050113106660173; Tuboly E, 2013, AM J PHYSIOL-CELL PH, V304, pC207, DOI 10.1152/ajpcell.00300.2012; Winter L, 2016, ACTA NEUROPATHOL, V132, P453, DOI 10.1007/s00401-016-1592-7	42	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166682	10.1371/journal.pone.0166682	http://dx.doi.org/10.1371/journal.pone.0166682			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861548	Green Accepted, Green Published, gold			2022-12-26	WOS:000388350300088
J	Hafner, AK; Beilstein, K; Graab, P; Ball, AK; Saul, MJ; Hofmann, B; Steinhilber, D				Haefner, Ann-Kathrin; Beilstein, Kim; Graab, Philipp; Ball, Ann-Katrin; Saul, Meike J.; Hofmann, Bettina; Steinhilber, Dieter			Identification and Characterization of a New Protein Isoform of Human 5-Lipoxygenase	PLOS ONE			English	Article							ARACHIDONIC-ACID; ACTIVATING PROTEIN; HUMAN-LYMPHOCYTES; ENZYME-ACTIVITY; C2-LIKE DOMAIN; MESSENGER-RNA; T-LYMPHOCYTES; B-LYMPHOCYTES; CELL-LINE; EXPRESSION	Leukotrienes (LTs) are inflammatory mediators that play a pivotal role in many diseases like asthma bronchiale, atherosclerosis and in various types of cancer. The key enzyme for generation of LTs is the 5-lipoxygenase (5-LO). Here, we present a novel putative protein isoform of human 5-LO that lacks exon 4, termed 5-LO Delta 4, identified in cells of lymphoid origin, namely the Burkitt lymphoma cell lines Raji and BL41 as well as primary B and T cells. Deletion of exon 4 does not shift the reading frame and therefore the mRNA is not subjected to non-mediated mRNA decay (NMD). By eliminating exon 4, the amino acids Trp144 until Ala184 are omitted in the corresponding protein. Transfection of HEK293T cells with a 5-LO Delta 4 expression plasmid led to expression of the corresponding protein which suggests that the 5-LO Delta 4 isoform is a stable protein in eukaryotic cells. We were also able to obtain soluble protein after expression in E. coli and purification. The isoform itself lacks canonical enzymatic activity as it misses the non-heme iron but it still retains ATP-binding affinity. Differential scanning fluorimetric analysis shows two transitions, corresponding to the two domains of 5-LO. Whilst the catalytic domain of 5-LO WT is destabilized by calcium, addition of calcium has no influence on the catalytic domain of 5-LO Delta 4. Furthermore, we investigated the influence of 5-LO Delta 4 on the activity of 5-LO WT and proved that it stimulates 5-LO product formation at low protein concentrations. Therefore regulation of 5-LO by its isoform 5-LO Delta 4 might represent a novel mechanism of controlling the biosynthesis of lipid mediators.	[Haefner, Ann-Kathrin; Beilstein, Kim; Graab, Philipp; Ball, Ann-Katrin; Saul, Meike J.; Hofmann, Bettina; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany; [Saul, Meike J.] Tech Univ Darmstadt, Dept Biol, D-64287 Darmstadt, Germany	Goethe University Frankfurt; Technical University of Darmstadt	Hafner, AK; Steinhilber, D (corresponding author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	haefner@pharmchem.uni-frankfurt.de; steinhilber@em.uni-frankfurt.de	Saul, Meike/T-6671-2019		Deutsche Forschungsgemeinschaft Else Kroner Fresenius-Stiftung [SFB 1039, 2013_A265]	Deutsche Forschungsgemeinschaft Else Kroner Fresenius-Stiftung	Deutsche Forschungsgemeinschaft (SFB 1039) Else Kroner Fresenius-Stiftung (2013_A265). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM RT, 1986, J IMMUNOPHARMACOL, V8, P165; Allain EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132607; AMBRUS JL, 1988, J IMMUNOL, V140, P2382; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boudreau LH, 2011, FASEB J, V25, P1097, DOI 10.1096/fj.10-173856; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Cook-Moreau JM, 2007, IMMUNOLOGY, V122, P157, DOI 10.1111/j.1365-2567.2007.02621.x; DAHLEN SE, 1983, P NATL ACAD SCI-BIOL, V80, P1712, DOI 10.1073/pnas.80.6.1712; Ding XZ, 1999, BIOCHEM BIOPH RES CO, V261, P218, DOI 10.1006/bbrc.1999.1012; Drazen J M, 1994, Adv Prostaglandin Thromboxane Leukot Res, V22, P251; Dwyer JH, 2004, NEW ENGL J MED, V350, P29, DOI 10.1056/NEJMoa025079; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Ellis JD, 2012, MOL CELL, V46, P884, DOI 10.1016/j.molcel.2012.05.037; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; Gilbert NC, 2012, FASEB J, V26, P3222, DOI 10.1096/fj.12-205286; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; GOETZL EJ, 1981, BIOCHEM BIOPH RES CO, V101, P344, DOI 10.1016/0006-291X(81)91266-3; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; Hafner AK, 2015, BBA-MOL CELL BIOL L, V1851, P1465, DOI 10.1016/j.bbalip.2015.08.010; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; Hegyi H, 2011, NUCLEIC ACIDS RES, V39, P1208, DOI 10.1093/nar/gkq843; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; JAKOBSSON PJ, 1995, EUR J BIOCHEM, V232, P37, DOI 10.1111/j.1432-1033.1995.tb20778.x; JAKOBSSON PJ, 1992, P NATL ACAD SCI USA, V89, P3521, DOI 10.1073/pnas.89.8.3521; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lehmann C, 2015, FASEB J, V29, P5029, DOI 10.1096/fj.15-275487; Luo M, 2003, P NATL ACAD SCI USA, V100, P12165, DOI 10.1073/pnas.2133253100; Michel AAY, 2008, PROTEIN EXPRES PURIF, V59, P110, DOI 10.1016/j.pep.2008.01.010; Ochs MJ, 2014, BASIC CLIN PHARMACOL, V114, P78, DOI 10.1111/bcpt.12115; Ottens F, 2016, PFLUG ARCH EUR J PHY, V468, P1013, DOI 10.1007/s00424-016-1826-5; PERCIVAL MD, 1992, BIOCHEM BIOPH RES CO, V186, P1265; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Romero PR, 2006, P NATL ACAD SCI USA, V103, P8390, DOI 10.1073/pnas.0507916103; Roos KLT, 2005, BIOCHEM BIOPH RES CO, V338, P62, DOI 10.1016/j.bbrc.2005.08.031; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Ryge MR, 2014, ARCH BIOCHEM BIOPHYS, V545, P179, DOI 10.1016/j.abb.2014.01.017; Schroder M, 2014, BBA-MOL CELL BIOL L, V1841, P1538, DOI 10.1016/j.bbalip.2014.07.022; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Wachtershauser A, 2000, BIOCHEM BIOPH RES CO, V268, P778, DOI 10.1006/bbrc.2000.2213; Wang P, 2005, 2005 IEEE COMP SYST, V102, P217, DOI [10.1109/CSBW.2005.129, DOI 10.1109/CSBW.2005.129]; Werz O, 1996, EUR J BIOCHEM, V242, P90, DOI 10.1111/j.1432-1033.1996.0090r.x; Werz O, 2000, EUR J BIOCHEM, V267, P1263, DOI 10.1046/j.1432-1327.2000.01000.x; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; ZHANG YY, 1993, J BIOL CHEM, V268, P2535; Zhang YY, 2000, BIOCHEM J, V351, P697, DOI 10.1042/0264-6021:3510697	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166591	10.1371/journal.pone.0166591	http://dx.doi.org/10.1371/journal.pone.0166591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855198	gold, Green Submitted, Green Published			2022-12-26	WOS:000387910200038
J	Miller, AL; Golledge, HDR; Leach, MC				Miller, Amy L.; Golledge, Huw D. R.; Leach, Matthew C.			The Influence of Isoflurane Anaesthesia on the Rat Grimace Scale	PLOS ONE			English	Article							BEHAVIOR; SYSTEM; MOUSE; PAIN; MICE	Over 234,000 rats were used in regulated procedures in the UK in 2014, many of which may have resulted in some degree of pain. When using animals in research, there is an ethical and legal responsibility to alleviate or at least reduce pain to an absolute minimum. To do this, we must be able to effectively assess pain in an accurate and timely manner. The Rat Grimace Scale (RGS) is a pain assessment tool, which is suggested to be both accurate and rapid in pain assessment. Many procedures involve the use of general anaesthesia. To date, the effects of anaesthesia on the RGS have not been assessed, limiting its potential utility for assessing pain following anaesthesia. Forty-eight Lister hooded rats were used in this study (24 in part A and 24 in a separate part B). Rats were randomly assigned to one of two treatment groups in part A; short duration isoflurane exposure, short duration control exposure (air) and one of two treatment groups in part B; surgical duration isoflurane exposure or surgical duration control exposure (oxygen). Rats were placed into an anaesthetic induction chamber and isoflurane, or control gas piped into the chamber for either 4 (short duration exposure) or 12 minutes (surgical duration exposure). Following recovery, photographs of the rats' faces were taken and then scored blindly using the RGS. Short duration isoflurane anaesthesia had no effect on RGS scores. However, when rats are anaesthetised for a longer duration, akin to a simple routine surgical procedure, the RGS score increases significantly and this increase remains on repeated exposure to this duration of anaesthesia over a 4-day period. This should be accounted for when using the RGS to assess pain in rats in the immediate time period following procedures involving the use of isoflurane anaesthesia.	[Miller, Amy L.; Leach, Matthew C.] Newcastle Univ, Sch Agr Food & Rural Dev, Agr Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Golledge, Huw D. R.] Newcastle Univ, Sch Med, Inst Neurosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Golledge, Huw D. R.] Univ Federat Anim Welf, Old Sch, Brewhouse Hill, Wheathampstead AL4 8AN, England	Newcastle University - UK; Newcastle University - UK	Miller, AL (corresponding author), Newcastle Univ, Sch Agr Food & Rural Dev, Agr Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	amy.miller@ncl.ac.uk		Golledge, Huw/0000-0002-2321-7929	National Centre for the 3Rs [G1100563]; Centre for Behaviour and Evolution, Newcastle University, UK; National Centre for the Replacement [G1100563/1] Funding Source: researchfish	National Centre for the 3Rs; Centre for Behaviour and Evolution, Newcastle University, UK; National Centre for the Replacement	This work was funded by National Centre for the 3Rs - grant number G1100563, and Centre for Behaviour and Evolution, Newcastle University, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brune K, 2011, ACCR 102 ANN M ORL F; Fleknell P, 2009, LAB ANIMAL ANAESTHES, V3rd ed., P54; HENDRICKX HHL, 1984, RESUSCITATION, V12, P213, DOI 10.1016/0300-9572(84)90008-X; Home Office, 2015, ANN STAT SCI PROC LI, V511; Kort WJ, 1998, LAB ANIM-UK, V32, P260, DOI 10.1258/002367798780559329; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; Miller A, 2015, APPL ANIM BEHAV SCI, V172, P58, DOI 10.1016/j.applanim.2015.08.038; Pinnock C, 2006, FUNDAMENTALS ANAESTH; Roughan JV, 2003, EUR J PAIN, V7, P397, DOI 10.1016/S1090-3801(02)00140-4; Roughan JV, 2001, PAIN, V90, P65, DOI 10.1016/S0304-3959(00)00387-0; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Wong D, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1000	13	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166652	10.1371/journal.pone.0166652	http://dx.doi.org/10.1371/journal.pone.0166652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855184	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200041
J	You, SC; Shim, CY; Hong, GR; Kim, D; Cho, IJ; Lee, S; Chang, HJ; Ha, JW; Chang, BC; Chung, N				You, Seng Chan; Shim, Chi Young; Hong, Geu-Ru; Kim, Darae; Cho, In Jeong; Lee, Sak; Chang, Hyuck-Jae; Ha, Jong-Won; Chang, Byung-Chul; Chung, Namsik			Incidence, Predictors, and Clinical Outcomes of Postoperative Cardiac Tamponade in Patients Undergoing Heart Valve Surgery	PLOS ONE			English	Article							RADIOFREQUENCY CATHETER ABLATION; PERICARDIAL-EFFUSION; ATRIAL-FIBRILLATION; CONSTRICTIVE PERICARDITIS; ECHOCARDIOGRAPHY; INFLAMMATION; INJURY	This study aimed to investigate the incidence, predictors, and clinical outcomes of cardiac tamponade after heart valve surgery. A total of 556 patients who underwent heart valve surgery in a single tertiary center between January 2010 and March 2012 were studied. All patients underwent transthoracic echocardiography (TTE) about 5 days after surgery and TTE was repeated regularly. Patients with suspected acute pericardial hemorrhage were excluded. Cardiac tamponade occurred in twenty-four (4.3%) patients and all underwent surgical or percutaneous pericardial drainage. The median time of pericardial drainage after surgery was 17 (interquartile range, IQR, 13-30) days. Infective endocarditis, mechanical valve replacement of aortic or mitral valve, and any amount of pericardial effusion (PE) on the first postoperative TTE were related to the occurrence of cardiac tamponade (all p<0.05). After multivariate adjustment, occurrence of cardiac tamponade was associated with any amount of PE on the first postoperative TTE (hazard ratio, HR, 14.00, p<0.001) and mechanical valve replacement (HR 2.69, p = 0.025). The mean hospital days in patients with cardiac tamponade was higher than those without (34.9 vs. 13.5, p = 0.031). After pericardial drainage, there was no echocardiographic recurrence of significant PE during a median of 34.8 (IQR 14.9-43.7) months after surgery. Cardiac tamponade after heart valve surgery is not uncommon. Patients with any amount of PE at the first postoperative TTE or mechanical valve replacement should receive higher attention with regard to the occurrence of cardiac tamponade. Although it prolongs hospital stay, cardiac tamponade exhibits a benign clinical course without recurrence after timely intervention.	[You, Seng Chan; Shim, Chi Young; Hong, Geu-Ru; Kim, Darae; Cho, In Jeong; Chang, Hyuck-Jae; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea; [Lee, Sak; Chang, Byung-Chul] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiovasc Surg, Seoul, South Korea; [You, Seng Chan] Ajou Univ, Sch Med, Dept Biomed informat, Suwon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ajou University	Shim, CY (corresponding author), Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Div Cardiol, Seoul, South Korea.	cysprs@yuhs.ac	Chang, Byung/AAP-9674-2020; Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Hong, Geu-Ru/0000-0003-4981-3304; Lee, Sak/0000-0001-6130-2342; Ha, Jong-Won/0000-0002-8260-2958; You, Seng Chan/0000-0002-5052-6399; Chang, Hyuk-Jae/0000-0002-6139-7545				BORKON AM, 1981, ANN THORAC SURG, V31, P512, DOI 10.1016/S0003-4975(10)61340-9; Cappato R, 2011, J AM COLL CARDIOL, V58, P2696, DOI 10.1016/j.jacc.2011.09.028; DENOTTER G, 1972, THORAX, V27, P105, DOI 10.1136/thx.27.1.105; Erdil N, 2005, J CARDIAC SURG, V20, P257, DOI 10.1111/j.1540-8191.2005.200375.x; Gaudino M, 2013, ANN THORAC SURG, V95, P731, DOI 10.1016/j.athoracsur.2012.08.059; IKAHEIMO MJ, 1988, AM HEART J, V116, P97, DOI 10.1016/0002-8703(88)90255-4; Im E, 2013, J AM COLL CARDIOL, V61, P2110, DOI 10.1016/j.jacc.2013.02.033; Imazio M, 2012, CURR OPIN PULM MED, V18, P366, DOI 10.1097/MCP.0b013e32835311a2; Imazio M, 2010, EUR HEART J, V31, P2749, DOI 10.1093/eurheartj/ehq319; KHAN AH, 1992, CLIN CARDIOL, V15, P67, DOI 10.1002/clc.4960150203; Knayzer B, 2007, J CARDIAC SURG, V22, P117, DOI 10.1111/j.1540-8191.2006.00366.x; Kuvin JT, 2002, ANN THORAC SURG, V74, P1148, DOI 10.1016/S0003-4975(02)03837-7; Liebe V, 2006, IN VIVO, V20, P427; Lim HS, 2014, CIRC-ARRHYTHMIA ELEC, V7, P83, DOI 10.1161/CIRCEP.113.000876; Maesen B, 2012, EUROPACE, V14, P159, DOI 10.1093/europace/eur208; Matsuyama K, 2001, JPN CIRC J, V65, P480, DOI 10.1253/jcj.65.480; Meurin P, 2004, CHEST, V125, P2182, DOI 10.1378/chest.125.6.2182; PEPI M, 1994, BRIT HEART J, V72, P327; Regueiro A, 2013, AM J CARDIOL, V112, P1646, DOI 10.1016/j.amjcard.2013.07.024; REID CL, 1987, AM J CARDIOL, V60, P394, DOI 10.1016/0002-9149(87)90259-1; SAHNI J, 1991, SCAND J THORAC CARD, V25, P63, DOI 10.3109/14017439109098085; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Watkin RW, 2007, J INFECTION, V55, P220, DOI 10.1016/j.jinf.2007.05.174; WEITZMAN LB, 1984, CIRCULATION, V69, P506, DOI 10.1161/01.CIR.69.3.506; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	25	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165754	10.1371/journal.pone.0165754	http://dx.doi.org/10.1371/journal.pone.0165754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855225	gold, Green Submitted, Green Published			2022-12-26	WOS:000387910200012
J	Chen, HM; Lin, HF; Huang, MF; Chang, CW; Yeh, YC; Lo, YC; Yen, CF; Chen, CS				Chen, Hui-Mei; Lin, Hsiu-Fen; Huang, Mei-Feng; Chang, Chun-Wei; Yeh, Yi-Chun; Lo, Yi-Ching; Yen, Cheng-Fang; Chen, Cheng-Sheng			Validation of Taiwan Performance-Based Instrumental Activities of Daily Living (TPIADL), a Performance- Based Measurement of Instrumental Activities of Daily Living for Patients with Vascular Cognitive Impairment	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; OLDER-ADULTS; DEMENTIA	Objective Patients with cerebrovascular diseases often presented both cognitive and physical impairment. Disability in everyday functioning involving cognitive impairment among patients may be hard to completely rely on informants' reports, as their reports may be confounded with physical impairment. The aim of this study was to validate a performance-based measure of functional assessment, the Taiwan Performance-Based Instrumental Activities of Daily Living (TPIADL), for vascular cognitive impairment (VCI) by examining its psychometric properties and diagnostic accuracy. Methods Ninety-seven patients with cerebrovascular diseases, including 30 with vascular dementia (VaD), 28 with mild cognitive impairment and 39 with no cognitive impairment, and 49 healthy control adults were recruited during study period. The TPIADL, as well as the Mini Mental State Examination (MMSE), Lawton-IADL and Barthel Index (BI), were performed. The internal consistency, convergent and criteria validity of the TPIADL were examined. Results Cronbach's alpha of the TPIADL test was 0.84. The TPIADL scores were significantly correlated with the Lawton IADL (r = -0.587, p <0.01). Notably, the TPIADL had a higher correlation coefficient with the cognitive domain of Lawton IADL (r = -0.663) than with physical domain of Lawton IADL (r = -0.541). The area under the relative operating characteristic curve was 0.888 (95% CI = 0.812 -0.965) to differentiate VaD from other groups. The optimal cut-off point of the TPIADL for detecting VaD was 6/7, which gives a sensitivity of 73.3% and a specificity of 84.5%. Conclusion The TPIADL is a brief and sensitive tool for the detection of IADL impairment in patients with VaD.	[Chen, Hui-Mei; Chang, Chun-Wei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Lin, Hsiu-Fen] Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Huang, Mei-Feng; Yeh, Yi-Chun; Yen, Cheng-Fang; Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat 3, Kaohsiung, Taiwan; [Chen, Hui-Mei; Huang, Mei-Feng; Yeh, Yi-Chun] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Lin, Hsiu-Fen] Kaohsiung Med Univ, Dept Neurol, Coll Med, Kaohsiung, Taiwan; [Huang, Mei-Feng; Yeh, Yi-Chun; Yen, Cheng-Fang; Chen, Cheng-Sheng] Kaohsiung Med Univ, Dept Psychiat, Coll Med, Kaohsiung, Taiwan; [Lo, Yi-Ching] Kaohsiung Med Univ, Dept Pharmacol, Coll Med, Kaohsiung, Taiwan; [Lo, Yi-Ching] Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University	Yen, CF; Chen, CS (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat 3, Kaohsiung, Taiwan.; Yen, CF; Chen, CS (corresponding author), Kaohsiung Med Univ, Dept Psychiat, Coll Med, Kaohsiung, Taiwan.	chfaye@cc.kmu.edu.tw; sheng@kmu.edu.tw		Lin, Hsiu-Fen/0000-0001-6343-826X; Chen, Hui-Mei/0000-0002-3712-5144	Kaohsiung Medical University Hospital [KMUH102-M204]	Kaohsiung Medical University Hospital	This research was supported by grants from the Kaohsiung Medical University Hospital (KMUH102-M204).	Canavan M, 2014, GERONTOLOGY, V60, P212, DOI 10.1159/000356744; Chen HM, 2015, PSYCHOGERIATRICS, V15, P227, DOI 10.1111/psyg.12096; den Ouden MEM, 2014, EXP GERONTOL, V58, P1, DOI 10.1016/j.exger.2014.06.002; Donoghue OA, 2014, ARCH PHYS MED REHAB, V95, P1954, DOI 10.1016/j.apmr.2014.06.008; Gold DA, 2012, J CLIN EXP NEUROPSYC, V34, P11, DOI 10.1080/13803395.2011.614598; Guo NW, 1988, TAIWAN J PHYS MED RE, V16, P52; Gure TR, 2010, J GERONTOL A-BIOL, V65, P434, DOI 10.1093/gerona/glp197; Hachinski V, 2006, STROKE, V37, P2220, DOI 10.1161/01.STR.0000237236.88823.47; Hamel R, 2015, PSYCHOL MED, V45, P1509, DOI 10.1017/S0033291714002645; Hamilton JM, 2014, ALZHEIMERS DEMENT, V10, P171, DOI 10.1016/j.jalz.2013.04.003; Harvey PD, 2007, SCHIZOPHRENIA BULL, V33, P1138, DOI 10.1093/schbul/sbm040; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; Jekel K, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0099-0; Kalaria RN, 2008, LANCET NEUROL, V7, P812, DOI 10.1016/S1474-4422(08)70169-8; Kim YH, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/852784; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MAHONEY F I, 1965, Md State Med J, V14, P61; Middleton L, 2008, J NEUROL SCI, V269, P80, DOI 10.1016/j.jns.2007.04.054; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Ng TP, 2006, J GERONTOL A-BIOL, V61, P726, DOI 10.1093/gerona/61.7.726; Ni JN, 2015, INT J GERIATR PSYCH, V30, P888, DOI 10.1002/gps.4317; Reppermund S, 2011, INT J GERIATR PSYCH, V26, P843, DOI 10.1002/gps.2612; Rockwood K, 2002, STROKE, V33, P1605, DOI 10.1161/01.STR.0000017878.85274.44; Rockwood K, 2007, J NEUROL SCI, V252, P106, DOI 10.1016/j.jns.2006.10.015; Rodakowski J, 2014, J AM GERIATR SOC, V62, P1347, DOI 10.1111/jgs.12878; Sadek JR, 2011, J INT NEUROPSYCH SOC, V17, P832, DOI 10.1017/S1355617711000841; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Tolea MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122878; Vasquez BP, 2015, J NEUROPSYCHOL, V9, P109, DOI 10.1111/jnp.12039; Wilms HU, 2007, COMPR PSYCHIAT, V48, P95, DOI 10.1016/j.comppsych.2006.04.001; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	31	2	3	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166546	10.1371/journal.pone.0166546	http://dx.doi.org/10.1371/journal.pone.0166546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851810	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300064
J	Koorevaar, RCT; van't Riet, E; Gerritsen, MJJ; Madden, K; Bulstra, SK				Koorevaar, Rinco C. T.; van't Riet, Esther; Gerritsen, Marleen J. J.; Madden, Kim; Bulstra, Sjoerd K.			The Influence of Preoperative and Postoperative Psychological Symptoms on Clinical Outcome after Shoulder Surgery: A Prospective Longitudinal Cohort Study	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; QUALITY-OF-LIFE; QUESTIONNAIRE 4DSQ; MUSCULOSKELETAL PAIN; PERCEIVED DISABILITY; DEPRESSIVE SYMPTOMS; DISTRESS; ANXIETY; VALIDATION; ARM	Background Psychological symptoms are highly prevalent in patients with shoulder complaints. Psychological symptoms in patients with shoulder complaints might play a role in the aetiology, perceived disability and pain and clinical outcome of treatment. The aim of this study was to assess whether preoperative symptoms of distress, depression, anxiety and somatisation were associated with a change in function after shoulder surgery and postoperative patient perceived improvement of pain and function. In addition, the change of psychological symptoms after shoulder surgery was analyzed and the influence of postoperative symptoms of psychological disorders after surgery on the change in function after shoulder surgery and perceived postoperative improvement of pain and function. Methods and Findings A prospective longitudinal cohort study was performed in a general teaching hospital. 315 consecutive patients planned for elective shoulder surgery were included. Outcome measures included change of Disabilities of the Arm, Shoulder and Hand (DASH) score and anchor questions about improvement in pain and function after surgery. Psychological symptoms were identified before and 12 months after surgery with the validated FourDimensional Symptom Questionnaire (4DSQ). Psychological symptoms were encountered in all the various shoulder diagnoses. Preoperative symptoms of psychological disorders persisted after surgery in 56% of patients, 10% of patients with no symptoms of psychological disorders before surgery developed new psychological symptoms. Preoperative symptoms of psychological disorders were not associated with the change of DASH score and perceived improvement of pain and function after shoulder surgery. Patients with symptoms of psychological disorders after surgery were less likely to improve on the DASH score. Postoperative symptoms of distress and depression were associated with worse perceived improvement of pain. Postoperative symptoms of distress, depression and somatisation were associated with worse perceived improvement of function. Conclusions Preoperative symptoms of distress, depression, anxiety and somatisation were not associated with worse clinical outcome 12 months after shoulder surgery. Symptoms of psychological disorders before shoulder surgery persisted in 56% of patients after surgery. Postoperative symptoms of psychological disorders 12 months after shoulder surgery were strongly associated with worse clinical outcome.	[Koorevaar, Rinco C. T.] Deventer Hosp, Dept Orthopaed, Deventer, Netherlands; [van't Riet, Esther] Deventer Hosp, Res Dept, Deventer, Netherlands; [Gerritsen, Marleen J. J.] Deventer Hosp, Dept Psychol, Deventer, Netherlands; [Madden, Kim] Mc Master Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands	Deventer Hospital; Deventer Hospital; Deventer Hospital; McMaster University; University of Groningen	Koorevaar, RCT (corresponding author), Deventer Hosp, Dept Orthopaed, Deventer, Netherlands.	C.T.Koorevaar@dz.nl	Madden, Kim/N-5761-2015	Madden, Kim/0000-0002-2861-9636				Alizadehkhaiyat O, 2007, CLIN J PAIN, V23, P482, DOI 10.1097/AJP.0b013e31805f70fa; Bingefors K, 2004, EUR J PAIN, V8, P435, DOI 10.1016/j.ejpain.2004.01.005; Cho CH, 2015, CLIN ORTHOP RELAT R, V473, P3494, DOI 10.1007/s11999-015-4258-1; Cho CH, 2013, J SHOULDER ELB SURG, V22, P1160, DOI 10.1016/j.jse.2013.02.006; Crosby RD, 2003, J CLIN EPIDEMIOL, V56, P395, DOI 10.1016/S0895-4356(03)00044-1; De Vet HCW, 2011, MEASUREMENT MED, P246; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Desai AS, 2010, ANN ROY COLL SURG, V92, P9, DOI 10.1308/003588410X12518836440522; Duivenvoorden T, 2013, OSTEOARTHR CARTILAGE, V21, P1834, DOI 10.1016/j.joca.2013.08.022; George SZ, 2016, ARTHRIT CARE RES, V68, P1671, DOI 10.1002/acr.22876; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; Jorgensen CK, 2000, BRIT J GEN PRACT, V50, P537; Karels CH, 2007, J CLIN EPIDEMIOL, V60, P839, DOI 10.1016/j.jclinepi.2006.11.012; Koorevaar RCT, 2016, J ORTHOP RES, V34, P683, DOI 10.1002/jor.23051; Lindenhovius ALC, 2008, J BONE JOINT SURG AM, V90A, P2090, DOI 10.2106/JBJS.G.00793; Pakarinen M, 2014, SPINE J, V14, P2392, DOI 10.1016/j.spinee.2014.01.047; Picavet HSJ, 2003, PAIN, V102, P167, DOI 10.1016/S0304-3959(02)00372-X; Potter MQ, 2015, CLIN ORTHOP RELAT R, V473, P3501, DOI 10.1007/s11999-015-4513-5; Ring D, 2004, J BONE JOINT SURG AM, V86A, P1387, DOI 10.2106/00004623-200407000-00005; Ring D, 2006, J BONE JOINT SURG AM, V88A, P1983, DOI 10.2106/JBJS.E.00932; Roh YH, 2012, CLIN ORTHOP RELAT R, V470, P3470, DOI 10.1007/s11999-012-2503-4; Roh YH, 2012, ARCH ORTHOP TRAUM SU, V132, P1251, DOI 10.1007/s00402-012-1545-0; Rosenberger PH, 2006, J AM ACAD ORTHOP SUR, V14, P397, DOI 10.5435/00124635-200607000-00002; Tashjian RZ, 2008, J SHOULDER ELB SURG, V17, P853, DOI 10.1016/j.jse.2008.04.003; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Terluin B, 2014, EUR J GEN PRACT, V20, P320, DOI 10.3109/13814788.2014.905826; Terluin B, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-58; Veehof Martine M, 2002, J Hand Ther, V15, P347; Vranceanu AM, 2009, J BONE JOINT SURG AM, V91A, P2014, DOI 10.2106/JBJS.H.01512	29	34	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166555	10.1371/journal.pone.0166555	http://dx.doi.org/10.1371/journal.pone.0166555			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846296	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600080
J	Willwacher, S; Herrmann, V; Heinrich, K; Funken, J; Strutzenberger, G; Goldmann, JP; Braunstein, B; Brazil, A; Irwin, G; Potthast, W; Bruggemann, GP				Willwacher, Steffen; Herrmann, Volker; Heinrich, Kai; Funken, Johannes; Strutzenberger, Gerda; Goldmann, Jan-Peter; Braunstein, Bjoern; Brazil, Adam; Irwin, Gareth; Potthast, Wolfgang; Brueggemann, Gert-Peter			Sprint Start Kinetics of Amputee and Non-Amputee Sprinters	PLOS ONE			English	Article							PERFORMANCE; MECHANICS; POWER; PUSH	The purpose of this study was to explore the relationship between the forces applied to the starting blocks and the start performances (SPs) of amputee sprinters (ASs) and non-amputee sprinters (NASs). SPs of 154 male and female NASs (100-m personal records [PRs], 9.58 - 14.00 s) and 7 male ASs (3 unilateral above knee, 3 unilateral below knee, 1 bilateral below knee; 100 m PRs, 11.70 - 12.70 s) with running specific prostheses (RSPs) were analysed during full-effort sprint starts using instrumented starting blocks that measured the applied forces in 3D. Using the NAS dataset and a combination of factor analysis and multiple regression techniques, we explored the relationship between force characteristics and SP (quantified by normalized average horizontal block power). Start kinetics were subsequently compared between ASs and NASs who were matched based on their absolute 100 m PR and their 100 m PR relative to the world record in their starting class. In NASs, 86% of the variance in SP was shared with five latent factors on which measured parameters related to force application to the rear and front blocks and the respective push-off directions in the sagittal plane of motion were loaded. Mediolateral force application had little influence on SP. The SP of ASs was significantly reduced compared to that of NASs matched on the basis of relative 100-m PR (-33.8%; d = 2.11, p < 0.001), while a non-significant performance reduction was observed when absolute 100-m PRs were used (-17.7%; d = 0.79, p = 0.09). These results are at least partially explained by the fact that force application to the rear block was clearly impaired in the affected legs of ASs.	[Willwacher, Steffen; Herrmann, Volker; Heinrich, Kai; Funken, Johannes; Goldmann, Jan-Peter; Braunstein, Bjoern; Potthast, Wolfgang; Brueggemann, Gert-Peter] German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany; [Strutzenberger, Gerda; Brazil, Adam; Irwin, Gareth] Cardiff Metropolitan Univ, Sch Sport, Cardiff, S Glam, Wales; [Strutzenberger, Gerda] Salzburg Univ, Dept Sport Sci & Kinesiol, Salzburg, Austria; [Goldmann, Jan-Peter; Braunstein, Bjoern] German Sport Univ Cologne, German Res Ctr Elite Sport, Cologne, Germany	German Sport University Cologne; Cardiff Metropolitan University; Salzburg University; German Sport University Cologne	Willwacher, S (corresponding author), German Sport Univ Cologne, Inst Biomech & Orthopaed, Cologne, Germany.	s.willwacher@dshs-koeln.de	Funken, Johannes/AAR-8238-2020; Heinrich, Kai/ABA-3038-2020; Goldmann, Jan-Peter/AAS-7638-2021; Braunstein, Bjoern/D-7142-2013; Mourot, Laurent/M-2114-2019	Funken, Johannes/0000-0002-0093-8686; Heinrich, Kai/0000-0001-9417-9619; Goldmann, Jan-Peter/0000-0003-2552-5762; Braunstein, Bjoern/0000-0002-5173-8916; Mourot, Laurent/0000-0001-9486-3090; Brazil, Adam/0000-0003-1850-9852; Strutzenberger, Gerda/0000-0001-5218-6183	International Association of Athletics Federations (IAAF)	International Association of Athletics Federations (IAAF)	SW, VH, KH, and GB received funding for the study for collecting data from non-amputee athletes from the International Association of Athletics Federations (IAAF). The funder was not involved in data collection and analysis, the decision to publish or the preparation of the manuscript.; The authors are grateful for the work of Martin Kusel-Feldker, Jurgen Geyermann and Thomas Forster in building the instrumented starting blocks used in this study. Parts of the study were funded by the International Association of Athletics Federations (IAAF).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Basilevsky A, 1981, CANADIAN J STAT, V9, P109, DOI DOI 10.2307/3315301; Bezodis NE, 2010, SPORT BIOMECH, V9, P258, DOI 10.1080/14763141.2010.538713; Bezodis NE, 2015, EUR J SPORT SCI, V15, P118, DOI 10.1080/17461391.2014.928915; Bruggemann Gert-Peter., 2008, SPORTS TECHNOLOGY, V1, P220, DOI [10.1002/jst.63, DOI 10.1002/JST.63, DOI 10.1080/19346182.2008.9648476]; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; CAVAGNA GA, 1971, J PHYSIOL-LONDON, V217, P709, DOI 10.1113/jphysiol.1971.sp009595; Charalambous L, 2012, J SPORT SCI, V30, P1, DOI 10.1080/02640414.2011.616948; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Debaere S, 2013, J SPORT SCI, V31, P137, DOI 10.1080/02640414.2012.722225; Grabowski AM, 2010, BIOL LETTERS, V6, P201, DOI 10.1098/rsbl.2009.0729; Harland MJ, 1997, SPORTS MED, V23, P11, DOI 10.2165/00007256-199723010-00002; HOF AL, 1996, GAIT POSTURE, V4, P222; James G., 2014, INTRO STAT LEARNING; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; McGowan CP, 2012, J ROYAL SOC INTERFAC; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; Morin JB, 2015, J BIOMECH, V48, P3149, DOI 10.1016/j.jbiomech.2015.07.009; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; Rabita G, 2015, SCAND J MED SCI SPOR, V25, P583, DOI 10.1111/sms.12389; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Taboga P, 2014, J APPL BIOMECH, V30, P381, DOI 10.1123/jab.2013-0113; Tellez T., 1984, TRACK TECHNIQUE, V88, P2802; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; Weyand PG, 2010, J APPL PHYSIOL, V108, P1011, DOI [10.1152/japplphysiol.01238.2009, 10.1152/japplphysiol.01238.2009a]; Willwacher S, 2013, PROCEDIA ENGINEER, V60, P124, DOI 10.1016/j.proeng.2013.07.073; Zatsiorsky VM, 2012, BIOMECHANICS SKELETA	28	40	40	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166219	10.1371/journal.pone.0166219	http://dx.doi.org/10.1371/journal.pone.0166219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846241	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600042
J	Wu, YS; Chen, YT; Bao, YT; Li, ZM; Zhou, XJ; He, JN; Dai, SJ; Li, CY				Wu, Yang Sheng; Chen, Yi-Tao; Bao, Yu-Ting; Li, Zhe-Ming; Zhou, Xiao-Jie; He, Jia-Na; Dai, Shi-Jie; Li, Chang Yu			Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; AGC PROTEIN-KINASES; GLUCOSE-METABOLISM; INSULIN-RESISTANCE; CELLS; DEFICIENCY; THERAPIES; SECRETION; DISEASE; CANCER	Background Berberine is used to treat diabetes and dyslipidemia. However, the effect of berberine on specific diabetes treatment targets is unknown. In the current study, we investigated the effect of berberine on the random plasma glucose, glycated hemoglobin (HbA1C), AST, ALT, BUN and CREA levels of Zucker diabetic fatty (ZDF) rats, and we identified and verified the importance of potential therapeutic target genes to provide molecular information for further investigation of the mechanisms underlying the anti-diabetic effects of berberine. Methods ZDF rats were randomly divided into control (Con), diabetic (DM) and berberine-treated (300 mg center dot kg(-1), BBR) groups. After the ZDF rats were treated with BBR for 12 weeks, its effect on the random plasma glucose and HbA1C levels was evaluated. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), blood urea nitrogen (BUN), CREA and OGTT were measured from blood, respectively. The levels of gene expression in liver samples were analyzed using an Agilent rat gene expression 4x44K microarray. The differentially expressed genes (DEGs) were screened as those with log2 (Con vs DM) >= 1 and log2 (BBR vs DM) >= 1 expression levels, which were the genes with up-regulated expression, and those with log2 (Con vs DM) <= -1 and log2 (BBR vs DM) <= -1 expression levels, which were the genes with down-regulated expression; the changes in gene expression were considered significant at P<0.05. The functions of the DEGs were determined using gene ontology (GO) and pathway analysis. Furthermore, a protein-protein interaction (PPI) network was constructed using STRING and Cytoscape software. The expression levels of the key node genes in the livers of the ZDF rats were also analyzed using qRT-PCR. Results We found that 12 weeks of berberine treatment significantly decreased the random plasma glucose, HbA1 C levels and improved glucose tolerance. There was a tendency for berberine to reduce AST, ALT, BUN except increase CREA levels. In the livers of the BBR group, we found 154 DEGs, including 91 genes with up-regulated expression and 63 genes with down-regulated expression. In addition, GO enrichment analysis showed significant enrichment of the DEGs in the following categories: metabolic process, localization, cellular process, biological regulation and response to stimulus process. After the gene screening, KEGG pathway analysis showed that the target genes are involved in multiple pathways, including the lysine degradation, glycosaminoglycan biosynthesischondroitin sulfate/dermatan sulfate and pyruvate metabolism pathways. By combining the results of PPI network and KEGG pathway analyses, we identified seven key node genes. The qRT-PCR results confirmed that the expression of the RHOA, MAPK4 and DLAT genes was significantly down-regulated compared with the levels in DM group, whereas the expression of the SgK494, DOT1 L, SETD2 and ME3 genes was significantly up-regulated in the BBR group. Conclusion Berberine can significantly improve glucose metabolism and has a protective effects of liver and kidney function in ZDF rats. The qRT-PCR results for the crucial DEGs validated the microarray results. These results suggested that the RHOA, MAPK4, SGK494, DOT1 L, SETD2, ME3 and DLAT genes are potential therapeutic target genes for the treatment of diabetes.	[Wu, Yang Sheng; Bao, Yu-Ting; Li, Zhe-Ming; Zhou, Xiao-Jie; He, Jia-Na; Dai, Shi-Jie; Li, Chang Yu] Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China; [Chen, Yi-Tao] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Zhejiang Chinese Medical University; Zhejiang Chinese Medical University	Li, CY (corresponding author), Zhejiang Chinese Med Univ, Coll Pharm, Hangzhou, Zhejiang, Peoples R China.	lcyzcmu@sina.com			Project of National Great New Drug Research and Development [2012ZX09503001-001]; Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University [752223A00201/005/019]	Project of National Great New Drug Research and Development; Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University	This work was supported by the Project of National Great New Drug Research and Development (No. 2012ZX09503001-001), and Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University (No. 752223A00201/005/019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Project of National Great New Drug Research and Development (No. 2012ZX09503001-001), and Traditional Chinese Medicine Open funds of Zhejiang Chinese Medical University (No. 752223A00201/005/019). We are grateful to Ms Yuanxiao Yang, Ms Ying He for constructive discussion, Ms Ling Xuan, Ms Jie Ying Zhang and Mr Xue Ming Chen for literature search.	Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Bragoszewski P, 2007, ACTA BIOCHIM POL, V54, P341, DOI 10.18388/abp.2007_3255; Bruder-Nascimento T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162731; Chen JL, 2014, EXP THER MED, V8, P836, DOI 10.3892/etm.2014.1843; Ciara E, 2016, MOL GENET METAB REP, V7, P70, DOI 10.1016/j.ymgmr.2016.03.004; Dentin R, 2005, BIOCHIMIE, V87, P81, DOI 10.1016/j.biochi.2004.11.008; Di Pierro F, 2013, CLIN PHARMACOL-ADV A, V5, P167, DOI 10.2147/CPAA.S54308; Dong Y, 2016, PHYTOTHER RES, V30, P823, DOI 10.1002/ptr.5587; Goguet-Rubio P, 2016, P NATL ACAD SCI USA, V113, P11004, DOI 10.1073/pnas.1602751113; Guo WG, 2013, EUR REV MED PHARMACO, V17, P1509; Hasan NM, 2015, MOL ENDOCRINOL, V29, P396, DOI 10.1210/me.2014-1249; Head RA, 2005, ANN NEUROL, V58, P234, DOI 10.1002/ana.20550; Iyer A, 2012, IMMUNOL CELL BIOL, V90, P39, DOI 10.1038/icb.2011.99; Jiang GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154028; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Knipe RS, 2015, PHARMACOL REV, V67, P103, DOI 10.1124/pr.114.009381; Lan AP, 2015, NEPHROL DIAL TRANSPL, V30, P385, DOI 10.1093/ndt/gfu196; Lan JR, 2015, J ETHNOPHARMACOL, V161, P69, DOI 10.1016/j.jep.2014.09.049; Lee MH, 2010, EARLY HUM DEV, V86, P45, DOI 10.1016/j.earlhumdev.2010.01.001; Li F, 2016, J HUAZHONG U SCI-MED, V36, P64, DOI 10.1007/s11596-016-1543-5; Liu C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/313808; Martinez-Abundis E, 2016, WORLD J DIABETES, V7, P142, DOI 10.4239/wjd.v7.i7.142; Pan DN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002761; Pang B, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/905749; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Rousseau J, 2010, MOL CELL BIOL, V30, P5752, DOI 10.1128/MCB.01147-10; Scarda A, 2010, INT J OBESITY, V34, P1319, DOI 10.1038/ijo.2010.47; Suzuki MG, 2014, INT J MOL SCI, V15, P6772, DOI 10.3390/ijms15046772; Tang YH, 2012, PLANTA MED, V78, P18, DOI 10.1055/s-0031-1280268; Tasdelen I, 2013, BIOCHEM J, V451, P45, DOI 10.1042/BJ20121113; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; Wei SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152097; Wu H., 2013, J NANOMATER, V2013, P8, DOI DOI 10.1371/J0URNAL.P0NE.0053342; Xie X, 2013, MOL CELL ENDOCRINOL, V381, P56, DOI 10.1016/j.mce.2013.07.019; Xu HY, 2003, J BIOL CHEM, V278, P30187, DOI 10.1074/jbc.M302010200; Xu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103702; Zhang Q, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-188; Zhou H, 2011, DIABETES-METAB RES, V27, P318, DOI 10.1002/dmrr.1182; Zhou Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047360	41	14	17	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166378	10.1371/journal.pone.0166378	http://dx.doi.org/10.1371/journal.pone.0166378			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846294	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600053
J	Kim, MS; Min, HG; Lee, SH; Kim, JG				Kim, Min-Suk; Min, Hyun-Gi; Lee, Sang-Hwan; Kim, Jeong-Gyu			The Effects of Various Amendments on Trace Element Stabilization in Acidic, Neutral, and Alkali Soil with Similar Pollution Index	PLOS ONE			English	Article							HEAVY-METALS; CONTAMINATED SOILS; AVAILABILITY; MOBILITY; HYPERACCUMULATOR; BIOAVAILABILITY; TOXICITY; BIOCHAR; LEAD; PH	Many studies have examined the application of soil amendments, including pH change-induced immobilizers, adsorbents, and organic materials, for soil remediation. This study evaluated the effects of various amendments on trace element stabilization and phytotoxicity, depending on the initial soil pH in acid, neutral, and alkali conditions. As in all types of soils, Fe and Ca were well stabilized on adsorption sites. There was an effect from pH control or adsorption mechanisms on the stabilization of cationic trace elements from inorganic amendments in acidic and neutral soil. Furthermore, acid mine drainage sludge has shown great potential for stabilizing most trace elements. In a phytotoxicity test, the ratio of the bioavailable fraction to the pseudo-total fraction significantly affected the uptake of trace elements by bok choy. While inorganic amendments efficiently decreased the bioavailability of trace elements, significant effects from organic amendments were not noticeable due to the short-term cultivation period. Therefore, the application of organic amendments for stabilizing trace elements in agricultural soil requires further study.	[Kim, Min-Suk; Kim, Jeong-Gyu] Korea Univ, O Jeong Ecoresilience Inst, Seoul, South Korea; [Min, Hyun-Gi; Kim, Jeong-Gyu] Korea Univ, Div Environm Sci & Ecol Engn, Coll Life & Environm Sci, Seoul, South Korea; [Lee, Sang-Hwan] Mine Reclamat Corp, Soil Remediat Team, Wonju, South Korea	Korea University; Korea University; Mine Reclamation Corporation	Kim, JG (corresponding author), Korea Univ, O Jeong Ecoresilience Inst, Seoul, South Korea.; Kim, JG (corresponding author), Korea Univ, Div Environm Sci & Ecol Engn, Coll Life & Environm Sci, Seoul, South Korea.	lemonkim@korea.ac.kr			National Research Foundation of Korea (NRF) [2015R1D1A1A01057594]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This study was funded by the National Research Foundation of Korea (NRF) [2015R1D1A1A01057594] http://nrf.re.kr/nri_tot_cms/indexisppmnsso-return2=none (to MS Kim). Mine Reclamation Corporation, Wonju, Republic of Korea, a commercial company, provided support in the form of salaries for authors SH Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution section.	Adriano DC, 2001, J ENVIRON QUAL, V30, P596, DOI 10.2134/jeq2001.302596x; ALLOWAY BJ, 1988, SCI TOTAL ENVIRON, V75, P41, DOI 10.1016/0048-9697(88)90159-3; BERNSTEIN L, 1975, ANNU REV PHYTOPATHOL, V13, P295, DOI 10.1146/annurev.py.13.090175.001455; Cao XD, 2003, ENVIRON POLLUT, V126, P157, DOI 10.1016/S0269-7491(03)00208-2; Chuan MC, 1996, WATER AIR SOIL POLL, V90, P543, DOI 10.1007/BF00282668; Comerford NB, 2005, ECOL STU AN, V181, P1; Davies NA, 2002, ENVIRON TOXICOL CHEM, V21, P2685, DOI 10.1897/1551-5028(2002)021<2685:CITABO>2.0.CO;2; Hettiarachchi GM, 2004, ENVIRON PROG, V23, P78, DOI 10.1002/ep.10004; 양주경, 2011, [Journal of the Korean Society of Water and Wastewater, 상하수도학회지], V25, P419; Karhu K, 2011, AGR ECOSYST ENVIRON, V140, P309, DOI 10.1016/j.agee.2010.12.005; Kim KR, 2012, J ENVIRON MANAGE, V102, P88, DOI 10.1016/j.jenvman.2012.02.001; Kim MS, 2014, J ENVIRON MANAGE, V146, P124, DOI 10.1016/j.jenvman.2014.07.001; Koo N, 2012, ENVIRON GEOCHEM HLTH, V34, P337, DOI 10.1007/s10653-011-9419-x; Korea Ministry of Environment, 2011, SOIL ENV STAND TEST; Lee S.-H., 2011, INT ATOMIC ENERGY AG, V43, P1; Lee SH, 2014, J ENVIRON MANAGE, V139, P15, DOI 10.1016/j.jenvman.2014.02.019; Li ZB, 1997, ENVIRON POLLUT, V95, P219, DOI 10.1016/S0269-7491(96)00077-2; Liu XY, 2012, ECOL ENG, V42, P168, DOI 10.1016/j.ecoleng.2012.01.016; Lopes C, 2012, ENVIRON POLLUT, V166, P17, DOI 10.1016/j.envpol.2012.02.017; LUCAS R. E., 1961, SOIL SCI, V92, P177, DOI 10.1097/00010694-196109000-00005; Martins Adão Luiz Castanheiro, 2003, Sci. agric. (Piracicaba, Braz.), V60, P747; McCauley A., 2009, SOIL PH ORGANIC MATT, V8, P4449; MEHLICH A, 1984, COMMUN SOIL SCI PLAN, V15, P1409, DOI 10.1080/00103628409367568; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Priha O, 1999, SOIL BIOL BIOCHEM, V31, P965, DOI 10.1016/S0038-0717(99)00006-1; SALTER PJ, 1969, EUR J SOIL SCI, V20, P126; SMITH SR, 1994, ENVIRON POLLUT, V85, P321, DOI 10.1016/0269-7491(94)90054-X; Suk Kim Min, 2014, [Korean Journal of Environmental Agriculture, 한국환경농학회지], V33, P78, DOI 10.5338/KJEA.2014.33.2.78; Tordoff GM, 2000, CHEMOSPHERE, V41, P219, DOI 10.1016/S0045-6535(99)00414-2; Wei BG, 2010, MICROCHEM J, V94, P99, DOI 10.1016/j.microc.2009.09.014; WOOLSON EA, 1973, SOIL SCI SOC AM J, V37, P254, DOI 10.2136/sssaj1973.03615995003700020028x; Zeng FR, 2011, ENVIRON POLLUT, V159, P84, DOI 10.1016/j.envpol.2010.09.019; Zhang XC, 2012, J HAZARD MATER, V229, P361, DOI 10.1016/j.jhazmat.2012.06.013; 윤정기, 2009, [The Journal of Korean Society of Soil and Groundwater Environment, 지하수토양환경], V14, P32	34	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166335	10.1371/journal.pone.0166335	http://dx.doi.org/10.1371/journal.pone.0166335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835687	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200040
J	Lu, Y; Liu, YL; Nie, JJ; Liang, XF; Yan, L; Wang, FZ; Zhai, XJ; Liu, JX; Zhu, FC; Chang, ZJ; Li, J				Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Liang, Xiao-Feng; Yan, Ling; Wang, Fu-Zhen; Zhai, Xiang-Jun; Liu, Jian-Xun; Zhu, Feng-Cai; Chang, Zhan-Jun; Li, Jie			Occult HBV Infection in Immunized Neonates Born to HBsAg-Positive Mothers: A Prospective and Follow-Up Study	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; CHILDREN BORN; SURFACE-ANTIGEN; VACCINATION; ASSAY; DNA	Objective Occult HBV infection (OBI) has been reported in infants born to HBsAg-positive mothers despite immunization. This study aims to determine the maintenance of this status in a prospective birth cohort. Methods A total of 158 neonates born to HBsAg-positive mothers were enrolled. All received passive-active immunization against HBV according to a 0-1-6 schedule. Sera were collected at 7 months of age. Those diagnosed with OBI were serially followed up at 12, 24 and 36 months of age. HBV serological markers were determined by Abbott i2000 system. HBV DNA was quantitated by Abbott m2000 system. Standard PCR followed by direct sequencing were applied for mother-child HBV pairs. Homology and phylogenetic comparisons were done by BLAST and Mega 5. Results All the 158 neonates were HBsAg-negative and anti-HBs-positive at 7 months of age, and 32 (20.3%) of them were diagnosed with OBI, with a median HBV DNA level of 1.97 (1.20-3.71) log IU/mL. Of them, HBV DNA was positive in 25.0%, 21.9% and 7.7% at 12, 24 and 36 months of age, respectively. HBV DNA disappeared at one of the follow-up points in 31 neonates, however, rebounded to low levels in 6 of them thereafter. HBV DNA persisted at low levels during follow-ups in the other one neonate apart from the above 31. All remained negative for HBsAg. Only two (6.3%) neonates were positive for anti-HBc after 24 months of age. HBV showed close homology and phylogenetic relationships for mother-child pairs. S-escape mutant, G145R, was not discovered. The first vaccine dose within 6 hours of birth significantly reduced the occurrence of OBI (59.4% vs. 83.3%, p = 0.003). Conclusions HBV may be controlled in immunized neonates of HBsAg-positive mothers, after being diagnosed with OBI. Timely vaccination against HBV may provide the utmost protection. Longterm and close monitorings are needed.	[Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Yan, Ling; Li, Jie] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Lu, Ying; Liu, Ya-Lin; Nie, Jing-Jing; Yan, Ling; Li, Jie] Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Liang, Xiao-Feng; Wang, Fu-Zhen] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China; [Zhai, Xiang-Jun; Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Dept Infect Dis, Nanjing 210009, Jiangsu, Peoples R China; [Liu, Jian-Xun; Chang, Zhan-Jun] Zhengzhou Municipal Ctr Dis Control & Prevent, Dept Major Projects, Zhengzhou 450053, Peoples R China	Peking University; Peking University; Chinese Center for Disease Control & Prevention; Jiangsu Provincial Center for Disease Control & Prevention	Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing 100191, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100191, Peoples R China.	jieli@bjmu.edu.cn			National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period [2012ZX10002001-001]	National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period	This study was supported by National Major Scientific and Technological Special Project during the Twelfth Five-year Plan Period (2012ZX10002001-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonio Bertoletti, 2010, CELLULAR MOL IMMUNOL, V12, P258; Bertoletti A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00441; Ciotti M, 2008, J CLIN MICROBIOL, V46, P1517, DOI 10.1128/JCM.02046-07; Deguchi M, 2004, J VIROL METHODS, V115, P217, DOI 10.1016/j.jviromet.2003.10.002; Foaud H, 2015, INFECTION, V43, P307, DOI 10.1007/s15010-015-0733-6; Friedt M, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-11; [金晖 JIN Hui], 2008, [中华流行病学杂志, Chinese Journal of Epidemiology], V29, P1235; Mulrooney-Cousins PM, 2007, WORLD J GASTROENTERO, V13, P5682, DOI 10.3748/wjg.v13.i43.5682; Nie JJ, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-121; Pande C, 2013, J VIRAL HEPATITIS, V20, P801, DOI 10.1111/jvh.12102; Pollicino T, 2014, J HEPATOL, V61, P688, DOI 10.1016/j.jhep.2014.04.036; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Sadeghi A, 2016, J VIRAL HEPATITIS, V23, P282, DOI 10.1111/jvh.12490; Shahmoradi S, 2012, J HEPATOL, V57, P515, DOI 10.1016/j.jhep.2012.04.021; Su HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070768; Wang JS, 2005, WORLD J GASTROENTERO, V11, P3582, DOI 10.3748/wjg.v11.i23.3582; Yeh CT, 2012, J HEPATOL, V57, P484, DOI 10.1016/j.jhep.2012.06.003; Zhou YH, 2016, J VIRAL HEPATITIS, V23, P830, DOI 10.1111/jvh.12559	19	12	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166317	10.1371/journal.pone.0166317	http://dx.doi.org/10.1371/journal.pone.0166317			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835694	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200037
J	Peng, H; Chen, L; Li, WF; Zhang, Y; Liu, LZ; Tian, L; Lin, AH; Sun, Y; Ma, J				Peng, Hao; Chen, Lei; Li, Wen-Fei; Zhang, Yuan; Liu, Li-Zhi; Tian, Li; Lin, Ai-Hua; Sun, Ying; Ma, Jun			Prognostic Correlations between ABO Blood Group and Pre-Treatment Plasma Epstein-Barr Virus DNA in Patients with Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; SURVIVAL; RISK; POPULATION; CANCER	Purpose The objective of this study is to assess the prognostic value of ABO blood group in nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT). Patients and Methods We retrospectively reviewed the data on 1397 patients with non-metastatic, newly diagnosed NPC treated using IMRT. Patient survival between different ABO blood groups were compared using log-rank test. Cox hazards model was adopted to establish independent prognostic factors. Results In our study, the distribution of the A, B, AB and O blood groups was 26.6% (372/1397), 26.2% (366/1397), 5.2% (73/1397) and 42.0% (586/1397), respectively. The cut-off value of pre-treatment Epstein-Barr virus (EBV) DNA based on disease-free survival (DFS) was 1355 copies/ml (area under curve [AUC], 0.649; sensitivity, 0.76; specificity, 0.496) for the whole cohort. Estimated four-year DFS, overall survival (OS), distant metastasis-free survival (DMFS) and locoregional relapse-free survival (LRRFS) rates were 81.7%, 89.2%, 89.4% and 92.3% for blood group A; 82.1%, 89.3%, 89.0% and 92.0% for group B; 83.3%, 88.1%, 86.2% and 95.5% for group AB, 80.9%, 90.7%, 88.4% and 90.2% for group O (P > 0.05 for all rates). Multivariate analysis revealed ABO blood group was not an independent prognostic factor for DFS, OS, DMFS or LRRFS (P > 0.05 for all rates) after adjusting for plasma EBV DNA in either the whole cohort or subgroup analysis by gender. Conclusions The prognostic value of ABO blood group may be limited for patients with NPC in the era of IMRT, and no substantial correlation between ABO blood group and plasma EBV DNA was observed.	[Peng, Hao; Chen, Lei; Li, Wen-Fei; Zhang, Yuan; Sun, Ying; Ma, Jun] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Liu, Li-Zhi; Tian, Li] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Imaging Diag & Intervent Ctr,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Lin, Ai-Hua] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Sch Publ Hlth, Guangzhou 510080, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Ma, J (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol Southern China, Dept Radiat Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.	majun2@mail.sysu.edu.cn			Health & Medical Collaborative Innovation Project of Guangzhou City, China [201400000001]; Sun Yat-sen University Clinical Research 5010 Program [2012011]; Science and Technology Project of Guangzhou City, China [14570006]; Planned Science and Technology Project of Guangdong Province [20136020400004]	Health & Medical Collaborative Innovation Project of Guangzhou City, China; Sun Yat-sen University Clinical Research 5010 Program; Science and Technology Project of Guangzhou City, China; Planned Science and Technology Project of Guangdong Province	This work was supported by grants from the Health & Medical Collaborative Innovation Project of Guangzhou City, China (No. 201400000001), the Sun Yat-sen University Clinical Research 5010 Program (No. 2012011), the Science and Technology Project of Guangzhou City, China (No. 14570006), and the Planned Science and Technology Project of Guangdong Province (No. 20136020400004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Health & Medical Collaborative Innovation Project of Guangzhou City, China (No. 201400000001), the Sun Yat-sen University Clinical Research 5010 Program (No. 2012011), the Science and Technology Project of Guangzhou City, China (No. 14570006), and the Planned Science and Technology Project of Guangdong Province (No. 2013B020400004).	Adam SI, 2012, J LARYNGOL OTOL, V126, P180, DOI 10.1017/S0022215111002507; Chan ATC, 2002, JNCI-J NATL CANCER I, V94, P1614, DOI 10.1093/jnci/94.21.1614; Chan KCA, 2014, CHIN J CANCER, V33, P598, DOI 10.5732/cjc.014.10192; CHANG YS, 1990, J CLIN MICROBIOL, V28, P2398, DOI 10.1128/JCM.28.11.2398-2402.1990; CHEN CL, 1993, INTERVIROLOGY, V36, P91, DOI 10.1159/000150327; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Engin H, 2012, ASIAN PAC J CANCER P, V13, P131, DOI 10.7314/APJCP.2012.13.1.131; Hou X, 2011, CLIN ONCOL-UK, V23, P128, DOI 10.1016/j.clon.2010.09.001; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Lin JC, 2004, NEW ENGL J MED, V350, P2461, DOI 10.1056/NEJMoa032260; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; Lu X, 2013, CHIN J CANCER, V32, P283, DOI 10.5732/cjc.012.10058; Miao SY, 2014, ASIA-PAC J CLIN ONCO, V10, P101, DOI 10.1111/ajco.12083; OuYang PY, 2013, BRIT J CANCER, V109, P2462, DOI 10.1038/bjc.2013.559; Rahbari NN, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-319; Shao JY, 2004, ANTICANCER RES, V24, P4059; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Sheng LM, 2013, INT J CANCER, V133, P893, DOI 10.1002/ijc.28087; Sun P, 2014, TUMOR BIOL, V35, P7201, DOI 10.1007/s13277-014-1960-7; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Xu LY, 2010, RADIOTHER ONCOL, V96, P94, DOI 10.1016/j.radonc.2010.04.006; Yang X, 2014, INT J CLIN EXP MED, V7, P2214; Yi JL, 2006, INT J RADIAT ONCOL, V65, P161, DOI 10.1016/j.ijrobp.2005.12.003; Zhang YX, 2014, ASIAN PAC J CANCER P, V15, P7459, DOI 10.7314/APJCP.2014.15.17.7459	26	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166194	10.1371/journal.pone.0166194	http://dx.doi.org/10.1371/journal.pone.0166194			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835689	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200031
J	Yu, J; Li, DQ; Lei, DS; Yuan, F; Pei, F; Zhang, HF; Yu, AM; Wang, K; Chen, H; Chen, L; Wu, XL; Tong, XL; Wang, YF				Yu, Jing; Li, Dongqing; Lei, Dansheng; Yuan, Feng; Pei, Feng; Zhang, Huifeng; Yu, Anming; Wang, Kun; Chen, Hu; Chen, Liang; Wu, Xianglei; Tong, Xianli; Wang, Yefu			Tumor-Specific D-Dimer Concentration Ranges and Influencing Factors: A Cross-Sectional Study	PLOS ONE			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM; PULMONARY-EMBOLISM; FIRST EPISODE; CANCER; BEVACIZUMAB; LEVEL	D-dimer level in cancer patients is associated with risk of venous thromboembolism and deep venous thrombosis. Most cancer patients have "\abnormal" D-dimer levels based on the current normal reference range. To investigate tumor-specific D-dimer reference range, we compared D-dimer levels for nine different tumour types with healthy controls by using simultaneous quantile regression and constructing a median, 5th percentile, and 95th percentile model of normal tumour D-dimer concentration. Associations with tumour primary site, stage, pathological type, and treatment were also explored. Additionally, 190 patients were tracked to reveal the relevance of initial D-dimer levels to cancer prognosis. D-dimer ranges (median, 5th, 95th) in various cancers (mg/L) were: liver 1.12, 0.27, 5.25; pancreatic 0.96, 0.23, 4.81; breast 0.44, 0.2, 2.17; gastric 0.65, 0.22, 5.03; colorectal 0.73, 0.22, 4.45; lung 0.7, 0.25, 4.0; gynaecological 0.61, 0.22, 3.98; oesophageal 0.23, 0.7, 3.45; and head and neck 0.22, 0.44, 2.19. All were significantly higher than that of healthy controls (0.18, 0.07, 0.57). D-dimer peaked 1-2 days postoperatively but had decreased to the normal range by 1 week. Additionally, cancer patients with high initial D-dimer were shown a tendency of poor prognosis in survival rate. In conclusion, D-dimer levels in cancer depend on patient age, tumour primary site, and tumour stage. Thrombosis prevention is necessary if D-dimer has not decreased to the tumor-specific baseline a week after surgery.	[Yu, Jing; Wang, Yefu] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Lei, Dansheng; Yuan, Feng; Pei, Feng; Zhang, Huifeng; Wang, Kun; Chen, Hu; Tong, Xianli] Hubei Canc Hosp, Dept Lab, Wuhan, Peoples R China; [Li, Dongqing] Wuhan Univ, Sch Basic Med Sci, Dept Microbiol, Wuhan, Peoples R China; [Yu, Anming] Stago Diag Co, Wuhan, Peoples R China; [Chen, Liang] Wuhan Univ, Dept Orthopaed, Renmin Hosp, Wuhan, Peoples R China; [Wu, Xianglei] Univ Lorraine, Immunol Lab, Lorraine, France	Wuhan University; Wuhan University; Wuhan University; Universite de Lorraine	Wang, YF (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	wangyefu2014@sina.com	Yu, Aimin/B-3848-2010	Yu, Aimin/0000-0001-9606-6255	National Natural Science Foundation of China [30901356]; Fundamental Research Funds for the Central Universities [3082008]; Ph.D. Programs Foundation of Ministry of Education of China [20090141120014]; Research Foundation of Health Department of Hubei Province [JX4B67]; Stago Diagnosis Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Research Foundation of Health Department of Hubei Province; Stago Diagnosis Company	This work was funded by grants from the National Natural Science Foundation of China (No. 30901356), Fundamental Research Funds for the Central Universities (No.3082008), Ph.D. Programs Foundation of Ministry of Education of China (No.20090141120014), and Research Foundation of Health Department of Hubei Province (No. JX4B67). The study sponsors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anming Yu is employed by Stago Diagnosis Company. Stago Diagnosis Company provided support by the supply of partial D-dimer testing reagents and some technic support and paid the salary for author AY, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Anming Yu is the one who supported technical support. This specific role of this author is articulated in the 'author contributions' section.	Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Aishima K, 2013, BRIT J NEUROSURG, V27, P348, DOI 10.3109/02688697.2012.737958; Ay C, 2012, HAEMATOL-HEMATOL J, V97, P1158, DOI 10.3324/haematol.2011.054718; Desciak MC, 2011, J CLIN ANESTH, V23, P153, DOI 10.1016/j.jclinane.2010.06.011; Di Nisio M, 2005, J THROMB HAEMOST, V3, P1239, DOI 10.1111/j.1538-7836.2005.01323.x; Diao DM, 2013, J SURG ONCOL, V108, P34, DOI 10.1002/jso.23339; Durczynski A, 2014, WORLD J GASTROENTERO, V20, P13167, DOI 10.3748/wjg.v20.i36.13167; Favaloro EJ, 2010, SEMIN THROMB HEMOST, V36, P458, DOI 10.1055/s-0030-1254055; Fernandez-Ros N, 2015, LIVER INT, V35, P1590, DOI 10.1111/liv.12592; Fijalkowska Anna, 2012, Pneumonol Alergol Pol, V80, P101; Haase C, 2013, THROMB RES, V132, P676, DOI 10.1016/j.thromres.2013.09.033; Hu QL, 2014, BIOCHEM CELL BIOL, V92, P547, DOI 10.1139/bcb-2014-0062; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090547; Liu P, 2015, CANCER CHEMOTH PHARM, V76, P1163, DOI 10.1007/s00280-015-2900-y; Misch M, 2013, ANTICANCER RES, V33, P2093; Ota S, 2005, AM J HEMATOL, V79, P274, DOI 10.1002/ajh.20396; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Paneesha S, 2006, BRIT J HAEMATOL, V135, P85, DOI 10.1111/j.1365-2141.2006.06260.x; Pinede L, 2001, CIRCULATION, V103, P2453; Righini M, 2014, JAMA-J AM MED ASSOC, V311, P1117, DOI 10.1001/jama.2014.2135; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Simonetti G, 2014, NEUROL SCI, V35, P83, DOI 10.1007/s10072-013-1583-6; Soares AA, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-54; Tomimaru Y, 2006, J AM COLL SURGEONS, V202, P139, DOI 10.1016/j.jamcollsurg.2005.08.008; Wang YZ, 2015, ONCOTARGETS THER, V8, P805, DOI 10.2147/OTT.S78154; Zhang PP, 2013, EJSO-EUR J SURG ONC, V39, P951, DOI 10.1016/j.ejso.2013.06.008	28	19	23	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165390	10.1371/journal.pone.0165390	http://dx.doi.org/10.1371/journal.pone.0165390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835633	Green Published, gold			2022-12-26	WOS:000387779200005
J	Chen, FA; Chien, CC; Chen, YW; Wu, YT; Lin, CC				Chen, Fu-An; Chien, Chih-Chiang; Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching			Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis	PLOS ONE			English	Article							FAILING DIALYSIS-ACCESS; NEOINTIMAL HYPERPLASIA; ARTERIOVENOUS-FISTULA; BALLOON ANGIOPLASTY; GRAFT PATENCY; STENT GRAFT; OUTCOMES; VEIN; SURVIVAL	Background Vascular access failure is a huge burden for patients undergoing hemodialysis. Many efforts have been made to maintain vascular access patency, including pharmacotherapy. Angiotensin converting enzyme inhibitor (ACE-I), angiotensin receptor blocker (ARB), and calcium channel blocker (CCB) are known for their antihypertensive and cardio-protective effects, however, their effects on long-term vascular access patency are still inconclusive. Design, setting, participants and measurements We retrospectively enrolled patients commencing maintenance hemodialysis between January 1, 2000, and December 31, 2006 by using National Health Insurance Research Database in Taiwan. Primary patency was defined as the date of first arteriovenous fistula (AVF) or arteriovenous graft (AVG) creation to the time of access thrombosis or any intervention aimed to maintain or re-establish vascular access patency. Cox proportional hazards models were used to adjust the influences of patient characteristics, co-morbidities and medications. Results Total 42244 patients were enrolled in this study, 37771 (89.4%) used AVF, 4473 (10.6%) used AVG as their first long term dialysis access. ACE-I, ARB, and CCB use were all associated with prolonged primary patency of AVF [hazard ratio (HR) 0.586, 95% confidence interval (CI) 0.557-0.616 for ACE-I use; HR 0.532, CI 0.508-0.556 for ARB use; HR 0.485, CI 0.470-0.501 for CCB use] and AVG (HR 0.557, CI 0.482-0.643 for ACE-I use, HR 0.536, CI 0.467-0.614 for ARB use, HR 0.482, CI 0.442-0.526 for CCB use). Conclusions In our analysis, ACE-I, ARB, and CCB were strongly associated with prolonged primary patency of both AVF and AVG. Further prospective randomized studies are still warranted to prove the causality.	[Chen, Fu-An; Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Fu-An] Natl Yang Ming Univ Hosp, Dept Internal Med, Yilan, Taiwan; [Chien, Chih-Chiang] Chi Mei Med Ctr, Dept Nephrol, Tainan, Taiwan; [Chen, Yu-Wei; Wu, Yu-Te; Lin, Chih-Ching] Taipei Vet Gen Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan	National Yang Ming Chiao Tung University; Chi Mei Hospital; Taipei Veterans General Hospital	Lin, CC (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Lin, CC (corresponding author), Taipei Vet Gen Hosp, Div Nephrol, Dept Internal Med, Taipei, Taiwan.	lincc2@vghtpe.gov.tw			Taipei Veterans General Hospital [V100C1-050, V101C-188, V102C-060, V102E2-001, V103C-043, V104C-026, V105C-075]; National Science Council [NSC101-2314-B-010-024-MY3]; Ministry of Science and Technology in Taiwan [MOST 104-2314-B-010-032-MY3]	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology in Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by intramural grants (V100C1-050, V101C-188, V102C-060, V102E2-001, V103C-043, V104C-026, V105C-075) from Taipei Veterans General Hospital, and grants from the National Science Council (NSC101-2314-B-010-024-MY3) and the Ministry of Science and Technology (MOST 104-2314-B-010-032-MY3) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astor BC, 2005, J AM SOC NEPHROL, V16, P1449, DOI 10.1681/ASN.2004090748; Bashar K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119958; Brauner R, 1997, J THORAC CARDIOV SUR, V114, P53, DOI 10.1016/S0022-5223(97)70117-X; Dixon BS, 2009, NEW ENGL J MED, V360, P2191, DOI 10.1056/NEJMoa0805840; Doi S, 2008, THER APHER DIAL, V12, P232, DOI 10.1111/j.1744-9987.2008.00579.x; Dolmatch BL, 2010, J VASC ACCESS, V11, P89, DOI 10.1177/112972981001100201; Gradzki R, 2001, AM J KIDNEY DIS, V38, P1240, DOI 10.1053/ajkd.2001.29220; Haskal ZJ, 2010, NEW ENGL J MED, V362, P494, DOI 10.1056/NEJMoa0902045; Huang P, 2001, AM J SURG, V181, P492, DOI 10.1016/S0002-9610(01)00615-8; Hung YN, 2010, CLIN J AM SOC NEPHRO, V5, P1029, DOI 10.2215/CJN.08181109; Jackson RS, 2011, J VASC SURG, V54, P1706, DOI 10.1016/j.jvs.2011.06.028; Lin CC, 2007, J AM SOC NEPHROL, V18, P985, DOI 10.1681/ASN.2006050534; Mihmanli I, 2001, J ULTRAS MED, V20, P217; Ng LJ, 2011, NEPHROL DIAL TRANSPL, V26, P3659, DOI 10.1093/ndt/gfr063; Ocak G, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-79; ODONOHOE MK, 1991, ANN SURG, V214, P727, DOI 10.1097/00000658-199112000-00014; Osborn G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002786.pub2; Ravani P, 2013, J AM SOC NEPHROL, V24, P465, DOI 10.1681/ASN.2012070643; Sajgure A, 2007, NEPHROL DIAL TRANSPL, V22, P1390, DOI 10.1093/ndt/gfl821; Saran R, 2002, AM J KIDNEY DIS, V40, P1255, DOI 10.1053/ajkd.2002.36895; Taber T E, 1995, ASAIO J, V41, P842; USRDS, 2014, US REN DAT SYST 2014; Wasse H, 2007, CLIN J AM SOC NEPHRO, V2, P708, DOI 10.2215/CJN.00170107; Yagi S, 2004, HYPERTENS RES, V27, P129, DOI 10.1291/hypres.27.129; Yamada T, 2007, ARTERIOSCL THROM VAS, V27, P2363, DOI 10.1161/ATVBAHA.107.147124	25	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166362	10.1371/journal.pone.0166362	http://dx.doi.org/10.1371/journal.pone.0166362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832203	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000110
J	Joshi, R; Buchanan, JC; Paruchuri, S; Morris, N; Tavana, H				Joshi, Ramila; Buchanan, James Carlton; Paruchuri, Sailaja; Morris, Nathan; Tavana, Hossein			Molecular Analysis of Stromal Cells-Induced Neural Differentiation of Mouse Embryonic Stem Cells	PLOS ONE			English	Article							RETINOIC ACID; TYROSINE-HYDROXYLASE; CORTICAL DEVELOPMENT; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; DOPAMINERGIC-NEURONS; SELF-RENEWAL; ES CELLS; EXPRESSION; INDUCTION	Deriving specific neural cells from embryonic stem cells (ESCs) is a promising approach for cell replacement therapies of neurodegenerative diseases. When co-cultured with certain stromal cells, mouse ESCs (mESCs) differentiate efficiently to neural cells. In this study, a comprehensive gene and protein expression analysis of differentiating mESCs is performed over a two-week culture period to track temporal progression of cells from a pluripotent state to specific terminally-differentiated neural cells such as neurons, astrocytes, and oligoden-drocytes. Expression levels of 26 genes consisting of marker genes for pluripotency, neural progenitors, and specific neuronal, astroglial, and oligodendrocytic cells are tracked using real time q-PCR. The time-course gene expression analysis of differentiating mESCs is combined with the hierarchal clustering and functional principal component analysis (FPCA) to elucidate the evolution of specific neural cells from mESCs at a molecular level. These statistical analyses identify three major gene clusters representing distinct phases of transition of stem cells from a pluripotent state to a terminally-differentiated neuronal or glial state. Temporal protein expression studies using immunohistochemistry demonstrate the generation of neural stem/progenitor cells and specific neural lineages and show a close agreement with the gene expression profiles of selected markers. Importantly, parallel gene and protein expression analysis elucidates long-term stability of certain proteins compared to those with a quick turnover. Describing the molecular regulation of neural cells commitment of mESCs due to stromal signaling will help identify major promoters of differentiation into specific cell types for use in cell replacement therapy applications.	[Joshi, Ramila; Buchanan, James Carlton; Tavana, Hossein] Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA; [Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Morris, Nathan] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA	University of Akron; University of Akron; Case Western Reserve University	Tavana, H (corresponding author), Univ Akron, Dept Biomed Engn, Akron, OH 44325 USA.	tavana@uakron.edu	Joshi, Ramila/U-5982-2019		National Science Foundation [1264562]; Ohio Third Frontier [TECG20140954]	National Science Foundation(National Science Foundation (NSF)); Ohio Third Frontier	This research is supported by the National Science Foundation, grant 1264562 and from Ohio Third Frontier, grant TECG20140954. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by grant 1264562 from National Science Foundation and grant TECG20140954 from Ohio Third Frontier.	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Akanuma Hiromi, 2012, Frontiers in Genetics, V3, P141, DOI 10.3389/fgene.2012.00141; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai C, 2007, DEV DYNAM, V236, P3255, DOI 10.1002/dvdy.21306; Chen XS, 2013, INT J MOL MED, V32, P25, DOI 10.3892/ijmm.2013.1372; Ding YC, 2002, NEUROL RES, V24, P829, DOI 10.1179/016164102101200816; Erceg S, 2009, STEM CELLS, V27, P78, DOI 10.1634/stemcells.2008-0543; Faigle R, 2012, BIOCHIM BIOPHYS ACTA, V1830, P2435, DOI DOI 10.1016/J.BBAGEN.2012.09.002; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Goldman S A., 1995, NEUROSCIENTIST, V1, P338; Haque A, 2012, BIOMATERIALS, V33, P5094, DOI 10.1016/j.biomaterials.2012.04.003; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; James G, 2000, BIOMETRIKA, V1, P1; Jiang XH, 2009, STEM CELLS DEV, V18, P1059, DOI 10.1089/scd.2008.0362; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kan LX, 2007, DEV BIOL, V310, P85, DOI 10.1016/j.ydbio.2007.07.026; Kasai M, 2005, GENES CELLS, V10, P777, DOI 10.1111/j.1365-2443.2005.00876.x; Katsetos CD, 2003, CELL MOTIL CYTOSKEL, V55, P77, DOI 10.1002/cm.10116; Kaufmann M, 2015, J BIOMOL SCREEN, V20, P1101, DOI 10.1177/1087057115588287; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitajima H, 2005, J NEUROSCI RES, V80, P467, DOI 10.1002/jnr.20469; Kondeti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071536; Kuegler PB, 2005, ENV PROT, P17; Kumar M, 2007, STEM CELLS DEV, V16, P667, DOI 10.1089/scd.2006.0115; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Liao Mei-Chih, 2014, World J Stem Cells, V6, P248, DOI 10.4252/wjsc.v6.i2.248; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Lindvall Olle, 2004, NeuroRx, V1, P379, DOI 10.1007/BF03206624; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Melchitzky DS, 2000, NEUROPSYCHOPHARMACOL, V22, P466, DOI 10.1016/S0893-133X(99)00139-6; Messam CA, 2002, DEV BRAIN RES, V134, P87, DOI 10.1016/S0165-3806(01)00325-X; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Ohtsuka T, 2011, STEM CELLS, V29, P1817, DOI 10.1002/stem.731; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; PAPALOPULU N, 1991, DEVELOPMENT, V113, P1145; Park D, 2010, STEM CELLS, V28, P2162, DOI 10.1002/stem.541; Paul D, 2009, ANN STAT, V37, P1229, DOI 10.1214/08-AOS608; Pomp O, 2005, STEM CELLS, V23, P923, DOI 10.1634/stemcells.2005-0038; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; Rosskothen-Kuhl N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092624; Sancho-Martinez I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10743; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sweeney CL, 2016, STEM CELLS, V34, P1513, DOI 10.1002/stem.2332; Taha MF, 2014, J BIOTECHNOL, V172, P1, DOI 10.1016/j.jbiotec.2013.11.028; Tavana H, 2011, BIOTECHNOL BIOENG, V108, P2509, DOI 10.1002/bit.23190; Tavana H, 2010, ADV MATER, V22, P2628, DOI 10.1002/adma.200904271; Tchorz JS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.65; Vazin T, 2008, STEM CELLS, V26, P1517, DOI 10.1634/stemcells.2008-0039; Venere M, 2012, DEVELOPMENT, V139, P3938, DOI 10.1242/dev.081133; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walsh FS, 2003, NEURAL CELL ADHESION; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; Willems E, 2006, INT J DEV BIOL, V50, P627, DOI 10.1387/ijdb.052130ew; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Yao F, 2005, J AM STAT ASSOC, V100, P577, DOI 10.1198/016214504000001745; Yin Dezhong, 2012, Methods Mol Biol, V873, P247, DOI 10.1007/978-1-61779-794-1_16; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang JN, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-7	67	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166316	10.1371/journal.pone.0166316	http://dx.doi.org/10.1371/journal.pone.0166316			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832161	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000095
J	Lim, L; Hart, H; Mehta, MA; Simmons, A; Mirza, K; Rubia, K				Lim, Lena; Hart, Heledd; Mehta, Mitul A.; Simmons, Andrew; Mirza, Kah; Rubia, Katya			Neurofunctional Abnormalities during Sustained Attention in Severe Childhood Abuse	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; POSTTRAUMATIC STRESS SYMPTOMS; SCHOOL-AGED CHILDREN; ADULT MENTAL-HEALTH; EARLY-LIFE STRESS; SEXUAL-ABUSE; MALTREATED CHILDREN; PHYSICAL ABUSE; EARLY DEPRIVATION; NEGLECT	Childhood maltreatment is associated with adverse affective and cognitive consequences including impaired emotion processing, inhibition and attention. However, the majority of functional magnetic resonance imaging (fMRI) studies in childhood maltreatment have examined emotion processing, while very few studies have tested the neurofunctional substrates of cognitive functions and none of attention. This study investigated the association between severe childhood abuse and fMRI brain activation during a parametric sustained attention task with a progressively increasing load of sustained attention in 21 medication-naive, drug-free young people with a history of childhood abuse controlling for psychiatric comorbidities by including 19 psychiatric controls matched for psychiatric diagnoses, and 27 healthy controls. Behaviorally, the participants exposed to childhood abuse showed increased omission errors in the task which correlated positively trend-wise with the duration of their abuse. Neurofunctionally, the participants with a history of childhood abuse, but not the psychiatric controls, displayed significantly reduced activation relative to the healthy controls during the most challenging attention condition only in typical attention regions including left inferior and dorsolateral prefrontal cortex, insula and temporal areas. We therefore show for the first time that severe childhood abuse is associated with neurofunctional abnormalities in key ventral frontal-temporal sustained attention regions. The findings represent a first step towards the delineation of abuse-related neurofunctional abnormalities in sustained attention, which may help in the development of effective treatments for victims of childhood abuse.	[Lim, Lena; Hart, Heledd; Mirza, Kah; Rubia, Katya] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England; [Mehta, Mitul A.; Simmons, Andrew] Kings Coll London, Dept Neuroimaging, Inst Psychiat Psychol & Neurosci, London, England; [Simmons, Andrew] South London & Maudsley Fdn NHS Trust, NIHR Biomed Res Ctr, London, England	University of London; King's College London; University of London; King's College London	Lim, L (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Child & Adolescent Psychiat, London, England.	lena.lim@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Hassan, Randa/AAW-3624-2021; Rubia, Katya/H-7497-2012	Simmons, Andrew/0000-0003-2306-5811; Rubia, Katya/0000-0002-1410-7701; Lim, Lena/0000-0002-3301-923X	Reta Lila Weston Trust for Medical Research; National Medical Research Council; UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London	Reta Lila Weston Trust for Medical Research; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London; Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London	This study, HH and LL were supported by the Reta Lila Weston Trust for Medical Research. LL was also supported by the National Medical Research Council. AS and KR were supported by the UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and the Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London.; This study, HH and LL were supported by the Reta Lila Weston Trust for Medical Research. LL was also supported by the National Medical Research Council. AS and KR were supported by the UK Department of Health via the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) for Mental Health at South London and the Maudsley NHS Foundation Trust and Institute of Psychiatry, Psychology and Neuroscience, King's College London. We thank all the individuals and their families who participated in this study. We also thank Dr. Kaylita Chantiluke and Miss Sinead King for their assistance with data collection as well as the staff of Kids Company London for their help with recruitment.	Ackerman PT, 1998, CHILD ABUSE NEGLECT, V22, P759, DOI 10.1016/S0145-2134(98)00062-3; Ardekani BA, 2002, COGNITIVE BRAIN RES, V14, P347, DOI 10.1016/S0926-6410(02)00137-4; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beers SR, 2002, AM J PSYCHIAT, V159, P483, DOI 10.1176/appi.ajp.159.3.483; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bledowski C, 2004, NEUROIMAGE, V22, P530, DOI 10.1016/j.neuroimage.2003.12.034; Bremner JD, 2001, DEV PSYCHOPATHOL, V13, P473, DOI 10.1017/S0954579401003042; Bucker J, 2012, COMPR PSYCHIAT, V53, P758, DOI 10.1016/j.comppsych.2011.12.006; Carrion VG, 2008, DEPRESS ANXIETY, V25, P514, DOI 10.1002/da.20346; Choi J, 2012, NEUROIMAGE, V59, P1071, DOI 10.1016/j.neuroimage.2011.09.033; Choi J, 2009, BIOL PSYCHIAT, V65, P227, DOI 10.1016/j.biopsych.2008.06.022; Christakou A, 2013, MOL PSYCHIATR, V18, P236, DOI 10.1038/mp.2011.185; CLAUSSEN AH, 1991, CHILD ABUSE NEGLECT, V15, P5, DOI 10.1016/0145-2134(91)90085-R; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Currie CE, 1997, HEALTH EDUC RES, V12, P385, DOI 10.1093/her/12.3.385; Dannlowski U, 2012, BIOL PSYCHIAT, V71, P286, DOI 10.1016/j.biopsych.2011.10.021; De Bellis MD, 2009, J INT NEUROPSYCH SOC, V15, P868, DOI 10.1017/S1355617709990464; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; DePrince AP, 2009, CHILD ABUSE NEGLECT, V33, P353, DOI 10.1016/j.chiabu.2008.08.002; Edmiston EE, 2011, ARCH PEDIAT ADOL MED, V165, P1069, DOI 10.1001/archpediatrics.2011.565; Edwards VJ, 2003, AM J PSYCHIAT, V160, P1453, DOI 10.1176/appi.ajp.160.8.1453; Elton A, 2014, HUM BRAIN MAPP, V35, P1654, DOI 10.1002/hbm.22280; Eluvathingal TJ, 2006, PEDIATRICS, V117, P2093, DOI 10.1542/peds.2005-1727; Feiring C, 1996, CHILD ABUSE NEGLECT, V20, P767, DOI 10.1016/0145-2134(96)00064-6; FINKELHOR D, 1985, AM J ORTHOPSYCHIAT, V55, P530, DOI 10.1111/j.1939-0025.1985.tb02703.x; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Friston KJ, 2006, NEUROIMAGE, V30, P1077, DOI 10.1016/j.neuroimage.2005.08.012; Fuller-Thomson E, 2014, J AGGRESS MALTREAT T, V23, P188, DOI 10.1080/10926771.2014.873510; Geoffroy MC, 2016, J AM ACAD CHILD PSY, V55, P33, DOI 10.1016/j.jaac.2015.10.012; Gibb BE, 2009, CHILD MALTREATMENT, V14, P148, DOI 10.1177/1077559508326358; Goodman R, 2000, J CHILD PSYCHOL PSYC, V41, P645, DOI 10.1017/S0021963099005909; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Gould F, 2012, J PSYCHIATR RES, V46, P500, DOI 10.1016/j.jpsychires.2012.01.005; Hanson JL, 2012, J NEUROSCI, V32, P7917, DOI 10.1523/JNEUROSCI.0307-12.2012; Hart H, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00052; Heim CM, 2013, AM J PSYCHIAT, V170, P616, DOI 10.1176/appi.ajp.2013.12070950; Herrenkohl TI, 2013, J FAM VIOLENCE, V28, P191, DOI 10.1007/s10896-012-9474-9; Huang H, 2012, NEUROPSYCHOPHARMACOL, V37, P2693, DOI 10.1038/npp.2012.133; Kremer I, 2016, ARCH SUICIDE RES, P1; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Lawrence NS, 2003, J COGNITIVE NEUROSCI, V15, P1028, DOI 10.1162/089892903770007416; Lewis T, 2016, CHILD ABUSE NEGLECT, V51, P31, DOI 10.1016/j.chiabu.2015.11.016; Lim L, 2015, AM J PSYCHIAT, V172, P892, DOI 10.1176/appi.ajp.2015.14081042; Lim L, 2014, AM J PSYCHIAT, V171, P854, DOI 10.1176/appi.ajp.2014.13101427; Loman MM, 2013, J CHILD PSYCHOL PSYC, V54, P37, DOI 10.1111/j.1469-7610.2012.02602.x; Lopez-Castroman J, 2013, WORLD PSYCHIATRY, V12, P149, DOI 10.1002/wps.20039; MacMillan HL, 2013, CHILD ABUSE NEGLECT, V37, P14, DOI 10.1016/j.chiabu.2012.06.005; Maheu FS, 2010, COGN AFFECT BEHAV NE, V10, P34, DOI 10.3758/CABN.10.1.34; Masten CL, 2008, CHILD ABUSE NEGLECT, V32, P139, DOI 10.1016/j.chiabu.2007.09.006; McCrory Eamon, 2011, Front Psychiatry, V2, P48, DOI 10.3389/fpsyt.2011.00048; McCrory E, 2010, J CHILD PSYCHOL PSYC, V51, P1079, DOI 10.1111/j.1469-7610.2010.02271.x; McCrory EJ, 2013, BRIT J PSYCHIAT, V202, P269, DOI 10.1192/bjp.bp.112.116624; McCrory EJ, 2011, CURR BIOL, V21, pR947, DOI 10.1016/j.cub.2011.10.015; McDermott JM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00167; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Mills R, 2011, PEDIATRICS, V127, P4, DOI 10.1542/peds.2009-3479; Miyake Y, 2004, ACTA NEUROBIOL EXP, V64, P415; Mueller SC, 2010, NEUROPSYCHOLOGIA, V48, P3037, DOI 10.1016/j.neuropsychologia.2010.06.013; Murphy CM, 2014, AM J PSYCHIAT, V171, P1107, DOI 10.1176/appi.ajp.2014.12030352; National Society for the Prevention of Cruelty to Children (NSPCC), 2011, CHILD ABUSE NEGLECT; NEY PG, 1994, CHILD ABUSE NEGLECT, V18, P705, DOI 10.1016/0145-2134(94)00037-9; Nolin P, 2007, CHILD ABUSE NEGLECT, V31, P631, DOI 10.1016/j.chiabu.2006.12.009; Norman RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001349; Ouyang LJ, 2008, J PEDIATR-US, V153, P851, DOI 10.1016/j.jpeds.2008.06.002; Pechtel P, 2011, PSYCHOPHARMACOLOGY, V214, P55, DOI 10.1007/s00213-010-2009-2; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; Pollak SD, 2005, CHILD DEV, V76, P968, DOI 10.1111/j.1467-8624.2005.00890.x; Pollak SD, 2010, CHILD DEV, V81, P224, DOI 10.1111/j.1467-8624.2009.01391.x; Raine A, 2001, AGGRESSIVE BEHAV, V27, P111, DOI 10.1002/ab.4; Read J, 2003, PSYCHOL PSYCHOTHER-T, V76, P1, DOI 10.1348/14760830260569210; Rubia K, 1998, NEUROPSYCHOLOGIA, V36, P1283, DOI 10.1016/S0028-3932(98)00038-4; Rubia K, 2013, EUR CHILD ADOLES PSY, V22, P719, DOI 10.1007/s00787-012-0291-8; Rubia K, 2009, NEUROPHARMACOLOGY, V57, P640, DOI 10.1016/j.neuropharm.2009.08.013; Rubia K, 2009, AM J PSYCHIAT, V166, P83, DOI 10.1176/appi.ajp.2008.08020212; Sarter M, 2001, BRAIN RES REV, V35, P146, DOI 10.1016/S0165-0173(01)00044-3; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shackman JE, 2007, EMOTION, V7, P838, DOI 10.1037/1528-3542.7.4.838; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Shonkoff JP, 2012, PEDIATRICS, V129, pE232, DOI 10.1542/peds.2011-2663; Smith AB, 2011, NEUROIMAGE, V56, P1693, DOI 10.1016/j.neuroimage.2011.01.072; Squire RF, 2013, ANNU REV NEUROSCI, V36, P451, DOI 10.1146/annurev-neuro-062111-150439; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Sugaya L, 2012, J TRAUMA STRESS, V25, P384, DOI 10.1002/jts.21719; Tana MG, 2010, COMPUTATIONAL INTELL; Taylor SE, 2006, BIOL PSYCHIAT, V60, P296, DOI 10.1016/j.biopsych.2005.09.027; Teicher MH, 1997, ANN NY ACAD SCI, V821, P160, DOI 10.1111/j.1749-6632.1997.tb48277.x; Tekin A, 2016, NORD J PSYCHIAT, V70, P88, DOI 10.3109/08039488.2015.1053097; Tottenham N, 2011, DEVELOPMENTAL SCI, V14, P190, DOI 10.1111/j.1467-7687.2010.00971.x; Trickett PK, 2011, CHILD ABUSE NEGLECT, V35, P876, DOI 10.1016/j.chiabu.2011.08.001; TRICKETT PK, 1995, DEV REV, V15, P311, DOI 10.1006/drev.1995.1012; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Weierich MR, 2008, J CONSULT CLIN PSYCH, V76, P39, DOI 10.1037/0022-006X.76.1.39; White MG, 2012, GENES BRAIN BEHAV, V11, P869, DOI 10.1111/j.1601-183X.2012.00837.x; Young JC, 2014, CHILD ABUSE NEGLECT, V38, P1369, DOI 10.1016/j.chiabu.2014.03.008; Zelazo PD, 2004, ACTA PSYCHOL, V115, P167, DOI 10.1016/j.actpsy.2003.12.005	97	18	18	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165547	10.1371/journal.pone.0165547	http://dx.doi.org/10.1371/journal.pone.0165547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832090	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000019
J	Fernandez-Verdejo, R; Vanwynsberghe, AM; Essaghir, A; Demoulin, JB; Hai, T; Deldicque, L; Francaux, M				Fernandez-Verdejo, Rodrigo; Vanwynsberghe, Aline M.; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Hai, Tsonwin; Deldicque, Louise; Francaux, Marc			Activating transcription factor 3 attenuates chemokine and cytokine expression in mouse skeletal muscle after exercise and facilitates molecular adaptation to endurance training	FASEB JOURNAL			English	Article						inflammation; microarray; phenotype	ADAPTIVE-RESPONSE GENE; NEGATIVE REGULATOR; ATF3; MECHANISMS; BIOLOGY; STRESS; INFLAMMATION; METABOLISM; MACROPHAGE; RESISTANCE	Activating transcription factor (ATF)3 regulates the expression of inflammation-related genes in several tissues under pathological contexts. In skeletal muscle, atf3 expression increases after exercise, but its target genes remain unknown. We aimed to identify those genes and to determine the influence of ATF3 on muscle adaptation to training. Skeletal muscles of ATF3-knockout (ATF3-KO) and control mice were analyzed at rest, after exercise, and after training. In resting muscles, there was no difference between genotypes in enzymatic activities or fiber type. After exercise, a microarray analysis in quadriceps revealed ATF3 affects genes modulating chemotaxis and chemokine/cytokine activity. Quantitative PCR showed that the mRNA levels of chemokine C-C motif ligand (ccl)8 and chemokine C-X-C motif ligand (cxcl)13 were higher in quadriceps of ATF3-KO mice than in control mice. The same was observed for ccl9 and cxcl13 in soleus. Also in soleus, ccl2, interleukin (il)6, il1, and cluster of differentiation (cd)68 mRNA levels increased after exercise only in ATF3-KO mice. Endurance training increased the basal mRNA level of hexokinase-2, hormone sensitive lipase, glutathione peroxidase-1, and myosin heavy chain IIa in quadriceps of control mice but not in ATF3-KO mice. In summary, ATF3 attenuates the expression of inflammation-related genes after exercise and thus facilitates molecular adaptation to training.	[Fernandez-Verdejo, Rodrigo; Vanwynsberghe, Aline M.; Deldicque, Louise; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Brussels, Belgium; [Hai, Tsonwin] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	Universite Catholique Louvain; Universite Catholique Louvain; University System of Ohio; Ohio State University	Francaux, M (corresponding author), Pl Pierre Coubertin 1,Bte L8-10-01, B-1348 Louvain, Belgium.	marc.francaux@uclouvain.be	Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Francaux, Marc/0000-0001-8182-1588; Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281; Deldicque, Louise/0000-0003-3393-5278	Belgian Fonds National de la Recherche Scientifique (FSR-FNRS) [23628981]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)	Belgian Fonds National de la Recherche Scientifique (FSR-FNRS)(Fonds de la Recherche Scientifique - FNRS); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Belgian Fonds National de la Recherche Scientifique (FSR-FNRS, No. 23628981) and by funds from the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) (to R.F.-V.). The authors thank Damien Naslain (Universite Catholique de Louvain) for technical assistance and Tijs Vandoorne (Katholieke Universiteit Leuven, Leuven, Belgium) for collaboration with the fiber typing method.	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Nguyen CT, 2014, J INFECT DIS, V210, P1745, DOI 10.1093/infdis/jiu352; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077788; LaFramboise WA, 2009, AM J PHYSIOL-CELL PH, V297, pC556, DOI 10.1152/ajpcell.00046.2009; Lai P. F., 2013, EVID-BASED COMPL ALT, V2013; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; MacNeil LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010695; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; McKenzie MJ, 2007, MED SCI SPORT EXER, V39, P1515, DOI 10.1249/mss.0b013e318074c256; McKenzie MJ, 2011, J SPORT SCI MED, V10, P385; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Porter JD, 2003, NEUROMUSCULAR DISORD, V13, P223, DOI 10.1016/S0960-8966(02)00242-0; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rodriguez J, 2016, MED SCI SPORT EXER, V48, P227, DOI 10.1249/MSS.0000000000000756; Samaan MC, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12012; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Zbinden-Foncea H, 2012, MED SCI SPORT EXER, V44, P1463, DOI 10.1249/MSS.0b013e31824e0d5d; Zhou H, 2014, INT J CARDIOL, V174, P838, DOI 10.1016/j.ijcard.2014.04.160; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	56	20	20	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					840	851		10.1096/fj.201600987R	http://dx.doi.org/10.1096/fj.201600987R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27856557	Green Submitted			2022-12-26	WOS:000394235400035
J	Bahamonde, PA; McMaster, ME; Servos, MR; Martyniuk, CJ; Munkittrick, KR				Bahamonde, Pauline A.; McMaster, Mark E.; Servos, Mark R.; Martyniuk, Christopher J.; Munkittrick, Kelly R.			Characterizing Transcriptional Networks in Male Rainbow Darter (Etheostoma caeruleum) that Regulate Testis Development over a Complete Reproductive Cycle	PLOS ONE			English	Article							MUNICIPAL WASTE-WATER; MEDAKA ORYZIAS-LATIPES; SEXUAL DISRUPTION; FISH; 17-BETA-ESTRADIOL; SPERMATOGENESIS; EXPRESSION; MATURATION; EFFLUENTS	Intersex is a condition that has been associated with exposure to sewage effluents in male rainbow darter (Etheostoma caeruleum). To better understand changes in the transcriptome that are associated with intersex, we characterized annual changes in the testis transcriptome in wild, unexposed fish. Rainbow darter males were collected from the Grand River (Ontario, Canada) in May (spawning), August (post-spawning), October (recrudescence), January (developing) and March (pre-spawning). Histology was used to determine the proportion of spermatogenic cell types that were present during each period of testicular maturation. Regression analysis determined that the proportion of spermatozoa versus spermatocytes in all stages of development (R-2 >= 0.58) were inversely related; however this was not the case when males were in the post-spawning period. Gene networks that were specific to the transition from developing to pre-spawning stages included nitric oxide biosynthesis, response to wounding, sperm cell function, and stem cell maintenance. The pre-spawning to spawning transition included gene networks related to amino acid import, glycogenesis, Sertoli cell proliferation, sperm capacitation, and sperm motility. The spawning to post-spawning transition included unique gene networks associated with chromosome condensation, ribosome biogenesis and assembly, and mitotic spindle assembly. Lastly, the transition from post-spawning to recrudescence included gene networks associated with egg activation, epithelial to mesenchymal transition, membrane fluidity, and sperm cell adhesion. Noteworthy was that there were a significant number of gene networks related to immune system function that were differentially expressed throughout reproduction, suggesting that immune network signalling has a prominent role in the male testis. Transcripts in the testis of post-spawning individuals showed patterns of expression that were most different for the majority of transcripts investigated when compared to the other stages. Interestingly, many transcripts associated with female sex differentiation (i.e. esr1, sox9, cdca8 and survivin) were significantly higher in the testis during the post-spawning season compared to other testis stages. At post-spawning, there were higher levels of estrogen and androgen receptors (esr1, esr2, ar) in the testis, while there was a decrease in the levels of sperm associated antigen 1 (spag1) and spermatogenesis associated 4 (spata4) mRNA. Cyp17a was more abundant in the testis of fish in the pre-spawning, spawning, and post-spawning seasons compared to those individuals that were recrudescent while aromatase (cyp19a) did not vary in expression over the year. This study identifies cell process related to testis development in a seasonally spawning species and improves our understanding regarding the molecular signaling events that underlie testicular growth. This is significant because, while there are a number of studies characterizing molecular pathways in the ovary, there are comparatively less describing transcriptomic patterns in the testis in wild fish.	[Bahamonde, Pauline A.; Martyniuk, Christopher J.; Munkittrick, Kelly R.] Univ New Brunswick, Canadian Rivers Inst, St John, NB, Canada; [Bahamonde, Pauline A.; Martyniuk, Christopher J.] Univ New Brunswick, Dept Biol, St John, NB, Canada; [McMaster, Mark E.] Environm Canada, Canada Ctr Inland Waters, Natl Water Res Inst, Aquat Contaminant Res Div, Burlington, ON, Canada; [Servos, Mark R.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada; [Bahamonde, Pauline A.] Fdn MERI, Beltran 2347, Santiago 7640392, Chile; [Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Dept Physiol Sci, UF Genet Inst, Gainesville, FL 32610 USA; [Martyniuk, Christopher J.] Univ Florida, Coll Vet Med, Ctr Environm & Human Toxicol, UF Genet Inst, Gainesville, FL USA	University of New Brunswick; University of New Brunswick; Environment & Climate Change Canada; Canada Centre for Inland Waters (CCIW); National Water Research Institute; University of Waterloo; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bahamonde, PA (corresponding author), Univ New Brunswick, Canadian Rivers Inst, St John, NB, Canada.; Bahamonde, PA (corresponding author), Univ New Brunswick, Dept Biol, St John, NB, Canada.; Bahamonde, PA (corresponding author), Fdn MERI, Beltran 2347, Santiago 7640392, Chile.	p.bahamondec@gmail.com	Munkittrick, Kelly/AAB-8929-2019	Bahamonde, Paulina/0000-0002-8880-8463; Martyniuk, Christopher J./0000-0003-0921-4796	Becas Chile [72120069]; Canadian Water Network [4033]; Canada Research Chairs; Natural Sciences and Engineering Research Council of Canada [238621-2011]	Becas Chile; Canadian Water Network; Canada Research Chairs(Canada Research ChairsCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Becas Chile (72120069); Canadian Water Network (4033); Canada Research Chairs; Natural Sciences and Engineering Research Council of Canada (238621-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahamonde PA, 2015, AQUAT TOXICOL, V159, P302, DOI 10.1016/j.aquatox.2014.11.022; Bahamonde PA, 2014, AQUAT TOXICOL, V148, P211, DOI 10.1016/j.aquatox.2014.01.010; Barrett TJ, 2010, ENVIRON REV, V18, P115, DOI 10.1139/A10-004; Bobe J, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-39; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cruz-Landim C, 2005, BRAZ J BIOL, V65, P241; Fuller RC, 1998, OHIO J SCI, V98, P2; Hook SE, 2011, ENVIRON TOXICOL CHEM, V30, P309, DOI 10.1002/etc.407; Jobling S, 1998, ENVIRON SCI TECHNOL, V32, P2498, DOI 10.1021/es9710870; Kang IJ, 2002, CHEMOSPHERE, V47, P71, DOI 10.1016/S0045-6535(01)00205-3; KIME DE, 1998, BESTIAIRE PLATON, V1st, DOI 10.1007/978-1-4615-4943-7; Kiros S, 2011, ICHTHYOL RES, V58, P217, DOI 10.1007/s10228-011-0213-7; Koger CS, 2000, MAR ENVIRON RES, V50, P201, DOI 10.1016/S0141-1136(00)00068-4; Liney KE, 2005, ENVIRON HEALTH PERSP, V113, P1299, DOI 10.1289/ehp.7921; Martyniuk CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059093; Martyniuk CJ, 2013, J PROTEOMICS, V79, P28, DOI 10.1016/j.jprot.2012.11.023; Martyniuk CJ, 2010, NEUROTOXICOLOGY, V31, P356, DOI 10.1016/j.neuro.2010.04.008; Mazurais D, 2005, GEN COMP ENDOCR, V142, P143, DOI 10.1016/j.ygcen.2005.02.018; Miura T, 2003, FISH PHYSIOL BIOCHEM, V28, P181, DOI 10.1023/B:FISH.0000030522.71779.47; MUNRO AD, 1990, REPROD SEASONALITY T; Nogueira-Ferreira R, 2013, ARCH BIOCHEM BIOPHYS, V538, P64, DOI 10.1016/j.abb.2013.07.027; Reading Benjamin J., 2012, BMC Research Notes, V5, P111, DOI 10.1186/1756-0500-5-111; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambroni E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076684; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Sreenivasan R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001791; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tetreault GR, 2014, ENVIRON TOXICOL CHEM, V33, P1077, DOI 10.1002/etc.2526; Tetreault GR, 2013, INTEGR ENVIRON ASSES, V9, P456, DOI 10.1002/ieam.1364; Tetreault GR, 2012, AQUAT TOXICOL, V110, P149, DOI 10.1016/j.aquatox.2012.01.004; Tetreault GR, 2012, RESPONSE WILD FISH M; Villeneuve DL, 2010, AQUAT TOXICOL, V98, P354, DOI 10.1016/j.aquatox.2010.03.006; Vlaming VL, 1972, J FISH BIOL, V4, P131	34	8	8	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0164722	10.1371/journal.pone.0164722	http://dx.doi.org/10.1371/journal.pone.0164722			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861489	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300004
J	Feng, B; Xiong, F; Liu, BY; Chen, J; Zhang, YP				Feng, Bo; Xiong, Feng; Liu, Bingyu; Chen, Jiang; Zhang, Yiping			Shear Performance of Horizontal Joints in Short Precast Concrete Columns with Sleeve Grouted Connections under Cyclic Loading	PLOS ONE			English	Article							STRENGTH	In this study, two short precast concrete columns and two cast-in-situ concrete columns were tested under cyclic loads. It was shown that the sleeve grouted connection was equivalent to the cast-in-situ connections for short columns when the axial compression ratio was 0.6. In order to determine the influence of the axial compression ratio and the shear-span ratio on the shear capacity of the horizontal joint, a FE model was established and verified. The analysis showed that the axial compression ratio is advantageous to the joint and the shear capacity of the horizontal joint increases with increase of the shear-span ratio. Based on the results, the methods used to estimate the shear capacity of horizontal joints in the Chinese Specification and the Japanese Guidelines are discussed and it was found that both overestimated the shear capacity of the horizontal joint. In addition, the Chinese Specification failed to consider the influence of the shear-span ratio.	[Feng, Bo; Xiong, Feng; Liu, Bingyu; Chen, Jiang] Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan Provinc, Peoples R China; [Zhang, Yiping] Sichuan Prov Architectural Design & Res Inst, Chengdu, Sichuan Provinc, Peoples R China; [Liu, Bingyu] JiZunFangZhong Architecture Design Co Ltd, Chengdu, Sichuan Provinc, Peoples R China	Sichuan University	Xiong, F (corresponding author), Sichuan Univ, Coll Architecture & Environm, Chengdu, Sichuan Provinc, Peoples R China.	fxiong@scu.edu.cn			National Key Research Program of China [2016YFC0701400]	National Key Research Program of China	This work was supported by National Key Research Program of China (Grant No.2016YFC0701400, http://www.most.gov.cn/). The founder provided support in the form of salaries for authors and the research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions' section".	[Anonymous], 2013, ABAQUS 6 12 ANAL USE; [Anonymous], 2008, STRUCT CONN PREC CON; [Anonymous], 2013, ABAQUS 6 12 ANAL USE; [Anonymous], 2013, ABAQUS 6 12 ANAL USE; Architectural Institute of Japan, 2002, AIJ GUID STRUCT DES; Belleri A, 2012, PCI J, P97; Bennett E. W., 1976, STRUCTURAL ENG LONDO, V54, P133; Choi HK, 2013, ENG STRUCT, V56, P1820, DOI 10.1016/j.engstruct.2013.07.021; Cordebois J P, 1982, MECH BEHAV ANISOTROP, P761, DOI DOI 10.1007/978-94-009-6827-1_44; Housing and Urban-rural Development of the People's Republic of China, 2010, COD DES CONCR STRUCT; Housing and Urban-rural Development of the People's Republic of China, 2014, TECHN SPEC PREC CONC; Housing and Urban-rural Development of the People's Republic of China, 2010, COD SEISM DES BUILD; Loov R. E., 1994, PCI J, V39, P48, DOI [10.15554/pcij.01011994.48.69, DOI 10.15554/PCIJ.01011994.48.69]; Mansur MA, 2008, J MATER CIVIL ENG, V20, P294, DOI 10.1061/(ASCE)0899-1561(2008)20:4(294); Park R., 1991, REINFORCED CONCRETE; Restrepo-Posada J. I., 1992, THESIS; Rizkalla SH, 1989, PCI J, V34, P104, DOI 10.15554/pcij.03011989.104.120; Walraven J. C, 1987, PCI J, V32, P66; WANG QX, 1995, NUCL ENG DES, V156, P75, DOI 10.1016/0029-5493(94)00936-S; Yee AA, 2001, PCI J, V46, P34, DOI 10.15554/pcij.07012001.34.42; Zhang WH, 2011, CONTINUUM DAMAGE MEC	21	4	5	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165988	10.1371/journal.pone.0165988	http://dx.doi.org/10.1371/journal.pone.0165988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861493	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300018
J	Boal, EP; Vallejo, RBD; Rodriguez, MF; Lopez, DL; Iglesias, MEL				Perez Boal, Eduardo; de Bengoa Vallejo, Ricardo Becerro; Fuentes Rodriguez, Miguel; Lopez Lopez, Daniel; Losa Iglesias, Marta Elena			Geometry of the Proximal Phalanx of Hallux and First Metatarsal Bone to Predict Hallux Abducto Valgus: A Radiological Study	PLOS ONE			English	Article							RADIOGRAPHIC ANALYSIS; INTRACLASS CORRELATIONS; FOOT; RELIABILITY; SIZE; POPULATION; PREVALENCE	Background Hallux abducto valgus (HAV) is one of the most common forefoot deformities in adulthood with a variable prevalence but has been reported as high as 48%. The study proposed that HAV development involves a skeletal parameter of the first metatarsal bone and proximal phalanx hallux (PPH) to determine if the length measurements of the metatarsal and PPH can be used to infer adult HAV. Methods All consecutive patients over 21 years of age with HAV by roentgenographic evaluation were included in a cross-sectional study. The control group included patients without HAV. The study included 160 individuals. We identified and assessed the following radiographic measurements to evaluate HAV: the distances from the medial (LDM), central (LDC), and lateral (LDL) aspects of the base to the corresponding regions of the head of the PPH. The difference between the medial and lateral aspect of PPH was also calculated. Results The reliability of the variables measured in 40 radiographic films show perfect reliability ranging from 0.941 to 1 with a small error ranging from 0.762 to 0. Also, there were no systematic errors between the two measurements for any variable (P > 0.05). The LDM PPH showed the highest reliability and lowest error. Conclusion It is more suitable to measure the LDM PPH instead of the LDC PPH when calculating the hallux valgus angle based on our reliability results. When the differences of the medial and lateral PPH are greater, the risk for developing HAV increases.	[Perez Boal, Eduardo; Fuentes Rodriguez, Miguel; Losa Iglesias, Marta Elena] Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain; [de Bengoa Vallejo, Ricardo Becerro] Univ Complutense Madrid, Fac Enfermeria Fisioterapia & Podol, Madrid, Spain; [Lopez Lopez, Daniel] Univ A Coruna, Fac Nursing & Podiatry, Dept Hlth Sci, Res Hlth & Podiatry Unit, Coruna, Spain	Universidad Rey Juan Carlos; Complutense University of Madrid; Universidade da Coruna	Iglesias, MEL (corresponding author), Univ Rey Juan Carlos, Fac Ciencias Salud, Madrid, Spain.	marta.losa@urjc.es	López-López, Daniel/K-9182-2013; Iglesias, Marta E Losa/B-8830-2009; Perez Boal, Eduardo/GLS-8297-2022; de Bengoa Vallejo, Ricardo Becerro/P-4153-2019	López-López, Daniel/0000-0002-9818-6290; Iglesias, Marta E Losa/0000-0001-7588-2069; Perez Boal, Eduardo/0000-0002-1242-3831	Ministry of Economy and competitiveness of the Government of Spain [DPI2013-44987-R]	Ministry of Economy and competitiveness of the Government of Spain(Spanish Government)	The authors gratefully acknowledge the support of the Ministry of Economy and competitiveness of the Government of Spain through the project DPI2013-44987-R.; The authors gratefully acknowledge the support of the Ministry of Economy and competitiveness of the Government of Spain through the project DPI2013-44987-R	Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Bonett DG, 2002, STAT MED, V21, P1331, DOI 10.1002/sim.1108; BONNEY G, 1952, J BONE JOINT SURG BR, V34, P366, DOI 10.1302/0301-620X.34B3.366; Bruton A, 2000, PHYSIOTHERAPY, V86, P94, DOI [10.1016/S0031-9406(05)61211-4, DOI 10.1016/S0031-9406(05)61211-4, 10.1016/s0031-9406(05)61211-4]; Bryant A, J FOOT ANKLE SURG, V39, P39; CAMASTA CA, 1991, J AM PODIAT MED ASSN, V81, P545, DOI 10.7547/87507315-81-10-545; Christman RA, 2001, J AM PODIAT MED ASSN, V91, P294, DOI 10.7547/87507315-91-6-294; Coughlin M J, 1997, Instr Course Lect, V46, P357; Coughlin Michael J, 2014, SURG FOOT ANKLE, P1546; Coughlin MJ, 1995, AAOS INSTR COURS LEC, V44, P371; Coughlin MJ, 2002, FOOT ANKLE INT, V23, P68, DOI 10.1177/107110070202300114; COUGHLIN MJ, 1995, FOOT ANKLE INT, V16, P682, DOI 10.1177/107110079501601104; Vallejo RBD, 2012, J FOOT ANKLE SURG, V51, P729, DOI 10.1053/j.jfas.2012.06.004; Dykyj D, 1989, Clin Podiatr Med Surg, V6, P1; ELLIS VH, 1951, J BONE JOINT SURG BR, V33, P415, DOI 10.1302/0301-620X.33B3.415; Ferrari J, 2004, J AM PODIAT MED ASSN, V94, P434, DOI 10.7547/0940434; GLANNESTRAS NJ, 1979, TRASTORNOS PIE, P345; GOTTSCHALK FAB, 1980, S AFR MED J, V57, P355; HARDY RH, 1951, J BONE JOINT SURG BR, V33, P376, DOI 10.1302/0301-620X.33B3.376; HEDEN RI, 1981, J AM POD ASSOC, V71, P200, DOI 10.7547/87507315-71-4-200; Herring J. A., 2013, DISORDERS LEG; JOHNSTON O, 1956, Clin Orthop, V8, P146; KATO T, 1981, CLIN ORTHOP RELAT R, P78; KILMARTIN TE, 1994, J BONE JOINT SURG BR, V76B, P210, DOI 10.1302/0301-620X.76B2.8113278; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laporta DM, 1994, PREOPERATIVE ASSESSM, P107; Laporta G, 1974, J Am Podiatry Assoc, V64, P544; Lee KM, 2012, CLIN ORTHOP RELAT R, V470, P2613, DOI 10.1007/s11999-012-2368-6; Lelievre J, 1982, PATOLOG PIE FISIOLOG, P1; LUNDBERG BJ, 1972, ACTA ORTHOP SCAND, V43, P576, DOI 10.3109/17453677208991280; Mancuso John E, 2003, J Foot Ankle Surg, V42, P319, DOI 10.1053/j.jfas.2003.09.001; MANN RA, 1981, CLIN ORTHOP RELAT R, P31; MCCREA JD, 1977, J AM POD ASSOC, V67, P837, DOI 10.7547/87507315-67-12-837; Morales-Orcajo E, 2015, MED BIOL ENG COMPUT, V53, P645, DOI 10.1007/s11517-015-1260-4; Munuera PV, 2008, INT ORTHOP, V32, P489, DOI 10.1007/s00264-007-0350-9; Munuera PV, 2007, J AM PODIAT MED ASSN, V97, P460, DOI 10.7547/0970460; Nix S, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-21; Park MS, 2010, J BONE JOINT SURG AM, V92A, P1732, DOI 10.2106/JBJS.I.00724; Rankin G, 1998, CLIN REHABIL, V12, P187, DOI 10.1191/026921598672178340; Root ML, 1977, NORMAL ABNORMAL FUNC, P478; Roukis Thomas S, 2005, J Foot Ankle Surg, V44, P13, DOI 10.1053/j.jfas.2004.11.012; SALTZMAN CL, 1994, FOOT ANKLE INT, V15, P661, DOI 10.1177/107110079401501206; SHIMAZAKI K, 1981, Kobe Journal of Medical Sciences, V27, P139; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; SIMFOOK L, 1958, J BONE JOINT SURG AM, V40, P1058, DOI 10.2106/00004623-195840050-00007; SMITH RW, 1984, FOOT ANKLE, V5, P92, DOI 10.1177/107110078400500208; Steel M W 3rd, 1980, Foot Ankle, V1, P151; TANAKA Y, 1995, J BONE JOINT SURG AM, V77A, P205, DOI 10.2106/00004623-199502000-00006; Tanaka Y, 1997, CLIN ORTHOP RELAT R, P186; Viladot A, 1973, Orthop Clin North Am, V4, P165; Wu K K, 1987, J Foot Surg, V26, P277	51	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166197	10.1371/journal.pone.0166197	http://dx.doi.org/10.1371/journal.pone.0166197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861517	Green Published, gold			2022-12-26	WOS:000388350300035
J	Wang, JF; Xu, YZ; Zhe, LS; Zou, Y; Kong, W; Dong, BJ; Huang, JW; Chen, YH; Xue, W; Huang, YR; Zhang, J				Wang, Jianfeng; Xu, Yunze; Zhe, Liangsong; Zou, Yun; Kong, Wen; Dong, Baijun; Huang, Jiwei; Chen, Yonghui; Xue, Wei; Huang, Yiran; Zhang, Jin			High Expression of Stearoyl-CoA Desaturase 1 Predicts Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							INTEGRATED STAGING SYSTEM; TARGETED THERAPIES; LIPID-METABOLISM; THERAPEUTIC TARGET; CANCER; SURVIVAL; LIPOGENESIS; MECHANISMS; DEATH	Stearoyl-CoA desaturase 1 (SCD1), the rate-limiting enzymes in the biosynthesis of mono-unsaturated fatty acids from saturated fatty acids, have been gradually recognized as a potential therapeutic target for various malignancies, particularly in clear-cell renal cell carcinoma (ccRCC). However, the prognostic value of SCD1 in ccRCC is still unknown. The aim of this study is to evaluate the clinical significance of SCD1 expression in patients with ccRCC. SCD1 expression in tumor tissues obtained from 359 patients who underwent nephrectomy for ccRCC are retrospectively assessed. During a median follow-up of 63 months (range: 1-144month), 56 patients in total died before the last follow-up in this study. Survival curves were plotted with the Kaplan-Meier method and compared with the log-rank test. Meanwhile, univariate and multivariate Cox regression models were applied to evaluate the prognostic value of SCD1 expression in overall survival (OS) for ccRCC patients. Moreover, SCD1 was enrolled into a newly built nomogram with factors selected by multivariate analysis, and the calibration was built to evaluate the predictive accuracy of nomogram. High SCD1 expression occurred in 61.6% (221/359) of ccRCC patients, which was significantly associated with age (p = 0.030), TNM stage (p = 0.021), pN stage (p = 0.014), Fuhrman grade (p = 0.014) and tumor sizes (p = 0.040). In multivariate analysis, SCD1 expression was confirmed as an adverse independent prognostic factor for OS. The prognostic accuracy of TNM stage, Fuhrman grade and tumor sizes was significantly increased when SCD1 expression was added. The independent prognostic factors, pT stage, pN stage, Fuhrman grade and tumor sizes, as well as SCD1 expression were integrated to establish a predictive nomogram with high predictive accuracy. Calibration curves revealed optimal consistency between observations and prognosis. In conclusion, high SCD1 expression is an independent prognostic factor for OS in patients with ccRCC. Our data suggest that the expression of SCD1 might guide the clinical decisions for patients with ccRCC.	[Wang, Jianfeng; Xu, Yunze; Zhe, Liangsong; Zou, Yun; Kong, Wen; Dong, Baijun; Huang, Jiwei; Chen, Yonghui; Xue, Wei; Huang, Yiran; Zhang, Jin] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai, Peoples R China	Shanghai Jiao Tong University	Huang, YR; Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai, Peoples R China.	med-zhangjin@vip.sina.com; huangyrrenji@163.com	Kong, Wen/GQH-3057-2022		National Natural Science Foundation of China [81472378, 81272841, 91129725]; Shanghai Committee of Science and Technology [13ZR1425100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by National Natural Science Foundation of China (No. 81472378, No. 81272841, and No. 91129725), and Shanghai Committee of Science and Technology (13ZR1425100). All these study sponsors have no roles in the study design, in the collection, analysis, and interpretation of data.; This work was supported by National Natural Science Foundation of China (No. 81472378, No. 81272841, No. 91129725), Shanghai Committee of Science and Technology (13ZR1425100). All these study sponsors have no roles in the study design, in the collection, analysis, and interpretation of data.	Adibi M, 2015, UROL ONCOL-SEMIN ORI, V33, P528, DOI 10.1016/j.urolonc.2015.10.003; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; Dobrzyn P, 2015, PROG LIPID RES, V57, P1, DOI 10.1016/j.plipres.2014.11.003; Eisen T, 2012, JNCI-J NATL CANCER I, V104, P93, DOI 10.1093/jnci/djr511; Ferreri C, 2012, EXPERT REV MOL DIAGN, V12, P767, DOI [10.1586/erm.12.73, 10.1586/ERM.12.73]; Ficarra V, 2009, BJU INT, V103, P165, DOI 10.1111/j.1464-410X.2008.07901.x; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Huang CF, 2015, INT J MOL SCI, V16, P924, DOI 10.3390/ijms16010924; Huang J., 2016, ONCOTARGET; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Kucharski M, 2014, POSTEP HIG MED DOSW, V68, P334, DOI 10.5604/17322693.1095856; Leung JY, 2013, CLIN CANCER RES, V19, P3111, DOI 10.1158/1078-0432.CCR-13-0800; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Minguet J, 2015, CANCER CHEMOTH PHARM, V76, P219, DOI 10.1007/s00280-015-2770-3; Mounier C, 2014, INT J ONCOL, V45, P485, DOI 10.3892/ijo.2014.2441; Ng CF, 2007, INT UROL NEPHROL, V39, P699, DOI 10.1007/s11255-006-9134-1; Poloni Soraia, 2015, Biology-Basel, V4, P383, DOI 10.3390/biology4020383; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soulieres D, 2013, CURR OPIN SUPPORT PA, V7, P254, DOI 10.1097/SPC.0b013e3283644c30; Takahashi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078250; Vargas T, 2015, ONCOTARGET, V6, P7348, DOI 10.18632/oncotarget.3130; von Roemeling CA, 2013, CLIN CANCER RES, V19, P2368, DOI 10.1158/1078-0432.CCR-12-3249; Xing TY, 2016, CHINESE J CANCER RES, V28, P80, DOI 10.3978/j.issn.1000-9604.2016.02.09; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zhang YD, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/705238	26	17	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166231	10.1371/journal.pone.0166231	http://dx.doi.org/10.1371/journal.pone.0166231			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861513	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300038
J	Wang, SH; Ming, YZ; Lin, PY; Wang, JY; Lin, HC; Hsieh, CE; Hsu, YL; Chen, YL				Wang, Szu-Han; Ming, Ying-Zi; Lin, Ping-Yi; Wang, Jiun-Yi; Lin, Hui-Chuan; Hsieh, Chia-En; Hsu, Ya-Lan; Chen, Yao-Li			Predictors of Diarrhea after Hepatectomy and Its Impact on Gastrointestinal Quality of Life in Living Donors	PLOS ONE			English	Article							HEPATIC LOBE DONATION; LIVER-TRANSPLANTATION; SINGLE-CENTER; FOLLOW-UP; CHOLECYSTECTOMY; INDEX	Background Donor safety and preservation of donor health after living liver donation are of paramount importance. Diarrhea has a significant influence on gastrointestinal quality of life among donors who have undergone living donor hepatectomy. Thus, we aimed to investigate predictors of diarrhea after hepatectomy and its impact on gastrointestinal quality of life in living donors. Methods We retrospectively examined the medical records of 204 living liver donors who underwent hepatectomy during the period January 2010 to June 2013 at a single medical center. Diarrhea was defined as the passing of three or more liquid stools per day. The Chinese version of the Gastrointestinal Quality of Life Index (GIQLI) was used to assess the influence of diarrhea on quality of life in donors. Results During the study period, diarrhea was diagnosed in 62 (30.3%) of the 204 donors and the duration of diarrhea in the majority of them (n = 46, 74%) was <12 months. Risk factors associated with diarrhea included age [risk ratio (RR) = 0.84, 95% confidence interval (CI): 0.79-0.89, risk difference = 16%], and chronic cholecystitis (RR = 0.48, 95% CI: 0.24-0.99, risk difference = 52%). Compared to donors without diarrhea, donors with diarrhea had lower GIQLI scores in the following GIQLI domains: GI symptoms (1.8 vs. 3.6), physical function (2.1 vs. 3.5), emotional function (3.0 vs. 3.6), social function (3.3 vs. 3.7), and treatment reaction (2.6 vs. 3.7). Conclusions Our findings show that younger donors and those without chronic cholecystitis are at increased risk for diarrhea after living donor hepatectomy and that diarrhea is associated with lower GIQLI scores after hepatectomy.	[Wang, Szu-Han; Hsieh, Chia-En; Hsu, Ya-Lan] Changhua Christian Hosp, Organ Transplant Ctr, Changhua, Taiwan; [Ming, Ying-Zi; Chen, Yao-Li] Cent S Univ, Xiangya Hosp 3, Transplantat Ctr, Changsha, Hunan, Peoples R China; [Chen, Yao-Li] Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan; [Wang, Jiun-Yi] Asia Univ, Dept Hlth Care Adm, Taichung, Taiwan; [Lin, Hui-Chuan] Hung Kuang Univ, Dept Senior Citizen Welf & Business, Taichung, Taiwan; [Chen, Yao-Li] Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan; [Chen, Yao-Li] Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan	Changhua Christian Hospital; Central South University; Changhua Christian Hospital; Asia University Taiwan; Hungkuang University; Changhua Christian Hospital; Kaohsiung Medical University	Chen, YL (corresponding author), Cent S Univ, Xiangya Hosp 3, Transplantat Ctr, Changsha, Hunan, Peoples R China.; Chen, YL (corresponding author), Changhua Christian Hosp, Transplant Med & Surg Res Ctr, Changhua, Taiwan.; Chen, YL (corresponding author), Changhua Christian Hosp, Dept Gen Surg, Changhua, Taiwan.; Chen, YL (corresponding author), Kaohsiung Med Univ, Sch Med, Kaohsiung, Taiwan.	31560@cch.org.tw						Bajor Judit, 2009, Orvosi Hetilap, V150, P1655, DOI 10.1556/OH.2009.28709; Barcia Juan Jose, 2003, Ann Diagn Pathol, V7, P147, DOI 10.1016/S1092-9134(03)00011-X; Cheah YL, 2013, LIVER TRANSPLANT, V19, P499, DOI 10.1002/lt.23575; Coelho JC, 2002, ARQ GASTROENTEROL, V42, P83; Dong-Wei X, 2015, INT J CLIN EXP MED, V8, P20; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Fisher M, 2008, ANZ J SURG, V78, P482, DOI 10.1111/j.1445-2197.2008.04539.x; Fort JM, 1996, GASTROENTEROLOGY, V111, P617, DOI 10.1053/gast.1996.v111.pm8780565; Heng-Hui L, 2007, J LAPAROENDOSC ADV S, V17, P429; Jia-Hong D, 2015, HEPATOL INT, V9, P603, DOI [10.1007/s12072-015-9628-y, DOI 10.1007/S12072-015-9628-Y]; Lauterio A, 2013, TRANSPL P, V45, P2680, DOI 10.1016/j.transproceed.2013.07.037; Marcello P, 2010, WORLD J GASTROENTERO, V14, P1171; Mullhaupt B., 2002, PRAXIS, V91, P1749, DOI [10.1024/0369-8394.91.42.1749, DOI 10.1024/0369-8394.91.42.1749]; Ozgor D, 2012, TRANSPL P, V44, P1604, DOI 10.1016/j.transproceed.2012.04.002; Parolin MB, 2004, TRANSPL P, V36, P912, DOI 10.1016/j.transproceed.2004.03.098; Sevmis S, 2007, TRANSPL P, V39, P826, DOI 10.1016/j.transproceed.2007.02.045; Sotiropoulos GC, 2011, ANN SURG, V254, P694, DOI 10.1097/SLA.0b013e31823594ae; Trotter JF, 2001, LIVER TRANSPLANT, V7, P485, DOI 10.1053/jlts.2001.24646; Tuan-Pin Y, 2014, ASIAN J SURG, V37, P171, DOI [10.1016/j.asjsur.2014.01.008, DOI 10.1016/J.ASJSUR.2014.01.008]; Wanjura V, 2016, WORLD J SURG, V40, P81, DOI 10.1007/s00268-015-3240-0; Yoon JH, 2014, HEPATO-GASTROENTEROL, V61, P902, DOI 10.5754/hge13608	21	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166576	10.1371/journal.pone.0166576	http://dx.doi.org/10.1371/journal.pone.0166576			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861547	Green Submitted, gold, Green Published			2022-12-26	WOS:000388350300073
J	Albi, T; Ruiz, MT; de los Reyes, P; Valverde, F; Romero, JM				Albi, Tomas; Teresa Ruiz, M.; de los Reyes, Pedro; Valverde, Federico; Romero, Jose M.			Characterization of the Sucrose Phosphate Phosphatase (SPP) Isoforms from Arabidopsis thaliana and Role of the S6PPc Domain in Dimerization	PLOS ONE			English	Article							GENE-EXPRESSION; SYNTHASE; PROTEIN; METABOLISM; CYANOBACTERIAL; LOCALIZATION; FAMILIES; PURIFICATION; REVEALS; CLONING	Sucrose-phosphate phosphatase (SPP) catalyses the final step in the sucrose biosynthesis pathway. Arabidopsis thaliana genome codifies four SPP isoforms. In this study, the four Arabidopsis thaliana genes coding for SPP isoforms have been cloned, expressed in Escherichia coli and the kinetic and regulatory properties of the purified enzymes analysed. SPP2 is the isoform showing the highest activity, with SPP3b and SPP3a showing lower activity levels. No activity was detected for SPP1. We propose that this lack of activity is probably due to the absence of an essential amino acid participating in catalysis and/or in the binding of the substrate, sucrose-6-phosphate (Suc6P). The expression patterns of Arabidopsis SPP genes indicate that SPP2 and SPP3b are the main isoforms expressed in different tissues and organs, although the non-catalytic SPP1 is the main isoform expressed in roots. Thus, SPP1 could have acquired new unknown functions. We also show that the three catalytically active SPPs from Arabidopsis are dimers. By generating a chimeric SPP composed of the monomeric cyanobacterial SPP fused to the higher plant non-catalytic S6PPc domain (from SPP2), we show that the S6PPc domain is responsible for SPP dimerization. This is the first experimental study on the functionality and gene expression pattern of all the SPPs from a single plant species.	[Romero, Jose M.] Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain; CSIC, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Instituto de Bioquimica Vegetal y Fotosintesis (IBVF); Consejo Superior de Investigaciones Cientificas (CSIC)	Romero, JM (corresponding author), Univ Seville, Inst Bioquim Vegetal & Fotosintesis, Seville, Spain.	jmromero@us.es	Valverde, Federico/K-1248-2014; Ruiz, Teresa/I-2116-2014; Romero, Jose M/D-5183-2009	Valverde, Federico/0000-0001-8063-0974; Ruiz, Teresa/0000-0001-5132-9824; Romero, Jose M/0000-0002-4621-5934; de los Reyes Rodriguez, Pedro/0000-0002-7725-3087	Spanish Ministry of Economy and Competitivity (MINECO) [28317]; Andalusian Government [P08-AGR-03582, CVI-281];  [BIO2011-28847-CO2-00];  [BIO2014-52425-P]	Spanish Ministry of Economy and Competitivity (MINECO)(Spanish Government); Andalusian Government; ; 	BIO2011-28847-CO2-00 and BIO2014-52425-P to FV and JMR; TRANSPLANTA Consolider 28317 project from Spanish Ministry of Economy and Competitivity (MINECO, https://sede.micinn.gob.es/portal/site/eSede/). Excellence Project P08-AGR-03582 and CVI-281 help from the Andalusian Government (http://www.juntadeandalucia.es/organismos/economiayconocimiento.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was published thanks to helps from the projects BIO2011-28847-C02-00 and BIO2014-52425-P to FV and JMR; by the TRANSPLANTA Consolider 28317 project from Spanish Ministry of Economy and Competitivity (MINECO) and by the Excellence Project P08-AGR-03582 and CVI-281 help from the Andalusian Government.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; Bahaji A, 2015, PLANT SCI, V238, P135, DOI 10.1016/j.plantsci.2015.06.009; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen SA, 2005, PLANTA, V221, P479, DOI 10.1007/s00425-004-1458-4; Chen S, 2008, PLANT CELL ENVIRON, V31, P165, DOI 10.1111/j.1365-3040.2007.01747.x; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Crevillen P, 2005, J BIOL CHEM, V280, P8143, DOI 10.1074/jbc.M411713200; Cumino A, 2001, PLANTA, V214, P250, DOI 10.1007/s004250100608; Cumino AC, 2010, FEBS LETT, V584, P4655, DOI 10.1016/j.febslet.2010.10.040; ECHEVERRIA E, 1993, PHYSIOL PLANTARUM, V88, P434, DOI 10.1111/j.1399-3054.1993.tb01356.x; Echeverria E, 1997, PLANT PHYSIOL, V115, P223, DOI 10.1104/pp.115.1.223; ECHEVERRIA E, 1994, PLANT SCI, V96, P15, DOI 10.1016/0168-9452(94)90217-8; Fieulaine S, 2005, PLANT CELL, V17, P2049, DOI 10.1105/tpc.105.031229; Fieulaine S, 2007, PROTEINS, V68, P796, DOI 10.1002/prot.21481; Fujisawa T, 2014, NUCLEIC ACIDS RES, V42, pD666, DOI 10.1093/nar/gkt1145; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; HAWKER JS, 1984, PHYTOCHEMISTRY, V23, P245, DOI 10.1016/S0031-9422(00)80311-8; HAWKER JS, 1987, PLANT PHYSIOL, V84, P1281, DOI 10.1104/pp.84.4.1281; HAWKER JS, 1966, BIOCHEM J, V99, P102, DOI 10.1042/bj0990102; HAWKER JS, 1966, PHYTOCHEMISTRY, V5, P1191, DOI 10.1016/S0031-9422(00)86114-2; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; Huber SC, 1996, ANNU REV PLANT PHYS, V47, P431, DOI 10.1146/annurev.arplant.47.1.431; Ortiz-Marchena MI, 2014, PLANT CELL, V26, P565, DOI 10.1105/tpc.114.122721; Jiang SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17583; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LELOIR LUIS F., 1955, JOUR BIOL CHEM, V214, P157; Lucas-Reina E, 2015, PLANT PHYSIOL, V168, P561, DOI 10.1104/pp.15.00321; Lunn JE, 1997, AUST J PLANT PHYSIOL, V24, P1, DOI 10.1071/PP96088; LUNN JE, 1990, BIOCHEM J, V267, P739, DOI 10.1042/bj2670739; Lunn JE, 1997, PLANTA, V202, P106, DOI 10.1007/s004250050108; Lunn JE, 2000, P NATL ACAD SCI USA, V97, P12914, DOI 10.1073/pnas.230430197; Lunn JE, 2003, CURR OPIN PLANT BIOL, V6, P208, DOI 10.1016/S1369-5266(03)00033-5; Lunn JE, 2003, GENE, V303, P187, DOI 10.1016/S0378-1119(02)01177-0; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; Lunn JE, 1999, NEW PHYTOL, V143, P221, DOI 10.1046/j.1469-8137.1999.00450.x; Maloney VJ, 2015, J EXP BOT, V66, P4383, DOI 10.1093/jxb/erv101; Osuna D, 2007, PLANT J, V49, P463, DOI 10.1111/j.1365-313X.2006.02979.x; Pal SK, 2013, PLANT PHYSIOL, V162, P1246, DOI 10.1104/pp.112.212258; Pedro CN, 2003, J BIOL CHEM, V278, P28508, DOI 10.1074/jbc.M304280200; Privat I, 2008, NEW PHYTOL, V178, P781, DOI 10.1111/j.1469-8137.2008.02425.x; RATHBUN WB, 1969, ANAL BIOCHEM, V28, P436, DOI 10.1016/0003-2697(69)90198-5; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Ruan YL, 2014, ANNU REV PLANT BIOL, V65, P33, DOI 10.1146/annurev-arplant-050213-040251; Salerno GL, 1996, CELL MOL BIOL, V42, P665; Satoh-Nagasawa N, 2006, NATURE, V441, P227, DOI 10.1038/nature04725; Seki M, 1998, PLANT J, V15, P707, DOI 10.1046/j.1365-313x.1998.00237.x; Seki M, 2002, SCIENCE, V296, P141, DOI 10.1126/science.1071006; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Toroser D, 1998, FEBS LETT, V435, P110, DOI 10.1016/S0014-5793(98)01048-5; Ventriglia T, 2008, PLANT PHYSIOL, V148, P65, DOI 10.1104/pp.108.122846; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WHITAKER DP, 1984, PHYTOCHEMISTRY, V23, P2429, DOI 10.1016/S0031-9422(00)84069-8; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Winter H, 2000, CRIT REV PLANT SCI, V19, P31, DOI 10.1016/S0735-2689(01)80002-2; Yadav UP, 2014, J EXP BOT, V65, P1051, DOI 10.1093/jxb/ert457; Yang HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042438	61	9	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166308	10.1371/journal.pone.0166308	http://dx.doi.org/10.1371/journal.pone.0166308			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855180	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200027
J	Peyser, ND; Pendleton, K; Gooding, WE; Lui, VWY; Johnson, DE; Grandis, JR				Peyser, Noah D.; Pendleton, Kelsey; Gooding, William E.; Lui, Vivian W. Y.; Johnson, Daniel E.; Grandis, Jennifer R.			Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CHRONIC MYELOID-LEUKEMIA; GROWTH-FACTOR RECEPTOR; ABL TYROSINE KINASE; LUNG-CANCER; SIGNAL TRANSDUCER; IN-VIVO; 1ST-LINE TREATMENT; FREQUENT MUTATION; COPY-NUMBER	Background Hyperactivation of STAT3 via constitutive phosphorylation of tyrosine 705 (Y705) is common in most human cancers, including head and neck squamous carcinoma (HNSCC). STAT3 is rarely mutated in cancer and the (epi)genetic alterations that lead to STAT3 activation are incompletely understood. Here we used an unbiased approach to identify genomic and epigenomic changes associated with pSTAT3(Y705) expression using data generated by The Cancer Genome Atlas (TCGA). Methods and Findings Mutation, mRNA expression, promoter methylation, and copy number alteration data were extracted from TCGA and examined in the context of pSTAT3(Y705) protein expression. mRNA expression levels of 1279 genes were found to be associated with pSTAT3(705) expression. Association of pSTAT3(Y705) expression with caspase-8 mRNA expression was validated by immunoblot analysis in HNSCC cells. Mutation, promoter hypermethylation, and copy number alteration of any gene were not significantly associated with increased pSTAT3(Y705) protein expression. Conclusions These cumulative results suggest that unbiased approaches may be useful in identifying the molecular underpinnings of oncogenic signaling, including STAT3 activation, in HNSCC. Larger datasets will likely be necessary to elucidate signaling consequences of infrequent alterations.	[Peyser, Noah D.; Grandis, Jennifer R.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA; [Pendleton, Kelsey] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15213 USA; [Pendleton, Kelsey; Johnson, Daniel E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Gooding, William E.] Univ Pittsburgh, Inst Canc, Biostat Facil, Pittsburgh, PA 15213 USA; [Lui, Vivian W. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Johnson, Daniel E.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Grandis, JR (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Surg, San Francisco, CA 94143 USA.	Jennifer.Grandis@ucsf.edu	Lui, Vivian W. Y./I-5458-2016	Lui, Vivian W. Y./0000-0001-6918-1573; Peyser, Noah/0000-0003-4529-8325	National Cancer Institute (NIH) [R01CA077308]; American Cancer Society [CRP-13-308-06-COUN]; NATIONAL CANCER INSTITUTE [R01CA077308, P50CA097190] Funding Source: NIH RePORTER	National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (NIH) R01CA077308 and the American Cancer Society CRP-13-308-06-COUN to JRG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Cancer Institute (NIH) R01CA077308 and the American Cancer Society CRP-13-308-06-COUN to JRG.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Alvarez JV, 2006, CANCER RES, V66, P3162, DOI 10.1158/0008-5472.CAN-05-3757; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Choe G, 2003, CANCER RES, V63, P2742; Coppo P, 2006, BRIT J HAEMATOL, V134, P171, DOI 10.1111/j.1365-2141.2006.06161.x; Dabney A, 2010, QVALUE Q VALUE ESTIM; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gan AM, 2013, J CELL BIOCHEM, V114, P2273, DOI 10.1002/jcb.24571; Gan AM, 2013, CELL TISSUE RES, V351, P161, DOI 10.1007/s00441-012-1510-9; Gao L, 2010, INT J RADIAT ONCOL, V77, P1223, DOI 10.1016/j.ijrobp.2009.12.036; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Guerrero-Preston R, 2014, CANCER RES, V74, DOI 10.1158/1538-7445.AM2014-2482; Hazan-Halevy I, 2010, BLOOD, V115, P2852, DOI 10.1182/blood-2009-10-230060; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Jo M, 2012, TOXICOL APPL PHARM, V258, P72, DOI 10.1016/j.taap.2011.10.009; Kunigal S, 2009, INT J ONCOL, V34, P1209, DOI 10.3892/ijo_00000249; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; Li J, 2013, NAT METHODS, V10, P1046, DOI [10.1038/nmeth.2650, 10.1038/NMETH.2650]; Licitra L, 2011, ANN ONCOL, V22, P1078, DOI 10.1093/annonc/mdq588; Lui VWY, 2013, CANCER DISCOV, V3, P761, DOI 10.1158/2159-8290.CD-13-0103; Lui VWY, 2014, P NATL ACAD SCI USA, V111, P1114, DOI 10.1073/pnas.1319551111; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marescalco MS, 2014, J ORAL PATHOL MED, V43, P20, DOI 10.1111/jop.12087; Muller A, 2006, INT J CANCER, V118, P2147, DOI 10.1002/ijc.21514; Nallar SC, 2013, J BIOL CHEM, V288, P7930, DOI 10.1074/jbc.M112.440610; Nault JC, 2012, J HEPATOL, V56, P184, DOI 10.1016/j.jhep.2011.07.018; Peyser ND, 2015, ONCOGENE; Peyser ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135750; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shah NG, 2006, INT J BIOL MARKER, V21, P175, DOI 10.1177/172460080602100307; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Wang JL, 2015, J CANCER, V6, P54, DOI 10.7150/jca.10631; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166185	10.1371/journal.pone.0166185	http://dx.doi.org/10.1371/journal.pone.0166185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855189	gold, Green Submitted, Green Published			2022-12-26	WOS:000387910200021
J	Ree, XM; Zuo, GF; Wu, W; Luo, J; Ye, P; Chen, SL; Hu, ZY				Ree, Xiao-min; Zuo, Guang-feng; Wu, Wen; Luo, Jie; Ye, Peng; Chen, Shao-liang; Hu, Zuo-ying			Atorvastatin Alleviates Experimental Diabetic Cardiomyopathy by Regulating the GSK-3 beta-PP2Ac-NF-kappa B Signaling Axis	PLOS ONE			English	Article							NF-KAPPA-B; GLYCOGEN-SYNTHASE KINASE-3; GLUCOSE-INDUCED APOPTOSIS; PROTEIN PHOSPHATASE-2A; OXIDATIVE STRESS; MUSCLE-CELLS; CARDIOMYOCYTES; ACTIVATION; EXPRESSION; HEART	Recent studies reported that atorvastatin (ATOR) alleviated progression of experimental diabetic cardiomyopathy (DCM), possibly by protecting against apoptosis. However, the underlying mechanisms of this protective effect remain unclear. Therefore, our study investigated the role of the glycogen synthase kinase (GSK)-3 beta-protein phosphatase 2A(PP2A)-NF-kappa B signaling pathway in the anti-apoptotic and cardioprotective effects of ATOR on cardiomyocytes cultured in high glucose (HG) and in DCM. Our results showed that, in HG-cultured cardiomyocytes, phosphorylation of GSK-3 beta was decreased, while that of the PP2A catalytic subunit C (PP2Ac) and IKK/I kappa Ba was increased, followed by NF-kappa B nuclear translocation and apoptosis. IKK/I kappa B alpha phosphorylation and NF-kappa B nuclear translocation were also increased by treatment of cells with okadaic acid (OA), a selective PP2A inhibitor, or by silencing PP2Ac expression. The opposite results were obtained by silencing GSK-3 beta expression, which resulted in PP2Ac activation. Furthermore, IKK/I kappa Ba phosphorylation and NF-kappa B nuclear translocation were markedly inhibited and apoptosis attenuated in cells treated with ATOR. These effects occurred through inactivation of GSK-3 beta and subsequent activation of PP2Ac. They were abolished by treatment of cells with OA or PP2Ac siRNA. In mice with type 1 diabetes mellitus, treatment with ATOR, at 10 mg-kg(-1)-d(-1), significantly suppressed GSK-3 beta activation, IKK/I kappa Ba phosphorylation, NF-kappa B nuclear translocation and caspase-3 activation, while also activating PP2Ac. Finally, improvements in histological abnormalities, fibrosis, apoptosis and cardiac dysfunction were observed in diabetic mice treated with ATOR. These findings demonstrated that ATOR protected against HG-induced apoptosis in cardiomyocytes and alleviated experimental DCM by regulating the GSK-3 beta-PP2A-NF-kappa B signaling pathway.	[Ree, Xiao-min; Zuo, Guang-feng; Wu, Wen; Luo, Jie; Ye, Peng; Chen, Shao-liang; Hu, Zuo-ying] Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China	Nanjing Medical University	Chen, SL; Hu, ZY (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Dept Cardiol, Nanjing 210006, Jiangsu, Peoples R China.	chen_s_l0931@sina.com; huzy0073@163.com			National Natural Science Foundation of China [NSFC-91439118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We acknowledge the National Natural Science Foundation of China (NSFC-91439118) for supporting completion of this study. Shao-liang Chen is the grant recipient and one of the corresponding authors in this manuscript.	Abdel-Hamid AAM, 2015, J MOL HISTOL, V46, P337, DOI 10.1007/s10735-015-9625-4; Allen DA, 2005, J NUTR BIOCHEM, V16, P705, DOI 10.1016/j.jnutbio.2005.06.007; Barone E, 2014, BIOCHEM PHARMACOL, V88, P605, DOI 10.1016/j.bcp.2013.10.030; Bertoni AG, 2003, DIABETES CARE, V26, P2791, DOI 10.2337/diacare.26.10.2791; Cai Lu, 2003, Cardiovasc Toxicol, V3, P219, DOI 10.1385/CT:3:3:219; Chen SL, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-150; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dandapat S, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0621-1; Fang D, 2014, EUR REV MED PHARMACO, V18, P242; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Henriksen EJ, 2006, CURR DRUG TARGETS, V7, P1435, DOI 10.2174/1389450110607011435; Jin Y, 2012, ACTA PHARMACOL SIN, V33, P861, DOI 10.1038/aps.2012.59; Khan S, 2016, MOL CELL ENDOCRINOL, V428, P101, DOI 10.1016/j.mce.2016.03.025; Liu GP, 2008, NEUROBIOL AGING, V29, P1348, DOI 10.1016/j.neurobiolaging.2007.03.012; Mandosi E, 2010, J ATHEROSCLER THROMB, V17, P539, DOI 10.5551/jat.2956; Nichols GA, 2001, DIABETES CARE, V24, P1614, DOI 10.2337/diacare.24.9.1614; Nizamutdinova IT, 2013, J CELL PHYSIOL, V228, P380, DOI 10.1002/jcp.24142; Obulesu M, 2014, NEUROCHEM RES, V39, P2301, DOI 10.1007/s11064-014-1454-4; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; Ouyang CH, 2014, J MOL CELL CARDIOL, V71, P71, DOI 10.1016/j.yjmcc.2013.10.014; Palomer X, 2013, INT J CARDIOL, V168, P3160, DOI 10.1016/j.ijcard.2013.07.150; Pan Y, 2014, DIABETES, V63, P3497, DOI 10.2337/db13-1577; Ribe EM, 2008, BIOCHEM J, V415, P165, DOI 10.1042/BJ20081118; Shirpoor A, 2009, J DIABETES COMPLICAT, V23, P310, DOI 10.1016/j.jdiacomp.2008.02.009; Somaratne JB, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-29; Tsai KH, 2012, J CELL PHYSIOL, V227, P1347, DOI 10.1002/jcp.22847; Wu C, 2003, J BIOL CHEM, V278, P31980, DOI 10.1074/jbc.M304278200; Xu JJ, 2014, CRIT CARE MED, V42, pE583, DOI 10.1097/CCM.0000000000000415; Yao XQ, 2011, BIOCHEM J, V437, P335, DOI 10.1042/BJ20110347; Yuan JY, 2009, APOPTOSIS, V14, P469, DOI 10.1007/s10495-008-0304-8	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166740	10.1371/journal.pone.0166740	http://dx.doi.org/10.1371/journal.pone.0166740			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851811	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300083
J	Fukano, Y; Tanaka, Y; Farkhary, SI; Kurachi, T				Fukano, Yuya; Tanaka, Yosuke; Farkhary, Sayed Ibrahim; Kurachi, Takuma			Flower-Visiting Butterflies Avoid Predatory Stimuli and Larger Resident Butterflies: Testing in a Butterfly Pavilion	PLOS ONE			English	Article							BUMBLEBEES BOMBUS-IGNITUS; LOCAL ENHANCEMENT; STINGLESS BEES; PLANT FITNESS; NET CAGE; POLLINATION; CONSPECIFICS; REDUCE; INFORMATION; VISITATION	The flower-visiting behaviors of pollinator species are affected not only by flower traits but also by cues of predators and resident pollinators. There is extensive research into the effects of predator cues and resident pollinators on the flower-visiting behaviors of bee pollinators. However, there is relatively little research into their effects on butterfly pollinators probably because of the difficulty in observing a large number of butterfly pollination events. We conducted a dual choice experiment using artificial flowers under semi-natural conditions in the butterfly pavilion at Tama Zoological Park to examine the effects of the presence of a dead mantis and resident butterflies have on the flower-visiting behavior of several butterfly species. From 173 hours of recorded video, we observed 3235 visitations by 16 butterfly species. Statistical analysis showed that (1) butterflies avoided visiting flowers occupied by a dead mantis, (2) butterflies avoided resident butterflies that were larger than the visitor, and (3) butterflies showed greater avoidance of a predator when the predator was present together with the resident butterfly than when the predator was located on the opposite flower of the resident. Finally, we discuss the similarities and differences in behavioral responses of butterfly pollinators and bees.	[Fukano, Yuya] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Tanaka, Yosuke] Tokyo Zool Pk Soc, Ueno Zool Gardens, Tokyo, Japan; [Farkhary, Sayed Ibrahim; Kurachi, Takuma] Tokyo Univ Agr & Technol, Dept Vet Med, Fac Agr, Tokyo, Japan	University of Tokyo; Tokyo University of Agriculture & Technology	Fukano, Y (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.	yuya.fukano@gmail.com			 [26-3225]		This work was supported in part by Grant-in-Aid for JSPS (Japanese society for promotion of science) Fellows (no. 26-3225). https://www.jsps.go.jp/english/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; ALM J, 1990, OECOLOGIA, V84, P53, DOI 10.1007/BF00665594; Baude M, 2011, P ROY SOC B-BIOL SCI, V278, P2806, DOI 10.1098/rspb.2010.2659; Cembrowski AR, 2014, AM NAT, V183, P133, DOI 10.1086/674101; Craig CL, 2001, EVOLUTION, V55, P986, DOI 10.1554/0014-3820(2001)055[0986:SPITWD]2.0.CO;2; Dawson EH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3174; Dukas R, 2005, ECOLOGY, V86, P1401, DOI 10.1890/04-1663; Dukas R, 2003, OIKOS, V101, P157, DOI 10.1034/j.1600-0706.2003.12143.x; Dukas R, 2001, ECOL LETT, V4, P327, DOI 10.1046/j.1461-0248.2001.00228.x; Fenster CB, 2004, ANNU REV ECOL EVOL S, V35, P375, DOI 10.1146/annurev.ecolsys.34.011802.132347; Goncalves-Souza T, 2008, ECOLOGY, V89, P2407, DOI 10.1890/07-1881.1; Hirota SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085601; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Kawaguchi LG, 2007, P ROY SOC B-BIOL SCI, V274, P2661, DOI 10.1098/rspb.2007.0860; KIKUCHI TOSHIHIDE, 1965, SCI REP TOHOKU UNTV SER IV BIOL, V31, P275; Leadbeater E, 2005, CURR BIOL, V15, pR447, DOI 10.1016/j.cub.2005.06.011; Makino TT, 2004, BEHAV ECOL SOCIOBIOL, V56, P155, DOI 10.1007/s00265-004-0773-x; Makino TT, 2005, BEHAV ECOL SOCIOBIOL, V57, P617, DOI 10.1007/s00265-004-0877-3; MORSE DH, 1982, INSECT SOC, V29, P445, DOI 10.1007/BF02226159; MORSE DH, 1986, OIKOS, V46, P223, DOI 10.2307/3565470; Munoz AA, 2004, OECOLOGIA, V138, P66, DOI 10.1007/s00442-003-1405-2; Otis GW, 2006, J INSECT BEHAV, V19, P685, DOI 10.1007/s10905-006-9049-9; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Rader R, 2016, P NATL ACAD SCI USA, V113, P146, DOI 10.1073/pnas.1517092112; Robertson IC, 2005, OIKOS, V109, P577, DOI 10.1111/j.0030-1299.2005.13903.x; Romero GQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020689; Schemske DW, 1999, P NATL ACAD SCI USA, V96, P11910, DOI 10.1073/pnas.96.21.11910; Slaa EJ, 2003, ECOL ENTOMOL, V28, P369, DOI 10.1046/j.1365-2311.2003.00512.x; Steffan-Dewenter I, 2005, TRENDS ECOL EVOL, V20, P651, DOI 10.1016/j.tree.2005.09.004; Suttle KB, 2003, ECOL LETT, V6, P688, DOI 10.1046/j.1461-0248.2003.00490.x; Tan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075841; Waser NM, 1996, ECOLOGY, V77, P1043, DOI 10.2307/2265575; WASER NM, 1983, NATURE, V302, P422, DOI 10.1038/302422a0; Willmer P., 2011, POLLINATION FLORAL E; ZIMMERMAN M, 1982, OIKOS, V38, P381, DOI 10.2307/3544681	35	1	1	6	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166365	10.1371/journal.pone.0166365	http://dx.doi.org/10.1371/journal.pone.0166365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846252	gold, Green Submitted, Green Published			2022-12-26	WOS:000387794600050
J	Le, CHH				Le, Chi Huu Hong			The Prevalence of Anemia and Moderate-Severe Anemia in the US Population (NHANES 2003-2012)	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; PHYSICAL PERFORMANCE; HEMOGLOBIN LEVELS; UNITED-STATES; MORTALITY; IMPAIRMENT; DISABILITY; PREGNANCY; AMERICAN; SYMPTOMS	Since anemia is associated with poor health outcomes, the prevalence of anemia is a significant public health indicator. Even though anemia is primarily caused by iron deficiency, low oxygen-carrying capacity may result from other conditions such as chronic diseases, which remain a relevant health concern in the United States. However, studies examining current rates of anemia in the total US population and in more specific subgroups are limited. Data from five National Health and Nutrition Examination Surveys (NHANES) from 2003 to 2012 were analyzed to assess two outcomes: anemia and moderate-severe anemia, which were based upon serum hemoglobin levels (Hb) as per World Health Organization (WHO) definitions. Statistical analysis using SAS examined temporal trends and the prevalence of anemia among sexes, age groups, and races/ethnicities. The study estimated that an average of 5.6% of the U. S. population met the criteria for anemia and 1.5% for moderate-severe anemia during this 10-year period. High-risk groups such as pregnant women, elderly persons, women of reproductive age, non-Hispanic blacks, and Hispanics were identified, and relationships between multiple risk factors were examined. Rates of anemia in men increased monotonically with age, while that of women increased bimodally with peaks in age group 40-49 years and 80-85 years. The effect of risk factors was observed to compound. For instance, the prevalence of anemia in black women aged 80-85 years was 35.6%, 6.4 times higher than the population average. Moreover, anemia is a growing problem because of the increased prevalence of anemia (4.0% to 7.1%) and moderate-severe anemia (1.0% to 1.9%), which nearly doubled from 2003-2004 to 2011-2012. Thus, these results augment the current knowledge on anemia prevalence, severity, and distribution among subgroups in the US and raised anemia as an issue that requires urgent public health intervention.	[Le, Chi Huu Hong] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Le, CHH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	chi.le@emory.edu						Adebisi OY, 2005, FAM MED, V37, P655; [Anonymous], 2011, HAEMOGLOBIN CONCENTR; Brabin BJ, 2001, J NUTR, V131, p604S, DOI 10.1093/jn/131.2.604S; Brotanek JM, 2007, PEDIATRICS, V120, P568, DOI 10.1542/peds.2007-0572; Brunner Christian, 2010, Ther Umsch, V67, P219, DOI 10.1024/0040-5930/a000040; Caro JJ, 2001, CANCER-AM CANCER SOC, V91, P2214, DOI 10.1002/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P; Carter RC, 2010, PEDIATRICS, V126, pE427, DOI 10.1542/peds.2009-2097; Culleton BF, 2006, BLOOD, V107, P3841, DOI 10.1182/blood-2005-10-4308; Cusick SE, 2008, AM J CLIN NUTR, V88, P1611, DOI 10.3945/ajcn.2008.25926; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Ezekowitz JA, 2003, CIRCULATION, V107, P223, DOI 10.1161/01.CIR.0000052622.51963.FC; Frith-Terhune AL, 2000, AM J CLIN NUTR, V72, P963; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Horwich TB, 2002, J AM COLL CARDIOL, V39, P1780, DOI 10.1016/S0735-1097(02)01854-5; Hung WW, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-47; Izaks GJ, 1999, JAMA-J AM MED ASSOC, V281, P1714, DOI 10.1001/jama.281.18.1714; Kassebaum NJ, 2014, BLOOD, V123, P615, DOI 10.1182/blood-2013-06-508325; KLEBANOFF MA, 1991, AM J OBSTET GYNECOL, V164, P59, DOI 10.1016/0002-9378(91)90626-3; LEVY A, 2005, EUR J OBSTET GYN R B, V122, P182, DOI DOI 10.1016/J.EJ0GRB.2005.02.015; Mahoney DH, 2008, AM J CLIN NUTR, V88, P1457, DOI 10.3945/ajcn.2008.26965; McClellan W, 2004, CURR MED RES OPIN, V20, P1501, DOI 10.1185/030079904X2763; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; NORDENBERG D, 1990, JAMA-J AM MED ASSOC, V264, P1556, DOI 10.1001/jama.264.12.1556; Ostchega Y, 2013, NATL HLTH NUTR EXAMI; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Penninx BWJH, 2003, AM J MED, V115, P104, DOI 10.1016/S0002-9343(03)00263-8; SALIVE ME, 1992, J AM GERIATR SOC, V40, P489, DOI 10.1111/j.1532-5415.1992.tb02017.x; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Viteri F E, 1994, SCN News, P14; WALTER T, 1989, PEDIATRICS, V84, P7; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809; WHO, 2007, ASS IR STAT POP INCL; World Health Organization, 2008, WHO GLOBAL DATABASE; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zakai NA, 2009, AM J EPIDEMIOL, V169, P355, DOI 10.1093/aje/kwn355	35	156	160	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166635	10.1371/journal.pone.0166635	http://dx.doi.org/10.1371/journal.pone.0166635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846276	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600095
J	Scalone, R; Lemke, A; Stefanic, E; Kolseth, AK; Rasic, S; Andersson, L				Scalone, Romain; Lemke, Andreas; Stefanic, Edita; Kolseth, Anna-Karin; Rasic, Sanda; Andersson, Lars			Phenological Variation in Ambrosia artemisiifolia L. Facilitates Near Future Establishment at Northern Latitudes	PLOS ONE			English	Article							INTER-POPULATION VARIATION; COMMON RAGWEED; RANGE SHIFTS; INVASIVE POPULATIONS; PERENNIAL RYEGRASS; RAPID EVOLUTION; SPECIES RANGE; FRANCE; POLLEN; LIMITS	The invasive weed Ambrosia artemisiifolia (common ragweed) constitutes a great threat to public health and agriculture in large areas of the globe. Climate change, characterized by higher temperatures and prolonged vegetation periods, could increase the risk of establishment in northern Europe in the future. However, as the species is a short-day plant that requires long nights to induce bloom formation, it might still fail to produce mature seeds before the onset of winter in areas at northern latitudes characterized by short summer nights. To survey the genetic variation in flowering time and study the effect of latitudinal origin on this trait, a reciprocal common garden experiment, including eleven populations of A. artemisiifolia from Europe and North America, was conducted. The experiment was conducted both outside the range limit of the species, in Sweden and within its invaded range, in Croatia. Our main hypothesis was that the photoperiodic-thermal requirements of A. artemisiifolia constitute a barrier for reproduction at northern latitudes and, thus, halts the northern range shift despite expected climate change. Results revealed the presence of a north-south gradient in flowering time at both garden sites, indicating that certain European populations are pre-adapted to photoperiodic and thermal conditions at latitudes up to, at least, 60 degrees N. This was confirmed by phenological recordings performed in a region close to the northern range limit, the north of Germany. Thus, we conclude that there exists a high risk for establishment and spread of A. artemisiifolia in FennoScandinavia in the near future. The range shift might occur independently of climate change, but would be accelerated by it.	[Scalone, Romain; Kolseth, Anna-Karin; Andersson, Lars] Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden; [Lemke, Andreas] Tech Univ Berlin, Dept Ecol Plant Ecol & Ecosyst Sci, Berlin, Germany; [Stefanic, Edita; Rasic, Sanda] Univ Josip Juraj Strossmayer, Fac Agr, Osijek, Croatia	Swedish University of Agricultural Sciences; Technical University of Berlin; University of JJ Strossmayer Osijek	Andersson, L (corresponding author), Swedish Univ Agr Sci, Dept Crop Prod Ecol, Uppsala, Sweden.	lars.andersson@slu.se		SCALONE, Romain/0000-0002-9687-8584	Svenska Forskningsradet Formas [217 - 2012-994]	Svenska Forskningsradet Formas(Swedish Research Council Formas)	The work was funded by Svenska Forskningsradet Formas (http://www.formas.se), grant number 217 - 2012-994. LA and AK received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], SUST MAN REGW EUR; [Anonymous], [No title captured]; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BIANCHI D. E., 1959, BOT GAZ, V120, P235, DOI 10.1086/336030; Brandes D., 2006, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V58, P286; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Chapman DS, 2014, GLOBAL CHANGE BIOL, V20, P192, DOI 10.1111/gcb.12380; Chauvel B, 2011, ACTA BOT GALLICA, V158, P309, DOI 10.1080/12538078.2011.10516276; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chun YJ, 2011, MOL ECOL, V20, P1378, DOI 10.1111/j.1365-294X.2011.05013.x; Chun YJ, 2010, NEW PHYTOL, V185, P1100, DOI 10.1111/j.1469-8137.2009.03129.x; Clements DR, 2011, WEED RES, V51, P227, DOI 10.1111/j.1365-3180.2011.00850.x; Colautti RI, 2013, SCIENCE, V342, P364, DOI 10.1126/science.1242121; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Dahl A., 1999, AEROBIOLOGIA, V15, P293, DOI [DOI 10.1023/A:1007678107552, 10.1023/A:1007678107552]; Deen W, 1998, WEED SCI, V46, P555, DOI 10.1017/S0043174500091098; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Dullinger S, 2009, BIOL INVASIONS, V11, P2401, DOI 10.1007/s10530-009-9424-5; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Essl F, 2015, J ECOL, V103, P1069, DOI 10.1111/1365-2745.12424; Fumanal B, 2007, ANN AGR ENV MED, V14, P233; Gaudeul M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017658; Genton BJ, 2005, MOL ECOL, V14, P4275, DOI 10.1111/j.1365-294X.2005.02750.x; Genton BJ, 2005, MOL ECOL NOTES, V5, P381, DOI 10.1111/j.1471-8286.2005.00934.x; Gladieux P, 2011, BIOL INVASIONS, V13, P933, DOI 10.1007/s10530-010-9880-y; Groom QJ, 2013, PEERJ, V1, DOI 10.7717/peerj.77; Gruvberger B, 2002, CONTACT DERMATITIS, V47, P157; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Hodgins KA, 2011, J EVOLUTION BIOL, V24, P2731, DOI 10.1111/j.1420-9101.2011.02404.x; Hodgins KA, 2013, MOL ECOL, V22, P2496, DOI 10.1111/mec.12179; Kasprzyk I, 2011, INT J BIOMETEOROL, V55, P633, DOI 10.1007/s00484-010-0376-3; Kazinczi G., 2008, Herbologia, V9, P119; Leiblein-Wild MC, 2014, BIOL INVASIONS, V16, P2003, DOI 10.1007/s10530-014-0644-y; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; Li XM, 2015, OECOLOGIA, V177, P669, DOI 10.1007/s00442-014-3127-z; Martin MD, 2014, MOL ECOL, V23, P1701, DOI 10.1111/mec.12675; Miguel A., 2011, ECOL LETT, V14, P511, DOI [10.1111/j.1461-0248.2011.01601.x, DOI 10.1111/J.1461-0248.2011.01601.X]; Moller H, 2002, CONTACT DERMATITIS, V47, P157, DOI 10.1034/j.1600-0536.2002.470306.x; Moloney KA, 2009, PERSPECT PLANT ECOL, V11, P311, DOI 10.1016/j.ppees.2009.05.002; Novy A, 2013, J EVOLUTION BIOL, V26, P443, DOI 10.1111/jeb.12047; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Sikoparija B, 2013, AGR FOREST METEOROL, V180, P112, DOI 10.1016/j.agrformet.2013.05.014; Sikoparija B, 2009, INT J BIOMETEOROL, V53, P263, DOI 10.1007/s00484-009-0212-9; Smith M, 2013, ENVIRON INT, V61, P115, DOI 10.1016/j.envint.2013.08.005; Storkey J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088156; Thalmann DJK, 2015, BIOL INVASIONS, V17, P1041, DOI 10.1007/s10530-014-0774-2; THOMAS RL, 1969, HEREDITY, V24, P91, DOI 10.1038/hdy.1969.9; THOMAS RL, 1967, HEREDITY, V22, P481, DOI 10.1038/hdy.1967.65; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Whitney KD, 2008, DIVERS DISTRIB, V14, P569, DOI 10.1111/j.1472-4642.2008.00473.x; Zink K, 2012, INT J BIOMETEOROL, V56, P669, DOI 10.1007/s00484-011-0468-8; Ziska L, 2011, P NATL ACAD SCI USA, V108, P4248, DOI 10.1073/pnas.1014107108	53	17	17	4	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166510	10.1371/journal.pone.0166510	http://dx.doi.org/10.1371/journal.pone.0166510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846312	Green Submitted, gold, Green Published			2022-12-26	WOS:000387794600073
J	Ling, QH; Song, YQ; Han, F; Yang, D; Huang, DS				Ling, Qing-Hua; Song, Yu-Qing; Han, Fei; Yang, Dan; Huang, De-Shuang			An Improved Ensemble of Random Vector Functional Link Networks Based on Particle Swarm Optimization with Double Optimization Strategy	PLOS ONE			English	Article							EXTREME LEARNING-MACHINE; FUNCTION APPROXIMATION; ALGORITHM	For ensemble learning, how to select and combine the candidate classifiers are two key issues which influence the performance of the ensemble system dramatically. Random vector functional link networks (RVFL) without direct input-to-output links is one of suitable base-classifiers for ensemble systems because of its fast learning speed, simple structure and good generalization performance. In this paper, to obtain a more compact ensemble system with improved convergence performance, an improved ensemble of RVFL based on attractive and repulsive particle swarm optimization (ARPSO) with double optimization strategy is proposed. In the proposed method, ARPSO is applied to select and combine the candidate RVFL. As for using ARPSO to select the optimal base RVFL, ARPSO considers both the convergence accuracy on the validation data and the diversity of the candidate ensemble system to build the RVFL ensembles. In the process of combining RVFL, the ensemble weights corresponding to the base RVFL are initialized by the minimum norm least-square method and then further optimized by ARPSO. Finally, a few redundant RVFL is pruned, and thus the more compact ensemble of RVFL is obtained. Moreover, in this paper, theoretical analysis and justification on how to prune the base classifiers on classification problem is presented, and a simple and practically feasible strategy for pruning redundant base classifiers on both classification and regression problems is proposed. Since the double optimization is performed on the basis of the single optimization, the ensemble of RVFL built by the proposed method outperforms that built by some single optimization methods. Experiment results on function approximation and classification problems verify that the proposed method could improve its convergence accuracy as well as reduce the complexity of the ensemble system.	[Ling, Qing-Hua; Song, Yu-Qing; Han, Fei; Yang, Dan] Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China; [Ling, Qing-Hua] Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Peoples R China; [Huang, De-Shuang] Tongji Univ, Sch Elect & Informat Engn, Shanghai, Peoples R China	Jiangsu University; Jiangsu University of Science & Technology; Tongji University	Ling, QH (corresponding author), Jiangsu Univ, Sch Comp Sci & Commun Engn, Zhenjiang, Peoples R China.; Ling, QH (corresponding author), Jiangsu Univ Sci & Technol, Sch Comp Sci & Engn, Zhenjiang, Peoples R China.	lingee_2000@163.com			National Natural Science Foundation of China [61271385, 61572241, 61572239, 61520106006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos.61271385, 61572241, 61572239, 61520106006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Wahab MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122827; AEBERHARD S, 1994, PATTERN RECOGN, V27, P1065, DOI 10.1016/0031-3203(94)90145-7; Cai Q, 2014, NEURAL NETWORKS, V58, P4, DOI 10.1016/j.neunet.2014.04.006; Chen HH, 2010, IEEE T KNOWL DATA EN, V22, P1738, DOI 10.1109/TKDE.2010.26; Chyzhyk D, 2015, NEURAL NETWORKS, V68, P23, DOI 10.1016/j.neunet.2015.04.002; Escandell-Montero P, 2014, EUR S ART NEUR NETW, P129; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Gastaldo P, 2016, NEURAL NETWORKS, V74, P22, DOI 10.1016/j.neunet.2015.10.011; Han B, 2015, MATH PROBL ENG, V3, P273; Han F, 2006, NEUROCOMPUTING, V69, P2369, DOI 10.1016/j.neucom.2006.02.013; Han F, 2015, IEEE IJCNN; Han F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097530; Han F, 2013, INT J INTELL SYST, V28, P271, DOI 10.1002/int.21569; HANSEN LK, 1990, IEEE T PATTERN ANAL, V12, P993, DOI 10.1109/34.58871; Huang G, 2015, NEURAL NETWORKS, V70, P1, DOI 10.1016/j.neunet.2015.06.002; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huixin Tian, 2010, 2010 IEEE Fifth International Conference on Bio-Inspired Computing: Theories and Applications (BIC-TA), P1076, DOI 10.1109/BICTA.2010.5645111; IGELNIK B, 1995, IEEE T NEURAL NETWOR, V6, P1320, DOI 10.1109/72.471375; Inoue H, 2004, 2004 47TH MIDWEST SYMPOSIUM ON CIRCUITS AND SYSTEMS, VOL III, CONFERENCE PROCEEDINGS, P85; Jeong SY, 2000, NEUROCOMPUTING, V35, P73, DOI 10.1016/S0925-2312(00)00296-4; Kabeya Shutaro, 2009, Proceedings 2009 International Joint Conference on Neural Networks (IJCNN 2009 - Atlanta), P1476, DOI 10.1109/IJCNN.2009.5178979; Kausar A, 2010, LECT NOTES ENG COMP, P671; Kennedy J., 1995, 1995 IEEE International Conference on Neural Networks Proceedings (Cat. No.95CH35828), P1942, DOI 10.1109/ICNN.1995.488968; Lan Y, 2009, NEUROCOMPUTING, V72, P3391, DOI 10.1016/j.neucom.2009.02.013; Lang K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143175; Lian C, 2014, NEURAL COMPUT APPL, V24, P99, DOI 10.1007/s00521-013-1446-3; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu N, 2010, IEEE SIGNAL PROC LET, V17, P754, DOI 10.1109/LSP.2010.2053356; Mansourvar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138493; Nabavi-Kerizi SH, 2010, COMPUT ELECTR ENG, V36, P886, DOI 10.1016/j.compeleceng.2008.04.006; Noel MM, 2012, APPL SOFT COMPUT, V12, P353, DOI 10.1016/j.asoc.2011.08.037; PAO YH, 1992, INT J CONTROL, V56, P263, DOI 10.1080/00207179208934315; Quinlan JR, 1996, PROCEEDINGS OF THE THIRTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE EIGHTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE, VOLS 1 AND 2, P725; Riget J, 200202 AARH U DEP CO; SCHMIDT WF, 1992, 11TH IAPR INTERNATIONAL CONFERENCE ON PATTERN RECOGNITION, PROCEEDINGS, VOL II, P1, DOI 10.1109/ICPR.1992.201708; Shi YH, 1998, IEEE C EVOL COMPUTAT, P69, DOI 10.1109/ICEC.1998.699146; Soria-Olivas E, 2011, IEEE T NEURAL NETWOR, V22, P505, DOI 10.1109/TNN.2010.2103956; Tian HX, 2010, IEEE T AUTOM SCI ENG, V7, P73, DOI 10.1109/TASE.2008.2005640; Wang DH, 2013, NEUROCOMPUTING, V102, P98, DOI 10.1016/j.neucom.2011.12.046; Wang S, 2013, IEEE T KNOWL DATA EN, V25, P206, DOI 10.1109/TKDE.2011.207; Yan DP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129157; Yang D, 2014, LECT NOTES COMPUT SC, V8588, P213, DOI 10.1007/978-3-319-09333-8_23; Zhang L, 2016, INFORM SCIENCES, V367, P1094, DOI 10.1016/j.ins.2015.09.025; Zhang R, 2012, IEEE T NEUR NET LEAR, V23, P365, DOI 10.1109/TNNLS.2011.2178124; Zhang X, 2007, IEEE INTL CONF CONTR, P260; Zhou ZH, 2002, ARTIF INTELL, V137, P239, DOI 10.1016/S0004-3702(02)00190-X	47	8	8	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165803	10.1371/journal.pone.0165803	http://dx.doi.org/10.1371/journal.pone.0165803			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835638	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200012
J	Lu, J; Cui, J; Li, XH; Wang, X; Zhou, Y; Yang, WJ; Chen, M; Zhao, J; Pei, G				Lu, Jing; Cui, Jin; Li, Xiaohang; Wang, Xin; Zhou, Yue; Yang, Wenjuan; Chen, Ming; Zhao, Jian; Pei, Gang			An Anti-Parkinson's Disease Drug via Targeting Adenosine A(2A) Receptor Enhances Amyloid-beta Generation and gamma-Secretase Activity	PLOS ONE			English	Article							ALPHA-SYNUCLEIN; A-BETA; PROTEIN; COMPLEX; MODULATORS; APP; ISTRADEFYLLINE; FLUORESCENCE; ANTAGONISTS; INHIBITORS	gamma-secretase mediates the intramembranous proteolysis of amyloid precursor protein (APP) and determines the generation of A beta which is associated with Alzheimer's disease (AD). Here we identified that an anti-Parkinson's disease drug, Istradefylline, could enhance A beta generation in various cell lines and primary neuronal cells of APP/PS1 mouse. Moreover, the increased generation of A beta 42 was detected in the cortex of APP/PS1 mouse after chronic treatment with Istradefylline. Istradefylline promoted the activity of gamma-secretase which could lead to increased A beta production. These effects of Istradefylline were reduced by the knockdown of A(2A)R but independent of A(2A)R-mediated G protein- or beta-arrestin-dependent signal pathway. We further observed that A(2A)R colocalized with gamma-secretase in endosomes and physically interacted with the catalytic subunit presenilin-1 (PS1). Interestingly, Istradefylline attenuated the interaction in time-and dosage-dependent manners. Moreover the knockdown of A(2A)R which in theory would release PS1 potentiated both A beta generation and gamma-secretase activity. Thus, our study implies that the association of A(2A)R could modulate gamma-secretase activity. Istradefylline enhance A beta generation and gamma-secretase activity possibly via modulating the interaction between A(2A)R and gamma-secretase, which may bring some undesired effects in the central nervous system (CNS).	[Lu, Jing; Cui, Jin; Li, Xiaohang; Wang, Xin; Zhou, Yue; Yang, Wenjuan; Pei, Gang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Cui, Jin; Li, Xiaohang; Wang, Xin; Yang, Wenjuan] Univ Chinese Acad Sci, Grad Sch, 320 Yueyang Rd, Shanghai 200031, Peoples R China; [Yang, Wenjuan] ShanghaiTech Univ, Sch Life Sci & Technol, 100 Haike Rd, Shanghai 201210, Peoples R China; [Chen, Ming] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Chem Biol Core Facil, Shanghai 200031, Peoples R China; [Zhao, Jian] Tongji Univ, Shanghai East Hosp, Sch Med, Translat Med Ctr Stem Cell Therapy, Shanghai 200120, Peoples R China; [Pei, Gang] Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Tongji University; Tongji University	Pei, G (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China.; Pei, G (corresponding author), Tongji Univ, Sch Life Sci & Technol, Collaborat Innovat Ctr Brain Sci, Shanghai 200092, Peoples R China.	gpei@sibs.ac.cn	Zhao, Jian/E-2008-2019	Zhao, Jian/0000-0002-8862-0591; Li, Xiaohang/0000-0002-7316-2196; Wang, Xin/0000-0001-6250-910X	Ministry of Science and Technology of China [2011CB910202]; National Natural Science Foundation of China [31371419]; Science and Technology Commission of Shanghai Municipality [13401900600]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This research was supported by the Ministry of Science and Technology of China (2011CB910202), the National Natural Science Foundation of China (31371419), Science and Technology Commission of Shanghai Municipality (13401900600).; We thank X. Xie (Shanghai Institute of Materia Medica) for the A2AR plasmid; Y. Shi for the pMLink vector (Tsinghua University); P. Wang (East China Normal University) for Rab5, Rab7 and Rab11 plasmids. We also thank Y. Wang, Y. Yu and National Center for Protein Science Shanghai for FRET and imaging technical support. We appreciate all the lab members for sharing reagents and advice. This research was supported by the Ministry of Science and Technology of China, the National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.	Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Burgueno J, 2003, J BIOL CHEM, V278, P37545, DOI 10.1074/jbc.M302809200; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Chavant F, 2011, BRIT J CLIN PHARMACO, V72, P898, DOI 10.1111/j.1365-2125.2011.04009.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Compta Y, 2014, NEURODEGENER DIS, V13, P154, DOI 10.1159/000354670; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; COSTA T, 1989, P NATL ACAD SCI USA, V86, P7321, DOI 10.1073/pnas.86.19.7321; Cui J, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.21; Davis AA, 2010, J NEUROSCI, V30, P4190, DOI 10.1523/JNEUROSCI.6393-09.2010; De Ponti C, 2007, J LEUKOCYTE BIOL, V82, P392, DOI 10.1189/jlb.0107060; Dolev I, 2013, NAT NEUROSCI, V16, P587, DOI 10.1038/nn.3376; Dungo RT, 2013, DRUGS, V73, P1503, DOI 10.1007/s40265-013-0111-6; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Fuxe K, 2007, MOVEMENT DISORD, V22, P1990, DOI 10.1002/mds.21440; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; He G, 2010, NATURE, V467, P95, DOI 10.1038/nature09325; Horita TK, 2013, PSYCHOPHARMACOLOGY, V230, P345, DOI 10.1007/s00213-013-3158-x; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jastrzebska J, 2014, NEUROPHARMACOLOGY, V81, P318, DOI 10.1016/j.neuropharm.2014.03.002; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Klotz KN, 1998, N-S ARCH PHARMACOL, V357, P1; Komatsu H, 2015, INT J MOL SCI, V16, P14109, DOI 10.3390/ijms160614109; Kotzbauer PT, 2012, ARCH NEUROL-CHICAGO, V69, P1326, DOI 10.1001/archneurol.2012.1608; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Levitan D, 2001, P NATL ACAD SCI USA, V98, P12186, DOI 10.1073/pnas.211321898; Li W, 2015, NEUROBIOL DIS, V80, P93, DOI 10.1016/j.nbd.2015.05.002; Liu XS, 2013, CELL RES, V23, P351, DOI 10.1038/cr.2012.167; Milligan G, 1997, TRENDS PHARMACOL SCI, V18, P468, DOI 10.1016/S0165-6147(97)90685-4; MIZOGUCHI K, 1994, BRAIN RES, V662, P255, DOI 10.1016/0006-8993(94)90821-4; Moscoso-Castro M, 2016, EUR NEUROPSYCHOPHARM, V26, P1227, DOI 10.1016/j.euroneuro.2016.04.003; Nelson CD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074680; Ni YX, 2006, NAT MED, V12, P1390, DOI 10.1038/nm1485; Nickols HH, 2014, NEUROBIOL DIS, V61, P55, DOI 10.1016/j.nbd.2013.09.013; Pinna A, 2014, CNS DRUGS, V28, P455, DOI 10.1007/s40263-014-0161-7; Richard CL, 2006, INT J CANCER, V119, P2044, DOI 10.1002/ijc.22084; Scarselli M, 2009, J BIOL CHEM, V284, P3577, DOI 10.1074/jbc.M806819200; Shen HY, 2009, CURR NEUROPHARMACOL, V7, P195, DOI 10.2174/157015909789152191; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Teng L, 2010, CELL RES, V20, P138, DOI 10.1038/cr.2010.3; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Thathiah A, 2011, NAT REV NEUROSCI, V12, P73, DOI 10.1038/nrn2977; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; UKENA D, 1993, BIOCHEM PHARMACOL, V45, P847, DOI 10.1016/0006-2952(93)90168-V; Valadas JS, 2012, J NEUROCHEM, V123, P1030, DOI 10.1111/jnc.12050; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang X, 2015, J ALZHEIMERS DIS, V47, P927, DOI 10.3233/JAD-150313; Wei CJ, 2011, BBA-BIOMEMBRANES, V1808, P1358, DOI 10.1016/j.bbamem.2010.12.018; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102	58	18	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166415	10.1371/journal.pone.0166415	http://dx.doi.org/10.1371/journal.pone.0166415			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835671	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200047
J	Kambire, D; Soeters, HM; Ouedraogo-Traore, R; Medah, I; Sangare, L; Yameogo, I; Sawadogo, G; Ouedraogo, AS; Hema-Ouangraoua, S; McGee, L; Srinivasan, V; Ake, F; Congo-Ouedraogo, M; Sanou, S; Ba, AK; Novak, RT; Van Beneden, C				Kambire, Dinanibe; Soeters, Heidi M.; Ouedraogo-Traore, Rasmata; Medah, Isaie; Sangare, Lassana; Yameogo, Issaka; Sawadogo, Guetawende; Ouedraogo, Abdoul-Salem; Hema-Ouangraoua, Soumeya; McGee, Lesley; Srinivasan, Velusamy; Ake, Flavien; Congo-Ouedraogo, Malika; Sanou, Soufian; Ba, Absatou Ky; Novak, Ryan T.; Van Beneden, Chris		MenAfriNet Consortium	Nationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013	PLOS ONE			English	Article							TIME PCR ASSAYS; STREPTOCOCCUS-PNEUMONIAE; CAPSULAR SEROTYPES; CHILDREN; BURDEN; SURVEILLANCE; EPIDEMICS; OUTBREAK	Background Following introduction of Haemophilus influenzae type b vaccine in 2006 and serogroup A meningococcal conjugate vaccine in 2010, Streptococcus pneumoniae (Sp) became the leading cause of bacterial meningitis in Burkina Faso. We describe bacterial meningitis epidemiology, focusing on pneumococcal meningitis, before 13-valent pneumococcal conjugate vaccine (PCV13) introduction in the pediatric routine immunization program in October 2013. Methods Nationwide population-based meningitis surveillance collects case-level demographic and clinical information and cerebrospinal fluid (CSF) laboratory results. Sp infections are confirmed by culture, real-time polymerase chain reaction (rt-PCR), or latex agglutination, and CSF serotyped using real-time and conventional PCR. We calculated incidence rates in cases per 100,000 persons, adjusting for age and proportion of cases with CSF tested at national reference laboratories, and case fatality ratios (CFR). Results During 2011-2013, 1,528 pneumococcal meningitis cases were reported. Average annual adjusted incidence rates were 26.9 (<1 year), 5.4 (1-4 years), 7.2 (5-14 years), and 3.0 (>= 15 years). Overall CFR was 23% and highest among children aged <1 year (32%) and adults >= 30 years (30%). Of 1,528 cases, 1,036 (68%) were serotyped: 71% were PCV13-associated serotypes, 14% were non-PCV13-associated serotypes, and 15% were non typeable by PCR. Serotypes 1 (45%) and 12F/12A/12B/44/46 (8%) were most common. Among children aged <1 year, serotypes 5 (15%), 6A/6B (13%) and 1 (12%) predominated. Conclusions In Burkina Faso, the highest morbidity and mortality due to pneumococcal meningitis occurred among children aged <1 year. The majority of cases were due to PCV13-associated serotypes; introduction of PCV13 should substantially decrease this burden.	[Kambire, Dinanibe; Ouedraogo-Traore, Rasmata] Ctr Hosp Univ Pediat Charles de Gaulle, Ouagadougou, Burkina Faso; [Soeters, Heidi M.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Soeters, Heidi M.; McGee, Lesley; Srinivasan, Velusamy; Novak, Ryan T.; Van Beneden, Chris] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Medah, Isaie; Yameogo, Issaka; Sawadogo, Guetawende] Minist Sante, Ouagadougou, Burkina Faso; [Sangare, Lassana; Congo-Ouedraogo, Malika] Ctr Hosp Univ Yalgado Ouedraogo, Ouagadougou, Burkina Faso; [Ouedraogo, Abdoul-Salem] Ctr Hosp Univ Souro Sanou, Bobo Dioulasso, Burkina Faso; [Hema-Ouangraoua, Soumeya] Ctr Muraz, Bobo Dioulasso, Burkina Faso; [Ake, Flavien] CDC Fdn, Ouagadougou, Burkina Faso; [Ba, Absatou Ky] Lab Natl Sante Publ, Ouagadougou, Burkina Faso	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centre Muraz	Kambire, D (corresponding author), Ctr Hosp Univ Pediat Charles de Gaulle, Ouagadougou, Burkina Faso.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.; Soeters, HM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.	dinanibekambire@yahoo.fr; hzx8@cdc.gov	Soeters, Heidi/H-3271-2019	Soeters, Heidi/0000-0002-9415-9340	Bill and Melinda Gates Foundation; Gavi; U.S. Centers for Disease Control and Prevention, World Health Organization; Agence de Medecine Preventive	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Gavi; U.S. Centers for Disease Control and Prevention, World Health Organization; Agence de Medecine Preventive	This work was supported by the MenAfriNet Consortium, a partnership between the U.S. Centers for Disease Control and Prevention, World Health Organization, and Agence de Medecine Preventive, through a grant from the Bill and Melinda Gates Foundation, and a grant from Gavi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arditi M, 1998, PEDIATRICS, V102, P1087, DOI 10.1542/peds.102.5.1087; Blumental S, 2015, CLIN VACCINE IMMUNOL, V22, P404, DOI 10.1128/CVI.00758-14; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chandran A, 2011, PEDIATR INFECT DIS J, V30, P3, DOI 10.1097/INF.0b013e3181ef25f7; Cibrelus L, 2015, EMERG INFECT DIS, V21, P2063, DOI 10.3201/eid2111.150304; Collard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060432; Decosas J, 2002, LANCET INFECT DIS, V2, P763, DOI 10.1016/S1473-3099(02)00455-3; Djingarey Mamoudou, 2012, Morbidity and Mortality Weekly Report, V61, P1025; Djingarey MH, 2008, 16 INT PATH NEISS C, pP166; Gessner BD, 2012, VACCINE, V30, pG41, DOI 10.1016/j.vaccine.2012.10.052; Janoff EN., 2015, MANDELL DOUGLAS BENN, V2; Kornelisse RF, 1995, CLIN INFECT DIS, V21, P1390, DOI 10.1093/clinids/21.6.1390; Leimkugel J, 2005, J INFECT DIS, V192, P192, DOI 10.1086/431151; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; Mueller JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052464; Novak RT, 2012, LANCET INFECT DIS, V12, P757, DOI 10.1016/S1473-3099(12)70168-8; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Parent dC I, 2005, CLIN INFECT DIS, V40, P17, DOI DOI 10.1086/426436; Pimenta FC, 2013, J CLIN MICROBIOL, V51, P647, DOI 10.1128/JCM.02927-12; Ritchie ND, 2012, FUTURE MICROBIOL, V7, P33, DOI [10.2217/fmb.11.146, 10.2217/FMB.11.146]; Sanou I, 2014, J MED MICROB DIAGN, V3, P130, DOI [10.4172/2161-0703.1000130, DOI 10.4172/2161-0703.1000130]; Sie A, 2008, TROP MED INT HEALTH, V13, P861, DOI 10.1111/j.1365-3156.2008.02056.x; Traore Y, 2009, CLIN INFECT DIS, V48, pS181, DOI 10.1086/596498; Tunkel AR, 2015, MANDELL DOUGLAS BENN, P1097; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; WHO-AFRO, 2009, STAND OP PROC ENH ME; World Health Organization, 2010, TECHN GUID INT DIS S; Yaro S, 2006, CLIN INFECT DIS, V43, P693, DOI 10.1086/506940	30	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166384	10.1371/journal.pone.0166384	http://dx.doi.org/10.1371/journal.pone.0166384			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832151	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000387725000117
J	Lim, CH; Lin, CH; Chen, DY; Chen, YM; Chao, WC; Liao, TL; Chen, HH				Lim, Chong-Hong; Lin, Ching-Heng; Chen, Der-Yuan; Chen, Yi-Ming; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Hsin-Hua			One-Year Tuberculosis Risk in Rheumatoid Arthritis Patients Starting Their First Tumor Necrosis Factor Inhibitor Therapy from 2008 to 2012 in Taiwan: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							INFECTION; DISEASE; METAANALYSIS	Objective To investigate the risk of tuberculosis (TB) among rheumatoid arthritis (RA) patients within 1 year after initiation of tumor necrosis factor inhibitor (TNFi) therapy from 2008 to 2012. Methods We used the 2003-2013 Taiwanese National Health Insurance Research Database to identify RA patients who started any RA-related medical therapy from 2008 to 2012. Those who initiated etanercept or adalimumab therapy during 2008-2012 were selected as the TNFi group and those who never received biologic disease-modifying anti-rheumatic drug therapy were identified as the comparison group after excluding the patients who had a history of TB or human immunodeficiency virus infection/acquired immune deficiency syndrome. We used propensity score matching (1: 6) for age, sex, and the year of the drug index date to re-select the TNFi group and the non-TNFi controls. After adjusting for potential confounders, hazard ratios (HRs) with 95% confidence intervals (CIs) were calculated to examine the 1-year TB risk in the TNFi group compared with the non-TNFi controls. Subgroup analyses according to the year of treatment initiation and specific TNFi therapy were conducted to assess the trend of 1-year TB risk in TNFi users from 2008 to 2012. Results This study identified 5,349 TNFi-treated RA patients and 32,064 matched non-TNFi-treated controls. The 1-year incidence rates of TB were 1,513 per 10 5 years among the TNFi group and 235 per 10 5 years among the non-TNFi controls (incidence rate ratio, 6.44; 95% CI, 4.69-8.33). After adjusting for age, gender, disease duration, comoridities, history of TB, and concomitant medications, TNFi users had an increased 1-year TB risk (HR, 7.19; 95% CI, 4.18-12.34) compared with the non-TNFi-treated controls. The 1-year TB risk in TNFi users increased from 2008 to 2011 and deceased in 2012 when the Food and Drug Administration in Taiwan announced the Risk Management Plan for patients scheduled to receive TNFi therapy. Conclusion This study showed that the 1-year TB risk in RA patients starting TNFi therapy was significantly higher than that in non-TNFi controls in Taiwan from 2008 to 2012.	[Lim, Chong-Hong] Pulau Pinang Gen Hosp, Dept Internal Med, Rheumatol Unit, Georgetown, Malaysia; [Lim, Chong-Hong; Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Lin, Ching-Heng; Chen, Yi-Ming; Chao, Wen-Cheng; Liao, Tsai-Ling; Chen, Hsin-Hua] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Chen, Hsin-Hua] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Liao, Tsai-Ling; Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming; Liao, Tsai-Ling; Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Hsin-Hua] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Der-Yuan] Taichung Vet Gen Hosp, Dept Med Educ, Taichung, Taiwan; [Chao, Wen-Cheng] Taichung Vet Gen Hosp, Div Chest Med, Dept Internal Med, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, HH (corresponding author), Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan.; Chen, HH (corresponding author), Chung Shan Med Univ, Sch Med, Taichung, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan.; Chen, HH (corresponding author), Natl Yang Ming Univ, Community Med Res Ctr, Taipei, Taiwan.	shc5555@hatmail.com	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Lim, Chong Hong/0000-0003-0752-2154				Ai JW, 2015, J RHEUMATOL, V42, P2229, DOI 10.3899/jrheum.150057; [Anonymous], 2012, RISK MAN PLAN TUM NE; ANTONUCCI G, 1995, JAMA-J AM MED ASSOC, V274, P143, DOI 10.1001/jama.274.2.143; Arkema EV, 2015, ANN RHEUM DIS, V74, P1212, DOI 10.1136/annrheumdis-2013-204960; Carmona L, 2003, J RHEUMATOL, V30, P1436; Centers for Disease Control Ministry of Health and Welfare R.O.C. (Taiwan), 2015, 2015 CTR DIS CONTR A; Chen DY, 2012, ANN RHEUM DIS, V71, P231, DOI 10.1136/annrheumdis-2011-200489; Chen DY, 2011, FORMOSAN J RHEUMATOL, V25, P5; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chen YH, 2012, FORMOSAN J RHEUMATOL, V26, P7; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; Chia S, 1998, INT J TUBERC LUNG D, V2, P989; Chiu YM, 2014, INT J RHEUM DIS, V17, P9, DOI 10.1111/1756-185X.12539; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dixon WG, 2010, ANN RHEUM DIS, V69, P522, DOI 10.1136/ard.2009.118935; Gomez-Reino JJ, 2003, ARTHRITIS RHEUM-US, V48, P2122, DOI 10.1002/art.11137; Gomez-Reino JJ, 2007, ARTHRIT RHEUM-ARTHR, V57, P756, DOI 10.1002/art.22768; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Hu HY, 2014, EPIDEMIOL INFECT, V142, P191, DOI 10.1017/S0950268813000551; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; JUNG Seung, 2015, INT J RHEUM DIS, V18, P323, DOI [10.1111/1756-185X.12530, DOI 10.1111/1756-185X.12530]; Ke WM, 2013, INT J TUBERC LUNG D, V17, P1590, DOI 10.5588/ijtld.13.0368; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Kourbeti IS, 2014, CLIN INFECT DIS, V58, P1649, DOI 10.1093/cid/ciu185; Lawn SD, 2011, LANCET, V378, P57, DOI 10.1016/S0140-6736(10)62173-3; Lee CH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-194; Liao TL, 2015, EMERG INFECT DIS, V21, P1387, DOI 10.3201/eid2108.141846; Lo HY, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-915; Ministry of the Interior, 2015, STUD OLD TAIP PRIS; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; Tam LS, 2010, CLIN EXP RHEUMATOL, V28, P679; Wang JY, 2007, J INFECT DIS, V196, P281, DOI 10.1086/518898; Wood R, 2000, J ACQ IMMUN DEF SYND, V23, P75; World Health Organization, GLOB TUB REP 2016; Wu VC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069556; Yamada T, 2006, ANN RHEUM DIS, V65, P1661, DOI 10.1136/ard.2005.047274; Yasui K, 2014, PEDIATR RHEUMATOL, V12, DOI 10.1186/1546-0096-12-45; Yeh JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110922	40	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166339	10.1371/journal.pone.0166339	http://dx.doi.org/10.1371/journal.pone.0166339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832150	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000101
J	Liu, M; Wang, P; Zhao, M; Liu, D				Liu, Mei; Wang, Peng; Zhao, Min; Liu, Dy			Intestinal Dendritic Cells Are Altered in Number, Maturity and Chemotactic Ability in Fulminant Hepatic Failure	PLOS ONE			English	Article							BACTERIAL TRANSLOCATION; IMMUNE-RESPONSES; INVARIANT CHAIN; LIVER-DISEASE; LYMPH-NODES; CHEMOKINE; MIGRATION; LIGANDS; CCL21; CCR7	Fulminant hepatic failure (FHF) is defined as rapid acute liver injury, often complicated with spontaneous bacterial peritonitis (SBP). The precise onset of FHF with SBP is still unknown, but it is thought that SBP closely correlates with a weakened intestinal barrier. Dendritic cells (DCs) play a crucial role in forming the intestinal immune barrier, therefore the number, maturity and chemotactic ability of intestinal DCs were studied in FHF. Mouse intestinal and spleen DCs were isolated by magnetic-activated cell sorting (MACS) and surface markers of DCs, namely CD11c, CD74, CD83 and CD86, were identified using flow cytometry. Immunohistochemistry and Western blotting were performed to detect the distribution and expression of CC-chemokine receptor 7 (CCR7) and CC-chemokine receptor 9 (CCR9), as well as their ligands-CC-chemokine ligand 21 (CCL21) and CC-chemokine ligand 25 (CCL25). Real-time PCR was used to detect CCR7 and CCR9 mRNA, along with their ligands-CCL21 and CCL25 mRNA. Flow cytometry analysis showed that the markers CD74, CD83 and CD86 of CD11c(+)DCs were lower in the D-galactosamine (D-GalN) group and were significantly decreased in the FHF group, while there were no significant changes in the expression of these markers in the lipopolysaccharide (LPS) group. Immunohistochemistry results showed that staining for CCR7 and CCR9, as well as their ligands-CCL21 and CCL25, was significantly weaker in the D-GalN and FHF groups compared with the normal saline (NS) group or the LPS group; the FHF group even showed completely unstained parts. Protein expression of CCR7 and CCR9, as well as their ligands-CCL21 and CCL25, was also lower in the D-GalN group and decreased even more significantly in the FHF group. At the gene level, CCR7 and CCR9, along with CCL21 and CCL25 mRNA expression, was lower in the D-GalN group and significantly decreased in the FHF group compared to the NS and LPS groups, consisting with the protein expression. Our study indicated that intestinal DCs were decreased in number, maturity and chemotactic ability in FHF and might contribute to a decreased function of the intestinal immune barrier in FHF.	[Liu, Mei; Zhao, Min; Liu, Dy] China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang, Liaoning Provin, Peoples R China; [Wang, Peng] China Med Univ, Shengjing Hosp, Dept Urol 2, Shenyang, Liaoning Provin, Peoples R China	China Medical University; China Medical University	Liu, D (corresponding author), China Med Univ, Shengjing Hosp, Med Res Ctr, Shenyang, Liaoning Provin, Peoples R China.	liudy19701010@sina.com			National Natural Science Foundation of China [30871158, 81170604]; Education Department Foundation of Liaoning Province [LK201620]; Outstanding Scientific Fund of Shengjing Hospital	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department Foundation of Liaoning Province; Outstanding Scientific Fund of Shengjing Hospital	This study was supported by the National Natural Science Foundation of China (#30871158, #81170604), the Education Department Foundation of Liaoning Province (#LK201620), and the Outstanding Scientific Fund of Shengjing Hospital.	Acton SE, 2016, IMMUNOL REV, V271, P221, DOI 10.1111/imr.12414; Bekker P, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628340; Bin Younis B, 2015, PAK J MED SCI, V31, P1009, DOI 10.12669/pjms.314.7618; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Britschgi MR, 2010, EUR J IMMUNOL, V40, P1266, DOI 10.1002/eji.200939921; Cao X, 2015, WORLD J GASTROENTERO, V21, P4883, DOI 10.3748/wjg.v21.i16.4883; Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Frolich D, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3767; Giannelli V, 2014, WORLD J GASTROENTERO, V20, P16795, DOI 10.3748/wjg.v20.i45.16795; Granucci F, 2008, CELL MOL LIFE SCI, V65, P1683, DOI 10.1007/s00018-008-8009-2; Gupta P, 2014, ONCOTARGET, V5, P10170, DOI 10.18632/oncotarget.2526; Johnson LA, 2010, INT IMMUNOL, V22, P839, DOI 10.1093/intimm/dxq435; Karakikes I, 2012, FASEB J, V26, P4886, DOI 10.1096/fj.12-211466; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Li GZ, 2012, WORLD J GASTROENTERO, V18, P5042, DOI 10.3748/wjg.v18.i36.5042; Li J, 2013, ARCH IMMUNOL THER EX, V61, P237, DOI 10.1007/s00005-013-0223-4; Liu DY, 2011, BRAZ J MED BIOL RES, V44, P477, DOI 10.1590/S0100-879X2011007500051; Lutz P, 2015, WORLD J HEPATOL, V7, P304, DOI 10.4254/wjh.v7.i3.304; Mandorfer M, 2014, GASTROENTEROLOGY, V146, P1680, DOI 10.1053/j.gastro.2014.03.005; Marsland BJ, 2005, IMMUNITY, V22, P493, DOI 10.1016/j.immuni.2005.02.010; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Moschovakis GL, 2012, EUR J IMMUNOL, V42, P1949, DOI 10.1002/eji.201242614; Noor S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-77; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Pande C, 2009, ALIMENT PHARM THER, V29, P1273, DOI 10.1111/j.1365-2036.2009.03994.x; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Raju R, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav106; Reiberger T, 2013, J HEPATOL, V58, P911, DOI 10.1016/j.jhep.2012.12.011; Reif K, 2002, NATURE, V416, P94, DOI 10.1038/416094a; Rescigno M, 2010, ADV IMMUNOL, V107, P109, DOI 10.1016/B978-0-12-381300-8.00004-6; Rochereau N, 2011, VACCINE, V29, P3655, DOI 10.1016/j.vaccine.2011.03.012; Rosenkilde MM, 2008, BRIT J PHARMACOL, V153, pS154, DOI 10.1038/sj.bjp.0707660; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yanagawa Y, 2003, BLOOD, V101, P4923, DOI 10.1182/blood-2002-11-3474	40	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166165	10.1371/journal.pone.0166165	http://dx.doi.org/10.1371/journal.pone.0166165			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832135	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000071
J	Stojic-Vukanic, Z; Pilipovic, I; Vujnovic, I; Nacka-Aleksic, M; Petrovic, R; Arsenovic-Ranin, N; Dimitrijevic, M; Leposavic, G				Stojic-Vukanic, Zorica; Pilipovic, Ivan; Vujnovic, Ivana; Nacka-Aleksic, Mirjana; Petrovic, Raisa; Arsenovic-Ranin, Nevena; Dimitrijevic, Mirjana; Leposavic, Gordana			GM-CSF-Producing Th Cells in Rats Sensitive and Resistant to Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; DENDRITIC CELLS; MYELOID CELLS; T(H)17 CELLS; IN-VIVO; EAE; INDUCTION; INFLAMMATION	Given that granulocyte macrophage colony-stimulating factor (GM-CSF) is identified as the key factor to endow auto-reactive Th cells with the potential to induce neuroinflammation in experimental autoimmune encephalomyelitis (EAE) models, the frequency and phenotype of GM-CSF-producing (GM-CSF+) Th cells in draining lymph nodes (dLNs) and spinal cord (SC) of Albino Oxford (AO) and Dark Agouti (DA) rats immunized for EAE were examined. The generation of neuroantigen-specific GM-CSF+ Th lymphocytes was impaired in dLNs of AO rats (relatively resistant to EAE induction) compared with their DA counterparts (susceptible to EAE) reflecting impaired CD4+ lymphocyte proliferation and less supportive of GM-CSF+ Th cell differentiation dLN cytokine microenvironment. Immunophenotyping of GM-CSF+ Th cells showed their phenotypic heterogeneity in both strains and revealed lower frequency of IL-17+ IFN-gamma+, IL-17+ IFN-gamma-, and IL-17-IFN-gamma+ cells accompanied by higher frequency of IL-17-IFN-gamma- cells among them in AO than in DA rats. Compared with DA, in AO rats was also found (i) slightly lower surface density of CCR2 (drives accumulation of highly pathogenic GM-CSF+ IFN-gamma+ Th17 cells in SC) on GM-CSF+ IFN-gamma+ Th17 lymphocytes from dLNs, and (ii) diminished CCL2 mRNA expression in SC tissue, suggesting their impaired migration into the SC. Moreover, dLN and SC cytokine environments in AO rats were shown to be less supportive of GM-CSF+ IFN-gamma+ Th17 cell differentiation (judging by lower expression of mRNAs for IL-1 beta, IL-6 and IL-23/p19). In accordance with the (i) lower frequency of GM-CSF+ Th cells in dLNs and SC of AO rats and their lower GM-CSF production, and (ii) impaired CCL2 expression in the SC tissue, the proportion of proinflammatory monocytes among peripheral blood cells and their progeny (CD45(hi) cells) among the SC CD11b+ cells were reduced in AO compared with DA rats. Collectively, the results indicate that the strain specificities in efficacy of several mechanisms controlling (auto) reactive CD4+ lymphocyte expansion/differentiation into the cells with pathogenic phenotype and migration of the latter to the SC contribute to AO rat resistance to EAE.	[Stojic-Vukanic, Zorica; Arsenovic-Ranin, Nevena] Univ Belgrade, Fac Pharm, Dept Microbiol & Immunol, Belgrade, Serbia; [Pilipovic, Ivan; Vujnovic, Ivana; Petrovic, Raisa; Leposavic, Gordana] Inst Virol Vaccines & Sera Torlak, Immunol Res Ctr Branislav Jankovic, Belgrade, Serbia; [Nacka-Aleksic, Mirjana; Leposavic, Gordana] Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia; [Dimitrijevic, Mirjana] Univ Belgrade, Inst Biol Res Sinisa Stankovic, Dept Immunol, Belgrade, Serbia	University of Belgrade; University of Belgrade; University of Belgrade	Leposavic, G (corresponding author), Inst Virol Vaccines & Sera Torlak, Immunol Res Ctr Branislav Jankovic, Belgrade, Serbia.; Leposavic, G (corresponding author), Univ Belgrade, Fac Pharm, Dept Physiol, Belgrade, Serbia.	Gordana.Leposavic@pharmacy.bg.ac.rs	Dimitrijević, Mirjana/B-9236-2016	Dimitrijević, Mirjana/0000-0002-9094-5248; Nacka-Aleksic, Mirjana/0000-0003-0750-9347	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije [175050]; MNTR of the Republic of Serbia [175050]	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije; MNTR of the Republic of Serbia	Ministarstvo prosvete, nauke i tehnoloskog razvoja Republike Srbije (http://www.mpn.gov.rs/), Grant Number 175050 (GL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work is supported by the grant 175050 (MNTR of the Republic of Serbia). http://www.nature.com/nrd/journal/v1/n1/authors/nrd705.html	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Ambrosini E, 2003, GLIA, V41, P290, DOI 10.1002/glia.10193; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Baxter AG, 2007, NAT REV IMMUNOL, V7, P904, DOI 10.1038/nri2190; Becher B, 2011, CURR OPIN IMMUNOL, V23, P707, DOI 10.1016/j.coi.2011.08.005; Bufan B, 2014, GENETIKA-BELGRADE, V46, P287, DOI 10.2298/GENSR1401287B; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Codarri L, 2013, TRENDS IMMUNOL, V34, P114, DOI 10.1016/j.it.2012.09.007; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Damsker JM, 2010, ANN NY ACAD SCI, V1183, P211, DOI 10.1111/j.1749-6632.2009.05133.x; deLuca LES, 2010, J IMMUNOL, V184, P3174, DOI 10.4049/jimmunol.0902881; Di Rosa F, 2000, INT IMMUNOL, V12, P711, DOI 10.1093/intimm/12.5.711; Djikic J, 2014, EXP GERONTOL, V58, P179, DOI 10.1016/j.exger.2014.08.005; Dogan RNE, 2008, J IMMUNOL, V180, P7376, DOI 10.4049/jimmunol.180.11.7376; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Fletcher JM, 2010, CLIN EXP IMMUNOL, V162, P1, DOI 10.1111/j.1365-2249.2010.04143.x; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Ghosh D, 2016, J LEUKOCYTE BIOL, V100, P747, DOI 10.1189/jlb.3A0815-359R; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Grifka-Walk HM, 2015, EUR J IMMUNOL, V45, P2780, DOI 10.1002/eji.201545800; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Kara EE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9644; Kinetics M., 2008, NEUROSCI LETT, V447, P148, DOI [10.1016/j.neulet.2008.09.082, DOI 10.1016/J.NEULET.2008.09.082]; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Kohler RE, 2003, J IMMUNOL, V170, P6298, DOI 10.4049/jimmunol.170.12.6298; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kreymborg K, 2007, J IMMUNOL, V179, P8098, DOI 10.4049/jimmunol.179.12.8098; KUMAR V, 1993, J EXP MED, V178, P909, DOI 10.1084/jem.178.3.909; Kurschus FC, 2015, BIOMED J, V38, P183, DOI 10.4103/2319-4170.155590; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lukic ML, 2003, NATO SCI SERIES, VI, P29; Markovic M, 2009, MOL IMMUNOL, V47, P141, DOI 10.1016/j.molimm.2009.01.012; MATSUMOTO Y, 1992, J NEUROIMMUNOL, V37, P23, DOI 10.1016/0165-5728(92)90152-B; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Miljkovic D, 2006, J NEUROSCI RES, V84, P379, DOI 10.1002/jnr.20883; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOSTARICASTOJKOVIC M, 1982, CLIN EXP IMMUNOL, V50, P311; Nacka-Aleksic M, 2015, BRAIN BEHAV IMMUN, V49, P101, DOI 10.1016/j.bbi.2015.04.017; Noster R, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008706; Pachner AR, 2011, CURR OPIN NEUROL, V24, P291, DOI 10.1097/WCO.0b013e328346c226; Potzl J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002951; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Roden DM, 2002, NAT REV DRUG DISCOV, V1, P37, DOI 10.1038/nrd705; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sheng W, 2014, CELL RES, V24, P1387, DOI 10.1038/cr.2014.154; Shiomi A, 2016, INFLAMM REGEN, V36, DOI 10.1186/s41232-016-0014-5; Shiomi A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/568543; Siojc-Vukanic Z, 2015, IMMUN AGEING, V12, P16, DOI [10.1186/s12979-015-0044-x, DOI 10.1186/S12979-015-0044-X]; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Stromnes IM, 2006, NAT PROTOC, V1, P1810, DOI 10.1038/nprot.2006.285; Sutton C, 2006, J EXP MED, V203, P1685, DOI 10.1084/jem.20060285; Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002; Varona R, 2006, LEUKEMIA LYMPHOMA, V47, P1469, DOI 10.1080/10428190500513819; Villares R, 2009, EUR J IMMUNOL, V39, P1671, DOI 10.1002/eji.200839123; VUKMANOVIC S, 1989, CELL IMMUNOL, V121, P237, DOI 10.1016/0008-8749(89)90022-1; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155; Zhang GX, 2002, EXP MOL PATHOL, V73, P35, DOI 10.1006/exmp.2002.2441	64	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166498	10.1371/journal.pone.0166498	http://dx.doi.org/10.1371/journal.pone.0166498			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832210	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000131
J	Tabata, N; Sueta, D; Akasaka, T; Arima, Y; Sakamoto, K; Yamamoto, E; Izumiya, Y; Yamamuro, M; Tsujita, K; Kojima, S; Kaikita, K; Morita, K; Oniki, K; Saruwatari, J; Nakagawa, K; Hokimoto, S				Tabata, Noriaki; Sueta, Daisuke; Akasaka, Tomonori; Arima, Yuichiro; Sakamoto, Kenji; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Yamamuro, Megumi; Tsujita, Kenichi; Kojima, Sunao; Kaikita, Koichi; Morita, Kazunori; Oniki, Kentaro; Saruwatari, Junji; Nakagawa, Kazuko; Hokimoto, Seiji			Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CAG PATHOGENICITY ISLAND; SYSTEMIC INFLAMMATION; HEART-DISEASE; MANAGEMENT; INFECTION; STRAINS; RISK; SUSCEPTIBILITY; SECRETION	Background Helicobacter pylori infection and interleukin-1 polymorphisms are associated with an increased risk of gastric cancer. We examined the prevalence of Helicobacter pylori seropositivity and interleukin-1 polymorphisms between ST-segment elevation myocardial infarction and non-ST-segment elevation acute coronary syndrome patients. Methods We recruited consecutive acute coronary syndrome patients, and 101 non-ST-segment elevation acute coronary syndrome patients and 103 ST-segment elevation myocardial infarction patients were enrolled. Interleukin-1 polymorphism analyses were performed for single nucleotide polymorphism in interleukin-1 beta-511 and the variable number of tandem repeats polymorphism in the interleukin-1 receptor antagonist by polymerase chain reaction. Immunoglobulin G antibodies against Helicobacter pylori and high sensitivity C-reactive protein were also measured. Results The rates of the simultaneous presence of interleukin-1 polymorphisms and Helicobacter pylori-seropositivity between non-ST-segment elevation acute coronary syndrome and ST-segment elevation myocardial infarction groups were 25.7% and 42.7%, respectively (P = 0.012). Helicobacter pylori-seropositive subjects with interleukin-1 polymorphisms showed significantly higher levels of high sensitivity C-reactive protein (0.04-0.12 vs. 0.02-0.05; P< 0.001). Multivariate logistic regression analysis revealed that the carriage of Helicobacter pylori-seropositivity and interleukin-1 polymorphisms was significantly associated with STsegment elevation myocardial infarction (odds ratio, 2.32; 95% confidence interval, 1.23-4.37; P = 0.009). The C-statistic of conventional risk factors was 0.68 (P<0.001) and that including Helicobacter pylori-seropositivity and interleukin- 1 polymorphisms was 0.70 (P< 0.001); continuous net reclassification improvement was 34% (P = 0.0094) and integrated discrimination improvement was 3.0% (P = 0.014). Conclusions The coincidence of Helicobacter pylori-seropositivity and interleukin- 1 polymorphisms was significantly associated with higher levels of high sensitivity C-reactive protein and the increased risk of ST-segment elevation myocardial infarction.	[Tabata, Noriaki; Sueta, Daisuke; Akasaka, Tomonori; Arima, Yuichiro; Sakamoto, Kenji; Yamamoto, Eiichiro; Izumiya, Yasuhiro; Yamamuro, Megumi; Tsujita, Kenichi; Kojima, Sunao; Kaikita, Koichi; Hokimoto, Seiji] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan; [Morita, Kazunori; Oniki, Kentaro; Saruwatari, Junji; Nakagawa, Kazuko] Kumamoto Univ, Grad Sch Med & Pharmaceut Sci, Div Pharmacol & Therapeut, Kumamoto, Japan	Kumamoto University; Kumamoto University	Hokimoto, S (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto, Japan.	shokimot@kumamoto-u.ac.jp	Saruwatari, Junji/Q-7748-2019; Tsujita, Kenichi/AAG-4562-2021	Saruwatari, Junji/0000-0001-6266-1347; Kojima, Sunao/0000-0002-1916-7252				Abbott JD, 2007, AM J CARDIOL, V100, P190, DOI 10.1016/j.amjcard.2007.02.083; Akopyants NS, 1998, MOL MICROBIOL, V28, P37, DOI 10.1046/j.1365-2958.1998.00770.x; Barua RS, 2010, THROMB RES, V126, P426, DOI 10.1016/j.thromres.2010.07.021; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; D'Aiuto F, 2004, CYTOKINE, V28, P29, DOI 10.1016/j.cyto.2004.06.005; Daida H, 2013, CIRC J, V77, P934, DOI 10.1253/circj.CJ-13-0174; Danesh J, 1999, BRIT MED J, V319, P1157, DOI 10.1136/bmj.319.7218.1157; Dong L, 2015, AM J CARDIOL, V115, P860, DOI 10.1016/j.amjcard.2015.01.008; El-Omar EM, 2001, GUT, V48, P743, DOI 10.1136/gut.48.6.743; Folsom AR, 1998, CIRCULATION, V98, P845, DOI 10.1161/01.CIR.98.9.845; Fujioka T, 2000, JPN J MED PHARM SCI, V43, P573; Gabrielli M, 2004, EUR HEART J, V25, P64, DOI 10.1016/j.ehj.2003.10.004; Georges JL, 2003, AM J CARDIOL, V92, P515, DOI 10.1016/S0002-9149(03)00717-3; Hamajima N, 2001, JPN J CANCER RES, V92, P383, DOI 10.1111/j.1349-7006.2001.tb01106.x; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hong YJ, 2010, J CARDIOL, V56, P15, DOI 10.1016/j.jjcc.2010.01.010; Hwang IR, 2002, GASTROENTEROLOGY, V123, P1793, DOI 10.1053/gast.2002.37043; Ikeda A, 2013, ATHEROSCLEROSIS, V230, P67, DOI 10.1016/j.atherosclerosis.2013.06.013; Liu J, 2015, HELICOBACTER, V20, P176, DOI 10.1111/hel.12188; Maeda S, 1999, GUT, V44, P336, DOI 10.1136/gut.44.3.336; Mather AN, 2013, INT J CARDIOL, V166, P458, DOI 10.1016/j.ijcard.2011.11.004; MATTILA KJ, 1989, BRIT MED J, V298, P779, DOI 10.1136/bmj.298.6676.779; Mazurkiewicz L, 2009, ANN NONINVAS ELECTRO, V14, P4, DOI 10.1111/j.1542-474X.2008.00267.x; Pasceri V, 1998, CIRCULATION, V97, P1675, DOI 10.1161/01.CIR.97.17.1675; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pietroiusti A, 2002, CIRCULATION, V106, P580, DOI 10.1161/01.CIR.0000023894.10871.2F; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; Reibis R, 2014, CLIN CARDIOL, V37, P213, DOI 10.1002/clc.22241; RICHARDS B, 1993, HUM MOL GENET, V2, P159, DOI 10.1093/hmg/2.2.159; Ridker PM, 2001, ANN INTERN MED, V135, P184, DOI 10.7326/0003-4819-135-3-200108070-00010; SAIKKU P, 1988, LANCET, V2, P983, DOI 10.1016/S0140-6736(88)90741-6; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; Shimoda A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18346; Sousa H, 2013, ARCH ORAL BIOL, V58, P1040, DOI 10.1016/j.archoralbio.2013.02.004; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tabata N, 2016, CLIN TRIALS REGUL SC, V17, P9; Tabata N, 2016, INT J CARDIOL, V212, P54, DOI 10.1016/j.ijcard.2016.03.034; Thygesen K, 2012, EUR HEART J, V33, P2551, DOI 10.1093/eurheartj/ehs184; Undas A, 2008, ATHEROSCLEROSIS, V196, P551, DOI 10.1016/j.atherosclerosis.2007.05.028; Undas A, 2011, ARTERIOSCL THROM VAS, V31, pE88, DOI 10.1161/ATVBAHA.111.230631; Undas A, 2011, POL ARCH MED WEWN, V121, P310, DOI 10.20452/pamw.1083; Wu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059996; Zhu JH, 2002, AM J CARDIOL, V89, P155, DOI 10.1016/S0002-9149(01)02192-0	45	13	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166240	10.1371/journal.pone.0166240	http://dx.doi.org/10.1371/journal.pone.0166240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832202	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000082
J	Makins, C; Ghosh, S; Roman-Melendez, GD; Malec, PA; Kennedy, RT; Marsh, ENG				Makins, Caitlyn; Ghosh, Soumi; Roman-Melendez, Gabriel D.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.			Does Viperin Function as a Radical S-Adenosyl-L-methionine-dependent Enzyme in Regulating Farnesylpyrophosphate Synthase Expression and Activity?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-INDUCIBLE PROTEIN; ADENOSYLMETHIONINE ENZYMES; VIRUS-REPLICATION; SAM SUPERFAMILY; BOND FORMATION; BIOSYNTHESIS; ELONGATOR; MECHANISM; INFECTION; DOMAIN	Viperin is an endoplasmic reticulum-associated antiviral responsive protein that is highly up-regulated in eukaryotic cells upon viral infection through both interferon-dependent and independent pathways. Viperin is predicted to be a radical S-adenosyl-L-methionine (SAM) enzyme, but it is unknown whether viperin actually exploits radical SAM chemistry to exert its antiviral activity. We have investigated the interaction of viperin with its most firmly established cellular target, farnesyl pyrophosphate synthase (FPPS). Numerous enveloped viruses utilize cholesterol-rich lipid rafts to bud from the host cell membrane, and it is thought that by inhibiting FPPS activity (and therefore cholesterol synthesis), viperin retards viral budding from infected cells. We demonstrate that, consistent with this hypothesis, overexpression of viperin in human embryonic kidney cells reduces the intracellular rate of accumulation of FPPS but does not inhibit or inactivate FPPS. The endoplasmic reticulum-localizing, N-terminal amphipathic helix of viperin is specifically required for viperin to reduce cellular FPPS levels. However, although viperin reductively cleaves SAM to form 5'-deoxyadenosine in a slow, uncoupled reaction characteristic of radical SAM enzymes, this cleavage reaction is independent of FPPS. Furthermore, mutation of key cysteinyl residues ligating the catalytic [Fe4S4] cluster in the radical SAM domain, surprisingly, does not abolish the inhibitory activity of viperin against FPPS; indeed, some mutations potentiate viperin activity. These observations imply that viperin does not act as a radical SAM enzyme in regulating FPPS.	[Makins, Caitlyn; Ghosh, Soumi; Roman-Melendez, Gabriel D.; Malec, Paige A.; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Makins, Caitlyn; Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu		Malec, Paige/0000-0002-9853-6078; Ghosh, Soumi/0000-0001-6101-0147	National Institutes of Health [GM 093088, DK 046960]; Natural Sciences and Engineering Research Council of Canada; National Science Foundation Award [DBI-0959823]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046960, R37DK046960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grants GM 093088 (to E. N. G. M.) and DK 046960 (to R. T. K.), a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (to C. M.), and National Science Foundation Award DBI-0959823 (to the SMART Center of the University of Michigan). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALLINGER MD, 1992, BIOCHEMISTRY-US, V31, P949, DOI 10.1021/bi00119a001; Bonissone S, 2013, MOL CELL PROTEOMICS, V12, P14, DOI 10.1074/mcp.M112.019075; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Chatterjee A, 2008, NAT CHEM BIOL, V4, P758, DOI 10.1038/nchembio.121; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Coquille S, 2013, J STRUCT BIOL, V184, P438, DOI 10.1016/j.jsb.2013.10.005; Davidson VL, 2012, BBA-PROTEINS PROTEOM, V1824, P1299, DOI 10.1016/j.bbapap.2012.01.008; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Fluhe L, 2013, CURR OPIN CHEM BIOL, V17, P605, DOI 10.1016/j.cbpa.2013.06.031; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; Fugate CJ, 2012, BBA-PROTEINS PROTEOM, V1824, P1213, DOI 10.1016/j.bbapap.2012.01.010; Fujimori DG, 2013, CURR OPIN CHEM BIOL, V17, P597, DOI 10.1016/j.cbpa.2013.05.032; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Kavanagh KL, 2006, P NATL ACAD SCI USA, V103, P7829, DOI 10.1073/pnas.0601643103; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Landgraf BJ, 2016, ANNU REV BIOCHEM, V85, P485, DOI 10.1146/annurev-biochem-060713-035504; Marsh ENG, 2010, CHEMBIOCHEM, V11, P604, DOI 10.1002/cbic.200900777; Miskiewicz K, 2011, NEURON, V72, P776, DOI 10.1016/j.neuron.2011.10.010; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; Roach PL, 2011, CURR OPIN CHEM BIOL, V15, P267, DOI 10.1016/j.cbpa.2010.11.015; Ruszczycky MW, 2012, BBA-PROTEINS PROTEOM, V1824, P1231, DOI 10.1016/j.bbapap.2011.11.006; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Selvadurai K, 2014, NAT CHEM BIOL, V10, P810, DOI [10.1038/nchembio.1610, 10.1038/NCHEMBIO.1610]; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Tsoumpra MK, 2015, BONE, V81, P478, DOI 10.1016/j.bone.2015.08.020; Upadhyay AS, 2014, CELL MICROBIOL, V16, P834, DOI 10.1111/cmi.12241; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Wang JR, 2014, ACS CHEM BIOL, V9, P1929, DOI 10.1021/cb5004674; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Yang LL, 2012, BIOCHEMISTRY-US, V51, P7173, DOI 10.1021/bi3010945; Young AP, 2013, CURR OPIN CHEM BIOL, V17, P613, DOI 10.1016/j.cbpa.2013.05.035; Zhang Q, 2012, ACCOUNTS CHEM RES, V45, P555, DOI 10.1021/ar200202c	39	23	23	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26806	26815		10.1074/jbc.M116.751040	http://dx.doi.org/10.1074/jbc.M116.751040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834682	hybrid, Green Published			2022-12-26	WOS:000391571400019
J	Xie, QS; Xu, Y; Wang, ZP; Xu, C; Zou, PC; Lin, ZY; Xu, CJ; Yang, C; Kang, FY; Wong, CP				Xie, Qisen; Xu, Yang; Wang, Zhipeng; Xu, Chao; Zou, Peichao; Lin, Ziyin; Xu, Chenjie; Yang, Cheng; Kang, Feiyu; Wong, Ching-Ping			Vapor-Phase Polymerized Poly( 3,4-Ethylenedioxythiophene) on a Nickel Nanowire Array Film: Aqueous Symmetrical Pseudocapacitors with Superior Performance	PLOS ONE			English	Article							CONDUCTING POLYMER; ELECTROCHEMICAL CAPACITORS; CYCLING STABILITY; ENERGY-STORAGE; SUPERCAPACITORS; ELECTRODES; POLYPYRROLE; HYBRID; NANOPARTICLES; NANOSHEETS	Three-dimensional (3D) nanometal scaffolds have gained considerable attention recently because of their promising application in high-performance supercapacitors compared with plain metal foils. Here, a highly oriented nickel (Ni) nanowire array (NNA) film was prepared via a simple magnetic-field-driven aqueous solution deposition process and then used as the electrode scaffold for the vapor-phase polymerization of 3,4-ethylenedioxythiophene (EDOT). Benefiting from the unique 3D open porous structure of the NNA that provided a highly conductive and oriented backbone for facile electron transfer and fast ion diffusion, the as-obtained poly(3,4-ethylenedioxythiophene) (PEDOT) exhibited an ultra-long cycle life (95.7% retention of specific capacitance after 20 000 charge/discharge cycles at 5 A/g) and superior capacitive performance. Furthermore, two electrodes were fabricated into an aqueous symmetric supercapacitor, which delivered a high energy density (30.38 Wh/kg at 529.49 W/kg) and superior long-term cycle ability (13.8% loss of capacity after 20 000 cycles). Based on these results, the vapor-phase polymerization of EDOT on metal nanowire array current collectors has great potential for use in supercapacitors with enhanced performance.	[Xie, Qisen; Xu, Yang; Wang, Zhipeng; Xu, Chao; Zou, Peichao; Yang, Cheng; Kang, Feiyu] Tsinghua Univ, Grad Sch Shenzhen, Div Energy & Environm, Shenzhen, Guangdong, Peoples R China; [Lin, Ziyin; Wong, Ching-Ping] Georgia Inst Technol, Sch Mat Sci & Engn, Atlanta, GA 30332 USA; [Xu, Chenjie] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore, Singapore	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; University System of Georgia; Georgia Institute of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yang, C (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Energy & Environm, Shenzhen, Guangdong, Peoples R China.	yang.cheng@sz.tsinghua.edu.cn	Wong, CP/M-6587-2017; xu, chenjie/E-4075-2012	Wong, CP/0000-0003-3556-8053; Xu, Chenjie/0000-0002-8278-3912; Kang, Feiyu/0000-0002-3704-4379; Zou, Peichao/0000-0003-0148-7482	National Key Basic Research Program of China [2014CB932400]; Guangdong Province Science and Technology Department [20146090917002, 2014A010105002, 2015A030306010]; Nanshan District "Rising Stars" [KC2014JSQN0010A]	National Key Basic Research Program of China(National Basic Research Program of China); Guangdong Province Science and Technology Department; Nanshan District "Rising Stars"	We are grateful to the National Key Basic Research Program of China (Project No. 2014CB932400), Guangdong Province Science and Technology Department (Project No. 20146090917002 & 2014A010105002 & 2015A030306010), and Nanshan District "Rising Stars" (Project No. KC2014JSQN0010A).	Anothumakkool B, 2015, ENERG ENVIRON SCI, V8, P1339, DOI 10.1039/c5ee00142k; Aradilla D, 2014, RSC ADV, V4, P26462, DOI 10.1039/c4ra03192j; Chen GF, 2015, CHEM-EUR J, V21, P4614, DOI 10.1002/chem.201405976; Chen X, 2015, J ELECTROANAL CHEM, V743, P99, DOI 10.1016/j.jelechem.2015.02.004; D'Arcy JM, 2014, ACS NANO, V8, P1500, DOI 10.1021/nn405595r; DeLongchamp D, 2001, ADV MATER, V13, P1455, DOI 10.1002/1521-4095(200110)13:19<1455::AID-ADMA1455>3.0.CO;2-7; Duay J, 2012, PHYS CHEM CHEM PHYS, V14, P3329, DOI 10.1039/c2cp00019a; Hu CX, 2015, RSC ADV, V5, P14441, DOI 10.1039/c4ra12220h; Jiang WC, 2015, ADV FUNCT MATER, V25, P1063, DOI 10.1002/adfm.201403354; Jiang YQ, 2013, NANO LETT, V13, P3524, DOI 10.1021/nl400921p; Jo K, 2015, CHEM MATER, V27, P7982, DOI 10.1021/acs.chemmater.5b03296; Kawamori M, 2014, NANO LETT, V14, P1932, DOI 10.1021/nl404753e; Kawamori M, 2011, J ELECTROCHEM SOC, V158, pE79, DOI 10.1149/1.3596703; Lee S, 2012, J MATER CHEM, V22, P1899, DOI 10.1039/c1jm13739e; Li C, 2004, MACROMOLECULES, V37, P2411, DOI 10.1021/ma035188w; Liu CG, 2010, NANO LETT, V10, P4863, DOI 10.1021/nl102661q; Liu R, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/21/215710; Liu TY, 2014, NANO LETT, V14, P2522, DOI 10.1021/nl500255v; Mo DZ, 2014, ELECTROCHIM ACTA, V132, P67, DOI 10.1016/j.electacta.2014.03.083; Padinger F, 2003, ADV FUNCT MATER, V13, P85, DOI 10.1002/adfm.200390011; Pang H, 2013, J MATER CHEM A, V1, P5053, DOI 10.1039/c3ta10523g; Shao MF, 2015, SMALL, V11, P3530, DOI 10.1002/smll.201403421; Song Y, 2015, ADV FUNCT MATER, V25, P4626, DOI 10.1002/adfm.201501709; Su YZ, 2014, J MATER CHEM A, V2, P13845, DOI 10.1039/c4ta02486a; Su Z., 2014, SCIENCE, V7, P2652, DOI DOI 10.1039/C4EE01195C; Sun D, 2013, CHEMPLUSCHEM, V78, P227, DOI 10.1002/cplu.201200206; Tong LY, 2015, J POWER SOURCES, V297, P195, DOI 10.1016/j.jpowsour.2015.06.128; Wang Z, 2015, ADV MATER SCI ENG, V2015, DOI 10.1155/2015/165631; Wang ZH, 2016, J MATER CHEM A, V4, P1714, DOI 10.1039/c5ta10122k; Wang ZP, 2015, ELECTROCHIM ACTA, V184, P338, DOI 10.1016/j.electacta.2015.10.085; Wang ZP, 2014, LANGMUIR, V30, P15581, DOI 10.1021/la503948f; Wang ZS, 2003, CHEM MATER, V15, P807, DOI 10.1021/cm0204268; Winther-Jensen B, 2008, SCIENCE, V321, P671, DOI 10.1126/science.1159267; Xia C, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401805; Xiao K, 2014, ELECTROCHIM ACTA, V149, P341, DOI 10.1016/j.electacta.2014.10.117; Xu C, 2016, ADV MATER, V28, P4105, DOI 10.1002/adma.201505644; Yang YJ, 2013, J MATER SCI-MATER EL, V24, P2245, DOI 10.1007/s10854-013-1086-5; Yu GH, 2013, NANO ENERGY, V2, P213, DOI 10.1016/j.nanoen.2012.10.006; Yu GH, 2011, NANO LETT, V11, P2905, DOI 10.1021/nl2013828; Zhang JT, 2012, J PHYS CHEM C, V116, P5420, DOI 10.1021/jp211474e; Zhang LL, 2009, CHEM SOC REV, V38, P2520, DOI 10.1039/b813846j; Zhou CS, 2013, ANAL CHEM, V85, P1171, DOI 10.1021/ac303107d; Zhou H, 2013, CARBON, V59, P495, DOI 10.1016/j.carbon.2013.03.045; Zhou Y, 2014, J MATER CHEM A, V2, P9964, DOI 10.1039/c4ta01785d	44	12	12	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166529	10.1371/journal.pone.0166529	http://dx.doi.org/10.1371/journal.pone.0166529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861534	Green Published, gold			2022-12-26	WOS:000388350300069
J	McDaniel, J; Piner, K; Lee, HH; Hill, K				McDaniel, Jenny; Piner, Kevin; Lee, Hui-Hua; Hill, Kevin			Evidence that the Migration of the Northern Subpopulation of Pacific Sardine (Sardinops sagax) off the West Coast of the United States Is Age-Based	PLOS ONE			English	Article							CALIFORNIA CURRENT; STOCK ASSESSMENT; SOUTHERN CALIFORNIA; BAJA-CALIFORNIA; ATLANTIC COD; POPULATION; FISH; DISCRIMINATION; SELECTIVITY; MANAGEMENT	Analysis of fish movements has been an important area of study for fisheries ecology and population dynamics for decades. Pacific sardine, Sardinops sagax, along the west coast of the United States exhibit a well-defined large-scale seasonal migration. Larger and older fish are found in the northern reaches of their range during summer and contract to southerly offshore areas for spawning during spring. Because of the close correlation between fish size and age it has not yet been determined if movements are size- or age-based. Measuring spatial changes in the age structure conditioned on individual lengths was used to determine the roles of age versus length in the seasonal migration. S. sagax have a pattern of increasing age-at-length with seasonal northward movements and offshore movements for spawning. The pattern of increasing age-at-length with distance from the origin eliminates a solely length-based process of movement and supports age-based movement. Patterns in the size and age when fish first show migratory behaviors, coupled with the patterns observed during the spawning season, support a hypothesis that migratory behaviors are linked to age-based ontogenetic changes associated with maturation.	[McDaniel, Jenny; Piner, Kevin; Lee, Hui-Hua; Hill, Kevin] NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA	National Oceanic Atmospheric Admin (NOAA) - USA	McDaniel, J (corresponding author), NOAA, Fisheries Resources Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, La Jolla, CA 92038 USA.	Jenny.McDaniel@noaa.gov						Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Clark F. N., 1945, Fishery Bulletin Sacramento, VNo. 61, P63; Clark F. N., 1945, Fishery Bulletin Sacramento, VNo. 61, P7; Clark F. N., 1955, Progress Reports California Ocean Fish Invest, V1953-55, P11; Corten A, 1999, ICES J MAR SCI, V56, P207, DOI 10.1006/jmsc.1998.0429; Demer DA, 2014, ICES J MAR SCI, V71, P328, DOI 10.1093/icesjms/fst135; Demer DA, 2012, FISH B-NOAA, V110, P52; Dorval E, 2013, CAL COOP OCEAN FISH, V54, P192; Felix-Uraga R, 2005, CAL COOP OCEAN FISH, V46, P113; Felix-Uraga R, 2004, CAL COOP OCEAN FISH, V45, P146; Flostrand L, 2014, CAN SCI ADVIS SEC RE, V113, P1; Francis RICC, 2016, FISH RES, V180, P77, DOI 10.1016/j.fishres.2015.02.018; Garcia-Morales R., 2012, CURR DEV OCEANOGR, V5, P23; Hill Kevin T., 2015, NOAA Technical Memorandum NMFS-SWFSC, V546, P1; Hoyle Simon D., 2006, Inter-American Tropical Tuna Commission Stock Assessment Report, V6, P3; Humston R, 2000, FISH OCEANOGR, V9, P136, DOI 10.1046/j.1365-2419.2000.00132.x; Humston R, 2004, T AM FISH SOC, V133, P1304, DOI 10.1577/T03-040.1; Jacobson LD, 1996, CAN J FISH AQUAT SCI, V53, P600, DOI 10.1139/f95-207a; Janssen J. F., 1945, Fishery Bulletin Sacramento, VNo. 61, P43; JANSSEN JOHN F., 1937, CALIFORNIA FISH AND GAME, V23, P190; JANSSEN JOHN F., 1938, CALIFORNIA FISH AND GAME, V24, P376; Jorgensen C, 2009, EVOL APPL, V2, P356, DOI 10.1111/j.1752-4571.2009.00075.x; KRAMER D, 1971, COMMER FISH REV, V33, P7; Le Bris A, 2013, ICES J MAR SCI, V70, P793, DOI 10.1093/icesjms/fst068; Lee HH, 2017, J FISH BIOL, V90, P222, DOI 10.1111/jfb.13177; Leggett W.C., 1985, Contributions in Marine Science, V27, P277; Lluch-B. D., 1991, P293; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Lo NCH, 2011, B MAR SCI, V87, P395, DOI 10.5343/bms.2010.1077; Lo NCH, 2010, FISH B-NOAA, V108, P174; MacCall AD, 2012, ICES J MAR SCI, V69, P267, DOI 10.1093/icesjms/fss008; Maunder MN, 2015, ICES J MAR SCI, V72, P7, DOI 10.1093/icesjms/fsu015; McClatchie S, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150628; McFarlane GA, 2002, AM FISH S S, V32, P195; McFarlane GA, 1999, PICES S SIDN CAN; Nottestad L, 1999, CAN J FISH AQUAT SCI, V56, P26, DOI 10.1139/cjfas-56-S1-26; PARRISH RH, 1989, CAN J FISH AQUAT SCI, V46, P2019, DOI 10.1139/f89-251; Piner KR, 2016, FISH RES, V180, P128, DOI 10.1016/j.fishres.2015.05.024; Polovina JJ, 1996, FISH OCEANOGR, V5, P114, DOI 10.1111/j.1365-2419.1996.tb00110.x; Radovich J., 1982, CALCOFI REPORTS, V23, P56; Robichaud D, 2004, FISH FISH, V5, P185, DOI 10.1111/j.1467-2679.2004.00141.x; Sampson DB, 2014, FISH RES, V158, P5, DOI 10.1016/j.fishres.2013.10.004; Schueller AM, 2014, FISH RES, V158, P26, DOI 10.1016/j.fishres.2013.10.023; Sharpe DMT, 2009, EVOL APPL, V2, P260, DOI 10.1111/j.1752-4571.2009.00080.x; Smith PE, 2005, CAL COOP OCEAN FISH, V46, P75; Taylor NG, 2005, CAN J FISH AQUAT SCI, V62, P215, DOI 10.1139/F04-189; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; von Bertalanffy L, 1938, HUM BIOL, V10, P181, DOI DOI 10.2307/41447359; VROOMAN AM, 1964, J FISH RES BOARD CAN, V21, P691, DOI 10.1139/f64-062; WALKER MM, 1984, J COMP PHYSIOL, V155, P673, DOI 10.1007/BF00610853; Yaremko ML, 1996, NOAATMNMFSSWFSC223, V223, P39	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166780	10.1371/journal.pone.0166780	http://dx.doi.org/10.1371/journal.pone.0166780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851805	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300085
J	Alfano, G; Kruczek, PM; Shah, AZ; Kramarz, B; Jeffery, G; Zelhof, AC; Bhattacharya, SS				Alfano, Giovanna; Kruczek, Przemyslaw M.; Shah, Amna Z.; Kramarz, Barbara; Jeffery, Glen; Zelhof, Andrew C.; Bhattacharya, Shomi S.			EYS Is a Protein Associated with the Ciliary Axoneme in Rods and Cones	PLOS ONE			English	Article							MUTATIONS; EYES; DIFFERENTIATION; DYSTROPHY; CELLS	Purpose Mutations in the EYS gene are a common cause of autosomal recessive retinitis pigmentosa (arRP), yet the role of the EYS protein in humans is presently unclear. The aim of this study was to investigate the isoform structure, expression and potential function of EYS in the mammalian retina in order to better understand its involvement in the pathogenesis of arRP. Methods To achieve the objective, we examined the expression of mRNA transcripts of EYS isoforms in human tissues and cell lines by RT-PCR. We also investigated the localisation of EYS in cultured cells and retinal cryo-sections by confocal fluorescence microscopy and Western blot analysis. Results RT-PCR analysis confirmed that EYS has at least four isoforms. In addition to the previously reported EYS isoforms 1 and 4, we present the experimental validation of two smaller variants referred to as EYS isoforms 2 and 3. All four isoforms are expressed in the human retina and Y79 cells and the short variants were additionally detected in the testis. Immunofluorescent confocal microscopy and Western blot analysis revealed that all EYS isoforms preferentially localise to the cytoplasm of Y79 and HeLa cells. Moreover, an enrichment of the endogenous protein was observed near the centrosomes in Y79 cells. Interestingly, EYS was observed at the ciliary axoneme in Y79 ciliated cells. In macaque retinal cryosections, EYS was found to localise in the region of the photoreceptor ciliary axoneme in both rods and cones as well as in the cytoplasm of the ganglion cells. Conclusion The results obtained in this study lead us to speculate that, in photoreceptor cells, EYS could be a protein involved in maintaining the stability of the ciliary axoneme in both rods and cones. The variability of its isoform structure suggests that other roles are also possible and yet to be established.	[Alfano, Giovanna; Kruczek, Przemyslaw M.; Shah, Amna Z.; Kramarz, Barbara; Jeffery, Glen; Bhattacharya, Shomi S.] UCL, Inst Ophthalmol, London EC1V 9EL, England; [Zelhof, Andrew C.] Indiana Univ, Dept Biol, 1001 East Third St, Bloomington, IN 47405 USA	University of London; University College London; Indiana University System; Indiana University Bloomington	Alfano, G (corresponding author), UCL, Inst Ophthalmol, London EC1V 9EL, England.	g.alfano@ucl.ac.uk	Bhattacharya, Shom/N-2926-2016	Bhattacharya, Shom/0000-0002-1601-6344; Zelhof, Andrew/0000-0001-7085-822X; Kramarz, Barbara/0000-0002-3898-1727	British Eye Research Foundation (Fight for Sight) [1111438, 1933/ST1107D]; Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust) [298582, M233-CD1]; Special Trustees of Moorfields Eye Hospital General Fund [228064]; Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust) [1140679]; National Institute for Health Research personal award; National Institute of Health [R21 EY024125]; NATIONAL EYE INSTITUTE [R21EY024125] Funding Source: NIH RePORTER	British Eye Research Foundation (Fight for Sight); Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust); Special Trustees of Moorfields Eye Hospital General Fund; Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust); National Institute for Health Research personal award; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the British Eye Research Foundation (Fight for Sight; charity number 1111438, PhD Studentship 1933/ST1107D to SSB); the Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust; charity number 298582) [Grant Number M233-CD1 to AZS, GA, and SSB]; the Special Trustees of Moorfields Eye Hospital General Fund (Charity Number 228064) personal award to SSB for infrastructure; the Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679) personal award to SSB for infrastructure; and the National Institute for Health Research personal award to SSB for infrastructure. ACZ was supported by National Institute of Health (R21 EY024125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank Dr. Naushin Waseem and Beverley Scott for their support with DNA sequencing. This work was supported by the British Eye Research Foundation (Fight for Sight; charity number 1111438, PhD Studentship 1933/ST1107D to SSB]; the Teresa Rosenbaum Golden Charitable Trust (Rosetrees Trust; charity number 298582) [Grant Number M233-CD1 to AZS, GA, and SSB]; the Special Trustees Of Moorfields Eye Hospital General Fund (Charity Number 228064) personal award to SSB for infrastructure; the Moorfields Eye Charity (Moorfields Eye Hospital NHS Foundation Trust; charity number 1140679) personal award to SSB for infrastructure; and the National Institute for Health Research personal award to SSB for infrastructure. ACZ was supported by National Institute of Health (R21 EY024125).	Abd El-Aziz MM, 2008, NAT GENET, V40, P1285, DOI 10.1038/ng.241; Anasagasti A, 2012, VISION RES, V75, P117, DOI 10.1016/j.visres.2012.09.012; Arai Y, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/819760; Barragan I, 2010, HUM MUTAT, V31, pE1772, DOI 10.1002/humu.21334; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bonilha VL, 2015, GRAEF ARCH CLIN EXP, V253, P295, DOI 10.1007/s00417-014-2868-z; Collin RWJ, 2008, AM J HUM GENET, V83, P594, DOI 10.1016/j.ajhg.2008.10.014; Cook B, 2008, NATURE, V452, P361, DOI 10.1038/nature06603; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Iwanami M, 2012, INVEST OPHTH VIS SCI, V53, P1033, DOI 10.1167/iovs.11-9048; Katagiri S, 2014, DOC OPHTHALMOL, V128, P211, DOI 10.1007/s10633-014-9435-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kowal TJ, 2015, CELL BIOL INT, V39, P1341, DOI 10.1002/cbin.10500; KYRITSIS A, 1984, EXP EYE RES, V38, P411, DOI 10.1016/0014-4835(84)90196-9; Littink KW, 2010, INVEST OPHTH VIS SCI, V51, P5943, DOI 10.1167/iovs.10-5797; Liu MM, 2013, CLIN GENET, V84, P142, DOI 10.1111/cge.12181; Nie J, 2012, DEV BIOL, V371, P312, DOI 10.1016/j.ydbio.2012.08.024; Raj B, 2015, NEURON, V87, P14, DOI 10.1016/j.neuron.2015.05.004; TSOKOS M, 1986, AM J PATHOL, V123, P542; Vento R, 1997, MOL CELL BIOCHEM, V170, P163, DOI 10.1023/A:1006813705101; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Zhang PB, 2015, PROTEOMICS, V15, P836, DOI 10.1002/pmic.201400397	26	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166397	10.1371/journal.pone.0166397	http://dx.doi.org/10.1371/journal.pone.0166397			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846257	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600057
J	Eichberg, C; Wohde, M; Muller, K; Rausch, A; Scherrmann, C; Scheuren, T; During, RA; Donath, TW				Eichberg, Carsten; Wohde, Manuel; Mueller, Kerstin; Rausch, Anja; Scherrmann, Christina; Scheuren, Theresa; Duering, Rolf-Alexander; Donath, Tobias W.			The Anthelmintic Ingredient Moxidectin Negatively Affects Seed Germination of Three Temperate Grassland Species	PLOS ONE			English	Article							MACROCYCLIC LACTONES; DISPERSAL; IVERMECTIN; RESTORATION; TOXICITY; IMPACT; SHEEP; DUNG; PHARMACOKINETICS; CONSEQUENCES	In animal farming, anthelmintics are regularly applied to control gastrointestinal nematodes. There is plenty of evidence that also non-target organisms, such as dung beetles, are negatively affected by residues of anthelmintics in faeces of domestic ungulates. By contrast, knowledge about possible effects on wild plants is scarce. To bridge this gap of knowledge, we tested for effects of the common anthelmintic formulation Cydectin and its active ingredient moxidectin on seed germination. We conducted a feeding experiment with sheep and germination experiments in a climate chamber. Three wide-spread plant species of temperate grasslands (Centaurea jacea, Galium verum, Plantago lanceolate) were studied. We found significant influences of both, Cydectin and moxidectin, on germination of the tested species. Across species, both formulation and active ingredient solely led to a decrease in germination percentage and synchrony of germination and an increase in mean germination time with the formulation showing a more pronounced response pattern. Our study shows for the first time that anthelmintics have the potential to negatively affect plant regeneration. This has practical implications for nature conservation since our results suggest that treatments of livestock with anthelmintics should be carefully timed to not impede endozoochorous seed exchange between plant populations.	[Eichberg, Carsten; Mueller, Kerstin; Rausch, Anja; Scherrmann, Christina; Scheuren, Theresa] Univ Trier, Reg & Environm Sci, Geobot, Trier, Germany; [Wohde, Manuel; Duering, Rolf-Alexander] Justus Liebig Univ, Inst Soil Sci & Soil Conservat, Giessen, Germany; [Donath, Tobias W.] Christian Albrechts Univ Kiel, Inst Nat Resource Conservat, Dept Landscape Ecol, Kiel, Germany	Universitat Trier; Justus Liebig University Giessen; University of Kiel	Eichberg, C (corresponding author), Univ Trier, Reg & Environm Sci, Geobot, Trier, Germany.	eichberg@uni-trier.de	Donath, Tobias W./B-2856-2012; Eichberg, Carsten/J-1970-2014	Donath, Tobias W./0000-0003-1874-1096; 				AFZAL J, 1994, J AGR FOOD CHEM, V42, P1767, DOI 10.1021/jf00044a037; Albert A, 2015, OIKOS, V124, P1109, DOI 10.1111/oik.02512; Bakker JP, 1999, TRENDS ECOL EVOL, V14, P63, DOI 10.1016/S0169-5347(98)01544-4; Bartikova H, 2016, CHEMOSPHERE, V144, P2290, DOI 10.1016/j.chemosphere.2015.10.137; Bartuszevige AM, 2008, J ARID ENVIRON, V72, P904, DOI 10.1016/j.jaridenv.2007.11.007; Baskin CC, 2014, SEEDS ECOLOGY BIOGGE; Beynon SA, 2012, VET PARASITOL, V189, P113, DOI 10.1016/j.vetpar.2012.03.040; Cobb R, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S2-S5; Coop R. L., 2002, P303, DOI 10.1079/9780851996172.0303; Cosyns E, 2005, J ECOL, V93, P353, DOI 10.1111/j.0022-0477.2005.00982.x; D'hondt B, 2011, PLANT BIOLOGY, V13, P118, DOI 10.1111/j.1438-8677.2010.00335.x; Eichberg C, 2007, FLORA, V202, P3, DOI 10.1016/j.flora.2006.01.004; Elter A, 2007, J BIOL CHEM, V282, P8786, DOI 10.1074/jbc.M607241200; Faust C, 2011, BASIC APPL ECOL, V12, P215, DOI 10.1016/j.baae.2011.02.009; FDAH (Fort Dodge Animal Health), 2001, ENV ASS CYDECTIN MOX, P1; Floate KD, 2002, B ENTOMOL RES, V92, P471, DOI 10.1079/BER2002201; Freund L, 2014, APPL VEG SCI, V17, P74, DOI 10.1111/avsc.12052; Ghassali F, 1998, EXP AGR, V34, P391, DOI 10.1017/S0014479798004086; Hempel H, 2006, ENVIRON TOXICOL CHEM, V25, P3155, DOI 10.1897/06-022R2.1; Iwasa M, 2008, APPL ENTOMOL ZOOL, V43, P271, DOI 10.1303/aez.2008.271; Jager E, 2011, ROTHMALER EXKURSIONS; Kadiri N, 1999, ANN SOC ENTOMOL FR, V35, P222; Kiehl K, 2010, BASIC APPL ECOL, V11, P285, DOI 10.1016/j.baae.2009.12.004; Kuiters AT, 2010, APPL VEG SCI, V13, P163, DOI 10.1111/j.1654-109X.2009.01058.x; Lifschitz A, 2005, J VET PHARMACOL THER, V28, P411, DOI 10.1111/j.1365-2885.2005.00674.x; Lloberas M, 2013, INT J PARASITOL-DRUG, V3, P20, DOI 10.1016/j.ijpddr.2012.11.001; Lumaret JP, 2012, CURR PHARM BIOTECHNO, V13, P1004, DOI 10.2174/138920112800399257; MALO JE, 1995, OECOLOGIA, V104, P246, DOI 10.1007/BF00328589; Mancilla-Leyton JM, 2012, SMALL RUMINANT RES, V107, P12, DOI 10.1016/j.smallrumres.2012.04.001; Martin R. J., 2002, P125, DOI 10.1079/9780851996172.0125; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Ozinga WA, 2009, ECOL LETT, V12, P66, DOI 10.1111/j.1461-0248.2008.01261.x; Pakeman RJ, 2002, FUNCT ECOL, V16, P296, DOI 10.1046/j.1365-2435.2002.00625.x; Perez R, 2001, VET J, V161, P85, DOI 10.1053/tvjl.2000.0521; Prichard R, 2012, INT J PARASITOL-DRUG, V2, P134, DOI 10.1016/j.ijpddr.2012.04.001; Pywell RF, 2002, J APPL ECOL, V39, P294, DOI 10.1046/j.1365-2664.2002.00718.x; Ranal Marli A., 2009, Braz. J. Bot., V32, P849, DOI 10.1590/S0100-84042009000400022; Ranal Marli A., 2006, Braz. J. Bot., V29, P1, DOI 10.1590/S0100-84042006000100002; Rendell D, 1996, AUST VET J, V73, P35, DOI 10.1111/j.1751-0813.1996.tb09954.x; Rosas CA, 2008, J VEG SCI, V19, P769, DOI 10.3170/2008-8-18447; Rosenthal G, 2012, TUEXENIA, P167; Ruhl AT, 2016, SEED SCI RES, V26, P93, DOI 10.1017/S0960258516000106; SAGAR GR, 1964, J ECOL, V52, P189, DOI 10.2307/2257792; Suarez VH, 2009, ECOTOX ENVIRON SAFE, V72, P1551, DOI 10.1016/j.ecoenv.2007.11.009; Sutherland I., 2010, GASTROINTESTINAL NEM; Traveset A, 1998, ECOL EVOL SYST, V1, P151, DOI DOI 10.1078/1433-8319-00057; Ulyatt M. J., 1986, Control of digestion and metabolism in ruminants. Proceedings of the Sixth International Symposium on Ruminant Physiology held at Banff, Canada, September 10th-14th, 1984, P498; Vercruysse J, 2002, MACROCYCLIC LACTONES; Ward JM, 2009, ANNU REV PHYSIOL, V71, P59, DOI 10.1146/annurev.physiol.010908.163204; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	50	9	9	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166366	10.1371/journal.pone.0166366	http://dx.doi.org/10.1371/journal.pone.0166366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846249	gold, Green Published			2022-12-26	WOS:000387794600051
J	Chen, WH; Zheng, LR; Li, KY; Wang, Q; Liu, GZ; Jiang, Q				Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing			A Novel and Effective Method for Congestive Heart Failure Detection and Quantification Using Dynamic Heart Rate Variability Measurement	PLOS ONE			English	Article							SENSITIVITY; SYSTEM	Risk assessment of congestive heart failure (CHF) is essential for detection, especially helping patients make informed decisions about medications, devices, transplantation, and end-of- life care. The majority of studies have focused on disease detection between CHF patients and normal subjects using short-/long-term heart rate variability (HRV) measures but not much on quantification. We downloaded 116 nominal 24-hour RR interval records from the MIT/BIH database, including 72 normal people and 44 CHF patients. These records were analyzed under a 4-level risk assessment model: no risk (normal people, N), mild risk (patients with New York Heart Association (NYHA) class I-II, P1), moderate risk (patients with NYHA III, P2), and severe risk (patients with NYHA III-IV, P3). A novel multistage classification approach is proposed for risk assessment and rating CHF using the non-equilibrium decision-tree-based support vector machine classifier. We propose dynamic indices of HRV to capture the dynamics of 5-minute short term HRV measurements for quantifying autonomic activity changes of CHF. We extracted 54 classical measures and 126 dynamic indices and selected from these using backward elimination to detect and quantify CHF patients. Experimental results show that the multistage risk assessment model can realize CHF detection and quantification analysis with total accuracy of 96.61%. The multistage model provides a powerful predictor between predicted and actual ratings, and it could serve as a clinically meaningful outcome providing an early assessment and a prognostic marker for CHF patients.	[Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Sun Yat Sen Univ, Sch Engn, Guangzhou, Guangdong, Peoples R China; [Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Sci & Technol Planning Project Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Chen, Wenhui; Zheng, Lianrong; Li, Kunyang; Wang, Qian; Liu, Guanzheng; Jiang, Qing] Guangdong Prov Engn & Technol Ctr Adv & Portable, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, GZ; Jiang, Q (corresponding author), Sun Yat Sen Univ, Sch Engn, Guangzhou, Guangdong, Peoples R China.; Liu, GZ; Jiang, Q (corresponding author), Sci & Technol Planning Project Guangdong Prov, Guangzhou, Guangdong, Peoples R China.; Liu, GZ; Jiang, Q (corresponding author), Guangdong Prov Engn & Technol Ctr Adv & Portable, Guangzhou, Guangdong, Peoples R China.	liugzh3@163.com; qjiang@mail.sysu.edu.cn			natural science foundation of China [61401521]; natural science foundation of Guangdong province [2014A030310163]	natural science foundation of China(National Natural Science Foundation of China (NSFC)); natural science foundation of Guangdong province(National Natural Science Foundation of Guangdong Province)	This work was supported by the natural science foundation of China (61401521), the natural science foundation of Guangdong province (2014A030310163).	Asyali MH, 2003, P ANN INT IEEE EMBS, V25, P200, DOI 10.1109/IEMBS.2003.1279568; BAIM DS, 1986, J AM COLL CARDIOL, V7, P661, DOI 10.1016/S0735-1097(86)80478-8; Bradley BD, 2013, CRIT CARE MED, V41, P433, DOI 10.1097/CCM.0b013e31826a47de; Camm AJ, 1996, CIRCULATION, V93, P1043; Cirugeda-Roldan E, 2014, ENTROPY-SWITZ, V16, P5901, DOI 10.3390/e16115901; D'Addio G, 2003, COMPUT CARDIOL, V30, P449, DOI 10.1109/CIC.2003.1291189; De Jong Marla J, 2005, J Cardiovasc Nurs, V20, P186; Duda R.O., 2006, PATTERN CLASSIFICATI; Flavell C, 2001, CIRCULATION, V104, pE89, DOI 10.1161/hc4301.099136; Fleg JL, 2000, CIRCULATION, V102, P1591, DOI 10.1161/01.CIR.102.13.1591; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Isler Y, 2007, COMPUT BIOL MED, V37, P1502, DOI 10.1016/j.compbiomed.2007.01.012; Kishi T, 2012, J CARDIOL, V59, P117, DOI 10.1016/j.jjcc.2011.12.006; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Liu GZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093399; Madzarov G, 2009, INFORM-J COMPUT INFO, V33, P225; Maestri R, 2007, J CARDIOVASC ELECTR, V18, P425, DOI 10.1111/j.1540-8167.2007.00728.x; Mao KZ, 2004, IEEE T SYST MAN CY B, V34, P629, DOI 10.1109/TSMCB.2002.804363; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Melillo P, 2013, IEEE J BIOMED HEALTH, V17, P727, DOI 10.1109/JBHI.2013.2244902; Mortara A, 1997, CIRCULATION, V96, P246; Pecchia L, 2011, IEEE T BIO-MED ENG, V58, P800, DOI 10.1109/TBME.2010.2092776; Pecchia L, 2011, IEEE T INF TECHNOL B, V15, P40, DOI 10.1109/TITB.2010.2091647; Provost F, 1998, MACH LEARN, V30, P127, DOI 10.1023/A:1007442505281; Rao AM, 2002, PROCEEDINGS OF THE IEEE 28TH ANNUAL NORTHEAST BIOENGINEERING CONFERENCE, P167, DOI 10.1109/NEBC.2002.999518; Raphael C, 2007, HEART, V93, P476, DOI 10.1136/hrt.2006.089656; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; Takahashi F, 2002, ICONIP'02: PROCEEDINGS OF THE 9TH INTERNATIONAL CONFERENCE ON NEURAL INFORMATION PROCESSING, P1418; Verkerk AO, 2003, CIRCULATION, V108, P760, DOI 10.1161/01.CIR.0000083719.51661.B9; Xue H, 2011, IEEE T NEURAL NETWOR, V22, P573, DOI 10.1109/TNN.2011.2108315; YBae BJ, 2001, TUBERCULOSIRESP DI, V71, P46; Yu SN, 2012, COMPUT BIOL MED, V42, P816, DOI 10.1016/j.compbiomed.2012.06.005; Zhou SX, 2009, EUROPACE, V11, P245, DOI 10.1093/europace/eun383; Zhu Y, 2014, IEEE T BIO-MED ENG, V61, P938, DOI 10.1109/TBME.2013.2292693	34	36	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0165304	10.1371/journal.pone.0165304	http://dx.doi.org/10.1371/journal.pone.0165304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835634	gold, Green Submitted, Green Published			2022-12-26	WOS:000387779200004
J	Godbout, R; Legare, S; Auger, M; Carpentier, C; Otis, F; Auger, M; Lague, P; Voyer, N				Godbout, Raphael; Legare, Sebastien; Auger, Maud; Carpentier, Claudia; Otis, Francois; Auger, Michele; Lague, Patrick; Voyer, Normand			Membrane Assembly and Ion Transport Ability of a Fluorinated Nanopore	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; AMINO-ACIDS; HALOGEN-BOND; FORCE-FIELD; CHANNEL; DESIGN; CHEMISTRY; MODELS; CHARMM; STABILITY	A novel 21-residue peptide incorporating six fluorinated amino acids was prepared. It was designed to fold into an amphiphilic alpha helical structure of nanoscale length with one hydrophobic face and one fluorinated face. The formation of a fluorous interface serves as the main vector for the formation of a superstructure in a bilayer membrane. Fluorescence assays showed this ion channel's ability to facilitate the translocation of alkali metal ions through a phospholipid membrane, with selectivity for sodium ions. Computational studies showed that a tetramer structure is the most probable and stable supramolecular assembly for the active ion channel structure. The results illustrate the possibility of exploiting multiple F delta(-):M+ interactions for ion transport and using fluorous interfaces to create functional nanostructures.	[Godbout, Raphael; Carpentier, Claudia; Otis, Francois; Voyer, Normand] Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada; [Legare, Sebastien; Lague, Patrick] Univ Laval, Dept Biochim Microbiol & Bioinformat, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada; [Auger, Maud; Auger, Michele] Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Ctr Rech Mat Avances CERMA,Ctr Quebecois Mat Fonc, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Voyer, N (corresponding author), Univ Laval, Dept Chim, Regrp Quebecois Rech Fonct Struct & Ingn Prot PRO, Quebec City, PQ, Canada.	normand.voyer@chm.ulaval.ca		Lague, Patrick/0000-0002-5236-4979	Fond de recherche du Quebec-Nature et technologic [182605-NV]	Fond de recherche du Quebec-Nature et technologic	This work was supported by Fond de recherche du Quebec-Nature et technologic (182605-NV), www.frqnt.gouv.qc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERFELDT KS, 1993, ACCOUNTS CHEM RES, V26, P191, DOI 10.1021/ar00028a009; Benachir T, 1996, BIOPHYS J, V70, P831, DOI 10.1016/S0006-3495(96)79622-4; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bilgicer B, 2001, J AM CHEM SOC, V123, P4393, DOI 10.1021/ja002961j; Buer BC, 2012, P NATL ACAD SCI USA, V109, P4810, DOI 10.1073/pnas.1120112109; Chan TY, 1996, TETRAHEDRON LETT, V37, P8097, DOI 10.1016/0040-4039(96)01849-7; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; Curran DP, 2008, J FLUORINE CHEM, V129, P898, DOI 10.1016/j.jfluchem.2008.05.025; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Fyles TM, 2007, CHEM SOC REV, V36, P335, DOI 10.1039/b603256g; Gokel GW, 2013, ACCOUNTS CHEM RES, V46, P2824, DOI 10.1021/ar400026x; Gottler LM, 2008, BIOCHEMISTRY-US, V47, P4484, DOI 10.1021/bi702476f; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Horvath IT, 1998, ACCOUNTS CHEM RES, V31, P641, DOI 10.1021/ar970342i; Jentzsch AV, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1902; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JULLIEN L, 1988, TETRAHEDRON LETT, V29, P3803, DOI 10.1016/S0040-4039(00)82119-X; Kaucher MS, 2006, J AM CHEM SOC, V128, P38, DOI 10.1021/ja056888e; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krishnamurthy VM, 2013, METHODS MOL BIOL, V1063, P227, DOI 10.1007/978-1-62703-583-5_13; LEAR JD, 1988, SCIENCE, V240, P1177, DOI 10.1126/science.2453923; Marsh ENG, 2014, ACCOUNTS CHEM RES, V47, P2878, DOI 10.1021/ar500125m; MONTAL M, 1995, ANNU REV BIOPH BIOM, V24, P31, DOI 10.1146/annurev.bb.24.060195.000335; Montenegro J, 2013, ACCOUNTS CHEM RES, V46, P2955, DOI 10.1021/ar400061d; Moszynski JM, 2010, ORG BIOMOL CHEM, V8, P5139, DOI 10.1039/c0ob00194e; Naarmann N, 2006, ANGEW CHEM INT EDIT, V45, P2588, DOI 10.1002/anie.200503567; Nyakatura EK, 2013, RSC ADV, V3, P6319, DOI 10.1039/c3ra41110a; Otis F, 2011, J AM CHEM SOC, V133, P6481, DOI 10.1021/ja110336s; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Priimagi A, 2013, ACCOUNTS CHEM RES, V46, P2686, DOI 10.1021/ar400103r; Sakai N, 2003, CHEM-EUR J, V9, P223, DOI 10.1002/chem.200390016; Salwiczek M, 2012, CHEM SOC REV, V41, P2135, DOI 10.1039/c1cs15241f; Salwiczek M, 2009, CHEM-EUR J, V15, P7628, DOI 10.1002/chem.200802136; Schrey A, 2000, ANGEW CHEM INT EDIT, V39, P900, DOI 10.1002/(SICI)1521-3773(20000303)39:5<900::AID-ANIE900>3.0.CO;2-D; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; SHARPE AG, 1990, J CHEM EDUC, V67, P309, DOI 10.1021/ed067p309; SMITH DW, 1977, J CHEM EDUC, V54, P540, DOI 10.1021/ed054p540; Son S, 2006, CHEMBIOCHEM, V7, P1251, DOI 10.1002/cbic.200500420; TABUSHI I, 1982, TETRAHEDRON LETT, V23, P4601, DOI 10.1016/S0040-4039(00)85664-6; Tomalia DA, 2003, NAT MATER, V2, P711, DOI 10.1038/nmat1004; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wang W, 2009, CHEM-EUR J, V15, P10543, DOI 10.1002/chem.200900898; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Yoder NC, 2002, CHEM SOC REV, V31, P335, DOI 10.1039/b201097f; Zheng J, 2015, HDB ION CHANNELS	47	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166587	10.1371/journal.pone.0166587	http://dx.doi.org/10.1371/journal.pone.0166587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835700	Green Submitted, Green Published, gold			2022-12-26	WOS:000387779200061
J	Kim, BR; Choi, SH; Yun, TJ; Lee, ST; Park, CK; Kim, TM; Kim, JH; Park, SW; Sohn, CH; Park, SH; Kim, IH				Kim, Bo Ram; Choi, Seung Hong; Yun, Tae Jin; Lee, Soon-Tae; Park, Chui-Kee; Kim, Tae Min; Kim, Ji-Hoon; Park, Sun-Won; Sohn, Chui-Ho; Park, Sung-Hye; Kim, Il Han			MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction	PLOS ONE			English	Article							TEMOZOLOMIDE; RECURRENCE; PATTERNS; BRAIN; RADIOTHERAPY; GLIOMAS; BEVACIZUMAB; ADJUVANT; INVASION; CRITERIA	Purpose To analyze the enhancement patterns and apparent diffusion coefficient (ADC) values of non-measurable surgical cavity wall enhancement pattern, newly appearing after completion of standard concurrent chemoradiotherapy (CCRT) with temozolomide in glioblastoma patients for the prognosis prediction. Materials and Methods From January 2010 to April 2014, among 190 patients with histopathologically confirmed glioblastoma, a total of 33 patients with non-measurable wall enhancement on post-CCRT MR imaging were enrolled and divided into two subgroups: non-progression (n = 18) and progression groups (n = 15). We analyzed the wall enhancement patterns, which were categorized into three patterns: thin, thick and nodular enhancement. ADC values were measured in the enhancing portions of the walls. The progression-free survival (PFS) related to the wall enhancement was analyzed by Kaplan-Meier analysis, and survival curves were compared using the log-rank test. Results Statistically significant differences in the surgical cavity wall enhancement patterns was shown between the progression and non-progression groups (P = 0.0032). Thin wall enhancement was more frequently observed in the non-progression group, and thick or nodular wall enhancement were observed in the progression group (P = 0.0016). There was no statistically significant difference in the mean ADC values between the progression and non-progression groups. The mean PFS was longer in patients with thin wall enhancement than in those with nodular or thick wall enhancement (35.5 months vs. 15.8 months, P = 0.008). Conclusion Pattern analysis of non-measurable surgical cavity wall enhancement on post-CCRT MR imaging might be useful tool for predicting prognosis of GBM patient before clear progression of non-measurable disease.	[Kim, Bo Ram; Choi, Seung Hong; Yun, Tae Jin; Kim, Ji-Hoon; Sohn, Chui-Ho] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Lee, Soon-Tae] Seoul Natl Univ Hosp, Dept Neurol, Seoul, South Korea; [Park, Chui-Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Kim, Tae Min] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Park, Sun-Won] Boramae Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Sung-Hye] Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Kim, Il Han] Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Choi, SH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.	verocay@snuh.org	Park, Chul-Kee/O-7842-2019; Sohn, ChulHo/AAV-4565-2021; Park, Chul-Kee/J-5499-2012	Park, Chul-Kee/0000-0002-2350-9876; Kim, Bo Ram/0000-0002-5968-3884; Lee, Soon-Tae/0000-0003-4767-7564	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs [HI16C1111]; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; Creative-Pioneering Researchers Program through Seoul National University (SNU);  [IBS-R006-D1]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs; Brain Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Creative-Pioneering Researchers Program through Seoul National University (SNU); 	The scientific guarantor of this publication is Seung Hong Choi. The authors of this manuscript declare no relationships with any companies. This study has received funding by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (HI16C1111); by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Creative-Pioneering Researchers Program through Seoul National University (SNU),; and by Project Code (IBS-R006-D1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The scientific guarantor of this publication is Seung Hong Choi. The authors of this manuscript declare no relationships with any companies. This study has received funding by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs (HI16C1111); by the Brain Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Creative-Pioneering Researchers Program through Seoul National University (SNU),; and by Project Code (IBS-R006-D1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandes AA, 2009, J CLIN ONCOL, V27, P1275, DOI 10.1200/JCO.2008.19.4969; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Dobelbower MC, 2011, J MED IMAG RADIAT ON, V55, P77, DOI 10.1111/j.1754-9485.2010.02232.x; Does MD, 1999, MAGNET RESON MED, V41, P236, DOI 10.1002/(SICI)1522-2594(199902)41:2<236::AID-MRM4>3.0.CO;2-3; Ekinci G, 2003, EUR J RADIOL, V45, P99, DOI 10.1016/S0720-048X(02)00027-X; Ellingson BM, 2011, J NEURO-ONCOL, V105, P91, DOI 10.1007/s11060-011-0567-8; Farace P, 2013, J NEURO-ONCOL, V111, P177, DOI 10.1007/s11060-012-0997-y; Gzell CE, 2016, J NEURO-ONCOL, V128, P67, DOI 10.1007/s11060-016-2074-4; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hayashida Y, 2006, AM J NEURORADIOL, V27, P1419; Hwang EJ, 2013, J NEURO-ONCOL, V112, P427, DOI 10.1007/s11060-013-1072-z; Jeon HJ, 2009, CLIN NEUROL NEUROSUR, V111, P679, DOI 10.1016/j.clineuro.2009.06.013; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Majos C, 2015, EUROPEAN RADIOLOGY, P1; Milano MT, 2010, INT J RADIAT ONCOL, V78, P1147, DOI 10.1016/j.ijrobp.2009.09.018; Nagashima G, 1999, SURG NEUROL, V51, P292, DOI 10.1016/S0090-3019(98)00056-1; Oh J, 2011, CAN J NEUROL SCI, V38, P621, DOI 10.1017/S0317167100012166; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Petrecca K, 2013, J NEURO-ONCOL, V111, P19, DOI 10.1007/s11060-012-0983-4; Schaefer PW, 2000, RADIOLOGY, V217, P331, DOI 10.1148/radiology.217.2.r00nv24331; Sehgal V, 2006, J MAGN RESON IMAGING, V24, P41, DOI 10.1002/jmri.20598; Sherriff J, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120414; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick W, 2008, NEURO-ONCOLOGY, V10, P1019, DOI 10.1215/15228517-2008-058	26	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166096	10.1371/journal.pone.0166096	http://dx.doi.org/10.1371/journal.pone.0166096			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835666	Green Published, Green Submitted, gold			2022-12-26	WOS:000387779200024
J	Bellomo, G; Marcocci, F; Bianchini, D; Mezzenga, E; D'Errico, V; Menghi, E; Zannoli, R; Sarnelli, A				Bellomo, Giovanni; Marcocci, Francesco; Bianchini, David; Mezzenga, Emilio; D'Errico, Vincenzo; Menghi, Enrico; Zannoli, Romano; Sarnelli, Anna			MR Spectroscopy in Prostate Cancer: New Algorithms to Optimize Metabolite Quantification	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; EPITHELIAL-CELLS; SEMINAL FLUID; BASIS-SET; QUANTITATION; CITRATE; BIOPSY; LOCALIZATION; SIMULATIONS; LCMODEL	Prostate cancer (PCa) is the most common non-cutaneous cancer in male subjects and the second leading cause of cancer-related death in developed countries. The necessity of a non-invasive technique for the diagnosis of PCa in early stage has grown through years. Proton magnetic resonance spectroscopy (H-1-MRS) and proton magnetic resonance spectroscopy imaging (H-1-MRSI) are advanced magnetic resonance techniques that can mark the presence of metabolites such as citrate, choline, creatine and polyamines in a selected voxel, or in an array of voxels (in MRSI) inside prostatic tissue. Abundance or lack of these metabolites can discriminate between pathological and healthy tissue. Although the use of magnetic resonance spectroscopy (MRS) is well established in brain and liver with dedicated software for spectral analysis, quantification of metabolites in prostate can be very difficult to achieve, due to poor signal to noise ratio and strong J-coupling of the citrate. The aim of this work is to develop a software prototype for automatic quantification of citrate, choline and creatine in prostate. Its core is an original fitting routine that makes use of a fixed step gradient descent minimization algorithm (FSGD) and MRS simulations developed with the GAMMA libraries in C++. The accurate simulation of the citrate spin systems allows to predict the correct J-modulation under different NMR sequences and under different coupling parameters. The accuracy of the quantifications was tested on measurements performed on a Philips Ingenia 3T scanner using homemade phantoms. Some acquisitions in healthy volunteers have been also carried out to test the software performance in vivo.	[Bellomo, Giovanni; Marcocci, Francesco; Bianchini, David; Mezzenga, Emilio; D'Errico, Vincenzo; Menghi, Enrico; Sarnelli, Anna] Ist Sci Romagnolo Studio & Cura Tumori IRCCS, Med Phys Unit, Meldola, FC, Italy; [Zannoli, Romano] Univ Bologna, Expt Diagnost & Specialty Med Dept DIMES, Bologna, Italy	IRCCS Meldola (IRST); University of Bologna	Marcocci, F (corresponding author), Ist Sci Romagnolo Studio & Cura Tumori IRCCS, Med Phys Unit, Meldola, FC, Italy.	francesco.marcocci@irst.emr.it	Bellomo, Giovanni/AAE-1090-2021; Mezzenga, Emilio/Q-1018-2018; Sarnelli, Anna/V-4284-2018	Bellomo, Giovanni/0000-0003-0456-5650; Mezzenga, Emilio/0000-0002-0150-7757; Sarnelli, Anna/0000-0001-5986-3845				Ackerstaff E, 2001, CANCER RES, V61, P3599; Basharat M, 2014, NMR BIOMED, V27, P459, DOI 10.1002/nbm.3082; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Caivano R, 2012, J MED IMAG RADIAT ON, V56, P606, DOI 10.1111/j.1754-9485.2012.02449.x; Costello LC, 1997, UROLOGY, V50, P3, DOI 10.1016/S0090-4295(97)00124-6; Garcia-Martin ML, 2011, MAGN RESON MED, V65, P329, DOI 10.1002/mrm.22631; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Gonzalez R.C., 2009, DIGITAL IMAGE PROCES, V2nd; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Jung AJ, 2014, J MAGN RESON IMAGING, V40, P314, DOI 10.1002/jmri.24383; KAVANAGH JP, 1985, J REPROD FERTIL, V75, P35; Keevil SF, 2006, PHYS MED BIOL, V51, pR579, DOI 10.1088/0031-9155/51/16/R01; Kobus T, 2014, NMR BIOMED, V27, P39, DOI 10.1002/nbm.2973; Kurhanewicz J, 2000, NEOPLASIA, V2, P166, DOI 10.1038/sj.neo.7900081; Levitt M. H., 2013, SPIN DYNAMICS BASICS; LYNCH MJ, 1994, J PHARMACEUT BIOMED, V12, P5, DOI 10.1016/0731-7085(94)80004-9; Mullerad M, 2005, J UROLOGY, V174, P2158, DOI 10.1097/01.ju.0000181224.95276.82; Nagarajan R, 2013, MAGN RESON INSIGHTS, V6, P51, DOI 10.4137/MRI.S10861; Nagarajan R, 2012, J MAGN RESON IMAGING, V36, P697, DOI 10.1002/jmri.23676; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Ouzzane A, 2015, J UROLOGY, V194, P350, DOI 10.1016/j.juro.2015.02.2938; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Ratiney H, 2005, NMR BIOMED, V18, P1, DOI 10.1002/nbm.895; Reynolds G, 2006, MAGN RESON MED, V56, P1211, DOI 10.1002/mrm.21081; Sarkar BK, 2014, FRONT BIOSCI-LANDMRK, V19, P1186, DOI 10.2741/4275; Schipper RG, 2003, BIOCHEM SOC T, V31, P375, DOI 10.1042/BST0310375; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008; Stables LA, 1999, J MAGN RESON, V140, P305, DOI 10.1006/jmre.1998.1850; StarLack J, 1997, MAGN RESON MED, V38, P311, DOI 10.1002/mrm.1910380222; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Thompson RB, 1999, MAGNET RESON MED, V41, P1162, DOI 10.1002/(SICI)1522-2594(199906)41:6<1162::AID-MRM12>3.0.CO;2-N; vanderGraaf M, 1996, J MAGN RESON SER B, V112, P58, DOI 10.1006/jmrb.1996.0109; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang P, 2008, KOREAN J RADIOL, V9, P432, DOI 10.3348/kjr.2008.9.5.432; Ward JF, 2005, BJU INT, V95, P751, DOI 10.1111/j.1464-410X.2005.05394.x	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165730	10.1371/journal.pone.0165730	http://dx.doi.org/10.1371/journal.pone.0165730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832096	gold, Green Submitted, Green Published			2022-12-26	WOS:000387725000032
J	Das Gupta, S; Mackenzie, MD				Das Gupta, Sanatan; Mackenzie, M. Derek			Spatial Patterns of Soil Respiration Links Above and Belowground Processes along a Boreal Aspen Fire Chronosequence	PLOS ONE			English	Article							CARBON-DIOXIDE EFFLUX; COARSE WOODY DEBRIS; BLACK SPRUCE; MICROBIAL BIOMASS; FOREST SOIL; CO2 EFFLUX; ECOSYSTEM RESPIRATION; SEASONAL-VARIATION; ENZYME-ACTIVITIES; ROOT RESPIRATION	Fire in boreal ecosystems is known to affect CO2 efflux from forest soils, which is commonly termed soil respiration (Rs). However, there is limited information on how fire and recovery from this disturbance affects spatial variation in Rs. The main objective of this study was to quantify the spatial variability of Rs over the growing season in a boreal aspen (Populus tremuloides Michx.) fire chronosequence. The chronosequence included three stands in northern Alberta; a post fire stand (1 year old, PF), a stand at canopy closure (9 years old, CC), and a mature stand (72 years old, MA). Soil respiration, temperature and moisture were measured monthly from May to August using an intensive spatial sampling protocol (n = 42, minimum lag = 2 m). Key aboveground and belowground properties were measured one time at each sampling point. No spatial structure was detected in Rs of the PF stand during the peak growing season (June and July), whereas Rs was auto-correlated at a scale of < 6 m in the CC and MA stands. The PF stand had the lowest mean Rs (4.60 pmol C m(-2) s(-1)) followed by the CC (5.41 pmol C m(-2) s(-1)), and the MA (7.32 pmol C m(-2) s(-1)) stand. Forest floor depth was the only aboveground factor that influenced the spatial pattern of Rs in all three stands and was strongest in the PF stand. Enzyme activity and fine root biomass, on the other hand, were the significant belowground factors driving the spatial pattern of Rs in the CC and MA stands. Persistent joint aboveground and belowground control on Rs in the CC and MA stands indicates a tight spatial coupling, which was not observed in the PF stand. Overall, the current study suggests that fire in the boreal aspen ecosystem alters the spatial structure of Rs and that fine scale heterogeneity develops quickly as stands reach the canopy closure phase (<10 years).	[Das Gupta, Sanatan] Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada; [Mackenzie, M. Derek] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	Natural Resources Canada; Canadian Forest Service; University of Alberta	Das Gupta, S (corresponding author), Nat Resources Canada, Northern Forestry Ctr, Canadian Forest Serv, Edmonton, AB, Canada.	sanatan@ualberta.ca			Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD); National Science and Engineering Research Council of Canada (NSERC); National Science and Engineering Research Council of Canada	Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development (CONRAD) and the National Science and Engineering Research Council of Canada (NSERC). No specific permissions were required for the studied locations; however, research activities on these sites were reported back to the ERRG committee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Environmental Research and Reclamation Group (ERRG) of the Canadian Oilsands Network for Research and Development, and the National Science and Engineering Research Council of Canada for providing funding. Special thanks go to Dr. Fangliang He for logistic support and suggestion in spatial data analysis. We would also like to thank a number of field technicians for helping to collect data, including Megan Lewis, Mark Howell, Sawyer Desaulniers, and Nicole Filipow.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Allison SD, 2010, NAT GEOSCI, V3, P336, DOI 10.1038/NGEO846; Amiro BD, 2003, AGR FOREST METEOROL, V115, P91, DOI 10.1016/S0168-1923(02)00170-3; [Anonymous], 2006, MICROBIOLOGICAL METH; ANSELIN L, 1988, GEOGR ANAL, V20, P1, DOI 10.1111/j.1538-4632.1988.tb00159.x; Anselin L., 2004, URBANA, V51, P61801; AZZALINI A, 1994, J R STAT SOC C-APPL, V43, P505; Bach CE, 2013, SOIL BIOL BIOCHEM, V67, P183, DOI 10.1016/j.soilbio.2013.08.022; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Beckingham J. D., 1996, FIELD GUIDE ECOSITES; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; BhupinderpalSingh, 2003, PLANT CELL ENVIRON, V26, P1287, DOI 10.1046/j.1365-3040.2003.01053.x; Boby LA, 2010, ECOL APPL, V20, P1633, DOI 10.1890/08-2295.1; Bond-Lamberty B, 2002, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2001JD000839; Bond-Lamberty B, 2004, TREE PHYSIOL, V24, P1387, DOI 10.1093/treephys/24.12.1387; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bond-Lamberty B, 2009, GLOBAL CHANGE BIOL, V15, P1242, DOI 10.1111/j.1365-2486.2008.01776.x; Bouma TJ, 1997, PLANT SOIL, V195, P221, DOI 10.1023/A:1004278421334; Brassard BW, 2010, STAND STRUCTURE COMP; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P1501, DOI 10.2136/sssaj1994.03615995005800050033x; Canadian Forest Service, 2013, NAT FIR DAT AG FIR D; Carreiro MM, 2000, ECOLOGY, V81, P2359, DOI 10.1890/0012-9658(2000)081[2359:MESELD]2.0.CO;2; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chen J, 2000, GLOBAL BIOGEOCHEM CY, V14, P839, DOI 10.1029/1999GB001207; Chen WJ, 2004, PLANT SOIL, V265, P31, DOI 10.1007/s11104-005-8503-3; CLAYTON MK, 1995, J AM STAT ASSOC, V90, P753, DOI 10.2307/2291088; Crown PH, 1970, M702 U ALB ALB I PED; Czimczik CI, 2005, EUR J SOIL SCI, V56, P417, DOI 10.1111/j.1365-2389.2004.00665.x; Czimczik CI, 2006, GLOBAL CHANGE BIOL, V12, P957, DOI 10.1111/j.1365-2486.2006.01107.x; Desrochers A, 2002, TREE PHYSIOL, V22, P725, DOI 10.1093/treephys/22.10.725; Dilly O, 2001, BIOL FERT SOILS, V34, P64, DOI 10.1007/s003740100375; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Fajardo A, 2007, AM NAT, V169, P647, DOI 10.1086/513492; Fang C, 1998, PLANT SOIL, V205, P135, DOI 10.1023/A:1004304309827; Finer L, 1997, CAN J FOREST RES, V27, P304, DOI 10.1139/x96-170; Fioretto A, 2005, APPL VEG SCI, V8, P13, DOI 10.1111/j.1654-109X.2005.tb00624.x; Flannigan M. D, 2008, COLD REGION ATMOSPHE, V1, P403; Foti Szilvia, 2009, Ekologia (Bratislava), V28, P389, DOI 10.4149/ekol_2009_04_389; FRITZE H, 1993, CAN J FOREST RES, V23, P1286, DOI 10.1139/x93-164; Gaumont-Guay D, 2008, TREE PHYSIOL, V28, P161, DOI 10.1093/treephys/28.2.161; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P203, DOI 10.1016/j.agrformet.2006.08.002; Gimeno-Garcia E, 2004, GEODERMA, V118, P17, DOI 10.1016/S0016-7061(03)00167-8; Gonzalez-Perez JA, 2004, ENVIRON INT, V30, P855, DOI 10.1016/j.envint.2004.02.003; Grant RF, 2007, TREE PHYSIOL, V27, P115, DOI 10.1093/treephys/27.1.115; Griffis TJ, 2004, AGR FOREST METEOROL, V125, P207, DOI 10.1016/j.agrformet.2004.04.006; Gross HL, 1981, DIS ASPEN SUCKES NO; Gulledge J, 2000, ECOSYSTEMS, V3, P269, DOI 10.1007/s100210000025; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Harmon ME, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001495; Hely C, 2000, CAN J FOREST RES, V30, P674, DOI 10.1139/cjfr-30-5-674; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Isaaks E.H., 1989, ISA; Jarvis PG, 1997, J GEOPHYS RES-ATMOS, V102, P28953, DOI 10.1029/97JD01176; KASISCHKE ES, 1995, ECOL APPL, V5, P437, DOI 10.2307/1942034; Kasischke ES, 2012, CLIMATE CHANGE CARBO; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Kelsey KC, 2012, ARCT ANTARCT ALP RES, V44, P457, DOI 10.1657/1938-4246-44.4.457; Khomik M, 2006, AGR FOREST METEOROL, V140, P244, DOI 10.1016/j.agrformet.2006.08.006; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Lavigne MB, 2003, CAN J FOREST RES, V33, P1744, DOI 10.1139/X03-090; Lavoie M, 2012, BIOGEOCHEMISTRY, V107, P227, DOI 10.1007/s10533-010-9547-x; Lee P, 1998, FOREST ECOL MANAG, V105, P263, DOI 10.1016/S0378-1127(97)00286-7; MacKenzie MD, 2006, PLANT SOIL, V287, P257, DOI 10.1007/s11104-006-9074-7; MacKenzie MD, 2008, SOIL SCI SOC AM J, V72, P1774, DOI 10.2136/sssaj2007.0363; Mariani L, 2006, SOIL BIOL BIOCHEM, V38, P1734, DOI 10.1016/j.soilbio.2005.11.029; McGuire AD, 2009, ECOL MONOGR, V79, P523, DOI 10.1890/08-2025.1; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; O'Neill KP, 2006, BIOGEOCHEMISTRY, V80, P1, DOI 10.1007/s10533-005-5964-7; O'Neill KP, 2002, CAN J FOREST RES, V32, P1525, DOI [10.1139/x02-077, 10.1139/X02-077]; Pedlar JH, 2002, FOREST ECOL MANAG, V158, P189, DOI 10.1016/S0378-1127(00)00711-8; Pietikainen J, 1996, SOIL MICROBIAL BIOMA, P337; Prokushkin A. S., 2001, Eurasian Journal of Forest Research, V2, P45; Quideau SA, 2013, SOIL SCI SOC AM J, V77, P145, DOI 10.2136/sssaj2012.0202; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Reichstein M, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002035; Richter DD, 2000, POSTFIRE STIMULATION, P197; Ruess RW, 1996, CAN J FOREST RES, V26, P1326, DOI 10.1139/x26-148; Russell CA, 1998, CAN J SOIL SCI, V78, P301, DOI 10.4141/S97-054; Saiz G, 2006, PLANT SOIL, V287, P161, DOI 10.1007/s11104-006-9052-0; Scott-Denton LE, 2003, SOIL BIOL BIOCHEM, V35, P525, DOI 10.1016/S0038-0717(03)00007-5; Shackle VJ, 2000, SOIL BIOL BIOCHEM, V32, P1935, DOI 10.1016/S0038-0717(00)00169-3; Shibata H, 2003, SOIL SCI PLANT NUTR, V49, P25, DOI 10.1080/00380768.2003.10409975; Shibistova O, 2002, TELLUS B, V54, P552, DOI 10.1034/j.1600-0889.2002.01348.x; Singh S, 2008, CAN J FOREST RES, V38, P647, DOI 10.1139/X07-200; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smithwick EAH, 2005, BIOGEOCHEMISTRY, V76, P517, DOI 10.1007/s10533-005-0031-y; Stocks BJ, 2002, J GEOPHYS RES-ATMOS, V108, P12, DOI 10.1029/2001jd000484; STRONG WL, 1985, FOREST ECOL MANAG, V12, P233, DOI 10.1016/0378-1127(85)90093-3; Tang JW, 2005, BIOGEOCHEMISTRY, V73, P183, DOI 10.1007/s10533-004-5889-6; Van Cleve K., 1971, ARCTIC ALPINE RES, V3, P17, DOI [DOI 10.2307/1550380, doi:10.2307/1550380]; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Vogel E., 2013, THESIS LUND U SWEDEN; Wang C, 2002, J GEOPHYS RES-ATMOS, V107; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Wickland KP, 2010, CAN J FOREST RES, V40, P2123, DOI 10.1139/X10-163; Yang PC, 1999, J GEOPHYS RES-ATMOS, V104, P27653, DOI 10.1029/1999JD900295; Yates SR., 2002, SOIL SCI SOC AM BOOK, V5, P81; Yuan ZY, 2012, FUNCT ECOL, V26, P991, DOI 10.1111/j.1365-2435.2012.02007.x; Zhao HM, 2012, GEODERMA, V189, P532, DOI 10.1016/j.geoderma.2012.05.013; Zhou W, 2016, BIOGEOSCIENCES DISCU	104	9	9	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e165602	10.1371/journal.pone.0165602	http://dx.doi.org/10.1371/journal.pone.0165602			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832089	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000021
J	Liu, Z; Fan, SH; Liu, HP; Yu, J; Qiao, R; Zhou, M; Yang, YT; Zhou, J; Xie, P				Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng			Enhanced Detection of Low-Abundance Human Plasma Proteins by Integrating Polyethylene Glycol Fractionation and Immunoaffinity Depletion	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; BIOMARKER DISCOVERY; PROTEOMIC ANALYSIS; CARDIOVASCULAR-DISEASE; QUANTITATIVE-ANALYSIS; SAMPLE PREPARATION; HUMAN SERUM; SEPARATION; PRECIPITATION; DEPTH	The enormous depth complexity of the human plasma proteome poses a significant challenge for current mass spectrometry-based proteomic technologies in terms of detecting low-level proteins in plasma, which is essential for successful biomarker discovery efforts. Typically, a single-step analytical approach cannot reduce this intrinsic complexity. Current simplex immunodepletion techniques offer limited capacity for detecting low-abundance proteins, and integrated strategies are thus desirable. In this respect, we developed an improved strategy for analyzing the human plasma proteome by integrating polyethylene glycol (PEG) fractionation with immunoaffinity depletion. PEG fractionation of plasma proteins is simple, rapid, efficient, and compatible with a downstream immunodepletion step. Compared with immunodepletion alone, our integrated strategy substantially improved the proteome coverage afforded by PEG fractionation. Coupling this new protocol with liquid chromatography-tandem mass spectrometry, 135 proteins with reported normal concentrations below 100 ng/mL were confidently identified as common low-abundance proteins. A side-by-side comparison indicated that our integrated strategy was increased by average 43.0% in the identification rate of low-abundance proteins, relying on an average 65.8% increase of the corresponding unique peptides. Further investigation demonstrated that this combined strategy could effectively alleviate the signal-suppressive effects of the major high-abundance proteins by affinity depletion, especially with moderate-abundance proteins after incorporating PEG fractionation, thereby greatly enhancing the detection of low abundance proteins. In sum, the newly developed strategy of incorporating PEG fractionation to immunodepletion methods can potentially aid in the discovery of plasma biomarkers of therapeutic and clinical interest.	[Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yang, Yongtao; Xie, Peng] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China; [Liu, Zhao; Fan, Songhua; Liu, Haipeng; Yu, Jia; Qiao, Rui; Zhou, Mi; Yang, Yongtao; Zhou, Jian; Xie, Peng] Chongqing Key Lab Neurobiol, Chongqing, Peoples R China; [Xie, Peng] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Xie, P (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Neurol, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Med Univ, Inst Neurosci, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Med Univ, Collaborat Innovat Ctr Brain Sci, Chongqing, Peoples R China.; Zhou, J; Xie, P (corresponding author), Chongqing Key Lab Neurobiol, Chongqing, Peoples R China.; Xie, P (corresponding author), Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China.	zhou_jian0615@163.com; xiepeng@cqmu.edu.cn	Fan, Song-Hua/E-1612-2017	Fan, Song-Hua/0000-0002-5456-2725	National Basic Research Program of China ("973 program") [2009CB918300]; National Natural Science Foundation of China [31570826, 81101009]; Foundation and Cutting-edge Research Plan Item of Chongqing [cstc2015jcyjA10052]; Fund for Young Backbone Teachers in Chongqing Colleges and Universities	National Basic Research Program of China ("973 program")(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation and Cutting-edge Research Plan Item of Chongqing; Fund for Young Backbone Teachers in Chongqing Colleges and Universities	This work was supported by the National Basic Research Program of China ("973 program", 2009CB918300), the National Natural Science Foundation of China (31570826, 81101009), the Foundation and Cutting-edge Research Plan Item of Chongqing (cstc2015jcyjA10052), and the Fund for Young Backbone Teachers in Chongqing Colleges and Universities.; We thank Dr. Rui Wang (Shanghai Institute for Biological Sciences, Chinese Academy of Sciences) for his assistance with the MS analysis. This work was supported by grants from the National Basic Research Program of China ("973 program", 2009CB918300), the National Natural Science Foundation of China (31570826, 81101009), the Foundation and Cutting-edge Research Plan Item of Chongqing (cstc2015jcyjA10052), and the Fund for Young Backbone Teachers in Chongqing Colleges and Universities.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Anderson L, 2005, J PHYSIOL-LONDON, V563, P23, DOI 10.1113/jphysiol.2004.080473; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; ATHA DH, 1981, J BIOL CHEM, V256, P2108; Bast RC, 2011, GYNECOL ONCOL, V121, P429, DOI 10.1016/j.ygyno.2011.04.032; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Cao ZJ, 2012, J PROTEOME RES, V11, P3090, DOI 10.1021/pr201068b; Chan R, 2004, BIOTECHNOL BIOENG, V85, P190, DOI 10.1002/bit.10866; Chen YY, 2005, ELECTROPHORESIS, V26, P2117, DOI 10.1002/elps.200410381; Ernoult E, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927917; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Fernandez C, 2011, ELECTROPHORESIS, V32, P2966, DOI 10.1002/elps.201100183; Fukao Y, 2013, PLANT CELL PHYSIOL, V54, P808, DOI 10.1093/pcp/pct033; Gretzer MB, 2004, PROSTATE, V60, P325, DOI 10.1002/pros.20066; Guipaud O, 2013, ADV EXP MED BIOL, V990, P61, DOI 10.1007/978-94-007-5896-4_4; Hoffman SA, 2007, J CHROMATOGR B, V849, P43, DOI 10.1016/j.jchromb.2006.10.069; Hu Y., 2013, MATH PROBL ENG, V2013, P1, DOI DOI 10.1155/2013/175616; Huang L, 2005, PROTEOMICS, V5, P3314, DOI 10.1002/pmic.200401277; Irizarry Michael C, 2004, NeuroRx, V1, P226; Issaq HJ, 2007, CHEM REV, V107, P3601, DOI 10.1021/cr068287r; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; Keshishian H, 2009, MOL CELL PROTEOMICS, V8, P2339, DOI 10.1074/mcp.M900140-MCP200; Kovacs A, 2013, CURR MED CHEM, V20, P483; Lee HJ, 2006, CURR OPIN CHEM BIOL, V10, P42, DOI 10.1016/j.cbpa.2006.01.007; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Mahn A, 2011, J CHROMATOGR B, V879, P3645, DOI 10.1016/j.jchromb.2011.09.024; Mehrani Hossein, 2011, Clin Proteomics, V8, P2, DOI 10.1186/1559-0275-8-2; Millioni R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019603; MOSESSON MW, 1970, J BIOL CHEM, V245, P5728; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Polaskova V, 2010, ELECTROPHORESIS, V31, P471, DOI 10.1002/elps.200900286; POLSON A, 1972, VOX SANG, V23, P107, DOI 10.1111/j.1423-0410.1972.tb03818.x; Qian WJ, 2008, MOL CELL PROTEOMICS, V7, P1963, DOI 10.1074/mcp.M800008-MCP200; Qian WJ, 2006, MOL CELL PROTEOMICS, V5, P1727, DOI 10.1074/mcp.M600162-MCP200; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shi TJ, 2012, METHODS, V56, P246, DOI 10.1016/j.ymeth.2011.09.001; Sriyam S, 2007, J CHROMATOGR B, V849, P91, DOI 10.1016/j.jchromb.2006.10.065; Sun BJ, 2011, ELECTROPHORESIS, V32, P2091, DOI 10.1002/elps.201000657; Tirumalai RS, 2003, MOL CELL PROTEOMICS, V2, P1096, DOI 10.1074/mcp.M300031-MCP200; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Velasco C, 2003, J COLLOID INTERF SCI, V266, P148, DOI 10.1016/S0021-9797(03)00613-1; Wang H, 2005, MOL CELL PROTEOMICS, V4, P618, DOI 10.1074/mcp.M400126-MCP200; Wisniewski JR, 2009, J PROTEOME RES, V8, P5674, DOI 10.1021/pr900748n; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Xu HB, 2012, INT J NEUROPSYCHOPH, V15, P1413, DOI 10.1017/S1461145712000302; Yang Y, 2013, NEUROSCIENCE, V247, P191, DOI 10.1016/j.neuroscience.2013.05.031; Zhan Y, 2014, EUR PSYCHIAT, V29, P307, DOI 10.1016/j.eurpsy.2014.03.004; Zhou J, 2011, J CHROMATOGR B, V879, P2957, DOI 10.1016/j.jchromb.2011.08.017	51	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166306	10.1371/journal.pone.0166306	http://dx.doi.org/10.1371/journal.pone.0166306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832179	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000093
J	Zeng, XJ; Shi, J; Zhao, M; Chen, QW; Wang, LP; Jiang, HY; Luo, FF; Zhu, LJ; Lu, LL; Wang, XC; Liu, ZQ				Zeng, Xuejun; Shi, Jian; Zhao, Min; Chen, Qingwei; Wang, Liping; Jiang, Huangyu; Luo, Feifei; Zhu, Lijun; Lu, Linlin; Wang, Xinchun; Liu, Zhongqiu			Regioselective Glucuronidation of Diosmetin and Chrysoeriol by the Interplay of Glucuronidation and Transport in UGT1A9-Overexpressing HeLa Cells	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; UDP-GLUCURONOSYLTRANSFERASES UGTS; ENZYMES REACTION-KINETICS; TANDEM MASS-SPECTROMETRY; ORAL BIOAVAILABILITY; SPECIES-DIFFERENCES; IN-VIVO; LUTEOLIN; METABOLISM; INHIBITION	This study aimed to determine the reaction kinetics of the regioselective glucuronidation of diosmetin and chrysoeriol, two important methylated metabolites of luteolin, by human liver microsomes (HLMs) and uridine-50-diphosphate glucuronosyltransferase (UGTs) enzymes. This study also investigated the effects of breast cancer resistance protein (BCRP) on the efflux of diosmetin and chrysoeriol glucuronides in HeLa cells overexpressing UGT1A9 (HeLa D UGT1A9). After incubation with HLMs in the presence of UDP-glucuronic acid, diosmetin and chrysoeriol gained two glucuronides each, and the OH D in each B ring of diosmetin and chrysoeriol was the preferable site for glucuronidation. Screening assays with 12 human expressed UGT enzymes and chemical-inhibition assays demonstrated that glucuronide formation was almost exclusively catalyzed by UGT1A1, UGT1A6, and UGT1A9. Importantly, in HeLa D UGT1A9, Ko143 significantly inhibited the efflux of diosmetin and chrysoeriol glucuronides and increased their intracellular levels in a dose-dependent manner. This observation suggested that BCRP-mediated excretion was the predominant pathway for diosmetin and chrysoeriol disposition. In conclusion, UGT1A1, UGT1A6, and UGT1A9 were the chief contributors to the regioselective glucuronidation of diosmetin and chrysoeriol in the liver. Moreover, cellular glucuronidation was significantly altered by inhibiting BCRP, revealing a notable interplay between glucuronidation and efflux transport. Diosmetin and chrysoeriol possibly have different effects on anti-cancer due to the difference of UGT isoforms in different cancer cells.	[Zeng, Xuejun; Chen, Qingwei; Wang, Xinchun] Shihezi Univ, Hosp Affiliated 1, Dept Pharm, Shihezi 832002, Xinjiang, Peoples R China; [Zeng, Xuejun; Shi, Jian; Zhao, Min; Chen, Qingwei; Wang, Liping; Jiang, Huangyu; Luo, Feifei; Zhu, Lijun; Lu, Linlin; Liu, Zhongqiu] Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China	Shihezi University; Guangzhou University of Chinese Medicine	Wang, XC (corresponding author), Shihezi Univ, Hosp Affiliated 1, Dept Pharm, Shihezi 832002, Xinjiang, Peoples R China.; Liu, ZQ (corresponding author), Guangzhou Univ Chinese Med, Int Inst Translat Chinese Med, Guangzhou 510006, Guangdong, Peoples R China.	cwjwxc@163.com; liuzq@gzucm.edu.cn	Liu, Zhongqiu/AHC-9661-2022; lu, Linlin/K-6600-2016	Liu, Zhongqiu/0000-0001-6986-9677; lu, Linlin/0000-0002-9943-2422	National Natural Science Foundation of China [U1203204, 81460638, 81360671]; Science and Technology Project of Guangzhou City [201509010004]; Guangdong Natural Science Foundation Province [2015AD030312012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangzhou City; Guangdong Natural Science Foundation Province	This research was supported by the joint fund set up by the National Natural Science Foundation of China (No. U1203204), the National Natural Science Foundation of China (No. 81460638, 81360671), Science and Technology Project of Guangzhou City (201509010004) and Guangdong Natural Science Foundation Province (2015AD030312012).	Androutsopoulos VP, 2013, J NUTR BIOCHEM, V24, P496, DOI 10.1016/j.jnutbio.2012.01.012; Balyan R, 2015, CHEM-BIOL INTERACT, V240, P208, DOI 10.1016/j.cbi.2015.08.011; Bonifacio MJ, 2009, BIOCHEM PHARMACOL, V78, P1043, DOI 10.1016/j.bcp.2009.05.036; Brand W, 2008, DRUG METAB DISPOS, V36, P1794, DOI 10.1124/dmd.107.019943; Chan BCL, 2013, PHYTOMEDICINE, V20, P611, DOI 10.1016/j.phymed.2013.02.007; Chen ZJ, 2013, MOL NUTR FOOD RES, V57, P877, DOI 10.1002/mnfr.201200584; Chen ZJ, 2012, FITOTERAPIA, V83, P1616, DOI 10.1016/j.fitote.2012.09.011; Chen ZJ, 2011, DRUG METAB DISPOS, V39, P667, DOI 10.1124/dmd.110.037333; Coughlin JL, 2012, DRUG METAB DISPOS, V40, P481, DOI 10.1124/dmd.111.042366; Dai PM, 2015, BIOPHARM DRUG DISPOS, V36, P622, DOI 10.1002/bdd.1989; Dong RH, 2012, PHYTOTHER RES, V26, P86, DOI 10.1002/ptr.3525; Ge A, 2015, ACTA BIOCH BIOPH SIN, V47, P604, DOI 10.1093/abbs/gmv052; Harbourt DE, 2012, ANAL CHEM, V84, P98, DOI 10.1021/ac201704a; Jiang W, 2012, DRUG METAB DISPOS, V40, P336, DOI 10.1124/dmd.111.041467; Kato R, 2014, BIOL PHARM BULL, V37, P1782, DOI 10.1248/bpb.b14-00438; Kiang TKL, 2005, PHARMACOL THERAPEUT, V106, P97, DOI 10.1016/j.pharmthera.2004.10.013; Konieczna A, 2015, Klin Onkol, V28, P431; Qiang L, 2015, J CHROMATOGR A, V1395, P116, DOI 10.1016/j.chroma.2015.03.069; Liu HM, 2014, XENOBIOTICA, V44, P696, DOI 10.3109/00498254.2014.891780; Liu HX, 2008, DRUG METAB DISPOS, V36, P1562, DOI 10.1124/dmd.108.020560; Liu ZQ, 2006, PHARM RES-DORDR, V23, P2768, DOI 10.1007/s11095-006-9100-8; Mishra B, 2003, BIOORGAN MED CHEM, V11, P2677, DOI 10.1016/S0968-0896(03)00232-3; Oda S, 2015, DRUG METAB PHARMACOK, V30, P30, DOI 10.1016/j.dmpk.2014.12.001; ORTMANN R, 1970, FEBS LETT, V7, P164, DOI 10.1016/0014-5793(70)80146-6; Pattanawongsa A, 2015, DRUG METAB DISPOS; Pick A, 2011, BIOORGAN MED CHEM, V19, P2090, DOI 10.1016/j.bmc.2010.12.043; Poor M, 2014, J PHOTOCH PHOTOBIO B, V132, P1, DOI 10.1016/j.jphotobiol.2014.01.016; Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8; Seo KA, 2014, DRUG METAB DISPOS, V42, P1803, DOI 10.1124/dmd.114.058818; Sun H, 2015, J PHARM SCI-US, V104, P2369, DOI 10.1002/jps.24464; Sun H, 2014, EXPERT OPIN DRUG MET, V10, P1325, DOI 10.1517/17425255.2014.954548; Tang L, 2014, PHARM RES-DORDR, V31, P847, DOI 10.1007/s11095-013-1207-0; Uchaipichat V, 2006, DRUG METAB DISPOS, V34, P449, DOI 10.1124/dmd.105.007369; Wu BJ, 2013, CURR TOP MED CHEM, V13, P1343; Wu BJ, 2012, PHARM RES-DORDR, V29, P3199, DOI 10.1007/s11095-012-0817-2; Wu BJ, 2011, DRUG METAB REV, V43, P440, DOI 10.3109/03602532.2011.615320; Wu BJ, 2011, J PHARM SCI-US, V100, P3655, DOI 10.1002/jps.22568; Wu J, 2016, J ETHNOPHARMACOL; Wu ZF, 2015, J PHARM PHARMACOL, V67, P583, DOI 10.1111/jphp.12351; Xu HY, 2009, MOL PHARMACEUT, V6, P1703, DOI 10.1021/mp900013d; Zhang L, 2013, CHEM RES TOXICOL, V26, P1570, DOI 10.1021/tx400268q; Zhou GY, 2011, J MED CHEM, V54, P7220, DOI 10.1021/jm200791z; Zhu L., 2015, WORLD J TRADIT CHIN, V1, P1	43	10	12	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166239	10.1371/journal.pone.0166239	http://dx.doi.org/10.1371/journal.pone.0166239			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832172	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000081
J	Ayuso, MI; Martinez-Alonso, E; Regidor, I; Alcazar, A				Ayuso, Maria I.; Martinez-Alonso, Emma; Regidor, Ignacio; Alcazar, Alberto			Stress Granule Induction after Brain Ischemia Is Independent of Eukaryotic Translation Initiation Factor (eIF) 2 alpha Phosphorylation and Is Correlated with a Decrease in eIF4B and eIF4E Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELAYED NEURONAL DEATH; RNA-BINDING PROTEINS; CEREBRAL-ISCHEMIA; CELL-DEATH; GENE-EXPRESSION; RAT-BRAIN; INHIBITION; AGGREGATION; REPERFUSION; TIA-1	Stress granules (SGs) are cytoplasmic ribonucleoprotein aggregates that are directly connected with the translation initiation arrest response to cellular stresses. Translation inhibition (TI) is observed in transient brain ischemia, a condition that induces persistent TI even after reperfusion, i.e. when blood flow is restored, and causes delayed neuronal death (DND) in selective vulnerable regions. We previously described a connection between TI and DND in the hippocampal cornu ammonis 1 (CA1) in an animal model of transient brain ischemia. To link the formation of SGs to TI and DND after brain ischemia, we investigated SG induction in brain regions with differential vulnerabilities to ischemia-reperfusion (IR) in this animal model. SG formation is triggered by both eukaryotic translation initiation factor (eIF) 2 alpha phosphorylation and eIF4F complex dysfunction. We analyzed SGs by immunofluorescence colocalization of granule-associated protein T-cell internal antigen-1 with eIF3b, eIF4E, and ribosomal protein S6 and studied eIF2 and eIF4F complex. The results showed that IR stress induced SG formation in the CA1 region after 3-day reperfusion, consistent with TI and DND in CA1. SGs were formed independently of eIF2 alpha phosphorylation, and their appearance was correlated with a decrease in the levels of eIF4F compounds, the cap-binding protein eIF4E, and eIF4B, suggesting that remodeling of the eIF4F complex was required for SG formation. Finally, pharmacological protection of CA1 ischemic neurons with cycloheximide decreased the formation of SGs and restored eIF4E and eIF4B levels in CA1. These findings link changes in eIF4B and eIF4E to SG induction in regions vulnerable to death after IR.	[Ayuso, Maria I.; Martinez-Alonso, Emma; Alcazar, Alberto] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Dept Invest, E-28034 Madrid, Spain; [Regidor, Ignacio] Hosp Ramon & Cajal, Inst Ramon & Cajal Invest Sanitaria, Dept Neurophysiol, E-28034 Madrid, Spain	Hospital Universitario Ramon y Cajal; Hospital Universitario Ramon y Cajal	Ayuso, MI (corresponding author), Inst Biomed Sevilla, Neurovasc Res Grp, Ave Manuel Siurot S-N, E-41013 Seville, Spain.; Alcazar, A (corresponding author), Hosp Ramon & Cajal, Ctra Colmenar Km 9-1, E-28034 Madrid, Spain.	mayuso-ibis@us.es; alberto.alcazar@hrc.es	IBiS, Neurovascular/P-5842-2016; Ayuso, Maria Irene/C-9435-2015	IBiS, Neurovascular/0000-0001-9511-0672; Ayuso, Maria Irene/0000-0003-0046-3657	Instituto de Salud Carlos III Grant from the Spanish Ministry of Economy and Competitiveness [PI14/00705]; Fondo Europeo de Desarrollo Regional (FEDER)	Instituto de Salud Carlos III Grant from the Spanish Ministry of Economy and Competitiveness; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission)	This work was supported by Instituto de Salud Carlos III Grant PI14/00705 from the Spanish Ministry of Economy and Competitiveness and Fondo Europeo de Desarrollo Regional (FEDER) (to A. A.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2002, CELL STRESS CHAPERON, V7, P213, DOI 10.1379/1466-1268(2002)007<0213:VSTROE>2.0.CO;2; Anderson P, 2002, J CELL SCI, V115, P3227; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Ayuso MI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121958; Buchan JR, 2014, RNA BIOL, V11, P1019, DOI 10.4161/15476286.2014.972208; COOPER HK, 1977, J NEUROCHEM, V28, P929, DOI 10.1111/j.1471-4159.1977.tb10652.x; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; de la Vega CM, 2001, NEUROREPORT, V12, P1021, DOI 10.1097/00001756-200104170-00031; DeGracia DJ, 2007, NEUROSCIENCE, V146, P562, DOI 10.1016/j.neuroscience.2007.01.050; DeGracia DJ, 2008, J NEUROCHEM, V106, P2288, DOI 10.1111/j.1471-4159.2008.05561.x; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fujimura K, 2012, NUCLEIC ACIDS RES, V40, P8099, DOI 10.1093/nar/gks566; Garcia-Bonilla L, 2007, J NEUROCHEM, V103, P1368, DOI 10.1111/j.1471-4159.2007.04844.x; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; GONZALEZ CI, 2007, TRANSLATIONAL CONTRO, P719; GOTO K, 1990, BRAIN RES, V534, P299, DOI 10.1016/0006-8993(90)90144-Z; Harukuni I, 2006, NEUROL CLIN, V24, P1, DOI 10.1016/j.ncl.2005.10.004; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; Hermann DM, 2001, NEUROSCIENCE, V104, P947, DOI 10.1016/S0306-4522(01)00125-7; Higashi S, 2013, J NEUROCHEM, V126, P288, DOI 10.1111/jnc.12194; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Ayuso MI, 2013, J CEREBR BLOOD F MET, V33, P1173, DOI 10.1038/jcbfm.2013.60; Jamison JT, 2008, NEUROSCIENCE, V154, P504, DOI 10.1016/j.neuroscience.2008.03.057; Jamison JT, 2011, NEUROSCIENCE, V199, P394, DOI 10.1016/j.neuroscience.2011.09.015; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kirino T, 2000, NEUROPATHOLOGY, V20, pS95; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu CL, 2005, NEUROSCIENCE, V134, P1273, DOI 10.1016/j.neuroscience.2005.05.015; Mazroui R, 2007, MOL BIOL CELL, V18, P2603, DOI 10.1091/mbc.E06-12-1079; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; Mokas S, 2009, MOL BIOL CELL, V20, P2673, DOI 10.1091/mbc.E08-10-1061; PAPAS S, 1992, EUR J NEUROSCI, V4, P758, DOI 10.1111/j.1460-9568.1992.tb00185.x; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Raught B., 2007, TRANSLATIONAL CONTRO, P369; Rhoads RE, 2009, J BIOL CHEM, V284, P16711, DOI 10.1074/jbc.R900002200; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; THILMANN R, 1986, ACTA NEUROPATHOL, V71, P88, DOI 10.1007/BF00687967; White BC, 2000, J NEUROL SCI, V179, P1, DOI 10.1016/S0022-510X(00)00386-5; Wolozin B, 2015, ADV EXP MED BIOL, V822, P11, DOI 10.1007/978-3-319-08927-0_3; Wolozin B, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-56; Zhang F, 2006, J NEUROCHEM, V98, P102, DOI 10.1111/j.1471-4159.2006.03838.x	46	16	17	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27252	27264		10.1074/jbc.M116.738989	http://dx.doi.org/10.1074/jbc.M116.738989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836976	hybrid, Green Published			2022-12-26	WOS:000391576300023
J	Law, NC; White, MF; Hunzicker-Dunn, ME				Law, Nathan C.; White, Morris F.; Hunzicker-Dunn, Mary E.			G protein-coupled receptors (GPCRs) That Signal via Protein Kinase A (PKA) Cross-talk at Insulin Receptor Substrate 1 (IRS1) to Activate the phosphatidylinositol 3-kinase (PI3K)/AKT Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOLLICLE-STIMULATING-HORMONE; PHOSPHOINOSITIDE 3-KINASE; SERINE/THREONINE PHOSPHORYLATION; TARGETED DISRUPTION; CELL-PROLIFERATION; REGULATORY SUBUNIT; SMOOTH-MUSCLE; IN-VITRO; FSH; BETA	G protein-coupled receptors (GPCRs) activate PI3K/v-AKT thymoma viral oncoprotein (AKT) to regulate many cellular functions that promote cell survival, proliferation, and growth. However, the mechanism by which GPCRs activate PI3K/AKT remains poorly understood. We used ovarian preantral granulosa cells (GCs) to elucidate the mechanism by which the GPCR agonist FSH via PKA activates the PI3K/AKT cascade. Insulinlike growth factor 1 (IGF1) is secreted in an autocrine/paracrine manner by GCs and activates the IGF1 receptor (IGF1R) but, in the absence of FSH, fails to stimulate YXXM phosphorylation of IRS1 (insulin receptor substrate 1) required for PI3K/AKT activation. We show that PKA directly phosphorylates the protein phosphatase 1 (PP1) regulatory subunit myosin phosphatase targeting subunit 1 (MYPT1) to activate PP1 associated with the IGF1R-IRS1 complex. Activated PP1 is sufficient to dephosphorylate at least four IRS1 Ser residues, Ser(318), Ser(346), Ser(612), and Ser(789), and promotes IRS1 YXXM phosphorylation by the IGF1R to activate the PI3K/AKT cascade. Additional experiments indicate that this mechanism also occurs in breast cancer, thyroid, and preovulatory granulosa cells, suggesting that the PKA-dependent dephosphorylation of IRS1 Ser/Thr residues is a conserved mechanism by which GPCRs signal to activate the PI3K/AKT pathway downstream of the IGF1R.	[Law, Nathan C.; Hunzicker-Dunn, Mary E.] Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg,Rm 233, Pullman, WA 99164 USA; [White, Morris F.] Harvard Med Sch, Boston Childrens Hosp, Dept Med, Div Endocrinol, Boston, MA 02115 USA	Washington State University; Harvard University; Boston Children's Hospital; Harvard Medical School	Hunzicker-Dunn, ME (corresponding author), Washington State Univ, Sch Mol Biosci, Biotechnol Life Sci Bldg,Rm 233, Pullman, WA 99164 USA.	mehd@wsu.edu			National Institute of Health [R01HD065859, R01HD062053, T32GM083864, R01DK098655-01, R01DK038712-22]; Fund for Science; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062053, R01HD065859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098655, R01DK038712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM083864, P50GM021700] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fund for Science; Poncin Scholarship Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institute of Health Grants R01HD065859 and R01HD062053 (to M. E. H. D.), T32GM083864 (to N. C. L), and R01DK098655-01 and R01DK038712-22 (to M. F. W.). Additional funding was provided by The Fund for Science (to M. E. H. D.) and the Poncin Scholarship Fund (to N. C. L). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Arcaro A, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00030; Baumgarten SC, 2014, J CLIN ENDOCR METAB, V99, P2995, DOI 10.1210/jc.2014-1139; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Britt KL, 2000, ENDOCRINOLOGY, V141, P2614, DOI 10.1210/en.141.7.2614; Butler T, 2013, AM J PHYSIOL-CELL PH, V304, pC485, DOI 10.1152/ajpcell.00161.2012; Chen XL, 2007, CHEM REV, V107, P1777, DOI 10.1021/cr050029r; CHENG HC, 1986, J BIOL CHEM, V261, P989; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; De Gregorio G, 2007, ONCOGENE, V26, P2039, DOI 10.1038/sj.onc.1210011; Donaubauer EM, 2016, J BIOL CHEM, V291, P19701, DOI 10.1074/jbc.M116.733972; Eto M, 2005, CELL MOTIL CYTOSKEL, V62, P100, DOI 10.1002/cm.20088; Flynn MP, 2016, J CELL SCI, V129, P2983, DOI 10.1242/jcs.190397; Fontal OI, 1999, ANAL BIOCHEM, V269, P289, DOI 10.1006/abio.1999.3099; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Geetha T, 2011, J AM SOC MASS SPECTR, V22, P457, DOI 10.1007/s13361-010-0051-2; Guillermet-Guibert J, 2008, P NATL ACAD SCI USA, V105, P8292, DOI 10.1073/pnas.0707761105; Hancer NJ, 2014, J BIOL CHEM, V289, P12467, DOI 10.1074/jbc.M114.554162; Hartog H, 2007, EUR J CANCER, V43, P1895, DOI 10.1016/j.ejca.2007.05.021; Herndon MK, 2016, MOL CELL ENDOCRINOL, V434, P116, DOI 10.1016/j.mce.2016.06.020; Herrema H, 2014, BIOCHEM BIOPH RES CO, V443, P689, DOI 10.1016/j.bbrc.2013.12.023; Hsueh AJW, 2015, ENDOCR REV, V36, P1, DOI 10.1210/er.2014-1020; Hunzicker-Dunn M., 2015, PHYSL REPROD, V4th, P895; Hunzicker-Dunn ME, 2012, P NATL ACAD SCI USA, V109, pE2979, DOI 10.1073/pnas.1205661109; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Klempner SJ, 2013, CANCER DISCOV, V3, P1345, DOI 10.1158/2159-8290.CD-13-0063; Kroeze WK, 2003, J CELL SCI, V116, P4867, DOI 10.1242/jcs.00902; Kuehn HS, 2011, J BIOL CHEM, V286, P391, DOI 10.1074/jbc.M110.164772; Kurosu H, 1997, J BIOL CHEM, V272, P24252, DOI 10.1074/jbc.272.39.24252; Law NC, 2016, J BIOL CHEM, V291, P4547, DOI 10.1074/jbc.M115.698761; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Lei ZM, 2001, MOL ENDOCRINOL, V15, P184, DOI 10.1210/me.15.1.184; Li Q, 2013, MOL ENDOCRINOL, V27, P1468, DOI 10.1210/me.2013-1082; Liu ZL, 2015, MOL ENDOCRINOL, V29, P1006, DOI 10.1210/me.2015-1103; Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412; Luo ML, 2005, ENDOCRINOLOGY, V146, P4410, DOI 10.1210/en.2005-0260; LUTTRELL LM, 1995, J BIOL CHEM, V270, P16495, DOI 10.1074/jbc.270.28.16495; Machida K, 2005, AM J PHYSIOL-LUNG C, V288, pL860, DOI 10.1152/ajplung.00131.2004; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Mothe I, 1996, J BIOL CHEM, V271, P11222, DOI 10.1074/jbc.271.19.11222; Murga C, 2000, J BIOL CHEM, V275, P12069, DOI 10.1074/jbc.275.16.12069; Ni L, 2007, ASSAY DRUG DEV TECHN, V5, P645, DOI 10.1089/adt.2007.079; Park Y, 2005, J BIOL CHEM, V280, P9135, DOI 10.1074/jbc.M409486200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Puri P, 2016, SCI REP-UK, V6, DOI 10.1038/srep28132; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; RORDORFNIKOLIC T, 1995, J BIOL CHEM, V270, P3662, DOI 10.1074/jbc.270.8.3662; Rozengurt E, 2010, CLIN CANCER RES, V16, P2505, DOI 10.1158/1078-0432.CCR-09-2229; Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934; SHOELSON SE, 1992, P NATL ACAD SCI USA, V89, P2027, DOI 10.1073/pnas.89.6.2027; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; STEPHENS L, 1994, CELL, V77, P83, DOI 10.1016/0092-8674(94)90237-2; STOYANOV B, 1995, SCIENCE, V269, P690, DOI 10.1126/science.7624799; Sun XJ, 2009, VITAM HORM, V80, P351, DOI 10.1016/S0083-6729(08)00613-4; Swingle Mark, 2007, V365, P23; Torella D, 2009, AM J PHYSIOL-HEART C, V297, pH2015, DOI 10.1152/ajpheart.00738.2009; Tzatsos A, 2007, J BIOL CHEM, V282, P18069, DOI 10.1074/jbc.M610101200; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang XL, 2012, J BIOL CHEM, V287, P10166, DOI 10.1074/jbc.M111.293274; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Yang G, 2015, CELL REP, V12, P937, DOI 10.1016/j.celrep.2015.07.016; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zeleznik AJ, 2003, ENDOCRINOLOGY, V144, P3985, DOI 10.1210/en.2003-0293; Zhang XM, 2014, J PROTEOMICS, V109, P63, DOI 10.1016/j.jprot.2014.06.010	76	34	40	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27160	27169		10.1074/jbc.M116.763235	http://dx.doi.org/10.1074/jbc.M116.763235			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856640	Green Published, hybrid			2022-12-26	WOS:000391576300016
J	Conway, DI; Robertson, C; Gray, H; Young, L; McDaid, LM; Winter, AJ; Campbell, C; Pan, JF; Kavanagh, K; Kean, S; Bhatia, R; Cubie, H; Clarkson, JE; Bagg, J; Pollock, KG; Cuschieri, K				Conway, David I.; Robertson, Chris; Gray, Heather; Young, Linda; McDaid, Lisa M.; Winter, Andrew J.; Campbell, Christine; Pan, Jiafeng; Kavanagh, Kimberley; Kean, Sharon; Bhatia, Ramya; Cubie, Heather; Clarkson, Jan E.; Bagg, Jeremy; Pollock, Kevin G.; Cuschieri, Kate			Human Papilloma Virus (HPV) Oral Prevalence in Scotland (HOPSCOTCH): A Feasibility Study in Dental Settings	PLOS ONE			English	Article							OROPHARYNGEAL-CANCER; INFECTION; MEN; TRENDS; EPIDEMIOLOGY; POPULATION; WORLDWIDE; SAMPLES; CAVITY; RATES	The purpose of this study was to test the feasibility of undertaking a full population investigation into the prevalence, incidence, and persistence of oral Human Papilloma Virus (HPV) in Scotland via dental settings. Male and female patients aged 16-69 years were recruited by Research Nurses in 3 primary care and dental outreach teaching centres and 2 General Dental Practices (GDPs), and by Dental Care Teams in 2 further GDPs. Participants completed a questionnaire (via an online tablet computer or paper) with socioeconomic, lifestyle, and sexual history items; and were followed up at 6-months for further questionnaire through appointment or post/online. Saline oral gargle/rinse samples, collected at baseline and follow- up, were subject to molecular HPV genotyping centrally. 1213 dental patients were approached and 402 individuals consented (participation rate 33.1%). 390 completed the baseline questionnaire and 380 provided a baseline oral specimen. Follow-up rate was 61.6% at 6 months. While recruitment was no different in Research Nurse vs Dental Care Team models the Nurse model ensured more rapid recruitment. There were relatively few missing responses in the questionnaire and high levels of disclosure of risk behaviours (99% answered some of the sexual history questions). Data linkage of participant data to routine health records including HPV vaccination data was successful with 99.1% matching. Oral rinse/gargle sample collection and subsequent HPV testing was feasible. Preliminary analyses found over 95% of samples to be valid for molecular HPV detection prevalence of oral HPV infection of 5.5% (95% CI 3.7, 8.3). It is feasible to recruit and follow-up dental patients largely representative/reflective of the wider population, suggesting it would be possible to undertake a study to investigate the prevalence, incidence, and determinants of oral HPV infection in dental settings.	[Conway, David I.; Bagg, Jeremy] Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland; [Robertson, Chris; Pan, Jiafeng; Kavanagh, Kimberley] Univ Strathclyde, Math & Stat, Glasgow, Lanark, Scotland; [Gray, Heather] Glasgow Caledonian Univ, Glasgow, Lanark, Scotland; [Young, Linda] NHS Educ Scotland, Dundee, Scotland; [McDaid, Lisa M.] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Winter, Andrew J.] NHS Greater Glasgow & Clyde Hlth Board, Sandyford Sexual Hlth Serv, Glasgow, Lanark, Scotland; [Campbell, Christine] Univ Edinburgh, Usher Inst, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Kean, Sharon] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Bhatia, Ramya; Cubie, Heather] Univ Edinburgh, Div Pathol, Human Papillomavirus Res Grp, Edinburgh, Midlothian, Scotland; [Clarkson, Jan E.] Univ Dundee, Sch Dent, Dundee, Scotland; [Pollock, Kevin G.] Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Cuschieri, Kate] Royal Infirm Edinburgh NHS Trust, Scottish HPV Reference Lab, Edinburgh, Midlothian, Scotland	University of Glasgow; University of Strathclyde; Glasgow Caledonian University; NHS Education for Scotland; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow; University of Edinburgh; University of Glasgow; University of Edinburgh; University of Dundee; NHS National Services Scotland; Royal Infirmary of Edinburgh; University of Edinburgh	Conway, DI (corresponding author), Univ Glasgow, Sch Med Dent & Nursing, Glasgow, Lanark, Scotland.	david.conway@glasgow.ac.uk	Gray, Heather/AAF-5337-2020	Gray, Heather/0000-0002-0556-5487; Kavanagh, Kimberley/0000-0002-2679-5409; McDaid, Lisa/0000-0002-7711-8723; Clarkson, Jan/0000-0001-5940-2926; Conway, David/0000-0001-7762-4063	Scottish Government Chief Scientist Office (CSO) [CZH/4/917]; UK Medical Research Council; CSO at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_UU_12017/2, MC_UU_12017/9, MC_UU_12017/11, SPHSU11]; Medical Research Council [MC_UU_12017/2, MC_UU_12017/9, MC_UU_12017/11] Funding Source: researchfish; Chief Scientist Office [CZH/4/917, SPHSU11] Funding Source: researchfish; MRC [MC_UU_12017/11, MC_UU_12017/2, MC_UU_12017/9] Funding Source: UKRI	Scottish Government Chief Scientist Office (CSO); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSO at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded by the Scottish Government Chief Scientist Office (CSO) grant number CZH/4/917. LMcD is funded by the UK Medical Research Council and CSO at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow (MC_UU_12017/2, MC_UU_12017/9, MC_UU_12017/11, SPHSU11). The funders had no role in study design, data collection and analysis, decision to publish, or in preparation of the manuscript. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the funding body.	Anantharaman D, 2016, INT J EPIDEMIOL, V45, P752, DOI 10.1093/ije/dyw069; Cameron RL, 2016, EMERG INFECT DIS, V22, P56, DOI 10.3201/eid2201.150736; Chaturvedi AK, 2013, J CLIN ONCOL, V31, P4550, DOI 10.1200/JCO.2013.50.3870; Conway DI, 2006, ORAL ONCOL, V42, P586, DOI 10.1016/j.oraloncology.2005.10.018; Conway David I, 2002, Prim Dent Care, V9, P119, DOI 10.1308/135576102322481938; Cuschieri K, 2013, DIAGN MOL PATHOL, V22, P85, DOI 10.1097/PDM.0b013e31827f3f7e; Cuschieri KS, 2003, J VIROL METHODS, V107, P107, DOI 10.1016/S0166-0934(02)00190-8; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Du J, 2012, EMERG INFECT DIS, V18, P1468, DOI 10.3201/eid1809.111731; Edelstein ZR, 2012, SEX TRANSM DIS, V39, P860, DOI 10.1097/OLQ.0b013e318269d098; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; Gillison ML, 2012, JAMA-J AM MED ASSOC, V307, P693, DOI 10.1001/jama.2012.101; Hashibe M, 2013, OTOLARYNG CLIN N AM, V46, P507, DOI 10.1016/j.otc.2013.05.001; Herrero R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068329; hrlund-Richter A, 2015, INFECT DIS, V47, P57; Information Services Division, 2016, DENT STAT NHS REG PA; Junor EJ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2512; Kho ME, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b866; Kreimer AR, 2013, LANCET, V382, P877, DOI 10.1016/S0140-6736(13)60809-0; Kreimer AR, 2011, CANCER EPIDEM BIOMAR, V20, P172, DOI 10.1158/1055-9965.EPI-10-0682; Kreimer AR, 2010, SEX TRANSM DIS, V37, P386, DOI 10.1097/OLQ.0b013e3181c94a3b; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Louie KS, 2015, ORAL ONCOL, V51, P341, DOI 10.1016/j.oraloncology.2015.01.002; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Migaldi M, 2012, J ORAL PATHOL MED, V41, P16, DOI 10.1111/j.1600-0714.2011.01062.x; Palmer TJ, 2016, BRIT J CANCER, V114, P576, DOI 10.1038/bjc.2015.473; Pavis S, 2015, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2541541; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Scottish Government, 2010, AN DENT WORKF SCOTL; Scottish Health Survey, 2012, 1 CONT SURV 2008 201; Sinka K, 2011, SEX TRANSM INFECT, V87, P548, DOI 10.1136/sextrans-2011-050211; The Scottish Government, 2012, SCOTT IND MULT DEPR	32	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165847	10.1371/journal.pone.0165847	http://dx.doi.org/10.1371/journal.pone.0165847			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861508	Green Published, gold, Green Accepted			2022-12-26	WOS:000388350300012
J	Ghaghada, KB; Starosolski, ZA; Lakoma, A; Kaffes, C; Agarwal, S; Athreya, KK; Shohet, J; Kim, E; Annapragada, A				Ghaghada, Ketan B.; Starosolski, Zbigniew A.; Lakoma, Anna; Kaffes, Caterina; Agarwal, Saurabh; Athreya, Khannan K.; Shohet, Jason; Kim, Eugene; Annapragada, Ananth			Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma	PLOS ONE			English	Article							CHEMOTHERAPY	Liposomal chemotherapeutics are exemplified by DOXIL (R) are commonly used in adult cancers. While these agents exhibit improved safety profile compared to their free drug counterparts, their treatment response rates have been similar to 20%, often attributed to the heterogeneous intratumoral uptake and distribution of liposomal nanoparticles. Non-invasive and quantitative monitoring of the uptake and distribution of liposomal nanoparticles in solid tumors could allow for patient stratification and personalized cancer nanomedicine. In this study, the variability of liposomal nanoparticle intratumoral distribution and uptake in orthotopic models of pediatric neuroblastoma was investigated using a liposomal nanoprobe visualized by high-resolution computed tomography (CT). Two human neuroblastoma cell lines (NGP: a MYCN-amplified line, and SH-SY5Y a MYCN non-amplified line) were implanted in the renal capsule of nude mice to establish the model. Intratumoral nanoparticle uptake was measured at tumor ages 1, 2, 3 and 4 weeks post implantation. The locations of uptake within the tumor were mapped in the 3-dimensional reconstructed images. Total uptake was measured by integration of the x-ray absorption signal over the intratumoral uptake locations. Both tumor models showed significant variation in nanoparticle uptake as the tumors aged. Observation of the uptake patterns suggested that the nanoparticle uptake was dominated by vascular leak at the surface/periphery of the tumor, and localized, heterogeneous vascular leak in the interior of the tumor. Slow growing SH-SY5Y tumors demonstrated uptake that correlated directly with the tumor volume. Faster growing NGP tumor uptake did not correlate with any tumor geometric parameters, including tumor volume, tumor surface area, and R30 and R50, measures of uptake localized to the interior of the tumor. However, uptake for both SH-SY5Y and NGP tumors correlated almost perfectly with the leak volume, as measured by CT. These results suggest that the uptake of nanoparticles is heterogeneous and not governed by tumor geometry. An imaging nanoprobe remains the best measure of nanoparticle uptake in these tumor models.	[Ghaghada, Ketan B.; Starosolski, Zbigniew A.; Annapragada, Ananth] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Lakoma, Anna; Kim, Eugene] Baylor Coll Med, Dept Surg, Div Pediat Surg, Michael E DeBakey, Houston, TX 77030 USA; [Kaffes, Caterina] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Agarwal, Saurabh; Shohet, Jason] Baylor Coll Med, Dept Pediat, Hematol Oncol Sect, Houston, TX 77030 USA; [Agarwal, Saurabh; Shohet, Jason] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Agarwal, Saurabh; Shohet, Jason; Annapragada, Ananth] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Athreya, Khannan K.] Univ Texas Hlth Sci Ctr Houston, Univ Texas Houston, Med Sch Houston, Houston, TX 77030 USA; [Kaffes, Caterina] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Imaging, Houston, TX 77030 USA; [Athreya, Khannan K.] Baylor Coll Med, Houston, TX 77030 USA; [Kim, Eugene] Univ Southern Calif, Keck Sch Med, Dept Surg, Div Pediat Surg, Los Angeles, CA 90033 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Texas Children's Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; University of Southern California	Annapragada, A (corresponding author), Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA.; Annapragada, A (corresponding author), Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA.	avannapr@texaschildrens.org	Annapragada, Ananth/GOK-1576-2022; Agarwal, Saurabh/G-2410-2015	Annapragada, Ananth/0000-0002-3156-9617; Agarwal, Saurabh/0000-0001-9758-6746; Kim, Eugene/0000-0001-7959-5614	Gillson Longenbaugh Foundation; National Institutes of Health [R01CA174808, R01DE024392]; NATIONAL CANCER INSTITUTE [R01CA174808] Funding Source: NIH RePORTER	Gillson Longenbaugh Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this work came from the Gillson Longenbaugh Foundation (M, JS), and the National Institutes of Health (R01CA174808 to JS, and R01DE024392 to AA).; The authors acknowledge financial support of the Gillson Longenbaugh Foundation. The authors also acknowledge the Texas Children's Small Animal Imaging Facility (SAIF) for access to the micro CT instrument used in this work.	Annapragada A, 2009, FUTURE ONCOL, V5, P409, DOI [10.2217/fon.09.21, 10.2217/FON.09.21]; Badea CT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034496; Ghaghada KB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152718; Ghaghada KB, 2011, ACAD RADIOL, V18, P20, DOI 10.1016/j.acra.2010.09.003; Hsu DM, 2013, CANCER RES, V73, P4134, DOI 10.1158/0008-5472.CAN-12-4056; Karathanasis E, 2007, MICROSC MICROANAL, V13, P2; Karathanasis E, 2008, BIOMATERIALS, V29, P4815, DOI 10.1016/j.biomaterials.2008.08.036; Karathanasis E, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/31/315101; Karathanasis E, 2009, RADIOLOGY, V250, P398, DOI 10.1148/radiol.2502080801; Park K, 2013, ACS NANO, V7, P7442, DOI 10.1021/nn404501g; Patterson Danielle M, 2011, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1417s52; Prabhakar U, 2013, CANCER RES, V73, P2412, DOI 10.1158/0008-5472.CAN-12-4561; Tanifum EA, 2014, J CEREB BLOOD FLOW M; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Zheng J, 2009, MOL PHARMACEUT, V6, P571, DOI 10.1021/mp800234r	15	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165877	10.1371/journal.pone.0165877	http://dx.doi.org/10.1371/journal.pone.0165877			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861510	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300013
J	Lopez, IP; Pineiro-Hermida, S; Pais, RS; Torrens, R; Hoeflich, A; Pichel, JG				Lopez, Iciar P.; Pineiro-Hermida, Sergio; Pais, Rosete S.; Torrens, Raquel; Hoeflich, Andreas; Pichel, Jose G.			Involvement of Igf1r in Bronchiolar Epithelial Regeneration: Role during Repair Kinetics after Selective Club Cell Ablation	PLOS ONE			English	Article							GROWTH-FACTOR-I; BRONCHIOALVEOLAR STEM-CELLS; CONDITIONAL DELETION; SIGNALING PATHWAY; LUNG MATURATION; RAT LUNG; INSULIN; RECEPTOR; MOUSE; MICE	Regeneration of lung epithelium is vital for maintaining airway function and integrity. An imbalance between epithelial damage and repair is at the basis of numerous chronic lung diseases such as asthma, COPD, pulmonary fibrosis and lung cancer. IGF (Insulin-like Growth Factors) signaling has been associated with most of these respiratory pathologies, although their mechanisms of action in this tissue remain poorly understood. Expression profiles analyses of IGF system genes performed in mouse lung support their functional implication in pulmonary ontogeny. Immuno-localization revealed high expression levels of Igf1r (Insulin-like Growth Factor 1 Receptor) in lung epithelial cells, alveolar macrophages and smooth muscle. To further understand the role of Igf1r in pulmonary homeostasis, two distinct lung epithelial-specific Igf1r mutant mice were generated and studied. The lack of Igf1r disturbed airway epithelial differentiation in adult mice, and revealed enhanced proliferation and altered morphology in distal airway club cells. During recovery after naphthalene-induced club cell injury, the kinetics of terminal bronchiolar epithelium regeneration was hindered in Igf1r mutants, revealing increased proliferation and delayed differentiation of club and ciliated cells. Amid airway restoration, lungs of Igf1r deficient mice showed increased levels of Igf1, Insr, Igfbp3 and epithelial precursor markers, reduced amounts of Scgb1a1 protein, and alterations in IGF signaling mediators. These results support the role of Igf1r in controlling the kinetics of cell proliferation and differentiation during pulmonary airway epithelial regeneration after injury.	[Lopez, Iciar P.; Pineiro-Hermida, Sergio; Pais, Rosete S.; Torrens, Raquel; Pichel, Jose G.] Fdn Rioja Salud, Ctr Invest Biomed Rioja CIBIR, Logrono, Spain; [Hoeflich, Andreas] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Pichel, JG (corresponding author), Fdn Rioja Salud, Ctr Invest Biomed Rioja CIBIR, Logrono, Spain.	jgpichel@rojasalud.es	Pichel, Jose G/AAF-2255-2019	Pichel, Jose G/0000-0001-8580-0952; Pineiro Hermida, Sergio/0000-0002-8915-5687	Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain); Fundacion Rioja Salud (Gobierno de La Rioja, Spain)	Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain); Fundacion Rioja Salud (Gobierno de La Rioja, Spain)	S.P.-H. thanks the Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain) for a PhD grant. I.P.L., S.P-H., R.T. and J.G.P. are part of the European Cooperation in Science and Technology COST Action BM1201, Developmental Origins of Chronic Lung Disease. This work was supported by grants from the Fundacion Rioja Salud (Gobierno de La Rioja, Spain) to J.G.P.; We are grateful to Drs. J. Bruning (University of Cologne, Germany), S. Anderson (UPenn/The Children's Hospital of Philadelphia, PA) and Michel Tauc (University of Nice-Sophia Antipolis, France) for providing Igf1<SUP>fl/fl</SUP>, Nkx2.1-Cre and Scgb1a1-Cre mouse lines, respectively. We would also like to thank Maria Iniguez (CIBIR, Logrono, Spain) for help with the RNA-seq analysis, Luong Chau (Leibniz-Institute for Farm Animal Biology (FBN), Germany) for her technical assistance with western blots, and Drs. J.M. Zubeldia (University General Hospital, "Gregorio Maranon", Madrid, Spain), and F. de Mora and R. Torres (Universitat Autonoma de Barcelona, Spain) for mouse respiratory functional analysis. S.P.-H. thanks the Sistema Riojano de Innovacion (Gobierno de La Rioja, Spain) for a PhD grant. I.P.L., S.P-H., R.T. and J.G.P. are part of the European Cooperation in Science and Technology COST Action BM1201, Developmental Origins of Chronic Lung Disease. This work was supported by grants from the Fundacion Rioja Salud (Gobierno de La Rioja, Spain) to J.G.P.	Abbas A, 2011, DIABETES, V60, P2169, DOI 10.2337/db11-0197; Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Ahamed K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-31; Annunziata M, 2011, ACTA DIABETOL, V48, P1, DOI 10.1007/s00592-010-0227-z; Bertin G, 2005, TRANSGENIC RES, V14, P645, DOI 10.1007/s11248-005-7214-0; Bessich JL, 2013, J IMMUNOL, V191, P378, DOI 10.4049/jimmunol.1300221; Boucherat O, 2014, DEVELOPMENT, V141, P3197, DOI 10.1242/dev.110254; Boucherat O, 2012, BIOL OPEN, V1, P677, DOI 10.1242/bio.20121701; BUCKPITT A, 1995, MOL PHARMACOL, V47, P74; Chan JY, 2016, ONCOGENE, V35, P4235, DOI 10.1038/onc.2015.488; Chand HS, 2012, AM J RESP CELL MOL, V47, P784, DOI 10.1165/rcmb.2012-0079OC; Chen WJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4472; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Choi JE, 2009, AM J RESP CRIT CARE, V179, P212, DOI 10.1164/rccm.200802-228OC; Chung C, 2013, P NATL ACAD SCI USA, V110, P7732, DOI 10.1073/pnas.1220603110; D'Addio F, 2015, CELL STEM CELL, V17, P486, DOI 10.1016/j.stem.2015.07.010; Dalbay MT, 2015, STEM CELLS, V33, P1952, DOI 10.1002/stem.1975; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; DeMaio L, 2012, J PATHOL, V226, P633, DOI 10.1002/path.3016; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Engberding N, 2009, ARTERIOSCL THROM VAS, V29, P408, DOI 10.1161/ATVBAHA.108.181727; Epaud R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048071; Fang P, 2012, J CLIN ENDOCR METAB, V97, pE243, DOI 10.1210/jc.2011-2142; Galvis LA, 2015, DEVELOPMENT, V142, P1458, DOI 10.1242/dev.122077; Gannage-Yared MH, 2013, EUR J ENDOCRINOL, V168, pK1, DOI 10.1530/EJE-12-0701; Ghosh MC, 2013, AM J PHYSIOL-LUNG C, V305, P1222, DOI 10.1152/ajplung.00014.2013; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Girnita L, 2014, CELL MOL LIFE SCI, V71, P2403, DOI 10.1007/s00018-013-1514-y; Guha A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088848; Han RNN, 2003, AM J RESP CELL MOL, V28, P159, DOI 10.1165/rcmb.4764; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JH, 2015, INT J PR ENG MAN-GT, V2, P197, DOI 10.1007/s40684-015-0024-9; Kim SR, 2012, ALLERGY, V67, P869, DOI 10.1111/j.1398-9995.2012.02837.x; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Le Roith Derek, 2003, Exp Diabesity Res, V4, P205, DOI 10.1155/EDR.2003.205; Lee H, 2014, AM J RESP CELL MOL, V50, P667, DOI 10.1165/rcmb.2013-0397TR; Lee YC, 2006, FEBS LETT, V580, P4515, DOI 10.1016/j.febslet.2006.07.031; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Li L, 2011, J PHARMACOL EXP THER, V339, P62, DOI 10.1124/jpet.111.184671; Lindskog C, 2014, FASEB J, V28, P5184, DOI 10.1096/fj.14-254862; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Mahoney JE, 2014, DEV CELL, V30, P137, DOI 10.1016/j.devcel.2014.06.003; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; Minoo P, 1995, DEV BIOL, V172, P694, DOI 10.1006/dbio.1995.8080; Moody G, 2014, J ENDOCRINOL, V221, P145, DOI 10.1530/JOE-13-0306; Moreno-Barriuso N, 2006, DEV DYNAM, V235, P2040, DOI 10.1002/dvdy.20842; Mori M, 2015, DEVELOPMENT, V142, P258, DOI 10.1242/dev.116855; MORISHIGE WK, 1977, ENDOCRINOLOGY, V100, P1710, DOI 10.1210/endo-100-6-1710; Morrisey EE, 2010, DEV CELL, V18, P8, DOI 10.1016/j.devcel.2009.12.010; Muller K, 2011, MOL ENDOCRINOL, V25, P1867, DOI 10.1210/me.2011-0065; Nagata K, 2007, PEDIATR SURG INT, V23, P953, DOI 10.1007/s00383-007-1977-8; Narasaraju TA, 2006, J CELL BIOCHEM, V97, P984, DOI 10.1002/jcb.20653; Oliver JR, 2011, LAB INVEST, V91, P1514, DOI 10.1038/labinvest.2011.100; Pan QP, 2004, GENE, V331, P73, DOI 10.1016/j.gene.2004.01.026; Panganiban RAM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078589; Lopez IP, 2015, TRANSGENIC RES, V24, P279, DOI 10.1007/s11248-014-9837-5; Pechart I, 1999, BIOL CELL, V91, P685, DOI 10.1016/S0248-4900(00)88532-9; Pichel JG, 2003, MECH DEVELOP, V120, P349, DOI 10.1016/S0925-4773(02)00449-5; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Prontera P, 2015, HUM MUTAT, V36, P1043, DOI 10.1002/humu.22853; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; ROBACK EW, 1991, AM J MED GENET, V38, P74, DOI 10.1002/ajmg.1320380117; Rock JR, 2009, P NATL ACAD SCI USA, V106, P12771, DOI 10.1073/pnas.0906850106; Rota LM, 2014, CANCER RES, V74, P5668, DOI 10.1158/0008-5472.CAN-14-0970; Schnapp LM, 2006, AM J PATHOL, V169, P86, DOI 10.2353/ajpath.2006.050612; Singh Suchita, 2013, J Allergy (Cairo), V2013, P627384, DOI 10.1155/2013/627384; SODOYEZGOFFAUX FR, 1981, PEDIATR RES, V15, P1303, DOI 10.1203/00006450-198109000-00014; Pais RS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083028; Spadaro O, 2016, CELL REP, V14, P1571, DOI 10.1016/j.celrep.2016.01.044; Sutherland BW, 2008, CANCER RES, V68, P3495, DOI 10.1158/0008-5472.CAN-07-6531; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Taub R, 1996, FASEB J, V10, P413, DOI 10.1096/fasebj.10.4.8647340; Tiozzo C, 2009, AM J RESP CRIT CARE, V180, P701, DOI 10.1164/rccm.200901-0100OC; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Varma S, 2012, J BIOL CHEM, V287, P37282, DOI 10.1074/jbc.M112.408401; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Wu S, 2009, PEDIATR RES, V65, P381, DOI 10.1203/PDR.0b013e3181991c67; Xing YM, 2015, DEV BIOL, V408, P56, DOI 10.1016/j.ydbio.2015.10.002; Xu Q, 2008, J COMP NEUROL, V506, P16, DOI 10.1002/cne.21529; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200; Ye J, 2014, LUNG, V192, P881, DOI 10.1007/s00408-014-9631-4; Yeh C, 2013, DEV CELL, V26, P358, DOI 10.1016/j.devcel.2013.07.014; Zhou F, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-78; Zhu D, 2009, J CELL SCI, V122, P2760, DOI 10.1242/jcs.046276	99	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166388	10.1371/journal.pone.0166388	http://dx.doi.org/10.1371/journal.pone.0166388			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861515	Green Submitted, Green Published, gold			2022-12-26	WOS:000388350300053
J	Yang, YC; Mo, YL; Yang, XZ; Zhang, HF; Wang, YQ; Li, H; Wei, CH; Zhang, X				Yang, Yongchao; Mo, Yanling; Yang, Xiaozheng; Zhang, Haifei; Wang, Yongqi; Li, Hao; Wei, Chunhua; Zhang, Xian			Transcriptome Profiling of Watermelon Root in Response to Short-Term Osmotic Stress	PLOS ONE			English	Article							DROUGHT STRESS; ABIOTIC STRESS; PROLINE BIOSYNTHESIS; DEVELOPMENTAL CONTROL; AUXIN BIOSYNTHESIS; WILD WATERMELON; ARABIDOPSIS; TOLERANCE; GROWTH; EXPRESSION	Osmotic stress adversely affects the growth, fruit quality and yield of watermelon (Citrullus lanatus (Thunb.) Matsum. & Nakai). Increasing the tolerance of watermelon to osmotic stress caused by factors such as high salt and water deficit is an effective way to improve crop survival in osmotic stress environments. Roots are important organs in water absorption and are involved in the initial response to osmosis stress; however, few studies have examined the underlying mechanism of tolerance to osmotic stress in watermelon roots. For better understanding of this mechanism, the inbred watermelon accession M08, which exhibits relatively high tolerance to water deficits, was treated with 20% polyethylene glycol (PEG) 6000. The root samples were harvested at 6 h after PEG treatment and untreated samples were used as controls. Transcriptome analyses were carried out by Illumina RNA sequencing. A total of 5246 differentially expressed genes were identified. Gene ontology enrichment and biochemical pathway analyses of these 5246 genes showed that short-term osmotic stress affected osmotic adjustment, signal transduction, hormone responses, cell division, cell cycle and ribosome, and M08 may repress root growth to adapt osmotic stress. The results of this study describe the watermelon root transcriptome under osmotic stress and propose new insight into watermelon root responses to osmotic stress at the transcriptome level. Accordingly, these results allow us to better understand the molecular mechanisms of watermelon in response to drought stress and will facilitate watermelon breeding projects to improve drought tolerance.	[Yang, Yongchao; Mo, Yanling; Yang, Xiaozheng; Zhang, Haifei; Wang, Yongqi; Li, Hao; Wei, Chunhua; Zhang, Xian] Northwest A&F Univ, Coll Hort, Yangling, Peoples R China; [Yang, Yongchao] Wenshan Acad Agr Sci, Wenshan, Peoples R China; [Wang, Yongqi] Hanzhong City Agrotechnol Extens Ctr, Hanzhong, Peoples R China	Northwest A&F University - China	Zhang, X (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Peoples R China.	zhangxian098@126.com			Modern Agro-industry Technology Research System of China [CARS-26-18]; county key technology project in Shaanxi province, China [2012XY-27]	Modern Agro-industry Technology Research System of China; county key technology project in Shaanxi province, China	This study was supported by the Modern Agro-industry Technology Research System of China (CARS-26-18), and the county key technology project in Shaanxi province, China (No. 2012XY-27). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Breuer C, 2010, CURR OPIN PLANT BIOL, V13, P654, DOI 10.1016/j.pbi.2010.10.006; Cao MM, 2010, PLANT SIGNAL BEHAV, V5, P1645, DOI 10.4161/psb.5.12.13811; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Collins JK, 2007, NUTRITION, V23, P261, DOI 10.1016/j.nut.2007.01.005; De Smet I, 2006, PLANT MOL BIOL, V60, P871, DOI 10.1007/s11103-005-4547-2; DELAUNEY AJ, 1993, PLANT J, V4, P215, DOI 10.1046/j.1365-313X.1993.04020215.x; Fan ML, 2014, PLANTA, V239, P397, DOI 10.1007/s00425-013-1976-z; Fukaki H, 2009, PLANT MOL BIOL, V69, P437, DOI 10.1007/s11103-008-9417-2; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Guo S, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL; Guo SG, 2013, NAT GENET, V45, P51, DOI 10.1038/ng.2470; Guo YS, 2010, PLANTA, V232, P1499, DOI 10.1007/s00425-010-1271-1; Hashimoto K, 2011, BIOCHIMIE, V93, P2054, DOI 10.1016/j.biochi.2011.05.019; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HU CAA, 1992, P NATL ACAD SCI USA, V89, P9354, DOI 10.1073/pnas.89.19.9354; Inze D, 2006, ANNU REV GENET, V40, P77, DOI 10.1146/annurev.genet.40.110405.090431; Javot H, 2002, ANN BOT-LONDON, V90, P301, DOI 10.1093/aob/mcf199; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawasaki S, 2000, PLANT CELL PHYSIOL, V41, P864, DOI 10.1093/pcp/pcd005; Kaya C, 2003, PLANT SOIL, V253, P287, DOI 10.1023/A:1024843419670; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Kong QS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090612; Kramer P.J., 1995, WATER RELATIONS PLAN; Lee BR, 2008, PHYSIOL PLANTARUM, V134, P403, DOI 10.1111/j.1399-3054.2008.01156.x; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li C, 2012, THESIS; Li HL, 2011, VIDEO SEGMENTATION AND ITS APPLICATIONS, P1, DOI 10.1007/978-1-4419-9482-0_1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo SF, 2008, PLANT CELL, V20, P2603, DOI 10.1105/tpc.108.060913; Lushchak VI, 2011, COMP BIOCHEM PHYS C, V153, P175, DOI 10.1016/j.cbpc.2010.10.004; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lyzenga WJ, 2012, J EXP BOT, V63, P599, DOI 10.1093/jxb/err310; Magalhaes JV, 2010, ANN BOT-LONDON, V106, P199, DOI 10.1093/aob/mcq115; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mashiguchi K, 2011, P NATL ACAD SCI USA, V108, P18512, DOI 10.1073/pnas.1108434108; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Morris PC, 2001, NEW PHYTOL, V151, P67, DOI 10.1046/j.1469-8137.2001.00167.x; Negi S, 2008, PLANT J, V55, P175, DOI 10.1111/j.1365-313X.2008.03495.x; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Peleg Z, 2011, CURR OPIN PLANT BIOL, V14, P290, DOI 10.1016/j.pbi.2011.02.001; Perkins-Veazie P, 2006, J AGR FOOD CHEM, V54, P2593, DOI 10.1021/jf052066p; Peterbauer T, 2001, SEED SCI RES, V11, P185; Qin XQ, 1999, P NATL ACAD SCI USA, V96, P15354, DOI 10.1073/pnas.96.26.15354; Ranty B, 2006, PLANT SIGNAL BEHAV, V1, P96, DOI 10.4161/psb.1.3.2998; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Roosens NHCJ, 1998, PLANT PHYSIOL, V117, P263, DOI 10.1104/pp.117.1.263; Sagi M, 2006, PLANT PHYSIOL, V141, P336, DOI 10.1104/pp.106.078089; Sanchez-Calderon L, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P135, DOI 10.5772/55043; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Schluepmann H, 2004, PLANT PHYSIOL, V135, P879, DOI 10.1104/pp.104.039503; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shao HB, 2008, CR BIOL, V331, P215, DOI 10.1016/j.crvi.2008.01.002; Sharma S, 2011, PLANT PHYSIOL, V157, P292, DOI 10.1104/pp.111.183210; Si Y, 2009, PLANT CELL REP, V28, P997, DOI 10.1007/s00299-009-0703-5; SPOLLEN WG, 1991, PLANT PHYSIOL, V96, P438, DOI 10.1104/pp.96.2.438; Stines AP, 1999, PLANT PHYSIOL, V120, P923, DOI 10.1104/pp.120.3.923; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Szekely G, 2008, PLANT J, V53, P11, DOI 10.1111/j.1365-313X.2007.03318.x; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tiwari M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03964; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vandepoele K, 2005, PLANT PHYSIOL, V139, P316, DOI 10.1104/pp.105.066290; Verslues PE, 1999, PLANT PHYSIOL, V119, P1349, DOI 10.1104/pp.119.4.1349; Wang WJ, 2013, PLANTA, V237, P1123, DOI 10.1007/s00425-012-1831-7; Wang ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106078; Wasteneys GO, 2003, ANNU REV PLANT BIOL, V54, P691, DOI 10.1146/annurev.arplant.54.031902.134818; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Won C, 2011, P NATL ACAD SCI USA, V108, P18518, DOI 10.1073/pnas.1108436108; Xiong LM, 2006, PLANT PHYSIOL, V142, P1065, DOI 10.1104/pp.106.084632; Xu YJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-662; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Zang BS, 2011, PLANT MOL BIOL, V76, P507, DOI 10.1007/s11103-011-9781-1; Zhao YD, 2012, MOL PLANT, V5, P334, DOI 10.1093/mp/ssr104; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	83	15	17	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166314	10.1371/journal.pone.0166314	http://dx.doi.org/10.1371/journal.pone.0166314			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861528	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300046
J	Iwanowicz, DD; Vandergast, AG; Cornman, RS; Adams, CR; Kohn, JR; Fisher, RN; Brehme, CS				Iwanowicz, Deborah D.; Vandergast, Amy G.; Cornman, Robert S.; Adams, Cynthia R.; Kohn, Joshua R.; Fisher, Robert N.; Brehme, Cheryl S.			Metabarcoding of Fecal Samples to Determine Herbivore Diets: A Case Study of the Endangered Pacific Pocket Mouse	PLOS ONE			English	Article							FOOD; SELECTION; PREY; DNA; IDENTIFICATION; SEQUENCES; ALIGNMENT; ACCURACY; AMPLICON; RODENT	Understanding the diet of an endangered species illuminates the animal's ecology, habitat requirements, and conservation needs. However, direct observation of diet can be difficult, particularly for small, nocturnal animals such as the Pacific pocket mouse (Heteromyidae: Perognathus longimembris pacificus). Very little is known of the dietary habits of this federally endangered rodent, hindering management and restoration efforts. We used a metabarcoding approach to identify source plants in fecal samples (N = 52) from the three remaining populations known. The internal transcribed spacers (ITS) of the nuclear ribosomal loci were sequenced following the Illumina MiSeq amplicon strategy and processed reads were mapped to reference databases. We evaluated a range of threshold mapping criteria and found the best-performing setting generally recovered two distinct mock communities in proportions similar to expectation. We tested our method on captive animals fed a known diet and recovered almost all plant sources, but found substantial heterogeneity among fecal pellets collected from the same individual at the same time. Observed richness did not increase with pooling of pellets from the same individual. In field-collected samples, we identified 4-14 plant genera in individual samples and 74 genera overall, but over 50 percent of reads mapped to just six species in five genera. We simulated the effects of sequencing error, variable read length, and chimera formation to infer taxon-specific rates of misassignment for the local flora, which were generally low with some exceptions. Richness at the species and genus levels did not reach a clear asymptote, suggesting that diet breadth remained underestimated in the current pool of samples. Large numbers of scat samples are therefore needed to make inferences about diet and resource selection in future studies of the Pacific pocket mouse. We conclude that our minimally invasive method is promising for determining herbivore diets given a library of sequences from local plants.	[Iwanowicz, Deborah D.; Adams, Cynthia R.] US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA; [Vandergast, Amy G.; Fisher, Robert N.; Brehme, Cheryl S.] US Geol Survey, Western Ecol Res Ctr, San Diego, CA USA; [Cornman, Robert S.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Kohn, Joshua R.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey; University of California System; University of California San Diego	Iwanowicz, DD (corresponding author), US Geol Survey, Leetown Sci Ctr, Kearneysville, WV 25430 USA.	diwanowicz@usgs.gov	Fisher, Robert/AAA-7301-2022	Fisher, Robert/0000-0002-2956-3240; Adams, Cynthia/0000-0003-4383-530X; Brehme, Cheryl/0000-0001-8904-3354	Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR [M3320013MPFE026]; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego	Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego	This work was funded by the Environmental Security Department, Resource Branch Management, Marine Corps Base Camp Pendleton, California - MIPR# M3320013MPFE026; USGS Ecosystems Mission Area; USGS Wildlife Research Program; ResMed Incorporated; San Diego Barcode of Life; Hattie Ettinger Conservation Fund; Consulate of Canada in San Diego.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Ando H, 2013, ECOL EVOL, V3, P4057, DOI 10.1002/ece3.773; Angly Florent E, 2012, Nucleic Acids Res, V40, pe94, DOI 10.1093/nar/gks251; BAILEY VERNON, 1939, JOUR MAMMAL, V20, P325, DOI 10.2307/1374258; BARKER RD, 1986, AUST WILDLIFE RES, V13, P559; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; BELOVSKY GE, 1986, OECOLOGIA, V70, P35, DOI 10.1007/BF00377109; BELOVSKY GE, 1981, ECOLOGY, V62, P1020, DOI 10.2307/1937001; Belovsky GE, 1984, P NATL ACAD SCI USA, V105, P1977; BERGERON JM, 1991, CAN J ZOOL, V69, P1496, DOI 10.1139/z91-209; Bloeker J. C. von., 1931, Journal of Mammalogy, V12, P369; Boyer S, 2013, PLOS ONE, V8; Bradley BJ, 2007, AM J PRIMATOL, V69, P699, DOI 10.1002/ajp.20384; Brehme CSS, 2014, PACIFIC POCKET MOUSE; Brehme CST, 2011, PACIFIC POCKET MOUSE; Calflora, 2016, INF WILD CAL PLANTS; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Clarke K. R., 2001, CHANGES MARINE COMMU; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Cornman RS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145365; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deagle BE, 2005, MOL ECOL, V14, P1831, DOI 10.1111/j.1365-294X.2005.02531.x; Deakin CT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRANK CL, 1988, PHYSIOL ZOOL, V61, P527, DOI 10.1086/physzool.61.6.30156161; FRETWELL SD, 1987, OIKOS, V50, P291, DOI 10.2307/3565489; Hammer O, 2001, PAST PALEONTOLOGICAL, V4; Heise W, 2015, BOT J LINN SOC, V177, P576, DOI 10.1111/boj.12261; Keller A, 2015, PLANT BIOLOGY, V17, P558, DOI 10.1111/plb.12251; Kempel A, 2015, ECOLOGY, V96, P2923, DOI 10.1890/14-2125.1; Khanam S, 2016, INTEGR ZOOL, V11, P98, DOI 10.1111/1749-4877.12172; King RA, 2008, MOL ECOL, V17, P947, DOI 10.1111/j.1365-294X.2007.03613.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Latinne A, 2014, J CAVE KARST STUD, V76, P139, DOI 10.4311/2013LSC0100; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McArthur C, 2014, OECOLOGIA, V176, P677, DOI 10.1007/s00442-014-3076-6; McClenaghan B, 2015, ECOL EVOL, V5, P3046, DOI 10.1002/ece3.1585; MESERVE PL, 1976, J MAMMAL, V57, P300, DOI 10.2307/1379690; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; MILTON K, 1979, AM NAT, V114, P362, DOI 10.1086/283485; Minnich RA, 2008, CALIFORNIA'S FADING WILDFLOWERS: LOST LEGACY AND BIOLOGICAL INVASIONS, P1; Ostoja SM, 2013, OIKOS, V122, P563, DOI 10.1111/j.1600-0706.2012.19969.x; Perry G, 1997, TRENDS ECOL EVOL, V12, P360, DOI 10.1016/S0169-5347(97)01097-5; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PULLIAM HR, 1974, AM NAT, V108, P59, DOI 10.1086/282885; Purcell M, 2004, FISH B-NOAA, V102, P213; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; Raye G, 2011, ECOL RES, V26, P265, DOI 10.1007/s11284-010-0780-5; REICHMAN OJ, 1977, ECOLOGY, V58, P454, DOI 10.2307/1935622; Schirmer M, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1341; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Stanford AM, 2000, AM J BOT, V87, P872, DOI 10.2307/2656895; Symondson WOC, 2002, MOL ECOL, V11, P627, DOI 10.1046/j.1365-294X.2002.01471.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tollit DJ, 2003, MAR MAMMAL SCI, V19, P724, DOI 10.1111/j.1748-7692.2003.tb01127.x; USFWS, 2010, PAC POCK MOUS PER LO; WESTOBY M, 1974, AM NAT, V108, P290, DOI 10.1086/282908; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Williams DF, 1973, AM SOC MAMMAL; Yunger JA, 2002, J MAMMAL, V83, P267, DOI 10.1644/1545-1542(2002)083<0267:ROTLDP>2.0.CO;2; Zagordi O, 2010, NUCLEIC ACIDS RES, V38, P7400, DOI 10.1093/nar/gkq655	64	22	23	4	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165366	10.1371/journal.pone.0165366	http://dx.doi.org/10.1371/journal.pone.0165366			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851756	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300014
J	Shi, XF; Yang, JC; Cui, XY; Huang, JS; Long, ZB; Zhou, YL; Liu, P; Tao, LL; Ruan, Z; Xiao, B; Zhang, W; Li, DY; Dai, KS; Mao, JH; Xi, XD				Shi, Xiaofeng; Yang, Jichun; Cui, Xiongying; Huang, Jiansong; Long, Zhangbiao; Zhou, Yulan; Liu, Ping; Tao, Lanlan; Ruan, Zheng; Xiao, Bing; Zhang, Wei; Li, Dongya; Dai, Kesheng; Mao, Jianhua; Xi, Xiaodong			Functional Effect of the Mutations Similar to the Cleavage during Platelet Activation at Integrin beta 3 Cytoplasmic Tail when Expressed in Mouse Platelets	PLOS ONE			English	Article							OUTSIDE-IN; INSIDE-OUT; CALPAIN CLEAVAGE; SIGNALING PATHWAY; BETA(3) SUBUNIT; CELL-ADHESION; SRC-KINASE; GPIIB-IIIA; ALPHA-IIB-BETA-3; DOMAIN	Previous studies in Chinese hamster ovary cells showed that truncational mutations of beta 3 at sites of F-754 and Y-759 mimicking calpain cleavage regulate integrin signaling. The roles of the sequence from F-754 to C-terminus and the conservative N-756 ITY759 motif in platelet function have yet to be elaborated. Mice expressing beta 3 with F-754 and Y-759 truncations, or NITY deletion (beta 3-Delta TNITYRGT, beta 3-Delta RGT, or beta 3-Delta NITY) were established through transplanting the homozygous beta 3-deficient mouse bone marrow cells infected by the GFP tagged MSCV MigR1 retroviral vector encoding different beta 3 mutants into lethally radiated wild-type mice. The platelets were harvested for soluble fibrinogen binding and platelet spreading on immobilized fibrinogen. Platelet adhesion on fibrinogen-and collagen-coated surface under flow was also tested to assess the ability of the platelets to resist hydrodynamic drag forces. Data showed a drastic inhibition of the beta 3-Delta TNITYRGT platelets to bind soluble fibrinogen and spread on immobilized fibrinogen in contrast to a partially impaired fibrinogen binding and an almost unaffected spreading exhibited in the beta 3-Delta NITY platelets. Behaviors of the beta 3-Delta RGT platelets were consistent with the previous observations in the beta 3-Delta RGT knock-in platelets. The adhesion impairment of platelets with the beta 3 mutants under flow was in different orders of magnitude shown as: beta 3-Delta TNITYRGT> beta 3-Delta RGT> beta 3-Delta NITY to fibrinogencoated surface, and beta 3-Delta TNITYRGT> beta 3-Delta NITY> beta 3-Delta RGT to collagen-coated surface. To evaluate the interaction of the beta 3 mutants with signaling molecules, GST pull-down and immunofluorescent assays were performed. Results showed that beta 3-Delta RGT interacted with kindlin but not c-Src, beta 3-Delta NITY interacted with c-Src but not kindlin, while beta 3-Delta TNITYRGT did not interact with both proteins. This study provided evidence in platelets at both static and flow conditions that the calpain cleavage-related sequences of integrin beta 3, i.e. T(755)NITYRGT(762), R(760)GT(762), and (NITY759)-I-756 participate in bidirectional, outside-in, and inside-out signaling, respectively and the association of c-Src or kindlin with beta 3 integrin may regulate these processes.	[Shi, Xiaofeng; Yang, Jichun; Cui, Xiongying; Huang, Jiansong; Long, Zhangbiao; Zhou, Yulan; Liu, Ping; Tao, Lanlan; Ruan, Zheng; Xiao, Bing; Zhang, Wei; Li, Dongya; Mao, Jianhua; Xi, Xiaodong] Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Collaborat Innovat Ctr Hematol, State Key Lab Med Genom,Sch Med,Ruijin Hosp,Shang, Shanghai 200025, Peoples R China; [Shi, Xiaofeng; Li, Dongya] Jiangsu Univ, Affiliated Hosp, Dept Hematol, Zhenjiang, Peoples R China; [Huang, Jiansong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Hematol,Inst Hematol, Hangzhou, Zhejiang, Peoples R China; [Dai, Kesheng] Soochow Univ, Key Lab Thrombosis & Hemostasis, Jiangsu Inst Hematol, Affiliated Hosp 1,Minist Hlth, Suzhou 215006, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Jiangsu University; Zhejiang University; Soochow University - China	Mao, JH; Xi, XD (corresponding author), Shanghai Jiao Tong Univ, Sino French Res Ctr Life Sci & Genom, Collaborat Innovat Ctr Hematol, State Key Lab Med Genom,Sch Med,Ruijin Hosp,Shang, Shanghai 200025, Peoples R China.	maojianhua110@163.com; xixiaodong@shsmu.edu.cn	Stefanadis, Christodoulos/ABH-2232-2020; Huang, Jiansong/AAI-1682-2019; Mao, Jianhua/GOK-2713-2022	Stefanadis, Christodoulos/0000-0001-5974-6454; Huang, Jiansong/0000-0003-0821-2801	National Natural Science Foundation of China [81670127, 81270594]; Basic Research Program of China [2013CB966800, 2012CB518000]; Science and Technology Commission of Shanghai Municipality of China [16PJ1406100, 16ZR1421000]; Science and Technology Department of Jiangsu Province of China [SBK2015043674]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Basic Research Program of China(National Basic Research Program of China); Science and Technology Commission of Shanghai Municipality of China(Science & Technology Commission of Shanghai Municipality (STCSM)); Science and Technology Department of Jiangsu Province of China	This work was supported by the research grants (grant number: 81670127 and 81270594, http://www.nsfc.gov.cn) from the National Natural Science Foundation of China, (grant number: 2013CB966800 and 2012CB518000, http://www.most.gov.cn/) from the National Basic Research Program of China to XX, (grant number: 16PJ1406100, 16ZR1421000, http://www.stcsm.gov.cn/) from the Science and Technology Commission of Shanghai Municipality of China to JM, and the research grant (grant number: SBK2015043674, http://www.jstd.gov.cn) from the Science and Technology Department of Jiangsu Province of China to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablooglu AJ, 2009, BLOOD, V113, P3585, DOI 10.1182/blood-2008-09-180687; Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Basani RB, 2009, BLOOD, V113, P902, DOI 10.1182/blood-2008-09-177337; Benoit MR, 2010, APPL ENVIRON MICROB, V76, P4136, DOI 10.1128/AEM.03065-09; Bledzka K, 2010, J BIOL CHEM, V285, P30370, DOI 10.1074/jbc.C110.134247; Blue R, 2009, BLOOD, V114, P195, DOI 10.1182/blood-2008-08-169243; Broos K, 2011, BLOOD REV, V25, P155, DOI 10.1016/j.blre.2011.03.002; Conant CG, 2010, J BIOMOL SCREEN, V15, P102, DOI 10.1177/1087057109353789; DU XP, 1995, J BIOL CHEM, V270, P26146, DOI 10.1074/jbc.270.44.26146; Fan XM, 2014, BLOOD, V124, P2421, DOI 10.1182/blood-2014-03-557645; Fitzpatrick P, 2014, J BIOL CHEM, V289, P11183, DOI 10.1074/jbc.M113.535369; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Gahmberg CG, 2009, BBA-GEN SUBJECTS, V1790, P431, DOI 10.1016/j.bbagen.2009.03.007; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; Giuliano S, 2003, BIOCHEM J, V372, P163, DOI 10.1042/BJ20020868; Goncalves I, 2003, J BIOL CHEM, V278, P34812, DOI 10.1074/jbc.M306504200; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang JS, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0159-8; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kroll MH, 1996, BLOOD, V88, P1525; Kuchay SM, 2012, J THROMB HAEMOST, V10, P1120, DOI 10.1111/j.1538-7836.2012.04715.x; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Mao YX, 2009, EMBO J, V28, P1831, DOI 10.1038/emboj.2009.155; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Morse EM, 2014, BIOCHEMISTRY-US, V53, P810, DOI 10.1021/bi401596q; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; Nesbitt WS, 2002, J BIOL CHEM, V277, P2965, DOI 10.1074/jbc.M110070200; Offermanns S, 2006, CIRC RES, V99, P1293, DOI 10.1161/01.RES.0000251742.71301.16; Ohmori T, 2010, BIOCHEM BIOPH RES CO, V400, P323, DOI 10.1016/j.bbrc.2010.08.056; Passacquale G, 2011, BRIT J CLIN PHARMACO, V72, P604, DOI 10.1111/j.1365-2125.2011.03906.x; Patel S, 2012, CIRCULATION, V126, P1385, DOI 10.1161/CIRCULATIONAHA.112.105452; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pfaff M, 1999, FEBS LETT, V460, P17, DOI 10.1016/S0014-5793(99)01250-8; PIDARD D, 1986, BLOOD, V67, P604; Pouwels J, 2012, J CELL SCI, V125, P3271, DOI 10.1242/jcs.093641; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Schoenwaelder SM, 1997, J BIOL CHEM, V272, P1694, DOI 10.1074/jbc.272.3.1694; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Shen B, 2013, NATURE, V503, P131, DOI 10.1038/nature12613; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Su XY, 2008, BLOOD, V112, P592, DOI 10.1182/blood-2007-09-110437; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takizawa H, 2010, J CLIN INVEST, V120, P179, DOI 10.1172/JCI39503; Tousoulis D, 2010, PHARMACOL THERAPEUT, V127, P108, DOI 10.1016/j.pharmthera.2010.05.001; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; Valera MC, 2012, BLOOD, V120, P1703, DOI 10.1182/blood-2012-01-405498; Wegener KL, 2008, J MOL BIOL, V382, P112, DOI 10.1016/j.jmb.2008.06.087; Woulfe D, 2002, J BIOL CHEM, V277, P23382, DOI 10.1074/jbc.M202212200; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xi XD, 2006, J BIOL CHEM, V281, P29426, DOI 10.1074/jbc.C600039200; Yin H, 2008, BLOOD, V112, P1139, DOI 10.1182/blood-2008-02-140970; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	60	4	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166136	10.1371/journal.pone.0166136	http://dx.doi.org/10.1371/journal.pone.0166136			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851790	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300038
J	Zhang, L; Wang, LL; Tian, P; Tian, SY				Zhang, Lei; Wang, Linlin; Tian, Pu; Tian, Suyan			Identification of Genes Discriminating Multiple Sclerosis Patients from Controls by Adapting a Pathway Analysis Method	PLOS ONE			English	Article							MICROARRAY DATA; SET ENRICHMENT; EXPRESSION; SELECTION; CLASSIFICATION; NETWORK; TOOL	The focus of analyzing data from microarray experiments has shifted from the identification of associated individual genes to that of associated biological pathways or gene sets. In bioinformatics, a feature selection algorithm is usually used to cope with the high dimensionality of microarray data. In addition to those algorithms that use the biological information contained within a gene set as a priori to facilitate the process of feature selection, various gene set analysis methods can be applied directly or modified readily for the purpose of feature selection. Significance analysis of microarray to gene-set reduction analysis (SAM-GSR) algorithm, a novel direction of gene set analysis, is one of such methods. Here, we explore the feature selection property of SAM-GSR and provide a modification to better achieve the goal of feature selection. In a multiple sclerosis (MS) microarray data application, both SAM-GSR and our modification of SAM-GSR perform well. Our results show that SAM-GSR can carry out feature selection indeed, and modified SAM-GSR outperforms SAM-GSR. Given pathway information is far from completeness, a statistical method capable of constructing biologically meaningful gene networks is of interest. Consequently, both SAM-GSR algorithms will be continuously revaluated in our future work, and thus better characterized.	[Zhang, Lei; Wang, Linlin; Tian, Pu] Jilin Univ, Coll Life Sci, 2699 Qianjin St, Changchun 130012, Jilin, Peoples R China; [Zhang, Lei] Jilin Univ, Dept Neurol, Hosp 2, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China; [Tian, Suyan] Jilin Univ, Div Clin Res, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China	Jilin University; Jilin University; Jilin University	Tian, P (corresponding author), Jilin Univ, Coll Life Sci, 2699 Qianjin St, Changchun 130012, Jilin, Peoples R China.; Tian, SY (corresponding author), Jilin Univ, Div Clin Res, Hosp 1, 71 Xinmin St, Changchun 130021, Jilin, Peoples R China.	tianpu@jlu.edu.cn; stian@rockefeller.edu	Tian, Suyan/W-3273-2019	Tian, Suyan/0000-0002-5942-1542; Zhang, Lei/0000-0002-2414-0505; Wang, Linlin/0000-0002-2805-7514	Natural Science Foundation of China [31401123, 31270758]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Natural Science Foundation of China (No 31401123 for ST and No 31270758 for PT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Becker N, 2009, BIOINFORMATICS, V25, P1711, DOI 10.1093/bioinformatics/btp286; Boulesteix AL, 2010, BIOINFORMATICS, V26, P437, DOI 10.1093/bioinformatics/btp648; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dinu I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-242; Dinu I, 2009, BRIEF BIOINFORM, V10, P24, DOI 10.1093/bib/bbn042; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fontoura P, 2010, RESULTS PROBL CELL D, V51, P259, DOI 10.1007/400_2010_36; FRIEDMAN JH, 2004, GRADIENT DIRECTED RE; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Guo P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100052; Huang J, 2009, BIOMETRIKA, V96, P339, DOI 10.1093/biomet/asp020; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kemppinen AK, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000053; Kim S, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-21; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Lauria M., 2013, SYSTEMS BIOMEDICINE, V1, P35; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim K, 2014, BIOINFORMATICS, V30, P189, DOI 10.1093/bioinformatics/btt625; Luo WJ, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-161; Ma SG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-60; Ma SG, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-271; Ma SG, 2009, STAT INTERFACE, V2, P1; McCall MN, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-369; Meyer P, 2012, BIOINFORMATICS, V28, P1193, DOI 10.1093/bioinformatics/bts116; Mycko MP, 2003, BRAIN, V126, P1048, DOI 10.1093/brain/awg107; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tajouri L, 2007, CURR GENOMICS, V8, P181, DOI 10.2174/138920207780833829; Tarca AL, 2013, SYST BIOMED, V1, P1; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Tian SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078302; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tsai CA, 2009, BIOINFORMATICS, V25, P897, DOI 10.1093/bioinformatics/btp098; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Zhang HH, 2006, BIOINFORMATICS, V22, P88, DOI 10.1093/bioinformatics/bti736; Zhao C, 2013, SYST BIOMED, V1, P247	45	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165543	10.1371/journal.pone.0165543	http://dx.doi.org/10.1371/journal.pone.0165543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846233	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600013
J	Pires-Neto, RC; Bernardi, FD; de Araujo, PA; Mauad, T; Dolhnikoff, M				Pires-Neto, Ruy Camargo; Bernardi, Fabiola Del Carlo; de Araujo, Priscila Alves; Mauad, Thais; Dolhnikoff, Marisa			The Expression of Water and Ion Channels in Diffuse Alveolar Damage Is Not Dependent on DAD Etiology	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; FLUID CLEARANCE; PULMONARY-EDEMA; K-ATPASE; AQUAPORINS; EPITHELIUM; RESOLUTION; RAT; NA	Introduction Aquaporins and ion channels are membrane proteins that facilitate the rapid movement of water and solutes across biological membranes. Experimental and in vitro studies reported that the function of these channels and pulmonary edema resolution are impaired in acute lung injury (ALI). Although current evidence indicates that alveolar fluid clearance is impaired in patients with ALI/diffuse alveolar damage (DAD), few human studies have addressed the alterations in pulmonary channels in this clinical condition. Additionally, it is not known whether the primary cause of DAD is a relevant variable for the channel dysfunction. Methods Autopsied lungs of 43 patients with acute respiratory failure (ARF) due to DAD of three different etiologies, non-pulmonary sepsis, H1N1 viral infection and leptospirosis, were compared to 18 normal lungs. We quantified the expression of aquaporin (AQP) 1, AQP3, AQP5, epithelial Na+ channel (ENaC) and sodium potassium ATPase (Na-K-ATPase) in the alveolar septum using immunohistochemistry and image analysis. Results The DAD group presented with increased expression of AQP3, AQP5 and Na-K-ATPase and decreased expression of ENaC compared to controls. However, there was no difference in protein expression within the DAD groups of different etiologies. Conclusion Water and ion channels are altered in patients with ARF due to DAD. The cause of DAD does not seem to influence the level of impairment of these channels.	[Pires-Neto, Ruy Camargo; Bernardi, Fabiola Del Carlo; de Araujo, Priscila Alves; Mauad, Thais; Dolhnikoff, Marisa] Univ Sao Paulo, Dept Patol, Fac Med, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Dolhnikoff, M (corresponding author), Univ Sao Paulo, Dept Patol, Fac Med, Sao Paulo, SP, Brazil.	maridol@usp.br	Dolhnikoff, Marisa/B-9019-2013	Dolhnikoff, Marisa/0000-0002-9073-9989	Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ)	Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP); Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Laboratorio de Investigagao Mica (LIM) 05 da Faculdade de Medicina da Universidade de Sao Paulo (FMUSP). Thais Mauad and Marisa Dolhnikoff are funded by Conselho Nacional de desenvolvimento Cientifico e Tecnologico (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi FD, 2012, HUM PATHOL, V43, P1601, DOI 10.1016/j.humpath.2011.11.017; De Brito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071743; Dellinger RP, 2013, CRIT CARE MED, V41, P637, DOI [DOI 10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-015-3827-9]; Dolhnikoff M, 2007, CURR OPIN PULM MED, V13, P230, DOI 10.1097/MCP.0b013e3280f9df74; Hasan B, 2014, RESP PHYSIOL NEUROBI, V200, P40, DOI 10.1016/j.resp.2014.05.008; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; Helenius Iiro T, 2010, Proc Am Thorac Soc, V7, P65, DOI 10.1513/pats.200907-082JS; Ishibashi K, 2009, CLIN EXP NEPHROL, V13, P107, DOI 10.1007/s10157-008-0118-6; Jang AS, 2004, INTENS CARE MED, V30, P489, DOI 10.1007/s00134-003-2129-9; Johnson MD, 2006, P NATL ACAD SCI USA, V103, P4964, DOI 10.1073/pnas.0600855103; Katzenstein ALA., 2006, KATZENSTEIN ASKINS S, P446; Kreda SM, 2001, AM J RESP CELL MOL, V24, P224, DOI 10.1165/ajrcmb.24.3.4367; Liu Y, 2007, BIOPHYS CHEM, V131, P1, DOI 10.1016/j.bpc.2007.08.007; Matthay Michael A, 2005, Proc Am Thorac Soc, V2, P206, DOI 10.1513/pats.200501-009AC; Matthay MA, 2014, AM J RESP CRIT CARE, V189, P1301, DOI 10.1164/rccm.201403-0535OE; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Morales MMB, 2011, CRIT CARE, V15, DOI 10.1186/cc9401; Pires-Neto RC, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.013; Song YL, 2000, J PHYSIOL-LONDON, V525, P771, DOI 10.1111/j.1469-7793.2000.00771.x; Sun CY, 2014, J RADIAT RES, V55, P683, DOI 10.1093/jrr/rru008; Towne JE, 2000, AM J RESP CELL MOL, V22, P34, DOI 10.1165/ajrcmb.22.1.3818; Uhlig C, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-56; Vadasz I, 2007, INTENS CARE MED, V33, P1243, DOI 10.1007/s00134-007-0661-8; Verkman AS, 2007, RESP PHYSIOL NEUROBI, V159, P324, DOI 10.1016/j.resp.2007.02.012; Ware LB, 2001, AM J RESP CRIT CARE, V163, P1376, DOI 10.1164/ajrccm.163.6.2004035; WARE LB, 2000, NEW ENGL J MED, V342, P1334, DOI [DOI 10.1056/NEJM200005043421806, 10.1056/NEJM200005043421806]; Zemans RL, 2004, CRIT CARE, V8, P469, DOI 10.1186/cc2906	27	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166184	10.1371/journal.pone.0166184	http://dx.doi.org/10.1371/journal.pone.0166184			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835672	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200030
J	An, CI; Ichihashi, Y; Peng, J; Sinha, NR; Hagiwara, N				An, Chung-Il; Ichihashi, Yasunori; Peng, Jie; Sinha, Neelima R.; Hagiwara, Nobuko			Transcriptome Dynamics and Potential Roles of Sox6 in the Postnatal Heart	PLOS ONE			English	Article							FETAL GENE PROGRAM; IN-VIVO; CARDIAC-HYPERTROPHY; SKELETAL-MUSCLE; HISTONE H3; CELL-DEATH; FIBER-TYPE; CYCLIN D1; MICE; GROWTH	The postnatal heart undergoes highly coordinated developmental processes culminating in the complex physiologic properties of the adult heart. The molecular mechanisms of postnatal heart development remain largely unexplored despite their important clinical implications. To gain an integrated view of the dynamic changes in gene expression during postnatal heart development at the organ level, time-series transcriptome analyses of the postnatal hearts of neonatal through adult mice (P1, P7, P14, P30, and P60) were performed using a newly developed bioinformatics pipeline. We identified functional gene clusters by principal component analysis with self-organizing map clustering which revealed organized, discrete gene expression patterns corresponding to biological functions associated with the neonatal, juvenile and adult stages of postnatal heart development. Using weighted gene co-expression network analysis with bootstrap inference for each of these functional gene clusters, highly robust hub genes were identified which likely play key roles in regulating expression of co-expressed, functionally linked genes. Additionally, motivated by the role of the transcription factor Sox6 in the functional maturation of skeletal muscle, the role of Sox6 in the postnatal maturation of cardiac muscle was investigated. Differentially expressed transcriptome analyses between Sox6 knockout (KO) and control hearts uncovered significant upregulation of genes involved in cell proliferation at postnatal day 7 (P7) in the Sox6 KO heart. This result was validated by detecting mitotically active cells in the P7 Sox6 KO heart. The current report provides a framework for the complex molecular processes of postnatal heart development, thus enabling systematic dissection of the developmental regression observed in the stressed and failing adult heart.	[An, Chung-Il; Hagiwara, Nobuko] Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA; [Ichihashi, Yasunori; Sinha, Neelima R.] Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA; [Peng, Jie] Univ Calif Davis, Dept Stat, Davis, CA 95616 USA; [Ichihashi, Yasunori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Ichihashi, Yasunori] JST, PRESTO, Kawaguchi, Saitama, Japan	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; RIKEN; Japan Science & Technology Agency (JST)	An, CI; Hagiwara, N (corresponding author), Univ Calif Davis, Dept Internal Med, Div Cardiovasc Med, Davis, CA 95616 USA.; Ichihashi, Y (corresponding author), Univ Calif Davis, Dept Plant Biol, Davis, CA 95616 USA.; Ichihashi, Y (corresponding author), RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan.; Ichihashi, Y (corresponding author), JST, PRESTO, Kawaguchi, Saitama, Japan.	can95616@gmail.com; yasunori.ichihashi@riken.jp; nhagiwara@ucdavis.edu	Ichihashi, Yasunori/D-1503-2017	Ichihashi, Yasunori/0000-0003-1935-4397	American Heart Association [063507N]; National Institutes of Health [AR055209]; National Science Foundation [IOS-0820854]; RIKEN Special Postdoctoral Researchers Program; Ministry of Education, Culture, Sports, Science and Technology, Japan [15K18589]; PRESTO, Japan Science and Technology Agency	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); RIKEN Special Postdoctoral Researchers Program; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by American Heart Association Scientist Development Grant (063507N to N.H.), the National Institutes of Health (AR055209 to N.H.), a National Science Foundation grant (IOS-0820854 to N.R.S. and J.P.), the RIKEN Special Postdoctoral Researchers Program (to Y.I.), Grant-in-Aid for Young Scientists (B; grant no. 15K18589) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (to Y.I.), and PRESTO, Japan Science and Technology Agency (to Y.I.).	Adams GN, 2013, BLOOD, V122, P1522, DOI 10.1182/blood-2012-10-460360; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; An CI, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-59; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Calabrese G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003150; Cameron VA, 2003, ENDOCRINOLOGY, V144, P2191, DOI 10.1210/en.2003-0127; Carlson MRJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-40; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Chen IY, 2006, J BIOL CHEM, V281, P19369, DOI 10.1074/jbc.M601443200; Chitwood DH, 2013, PLANT PHYSIOL, V162, P537, DOI 10.1104/pp.112.213546; Cohen-Barak O, 2003, NUCLEIC ACIDS RES, V31, P5941, DOI 10.1093/nar/gkg807; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dai N, 2011, GENE DEV, V25, P1159, DOI 10.1101/gad.2042311; Desviat LR, 2004, MOL GENET METAB, V83, P28, DOI 10.1016/j.ymgme.2004.08.001; Dumitriu B, 2006, GENESIS, V44, P219, DOI 10.1002/dvg.20210; Dunning M., ILLUMINAMOUSEV2 DB I; Dziarski R, 2003, CELL MOL LIFE SCI, V60, P1793, DOI 10.1007/s00018-003-3019-6; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fernandez E, 2001, DEV DYNAM, V221, P302, DOI 10.1002/dvdy.1139; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fransen M, 2012, BBA-MOL BASIS DIS, V1822, P1363, DOI 10.1016/j.bbadis.2011.12.001; Gan JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133288; Hagiwara N, 2000, P NATL ACAD SCI USA, V97, P4180, DOI 10.1073/pnas.97.8.4180; Hagiwara N, 2007, DEV DYNAM, V236, P2062, DOI 10.1002/dvdy.21223; Hagiwara N, 2011, DEV DYNAM, V240, P1311, DOI 10.1002/dvdy.22639; Hamaguchi T, 2008, INT J ONCOL, V33, P725, DOI 10.3892/ijo_00000058; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hetheridge C, 2012, J CELL SCI, V125, P1420, DOI 10.1242/jcs.091066; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hsu SC, 2013, CARDIOVASC RES, V100, P222, DOI 10.1093/cvr/cvt190; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Huang ZQ, 2009, CELL PHYSIOL BIOCHEM, V24, P17, DOI 10.1159/000227809; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Ishida T, 2003, J BIOL CHEM, V278, P34598, DOI 10.1074/jbc.M304890200; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Kalsotra A, 2011, NAT REV GENET, V12, P715, DOI 10.1038/nrg3052; Kalsotra A, 2008, P NATL ACAD SCI USA, V105, P20333, DOI 10.1073/pnas.0809045105; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Kim MS, 2012, BBA-MOL CELL BIOL L, V1821, P800, DOI 10.1016/j.bbalip.2011.10.001; Klose T, 2012, PANCREATOLOGY, V12, P350, DOI 10.1016/j.pan.2012.05.012; Kohonen T, 1997, SELF ORGANIZING MAPS; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laustsen PG, 2007, MOL CELL BIOL, V27, P1649, DOI 10.1128/MCB.01110-06; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Li FQ, 1996, J MOL CELL CARDIOL, V28, P1737, DOI 10.1006/jmcc.1996.0163; Li S, 2013, ANN APPL STAT, V7, P391, DOI 10.1214/12-AOAS589; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074504; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liu QQ, 1996, CIRC RES, V79, P716, DOI 10.1161/01.RES.79.4.716; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; LYONS GE, 1990, J CELL BIOL, V111, P2427, DOI 10.1083/jcb.111.6.2427; MacLellan WR, 2000, ANNU REV PHYSIOL, V62, P289, DOI 10.1146/annurev.physiol.62.1.289; Maillet M, 2008, J BIOL CHEM, V283, P31246, DOI 10.1074/jbc.M806085200; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Martin OJ, 2014, CIRC RES, V114, P626, DOI 10.1161/CIRCRESAHA.114.302562; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Natarajan SK, 2012, FREE RADICAL BIO MED, V53, P1181, DOI 10.1016/j.freeradbiomed.2012.07.002; Nemer M, 2008, CARDIOVASC PATHOL, V17, P48, DOI 10.1016/j.carpath.2007.06.005; O'Meara CC, 2015, CIRC RES, V116, P804, DOI 10.1161/CIRCRESAHA.116.304269; Ohnuki H, 2012, BLOOD, V119, P2688, DOI 10.1182/blood-2011-03-345306; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Qiu HY, 2011, CIRCULATION, V124, P406, DOI 10.1161/CIRCULATIONAHA.110.013847; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; Quiros PM, 2012, EMBO J, V31, P2117, DOI 10.1038/emboj.2012.70; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Riley PR, 2011, CARDIOVASC RES, V91, P260, DOI 10.1093/cvr/cvr035; Rinaldo P, 2002, ANNU REV PHYSIOL, V64, P477, DOI 10.1146/annurev.physiol.64.082201.154705; Romanoski CE, 2011, CIRC RES, V109, pE27, DOI 10.1161/CIRCRESAHA.111.241869; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; SCHIAFFINO S, 1989, CIRC RES, V64, P937, DOI 10.1161/01.RES.64.5.937; Shieh JTC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019481; Sluijter JPG, 2010, ARTERIOSCL THROM VAS, V30, P859, DOI 10.1161/ATVBAHA.109.197434; Smit A, REPEATMASKER OPEN 4; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Sung MM, 2015, CARDIOVASC RES, V107, P235, DOI 10.1093/cvr/cvv166; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tanackovic G, 2005, MOL BIOL CELL, V16, P1366, DOI 10.1091/mbc.E04-11-1034; Tao G, 2016, NATURE, V534, P119, DOI 10.1038/nature17959; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; VANGRONINGEN JP, 1991, ANAT EMBRYOL, V184, P65; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; von Hofsten J, 2008, EMBO REP, V9, P683, DOI 10.1038/embor.2008.73; Walsh S, 2010, CARDIOVASC RES, V86, P365, DOI 10.1093/cvr/cvq005; Wang X, 2013, MATER RES LETT, V1, P19, DOI 10.1080/21663831.2012.686586; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Wehrens R, 2007, J STAT SOFTW, V21, P1; Wei G, 2009, BLOOD, V114, P1123, DOI 10.1182/blood-2009-03-211391; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364; Yazdi PG, 2013, CTS-CLIN TRANSL SCI, V6, P347, DOI 10.1111/cts.12083; Yeghiazarians Y, 2014, J CARDIOVASC PHARM, V63, P406, DOI 10.1097/FJC.0000000000000061; ZHANG B, 1989, ANN NY ACAD SCI, V573, P130, DOI 10.1111/j.1749-6632.1989.tb14991.x; Zhou HM, 2004, MOL CELL BIOL, V24, P96, DOI 10.1128/MCB.24.1.96-104.2004	121	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166574	10.1371/journal.pone.0166574	http://dx.doi.org/10.1371/journal.pone.0166574			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832192	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000135
J	Heidlmayr, K; Dore-Mazars, K; Aparicio, X; Isel, F				Heidlmayr, Karin; Dore-Mazars, Karine; Aparicio, Xavier; Isel, Frederic			Multiple Language Use Influences Oculomotor Task Performance: Neurophysiological Evidence of a Shared Substrate between Language and Motor Control	PLOS ONE			English	Article							HIGHLY PROFICIENT BILINGUALS; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; EXECUTIVE CONTROL; INHIBITORY CONTROL; ANTISACCADE TASK; INDIVIDUAL-DIFFERENCES; CORTICAL POTENTIALS; CONFLICT-RESOLUTION; VOLUNTARY CONTROL	In the present electroencephalographical study, we asked to which extent executive control processes are shared by both the language and motor domain. The rationale was to examine whether executive control processes whose efficiency is reinforced by the frequent use of a second language can lead to a benefit in the control of eye movements, i.e. a non-linguistic activity. For this purpose, we administrated to 19 highly proficient late French-German bilingual participants and to a control group of 20 French monolingual participants an antisaccade task, i.e. a specific motor task involving control. In this task, an automatic saccade has to be suppressed while a voluntary eye movement in the opposite direction has to be carried out. Here, our main hypothesis is that an advantage in the antisaccade task should be observed in the bilinguals if some properties of the control processes are shared between linguistic and motor domains. ERP data revealed clear differences between bilinguals and monolinguals. Critically, we showed an increased N2 effect size in bilinguals, thought to reflect better efficiency to monitor conflict, combined with reduced effect sizes on markers reflecting inhibitory control, i.e. cue-locked positivity, the target-locked P3 and the saccade-locked presaccadic positivity (PSP). Moreover, effective connectivity analyses (dynamic causal modelling; DCM) on the neuronal source level indicated that bilinguals rely more strongly on ACC-driven control while monolinguals rely on PFC-driven control. Taken together, our combined ERP and effective connectivity findings may reflect a dynamic interplay between strengthened conflict monitoring, associated with subsequently more efficient inhibition in bilinguals. Finally, L2 proficiency and immersion experience constitute relevant factors of the language background that predict efficiency of inhibition. To conclude, the present study provided ERP and effective connectivity evidence for domain-general executive control involvement in handling multiple language use, leading to a control advantage in bilingualism.	[Heidlmayr, Karin; Dore-Mazars, Karine] Paris Descartes Sorbonne Paris Cite Univ, Inst Psychol, Lab Vis Act Cognit EA 7326, Paris, France; [Heidlmayr, Karin; Isel, Frederic] Paris Lumieres Paris Ouest Nanterre La Def Univ, Lab MoDyCo UMR 7114, CNRS, Paris, France; [Aparicio, Xavier] Paris Est Creteil Univ, Lab CHArt EA 4004, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Isel, F (corresponding author), Paris Lumieres Paris Ouest Nanterre La Def Univ, Lab MoDyCo UMR 7114, CNRS, Paris, France.	fisel@u-paris10.fr		Heidlmayr, Karin/0000-0002-0550-1598	French National Research Agency (ANR), program "Investissements d'Avenir" [ANR-10-LABX-0083]; Paris Descartes-Sorbonne Paris Cite University	French National Research Agency (ANR), program "Investissements d'Avenir"(French National Research Agency (ANR)); Paris Descartes-Sorbonne Paris Cite University	This research has been supported by a public grant overseen by the French National Research Agency (ANR) as part of the program "Investissements d'Avenir" (reference: ANR-10-LABX-0083) and by internal funding from the Paris Descartes-Sorbonne Paris Cite University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutalebi J, 2007, J NEUROLINGUIST, V20, P242, DOI 10.1016/j.jneuroling.2006.10.003; Abutalebi J, 2013, BRAIN LANG, V125, P307, DOI 10.1016/j.bandl.2012.03.009; Aichert DS, 2012, PSYCHOPHYSIOLOGY, V49, P345, DOI 10.1111/j.1469-8986.2011.01306.x; Alahyane N, 2014, NEUROIMAGE, V98, P103, DOI 10.1016/j.neuroimage.2014.03.008; Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Bialystok E, 2006, J EXP PSYCHOL LEARN, V32, P1341, DOI 10.1037/0278-7393.32.6.1341; Bialystok E, 2009, COGNITION, V112, P494, DOI 10.1016/j.cognition.2009.06.014; Blumenfeld HK, 2013, J COGN PSYCHOL, V25, P547, DOI 10.1080/20445911.2013.812093; Bocquillon P, 2014, NEUROSCIENCE, V271, P9, DOI 10.1016/j.neuroscience.2014.04.014; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brysbaert M, 2003, MASKED PRIMING STATE; Buchholz VN, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00446; Calabria M, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00399; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chen AT, 2008, HUM BRAIN MAPP, V29, P1028, DOI 10.1002/hbm.20449; Collins T, 2008, J NEUROPHYSIOL, V99, P2708, DOI 10.1152/jn.01082.2007; Cordones I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063751; Costa A, 2004, J MEM LANG, V50, P491, DOI 10.1016/j.jml.2004.02.002; Costa A, 2008, BILING-LANG COGN, V11, P121, DOI 10.1017/S1366728907003252; Costa A, 2008, COGNITION, V106, P59, DOI 10.1016/j.cognition.2006.12.013; Costa A, 2006, J EXP PSYCHOL LEARN, V32, P1057, DOI 10.1037/0278-7393.32.5.1057; Costa A, 2009, COGNITION, V113, P135, DOI 10.1016/j.cognition.2009.08.001; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; De Baene W, 2015, J COGNITIVE NEUROSCI, V27, P1752, DOI 10.1162/jocn_a_00817; de Bruin A, 2014, NEUROIMAGE, V90, P348, DOI 10.1016/j.neuroimage.2013.12.049; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dijkstra T, 2002, BILING LANG COGN, V5; Dijkstra Ton, 2005, HDB BILINGUALISM PSY, P179; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Evdokimidis I, 1996, ELECTROEN CLIN NEURO, V98, P377, DOI 10.1016/0013-4694(96)94699-4; Everling S, 1997, ELECTROEN CLIN NEURO, V102, P356, DOI 10.1016/S0013-4694(96)96569-4; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Fecteau JH, 2003, NAT REV NEUROSCI, V4, P435, DOI 10.1038/nrn1114; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Festman J, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00115; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Friedman NP, 2006, PSYCHOL SCI, V17, P172, DOI 10.1111/j.1467-9280.2006.01681.x; Friedman NP, 2004, J EXP PSYCHOL GEN, V133, P101, DOI 10.1037/0096-3445.133.1.101; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Garrido MI, 2007, NEUROIMAGE, V36, P571, DOI 10.1016/j.neuroimage.2007.03.014; Gathercole VCM, 2010, INT J BILING EDUC BI, V13, P617, DOI 10.1080/13670050.2010.488289; Gentilucci M, 2000, EXP BRAIN RES, V133, P468, DOI 10.1007/s002210000431; Green D., 1998, BILING-LANG COGN, V1, P67, DOI [DOI 10.1017/S1366728998000133, 10.1017/S1366728998000133]; Green DW, 2014, APPL PSYCHOLINGUIST, V35, P910, DOI 10.1017/S0142716414000228; Green DW, 2013, J COGN PSYCHOL, V25, P515, DOI 10.1080/20445911.2013.796377; Green DW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00103; Greenhill P, 2010, FAIRY TALE FILMS: VISIONS OF AMBIGUITY, P1; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hamm JP, 2012, EXP BRAIN RES, V221, P123, DOI 10.1007/s00221-012-3167-8; Harnishfeger Katherine Kipp, 1995, P175, DOI 10.1016/B978-012208930-5/50007-6; Harper J, 2014, CLIN NEUROPHYSIOL, V125, P124, DOI 10.1016/j.clinph.2013.06.025; Hauk O, 2004, NEURON, V41, P301, DOI 10.1016/S0896-6273(03)00838-9; Heidlmayr K, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00821; Heidlmayr K, 2014, BILING-LANG COGN, V17, P630, DOI 10.1017/S1366728913000539; Hernandez M, 2010, BILING-LANG COGN, V13, P315, DOI 10.1017/S1366728909990010; Hilchey MD, 2011, PSYCHON B REV, V18, P625, DOI 10.3758/s13423-011-0116-7; Hoshino N, 2011, BRAIN RES, V1371, P100, DOI 10.1016/j.brainres.2010.11.053; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Jackson SR, 1999, NEUROREPORT, V10, P861, DOI 10.1097/00001756-199903170-00035; Jahfari S, 2012, J NEUROSCI, V32, P10870, DOI 10.1523/JNEUROSCI.0902-12.2012; Jiang JF, 2014, CEREB CORTEX, V24, P1793, DOI 10.1093/cercor/bht029; Jonkman LM, 2006, BRAIN RES, V1097, P181, DOI 10.1016/j.brainres.2006.04.064; Keppel G., 1991, DESIGN AND ANAL, V3rd; Koch I, 2010, PSYCHON B REV, V17, P1, DOI 10.3758/PBR.17.1.1; Kossowska M, 2014, NEUROSCI LETT, V570, P38, DOI 10.1016/j.neulet.2014.04.002; Kousaie S, 2012, BRAIN RES, V1446, P71, DOI 10.1016/j.brainres.2012.01.052; Kovacs AM, 2009, SCIENCE, V325, P611, DOI 10.1126/science.1173947; Kroll JF, 2013, J COGN PSYCHOL, V25, P497, DOI 10.1080/20445911.2013.799170; Kutas M, 2008, LIT STUD, V1, P153, DOI 10.1007/978-0-387-74980-8_6; Li P, 2014, CORTEX, V58, P301, DOI 10.1016/j.cortex.2014.05.001; Li SC, 2013, NEUROSCI BIOBEHAV R, V37, P2201, DOI 10.1016/j.neubiorev.2013.07.019; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Luck S, 2014, APA HDB RES METHODS, P1; Luna B, 2009, ADV CHILD DEV BEHAV, V37, P233, DOI 10.1016/S0065-2407(09)03706-9; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Marshall TR, 2015, J NEUROSCI, V35, P1638, DOI 10.1523/JNEUROSCI.3116-14.2015; Martensson J, 2012, NEUROIMAGE, V63, P240, DOI 10.1016/j.neuroimage.2012.06.043; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Mueller SC, 2009, NEUROIMAGE, V45, P191, DOI 10.1016/j.neuroimage.2008.11.019; Muhle-Karbe PS, 2014, NEUROIMAGE, V99, P332, DOI 10.1016/j.neuroimage.2014.05.058; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nieuwenhuis S, 2004, BRAIN COGNITION, V56, P198, DOI 10.1016/j.bandc.2003.12.002; Nigg JT, 2000, PSYCHOL BULL, V126, P220, DOI 10.1037/0033-2909.126.2.220; Paap KR, 2015, AIMS NEUROSCI, V2, P1, DOI 10.3934/Neuroscience.2015.1.1; Paap KR, 2013, COGNITIVE PSYCHOL, V66, P232, DOI 10.1016/j.cogpsych.2012.12.002; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Prior A, 2011, J INT NEUROPSYCH SOC, V17, P682, DOI 10.1017/S1355617711000580; Prior A, 2010, BILING-LANG COGN, V13, P253, DOI 10.1017/S1366728909990526; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Runnqvist E, 2012, J MEM LANG, V66, P850, DOI 10.1016/j.jml.2012.02.007; Schall JD, 2002, NEURON, V36, P309, DOI 10.1016/S0896-6273(02)00964-9; Schlegel AA, 2012, J COGNITIVE NEUROSCI, V24, P1664, DOI 10.1162/jocn_a_00240; Segalowitz N., 2010, ANAL CELL PATHOL, DOI [10.4324/9780203851357, DOI 10.1155/2010/519498]; Segalowitz N., 2005, HDB BILINGUALISM PSY, P371; Singh N, 2015, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01481; Stein M, 2012, CORTEX, V48, P458, DOI 10.1016/j.cortex.2010.10.007; Stephan KE, 2010, NEUROIMAGE, V49, P3099, DOI 10.1016/j.neuroimage.2009.11.015; Stocco A, 2014, INT J BILINGUAL, V18, P67, DOI 10.1177/1367006912456617; Valian V, 2015, BILING-LANG COGN, V18, P3, DOI 10.1017/S1366728914000522; van Heuven WJB, 1998, J MEM LANG, V39, P458, DOI 10.1006/jmla.1998.2584; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Watanabe M, 2009, EUR J NEUROSCI, V30, P2165, DOI 10.1111/j.1460-9568.2009.06998.x; Weissberger GH, 2015, NEUROPSYCHOLOGIA, V66, P193, DOI 10.1016/j.neuropsychologia.2014.10.037	112	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165029	10.1371/journal.pone.0165029	http://dx.doi.org/10.1371/journal.pone.0165029			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832065	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000007
J	Kruer, TL; Dougherty, SM; Reynolds, L; Long, E; de Silva, T; Lockwood, WW; Clem, BF				Kruer, Traci L.; Dougherty, Susan M.; Reynolds, Lindsey; Long, Elizabeth; de Silva, Tanya; Lockwood, William W.; Clem, Brian F.			Expression of the IncRNA Maternally Expressed Gene 3 (MEG3) Contributes to the Control of Lung Cancer Cell Proliferation by the Rb Pathway	PLOS ONE			English	Article							NONCODING RNA MEG3; TGF-BETA; TUMOR-SUPPRESSOR; HYPERMETHYLATION; PROGRESSION; ACTIVATION; MECHANISMS; REGION; ROLES; P53	Maternally expressed gene 3 (MEG3, mouse homolog GtI2 encodes a long noncoding RNA (IncRNA) that is expressed in many normal tissues, but is suppressed in various cancer cell lines and tumors, suggesting it plays a functional role as a tumor suppressor. Hyper-methylation has been shown to contribute to this loss of expression. We now demonstrate that MEG3 expression is regulated by the retinoblastoma protein (Rb) pathway and correlates with a change in cell proliferation. Microarray analysis of mouse embryonic fibroblasts (MEFs) isolated from mice with genetic deletion of all three Rb family members (TKO) revealed a significant silencing of GtI2/MEG3 expression compared to WT MEFs, and re expression of GtI2/MEG3 caused decrease in cell proliferation and increased apoptosis. MEG3 levels also were suppressed in A549 lung cancer cells compared with normal human bronchial epithelial (NHBE) cells, and, similar to the TKO cells, re-constitution of MEG3 led to a decrease in cell proliferation and elevated apoptosis. Activation of pRb by treatment of A549 and SK-MES-1 cells with palbociclib, a CDK4/6 inhibitor, increased the expression of MEG3 in a dose-dependent manner, while knockdown of pRb/p107 attenuated this effect. In addition, expression of phosphorylation-deficient mutant of pRb increased MEG3 levels in both lung cancer cell types. Treatment of these cells with palbociclib also decreased the expression of pRb-regulated DNA methyltransferase 1 (DNMT1), while conversely, knockdown of DNMT1 resulted in increased expression of MEG3. As gene methylation has been suggested for MEG3 regulation, we found that palbociclib resulted in decreased methylation of the MEG3 locus similar to that observed with 5-aza-deoxycytidine. Anti-sense oligonucleotide silencing of drug-induced MEG3 expression in A549 and SK-MES-1 cells partially rescued the palbociclib-mediated decrease in cell proliferation, while analysis of the TCGA database revealed decreased MEG3 expression in human lung tumors harboring a disrupted RB pathway. Together, these data suggest that disruption of the pRb-DNMT1 pathway leads to a decrease in MEG3 expression, thereby contributing to the pro-proliferative state of certain cancer cells.	[Kruer, Traci L.; Dougherty, Susan M.; Reynolds, Lindsey; Long, Elizabeth; Clem, Brian F.] Univ Louisville, James Graham Brown Canc Ctr, Dept Biochem & Mol Genet, Louisville, KY 40292 USA; [de Silva, Tanya; Lockwood, William W.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada; [de Silva, Tanya; Lockwood, William W.] BC Canc Res Ctr, Integrat Oncol, Vancouver, BC, Canada	University of Louisville; University of British Columbia; British Columbia Cancer Agency	Clem, BF (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Biochem & Mol Genet, Louisville, KY 40292 USA.	bfclem01@louisville.edu		Kruer, Traci/0000-0002-9211-6304; Conroy, Lindsey/0000-0003-4593-0896	National Cancer Institute [CM166327]; American Cancer Society [RSG-13-139-01-CNE]; NATIONAL CANCER INSTITUTE [R01CA166327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106396] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, CM166327 (BFC), www.cancer.gov, and American Cancer Society, RSG 13-139-01-CNE (BFC), www.cancer.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to acknowledge Sabine Weigel and the James Brown Cancer Center Genomics Core Facility for performing and analyzing the microarray study and would like to thank Dr. Levi Beverly for insightful discussions regarding this work and Drs. Alan Kerr, Sucheta Telang, and Yoannis Imbert-Fernandez for critical reading of the manuscript. This work was supported by the National Cancer Institute (CA166327) and the American Cancer Society (RSG-13-139-01-CNE) to B.F.C.	Angus SP, 2012, ONCOGENE, V31, P4709, DOI 10.1038/onc.2011.622; Anwar SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049462; Balik V, 2013, J NEURO-ONCOL, V112, P1, DOI 10.1007/s11060-012-1038-6; Benetatos L, 2010, LEUKEMIA RES, V34, P148, DOI 10.1016/j.leukres.2009.06.019; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Connolly EC, 2012, INT J BIOL SCI, V8, P964, DOI 10.7150/ijbs.4564; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Gejman R, 2008, J CLIN ENDOCR METAB, V93, P4119, DOI 10.1210/jc.2007-2633; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; He Y, 2014, BBA-MOL BASIS DIS, V1842, P2204, DOI 10.1016/j.bbadis.2014.08.015; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Indovina P, 2013, J CELL PHYSIOL, V228, P525, DOI 10.1002/jcp.24170; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114586; Lu KH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-461; Mangini NS, 2015, ANN PHARMACOTHER, V49, P1252, DOI 10.1177/1060028015602273; McCabe MT, 2005, CANCER RES, V65, P3624, DOI 10.1158/0008-5472.CAN-04-2158; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schuster-Gossler K, 1998, DEV DYNAM, V212, P214, DOI 10.1002/(SICI)1097-0177(199806)212:2<214::AID-AJA6>3.0.CO;2-K; Sun M, 2014, TUMOR BIOL, V35, P1065, DOI 10.1007/s13277-013-1142-z; Wang PJ, 2012, J CELL BIOCHEM, V113, P1868, DOI 10.1002/jcb.24055; Witkiewicz AK, 2014, ONCOGENE, V33, P3980, DOI 10.1038/onc.2013.367; Zhang X, 2003, J CLIN ENDOCR METAB, V88, P5119, DOI 10.1210/jc.2003-030222; Zhang X, 2010, CANCER RES, V70, P2350, DOI 10.1158/0008-5472.CAN-09-3885; Zhao J, 2005, J CLIN ENDOCR METAB, V90, P2179, DOI 10.1210/jc.2004-1848; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200; Zhou YL, 2012, J MOL ENDOCRINOL, V48, pR45, DOI 10.1530/JME-12-0008	30	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166363	10.1371/journal.pone.0166363	http://dx.doi.org/10.1371/journal.pone.0166363			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832204	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000111
J	Martinez-Castillo, M; Bonilla-Moreno, R; Aleman-Lazarini, L; Meraz-Rios, MA; Orozco, L; Cedillo-Barron, L; Cordova, EJ; Villegas-Sepulveda, N				Martinez-Castillo, Macario; Bonilla-Moreno, Raul; Aleman-Lazarini, Leticia; Antonio Meraz-Rios, Marco; Orozco, Lorena; Cedillo-Barron, Leticia; Cordova, Emilio J.; Villegas-Sepulveda, Nicolas			A Subpopulation of the K562 Cells Are Killed by Curcumin Treatment after G2/M Arrest and Mitotic Catastrophe	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; NF-KAPPA-B; DNA-DAMAGE; APOPTOSIS; INHIBITION; ACTIVATION; KINASE; ABL; PROLIFERATION; PATHOGENESIS	Curcumin is extensively investigated as a good chemo-preventive agent in the development of many cancers and particularly in leukemia, including treatment of chronic myelogenous leukemia and it has been proposed as an adjuvant for leukemia therapies. Human chronic myeloid leukemia cells (K562), were treated with 20 mu M of curcumin, and we found that a subpopulation of these cells were arrested and accumulate in the G2/M phase of the cell cycle. Characterization of this cell subpopulation showed that the arrested cells presented nuclear morphology changes resembling those described for mitotic catastrophe. Mitotic cells displayed abnormal chromatin organization, collapse of the mitotic spindle and abnormal chromosome segregation. Then, these cells died in an apoptosis dependent manner and showed diminution in the protein levels of BCL-2 and XIAP. Moreover, our results shown that a transient activation of the nuclear factor kappa B (NF kappa B) occurred early in these cells, but decreased after 6 h of the treatment, explaining in part the diminution of the antiapoptotic proteins. Additionally, P73 was translocated to the cell nuclei, because the expression of the C/EBP alpha, a cognate repressor of the P73 gene, was decreased, suggesting that apoptosis is trigger by elevation of P73 protein levels acting in concert with the diminution of the two anti-apoptotic molecules. In summary, curcumin treatment might produce a P73-dependent apoptotic cell death in chronic myelogenous leukemia cells (K562), which was triggered by mitotic catastrophe, due to sustained BAX and survivin expression and impairment of the anti-apoptotic proteins BCL-2 and XIAP.	[Martinez-Castillo, Macario; Bonilla-Moreno, Raul; Aleman-Lazarini, Leticia; Antonio Meraz-Rios, Marco; Cedillo-Barron, Leticia; Villegas-Sepulveda, Nicolas] Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico; [Orozco, Lorena; Cordova, Emilio J.] Inst Nacl Med Genom, Lab Inmunogen & Enfermedades Metab, Secretaria Salud, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Nacional de Medicina Genomica	Villegas-Sepulveda, N (corresponding author), Ctr Invest & Estudios Avanzados, Dept Biomed Mol, Mexico City, DF, Mexico.; Cordova, EJ (corresponding author), Inst Nacl Med Genom, Lab Inmunogen & Enfermedades Metab, Secretaria Salud, Mexico City, DF, Mexico.	ecordova@inmegen.gob.mx; nvillega@cinvestav.mx	MERAZ RIOS, MARCO ANTONIO/F-4194-2016	MERAZ RIOS, MARCO ANTONIO/0000-0001-6748-8117; Villegas-Sepulveda, Nicolas/0000-0001-9489-2545; Orozco, Lorena/0000-0002-5801-9180	CONACyT, Mexico; CINVESTAV; INMEGEN; CONACyT [128686]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CINVESTAV; INMEGEN; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MMC is indebted to CONACyT, Mexico for a doctoral fellowship. This work was supported in part by funds allocated to NVS and EJC by CINVESTAV and INMEGEN, respectively, and by grant 128686 from CONACyT.	Ara SA, 2016, J CANCER RES THER, V12, P175, DOI 10.4103/0973-1482.171370; Banerjee M, 2010, FEBS J, V277, P3437, DOI 10.1111/j.1742-4658.2010.07750.x; Berberich-Siebelt F, 2006, J IMMUNOL, V176, P4843, DOI 10.4049/jimmunol.176.8.4843; Bose S, 2015, CELL DIV, V10, DOI 10.1186/s13008-015-0012-z; Boyanapalli Sarandeep S S, 2015, Curr Pharmacol Rep, V1, P129; Braeuer SJ, 2006, MOL CANCER RES, V4, P715, DOI 10.1158/1541-7786.MCR-05-0231; Chen M, 2013, JNCI-J NATL CANCER I, V105, P405, DOI 10.1093/jnci/djt006; Chereda B, 2015, ANN HEMATOL, V94, pS107, DOI 10.1007/s00277-015-2325-z; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Cui L, 2007, ANTIMICROB AGENTS CH, V51, P488, DOI 10.1128/AAC.01238-06; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Jang SY, 2015, BIOCHEM BIOPH RES CO, V465, P71, DOI 10.1016/j.bbrc.2015.07.131; Jobin C, 1999, J IMMUNOL, V163, P3474; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Konig H, 2008, BLOOD, V111, P2329, DOI 10.1182/blood-2007-05-092056; LAW JC, 1993, LEUKEMIA RES, V17, P1045, DOI 10.1016/0145-2126(93)90161-D; Li WJ, 2016, CHEM RES TOXICOL, V29, P694, DOI 10.1021/acs.chemrestox.6b00016; Li Y, 2015, J AGR FOOD CHEM, V63, P7731, DOI 10.1021/acs.jafc.5b02011; Li YQ, 2012, J CELL BIOCHEM, V113, P3165, DOI 10.1002/jcb.24194; Marabese M, 2003, NUCLEIC ACIDS RES, V31, P6624, DOI 10.1093/nar/gkg869; Matassov Demetrius, 2004, Methods Mol Biol, V282, P1; Mitsushima M, 2010, J CELL BIOL, V191, P453, DOI 10.1083/jcb.201007136; O'Connor DS, 2002, CANCER CELL, V2, P43, DOI 10.1016/S1535-6108(02)00084-3; Polishchuk L. A., 2014, Experimental Oncology, V36, P138; Rajitha B, 2016, CANCER LETT, V373, P227, DOI 10.1016/j.canlet.2016.01.052; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rudiger H., 2012, BLOOD, V120, P737, DOI [10.1182/blood-2012-03-380147, DOI 10.1182/BLOOD-2012-03-380147]; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Rumpold H, 2011, CURR CANCER DRUG TAR, V11, P3, DOI 10.2174/156800911793743619; Saussele S, 2015, ANN HEMATOL, V94, pS159, DOI 10.1007/s00277-015-2324-0; Shishodia S, 2005, BIOCHEM PHARMACOL, V70, P700, DOI 10.1016/j.bcp.2005.04.043; Syng-ai C, 2004, MOL CANCER THER, V3, P1101; Taylor William R, 2004, Methods Mol Biol, V281, P293; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Wolanin K, 2006, MOL CANCER RES, V4, P457, DOI 10.1158/1541-7786.MCR-05-0172; Wu LX, 2014, ACTA PHARMACOL SIN, V35, P401, DOI 10.1038/aps.2013.180; Xia YQ, 2014, ASIAN PAC J CANCER P, V15, P6893, DOI 10.7314/APJCP.2014.15.16.6893; Zhou QY, 2016, CLIN EXP PHARMACOL P, V43, P394, DOI 10.1111/1440-1681.12546	39	13	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165971	10.1371/journal.pone.0165971	http://dx.doi.org/10.1371/journal.pone.0165971			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832139	gold, Green Submitted, Green Published			2022-12-26	WOS:000387725000049
J	Rodrigues, NCP; Lino, VTS; Daumas, RP; Andrade, MKD; O'Dwyer, G; Monteiro, DLM; Gerardi, A; Fernandes, GHBV; Ramos, JA; Ferreira, CEG; Leitelf, LD				Pinheiro Rodrigues, Nadia Cristina; Saraiva Lino, Valeria Teresa; Daumas, Regina Paiva; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Maia Monteiro, Denise Leite; Gerardi, Alyssa; Barroso Viana Fernandes, Gabriel Henrique; Sapienza Ramos, Jose Augusto; Goncalves Ferreira, Carlos Eduardo; Leite, Luri da Costa			Temporal and Spatial Evolution of Dengue Incidence in Brazil, 2001-2012	PLOS ONE			English	Article							AEDES-AEGYPTI; VIRUS TYPE-4; SAO-PAULO; STATE; CLIMATE	Background In Brazil, the incidence of dengue greatly increased in the last two decades and there are several factors impeding the control of the disease. The present study focused on describing the space-time evolution of dengue in Brazil from 2001 to 2012 and analyzing the relationship of the reported cases with socio-demographic and environmental factors. Methods The analytic units used in the preparation of thematic maps were municipalities. Statistical tests and multilevel regression models were used to evaluate the association between dengue incidence and the following factors: climate, diagnostic period, demographic density, percentage of people living in rural areas, Gross Domestic Product, Gini index, percentage of garbage collection and the rate of households with a sewage network. Results The largest accumulation of dengue cases in Brazil was concentrated on the Atlantic coast and in the interior part of Sao Paulo State. The risk of dengue in subtropical and tropical climates was 1.20-11 times lower than that observed in semi-arid climates. In 2009-2010 and 2011-2012, the risks were ten and six times higher than in 2003-2004, respectively. Conclusion Dengue is a common infection in the Brazilian population, with the largest accumulation of dengue cases concentrated on the Atlantic coast and in the interior area of Sao Paulo State.The high dengue rates observed in the Brazilian coastal region suggest that the cases imported from neighboring countries contribute to the spread of the disease in the country. Our results suggest that several socio-demographic and environmental factors resulted in the increase of dengue in the country over time. This is likely applicable to the occurrence of other arboviruses like Zika and chikungunya. To reverse the situation, Brazil must implement effective public policies that offer basic services such as garbage collection and sanitation networks as well as reduce vector populations.	[Pinheiro Rodrigues, Nadia Cristina; Saraiva Lino, Valeria Teresa; Daumas, Regina Paiva; de Noronha Andrade, Monica Kramer; O'Dwyer, Gisele; Leite, Luri da Costa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina; Maia Monteiro, Denise Leite] Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil; [de Noronha Andrade, Monica Kramer] Vital Brazil Inst, Ctr Studies & Res Ageing, Rio De Janeiro, Brazil; [Gerardi, Alyssa] Georgetown Univ, Washington, DC USA; [Barroso Viana Fernandes, Gabriel Henrique; Sapienza Ramos, Jose Augusto; Goncalves Ferreira, Carlos Eduardo] Univ Estado Rio De Janeiro, Sch Geol, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil; [Pinheiro Rodrigues, Nadia Cristina] Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro; Georgetown University; Universidade do Estado do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade do Estado do Rio de Janeiro	Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ Sergio Arouca, Ctr Saude Germano Sinval Faria, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio de Janeiro, Fac Med, Dept Tecnol Informacao & Educ Saude, Rio De Janeiro, Brazil.	nadiacristinapr@gmail.com	Monteiro, Denise LM/G-2652-2012; DAUMAS, REGINA P/M-9387-2013; Lino, Valeria/ADI-4254-2022; kar, paritosh kumar/U-6713-2019	Monteiro, Denise LM/0000-0003-4679-1859; DAUMAS, REGINA P/0000-0002-8923-7711; 				Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804; [Anonymous], 2015, PLOS NEGLECTED TROPI; Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285; Barreto Maurício L., 2008, Estud. av., V22, P53, DOI 10.1590/S0103-40142008000300005; Bertolacci-Rocha LG, 2014, CAD SAUDE PUBLICA, V30, P1789, DOI 10.1590/0102-311X00003914; Camara FP, 2007, REV SOC BRAS MED TRO, V40, P192, DOI 10.1590/S0037-86822007000200009; Chahad-Ehlers S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052559; Chowell G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-164; DATASUS, 2015, HLTH INF; de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439; FIOCRUZ FOC, 2016, AED AEG MOSQ PART HI; FUNASA BHM, 2011, HIST PUBL HLTH CHRON; Gelman A., 2007, DATA ANAL USING REGR; Gentile C, 2013, MEM I OSWALDO CRUZ, V108, P80, DOI 10.1590/0074-0276130471; Glasser CM, 2002, REV SAUDE PUBL, V36, P166, DOI 10.1590/S0034-89102002000200008; Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280; HM BHM, 2009, DENG BRAS INF EP 17; HM BHM, 2012, EP B DENG EP SIT; HM BHM, 2016, COMP PROB CAS DENG 2; IBGE, 2010, SUBN CLUST TERR INF; IBGE, 2015, IBGE MALH DIG; IBGE BIoGaS, 2014, EST RES POP BRAZ FED; IPEA, 2016, EC APPL RES; Ismail N., 2007, CASUALTY ACTUARIAL S, V2007, P103; Jacobi P., 2004, URBAN ENV IMPACTS RI; Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487; Mendonça Francisco de Assis, 2009, Soc. nat., V21, P257, DOI 10.1590/S1982-45132009000300003; Muhamad M, 2010, INT J BIOL SCI, V6, P294; Nogueira RMR, 2011, MEM I OSWALDO CRUZ, V106, P255, DOI 10.1590/S0074-02762011000300001; Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376; Ribeiro AF, 2006, REV SAUDE PUBL, V40, P671, DOI 10.1590/S0034-89102006000500017; RIPSA RIdIpS, 2012, IND DAD BAS BRAS 201; Rocco Iray Maria, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P55, DOI 10.1590/S0036-46652001000100011; Rolim Glauco de Souza, 2007, Bragantia, V66, P711, DOI 10.1590/S0006-87052007000400022; Sampaio MdS, 2011, AN 15 S BRAS SENS RE, P8857; Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091; Teixeira MG, 2012, REV INST MED TROP SP, V54, pS1, DOI 10.1590/S0036-46652012000700002; UJVARI SC, 2003, REV INST MED TROP SP, V45, P212; Vlahov D, 2007, J URBAN HEALTH, V84, pI16, DOI 10.1007/s11524-007-9169-3; World Bank, 2006, EQ DEV; World Health Organization, 2009, DENGUE GUIDELINES DI; World Health Organization, 2012, GLOB STRAT DENG PREV	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165945	10.1371/journal.pone.0165945	http://dx.doi.org/10.1371/journal.pone.0165945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832129	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000045
J	Luna, CA; Loayza, AP; Squeo, FA				Luna, Claudia A.; Loayza, Andrea P.; Squeo, Francisco A.			Fruit Size Determines the Role of Three Scatter-Hoarding Rodents as Dispersers or Seed Predators of a Fleshy-Fruited Atacama Desert Shrub	PLOS ONE			English	Article							MYRCIANTHES-COQUIMBENSIS; SELECTIVE PRESSURES; HERBIVOROUS RODENT; CACHING BEHAVIOR; OCTODON-DEGUS; BIRDS; DECISION; ECOLOGY; FOREST; PULP	Scatter-hoarding rodents can act as both predators and dispersers for many large-seeded plants because they cache seeds for future use, but occasionally forget them in sites with high survival and establishment probabilities. The most important fruit or seed trait influencing rodent foraging behavior is seed size; rodents prefer large seeds because they have higher nutritional content, but this preference can be counterbalanced by the higher costs of handling larger seeds. We designed a cafeteria experiment to assess whether fruit and seed size of Myrcianthes coquimbensis, an endangered desert shrub, influence the decision-making process during foraging by three species of scatter-hoarding rodents differing in body size: Abrothrix olivaceus, Phyllotis darwini and Octodon degus. We found that the size of fruits and seeds influenced foraging behavior in the three rodent species; the probability of a fruit being harvested and hoarded was higher for larger fruits than for smaller ones. Patterns of fruit size preference were not affected by rodent size; all species were able to hoard fruits within the entire range of sizes offered. Finally, fruit and seed size had no effect on the probability of seed predation, rodents typically ate only the fleshy pulp of the fruits offered and discarded whole, intact seeds. In conclusion, our results reveal that larger M. coquimbensis fruits have higher probabilities of being harvested, and ultimately of its seeds being hoarded and dispersed by scatter-hoarding rodents. As this plant has no other dispersers, rodents play an important role in its recruitment dynamics.	[Luna, Claudia A.; Loayza, Andrea P.; Squeo, Francisco A.] Univ La Serena, Dept Biol, La Serena, Chile; [Squeo, Francisco A.] IEB, Santiago, Chile; [Squeo, Francisco A.] CEAZA, La Serena, Chile	Universidad de La Serena	Luna, CA (corresponding author), Univ La Serena, Dept Biol, La Serena, Chile.	cluna@userena.cl		Squeo, Francisco/0000-0003-3559-0250	Institute of Ecology and Biodiversity (IEB; Chilean Millennium Initiative) [P05-002]; Department of Research of Universidad de La Serena (DIULS) [PT14122]; FONDECYT Initiation Research Grant [11140400]; IEB [P05-002]; CONICYT [PFB-23]	Institute of Ecology and Biodiversity (IEB; Chilean Millennium Initiative); Department of Research of Universidad de La Serena (DIULS); FONDECYT Initiation Research Grant; IEB; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This research was supported by grants awarded to CAL from the Institute of Ecology and Biodiversity (IEB; Chilean Millennium Initiative [P05-002]) and the Department of Research of Universidad de La Serena (DIULS [PT14122]). APL was supported by a FONDECYT Initiation Research Grant (11140400), the IEB (P05-002) and CONICYT (PFB-23).; We want to thank Jose M. Fedriani and Mauro Galetti for their helpful comments on the manuscript. Rodrigo S. Rios and Maria Calvino-Cancela helped improve earlier versions of this paper. Special thanks to all those who assisted with data collection and experimental setup, particularly Danny E. Carvajal and Patricio Garcia-Guzman. This research was supported by grants awarded to CAL from the Instituto de Ecologia y Biodiversidad (IEB; Chilean Millennium Initiative [P05-002]) and the Departamento de Investigacion of Universidad de La Serena (DIULS [PT14122]). APL was supported by a FONDECYT Initiation Research Grant (11140400) and CONICYT (PFB-23).	[Anonymous], FORAGING THEORY; Beck MJ, 2010, J ECOL, V98, P1300, DOI 10.1111/j.1365-2745.2010.01716.x; Bello C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501105; Bonal R, 2006, EVOLUTIONARY ECOLOGY, V21, P367; Bozinovic F, 1997, COMP BIOCHEM PHYS A, V118, P625, DOI 10.1016/S0300-9629(96)00480-X; BOZINOVIC F, 1995, J MAMMAL, V76, P627, DOI 10.2307/1382371; Bronstein J. L., 2007, Seed dispersal: theory and its application in a changing world, P148, DOI 10.1079/9781845931650.0148; Chamberlain SA, 2014, ECOL LETT, V17, P881, DOI 10.1111/ele.12279; Crespin L, 2006, REV CHIL HIST NAT, V79, P295; Dalling JW, 2002, ECOLOGIA CONSERVACIO, P346; Fedriani JM, 2006, FUNCT ECOL, V20, P1070, DOI 10.1111/j.1365-2435.2006.01199.x; Fedriani JM, 2013, J ECOL, V101, P1581, DOI 10.1111/1365-2745.12146; Forget P.-M., 1998, P25; Forget Pierre-Michel, 2002, P241, DOI 10.1079/9780851995250.0241; Galetti M, 2015, BIOTROPICA, V47, P521, DOI 10.1111/btp.12246; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Galetti M, 2010, ZOOLOGIA-CURITIBA, V27, P472, DOI 10.1590/S1984-46702010000300022; Garcia-Guzman P, 2012, PLANT ECOL DIVERS, V5, P197, DOI 10.1080/17550874.2011.583286; Gomez JM, 2004, EVOLUTION, V58, P71, DOI 10.1111/j.0014-3820.2004.tb01574.x; Grubb PJ, 1998, J TROP ECOL, V14, P177, DOI 10.1017/S0266467498000145; Guimaraes PR, 2006, AUSTRAL ECOL, V31, P95, DOI 10.1111/j.1442-9993.2006.01554.x; Guimaraes PR, 2005, J TROP ECOL, V21, P109, DOI 10.1017/S0266467404001932; Herrera M, 2014, THESIS; Hirsch BT, 2012, ECOL LETT, V15, P1423, DOI 10.1111/ele.12000; Hulme PE, 2002, GRANIVORY PLANT ANIM, P132; Hulme Philip E., 2002, P257, DOI 10.1079/9780851995250.0257; JACOBS LF, 1992, ANIM BEHAV, V43, P522, DOI 10.1016/S0003-3472(05)80111-3; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; Jansen PA, 2001, MONOG BIOL, V80, P275; Jansen PA, 2012, P NATL ACAD SCI USA, V109, P12610, DOI 10.1073/pnas.1205184109; Jansen Patrick A., 2002, P209, DOI 10.1079/9780851995250.0209; Jordano P., 2000, Seeds: the ecology of regeneration in plant communities, P125, DOI 10.1079/9780851994321.0125; Kelt DA, 2004, OIKOS, V104, P133, DOI 10.1111/j.0030-1299.2004.12714.x; KERLEY GIH, 1991, OECOLOGIA, V86, P261, DOI 10.1007/BF00317539; Loayza AP, 2015, REV CHIL HIST NAT, V88, DOI [10.1186/s40693-015-0039-1, 10.1186/S40693-015-0039-1]; Loayza AP, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00283.1; Luna CA, 2016, THESIS; Martinez I, 2007, EVOL ECOL, V21, P517, DOI 10.1007/s10682-006-9132-x; Mu?oz-Pedreros A., 2000, MAMIFEROS CHILE; Munoz A, 2008, ANIM BEHAV, V76, P709, DOI 10.1016/j.anbehav.2008.03.017; MUNOZPEDREROS A, 1992, REV CHIL HIST NAT, V65, P417; Perea R, 2012, EUR J FOREST RES, V131, P623, DOI 10.1007/s10342-011-0536-y; R Development Core Team, 2013, R LANG ENV STAT COMP; Rojas-Robles R, 2012, REV BIOL TROP, V60, P1445; Saldias G, 2014, GAYANA BOT, V71, P17; Shiels AB, 2011, BIOL INVASIONS, V13, P883, DOI 10.1007/s10530-010-9876-7; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; Smith CC, 1975, COEVOLUTION ANIMALS, P53; SMYTHE N, 1978, Smithsonian Contributions to Zoology, P1; Theimer Tad C., 2005, P283, DOI 10.1079/9780851998060.0283; Theimer TC, 2003, J TROP ECOL, V19, P95, DOI 10.1017/S0266467403003110; Vanasco NB, 2003, PREV VET MED, V60, P227, DOI 10.1016/S0167-5877(03)00144-2; Vander Wall SB, 2001, BOT REV, V67, P74, DOI 10.1007/BF02857850; Vander Wall SB, 2003, OIKOS, V100, P25, DOI 10.1034/j.1600-0706.2003.11973.x; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Vargas M, 2016, THESIS; Wall SBV, 2010, PHILOS T R SOC B, V365, P989, DOI 10.1098/rstb.2009.0205; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111389; Wang B, 2013, OIKOS, V122, P1027, DOI 10.1111/j.1600-0706.2012.20823.x; Wang B, 2012, PLANT ECOL, V213, P1329, DOI 10.1007/s11258-012-0091-8; Wang B, 2009, ECOLOGY, V90, P3023, DOI 10.1890/08-2188.1; Wenny DG, 2001, EVOL ECOL RES, V3, P51; Williams JB, 2002, INTEGR COMP BIOL, V42, P68, DOI 10.1093/icb/42.1.68; Xiao ZS, 2005, ACTA OECOL, V28, P221, DOI 10.1016/j.actao.2005.04.006	65	11	12	4	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							0166824	10.1371/journal.pone.0166824	http://dx.doi.org/10.1371/journal.pone.0166824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861550	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300116
J	N'Guessan, R; Odjo, A; Ngufor, C; Malone, D; Rowland, M				N'Guessan, Raphael; Odjo, Abibatou; Ngufor, Corine; Malone, David; Rowland, Mark			A Chlorfenapyr Mixture Net Interceptor (R) G2 Shows High Efficacy and Wash Durability against Resistant Mosquitoes in West Africa	PLOS ONE			English	Article							PYRROLE INSECTICIDE CHLORFENAPYR; EXPERIMENTAL HUT EVALUATION; PYRETHROID-RESISTANT; CULEX-QUINQUEFASCIATUS; ANOPHELES-GAMBIAE; MALARIA VECTORS; TREATED NETS; BENIN; CULICIDAE; DIPTERA	Background Malaria control through use of long-lasting insecticidal nets (LN) is threatened by the selection of anopheline mosquitoes strongly resistant to pyrethroid insecticides. To sustain future effectiveness it is essential to identify and evaluate novel insecticides suitable for nets. Mixtures of two insecticides with contrasting mode of action have the potential to kill resistant vectors and restore transmission control provided the formulation can withstand regular washing over the net's life span. Method The efficacy of a novel mixture LN, Interceptor (R) G2, that combines the pyrrole chlorfenapyr and pyrethroid alpha-cypermethrin was evaluated under controlled household conditions (experimental hut trial) and by laboratory bioassay against pyrethroid resistant An. gambiae in Benin before and after standardized washing. Comparison arms included standard alphacypermethrin LN, nets hand-treated with chlorfenapyr-only and untreated nets. Results The chlorfenapyr-alphacypermethrin LN demonstrated improved efficacy and wash resistance compared to a standard alpha-cypermethrin LN against pyrethroid resistant mosquitoes (resistance ratio 207). In experimental hut trial alpha-cypermethrin LN killed only 20% (95% CI 15-26%) of host-seeking An. gambiae whilst mixture LN killed 71% (95% CI 65-77%). Mixture LN washed 20 times killed 65% (95% CI 58-71%), and thus intensive washing reduced efficacy by only 6% (95% CI 1.3-11%). The chlorfenapyr net killed 76% (95% CI 70-81%). Personal protection and blood feeding inhibition did not differ between mixture and pyrethroid LN; however, the mixture LN was 2.5 (95% CI: 2.1-3.1) times more protective than untreated nets. Standard WHO cone bioassays conducted during day time hours failed to anticipate field efficacy but overnight tunnel tests successfully predicted mixture LN and chlorfenapyr net efficacy in field trials. Conclusion Interceptor (R) G2 LN demonstrates the potential to control transmission and provide community protection over the normal lifespan of long lasting nets where standard pyrethroid LN show signs of failing due to resistance.	[N'Guessan, Raphael; Ngufor, Corine; Rowland, Mark] London Sch Hyg & Trop Med, London, England; [N'Guessan, Raphael; Odjo, Abibatou; Ngufor, Corine] Minist Hlth, Ctr Rech Entomol Cotonou, Cotonou, Benin; [N'Guessan, Raphael; Ngufor, Corine; Rowland, Mark] Pan African Malaria Vector Res Consortium PAMVERC, London, England; [Malone, David] Innovat Vector Control Consortium, Liverpool, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Rowland, M (corresponding author), London Sch Hyg & Trop Med, London, England.; Rowland, M (corresponding author), Pan African Malaria Vector Res Consortium PAMVERC, London, England.	mark.rowland@lshtm.ac.uk		NGuessan, Raphael/0000-0003-4930-4534; Ngufor, Corine/0000-0002-7755-9609	Bill and Melinda Gates Foundation; Innovative Vector Control Consortium; Bill and Melinda Gates Foundation through the Innovative Vector Control Consortium (IVCC).	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Innovative Vector Control Consortium; Bill and Melinda Gates Foundation through the Innovative Vector Control Consortium (IVCC).	This work was supported by the Bill and Melinda Gates Foundation (http://www.gatestoundation.org/) and the Innovative Vector Control Consortium (http://www.ivcc.com). The institutional funders had no role in study design, data collection and analysis, preparation of the manuscript or decision to publish.; We thank Egon Weinmuller, Susanne Stutz, James Austin (BASF SE) for technical input and samples, and Robert Farlow (consultant), Robert Sloss (IVCC) and Martin Akogbeto (CREC) for technical and programme support. We thank Achille Oumbouke, Augustin Foungnikin Abel Agbevo, Estelle Vigninou and Laurette Kiki for technical assistance. Funded by the Bill and Melinda Gates Foundation through the Innovative Vector Control Consortium (IVCC).	[Anonymous], 2013, WHOHTMNTDWHOPES2013; [Anonymous], 2006, WHOCDSWHOPESGCDPP200; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bagi J, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0721-4; BLACK BC, 1994, PESTIC BIOCHEM PHYS, V50, P115, DOI 10.1006/pest.1994.1064; CURTIS CF, 1985, B ENTOMOL RES, V75, P259, DOI 10.1017/S0007485300014346; David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429; Knox TB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-76; Malima R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-296; Mosha FW, 2008, TROP MED INT HEALTH, V13, P644, DOI 10.1111/j.1365-3156.2008.02058.x; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; N'Guessan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087710; N'Guessan R, 2010, T ROY SOC TROP MED H, V104, P758, DOI 10.1016/j.trstmh.2010.08.008; Ngufor C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0981-z; Oliver SV, 2010, TROP MED INT HEALTH, V15, P127, DOI 10.1111/j.1365-3156.2009.02416.x; Oxborough RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0639-x; Oxborough RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055781; Raghavendra K, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-16; Tungu P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1490-9; West PA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115661; WHO, 2015, WORLD MAL REP 2015; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; World Health Organisation, 2007, WHOCDNTDWHOPES20071; World Health Organisation, 2014, 3 M VECT CONTR ADV G; World Health Organization, 2012, WHO GLOB MAL PROGR G; Yuan JZ, 2015, ACTA TROP, V143, P13, DOI 10.1016/j.actatropica.2014.12.002	27	44	45	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165925	10.1371/journal.pone.0165925	http://dx.doi.org/10.1371/journal.pone.0165925			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851828	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000387909300027
J	Vazquez, E; Barranco, A; Ramirez, M; Gruart, A; Delgado-Garcia, JM; Jimenez, ML; Buck, R; Rueda, R				Vazquez, Enrique; Barranco, Alejandro; Ramirez, Maria; Gruart, Agnes; Delgado-Garcia, Jose M.; Jimenez, Maria L.; Buck, Rachael; Rueda, Ricardo			Dietary 2 '-Fucosyllactose Enhances Operant Conditioning and Long-Term Potentiation via Gut-Brain Communication through the Vagus Nerve in Rodents	PLOS ONE			English	Article							HUMAN-MILK OLIGOSACCHARIDES; FUCOSYL GLYCOPROTEINS; MICROBIOTA; STIMULATION; HIPPOCAMPUS; EXPRESSION; PLASTICITY; BENEFITS; MEMORY; MOUSE	2'-fucosyllactose (2'-FL) is an abundant human milk oligosaccharide (HMO) in human milk with diverse biological effects. We recently reported ingested 2'-FL stimulates central nervous system (CNS) function, such as hippocampal long term potentiation (LTP) and learning and memory in rats. Conceivably the effect of 2'-FL on CNS function may be via the gutbrain axis (GBA), specifically the vagus nerve, and L-fucose (Fuc) may play a role. This study had two aims: (1) determine if the effect of ingested 2'-FL on the modulation of CNS function is dependent on the integrity of the molecule; and (2) confirm if oral 2'-FL modified hippocampal LTP and associative learning related skills in rats submitted to bilateral subdiaphragmatic vagotomy. Results showed that 2'-FL but not Fuc enhanced LTP, and vagotomy inhibited the effects of oral 2'-FL on LTP and associative learning related paradigms. Taken together, the data show that dietary 2'-FL but not its Fuc moiety affects cognitive domains and improves learning and memory in rats. This effect is dependent on vagus nerve integrity, suggesting GBA plays a role in 2'-FL-mediated cognitive benefits.	[Vazquez, Enrique; Barranco, Alejandro; Ramirez, Maria; Jimenez, Maria L.; Rueda, Ricardo] Abbott Nutr, Strateg R&D Dept, Granada 18004, Spain; [Buck, Rachael] Abbott Nutr, Strateg R&D Dept, Columbus, OH USA; [Gruart, Agnes; Delgado-Garcia, Jose M.] Pablo de Olavide Univ, Div Neurosci, Seville 41013, Spain	Universidad Pablo de Olavide	Vazquez, E (corresponding author), Abbott Nutr, Strateg R&D Dept, Granada 18004, Spain.	Enrique.vazquez@abbott.com	Delgado-Garcia, Jose M./V-1567-2019		Abbott Nutrition	Abbott Nutrition(Abbott Laboratories)	The study has been exclusively funded by Abbott Nutrition. The funder provided support in the form of salaries for authors [EV, AB, MR, MLJ, RB, RR] as well as budget for expenses associated with experimental work. The funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Bienenstock J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076236; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; Bode L, 2015, EARLY HUM DEV, V91, P619, DOI 10.1016/j.earlhumdev.2015.09.001; Bode L, 2012, GLYCOBIOLOGY, V22, P1147, DOI 10.1093/glycob/cws074; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Castanys-Munoz E, 2013, NUTR REV, V71, P773, DOI 10.1111/nure.12079; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Erney RM, 2000, J PEDIATR GASTR NUTR, V30, P181, DOI 10.1097/00005176-200002000-00016; Feldman DE, 2009, ANNU REV NEUROSCI, V32, P33, DOI 10.1146/annurev.neuro.051508.135516; Forsythe P, 2013, CELL MOL LIFE SCI, V70, P55, DOI 10.1007/s00018-012-1028-z; Gallaher ZR, 2012, NEUROSCI LETT, V513, P31, DOI 10.1016/j.neulet.2012.01.079; German JB, 2008, NESTLE NUTR WORKS SE, V62, P205, DOI 10.1159/000146322; Goehring KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101692; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; GURD JW, 1979, BIOCHIM BIOPHYS ACTA, V555, P221, DOI 10.1016/0005-2736(79)90162-7; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Jantscher-Krenn E, 2012, MINERVA PEDIATR, V64, P83; Jantscher-Krenn E, 2013, BRIT J NUTR, V110, P640, DOI 10.1017/S0007114512005727; Jantscher-Krenn E, 2012, GUT, V61, P1417, DOI 10.1136/gutjnl-2011-301404; JORK R, 1986, PHARMACOL BIOCHEM BE, V25, P1137, DOI 10.1016/0091-3057(86)90100-0; Keightley P, 2015, AUSTRALAS PSYCHIATRY, V23, P403, DOI 10.1177/1039856215590033; Keightley PC, 2015, AUST NZ J PSYCHIAT, V49, P207, DOI 10.1177/0004867415569801; Knowles CH, 2013, NAT REV GASTRO HEPAT, V10, P206, DOI 10.1038/nrgastro.2013.18; Kramer MS, 2008, ARCH GEN PSYCHIAT, V65, P578, DOI 10.1001/archpsyc.65.5.578; KRUG M, 1994, BRAIN RES, V643, P130, DOI 10.1016/0006-8993(94)90018-3; Matteoli G, 2013, GUT, V62, P1214, DOI 10.1136/gutjnl-2012-302550; Matthies H, 1996, BRAIN RES, V725, P276, DOI 10.1016/0006-8993(96)00406-4; Matthies H, 2000, LEARN MEMORY, V7, P227, DOI 10.1101/lm.7.4.227; Matthies H, 1999, NEUROSCIENCE, V91, P175, DOI 10.1016/S0306-4522(98)00628-9; Murrey HE, 2006, P NATL ACAD SCI USA, V103, P21, DOI 10.1073/pnas.0503381102; Murrey HE, 2009, BIOCHEMISTRY-US, V48, P7261, DOI 10.1021/bi900640x; Oliveros E, 2016, J NUTR BIOCHEM, V31, P20, DOI 10.1016/j.jnutbio.2015.12.014; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peters JH, 2013, J COMP NEUROL, V521, P3584, DOI 10.1002/cne.23374; Pickard JM, 2015, J IMMUNOL, V194, P5588, DOI 10.4049/jimmunol.1500395; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Rudloff S, 2006, GLYCOBIOLOGY, V16, P477, DOI 10.1093/glycob/cwj092; Rudloff S, 2012, BRIT J NUTR, V107, P957, DOI 10.1017/S0007114511004016; Sanchez-Campusano R, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00039; Santos-Fandila A, 2014, TALANTA, V118, P137, DOI 10.1016/j.talanta.2013.10.013; Schack-Nielsen L, 2007, J NUTR, V137, p503S, DOI 10.1093/jn/137.2.503S; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Sherman MP, 2015, PEDIATR RES, V77, P127, DOI 10.1038/pr.2014.161; Sherrill KR, 2013, J NEUROSCI, V33, P19304, DOI 10.1523/JNEUROSCI.1825-13.2013; SUKUMAR R, 1980, J NEUROCHEM, V34, P1000, DOI 10.1111/j.1471-4159.1980.tb09677.x; Tao N, 2008, J DAIRY SCI, V91, P3768, DOI 10.3168/jds.2008-1305; Udit S, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00134; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Vazquez E, 2015, J NUTR BIOCHEM, V26, P455, DOI 10.1016/j.jnutbio.2014.11.016; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Wu SA, 2011, J PROTEOME RES, V10, P856, DOI 10.1021/pr101006u; Wu SA, 2010, J PROTEOME RES, V9, P4138, DOI 10.1021/pr100362f; ZATZ M, 1971, J NEUROCHEM, V18, P1125, DOI 10.1111/j.1471-4159.1971.tb12041.x; Zuo YT, 2007, PHYSIOL BEHAV, V90, P583, DOI 10.1016/j.physbeh.2006.11.009	58	36	39	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166070	10.1371/journal.pone.0166070	http://dx.doi.org/10.1371/journal.pone.0166070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851789	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300034
J	Abera, B; Kibret, M; Mulu, W				Abera, Bayeh; Kibret, Mulugeta; Mulu, Wondemagegn			Extended-Spectrum beta (beta)-Lactamases and Antibiogram in Enterobacteriaceae from Clinical and Drinking Water Sources from Bahir Dar City, Ethiopia	PLOS ONE			English	Article							ESCHERICHIA-COLI; RESISTANT; LACTAMASES; HEALTH	Background The spread of Extended-Spectrum beta (beta)-Lactamases (ESBL)-producing Enterobacteriaceae has become a serious global problem. ESBL-producing Enterobacteriaceae vary based on differences in antibiotic use, nature of patients and hospital settings. This study was aimed at determining ESBL and antibiogram in Enterobacteriaceae isolates from clinical and drinking water sources in Bahir Dar City, Northwest Ethiopia. Methods Enterobacteriaceae species were isolated from clinical materials and tap water using standard culturing procedures from September 2013 to March 2015. ESBL-producing-Enterobacteriaceae were detected using double-disk method by E-test Cefotaxim/cefotaxim+ clavulanic acid and Ceftazidime/ceftazidime+ clavulanic acid (BioMerieux SA, France) on Mueller Hinton agar (Oxoid, UK). Results Overall, 274 Enterobacteriaceae were isolated. Of these, 210 (44%) were from patients and 64 (17.1%) were from drinking water. The median age of the patients was 28 years. Urinary tract infection and blood stream infection accounted for 60% and 21.9% of Enterobacteriaceae isolates, respectively. Klebsiella pneumoniae was isolated from 9 (75%) of neonatal sepsis. The overall prevalence of ESBL-producing Enterobacteriaceae in clinical and drinking water samples were 57.6% and 9.4%, respectively. The predominant ESBL-producers were K. pneumoniae 34 (69.4%) and Escherichia coli 71 (58.2%). Statistically significant associations were noted between ESBL-producing and non-producing Enterobacteriaceae with regard to age of patients, infected body sites and patient settings (P = 0.001). ESBLproducing Enterobacteriaceae showed higher levels of resistance against chloramphenicol, ciprofloxacin and cotrimoxazole than non-ESBL producers (P = 0.001) Conclusions ESBL-producing Enterobacteriaceae coupled with high levels of other antimicrobials become a major concern for treatment of patients with invasive infections such as blood stream infections, neonatal sepsis and urinary tract infections. ESBL-producing Enterobacteriaceae were also detected in drinking water sources.	[Abera, Bayeh; Mulu, Wondemagegn] Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Kibret, Mulugeta] Bahir Dar Univ, Dept Biol, Coll Sci, Bahir Dar, Ethiopia	Bahir Dar University; Bahir Dar University	Abera, B (corresponding author), Bahir Dar Univ, Dept Microbiol Immunol & Parasitol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.	bayeabera15@gmail.com	Mulu, Wondemagegn/X-3190-2019; Abera, Bayeh/AAU-8754-2020		Biotechnology Research Institute of Bahir University [1/339/1.11.10]	Biotechnology Research Institute of Bahir University	The authors cordially acknowledge the Biotechnology Research Institute of Bahir University for the financial support on grant number 1/339/1.11.10.; The authors cordially acknowledge the Biotechnology Research Institute of Bahir University for the financial support on grant number 1/339/1.11.10. We also acknowledge the technical support of the staff of the Bahir Dar Regional Health Research Laboratory Centre.	Abera B, 2014, J WATER SANIT HYG DE, V4, P384, DOI 10.2166/washdev.2014.105; Alzahrani AM, 2011, AFR J MICROBIOL RES, V5, P123; [Anonymous], 2003, BASIC LAB PROCEDURES; Aruna K, 2012, EXCLI J, V11, P363; Blaak H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127752; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Chesbrougn M, 2000, MANUAL MED MICROBIOL, P251; Clinical Laboratory Standards Institute, 2013, M100S21 CLSI; De Boeck H, 2012, EMERG INFECT DIS, V18, P1019, DOI 10.3201/eid1806.111214; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Johnson JR, 2002, J INFECT DIS, V186, P859, DOI 10.1086/342490; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Mehrgan H, 2010, J INFECT DEV COUNTR, V4, P132, DOI 10.3855/jidc.488; Mulualem Yohannes, 2012, East Afr J Public Health, V9, P58; Odumosu B, 2014, AFR J CLIN EXPT MICR, V16, P28; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; Rashid Mahmudur, 2015, Infection Ecology & Epidemiology, V5, P26712, DOI 10.3402/iee.v5.26712; Sahoo KC, 2012, INT J ENV RES PUB HE, V9, P746, DOI 10.3390/ijerph9030746; Seid J, 2005, ACTA TROP, V95, P143, DOI 10.1016/j.actatropica.2005.05.009; Sethaphanich N, 2016, PEDIATR INT, V58, P338, DOI 10.1111/ped.12845; Somily AM, 2014, J INFECT DEV COUNTR, V8, P1129, DOI 10.3855/jidc.4292; Teferra Abula, 2004, Ethiopian Journal of Health Development, V18, P35; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; World Health Organization, 2004, GUID DRINK WAT QUAL, P1, DOI DOI 10.1037/E333612004-001	27	19	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166519	10.1371/journal.pone.0166519	http://dx.doi.org/10.1371/journal.pone.0166519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846254	Green Submitted, gold, Green Published			2022-12-26	WOS:000387794600074
J	Sumimoto, H; Takano, A; Teramoto, K; Daigo, Y				Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro			RAS-Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers	PLOS ONE			English	Article							TARGETED THERAPY; IMMUNE EVASION; IFN-GAMMA; B7-H1; PATHWAY; METASTASIS; MELANOMA; CELLS; INFECTION; MIGRATION	Ectopic programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancers (NSCLCs) is related to immune evasion by cancer, and it is a molecular target of immune checkpoint therapies. Although some altered signals in NSCLCs are responsible for ectopic PD-L1 expression, the precise mechanisms remain obscure. Because we found a higher frequency of EGFR/KRAS mutations in NSCLC cell lines with high PD-L1 expression (p < 0.001), we evaluated the relationships between downstream signals and PD-L1 expression, particularly in three KRAS-mutant adenocarcinoma cell lines. The MEK inhibitor U0126 (20 mu M) significantly decreased the surface PD-L1 levels by 50-60% compared with dimethyl sulfoxide (p < 0.0001). Phorbol 12-myristate 13-acetate stimulation (100 nM, 15 min) increased (p < 0.05) and two ERK2 siRNAs as well as KRAS siRNAs decreased (p < 0.05) PD-L1 expression. The transcriptional activity of the potential AP-1 site (+ 4785 to + 5056 from the transcription start site) in the PD-L1 gene was demonstrated by luciferase assays, which was inhibited by U0126. The chromatin immunoprecipitation assay demonstrated the binding of cJUN to the AP-1 site. Two STAT3 siRNAs decreased PD-L1 expression by 10 +/- 32% in two of the three KRAS-mutant lung adenocarcinoma cell lines (p < 0.05), while the PI3K inhibitor LY294002 (40 mu M) did not change the expression level. Supervised cluster analysis and gene set enrichment analysis between the PD-L1-high and-low NSCLCs revealed a correlation between PD-L1 expression and genes/pathways related to cell motility/adhesion. These results indicate that MAPK signaling is the dominant downstream signal responsible for ectopic PD-L1 expression, in which STAT3 is also involved to some extent. Furthermore, MAPK signaling may control the expression of PD-L1 and several genes related to enhanced cell motility. Our findings suggest that MAPK, along with STAT3, is important for determining PD-L1 expression, which could be useful for targeted therapies against lung cancers.	[Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro] Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan; [Sumimoto, Hidetoshi; Takano, Atsushi; Teramoto, Koji; Daigo, Yataro] Shiga Univ Med Sci, Ctr Canc, Otsu, Shiga, Japan; [Takano, Atsushi; Daigo, Yataro] Univ Tokyo, Res Hosp, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Tokyo, Japan	Shiga University of Medical Science; Shiga University of Medical Science; University of Tokyo	Daigo, Y (corresponding author), Shiga Univ Med Sci, Dept Med Oncol, Otsu, Shiga, Japan.; Daigo, Y (corresponding author), Shiga Univ Med Sci, Ctr Canc, Otsu, Shiga, Japan.; Daigo, Y (corresponding author), Univ Tokyo, Res Hosp, Inst Med Sci, Ctr Antibody & Vaccine Therapy, Tokyo, Japan.	ydago@ims.u-tokyo.ac.jp	Sumimoto, Hidetoshi/AAE-6873-2020	Daigo, Yataro/0000-0002-0915-3025	Japan Society for the Promotion of Science; JSPS KAKENHI [15H04761, 16H06277]; Shiga Prefecture (Japan)	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Shiga Prefecture (Japan)	This work was supported in part by Grant-in-Aid for Scientific Research (B) and Grant in-Aid for Scientific Research on Innovative Areas from The Japan Society for the Promotion of Science to Y.D. (JSPS KAKENHI Grant Number JP: 15H04761 and 16H06277). Y.D. is a member of Shiga Cancer Treatment Project supported by Shiga Prefecture (Japan).	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Azuma K, 2014, ANN ONCOL, V25, P1935, DOI 10.1093/annonc/mdu242; CAMIENER GW, 1965, BIOCHEM PHARMACOL, V14, P1405, DOI 10.1016/0006-2952(65)90175-9; Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Green MR, 2012, CLIN CANCER RES, V18, P1611, DOI 10.1158/1078-0432.CCR-11-1942; Hu-Lieskovan S, 2014, J CLIN ONCOL, V32, P2248, DOI 10.1200/JCO.2013.52.1377; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Kuo PL, 2011, J CELL PHYSIOL, V226, P1224, DOI 10.1002/jcp.22445; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Liu JZ, 2007, BLOOD, V110, P296, DOI 10.1182/blood-2006-10-051482; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Meacham CE, 2009, NAT GENET, V41, P1133, DOI 10.1038/ng.451; Noman MZ, 2014, J EXP MED, V211, P781, DOI 10.1084/jem.20131916; Ota K, 2015, CLIN CANCER RES, V21, P4014, DOI 10.1158/1078-0432.CCR-15-0016; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Skoulidis F, 2015, CANCER DISCOV, V5, P860, DOI 10.1158/2159-8290.CD-14-1236; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Wolfle SJ, 2011, EUR J IMMUNOL, V41, P413, DOI 10.1002/eji.201040979; Yamamoto R, 2009, CANCER SCI, V100, P2093, DOI 10.1111/j.1349-7006.2009.01302.x; Yao X, 2014, UROL ONCOL-SEMIN ORI, V32, P162, DOI 10.1016/j.urolonc.2012.12.006	30	111	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166626	10.1371/journal.pone.0166626	http://dx.doi.org/10.1371/journal.pone.0166626			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846317	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600092
J	Burri, A; Marinova, Z; Robinson, MD; Kuhnel, B; Waldenberger, M; Wahl, S; Kunze, S; Gieger, C; Livshits, G; Williams, F				Burri, Andrea; Marinova, Zoya; Robinson, Mark D.; Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian; Livshits, Gregory; Williams, Frances			Are Epigenetic Factors Implicated in Chronic Widespread Pain?	PLOS ONE			English	Article							MONOAMINE-OXIDASE-B; DNA METHYLATION; FIBROMYALGIA SYNDROME; COLLAGEN; COMORBIDITIES; ASSOCIATION; INVOLVEMENT	Background Chronic widespread musculoskeletal pain (CWP) is the cardinal symptom of fibromyalgia and affects about 12% of the general population. Familial aggregation of CWP has been repeatedly demonstrated with estimated heritabilities of around 50%, indicating a genetic susceptibility. The objective of the study was to explore genome-wide disease-differentially methylated positions (DMPs) for chronic widespread pain (CWP) in a sample of unrelated individuals and a subsample of discordant monozygotic (MZ) twins. Methodology/Principle Findings A total of N = 281 twin individuals from the TwinsUK registry, including N = 33 MZ twins discordant for self-reported CWP, were part of the discovery sample. The replication sample included 729 men and 756 women from a subsample of the KORA S4 survey-an independent population-based cohort from Southern Germany. Epigenome-wide analysis of DNA methylation was conducted using the Illumina Infinium HumanMethylation 450 DNA Bead-Chip in both the discovery and replication sample. Of our 40 main loci that were carried forward for replication, three CPGs reached significant p-values in the replication sample, including malate dehydrogenase 2 (MDH2; p-value 0.017), tetranectin (CLEC3B; p-value 0.039), and heat shock protein beta-6 (HSPB6; p-value 0.016). The associations between the collagen type I, alpha 2 chain (COL1A2) and monoamine oxidase B (MAOB) observed in the discovery sample-both of which have been previously reported to be biological candidates for pain-could not be replicated. Conclusion/Significance Our results may serve as a starting point to encourage further investigation in large and independent population-based cohorts of DNA methylation and other epigenetic changes as possible disease mechanisms in CWP. Ultimately, understanding the key mechanisms underlying CWP may lead to new treatments and inform clinical practice.	[Burri, Andrea] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand; [Burri, Andrea] North Shore Hosp, Dept Anaesthesia & Perioperat Med, Waitemata Pain Serv, Auckland, New Zealand; [Burri, Andrea] Univ Zurich, Dept Psychol, Binzmuhlestr 14, CH-8050 Zurich, Switzerland; [Marinova, Zoya] Clin Barmelweid, Dept Psychosomat Med, CH-5017 Barmelweid, Switzerland; [Robinson, Mark D.] Univ Zurich, Swiss Inst Bioinformat, CH-8057 Zurich, Switzerland; [Robinson, Mark D.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian] Helmholtz Zentrum Munchen, Res Unit Mol Epidemiol, Munich, Germany; [Kuehnel, Brigitte; Waldenberger, Melanie; Wahl, Simone; Kunze, Sonja; Gieger, Christian] Helmholtz Zentrum Munchen, Inst Epidemiol 2, Munich, Germany; [Livshits, Gregory] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Livshits, Gregory; Williams, Frances] Kings Coll London, St Thomas Hosp, Dept Twin Res & Genet Epidemiol, Westminster Bridge Rd, London SE1 7EH, England	Auckland University of Technology; University of Zurich; Swiss Institute of Bioinformatics; University of Zurich; University of Zurich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Tel Aviv University; Sackler Faculty of Medicine; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Burri, A (corresponding author), Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland, New Zealand.; Burri, A (corresponding author), North Shore Hosp, Dept Anaesthesia & Perioperat Med, Waitemata Pain Serv, Auckland, New Zealand.; Burri, A (corresponding author), Univ Zurich, Dept Psychol, Binzmuhlestr 14, CH-8050 Zurich, Switzerland.	a.burri@psychologie.uzh.ch	Livshits, Gregory/AAG-7051-2019; Waldenberger, Melanie/B-5355-2014; Robinson, Mark D./O-2254-2019	Livshits, Gregory/0000-0003-3766-7493; Waldenberger, Melanie/0000-0003-0583-5093; Robinson, Mark D./0000-0002-3048-5518; Burri, Andrea/0000-0002-4705-3551; Kunze, Sonja/0000-0002-9685-2675; Williams, Frances/0000-0002-2998-2744	Arthritis Research UK [20682]; Wellcome Trust; European Community's Seventh Framework Programme (FP7); National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's; St Thomas' NHS Foundation Trust; Helmholtz Zentrum Munchen German Research Center for Environmental Health; German Federal Ministry of Education and Research (BMBF); State of Bavaria; European Union Seventh Framework Programme (FP7) [603288, HEALTH-F2-2013-602736]; European Union's Seventh Framework Programme (FP7-Health-F5) [305280]; Swiss National Science Foundation; Swisslife Jubilaumsstiftung; Swiss National Science Foundation [143883]; European Commission through the 7th Framework Collaborative Project RADIANT [305626]; Versus Arthritis [20682] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission); European Community's Seventh Framework Programme (FP7)(European Commission); National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's; St Thomas' NHS Foundation Trust; Helmholtz Zentrum Munchen German Research Center for Environmental Health(Helmholtz Association); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria; European Union Seventh Framework Programme (FP7); European Union's Seventh Framework Programme (FP7-Health-F5); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swisslife Jubilaumsstiftung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Commission through the 7th Framework Collaborative Project RADIANT; Versus Arthritis(Versus Arthritis)	The study was supported by Arthritis Research UK (grant 20682). TwinsUK: the cohort was supported by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013). The study also receives support from the National Institute for Health Research (NIHR)- funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The authors declare no conflict of interest. The KORA study was initiated and financed by the Helmholtz Zentrum Munchen German Research Center for Environmental Health (https://www.helmholtz-muenchen.de/), which is funded by the German Federal Ministry of Education and Research (BMBF; https://www.bmbf.de/en/) and by the State of Bavaria. The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no 603288 (SysVasc), HEALTH-F2-2013-602736 (PAIN-OMICS) and European Union's Seventh Framework Programme (FP7-Health-F5-2012) under grant agreement 305280 (MIMOmics). AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation and a project grant from the Swisslife Jubilaumsstiftung. FW has grant support from Arthritis Research UK (grant 20682). MDR acknowledges funding from a Swiss National Science Foundation project grant (143883) and from the European Commission through the 7th Framework Collaborative Project RADIANT (grant agreement number 305626).; AB reports an Ambizione personal career fellowship by the Swiss National Science Foundation and a project grant from the Swisslife Jubilaumsstiftung. FW has grant support from Arthritis Research UK (grant 20682). MDR acknowledges funding from a Swiss National Science Foundation project grant (143883) and from the European Commission through the 7th Framework Collaborative Project RADIANT (grant agreement number 305626). The KORA-Study Group consists of A. Peters, J. Heinrich, R. Holle, R. Leidl, C. Meisinger, K. Strauch, and their co-workers, who are responsible for the design and conduct of the KORA studies.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Barfield RT, 2012, BIOINFORMATICS, V28, P1280, DOI 10.1093/bioinformatics/bts124; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Burri A, 2015, PAIN, V156, P1458, DOI 10.1097/j.pain.0000000000000182; Choi WJ, 2014, FOOT ANKLE INT, V35, P1045, DOI 10.1177/1071100714540885; COQUOZ D, 1993, CLIN PHARMACOL THER, V54, P339, DOI 10.1038/clpt.1993.156; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Genc H, 2003, YONSEI MED J, V44, P619, DOI 10.3349/ymj.2003.44.4.619; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gronemann ST, 2004, RHEUMATOLOGY, V43, P27, DOI 10.1093/rheumatology/keg452; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Hansen KD, 2014, PACKAGE MINFI ANAL I; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Lehne B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0600-x; Limer KL, 2008, RHEUMATOLOGY, V47, P572, DOI 10.1093/rheumatology/ken027; Livshits G, 2014, ANN HUM GENET, V78, P357, DOI [10.1111/ahg.12074, DOI 10.1111/AHG.12074]; Lu CE, 2015, J NEUROL SCI, V352, P48, DOI 10.1016/j.jns.2015.03.018; Malkin I, 2015, PAIN, V156, P1845, DOI [10.1097/j.pain.0000000000000200, DOI 10.1097/J.PAIN.0000000000000200]; Mansfield KE, 2016, PAIN, V157, P55, DOI 10.1097/j.pain.0000000000000314; Menzies V, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/795784; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Olson GB, 2000, CRANIO, V18, P135, DOI 10.1080/08869634.2000.11746125; Peters MJ, 2013, ANN RHEUM DIS, V72, P427, DOI 10.1136/annrheumdis-2012-201742; Pirildar Sebnem, 2003, Psychopharmacol Bull, V37, P127; R Core Team, 2020, R LANG ENV STAT COMP; Ribel-Madsen S, 2005, INT J TISSUE REACT, V27, P75; Schreiber S, 1998, NEUROSCI LETT, V253, P183, DOI 10.1016/S0304-3940(98)00638-7; Sery O, 2006, NEUROENDOCRINOL LETT, V27, P333; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Szyf M, 2013, CHILD DEV, V84, P49, DOI 10.1111/j.1467-8624.2012.01793.x; Tort S, 2012, COCHRANE DB SYST REV, V8; Treister R, 2009, PAIN, V147, P187, DOI 10.1016/j.pain.2009.09.001; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Villarinho JG, 2012, EUR J PHARMACOL, V690, P107, DOI 10.1016/j.ejphar.2012.06.042; von Wurmb-Schwark Nicole, 2004, Leg Med (Tokyo), V6, P125, DOI 10.1016/j.legalmed.2003.12.002; Wade J. B, 2000, PERSONALITY CHARACTE, P89; White KP, 1999, J RHEUMATOL, V26, P885; Willis DE, 2015, NEUROSCI LETT; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	44	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165548	10.1371/journal.pone.0165548	http://dx.doi.org/10.1371/journal.pone.0165548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832094	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000387725000020
J	Enciso, M; Meftahi, N; Walker, ML; Smith, BJ				Enciso, Marta; Meftahi, Nastaran; Walker, Michael L.; Smith, Brian J.			BioPPSy: An Open-Source Platform for QSAR/QSPR Analysis	PLOS ONE			English	Article							POLAR SURFACE-AREA; AQUEOUS SOLUBILITY; DRUG DISCOVERY; ORGANIC-COMPOUNDS; ADME EVALUATION; DIVERSE SET; PREDICTION; PERMEABILITY; TRANSPORT; MOLECULES	The reliability of quantitative structure-property relationship (QSPR) and quantitative structure-activity relationship (QSAR) models is often difficult to assess due to the problems of accessing the tools and data used to build the models. We present here BioPPSy, which aims to fill this gap by providing an easy-to-use open-source software platform. We demonstrate the program capabilities by calculating three key properties used in drug discovery, aqueous solubility, Caco-2 cell permeability and blood-brain barrier permeability. A comparison is made with a number of previously reported methods, taken from the literature, for each property.	[Enciso, Marta; Meftahi, Nastaran; Walker, Michael L.; Smith, Brian J.] La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem & Phys, Bundoora, Vic 3086, Australia	La Trobe University	Smith, BJ (corresponding author), La Trobe Univ, La Trobe Inst Mol Sci, Dept Chem & Phys, Bundoora, Vic 3086, Australia.	brian.smith@latrobe.edu.au	Enciso, Marta/AAZ-2849-2021; Smith, Brian J/F-8282-2011	Enciso, Marta/0000-0002-3426-3752; Smith, Brian J/0000-0003-0498-1910; Meftahi, Nastaran/0000-0003-2664-4368	Australian Research Council [DP130100998]; VLSCI's Life Sciences Computation Centre; University of Melbourne; Monash University; La Trobe University	Australian Research Council(Australian Research Council); VLSCI's Life Sciences Computation Centre; University of Melbourne(University of Melbourne); Monash University(Monash University); La Trobe University	This work was supported financially through grants from Australian Research Council (DP130100998) and from the VLSCI's Life Sciences Computation Centre, a collaboration between The University of Melbourne, Monash University and La Trobe University, and an initiative of the Victorian Government, Australia.; This work was supported financially through grants from the Australian Research Council (DP130100998) and from the VLSCI's Life Sciences Computation Centre, a collaboration between The University of Melbourne, Monash University and La Trobe University, and an initiative of the Victorian Government, Australia. We are endebted to Eden Duthie, Jocelyn Penington, Nicholas Smith and Jakub Szarlat for their contributions.	Artursson P, 2012, ADV DRUG DELIVER REV, V64, P280, DOI 10.1016/j.addr.2012.09.005; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Clark DE, 1999, J PHARM SCI, V88, P815, DOI 10.1021/js980402t; Delaney JS, 2004, J CHEM INF COMP SCI, V44, P1000, DOI 10.1021/ci034243x; Di L, 2009, CURR PHARM DESIGN, V15, P2184, DOI 10.2174/138161209788682479; Duchowicz PR, 2009, INT J MOL SCI, V10, P2558, DOI 10.3390/ijms10062558; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Fan Y, 2010, J CHEM INF MODEL, V50, P1123, DOI 10.1021/ci900384c; Feher M, 2000, INT J PHARMACEUT, V201, P239, DOI 10.1016/S0378-5173(00)00422-1; Garg P, 2006, J CHEM INF MODEL, V46, P289, DOI 10.1021/ci050303i; Gozalbes R, 2011, BIOORGAN MED CHEM, V19, P2615, DOI 10.1016/j.bmc.2011.03.011; Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b; Hou TJ, 2004, J CHEM INF COMP SCI, V44, P266, DOI 10.1021/ci034184n; Hou TJ, 2002, J MOL MODEL, V8, P337, DOI 10.1007/s00894-002-0101-1; Howard PH, 2000, PHYSPROP DATABASE; Huuskonen J, 2000, J CHEM INF COMP SCI, V40, P773, DOI 10.1021/ci9901338; Khan MTH, 2010, CURR DRUG METAB, V11, P285; Klopman G, 2001, J CHEM INF COMP SCI, V41, P439, DOI 10.1021/ci000152d; Lipinski C., 2002, AM PHARM REV, V5, P82; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu PX, 2009, INT J MOL SCI, V10, P1978, DOI 10.3390/ijms10051978; McElroy NR, 2001, J CHEM INF COMP SCI, V41, P1237, DOI 10.1021/ci010035y; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Nantasenamat C, 2009, EXCLI J, V8, P74; Osterberg T, 2000, J CHEM INF COMP SCI, V40, P1408, DOI 10.1021/ci000065l; Palm K, 1996, J PHARM SCI, V85, P32, DOI 10.1021/js950285r; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y; Sushko I, 2011, J COMPUT AID MOL DES, V25, P533, DOI 10.1007/s10822-011-9440-2; Tetko IV, 2001, J CHEM INF COMP SCI, V41, P1488, DOI 10.1021/ci000392t; Todeschini R., 2000, WILEY VCH, V11, P688; van de Waterbeemd H, 1998, J DRUG TARGET, V6, P151, DOI 10.3109/10611869808997889; VANDEWATERBEEMD H, 1992, CHIMIA, V46, P299; vandeWaterbeemd H, 1996, QUANT STRUCT-ACT REL, V15, P480, DOI 10.1002/qsar.19960150604; Walker T, 2010, BIOINFORMATICS, V26, P3000, DOI 10.1093/bioinformatics/btq556; Yalkowsky S.H., 1992, AQUASOL DATABASE AQU	38	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166298	10.1371/journal.pone.0166298	http://dx.doi.org/10.1371/journal.pone.0166298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832156	gold, Green Submitted, Green Published			2022-12-26	WOS:000387725000091
J	Hurnakova, J; Hulejova, H; Zavada, J; Komarc, M; Hanova, P; Klein, M; Mann, H; Sleglova, O; Olejarova, M; Forejtova, S; Ruzickova, O; Vencovsky, J; Pavelka, K; Senolt, L				Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Komarc, Martin; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav			Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission	PLOS ONE			English	Article							MODIFYING ANTIRHEUMATIC DRUGS; POWER DOPPLER ULTRASOUND; SYNOVIAL INFLAMMATION; DAMAGE; PROTEINS; SCORES; JOINTS; ULTRASONOGRAPHY; DETERIORATION; METHOTREXATE	Objective Clinical remission in some patients with rheumatoid arthritis (RA) may be associated with ongoing synovial inflammation that is not always detectable on clinical examination or reflected by laboratory tests but can be visualized by musculoskeletal ultrasound. The goal of our study was to determine the levels of serum calprotectin, a major leukocyte protein, in patients with RA in clinical remission and to investigate the ability of serum calprotectin levels to distinguish patients in ultrasound-defined remission from those with residual ultrasound subclinical inflammation. Methods Seventy RA patients in clinical remission underwent clinical and ultrasound examination. Ultrasound examination was performed according to the German US7 score. Ultrasound remission was defined as grey scale (GS) range 0-1 and power Doppler (PD) range 0. The levels of serum calprotectin and C-reactive protein (CRP) were determined. The discriminatory capacity of calprotectin and CRP in detecting residual ultrasound inflammation was assessed using ROC curves. Results The total number of patients fulfilling the DAS28-ESR, DAS28-CRP, SDAI and CDAI remission criteria was 58, 67, 32 and 31, respectively. Residual synovial inflammation was found in 58-67% of the patients who fulfilled at least one set of clinical remission criteria. Calprotectin levels were significantly higher in patients with residual synovial inflammation than in those with ultrasound-defined remission (mean 2.5 +/- 1.3 vs. 1.7 +/- 0.8 mu g/mL, p<0.005). Using ultrasound-defined remission criteria, calprotectin had an AUC of 0.692, p<0.05 using DAS28-ESR remission criteria and an AUC of 0.712, p<0.005 using DAS28-CRP remission criteria. Calprotectin correctly distinguished ultrasound remission from subclinical activity in 70% of patients. CRP (AUC DAS28-ESR = 0.494, p = NS; AUC DAS28-CRP = 0.498, p = NS) had lower and insignificant discriminatory capacity. Conclusion The present study demonstrates the potential of calprotectin to distinguish RA patients in both clinical and ultrasound-defined remission from patients in clinical remission but with residual subclinical disease activity.	[Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Inst Rheumatol, Prague, Czech Republic; [Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Klein, Martin; Mann, Herman; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Charles Univ Prague, Dept Rheumatol, Fac Med 1, Prague, Czech Republic; [Komarc, Martin] Charles Univ Prague, Dept Methodol, Fac Phys Educ & Sport, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague; Charles University Prague	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.; Senolt, L (corresponding author), Charles Univ Prague, Dept Rheumatol, Fac Med 1, Prague, Czech Republic.	senolt@revma.cz	Hulejová, Hana/H-1909-2019; Komarc, Martin/A-7308-2017; Hurnakova, Jana/P-1932-2017; Olejárová, Marta/O-8800-2017; Vencovsky, Jiri/G-6094-2017; Klein, Martin/N-6958-2017; Hanova, Petra/O-6675-2017; Mann, Herman Felix/G-5871-2014; Komarc, Martin/O-2575-2019; Šenolt, Ladislav/O-6097-2017; Závada, Jakub/N-3159-2017; Ruzickova, Olga/O-4214-2017; Šléglová, Olga/N-3022-2017; Forejtova, Sarka/N-7448-2017; Pavelka, Karel/E-6578-2017	Hulejová, Hana/0000-0002-2335-6996; Komarc, Martin/0000-0003-4106-5217; Hurnakova, Jana/0000-0002-1139-539X; Olejárová, Marta/0000-0002-0586-361X; Vencovsky, Jiri/0000-0002-0851-0713; Klein, Martin/0000-0002-1027-0923; Hanova, Petra/0000-0003-4473-9766; Mann, Herman Felix/0000-0002-4243-235X; Komarc, Martin/0000-0003-4106-5217; Šenolt, Ladislav/0000-0001-5500-7312; Závada, Jakub/0000-0002-9802-6545; Ruzickova, Olga/0000-0003-4284-1003; Šléglová, Olga/0000-0003-1764-5852; Forejtova, Sarka/0000-0002-7510-7895; Pavelka, Karel/0000-0003-1952-8422	Ministry of Health of the Czech Republic [023728]; Internal grant agency of the Ministry of Health of the Czech Republic [NT12437]; Charles University Grant Agency (GAUK); Czech Republic [1010213]; Specific Academy Research Projects [260 031]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Internal grant agency of the Ministry of Health of the Czech Republic; Charles University Grant Agency (GAUK); Czech Republic(Czech Republic Government); Specific Academy Research Projects	This work was supported by a project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728], Internal grant agency of the Ministry of Health of the Czech Republic [NT12437], Charles University Grant Agency (GAUK), Czech Republic [1010213] and Specific Academy Research Projects (SW) [260 031]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, ARTHRITIS RES THER, V7, pR796, DOI 10.1186/ar1740; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Backhaus M, 1999, ARTHRITIS RHEUM-US, V42, P1232, DOI 10.1002/1529-0131(199906)42:6<1232::AID-ANR21>3.0.CO;2-3; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; Backhaus M, 2013, ARTHRITIS RHEUM-US, V65, pS829; Balsa A, 2010, RHEUMATOLOGY, V49, P683, DOI 10.1093/rheumatology/kep442; BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Cohen G, 2007, ANN RHEUM DIS, V66, P358, DOI 10.1136/ard.2006.057497; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foltz V, 2012, ARTHRITIS RHEUM-US, V64, P67, DOI 10.1002/art.33312; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Inciarte-Mundo J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1032-z; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Korpela M, 2004, ARTHRITIS RHEUM, V50, P2072, DOI 10.1002/art.20351; Molenaar ETH, 2004, ARTHRITIS RHEUM, V50, P36, DOI 10.1002/art.11481; Mulherin D, 1996, BRIT J RHEUMATOL, V35, P1263; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; Ohrndorf S, 2013, ANN RHEUM DIS, V72, P69, DOI 10.1136/annrheumdis-2012-202197; Ozgocmen S, 2008, SOUTH MED J, V101, P240, DOI 10.1097/SMJ.0b013e318164e16a; Padovano I, 2016, ANN RHEUM DIS, V75, P1819, DOI 10.1136/annrheumdis-2015-208103; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ramirez J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0970-9; Saleem B, 2011, ANN RHEUM DIS, V70, P792, DOI 10.1136/ard.2010.134445; Saleem B, 2009, ARTHRITIS RHEUM-US, V60, P1915, DOI 10.1002/art.24596; Scire CA, 2009, RHEUMATOLOGY, V48, P1092, DOI 10.1093/rheumatology/kep171; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Szkudlarek M, 2012, RHEUMATOLOGY, V51, P6, DOI 10.1093/rheumatology/kes334; Witt M, 2013, ARTHRITIS RHEUM-US, V65, P1694, DOI 10.1002/art.37954; Youssef P, 1999, J RHEUMATOL, V26, P2523	39	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165498	10.1371/journal.pone.0165498	http://dx.doi.org/10.1371/journal.pone.0165498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832086	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000015
J	Pang, LJ; Yan, XX; Zhao, HY; Hu, YF; Li, HX				Pang, Liaojun; Yan, Xuxia; Zhao, Huiyang; Hu, Yufei; Li, Huixian			A Novel Multi-Receiver Signcryption Scheme with Complete Anonymity	PLOS ONE			English	Article							IDENTITY-BASED ENCRYPTION; KEY AGREEMENT PROTOCOL; PROVABLY SECURE; EFFICIENT; CRYPTANALYSIS	Anonymity, which is more and more important to multi-receiver schemes, has been taken into consideration by many researchers recently. To protect the receiver anonymity, in 2010, the first multi-receiver scheme based on the Lagrange interpolating polynomial was proposed. To ensure the sender's anonymity, the concept of the ring signature was proposed in 2005, but afterwards, this scheme was proven to has some weakness and at the same time, a completely anonymous multi-receiver signcryption scheme is proposed. In this completely anonymous scheme, the sender anonymity is achieved by improving the ring signature, and the receiver anonymity is achieved by also using the Lagrange interpolating polynomial. Unfortunately, the Lagrange interpolation method was proven a failure to protect the anonymity of receivers, because each authorized receiver could judge whether anyone else is authorized or not. Therefore, the completely anonymous multi-receiver signcryption mentioned above can only protect the sender anonymity. In this paper, we propose a new completely anonymous multi-receiver signcryption scheme with a new polynomial technology used to replace the Lagrange interpolating polynomial, which can mix the identity information of receivers to save it as a ciphertext element and prevent the authorized receivers from verifying others. With the receiver anonymity, the proposed scheme also owns the anonymity of the sender at the same time. Meanwhile, the decryption fairness and public verification are also provided.	[Pang, Liaojun; Yan, Xuxia; Zhao, Huiyang; Hu, Yufei] Xidian Univ, Sch Life Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Shaanxi, Peoples R China; [Pang, Liaojun] Wayne State Univ, Dept Comput Sci, Detroit, MI 48202 USA; [Li, Huixian] Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Shaanxi, Peoples R China	Xidian University; Wayne State University; Northwestern Polytechnical University	Pang, LJ (corresponding author), Xidian Univ, Sch Life Sci & Technol, State Key Lab Integrated Serv Networks, Xian 710071, Shaanxi, Peoples R China.; Pang, LJ (corresponding author), Wayne State Univ, Dept Comput Sci, Detroit, MI 48202 USA.; Li, HX (corresponding author), Northwestern Polytech Univ, Sch Comp Sci & Engn, Xian 710072, Shaanxi, Peoples R China.	ljpang@mail.xidian.edu.cn; lihuixian@nwpu.edu.cn			Natural Science Foundation of China [61103178]; Natural Science Basic Research Plan in Shaanxi Province of China [2016JM6002, 2015JM6294]; Fundamental Research Funds for the Central Universities [3102015JSJ0003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Plan in Shaanxi Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by Natural Science Foundation of China (61103178), Natural Science Basic Research Plan in Shaanxi Province of China (2016JM6002 & 2015JM6294), and Fundamental Research Funds for the Central Universities (3102015JSJ0003).	Baek J, 2005, LECT NOTES COMPUT SC, V3386, P380; Bellare M, 2003, LECT NOTES COMPUT SC, V2567, P85; Bellare M, 2000, LECT NOTES COMPUT SC, V1807, P259; Cao XF, 2010, INFORM SCIENCES, V180, P2895, DOI 10.1016/j.ins.2010.04.002; Chatterjee S, 2006, LECT NOTES COMPUT SC, V4329, P394; Duan SS, 2006, LECT NOTES COMPUT SC, V4058, P195; Elkamchouchi Hassan, 2009, 2009 International Conference on Networking and Media Convergence (ICNM'09), P70, DOI 10.1109/ICNM.2009.4907192; Fan CI, 2010, IEEE T COMPUT, V59, P1239, DOI 10.1109/TC.2010.23; Huang XY, 2005, AINA 2005: 19TH INTERNATIONAL CONFERENCE ON ADVANCED INFORMATION NETWORKING AND APPLICATIONS, VOL 2, P649; Islam SKH, 2013, INT J COMPUT MATH, V90, P2244, DOI 10.1080/00207160.2013.776674; Islam SKH, 2012, ANN TELECOMMUN, V67, P547, DOI 10.1007/s12243-012-0296-9; Jianhong Zhang, 2012, 2012 4th International Conference on Intelligent Networking and Collaborative Systems (INCoS 2012), P473, DOI 10.1109/iNCoS.2012.117; Khullar S., 2013, INT J ADV RES TECHNO, V2, P189; Kurosawa K., 2002, Public Key Cryptography. 4th International Workshop on Practice and Theory in Public Key Cryptosystems, PKC 2002. Proceedings (Lecture Notes in Computer Science Vol.2274), P48; Lal S, 2009, IACR CRYPTOLOGY EPRI, P345; Li Fagen, 2007, Wuhan University Journal of Natural Sciences, V12, P17, DOI 10.1007/s11859-006-0133-y; Li FG, 2013, CONCURR COMP-PRACT E, V25, P2112, DOI 10.1002/cpe.2826; Li F, 2012, J NETW COMPUT APPL, V35, P340, DOI 10.1016/j.jnca.2011.08.001; Li FG, 2011, IETE TECH REV, V28, P265, DOI 10.4103/0256-4602.81236; Li FG, 2012, FUTURE GENER COMP SY, V28, P306, DOI 10.1016/j.future.2010.11.004; Li FG, 2009, 2009 INTERNATIONAL CONFERENCE ON COMMUNICATIONS, CIRCUITS AND SYSTEMS PROCEEDINGS, VOLUMES I & II, P296, DOI 10.1109/ICCCAS.2009.5250510; Li HX, 2014, IET INFORM SECUR, V8, P8, DOI 10.1049/iet-ifs.2012.0354; Li Z, NCIS 2012, P388, DOI [10.1007/978-3-642-35211-9_51, DOI 10.1007/978-3-642-35211-9_51]; Pang LJ, 2015, IET INFORM SECUR, V9, P194, DOI 10.1049/iet-ifs.2014.0360; Pang LJ, 2013, COMPUT INFORM, V32, P441; Pang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063562; Park J.-H., 2008, PROC ACM S INF COMPU, P373; Qin HW, 2011, SECUR COMMUN NETW, V4, P1331, DOI 10.1002/sec.259; Qin L, 2008, 2008 IEEE GLOB TEL C; Selvi SSD, 2009, LECT NOTES COMPUT SC, V5824, P71, DOI 10.1007/978-3-642-04846-3_6; Wang H, 2012, IET INFORM SECUR, V6, P20, DOI 10.1049/iet-ifs.2010.0252; Yang Ming, 2010, Proceedings of the 2010 International Conference of Information Science and Management Engineering. ISME 2010, P382, DOI 10.1109/ISME.2010.28; Yang XY, 2008, HPCC 2008: 10TH IEEE INTERNATIONAL CONFERENCE ON HIGH PERFORMANCE COMPUTING AND COMMUNICATIONS, PROCEEDINGS, P1042, DOI 10.1109/HPCC.2008.82; Yu Y, 2007, LECT NOTES COMPUT SC, V4610, P13; Zhang B, 2010, LECT NOTES COMPUT SC, V6059, P15, DOI 10.1007/978-3-642-13577-4_2; Zhang JH, 2009, LECT NOTES COMPUT SC, V5446, P604, DOI 10.1007/978-3-642-00672-2_58; Zheng YL, 1997, LECT NOTES COMPUT SC, V1294, P165	37	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166173	10.1371/journal.pone.0166173	http://dx.doi.org/10.1371/journal.pone.0166173			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832105	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000072
J	Yashiro, H; Takagahara, S; Tamura, YO; Miyahisa, I; Matsui, J; Suzuki, H; Ikeda, S; Watanabe, M				Yashiro, Hiroaki; Takagahara, Shuichi; Tamura, Yumiko Okano; Miyahisa, Ikuo; Matsui, Junji; Suzuki, Hideo; Ikeda, Shota; Watanabe, Masanori			A Novel Selective Inhibitor of Delta-5 Desaturase Lowers Insulin Resistance and Reduces Body Weight in Diet-Induced Obese C57BL/6J Mice	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ADIPOSE-TISSUE; CARDIOVASCULAR RISK; METABOLIC SYNDROME; GENE-EXPRESSION; PLASMA; RATIO; OMEGA-3-FATTY-ACIDS; HYPERTENSION; CONTRIBUTES	Obesity is now recognized as a state of chronic low-grade inflammation and is called as metabolic inflammation. Delta-5 desaturase (D5D) is an enzyme that metabolizes dihomo-gamma-linolenic acid (DGLA) to arachidonic acid (AA). Thus, D5D inhibition increases DGLA (precursor to anti-inflammatory eicosanoids) while decreasing AA (precursor to pro-inflammatory eicosanoids), and could result in synergistic improvement in the low-grade inflammatory state. Here, we demonstrate reduced insulin resistance and the anti-obesity effect of a D5D selective inhibitor (compound-326), an orally active small-molecule, in a high-fat dietinduced obese (DIO) mouse model. In vivo D5D inhibition was confirmed by determining changes in blood AA/DGLA profiles. In DIO mice, chronic treatment with compound-326 lowered insulin resistance and caused body weight loss without significant impact on cumulative calorie intake. Decreased macrophage infiltration into adipose tissue was expected from mRNA analysis. Increased daily energy expenditure was also observed following administration of compound-326, in line with sustained body weight loss. These data indicate that the novel D5D selective inhibitor, compound-326, will be a new class of drug for the treatment of obese and diabetic patients.	[Yashiro, Hiroaki; Takagahara, Shuichi; Tamura, Yumiko Okano; Miyahisa, Ikuo; Matsui, Junji; Suzuki, Hideo; Ikeda, Shota; Watanabe, Masanori] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tokyo, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd	Yashiro, H (corresponding author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Tokyo, Kanagawa, Japan.	hiroaki.yashiro@takeda.com		Ikeda, Shota/0000-0003-1358-524X	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was financially supported by Takeda Pharmaceutical Company Limited. Employees of Takeda played roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astorg P, 2008, EUR J CLIN NUTR, V62, P1155, DOI 10.1038/sj.ejcn.1602836; Baugh SDP, 2015, BIOORG MED CHEM LETT, V25, P3836, DOI 10.1016/j.bmcl.2015.07.066; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chopra M, 2002, B WORLD HEALTH ORGAN, V80, P952; Covington MB, 2004, AM FAM PHYSICIAN, V70, P133; Domei T, 2012, CIRC J, V76, P423, DOI 10.1253/circj.CJ-11-0941; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Haidar Yarah M, 2011, Clin Colon Rectal Surg, V24, P205, DOI 10.1055/s-0031-1295684; Hondares E, 2011, J BIOL CHEM, V286, P43112, DOI 10.1074/jbc.M111.252775; Inoue K, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-25; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; KIRTLAND SJ, 1988, PROSTAG LEUKOTR ESS, V32, P165, DOI 10.1016/0952-3278(88)90168-8; KNAPP HR, 1978, LIPIDS, V13, P804, DOI 10.1007/BF02533480; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendis S, 2007, J HYPERTENS, V25, P1578, DOI 10.1097/HJH.0b013e3282861fd3; Miyahisa I, 2016, ACS MED CHEM LETT, V7, P868, DOI 10.1021/acsmedchemlett.6b00241; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Pan A, 2012, CIRCULATION, V126, P163, DOI 10.1161/CIRCULATIONAHA.112.115923; Park H, 2010, CLIN CHIM ACTA, V411, P1735, DOI 10.1016/j.cca.2010.07.012; Perwitz N, 2010, DIABETES OBES METAB, V12, P158, DOI 10.1111/j.1463-1326.2009.01133.x; Pisani DF, 2014, MOL METAB, V3, P834, DOI 10.1016/j.molmet.2014.09.003; Powell DR, 2016, DIABETES METAB SYNDR, V9, P185, DOI 10.2147/DMSO.S106653; Rimoldi OJ, 2001, BIOCHEM BIOPH RES CO, V283, P323, DOI 10.1006/bbrc.2001.4785; Russo C, 1997, HYPERTENSION, V29, P1058, DOI 10.1161/01.HYP.29.4.1058; Saito E, 2013, PROSTAG LEUKOTR ESS, V88, P307, DOI 10.1016/j.plefa.2013.01.005; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; Simopoulos AP, 2004, WORLD REV NUTR DIET, V93, P1; Speakman JR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00034; Steffen LM, 2008, INT J OBESITY, V32, P1297, DOI 10.1038/ijo.2008.89; Stoffel W, 2014, EMBO REP, V15, P110, DOI 10.1002/embr.201338041; Suzuki H, [No title captured], Patent No. [WO 2010087467 A1, 2010087467]; Swanson D, 2012, ADV NUTR, V3, P1, DOI 10.3945/an.111.000893; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Verty ANA, 2009, OBESITY, V17, P254, DOI 10.1038/oby.2008.509; Vessby B, 2002, ANN NY ACAD SCI, V967, P183; Vessby B, 2003, CURR OPIN LIPIDOL, V14, P15, DOI 10.1097/00041433-200302000-00004; Wang MY, 1999, J BIOL CHEM, V274, P17541, DOI 10.1074/jbc.274.25.17541; Warensjo E, 2006, NUTR METAB CARDIOVAS, V16, P128, DOI 10.1016/j.numecd.2005.06.001; Warensjo E, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-37; Zhang L., 2012, AEROSP MAT TECHNOL, V6, P20; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; ZURIER RB, 1991, ADV PROSTAG THROMB L, V21, P947	47	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166198	10.1371/journal.pone.0166198	http://dx.doi.org/10.1371/journal.pone.0166198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832159	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000075
J	Yu, SH; Dubey, NK; Li, WS; Liu, MC; Chiang, HS; Leu, SJ; Shieh, YH; Tsai, FC; Deng, WP				Yu, Sung-Hsun; Dubey, Navneet Kumar; Li, Wei-Shan; Liu, Ming-Che; Chiang, Han-Sun; Leu, Sy-Jye; Shieh, Ying-Hua; Tsai, Feng-Chou; Deng, Win-Ping			Cordyceps militaris Treatment Preserves Renal Function in Type 2 Diabetic Nephropathy Mice	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; FRUITING BODY; KIDNEY; INSULIN; PATHOGENESIS; CHOLESTEROL; PROGRESSION; ANTIFUNGAL; THERAPY; GLUCOSE	Diabetic nephropathy is derived from long-term effects of high blood glucose on kidney function in type 2 diabetic patients. Several antidiabetic drugs and herbal medications have failed to prevent episodes of DN. Hence, this study aimed to further investigate the renal injury-reducing effect of antidiabetic CmNo1, a novel combination of powders of fruiting bodies and mycelia of Cordyceps militaris. After being administered with streptozotocin-nicotinamide and high-fat-diet, the diabetic nephropathy mouse model displayed elevated blood glucose and renal dysfunction markers including serum creatinine and kidney-to-body weight ratio. These elevated markers were significantly mitigated following 8 weeks CmNo1 treatment. Moreover, the chronic hyperglycemia-induced pathological alteration in renal tissue were also ameliorated. Besides, immunohistochemical study demonstrated a substantial reduction in elevated levels of carboxymethyl lysine, an advanced glycation end product. Elevated collagenous deposition in DN group was also attenuated through CmNo1 administration. Moreover, the enhanced levels of transforming growth factor-beta 1, a fibrosis-inducing protein in glomerulus were also markedly dampened. Furthermore, auxiliary risk factors in DN like serum triglycerides and cholesterol were found to be increased but were decreased by CmNo1 treatment. Conclusively, the results suggests that CmNo1 exhibit potent and efficacious renoprotective action against hyperglycemia-induced DN.	[Yu, Sung-Hsun; Leu, Sy-Jye] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Yu, Sung-Hsun; Dubey, Navneet Kumar; Li, Wei-Shan; Deng, Win-Ping] Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan; [Dubey, Navneet Kumar; Liu, Ming-Che; Deng, Win-Ping] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Liu, Ming-Che] Taipei Med Univ Hosp, Dept Urol, Taipei, Taiwan; [Liu, Ming-Che] Taipei Med Univ, Sch Med, Dept Urol, Coll Med, Taipei, Taiwan; [Chiang, Han-Sun] Cathay Gen Hosp, Div Urol, Dept Surg, New Taipei, Taiwan; [Chiang, Han-Sun; Deng, Win-Ping] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Leu, Sy-Jye] Taipei Med Univ, Sch Med, Dept Microbiol & Immunol, Coll Med, Taipei, Taiwan; [Shieh, Ying-Hua] Taipei Med Univ, Wan Fang Hosp, Dept Family Med, Taipei, Taiwan; [Tsai, Feng-Chou] Cosmet Clin Grp, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Cathay General Hospital; Fu Jen Catholic University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital	Deng, WP (corresponding author), Taipei Med Univ, Stem Cell Res Ctr, Taipei, Taiwan.; Deng, WP (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Deng, WP (corresponding author), Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan.	wpdeng@tmu.edu.tw	Dubey, Navneet Kumar/H-3870-2019; 黎, 伟/GXM-4040-2022; Yu, Sung-Hsun/H-7601-2019; wei, li/GSD-3630-2022	Dubey, Navneet Kumar/0000-0002-3540-5281; 	National Science Council, Taiwan [NSC 99-2628-B-038-010-MY3, 101-2314-B-038-023, 102-2314-B-038-058, 102-2314-B-038-015]; Department of Health, Taiwan [DOH102-TD-PB-111-NSC009]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Department of Health, Taiwan	Supported by the following agencies (grant no.): National Science Council, Taiwan (NSC 99-2628-B-038-010-MY3, 101-2314-B-038-023, 102-2314-B-038-058 and 102-2314-B-038-015) and Department of Health, Taiwan. (DOH102-TD-PB-111-NSC009). URL NSC: https://www.most.gov.tw/en/public. URL DoH Taiwan: http://www mohw.gov.tw/EN/Ministry/Index.aspx.	Agarwal Pankaj, 2013, Indian J Endocrinol Metab, V17, pS55, DOI 10.4103/2230-8210.119506; Akpan EE, 2015, CASE REP MED, V2015, DOI 10.1155/2015/150204; Alaveras AEG, 1997, NEPHROL DIAL TRANSPL, V12, P71; Almquist T, 2014, EUR J CLIN INVEST, V44, P276, DOI 10.1111/eci.12230; Awazu M, 2003, J AM SOC NEPHROL, V14, P699, DOI 10.1097/01.ASN.0000051726.41601.C0; Batlle D, 2003, KIDNEY INT, V63, P2319, DOI 10.1046/j.1523-1755.2003.00053.x; Berg TJ, 1997, METABOLISM, V46, P661, DOI 10.1016/S0026-0495(97)90010-X; BUNDSCHUH I, 1992, EUR J CLIN CHEM CLIN, V30, P651; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Cho EJ, 2007, APPL MICROBIOL BIOT, V75, P1257, DOI 10.1007/s00253-007-0972-2; Choi YE, 2010, EVID-BASED COMPL ALT, V7, P433, DOI 10.1093/ecam/nen021; Clee SM, 2007, ENDOCR REV, V28, P48, DOI 10.1210/er.2006-0035; Deshpande SD, 2013, DIABETES, V62, P3151, DOI 10.2337/db13-0305; Dong Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160980; Fioretto P, 2007, SEMIN NEPHROL, V27, P195, DOI 10.1016/j.semnephrol.2007.01.012; Gao SM, 2012, FASEB J, V26; Genovese F, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-4; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hong In-Pyo, 2010, Mycobiology, V38, P128, DOI 10.4489/MYCO.2010.38.2.128; Hosten AO, 1990, BUN CREATININE 1990; Hsu Chia-Hsiu, 2008, Pediatrics and Neonatology, V49, P171, DOI 10.1016/S1875-9572(09)60004-8; Hsu SHJ, 2015, INTERNAL MED, V54, P2291, DOI 10.2169/internalmedicine.54.4308; Hur Hyun, 2008, Mycobiology, V36, P233, DOI 10.4489/MYCO.2008.36.4.233; Jeong MH, 2013, ONCOL REP, V30, P1996, DOI 10.3892/or.2013.2660; Pang J, 2014, WORLD J DIABETES, V5, P165, DOI 10.4239/wjd.v5.i2.165; Kang J, 2005, ACTA DIABETOL, V42, P110, DOI 10.1007/s00592-005-0188-9; LARKINS RG, 1992, DIABETOLOGIA, V35, P499, DOI 10.1007/BF00400475; Lee HS, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.S9-008; Li A, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/691594; Lin S, 2016, APPL BIOCHEM BIOTECH, V179, P633, DOI 10.1007/s12010-016-2020-0; Liu Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/575063; Lo HC, 2004, LIFE SCI, V74, P2897, DOI 10.1016/j.lfs.2003.11.003; MULEC H, 1993, AM J KIDNEY DIS, V22, P196, DOI 10.1016/S0272-6386(12)70186-5; Nagai R, 2002, DIABETES, V51, P2833, DOI 10.2337/diabetes.51.9.2833; Nagai R, 1997, BIOCHEM BIOPH RES CO, V234, P167, DOI 10.1006/bbrc.1997.6608; Nagai R, 2010, BIOCHEM BIOPH RES CO, V393, P118, DOI 10.1016/j.bbrc.2010.01.095; Nasri H, 2015, J RES MED SCI, V20, P1112, DOI 10.4103/1735-1995.172845; Norlin J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152315; Olatunji OJ, 2016, ENVIRON TOXICOL PHAR, V44, P53, DOI 10.1016/j.etap.2016.02.009; Peng J, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/678214; Qian Y, 2008, DIABETES, V57, P1439, DOI 10.2337/db08-0061; Rave K, 2001, DIABETES CARE, V24, P886, DOI 10.2337/diacare.24.5.886; Raz I, 2003, NEPHROL DIAL TRANSPL, V18, P1293, DOI 10.1093/ndt/gfg170; Reis FS, 2013, FOOD CHEM TOXICOL, V62, P91, DOI 10.1016/j.fct.2013.08.033; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Rosario Rey F, 2006, Curr Diab Rep, V6, P455, DOI 10.1007/s11892-006-0079-7; Saito T, 1997, TOHOKU J EXP MED, V181, P321, DOI 10.1620/tjem.181.321; Schena FP, 2005, J AM SOC NEPHROL, V16, P30, DOI DOI 10.1681/ASN.2004110970; Sugar AM, 1998, ANTIMICROB AGENTS CH, V42, P1424, DOI 10.1128/AAC.42.6.1424; Ton ALY, 2007, SEMIN NEPHROL, V27, P130, DOI 10.1016/j.semnephrol.2007.01.006; TRIGG PI, 1971, T ROY SOC TROP MED H, V65, P514, DOI 10.1016/0035-9203(71)90162-3; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; Wang H., 2014, AM J MAR SCI, V2, P1, DOI DOI 10.1371/J0URNAL.P0NE.0088779; WILLIAMSON JR, 1993, DIABETES, V42, P801, DOI 10.2337/diabetes.42.6.801; Won KJ, 2009, J PHARMACOL SCI, V109, P403, DOI 10.1254/jphs.08308FP; Yamagishi S, 2010, OXID MED CELL LONGEV, V3, P101, DOI 10.4161/oxim.3.2.11148; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Yokozawa T, 2004, NEPHRON EXP NEPHROL, V97, pE38, DOI 10.1159/000078405; Yokozawa T, 2001, EXP TOXICOL PATHOL, V53, P359, DOI 10.1078/0940-2993-00203; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yun YunHa, 2003, Natural Product Sciences, V9, P291; Zhang GQ, 2006, APPL MICROBIOL BIOT, V72, P1152, DOI 10.1007/s00253-006-0411-9; Zhang YW, 2007, J ETHNOPHARMACOL, V114, P387, DOI 10.1016/j.jep.2007.08.024	63	27	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166342	10.1371/journal.pone.0166342	http://dx.doi.org/10.1371/journal.pone.0166342			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832180	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000103
J	Nuth, M; Guan, HC; Ricciardi, RP				Nuth, Manunya; Guan, Hancheng; Ricciardi, Robert P.			A Conserved Tripeptide Sequence at the C Terminus of the Poxvirus DNA Processivity Factor D4 Is Essential for Protein Integrity and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CRYSTAL-STRUCTURE; A20R PROTEIN; IN-VITRO; POLYMERASE; GLYCOSYLASE; REPLICATION; BINDING; IDENTIFICATION; INHIBITORS	Vaccinia virus (VACV) is a poxvirus, and the VACV D4 protein serves both as a uracil-DNA glycosylase and as an essential component required for processive DNA synthesis. The VACV A20 protein has no known catalytic function itself but associates with D4 to form the D4-A20 heterodimer that functions as the poxvirus DNA processivity factor. The heterodimer enables the DNA polymerase to efficiently synthesize extended strands of DNA. Upon characterizing the interaction between D4 and A20, we observed that the C terminus of D4 is susceptible to perturbation. Further analysis demonstrated that a conserved hexapeptide stretch at the extreme C terminus of D4 is essential for maintaining protein integrity, as assessed by its requirement for the production of soluble recombinant protein that is functional in processive DNA synthesis. From the known crystal structures of D4, the C-terminal hexapeptide is shown to make intramolecular contact with residues spanning the inner core of the protein. Our mutational analysis revealed that a tripeptide motif ((215)GFI(217)) within the hexapeptide comprises apparent residues necessary for the contact. Prediction of protein disorder identified the hexapeptide and several regions upstream of Gly(215) that comprise residues of the interface surfaces of the D4-A20 heterodimer. Our study suggests that (215)GFI(217) anchors these potentially dynamic upstream regions of the protein to maintain protein integrity. Unlike uracil-DNA glycosylases from diverse sources, where the C termini are disordered and do not form comparable intramolecular contacts, this feature may be unique to orthopoxviruses.	[Nuth, Manunya; Guan, Hancheng; Ricciardi, Robert P.] Univ Penn, Sch Dent Med, Dept Microbiol, 221 Levy Res Bldg,4010 Locust St, Philadelphia, PA 19104 USA; [Ricciardi, Robert P.] Univ Penn, Sch Med, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Ricciardi, RP (corresponding author), Univ Penn, Sch Dent Med, Dept Microbiol, 221 Levy Res Bldg,4010 Locust St, Philadelphia, PA 19104 USA.	ricciard@upenn.edu		Nuth, Manunya/0000-0002-3457-8201	National Institutes of Health [5U01-A1082211, 1R44AI115759-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R44AI115759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants 5U01-A1082211 and 1R44AI115759-01. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGULNICK AD, 1993, J GEN VIROL, V74, P1003, DOI 10.1099/0022-1317-74-6-1003; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Bhuyan AK, 2002, BIOCHEMISTRY-US, V41, P13386, DOI 10.1021/bi020371n; Boyle KA, 2011, J BIOL CHEM, V286, P24702, DOI 10.1074/jbc.M111.222216; Burmeister WP, 2015, J BIOL CHEM, V290, P17923, DOI 10.1074/jbc.M115.648352; Contesto-Richefeu C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003978; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ellison V, 2001, CELL, V106, P655, DOI 10.1016/S0092-8674(01)00498-6; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GOTTLIEB J, 1990, J VIROL, V64, P5976, DOI 10.1128/JVI.64.12.5976-5987.1990; Ishii K, 2002, VIROLOGY, V303, P232, DOI 10.1006/viro.2002.1721; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kelman Z, 1997, ONCOGENE, V14, P629, DOI 10.1038/sj.onc.1200886; KIEHL A, 1991, VIROLOGY, V184, P330, DOI 10.1016/0042-6822(91)90849-7; Klemperer N, 2001, J VIROL, V75, P12298, DOI 10.1128/JVI.75.24.12298-12307.2001; KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lin K, 2000, J VIROL METHODS, V88, P219, DOI 10.1016/S0166-0934(00)00190-7; Lin K, 1998, J VIROL, V72, P6228, DOI 10.1128/JVI.72.7.6228-6232.1998; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MILLNS AK, 1994, VIROLOGY, V198, P504, DOI 10.1006/viro.1994.1061; Moss B., 2013, COLD SPRING HARBOR P, V5, P1; Murphy PJM, 2001, J BIOL CHEM, V276, P30092, DOI 10.1074/jbc.M103773200; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Nuth M, 2013, J MED CHEM, V56, P3235, DOI 10.1021/jm301735k; Nuth M, 2011, J MED CHEM, V54, P3260, DOI 10.1021/jm101554k; Parikh SS, 1998, EMBO J, V17, P5214, DOI 10.1093/emboj/17.17.5214; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rachofsky EL, 2001, BIOCHEMISTRY-US, V40, P957, DOI 10.1021/bi001665g; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Schormann N, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-45; Schormann N, 2015, BMC STRUCT BIOL, V15, DOI 10.1186/s12900-015-0037-1; Sele C, 2013, J VIROL, V87, P1679, DOI 10.1128/JVI.01533-12; Shudofsky AMD, 2010, J VIROL, V84, P12325, DOI 10.1128/JVI.01435-10; SKLENAR V, 1993, J AM CHEM SOC, V115, P12181, DOI 10.1021/ja00078a073; Slupphaug G, 1996, NATURE, V384, P87, DOI 10.1038/384087a0; Stanitsa ES, 2006, J BIOL CHEM, V281, P3439, DOI 10.1074/jbc.M511239200; STUART DT, 1993, J VIROL, V67, P2503, DOI 10.1128/JVI.67.5.2503-2512.1993; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; UPTON C, 1993, P NATL ACAD SCI USA, V90, P4518, DOI 10.1073/pnas.90.10.4518; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110	49	3	3	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27087	27097		10.1074/jbc.M116.761908	http://dx.doi.org/10.1074/jbc.M116.761908			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27836975	hybrid, Green Published			2022-12-26	WOS:000391576300010
J	Qiu, YX; Hassaninasab, A; Han, GS; Carman, GM				Qiu, Yixuan; Hassaninasab, Azam; Han, Gil-Soo; Carman, George M.			Phosphorylation of Dgk1 Diacylglycerol Kinase by Casein Kinase II Regulates Phosphatidic Acid Production in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA CARBOXYLASE; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; NUCLEAR-MEMBRANE GROWTH; PHOSPHOLIPID-SYNTHESIS; LIPID-METABOLISM; SIGNALING FUNCTIONS; BETA-SUBUNIT; PROTEIN-PHOSPHORYLATION; MEDIATED REGULATION; ORTHOLOGUE PAH1P	In the yeast Saccharomyces cerevisiae, Dgk1 diacylglycerol (DAG) kinase catalyzes the CTP-dependent phosphorylation of DAG to form phosphatidic acid (PA). The enzyme in conjunction with Pah1 PA phosphatase controls the levels of PA and DAG for the synthesis of triacylglycerol and membrane phospholipids, the growth of the nuclear/endoplasmic reticulum membrane, and the formation of lipid droplets. Little is known about how DAG kinase activity is regulated by posttranslational modification. In this work, we examined the phosphorylation of Dgk1 DAG kinase by casein kinase II (CKII). When phosphate groups were globally reduced using nonspecific alkaline phosphatase, Triton X-100-solubilized membranes from DGK1-overexpressing cells showed a 7.7-fold reduction in DAG kinase activity; the reduced enzyme activity could be increased 5.5-fold by treatment with CKII. Dgk1(1-77) expressed heterologously in Escherichia coli was phosphorylated by CKII on a serine residue, and its phosphorylation was dependent on time as well as on the concentrations of CKII, ATP, and Dgk1(177). We used site-specific mutagenesis, coupled with phosphorylation analysis and phosphopeptide mapping, to identify Ser-45 and Ser-46 of Dgk1 as the CKII target sites, with Ser-46 being the major phosphorylation site. In vivo, the S46A and S45A/S46A mutations of Dgk1 abolished the stationary phase-dependent stimulation of DAG kinase activity. Inaddition, the phosphorylation-deficientmutations decreased Dgk1 function in PA production and in eliciting pah1 Delta phenotypes, such as the expansion of the nuclear/endoplasmic reticulum membrane, reduced lipid droplet formation, and temperature sensitivity. This work demonstrates that the CKII-mediated phosphorylation of Dgk1 regulates its function in the production of PA.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA; Rutgers State Univ, New Jersey Inst Food Nutr & Hlth, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 61 Dudley Rd, New Brunswick, NJ 08901 USA.	gcarman@rutgers.edu			National Institutes of Health from the United States Public Health Service [GM028140, GM050679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028140, R01GM028140, R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM028140 and GM050679 from the United States Public Health Service. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramovici H, 2003, MOL BIOL CELL, V14, P4499, DOI 10.1091/mbc.E03-03-0190; Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; ALFEEL W, 1992, P NATL ACAD SCI USA, V89, P4534, DOI 10.1073/pnas.89.10.4534; Baldanzi G, 2008, ONCOGENE, V27, P942, DOI 10.1038/sj.onc.1210717; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; BIDWAI AP, 1995, J BIOL CHEM, V270, P10395, DOI 10.1074/jbc.270.18.10395; BISHOP WR, 1986, J BIOL CHEM, V261, P6993; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brauer MJ, 2005, MOL BIOL CELL, V16, P2503, DOI 10.1091/mbc.E04-11-0968; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; Carrasco S, 2007, TRENDS BIOCHEM SCI, V32, P27, DOI 10.1016/j.tibs.2006.11.004; Chang YF, 2006, J BIOL CHEM, V281, P4754, DOI 10.1074/jbc.M513064200; CHENWU JLP, 1988, MOL CELL BIOL, V8, P4981, DOI 10.1128/MCB.8.11.4981; Choi HS, 2012, J BIOL CHEM, V287, P11290, DOI 10.1074/jbc.M112.346023; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; Connerth M, 2009, METHODS MOL BIOL, V579, P359, DOI 10.1007/978-1-60761-322-0_18; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Czabany T, 2007, BBA-MOL CELL BIOL L, V1771, P299, DOI 10.1016/j.bbalip.2006.07.001; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Donkor J, 2009, J BIOL CHEM, V284, P29968, DOI 10.1074/jbc.M109.023663; Fakas S, 2011, J BIOL CHEM, V286, P29074, DOI 10.1074/jbc.M111.258798; Fakas S, 2011, J BIOL CHEM, V286, P1464, DOI 10.1074/jbc.M110.194308; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; Goto K, 1999, CHEM PHYS LIPIDS, V98, P109, DOI 10.1016/S0009-3084(99)00023-7; GUENGERICH FP, 1982, BIOCHEMISTRY-US, V21, P1698, DOI 10.1021/bi00536a035; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; HAID A, 1983, METHOD ENZYMOL, V96, P192; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; HASSLACHER M, 1993, J BIOL CHEM, V268, P10946; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; Howe AG, 2006, CAN J PHYSIOL PHARM, V84, P29, DOI 10.1139/Y05-138; Hsieh LS, 2016, J BIOL CHEM, V291, P9974, DOI 10.1074/jbc.M116.726588; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JU QD, 1990, MOL CELL BIOL, V10, P5226, DOI 10.1128/MCB.10.10.5226; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kim HB, 2010, MOL CELL BIOL, V30, P3126, DOI 10.1128/MCB.01671-09; Krishna S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00178; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVIN DE, 1990, CELL, V62, P213, DOI 10.1016/0092-8674(90)90360-Q; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lindegaard B, 2007, INT J OBESITY, V31, P449, DOI 10.1038/sj.ijo.0803434; Litchfield DW, 2003, BIOCHEM J, V369, P1, DOI 10.1042/BJ20021469; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lussier M, 1997, GENETICS, V147, P435; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MARIN O, 1986, EUR J BIOCHEM, V160, P239, DOI 10.1111/j.1432-1033.1986.tb09962.x; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Michot C, 2013, BBA-MOL BASIS DIS, V1832, P2103, DOI 10.1016/j.bbadis.2013.07.021; Morita S, 2009, J LIPID RES, V50, P1945, DOI 10.1194/jlr.D900014-JLR200; Mul JD, 2011, J BIOL CHEM, V286, P26781, DOI 10.1074/jbc.M110.197947; Muller MO, 2000, J BIOL CHEM, V275, P19475, DOI 10.1074/jbc.M002575200; Nadra K, 2008, GENE DEV, V22, P1647, DOI 10.1101/gad.1638008; Nadra K, 2012, MOL CELL BIOL, V32, P4794, DOI 10.1128/MCB.00512-12; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; PADMANABHA R, 1987, J BIOL CHEM, V262, P1829; Park Y, 2015, J BIOL CHEM, V290, P25382, DOI 10.1074/jbc.M115.680314; Pascual F, 2014, J BIOL CHEM, V289, P9811, DOI 10.1074/jbc.M114.550103; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; Pascual F, 2013, BBA-MOL CELL BIOL L, V1831, P514, DOI 10.1016/j.bbalip.2012.08.006; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Poole A, 2005, MOL CELL BIOCHEM, V274, P163, DOI 10.1007/s11010-005-2945-z; Qiu YX, 2013, J BIOL CHEM, V288, P29124, DOI 10.1074/jbc.M113.507392; Raben DM, 2008, FRONT BIOSCI-LANDMRK, V13, P590, DOI 10.2741/2704; REED JC, 1994, J BIOL CHEM, V269, P18192; Rincon E, 2012, PROG LIPID RES, V51, P1, DOI 10.1016/j.plipres.2011.10.001; Ruiz C, 1999, YEAST, V15, P1001; Sakane F, 2008, CURR DRUG TARGETS, V9, P626, DOI 10.2174/138945008785132394; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santos-Rosa H, 2005, EMBO J, V24, P1931, DOI 10.1038/sj.emboj.7600672; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Sciorra VA, 2002, BBA-MOL CELL BIOL L, V1582, P45, DOI 10.1016/S1388-1981(02)00136-1; Shulga YV, 2011, CHEM REV, V111, P6186, DOI 10.1021/cr1004106; SIKORSKI RS, 1989, GENETICS, V122, P19; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Soufi B, 2009, MOL BIOSYST, V5, P1337, DOI 10.1039/b902256b; Su WM, 2014, J BIOL CHEM, V289, P34699, DOI 10.1074/jbc.M114.614883; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; Su WM, 2012, J BIOL CHEM, V287, P33364, DOI 10.1074/jbc.M112.402339; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Testerink C, 2005, TRENDS PLANT SCI, V10, P368, DOI 10.1016/j.tplants.2005.06.002; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; Topham MK, 1998, NATURE, V394, P697, DOI 10.1038/29337; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Waggoner DW, 1999, BBA-MOL CELL BIOL L, V1439, P299, DOI 10.1016/S1388-1981(99)00102-X; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; WIMMER C, 1992, EMBO J, V11, P5051, DOI 10.1002/j.1460-2075.1992.tb05612.x; WITTERS LA, 1990, BIOCHEM BIOPH RES CO, V169, P369, DOI 10.1016/0006-291X(90)90341-J; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yamaguchi Y, 2006, J BIOL CHEM, V281, P31627, DOI 10.1074/jbc.M606992200; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983; Zeharia A, 2008, AM J HUM GENET, V83, P489, DOI 10.1016/j.ajhg.2008.09.002; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	124	11	11	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2016	291	51					26455	26467		10.1074/jbc.M116.763839	http://dx.doi.org/10.1074/jbc.M116.763839			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH1ZY	27834677	hybrid, Green Published			2022-12-26	WOS:000391568200019
J	Datta-Nemdharry, P; Thomson, A; Beynon, J				Datta-Nemdharry, Preeti; Thomson, Andrew; Beynon, Julie			Opportunities and Challenges in Developing a Cohort of Patients with Type 2 Diabetes Mellitus Using Electronic Primary Care Data	PLOS ONE			English	Article							GLUCOSE-LOWERING AGENTS; RISK; CANCER; PEOPLE; INITIATION; FAILURE; UK	Purpose To develop a cohort of patients with T2DM treated with insulin using CPRD to obtain an accurate diagnosis date. This was used to analyse time from T2DM diagnosis to first ever insulin prescription between 01/01/2000 and 30/06/2012, for patients in England and Wales. Methods Patients aged 18 years and over at diagnosis, were included if prescribed an anti-diabetic drug and were excluded if first diagnosis-specific code was inconsistent with a T2DM diagnosis. Diagnosis codes were split into 8 categories based on whether they related to specific T2DM or non-specific diabetes codes. Patients were excluded if they had non-specific diagnosis codes and were prescribed insulin as their first-ever treatment for diabetes. Descriptive statistics for time from T2DM diagnosis to insulin initiation were calculated. Results Two hundred and fifty-six codes were identified which were consistent with a first-ever diagnosis of T2DM. 7 codes were considered to clearly define a diagnosis of T2DM, which were reported for 64% of patients. The final cohort comprised 11,917 patients and the median time to first insulin prescription from the date of diagnosis was 4.4 years. Conclusions A clear definition of cohort development is required to compare and interpret results from studies. Use of diagnosis and product codes is essential when examining use of drugs such as insulin, where competing diagnoses need to be considered separately.	[Datta-Nemdharry, Preeti; Thomson, Andrew; Beynon, Julie] MHRA, VRMM, London SW1W 9SZ, England; [Thomson, Andrew] European Med Agcy, London E14 5EU, England		Datta-Nemdharry, P (corresponding author), MHRA, VRMM, London SW1W 9SZ, England.	preeti.datta-nemdharry@mhra.gsi.gov.uk						Azoulay L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3645; Bodmer M, 2012, AM J GASTROENTEROL, V107, P620, DOI 10.1038/ajg.2011.483; Filion KB, 2011, PHARMACOEPIDEM DR S, V20, P785, DOI 10.1002/pds.2165; Jick SS, 2004, BRIT J CLIN PHARMACO, V58, P303, DOI 10.1111/j.1365-2125.2004.02142.x; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; Kostev K, 2013, PRIM CARE DIABETES, V7, P229, DOI 10.1016/j.pcd.2013.03.003; Li L, 2013, PAIN PHYSICIAN, V16, P77; Morgan CL, 2012, J CLIN ENDOCR METAB, V97, P4605, DOI 10.1210/jc.2012-3034; Office for National Statistics, 1998, KEY HLTH STAT GEN PR; Rubino A, 2007, DIABETIC MED, V24, P1412, DOI 10.1111/j.1464-5491.2007.02279.x; Suissa S, 2011, DIABETOLOGIA, V54, P2254, DOI 10.1007/s00125-011-2190-9; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; Vamos EP, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5567; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3	14	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0162236	10.1371/journal.pone.0162236	http://dx.doi.org/10.1371/journal.pone.0162236			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861488	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300001
J	Chen, YF; Lv, MF; Liao, LS; Gu, YF; Liang, ZB; Shi, ZR; Liu, SY; Zhou, JN; Zhang, LH				Chen, Yufan; Lv, Mingfa; Liao, Lisheng; Gu, Yanfang; Liang, Zhibin; Shi, Zurong; Liu, Shiyin; Zhou, Jianuan; Zhang, Lianhui			Genetic Modulation of c-di-GMP Turnover Affects Multiple Virulence Traits and Bacterial Virulence in Rice Pathogen Dickeya zeae	PLOS ONE			English	Article							ERWINIA-CHRYSANTHEMI 3937; QUORUM-SENSING SYSTEM; III SECRETION SYSTEM; PSEUDOMONAS-AERUGINOSA; XANTHOMONAS-CAMPESTRIS; DIGUANYLATE CYCLASE; BIOFILM FORMATION; ESCHERICHIA-COLI; EXOPOLYSACCHARIDE PRODUCTION; MECHANISTIC INSIGHTS	The frequent outbreaks of rice foot rot disease caused by Dickeya zeae have become a significant concern in rice planting regions and countries, but the regulatory mechanisms that govern the virulence of this important pathogen remain vague. Given that the second messenger cyclic di-GMP (c-di-GMP) is associated with modulation of various virulence-related traits in various microorganisms, here we set to investigate the role of the genes encoding cdi-GMP metabolism in the regulation of the bacterial physiology and virulence by construction all in-frame deletion mutants targeting the annotated c-di-GMP turnover genes in D. zeae strain EC1. Phenotype analyses identified individual mutants showing altered production of exoenzymes and phytotoxins, biofilm formation and bacterial motilities. The results provide useful clues and a valuable toolkit for further characterization and dissection of the regulatory complex that modulates the pathogenesis and persistence of this important bacterial pathogen.	[Chen, Yufan; Lv, Mingfa; Liao, Lisheng; Gu, Yanfang; Liang, Zhibin; Shi, Zurong; Liu, Shiyin; Zhou, Jianuan; Zhang, Lianhui] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China; [Chen, Yufan; Lv, Mingfa; Liao, Lisheng; Gu, Yanfang; Liang, Zhibin; Shi, Zurong; Liu, Shiyin; Zhou, Jianuan; Zhang, Lianhui] South China Agr Univ, Integrat Microbiol Res Ctr, Guangzhou, Guangdong, Peoples R China; [Zhang, Lianhui] State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhou, JN; Zhang, LH (corresponding author), South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou, Guangdong, Peoples R China.; Zhou, JN; Zhang, LH (corresponding author), South China Agr Univ, Integrat Microbiol Res Ctr, Guangzhou, Guangdong, Peoples R China.; Zhang, LH (corresponding author), State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou 510642, Guangdong, Peoples R China.	jianuanzhou@scau.edu.cn; lhzhang01@scau.edu.cn	Liu, Shiyin/AAT-4278-2020	CHEN, YUFAN/0000-0001-9669-7380	National Basic Research Program of China (973 Program) [2015CB150600]; National Natural Science Foundation of China [31270170, 31201479, 31470236]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work is supported by the grants from the National Basic Research Program of China (973 Program, grant number 2015CB150600) and the National Natural Science Foundation of China (Grant numbers 31270170, 31201479 and 31470236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; An SW, 2010, APPL ENVIRON MICROB, V76, P8160, DOI 10.1128/AEM.01233-10; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Antunez-Lamas M, 2009, MICROBIOL-SGM, V155, P434, DOI 10.1099/mic.0.022244-0; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Bernier SP, 2011, RES MICROBIOL, V162, P680, DOI 10.1016/j.resmic.2011.04.014; BOCCARA M, 1989, J BACTERIOL, V171, P4085, DOI 10.1128/jb.171.7.4085-4087.1989; Boehm A, 2010, CELL, V141, P107, DOI 10.1016/j.cell.2010.01.018; Boyd CD, 2012, ANNU REV CELL DEV BI, V28, P439, DOI 10.1146/annurev-cellbio-101011-155705; Brombacher E, 2003, MICROBIOL-SGM, V149, P2847, DOI 10.1099/mic.0.26306-0; Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; CHATTERJEE A, 1995, APPL ENVIRON MICROB, V61, P1959, DOI 10.1128/AEM.61.5.1959-1967.1995; Cheng YY, 2013, MOL PLANT MICROBE IN, V26, P1294, DOI 10.1094/MPMI-04-13-0098-R; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Collmer A, 1994, Curr Top Microbiol Immunol, V192, P43; COLLMER A, 1985, J BACTERIOL, V161, P913, DOI 10.1128/JB.161.3.913-920.1985; Condemine G, 1999, MOL PLANT MICROBE IN, V12, P45, DOI 10.1094/MPMI.1999.12.1.45; DIOLEZ A, 1985, J BACTERIOL, V163, P913, DOI 10.1128/JB.163.3.913-917.1985; Expert D, 1999, ANNU REV PHYTOPATHOL, V37, P307, DOI 10.1146/annurev.phyto.37.1.307; Fang X, 2010, MOL MICROBIOL, V76, P1295, DOI 10.1111/j.1365-2958.2010.07179.x; Fang Y., 2014, COMPLEXITY, V2014, P1, DOI DOI 10.1016/J.CELREP.2014.03.032; Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Glasner JD, 2011, J BACTERIOL, V193, P2076, DOI 10.1128/JB.01513-10; GOTO M, 1979, PHYTOPATHOLOGY, V69, P213, DOI 10.1094/Phyto-69-213; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; He YW, 2008, FEMS MICROBIOL REV, V32, P842, DOI 10.1111/j.1574-6976.2008.00120.x; He YW, 2007, MOL MICROBIOL, V64, P281, DOI 10.1111/j.1365-2958.2007.05670.x; He YW, 2009, MOL MICROBIOL, V71, P1464, DOI 10.1111/j.1365-2958.2009.06617.x; HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Heikaus CC, 2009, STRUCTURE, V17, P1551, DOI 10.1016/j.str.2009.07.019; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102; Hommais F, 2008, J BACTERIOL, V190, P7508, DOI 10.1128/JB.00553-08; Hussain MBBM, 2008, J BACTERIOL, V190, P1045, DOI 10.1128/JB.01472-07; Kazemi-Pour N, 2004, PROTEOMICS, V4, P3177, DOI 10.1002/pmic.200300814; KOTOUJANSKY A, 1985, EMBO J, V4, P781, DOI 10.1002/j.1460-2075.1985.tb03697.x; Kuchma SL, 2015, J BACTERIOL, V197, P420, DOI 10.1128/JB.02130-14; Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x; Liao LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116047; Lindenberg S, 2013, EMBO J, V32, P2001, DOI 10.1038/emboj.2013.120; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Matsuyama BY, 2016, P NATL ACAD SCI USA, V113, pE209, DOI 10.1073/pnas.1523148113; McAllisterLucas LM, 1995, J BIOL CHEM, V270, P30671, DOI 10.1074/jbc.270.51.30671; Merkel TJ, 1998, J BACTERIOL, V180, P1682, DOI 10.1128/JB.180.7.1682-1690.1998; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Moscoso JA, 2014, J BACTERIOL, V196, P4081, DOI 10.1128/JB.01850-14; Nikolskaya AN, 2003, J MOL MICROB BIOTECH, V5, P11, DOI 10.1159/000068720; Paul K, 2010, FEMS MICROBIOL REV, V38, P128, DOI DOI 10.1016/J.M0LCEL.2010.03.001; Perez-Mendoza D, 2011, MOL MICROBIOL, V82, P719, DOI 10.1111/j.1365-2958.2011.07849.x; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; Povolotsky TL, 2012, J BIOTECHNOL, V160, P10, DOI 10.1016/j.jbiotec.2011.12.024; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Reverchon S, 1998, MOL MICROBIOL, V29, P1407, DOI 10.1046/j.1365-2958.1998.01023.x; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2007, MOL MICROBIOL, V63, P429, DOI 10.1111/j.1365-2958.2006.05531.x; Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200; Samson R, 2005, INT J SYST EVOL MICR, V55, P1415, DOI 10.1099/ijs.0.02791-0; Sinha S K, 1977, Zentralbl Bakteriol Parasitenkd Infektionskr Hyg, V132, P81; Tao F, 2010, J BACTERIOL, V192, P1020, DOI 10.1128/JB.01253-09; Tuckerman JR, 2011, J MOL BIOL, V407, P633, DOI 10.1016/j.jmb.2011.02.019; Tuckerman JR, 2009, BIOCHEMISTRY-US, V48, P9764, DOI 10.1021/bi901409g; Wada T, 2012, MICROBIOL-SGM, V158, P1533, DOI 10.1099/mic.0.056036-0; Whiteley CG, 2015, BIOTECHNOL ADV, V33, P124, DOI 10.1016/j.biotechadv.2014.11.010; Whitney JC, 2012, J BIOL CHEM, V287, P23582, DOI 10.1074/jbc.M112.375378; Wu J, 2010, CHEM COMMUN, V46, P333, DOI 10.1039/b916307g; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005; Yi XA, 2010, MOL MICROBIOL, V77, P787, DOI 10.1111/j.1365-2958.2010.07246.x; Zhou JN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1545-x; Zhou JU, 2011, MOL PLANT MICROBE IN, V24, P1156, DOI 10.1094/MPMI-04-11-0087; Zhulin IB, 1997, TRENDS BIOCHEM SCI, V22, P331, DOI 10.1016/S0968-0004(97)01110-9	76	16	16	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165979	10.1371/journal.pone.0165979	http://dx.doi.org/10.1371/journal.pone.0165979			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855163	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200016
J	Chen, CF; Shu, ML; Wang, YL; Yang, M; Zhang, CQ				Chen, Changfang; Shu, Minglei; Wang, Yinglong; Yang, Ming; Zhang, Chongqing			Outage Probability of MRC for kappa-mu Shadowed Fading Channels under Co-Channel Interference	PLOS ONE			English	Article							PERFORMANCE ANALYSIS; COMMUNICATION-SYSTEMS; SUM	In this paper, exact closed-form expressions are derived for the outage probability (OP) of the maximal ratio combining (MRC) scheme in the kappa-mu shadowed fading channels, in which both the independent and correlated shadowing components are considered. The scenario assumes the received desired signals are corrupted by the independent Rayleigh-faded co-channel interference (CCI) and background white Gaussian noise. To this end, first, the probability density function (PDF) of the kappa-mu shadowed fading distribution is obtained in the form of a power series. Then the incomplete generalized moment-generating function (IG-MGF) of the received signal-to-interference-plus-noise ratio (SINR) is derived in the closed form. By using the IG-MGF results, closed-form expressions for the OP of MRC scheme are obtained over the kappa-mu shadowed fading channels. Simulation results are included to validate the correctness of the analytical derivations. These new statistical results can be applied to the modeling and analysis of several wireless communication systems, such as body centric communications.	[Chen, Changfang; Shu, Minglei; Wang, Yinglong; Yang, Ming] Natl Supercomp Ctr Jinan, Shandong Comp Sci Ctr, Jinan 250014, Peoples R China; [Chen, Changfang; Shu, Minglei; Wang, Yinglong; Yang, Ming] Shandong Prov Key Lab Comp Networks, Jinan 250014, Peoples R China; [Zhang, Chongqing] Shandong Univ Sci & Technol, Coll Informat Sci & Engn, Qingdao 266590, Peoples R China	Qilu University of Technology; Shandong University of Science & Technology	Chen, CF (corresponding author), Natl Supercomp Ctr Jinan, Shandong Comp Sci Ctr, Jinan 250014, Peoples R China.; Chen, CF (corresponding author), Shandong Prov Key Lab Comp Networks, Jinan 250014, Peoples R China.	chenchangfang012@163.com			National Natural Science Foundation of China [61603224, 61304008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China under Grant 61603224 and Grant 61304008, http://www.nsfc.gov.cn/. Role of any sponsors or funders: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by the National Natural Science Foundation of China under Grant 61603224 and Grant 61304008.	Aalo VA, 2001, IEEE T VEH TECHNOL, V50, P497, DOI 10.1109/25.923061; Alfano G, 2007, IEEE T WIREL COMMUN, V6, P3540, DOI 10.1109/TWC.2007.060202; Alouini MS, 2001, IEEE T VEH TECHNOL, V50, P1471, DOI 10.1109/25.966578; [Anonymous], 2007, IEEE ANTENN PROPAG M, V49, P68, DOI [10.1109/MAP.2007.370983, DOI 10.1109/MAP.2007.370983]; Bhatnagar MR, 2015, IEEE T VEH TECHNOL, V64, P2678, DOI 10.1109/TVT.2014.2343453; Bhatnagar MR, 2014, IEEE COMMUN LETT, V18, P54, DOI 10.1109/LCOMM.2013.111313.131963; Chopra A, 2013, IEEE T WIREL COMMUN, V12, P550, DOI 10.1109/TWC.2012.121412.111704; Cotton SL, 2008, IEEE ANTENN WIREL PR, V7, P66, DOI 10.1109/LAWP.2008.915807; Cotton SL, 2015, IEEE J SEL AREA COMM, V33, P111, DOI 10.1109/JSAC.2014.2369613; Cotton SL, 2014, IEEE T ANTENN PROPAG, V62, P1416, DOI 10.1109/TAP.2013.2295211; Dhungana Y, 2012, IEEE T VEH TECHNOL, V61, P3590, DOI 10.1109/TVT.2012.2208484; Du Q, 2014 10 INT C MOB AD; Erdelyi A, 1954, TABLES INTEGRALS TRA; Gradshteyn I., 2000, TABLE INTEGRALS SERI; He HL, 2015, IEEE ICC, P617, DOI 10.1109/ICC.2015.7248390; Houbing Song CB., 2016, CYBER PHYS SYSTEMS F; Huang L, 2017, IEEE T IND INFORM, V13, P782, DOI 10.1109/TII.2016.2597744; Jimenez DM, 2012, IEEE COMMUNICATIONS, V16, P674, DOI [10.1109/, DOI 10.1109/LCOMM.2012.031212.120154]; Kumar S, 2015, IEEE WIREL COMMUN LE, V4, P301, DOI 10.1109/LWC.2015.2411269; Marichev O. I, 1992, INTEGRALS SERIES DIR, V2; Morales-Jimenez D, 2014, IEEE T VEH TECHNOL, V33, P111, DOI [10.1109/JSAC.2014.2369613, DOI 10.1109/TVT.2013.2281213]; Morales-Jimenez D, 2010, OUTAGE PROBABILITY A, V14, P521, DOI [10.1109/LCOMM.2010.06.092501, DOI 10.1109/LCOMM.2010.06.092501]; Paris JF, 2010, IEEE T WIREL COMMUN, V9, P1272, DOI 10.1109/TWC.2010.04.090295; Romero-Jerez JM, 2008, IEEE T WIREL COMMUN, V7, P920, DOI 10.1109/TWC.2008.060705; Ruiz-Vega F, 2012, P UCOMMS C SESTR IT, P1; Shojafar M, 2019, IEEE T CLOUD COMPUT, V7, P196, DOI 10.1109/TCC.2016.2551747; Shojafar M, 2015, WIRELESS PERS COMMUN, V82, P61, DOI 10.1007/s11277-014-2194-0; SIMON M. K., 2005, DIGITAL COMMUNICATIO, V2nd; Song HB, 2013, J LIGHTWAVE TECHNOL, V31, P846, DOI 10.1109/JLT.2012.2235409; Song HB, 2011, IEEE ICC; Srivastava H.M., 1985, MULTIPLE GAUSSIAN HY; Xiong JP, 2016, IEEE ACCESS, V4, P3076, DOI 10.1109/ACCESS.2016.2580594; XU DT, 2016, IET COMMUN, V10, P292, DOI DOI 10.1049/IET-C0M.2015.0229	33	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166528	10.1371/journal.pone.0166528	http://dx.doi.org/10.1371/journal.pone.0166528			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851817	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300062
J	Greene, SB; Dago, AE; Leitz, LJ; Wang, YP; Lee, J; Werner, SL; Gendreau, S; Patel, P; Jia, SD; Zhang, LX; Tucker, EK; Malchiodi, M; Graf, RP; Dittamore, R; Marrinucci, D; Landers, M				Greene, Stephanie B.; Dago, Angel E.; Leitz, Laura J.; Wang, Yipeng; Lee, Jerry; Werner, Shannon L.; Gendreau, Steven; Patel, Premal; Jia, Shidong; Zhang, Liangxuan; Tucker, Eric K.; Malchiodi, Michael; Graf, Ryon P.; Dittamore, Ryan; Marrinucci, Dena; Landers, Mark			Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; CIRCULATING TUMOR-CELLS; INTRATUMOR HETEROGENEITY; ANDROGEN RECEPTOR; BREAST-CANCER; EVOLUTION; PTEN; HYBRIDIZATION; AMPLIFICATION; EXPRESSION	Genomic instability is a hallmark of cancer often associated with poor patient outcome and resistance to targeted therapy. Assessment of genomic instability in bulk tumor or biopsy can be complicated due to sample availability, surrounding tissue contamination, or tumor heterogeneity. The Epic Sciences circulating tumor cell (CTC) platform utilizes a non-enrichment based approach for the detection and characterization of rare tumor cells in clinical blood samples. Genomic profiling of individual CTCs could provide a portrait of cancer heterogeneity, identify clonal and sub-clonal drivers, and monitor disease progression. To that end, we developed a single cell Copy Number Variation (CNV) Assay to evaluate genomic instability and CNVs in patient CTCs. For proof of concept, prostate cancer cell lines, LNCaP, PC3 and VCaP, were spiked into healthy donor blood to create mock patient-like samples for downstream single cell genomic analysis. In addition, samples from seven metastatic castration resistant prostate cancer (mCRPC) patients were included to evaluate clinical feasibility. CTCs were enumerated and characterized using the Epic Sciences CTC Platform. Identified single CTCs were recovered, whole genome amplified, and sequenced using an Illumina NextSeq 500. CTCs were then analyzed for genome-wide copy number variations, followed by genomic instability analyses. Large-scale state transitions (LSTs) were measured as surrogates of genomic instability. Genomic instability scores were determined reproducibly for LNCaP, PC3, and VCaP, and were higher than white blood cell (WBC) controls from healthy donors. A wide range of LST scores were observed within and among the seven mCRPC patient samples. On the gene level, loss of the PTEN tumor suppressor was observed in PC3 and 5/7 (71%) patients. Amplification of the androgen receptor (AR) gene was observed in VCaP cells and 5/7 (71%) mCRPC patients. Using an in silico down-sampling approach, we determined that DNA copy number and genomic instability can be detected with as few as 350K sequencing reads. The data shown here demonstrate the feasibility of detecting genomic instabilities at the single cell level using the Epic Sciences CTC Platform. Understanding CTC heterogeneity has great potential for patient stratification prior to treatment with targeted therapies and for monitoring disease evolution during treatment.	[Greene, Stephanie B.; Dago, Angel E.; Leitz, Laura J.; Wang, Yipeng; Lee, Jerry; Werner, Shannon L.; Tucker, Eric K.; Malchiodi, Michael; Graf, Ryon P.; Dittamore, Ryan; Marrinucci, Dena; Landers, Mark] Epic Sci Inc, San Diego, CA 92121 USA; [Gendreau, Steven; Patel, Premal; Jia, Shidong; Zhang, Liangxuan] Genentech Inc, Roche, 460 Point San Bruno Blvd, San Francisco, CA 94080 USA; [Jia, Shidong] Predicine Holdings Ltd, Palo Alto, CA USA	Roche Holding; Genentech	Landers, M (corresponding author), Epic Sci Inc, San Diego, CA 92121 USA.	mark.landers@epicsciences.com	t, lf/AAJ-4924-2020	Graf, Ryon/0000-0002-8065-4148	Genentech, Inc./ Roche	Genentech, Inc./ Roche	SBG, AED, LJL, YW, JL, SLW, EKT, MM, RPG, RD, DM, ML are employees of Epic Sciences, Inc. SG, PP, SJ, LZ are employees of Genentech, Inc./ Roche. Epic Sciences, Inc., and Genentech, Inc./ Roche provided support in the form of salaries for authors, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alimirah F, 2006, FEBS LETT, V580, P2294, DOI 10.1016/j.febslet.2006.03.041; Andor N., 2015, NAT MED; [Anonymous], 2011, CURR PROB CANCER, V35, P7, DOI 10.1016/j.currproblcancer.2010.12.002; Attard G, 2011, CLIN CANCER RES, V17, P3048, DOI 10.1158/1078-0432.CCR-10-3234; Baslan T, 2012, NAT PROTOC, V7, P1024, DOI 10.1038/nprot.2012.039; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Burrell RA, 2013, NATURE, V501, P338, DOI 10.1038/nature12625; Chen Y, 2001, CANCER RES, V61, P4112; Ciuffreda Ludovica, 2014, Advances in Biological Regulation, V56, P66, DOI 10.1016/j.jbior.2014.07.002; Crockford A, 2014, J PATHOL, V232, P264, DOI 10.1002/path.4270; Dago AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101777; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Fox JJ, 2011, J NUCL MED, V52, P1727, DOI 10.2967/jnumed.111.089326; Garvin T, 2015, NAT METHODS, V12, P1058, DOI [10.1038/NMETH.3578, 10.1038/nmeth.3578]; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Ha S, 2011, ENDOCR-RELAT CANCER, V18, P245, DOI 10.1530/ERC-10-0204; Hayes JL, 2013, GENOMICS, V102, P174, DOI 10.1016/j.ygeno.2013.04.006; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Heitzer E, 2013, GENOME MED, V5, DOI 10.1186/gm434; Heitzer E, 2013, CANCER RES, V73, P2965, DOI 10.1158/0008-5472.CAN-12-4140; Hiley C, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0453-8; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Liu WN, 2008, NEOPLASIA, V10, P897, DOI 10.1593/neo.08428; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Marrinucci D, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/016003; Mateo J, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0448-5; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Perkins G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047020; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Punnoose EA, 2015, BR J CANC; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Schmitt M.W., 2015, NAT REV CLIN ONCOL; Seol H, 2012, MODERN PATHOL, V25, P938, DOI 10.1038/modpathol.2012.36; Sobel RE, 2005, J UROLOGY, V173, P342, DOI 10.1097/01.ju.0000141580.30910.57; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Watkins JA, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3670; Weiss MM, 1999, J CLIN PATHOL-MOL PA, V52, P243; Wendel M, 2012, PHYS BIOL, V9, DOI [10.1088/1478-3967/9/1/016005, 10.1088/1478-3975/9/1/016005]; Werner SL, 2015, J CIRCULATING BIOMAR, V4; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Xu HT, 2015, J CANCER, V6, P247, DOI 10.7150/jca.10747; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Yap TA, 2014, CLIN CANCER RES, V20, P2553, DOI 10.1158/1078-0432.CCR-13-2664; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhang S, 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1155/2014/302702; Zhang X, 2015, ONCOL LETT, V9, P2617, DOI 10.3892/ol.2015.3114	49	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165089	10.1371/journal.pone.0165089	http://dx.doi.org/10.1371/journal.pone.0165089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851748	Green Submitted, Green Published, gold			2022-12-26	WOS:000387909300010
J	Naess, M; Holmen, TL; Langaas, M; Bjorngaard, JH; Kvaloy, K				Naess, Marit; Holmen, Turid Lingaas; Langaas, Mette; Bjorngaard, Johan Hakon; Kvaloy, Kirsti			Intergenerational Transmission of Overweight and Obesity from Parents to Their Adolescent Offspring - The HUNT Study	PLOS ONE			English	Article							BODY-MASS INDEX; ASSORTATIVE WEIGHT-GAIN; FATHER-SON PAIRS; WAIST CIRCUMFERENCE; CHILDHOOD OVERWEIGHT; MOTHER-DAUGHTER; TRENDS; CHILDREN; ASSOCIATIONS; PREVALENCE	Purpose The main aim of this study was to examine weight associations between parents and offspring at two time points: 1995-97 and 2006-08, taking into account body mass index (BMI) and waist circumference. Methods The study included 8425 parent-offspring trios who participated in the population based Health Study of Nord Tr phi ndelag (the HUNT Study), Norway, at either the HUNT2 (1995-97) or the HUNT3 (2006-08) survey. We used linear mixed effects models with siblings clustered within mothers to analyze the associations between 1) parental grouped BMI and offspring BMI z-scores and 2) parental grouped waist circumference and offspring waist circumference z-scores. Results Adolescent and adult overweight and obesity were higher in 2006-08 than in 1995-97, with the greatest increase observed in waist circumference. Both mother's and father's BMI and waist circumference were strongly associated with corresponding measures in offspring. Compared with both parents being normal weight (BMI < 25 kg/m(2)), having two overweight or obese parents (BMI<25 kg/m(2)) was associated with a higher offspring BMI z-score of 0.76 (95% CI; 0.65, 0.87) and 0.64 (95% CI; 0.48, 0.80) in daughters, and 0.76 (95% CI; 0.65, 0.87) and 0.69 (95% CI; 0.53, 0.80) in sons, in 1995-97 and 2006-08 respectively. Offspring with one parent being overweight/obese had BMI z-scores of approximately half of offspring with two parents categorized as overweight/obese. The results of the waist circumference based analyses did not differ substantially from the BMI based analyses. Conclusions Parental overweight was strongly positively associated with offspring weight both in 1995-97 and 2006-08 where both parents being overweight/obese gave the largest effect. This seemingly stable association, strongly address the importance of public health initiatives towards preventing obesity in parents of both sexes to decrease further obesity expansion in offspring.	[Naess, Marit; Holmen, Turid Lingaas; Kvaloy, Kirsti] NTNU Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Naess, Marit; Kvaloy, Kirsti] Nord Trondelag Hlth Trust, Levanger Hosp, Dept Res & Dev, Levanger, Norway; [Langaas, Mette] NTNU Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway; [Bjorngaard, Johan Hakon] NTNU Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, Fac Med, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olays Univ Hosp Trondheim, Forens Dept, Trondheim, Norway; [Bjorngaard, Johan Hakon] St Olays Univ Hosp Trondheim, Res Ctr Broset, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Naess, M (corresponding author), NTNU Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Trondheim, Norway.; Naess, M (corresponding author), Nord Trondelag Hlth Trust, Levanger Hosp, Dept Res & Dev, Levanger, Norway.	marit.nass@ntnu.no	Langaas, Mette/G-7423-2012; Langaas, Mette/AAD-5948-2020	Langaas, Mette/0000-0002-5714-0288	Liaison Committee; NTNU - Norwegian University of Science and Technology [2013/7511]; Norwegian Research Council	Liaison Committee; NTNU - Norwegian University of Science and Technology; Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the Liaison Committee between the Norwegian University of Science and Technology and Helse Midt-Norge, and the NTNU - Norwegian University of Science and Technology grant number 2013/7511 and The Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia N, 2015, EUR J PUBLIC HEALTH, V25, P28, DOI 10.1093/eurpub/ckv016; Ajala O, 2011, INT J PEDIATR OBES, V6, P223, DOI 10.3109/17477166.2011.583662; Ajslev TA, 2015, OBESITY, V23, P1279, DOI 10.1002/oby.21060; Andersen LF, 2005, SCAND J PUBLIC HEALT, V33, P99, DOI 10.1080/140349404100410019172; Bahk J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-015-2616-2; Bjelland M, 2010, SCAND J PUBLIC HEALT, V38, P19, DOI 10.1177/1403494810385036; Bjornelv S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-279; Brannsether B, 2011, ACTA PAEDIATR, V100, P1576, DOI 10.1111/j.1651-2227.2011.02370.x; Chau JY, 2014, J SCI MED SPORT, V17, P78, DOI 10.1016/j.jsams.2013.03.004; Chinn S, 2001, BRIT MED J, V322, P24, DOI 10.1136/bmj.322.7277.24; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Holmen T. L, 2013, INT J EPIDEMIOL; Jaaskelainen A, 2011, INT J OBESITY, V35, P1289, DOI 10.1038/ijo.2011.150; Kohn Michael, 2003, Adolesc Med, V14, P1; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lake JK, 1997, ARCH DIS CHILD, V77, P376, DOI 10.1136/adc.77.5.376; Livingstone M B, 2001, Public Health Nutr, V4, P109; McCarthy HD, 2006, INT J OBESITY, V30, P988, DOI 10.1038/sj.ijo.0803226; Midthjell K, 2013, CLIN OBES, V3, P12, DOI 10.1111/cob.12009; Miqueleiz E, 2014, EUR J CLIN NUTR, V68, P209, DOI 10.1038/ejcn.2013.255; Mostazir M, 2014, PEDIATR OBES, V9, P176, DOI 10.1111/j.2047-6310.2013.00157.x; O'Rahilly S, 2006, PHILOS T R SOC B, V361, P1095, DOI 10.1098/rstb.2006.1850; Perez-Pastor EM, 2009, INT J OBESITY, V33, P727, DOI 10.1038/ijo.2009.76; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Rangul V, 2011, J ADOLESCENT HEALTH, V48, P616, DOI 10.1016/j.jadohealth.2010.09.013; Silventoinen K, 2010, INT J OBESITY, V34, P29, DOI 10.1038/ijo.2009.177; Silventoinen K, 2009, OBESITY FACTS, V2, P196, DOI 10.1159/000219675; Smith GD, 2007, ARCH DIS CHILD, V92, P876, DOI 10.1136/adc.2006.104869; SSB, 2003, NORW STAND CLASS ED; Walls HL, 2011, OBESITY, V19, P216, DOI 10.1038/oby.2010.149; Wardle J, 2008, INT J OBESITY, V32, P527, DOI 10.1038/sj.ijo.0803740; Whitaker KL, 2010, AM J CLIN NUTR, V91, P1560, DOI 10.3945/ajcn.2009.28838; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; World Health Organization, 2000, OB PREV MAN GLOB EP, Vxii; Xi B, 2014, PEDIATRICS, V134, pE334, DOI 10.1542/peds.2014-0970	36	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166585	10.1371/journal.pone.0166585	http://dx.doi.org/10.1371/journal.pone.0166585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851798	Green Published, gold, Green Submitted			2022-12-26	WOS:000387909300071
J	Almawi, WY; Gammoh, E; Malalla, ZH; Al-Madhi, SA				Almawi, Wassim Y.; Gammoh, Emily; Malalla, Zainab H.; Al-Madhi, Safa A.			Analysis of VEGFA Variants and Changes in VEGF Levels Underscores the Contribution of VEGF to Polycystic Ovary Syndrome	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE POLYMORPHISMS; DIAGNOSTIC-CRITERIA; BLOOD-FLOW; WOMEN; RISK; PREECLAMPSIA; POPULATION; PREVALENCE; FAMILY	Background Vascular endothelial growth factor (VEGF) contributes to the pathogenesis of polycystic ovary syndrome (PCOS), and genetic variations in VEGFA gene were suggested to contribute to VEGF secretion and PCOS. Aim To evaluate the association of altered VEGF levels, stemming from the presence of specific VEGFA variants, with altered risk of PCOS. Subjects and Methods Retrospective case-control study, performed between 2012-2015. Study subjects comprised 382 women with PCOS, and 393 control subjects. ELISA measured VEGF levels; genotyping of VEGFA variants was done by allelic exclusion. Results Among the 12 tested VEGFA SNPs, minor allele frequency of only rs3025020 was significantly higher in PCOS cases than control women. Increased and reduced PCOS risk was seen with rs3025020 and rs2010963 genotypes, respectively. Increases and reduction in VEGF levels were associated with rs3025020 and rs2010963, respectively. Increased fasting insulin and HOMA-IR, and bioactive testosterone were linked with rs3025020, while carriage of rs2010963 was linked with reduction in fasting insulin, and free and bioactive testosterone. Of the 12 VEGFA variants, 9 were in LD, thus allowing construction of 9-locus haplotypes. Increased frequency of CAACAGCGA haplotype was seen in PCOS cases, after controlling for BMI, free and bioactive testosterone, SHBG, free insulin and HOMA-IR. Conclusion This study confirms the contribution of altered VEGF secretion, resulting from genetic variation in VEGFA gene into the pathogenesis of PCOS. This supports a role for VEGF as PCOS candidate locus.	[Almawi, Wassim Y.; Gammoh, Emily; Malalla, Zainab H.; Al-Madhi, Safa A.] Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain	Arabian Gulf University	Almawi, WY (corresponding author), Arabian Gulf Univ, Dept Med Biochem, Manama, Bahrain.	wassim@agu.edu.bh	Almawi, Wassim/FGW-0821-2022					Abd El Aal DEM, 2005, EUR J OBSTET GYN R B, V118, P219, DOI 10.1016/j.ejogrb.2004.07.024; Agrawal R, 1998, HUM REPROD, V13, P651, DOI 10.1093/humrep/13.3.651; Al-Habboubi HH, 2011, EUR CYTOKINE NETW, V22, P154, DOI 10.1684/ecn.2011.0289; Al-Habboubi HH, 2012, EUR J HAEMATOL, V89, P403, DOI 10.1111/ejh.12003; Almawi WY, 2013, HUM REPROD, V28, P2628, DOI 10.1093/humrep/det308; Andraweera PH, 2013, J MATERN-FETAL NEO M, V26, P532, DOI 10.3109/14767058.2012.743520; Artini PG, 2009, HUM FERTIL, V12, P40, DOI 10.1080/14647270802621358; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P2745, DOI 10.1210/jc.2003-032046; Banyasz I, 2006, MOL HUM REPROD, V12, P233, DOI 10.1093/molehr/gal024; Carmina E, 2013, FRONT HORM RES, V40, P40, DOI 10.1159/000341840; Dumesic DA, 2015, ENDOCR REV, V36, P487, DOI 10.1210/er.2015-1018; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; Geva E, 2000, FERTIL STERIL, V74, P429, DOI 10.1016/S0015-0282(00)00670-1; Guruvaiah P, 2014, J ASSIST REPROD GEN, V31, P1383, DOI 10.1007/s10815-014-0310-4; Hefler LA, 2007, CLIN CANCER RES, V13, P898, DOI 10.1158/1078-0432.CCR-06-1008; Houck K. A., 1991, ENDOCRINOLOGY, V5, P1806, DOI [10.1210/mend-5-12-1806, DOI 10.1210/MEND-5-12-1806]; Hurd WW, 2011, FERTIL STERIL, V96, P1043, DOI 10.1016/j.fertnstert.2011.07.002; Korytkowski M., 2000, WOMEN HLTH PRIM CARE, V3, P55; Lee EJ, 2008, FERTIL STERIL, V89, P1751, DOI 10.1016/j.fertnstert.2007.06.049; Locke JM, 2011, DIABETOLOGIA, V54, P3078, DOI 10.1007/s00125-011-2290-6; Luo L, 2013, J MATERN-FETAL NEO M, V26, P686, DOI 10.3109/14767058.2012.746305; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Menon MC, 2015, J CLIN INVEST, V125, P208, DOI 10.1172/JCI76902; Nagy B, 2008, CLIN CHIM ACTA, V389, P126, DOI 10.1016/j.cca.2007.12.003; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Peitsidis P, 2010, REPROD BIOMED ONLINE, V20, P444, DOI 10.1016/j.rbmo.2010.01.007; Resende AV, 2001, GYNECOL OBSTET INVES, V52, P153, DOI 10.1159/000052964; Ruggiero D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016982; Stevens A, 2003, CANCER RES, V63, P812; Tulandi T, 2000, FERTIL STERIL, V74, P585, DOI 10.1016/S0015-0282(00)00684-1; Vincenti V, 1996, CIRCULATION, V93, P1493, DOI 10.1161/01.CIR.93.8.1493; Vink JM, 2006, J CLIN ENDOCR METAB, V91, P2100, DOI 10.1210/jc.2005-1494; Vural P, 2009, EUR J OBSTET GYN R B, V147, P57, DOI 10.1016/j.ejogrb.2009.06.026; Watson CJ, 2000, CYTOKINE, V12, P1232, DOI 10.1006/cyto.2000.0692; Zidi S, 2015, CYTOKINE, V74, P108, DOI 10.1016/j.cyto.2014.11.009	35	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165636	10.1371/journal.pone.0165636	http://dx.doi.org/10.1371/journal.pone.0165636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846231	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600016
J	Domazet-Loso, M; Domazet-LoSo, T				Domazet-Loso, Mirjana; Domazet-Loso, Tomislav			gmos: Rapid Detection of Genome Mosaicism over Short Evolutionary Distances	PLOS ONE			English	Article							RECOMBINATION; SEQUENCE; INFERENCE; ALIGNMENT; SEARCH; BLAST; MODEL	Prokaryotic and viral genomes are often altered by recombination and horizontal gene transfer. The existing methods for detecting recombination are primarily aimed at viral genomes or sets of loci, since the expensive computation of underlying statistical models often hinders the comparison of complete prokaryotic genomes. As an alternative, alignment-free solutions are more efficient, but cannot map (align) a query to subject genomes. To address this problem, we have developed gmos (Genome MOsaic Structure), a new program that determines the mosaic structure of query genomes when compared to a set of closely related subject genomes. The program first computes local alignments between query and subject genomes and then reconstructs the query mosaic structure by choosing the best local alignment for each query region. To accomplish the analysis quickly, the program mostly relies on pairwise alignments and constructs multiple sequence alignments over short overlapping subject regions only when necessary. This fine-tuned implementation achieves an efficiency comparable to an alignment-free tool. The program performs well for simulated and real data sets of closely related genomes and can be used for fast recombination detection; for instance, when a new prokaryotic pathogen is discovered. As an example, gmos was used to detect genome mosaicism in a pathogenic Enterococcus faecium strain compared to seven closely related genomes. The analysis took less than two minutes on a single 2.1 GHz processor. The output is available in fasta format and can be visualized using an accessory program, gmosDraw (freely available with gmos).	[Domazet-Loso, Mirjana] Univ Zagreb, Fac Elect Engn & Comp, Dept Appl Comp, Zagreb, Croatia; [Domazet-Loso, Tomislav] Rudjer Boskovic Inst, Lab Evolutionary Genet, Zagreb, Croatia; [Domazet-Loso, Tomislav] Catholic Univ Croatia, Zagreb, Croatia	University of Zagreb; Rudjer Boskovic Institute	Domazet-Loso, M (corresponding author), Univ Zagreb, Fac Elect Engn & Comp, Dept Appl Comp, Zagreb, Croatia.	mirjana.domazet@fer.hr			University of Zagreb [TP1.13]; Adris Foundation; City of Zagreb grant	University of Zagreb; Adris Foundation; City of Zagreb grant	This research was supported by the University of Zagreb research grant TP1.13 (2014) to MDL. TDL is supported by Adris Foundation and the City of Zagreb grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abouelhoda M. I., 2004, Journal of Discrete Algorithms, V2, P53, DOI 10.1016/S1570-8667(03)00065-0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angiuoli SV, 2011, BIOINFORMATICS, V27, P334, DOI 10.1093/bioinformatics/btq665; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bulla I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-205; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cartwright RA, 2005, BIOINFORMATICS, V21, P31, DOI 10.1093/bioinformatics/bti1200; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004041; Didelot X, 2010, GENETICS, V186, P1435, DOI 10.1534/genetics.110.120121; Diemer GS, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-13; Domazet-Loso Mirjana, 2011, Mob Genet Elements, V1, P230; Domazet-Loso M, 2011, BIOINFORMATICS, V27, P1466, DOI 10.1093/bioinformatics/btr176; Gertz EM, 2005, BLAST SCORING PARAME; Gonzalez-Candelas F, 2011, VIRUSES-BASEL, V3, P2006, DOI 10.3390/v3102006; Haubold B, 2009, J COMPUT BIOL, V16, P1487, DOI 10.1089/cmb.2009.0106; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; Korf I., 2003, BLAST; Kumar S., 2016, MOL BIOL EVOLUTION, V33, DOI [DOI 10.1093/M0LBEV/MSW054, https://doi.org/10.1093/molbev/msw054, 10.1093/molbev/msw054]; Lawson DJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002453; Manzini G, 2004, ALGORITHMICA, V40, P33, DOI 10.1007/s00453-004-1094-1; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Marttinen P, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr928; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Mori Y., 2008, LIBDIVSUFSORT LIGHTW; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Palmer KL, 2012, MBIO, V3, DOI 10.1128/mBio.00318-11; Peng J, 2011, PROTEINS, V79, P1930, DOI 10.1002/prot.23016; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Repizo GD, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-489; Schultz AK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-265; Schultz AK, 2012, NUCLEIC ACIDS RES, V40, pW193, DOI 10.1093/nar/gks414; Sung, 2010, ALGORITHMS BIOINFORM; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Wiedenbeck J, 2011, FEMS MICROBIOL REV, V35, P957, DOI 10.1111/j.1574-6976.2011.00292.x; Yahara K, 2014, MOL BIOL EVOL, V31, P1593, DOI 10.1093/molbev/msu082; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166602	10.1371/journal.pone.0166602	http://dx.doi.org/10.1371/journal.pone.0166602			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846272	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600089
J	Errea, A; Cayet, D; Marchetti, P; Tang, C; Kluza, J; Offermanns, S; Sirard, JC; Rumbo, M				Errea, Agustina; Cayet, Delphine; Marchetti, Philippe; Tang, Cong; Kluza, Jerome; Offermanns, Stefan; Sirard, Jean-Claude; Rumbo, Martin			Lactate Inhibits the Pro-Inflammatory Response and Metabolic Reprogramming in Murine Macrophages in a GPR81-Independent Manner	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; LACTIC-ACID; INNATE IMMUNITY; POLARIZATION; GLYCOLYSIS; CANCER; INJURY; CELLS; COLON; LUNG	Lactate is an essential component of carbon metabolism in mammals. Recently, lactate was shown to signal through the G protein coupled receptor 81 (GPR81) and to thus modulate inflammatory processes. This study demonstrates that lactate inhibits pro-inflammatory signaling in a GPR81-independent fashion. While lipopolysaccharide (LPS) triggered expression of IL-6 and IL-12 p40, and CD40 in bone marrow-derived macrophages, lactate was able to abrogate these responses in a dose dependent manner in Gpr81(-/-) cells as well as in wild type cells. Macrophage activation was impaired when glycolysis was blocked by chemical inhibitors. Remarkably, lactate was found to inhibit LPS-induced glycolysis in wild type as well as in Gpr81(-/-) cells. In conclusion, our study suggests that lactate can induce GPR81-independent metabolic changes that modulate macrophage pro-inflammatory activation.	[Errea, Agustina; Rumbo, Martin] Univ Nacl La Plata, CONICET, Inst Estudios Inmunol & Fisiopatol, RA-1900 La Plata, Buenos Aires, Argentina; [Cayet, Delphine; Sirard, Jean-Claude] Univ Lille, CHU Lille, CIIL U1019 UMR8204, Inst Pasteur Lille,INSERM,CNRS, F-59000 Lille, France; [Marchetti, Philippe; Kluza, Jerome] Univ Lille, INSERM, CHU Lille,JPArc, Ctr Rech JeanPierre AUBERT Neurosci & Ctr,UMR,S 1, F-59000 Lille, France; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Offermanns, Stefan] Goethe Univ Frankfurt, Fac Med, D-60590 Frankfurt, Germany	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Goethe University Frankfurt	Rumbo, M (corresponding author), Univ Nacl La Plata, CONICET, Inst Estudios Inmunol & Fisiopatol, RA-1900 La Plata, Buenos Aires, Argentina.	martinr@biol.unlp.edu.ar	Sirard, Jean-Claude/B-5932-2011; Kluza, Jérome/B-6312-2012; Offermanns, Stefan/L-3313-2017	Sirard, Jean-Claude/0000-0001-9854-4652; Kluza, Jérome/0000-0002-7346-1305; CAYET, Delphine/0000-0003-1720-0845; MARCHETTI, Philippe/0000-0002-4663-6800; Offermanns, Stefan/0000-0001-8676-6805; Tang, Cong/0000-0002-5228-3052	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille; CONICET-DAAD; Argentinian Ministry of Science, Technology and Innovation; French Ministry for Research and Higher Education [EGOS A12803]; CONICET	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille; CONICET-DAAD; Argentinian Ministry of Science, Technology and Innovation; French Ministry for Research and Higher Education; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille, CONICET-DAAD and the Argentinian Ministry of Science, Technology and Innovation and the French Ministry for Research and Higher Education (grant EGOS A12803). AE received a Bernardo Houssay fellowship from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AE and MR are members of the Argentinian National Research Council (CONICET), and JCS a member of INSERM. AE received a Bernardo Houssay fellowship from CONICET. The work was supported by grants from Agencia Nacional de PromociOn Cientifica y Tecnologica (ANPCYT), INSERM, CNRS, Institut Pasteur de Lille, Universite de Lille, CONICET-DAAD and the Argentinian Ministry of Science, Technology and Innovation and the French Ministry for Research and Higher Education (grant EGOS A12B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aaronson DS, 2002, SCIENCE, V296, P1653, DOI 10.1126/science.1071545; Ahmed K, 2010, CELL METAB, V11, P311, DOI 10.1016/j.cmet.2010.02.012; Blad CC, 2012, NAT REV DRUG DISCOV, V11, P603, DOI 10.1038/nrd3777; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Dietl K, 2010, J IMMUNOL, V184, P1200, DOI 10.4049/jimmunol.0902584; Doherty JR, 2014, CANCER RES, V74, P908, DOI 10.1158/0008-5472.CAN-13-2034; Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463; Garrote GL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00629; Goodwin ML, 2014, CANCER CELL, V26, P851, DOI 10.1016/j.ccell.2014.10.003; Gottfried E, 2006, BLOOD, V107, P2013, DOI 10.1182/blood-2005-05-1795; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Hoque R, 2014, GASTROENTEROLOGY, V146, P1763, DOI 10.1053/j.gastro.2014.03.014; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; Hur H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098581; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Kami K, 2013, METABOLOMICS, V9, P444, DOI 10.1007/s11306-012-0452-2; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Luc R, 2015, MOL BIOL REP, V42, P835, DOI 10.1007/s11033-015-3859-9; Nasi A, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26744; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; O'Neill LAJ, 2015, IMMUNITY, V42, P393, DOI 10.1016/j.immuni.2015.02.017; Offermanns S, 2014, ANNU REV PHARMACOL, V54, P407, DOI 10.1146/annurev-pharmtox-011613-135945; Okada T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2668; Pearce EJ, 2015, NAT REV IMMUNOL, V15, P18, DOI 10.1038/nri3771; Shi LB, 2015, SCI REP-UK, V5, DOI 10.1038/srep18176; Somashekar BS, 2011, J PROTEOME RES, V10, P4186, DOI 10.1021/pr2003352; Tan Z, 2015, J BIOL CHEM, V290, P46, DOI 10.1074/jbc.M114.603589; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Van Maele L, 2014, MUCOSAL IMMUNOL, V7, P489, DOI 10.1038/mi.2013.66; Wang AS, 2014, NMR BIOMED, V27, P1361, DOI 10.1002/nbm.3198; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG506, DOI 10.1152/ajpgi.90553.2008	33	83	84	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0163694	10.1371/journal.pone.0163694	http://dx.doi.org/10.1371/journal.pone.0163694			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846210	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600003
J	Kim, D; Choi, Y; Ireland, J; Foreman, O; Tam, RN; Patel, R; Schleifman, EB; Motlhabi, M; French, D; Wong, CV; Peters, E; Molinero, L; Raja, R; Amler, LC; Hampton, GM; Lackner, MR; Kabbarah, O				Kim, Doris; Choi, YounJeong; Ireland, James; Foreman, Oded; Tam, Rachel N.; Patel, Rajesh; Schleifman, Erica B.; Motlhabi, Maipelo; French, Dorothy; Wong, Cheryl V.; Peters, Eric; Molinero, Luciana; Raja, Rajiv; Amler, Lukas C.; Hampton, Garret M.; Lackner, Mark R.; Kabbarah, Omar			Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder Cancers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; EXTRACELLULAR DOMAIN; PROGNOSTIC-FACTORS; MUTATIONS; CARCINOMA; FGFR3; GENE; CLASSIFICATION; PROGRESSION; EXPRESSION	In the age of personalized medicine stratifying tumors into molecularly defined subtypes associated with distinctive clinical behaviors and predictable responses to therapies holds tremendous value. Towards this end, we developed a custom microfluidics-based bladder cancer gene expression panel for characterization of archival clinical samples. In silico analysis indicated that the content of our panel was capable of accurately segregating bladder cancers from several public datasets into the clinically relevant basal and luminal subtypes. On a technical level, our bladder cancer panel yielded robust and reproducible results when analyzing formalin-fixed, paraffin-embedded (FFPE) tissues. We applied our panel in the analysis of a novel set of 204 FFPE samples that included non-muscle invasive bladder cancers (NMIBCs), muscle invasive disease (MIBCs), and bladder cancer metastases (METs). We found NMIBCs to be mostly luminal-like, MIBCs to include both luminal-and basal-like types, and METs to be predominantly of a basal-like transcriptional profile. Mutational analysis confirmed the expected enrichment of FGFR3 mutations in luminal samples, and, consistently, FGFR3 IHC showed high protein expression levels of the receptor in these tumors. Our bladder cancer panel enables basal/luminal characterization of FFPE tissues and with further development could be used for stratification of bladder cancer samples in the clinic.	[Kim, Doris; Tam, Rachel N.; Patel, Rajesh; Schleifman, Erica B.; Motlhabi, Maipelo; Wong, Cheryl V.; Peters, Eric; Molinero, Luciana; Raja, Rajiv; Amler, Lukas C.; Hampton, Garret M.; Lackner, Mark R.; Kabbarah, Omar] Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA; [Choi, YounJeong] Genentech Inc, Dept Biostat, San Francisco, CA 94080 USA; [Ireland, James] Alternate Allele Consulting, Orinda, CA USA; [Foreman, Oded; French, Dorothy] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Kabbarah, O (corresponding author), Genentech Inc, Oncol Biomarker Dev, San Francisco, CA 94080 USA.	kabbaraa@gene.com			Genentech, Inc.	Genentech, Inc.(Roche HoldingGenentech)	DK, YC, OF, RNT, RP, EBS, MM, DF, CVVV, EP, LM, RR, LCA, GMH, MRL, and OK are current or former employees of Genentech, Inc. Genentech, Inc. provided support in the form of salaries for these authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. JI is an employee of Alternative Allele Consulting. Alternative Allele Consulting provided support in the form of salary for this author but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al-Ahmadie HA, 2011, J PATHOL, V224, P270, DOI 10.1002/path.2892; Blaveri E, 2005, CLIN CANCER RES, V11, P4044, DOI 10.1158/1078-0432.CCR-04-2409; Cappellen D, 1999, NAT GENET, V23, P18, DOI 10.1038/12615; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Choi W, 2014, CANCER CELL, V25, P152, DOI 10.1016/j.ccr.2014.01.009; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Damrauer JS, 2014, P NATL ACAD SCI USA, V111, P3110, DOI 10.1073/pnas.1318376111; Dudoit S, 2002, GENOME BIOL, V3; Dyrskjot L, 2003, NAT GENET, V33, P90, DOI 10.1038/ng1061; George B, 2007, J CLIN ONCOL, V25, P5352, DOI 10.1200/JCO.2006.10.4125; Gust KM, 2013, MOL CANCER THER, V12, P1245, DOI 10.1158/1535-7163.MCT-12-1150; Hall MC, 1998, UROLOGY, V52, P594, DOI 10.1016/S0090-4295(98)00295-7; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; HENEY NM, 1992, UROL CLIN N AM, V19, P429; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hurst CD, 2012, CLIN CANCER RES, V18, P5865, DOI 10.1158/1078-0432.CCR-12-1807; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Juanpere N, 2012, HUM PATHOL, V43, P1573, DOI 10.1016/j.humpath.2011.10.026; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Knowles MA, 2007, FRONT BIOSCI-LANDMRK, V12, P2233, DOI 10.2741/2226; Kompier LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013821; Lindgren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038863; Liu X, 2014, GENET MOL RES, V13, P1109, DOI 10.4238/2014.February.20.12; Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039; Martinez-Torrecuadrada JM, 2005, CLIN CANCER RES, V11, P6280, DOI 10.1158/1078-0432.CCR-05-0282; McConkey DJ, 2016, EUR UROL, V69, P855, DOI 10.1016/j.eururo.2015.08.034; McConkey DJ, 2010, UROL ONCOL-SEMIN ORI, V28, P429, DOI 10.1016/j.urolonc.2010.04.008; Millan-Rodriguez F, 2000, J UROLOGY, V163, P73, DOI 10.1016/S0022-5347(05)67975-X; Nargund VH, 2012, SEMIN ONCOL, V39, P559, DOI 10.1053/j.seminoncol.2012.08.001; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Rebouissou S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008970; Resnick MJ, 2013, CURR OPIN ONCOL, V25, P281, DOI 10.1097/CCO.0b013e32835eb583; Ross JS, 2014, CLIN CANCER RES, V20, P68, DOI 10.1158/1078-0432.CCR-13-1992; Sanchez-Carbayo M, 2007, SEMIN ONCOL, V34, P75, DOI 10.1053/j.seminoncol.2006.12.013; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090761; Schleifman EB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088401; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sjodahl G, 2012, CLIN CANCER RES, V18, P3377, DOI 10.1158/1078-0432.CCR-12-0077-T; Team RDC, 2006, R LANG ENV STAT COMP; Tomlinson DC, 2007, J PATHOL, V213, P91, DOI 10.1002/path.2207; Tukey JW, 1977, EXPLORATORY DATA ANA; van Rhijn BWG, 2002, J PATHOL, V198, P245, DOI 10.1002/path.1202; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165856	10.1371/journal.pone.0165856	http://dx.doi.org/10.1371/journal.pone.0165856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846280	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600021
J	Baba, S; Iso, H; Fujiwara, T				Baba, Sachiko; Iso, Hiroyasu; Fujiwara, Takeo			Area-Level and Individual-Level Factors for Teenage Motherhood: A Multilevel Analysis in Japan	PLOS ONE			English	Article							POPULATION; PREGNANCY; RISK; CONSEQUENCES; COHORT; OUTCOMES; POVERTY; PEOPLE; AGE	Background Teenage motherhood is strongly associated with a range of disadvantages for both the mother and the child. No epidemiological studies have examined related factors for teenage motherhood at both area and individual levels among Japanese women. Therefore, we performed a multilevel analysis of nationwide data in Japan to explore the association of area- and individual-level factors with teenage motherhood. Methods The study population comprised 21,177 mothers living in 47 prefectures who had their first, singleton baby between 10 and 17 January or between 10 and 17 July, 2001. Information on the prefecture in which the mothers resided was linked to prefecture-level variables. Primary outcomes were area-level characteristics (single-mother households, three-generation households, college enrollment, abortions, juvenile crime, and per capita income) and individual-level characteristics, and divided into tertiles or quintiles based on their variable distributions. Multilevel logistic regression analysis was then performed. Results There were 440 teenage mothers (2.1%) in this study. In addition to individual low level of education [adjusted odds ratio (OR), 7.40; 95% confidence interval (CI), 5.59-9.78], low income [4.23 (2.95-6.08)], and smoking [1.65 (1.31-2.07)], high proportions of single-mother households [1.72 (1.05-2.80)] and three-generation household [1.81 (1.17-2.78)], and per capita income [2.19 (1.06-3.81)] at an area level were positively associated, and high level of college enrollment [0.46 (0.25-0.83)] and lower crime rate [0.62 (0.40-0.98)] at area level were inversely associated with teenage motherhood compared with the corresponding women living in prefectures with the lowest levels of these variables. Conclusions Our findings suggest that encouraging the completion of higher education and reducing the number of single-mother household at an area level may be important public health strategies to reduce teenage motherhood.	[Baba, Sachiko] Osaka Univ, Grad Sch Med, Ctr Int Relat, Suita, Osaka, Japan; [Baba, Sachiko; Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Dept Social Med, Publ Hlth, Suita, Osaka, Japan; [Fujiwara, Takeo] Tokyo Med & Dent Univ, Dept Global Hlth Promot, Tokyo, Japan	Osaka University; National Center for Child Health & Development - Japan; Osaka University; Tokyo Medical & Dental University (TMDU)	Baba, S (corresponding author), Osaka Univ, Grad Sch Med, Ctr Int Relat, Suita, Osaka, Japan.; Baba, S (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan.	baba@cir.med.osaka-u.ac.jp		Baba, Sachiko/0000-0002-6213-8115	Japan Society for the Promotion of Science [26870331]; Grants-in-Aid for Scientific Research [26870331] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Young Scientist (B) from the Japan Society for the Promotion of Science (grant 26870331) (https://www.jsps.go.english/e-grants/grants01.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba S, 2014, J OBSTET GYNAECOL RE, V40, P125, DOI 10.1111/jog.12138; Baba Sachiko, 2005, Environmental Health and Preventive Medicine, V10, P9, DOI 10.1265/ehpm.10.9; BARKER DJP, 1986, LANCET, V1, P1077; Burack R, 1999, BRIT J FAM PLAN, V24, P145; Cabinet Office Government of Japan, 2001, ANN REP PREF ACC FIS; Chang Z, 2014, INT J EPIDEMIOL, V43, P1815, DOI 10.1093/ije/dyu204; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Gaudie J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-63; Hardy R, 2009, J EPIDEMIOL COMMUN H, V63, P99, DOI 10.1136/jech.2008.076943; Harrison Ayanna T., 2012, Morbidity and Mortality Weekly Report, V61, P25; Hobcraft J, 2001, BRIT J SOCIOL, V52, P495; Hogan DP, 2000, AM J PUBLIC HEALTH, V90, P1421; Johns SE, 2011, HEALTH PLACE, V17, P122, DOI 10.1016/j.healthplace.2010.09.006; Kane JB, 2013, DEMOGRAPHY, V50, P2129, DOI 10.1007/s13524-013-0238-9; Kirby D, 2001, FAM PLANN PERSPECT, V33, P63, DOI 10.2307/2673751; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Lipman EL, 2011, J AM ACAD CHILD PSY, V50, P232, DOI 10.1016/j.jaac.2010.12.007; McLeod A, 2001, BRIT MED J, V323, P199, DOI 10.1136/bmj.323.7306.199; Ministry of Education Culture Sports Science and Technology, REP SCH REF DROP HIG; Ministry of education culture sports science and technology, 2001, SCH BAS SURV FISC YE; Ministry of Education Culture Sports Science and Technology, FY 2014 SCH BAS SURV; Ministry of health labour and welfare., 2001, VIT STAT SPEC ISS 20; Ministry of health labour and welfare, 2001, REP PUBL HLTH ADM SE; Nanchahal K, 2005, J EPIDEMIOL COMMUN H, V59, P828, DOI 10.1136/jech.2004.026021; National Police Agency, 2001, OV JUV DEL PROT 2000; Noll JG, 2013, PEDIATRICS, V131, pE1181, DOI 10.1542/peds.2012-3072; OECD, 2013, ED IND FOC; Olausson PO, 1999, BRIT J OBSTET GYNAEC, V106, P116, DOI 10.1111/j.1471-0528.1999.tb08210.x; Patel PH, 2012, MATERN CHILD HLTH J, V16, P1063, DOI 10.1007/s10995-011-0829-2; Paul C, 2000, J ADOLESCENT HEALTH, V27, P136, DOI 10.1016/S1054-139X(99)00095-6; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; Saito E, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-93; Silverstein M, 2006, J GERONTOL B-PSYCHOL, V61, pS256, DOI 10.1093/geronb/61.5.S256; Smith Debbie M, 2006, Psychol Health Med, V11, P399, DOI 10.1080/13548500500429353; Statistics Bureau Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA PORT SIT OFF STAT JA; Thornberry TP, 2014, CHILD ABUSE NEGLECT, V38, P706, DOI 10.1016/j.chiabu.2013.08.009; UNICEF, 2001, LEAGUE TABLE TEENAGE; Uren Zoe, 2007, Health Stat Q, P34; Webb RT, 2011, PSYCHOL MED, V41, P1867, DOI 10.1017/S0033291711000055	40	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166345	10.1371/journal.pone.0166345	http://dx.doi.org/10.1371/journal.pone.0166345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832177	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000105
J	Parker, ML; Houston, S; Wetherell, C; Cameron, CE; Boulanger, MJ				Parker, Michelle L.; Houston, Simon; Wetherell, Charmaine; Cameron, Caroline E.; Boulanger, Martin J.			The Structure of Treponema pallidum Tp0624 Reveals a Modular Assembly of Divergently Functionalized and Previously Uncharacterized Domains	PLOS ONE			English	Article							BACTERIAL FLAGELLAR MOTOR; PEPTIDOGLYCAN; PROTEIN; MECHANISM; RMPM	Treponema pallidum subspecies pallidum is the causative agent of syphilis, a chronic, multistage, systemic infection that remains a major global health concern. The molecular mechanisms underlying T. pallidum pathogenesis are incompletely understood, partially due to the phylogenetic divergence of T. pallidum. One aspect of T. pallidum that differentiates it from conventional Gram-negative bacteria, and is believed to play an important role in pathogenesis, is its unusual cell envelope ultrastructure; in particular, the T. pallidum peptidoglycan layer is chemically distinct, thinner and more distal to the outer membrane. Established functional roles for peptidoglycan include contributing to the structural integrity of the cell envelope and stabilization of the flagellar motor complex, which are typically mediated by the OmpA domain-containing family of proteins. To gain insight into the molecular mechanisms that govern peptidoglycan binding and cell envelope biogenesis in T. pallidum we report here the structural characterization of the putative OmpA-like domain-containing protein, Tp0624. Analysis of the 1.70 A resolutionp0624 crystal structure reveals a multi-modular architecture comprised of three distinct domains including a C-terminal divergent OmpA-like domain, which we show is unable to bind the conventional peptidoglycan component diaminopimelic acid, and a previously uncharacterized tandem domain unit. Intriguingly, bioinformatic analysis indicates that the three domains together are found in all orthologs from pathogenic treponemes, but are not observed together in genera outside Treponema. These findings provide the first structural insight into a multi-modular treponemal protein containing an OmpA-like domain and its potential role in peptidoglycan coordination and stabilization of the T. pallidum cell envelope.	[Parker, Michelle L.; Houston, Simon; Wetherell, Charmaine; Cameron, Caroline E.; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Victoria	Cameron, CE; Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada.	caroc@uvic.ca; mboulang@uvic.ca	Cameron, Caroline/HIR-2880-2022	Cameron, Caroline/0000-0002-8786-4359; Houston, Simon/0000-0001-5961-5227	Natural Sciences and Engineering Research Council of Canada; Canada Chairs Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051334, R01AI051334] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Chairs Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Natural Sciences and Engineering Research Council of Canada grants to MJB and CEC. MJB and CEC gratefully acknowledge the Canada Chairs Research Program for salary support.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Artola-Recolons C, 2014, ACS CHEM BIOL, V9, P2058, DOI 10.1021/cb500439c; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bouveret E, 1999, J BACTERIOL, V181, P6306, DOI 10.1128/JB.181.20.6306-6311.1999; Charon NW, 2002, ANNU REV GENET, V36, P47, DOI 10.1146/annurev.genet.36.041602.134359; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Confer AW, 2013, VET MICROBIOL, V163, P207, DOI 10.1016/j.vetmic.2012.08.019; Crawford J, 2010, J BIOL CHEM, V285, P12063, DOI 10.1074/jbc.M109.054866; Crawford J, 2009, J BIOL CHEM, V284, P9192, DOI 10.1074/jbc.M808714200; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLT SC, 1978, MICROBIOL REV, V42, P114, DOI 10.1128/MMBR.42.1.114-160.1978; Izard J, 2009, J BACTERIOL, V191, P7566, DOI 10.1128/JB.01031-09; JOSEPH R, 1973, J BACTERIOL, V115, P426, DOI 10.1128/JB.115.1.426-435.1973; Kelkar YD, 2013, GENETICS, V193, P303, DOI 10.1534/genetics.112.145656; Kojima S, 2009, MOL MICROBIOL, V73, P710, DOI 10.1111/j.1365-2958.2009.06802.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristensen O, 2003, STRUCTURE, V11, P1547, DOI 10.1016/j.str.2003.11.003; Liu J, 2010, J MOL BIOL, V403, P546, DOI 10.1016/j.jmb.2010.09.020; Liu J, 2009, J BACTERIOL, V191, P5026, DOI 10.1128/JB.00340-09; Lukehart Sheila A, 2007, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12a01s7; Maharjan S, 2016, MICROBIOL-SGM, V162, P364, DOI 10.1099/mic.0.000227; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murphy GE, 2006, NATURE, V442, P1062, DOI 10.1038/nature05015; Nash RP, 2010, NUCLEIC ACIDS RES, V38, P5929, DOI 10.1093/nar/gkq303; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nguyen CC, 1996, RES MICROBIOL, V147, P317, DOI 10.1016/0923-2508(96)84707-3; Nusbaum Margaret R H, 2004, J Am Osteopath Assoc, V104, P527; Organization WH., 2011, PREV INC SEX TRANSM; Osbak KK, 2016, PLOS NEGL T IN PRESS; Park JS, 2012, FASEB J, V26, P219, DOI 10.1096/fj.11-188425; Parker ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139407; Petrosova H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074319; Reboul CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018981; Roujeinikova A, 2008, P NATL ACAD SCI USA, V105, P10348, DOI 10.1073/pnas.0803039105; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smajs D, 2005, J BACTERIOL, V187, P1866, DOI 10.1128/JB.187.5.1866-1874.2005; Tonkin ML, 2013, J BIOL CHEM, V288, P12805, DOI 10.1074/jbc.M113.455667; Tuteja R, 2005, ARCH BIOCHEM BIOPHYS, V441, P107, DOI 10.1016/j.abb.2005.07.013; UMEMOTO T, 1981, INFECT IMMUN, V31, P767, DOI 10.1128/IAI.31.2.767-774.1981; Volokhina EB, 2009, J BACTERIOL, V191, P7074, DOI 10.1128/JB.00737-09; YANAGIHARA Y, 1984, MICROBIOL IMMUNOL, V28, P535, DOI 10.1111/j.1348-0421.1984.tb00706.x	49	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166274	10.1371/journal.pone.0166274	http://dx.doi.org/10.1371/journal.pone.0166274			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832149	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000087
J	Piszter, G; Kertesz, K; Balint, Z; Biro, LP				Piszter, Gabor; Kertesz, Krisztian; Balint, Zsolt; Biro, Laszlo Peter			Variability of the Structural Coloration in Two Butterfly Species with Different Prezygotic Mating Strategies	PLOS ONE			English	Article							WING SCALES; SEXUAL SELECTION; PHOTONIC NANOARCHITECTURES; EVOLUTION; CRYSTALS; SIGNALS; GREEN; MOTH	Structural coloration variability was investigated in two Blue butterfly species that are common in Hungary. The males of Polyommatus icarus (Common Blue) and Plebejus argus (Silver -studded Blue) use their blue wing coloration for conspecific recognition. Despite living in the same type of habitat, these two species display differences in prezygotic mating strategy: the males of P. icarus are patrolling, while P. argus males have sedentary behavior. Therefore, the species-specific photonic nanoarchitecture, which is the source of the structural coloration, may have been subjected to different evolutionary effects. Despite the increasing interest in photonic nanoarchitectures of biological origin, there is a lack of studies focused on the biological variability of structural coloration that examine a statistically relevant number of individuals from the same species. To investigate possible structural color variation within the same species in populations separated by large geographical distances, climatic differences, or applied experimental conditions, one has to be able to compare these variations to the normal biological variability within a single population. The structural coloration of the four wings of 25 male individuals (100 samples for each species) was measured and compared using different light-collecting setups: perpendicular and with an integrating sphere. Significant differences were found in the near UV wavelength region that are perceptible by these polyommatine butterflies but are invisible to human observers. The differences are attributed to the differences in the photonic nanoarchitecture in the scales of these butterflies. Differences in the intensity of structural coloration were also observed and were tentatively attributed to the different prezygotic mating strategies of these insects. Despite the optical complexity of the scale covered butterfly wings, for sufficiently large sample batches, the averaged normal incidence measurements and the averaged measurements using an integrating sphere are in agreement.	[Piszter, Gabor; Kertesz, Krisztian; Biro, Laszlo Peter] Inst Tech Phys & Mat Sci, Energy Res Ctr, Budapest, Hungary; [Balint, Zsolt] Hungarian Nat Hist Museum, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences	Piszter, G (corresponding author), Inst Tech Phys & Mat Sci, Energy Res Ctr, Budapest, Hungary.	piszter@mfa.kfki.hu	Biro, Laszlo/GRO-3819-2022	Balint, Zsolt/0000-0001-8174-878X; Piszter, Gabor/0000-0001-7155-4025	Hungarian Scientific Research Fund [OTKA K 111741, OTKA K 115724]	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Hungarian Scientific Research Fund (http://www.otka.hu/en) OTKA K 111741 and OTKA K 115724 grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Balint Z, 2012, J R SOC INTERFACE, V9, P1745, DOI 10.1098/rsif.2011.0854; Balinti Zsolt, 2010, Genus (Wroclaw), V21, P163; Bateson P., 1983, MATE CHOICE; Biro LP, 2011, LASER PHOTONICS REV, V5, P27, DOI 10.1002/lpor.200900018; Biro LP, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.021907; Burghardt F, 2000, NATURWISSENSCHAFTEN, V87, P304, DOI 10.1007/s001140050726; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ghiradella H, 2010, ADV INSECT PHYSIOL, V38, P135, DOI 10.1016/S0065-2806(10)38006-4; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; Han ZW, 2014, RSC ADV, V4, P45214, DOI 10.1039/c4ra06117a; Kertesz K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.021922; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Levin SA, 2013, ENCY BIODIVERSITY; Lewis OT, 1997, ECOL ENTOMOL, V22, P283, DOI 10.1046/j.1365-2311.1997.00074.x; Mafuku M., 2013, EUR J ENTOMOL, V110, P435; Meadows MG, 2011, BEHAV ECOL SOCIOBIOL, V65, P1317, DOI 10.1007/s00265-010-1135-5; Michielsen K, 2008, J R SOC INTERFACE, V5, P85, DOI 10.1098/rsif.2007.1065; Michielsen K, 2010, J R SOC INTERFACE, V7, P765, DOI 10.1098/rsif.2009.0352; Mitesser O, 2015, INT J ELECTR COMPUT, V6, P29; Piszter G, 2014, OPT EXPRESS, V22, P22649, DOI 10.1364/OE.22.022649; Piszter G, 2011, ANAL METHODS-UK, V3, P78, DOI 10.1039/c0ay00410c; Sison-Mangus MP, 2008, J EXP BIOL, V211, P361, DOI 10.1242/jeb.012617; Stavenga DG, 2006, OPT EXPRESS, V14, P4880, DOI 10.1364/OE.14.004880; Stavenga DG, 2009, OPT EXPRESS, V17, P193, DOI 10.1364/OE.17.000193; Thomas J., 2010, BUTTERFLIES BRITAIN; Vukusic P, 2000, NATURE, V404, P457, DOI 10.1038/35006561; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794; Wasik BR, 2014, P NATL ACAD SCI USA, V111, P12109, DOI 10.1073/pnas.1402770111; White TE, 2015, EVOLUTION, V69, P14, DOI 10.1111/evo.12551; Whitman D. W., 2009, Phenotypic plasticity of insects: mechanisms and consequences, P1; Wilts BD, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0160-9; Wilts BD, 2009, J R SOC INTERFACE, V6, pS185, DOI 10.1098/rsif.2008.0299.focus; Yoshioka S, 2007, OPT EXPRESS, V15, P2691, DOI 10.1364/OE.15.002691; Zhang D, 2015, PROG MATER SCI, V68, P67, DOI 10.1016/j.pmatsci.2014.10.003	36	17	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165857	10.1371/journal.pone.0165857	http://dx.doi.org/10.1371/journal.pone.0165857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832120	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000037
J	Schreeg, ME; Marr, HS; Tarigo, JL; Cohn, LA; Bird, DM; Scholl, EH; Levy, MG; Wiegmann, BM; Birkenheuer, AJ				Schreeg, Megan E.; Marr, Henry S.; Tarigo, Jaime L.; Cohn, Leah A.; Bird, David M.; Scholl, Elizabeth H.; Levy, Michael G.; Wiegmann, Brian M.; Birkenheuer, Adam J.			Mitochondrial Genome Sequences and Structures Aid in the Resolution of Piroplasmida phylogeny	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; BABESIA-MICROTI; SOUTHERN EUROPE; THEILERIA-PARVA; SP NOV.; APICOMPLEXAN PARASITES; CYTAUXZOON-FELIS; STRAY CATS; EVOLUTION; DNA	The taxonomy of the order Piroplasmida, which includes a number of clinically and economically relevant organisms, is a hotly debated topic amongst parasitologists. Three genera (Babesia, Theileria, and Cytauxzoon) are recognized based on parasite life cycle characteristics, but molecular phylogenetic analyses of 18S sequences have suggested the presence of five or more distinct Piroplasmida lineages. Despite these important advancements, a few studies have been unable to define the taxonomic relationships of some organisms (e.g. C. felis and T. equi) with respect to other Piroplasmida. Additional evidence from mitochondrial genome sequences and synteny should aid in the inference of Piroplasmida phylogeny and resolution of taxonomic uncertainties. In this study, we have amplified, sequenced, and annotated seven previously uncharacterized mitochondrial genomes (Babesia canis, Babesia vogeli, Babesia rossi, Babesia sp. Coco, Babesia conradae, Babesia microti-like sp., and Cytauxzoon felis) and identified additional ribosomal fragments in ten previously characterized mitochondrial genomes. Phylogenetic analysis of concatenated mitochondrial and 18S sequences as well as cox1 amino acid sequence identified five distinct Piroplasmida groups, each of which possesses a unique mitochondrial genome structure. Specifically, our results confirm the existence of four previously identified clades (B. microti group, Babesia sensu stricto, Theileria equi, and a Babesia sensu latu group that includes B. conradae) while supporting the integration of Theileria and Cytauxzoon species into a single fifth taxon. Although known biological characteristics of Piroplasmida corroborate the proposed phylogeny, more investigation into parasite life cycles is warranted to further understand the evolution of the Piroplasmida. Our results provide an evolutionary framework for comparative biology of these important animal and human pathogens and help focus renewed efforts toward understanding the phylogenetic relationships within the group.	[Schreeg, Megan E.; Marr, Henry S.; Tarigo, Jaime L.; Levy, Michael G.; Birkenheuer, Adam J.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Tarigo, Jaime L.] Univ Georgia, Coll Vet Med, Athens, GA USA; [Cohn, Leah A.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Bird, David M.; Scholl, Elizabeth H.; Wiegmann, Brian M.] North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University System of Georgia; University of Georgia; University of Missouri System; University of Missouri Columbia; University of North Carolina; North Carolina State University	Birkenheuer, AJ (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.; Wiegmann, BM (corresponding author), North Carolina State Univ, Coll Agr & Life Sci, Raleigh, NC 27695 USA.	bwiegman@ncsu.edu; ajbirken@ncsu.edu		Birkenheuer, Adam/0000-0002-2617-2252; Bird, David/0000-0002-1041-6769; Wiegmann, Brian/0000-0002-1869-9759	charitable organization	charitable organization	This work was funded by a charitable organization that wishes to remain anonymous. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsopp MTEP, 2006, ANN NY ACAD SCI, V1081, P509, DOI 10.1196/annals.1373.076; ALLSOPP MTEP, 1994, PARASITOLOGY, V108, P147, DOI 10.1017/S0031182000068232; Andre MR, 2015, TICKS TICK-BORNE DIS, V6, P779, DOI 10.1016/j.ttbdis.2015.07.004; Aurrecoechea C, 2010, NUCLEIC ACIDS RES, V38, pD415, DOI 10.1093/nar/gkp941; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bajer A, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0572-9; Baneth G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0830-5; Birkenheuer AJ, 2004, VET PARASITOL, V124, P151, DOI 10.1016/j.vetpar.2004.07.008; Bishop R, 2004, PARASITOLOGY, V129, pS271, DOI 10.1017/S0031182003004748; BLOUIN EF, 1987, J WILDLIFE DIS, V23, P499, DOI 10.7589/0090-3558-23.3.499; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Bosman AM, 2010, J CLIN MICROBIOL, V48, P2703, DOI 10.1128/JCM.02266-09; Carli E, 2012, VET PARASITOL, V183, P343, DOI 10.1016/j.vetpar.2011.07.025; Chantangsi C, 2008, MOL PHYLOGENET EVOL, V49, P979, DOI 10.1016/j.ympev.2008.09.017; Chauvin A, 2009, VET RES, V40, DOI 10.1051/vetres/2009020; Conrad PA, 2006, INT J PARASITOL, V36, P779, DOI 10.1016/j.ijpara.2006.03.008; Cornillot E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072657; Cornillot E, 2012, NUCLEIC ACIDS RES, V40, P9102, DOI 10.1093/nar/gks700; Criado-Fornelio A, 2003, VET PARASITOL, V113, P189, DOI 10.1016/S0304-4017(03)00078-5; Criado-Fornelio A, 2003, VET PARASITOL, V114, P173, DOI 10.1016/S0304-4017(03)00141-9; Criado-Fornelio A, 2003, VET MICROBIOL, V93, P307, DOI 10.1016/S0378-1135(03)00044-0; Dobbelaere D, 1999, ANNU REV MICROBIOL, V53, P1, DOI 10.1146/annurev.micro.53.1.1; Feagin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038320; Giadinis ND, 2012, VET REC, V170, p155B, DOI 10.1136/vr.100394; Goethert HK, 2003, PARASITOLOGY, V127, P301, DOI 10.1017/S0031182003003822; Gohil S, 2013, INT J PARASITOL, V43, P125, DOI 10.1016/j.ijpara.2012.09.008; GORENFLOT A, 1991, PARASITOL RES, V77, P3, DOI 10.1007/BF00934377; Gou HT, 2012, ACTA TROP, V124, P92, DOI 10.1016/j.actatropica.2012.07.001; GROOTENHUIS JG, 1979, RES VET SCI, V27, P59, DOI 10.1016/S0034-5288(18)32860-1; Hagiwara K, 1997, INT J PARASITOL, V27, P1375, DOI 10.1016/S0020-7519(97)00092-1; Harris DJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1567-5; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; He L, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-82; Hikosaka K, 2013, MOL BIOCHEM PARASIT, V188, P26, DOI 10.1016/j.molbiopara.2013.02.006; Hikosaka K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-622; Hikosaka K, 2010, MOL BIOL EVOL, V27, P1107, DOI 10.1093/molbev/msp320; Hornok S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1052-6; Irwin PJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-S1-S4; Kappmeyer LS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-603; Ketz-Riley CJ, 2003, J WILDLIFE DIS, V39, P424, DOI 10.7589/0090-3558-39.2.424; Kher CP, 2011, PROTIST, V162, P2, DOI 10.1016/j.protis.2010.03.004; Kjemtrup AM, 2006, VET PARASITOL, V138, P103, DOI 10.1016/j.vetpar.2006.01.044; Kjemtrup AM, 2000, PARASITOLOGY, V120, P487, DOI 10.1017/S003118209900582X; Kjemtrup AM, 2001, J PARASITOL, V87, P373, DOI 10.1645/0022-3395(2001)087[0373:DAEOTY]2.0.CO;2; Kjemtrup AM, 2000, INT J PARASITOL, V30, P1501, DOI 10.1016/S0020-7519(00)00120-X; Kjemtrup AM, 2006, VET PARASITOL, V138, P112, DOI 10.1016/j.vetpar.2006.01.045; Lack JB, 2012, INT J PARASITOL, V42, P353, DOI 10.1016/j.ijpara.2012.02.005; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Le TH, 2000, ACTA TROP, V77, P243, DOI 10.1016/S0001-706X(00)00157-1; Leclaire S, 2015, PARASITOLOGY, V142, P543, DOI 10.1017/S0031182014001504; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; LEVINE ND, 1971, T AM MICROSC SOC, V90, P2, DOI 10.2307/3224894; Levine ND., 1988, PROTOZOAN PHYLUM API; Maia C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-115; MEHLHORN H, 1986, DEUT TIERARZTL WOCH, V93, P400; Mehlhorn H, 1998, PARASITOL RES, V84, P467, DOI 10.1007/s004360050431; Meinkoth JH, 2005, VET CLIN N AM-SMALL, V35, P89, DOI 10.1016/j.cvsm.2004.08.003; Merino S, 1998, J PARASITOL, V84, P422, DOI 10.2307/3284504; Millan J, 2007, PARASITOLOGY, V134, P995, DOI 10.1017/S003118200700248X; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; MOTZEL SL, 1990, VET PARASITOL, V35, P131, DOI 10.1016/0304-4017(90)90122-R; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; NEITZ W. O., 1948, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V23, P63; Nijhof AM, 2005, J CLIN MICROBIOL, V43, P5907, DOI 10.1128/JCM.43.12.5907-5911.2005; Nijhof AM, 2003, J CLIN MICROBIOL, V41, P2249, DOI 10.1128/JCM.41.5.2249-2254.2003; Ogedengbe JD, 2011, INT J PARASITOL, V41, P843, DOI 10.1016/j.ijpara.2011.03.007; Paparini A, 2015, PROTIST, V166, P609, DOI 10.1016/j.protis.2015.10.001; Paparini A, 2014, PARASITOL RES, V113, P4407, DOI 10.1007/s00436-014-4118-z; QUICK RE, 1993, ANN INTERN MED, V119, P284, DOI 10.7326/0003-4819-119-4-199308150-00006; Ramsay JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076996; Reichard MV, 2005, J PARASITOL, V91, P420, DOI 10.1645/GE-384R; SANKOFF D, 1992, P NATL ACAD SCI USA, V89, P6575, DOI 10.1073/pnas.89.14.6575; SATO M, 1993, J VET MED SCI, V55, P571, DOI 10.1292/jvms.55.571; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schnittger L, 2012, INFECT GENET EVOL, V12, P1788, DOI 10.1016/j.meegid.2012.07.004; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sikorski LE, 2010, J VET INTERN MED, V24, P127, DOI 10.1111/j.1939-1676.2009.0440.x; Sivakumar T, 2014, INFECT GENET EVOL, V27, P250, DOI 10.1016/j.meegid.2014.07.013; Soares JF, 2015, VET PARASITOL, V210, P98, DOI 10.1016/j.vetpar.2015.03.013; Solano-Gallego L, 2011, VET PARASITOL, V181, P48, DOI 10.1016/j.vetpar.2011.04.023; SPOONER RL, 1988, PARASITE IMMUNOL, V10, P619, DOI 10.1111/j.1365-3024.1988.tb00249.x; SPOONER RL, 1989, IMMUNOLOGY, V66, P284; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Su XZ, 1996, NUCLEIC ACIDS RES, V24, P1574, DOI 10.1093/nar/24.8.1574; Susta L, 2009, VET PATHOL, V46, P1197, DOI 10.1354/vp.08-VP-0132-B-FL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tarigo JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071233; THOMAS SE, 1982, ONDERSTEPOORT J VET, V49, P163; Tian Z, 2012, INFECT GENET EVOL; UILENBERG G, 1987, VET PARASITOL, V26, P21, DOI 10.1016/0304-4017(87)90073-2; Uilenberg G, 2006, VET PARASITOL, V138, P3, DOI 10.1016/j.vetpar.2006.01.035; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vannier EG, 2015, INFECT DIS CLIN N AM, V29, P357, DOI 10.1016/j.idc.2015.02.008; Wilson RJM, 1997, MICROBIOL MOL BIOL R, V61, P1; Wise LN, 2013, J VET INTERN MED, V27, P1334, DOI 10.1111/jvim.12168; Yabsley Michael J., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P18, DOI 10.1016/j.ijppaw.2012.11.003; Yabsley MJ, 2006, J PARASITOL, V92, P423, DOI 10.1645/GE-617R.1; YOUNG AS, 1980, PARASITOLOGY, V81, P129, DOI 10.1017/S0031182000055104; Zahler M, 2000, PARASITOL RES, V86, P642, DOI 10.1007/PL00008545; Zahler M, 2000, PARASITOLOGY, V120, P365, DOI 10.1017/S0031182099005557	102	69	72	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165702	10.1371/journal.pone.0165702	http://dx.doi.org/10.1371/journal.pone.0165702			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832128	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000027
J	Zhao, JW; Liu, JJ; Lee, JF; Zhang, WL; Kandouz, M; VanHecke, GC; Chen, SY; Ahn, YH; Lonardo, F; Lee, MJ				Zhao, Jiawei; Liu, Jingjing; Lee, Jen-Fu; Zhang, Wenliang; Kandouz, Mustapha; VanHecke, Garrett C.; Chen, Shiyou; Ahn, Young-Hoon; Lonardo, Fulvio; Lee, Menq-Jer			TGF-beta/SMAD3 Pathway Stimulates Sphingosine-1 Phosphate Receptor 3 Expression IMPLICATION OF SPHINGOSINE-1 PHOSPHATE RECEPTOR 3 IN LUNG ADENOCARCINOMA PROGRESSION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; CELL LUNG-CANCER; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; SIGNALING PATHWAY; TUMOR PROGRESSION; MUTATION ANALYSIS	Previously, we showed that levels of sphingosine-1 phosphate receptor 3 (S1PR3) are increased in a panel of cultured human lung adenocarcinoma cell lines, and that S1PR3-mediated signaling pathways regulate proliferation, soft agar growth, and invasion of human lung adenocarcinoma cells in vitro. In the present study, we examine S1PR3 levels in human lung adenocarcinoma specimens. cDNA array and tumor microarray analysis shows that mRNA and protein levels of S1PR3 are significantly increased in human lung adenocarcinomas when compared with normal lung epithelial cells. Promoter analysis shows 16 candidate SMAD3 binding sites in the promoter region of S1PR3. ChIP indicates that TGF-beta treatment stimulates the binding of SMAD3 to the promoter region of S1PR3. Luciferase reporter assay demonstrates that SMAD3 transactivates S1PR3 promoter. TGF-beta stimulation or ectopic expression of TGF-beta up-regulates S1PR3 levels in vitro and ex vivo. Pharmacologic inhibition of TGF-beta receptor or SMAD3 abrogates the TGF-beta-stimulated S1PR3 up-regulation. Moreover, S1PR3 knockdown dramatically inhibits tumor growth and lung metastasis, whereas ectopic expression of S1PR3 promotes the growth of human lung adenocarcinoma cells in animals. Pharmacological inhibition of S1PR3 profoundly inhibits the growth of lung carcinoma in mice. Our studies suggest that levels of S1PR3 are up-regulated in human lung adenocarcinomas, at least in part due to the TGF-beta/SMAD3 signaling axis. Furthermore, S1PR3 activity promotes the progression of human lung adenocarcinomas. Therefore, S1PR3 may represent a novel therapeutic target for the treatment of deadly lung adenocarcinomas.	[Zhao, Jiawei; Liu, Jingjing; Lee, Jen-Fu; Zhang, Wenliang; Kandouz, Mustapha; Lonardo, Fulvio; Lee, Menq-Jer] Wayne State Univ, Sch Med, Dept Pathol, 540 East Canfield Ave,Scott Hall,Rm 9215, Detroit, MI 48201 USA; [VanHecke, Garrett C.; Ahn, Young-Hoon] Wayne State Univ, Sch Med, Dept Chem, Detroit, MI 48201 USA; [Lonardo, Fulvio; Lee, Menq-Jer] Wayne State Univ, Sch Med, Karmanos Canc Inst, Detroit, MI 48201 USA; [Lee, Menq-Jer] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI 48201 USA; [Chen, Shiyou] Univ Georgia, Coll Vet Med, Dept Physiol & Pharmacol, Athens, GA 30602 USA	Wayne State University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Wayne State University; University System of Georgia; University of Georgia	Lee, MJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, 540 East Canfield Ave,Scott Hall,Rm 9215, Detroit, MI 48201 USA.	menqjer.lee@wayne.edu	LEE, JEN-FU/GRO-3670-2022		Department of Defense [W81XWH-14-1-0346]; Wayne State University; Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute; National Institutes of Health [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119053, R01HL123302] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Wayne State University; Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Department of Defense Grant W81XWH-14-1-0346, a funding support of Wayne State University, a Strategic Research Initiative Grant (SRIG) award of the Karmanos Cancer Institute (to M. L.), and National Institutes of Health Grants HL123302 and HL119053 (to S. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; An SZ, 1998, J CELL BIOCHEM, P147; Aoyagi T, 2012, LYMPHAT RES BIOL, V10, P97, DOI 10.1089/lrb.2012.0010; Barthelemy-Brichant N, 2002, EUR J CLIN INVEST, V32, P193, DOI 10.1046/j.1365-2362.2002.00956.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Cencetti F, 2010, MOL BIOL CELL, V21, P1111, DOI 10.1091/mbc.E09-09-0812; Chen MF, 2012, CLIN SCI, V122, P459, DOI 10.1042/CS20110434; Cui Y, 2011, INT J BIOCHEM CELL B, V43, P1122, DOI 10.1016/j.biocel.2011.04.005; Davis MD, 2005, J BIOL CHEM, V280, P9833, DOI 10.1074/jbc.M412356200; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dornagafa-Kulawik J, 2006, ARCH IMMUNOL THER EX, V54, P143, DOI 10.1007/s00005-006-0016-0; Estrada R, 2008, J BIOL CHEM, V283, P30363, DOI 10.1074/jbc.M804392200; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Gauldie J, 2008, AM J PHYSIOL-LUNG C, V294, pL151, DOI 10.1152/ajplung.00520.2007; Giannelli G, 2014, CANCER RES, V74, P1890, DOI 10.1158/0008-5472.CAN-14-0243; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hasegawa Y, 2001, CANCER-AM CANCER SOC, V91, P964, DOI 10.1002/1097-0142(20010301)91:5<964::AID-CNCR1086>3.0.CO;2-O; Haura EB, 2006, CLIN LUNG CANCER, V7, P273, DOI 10.3816/CLC.2006.n.006; Hirata N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5806; Hong S, 2010, WORLD J GASTROENTERO, V16, P2080, DOI 10.3748/wjg.v16.i17.2080; Hsu A, 2012, INT J ONCOL, V40, P1619, DOI 10.3892/ijo.2012.1379; Ivanova MM, 2009, MOL CELL ENDOCRINOL, V305, P12, DOI 10.1016/j.mce.2009.01.021; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jenne CN, 2009, J EXP MED, V206, P2469, DOI 10.1084/jem.20090525; Karachaliou N, 2013, CLIN LUNG CANCER, V14, P205, DOI 10.1016/j.cllc.2012.09.007; Larsen JE, 2007, CARCINOGENESIS, V28, P760, DOI 10.1093/carcin/bgl207; Lee JC, 2004, J IMMUNOL, V172, P7335, DOI 10.4049/jimmunol.172.12.7335; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee MJ, 1999, CELL, V99, P301, DOI 10.1016/S0092-8674(00)81661-X; Lee MJ, 2001, MOL CELL, V8, P693, DOI 10.1016/S1097-2765(01)00324-0; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Mantel PY, 2011, METHODS MOL BIOL, V677, P303, DOI 10.1007/978-1-60761-869-0_21; Miller AV, 2008, MOL CELL BIOL, V28, P4142, DOI 10.1128/MCB.01465-07; Murakami A, 2010, MOL PHARMACOL, V77, P704, DOI 10.1124/mol.109.061481; Naber HPH, 2008, CURR CANCER DRUG TAR, V8, P466, DOI 10.2174/156800908785699342; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nalluri SM, 2015, CYTOSKELETON, V72, P557, DOI 10.1002/cm.21263; Nowrin K, 2014, EXPERT REV RESP MED, V8, P547, DOI 10.1586/17476348.2014.948853; Nussbaum C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7416; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Olejniczak ET, 2007, MOL CANCER RES, V5, P331, DOI 10.1158/1541-7786.MCR-06-0367; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Pyne NJ, 2012, BIOCHEM SOC T, V40, P94, DOI 10.1042/BST20110602; Rak J, 1995, CANCER METAST REV, V14, P263, DOI 10.1007/BF00690598; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Saito H, 1999, CANCER, V86, P1455, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1455::AID-CNCR11>3.0.CO;2-L; Saitoh M, 2015, CANCER SCI, V106, P481, DOI 10.1111/cas.12630; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Sholl LM, 2015, J THORAC ONCOL, V10, P768, DOI 10.1097/JTO.0000000000000516; Siow DL, 2011, ADV ENZYME REGUL, V51, P229, DOI 10.1016/j.advenzreg.2010.09.004; Tian MZ, 2011, CELL SIGNAL, V23, P951, DOI 10.1016/j.cellsig.2010.10.015; Tsushima H, 1996, GASTROENTEROLOGY, V110, P375, DOI 10.1053/gast.1996.v110.pm8566583; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Xie WB, 2011, J BIOL CHEM, V286, P15050, DOI 10.1074/jbc.M110.202747; Xin CY, 2004, J BIOL CHEM, V279, P35255, DOI 10.1074/jbc.M312091200; Yamamoto H, 2009, LUNG CANCER, V63, P315, DOI 10.1016/j.lungcan.2008.06.021; Yamanaka M, 2004, J BIOL CHEM, V279, P53994, DOI 10.1074/jbc.M410144200; YANAGAWA H, 1995, BRIT J CANCER, V71, P1095, DOI 10.1038/bjc.1995.212; Yang L, 2010, CANCER METAST REV, V29, P263, DOI 10.1007/s10555-010-9226-3; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yester JW, 2011, CANCER METAST REV, V30, P577, DOI 10.1007/s10555-011-9305-0; Yu H, 2015, NEOPLASMA, V62, P1, DOI 10.4149/neo_2015_002; Zhang WL, 2014, J BIOL CHEM, V289, P32178, DOI 10.1074/jbc.M114.601096; Zhang WL, 2013, PROSTAG OTH LIPID M, V106, P62, DOI 10.1016/j.prostaglandins.2013.06.001; Zhang WL, 2013, J BIOL CHEM, V288, P32126, DOI 10.1074/jbc.M113.495218; Zhao P, 2013, ONCOGENE, V32, P5186, DOI 10.1038/onc.2012.542	75	27	30	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27343	27353		10.1074/jbc.M116.740084	http://dx.doi.org/10.1074/jbc.M116.740084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856637	Green Published, hybrid			2022-12-26	WOS:000391576300031
J	Bueno, S; Pasqua, LA; de Araujo, G; Lima-Silva, AE; Bertuzzi, R				Bueno, Salomao; Pasqua, Leonardo A.; de Araujo, Gustavo; Lima-Silva, Adriano Eduardo; Bertuzzi, Romulo			The Association of ACE Genotypes on Cardiorespiratory Variables Related to Physical Fitness in Healthy Men	PLOS ONE			English	Article							ENZYME ID POLYMORPHISM; INSERTION/DELETION POLYMORPHISM; ENDURANCE PERFORMANCE; OXYGEN-UPTAKE; EXERCISE; MUSCLE; WOMEN; VO2MAX	Aerobic power (VO(2)max), aerobic capacity (RCP), and running efficiency (RE) are important markers of aerobic fitness. However, the influence of the angiotensin converting enzyme (ACE) polymorphism on these markers has not been investigated in healthy individuals. One hundred and fifty physically active young men (age 25 +/- 3 years; height 1.77 +/- 0.06 m; body mass 76.6 +/- 0.9 kg; VO(2)max 47.7 +/- 5.5 ml.kg(-1).min(-1)) visited the laboratory on two separate occasions, and performed the following tests: a) a maximal incremental treadmill test to determine VO(2)max and RCP, and b) two constant-speed running tests (10 km.h(-1) and 12 km.h(-1)) to determine RE. The genotype frequency was II = 21%; ID = 52%; and DD = 27%. There was a tendency for higher VO(2)max with the ACE II genotype (p = 0.08) compared to DD and ID genotypes. Magnitude based inferences suggested a likely beneficial effect on VO(2)max with the ACE II genotype. There was no association between genotypes for other variable. These findings suggest that individuals with the ACE II genotype have a tendency towards better values in aerobic power, but not with aerobic capacity or running economy.	[Bueno, Salomao; Pasqua, Leonardo A.; Bertuzzi, Romulo] Univ Sao Paulo, Endurance Sports Res Grp, Sch Phys Educ & Sport, Sao Paulo, Brazil; [de Araujo, Gustavo] Univ Fed Alagoas, Sports Sci Res Grp, Maceio, Brazil; [Lima-Silva, Adriano Eduardo] Univ Fed Pernambuco, Acad Ctr Vitoria, Sports Sci Res Grp, Vitoria De Santo Antao, Brazil	Universidade de Sao Paulo; Universidade Federal de Alagoas; Universidade Federal de Pernambuco	Bueno, S (corresponding author), Univ Sao Paulo, Endurance Sports Res Grp, Sch Phys Educ & Sport, Sao Paulo, Brazil.	salomao.silva@usp.bt	de Araujo, Gustavo/S-5301-2019; Bertuzzi, Romulo/E-7048-2012; Lima-Silva, Adriano/Y-2404-2019; de Araujo, Gustavo Gomes/C-9172-2013; Lima-Silva, Adriano Eduardo/C-2800-2013	Lima-Silva, Adriano/0000-0002-0613-5104; Lima-Silva, Adriano Eduardo/0000-0002-0613-5104	CAPES [1182744]; FAPESP [2010/13913-6]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by CAPES (grant 1182744) (SB) and FAPESP (grant 2010/13913-6) (LP).; Salomao Bueno is supported by CAPES (grant 1182744). Leonardo A. Pasqua is supported by FAPESP (grant 2010/13913-6).	Almeida JA, 2012, ARQ BRAS CARDIOL, V98, P315, DOI 10.1590/S0066-782X2012005000029; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bijker KE, 2002, EUR J APPL PHYSIOL, V87, P556, DOI 10.1007/s00421-002-0663-8; Bouchard C, 1999, J APPL PHYSIOL, V87, P1003, DOI 10.1152/jappl.1999.87.3.1003; BROZEK J, 1963, ANN NY ACAD SCI, V110, P113, DOI 10.1111/j.1749-6632.1963.tb17079.x; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Day SH, 2007, EUR J APPL PHYSIOL, V99, P11, DOI 10.1007/s00421-006-0309-3; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gomez-Gallego F, 2009, INT J SPORTS MED, V30, P66, DOI 10.1055/s-2008-1038677; Hagberg JM, 2002, J APPL PHYSIOL, V92, P1083, DOI 10.1152/japplphysiol.00135.2001; HAMEL P, 1986, MED SCI SPORT EXER, V18, P690; HEYWARD V, 1978, RES QUART, V49, P301, DOI 10.1080/10671315.1978.10615538; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; Meyer T, 2005, INT J SPORTS MED, V26, pS38, DOI 10.1055/s-2004-830514; Montgomery HE, 1997, CIRCULATION, V96, P741; Montgomery HE, 1998, NATURE, V393, P221, DOI 10.1038/30374; Myburgh KH, 2003, COMP BIOCHEM PHYS A, V136, P171, DOI 10.1016/S1095-6433(03)00220-4; Norton, 1996, ANTHROPOMETRICA; Orysiak J, 2013, BIOL SPORT, V30, P249, DOI 10.5604/20831862.1077549; Puthucheary Z, 2011, SPORTS MED, V41, P433, DOI 10.2165/11588720-000000000-00000; Rankinen T, 2000, J APPL PHYSIOL, V88, P1571, DOI 10.1152/jappl.2000.88.5.1571; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Storen O, 2008, MED SCI SPORT EXER, V40, P1087, DOI 10.1249/MSS.0b013e318168da2f; Vaughan D, 2013, EUR J APPL PHYSIOL, V113, P1719, DOI 10.1007/s00421-012-2583-6; Williams AG, 2000, NATURE, V403, P614, DOI 10.1038/35001141; Zhang B, 2005, HYPERTENS RES, V28, P681, DOI 10.1291/hypres.28.681; Zhang B, 2003, CLIN GENET, V63, P139, DOI 10.1034/j.1399-0004.2003.00029.x; Zhao B, 2003, LIFE SCI, V73, P2625, DOI 10.1016/S0024-3205(03)00608-8	30	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165310	10.1371/journal.pone.0165310	http://dx.doi.org/10.1371/journal.pone.0165310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861507	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300005
J	Taj, T; Stroh, E; Astrom, DO; Jakobsson, K; Oudin, A				Taj, Tahir; Stroh, Emilie; Astrom, Daniel Oudin; Jakobsson, Kristina; Oudin, Anna			Short-Term Fluctuations in Air Pollution and Asthma in Scania, Sweden. Is the Association Modified by Long-Term Concentrations?	PLOS ONE			English	Article							CASE-CROSSOVER ANALYSIS; HOSPITAL ADMISSIONS; APPARENT TEMPERATURE; NITROGEN-DIOXIDE; HONG-KONG; EXPOSURE; CHILDREN; COPENHAGEN; DENMARK; HEALTH	Background and aims Asthma is one of the most common respiratory diseases in the world. Research has shown that temporal increases in air pollution concentrations can aggravate asthma symptoms. The aim of this study was to assess whether individuals living in areas with higher air pollution concentrations responded differently to short-term temporal exposure to air pollution than those living in lower air pollution areas. Method The study was designed as a case-crossover study in Scania, Sweden. Outcome data was visits to primary health care clinics with asthma as the main complaint during the years 2007 to 2010. Nitrogen dioxide levels were obtained from 21 different air pollution monitoring stations. Short-term exposure was defined as the average concentration four days prior to the visit. Data was pooled for areas above and below a two-year average NO2 concentration of 10 mu g/m3, dispersion modelled with an emission database. Results The short-term association between NO2 and asthma visits seemed stronger in areas with NO2 levels below 10 mu g/m3, with an odds ratio (OR) of 1.15 (95% confidence interval (CI): 1.08-1.23) associated with a 10 mu g/m3 increase in NO2 compared to areas above 10 mu g/m3 NO2 levels, where corresponding OR of 1.09 (95% CI: 1.02-1.17). However, this difference was not statistically significant. (p = 0.13) Conclusions The study provided some evidence, although not statistically significant, that short-term associations between air pollution and asthma may depend on background air pollution levels. However, we cannot rule out that the association is due to other spatially dependent factors in Scania. The study should be reproduced in other study areas.	[Taj, Tahir; Stroh, Emilie; Jakobsson, Kristina; Oudin, Anna] Lund Univ, Dept Occupat & Environm Med, Lund, Sweden; [Astrom, Daniel Oudin] Lund Univ, Ctr Primary Hlth Care Res, Dept Clin Sci, Lund, Sweden; [Astrom, Daniel Oudin; Oudin, Anna] Umea Univ, Dept Occupat & Environm Med, Umea, Sweden	Lund University; Lund University; Umea University	Taj, T (corresponding author), Lund Univ, Dept Occupat & Environm Med, Lund, Sweden.	tahir.taj@med.lu.se	Oudin, Anna/A-5446-2013	Oudin, Anna/0000-0002-9876-0627	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; Faculty of Medicine, Lund University, Sweden	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Faculty of Medicine, Lund University, Sweden	The authors would like to thank FORMAS, The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning and the Faculty of Medicine, Lund University, Sweden for funding the research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(AAIR) CfAAIR, ASTHM EU BETT MAN RE; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Andersen ZJ, 2008, OCCUP ENVIRON MED, V65, P458, DOI 10.1136/oem.2007.033290; Arbex MA, 2012, J BRAS PNEUMOL, V38, P643, DOI 10.1590/S1806-37132012000500015; Asthma NG, ASTHMA MAY AFFECT MA; Atkinson RW, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009493; BATES DV, 1995, ENVIRON HEALTH PERSP, V103, P243, DOI 10.2307/3432380; Baxter LK, 2007, ATMOS ENVIRON, V41, P6561, DOI 10.1016/j.atmosenv.2007.04.027; Berhane K, 2014, OCCUP ENVIRON MED, V71, P507, DOI 10.1136/oemed-2013-101874; Bloomfield SF, 2006, CLIN EXP ALLERGY, V36, P402, DOI 10.1111/j.1365-2222.2006.02463.x; Boriani S, 1985, Chir Organi Mov, V70, P149; Bowatte G, 2015, ALLERGY, V70, P245, DOI 10.1111/all.12561; Braga ALF, 2001, PEDIATR PULM, V31, P106, DOI 10.1002/1099-0496(200102)31:2<106::AID-PPUL1017>3.0.CO;2-M; Burnett RT, 2001, AM J EPIDEMIOL, V153, P444, DOI 10.1093/aje/153.5.444; Carracedo-Martinez E, 2010, ENVIRON HEALTH PERSP, V118, P1173, DOI 10.1289/ehp.0901485; Chanel O, 2016, EUR J HEALTH ECON, V17, P1101, DOI 10.1007/s10198-015-0748-z; Fuertes E, 2013, PEERJ, V1, DOI 10.7717/peerj.193; Gao Y, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-105; Gaviola C, 2016, THORAX, V71, P154, DOI 10.1136/thoraxjnl-2015-207584; GRAHAM R, 1989, PRACTITIONER, V233, P555; Hansell A, 2016, THORAX, V71, P330, DOI 10.1136/thoraxjnl-2015-207111; Herrant M, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0090-0; Jie Y, 2013, REV ENVIRON CONTAM T, V226, P33, DOI 10.1007/978-1-4614-6898-1_2; KOREN HS, 1995, ENVIRON HEALTH PERSP, V103, P235, DOI 10.2307/3432379; Kunzli N, 2008, EPIDEMIOLOGY, V19, P179, DOI 10.1097/EDE.0b013e3181633c2f; Kunzli N, 2012, THORAX, V67, P2, DOI 10.1136/thoraxjnl-2011-200919; Levy I, 2014, ENVIRON HEALTH PERSP, V122, P65, DOI 10.1289/ehp.1306518; Lotvall J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-94; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Menichini F, 2010, PHARMACOEPIDEM DR S, V19, P1300, DOI 10.1002/pds.2033; O'Connor GT, 2008, J ALLERGY CLIN IMMUN, V121, P1133, DOI 10.1016/j.jaci.2008.02.020; Oudin A, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-301; Sommar JN, 2013, BMJ OPEN RESPIR RES, V1, DOI 10.1136/bmjresp-2014-000039; Stroh E, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-10; Timm S, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010093; Trenga CA, 2001, ARCH ENVIRON HEALTH, V56, P242, DOI 10.1080/00039890109604448; Ware LB, 2016, AM J RESP CRIT CARE, V193, P1143, DOI 10.1164/rccm.201507-1418OC; Weichenthal SA, 2016, AM J RESP CRIT CARE, V194, P577, DOI 10.1164/rccm.201512-2434OC; Wichmann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053684; Wichmann J, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-19; Wichmann J, 2011, INT J ENV RES PUB HE, V8, P3712, DOI 10.3390/ijerph8093712; Wong GWK, 2001, CLIN EXP ALLERGY, V31, P565, DOI 10.1046/j.1365-2222.2001.01063.x; Yang QY, 2003, INHAL TOXICOL, V15, P1297, DOI 10.1080/08958370390241768; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zhang SQ, 2016, ENVIRON RES, V148, P15, DOI 10.1016/j.envres.2016.03.008	45	4	5	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166614	10.1371/journal.pone.0166614	http://dx.doi.org/10.1371/journal.pone.0166614			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861543	gold, Green Published, Green Submitted			2022-12-26	WOS:000388350300077
J	Boucher-Lalonde, V; Currie, DJ				Boucher-Lalonde, Veronique; Currie, David J.			Spatial Autocorrelation Can Generate Stronger Correlations between Range Size and Climatic Niches Than the Biological Signal - A Demonstration Using Bird and Mammal Range Maps	PLOS ONE			English	Article							POSTGLACIAL DISPERSAL LIMITATION; SPECIES DISTRIBUTIONS; GEOGRAPHICAL RANGE; DISTRIBUTION MODELS; THERMAL TOLERANCE; POTENTIAL RANGE; RICHNESS; BREADTH; ASSOCIATIONS; ABUNDANCE	Species' geographic ranges could primarily be physiological tolerances drawn in space. Alternatively, geographic ranges could be only broadly constrained by physiological climatic tolerances: there could generally be much more proximate constraints on species' ranges (dispersal limitation, biotic interactions, etc.) such that species often occupy a small and unpredictable subset of tolerable climates. In the literature, species' climatic tolerances are typically estimated from the set of conditions observed within their geographic range. Using this method, studies have concluded that broader climatic niches permit larger ranges. Similarly, other studies have investigated the biological causes of incomplete range filling. But, when climatic constraints are measured directly from species' ranges, are correlations between species' range size and climate necessarily consistent with a causal link? We evaluated the extent to which variation in range size among 3277 bird and 1659 mammal species occurring in the Americas is statistically related to characteristics of species' realized climatic niches. We then compared how these relationships differed from the ones expected in the absence of a causal link. We used a null model that randomizes the predictor variables (climate), while retaining their broad spatial autocorrelation structure, thereby removing any causal relationship between range size and climate. We found that, although range size is strongly positively related to climatic niche breadth, range filling and, to a lesser extent, niche position in nature, the observed relationships are not always stronger than expected from spatial autocorrelation alone. Thus, we conclude that equally strong relationships between range size and climate would result from any processes causing ranges to be highly spatially autocorrelated.	[Boucher-Lalonde, Veronique; Currie, David J.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Boucher-Lalonde, Veronique] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada	University of Ottawa; University of Sherbrooke	Boucher-Lalonde, V (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.; Boucher-Lalonde, V (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ, Canada.	veronique.boucher.lalonde@gmail.com			Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council of Canada; Fonds Quebecois de Recherche en Nature et Technologies	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Fonds Quebecois de Recherche en Nature et Technologies	VBL was funded by an Ontario Graduate Scholarship, https://osap.gov.on.ca/OSAPPortal/en/A-ZListofAid/PRDR013089.html, and a postgraduate scholarship from the Natural Sciences and Engineering Research Council of Canada http://www.nserc-crsng.gc.ca/. VBL is currently funded by a Postdoctoral research scholarship from the Fonds Quebecois de Recherche en Nature et Technologies, http://www.frqnt.gouv.qc.ca/. DJC is funded by a discovery grant from the Natural Sciences and Engineering Research Council of Canada, http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Bahn V, 2007, GLOBAL ECOL BIOGEOGR, V16, P733, DOI 10.1111/j.1466-8238.2007.00331.x; Bahn V, 2013, OIKOS, V122, P321, DOI 10.1111/j.1600-0706.2012.00299.x; Barnagaud JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032819; Bates AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1958; Beale CM, 2009, P NATL ACAD SCI USA, V106, pE41, DOI 10.1073/pnas.0902229106; Beale CM, 2008, P NATL ACAD SCI USA, V105, P14908, DOI 10.1073/pnas.0803506105; Boucher-Lalonde V, 2014, OIKOS, V123, P1029, DOI 10.1111/oik.01277; Boucher-Lalonde V, 2014, J BIOGEOGR, V41, P443, DOI 10.1111/jbi.12232; Boucher-Lalonde V, 2012, GLOBAL ECOL BIOGEOGR, V21, P1157, DOI 10.1111/j.1466-8238.2012.00764.x; Boulangeat I, 2012, ECOL LETT, V15, P584, DOI 10.1111/j.1461-0248.2012.01772.x; Bozinovic F, 2011, ANNU REV ECOL EVOL S, V42, P155, DOI 10.1146/annurev-ecolsys-102710-145055; Briers RA, 2003, GLOBAL ECOL BIOGEOGR, V12, P47, DOI 10.1046/j.1466-822X.2003.00316.x; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Calosi P, 2008, THERMAL TOLERANCE AC; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Chapman DS, 2010, GLOBAL ECOL BIOGEOGR, V19, P831, DOI 10.1111/j.1466-8238.2010.00561.x; Chejanovski ZA, 2014, J BIOGEOGR, V41, P1936, DOI 10.1111/jbi.12345; Currie D.J., 2014, P ROY SOC LOND B BIO, V281, P1776; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Gaston KJ, 1997, J ANIM ECOL, V66, P579, DOI 10.2307/5951; Gouveia SF, 2014, GLOBAL ECOL BIOGEOGR, V23, P446, DOI 10.1111/geb.12114; Hargreaves AL, 2014, AM NAT, V183, P157, DOI 10.1086/674525; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Hubbell Stephen P., 2001, V32, pi; Hurlbert AH, 2007, P NATL ACAD SCI USA, V104, P13384, DOI 10.1073/pnas.0704469104; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Laube I, 2013, GLOBAL ECOL BIOGEOGR, V22, P223, DOI 10.1111/j.1466-8238.2012.00796.x; Luna B, 2010, PLANT ECOL, V210, P85, DOI 10.1007/s11258-010-9740-y; McGill B, 2003, EVOL ECOL RES, V5, P469; Morin X, 2013, ECOGRAPHY, V36, P300, DOI 10.1111/j.1600-0587.2012.07340.x; Munguia M, 2008, J BIOGEOGR, V35, P1879, DOI 10.1111/j.1365-2699.2008.01921.x; Nakazawa Y, 2013, BIOL J LINN SOC, V108, P241, DOI 10.1111/j.1095-8312.2012.02018.x; Nogues-Bravo D, 2014, PERSPECTIVES PLANT E; Ordonez A, 2013, AM J BOT, V100, P1255, DOI 10.3732/ajb.1300043; Pannek A, 2013, GLOBAL ECOL BIOGEOGR, V22, P1019, DOI 10.1111/geb.12055; PATTERSON B. D., 2007, DIGITAL DISTRIBUTION; Pither J, 2003, P ROY SOC B-BIOL SCI, V270, P475, DOI 10.1098/rspb.2002.2275; Quintero I, 2013, GLOBAL ECOL BIOGEOGR, V22, P422, DOI 10.1111/geb.12001; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Schlather M, 2014, RANDOMFIELDS SIMULA; Schurr FM, 2007, GLOBAL ECOL BIOGEOGR, V16, P449, DOI 10.1111/j.1466-8238.2006.00293.x; Skov F, 2004, ECOGRAPHY, V27, P366, DOI 10.1111/j.0906-7590.2004.03823.x; Slatyer RA, 2013, ECOL LETT, V16, P1104, DOI 10.1111/ele.12140; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Soininen J, 2011, ECOL COMPLEX, V8, P130, DOI 10.1016/j.ecocom.2010.12.001; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Strubbe D, 2014, ECOGRAPHY; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Svenning JC, 2008, ECOGRAPHY, V31, P316, DOI 10.1111/j.0906-7590.2008.05206.x; Svenning JC, 2007, ECOL LETT, V10, P453, DOI 10.1111/j.1461-0248.2007.01038.x; Warren DL, 2014, TRENDS ECOL EVOL, V29, P572, DOI 10.1016/j.tree.2014.08.003; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Wiens JJ, 2011, Q REV BIOL, V86, P75, DOI 10.1086/659883	67	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166243	10.1371/journal.pone.0166243	http://dx.doi.org/10.1371/journal.pone.0166243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855201	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200024
J	Drake, A; Kaur, M; Iliopoulou, BP; Phennicie, R; Hanson, A; Chen, JZ				Drake, Adam; Kaur, Mandeep; Iliopoulou, Bettina P.; Phennicie, Ryan; Hanson, Amanda; Chen, Jianzhu			Interleukins 7 and 15 Maintain Human T Cell Proliferative Capacity through STAT5 Signaling	PLOS ONE			English	Article							SCID IL2R-GAMMA(NULL) MICE; IMMUNE-RESPONSES; IN-VIVO; ANTIBODY-RESPONSES; MOUSE MODELS; NOG MICE; DIFFERENTIATION; RECONSTITUTION; CYTOKINES; PROMOTES	T lymphocytes require signals from self-peptides and cytokines, most notably interleukins 7 and 15 (IL-7, IL-15), for survival. While mouse T cells die rapidly if IL-7 or IL-15 is withdrawn, human T cells can survive prolonged withdrawal of IL-7 and IL-15. Here we show that IL-7 and IL-15 are required to maintain human T cell proliferative capacity through the STAT5 signaling pathway. T cells from humanized mice proliferate better if stimulated in the presence of human IL-7 or IL-15 or if T cells are exposed to human IL-7 or IL-15 in mice. Freshly isolated T cells from human peripheral blood lose proliferative capacity if cultured for 24 hours in the absence of IL-7 or IL-15. We further show that phosphorylation of STAT5 correlates with proliferation and inhibition of STAT5 reduces proliferation. These results reveal a novel role of IL-7 and IL-15 in maintaining human T cell function, provide an explanation for T cell dysfunction in humanized mice, and have significant implications for in vitro studies with human T cells.	[Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Iliopoulou, Bettina P.] Stanford Univ, Sch Med, Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Drake, Adam; Phennicie, Ryan] New Paradigm Biosci, Woburn, MA 01801 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Stanford University	Chen, JZ (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	jchen@mit.edu		Phennicie, Ryan/0000-0002-5105-7926	National Institutes of Health [AI69208]; National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology Infectious Disease Interdisciplinary Research Group; Ivan R. Cottrell Professorship and Research Fund; Koch Institute from the National Cancer Institute [P30-CA14051]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology Infectious Disease Interdisciplinary Research Group; Ivan R. Cottrell Professorship and Research Fund; Koch Institute from the National Cancer Institute	This work was supported in part by National Institutes of Health Grant AI69208, the National Research Foundation Singapore through the Singapore-MIT Alliance for Research and Technology Infectious Disease Interdisciplinary Research Group, the Ivan R. Cottrell Professorship and Research Fund (to J.C.), and the Koch Institute Support (core) Grant P30-CA14051 from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Billerbeck E, 2013, J IMMUNOL, V191, P1753, DOI 10.4049/jimmunol.1201518; Brehm MA, 2014, J IMMUNOL METHODS, V410, P3, DOI 10.1016/j.jim.2014.02.011; Chen QF, 2012, J IMMUNOL, V189, P5223, DOI 10.4049/jimmunol.1201789; Chen QF, 2009, P NATL ACAD SCI USA, V106, P21783, DOI 10.1073/pnas.0912274106; Danner R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019826; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Drake AC, 2012, CELL MOL IMMUNOL, V9, P215, DOI 10.1038/cmi.2012.6; Drake AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018382; Giassi LJ, 2008, EXP BIOL MED, V233, P997, DOI 10.3181/0802-RM-70; Gonzalez-Quintial R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027528; Heltemes-Harris LM, 2012, CURR OPIN IMMUNOL, V24, P146, DOI 10.1016/j.coi.2012.01.015; Huntington ND, 2011, P NATL ACAD SCI USA, V108, P6217, DOI 10.1073/pnas.1019167108; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ito R, 2013, J IMMUNOL, V191, P2890, DOI 10.4049/jimmunol.1203543; Jaiswal S, 2012, IMMUNOLOGY, V136, P334, DOI 10.1111/j.1365-2567.2012.03585.x; Jiang Q, 2004, MOL CELL BIOL, V24, P6501, DOI 10.1128/MCB.24.14.6501-6513.2004; Katzman SD, 2011, CYTOKINE, V56, P116, DOI 10.1016/j.cyto.2011.07.005; Klein M, 2012, J IMMUNOL, V188, P1091, DOI 10.4049/jimmunol.1102045; Kortum RL, 2013, TRENDS IMMUNOL, V34, P259, DOI 10.1016/j.it.2013.02.004; Lepus CM, 2009, HUM IMMUNOL, V70, P790, DOI 10.1016/j.humimm.2009.06.005; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Osborne LC, 2010, CYTOKINE, V50, P105, DOI 10.1016/j.cyto.2009.09.008; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Rathinam C, 2011, BLOOD, V118, P3119, DOI 10.1182/blood-2010-12-326926; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Rongvaux A, 2011, P NATL ACAD SCI USA, V108, P2378, DOI 10.1073/pnas.1019524108; Scholbach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046772; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Suzuki M, 2012, INT IMMUNOL, V24, P243, DOI 10.1093/intimm/dxs045; Takagi S, 2012, BLOOD, V119, P2768, DOI 10.1182/blood-2011-05-353201; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; Wallace DL, 2006, IMMUNOLOGY, V119, P243, DOI 10.1111/j.1365-2567.2006.02429.x; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Willinger T, 2011, P NATL ACAD SCI USA, V108, P2390, DOI 10.1073/pnas.1019682108	39	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166280	10.1371/journal.pone.0166280	http://dx.doi.org/10.1371/journal.pone.0166280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855183	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200026
J	Aslam, MN; Bassis, CM; Zhang, L; Zaidi, S; Varani, J; Bergin, IL				Aslam, Muhammad Nadeem; Bassis, Christine M.; Zhang, Li; Zaidi, Sameer; Varani, James; Bergin, Ingrid L.			Calcium Reduces Liver Injury in Mice on a High-Fat Diet: Alterations in Microbial and Bile Acid Profiles	PLOS ONE			English	Article							VITAMIN-D; HEPATOCELLULAR-CARCINOMA; MILK-PRODUCTS; ANIMAL-MODELS; OBESITY; DISEASE; COLON; METABOLISM; C57BL/6; SALMONELLA	A high-fat "Western-style" diet (HFWD) promotes obesity-related conditions including nonalcoholic steatohepatitis (NASH), the histologic manifestation of non-alcoholic fatty liver disease (NAFLD). In addition to high saturated fat and processed carbohydrates, the typical HFWD is deficient in calcium. Calcium-deficiency is an independent risk factor for many conditions associated with the Western-style diet. However, calcium has not been widely evaluated in the context of NAFLD. The goal of the present study was to determine if dietary calcium supplementation could protect mice fed a HFWD from NAFLD, specifically by decreasing non-alcoholic steatohepatitis (NASH) and its down-stream consequences. Male C57BL/6NCrl mice were maintained for 18-months on a HFWD containing dietary calcium at either 0.41 gm/kg feed (unsupplemented) or 5.25 gm/kg feed (supplemented). Although there was no difference in body weight or steatosis, calcium-supplemented mice were protected against downstream consequences of hepatic steatosis, manifested by lower inflammation, less fibrosis, and by lower overall histologic NAFLD activity scores (NAS). Calcium supplementation correlated with distinctly segregating gut fecal and cecal microbial communities as defined by 16S rRNA gene sequence. Further, calcium supplementation also correlated with decreased hepatic concentration of the major conjugated murine primary bile acid, tauro-beta-muricholic acid (as well as a decrease in the parent unconjugated bile acid). Thus, calcium was protective against progression of diet-induced hepatic steatosis to NASH and end-stage liver disease, suggesting that calcium supplementation may effectively protect against adverse hepatic consequences of HFWD in cases where overall diet modification cannot be sustained. This protective effect occurred in concert with calcium-mediated gut microbial community shifts and alterations of the hepatic bile acid pool.	[Aslam, Muhammad Nadeem; Zaidi, Sameer; Varani, James] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Bassis, Christine M.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zhang, Li] Univ Michigan, Michigan Reg Comprehens Metabol Resource Ctr, Ann Arbor, MI 48109 USA; [Bergin, Ingrid L.] Univ Michigan, Unit Lab Anim Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Aslam, MN (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	mnaslam@med.umich.edu	Aslam, Muhammad/GRS-8220-2022; Aslam, Muhammad Nadeem/I-7314-2012	Aslam, Muhammad/0000-0002-6071-5468; Aslam, Muhammad Nadeem/0000-0003-1361-5357; Bassis, Christine/0000-0001-6047-0678	Association for International Cancer Research [11-0577]; NIH Common Funds Project [U24 DK097153]; Host Microbiome Initiative (HMI) of the University of Michigan Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153] Funding Source: NIH RePORTER	Association for International Cancer Research; NIH Common Funds Project(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Host Microbiome Initiative (HMI) of the University of Michigan Medical School; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grant 11-0577 from the Association for International Cancer Research (http://www.worldwidecancerresearch.org/), St. Andrews, Fife, Scotland (JV). Bile acid analysis was performed at the Michigan Regional Comprehensive Metabolomics Resource Core (MRC2), funded by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan. Work represented in this paper was supported by the Host Microbiome Initiative (HMI) of the University of Michigan Medical School.; This study was supported in part by grant 11-0577 from the Association for International Cancer Research, St. Andrews, Fife, Scotland (W). Bile acid analysis was performed at the Michigan Regional Comprehensive Metabolomics Resource Core (MRC<SUP>2</SUP>), funded by grant U24 DK097153 of NIH Common Funds Project to the University of Michigan (ILB). Microbial work represented in this paper was supported by the Host Microbiome Initiative (HMI) of the University of Michigan Medical School (ILB & MNA). Microbial community 16S sequencing was performed through the Microbial Systems Molecular Biology Lab of the HMI of the University of Michigan Medical School.	Alba LM, 2003, ALIMENT PHARM THER, V17, P977, DOI 10.1046/j.1365-2036.2003.01493.x; Alnouti Y, 2008, J CHROMATOGR B, V873, P209, DOI 10.1016/j.jchromb.2008.08.018; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2013, DIVERSITY-BASEL, DOI DOI 10.3390/d5030627; Aslam MN, 2012, CALCIFIED TISSUE INT, V86, P313; Aslam MN, 2012, NUTR CANCER, V64, P1020, DOI 10.1080/01635581.2012.713160; Aslam MN, 2012, BIOL TRACE ELEM RES, V147, P267, DOI 10.1007/s12011-011-9316-2; Aslam MN, 2010, INTEGR CANCER THER, V9, P93, DOI 10.1177/1534735409360360; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bastie CC, 2012, J NUTR, V142, P859, DOI 10.3945/jn.111.149914; BoveeOudenhoven I, 1996, GUT, V38, P59, DOI 10.1136/gut.38.1.59; BoveeOudenhoven IMJ, 1997, GASTROENTEROLOGY, V113, P550, DOI 10.1053/gast.1997.v113.pm9247475; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Cani PD, 2014, J HEPATOL, V61, P5, DOI 10.1016/j.jhep.2014.04.006; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; DELZENNE NM, 1992, TOXICOL LETT, V61, P291, DOI 10.1016/0378-4274(92)90156-E; Denda A, 2002, JPN J CANCER RES, V93, P125, DOI 10.1111/j.1349-7006.2002.tb01250.x; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Ervin R Bethene, 2004, Adv Data, P1; Fontaine DA, 2016, DIABETES, V65, P25, DOI 10.2337/db15-0982; Fothergill E, 2016, OBESITY, V24, P1612, DOI 10.1002/oby.21538; Gerard Philippe, 2013, Pathogens, V3, P14, DOI 10.3390/pathogens3010014; Gomes JMG, 2015, BRIT J NUTR, V114, P1756, DOI 10.1017/S0007114515003608; Govers MJAP, 1996, CANCER RES, V56, P3270; Green CJ, 2014, NUTRIENTS, V6, P5018, DOI 10.3390/nu6115018; Griffiths WJ, 2010, J LIPID RES, V51, P23, DOI 10.1194/jlr.R001941-JLR200; Hashimoto E, 2012, HEPATOL RES, V42, P1, DOI 10.1111/j.1872-034X.2011.00872.x; Ibrahim SH, 2016, DIGEST DIS SCI, V61, P1325, DOI 10.1007/s10620-015-3977-1; Ito M, 2007, HEPATOL RES, V37, P50, DOI 10.1111/j.1872-034X.2007.00008.x; Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3309/fcimb.2015.00004, 10.3389/fcimb.2015.00084]; Kahle M, 2013, MOL METAB, V2, P435, DOI 10.1016/j.molmet.2013.07.009; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kudlacek S, 2003, EUR J CLIN INVEST, V33, P323, DOI 10.1046/j.1365-2362.2003.01127.x; Kwok RM, 2013, HEPATOLOGY, V58, P1166, DOI 10.1002/hep.26390; Laraichi S, 2013, LIPIDS, V48, P817, DOI 10.1007/s11745-013-3798-y; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Moore-Schiltz L, 2015, BRIT J NUTR, V114, P924, DOI 10.1017/S0007114515002482; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; Newmark HL, 2001, CARCINOGENESIS, V22, P1871, DOI 10.1093/carcin/22.11.1871; Pais P, 2014, DRUGS R&D, V14, P291, DOI 10.1007/s40268-014-0068-2; Pannu Poonam K, 2016, Adv Food Nutr Res, V77, P57, DOI 10.1016/bs.afnr.2015.11.001; Paolella G, 2014, WORLD J GASTROENTERO, V20, P15518, DOI 10.3748/wjg.v20.i42.15518; Parra P, 2008, J NUTR BIOCHEM, V19, P109, DOI 10.1016/j.jnutbio.2007.01.009; Peterlik M, 2005, EUR J CLIN INVEST, V35, P290, DOI 10.1111/j.1365-2362.2005.01487.x; Piguet AC, 2015, J HEPATOL, V62, P1296, DOI 10.1016/j.jhep.2015.01.017; Pilvi TK, 2007, BRIT J NUTR, V98, P900, DOI 10.1017/S0007114507764760; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sass DA, 2005, DIGEST DIS SCI, V50, P171, DOI 10.1007/s10620-005-1267-z; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643; Seekatz AM, 2015, INFECT IMMUN, V83, P3838, DOI 10.1128/IAI.00459-15; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Slattery ML, 1998, AM J EPIDEMIOL, V148, P4, DOI 10.1093/aje/148.1.4-a; Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594; Takahashi Y, 2014, WORLD J GASTROENTERO, V20, P15539, DOI 10.3748/wjg.v20.i42.15539; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; US Department of Health and Human Services; US Department of Agriculture, 2015, 2015 2020 DIET GUID; Vajro P, 2013, J PEDIATR GASTR NUTR, V56, P461, DOI 10.1097/MPG.0b013e318284abb5; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; VanderMeer R, 1997, CANCER LETT, V114, P75, DOI 10.1016/S0304-3835(97)04629-6; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	71	24	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166178	10.1371/journal.pone.0166178	http://dx.doi.org/10.1371/journal.pone.0166178			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851786	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300040
J	Flood, A; Estrada, M; McAdams, D; Ji, YH; Chen, DX				Flood, Alexander; Estrada, Marcus; McAdams, David; Ji, Yuhua; Chen, Dexiang			Development of a Freeze-Dried, Heat-Stable Influenza Subunit Vaccine Formulation	PLOS ONE			English	Article							RATIONAL DESIGN; STABILITY; POWDER; LYOPHILIZATION; STABILIZATION; HEMAGGLUTININ; TECHNOLOGY; CHALLENGES; STORAGE; STEP	An influenza pandemic remains a major public health concern. A key strategy to prevent a pandemic is to stockpile and pre-position stable influenza vaccine to allow rapid deployment in response to an outbreak. However, most influenza vaccines today are formulated as liquids that are stable only within a temperature range of 2 degrees C to 8 degrees C and require use of a cold chain, making vaccine transportation, distribution, and storage complicated and expensive, particularly for developing countries. To support the National Strategy for Pandemic Influenza preparedness in the United States and internationally, we developed two lead dry formulations of stable H1N1 influenza subunit vaccines using freeze-drying technology. The stable formulations contain an excipient combination of a disaccharide, such as sucrose or trehalose, and glycine, in addition to a surfactant and phosphate buffer. The freeze-dried vaccines were shown to be safe and remained immunogenic in an in vivo study in mice. Moreover, the lead formulations demonstrated no significant loss of activity after 40 months at storage temperatures of 25 degrees C and 37 degrees C. This stability can be particularly attractive as it could eliminate the need to use a cold chain for vaccine deployment and facilitate integration of vaccine distribution with general drug distribution where appropriate. These freeze-dried thermostable influenza subunit vaccines could also reduce the frequency of vaccine stockpile turnover, offering a cost-effective option for pandemic preparedness.	[Flood, Alexander; Estrada, Marcus; McAdams, David; Chen, Dexiang] PATH, Devices & Tools Program, Seattle, WA 98109 USA; [Ji, Yuhua] PATH, Drug Dev Program, Seattle, WA USA		Chen, DX (corresponding author), PATH, Devices & Tools Program, Seattle, WA 98109 USA.	dchen@path.org			Biomedical Advanced Research and Development Authority (BARDA) [HHSO1002011000040C]	Biomedical Advanced Research and Development Authority (BARDA)	The authors received funding from the Biomedical Advanced Research and Development Authority (BARDA) for this work, under grant contract number HHSO1002011000040C (http://www.phe.gov/about/BARDA/Pages/default.aspx). Novartis Pharmaceuticals (East Hanover, NJ) provided the generous supply of two lots of influenza H1N1 subunit bulk vaccine. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.; This work was made possible by a grant from Biomedical Advanced Research and Development Authority (BARDA, Contract Number HHSO100201000040C, http://www.phe.gov/about/barda). The authors wish to thank the following organization and people: Novartis Pharmaceuticals (East Hanover, NJ) for the generous supply of two lots of influenza H1N1 subunit bulk vaccine; scientific advisors Dr. Philip Dormitzer from Novartis and Dr. George Robertson and Ms. Debra Kristensen from PATH; Professor Thomas G. Voss and his team at Tulane University School of Medicine for performing the immunogenicity study reported in this paper; and Mr. John Ballenot and Mr. Clint Posey at PATH for editing the manuscript.	Allison SD, 2000, BBA-BIOMEMBRANES, V1468, P127, DOI 10.1016/S0005-2736(00)00251-0; Amorij JP, 2007, VACCINE, V25, P6447, DOI 10.1016/j.vaccine.2007.06.054; Amorij JP, 2008, PHARM RES-DORDR, V25, P1256, DOI 10.1007/s11095-008-9559-6; Anamur C, 2015, INT J PHARMACEUT, V483, P131, DOI 10.1016/j.ijpharm.2015.01.053; Carpenter JF, 1997, PHARMACEUT RES, V14, P969, DOI 10.1023/A:1012180707283; CARPENTER JF, 1989, BIOCHEMISTRY-US, V28, P3916, DOI 10.1021/bi00435a044; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Chang BS, 1996, ARCH BIOCHEM BIOPHYS, V331, P249, DOI 10.1006/abbi.1996.0305; Chang BS, 1996, PHARMACEUT RES, V13, P243, DOI 10.1023/A:1016043114998; Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364; Chen DX, 2009, EXPERT REV VACCINES, V8, P547, DOI [10.1586/erv.09.20, 10.1586/ERV.09.20]; Coenen F, 2006, VACCINE, V24, P525, DOI 10.1016/j.vaccine.2005.07.081; Homeland Security Council, 2006, NAT STRAT PAND INFL; Huang J, 2004, VACCINE, V23, P794, DOI 10.1016/j.vaccine.2004.06.049; Johnson RE, 2002, J PHARM SCI, V91, P914, DOI 10.1002/jps.10094; Kamerzell TJ, 2011, ADV DRUG DELIVER REV, V63, P1118, DOI 10.1016/j.addr.2011.07.006; Kasraian K, 1998, Pharm Dev Technol, V3, P233, DOI 10.3109/10837459809028500; Kawai K, 2007, PHARM RES-DORDR, V24, P1883, DOI 10.1007/s11095-007-9312-6; Liu W, 2005, AAPS PHARMSCITECH, V6, DOI 10.1208/pt060223; Luykx DMAM, 2004, EUR J PHARM SCI, V23, P65, DOI 10.1016/j.ejps.2004.05.007; Maa YF, 2004, J PHARM SCI-US, V93, P1912, DOI 10.1002/jps.20104; Molina MD, 2004, J PHARM SCI-US, V93, P2259, DOI 10.1002/jps.20138; Ohtake S, 2011, ADV DRUG DELIVER REV, V63, P1053, DOI 10.1016/j.addr.2011.06.011; Orszag PR, 2008, US POLICY REGARDING, P25; Pikal-Cleland KA, 2002, J PHARM SCI, V91, P1969, DOI 10.1002/jps.10184; Rasband W., 2006, IMAGEJ; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; The Department of Health and Human Services (DHHS), 2009, PAND INFL PREP SPEND; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3	29	20	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164692	10.1371/journal.pone.0164692	http://dx.doi.org/10.1371/journal.pone.0164692			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851765	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300005
J	Morehouse, AT; Graves, TA; Mikle, N; Boyce, MS				Morehouse, Andrea T.; Graves, Tabitha A.; Mikle, Nate; Boyce, Mark S.			Nature vs. Nurture: Evidence for Social Learning of Conflict Behaviour in Grizzly Bears	PLOS ONE			English	Article							FORAGING BEHAVIOR; BLACK BEARS; PARENTAGE ANALYSIS; NORTH-AMERICA; AGRICULTURAL LANDS; SIBSHIP INFERENCE; NATIONAL-PARK; URSUS-ARCTOS; BRAIN SIZE; POPULATION	The propensity for a grizzly bear to develop conflict behaviours might be a result of social learning between mothers and cubs, genetic inheritance, or both learning and inheritance. Using non-invasive genetic sampling, we collected grizzly bear hair samples during 2011-2014 across southwestern Alberta, Canada. We targeted private agricultural lands for hair samples at grizzly bear incident sites, defining an incident as an occurrence in which the grizzly bear caused property damage, obtained anthropogenic food, or killed or attempted to kill livestock or pets. We genotyped 213 unique grizzly bears (118 M, 95 F) at 24 micro-satellite loci, plus the amelogenin marker for sex. We used the program COLONY to assign parentage. We evaluated 76 mother-offspring relationships and 119 father-offspring relationships. We compared the frequency of problem and non-problem offspring from problem and non-problem parents, excluding dependent offspring from our analysis. Our results support the social learning hypothesis, but not the genetic inheritance hypothesis. Offspring of problem mothers are more likely to be involved in conflict behaviours, while offspring from non-problem mothers are not likely to be involved in incidents or human-bear conflicts themselves (Barnard's test, p = 0.05, 62.5% of offspring from problem mothers were problem bears). There was no evidence that offspring are more likely to be involved in conflict behaviour if their fathers had been problem bears (Barnard's test, p = 0.92, 29.6% of offspring from problem fathers were problem bears). For the mother-offspring relationships evaluated, 30.3% of offspring were identified as problem bears independent of their mother's conflict status. Similarly, 28.6% of offspring were identified as problem bears independent of their father's conflict status. Proactive mitigation to prevent female bears from becoming problem individuals likely will help prevent the perpetuation of conflicts through social learning.	[Morehouse, Andrea T.; Boyce, Mark S.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Graves, Tabitha A.; Mikle, Nate] US Geol Survey, Northern Rocky Mt Sci Ctr, West Glacier, MT USA	University of Alberta; United States Department of the Interior; United States Geological Survey	Morehouse, AT (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	morehous@ualberta.ca	Boyce, Mark S/A-2620-2014	Boyce, Mark S/0000-0001-5811-325X; Morehouse, Andrea/0000-0002-2015-9938	Alberta Conservation Association Grants in Biodiversity; Alberta Ecotrust; Alberta Environment and Parks; Alberta Innovates Bio Solutions; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund; Drywood Yarrow Conservation Partnership; Environment Canada Science Horizons; Glacier National Park Conservancy; International Association for Bear Research and Management; Minister's Special License; Miistakis Institute; Nature Conservancy of Canada; Natural Sciences and Engineering Research Council of Canada; National Science Foundation Division of Environmental Biology; DEB [0919239]; Parks Canada; Safari Club International Foundation; Safari Club International Northern Alberta Chapter; Shell Canada; TD Friends of the Environment Foundation; University of Alberta; US Geological Survey; US Bureau of Land Management; US Forest Service; Waterton Biosphere Reserve Association; Yellowstone to Yukon; Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; US Fish and Wildlife Service	Alberta Conservation Association Grants in Biodiversity; Alberta Ecotrust; Alberta Environment and Parks; Alberta Innovates Bio Solutions; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund; Drywood Yarrow Conservation Partnership; Environment Canada Science Horizons; Glacier National Park Conservancy; International Association for Bear Research and Management; Minister's Special License; Miistakis Institute; Nature Conservancy of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DEB; Parks Canada; Safari Club International Foundation; Safari Club International Northern Alberta Chapter; Shell Canada; TD Friends of the Environment Foundation; University of Alberta(University of Alberta); US Geological Survey(United States Geological Survey); US Bureau of Land Management; US Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Waterton Biosphere Reserve Association; Yellowstone to Yukon; Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; US Fish and Wildlife Service(US Fish & Wildlife Service)	This study was funded by the organizations listed below, including: Alberta Conservation Association Grants in Biodiversity: http//www.ab-conservation.com/go/default/index.cfm/grants/grant-eligible-conservation-fund/overview/; Alberta Ecotrust: http://albertaecotrust.com/; Alberta Environment and Parks: http://aep.alberta.ca/; Alberta Innovates Bio Solutions: http://bio.albertainnovates.ca/; Alberta Sport Recreation Parks and Wildlife Foundation; Disney Worldwide Conservation Fund: https//thewaltdisneycompany.com/environment#disney-conservation-fund; Drywood Yarrow Conservation Partnership: Environment Canada Science Horizons: http://www.ec.gc.caiscitech/default.asp? lang.En & Glacier National Park Conservancy: https://mw.glacierconservancy.org/; International Association for Bear Research and Management: http://www.bearbiology.com/; Minister's Special License: http://www.afga.org/ministers-special-licence/html; Miistakis Institute: http://www.rockies.ca/; Nature Conservancy of Canada: http://www.natureconservancy.ca/en/; Natural Sciences and Engineering Research Council of Canada: http://www.nserc-crsng.gc.ca/index_eng.asp; National Science Foundation Division of Environmental Biology: https://www. nsf.gov/funding/pgm_list.isp?org DEB, Grant # 0919239; Parks Canada: http://www.pc.gc.ca/eng/index.aspx; Safari Club International Foundation: http://safariclubfoundation.og Safari Club International Northern Alberta Chapter: http://sci-northern.ab.ca/; Shell Canada: http://www.shell.ca/; TD Friends of the Environment Foundation: https://fettd.com/; University of Alberta: https://galberta.ca/; US Geological Survey: http://www.usgs.govt, US Bureau of Land Management: http://www.blm.gov/wo/st/en.html; US Forest Service: http://www.fs.fed.us/; Waterton Biosphere Reserve Association: http://www.watertonbiosphere.com/; Yellowstone to Yukon: https://y2y.net/. Additional in-kind support came from the Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; and the US Fish and Wildlife Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the agencies and organizations that provided funding for this research: Alberta Conservation Association Grants in Biodiversity, Alberta Ecotrust, Alberta Environment and Parks, Alberta Innovates-Bio Solutions, Alberta Sport Recreation Parks and Wildlife Foundation, Disney Worldwide Conservation Fund, Drywood Yarrow Conservation Partnership, Environment Canada Science Horizons, Glacier National Park Conservancy, International Association for Bear Research and Management, Minister's Special License, Miistakis Institute, Nature Conservancy of Canada, Natural Sciences and Engineering Research Council of Canada, National Science Foundation Division of Environmental Biology, Parks Canada, Safari Club International Foundation, Safari Club International Northern Alberta Chapter, Shell Canada, TD Friends of the Environment Foundation, University of Alberta, US Geological Survey, US Bureau of Land Management, US Forest Service, Waterton Biosphere Reserve Association, and Yellowstone to Yukon. Additional in-kind and logistical support was provided by the Blackfeet Nation; Blood Tribe Land Management; Confederated Salish and Kootenai Tribes; Hab-Tec Environmental; Montana Department of Fish, Wildlife, and Parks; Montana Department of Natural Resources and Conservation; National Park Service; Northwest Connections; and the US Fish and Wildlife Service. Over 200 people assisted in the collection of grizzly bear hair samples; this project would not have been possible without their contributions. In particular, we thank M. Urmson, A. Loosen, S. Rettler, and T. Malish who worked on the Alberta portion of the project for multiple seasons and assisted with field work as well as data entry and management. Over 70 landowners provided land access and/or collected opportunistic hair samples; we are thankful for their support. In particular, we thank the Waterton Biosphere Reserve's Carnivore Working Group for supporting the project and helping to facilitate communication with landowners. We thank Alberta Environment and Parks, British Columbia Ministry of Forests, Lands, and Natural Resource Operations, and the Foothills Research Institute Grizzly Bear Program for the DNA data sets provided. Thanks to Lori Roberts for sharing conflict history from Montana grizzly bears. We thank Kate Kendall, Garth Mowat and Gord Stenhouse for leading hair collection in neighboring study areas. Finally, Garth Mowat and Gord Stenhouse also provided helpful comments on earlier versions of our manuscript.	Alberta Environment and Parks, 2016, ALB GRIZZL BEAR UR A, V38; Alberta Government, 2009, GRIZZL BEAR RESP GUI; Alberta Grizzly Bear Inventory Team, 2008, GRIZZL BEAR POP DENS; Alberta Sustainable Resource Development Alberta Conservation Association, 2010, 37 ALB SUST RES DEV; Anderson CR, 2002, URSUS, V13, P247; [Anonymous], 2008, ALB GRIZZL BEAR REC; Arnold S.J., 1981, P409; BARNARD GA, 1945, NATURE, V156, P177, DOI 10.1038/156177a0; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann JP, 2003, J MAMMAL, V84, P594, DOI 10.1644/1545-1542(2003)084<0594:UBBTTI>2.0.CO;2; Bino G, 2010, J APPL ECOL, V47, P1262, DOI 10.1111/j.1365-2664.2010.01882.x; BLANCHARD BM, 1995, J WILDLIFE MANAGE, V59, P560, DOI 10.2307/3802463; Bojarska K, 2012, MAMMAL REV, V42, P120, DOI 10.1111/j.1365-2907.2011.00192.x; Breck SW, 2008, J MAMMAL, V89, P428, DOI 10.1644/07-MAMM-A-028R2.1; Breed M., 2010, NATURE ED KNOWLEDGE, V3, P68; Brown L, 2014, 23 INT C BEAR RES MA; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Fonturbel FE, 2011, WILDLIFE BIOL, V17, P217, DOI 10.2981/10-091; Galef BG, 2001, ANIM BEHAV, V62, P41, DOI 10.1006/anbe.2000.1721; Galef BG, 2005, BIOSCIENCE, V55, P489, DOI 10.1641/0006-3568(2005)055[0489:SLIAES]2.0.CO;2; Galton F., 1874, P ROYAL I, V7, P227; Galton F., 1983, INQUIRY HUMAN FACULT; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; GILBERT BK, 1999, MAMMALIAN SOCIAL LEA, P225; Gillin C.M., 1994, INT C BEAR RES MANAG, V9, P503, DOI DOI 10.2307/3872738; GITTLEMAN JL, 1986, J MAMMAL, V67, P23, DOI 10.2307/1380998; *GOV ALB, 2010, GRIZZL BEAR CONS ALB; Harris R.B., 2006, WILDL MONOGR, V161, P44; Harrison HB, 2013, MOL ECOL, V22, P1158, DOI 10.1111/mec.12138; HEDRICK AV, 1989, OECOLOGIA, V80, P533, DOI 10.1007/BF00380078; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hopkins JB, 2013, J MAMMAL, V94, P1214, DOI 10.1644/13-MAMM-A-009.1; Hopkins JB, 2010, URSUS, V21, P154, DOI 10.2192/URSUS-D-10-00005.1; Jones AG, 2010, MOL ECOL RESOUR, V10, P6, DOI 10.1111/j.1755-0998.2009.02778.x; Jones AG, 2003, MOL ECOL, V12, P2511, DOI 10.1046/j.1365-294X.2003.01928.x; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Laland KN, 2004, LEARN BEHAV, V32, P4; Launchbaugh KL, 1999, GRAZING BEHAV LIVEST, P28; Lefebvre Louis, 1996, P107, DOI 10.1016/B978-012273965-1/50007-8; Leigh Jennifer, 2008, Human-Wildlife Conflicts, V2, P175; Linnell JDC, 1997, BIODIVERS CONSERV, V6, P1245, DOI 10.1023/B:BIOC.0000034011.05412.cd; Lydersen S, 2009, RECOMMENDED TESTS AS, V28, P1159, DOI [10.1002/sim.3531, DOI 10.1002/SIM.3531]; Mace RD, 2012, J WILDLIFE MANAGE, V76, P119, DOI 10.1002/jwmg.250; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mazur R, 2008, ANIM BEHAV, V75, P1503, DOI 10.1016/j.anbehav.2007.10.027; Mazur RL, 2010, J WILDLIFE MANAGE, V74, P48, DOI 10.2193/2008-163; MCLELLAN B, 1994, INT BEAR MS, P15; Mikle N, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1467; MOREHOUSE A.T., 2016, THESIS; Morehouse AT, 2016, J WILDLIFE MANAGE, V80, P1152, DOI 10.1002/jwmg.21104; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G., 2013, SO ROCKIES FLATHEAD; Nielsen SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053721; Northrup JM, 2012, ANIM CONSERV, V15, P369, DOI 10.1111/j.1469-1795.2012.00525.x; Paetkau D, 2004, J WILDLIFE MANAGE, V68, P449, DOI 10.2193/0022-541X(2004)068[0449:TONOMI]2.0.CO;2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Page RE, 1995, ANIM BEHAV, V50, P1617, DOI 10.1016/0003-3472(95)80015-8; Pokrovskaya L, 2015, MAMM BIOL, V80, P355, DOI 10.1016/j.mambio.2015.02.007; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Proctor MF, 2012, WILDLIFE MONOGR, P1, DOI 10.1002/wmon.6; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reader SM, 2002, P NATL ACAD SCI USA, V99, P4436, DOI 10.1073/pnas.062041299; Riley SJ., 1994, URSUS, V9, P567, DOI [10.2307/3872745, DOI 10.2307/3872745]; Sameroff A, 2010, CHILD DEV, V81, P6, DOI 10.1111/j.1467-8624.2009.01378.x; Shivik JA, 2006, CONS BIOL, V17, P1531; SKULASON S, 1993, ANIM BEHAV, V45, P1179, DOI 10.1006/anbe.1993.1140; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; U.S. Fish and Wildlife Service, 1993, GRIZZL BEAR REC PLAN; van Manen FT, 2014, CONSERV LETT, V7, P323, DOI 10.1111/conl.12095; Wang J, 2009, GENETICS, V181, P1579, DOI 10.1534/genetics.108.100214; Wang JL, 2014, MOL ECOL RESOUR, V14, P541, DOI 10.1111/1755-0998.12210; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wilson SM, 2006, BIOL CONSERV, V130, P47, DOI 10.1016/j.biocon.2005.12.001; Wilson SM, 2005, URSUS, V16, P117, DOI 10.2192/1537-6176(2005)016[0117:NLFHAA]2.0.CO;2	78	35	35	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165425	10.1371/journal.pone.0165425	http://dx.doi.org/10.1371/journal.pone.0165425			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851753	Green Published, gold			2022-12-26	WOS:000387909300015
J	Nyiro, JU; Sande, CJ; Mutunga, M; Kiyuka, PK; Munywoki, PK; Scott, JAG; Nokes, DJ				Nyiro, Joyce Uchi; Sande, Charles Jumba; Mutunga, Martin; Kiyuka, Patience Kerubo; Munywoki, Patrick Kioo; Scott, John Anthony G.; Nokes, David James			Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus ( RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya	PLOS ONE			English	Article							MATERNAL ANTIBODY; KILIFI DISTRICT; IMMUNE GLOBULIN; YOUNG-CHILDREN; BIRTH COHORT; INFECTION; RISK; IGG; PNEUMONIA; VACCINE	Background The target group for severe respiratory syncytial virus (RSV) disease prevention is infants under 6 months of age. Vaccine boosting of antibody titres in pregnant mothers could protect these young infants from severe respiratory syncytial virus (RSV) associated disease. Quantifying protective levels of RSV-specific maternal antibody at birth would inform vaccine development. Methods A case control study nested in a birth cohort (2002-07) was conducted in Kilifi, Kenya; where 30 hospitalised cases of RSV-associated severe disease were matched to 60 controls. Participants had a cord blood and 2 subsequent 3-monthly blood samples assayed for RSV-specific neutralising antibody by the plaque reduction neutralisation test (PRNT). Two sample paired t test and conditional logistic regression were used in analyses of log(2)PRNT titres. Results The mean RSV log2PRNT titre at birth for cases and controls were not significantly different (P = 0.4) and remained so on age-stratification. Cord blood PRNT titres showed considerable overlap between cases and controls. The odds of RSV disease decreased with increase in log(2)PRNT cord blood titre. There was a 30% reduction in RSV disease per unit increase in log(2)PRNT titre (< 3months age group) but not significant (P = 0.3). Conclusions From this study, there is no strong evidence of protection by maternal RSV specific antibodies from severe RSV disease. Cord antibody levels show wide variation with considerable overlap between cases and controls. It is likely that, there are additional factors to specific PRNT antibody levels which determine susceptibility to severe RSV disease. In addition, higher levels of neutralizing antibody beyond the normal range may be required for protection; which it is hoped can be achieved by a maternal RSV vaccine.	[Nyiro, Joyce Uchi; Sande, Charles Jumba; Mutunga, Martin; Kiyuka, Patience Kerubo; Munywoki, Patrick Kioo; Scott, John Anthony G.; Nokes, David James] Kenya Med Res Inst KEMRI, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya; [Scott, John Anthony G.] London Sch Hyg & Trop Med, London, England; [Nokes, David James] Univ Warwick, Sch Life Sci, Coventry, W Midlands, England; [Nokes, David James] Univ Warwick, WIDER Ctr, Coventry, W Midlands, England; [Sande, Charles Jumba] Univ Oxford, Oxford, England	Kenya Medical Research Institute; University of London; London School of Hygiene & Tropical Medicine; University of Warwick; University of Warwick; University of Oxford	Nyiro, JU (corresponding author), Kenya Med Res Inst KEMRI, Wellcome Trust Res Programme, Ctr Geog Med Res Coast, Kilifi, Kenya.	Jnyiro@kemri-wellcome.org	Munywoki, Patrick K./GQP-4775-2022	Munywoki, Patrick K./0000-0001-9419-7155; Sande, Charles/0000-0002-8364-6063; Kiyuka, Patience/0000-0002-3257-5920	PATH [R.LFJN.3003]; Wellcome Trust [077092, 084633, 098532]	PATH; Wellcome Trust(Wellcome TrustEuropean Commission)	DJN received funding from PATH [Grant ref:R.LFJN.3003]; and the Wellcome Trust [077092], [084633] while JAGS recieved funding from the Wellcome Trust [098532]. The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.; We thank all the study participants for their contribution of study samples. We are grateful to field, laboratory and data management staff of the KEMRI Wellcome Trust Research Programme for collection and storage of the samples and data retrieval, and specifically the support of Lilian Mwango and Anne Bett. Finally, we acknowledge the funding support from PATH [Grant ref: R.LFJN.3003] and the Wellcome Trust [077092], [084633], [098532]. This paper is published with the permission of the Director of KEMRI.	Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Bulkow LR, 2002, PEDIATRICS, V109, P210, DOI 10.1542/peds.109.2.210; Chu HY, 2014, J INFECT DIS; Craiu RV, 2008, BIOMETRICAL J, V50, P97, DOI 10.1002/bimj.200610379; English M, 2003, AM J TROP MED HYG, V69, P228, DOI 10.4269/ajtmh.2003.69.228; Englund J, 1998, VACCINE, V16, P1456, DOI 10.1016/S0264-410X(98)00108-X; Glenn GM, 2015, J INFECT DIS; GLEZEN WP, 1981, J PEDIATR-US, V98, P708, DOI 10.1016/S0022-3476(81)80829-3; Graham BS, 2014, J INFECT DIS, V209, P1679, DOI 10.1093/infdis/jiu075; GROOTHUIS JR, 1993, NEW ENGL J MED, V329, P1524, DOI 10.1056/NEJM199311183292102; Karron RA, 2013, CURR TOP MICROBIOL, V372, P259, DOI 10.1007/978-3-642-38919-1_13; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; LAMPRECHT CL, 1976, J INFECT DIS, V134, P211, DOI 10.1093/infdis/134.3.211; Munoz FM, 2003, VACCINE, V21, P3465, DOI 10.1016/S0264-410X(03)00352-9; Munoz FM, 2003, PEDIATRICS, V111, P218, DOI 10.1542/peds.111.1.218; MURPHY BR, 1986, J CLIN MICROBIOL, V24, P894, DOI 10.1128/JCM.24.5.894-898.1986; Nair H, 2010, LANCET, V375, P1545, DOI 10.1016/S0140-6736(10)60206-1; Ngwuta JO, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4241; Nokes DJ, 2008, CLIN INFECT DIS, V46, P50, DOI 10.1086/524019; Nokes DJ, 2009, CLIN INFECT DIS, V49, P1341, DOI 10.1086/606055; Nokes DJ, 2004, J INFECT DIS, V190, P1828, DOI 10.1086/425040; Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531; Nyiro JU, 2015, VACCINE, V33, P1797, DOI 10.1016/j.vaccine.2015.02.039; Ochola R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008088; Okiro EA, 2008, J CLIN MICROBIOL, V46, P1659, DOI 10.1128/JCM.02190-07; Okoko JB, 2001, TROP MED INT HEALTH, V6, P529, DOI 10.1046/j.1365-3156.2001.00741.x; Raghunandan R, 2014, VACCINE, V32, P6485, DOI 10.1016/j.vaccine.2014.09.030; Roca A, 2002, J MED VIROL, V67, P616, DOI 10.1002/jmv.10148; Rodriguez WJ, 1997, PEDIATRICS, V100, P937, DOI 10.1542/peds.100.6.937; Rudan I, 2013, J GLOB HEALTH, V3, DOI 10.7189/jogh.03.010401; Sande CJ, 2013, J MED VIROL, V85, P2020, DOI 10.1002/jmv.23696; Sande CJ, 2013, J INFECT DIS, V207, P489, DOI 10.1093/infdis/jis700; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Stensballe LG, 2009, J PEDIATR-US, V154, P296, DOI 10.1016/j.jpeds.2008.07.053; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C	35	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166706	10.1371/journal.pone.0166706	http://dx.doi.org/10.1371/journal.pone.0166706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851799	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000387909300079
J	Thompson, SJ; Handel, CM; Richardson, RM; McNew, LB				Thompson, Sarah J.; Handel, Colleen M.; Richardson, Rachel M.; McNew, Lance B.			When Winners Become Losers: Predicted Nonlinear Responses of Arctic Birds to Increasing Woody Vegetation	PLOS ONE			English	Article							SPECIES RICHNESS; NORTHERN ALASKA; COMMUNITY; PLANT; ABUNDANCE; INFERENCE; SELECTION; HABITAT; MODELS; HETEROGENEITY	Climate change is facilitating rapid changes in the composition and distribution of vegetation at northern latitudes, raising questions about the responses of wildlife that rely on arctic ecosystems. One widely observed change occurring in arctic tundra ecosystems is an increasing dominance of deciduous shrub vegetation. Our goals were to examine the tolerance of arctic-nesting bird species to existing gradients of vegetation along the boreal forest-tundra ecotone, to predict the abundance of species across different heights and densities of shrubs, and to identify species that will be most or least responsive to ongoing expansion of shrubs in tundra ecosystems. We conducted 1,208 point counts on 12 study blocks from 2012-2014 in northwestern Alaska, using repeated surveys to account for imperfect detection of birds. We considered the importance of shrub height, density of low and tall shrubs (i.e. shrubs >0.5 m tall), percent of ground cover attributed to shrubs (including dwarf shrubs <0.5 m tall), and percent of herbaceous plant cover in predicting bird abundance. Among 17 species considered, only gray-cheeked thrush (Catharus minimus) abundance was associated with the highest values of all shrub metrics in its top predictive model. All other species either declined in abundance in response to one or more shrub metrics or reached a threshold where further increases in shrubs did not contribute to greater abundance. In many instances the relationship between avian abundance and shrubs was nonlinear, with predicted abundance peaking at moderate values of the co-variate, then declining at high values. In particular, a large number of species were responsive to increasing values of average shrub height with six species having highest abundance at near-zero values of shrub height and abundance of four other species decreasing once heights reached moderate values <= 33 cm). Our findings suggest that increases in shrub cover and density will negatively affect abundance of only a few bird species and may potentially be beneficial for many others. As shrub height increases further, however, a considerable number of tundra bird species will likely find habitat increasingly unsuitable.	[Thompson, Sarah J.; Handel, Colleen M.; Richardson, Rachel M.; McNew, Lance B.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [McNew, Lance B.] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA	United States Department of the Interior; United States Geological Survey; Montana State University System; Montana State University Bozeman	Thompson, SJ (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	sjthompson@usgs.gov	Batova, Olga/A-7438-2017	Batova, Olga/0000-0002-7822-6507	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative; Wildlife Program of the USGS Ecosystem Mission Area	Funding was received by CMH from U.S. Geological Survey's (USGS) Changing Arctic Ecosystem Initiative and this work is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area.; This work is part of the U.S. Geological Survey (USGS) Changing Arctic Ecosystem Initiative and is supported by funding from the Wildlife Program of the USGS Ecosystem Mission Area. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. We are grateful to everyone who helped collect bird and habitat data for this project: C. Anderson, C. Davis, A. Emrie, M. McDermott, M. Milligan, N. Okun, L. Pajot, J. Peterson, R. Roth, J. Terenzi, M. Trainor, C. Van Hemert, and S. Vold. We thank S. Matsuoka for helpful comments on an earlier draft of this paper and C. Amundson for guidance with data analysis.	Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Ballantyne K, 2011, WATERBIRDS, V34, P151, DOI 10.1675/063.034.0203; Batova ON, 2011, BIOL BULL+, V38, P259, DOI 10.1134/S1062359011030022; Boelman NT, 2015, GLOBAL CHANGE BIOL, V21, P1508, DOI 10.1111/gcb.12761; Buckland S. T., 2005, ENCY BIOSTATISTICS, V2, P1, DOI [10. 1002/0470011815. b2a16019, DOI 10.1002/0470011815.B2A16019, 10.1002/0470011815.b2a16019]; Chandler RB, 2011, ECOLOGY, V92, P1429, DOI 10.1890/10-2433.1; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cody M.L., 1985, P3; COTTAM G, 1956, ECOLOGY, V37, P451, DOI 10.2307/1930167; Cunningham MA, 2006, ECOL APPL, V16, P1062, DOI 10.1890/1051-0761(2006)016[1062:PALFIG]2.0.CO;2; Dail D, 2011, BIOMETRICS, V67, P577, DOI 10.1111/j.1541-0420.2010.01465.x; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Dial RJ, 2016, GLOBAL CHANGE BIOL, V22, P1841, DOI 10.1111/gcb.13207; Fieberg J, 2015, J WILDLIFE MANAGE, V79, P708, DOI 10.1002/jwmg.894; Fiske I, J STAT SOFTW, V43; Grant TA, 2004, WILDLIFE SOC B, V32, P807, DOI 10.2193/0091-7648(2004)032[0807:TASIIN]2.0.CO;2; Hinzman LD, 2005, CLIMATIC CHANGE, V72, P251, DOI 10.1007/s10584-005-5352-2; Hocking DJ, 2013, FOREST ECOL MANAG, V287, P32, DOI 10.1016/j.foreco.2012.09.013; Hudson JMG, 2009, ECOLOGY, V90, P2657, DOI 10.1890/09-0102.1; Hussell DJT, 2002, BIRDS N AM ONLINE; HUTTO RL, 1986, AUK, V103, P593, DOI 10.1093/auk/103.3.593; Julliard R, 2006, ECOL LETT, V9, P1237, DOI 10.1111/j.1461-0248.2006.00977.x; Kery M, 2005, ECOL APPL, V15, P1450, DOI 10.1890/04-1120; Kery M, 2015, APPL HIERARCHICAL MO, V1; Kessel B., 1989, BIRDS SEWARD PENNINS; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P327, DOI 10.1111/j.1466-8238.2007.00379.x; MACARTHUR R, 1961, ECOLOGY, V42, P594, DOI 10.2307/1932254; MACARTHUR RH, 1958, ECOLOGY, V39, P599, DOI 10.2307/1931600; Marcot BG, 2015, CLIMATIC CHANGE, V130, P145, DOI 10.1007/s10584-015-1354-x; McNew LB, 2015, ECOL APPL, V25, P1669, DOI 10.1890/14-1248.1; Mizel JD, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1264; Myers-Smith IH, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045509; Myers-Smith IH, 2011, AMBIO, V40, P610, DOI 10.1007/s13280-011-0168-y; R Core Team, 2021, R LANGUAGE ENV STAT; Raynolds MK, 2005, PHYTOCOENOLOGIA, V35, P821, DOI 10.1127/0340-269X/2005/0035-0821; Rich ME, 2013, ECOGRAPHY, V36, P994, DOI 10.1111/j.1600-0587.2012.00078.x; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2004, ECOLOGY, V85, P1591, DOI 10.1890/03-3127; Rupp TS, 2000, GLOBAL CHANGE BIOL, V6, P541, DOI 10.1046/j.1365-2486.2000.00337.x; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stein A, 2014, ECOL LETT, V17, P866, DOI 10.1111/ele.12277; Swanson JD, 1985, RANGE SURVEY SEWARD; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Thompson SJ, 2014, CONDOR, V116, P303, DOI 10.1650/CONDOR-13-072.1; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Wahrhaftig C, 1965, PHYSIOGRAPHIC DIVISI; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WIENS JA, 1981, ECOL MONOGR, V51, P21, DOI 10.2307/2937305; Zellweger F, 2016, J BIOGEOGR, V43, P1080, DOI 10.1111/jbi.12696; Zuur AF, 2007, STAT BIOL HEALTH, P163	55	23	24	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0164755	10.1371/journal.pone.0164755	http://dx.doi.org/10.1371/journal.pone.0164755			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851768	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300006
J	Soldano, S; Pizzorni, C; Paolino, S; Trombetta, AC; Montagna, P; Brizzolara, R; Ruaro, B; Sulli, A; Cutolo, M				Soldano, Stefano; Pizzorni, Carmen; Paolino, Sabrina; Trombetta, Amelia Chiara; Montagna, Paola; Brizzolara, Renata; Ruaro, Barbara; Sulli, Alberto; Cutolo, Maurizio			Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EPITHELIAL-MESENCHYMAL TRANSITION; SYSTEMIC-SCLEROSIS; TISSUE-REPAIR; CANCER-CELLS; FIBROSIS; DISEASE; SKIN; POLARIZATION; PLASTICITY	Background Alternatively activated (M2) macrophages are phenotypically characterized by the expression of specific markers, mainly macrophage scavenger receptors (CD204 and CD163) and mannose receptor-1 (CD206), and participate in the fibrotic process by over-producing profibrotic molecules, such as transforming growth factor-beta1 (TGFbeta1) and metalloproteinase (MMP)-9. Endothelin-1 (ET-1) is implicated in the fibrotic process, exerting its profibrotic effects through the interaction with its receptors (ETA and ETB). The study investigated the possible role of ET-1 in inducing the transition from cultured human macrophages into M2 cells. Methods Cultured human monocytes (THP-1 cell line) were activated into macrophages (M0 macrophages) with phorbol myristate acetate and subsequently maintained in growth medium (M0-controls) or treated with either ET-1 (100nM) or interleukin-4 (IL-4, 10ng/mL, M2 inducer) for 72 hours. Similarly, primary cultures of human peripheral blood monocyte (PBM)-derived macrophages obtained from healthy subjects, were maintained in growth medium (untreated cells) or treated with ET-1 or IL-4 for 6 days. Both M0 and PBM-derived macrophages were pre-treated with ET receptor antagonist (ET(A/B)RA, bosentan 10(-5) M) for 1 hour before ET-1 stimulation. Protein and gene expression of CD204, CD206, CD163, TGFbeta1 were analysed by immunocytochemistry, Western blotting and quantitative real time polymerase chain reaction (qRT-PCR). Gene expression of interleukin(IL)-10 and macrophage derived chemokine (CCL-22) was evaluated by qRT-PCR. MMP-9 production was investigated by gel zymography. Results ET-1 significantly increased the expression of M2 phenotype markers CD204, CD206, CD163, IL-10 and CCL-22, and the production of MMP-9 in both cultures of M0 and PBM-derived macrophages compared to M0-controls and untreated cells. In cultured PBM-derived macrophages, ET-1 increased TGFbeta1 protein and gene expression compared to untreated cells. The ET-1-mediated effects were contrasted by ETA/BRA treatment in both cultured cell types. Conclusion ET-1 seems to induce the M2 phenotype in cultured human macrophages, a process apparently contrasted by the action of the ETA/BRA, suggesting possible clinical implications in those fibrotic diseases characterized by increased ET-1 concentrations, such as systemic sclerosis but also type 2 diabetes.	[Soldano, Stefano] Univ Genoa, Dept Internal Med, Res Lab, Genoa, Italy; Univ Genoa, Dept Internal Med, Acad Div Clin Rheumatol, Genoa, Italy	University of Genoa; University of Genoa	Soldano, S (corresponding author), Univ Genoa, Dept Internal Med, Res Lab, Genoa, Italy.	stefano.soldano@unige.it	Soldano, Stefano/AAE-6043-2022; Trombetta, Amelia Chiara/AAL-1841-2021; Ruaro, Barbara/AAA-4408-2019; Sulli, Alberto/AAD-1257-2022	Ruaro, Barbara/0000-0001-8990-859X; Montagna, Paola/0000-0002-0595-1484; Soldano, Stefano/0000-0001-8796-6032				Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Barisione C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149276; Beamer CA, 2005, AM J PHYSIOL-LUNG C, V289, pL186, DOI 10.1152/ajplung.00474.2004; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Cardenas CLL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003291; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Christmann RB, 2011, ARTHRITIS RHEUM-US, V63, P1718, DOI 10.1002/art.30318; Cipriani P, 2015, J RHEUMATOL, V42, P1808, DOI 10.3899/jrheum.150088; Cutolo M, 2013, CLIN EXP RHEUMATOL; Cutolo M, 2015, NAT REV RHEUMATOL, V11, P570, DOI 10.1038/nrrheum.2015.111; Cutolo M, 2015, J RHEUMATOL, V42, P456, DOI 10.3899/jrheum.141070; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Elisa T, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/147616; Fabriek BO, 2005, IMMUNOBIOLOGY, V210, P153, DOI 10.1016/j.imbio.2005.05.010; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Fujimura T, 2016, J DERMATOL SCI, V83, P167, DOI 10.1016/j.jdermsci.2016.05.015; Genin M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1546-9; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Hashimoto O, 2016, J PATHOL, V240, P211, DOI 10.1002/path.4769; Higashi-Kuwata N, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3066; Higashi-Kuwata N, 2009, EXP DERMATOL, V18, P727, DOI 10.1111/j.1600-0625.2008.00828.x; Kurzepa J, 2014, HEPATOB PANCREAT DIS, V13, P570, DOI 10.1016/S1499-3872(14)60261-7; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manetti M, 2015, EXP DERMATOL, V24, P576, DOI 10.1111/exd.12727; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Novak ML, 2013, J LEUKOCYTE BIOL, V93, P875, DOI 10.1189/jlb.1012512; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Park JY, 2016, CLIN RES HEPATOL GAS, V40, P357, DOI 10.1016/j.clinre.2015.09.005; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Shigeoka M, 2013, CANCER SCI, V104, P1112, DOI 10.1111/cas.12188; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Stifano G, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-015-0554-8; Sulli A, 2009, J RHEUMATOL, V36, P1235, DOI 10.3899/jrheum.081030; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tulapurkar ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118010; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang Y, 2015, AGING CELL, V14, P678, DOI 10.1111/acel.12350; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yu AP, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0108-2; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84	50	42	42	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166433	10.1371/journal.pone.0166433	http://dx.doi.org/10.1371/journal.pone.0166433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846260	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600063
J	Venkatraman, L; Regan, ER; Bentley, K				Venkatraman, Lakshmi; Regan, Erzsebet Ravasz; Bentley, Katie			Time to Decide? Dynamical Analysis Predicts Partial Tip/Stalk Patterning States Arise during Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; BCL-2 APOPTOTIC SWITCH; TUMOR ANGIOGENESIS; NOTCH; CELLS; FEEDBACK; EXPRESSION; SIRT1; DLL4; SOMITOGENESIS	Angiogenesis is a highly dynamic morphogenesis process; however, surprisingly little is known about the timing of the different molecular processes involved. Although the role of the VEGF-notch-DLL4 signaling pathway has been established as essential for tip/stalk cell competition during sprouting, the speed and dynamic properties of the underlying process at the individual cell level has not been fully elucidated. In this study, using mathematical modeling we investigate how specific, biologically meaningful, local conditions around and within an individual cell can influence their unique tip/stalk phenotype switching kinetics. To this end we constructed an ordinary differential equation model of VEGF-notch-DLL4 signaling in a system of two, coupled endothelial cells (EC). Our studies reveal that at any given point in an angiogenic vessel the time it takes a cell to decide to take on a tip or stalk phenotype may be drastically different, and this asynchrony of tip/stalk cell decisions along vessels itself acts to speed up later competitions. We unexpectedly uncover intermediate "partial" yet stable states lying between the tip and stalk cell fates, and identify that internal cellular factors, such as NAD-dependent deacetylase sirtuin-1 (Sirt1) and Lunatic fringe 1 (Lfng1), can specifically determine the length of time a cell spends in these newly identified partial tip/stalk states. Importantly, the model predicts that these partial EC states can arise during normal angiogenesis, in particular during cell rearrangement in sprouts, providing a novel two-stage mechanism for rapid adaptive behavior to the cells highly dynamic environment. Overall, this study demonstrates that different factors (both internal and external to EC) can be used to modulate the speed of tip/stalk decisions, opening up new opportunities and challenges for future biological experiments and therapeutic targeting to manipulate vascular network topology, and our basic understanding of developmental/pathological angiogenesis.	[Venkatraman, Lakshmi; Regan, Erzsebet Ravasz; Bentley, Katie] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Regan, Erzsebet Ravasz] Coll Wooster, Dept Biochem & Mol Biol, Wooster, OH 44691 USA; [Bentley, Katie] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; College of Wooster; Uppsala University	Venkatraman, L; Bentley, K (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA.; Bentley, K (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	Venkatraman.lakshmi@gmail.com; kbentley@bidmc.harvard.edu	Regan, Erzsébet Ravasz/AAG-8989-2019	Regan, Erzsébet Ravasz/0000-0002-8663-3153; Bentley, Katie/0000-0002-9391-659X	Marfan Foundation; Beth Israel Medical Deaconess Center; NSF [1517390]; Knut and Alice Wallenberg Foundation	Marfan Foundation; Beth Israel Medical Deaconess Center; NSF(National Science Foundation (NSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	LV is funded by Victor A. McKusick Fellowship from the Marfan Foundation. ER and KB are funded by Beth Israel Medical Deaconess Center. KB is also funded by NSF (Ref. 1517390) and the Knut and Alice Wallenberg Foundation.; LV is funded by Victor A. McKusick Fellowship from the Marfan Foundation. ER and KB are funded by Beth Israel Medical Deaconess Center. KB is also funded by NSF (Ref. 1517390) and the Knut and Alice Wallenberg Foundation. LV performed the simulations. LV and KB designed the study; LV, ER and KB analyzed and interpreted the simulation results, prepared and edited the manuscript.	AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bentley K, 2014, HETEROGENEOUS COLLEC, P1; Bentley K, CAN ACTIVE PERCEPTIO; Bentley K, 2008, J THEOR BIOL, V250, P25, DOI 10.1016/j.jtbi.2007.09.015; Bentley K, 2014, DEV CELL, V29, P146, DOI 10.1016/j.devcel.2014.03.019; Bentley K, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000549; Bernard S, 2006, PHILOS T R SOC A, V364, P1155, DOI 10.1098/rsta.2006.1761; Blanco R, 2013, PLOS ONE, V3; Boareto M, 2015, P NATL ACAD SCI USA, V112, pE3836, DOI 10.1073/pnas.1511814112; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Castel D, 2013, GENE DEV, V27, P1059, DOI 10.1101/gad.211912.112; Cen Y, 2011, CURR MED CHEM, V18, P1919, DOI 10.2174/092986711795590084; Chen C, 2007, FEBS LETT, V581, P5143, DOI 10.1016/j.febslet.2007.09.063; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Cui J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001469; Dardik R, 2003, J CELL PHYSL, V194, P237, DOI [10.1002/jcp.10208, DOI 10.1002/JCP.10208]; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Guarani V, 2011, NATURE, V473, P234, DOI 10.1038/nature09917; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holt MR, 2001, TRENDS CELL BIOL, V11, P38, DOI 10.1016/S0962-8924(00)01876-6; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Kageyama R, 2012, WIRES DEV BIOL, V1, P629, DOI 10.1002/wdev.46; Kato TM, 2010, MOL CELL NEUROSCI, V45, P12, DOI 10.1016/j.mcn.2010.05.004; Kim JJ, 2012, J ENDODONT, V38, P899, DOI 10.1016/j.joen.2012.04.006; Koch S, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006502; Kuhnert F, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-20; Kur E, 2016, ELIFE, V5, DOI 10.7554/eLife.13212; Larrivee B, 2012, DEV CELL NIH PUBLIC, V22, P500; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Meinhardt H, 2004, BIOESSAYS, V26, P1260, DOI 10.1002/bies.20135; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; PHILLIPS GD, 1991, AM J ANAT, V192, P257, DOI 10.1002/aja.1001920305; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Serth K, 2003, GENE DEV, V17, P912, DOI 10.1101/gad.250603; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Ubezio B, 2016, ELIFE, V5, DOI 10.7554/eLife.12167; Uexkull Jakob von, 1920, THEORETISCHE BIOLOGI; Vaggi F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002088; Venkatraman L, 2012, BIOPHYS J, V102, p730A, DOI 10.1016/j.bpj.2011.11.3964; Xie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045331; Zi ZK, 2005, FEBS LETT, V579, P1101, DOI 10.1016/j.febslet.2005.01.009	52	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166489	10.1371/journal.pone.0166489	http://dx.doi.org/10.1371/journal.pone.0166489			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846305	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600070
J	Chen, HL; Lee, WT; Lee, PL; Liu, PL; Yang, RC				Chen, Hsiu-Lin; Lee, Wei-Te; Lee, Pei-Lun; Liu, Po-Len; Yang, Rei-Cheng			Postnatal Changes in Tibial Bone Speed of Sound of Preterm and Term Infants during Infancy	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; QUANTITATIVE ULTRASOUND; GESTATIONAL-AGE; ADOLESCENTS; CHILDREN; OSTEOPOROSIS; OSTEOPENIA; CHILDHOOD; FRACTURES; RICKETS	This study aimed to evaluate changes in tibial bone speed of sound (SOS) over time, in preterm and term infants during infancy, in addition to identifying factors influencing the development of tibial SOS during infancy. Preterm (n = 155) and term (n = 65) infants were enrolled in this study. Tibial bone SOS was measured using quantitative ultrasonography (QUS) on the left tibia of newborn infants after birth (within 7 days), at 1 month old, and then every 2 months until subjects were approximately 12-15 months old. Follow-up checks included anthropometric measurements and tibial bone SOS. Mean tibial bone SOS at birth was significantly higher in term infants (mean-SD, 2968.5-99.7 m/s) than in preterm infants (2912.2-122.6 m/s). Values of follow-up tibial bone SOS declined for the first 4 months, and then increased gradually until 12-15 months old. This increasing trend was greater in preterm infants after 2 months of corrected age than in term infants. There were no significant differences by 12-15 months of age between preterm and term infants. A longitudinal mixed-effect model controlling for internal correlations and other covariates in the two groups showed that age and the SOS value at birth were important factors affecting the tibial bone SOS in both preterm and term newborn infants during infancy. There are significant differences in the pattern of change in tibial bone SOS values between preterm and term infants during the first 12-15 months of life. Age and SOS value at birth were important factors affecting the pattern of tibial bone SOS change in both preterm and term newborn infants during infancy.	[Chen, Hsiu-Lin; Lee, Wei-Te; Lee, Pei-Lun; Yang, Rei-Cheng] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan; [Chen, Hsiu-Lin; Liu, Po-Len] Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan; [Yang, Rei-Cheng] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Chen, HL (corresponding author), Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung, Taiwan.; Chen, HL (corresponding author), Kaohsiung Med Univ, Dept Resp Therapy, Coll Med, Kaohsiung, Taiwan.	ch840062@kmi.edu.tw	Chen, Hsiu-Lin/B-9238-2012; Chen, Hsiu-Lin/S-8325-2019; Chen, Hsiu-Lin/GRY-7492-2022	Chen, Hsiu-Lin/0000-0002-0565-4631; Chen, Hsiu-Lin/0000-0002-0565-4631; Lee, Wei-Te/0000-0002-9366-6180	Kaohsiung Medical University Research Foundation [KMU-Q098014]	Kaohsiung Medical University Research Foundation	This study was supported by a grant from Kaohsiung Medical University Research Foundation (KMU-Q098014)(HLC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Chen HL, 2012, EARLY HUM DEV, V88, P617, DOI 10.1016/j.earlhumdev.2012.01.008; Chen HL, 2010, J PAEDIATR CHILD H, V46, P653, DOI 10.1111/j.1440-1754.2010.01822.x; De Cunto A, 2014, ARCH DIS CHILD-FETAL, V99, pF238, DOI 10.1136/archdischild-2013-305386; Guglielmi G, 2009, EUR RADIOL, V19, P1837, DOI 10.1007/s00330-009-1354-1; Gursoy T, 2008, J PEDIATR ENDOCR MET, V21, P1065; Hsieh Wu-Shiun, 2006, Acta Paediatrica Taiwanica, V47, P25; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Kaga M, 2002, J BONE MINER METAB, V20, P111, DOI 10.1007/s007740200015; Koo WWK, 2008, PEDIATR RADIOL, V38, P1323, DOI 10.1007/s00247-008-1040-5; Koo WWK, 1998, J AM COLL NUTR, V17, P65, DOI 10.1080/07315724.1998.10720457; KOO WWK, 1985, AM J DIS CHILD, V139, P1045, DOI 10.1001/archpedi.1985.02140120091034; KOO WWK, 1989, J PEDIATR ORTHOPED, V9, P326, DOI 10.1097/01202412-198909030-00012; Land C, 2008, BEST PRACT RES CL EN, V22, P107, DOI 10.1016/j.beem.2007.09.005; Lequin MH, 2000, CALCIFIED TISSUE INT, V67, P101, DOI 10.1007/s00223001119; Liao XP, 2005, PEDIATR RADIOL, V35, P847, DOI 10.1007/s00247-005-1481-z; Littner Y, 2003, J PEDIATR ENDOCR MET, V16, P43; McDevitt H, 2005, ARCH DIS CHILD-FETAL, V90, pF341, DOI 10.1136/adc.2004.065276; Moshang TJ., 2005, PEDIAT ENDOCRINOLOGY, P241; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Pereda Lourdes, 2003, J Perinatol, V23, P655, DOI 10.1038/sj.jp.7211006; Prevrhal S, 2001, OSTEOPOROSIS INT, V12, P28, DOI 10.1007/s001980170154; Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597; Ritschl E, 2005, PEDIATR RES, V58, P341, DOI 10.1203/01.PDR.0000169996.25179.EC; Rubinacci A, 2003, EUR J ENDOCRINOL, V149, P307, DOI 10.1530/eje.0.1490307; Teitelbaum JE, 2006, J CLIN DENSITOM, V9, P358, DOI 10.1016/j.jocd.2006.03.013; Vignolo M, 2003, CALCIFIED TISSUE INT, V72, P681, DOI 10.1007/s00223-002-2028-z; Williford AL, 2008, NEONATAL NETW, V27, P57, DOI 10.1891/0730-0832.27.1.57	29	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166434	10.1371/journal.pone.0166434	http://dx.doi.org/10.1371/journal.pone.0166434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832193	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000123
J	Chroma, K; Mistrik, M; Moudry, P; Gursky, J; Liptay, M; Strauss, R; Skrott, Z; Vrtel, R; Bartkova, J; Kramara, J; Bartek, J				Chroma, K.; Mistrik, M.; Moudry, P.; Gursky, J.; Liptay, M.; Strauss, R.; Skrott, Z.; Vrtel, R.; Bartkova, J.; Kramara, J.; Bartek, J.			Tumors overexpressing RNF168 show altered DNA repair and responses to genotoxic treatments, genomic instability and resistance to proteotoxic stress	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; DAMAGE-RESPONSE; HOMOLOGOUS RECOMBINATION; 53BP1 RECRUITMENT; CHROMATIN RESPONSE; PARP INHIBITORS; PROTEIN; BRCA1; CELLS; ACCUMULATION	Chromatin DNA damage response (DDR) is orchestrated by the E3 ubiquitin ligase ring finger protein 168 (RNF168), resulting in ubiquitin-dependent recruitment of DDR factors and tumor suppressors breast cancer 1 (BRCA1) and p53 binding protein 1 (53BP1). This ubiquitin signaling regulates pathway choice for repair of DNA double-strand breaks (DSB), toxic lesions whose frequency increases during tumorigenesis. Recruitment of 53BP1 curbs DNA end resection, thereby limiting homologous recombination (HR) and directing DSB repair toward error-prone non-homologous end joining (NHEJ). Under cancer-associated ubiquitin starvation conditions reflecting endogenous or treatment-evoked proteotoxic stress, the ubiquitin-dependent accrual of 53BP1 and BRCA1 at the DNA damage sites is attenuated or lost. Challenging this current paradigm, here we identified diverse human cancer cell lines that display 53BP1 recruitment to DSB sites even under proteasome inhibitor-induced proteotoxic stress, that is, under substantial depletion of free ubiquitin. We show that central to this unexpected phenotype is overabundance of RNF168 that enables more efficient exploitation of the residual-free ubiquitin. Cells with elevated RNF168 are more resistant to combined treatment by ionizing radiation and proteasome inhibition, suggesting that such aberrant RNF168-mediated signaling might reflect adaptation to chronic proteotoxic and genotoxic stresses experienced by tumor cells. Moreover, the overabundant RNF168 and the ensuing unorthodox recruitment patterns of 53BP1, RIF1 and REV7 (monitored on laser micro-irradiation-induced DNA damage) shift the DSB repair balance from HR toward NHEJ, a scenario accompanied by enhanced chromosomal instability/micronuclei formation and sensitivity under replication stress-inducing treatments with camptothecin or poly(ADP-ribose) polymerase (PARP) inhibitor. Overall, our data suggest that the deregulated RNF168/53BP1 pathway could promote tumorigenesis by selecting for a more robust, better stress-adapted cancer cell phenotype, through altered DNA repair, fueling genomic instability and tumor heterogeneity. Apart from providing insights into cancer (patho) biology, the elevated RNF168, documented here also by immunohistochemistry on human clinical tumor specimens, may impact responses to standard-of-care and some emerging targeted cancer therapies.	[Chroma, K.; Mistrik, M.; Moudry, P.; Gursky, J.; Liptay, M.; Skrott, Z.; Kramara, J.; Bartek, J.] Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Hnevotinska 5, Olomouc 77515, Czech Republic; [Moudry, P.; Strauss, R.; Bartkova, J.; Bartek, J.] Danish Canc Soc Res Ctr, Genome Integr Unit, Strandboulevarden 49, DK-2100 Copenhagen, Denmark; [Vrtel, R.] Univ Hosp Olomouc, Dept Clin Genet, Olomouc, Czech Republic; [Bartkova, J.; Bartek, J.] Karolinska Inst, Div Translat Med & Chem Biol, Dept Med Biochem & Biophys, Sci Life Lab, Solna, Sweden	Palacky University Olomouc; Danish Cancer Society; University Hospital Olomouc; Karolinska Institutet	Kramara, J (corresponding author), Palacky Univ, Fac Med & Dent, Inst Mol & Translat Med, Hnevotinska 5, Olomouc 77515, Czech Republic.; Bartek, J (corresponding author), Danish Canc Soc Res Ctr, Genome Integr Unit, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	juraj.kramara@upol.cz; jb@cancer.dk		Mistrik, Martin/0000-0002-2321-0348; Chroma, Katarina/0000-0003-0141-0469; Skrott, Zdenek/0000-0001-6004-3609	Grant Agency of the Czech Republic [13-17555S]; Czech National Program of Sustainability [LO1304]; Kellner Family Foundation; Norwegian Financial Mechanism CZ09 [PHOSCAN 7F14061]; MEYS CR [LM2015062]; EU operation program [CZ.1.07/2.3.00/30.0004]; Danish National Research Foundation [DNRF125]; Danish Cancer Society; Swedish Research Council; Lundbeck Foundation; Cancer Fonden; Danish Council for Independent Research;  [IGA-LF-2016-030]; Novo Nordisk Fonden [NNF15OC0016584, NNF12OC0002290] Funding Source: researchfish; The Danish Cancer Society [R124-A7785] Funding Source: researchfish	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Czech National Program of Sustainability; Kellner Family Foundation; Norwegian Financial Mechanism CZ09; MEYS CR; EU operation program; Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lundbeck Foundation(Lundbeckfonden); Cancer Fonden(Swedish Cancer Society); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); ; Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)	We thank Jan Bouchal, Katerina Bouchalova and our colleagues from the Laboratory of Genome Integrity for technical assistance, suggestions and comments on the manuscript. This work was supported by grants from the following foundations: Grant Agency of the Czech Republic 13-17555S, Czech National Program of Sustainability LO1304, the Kellner Family Foundation, the Norwegian Financial Mechanism CZ09 (Project PHOSCAN 7F14061), MEYS CR (LM2015062 Czech-BioImaging), the internal grant IGA-LF-2016-030, the EU operation program CZ.1.07/2.3.00/30.0004, the Danish National Research Foundation (DNRF125, project CARD), Danish Cancer Society, the Swedish Research Council, the Lundbeck Foundation, Cancer Fonden, and the Danish Council for Independent Research.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Bartek J, 2007, ONCOGENE, V26, P7773, DOI 10.1038/sj.onc.1210881; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bekker-Jensen S, 2010, NAT CELL BIOL, V12, P80, DOI 10.1038/ncb2008; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Callen E, 2013, CELL, V153, P1266, DOI 10.1016/j.cell.2013.05.023; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Chapman JR, 2013, MOL CELL, V49, P858, DOI 10.1016/j.molcel.2013.01.002; Chauhan D, 2005, ANNU REV PHARMACOL, V45, P465, DOI 10.1146/annurev.pharmtox.45.120403.100037; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Daley JM, 2014, MOL CELL BIOL, V34, P1380, DOI 10.1128/MCB.01639-13; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Densham RM, 2016, NAT STRUCT MOL BIOL, V23, P647, DOI 10.1038/nsmb.3236; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Devgan SS, 2011, CELL DEATH DIFFER, V18, P1500, DOI 10.1038/cdd.2011.18; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Evangelou K, 2013, CELL DEATH DIFFER, V20, P1485, DOI 10.1038/cdd.2013.76; Fradet-Turcotte A, 2013, NATURE, V499, P50, DOI 10.1038/nature12318; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hjerpe R, 2012, BIOCHEM J, V441, P927, DOI 10.1042/BJ20111671; Inbar-Rozensal D, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2445; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Kocylowski MK, 2015, CELL CYCLE, V14, P1748, DOI 10.1080/15384101.2015.1010918; Livraghi L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0425-1; Lukas J, 2011, NAT CELL BIOL, V13, P1161, DOI 10.1038/ncb2344; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma T, 2013, MOL CELL, V49, P897, DOI 10.1016/j.molcel.2013.01.006; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Mistrik M, 2016, SCI REP-UK, V6, DOI 10.1038/srep19567; Munoz MC, 2014, NUCLEIC ACIDS RES, V42, P7720, DOI 10.1093/nar/gku421; Munoz MC, 2012, J BIOL CHEM, V287, P40618, DOI 10.1074/jbc.M112.410951; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Ricks TK, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00222; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Tang JB, 2013, NAT STRUCT MOL BIOL, V20, P317, DOI 10.1038/nsmb.2499; Thorslund T, 2015, NATURE, V527, P389, DOI 10.1038/nature15401; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Velimezi G, 2013, NAT CELL BIOL, V15, P967, DOI 10.1038/ncb2795; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Wee S, 2008, P NATL ACAD SCI USA, V105, P13057, DOI 10.1073/pnas.0802655105; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Zhao Y, 2014, TRENDS CELL BIOL, V24, P426, DOI 10.1016/j.tcb.2014.01.005; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573; Zong DL, 2015, NUCLEIC ACIDS RES, V43, P4950, DOI 10.1093/nar/gkv336	59	25	25	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 27	2017	36	17					2405	2422		10.1038/onc.2016.392	http://dx.doi.org/10.1038/onc.2016.392			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ET4QE	27841863				2022-12-26	WOS:000400268900007
J	Thompson, JM; Nguyen, QH; Singh, M; Pavesic, MW; Nesterenko, I; Nelson, LJ; Liao, AC; Razorenova, OV				Thompson, J. M.; Nguyen, Q. H.; Singh, M.; Pavesic, M. W.; Nesterenko, I.; Nelson, L. J.; Liao, A. C.; Razorenova, O. V.			Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-SUPPRESSOR; UP-REGULATION; INTERFERON-ALPHA; ROCK-II; HYPOXIA; GENE; EXPRESSION; Y-27632; PROGRESSION	Clear cell renal cell carcinoma (CC-RCC) is the most lethal of all genitourinary cancers. The functional loss of the von Hippel-Lindau (VHL) gene occurs in 90% of CC-RCC, driving cancer progression. The objective of this study was to identify chemical compounds that are synthetically lethal with VHL deficiency in CC-RCC. An annotated chemical library, the library of pharmacologically active compounds (LOPAC), was screened in parallel on VHL-deficient RCC4 cells and RCC4VHL cells with re-introduced VHL. The ROCK inhibitor, Y-27632, was identified and validated for selective targeting of VHL-deficient CC-RCC in multiple genetic backgrounds by clonogenic assays. Downregulation of ROCK1 by small interfering RNA (siRNA) selectively reduced the colony-forming ability of VHL-deficient CC-RCC, thus mimicking the effect of Y-27632 treatment, whereas downregulation of ROCK2 had no effect. In addition, two other ROCK inhibitors, RKI 1447 and GSK 429286, selectively targeted VHL-deficient CC-RCC. CC-RCC treatment with ROCK inhibitors is cytotoxic and cytostatic based on bromodeoxyuridine (BrdU) assay, propidium iodide (PI) staining and growth curves, and blocks cell migration based on transwell assay. On the one hand, knockdown of hypoxia-inducible factor (HIF) beta in the VHL-deficient CC-RCC had a protective effect against Y-27632 treatment, mimicking VHL reintroduction. On the other hand, CC-RCCVHL cells were sensitized to Y-27632 treatment in hypoxia (2% O-2). These results suggest that synthetic lethality between ROCK inhibition and VHL deficiency is dependent on HIF activation. Moreover, HIF1 alpha or HIF2 alpha overexpression in CC-RCCVHL cells is sufficient to sensitize them to ROCK inhibition. Finally, Y-27632 treatment inhibited growth of subcutaneous 786-OT1 CC-RCC tumors in mice. Thus, ROCK inhibitors represent potential therapeutics for VHL-deficient CC-RCC.	[Thompson, J. M.; Nguyen, Q. H.; Singh, M.; Pavesic, M. W.; Nesterenko, I.; Nelson, L. J.; Liao, A. C.; Razorenova, O. V.] Univ Calif Irvine, Dept Mol Biol & Biochem, 845 Hlth Sci Rd,Gross Hall Room 3010, Irvine, CA 92717 USA	University of California System; University of California Irvine	Razorenova, OV (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 845 Hlth Sci Rd,Gross Hall Room 3010, Irvine, CA 92717 USA.	olgar@uci.edu			NCI [R03 CA202563-01]; NIH T32 [2T32CA009054-36A1]; NIH [T32 NS82174-3]; NIH ICTS [UL1 TR001414];  [ACS-IRG-98-279-10]; NATIONAL CANCER INSTITUTE [T32CA009054, R03CA202563] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001415, UL1TR001414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS082174] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH T32(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH ICTS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by ACS-IRG-98-279-10 and NCI R03 CA202563-01 to OVR, NIH T32 (2T32CA009054-36A1) to JMT, NIH T32 NS82174-3 to IN and NIH ICTS (UL1 TR001414) to LJN. We thank Dr David Fruman and Dr Hung Fan for critical reading of the manuscript and anonymous reviewers for constructive critique.	Abe H, 2008, BIOMED RES-TOKYO, V29, P155, DOI 10.2220/biomedres.29.155; Amin E, 2013, BIOL CHEM, V394, P1399, DOI 10.1515/hsz-2013-0181; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Buczek M, 2014, BBA-REV CANCER, V1845, P31, DOI 10.1016/j.bbcan.2013.10.001; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Escudier B, 2011, DRUGS R&D, V11, P113, DOI 10.2165/11591240-000000000-00000; Gilkes DM, 2014, P NATL ACAD SCI USA, V111, pE384, DOI 10.1073/pnas.1321510111; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Greijer AE, 2005, J PATHOL, V206, P291, DOI 10.1002/path.1778; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Inan SY, 2008, BRIT J PHARMACOL, V155, P44, DOI 10.1038/bjp.2008.225; Isler D, 2014, PHARMACOL REP, V66, P114, DOI 10.1016/j.pharep.2013.06.006; Jonasch E, 2012, MOL CANCER RES, V10, P859, DOI 10.1158/1541-7786.MCR-12-0117; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2004, CLIN CANCER RES, V10, P4799, DOI 10.1158/1078-0432.CCR-0436-03; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Liao DK, 2007, J CARDIOVASC PHARM, V50, P17, DOI 10.1097/FJC.0b013e318070d1bd; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Liu XZ, 2011, J ORTHOP RES, V29, P1259, DOI 10.1002/jor.21403; Lochhead PA, 2010, ONCOGENE, V29, P2591, DOI 10.1038/onc.2010.3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mizukami Y, 2006, J BIOL CHEM, V281, P13957, DOI 10.1074/jbc.M511763200; Mleczak A, 2013, CELL SIGNAL, V25, P1, DOI 10.1016/j.cellsig.2012.09.010; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Patel RA, 2012, CANCER RES, V72, P5025, DOI 10.1158/0008-5472.CAN-12-0954; Pinto A, 2014, CLIN GENITOURIN CANC, V12, P408, DOI 10.1016/j.clgc.2014.06.012; Razorenova OV, 2014, MOL CELL BIOL, V34, P739, DOI 10.1128/MCB.00644-12; Razorenova OV, 2011, P NATL ACAD SCI USA, V108, P1931, DOI 10.1073/pnas.1011777108; Razorenova OV, 2005, GENE, V350, P89, DOI 10.1016/j.gene.2005.02.006; Rikitake Y, 2005, STROKE, V36, P2251, DOI 10.1161/01.STR.0000181077.84981.11; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.10; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sternberg CN, 2010, J CLIN ONCOL, V28, P1061, DOI 10.1200/JCO.2009.23.9764; Sutphin PD, 2007, CANCER RES, V67, P5896, DOI 10.1158/0008-5472.CAN-07-0604; Takata K, 2008, MOL CANCER THER, V7, P1551, DOI 10.1158/1535-7163.MCT-07-0428; Thompson Jordan M., 2015, Yale Journal of Biology and Medicine, V88, P145; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Woldemichael GM, 2012, NEOPLASIA, V14, P771, DOI 10.1593/neo.12852; Wolff NC, 2015, ONCOTARGET, V6, P16951, DOI 10.18632/oncotarget.4773; Zhang C, 2014, ONCOGENE, V33, P5582, DOI 10.1038/onc.2013.505; Zhang QH, 2012, ADV DIFFER EQU-NY, DOI 10.1186/1687-1847-2012-136	54	22	22	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1080	1089		10.1038/onc.2016.272	http://dx.doi.org/10.1038/onc.2016.272			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27841867	Green Accepted, Green Submitted			2022-12-26	WOS:000395371500006
J	Fuku, N; Alis, R; Yvert, T; Zempo, H; Naito, H; Abe, Y; Arai, Y; Murakami, H; Miyachi, M; Pareja-Galeano, H; Emanuele, E; Hirose, N; Lucia, A				Fuku, Noriyuki; Alis, Rafael; Yvert, Thomas; Zempo, Hirofumi; Naito, Hisashi; Abe, Yukiko; Arai, Yasumichi; Murakami, Haruka; Miyachi, Motohiko; Pareja-Galeano, Helios; Emanuele, Enzo; Hirose, Nobuyoshi; Lucia, Alejandro			Muscle-Related Polymorphisms (MSTN rs1805086 and ACTN3 rs1815739) Are Not Associated with Exceptional Longevity in Japanese Centenarians	PLOS ONE			English	Article							ALPHA-ACTININ-3 DEFICIENCY; K153R POLYMORPHISM; MYOSTATIN GENE; METABOLISM; SELECTION; INSIGHTS; AFRICAN	Myostatin (MSTN) and alpha-actinin-3 (ACTN3) genes are potentially associated with preservation of muscle mass and oxidative capacity, respectively. To explore the possible role of these genes in exceptional longevity (EL), the allele/genotype frequency distribution of two polymorphisms in MSTN (rs1805086, K153R) and ACTN3 (rs1815739, R577X) was studied in Japanese centenarians of both sexes (n = 742) and healthy controls (n = 814). The rs1805086 R-allele (theoretically associated with muscle mass preservation at the expense of oxidative capacity) was virtually absent in the two groups, where genotype distributions were virtually identical. Likewise, no differences in allele (p = 0.838 (women); p = 0.193 (men); p = 0.587 (both sexes)) or genotype distribution were found between groups for ACTN3 rs1815739 (p = 0.975 (women), p = 0.136 (men), p = 0.752 (both sexes)). Of note, however, the frequency of the rs1805086 R-allele observed here is the lowest been reported to date whereas that of the 'highly oxidative/efficient' rs1815739 XX genotype in Japanese male centenarians (33.3%) or supercentenarians of both sexes (>= 110 years) are the highest (32.6%), for a non-American population. No definite conclusions can be inferred in relation to EL owing to its lack of association with both rs1815739 and rs1805086. However, it cannot be excluded that these gene variants could eventually be related to a "healthy" metabolic phenotype in the Japanese population. Further research might determine if such metabolic profile is among the factors that can potentially predispose these individuals to live longer than Caucasians and what genetic variants might be actually involved.	[Fuku, Noriyuki; Zempo, Hirofumi; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba, Japan; [Alis, Rafael] Catholic Univ Valencia San Vicente Martir, Sch Med, Valencia, Spain; [Alis, Rafael] Catholic Univ Valencia San Vicente Martir, Res Inst Dr Vina Giner Mol & Mitochondrial Med, Valencia, Spain; [Alis, Rafael] Hosp Univ & Politecn La Fe, Serv Nefrol, Valencia, Spain; [Yvert, Thomas] Univ Europea Madrid, Sch Doctorate Studies & Res, Madrid, Spain; [Abe, Yukiko; Arai, Yasumichi; Hirose, Nobuyoshi] Keio Univ, Ctr Supercentenarian Study, Sch Med, Tokyo, Japan; [Murakami, Haruka; Miyachi, Motohiko] Natl Inst Hlth Nutr, Dept Hlth Promot & Exercise, Tokyo, Japan; [Pareja-Galeano, Helios; Lucia, Alejandro] European Univ Madrid, Madrid, Spain; [Pareja-Galeano, Helios; Lucia, Alejandro] Res Inst Hosp 12 Octubre I 12, Madrid, Spain; [Emanuele, Enzo] 2E Sci, Pavia, Italy	Juntendo University; Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir; Hospital Universitari i Politecnic La Fe; European University of Madrid; Keio University; National Institute of Health & Nutrition - Japan; European University of Madrid	Alis, R (corresponding author), Catholic Univ Valencia San Vicente Martir, Sch Med, Valencia, Spain.; Alis, R (corresponding author), Catholic Univ Valencia San Vicente Martir, Res Inst Dr Vina Giner Mol & Mitochondrial Med, Valencia, Spain.; Alis, R (corresponding author), Hosp Univ & Politecn La Fe, Serv Nefrol, Valencia, Spain.	rafael.alis@ucv.es	Pareja-Galeano, Helios/M-2380-2014; Naito, Hisashi/F-5655-2011; Alis, Rafael/M-1581-2014; Miyachi, Motohiko/AAW-3403-2020; Pareja-Galeano, Helios/Q-2475-2019; Zempo, Hirofumi/HHZ-7173-2022	Pareja-Galeano, Helios/0000-0002-5780-2712; Naito, Hisashi/0000-0002-0522-9512; Alis, Rafael/0000-0002-9169-5084; Miyachi, Motohiko/0000-0002-1146-0905; Zempo, Hirofumi/0000-0003-2248-8580; Murakami, Haruka/0000-0001-9160-0033; Yvert, Thomas/0000-0002-9451-9799; Fuku, Noriyuki/0000-0001-7792-5835; Lucia, Alejandro/0000-0002-5565-0997	Ministry of Education, Culture, Sports, Science and Technology [15H03081]; Ministry of Health, Labor, and Welfare of Japan; Fondo de Investigaciones Sanitarias (FIS) [PI15/00558]; Fondos Feder; Catedra Real Madrid-Universidad Europea [2016/RM02]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Fondo de Investigaciones Sanitarias (FIS)(Instituto de Salud Carlos III); Fondos Feder(European Commission); Catedra Real Madrid-Universidad Europea	This work was supported in part by grants from the Grant-in-Aid for Scientific Research (B) (15H03081 to N.F.) program of the Ministry of Education, Culture, Sports, Science and Technology and by a grant-in-aid for scientific research from the Ministry of Health, Labor, and Welfare of Japan (to M.M.). Research in the field by A.L. is supported by Fondo de Investigaciones Sanitarias (FIS, grant # PI15/00558) and Fondos Feder as well as by Catedra Real Madrid-Universidad Europea (grant # 2015/02RM). H.P.G. is supported by a grant from Catedra Real Madrid-Universidad Europea (grant # 2016/RM02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim CEG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115449; Fernandez-Santander A, 2012, ANN HUM BIOL, V39, P166, DOI 10.3109/03014460.2012.657243; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Fiuza-Luces C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017558; Fuku N, 2015, AGING CELL, V14, P921, DOI 10.1111/acel.12389; Garatachea N, 2015, REJUV RES, V18, P57, DOI 10.1089/rej.2014.1623; Garatachea N, 2014, EXP GERONTOL, V53, P16, DOI 10.1016/j.exger.2014.02.004; Garatachea N, 2013, AGE, V35, P2445, DOI 10.1007/s11357-013-9513-3; Garatachea N, 2013, AGE, V35, P207, DOI 10.1007/s11357-011-9327-0; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Lewis SJ, 2004, INT J EPIDEMIOL, V33, P962, DOI 10.1093/ije/dyh214; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Loumaye A, 2015, J CLIN ENDOCR METAB, V100, P2030, DOI 10.1210/jc.2014-4318; MacArthur DG, 2008, HUM MOL GENET, V17, P1076, DOI 10.1093/hmg/ddm380; MacArthur DG, 2007, NAT GENET, V39, P1261, DOI 10.1038/ng2122; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Mouisel E, 2014, AM J PHYSIOL-REG I, V307, pR444, DOI 10.1152/ajpregu.00377.2013; Murakami H, 2014, PHYSIOL BEHAV, V129, P199, DOI 10.1016/j.physbeh.2014.02.053; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; Szlama G, 2015, FEBS LETT, V589, P295, DOI 10.1016/j.febslet.2014.12.011; Takayama M, 2007, J GERONTOL A-BIOL, V62, P774, DOI 10.1093/gerona/62.7.774; Tosun Tasar P, 2015, GENET TEST MOL BIOMA, V19, P457, DOI 10.1089/gtmb.2015.0033; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; Yang N, 2007, MED SCI SPORT EXER, V39, P1985, DOI 10.1249/mss.0b013e31814844c9	24	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166605	10.1371/journal.pone.0166605	http://dx.doi.org/10.1371/journal.pone.0166605			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861536	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300076
J	Ho, EV; Klenotich, SJ; McMurray, MS; Dulawa, SC				Ho, Emily V.; Klenotich, Stephanie J.; McMurray, Matthew S.; Dulawa, Stephanie C.			Activity-Based Anorexia Alters the Expression of BDNF Transcripts in the Mesocorticolimbic Reward Circuit	PLOS ONE			English	Article							RESTRICTED FEEDING SCHEDULE; NEUROTROPHIC FACTOR; EATING-DISORDERS; DRUG REWARD; VOLUNTARY EXERCISE; NUCLEUS-ACCUMBENS; MESSENGER-RNA; NERVOSA; BRAIN; ADDICTION	Anorexia nervosa (AN) is a complex eating disorder with severe dysregulation of appetitive behavior. The activity-based anorexia (ABA) paradigm is an animal model in which rodents exposed to both running wheels and scheduled feeding develop aspects of AN including paradoxical hypophagia, dramatic weight loss, and hyperactivity, while animals exposed to only one condition maintain normal body weight. Brain-derived neurotrophic factor (BDNF), an activity-dependent modulator of neuronal plasticity, is reduced in the serum of AN patients, and is a known regulator of feeding and weight maintenance. We assessed the effects of scheduled feeding, running wheel access, or both on the expression of BDNF transcripts within the mesocorticolimbic pathway. We also assessed the expression of neuronal cell adhesion molecule 1 (NCAM1) to explore the specificity of effects on BDNF within the mesocorticolimbic pathway. Scheduled feeding increased the levels of both transcripts in the hippocampus (HPC), increased NCAM1 mRNA expression in the ventral tegmental area (VTA), and decreased BDNF mRNA levels in the medial prefrontal cortex (mPFC). In addition, wheel running increased BDNF mRNA expression in the VTA. No changes in either transcript were observed in the nucleus accumbens (NAc). Furthermore, no changes in either transcript were induced by the combined scheduled feeding and wheel access condition. These data indicate that scheduled feeding or wheel running alter BDNF and NCAM1 expression levels in specific regions of the mesocorticolimbic pathway. These findings contribute to our current knowledge of the molecular alterations induced by ABA and may help elucidate possible mechanisms of AN pathology.	[Ho, Emily V.; Dulawa, Stephanie C.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Klenotich, Stephanie J.] Univ Chicago, Dept Psychiat, Chicago, IL 60637 USA; [McMurray, Matthew S.] Univ Illinois, Dept Psychol, Chicago, IL USA	University of California System; University of California San Diego; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Dulawa, SC (corresponding author), Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA.	sdulawa@ucsd.edu	Dulawa, Stephanie/M-8070-2016	Dulawa, Stephanie/0000-0003-1281-782X; McMurray, Matthew/0000-0002-1898-2933	NIMH [R01MH099248-02]; NARSAD; CTSA [UL1 RR024999]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NARSAD(NARSAD); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NIMH grant R01MH099248-02, NARSAD, and CTSA UL1 RR024999 (SCD). The authors have no potential conflicts of interest, financial or otherwise, to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; Bessa JM, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.39; Boraska V, 2014, MOL PSYCHIATR, V19, P1085, DOI 10.1038/mp.2013.187; Brandys MK, 2013, WORLD J BIOL PSYCHIA, V14, P441, DOI 10.3109/15622975.2011.605470; Brandys MK, 2011, WORLD J BIOL PSYCHIA, V12, P444, DOI 10.3109/15622975.2011.562244; Bulik CM, 2007, ANNU REV NUTR, V27, P263, DOI 10.1146/annurev.nutr.27.061406.093713; BURDEN VR, 1993, J NUTR, V123, P1217, DOI 10.1093/jn/123.7.1217; Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002; Choi DC, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.128; Conner JM, 1997, J NEUROSCI, V17, P2295; Cowdrey FA, 2011, BIOL PSYCHIAT, V70, P736, DOI 10.1016/j.biopsych.2011.05.028; Davis C, 1998, ADDICT BEHAV, V23, P463, DOI 10.1016/S0306-4603(98)00009-4; Davis C, 2002, COMPR PSYCHIAT, V43, P189, DOI 10.1053/comp.2002.32356; Duan WZ, 2003, ENDOCRINOLOGY, V144, P2446, DOI 10.1210/en.2002-0113; Ehrlich Stefan, 2009, J Psychiatry Neurosci, V34, P323; Frank GKW, 2012, NEUROPSYCHOPHARMACOL, V37, P2031, DOI 10.1038/npp.2012.51; Gelegen C, 2008, GENES BRAIN BEHAV, V7, P552, DOI 10.1111/j.1601-183X.2008.00394.x; Ghitza UE, 2010, NEUROSCI BIOBEHAV R, V35, P157, DOI 10.1016/j.neubiorev.2009.11.009; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Gomez-Pinilla F, 2002, J NEUROPHYSIOL, V88, P2187, DOI 10.1152/jn.00152.2002; Gutierrez E, 2002, PSYCHON B REV, V9, P239, DOI 10.3758/BF03196278; HALL JF, 1954, J COMP PHYSIOL PSYCH, V47, P362, DOI 10.1037/h0060276; Harris AM, 2008, INT J EAT DISORDER, V41, P280, DOI 10.1002/eat.20486; Harrison A, 2010, PSYCHIAT RES, V177, P1, DOI 10.1016/j.psychres.2009.06.010; Huang C, 1994, CELL, V76, P989; Jappe LM, 2011, INT J EAT DISORDER, V44, P317, DOI 10.1002/eat.20815; Kanarek RB, 2009, BEHAV NEUROSCI, V123, P905, DOI 10.1037/a0015896; Kaye WH, 2004, AM J PSYCHIAT, V161, P2215, DOI 10.1176/appi.ajp.161.12.2215; Keating C, 2014, ANHEDONIA COMPREHENS, VII, P191; Klein DA, 2004, CNS SPECTRUMS, V9, P531, DOI 10.1017/S1092852900009627; Klenotich SJ, 2012, NEUROPSYCHOPHARMACOL; Klenotich SJ, 2012, METHODS MOL BIOL, V829, P377, DOI 10.1007/978-1-61779-458-2_25; Koo JW, 2012, SCIENCE, V338, P124, DOI 10.1126/science.1222265; Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027; Liu S, 2011, BRAIN RES, V1400, P31, DOI 10.1016/j.brainres.2011.05.028; McCarthy Deirdre M., 2012, Yale Journal of Biology and Medicine, V85, P437; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Pan Y, 2011, NEUROSCIENCE, V197, P330, DOI 10.1016/j.neuroscience.2011.08.065; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Ribases M, 2003, MOL PSYCHIATR, V8, P745, DOI 10.1038/sj.mp.4001281; ROUTTENBERG A, 1967, J COMP PHYSIOL PSYCH, V64, P414, DOI 10.1037/h0025205; Russo-Neustadt AA, 2004, NEUROPSYCHOPHARMACOL, V29, P2189, DOI 10.1038/sj.npp.1300514; Schachner M, 1997, CURR OPIN CELL BIOL, V9, P627, DOI 10.1016/S0955-0674(97)80115-9; Stranahan AM, 2009, HIPPOCAMPUS, V19, P951, DOI 10.1002/hipo.20577; Swerdlow NR, 2013, NEUROPHARMACOLOGY, V75, P38, DOI 10.1016/j.neuropharm.2013.06.003; Van Hoomissen JD, 2003, BRAIN RES, V974, P228, DOI 10.1016/S0006-8993(03)02584-8; Wagner A, 2007, AM J PSYCHIAT, V164, P1842, DOI 10.1176/appi.ajp.2007.07040575; Wang CF, 2010, BRAIN RES, V1336, P66, DOI 10.1016/j.brainres.2010.04.013; WATANABE K, 1992, PHYSIOL BEHAV, V51, P827, DOI 10.1016/0031-9384(92)90122-I; Wu Q, 2012, NATURE, V483, P594, DOI 10.1038/nature10899	54	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166756	10.1371/journal.pone.0166756	http://dx.doi.org/10.1371/journal.pone.0166756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861553	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300100
J	Hu, K; Gui, ZP; Cheng, XQ; Qi, KL; Zheng, J; You, L; Wu, HY				Hu, Kai; Gui, Zhipeng; Cheng, Xiaoqiang; Qi, Kunlun; Zheng, Jie; You, Lan; Wu, Huayi			Content-Based Discovery for Web Map Service using Support Vector Machine and User Relevance Feedback	PLOS ONE			English	Article							QUALITY; PERFORMANCE	Many discovery methods for geographic information services have been proposed. There are approaches for finding and matching geographic information services, methods for constructing geographic information service classification schemes, and automatic geographic information discovery. Overall, the efficiency of the geographic information discovery keeps improving., There are however, still two problems in Web Map Service (WMS) discovery that must be solved. Mismatches between the graphic contents of a WMS and the semantic descriptions in the metadata make discovery difficult for human users. End-users and computers comprehend WMSs differently creating semantic gaps in human-computer interactions. To address these problems, we propose an improved query process for WMSs based on the graphic contents of WMS layers, combining Support Vector Machine (SVM) and user relevance feedback. Our experiments demonstrate that the proposed method can improve the accuracy and efficiency of WMS discovery.	[Hu, Kai; Zheng, Jie; Wu, Huayi] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan, Peoples R China; [Gui, Zhipeng] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Peoples R China; [Cheng, Xiaoqiang] Hubei Univ, Fac Resources & Environm Sci, Wuhan, Peoples R China; [Qi, Kunlun] Univ Geosci, Natl Engn Res Ctr Geog Informat Syst, Wuhan, Peoples R China; [You, Lan] Hubei Univ, Fac Comp Sci & Informat Engn, Wuhan, Peoples R China; [Hu, Kai; Gui, Zhipeng; Wu, Huayi] Wuhan Univ, Collaborat Innovat Ctr Geospatial Technol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Hubei University; Hubei University; Wuhan University	Gui, ZP (corresponding author), Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan, Peoples R China.; Gui, ZP (corresponding author), Wuhan Univ, Collaborat Innovat Ctr Geospatial Technol, Wuhan, Peoples R China.	zhipeng.gui@whu.edu.cn	Gui, Zhipeng/I-1068-2019; hu, kai/AAA-3425-2019	Gui, Zhipeng/0000-0001-9467-9680; hu, kai/0000-0002-3521-4178	National Natural Science Foundation of China [41371372, 41501434, 41501443]; GeoSquare team of the State Key Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); GeoSquare team of the State Key Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing	This research is supported by the National Natural Science Foundation of China (No. 41371372, No. 41501434 and No. 41501443). The funders had no role in study design, data collection and analysis, decision and publish, or preparation of the manuscript.; This work was supported by GeoSquare team of the State Key Laboratory of Information Engineering in Surveying, Mapping and Remote Sensing. Thanks Mr. Stephen C. McClure for helping us with the English revisions. Thanks the anonymous reviewers for their constructive comments and suggestions.	Ballerini L, 2009, QUERY BY EXAMPLE CON, P31; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cheng XQ, 2015, INT ARCH PHOTOGRAMM, V46, P1, DOI 10.5194/isprsarchives-XL-6-W1-1-2015; Datta R, 2008, ACM COMPUT SURV, V40, DOI 10.1145/1348246.1348248; DOERSCHLER JS, 1992, COMMUN ACM, V35, P68, DOI 10.1145/129617.129620; Gui Z., 2013, ANN GIS, V19, P109, DOI DOI 10.1080/19475683.2013.782467; Gui ZP, 2016, ISPRS INT J GEO-INF, V5, DOI 10.3390/ijgi5060088; Gui ZP, 2013, INT J GEOGR INF SCI, V27, P1109, DOI 10.1080/13658816.2012.739692; Hasan Mokhtar M., 2012, ARPN J SCI TECHNOLOG, V2, P265; Huayi Wu, 2015, Annals of GIS, V21, P287, DOI 10.1080/19475683.2015.1098727; Ke Yan, 2006, 2006 IEEE COMPUTER S, V1, P419, DOI DOI 10.1109/CVPR.2006.303; Lazebnik S., 2006, P IEEE INT C COMP VI, V2, P2169, DOI DOI 10.1109/CVPR.2006.68; Li ZL, 2011, INT J GEOGR INF SCI, V25, P595, DOI 10.1080/13658816.2010.484811; Manson SM, 2012, CARTOGR GEOGR INF SC, V39, P48, DOI 10.1559/1523040639148; Marchesotti L, 2011, IEEE I CONF COMP VIS, P1784, DOI 10.1109/ICCV.2011.6126444; [苗立志 Miao Lizhi], 2015, [测绘学报, Acta Geodetica et Cartographica Sinica], V44, P1029; Rui Y, 1998, IEEE T CIRC SYST VID, V8, P644, DOI 10.1109/76.718510; Shen SY, 2012, T GIS, V16, P745, DOI 10.1111/j.1467-9671.2012.01363.x; Upadhyaya N., 2016, REV RELATING LOW LEV; Wagan AI, 2008, MAP QUALITY ASSESSME, P278; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wu H, 2004, RASTER BASED MAP INF, P365; Wu HY, 2011, COMPUT GEOSCI-UK, V37, P485, DOI 10.1016/j.cageo.2010.05.026	23	9	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166098	10.1371/journal.pone.0166098	http://dx.doi.org/10.1371/journal.pone.0166098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861505	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300027
J	Malki, K; Shapiro, JW; Price, TK; Hilt, EE; Thomas-White, K; Sircar, T; Rosenfeld, AB; Kuffel, G; Zilliox, MJ; Wolfe, AJ; Putonti, C				Malki, Kema; Shapiro, Jason W.; Price, Travis K.; Hilt, Evann E.; Thomas-White, Krystal; Sircar, Trina; Rosenfeld, Amy B.; Kuffel, Gina; Zilliox, Michael J.; Wolfe, Alan J.; Putonti, Catherine			Genomes of Gardnerella Strains Reveal an Abundance of Prophages within the Bladder Microbiome	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; VAGINAL MICROBIOME; 16S RDNA; URINE; BACTERIA; RESISTANCE; SEQUENCE	Bacterial surveys of the vaginal and bladder human microbiota have revealed an abundance of many similar bacterial taxa. As the bladder was once thought to be sterile, the complex interactions between microbes within the bladder have yet to be characterized. To initiate this process, we have begun sequencing isolates, including the clinically relevant genus Gardnerella. Herein, we present the genomic sequences of four Gardnerella strains isolated from the bladders of women with symptoms of urgency urinary incontinence; these are the first Gardnerella genomes produced from this niche. Congruent to genomic characterization of Gardnerella isolates from the reproductive tract, isolates from the bladder reveal a large pangenome, as well as evidence of high frequency horizontal gene transfer. Prophage gene sequences were found to be abundant amongst the strains isolated from the bladder, as well as amongst publicly available Gardnerella genomes from the vagina and endometrium, motivating an in depth examination of these sequences. Amongst the 39 Gardnerella strains examined here, there were more than 400 annotated prophage gene sequences that we could cluster into 95 homologous groups; 49 of these groups were unique to a single strain. While many of these prophages exhibited no sequence similarity to any lytic phage genome, estimation of the rate of phage acquisition suggests both vertical and horizontal acquisition. Furthermore, bioinformatic evidence indicates that prophage acquisition is ongoing within both vaginal and bladder Gardnerella populations. The abundance of prophage sequences within the strains examined here suggests that phages could play an important role in the species' evolutionary history and in its interactions within the complex communities found in the female urinary and reproductive tracts.	[Malki, Kema; Shapiro, Jason W.; Putonti, Catherine] Loyola Univ Chicago, Dept Biol, Chicago, IL 60660 USA; [Shapiro, Jason W.; Sircar, Trina; Putonti, Catherine] Loyola Univ Chicago, Bioinformat Program, Chicago, IL USA; [Price, Travis K.; Hilt, Evann E.; Thomas-White, Krystal; Wolfe, Alan J.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL USA; [Rosenfeld, Amy B.; Kuffel, Gina] Loyola Univ Chicago, Loyola Genom Facil, Ctr Biomed Informat, Maywood, IL USA; [Zilliox, Michael J.] Loyola Univ Chicago, Stritch Sch Med, Dept Publ Hlth Sci, Maywood, IL USA; [Putonti, Catherine] Loyola Univ Chicago, Dept Comp Sci, Chicago, IL USA	Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago; Loyola University Chicago	Putonti, C (corresponding author), Loyola Univ Chicago, Dept Biol, Chicago, IL 60660 USA.; Putonti, C (corresponding author), Loyola Univ Chicago, Bioinformat Program, Chicago, IL USA.; Putonti, C (corresponding author), Loyola Univ Chicago, Dept Comp Sci, Chicago, IL USA.	cputonti@luc.edu	Hilt, Evann/AGY-7111-2022	Thomas-White, Krystal/0000-0002-4635-1426; Malki, Kema/0000-0002-3051-2176	Loyola University Chicago's Multidisciplinary Research Award; NSF [1149387]; NIH [R21DK097435-01A1, 1R56DK104718-01, R01DK104718]; Div Of Biological Infrastructure [1149387] Funding Source: National Science Foundation	Loyola University Chicago's Multidisciplinary Research Award; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	AJW and CP are supported by Loyola University Chicago's Multidisciplinary Research Award. http://www.luc.edu/ors/. This work was also partially funded by the NSF (1149387 to CP http.//www.nsf.gov/) and the NIH (R21DK097435-01A1, 1R56DK104718-01 and R01DK104718 to AJW, https://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles SR, 2014, J MOL BIOL, V426, P3892, DOI 10.1016/j.jmb.2014.07.002; Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Anukam KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059239; Baugher JL, 2014, APPL ENVIRON MICROB, V80, P3508, DOI 10.1128/AEM.04092-13; Beaulieu J. M, 2012, CORHMM HIDDEN MARKOV; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Brubaker L, 2014, INT UROGYNECOL J, V25, P1179, DOI 10.1007/s00192-013-2325-2; Castro J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11640; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Harwich MD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-375; Hickey RJ, 2014, J INFECT DIS, V210, P1682, DOI 10.1093/infdis/jiu303; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Huddleston JR, 2014, INFECT DRUG RESIST, V7, P167, DOI 10.2147/IDR.S48820; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Jordan GE, 2008, BIOINFORMATICS, V24, P1641, DOI 10.1093/bioinformatics/btn235; Khasriya R, 2013, J CLIN MICROBIOL, V51, P2054, DOI 10.1128/JCM.03314-12; Kilic AO, 2001, CLIN DIAGN LAB IMMUN, V8, P31, DOI 10.1128/CDLI.8.1.31-39.2001; Koskella B, 2014, FEMS MICROBIOL REV, V38, P916, DOI 10.1111/1574-6976.12072; Kumar S, 2014, ANTIMICROB AGENTS CH, V58, P923, DOI 10.1128/AAC.02238-13; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Lewis WG, 2013, J BIOL CHEM, V288, P12067, DOI 10.1074/jbc.M113.453654; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Martin R, 2010, INT MICROBIOL, V13, P113, DOI 10.2436/20.1501.01.116; Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Ojala T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1070; Oshima K, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00286-15; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14; Pleckaityte M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-301; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Roberts AP, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00124; Schellenberg JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146510; Schuyler JA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01345-15; Schuyler JA, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00992-15; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Turovskiy Y, 2011, J APPL MICROBIOL; Van Domselaar GH, 2005, NUCLEIC ACIDS RES, V33, pW455, DOI 10.1093/nar/gki593; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wren BW, 1998, MICROBIOL-SGM, V144, P1205, DOI 10.1099/00221287-144-5-1205; Xu WS, 2014, AM J CLIN EXP UROL, V2, P57; Yeoman CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012411; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	56	27	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166757	10.1371/journal.pone.0166757	http://dx.doi.org/10.1371/journal.pone.0166757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861551	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300101
J	Margoles, LM; Mittal, R; Klingensmith, NJ; Lyons, JD; Liang, Z; Serbanescu, MA; Wagener, ME; Coopersmith, CM; Ford, ML				Margoles, Lindsay M.; Mittal, Rohit; Klingensmith, Nathan J.; Lyons, John D.; Liang, Zhe; Serbanescu, Mara A.; Wagener, Maylene E.; Coopersmith, Craig M.; Ford, Mandy L.			Chronic Alcohol Ingestion Delays T Cell Activation and Effector Function in Sepsis	PLOS ONE			English	Article							CHRONIC ETHANOL-CONSUMPTION; IMMUNE-SYSTEM; HOST-DEFENSE; CD43; CD69; DIFFERENTIATION; MORTALITY; RESPONSES; IMMUNOTHERAPY; DYSFUNCTION	Sepsis is the leading cause of death in intensive care units in the US, and it is known that chronic alcohol use is associated with higher incidence of sepsis, longer ICU stays, and higher mortality from sepsis. Both sepsis and chronic alcohol use are associated with immune deficits such as decreased lymphocyte numbers, impaired innate immunity, delayed-type hypersensitivity reactions, and susceptibility to infections; however, understanding of specific pathways of interaction or synergy between these two states of immune dysregulation is lacking. This study therefore sought to elucidate mechanisms underlying the immune dysregulation observed during sepsis in the setting of chronic alcohol exposure. Using a murine model of chronic ethanol ingestion followed by sepsis induction via cecal ligation and puncture, we determined that while CD4+ and CD8+ T cells isolated from alcohol fed mice eventually expressed the same cellular activation markers (CD44, CD69, and CD43) and effector molecules (IFN-gamma, TNF) as their water fed counterparts, there was an overall delay in the acquisition of these phenotypes. This early lag in T cell activation was associated with significantly reduced IL-2 production at a later timepoint in both the CD4+ and CD8+ T cell compartments in alcohol sepsis, as well as with a reduced accumulation of CD8(dim) activated effectors. Taken together, these data suggest that delayed T cell activation may result in qualitative differences in the immune response to sepsis in the setting of chronic alcohol ingestion.	[Margoles, Lindsay M.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Mittal, Rohit; Klingensmith, Nathan J.; Lyons, John D.; Liang, Zhe; Serbanescu, Mara A.; Wagener, Maylene E.; Coopersmith, Craig M.; Ford, Mandy L.] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Wagener, Maylene E.; Ford, Mandy L.] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA; [Coopersmith, Craig M.] Emory Univ, Emory Crit Care Ctr, Atlanta, GA 30322 USA; [Margoles, Lindsay M.] Tufts Med Ctr, Div Infect Dis & Geog Med, Boston, MA USA	Emory University; Emory University; Emory University; Emory University; Tufts Medical Center	Ford, ML (corresponding author), Emory Univ, Dept Surg, Atlanta, GA 30322 USA.; Ford, ML (corresponding author), Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA.	mandy.ford@emory.edu			National Institutes of Health [NIGMS R01GM109779, R01GM109779, R01 GM113228, T32GM095442]; National Institutes of Health (NIH/Emory Lung and Alcohol Biology Center) [P50AA013757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109779, R01GM113228, T32GM095442, R01GM104323, R01GM072808] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA013757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH/Emory Lung and Alcohol Biology Center); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health (NIGMS R01GM109779, R01GM109779, and R01 GM113228 jointly to MLF and CMC, and T32GM095442 to CMC and the NIH/Emory Lung and Alcohol Biology Center Grant P50AA013757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health (NIGMS R01GM109779 and R01 GM113228 to CMC and MLF and T32GM095442 to CMC and the NIH/Emory Lung and Alcohol Biology Center Grant P50AA013757).	Alari-Pahissa E, 2012, J LEUKOCYTE BIOL, V92, P145, DOI 10.1189/jlb.1011499; Alcaide P, 2007, J INVEST DERMATOL, V127, P1964, DOI 10.1038/sj.jid.5700805; BAKER CC, 1983, SURGERY, V94, P331; Barros FR, 2012, ALCOHOL ALCOHOLISM, V47, P677, DOI 10.1093/alcalc/ags081; Beus JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071221; Boomer JS, 2014, VIRULENCE, V5, P45, DOI [10.4161/viru.26516, 10.4161/viru.27794]; Brahmamdam P, 2010, J LEUKOCYTE BIOL, V88, P233, DOI 10.1189/jlb.0110037; Cabrera-Perez J, 2014, J LEUKOCYTE BIOL, V96, P767, DOI 10.1189/jlb.5MR0114-067R; Cannon JL, 2008, J IMMUNOL, V180, P7385, DOI 10.4049/jimmunol.180.11.7385; Cheng GY, 2011, IMMUNOL REV, V241, P63, DOI 10.1111/j.1600-065X.2011.01004.x; Cook RT, 2007, ALCOHOL CLIN EXP RES, V31, P1746, DOI 10.1111/j.1530-0277.2007.00478.x; Cruz-Adalia A, 2010, CIRCULATION, V122, P1396, DOI 10.1161/CIRCULATIONAHA.110.952820; de la Fuente H, 2014, MOL CELL BIOL, V34, P2479, DOI 10.1128/MCB.00348-14; de Wit M, 2010, CHEST, V138, P994, DOI 10.1378/chest.09-1425; Doll K, 2013, MALARIA METHODS MOL, P11; Duong S, 2014, J IMMUNOL, V192, P3618, DOI 10.4049/jimmunol.1303460; Fierro NA, 2006, J IMMUNOL, V176, P7346, DOI 10.4049/jimmunol.176.12.7346; Ford ML, 2003, J IMMUNOL, V171, P6527, DOI 10.4049/jimmunol.171.12.6527; Geissler M, 1997, J IMMUNOL, V159, P5107; Gonzalez-Amaro R, 2013, TRENDS MOL MED, V19, P625, DOI 10.1016/j.molmed.2013.07.006; Grant B. F., 2015, JAMA PSYCHIAT; Hemann EA, 2014, ALCOHOL CLIN EXP RES, V38, P2403, DOI 10.1111/acer.12522; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hutchins NIA, 2014, TRENDS MOL MED, V20, P224, DOI 10.1016/j.molmed.2014.01.002; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liao W, 2011, NAT IMMUNOL, V12, P551, DOI 10.1038/ni.2030; MANJUNATH N, 1995, NATURE, V377, P535, DOI 10.1038/377535a0; Martignoni A, 2008, SHOCK, V29, P591, DOI 10.1097/SHK.0b013e318157f427; Martin P, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001825; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; Matsumoto M, 2007, J IMMUNOL, V178, P2499, DOI 10.4049/jimmunol.178.4.2499; Molina PE, 2010, ALCOHOL RES HEALTH, V33, P97; O'Brien JM, 2007, CRIT CARE MED, V35, P345, DOI 10.1097/01.CCM.0000254340.91644.B2; Onami TM, 2002, J IMMUNOL, V168, P6022, DOI 10.4049/jimmunol.168.12.6022; Parlet CP, 2014, ALCOHOL CLIN EXP RES, V38, P1356, DOI 10.1111/acer.12358; Peterson JD, 1998, ALCOHOL CLIN EXP RES, V22, P245, DOI 10.1111/j.1530-0277.1998.tb03645.x; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Schwulst S, 2005, J AM COLL SURGEONS, V206, P335; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Song KJ, 2002, J LEUKOCYTE BIOL, V72, P1109; Szabo G, 1999, ALCOHOL ALCOHOLISM, V34, P830, DOI 10.1093/alcalc/34.6.830; Szabo G, 2009, ALCOHOL CLIN EXP RES, V33, P220, DOI 10.1111/j.1530-0277.2008.00842.x; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Wagner MC, 2012, ALCOHOL CLIN EXP RES, V36, P197, DOI 10.1111/j.1530-0277.2011.01599.x; Waltenbaugh C, 1998, ALCOHOL CLIN EXP RES, V22, p220S, DOI 10.1111/j.1530-0277.1998.tb04006.x; Yoseph BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062792	46	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165886	10.1371/journal.pone.0165886	http://dx.doi.org/10.1371/journal.pone.0165886			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861506	Green Submitted, gold, Green Published			2022-12-26	WOS:000388350300014
J	Ye, XH; Liao, CH; Liu, GP; Xu, YP; Tan, J; Song, ZS				Ye, Xinhai; Liao, Caihe; Liu, Guangpeng; Xu, Yipin; Tan, Jian; Song, Zhenshun			Age-Related Changes in the Regenerative Potential of Adipose-Derived Stem Cells Isolated from the Prominent Fat Pads in Human Lower Eyelids	PLOS ONE			English	Article							ORBITAL FAT; OSTEOGENIC DIFFERENTIATION; DONOR AGE; TISSUE; PROLIFERATION; SCAFFOLD; ANATOMY; GROWTH; YIELD	The existence of multipotent adipose-derived stem cells isolated from human orbital fat (OF) tissue has shown great therapeutic potential in tissue engineering and regenerative medicine. But the use of stem cells for therapeutic applications is influenced by their proliferative and differentiation potentials, which may be affected by the age of the donor. So far there is little knowledge about the effects of donor age on the biological properties of human orbital adipose-derived stem cells (OASCs). The intraorbital fat protrusion in the lower eyelids occurs as an aging process, and the protruded fat is routinely removed during aesthetic surgeries. Based on the ease of OF harvest and the availability of OASCs, we investigated in this study the relationship between age and the differentiation and proliferation potentials of human OASCs. Human orbital adipose samples were harvested from young (with normal lower eyelid appearance) and old donors (having protruded fat pads in the lower eyelids). The morphological properties of orbital adipocytes were assessed and the fat cell size displayed a decreasing trend with advancing age. OASCs were isolated from the fat samples, expanded in vitro and cultured under appropriate inducive conditions. Compared to the young cells, although no difference was found in the cell yield and phenotype expression, aged OASCs showed fewer progenitor cell numbers, reduced proliferative rates, increased senescent features and decreased differentiation potentials towards adipogenic, osteogenic and chondrogenic lineages. Our data suggested that using autologous OASCs from elderly patients for potential therapeutic purposes might be restricted.	[Ye, Xinhai; Liao, Caihe; Liu, Guangpeng; Xu, Yipin; Tan, Jian] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China; [Song, Zhenshun] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Hepatobiliary & Pancreat Surg, Shanghai, Peoples R China	Tongji University; Tongji University	Liu, GP (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Plast & Reconstruct Surg, Shanghai, Peoples R China.; Song, ZS (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Hepatobiliary & Pancreat Surg, Shanghai, Peoples R China.	guangpengliu@163.com; zhenshunsong@aliyun.com			National Science Foundation of China [31271027, 81171475]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the grants of National Science Foundation of China (Grant numbers:31271027 and 81171475) (http://www.nsf.gov.cn/). This work was financially supported by the grants of National Science Foundation of China (31271027 and 81171475).	Billon N, 2008, BIOL CELL, V100, P563, DOI 10.1042/BC20080011; Bujalska IJ, 2007, J ENDOCRINOL, V192, P279, DOI 10.1677/JOE-06-0042; Chen HT, 2012, J CELL MOL MED, V16, DOI 10.1111/j.1582-4934.2011.01335.x; Chen SY, 2014, INVEST OPHTH VIS SCI, V55, P4842, DOI 10.1167/iovs.14-14441; Choudhery MS, 2015, BIORESEARCH OPEN ACC, V4, P131, DOI 10.1089/biores.2014.0059; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; De Francesco F, 2015, TISSUE ENG PART B-RE, V21, P572, DOI [10.1089/ten.teb.2014.0608, 10.1089/ten.TEB.2014.0608]; de Girolamo L, 2009, CYTOTHERAPY, V11, P793, DOI 10.3109/14653240903079393; De Ugarte DA, 2003, CELLS TISSUES ORGANS, V174, P101, DOI 10.1159/000071150; Dremond-Gignac D, 2004, SURG RADIOL ANAT, V26, P297, DOI [10.1007/s00276-004-0223-5, DOI 10.1007/S00276-004-0223-5]; Ho JHC, 2011, TISSUE ENG PT A, V17, P255, DOI 10.1089/ten.TEA.2010.0106; Jurgens WJFM, 2008, CELL TISSUE RES, V332, P415, DOI 10.1007/s00441-007-0555-7; Kim YJ, 2008, LIFE SCI, V83, P851, DOI 10.1016/j.lfs.2008.09.030; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kirkland JL, 1997, J AM GERIATR SOC, V45, P959, DOI 10.1111/j.1532-5415.1997.tb02967.x; Korn BS, 2009, OPHTHAL PLAST RECONS, V25, P27, DOI 10.1097/IOP.0b013e3181912292; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Lee JM, 2011, ANN PLAS SURG, V66, P192, DOI 10.1097/SAP.0b013e3181e6d052; Lin KJ, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt223; Lin TM, 2005, STEM CELLS DEV, V14, P92, DOI 10.1089/scd.2005.14.92; Liu GP, 2008, CRYOBIOLOGY, V57, P18, DOI 10.1016/j.cryobiol.2008.04.002; Liu GP, 2013, BIOMATERIALS, V34, P2655, DOI 10.1016/j.biomaterials.2013.01.004; Maredziak M, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2152435; Muzaffar AR, 2002, PLAST RECONSTR SURG, V110, P873, DOI 10.1097/00006534-200209010-00025; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Ratisoontorn C, 2005, BONE, V36, P627, DOI 10.1016/j.bone.2005.01.010; Reckhenrich AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091169; Rohrich RJ, 2009, AESTHET SURG J, V29, P189, DOI 10.1016/j.asj.2009.02.002; Schipper BM, 2008, ANN PLAS SURG, V60, P538, DOI 10.1097/SAP.0b013e3181723bbe; Shi YY, 2005, PLAST RECONSTR SURG, V116, P1686, DOI 10.1097/01.prs.0000185606.03222.a9; Toyoda M, 2009, CELL BIOCHEM FUNCT, V27, P440, DOI 10.1002/cbf.1591; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Zhu M, 2009, J TISSUE ENG REGEN M, V3, P290, DOI 10.1002/term.165	33	13	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166590	10.1371/journal.pone.0166590	http://dx.doi.org/10.1371/journal.pone.0166590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855196	Green Published, Green Submitted, gold			2022-12-26	WOS:000387910200037
J	Yoshikawa, F; Sato, Y; Tohyama, K; Akagi, T; Furuse, T; Sadakata, T; Tanaka, M; Shinoda, Y; Hashikawa, T; Itohara, S; Sano, Y; Ghandour, MS; Wakana, S; Furuichi, T				Yoshikawa, Fumio; Sato, Yumi; Tohyama, Koujiro; Akagi, Takumi; Furuse, Tamio; Sadakata, Tetsushi; Tanaka, Mika; Shinoda, Yo; Hashikawa, Tsutomu; Itohara, Shigeyoshi; Sano, Yoshitake; Ghandour, M. Said; Wakana, Shigeharu; Furuichi, Teiichi			Mammalian-Specific Central Myelin Protein Opalin Is Redundant for Normal Myelination: Structural and Behavioral Assessments	PLOS ONE			English	Article							NERVOUS-SYSTEM; GAP-JUNCTIONS; GENE; MICE; IDENTIFICATION; GLYCOPROTEIN; CELLS; AXONS; OLIGODENDROCYTES; TMEM10/OPALIN	Opalin, a central nervous system-specific myelin protein phylogenetically unique to mammals, has been suggested to play a role in mammalian-specific myelin. To elucidate the role of Opalin in mammalian myelin, we disrupted the Opalin gene in mice and analyzed the impacts on myelination and behavior. Opalin-knockout (Opalin(-/-)) mice were born at a Mendelian ratio and had a normal body shape and weight. Interestingly, Opalin(-/-) mice had no obvious abnormalities in major myelin protein compositions, expression of oligodendrocyte lineage markers, or domain organization of myelinated axons compared with WT mice (Opalin(+/+)) mice. Electron microscopic observation of the optic nerves did not reveal obvious differences between Opalin(+/+) and Opalin(-/-) mice in terms of fine structures of paranodal loops, transverse bands, and multi-lamellae of myelinated axons. Moreover, sensory reflex, circadian rhythm, and locomotor activity in the home cage, as well as depression-like behavior, in the Opalin(-/-) mice were indistinguishable from the Opalin(+/+) mice. Nevertheless, a subtle but significant impact on exploratory activity became apparent in Opalin(-/-) mice exposed to a novel environment. These results suggest that Opalin is not critical for central nervous system myelination or basic sensory and motor activities under conventional breeding conditions, although it might be required for fine-tuning of exploratory behavior.	[Yoshikawa, Fumio; Sato, Yumi; Sadakata, Tetsushi; Shinoda, Yo; Furuichi, Teiichi] RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan; [Tohyama, Koujiro] Iwate Med Univ, Ctr Electron Microscopy & Bioimaging Res, Morioka, Iwate 0208505, Japan; [Akagi, Takumi; Hashikawa, Tsutomu] RIKEN Brain Sci Inst, Support Unit Neuromorphol Anal, Wako, Saitama 3510198, Japan; [Furuse, Tamio; Wakana, Shigeharu] RIKEN BioResource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan; [Sadakata, Tetsushi] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma 3718511, Japan; [Tanaka, Mika; Itohara, Shigeyoshi] RIKEN Brain Sci Inst, Lab Behav Genet, Wako, Saitama 3510198, Japan; [Shinoda, Yo] Tokyo Univ Pharm & Life Sci, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Sano, Yoshitake; Furuichi, Teiichi] Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788510, Japan; [Ghandour, M. Said] Univ Strasbourg, Unite Mixte Rech 7357, F-67085 Strasbourg, France; [Ghandour, M. Said] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA USA; [Yoshikawa, Fumio] Yoshikawa Hosp, Izumiotsu, Osaka 5950061, Japan; [Sato, Yumi] Kanazawa Univ, Canc Res Inst, Grad Sch Med Sci, Div Mol Virol & Oncol, Kanazawa, Ishikawa 9201192, Japan; [Akagi, Takumi] Nippon Med Sch, Dept Physiol, Tokyo 1138602, Japan	RIKEN; Iwate Medical University; RIKEN; RIKEN; Gunma University; RIKEN; Tokyo University of Pharmacy & Life Sciences; Tokyo University of Science; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Virginia Commonwealth University; Kanazawa University; Nippon Medical School	Furuichi, T (corresponding author), RIKEN Brain Sci Inst, Lab Mol Neurogenesis, Wako, Saitama 3510198, Japan.; Furuichi, T (corresponding author), Tokyo Univ Sci, Fac Sci & Technol, Dept Appl Biol Sci, Chiba 2788510, Japan.	tfuruichi@rs.tus.ac.jp	Shinoda, Yo/H-3091-2019; Furuse, Tamio/I-2163-2019; Furuichi, Teiichi/B-5086-2014; Itohara, Shigeyoshi/I-8769-2012; Sadakata, Tetsushi/W-9324-2018	Shinoda, Yo/0000-0003-3253-2194; Furuse, Tamio/0000-0002-9276-6040; Furuichi, Teiichi/0000-0002-9676-1888; Itohara, Shigeyoshi/0000-0002-2410-9989; Sadakata, Tetsushi/0000-0003-0276-4162; Sano, Yoshitake/0000-0001-5188-3104	(KAKENHI) from the Japan Society for the Promotion of Science [20300134, 23300137, 26290026, 15K14356]; Hamaguchi Foundation for the Advancement of Biochemistry; Tokyo University of Science; University of Strasbourg; Grants-in-Aid for Scientific Research [15K14356] Funding Source: KAKEN	(KAKENHI) from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Hamaguchi Foundation for the Advancement of Biochemistry(Hamaguchi Foundation for the Advancement of Biochemistry); Tokyo University of Science; University of Strasbourg; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants (KAKENHI 20300134, 23300137, 26290026, 15K14356) from the Japan Society for the Promotion of Science, the Hamaguchi Foundation for the Advancement of Biochemistry, and Tokyo University of Science, and the Exchange Program between Tokyo University of Science and the University of Strasbourg.	Aruga J, 2007, J NEUROCHEM, V102, P1533, DOI 10.1111/j.1471-4159.2007.04583.x; Biffiger K, 2000, J NEUROSCI, V20, P7430; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; Dorval V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085510; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Fletcher JL, 2011, BBA-MOL BASIS DIS, V1812, P1418, DOI 10.1016/j.bbadis.2011.06.001; GHANDOUR MS, 1980, NEUROSCIENCE, V5, P559, DOI 10.1016/0306-4522(80)90053-6; GHANDOUR MS, 1980, DEV BIOL, V77, P73, DOI 10.1016/0012-1606(80)90457-1; Golan N, 2008, GLIA, V56, P1176, DOI 10.1002/glia.20688; Gomi H, 2005, J CELL BIOL, V171, P99, DOI 10.1083/jcb.200505179; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; Gow A, 1999, CELL, V99, P649, DOI 10.1016/S0092-8674(00)81553-6; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Irie M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005521; Jin J, 2015, HUM MOL GENET, V24, P2508, DOI 10.1093/hmg/ddv016; Kamasawa N, 2005, NEUROSCIENCE, V136, P65, DOI 10.1016/j.neuroscience.2005.08.027; Kanki H, 2006, EXP ANIM TOKYO, V55, P137, DOI 10.1538/expanim.55.137; Kippert A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-40; Koide T, 2000, MAMM GENOME, V11, P664, DOI 10.1007/s003350010129; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; Miyamoto T, 2005, J CELL BIOL, V169, P527, DOI 10.1083/jcb.200501154; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Nagy JI, 2004, BRAIN RES REV, V47, P191, DOI 10.1016/j.brainresrev.2004.05.005; Nobile C, 2002, GENE, V282, P87, DOI 10.1016/S0378-1119(01)00846-0; Norton W T, 1974, Methods Enzymol, V31, P435; Orthmann-Murphy JL, 2007, J NEUROSCI, V27, P13949, DOI 10.1523/JNEUROSCI.3395-07.2007; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Pedraza L, 2001, NEURON, V30, P335, DOI 10.1016/S0896-6273(01)00306-3; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; Salzer JL, 2003, NEURON, V40, P297, DOI 10.1016/S0896-6273(03)00628-7; Sato Y, 2014, NEUROSCI LETT, V581, P14, DOI 10.1016/j.neulet.2014.08.017; Schachner M, 2000, GLIA, V29, P154, DOI 10.1002/(SICI)1098-1136(20000115)29:2<154::AID-GLIA9>3.0.CO;2-3; Sevastou I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157754; Spiegel I, 2002, MOL MEMBR BIOL, V19, P95, DOI 10.1080/09687680210130009; Wakana S, 2009, EXP ANIM TOKYO, V58, P443, DOI 10.1538/expanim.58.443; YAGI T, 1990, P NATL ACAD SCI USA, V87, P9918, DOI 10.1073/pnas.87.24.9918; Yoshikawa F, 1999, J BIOL CHEM, V274, P328, DOI 10.1074/jbc.274.1.328; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200; Zalc B, 2008, CURR BIOL, V18, pR511, DOI 10.1016/j.cub.2008.04.010	39	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166732	10.1371/journal.pone.0166732	http://dx.doi.org/10.1371/journal.pone.0166732			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855200	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200048
J	Chen, B; Dai, DN; Tang, HL; Ai, XH; Chen, X; Zhang, XY; Li, ZY; Xie, XM				Chen, Bo; Dai, Danian; Tang, Hailin; Ai, Xiaohong; Chen, Xi; Zhang, Xiaoyan; Li, Zhiyan; Xie, Xiaoming			Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; ANEMIA; IMPACT; ERYTHROPOIETIN; HYPOXIA; CARCINOMA; SURVIVAL; LEVEL	Background Anemia usually refers to low hemoglobin (Hb) levels. Previous studies indicated that anemia negatively influence the survival in various cancers. Hematocrit (HCT) is the volume percentage of red blood cells in blood, which could indicate anemia in both individuals and populations. This study compared the value of HCT with that of Hb for predicting outcomes of patients who underwent treatment for triple negative breast cancer (TNBC). Methods A retrospective study of 293 triple negative breast cancer patients, accepting treatment from January 2004 to December 2009 at Sun Yat-sen University Cancer Center, was conducted. Kaplan-Meier curves and multivariate Cox proportional models were used to calculate disease free survival (DFS) and overall survival (OS). Results The cut-off value of HCT was 35.9% determined by X-tile software analysis. The cut-off value of Hb was 12.0 g/dl based on the World Health Organization (WHO) criteria. In univariate analysis, low HCT and low Hb were both significantly associated with decreased DFS and OS. In multivariate analysis, HCT (HR: 0.570; 95% CI: 0.331-0.981, P = 0.042 for DFS; HR: 0.456; 95% CI: 0.256-0.813, P = 0.008 for OS) was still identified as independent predictor of outcome, but not Hb. Conclusion Pretreatment low HCT is independently associated with poor prognosis in TNBC patients. However, HCT was found to be superior to Hb in terms of predicting breast cancer mortality.In the future, large-scale prospective studies or validation studies are needed to verify our findings.	[Chen, Bo; Dai, Danian; Tang, Hailin; Xie, Xiaoming] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Ai, Xiaohong] Univ South China, Affiliated Hosp 1, Dept Radiotherapy, Hengyang, Hunan, Peoples R China; [Chen, Xi] Univ South China, Coll Med, Dept Anat, Hengyang, Hunan, Peoples R China; [Zhang, Xiaoyan; Li, Zhiyan] Univ South China, Affiliated Nanhua Hosp, Dept Gastroenterol, Hengyang, Hunan, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; University of South China; University of South China; University of South China	Xie, XM (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Breast Oncol,Canc Ctr, Guangzhou, Guangdong, Peoples R China.	xiexm@sysucc.org.cn			National Natural Science Foundation of China [81472575, 81272514, 81372133, 81472469]; Science and Technology Planning Projects of Guangdong and Guangzhou [2014J4100169, 20136060300009, 20156020211002, 20156090901050, 2014A020212079]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Projects of Guangdong and Guangzhou	This work was supported by funds from the National Natural Science Foundation of China (81472575, 81272514 and 81372133 to X. Xie; 81472469 to H. Tang), the Science and Technology Planning Projects of Guangdong and Guangzhou (2014J4100169 to H. Tang; 20136060300009, 20156020211002, 20156090901050 and 2014A020212079 to X. Xie).	Barkati M, 2013, INT J GYNECOL CANCER, V23, P724, DOI 10.1097/IGC.0b013e31828a0623; Bissinger R, 2016, ONCOTARGET; Boehm DU, 2007, ANTICANCER RES, V27, P1223; Camp RL., 2004, CLIN CANCER RES, V10, P7252, DOI [DOI 10.1158/1078-0432.CCR-04-0713, 10.1158/1078-0432.CCR-04-0713]; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; DUNPHY EP, 1989, INT J RADIAT ONCOL, V16, P1173, DOI 10.1016/0360-3016(89)90277-0; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Erkut N, 2015, CANCER BIOMARK, V15, P559, DOI 10.3233/CBM-150495; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Grogan M, 1999, CANCER, V86, P1528, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1528::AID-CNCR20>3.0.CO;2-E; Habler OP, 2000, ADV DRUG DELIVER REV, V40, P171, DOI 10.1016/S0169-409X(99)00048-4; Hartz A, 2012, CANCER CAUSE CONTROL, V23, P1599, DOI 10.1007/s10552-012-0037-4; Hu Kenneth, 2005, Curr Treat Options Oncol, V6, P31, DOI 10.1007/s11864-005-0011-4; Kadri Z, 2015, GENE DEV, V29, P2603, DOI 10.1101/gad.267633.115; Keen M L, 1998, ANNA J, V25, P83; Kemal Y, 2015, CLIN CHEM LAB MED, V53, P823, DOI 10.1515/cclm-2014-0699; Knight K, 2004, AM J MED, V116, P11, DOI 10.1016/j.amjmed.2003.12.008; Koma Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080240; Kozak MM, 2017, AM J CLIN ONCOL-CANC, V40, P405, DOI 10.1097/COC.0000000000000183; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lim Soyi, 2014, Obstet Gynecol Sci, V57, P471, DOI 10.5468/ogs.2014.57.6.471; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Metzger ML, 2008, J CLIN ONCOL, V26, P1282, DOI 10.1200/JCO.2007.14.0699; Ortega Seda Carlos Javier, 2011, Archivos Espanoles de Urologia, V64, P883; Rodriguez-Morales AJ, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-166; Schwartz RN, 2007, AM J HEALTH-SYST PH, V64, pS5, DOI 10.2146/ajhp060601; Shamseddine A, 1998, EUR J GYNAECOL ONCOL, V19, P591; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sun JF, 2012, EXP MOL MED, V44, P674, DOI 10.3858/emm.2012.44.11.076; Szkandera J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107297; van de Nieuwenhof HP, 2010, VIRCHOWS ARCH, V457, P693, DOI 10.1007/s00428-010-0981-x; van de Pol SMG, 2006, ORAL ONCOL, V42, P131, DOI 10.1016/j.oraloncology.2005.06.021; van Rensburg S J, 1983, Nutr Cancer, V4, P206, DOI 10.1080/01635588209513759; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; Wan GX, 2016, CLIN CHIM ACTA, V452, P199, DOI 10.1016/j.cca.2015.11.025; Wang C, 2015, CANCER CAUSE CONTROL, V26, P45, DOI 10.1007/s10552-014-0481-4; Zhang YJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-844; Zheng R, 2015, CANC LETT; Zhu WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136268	40	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165133	10.1371/journal.pone.0165133	http://dx.doi.org/10.1371/journal.pone.0165133			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851755	Green Submitted, gold, Green Published			2022-12-26	WOS:000387909300011
J	Korvel-Hanquist, A; Koch, A; Niclasen, J; Dammeye, J; Lous, J; Olsen, SF; Homoe, P				Korvel-Hanquist, Asbjorn; Koch, Anders; Niclasen, Janni; Dammeye, Jesper; Lous, Jorgen; Olsen, Sjurdur Frodi; Homoe, Preben			Risk Factors of Early Otitis Media in the Danish National Birth Cohort	PLOS ONE			English	Article							SYNCYTIAL VIRUS-INFECTION; PARENT-REPORTED SYMPTOMS; YOUNG-CHILDREN; ONSET; INFANTS; EXPOSURE; EFFUSION; EPIDEMIOLOGY; ANTIBIOTICS; EFFICACY	Objective To assess risk factors of otitis media (OM) in six-months-old children. Method The sample consisted of 69,105 mothers and their children from the Danish National Birth Cohort. The women were interviewed twice during pregnancy and again 6 months after birth. The outcome "one or more" maternal reported episodes of OM at age six months. In total 37 factors were assessed, covering prenatal, maternal, perinatal and postnatal factors. Results At age six months 5.3% (95% CI 5.1-5.5) of the children had experienced one or more episodes of OM. From the regression analysis, 11 variables were associated with a risk of OM. When a Bonferroni correction was introduced, gender, prematurity, parity, maternal age, maternal self-estimated health, taking penicillin during pregnancy, and terminating breast-feeding before age six months, was associated with a risk of early OM. The adjusted ORs of OM for boys versus girls was 1.30 (95% CI 1.18-1.44). The OR having one sibling versus no siblings was 3.0 (95% CI 2.64-3.41). If the woman had been taking penicillin during pregnancy, the OR was 1.35 (95% CI 1.15-1.58). Children born before 38 th gestational week had an increased OR for early OM of 1.49 (95% CI 1.21-1.82). Children of young women had an increased OR of early OM compared to children of older women. Additionally, children of women who rated their own health low compared to those rating their health as high, had an increased OR of 1.38 (95% CI 1.10-1.74). Finally, children being breastfeed less than 6 months, had an increased OR of 1.42 (95% CI 1.28-1.58) compared to children being breastfeed beyond 6 months. Conclusion These findings indicate that prenatal factors are of less importance regarding early OM before the age of six months. Postnatal risk factors seem to pose the main risk of early OM.	[Korvel-Hanquist, Asbjorn; Homoe, Preben] Zealand Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Koge, Denmark; [Koch, Anders] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Koch, Anders] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark; [Niclasen, Janni; Dammeye, Jesper] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Niclasen, Janni] Aarhus Univ, Ctr Collaborat Hlth, Aarhus, Denmark; [Lous, Jorgen] Univ Southern Denmark, Res Unit Gen Practice, Inst Publ Hlth, Odense, Denmark; [Olsen, Sjurdur Frodi] Statens Serum Inst, Ctr Fetal Programming, Dept Epidemiol Res, Copenhagen, Denmark	Statens Serum Institut; Statens Serum Institut; University of Copenhagen; Aarhus University; University of Southern Denmark; Statens Serum Institut	Korvel-Hanquist, A (corresponding author), Zealand Univ Hosp, Dept Otorhinolaryngol & Maxillofacial Surg, Koge, Denmark.	Asbp@regionsjaelland.dk		Koch, Anders/0000-0001-9205-1048; Homoe, Preben/0000-0003-2877-3518; Dammeyer, Jesper/0000-0001-6753-8516; Korvel-Hanquist, Asbjorn/0000-0002-6645-1926; Olsen, Sjurdur/0000-0003-3017-7096	Region Zealand Research Foundation [12-000095, 13-00835]; Oticon Foundation [14-3586]; Danish National Research Foundation; Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation; Augustinus Foundation; Health Foundation	Region Zealand Research Foundation; Oticon Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Pharmacy Foundation; Egmont Foundation; March of Dimes Birth Defects Foundation(March of Dimes); Augustinus Foundation; Health Foundation	The study was funded by the Region Zealand Research Foundation (Grant ref 12-000095 and 13-00835) and the Oticon Foundation (14-3586). The Danish National Birth Cohort was funded by The Danish National Research Foundation, the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation.; The Danish National Research Foundation has established the Danish Epidemiology Science Centre that initiated and created the Danish National Birth Cohort. The cohort is furthermore a result of a major grant from this Foundation. Additional support for the Danish National Birth Cohort is obtained from the Pharmacy Foundation, the Egmont Foundation, the March of Dimes Birth Defects Foundation, the Augustinus Foundation, and the Health Foundation.	Aarhus L, 2014, EAR HEAR; ALHO OP, 1990, AM J EPIDEMIOL, V132, P1164, DOI 10.1093/oxfordjournals.aje.a115759; ALHO OP, 1990, INT J PEDIATR OTORHI, V19, P151, DOI 10.1016/0165-5876(90)90221-C; Rodriguez DA, 2014, PEDIATR PULM, V49, P269, DOI 10.1002/ppul.22781; [Anonymous], 2005, INTERNET J EPIDEMIOL; Azab SN, 2014, INT J PEDIATR OTORHI, V78, P670, DOI 10.1016/j.ijporl.2014.01.033; Bentdal YE, 2010, INT J PEDIATR OTORHI, V74, P168, DOI 10.1016/j.ijporl.2009.11.001; Bhaskaran K, 2014, INT J EPIDEMIOL, V43, P1336, DOI 10.1093/ije/dyu080; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; Brennan-Jones CG, 2015, J PAEDIATR CHILD H, V51, P403, DOI 10.1111/jpc.12741; Chonmaitree T, 2008, CLIN INFECT DIS, V46, P815, DOI 10.1086/528685; Daly KA, 1999, PEDIATRICS, V103, P1158, DOI 10.1542/peds.103.6.1158; Daly KA, 2007, AM J PUBLIC HEALTH, V97, P317, DOI 10.2105/AJPH.2004.052837; Daly KA, 2010, INT J PEDIATR OTORHI, V74, P231, DOI 10.1016/j.ijporl.2009.09.006; Engel J, 2000, SCAND J PRIM HEALTH, V18, P25; Engel JAM, 1999, CLIN OTOLARYNGOL, V24, P417, DOI 10.1046/j.1365-2273.1999.00281.x; Engel JAM, 2005, INT J PEDIATR OTORHI, V69, P533, DOI 10.1016/j.ijporl.2004.11.026; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Flynn T, 2009, INT J PEDIATR OTORHI, V73, P1441, DOI 10.1016/j.ijporl.2009.07.015; Fortanier AC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001480.pub4; Greene N, 2011, EPIDEMIOLOGY, V22, P815, DOI 10.1097/EDE.0b013e31822939fd; Gunville CF, 2010, J PEDIATR-US, V157, P209, DOI 10.1016/j.jpeds.2010.02.006; Haberg SE, 2010, ACTA PAEDIATR, V99, P99, DOI 10.1111/j.1651-2227.2009.01506.x; Hogan A, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-65; Jackson C, 1995, HOUSEHOLDS UNPAID WO; Jacobsen TN, 2010, EUR J EPIDEMIOL, V25, P349, DOI 10.1007/s10654-010-9448-2; Jensen RG, 2013, ENVIRON INT, V54, P112, DOI 10.1016/j.envint.2013.01.015; Jones LL, 2012, ARCH PEDIAT ADOL MED, V166, P18, DOI 10.1001/archpediatrics.2011.158; Kayhty H, 2005, PEDIATR INFECT DIS J, V24, P108, DOI 10.1097/01.inf.0000151022.92222.be; Kvestad E, 2006, INT J PEDIATR OTORHI, V70, P597, DOI 10.1016/j.ijporl.2005.08.005; Lasisi AO, 2008, EUR ARCH OTO-RHINO-L, V265, P765, DOI 10.1007/s00405-007-0544-1; Lieu JEC, 2002, ARCH PEDIAT ADOL MED, V156, P147, DOI 10.1001/archpedi.156.2.147; MacIntyre EA, 2010, PAED CHILD HEALT-CAN, V15, P437, DOI 10.1093/pch/15.7.437; Maruthy S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-17; Miyashita C, 2011, ENVIRON RES, V111, P551, DOI 10.1016/j.envres.2011.01.021; Niclasen J, 2016, INT J PEDIATR OTORHI, V84, P12, DOI 10.1016/j.ijporl.2016.02.017; Olesen C, 2001, EPIDEMIOLOGY, V12, P497, DOI 10.1097/00001648-200109000-00006; Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201; Olsen J, 2014, NOR EPIDEMIOL, V24; Otters HBM, 2004, J ANTIMICROB CHEMOTH, V53, P361, DOI 10.1093/jac/dkh062; Paradise JL, 1997, PEDIATRICS, V99, P318, DOI 10.1542/peds.99.3.318; Pavia M, 2009, PEDIATRICS, V123, pE1103, DOI 10.1542/peds.2008-3422; Pettigrew MM, 2004, PAEDIATR PERINAT EP, V18, P441, DOI 10.1111/j.1365-3016.2004.00596.x; Pottegard A, 2015, PEDIATR INFECT DIS J, V34, pE16, DOI 10.1097/INF.0000000000000519; Rvachew S, 1999, J ACOUST SOC AM, V105, P467, DOI 10.1121/1.424575; Sarpong EM, 2015, HEALTH SERV RES, V50, P830, DOI 10.1111/1475-6773.12260; Simon A, 2007, EUR J PEDIATR, V166, P1273, DOI 10.1007/s00431-007-0426-y; Speets AM, 2011, SCAND J PUBLIC HEALT, V39, P137, DOI 10.1177/1403494810393553; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Todberg T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111732; Uhari M, 1996, CLIN INFECT DIS, V22, P1079, DOI 10.1093/clinids/22.6.1079; Ventola C Lee, 2015, P T, V40, P277; Vernacchio L, 2007, J AM BOARD FAM MED, V20, P160, DOI 10.3122/jabfm.2007.02.060125; Winskel H, 2006, BRIT J EDUC PSYCHOL, V76, P727, DOI 10.1348/000709905X68312; Yiengprugsawan V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-28	55	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166465	10.1371/journal.pone.0166465	http://dx.doi.org/10.1371/journal.pone.0166465			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851778	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300053
J	Nadimpalli, M; Stewart, JR; Pierce, E; Pisanic, N; Love, DC; Hall, D; Larsen, J; Carroll, KC; Tekle, T; Perl, TM; Heaney, CD				Nadimpalli, Maya; Stewart, Jill R.; Pierce, Elizabeth; Pisanic, Nora; Love, David C.; Hall, Devon; Larsen, Jesper; Carroll, Karen C.; Tekle, Tsigereda; Perl, Trish M.; Heaney, Christopher D.			Livestock-Associated, Antibiotic-Resistant Staphylococcus aureus Nasal Carriage and Recent Skin and Soft Tissue Infection among Industrial Hog Operation Workers	PLOS ONE			English	Article							LACERATION INJURIES; PUBLIC-HEALTH; CC398; MRSA; IDENTIFICATION; COLONIZATION; TETRACYCLINE; TRANSMISSION; CONFIRMATION; PERSISTENCE	Swine production work is a risk factor for nasal carriage of livestock-associated (LA-) Staphylococcus aureus and also for skin and soft tissue infection (SSTI). However, whether LA-S. aureus nasal carriage is associated with increased risk of SSTI remains unclear. We aimed to examine S. aureus nasal carriage and recent (<= 3 months prior to enrollment) SSTI symptoms among industrial hog operation (IHO) workers and their household contacts. IHO workers and their household contacts provided a nasal swab and responded to a questionnaire assessing self-reported personal and occupational exposures and recent SSTI symptoms. Nasal swabs were analyzed for S. aureus, including methicillin-resistant S. aureus (MRSA), multidrug-resistant-S. aureus (MDRSA), absence of scn (livestock association), and spa type. S. aureus with at least one indicator of LA was observed among 19% of 103 IHO workers and 6% of 80 household members. Prevalence of recent SSTI was 6% among IHO workers and 11% among 54 minor household members (0/26 adult household members reported SSTI). Among IHO workers, nasal carriers of MDRSA and scn-negative S. aureus were 8.8 (95% CI: 1.8, 43.9) and 5.1 (95% CI: 1.2, 22.2) times as likely to report recent SSTI as non-carriers, respectively. In one household, both an IHO worker and child reported recent SSTI and carried the same S. aureus spa type (t4976) intranasally. Prevalence of scn-negative S. aureus (PR: 5.0, 95% CI: 1.2, 21.4) was elevated among IHO workers who reported never versus always wearing a face mask at work. Although few SSTI were reported, this study of IHO workers and their household contacts is the first to characterize a relation between nasal carriage of antibiotic-resistant LA-S. aureus and SSTI. The direction and temporality of this relation and IHO workers' use of face masks to prevent nasal carriage of these bacteria warrant further investigation.	[Nadimpalli, Maya; Stewart, Jill R.; Pierce, Elizabeth] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Environm Sci & Engn, Chapel Hill, NC USA; [Pisanic, Nora; Love, David C.; Heaney, Christopher D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA; [Love, David C.] Johns Hopkins Univ, Johns Hopkins Ctr Livable Future, Baltimore, MD USA; [Hall, Devon] Rural Empowerment Assoc Community Help, Warsaw, NC USA; [Larsen, Jesper] Statens Serum Inst, Microbiol & Infect Control, Copenhagen, Denmark; [Carroll, Karen C.] Johns Hopkins Univ, Sch Med, Div Med Microbiol, Baltimore, MD USA; [Carroll, Karen C.; Tekle, Tsigereda] Johns Hopkins Univ Hosp, Microbiol Lab, Baltimore, MD 21287 USA; [Perl, Trish M.] Johns Hopkins Univ, Sch Med, Dept Med, Div Infect Dis, Baltimore, MD 21205 USA; [Perl, Trish M.; Heaney, Christopher D.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Statens Serum Institut; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Heaney, CD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD 21205 USA.; Heaney, CD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	cheaney1@jhu.edu	Larsen, Jesper/AAJ-3161-2021; Stewart, Jill/T-6862-2018	Larsen, Jesper/0000-0003-0582-0457; Stewart, Jill/0000-0002-3474-5233; Pisanic, Nora/0000-0002-0042-9232	National Institute for Occupational Health and Safety (NIOSH) [1K010H010193-01A1]; Johns Hopkins NIOSH Education and Research Center; Johns Hopkins Center fora Livable Future from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University [018HEA2013]; School of Medicine; Department of Medicine; Division of Infectious Diseases; NSF, NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program [1316318]; National Institute of Environmental Health Sciences [5T32ES007141-30]; Royster Society fellowship; EPA Science to Achieve Results fellowship; GRACE Communications Foundation; National Institute of Allergy and Infectious Diseases [1R01A1101371-01A1]; NIOSH [1K010H010193-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141] Funding Source: NIH RePORTER; Division Of Environmental Biology [1316318] Funding Source: National Science Foundation	National Institute for Occupational Health and Safety (NIOSH)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Johns Hopkins NIOSH Education and Research Center; Johns Hopkins Center fora Livable Future from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University; School of Medicine; Department of Medicine; Division of Infectious Diseases; NSF, NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Royster Society fellowship; EPA Science to Achieve Results fellowship; GRACE Communications Foundation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this study was provided by National Institute for Occupational Health and Safety (NIOSH) grant 1K010H010193-01A1, the Johns Hopkins NIOSH Education and Research Center, a directed research award from the Johns Hopkins Center fora Livable Future, Award 018HEA2013 from the Sherrilyn and Ken Fisher Center for Environmental Infectious Diseases Discovery Program at the Johns Hopkins University, School of Medicine, Department of Medicine, Division of Infectious Diseases, and NSF grant 1316318 as part of the joint NSF-NIH-USDA Ecology and Evolution of Infectious Diseases program. NP was supported by National Institute of Environmental Health Sciences award no. 5T32ES007141-30. MN was supported by a Royster Society fellowship and an EPA Science to Achieve Results fellowship. DL was supported by a gift from the GRACE Communications Foundation. JL was supported by the National Institute of Allergy and Infectious Diseases grant 1R01A1101371-01A1. CDH was supported by NIOSH grant 1K010H010193-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akmatov MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048508; Argudin MA, 2011, APPL ENV MICROBIOL; Ballhausen B, 2014, INT J MED MICROBIOL, V304, P777, DOI 10.1016/j.ijmm.2014.06.006; Becker K, 2015, VET MICROBIOL; Benito D, 2014, INT J MED MICROBIOL, V304, P1226, DOI 10.1016/j.ijmm.2014.09.004; Bootsma MCJ, 2010, J R SOC INTERFACE; Bosch T, 2015, APPL ENVIRON MICROB, V81, P124, DOI 10.1128/AEM.02803-14; Cai CB, 2005, AM J IND MED, V47, P403, DOI 10.1002/ajim.20157; Census of Agriculture, 2007, 2007 CENS AGR; Clinical and Laboratory Standards Institute, 2013, PERF STAND ANT SUC S; Cole D, 2000, ENVIRON HEALTH PERSP, V108, P685, DOI 10.2307/3434721; Culp Kennith, 2008, J Agromedicine, V13, P7, DOI 10.1080/10599240801985373; DONHAM KJ, 1977, J OCCUP ENVIRON MED, V19, P383, DOI 10.1097/00043764-197706000-00004; European Union Reference Laboratory for Antimicrobial Resistance, 2009, PROT SPA TYP; Fritz SA, 2011, INFECT CONT HOSP EP, V32, P872, DOI 10.1086/661285; Goerge T, 2017, VET MICROBIOL, V200, P6, DOI 10.1016/j.vetmic.2015.10.027; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hetem DJ, 2013, EMERG INFECT DIS, V19, P1797, DOI 10.3201/eid1911.121085; Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803; Kyeremateng-Amoah E, 2014, AM J IND MED, V57, P669, DOI 10.1002/ajim.22325; Larsen J, 2015, EURO SURVEILL B EUR, V20; Larson KRL, 2010, ANN AGR ENV MED, V17, P331; LeJeune J, 2010, J AGRIC SAF HEALTH, V16, P161, DOI 10.13031/2013.32041; Lekkerkerk WSN, 2012, CLIN MICROBIOL INFEC, V18, P656, DOI 10.1111/j.1469-0691.2011.03662.x; Lewis HC, 2008, EMERG INFECT DIS, V14, P1383, DOI 10.3201/eid1409.071576; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Lozano C, 2012, J ANTIMICROB CHEMOTH, V67, P330, DOI 10.1093/jac/dkr497; Nadimpalli M, 2015, OCCUP ENVIRON MED, V72, P90, DOI 10.1136/oemed-2014-102095; Nadimpalli M, 2013, J MED MICROBIOL, V62, P1365, DOI 10.1099/jmm.0.058248-0; Nehme B, 2008, ENVIRON MICROBIOL, V10, P665, DOI 10.1111/j.1462-2920.2007.01489.x; Patchanee P, 2014, J VET SCI, V15, P529, DOI 10.4142/jvs.2014.15.4.529; Paterson GK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7560; Price JR, 2014, CLIN INFECT DIS, V58, P609, DOI 10.1093/cid/cit807; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Reischl U, 2000, J CLIN MICROBIOL, V38, P2429; Rinsky JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067641; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; Salim B, 2005, J INFECT DIS, V191, P444; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Smith TC, 2014, CURR ENV HEAL REPORT, V2, P41; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; United States Department of Agriculture, 2010, 2010 NAT AGR STAT SE; United States Department of Commerce, 2010, 2010 CURR POP SURV; Van Cleef BA, 2016, EPIDEMIOL INFECT, DOI [10.1016/j.ijmm.21014.09.004, DOI 10.1016/J.IJMM.2014.09.004]; van Rijen MML, 2014, LIVESTOCK ASS MRSA C; Wardyn SE, 2015, CLIN INFECT DIS; Wertheim H, 2001, J CLIN MICROBIOL, V39, P2660, DOI 10.1128/JCM.39.7.2660-2662.2001; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Yang ES, 2010, CLIN MICROBIOL INFEC, V16, P425, DOI 10.1111/j.1469-0691.2009.02836.x; Ye XH, 2016, APPL ENVIRON MICROB, V82, P3892, DOI 10.1128/AEM.00091-16; Ye XH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19184	52	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165713	10.1371/journal.pone.0165713	http://dx.doi.org/10.1371/journal.pone.0165713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851746	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300024
J	Werner, SJ; Hobson, KA; Van Wilgenburg, SL; Fischer, JW				Werner, Scott J.; Hobson, Keith A.; Van Wilgenburg, Steven L.; Fischer, Justin W.			Multi-Isotopic (delta H-2, delta C-13, delta N-15) Tracing of Molt Origin for Red-Winged Blackbirds Associated with Agro-Ecosystems	PLOS ONE			English	Article							MIGRATORY CONNECTIVITY; WINTERING GROUNDS; NITROGEN ISOTOPES; ANIMAL MIGRATION; FEATHER ISOSCAPE; STABLE HYDROGEN; BIRDS; REPELLENT; FIDELITY; DAMAGE	We analyzed stable-hydrogen (delta H-2), carbon (delta C-13) and nitrogen (delta N-15) isotope ratios in feathers to better understand the molt origin and food habits of Red-winged Blackbirds (Agelaius phoeniceus) near sunflower production in the Upper Midwest and rice production in the Mid-South of the United States. Outer primary feathers were used from 661 after-second-year (ASY) male blackbirds collected in Minnesota, Montana, North Dakota and South Dakota (spring collection), and Arkansas, Louisiana, Mississippi, Missouri and Texas (winter collection). The best-fit model indicated that the combination of feather delta H-2, delta C-13 and delta N-15 best predicted the state of sample collections and thus supported the use of this approach for tracing molt origins in Red-winged Blackbirds. When considering only birds collected in spring, 56% of birds were classified to their collection state on the basis of delta H-2 and delta C-13 alone. We then developed feather isoscapes for delta C-13 based upon these data and for delta H-2 based upon continental patterns of delta H-2 in precipitation. We used 81 birds collected at the ten independent sites for model validation. The spatially-explicit assignment of these 81 birds to the delta H-2 isoscape resulted in relatively high rates (similar to 77%) of accurate assignment to collection states. We also modeled the spatial extent of C3 (e.g. rice, sunflower) and C4 (corn, millet, sorghum) agricultural crops grown throughout the Upper Midwest and Mid-South United States to predict the relative use of C3-versus C4-based foodwebs among sampled blackbirds. Estimates of C3 inputs to diet ranged from 50% in Arkansas to 27% in Minnesota. As a novel contribution to blackbird conservation and management, we demonstrate how such feather isoscapes can be used to predict the molt origin and interstate movements of migratory blackbirds for subsequent investigations of breeding biology (e.g. sex-specific philopatry), agricultural depredation, feeding ecology, physiology of migration and sensitivity to environmental change.	[Werner, Scott J.; Fischer, Justin W.] US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA; [Hobson, Keith A.] Environm Canada, 11 Innovat Blvd, Saskatoon, SK S7N 3H5, Canada; [Hobson, Keith A.] Univ Western Ontario, Dept Biol, 1151 Richmond St N, London, ON N6A 5B7, Canada; [Van Wilgenburg, Steven L.] Environm Canada, Prairie & Northern Wildlife Res Ctr, Canadian Wildlife Serv, 115 Perimeter Rd, Saskatoon, SK S7N 0X4, Canada	United States Department of Agriculture (USDA); Environment & Climate Change Canada; Western University (University of Western Ontario); Environment & Climate Change Canada; Canadian Wildlife Service	Werner, SJ (corresponding author), US Anim & Plant Hlth Inspect Serv, USDA, Wildlife Serv, Natl Wildlife Res Ctr, 4101 LaPorte Ave, Ft Collins, CO 80521 USA.	Scott.J.Werner@aphis.usda.gov	Hobson, Keith/Q-9306-2019	Fischer, Justin/0000-0002-9472-8945; Van Wilgenburg, Steven/0000-0002-6742-4567	USDA's National Wildlife Research Center	USDA's National Wildlife Research Center	SW and KH received Blue Sky Grant from USDA's National Wildlife Research Center for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; BELETSKY LD, 1991, ECOLOGY, V72, P787, DOI 10.2307/1940581; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Carlson JC, 2013, APPL ANIM BEHAV SCI, V145, P26, DOI 10.1016/j.applanim.2013.01.011; Chabot AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043627; Craine JM, 2009, NEW PHYTOL, V183, P980, DOI 10.1111/j.1469-8137.2009.02917.x; Cummings JL, 2011, J WILDLIFE MANAGE, V75, P353, DOI 10.1002/jwmg.65; Freckleton RP, 2011, BEHAV ECOL SOCIOBIOL, V65, P91, DOI 10.1007/s00265-010-1045-6; Grocke DR, 1997, EARTH PLANET SC LETT, V153, P279, DOI 10.1016/S0012-821X(97)00189-1; Hijmans RJ., 2015, PACKAGE RASTER R PAC; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 2008, HDB TERRESTRIAL ECOL; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2016, AUK, V133, P86, DOI 10.1642/AUK-15-149.1; Hobson KA, 2014, J FIELD ORNITHOL, V85, P237, DOI 10.1111/jofo.12065; Hobson KA, 2014, ACTA ORNITHOL, V49, P57, DOI 10.3161/000164514X682896; Hobson KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035137; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Linz GM, 2011, BIOSCIENCE, V61, P960, DOI 10.1525/bio.2011.61.12.6; Mayer B, 2012, J GREAT LAKES RES, V38, P135, DOI 10.1016/j.jglr.2012.02.004; Meanley B., 1965, Wilson Bulletin, V77, P217; Meanley B, 1970, Bird Banding, V41, P22; Nadelhoffer KJ, 1994, STABLE ISOTOPES ECOL; Nagy, 1988, STABLE ISOTOPES ECOL, P1; NERO RW, 1984, REDWINGS; Oksanen J, 2022, R PACKAGE VERSION; Pardieck KL, 2007, BIRD POPULATIONS, V8, P28; Pardo LH, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P221, DOI 10.1007/978-90-481-3354-3_11; Partners in Flight Scientific Committee, POP EST DAT VERS 201; PICMAN J, 1981, CAN J ZOOL, V59, P2284, DOI 10.1139/z81-307; R Core Team, 2013, R LANG ENV STAT COMP; Still CJ, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P179, DOI 10.1007/978-90-481-3354-3_9; Terzer S, 2013, HYDROL EARTH SYST SC, V17, P4713, DOI 10.5194/hess-17-4713-2013; Tupper SK, 2009, WILDLIFE RES, V36, P319, DOI 10.1071/WR09015; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Vander Zanden HB, 2014, METHODS ECOL EVOL, V5, P891, DOI 10.1111/2041-210X.12229; Veen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098075; Wassenaar LI, 2000, ECOL APPL, V10, P911, DOI 10.1890/1051-0761(2000)010[0911:SCAHIR]2.0.CO;2; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Werner SJ, 2014, APPL ANIM BEHAV SCI, V159, P107, DOI 10.1016/j.applanim.2014.06.012; Wunder MB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P251, DOI 10.1007/978-90-481-3354-3_12; Yasukawa K., 1995, BIRDS N AM, DOI [10.2173/bna.184, DOI 10.2173/BNA.184]	48	10	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0165996	10.1371/journal.pone.0165996	http://dx.doi.org/10.1371/journal.pone.0165996			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846302	Green Published, gold			2022-12-26	WOS:000387794600026
J	Aibana, O; Acharya, X; Huang, CC; Becerra, MC; Galea, JT; Chiang, SS; Contreras, C; Calderon, R; Yataco, R; Velasquez, GE; Tintaya, K; Jimenez, J; Lecca, L; Murray, MB				Aibana, Omowunmi; Acharya, Xeno; Huang, Chuan-Chin; Becerra, Mercedes C.; Galea, Jerome T.; Chiang, Silvia S.; Contreras, Carmen; Calderon, Roger; Yataco, Rosa; Velasquez, Gustavo E.; Tintaya, Karen; Jimenez, Judith; Lecca, Leonid; Murray, Megan B.			Nutritional Status and Tuberculosis Risk in Adult and Pediatric Household Contacts	PLOS ONE			English	Article							BODY-MASS INDEX; MYCOBACTERIUM-TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; INFECTION; LEPTIN; PERSISTENCE; MACROPHAGES; MECHANISMS; CHILDHOOD; CHILDREN	Background Studies show obesity decreases risk of tuberculosis (TB) disease. There is limited evidence on whether high body mass index also protects against TB infection; how very high body mass indices influence TB risk; or whether nutritional status predicts this risk in children. We assessed the impact of body mass index on incident TB infection and disease among adults and children. Methods and Findings We conducted a prospective cohort study among household contacts of pulmonary TB cases in Lima, Peru. We determined body mass index at baseline and followed participants for one year for TB infection and disease. We used Cox proportional regression analyses to estimate hazard ratios for incident TB infection and disease. We enrolled 14,044 household contacts, and among 6853 negative for TB infection and disease at baseline, 1787 (26.1%) became infected. A total of 406 contacts developed secondary TB disease during follow-up. Body mass index did not predict risk of TB infection but overweight household contacts had significantly decreased risk of TB disease (HR 0.48; 95% CI 0.37-0.64; p < 0.001) compared to those with normal weight. Among adults, body mass index >= 35 kg/m(2) continued to predict a lower risk of TB disease (HR 0.30; 95% CI 0.12-0.74; p 0.009). We found no association between high body mass index and TB infection or disease among children under 12 years of age. Conclusions High body mass index protects adults against TB disease even at levels >= 35 kg/m(2). This protective effect does not extend to TB infection and is not seen in children.	[Aibana, Omowunmi] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Div Gen Internal Med, McGovern Med Sch, Houston, TX 77030 USA; [Acharya, Xeno] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London, England; [Huang, Chuan-Chin] Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Becerra, Mercedes C.; Galea, Jerome T.; Velasquez, Gustavo E.; Murray, Megan B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA; [Becerra, Mercedes C.; Galea, Jerome T.; Contreras, Carmen; Calderon, Roger; Yataco, Rosa; Tintaya, Karen; Jimenez, Judith; Lecca, Leonid] Partners Hlth Socios Salud Sucursal Peru, Lima, Peru; [Chiang, Silvia S.] Brown Univ, Dept Pediat, Alpert Sch Med, Providence, RI 02912 USA; [Chiang, Silvia S.] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Velasquez, Gustavo E.] Brigham & Womens Hosp, Dept Internal Med, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA	University of Texas System; University of Texas Health Science Center Houston; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Harvard University; Brigham & Women's Hospital	Murray, MB (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA.	megan.murray.epi@gmail.com	Galea, Jerome T./AAF-2172-2019; Galea, Jerome T/HGV-0203-2022	Galea, Jerome T./0000-0001-8732-6959; Galea, Jerome T/0000-0001-8732-6959; Velasquez, Gustavo/0000-0003-1438-0692; Lecca, Leonid/0000-0003-1363-3985; Chiang, Silvia/0000-0002-2318-3802; Aibana, Omowunmi/0000-0003-0665-5393; Calderon, Roger I./0000-0001-8932-0489	National Institute of Allergy and Infectious Diseases; National Institute on Drug Abuse [T32 DA013911];  [U19 AI076217];  [U01 AI057786];  [T32 AI007433];  [L30 AI120170]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007433, U01AI057786, U19AI076217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA013911] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute of Allergy and Infectious Diseases [U19 AI076217 to MBM; U01 AI057786 to MCB; T32 AI007433 and L30 AI120170 to GEV] and the National Institute on Drug Abuse [T32 DA013911 to OA and SC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2014, MICROBES INFECT, V16, P571, DOI 10.1016/j.micinf.2014.04.006; Andersen CJ, 2016, ADV NUTR, V7, P66, DOI 10.3945/an.115.010207; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BOUTTON TW, 1987, AM J CLIN NUTR, V45, P513, DOI 10.1093/ajcn/45.3.513; Carbone F, 2012, BIOCHIMIE, V94, P2082, DOI 10.1016/j.biochi.2012.05.018; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Chang SW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054564; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; EDWARDS LB, 1971, ARCH ENVIRON HEALTH, V22, P106, DOI 10.1080/00039896.1971.10665820; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hanrahan CF, 2010, AIDS, V24, P1501, DOI 10.1097/QAD.0b013e32833a2a4a; Heitzinger K, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/1472-698X-14-19; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Miranda JJ, 2011, HEART, V97, P787, DOI 10.1136/hrt.2010.218537; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Koethe JR, 2011, CLIN INFECT DIS, V53, P952, DOI 10.1093/cid/cir606; Lawn SD, 2002, MICROBES INFECT, V4, P635, DOI 10.1016/S1286-4579(02)01582-4; Leslie DS, 2002, J EXP MED, V196, P1575, DOI 10.1084/jem.20021515; Leung CC, 2007, ARCH INTERN MED, V167, P1297, DOI 10.1001/archinte.167.12.1297; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Lumeng CN, 2013, MOL ASPECTS MED, V34, P12, DOI 10.1016/j.mam.2012.10.002; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Naing C, 2013, LUNG, V191, P27, DOI 10.1007/s00408-012-9440-6; Neyrolles O, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000043; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; PALMER CE, 1957, AM REV TUBERC PULM, V76, P517; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Perez-Guzman C, 2014, SALUD PUBLICA MEXICO, V56, P189; Peru Ministerio de Salud. Norma Tecnica de Salud para el Control de la Tuberculosis. Direccion General de Salud de las Personas, 2006, NORM TECN SAL CONTR; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Seclen SN, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000110; Tobin DM, 2013, CURR OPIN PHARMACOL, V13, P641, DOI 10.1016/j.coph.2013.06.007; Tobin DM, 2012, CELL, V148, P434, DOI 10.1016/j.cell.2011.12.023; TVERDAL A, 1986, EUR J RESPIR DIS, V69, P355; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Wieland CW, 2005, INT IMMUNOL, V17, P1399, DOI 10.1093/intimm/dxh317; World Health Organization (WHO), 2011, CHILD GROWTH STAND; Zhang AJX, 2013, J INFECT DIS, V207, P1270, DOI 10.1093/infdis/jit031	45	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166333	10.1371/journal.pone.0166333	http://dx.doi.org/10.1371/journal.pone.0166333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835678	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000387779200039
J	Lee, J; Han, JH; Jang, A; Kim, JW; Hong, SA; Myung, SC				Lee, Jaehyouk; Han, Jun Hyun; Jang, Ara; Kim, Jin Wook; Hong, Soon Auck; Myung, Soon Chul			DNA Methylation-Mediated Downregulation of DEFB1 in Prostate Cancer Cells	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; GENE; HYPERMETHYLATION; DISEASE; MICRODISSECTION; BETA-DEFENSIN-1; CARCINOGENESIS; ASSOCIATION; EPIGENETICS; CARCINOMA	Epigenetic aberrations play crucial roles in prostate cancer (PCa) development and progression. The DEFB1 gene, which encodes human beta-defensin-1 (HBD-1), contributes to innate immune responses and functions as a potential tumor suppressor in urological cancers. We investigated whether differential DNA methylation at the low CpG-content promoter (LCP) of DEFB1 was associated with transcriptional regulation of DEFB1 in PCa cells. To identify distinct CpG loci within the DEFB1 LCP related to the epigenetic regulation of DEFB1, we performed an in vitro methylated reporter assay followed by bisulfite sequencing of the DEFB1 promoter fragment. The methylation status of two adjacent CpG loci in the DEFB1 LCP was found to be important for DEFB1 expression in PCa cells. Paired epithelial specimens of PCa patients (n = 60), which were distinguished as non-tumor and tumor tissues by microdissection, were analyzed by bisulfite pyrosequencing of site-specific CpG dinucleotide units in the DEFB1 LCP. CpG methylation frequencies in the DEFB1 LCP were significantly higher in malignant tissues than in adjacent benign tissues across almost all PCa patients. These results suggested that methylation status of each CpG site in the DEFB1 promoter could mediate downregulation of DEFB1 in PCa cells.	[Lee, Jaehyouk; Jang, Ara; Myung, Soon Chul] Chung Ang Univ, Dept Urol, Coll Med, Seoul 06974, South Korea; [Lee, Jaehyouk; Jang, Ara; Myung, Soon Chul] Chung Ang Univ, Adv Urogenital Dis Res Ctr, Coll Med, Seoul 06974, South Korea; [Lee, Jaehyouk; Jang, Ara; Kim, Jin Wook; Myung, Soon Chul] Chung Ang Univ, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul 06974, South Korea; [Han, Jun Hyun] Hallym Univ, Dept Urol, Dongtan Sacred Heart Hosp, Hwaseong Si 18450, South Korea; [Hong, Soon Auck] Soonchunhyang Univ, Dept Pathol, Coll Med, Cheonan 31151, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital; Chung Ang University; Hallym University; Soonchunhyang University	Myung, SC (corresponding author), Chung Ang Univ, Dept Urol, Coll Med, Seoul 06974, South Korea.; Myung, SC (corresponding author), Chung Ang Univ, Adv Urogenital Dis Res Ctr, Coll Med, Seoul 06974, South Korea.; Myung, SC (corresponding author), Chung Ang Univ, Biointegrat Res Ctr Nutra Pharmaceut Epigenet, Seoul 06974, South Korea.	uromyung@cau.ac.kr	Kim, Jin Wook/AAW-3716-2021	Kim, Jin Wook/0000-0003-4157-9365	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011824]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Chung-Ang University Hospital Biomedical Research Institute for kindly offering research equipment. This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011824).	Andresen E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021898; Blute ML, 2015, CURR OPIN UROL, V25, P83, DOI 10.1097/MOU.0000000000000132; Chai H, 2009, ANN CLIN LAB SCI, V39, P331; Chen Y, 2013, EUR J HUM GENET, V21, P929, DOI 10.1038/ejhg.2012.281; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Donald CD, 2003, LAB INVEST, V83, P501, DOI 10.1097/01.LAB.0000063929.61760.F6; Enokida H, 2005, CLIN CANCER RES, V11, P6582, DOI 10.1158/1078-0432.CCR-05-0658; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Graca I, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0264-8; Henrique R, 2006, MOL CANCER RES, V4, P1, DOI 10.1158/1541-7786.MCR-05-0113; Jeronimo C, 2011, EUR UROL, V60, P753, DOI 10.1016/j.eururo.2011.06.035; Keil KP, 2015, EPIGENOMICS-UK, V7, P413, DOI 10.2217/epi.15.8; Kim HJ, 2011, BJU INT, V107, P144, DOI 10.1111/j.1464-410X.2010.09469.x; Kuzmin I, 2002, CANCER RES, V62, P3498; Kwabi-Addo B, 2007, CLIN CANCER RES, V13, P3796, DOI 10.1158/1078-0432.CCR-07-0085; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lee JY, 1998, VIRCHOWS ARCH, V433, P305, DOI 10.1007/s004280050253; Liu LM, 2002, ONCOGENE, V21, P6835, DOI 10.1038/sj.onc.1205814; Nakayama M, 2003, AM J PATHOL, V163, P923, DOI 10.1016/S0002-9440(10)63452-9; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Nonn L, 2009, PROSTATE, V69, P1470, DOI 10.1002/pros.20983; Patel AR, 2009, NAT CLIN PRACT UROL, V6, P87, DOI 10.1038/ncpuro1290; Perry AS, 2010, NAT REV UROL, V7, P668, DOI 10.1038/nrurol.2010.185; Prado-Montes de Oca E, 2010, INT J BIOCHEM CELL B, V42, P800, DOI 10.1016/j.biocel.2010.01.021; Rakyan VK, 2011, NAT REV GENET, V12, P529, DOI 10.1038/nrg3000; Richiardi L, 2009, J CLIN ONCOL, V27, P3161, DOI 10.1200/JCO.2008.18.2485; Roupret M, 2007, CLIN CANCER RES, V13, P1720, DOI 10.1158/1078-0432.CCR-06-2467; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Semple F, 2012, J INNATE IMMUN, V4, P337, DOI 10.1159/000336619; Strand SH, 2014, INT J MOL SCI, V15, P16544, DOI 10.3390/ijms150916544; Sun CQ, 2006, CANCER RES, V66, P8542, DOI 10.1158/0008-5472.CAN-06-0294; Valdes-Mora F, 2015, ONCOGENE, V34, P1609, DOI 10.1038/onc.2014.111; Van Neste L, 2012, PROSTATE, V72, P1248, DOI 10.1002/pros.22459; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Woodson K, 2006, EPIGENETICS-US, V1, P183, DOI 10.4161/epi.1.4.3530	36	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166664	10.1371/journal.pone.0166664	http://dx.doi.org/10.1371/journal.pone.0166664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835705	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200064
J	Zhou, ZW; Song, K; Qiu, J; Wang, YY; Liu, CX; Zhou, H; Xu, YF; Guo, ZR; Zhang, B; Dong, C				Zhou, Zhiwei; Song, Kai; Qiu, Jing; Wang, Yiying; Liu, Chunxing; Zhou, Hui; Xu, Yunfang; Guo, Zhirong; Zhang, Biao; Dong, Chen			Associations between Serum Uric Acid and the Remission of Non-Alcoholic Fatty Liver Disease in Chinese Males	PLOS ONE			English	Article							METABOLIC SYNDROME; METAANALYSIS; POPULATION; ULTRASONOGRAPHY; DYSFUNCTION; CHILDREN; RISK	Epidemiological studies suggest that higher serum uric acid (sUA) level is significantly associated with nonalcoholic fatty liver disease (NAFLD) development. However, little information is available on the relationships between sUA and NAFLD remission. In the present study, 841 NAFLD males (30-75 years) were recruited from a Chinese prospective cohort study (PMMJS) and followed up for five years. The baseline sUA levels of participants were categorized into four quartiles: 191 mu mol/L <= sUA <= 347 mu mol/L, 347 mu mol/L < sUA <= 392 mu mol/L, 392 mu mol/L < sUA <= 441 mu mol/L and 441 mu mol/L < SUA <= 676 mu mol/L. As the results show, participants with elevated sUA levels at baseline were significantly associated with the decreased rate of NAFLD remission at the end of study (p<0.0001). After adjustment, RR (95% CI) for remitted NAFLD comparing Q1 to Q3 vs Q4 of sUA were 2.95 (1.49-5.83), 2.40 (1.22-4.73) and 1.39 (0.67-2.86), respectively. Furthermore, the sensitivity analysis showed these significant associations were not affected even after exclusion of participants who had hypertension, diabetes mellitus, MetS and hyperlipidemia. Additionally, the presence of the lowest quartile of sUA levels was still significantly associated with remitted NAFLD when the study population was stratified according to the smoking, and the median values of age, ALT, AST, serum creatinine, HDL-C and LDL-C. Therefore, our present study extended the previous findings and suggested that modulation of sUA levels may attenuate the progression of NAFLD.	[Zhou, Zhiwei; Song, Kai; Qiu, Jing; Wang, Yiying; Liu, Chunxing; Guo, Zhirong; Dong, Chen] Soochow Univ, Dept Epidemiol & Stat, Jiangsu Key Lab & Translat Med Geriatr Dis, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China; [Zhou, Hui] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Peoples R China; [Xu, Yunfang; Zhang, Biao] Huaian Forth Hosp, Huaian, Peoples R China	Soochow University - China	Dong, C (corresponding author), Soochow Univ, Dept Epidemiol & Stat, Jiangsu Key Lab & Translat Med Geriatr Dis, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China.; Zhang, B (corresponding author), Huaian Forth Hosp, Huaian, Peoples R China.	hasykjk@163.com; cdong1974@163.com						Babio N, 2015, NUTR METAB CARDIOVAS, V25, P173, DOI 10.1016/j.numecd.2014.10.006; Chacko KR, 2016, CLIN LIVER DIS, V20, P387, DOI 10.1016/j.cld.2015.10.004; Choi H, 2016, ARCH GERONTOL GERIAT, V64, P51, DOI 10.1016/j.archger.2016.01.005; El-Koofy N, 2012, EUR J RADIOL, V81, P3120, DOI 10.1016/j.ejrad.2012.06.020; Fan JG, 2013, J GASTROEN HEPATOL, V28, P11, DOI 10.1111/jgh.12036; Fan Jian-gao, 2007, Zhonghua Gan Zang Bing Za Zhi, V15, P552; Farrell GC, 2013, NAT REV GASTRO HEPAT, V10, P307, DOI 10.1038/nrgastro.2013.34; Garcia-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313; Goh GBB, 2016, DIGEST DIS SCI, V61, P1226, DOI 10.1007/s10620-016-4095-4; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Huh JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143560; Kuriyama S, 2015, CLIN EXP NEPHROL, V19, P1127, DOI 10.1007/s10157-015-1120-4; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Liu ZT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14325; Lonardo A, 2002, DIGEST LIVER DIS, V34, P204, DOI 10.1016/S1590-8658(02)80194-3; Luo WS, 2016, ANN HUM BIOL, V43, P67, DOI 10.3109/03014460.2015.1023847; Pascale A, 2010, J GASTROINTEST LIVER, V19, P415; Patterson RA, 2003, J LIPID RES, V44, P512, DOI 10.1194/jlr.M200407-JLR200; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Shih MH, 2015, J FORMOS MED ASSOC, V114, P314, DOI 10.1016/j.jfma.2012.11.014; Tarantino G, 2014, J GASTROINTEST LIVER, V23, P291, DOI [10.1543/jgld.2014.1121.233.gvt, 10.15403/jgld.2014.1121.233.gvt]; Valle M, 2015, PEDIATR DIABETES, V16, P441, DOI 10.1111/pedi.12199; Wang B, 2016, CLIN EXP HYPERTENS, V38, P312, DOI 10.3109/10641963.2015.1107088; Wu AH, 2016, INT J CARDIOL, V213, P4, DOI 10.1016/j.ijcard.2015.08.110; Wu SJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000802; Xia X, 2016, NUTR METAB CARDIOVAS, V26, P20, DOI 10.1016/j.numecd.2015.10.011; Xie YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067152; Ye X, 2014, J DIABETES, V6, P42, DOI 10.1111/1753-0407.12079; Zhou YJ, 2016, CLIN BIOCHEM, V49, P636, DOI 10.1016/j.clinbiochem.2015.12.010; Zhu JZ, 2015, DIGEST DIS SCI, V60, P3194, DOI 10.1007/s10620-015-3728-3	30	11	11	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166072	10.1371/journal.pone.0166072	http://dx.doi.org/10.1371/journal.pone.0166072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835657	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200023
J	Wang, L; Branson, OE; Shilo, K; Hitchcock, CL; Freitas, MA				Wang, Linan; Branson, Owen E.; Shilo, Konstantin; Hitchcock, Charles L.; Freitas, Michael A.			Proteomic Signatures of Thymomas	PLOS ONE			English	Article							T-CELL DEVELOPMENT; LARGE GENE LISTS; DAVID BIOINFORMATICS RESOURCES; THYMIC EPITHELIAL TUMORS; ALPHA-B-CRYSTALLIN; HISTOLOGIC CLASSIFICATION; STATHMIN 1; LINEAGE COMMITMENT; PROTHYMOSIN-ALPHA; THYMOSIN ALPHA-1	Based on the histological features and outcome, the current WHO classification separates thymomas into A, AB, B1, B2 and B3 subtypes. It is hypothesized that the type A thymomas are derived from the thymic medulla while the type B thymomas are derived from the cortex. Due to occasional histological overlap between the tumor subtypes creating difficulties in their separation, the aim of this study was to provide their proteomic characterization and identify potential immunohistochemical markers aiding in tissue diagnosis. Pair-wise comparison of neoplastic and normal thymus by liquid chromatography tandem mass spectrometry (LC-MS/MS) of formalin fixed paraffin embedded tissue revealed 61 proteins differentially expressed in thymomas compared to normal tissue. Hierarchical clustering showed distinct segregation of subtypes AB, B1 and B2 from that of A and B3. Most notably, desmoyokin, a protein that is encoded by the AHNAK gene, was associated with type A thymomas and medulla of normal thymus, by LC-MS/MS and immunohistochemistry. In this global proteomic characterization of the thymoma, several proteins unique to different thymic compartments and thymoma subtypes were identified. Among differentially expressed proteins, desmoyokin is a marker specific for thymic medulla and is potentially promising immunohistochemical marker in separation of type A and B3 thymomas.	[Wang, Linan; Branson, Owen E.; Freitas, Michael A.] Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA; [Wang, Linan; Branson, Owen E.; Freitas, Michael A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Shilo, Konstantin; Hitchcock, Charles L.] Ohio State Univ, Dept Pathol, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Freitas, MA (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Canc Biol & Genet, Columbus, OH 43210 USA.; Freitas, MA (corresponding author), Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA.	freitas.5@osu.edu	Freitas, Michael/C-8953-2009; Shilo, K/AAV-2360-2020	Freitas, Michael/0000-0002-3103-8410; Shilo, K/0000-0002-6702-3130				ALLEN TC, 1992, LAB METHODS HISTOTEC, P53; Anderson SJ, 2007, IMMUNITY, V26, P759, DOI 10.1016/j.immuni.2007.04.012; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Brodeur JF, 2009, J IMMUNOL, V182, P4844, DOI 10.4049/jimmunol.0803679; Carney BK, 2010, CANCER BIOL THER, V9, P699, DOI 10.4161/cbt.9.9.11430; Chen C, 2008, CANCER EPIDEM BIOMAR, V17, P2152, DOI 10.1158/1055-9965.EPI-07-2893; Chen G, 2002, CANCER, V95, P420, DOI 10.1002/cncr.10665; Chen J, 2013, ONCOGENE, V32, P1330, DOI 10.1038/onc.2012.141; Chiang YJ, 2016, EUR J IMMUNOL, V46, P2401, DOI 10.1002/eji.201646440; Chin D, 2005, LARYNGOSCOPE, V115, P1239, DOI 10.1097/01.MLG.0000164715.86240.55; CLEVERS H, 1988, ANNU REV IMMUNOL, V6, P629, DOI 10.1146/annurev.iy.06.040188.003213; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Danzl NM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086129; Dave VP, 1997, EMBO J, V16, P1360, DOI 10.1093/emboj/16.6.1360; DeJarnette JB, 1998, P NATL ACAD SCI USA, V95, P14909, DOI 10.1073/pnas.95.25.14909; Dooley J, 2007, DEV DYNAM, V236, P3459, DOI 10.1002/dvdy.21364; Engels EA, 2010, J THORAC ONCOL, V5, pS260, DOI 10.1097/JTO.0b013e3181f1f62d; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Filbert EL, 2012, J IMMUNOL, V188, P5421, DOI 10.4049/jimmunol.1200242; Fischer A, 2010, SEMIN IMMUNOPATHOL, V32, P107, DOI 10.1007/s00281-010-0196-x; Gelkop S, 2005, J IMMUNOL, V175, P8123, DOI 10.4049/jimmunol.175.12.8123; Hager-Theodorides AL, 2007, EUR J IMMUNOL, V37, P487, DOI 10.1002/eji.200636503; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Hassan Mohamed Kamel, 2015, Oncoscience, V2, P294; Hayashi M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-108; He XY, 2016, TUMOR BIOL, V37, P9951, DOI 10.1007/s13277-016-4869-5; Hemdan T, 2014, BRIT J CANCER, V111, P1180, DOI 10.1038/bjc.2014.427; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Ho PY, 2013, UROL ONCOL-SEMIN ORI, V31, P1367, DOI 10.1016/j.urolonc.2012.01.015; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Khor GH, 2013, INT J MED SCI, V10, P1727, DOI 10.7150/ijms.6884; Kim YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-576; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Kondo K, 2004, ANN THORAC SURG, V77, P1183, DOI 10.1016/j.athoracsur.2003.07.042; Kuhns MS, 2006, IMMUNITY, V24, P133, DOI 10.1016/j.immuni.2006.01.006; Lee IH, 2014, ONCOGENE, V33, P4675, DOI 10.1038/onc.2014.69; Liu PT, 2010, IMMUNOL REV, V238, P138, DOI 10.1111/j.1600-065X.2010.00953.x; Liu XL, 2015, INT J CLIN EXP MED, V8, P6502; LOPEZ F, 1991, CYTOMETRY, V12, P42, DOI 10.1002/cyto.990120107; Machado-Neto JA, 2014, BMB REP, V47, P660, DOI 10.5483/BMBRep.2014.47.12.020; MALISSEN M, 1995, EMBO J, V14, P4641, DOI 10.1002/j.1460-2075.1995.tb00146.x; Murre C, 2007, IMMUNITY, V26, P751, DOI 10.1016/j.immuni.2007.06.001; NEGISHI I, 1995, NATURE, V376, P435, DOI 10.1038/376435a0; Nemunaitis J, 2012, EXPERT OPIN THER TAR, V16, P631, DOI 10.1517/14728222.2012.696101; Nipp M, 2012, J MOL MED, V90, P163, DOI 10.1007/s00109-011-0815-6; Novak M, 2015, GYNECOL ONCOL, V139, P104, DOI 10.1016/j.ygyno.2015.07.100; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Okamoto T, 2007, CURR PHARM DESIGN, V13, P447, DOI 10.2174/138161207780162944; Okumura M, 2002, CANCER-AM CANCER SOC, V94, P624, DOI 10.1002/cncr.10226; Paweletz CP, 2000, CANCER RES, V60, P6293; Pierluigi B, 2010, ANN NY ACAD SCI, V1194, P1, DOI 10.1111/j.1749-6632.2010.05465.x; Polanski M, 2006, BIOMARK INSIGHTS, V1, P1; Ried M, 2016, EUR J CARDIO-THORAC, V49, P1545, DOI 10.1093/ejcts/ezv426; Rodriguez-Vicente AE, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1212-2; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Scorsetti M, 2016, CRIT REV ONCOL HEMAT, V99, P332, DOI 10.1016/j.critrevonc.2016.01.012; Serafino A, 2012, ANN NY ACAD SCI, V1270, P13, DOI 10.1111/j.1749-6632.2012.06707.x; Shapiro JP, 2012, J PROTEOMICS, V77, P433, DOI 10.1016/j.jprot.2012.09.019; SHTIVELMAN E, 1993, J CELL BIOL, V120, P625, DOI 10.1083/jcb.120.3.625; SHTIVELMAN E, 1992, P NATL ACAD SCI USA, V89, P5472, DOI 10.1073/pnas.89.12.5472; Staudt LM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000109; Strobel P, 2014, HISTOPATHOLOGY, V64, P557, DOI 10.1111/his.12279; Sun QL, 2012, CHINESE MED J-PEKING, V125, P2811, DOI 10.3760/cma.j.issn.0366-6999.2012.16.003; TSITSILONI OE, 1994, J IMMUNOL METHODS, V169, P163, DOI 10.1016/0022-1759(94)90260-7; TSITSILONI OE, 1993, P NATL ACAD SCI USA, V90, P9504, DOI 10.1073/pnas.90.20.9504; Van Laethem F, 2013, CELL, V154, P1326, DOI 10.1016/j.cell.2013.08.009; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Wang F, 2014, ASIAN PAC J CANCER P, V15, P3613, DOI 10.7314/APJCP.2014.15.8.3613; Wang NH, 1998, INT IMMUNOL, V10, P1777, DOI 10.1093/intimm/10.12.1777; Wei B, 2015, CLIN CHIM ACTA, V447, P72, DOI 10.1016/j.cca.2015.05.016; WHITELAND JL, 1995, J HISTOCHEM CYTOCHEM, V43, P313, DOI 10.1177/43.3.7868861; Xin W, 2003, AM J PATHOL, V162, P255, DOI 10.1016/S0002-9440(10)63816-3; Yamada Y, 2011, AM J SURG PATHOL, V35, P1296, DOI 10.1097/PAS.0b013e3182237f5d	81	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166494	10.1371/journal.pone.0166494	http://dx.doi.org/10.1371/journal.pone.0166494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832160	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000130
J	Ma, SQ; Cao, BR; Zhang, H; Luo, LP; Ren, Y; Hu, T; Chen, CM				Ma, S. Q.; Cao, B. R.; Zhang, H.; Luo, L. P.; Ren, Y.; Hu, T.; Chen, C. M.			The lack of Raf-1 kinase feedback regulation enhances antiapoptosis in cancer cells	ONCOGENE			English	Article							EPIDERMAL-GROWTH-FACTOR; INDEPENDENT MECHANISM; PROSTATE-CANCER; C-RAF-1 GENE; APOPTOSIS; EXPRESSION; MEK; ACTIVATION; PHOSPHORYLATION; OVEREXPRESSION	Raf-1 has an important role in cellular antiapoptosis. So far, there is no solid evidence that shows that Raf-1 mutation is associated with cancer development. In the course of further study of Raf-1 signaling, we have reported that Raf-1 hyperphosphorylation inhibits its kinase activity toward its downstream mitogen-activated protein kinase kinase 1/2 (MEK1/2) and proposed a model for negative feedback regulation of Raf-1. Here, we show that there is no hyperphosphorylation in some cancer cells, which results in increased kinase activity and enhances the antiapoptotic ability. Inhibition of either Raf-1 or ALG-2 (apoptosis-linked gene 2) expression results in apoptosis signal-regulating kinase 1/c-Jun N-terminal kinase (ASK1/JNK) signaling activation, and cell sensitivity to chemotherapeutic reagents, indicating that inhibition of ASK1/JNK apoptotic signaling by Raf-1 is mediated by ALG-2. A previous report indicated that extracellular signal-regulated kinase 1/2 (ERK1/2) were responsible for Raf-1 hyperphosphorylation. However, our evidence shows that when ERK1/2 are activated and the Raf-1 gene is not mutated, Raf-1 is not hyperphosphorylated in these cells, indicating that ERK1/2 are not responsible for the Raf-1 hyperphosphorylation in these cancer cell lines. Surprisingly, we also found that Raf-1 is not a necessary kinase for MEK1/2 activation under normal tissue culture conditions, but is required for MEK1/2 activation under apoptosis-inducing conditions. Our research demonstrates that although Raf-1 gene is not mutated, an abnormality of Raf-1 kinase feedback regulation enhances its antiapoptotic function, and Raf-1 can still be a pharmaceutical target to increase chemotherapy or radiotherapy sensitivity in these cancer cells.	[Ma, S. Q.; Cao, B. R.; Zhang, H.; Luo, L. P.; Ren, Y.; Chen, C. M.] Sichuan Canc Hosp Inst, Dept Basic Res, 55 Renmin Ave Fourth Sect, Chengdu 610041, Sichuan, Peoples R China; [Hu, T.] Sichuan Canc Hosp Inst, Dept Gynecol Oncol, Chengdu, Peoples R China		Chen, CM (corresponding author), Sichuan Canc Hosp Inst, Dept Basic Res, 55 Renmin Ave Fourth Sect, Chengdu 610041, Sichuan, Peoples R China.	changmin_chen@sichuancancer.org	, 曹邦荣/AAN-3604-2020	Cao, Bangrong/0000-0002-3865-3563	Sichuan Scientific and Technology Department Basic Research Fund [2015JY0011]; Sichuan Cancer Hospital Research Fund	Sichuan Scientific and Technology Department Basic Research Fund; Sichuan Cancer Hospital Research Fund	This work was financially supported by Sichuan Scientific and Technology Department Basic Research Fund (2015JY0011) (to CC) and Sichuan Cancer Hospital Research Fund (to CC).	Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Appert-Collin A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00283; Bieker R, 2003, CANCER RES, V63, P7241; Brady G, 2007, INT J ONCOL, V31, P875; Chen CM, 2005, BIOCHEM BIOPH RES CO, V333, P51, DOI 10.1016/j.bbrc.2005.05.074; Chen CM, 2004, BLOOD, V104, P73, DOI 10.1182/blood-2003-04-1340; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Culig Z, 2002, MOL CELL ENDOCRINOL, V197, P231, DOI 10.1016/S0303-7207(02)00263-0; CULIG Z, 1994, CANCER RES, V54, P5474; Cussenot O, 1997, ANN ENDOCRINOL-PARIS, V58, P370; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Huser M, 2001, EMBO J, V20, P1940, DOI 10.1093/emboj/20.8.1940; Hwang IS, 2002, FEBS LETT, V529, P183, DOI 10.1016/S0014-5793(02)03329-X; Kaplan PJ, 1996, CARCINOGENESIS, V17, P2571, DOI 10.1093/carcin/17.12.2571; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Latil A, 2000, INT J CANCER, V89, P167, DOI 10.1002/(SICI)1097-0215(20000320)89:2<167::AID-IJC11>3.0.CO;2-9; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Li R, 2004, PROSTATE, V58, P193, DOI 10.1002/pros.10321; Little AS, 2013, ONCOGENE, V32, P1207, DOI 10.1038/onc.2012.160; Matallanas David, 2011, Genes Cancer, V2, P232, DOI 10.1177/1947601911407323; Mikula M, 2001, EMBO J, V20, P1952, DOI 10.1093/emboj/20.8.1952; Murakami MS, 2001, SCI STKE, V2001, pE30; Osborne JK, 2012, CELL RES, V22, P14, DOI 10.1038/cr.2011.193; Park SJ, 2015, INT J CLIN EXP PATHO, V8, P8298; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Poulikakos PI, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001948; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pritchard C, 1997, NAT GENET, V16, P214, DOI 10.1038/ng0797-214; ROBERTS TM, 1992, NATURE, V360, P534, DOI 10.1038/360534a0; Segaliny AI, 2015, J BONE ONCOL, V4, P1, DOI 10.1016/j.jbo.2015.01.001; Sewing A, 1997, MOL CELL BIOL, V17, P5588, DOI 10.1128/MCB.17.9.5588; Steelman LS, 2011, LEUKEMIA, V25, P1080, DOI 10.1038/leu.2011.66; Trojan L, 2004, UROL RES, V32, P97, DOI 10.1007/s00240-003-0383-5; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yu PC, 2014, MICROVASC RES, V96, P10, DOI 10.1016/j.mvr.2014.07.016; Zhang WY, 1999, J BONE MINER RES, V14, P528, DOI 10.1359/jbmr.1999.14.4.528	39	12	13	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 6	2017	36	14					2014	2022		10.1038/onc.2016.384	http://dx.doi.org/10.1038/onc.2016.384			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ER6EQ	27841865				2022-12-26	WOS:000398898500011
J	Alvarez-Curto, E; Inoue, A; Jenkins, L; Raihan, SZ; Prihandoko, R; Tobin, AB; Milligan, G				Alvarez-Curto, Elisa; Inoue, Asuka; Jenkins, Laura; Raihan, Sheikh Zahir; Prihandoko, Rudi; Tobin, Andrew B.; Milligan, Graeme			Targeted Elimination of G Proteins and Arrestins Defines Their Specific Contributions to Both Intensity and Duration of G Protein-coupled Receptor Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; ERK1/2 ACTIVATION; HORMONE RECEPTOR; 4 FFA4/GPR120; PHOSPHORYLATION; AGONIST; INTERNALIZATION; DESENSITIZATION; MECHANISMS; HISTORY	G protein-coupled receptors (GPCRs) can initiate intracellular signaling cascades by coupling to an array of heterotrimeric G proteins and arrestin adaptor proteins. Understanding the contribution of each of these coupling options to GPCR signaling has been hampered by a paucity of tools to selectively perturb receptor function. Here we employ CRISPR/Cas9 genome editing to eliminate selected G proteins (G alpha(q) and G alpha(11)) or arrestin2 and arrestin3 from HEK293 cells together with the elimination of receptor phosphorylation sites to define the relative contribution of G proteins, arrestins, and receptor phosphorylation to the signaling outcomes of the free fatty acid receptor 4 (FFA4). A lack of FFA4-mediated elevation of intracellular Ca2+ in G alpha q/G alpha(11)-null cells and agonist-mediated receptor internalization in arrestin2/3-null cells confirmed previously reported canonical signaling features of this receptor, thereby validating the genome-edited HEK293 cells. FFA4-mediated ERK1/2 activation was totally dependent on G(q)/(11) but intriguingly was substantially enhanced for FFA4 receptors lacking sites of regulated phosphorylation. This was not due to a simple lack of desensitization of G(q)/(11) signaling because the G(q)/(11)-dependent calcium response was desensitized by both receptor phosphorylation and arrestin-dependent mechanisms, whereas a substantially enhanced ERK1/2 response was only observed for receptors lacking phosphorylation sites and not in arrestin2/3-null cells. In conclusion, we validate CRISPR/Cas9 engineered HEK293 cells lacking G(q)/(11) or arrestin2/3 as systems for GPCR signaling research and employ these cells to reveal a previously unappreciated interplay of signaling pathways where receptor phosphorylation can impact on ERK1/2 signaling through a mechanism that is likely independent of arrestins.	[Alvarez-Curto, Elisa; Jenkins, Laura; Raihan, Sheikh Zahir; Prihandoko, Rudi; Tobin, Andrew B.; Milligan, Graeme] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Ctr Translat Pharmacol, Glasgow G12 8QQ, Lanark, Scotland; [Inoue, Asuka] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan; [Inoue, Asuka] Japan Sci & Technol Agcy JST, Precursory Embryon Sci & Technol PRESTO, Kawaguchi, Saitama 3320012, Japan	University of Glasgow; Tohoku University; Japan Science & Technology Agency (JST)	Alvarez-Curto, E; Milligan, G (corresponding author), Univ Glasgow, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Elisa.Alvarez-Curto@glasgow.ac.uk; Graeme.Milligan@glasgow.ac.uk		Milligan, Graeme/0000-0002-6946-3519	Biotechnology and Biological Sciences Research Council [BB/K019864/1, BB/K019856/1]; PRESTO, Japan Science and Technology Agency; BBSRC [BB/K019864/1, BB/L02781X/1, BB/K019856/1, BB/K019856/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019856/2, BB/L02781X/1, 1653478] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); PRESTO, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grants BB/K019864/1 (to G. M.) and BB/K019856/1 (to A. B. T.) and PRESTO, Japan Science and Technology Agency (to A. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Birdsong WT, 2013, J NEUROSCI, V33, P4118, DOI 10.1523/JNEUROSCI.4187-12.2013; Burns RN, 2014, BIOCHEM PHARMACOL, V87, P650, DOI 10.1016/j.bcp.2013.12.016; Butcher AJ, 2016, J BIOL CHEM, V291, P8862, DOI 10.1074/jbc.M115.681726; Butcher AJ, 2014, J BIOL CHEM, V289, P18451, DOI 10.1074/jbc.M114.568816; Canals M, 2006, J BIOL CHEM, V281, P16757, DOI 10.1074/jbc.M601121200; Charest PG, 2007, CELL SIGNAL, V19, P32, DOI 10.1016/j.cellsig.2006.05.020; Coffa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028723; Coffa S, 2011, BIOCHEMISTRY-US, V50, P6951, DOI 10.1021/bi200745k; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; Gurevich V. V., 2015, PROG MOL BIOL TRANSL, V132, P1; Hudson BD, 2014, J BIOL CHEM, V289, P20345, DOI 10.1074/jbc.M114.561449; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Kriz V, 2014, J BIOL CHEM, V289, P1128, DOI 10.1074/jbc.M113.498444; Kuhar JR, 2015, CELL SIGNAL, V27, P1799, DOI 10.1016/j.cellsig.2015.05.019; LEE CH, 1992, J BIOL CHEM, V267, P16044; Lefkowitz RJ, 2013, ANGEW CHEM INT EDIT, V52, P6366, DOI 10.1002/anie.201301924; Li Z, 2016, EXPERT OPIN INV DRUG, V25, P871, DOI 10.1080/13543784.2016.1189530; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Luttrell LM, 2010, PHARMACOL REV, V62, P305, DOI 10.1124/pr.109.002436; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Milligan G, 2006, BRIT J PHARMACOL, V147, pS46, DOI 10.1038/sj.bjp.0706405; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Nishimura A, 2010, P NATL ACAD SCI USA, V107, P13666, DOI 10.1073/pnas.1003553107; Nuber S, 2016, NATURE, V531, P661, DOI 10.1038/nature17198; Peng RX, 2016, FEBS J, V283, P1218, DOI 10.1111/febs.13586; Prihandoko R, 2016, MOL PHARMACOL, V89, P505, DOI 10.1124/mol.115.101949; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Smith JS, 2016, J BIOL CHEM, V291, P8969, DOI 10.1074/jbc.R115.713313; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stone VM, 2014, DIABETOLOGIA, V57, P1182, DOI 10.1007/s00125-014-3213-0; Taboubi S, 2007, FASEB J, V21, P4047, DOI 10.1096/fj.06-7476com; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Vibhuti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019585; Yu R, 1999, J BIOL CHEM, V274, P15745, DOI 10.1074/jbc.274.22.15745; Zhang F, 2014, HUM MOL GENET, V23, pR40, DOI 10.1093/hmg/ddu125; Zhou L, 2014, CURR OPIN CELL BIOL, V27, P102, DOI 10.1016/j.ceb.2013.11.010	43	94	94	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27147	27159		10.1074/jbc.M116.754887	http://dx.doi.org/10.1074/jbc.M116.754887			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27852822	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000391576300015
J	Janevska, S; Arndt, B; Niehaus, EM; Burkhardt, I; Rosler, SM; Brock, NL; Humpf, HU; Dickschat, JS; Tudzynski, B				Janevska, Slavica; Arndt, Birgit; Niehaus, Eva-Maria; Burkhardt, Immo; Roesler, Sarah M.; Brock, Nelson L.; Humpf, Hans-Ulrich; Dickschat, Jeroen S.; Tudzynski, Bettina			Gibepyrone Biosynthesis in the Rice Pathogen Fusarium fujikuroi Is Facilitated by a Small Polyketide Synthase Gene Cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIBBERELLA-FUJIKUROI; SECONDARY METABOLISM; ENDOPHYTIC FUNGUS; SACCHAROMYCES-CEREVISIAE; TRICHODERMA-HARZIANUM; TRANSCRIPTION FACTORS; BIOLOGICAL-ACTIVITY; MASS-SPECTROMETRY; NATURAL-PRODUCTS; SPECIES COMPLEX	The 2H-pyran-2-one gibepyrone A and its oxidized derivatives gibepyrones B-F have been isolated from the rice pathogenic fungus Fusarium fujikuroi already more than 20 years ago. However, these products have not been linked to the respective biosynthetic genes, and therefore, their biosynthesis has not yet been analyzed on a molecular level. Feeding experiments with isotopically labeled precursors clearly supported a polyketide origin for the formal monoterpenoid gibepyrone A, whereas the terpenoid pathway could be excluded. Targeted gene deletion verified that the F. fujikuroi polyketide synthase PKS13, designated Gpy1, is responsible for gibepyrone A biosynthesis. Next to Gpy1, the ATP-binding cassette transporter Gpy2 is encoded by the gibepyrone gene cluster. Gpy2 was shown to have only a minor impact on the actual efflux of gibepyrone A out of the cell. Instead, we obtained evidence that Gpy2 is involved in gene regulation as it represses GPY1 gene expression. Thus, GPY1 was up-regulated and gibepyrone A production was enhanced both extra-and intracellularly in Delta gpy2 mutants. Furthermore, expression of GPY genes is strictly repressed by members of the fungus-specific velvet complex, Vel1, Vel2, and Lae1, whereas Sge1, a major regulator of secondary metabolism in F. fujikuroi, affects gibepyrone biosynthesis in a positive manner. The gibepyrone A derivatives gibepyrones B and D were shown to be produced by cluster-independent P450 monooxygenases, probably to protect the fungus from the toxic product. In contrast, the formation of gibepyrones E and F from gibepyrone A is a spontaneous process and independent of enzymatic activity.	[Janevska, Slavica; Niehaus, Eva-Maria; Roesler, Sarah M.; Tudzynski, Bettina] Westfal Wilhelms Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 8, D-48143 Munster, Germany; [Arndt, Birgit; Roesler, Sarah M.; Humpf, Hans-Ulrich] Westfal Wilhelms Univ Munster, Inst Lebensmittelchem, Corrensstr 45, D-48149 Munster, Germany; [Burkhardt, Immo; Brock, Nelson L.; Dickschat, Jeroen S.] Rhein Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany	University of Munster; University of Munster; University of Bonn	Tudzynski, B (corresponding author), Westfal Wilhelms Univ Munster, Inst Biol & Biotechnol Pflanzen, Schlosspl 8, D-48143 Munster, Germany.; Dickschat, JS (corresponding author), Rhein Friedrich Wilhelms Univ Bonn, Kekule Inst Organ Chem & Biochem, Gerhard Domagk Str 1, D-53121 Bonn, Germany.	dickschat@uni-bonn.de; tudzynsb@uni-muenster.de	Humpf, Hans-Ulrich/AAV-4845-2020	Janevska, Slavica/0000-0001-7361-495X; Humpf, Hans-Ulrich/0000-0003-3296-3058	German Research Foundation [TU101/16-2, HU730/9-3]; Collaborative Research Centre "Chemistry at Spin Centres" [SFB 813]	German Research Foundation(German Research Foundation (DFG)); Collaborative Research Centre "Chemistry at Spin Centres"	This work was supported by the German Research Foundation (projects TU101/16-2 and HU730/9-3) and by the Collaborative Research Centre SFB 813 "Chemistry at Spin Centres." The authors declare that they have no conflicts of interest with the contents of this article.	ABBAS HK, 1992, MYCOPATHOLOGIA, V118, P115, DOI 10.1007/BF00442540; ABRAHAM WR, 1990, PHYTOCHEMISTRY, V29, P2877, DOI 10.1016/0031-9422(90)87095-C; ABRAHAM WR, 1988, PHYTOCHEMISTRY, V27, P3310, DOI 10.1016/0031-9422(88)80051-7; ABRELL LM, 1994, TETRAHEDRON LETT, V35, P9159, DOI 10.1016/0040-4039(94)88453-6; Ahmed YL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001750; Arndt B, 2015, FUNGAL GENET BIOL, V84, P26, DOI 10.1016/j.fgb.2015.09.006; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; AVENT AG, 1992, PHYTOCHEMISTRY, V31, P3447, DOI 10.1016/0031-9422(92)83704-3; BARRERO AF, 1993, TETRAHEDRON, V49, P141, DOI 10.1016/S0040-4020(01)80514-7; Bayram O, 2012, FEMS MICROBIOL REV, V36, P1, DOI 10.1111/j.1574-6976.2011.00285.x; BENTLEY R, 1967, J AM CHEM SOC, V89, P676, DOI 10.1021/ja00979a036; Bertrand S, 2014, MOL BIOSYST, V10, P2289, DOI 10.1039/c4mb00223g; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Bok JW, 2006, MOL MICROBIOL, V61, P1636, DOI 10.1111/j.1365-2958.2006.05330.x; Brock NL, 2013, CHEMBIOCHEM, V14, P311, DOI 10.1002/cbic.201200695; Brock NL, 2011, CHEMBIOCHEM, V12, P2667, DOI 10.1002/cbic.201100516; Burkhardt I, 2016, ANGEW CHEM INT EDIT, V55, P8748, DOI 10.1002/anie.201603782; Cacho RA, 2015, J AM CHEM SOC, V137, P15688, DOI 10.1021/jacs.5b11814; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CLAYDON N, 1987, T BRIT MYCOL SOC, V88, P503, DOI 10.1016/S0007-1536(87)80034-7; Coleman JJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000618; COLLINS RP, 1972, J AGR FOOD CHEM, V20, P437, DOI 10.1021/jf60180a010; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Cook RJ., 1981, FUSARIUM DIS BIOL TA, P104; Cooney JM, 1997, J NAT PROD, V60, P1242, DOI 10.1021/np970337n; Crutcher FK, 2015, MICROBIOL-SGM, V161, P875, DOI 10.1099/mic.0.000043; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; DICKINSON JM, 1993, NAT PROD REP, V10, P71, DOI 10.1039/np9931000071; Dickschat JS, 2014, NAT PROD REP, V31, P838, DOI 10.1039/c3np70080a; Dickschat JS, 2011, EUR J ORG CHEM, V2011, P3339, DOI 10.1002/ejoc.201100188; Donaton MCV, 2003, MOL MICROBIOL, V50, P911, DOI 10.1046/j.1365-2958.2003.03732.x; Evidente Antonio, 1994, Natural Toxins, V2, P4, DOI 10.1002/nt.2620020103; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; GHISALBERTI EL, 1990, PLANT SOIL, V121, P287, DOI 10.1007/BF00012323; Hentschel U, 2012, NAT REV MICROBIOL, V10, P641, DOI 10.1038/nrmicro2839; JOFFE AZ, 1969, J STORED PROD RES, V5, P211, DOI 10.1016/0022-474X(69)90035-6; KAGAN RM, 1994, ARCH BIOCHEM BIOPHYS, V310, P417, DOI 10.1006/abbi.1994.1187; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; LEE JC, 1995, CHEM BIOL, V2, P721, DOI 10.1016/1074-5521(95)90100-0; Leslie J F, 2006, Mycotoxin Res, V22, P73, DOI 10.1007/BF02956766; LIGHT RJ, 1966, BIOCHEMISTRY-US, V5, P4037, DOI 10.1021/bi00876a038; Liu D, 2013, HELV CHIM ACTA, V96, P437, DOI 10.1002/hlca.201200195; Ma SM, 2009, SCIENCE, V326, P589, DOI 10.1126/science.1175602; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; McGlacken GP, 2005, NAT PROD REP, V22, P369, DOI 10.1039/b416651p; Menke J, 2012, MOL PLANT MICROBE IN, V25, P1408, DOI 10.1094/MPMI-04-12-0081-R; Michielse CB, 2015, ENVIRON MICROBIOL, V17, P2690, DOI 10.1111/1462-2920.12592; MOSS MO, 1975, PHYTOCHEMISTRY, V14, P2706, DOI 10.1016/0031-9422(75)85255-1; NAIR MSR, 1975, TETRAHEDRON LETT, P1655; Nguyen VQ, 2008, P NATL ACAD SCI USA, V105, P4880, DOI 10.1073/pnas.0710448105; Niehaus EM, 2016, ENVIRON MICROBIOL, V18, P4282, DOI 10.1111/1462-2920.13576; Niehaus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103336; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; Niehaus EM, 2013, CHEM BIOL, V20, P1055, DOI 10.1016/j.chembiol.2013.07.004; Nirenberg HI, 1998, MYCOLOGIA, V90, P434, DOI 10.2307/3761403; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Proctor RH, 2003, FUNGAL GENET BIOL, V38, P237, DOI 10.1016/S1087-1845(02)00525-X; Rosler SM, 2016, APPL MICROBIOL BIOT, V100, P5869, DOI 10.1007/s00253-016-7426-7; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Shimizu BI, 2005, Z NATURFORSCH C, V60, P862; Short DPG, 2013, FUNGAL GENET BIOL, V53, P59, DOI 10.1016/j.fgb.2013.01.004; Skellam EJ, 2010, MOL BIOSYST, V6, P680, DOI 10.1039/b923990a; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Studt L, 2016, ENVIRON MICROBIOL, V18, P936, DOI 10.1111/1462-2920.13150; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Tang SG, 2012, REC NAT PROD, V6, P398; Tudzynski B, 2005, APPL MICROBIOL BIOT, V66, P597, DOI 10.1007/s00253-004-1805-1; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Tudzynski B, 1998, FUNGAL GENET BIOL, V25, P157, DOI 10.1006/fgbi.1998.1095; Turkkan M, 2011, PHYTOPATHOL MEDITERR, V50, P154; UMBREIT MA, 1977, J AM CHEM SOC, V99, P5526, DOI 10.1021/ja00458a072; VENKATASUBBAIAH P, 1991, PHYTOCHEMISTRY, V30, P1471, DOI 10.1016/0031-9422(91)84189-Y; VISCONTI A, 1994, J NAT PROD, V57, P695, DOI 10.1021/np50108a002; Wang DN, 2014, MED MYCOL, V52, P504, DOI 10.1093/mmy/myu007; Wang QX, 2011, FITOTERAPIA, V82, P777, DOI 10.1016/j.fitote.2011.04.002; Wickel SM, 2013, EUR J ORG CHEM, V2013, P2906, DOI 10.1002/ejoc.201300049; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107; Yu FG, 2005, FEMS MICROBIOL LETT, V248, P257, DOI 10.1016/j.femsle.2005.05.053	89	29	31	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 30	2016	291	53					27403	27420		10.1074/jbc.M116.753053	http://dx.doi.org/10.1074/jbc.M116.753053			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2CZ	27856636	hybrid, Green Published			2022-12-26	WOS:000391576300036
J	Hu, H; Luo, C; Zheng, YG				Hu, Hao; Luo, Cheng; Zheng, Y. George			Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC DIMETHYLARGININE; SUBSTRATE-SPECIFICITY; FUNCTIONAL INSIGHTS; MOLECULAR-MECHANISM; CRYSTAL-STRUCTURE; KIDNEY-DISEASE; PRMT1; METHYLATION; INHIBITORS; CARM1	Protein arginine methyltransferases (PRMTs) are the enzymes responsible for posttranslational methylation of protein arginine residues in eukaryotic cells, particularly within the histone tails. A detailed mechanistic model of PRMT-catalyzed methylation is currently lacking, but it is essential for understanding the functions of PRMTs in various cellular pathways and for efficient design of PRMT inhibitors as potential treatments for a range of human diseases. In this work, we used stopped-flow fluorescence in combination with global kinetic simulation to dissect the transient kinetics of PRMT1, the predominant type I arginine methyltransferase. Several important mechanistic insights were revealed. The cofactor and the peptide substrate bound to PRMT1 in a random manner and then followed a kinetically preferred pathway to generate the catalytic enzyme-cofactor-substrate ternary complex. Product release proceeded in an ordered fashion, with peptide dissociation followed by release of the byproduct S-adenosylhomocysteine. Importantly, the dissociation rate of the monomethylated intermediate from the ternary complex was much faster than the methyl transfer. Such a result provided direct evidence for distributive arginine dimethylation, which means the monomethylated substrate has to be released to solution and rebind with PRMT1 before it undergoes further methylation. In addition, cofactor binding involved a conformational transition, likely an open-to-closed conversion of the active site pocket. Further, the histone H4 peptide bound to the two active sites of the PRMT1 homodimer with differential affinities, suggesting a negative cooperativity mechanism of substrate binding. These findings provide a new mechanistic understanding of how PRMTs interact with their substrates and transfer methyl groups.	[Hu, Hao; Zheng, Y. George] Univ Georgia, Dept Pharmaceut & Biomed Sci, 250 W Green St, Athens, GA 30602 USA; [Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	University System of Georgia; University of Georgia; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Zheng, YG (corresponding author), Univ Georgia, Dept Pharmaceut & Biomed Sci, 250 W Green St, Athens, GA 30602 USA.	yzheng@uga.edu	Stefanadis, Christodoulos/ABH-2232-2020; Hu, Hao/AAJ-8523-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Hu, Hao/0000-0003-1365-0267	American Heart Association [12GRNT12070056]; National Institutes of Health [R01 GM086717]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR028859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086717] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 12GRNT12070056 and National Institutes of Health Grant R01 GM086717. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bonnefond L, 2015, J STRUCT BIOL, V191, P175, DOI 10.1016/j.jsb.2015.06.017; Boriack-Sjodin PA, 2016, ACS CHEM BIOL, V11, P763, DOI 10.1021/acschembio.5b00773; Bouras G, 2013, CURR TOP MED CHEM, V13, P180, DOI 10.2174/1568026611313020007; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Copeland RA, 2004, ENZYMES PRACTICAL IN; Cura V, 2014, ACTA CRYSTALLOGR D, V70, P2401, DOI 10.1107/S1399004714014278; Cvetkovic T, 2012, J MED BIOCHEM, V31, P301, DOI 10.2478/v10011-012-0029-7; Da LT, 2014, ADV EXP MED BIOL, V805, P29, DOI 10.1007/978-3-319-02970-2_2; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Di Lorenzo A, 2011, FEBS LETT, V585, P2024, DOI 10.1016/j.febslet.2010.11.010; Feng Y, 2011, BIOCHEMISTRY-US, V50, P7033, DOI 10.1021/bi200456u; Feng Y, 2009, BIOCHEM BIOPH RES CO, V379, P567, DOI 10.1016/j.bbrc.2008.12.119; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gui SY, 2013, BIOCHEMISTRY-US, V52, P199, DOI 10.1021/bi301283t; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hu H, 2016, EXPERT OPIN INV DRUG, V25, P335, DOI 10.1517/13543784.2016.1144747; Hu H, 2015, J MED CHEM, V58, P1228, DOI 10.1021/jm501452j; Jacques SL, 2016, BIOCHEMISTRY-US, V55, P1635, DOI 10.1021/acs.biochem.5b01071; Johnson K. A., 1992, ENZYMES, P1; Johnson KA, 2013, FEBS LETT, V587, P2753, DOI 10.1016/j.febslet.2013.07.012; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kolbel K, 2009, J BIOL CHEM, V284, P8274, DOI 10.1074/jbc.M809547200; Lakowski TM, 2008, J BIOL CHEM, V283, P10015, DOI 10.1074/jbc.M710176200; Lakowski TM, 2009, BIOCHEM J, V421, P253, DOI 10.1042/BJ20090268; Larsen SC, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7329; Le Romancer M, 2010, STEROIDS, V75, P560, DOI 10.1016/j.steroids.2010.01.013; Lee WC, 2015, BIOCHEMISTRY-US, V54, P7514, DOI 10.1021/acs.biochem.5b00995; Matsuguma K, 2006, J AM SOC NEPHROL, V17, P2176, DOI 10.1681/ASN.2005121379; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Obianyo O, 2008, BIOCHEMISTRY-US, V47, P10420, DOI 10.1021/bi800904m; Obianyo O, 2012, J BIOL CHEM, V287, P6062, DOI 10.1074/jbc.M111.333609; Osborne TC, 2007, BIOCHEMISTRY-US, V46, P13370, DOI 10.1021/bi701558t; Raptis V, 2013, NEPHROLOGY, V18, P11, DOI 10.1111/j.1440-1797.2012.01659.x; Sack JS, 2011, BIOCHEM J, V436, P331, DOI 10.1042/BJ20102161; Schapira M, 2014, MEDCHEMCOMM, V5, P1779, DOI 10.1039/c4md00269e; Segel IH., 1993, ENZYME KINETICS BEHA; Seligson DB, 2005, NATURE, V435, P1262, DOI 10.1038/nature03672; Shia WJ, 2012, BLOOD, V119, P4953, DOI 10.1182/blood-2011-04-347476; Sinha SH, 2012, EUR J MED CHEM, V54, P647, DOI 10.1016/j.ejmech.2012.06.017; Svedruzic ZM, 2005, BIOCHEMISTRY-US, V44, P14977, DOI 10.1021/bi050988f; T Hart P, 2012, MEDCHEMCOMM, V3, P1235; Troffer-Charlier N, 2007, EMBO J, V26, P4391, DOI 10.1038/sj.emboj.7601855; Tymoczko J. L., 2011, BIOCH SHORT COURSE, P606; Wang CY, 2014, STRUCTURE, V22, P756, DOI 10.1016/j.str.2014.03.003; Wang M, 2014, BIOCHEMISTRY-US, V53, P7884, DOI 10.1021/bi501279g; Wang M, 2013, BIOCHEMISTRY-US, V52, P5430, DOI 10.1021/bi4005123; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wu J, 2012, J BIOMOL SCREEN, V17, P237, DOI 10.1177/1087057111414903; Xie N, 2009, BIOCONJUGATE CHEM, V20, P360, DOI 10.1021/bc800467a; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yue WW, 2007, EMBO J, V26, P4402, DOI 10.1038/sj.emboj.7601856; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zheng YG, 2008, MED RES REV, V28, P645, DOI 10.1002/med.20120; Zhou R, 2015, J CHEM INF MODEL, V55, P2623, DOI 10.1021/acs.jcim.5b00454	60	20	20	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26722	26738		10.1074/jbc.M116.757625	http://dx.doi.org/10.1074/jbc.M116.757625			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27834681	Green Published, hybrid			2022-12-26	WOS:000391571400012
J	Merewitz, E; Xu, Y; Huang, BR				Merewitz, Emily; Xu, Yi; Huang, Bingru			Differentially Expressed Genes Associated with Improved Drought Tolerance in Creeping Bentgrass Overexpressing a Gene for Cytokinin Biosynthesis	PLOS ONE			English	Article							SUPPRESSION SUBTRACTIVE HYBRIDIZATION; LEAF SENESCENCE; WATER-DEFICIT; STRESS; IDENTIFICATION; RESPONSES; PLANTS; DEHYDRATION; ACCLIMATION; CATALASE	Transformation with an isopentenyl transferase (ipt) gene controlling cytokinin (CK) synthesis has been shown to enhance plant drought tolerance. The objective of this study was to identify differentially-expressed genes (DEGs) in creeping bentgrass (Agrostis stolonifera) overexpressing ipt compared to non-transgenic plants. The ipt transgene was controlled by a senescence-activated promoter (SAG12). Both a null transformed line (NT) and SAG12-ipt plants were exposed to drought stress in an environmentally-controlled growth chamber until the soil water content declined to approximately 5% and leaf relative water content declined to 47%, which were both significantly below the well-watered controls. RNA was extracted from leaf samples of both well-watered and drought-stressed plants. Eight sets of subtractive hybridizations were performed for detection of up-regulated and down-regulated genes due to the presence of the transgene and due to drought stress in both NT and transgenic plants. Sequencing analysis revealed the identity of 252 DEGs due to either the transgene and drought stress. Sequencing analysis of 170 DEGs identified genes encoding for proteins that were related to energy production, metabolism, stress defense, signaling, protein synthesis and transport, and membrane transport could play major roles in the improved drought tolerance by overexpressing ipt in creeping bentgrass.	[Merewitz, Emily] Michigan State Univ, Dept Plant Soil & Microbial Sci, E Lansing, MI 48824 USA; [Xu, Yi; Huang, Bingru] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Michigan State University; Rutgers State University New Brunswick	Huang, BR (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA.	huang@aesop.rutgers.edu			OJ Noer Foundation; Rutgers Center of Turfgrass Science	OJ Noer Foundation; Rutgers Center of Turfgrass Science	The authors wish to thank the OJ Noer Foundation and Rutgers Center of Turfgrass Science for funding support for this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the OJ Noer Foundation and Rutgers Center of Turfgrass Science for funding support for this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aprile A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-279; Aridor M, 2001, J CELL BIOL, V152, P213, DOI 10.1083/jcb.152.1.213; Bevan M, 1998, NATURE, V391, P485, DOI 10.1038/35140; Bian SM, 2009, SCI HORTIC-AMSTERDAM, V120, P264, DOI 10.1016/j.scienta.2008.10.014; Blomstedt CK, 1998, PLANT GROWTH REGUL, V24, P153, DOI 10.1023/A:1005923528109; Bohnert HJ, 1998, CURR OPIN PLANT BIOL, V1, P267, DOI 10.1016/S1369-5266(98)80115-5; Bollivar DW, 1996, PLANT PHYSIOL, V112, P105, DOI 10.1104/pp.112.1.105; Bray EA, 2004, J EXP BOT, V55, P2331, DOI 10.1093/jxb/erh270; Clark DG, 2004, J AM SOC HORTIC SCI, V129, P93, DOI 10.21273/JASHS.129.1.0093; Clement M, 2008, GENE, V426, P15, DOI 10.1016/j.gene.2008.08.016; Desai S, 2000, PRACT APPROACH SER, P81; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Franca MB, 2005, CELL STRESS CHAPERON, V10, P167, DOI 10.1379/CSC-103R.1; Gorantla M, 2005, CURR SCI INDIA, V89, P496; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; Hazen Samuel P., 2005, Functional & Integrative Genomics, V5, P104, DOI 10.1007/s10142-004-0126-x; Heath LS, 2002, COMP FUNCT GENOM, V3, P226, DOI 10.1002/cfg.169; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang LY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1026; Hummel I, 2010, PLANT PHYSIOL, V154, P357, DOI 10.1104/pp.110.157008; Isokpehi RD, 2011, BIOINFORM BIOL INSIG, V5, P41, DOI 10.4137/BBI.S6061; Jain D, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-24; Jiang YW, 2010, J AM SOC HORTIC SCI, V135, P303, DOI 10.21273/JASHS.135.4.303; Kim YS, 2007, PLANT SIGNAL BEHAV, V2, P15, DOI 10.4161/psb.2.1.3606; Kosmala A, 2009, J EXP BOT, V60, P3595, DOI 10.1093/jxb/erp205; Krishnan S, 2016, J AM SOC HORTIC SCI, V141, P66, DOI 10.21273/JASHS.141.1.66; Li HuiYong, 2007, Agricultural Sciences in China, V6, P647, DOI 10.1016/S1671-2927(07)60095-9; Li WT, 2010, THEOR APPL GENET, V121, P907, DOI 10.1007/s00122-010-1359-9; Lin JZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024790; Liu SW, 2010, PHYSIOL PLANTARUM, V139, P375, DOI 10.1111/j.1399-3054.2010.01374.x; Manning VA, 2007, MOL PLANT MICROBE IN, V20, P168, DOI 10.1094/MPMI-20-2-0168; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021; Merewitz E, 2011, J EXPT BOT, V8, P1; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Merewitz EB, 2011, J EXP BOT, V62, P383, DOI 10.1093/jxb/erq285; Merewitz EB, 2010, J AM SOC HORTIC SCI, V135, P230, DOI 10.21273/JASHS.135.3.230; Miao HX, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0204-x; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Novakova M, 2007, BIOTECHNOLOGY AND SUSTAINABLE AGRICULTURE 2006 AND BEYOND, P171, DOI 10.1007/978-1-4020-6635-1_25; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Rivero RM, 2007, P NATL ACAD SCI USA, V104, P19631, DOI 10.1073/pnas.0709453104; Rivero RM, 2010, PLANT CELL PHYSIOL, V51, P1929, DOI 10.1093/pcp/pcq143; Salekdeh GH, 2002, PROTEOMICS, V2, P1131, DOI 10.1002/1615-9861(200209)2:9<1131::AID-PROT1131>3.0.CO;2-1; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Phung TH, 2011, PLANT PHYSIOL, V157, P1746, DOI 10.1104/pp.111.188276; Tian J, 2009, J PLANT PHYSIOL, V166, P588, DOI 10.1016/j.jplph.2008.09.003; TOPP GC, 1980, WATER RESOUR RES, V16, P574, DOI 10.1029/WR016i003p00574; VELASCO R, 1994, PLANT MOL BIOL, V26, P541, DOI 10.1007/BF00039567; Watkinson JI, 2003, PLANT PHYSIOL, V133, P1702, DOI 10.1104/pp.103.026914; Wei Min, 2006, Chinese Journal of Rice Science, V20, P567; Willekens H, 1997, EMBO J, V16, P4806, DOI 10.1093/emboj/16.16.4806; Xing JP, 2009, J AM SOC HORTIC SCI, V134, P602, DOI 10.21273/JASHS.134.6.602; Xu Y, 2009, PLANT GROWTH REGUL, V57, P281, DOI 10.1007/s10725-008-9346-8; Xu ZW, 2004, PLANT MOL BIOL, V55, P343, DOI 10.1007/s11103-004-0790-1; Zavaleta-Mancera HA, 2007, J PLANT PHYSIOL, V164, P1572, DOI 10.1016/j.jplph.2007.02.003; Zhang Ling, 2009, BMC Res Notes, V2, P120, DOI 10.1186/1756-0500-2-120; Zhang P, 2005, GLOBAL FOOD PRODUCT, P277; Zhang Y, 2005, J EXP BOT, V56, P897, DOI 10.1093/jxb/eri082	65	17	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166676	10.1371/journal.pone.0166676	http://dx.doi.org/10.1371/journal.pone.0166676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855226	Green Submitted, gold, Green Published			2022-12-26	WOS:000387910200044
J	Yoshizaki, K; Furuse, T; Kimura, R; Tucci, V; Kaneda, H; Wakana, S; Osumi, N				Yoshizaki, Kaichi; Furuse, Tamio; Kimura, Ryuichi; Tucci, Valter; Kaneda, Hideki; Wakana, Shigeharu; Osumi, Noriko			Paternal Aging Affects Behavior in Pax6 Mutant Mice: A Gene/Environment Interaction in Understanding Neurodevelopmental Disorders	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AUTISM SPECTRUM DISORDERS; DEVELOPMENTAL DELAY; SYNAPTIC PLASTICITY; WAGR SYNDROME; MOUSE MODELS; AGE; GENETICS; CHILDREN; COMMON	Neurodevelopmental disorders such as autism spectrum disorder (ASD) and attention deficit and hyperactivity disorder (ADHD) have increased over the last few decades. These neurodevelopmental disorders are characterized by a complex etiology, which involves multiple genes and gene-environmental interactions. Various genes that control specific properties of neural development exert pivotal roles in the occurrence and severity of phenotypes associated with neurodevelopmental disorders. Moreover, paternal aging has been reported as one of the factors that contribute to the risk of ASD and ADHD. Here we report, for the first time, that paternal aging has profound effects on the onset of behavioral abnormalities in mice carrying a mutation of Pax6, a gene with neurodevelopmental regulatory functions. We adopted an in vitro fertilization approach to restrict the influence of additional factors. Comprehensive behavioral analyses were performed in Sey/+ mice (i.e., Pax6 mutant heterozygotes) born from in vitro fertilization of sperm taken from young or aged Sey/+ fathers. No body weight changes were found in the four groups, i.e., Sey/+ and wild type (WT) mice born to young or aged father. However, we found important differences in maternal separation-induced ultrasonic vocalizations of Sey/+ mice born from young father and in the level of hyperactivity of Sey/+ mice born from aged fathers in the open-field test, respectively, compared to WT littermates. Phenotypes of anxiety were observed in both genotypes born from aged fathers compared with those born from young fathers. No significant difference was found in social behavior and sensorimotor gating among the four groups. These results indicate that mice with a single genetic risk factor can develop different phenotypes depending on the paternal age. Our study advocates for serious considerations on the role of paternal aging in breeding strategies for animal studies.	[Yoshizaki, Kaichi; Kimura, Ryuichi; Osumi, Noriko] Tohoku Univ, Grad Sch Med, Dept Dev Neurosci, Sendai, Miyagi, Japan; [Furuse, Tamio; Kaneda, Hideki; Wakana, Shigeharu] RIKEN BRC, Japan Mouse Clin, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki, Japan; [Tucci, Valter] Ist Italiano Tecnol, Dept Neurosci & Brain Technol, Genoa, Italy	Tohoku University; RIKEN; Istituto Italiano di Tecnologia - IIT	Osumi, N (corresponding author), Tohoku Univ, Grad Sch Med, Dept Dev Neurosci, Sendai, Miyagi, Japan.	osumi@med.tohoku.ac.jp	Furuse, Tamio/I-2163-2019; Osumi, Noriko/T-2823-2019	Furuse, Tamio/0000-0002-9276-6040; Osumi, Noriko/0000-0003-0548-6452; Tucci, Valter/0000-0002-3796-3826	KAKENHI from Ministry of Education, Culture, Sports, Science and Technology of Japan [25640002, 16H06530]; Grants-in-Aid for Scientific Research [26250024] Funding Source: KAKEN	KAKENHI from Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI (25640002 to K.Y. and 16H06530 to N. 0.) from Ministry of Education, Culture, Sports, Science and Technology of Japan.; The authors thank the Japan Mouse Clinic at RIKEN Biological Resource Center, Dr. Ikuko Yamada, Ms. Tomoko Kushida and Ms. Kashimura Misho for production of mice via IVF and their maintenance, Dr. Yosefu Arime for scientific discussion, and Ms. Sayaka Makino for animal care. The authors are also grateful to all members of their laboratory for fruitful discussions. This work was supported in part by KAKENHI (25640002 to K.Y. and 16H06530 to N.O.) from Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Ban HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018455; Bourgeron T, 2015, NAT REV NEUROSCI, V16, P551, DOI 10.1038/nrn3992; Brendgen M, 2006, DEV PSYCHOL, V42, P1299, DOI 10.1037/0012-1649.42.6.1299; Chao YC, 2015, EMBO J, V34, P294, DOI 10.15252/embj.201489652; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; Craig F, 2015, AUTISM RES, V8, P328, DOI 10.1002/aur.1449; D'Onofrio BM, 2014, JAMA PSYCHIAT, V71, P432, DOI 10.1001/jamapsychiatry.2013.4525; Davis LK, 2008, HUM GENET, V123, P371, DOI 10.1007/s00439-008-0484-x; De Rubeis S, 2015, HUM MOL GENET, V24, pR24, DOI 10.1093/hmg/ddv273; Donjacour A, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113134; Dworzynski K, 2009, J AUTISM DEV DISORD, V39, P1197, DOI 10.1007/s10803-009-0736-1; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Feuer SK, 2014, ENDOCRINOLOGY, V155, P1956, DOI 10.1210/en.2013-2081; Foldi CJ, 2010, EUR J NEUROSCI, V31, P556, DOI 10.1111/j.1460-9568.2010.07074.x; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Frans E, 2015, WORLD PSYCHIATRY, V14, P91, DOI 10.1002/wps.20190; Free SL, 2003, NEUROIMAGE, V20, P2281, DOI 10.1016/j.neuroimage.2003.07.001; Georgala PA, 2011, DEV NEUROBIOL, V71, P690, DOI 10.1002/dneu.20895; Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Grzadzinski R, 2011, J AUTISM DEV DISORD, V41, P1178, DOI 10.1007/s10803-010-1135-3; Gurney JG, 2003, ARCH PEDIAT ADOL MED, V157, P622, DOI 10.1001/archpedi.157.7.622; HANSON I, 1995, TRENDS GENET, V11, P268, DOI 10.1016/S0168-9525(00)89073-3; Hinney A, 2011, AM J MED GENET B, V156B, P888, DOI 10.1002/ajmg.b.31246; Hiraoka K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158153; Iijima M, 2005, PHARMACOL BIOCHEM BE, V82, P652, DOI 10.1016/j.pbb.2005.11.005; Kimura R, 2015, J ANAT, V227, P1, DOI 10.1111/joa.12318; Kohda T, 2011, BIOCHEM BIOPH RES CO, V410, P282, DOI 10.1016/j.bbrc.2011.05.133; Kwong WY, 2000, DEVELOPMENT, V127, P4195; Lesch KP, 2008, J NEURAL TRANSM, V115, P1573, DOI 10.1007/s00702-008-0119-3; Lundstrom S, 2010, J CHILD PSYCHOL PSYC, V51, P850, DOI 10.1111/j.1469-7610.2010.02223.x; Maekawa M, 2009, NEUROSCI LETT, V462, P267, DOI 10.1016/j.neulet.2009.07.021; Malaspina D, 2001, ARCH GEN PSYCHIAT, V58, P361, DOI 10.1001/archpsyc.58.4.361; Mick E, 2010, J AM ACAD CHILD PSY, V49, P898, DOI 10.1016/j.jaac.2010.02.014; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P906, DOI 10.1016/j.jaac.2010.06.007; Neale BM, 2008, AM J MED GENET B, V147B, P1337, DOI 10.1002/ajmg.b.30866; Numayama-Tsuruta K, 2006, FUTURE MEDICAL ENGINEERING BASED ON BIONANOTECHNOLOGY, PROCEEDINGS, P151, DOI 10.1142/9781860948800_0017; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Osumi N, 1997, DEVELOPMENT, V124, P2961; Osumi N, 2013, ROLE TRANSCRIPTION F, P43; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Pierce JE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01013; Reichenberg A, 2006, ARCH GEN PSYCHIAT, V63, P1026, DOI 10.1001/archpsyc.63.9.1026; Rexhaj E, 2013, J CLIN INVEST, V123, P5052, DOI 10.1172/JCI68943; Ronald A, 2006, SCIENCE, V311, P952, DOI 10.1126/science.311.5763.952a; Sampino S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.27; Sandin S, 2016, MOL PSYCHIATR, V21, P693, DOI 10.1038/mp.2015.70; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Shinawi M, 2011, AM J MED GENET A, V155A, P1272, DOI 10.1002/ajmg.a.33878; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Simpson TI, 2002, BIOESSAYS, V24, P1041, DOI 10.1002/bies.10174; Sisodiya SM, 2001, NAT GENET, V28, P214, DOI 10.1038/90042; Smith RG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008456; Stergiakouli E, 2012, AM J PSYCHIAT, V169, P186, DOI 10.1176/appi.ajp.2011.11040551; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Tomchek SD, 2007, AM J OCCUP THER, V61, P190, DOI 10.5014/ajot.61.2.190; TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6; Tuoc TC, 2013, DEV CELL, V25, P256, DOI 10.1016/j.devcel.2013.04.005; Tucci V, 2014, J CLIN INVEST, V124, P1468, DOI 10.1172/JCI70372; Tuchman R, 2010, BRAIN DEV-JPN, V32, P709, DOI 10.1016/j.braindev.2010.04.008; Tuoc TC, 2009, J NEUROSCI, V29, P8335, DOI 10.1523/JNEUROSCI.5669-08.2009; Umeda T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015500; van Steensel FJA, 2011, CLIN CHILD FAM PSYCH, V14, P302, DOI 10.1007/s10567-011-0097-0; Weintraub K, 2011, NATURE, V479, P22, DOI 10.1038/479022a; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xu S, 2008, CYTOGENET GENOME RES, V122, P181, DOI 10.1159/000172086; Yamamoto T, 2014, AM J MED GENET A, V164, P634, DOI 10.1002/ajmg.a.36325; Yang L, 2013, AM J MED GENET B, V162B, P419, DOI 10.1002/ajmg.b.32169; Yogarajah M, 2016, ANN CLIN TRANSL NEUR, V3, P314, DOI 10.1002/acn3.297; Ypsilanti AR, 2016, J COMP NEUROL, V524, P609, DOI 10.1002/cne.23866; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2	76	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166665	10.1371/journal.pone.0166665	http://dx.doi.org/10.1371/journal.pone.0166665			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855195	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200043
J	Li, J; Wu, MF; Lu, HW; Zhang, BZ; Wang, LJ; Lin, ZQ				Li, Jing; Wu, Miao-fang; Lu, Huai-wu; Zhang, Bing-zhong; Wang, Li-juan; Lin, Zhong-qiu			Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer	PLOS ONE			English	Article							FASTING BLOOD-GLUCOSE; BREAST-CANCER; DIABETES-MELLITUS; PATHOLOGICAL-RESPONSE; RADICAL HYSTERECTOMY; INSULIN-RECEPTORS; SURVIVAL; PROGNOSIS; CARCINOMA; TRANSPORTERS	Background The impact of hyperglycemia on survival of patients undergoing neoadjuvant chemotherapy (NACT) for bulky early stage cervical cancer (BESCC) has not been explored. Method Records of patients who received NACT and radical hysterectomy in our institution between January 2005 and June 2010 were reviewed. Results In total, 347 patients were included. The median follow-up time was 37 months (range: 4-65). Patients with hyperglycemia (fasting blood glucose >= 100 mg/dl) had shorter recurrence-free survival (RFS) (univariate hazard ratio [HR] = 1.95, 95% confidence interval [CI] [1.16, 3.28], P = 0.010) and cancer-specific survival (CSS) (univariate HR = 2.24, 95% CI [1.33, 3.78], P = 0.002) compared with those with euglycemia (fasting blood glucose < 100 mg/dl). In multivariate analysis, positive surgical margins, parametrium invasion, node metastasis, hyperglycemia and complete response to NACT independently predicted recurrence and cancer-specific death. To further validate the prognostic value of hyperglycemia, we conducted a subgroup analysis based on patient baseline characteristics and prognostic effect of hyperglycemia remained significant in all subgroups. On multivariable logistic regression analysis, euglycemia before NACT, squamous cell tumor and pre-treatment squamous cell carcinoma antigen levels < 3.5ng/ml were identified as independent predictors of complete response after NACT. Conclusions FBG >= 100 mg/dl is a negative prognostic predictor for cervical cancer patients receiving NACT for BESCC. Patients with hyperglycemia are less likely to achieve complete response after NACT. Our findings underscore the clinical utility of hyperglycemia screening of for cervical cancer patients.	[Li, Jing; Wu, Miao-fang; Lu, Huai-wu; Zhang, Bing-zhong; Wang, Li-juan; Lin, Zhong-qiu] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol Oncol, Guangzhou, Guangdong, Peoples R China; [Li, Jing] Sun Yat Sen Univ, Team Based Learning Grp Clin Study, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Wang, LJ; Lin, ZQ (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Gynecol Oncol, Guangzhou, Guangdong, Peoples R China.	wanglijuan_sysu@sina.com; zhongqiu_lin@163.com		Li, Jing/0000-0003-1361-7790; Li, Jing/0000-0002-9609-5846				Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS55, DOI 10.2337/dc08-S055; Anonymous, 2007, Zhonghua Xinxueguanbing Zazhi, V35, P390; Belfiore A, 1996, ANN NY ACAD SCI, V784, P173, DOI 10.1111/j.1749-6632.1996.tb16235.x; Boronow RC, 2000, GYNECOL ONCOL, V78, P313, DOI 10.1006/gyno.2000.5911; Brunello A, 2011, AM J CLIN ONCOL-CANC, V34, P292, DOI 10.1097/COC.0b013e3181e1d0c0; Buda A, 2015, INT J GYNECOL CANCER, V25, P1468, DOI 10.1097/IGC.0000000000000515; Cai Q, 2013, BRIT J CANCER, V108, P380, DOI 10.1038/bjc.2012.566; Choi JI, 2015, GYNECOL ONCOL, V139, P319, DOI 10.1016/j.ygyno.2015.09.004; Chu CK, 2010, ANN SURG ONCOL, V17, P502, DOI 10.1245/s10434-009-0789-6; Coyle C, 2016, ANN ONCOL, V27, P2184, DOI 10.1093/annonc/mdw410; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Erickson K, 2011, J CLIN ONCOL, V29, P54, DOI 10.1200/JCO.2010.29.3183; Frumovitz M, 2005, J CLIN ONCOL, V23, P7428, DOI 10.1200/JCO.2004.00.3996; Gadducci A, 2013, GYNECOL ONCOL, V131, P640, DOI 10.1016/j.ygyno.2013.09.029; Gadducci A, 2016, CRIT REV ONCOL HEMAT, V105, P73, DOI 10.1016/j.critrevonc.2016.06.006; Goodwin PJ, 2002, J CLIN ONCOL, V20, P42, DOI 10.1200/JCO.20.1.42; Goss PE, 2014, LANCET ONCOL, V15, P489, DOI 10.1016/S1470-2045(14)70029-4; HACKER NF, 1995, INT J GYNECOL CANCER, V5, P250, DOI 10.1046/j.1525-1438.1995.05040250.x; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Kiderlen M, 2013, ANN ONCOL, V24, P3011, DOI 10.1093/annonc/mdt367; Koh WJ, 2015, J NATL COMPR CANC NE, V13, P395, DOI 10.6004/jnccn.2015.0055; Kupets R, 2002, GYNECOL ONCOL, V87, P163, DOI 10.1006/gyno.2002.6815; Lamkin DM, 2009, CANCER-AM CANCER SOC, V115, P1021, DOI 10.1002/cncr.24126; Lee YY, 2010, GYNECOL ONCOL, V116, P459, DOI 10.1016/j.ygyno.2009.11.016; Li X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122361; Luo JH, 2012, LUNG CANCER, V76, P242, DOI 10.1016/j.lungcan.2011.10.019; Mathieu MC, 1997, P ASSOC AM PHYSICIAN, V109, P565; Medina RA, 2002, BIOL RES, V35, P9, DOI 10.4067/S0716-97602002000100004; Meyerkardt JA, 2003, J CLIN ONCOL, V21, P433, DOI 10.1200/JCO.2003.07.125; Tieu MT, 2015, J NEURO-ONCOL, V124, P119, DOI 10.1007/s11060-015-1815-0; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Papa V, 1996, J ENDOCRINOL INVEST, V19, P324, DOI 10.1007/BF03347871; Ryu HS, 2007, INT J GYNECOL CANCER, V17, P132, DOI 10.1111/j.1525-1438.2007.00803.x; Ryu TY, 2014, DIABETES METAB J, V38, P330, DOI 10.4093/dmj.2014.38.5.330; Satariano WA, 1992, J GERONTOLOGY, V47; Nomelini RS, 2011, CLIN MED INSIGHTS-ON, V5, P77, DOI 10.4137/CMO.S6916; Sonabend RY, 2009, J PEDIATR-US, V155, P73, DOI 10.1016/j.jpeds.2009.01.072; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Takatori E, 2015, INT J CLIN ONCOL, V20, P345, DOI 10.1007/s10147-014-0702-6; Tseng CH, 2016, ONCOTARGET, DOI 10.18632/oncotarget.8399; Tseng CH, 2015, DIABETES-METAB RES, V31, P619, DOI 10.1002/dmrr.2649; Uma S, 2013, J OBSTET GYN INDIA, V63, P273, DOI 10.1007/s13224-012-0342-6; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ye Q, 2013, J CANCER RES CLIN, V139, P1887, DOI 10.1007/s00432-013-1509-y; Zhao YB, 2012, ASIAN PAC J CANCER P, V13, P1487, DOI 10.7314/APJCP.2012.13.4.1487	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166612	10.1371/journal.pone.0166612	http://dx.doi.org/10.1371/journal.pone.0166612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851819	Green Submitted, gold, Green Published			2022-12-26	WOS:000387909300073
J	Obert, A; Gierski, F; Calmus, A; Flucher, A; Portefaix, C; Pierot, L; Kaladjian, A; Caillies, S				Obert, Alexandre; Gierski, Fabien; Calmus, Arnaud; Flucher, Aurelie; Portefaix, Christophe; Pierot, Laurent; Kaladjian, Arthur; Caillies, Stephanie			Neural Correlates of Contrast and Humor: Processing Common Features of Verbal Irony	PLOS ONE			English	Article							FIGURATIVE LANGUAGE; SEMANTIC AMBIGUITY; COMPREHENSION; BRAIN; FMRI; CONTEXT; SARCASM; REWARD; APPRECIATION; SENTENCES	Irony is a kind of figurative language used by a speaker to say something that contrasts with the context and, to some extent, lends humor to a situation. However, little is known about the brain regions that specifically support the processing of these two common features of irony. The present study had two main aims: (i) investigate the neural basis of irony processing, by delivering short ironic spoken sentences (and their literal counterparts) to participants undergoing fMRI; and (ii) assess the neural effect of two irony parameters, obtained from normative studies: degree of contrast and humor appreciation. Results revealed activation of the bilateral inferior frontal gyrus (IFG), posterior part of the left superior temporal gyrus, medial frontal cortex, and left caudate during irony processing, suggesting the involvement of both semantic and theory-of-mind networks. Parametric models showed that contrast was specifically associated with the activation of bilateral frontal and subcortical areas, and that these regions were also sensitive to humor, as shown by a conjunction analysis. Activation of the bilateral IFG is consistent with the literature on humor processing, and reflects incongruity detection/resolution processes. Moreover, the activation of subcortical structures can be related to the reward processing of social events.	[Obert, Alexandre; Gierski, Fabien; Calmus, Arnaud; Flucher, Aurelie; Kaladjian, Arthur; Caillies, Stephanie] Univ Reims, Lab EA C2S 6291, Reims, France; [Gierski, Fabien; Kaladjian, Arthur] Reims Univ Hosp, Robert Debre Hosp, Dept Psychiat, Reims, France; [Calmus, Arnaud] Reims Univ Hosp, Sebastopol Hosp, Dept Phys Med & Rehabil, Reims, France; [Portefaix, Christophe; Pierot, Laurent] Reims Univ Hosp, Maison Blanche Hosp, Dept Med Imaging, Reims, France; [Portefaix, Christophe] Univ Reims, CReSTIC Lab EA 3804, Reims, France	Universite de Reims Champagne-Ardenne; CHU de Reims; CHU de Reims; CHU de Reims; Universite de Reims Champagne-Ardenne	Obert, A (corresponding author), Univ Reims, Lab EA C2S 6291, Reims, France.	obert.alexandre@gmail.com	Obert, Alexandre/CAG-4685-2022; Obert, Alexandre/F-6284-2012	Obert, Alexandre/0000-0003-3083-3591; GIERSKI, Fabien/0000-0001-9168-2024				Akimoto Y, 2014, HUM BRAIN MAPP, V35, P1167, DOI 10.1002/hbm.22242; Attardo S, 2003, HUMOR, V16, P243, DOI 10.1515/humr.2003.012; Attardo S, 2002, HUMOR IRONY INTERACT, P165; Bartolo A, 2006, J COGNITIVE NEUROSCI, V18, P1789, DOI 10.1162/jocn.2006.18.11.1789; Bekinschtein TA, 2011, J NEUROSCI, V31, P9665, DOI 10.1523/JNEUROSCI.5058-10.2011; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Bryant GA, 2002, METAPHOR SYMBOL, V17, P99, DOI 10.1207/S15327868MS1702_2; Buchel C, CHARACTERIZING STIMU; Calmus A, 2014, INT J PSYCHOL, V49, P46, DOI 10.1002/ijop.12003; Chan YC, 2012, NEUROIMAGE, V61, P899, DOI 10.1016/j.neuroimage.2012.03.052; Colston HL, 2000, DISCOURSE PROCESS, V30, P179, DOI 10.1207/S15326950DP3002_05; Colston HL, 2000, J PRAGMATICS, V32, P1557, DOI 10.1016/S0378-2166(99)00110-1; DEWS S, 1995, DISCOURSE PROCESS, V19, P347, DOI 10.1080/01638539509544922; Eviatar Z, 2006, NEUROPSYCHOLOGIA, V44, P2348, DOI 10.1016/j.neuropsychologia.2006.05.007; Franklin RG, 2011, COGN AFFECT BEHAV NE, V11, P508, DOI 10.3758/s13415-011-0049-7; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Fruehholz S, 2013, NEUROSCI BIOBEHAV R, V37, P2847, DOI 10.1016/j.neubiorev.2013.10.007; Gardner H, 1975, COMPREHENSION APPREC; Gerrig RJ., 2000, METAPHOR SYMBOL, V15, P197, DOI [10.1207/S15327868MS1504_1, DOI 10.1207/S15327868MS1504_1]; Gibbs Raymond W., 1994, POETICS MIND FIGURAT; Ivanko SL, 2003, DISCOURSE PROCESS, V35, P241, DOI 10.1207/S15326950DP3503_2; Ketteler D, 2008, NEUROIMAGE, V39, P2002, DOI 10.1016/j.neuroimage.2007.10.023; Kim SI, 2012, J PSYCHOLINGUIST RES, V41, P311, DOI 10.1007/s10936-011-9185-z; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Leggitt JS, 2010, DISCOURSE PROCESS, V29, P37; Lerner Y, 2011, J NEUROSCI, V31, P2906, DOI 10.1523/JNEUROSCI.3684-10.2011; Matsui T, 2016, NEUROPSYCHOLOGIA, V87, P74, DOI 10.1016/j.neuropsychologia.2016.04.031; Mobbs D, 2003, NEURON, V40, P1041, DOI 10.1016/S0896-6273(03)00751-7; Moran JM, 2004, NEUROIMAGE, V21, P1055, DOI 10.1016/j.neuroimage.2003.10.017; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rapp AM, 2010, BRAIN LANG, V113, P1, DOI 10.1016/j.bandl.2009.11.007; Rapp AM, 2012, NEUROIMAGE, V63, P600, DOI 10.1016/j.neuroimage.2012.06.022; Redcay E, 2008, NEUROSCI BIOBEHAV R, V32, P123, DOI 10.1016/j.neubiorev.2007.06.004; ROBERTS RM, 1994, PSYCHOL SCI, V5, P159, DOI 10.1111/j.1467-9280.1994.tb00653.x; Rodd JM, 2010, BRAIN LANG, V115, P182, DOI 10.1016/j.bandl.2010.07.005; Samson AC, 2008, SOC NEUROSCI-UK, V3, P125, DOI 10.1080/17470910701745858; Samson AC, 2009, NEUROPSYCHOLOGIA, V47, P1023, DOI 10.1016/j.neuropsychologia.2008.10.028; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Shibata M, 2010, BRAIN RES, V1308, P114, DOI 10.1016/j.brainres.2009.10.030; Spotorno N, 2012, NEUROIMAGE, V63, P25, DOI 10.1016/j.neuroimage.2012.06.046; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uchiyama H, 2006, BRAIN RES, V1124, P100, DOI 10.1016/j.brainres.2006.09.088; Uchiyama HT, 2012, CORTEX, V48, P563, DOI 10.1016/j.cortex.2011.01.004; Varga E, 2013, BRAIN LANG, V126, P231, DOI 10.1016/j.bandl.2013.05.017; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Vrticka P, 2013, NAT REV NEUROSCI, V14, P860, DOI 10.1038/nrn3566; Wang AT, 2006, SOC COGN AFFECT NEUR, V1, P107, DOI 10.1093/scan/nsl018; Wang AT, 2006, BRAIN, V129, P932, DOI 10.1093/brain/awl032; Watson KK, 2007, CEREB CORTEX, V17, P314, DOI 10.1093/cercor/bhj149; WYER RS, 1992, PSYCHOL REV, V99, P663, DOI 10.1037/0033-295X.99.4.663; Ye Z, 2014, HUM BRAIN MAPP, V35, P367, DOI 10.1002/hbm.22182; Zhu ZD, 2009, NEUROIMAGE, V47, P756, DOI 10.1016/j.neuroimage.2009.04.086	55	10	10	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166704	10.1371/journal.pone.0166704	http://dx.doi.org/10.1371/journal.pone.0166704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851821	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300078
J	Ericsson, AC; Johnson, PJ; Lopes, MA; Perry, SC; Lanter, HR				Ericsson, Aaron C.; Johnson, Philip J.; Lopes, Marco A.; Perry, Sonja C.; Lanter, Hannah R.			A Microbiological Map of the Healthy Equine Gastrointestinal Tract	PLOS ONE			English	Article							RISK-FACTORS; HORSES; MICROBIOTA; DIETARY; CONCENTRATE; MICROFLORA; DIVERSITY; PATTERNS	Horses are exquisitely sensitive to non-specific gastrointestinal disturbances as well as systemic and extraintestinal conditions related to gut health, yet minimal data are available regarding the composition of the microbiota present in the equine stomach, small intestine, and cecum and their relation to fecal microbiota. Moreover, there is minimal information regarding the concordance of the luminal and mucosal microbial communities throughout the equine gut. Illumina-based 16S rRNA gene amplicon sequencing of the luminal and mucosal microbiota present in seven regions of the gastrointestinal tract of nine healthy adult horses revealed a distinct compositional divide between the small and large intestines. This disparity in composition was more pronounced within the luminal contents, but was also detected within mucosal populations. Moreover, the uniformity of the gut microbiota was much higher in the cecum and colon relative to that in the stomach, jejunum and ileum, despite a significantly higher number of unique sequences detected in the colon. Collectively, the current data suggest that while colonic samples (a proxy for feces) may provide a reasonable profile of the luminal contents of the healthy equine large intestine, they are not informative with regard to the contents of the stomach or small intestine. In contrast to the distinct difference between the highly variable upper gastrointestinal tract microbiota and relatively uniform large bowel microbiota present within the lumen, these data also demonstrate a regional continuity present in mucosal microbial communities throughout the length of the equine gut.	[Ericsson, Aaron C.] Univ Missouri, Metagen Ctr, Dept Vet Pathobiol, 4011 Discovery Dr, Columbia, MO 65201 USA; [Ericsson, Aaron C.; Johnson, Philip J.; Lopes, Marco A.; Perry, Sonja C.; Lanter, Hannah R.] Univ Missouri, Coll Vet Med, 1600 Rollins Rd, Columbia, MO 65211 USA; [Johnson, Philip J.; Lopes, Marco A.] Univ Missouri, Dept Vet Med & Surg, 1600 Rollins Rd, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Ericsson, AC (corresponding author), Univ Missouri, Metagen Ctr, Dept Vet Pathobiol, 4011 Discovery Dr, Columbia, MO 65201 USA.; Ericsson, AC (corresponding author), Univ Missouri, Coll Vet Med, 1600 Rollins Rd, Columbia, MO 65211 USA.	ericssona@missouri.edu	Ericsson, Aaron C./AAJ-1406-2021; Lopes, Marco/AEN-2677-2022	Ericsson, Aaron C./0000-0002-3053-7269; Lopes, Marco/0000-0003-4901-9733	USDA National Institute of Food and Agriculture, Animal Health project [1005882]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K01OD019924] Funding Source: NIH RePORTER	USDA National Institute of Food and Agriculture, Animal Health project; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported by the USDA National Institute of Food and Agriculture, Animal Health project 1005882 (ACE) and internal funding for Clinician Scientists at the University of Missouri College of Veterinary Medicine (PJJ).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Cohen ND, 1999, J AM VET MED ASSOC, V215, P53; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Costa MC, 2015, VET J, V205, P74, DOI 10.1016/j.tvjl.2015.03.018; Costa MC, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0335-7; Costa MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041484; de Fombelle A, 2003, ANIM SCI, V77, P293; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dougal K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077660; Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Hammer O., PAST 3 X 2016; Hart ML, 2015, PLOS ONE INPRESS; Hillyer MH, 2001, EQUINE VET J, V33, P380, DOI 10.2746/042516401776249499; Kaneene JB, 1997, PREV VET MED, V30, P23, DOI 10.1016/S0167-5877(96)01102-6; Kuczynski Justin, 2012, Curr Protoc Microbiol, VChapter 1, DOI [10.1002/0471250953.bi1007s36, 10.1002/9780471729259.mc01e05s27]; MACKIE RI, 1988, APPL ENVIRON MICROB, V54, P2155, DOI 10.1128/AEM.54.9.2155-2160.1988; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Milinovich GJ, 2007, ENVIRON MICROBIOL, V9, P2090, DOI 10.1111/j.1462-2920.2007.01327.x; O' Donnell MM, 2013, LETT APPL MICROBIOL, V57, P492, DOI 10.1111/lam.12137; Perkins GA, 2012, APPL ENVIRON MICROB, V78, P2522, DOI 10.1128/AEM.06252-11; Respondek F, 2011, J ANIM SCI, V89, P77, DOI 10.2527/jas.2010-3108; Schoster A., 2015, EQUINE VET J; Shepherd ML, 2012, FEMS MICROBIOL LETT, V326, P62, DOI 10.1111/j.1574-6968.2011.02434.x; Steelman SM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-231; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; Tsugawa H., 2016, PLATFORM RIKEN METAB; Van Weyenberg S, 2006, LIVEST SCI, V99, P3, DOI 10.1016/j.livprodsci.2005.04.008; Varloud M, 2007, J ANIM SCI, V85, P2508, DOI 10.2527/jas.2006-182; Weese JS, 2015, EQUINE VET J, V47, P641, DOI 10.1111/evj.12361; Willing B, 2009, EQUINE VET J, V41, P908, DOI 10.2746/042516409X447806; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yuki N, 2000, APPL ENVIRON MICROB, V66, P5030, DOI 10.1128/AEM.66.11.5030-5034.2000; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	39	62	65	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166523	10.1371/journal.pone.0166523	http://dx.doi.org/10.1371/journal.pone.0166523			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846295	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600075
J	Wang, JQ; Fei, XC; Wu, WZ; Chen, XH; Su, LP; Zhu, ZG; Zhou, YY				Wang, Junqing; Fei, Xiaochun; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang; Zhou, Yunyun			SLC7A5 Functions as a Downstream Target Modulated by CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; EXPRESSION; LAT1; CARCINOMA; PROLIFERATION; MIR-126; GROWTH	SLC7A5, who is also named LAT-1, has been validated as a promoter regulated by miRNA-126 in our previous research for gastric cancer cells. However, the mechanisms driving SLC7A5 to affect the bio-function of gastric cancer cells are unclear, remaining us lots of to elucidate. The aim of this study is to investigate the regulating effect of CRKL, one of the critical genes involving with gastric cancer progression, on SLC7A5 expression. By studying the gastric cancer cell lines and clinical pathological specimens, we found that the expression of SLC7A5 was significantly correlated to CRKL. By depleting CRKL in gastric cancer SGC-7901 cells, the SLC7A5 expression was impaired, and the invasion and migration of SGC-7901 cells were suppressed. Ectopic expression of SLC7A5 could drastically rescue the phenotypes induced by CRKL depletion in this study. Accordingly, we conclude that SLC7A5 functions as a promoter in gastric cancer metastasis, and CRKL could be one of its regulators modulating the expression of SLC7A5 and consequentially affect the metastatic feature of SGC-7901 cells. The findings in this study indicate a regulation relationship between CRKL and SLC7A5, and provide useful evidence for gastric cancer therapeutic strategies.	[Wang, Junqing; Wu, Weize; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Surg, Sch Med, Shanghai, Peoples R China; [Wang, Junqing; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China; [Wang, Junqing; Wu, Weize; Chen, Xuehua; Su, Liping; Zhu, Zhenggang] Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Sch Med, Shanghai, Peoples R China; [Fei, Xiaochun] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Zhou, Yunyun] Univ Mississippi, Med Ctr, Dept Data Sci, Jackson, MS 39216 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Mississippi; University of Mississippi Medical Center	Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Surg, Sch Med, Shanghai, Peoples R China.; Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Gastr Neoplasms, Sch Med, Shanghai, Peoples R China.; Wang, JQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Digest Surg, Ruijin Hosp, Sch Med, Shanghai, Peoples R China.; Zhou, YY (corresponding author), Univ Mississippi, Med Ctr, Dept Data Sci, Jackson, MS 39216 USA.	wangjunqingmd@hotmail.com; zhouyy666041@126.com		/0000-0001-6874-9614	National Natural Science Foundation of China [81602544, 81372187]; Techpool Fund commercial in China [UF201401]; Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Techpool Fund commercial in China; Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai	This study was kindly supported by grants from the following: National Natural Science Foundation of China (No. 81602544, No. 81372187), Techpool Fund commercial in China (No. UF201401), and Liu Haoqing Foundation for Medicine, Ruijin Hospital Shanghai.	[Anonymous], 2011, ANN SURG ONCOL, V18, P1060, DOI [10.1245/s10434-010-1424-2, DOI 10.1245/S10434-010-1424-2]; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Cheng SM, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0494-1; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Dolgodilina E, 2016, J CEREBR BLOOD F MET, V36, P1929, DOI 10.1177/0271678X15609331; Elorza A, 2012, MOL CELL, V48, P681, DOI 10.1016/j.molcel.2012.09.017; Furuya M, 2012, NIHON RINSHO S7, V70, P443; Galluccio M, 2013, PROTEIN J, V32, P442, DOI 10.1007/s10930-013-9503-4; Ghosh A, 2016, INT J CANCER, V138, P2732, DOI 10.1002/ijc.29999; Habermeier A, 2015, AMINO ACIDS, V47, P335, DOI 10.1007/s00726-014-1863-3; Huang YP, 2015, J CLIN INVEST, V125, P1019, DOI 10.1172/JCI77278; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Li Nan, 2013, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V38, P809, DOI 10.3969/j.issn.1672-7347.2013.08.009; Lindskog C, 2015, EXPERT REV MOL DIAGN, V15, P471, DOI 10.1586/14737159.2015.1002772; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Napolitano L, 2015, INT J BIOCHEM CELL B, V67, P25, DOI 10.1016/j.biocel.2015.08.004; Panigrahi S, 2012, PLOS ONE, V7, P6, DOI 10.1371/journal.pone.0028395; Patel M, 2013, INT J PHARMACEUT, V443, P245, DOI 10.1016/j.ijpharm.2012.12.029; Rosilio C, 2015, LEUKEMIA, V29, P1253, DOI 10.1038/leu.2014.338; Russo F, 2014, WORLD J GASTROENTERO, V20, P13258, DOI 10.3748/wjg.v20.i37.13258; Singer CF, 2006, ONCOL REP, V15, P353; Ungewiss C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18652; Wang JQ, 2013, CHEM-BIOL INTERACT, V206, P230, DOI 10.1016/j.cbi.2013.09.003; Wang JQ, 2013, BIOMED PHARMACOTHER, V67, P693, DOI 10.1016/j.biopha.2013.05.003; Wang W, COMP UICC TNM STAGIN; Xie XL, 2013, FOOD CHEM TOXICOL, V59, P137, DOI 10.1016/j.fct.2013.05.044; Xu MH, 2016, J UROLOGY, V195, P1588, DOI 10.1016/j.juro.2015.11.071; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4	29	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166147	10.1371/journal.pone.0166147	http://dx.doi.org/10.1371/journal.pone.0166147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846244	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600034
J	Fallah, Z; Jamali, Y; Rafii-Tabar, H				Fallah, Zohreh; Jamali, Yousef; Rafii-Tabar, Hashem			Structural and Functional Effect of an Oscillating Electric Field on the Dopamine-D3 Receptor: A Molecular Dynamics Simulation Study	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; D-3 RECEPTORS; HEPTAHELICAL RECEPTORS; THERAPEUTIC AGENTS; MEMBRANE-PROTEINS; D3 RECEPTOR; IONIC LOCK	Dopamine as a neurotransmitter plays a critical role in the functioning of the central nervous system. The structure of D3 receptor as a member of class A G-protein coupled receptors (GPCRs) has been reported. We used MD simulation to investigate the effect of an oscillating electric field, with frequencies in the range 0.6-800 GHz applied along the z-direction, on the dopamine-D3R complex. The simulations showed that at some frequencies, the application of an external oscillating electric field along the z-direction has a considerable effect on the dopamine-D3R. However, there is no enough evidence for prediction of changes in specific frequency, implying that there is no order in changes. Computing the correlation coefficient parameter showed that increasing the field frequency can weaken the interaction between dopamine and D3R and may decrease the Arg128{3.50}-Glu324{6.30} distance. Because of high stability of a helices along the z-direction, applying an oscillating electric field in this direction with an amplitude 10-time higher did not have a considerable effect. However, applying the oscillating field at the frequency of 0.6 GHz along other directions, such as X-Y and Y-Z planes, could change the energy between the dopamine and the D3R, and the number of internal hydrogen bonds of the protein. This can be due to the effect of the direction of the electric field vis-a-vis the ligands orientation and the interaction of the oscillating electric field with the dipole moment of the protein.	[Fallah, Zohreh; Jamali, Yousef] Inst Res Fundamental Sci IPM, Sch Nanosci, Tehran, Iran; [Jamali, Yousef] Tarbiat Modares Univ, Dept Math, Tehran, Iran; [Rafii-Tabar, Hashem] Shahid Beheshti Univ Med Sci, Dept Med Phys & Biomed Engn, Fac Med, Tehran, Iran	Tarbiat Modares University; Shahid Beheshti University Medical Sciences	Rafii-Tabar, H (corresponding author), Shahid Beheshti Univ Med Sci, Dept Med Phys & Biomed Engn, Fac Med, Tehran, Iran.	rafii-tabar@nano.ipm.ac.ir	Jamali, Yousef/V-5156-2019	Jamali, Yousef/0000-0002-5709-3821				Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Boeckler F, 2005, J MED CHEM, V48, P694, DOI 10.1021/jm049612a; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Cho DI, 2010, ARCH PHARM RES, V33, P1521, DOI 10.1007/s12272-010-1005-8; CIVELLI O, 1991, EUR J PHARM-MOLEC PH, V207, P277, DOI 10.1016/0922-4106(91)90001-X; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Dror RO, 2009, P NATL ACAD SCI USA, V106, P4689, DOI 10.1073/pnas.0811065106; Feng ZW, 2012, J MOL MODEL, V18, P5051, DOI 10.1007/s00894-012-1509-x; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Garate JA, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3529428; Grossfield A, 2007, PROTEINS, V67, P31, DOI 10.1002/prot.21308; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hall DA, 1999, BIOCHEM PHARMACOL, V58, P285, DOI 10.1016/S0006-2952(99)00101-X; Heidbreder CA, 2005, BRAIN RES REV, V49, P77, DOI 10.1016/j.brainresrev.2004.12.033; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Isberg V, 2011, J CHEM INF MODEL, V51, P315, DOI 10.1021/ci100402f; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Joyce JN, 2005, DRUG DISCOV TODAY, V10, P917, DOI 10.1016/S1359-6446(05)03491-4; Jurkiewicz P, 2012, BBA-BIOMEMBRANES, V1818, P609, DOI 10.1016/j.bbamem.2011.11.033; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lefkowitz RJ, 2000, NAT CELL BIOL, V2, pE133, DOI 10.1038/35017152; Levant B, 1997, PHARMACOL REV, V49, P231; Lindahl E, 2008, CURR OPIN STRUC BIOL, V18, P425, DOI 10.1016/j.sbi.2008.02.003; Lohrasebi A, 2012, PHYS MEDICA, V28, P221, DOI 10.1016/j.ejmp.2011.07.004; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Newman AH, 2005, J MED CHEM, V48, P3663, DOI 10.1021/jm040190e; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ortega R, 2009, BIOORG MED CHEM LETT, V19, P1773, DOI 10.1016/j.bmcl.2009.01.067; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Plesnar E, 2012, BBA-BIOMEMBRANES, V1818, P520, DOI 10.1016/j.bbamem.2011.10.023; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sajadi M, 2014, MOL SIMULAT, V40, P399, DOI 10.1080/08927022.2013.812789; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; SOKOLOFF P, 1992, EUR J PHARM-MOLEC PH, V225, P331, DOI 10.1016/0922-4106(92)90107-7; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Tate CG, 2009, CURR OPIN STRUC BIOL, V19, P386, DOI 10.1016/j.sbi.2009.07.004; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793; Zoete V, 2011, J COMPUT CHEM, V32, P2359, DOI 10.1002/jcc.21816	59	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166412	10.1371/journal.pone.0166412	http://dx.doi.org/10.1371/journal.pone.0166412			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832207	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000122
J	Ge, BB; Liu, BH; Nwet, TT; Zhao, WJ; Shi, LM; Zhang, KC				Ge, Beibei; Liu, Binghua; Thinn Thinn Nwet; Zhao, Wenjun; Shi, Liming; Zhang, Kecheng			Bacillus methylotrophicus Strain NKG-1, Isolated from Changbai Mountain, China, Has Potential Applications as a Biofertilizer or Biocontrol Agent	PLOS ONE			English	Article							PLANT-GROWTH PROMOTION; BIOLOGICAL-CONTROL; SUBTILIS; BIOSURFACTANT; LIPOPEPTIDES; BACTERIUM; DISEASE; ACID	Chemical pesticides are widely used in agriculture, which endangers both environmental health and food safety. Biocontrol is an environmentally-friendly and cost-effective green technique in environmental protection and agricultural production; it generally uses selected bioresources, including beneficial microorganisms. We isolated a novel bacterial strain (NKG-1) from the rare dormant volcanic soils of Changbai Mountain in China's Jilin Province. The strain was identified as Bacillus methylotrophicus using morphological, biochemical, physiological, and phylogenetic 16S rDNA sequencing data. This strain was able to suppress mycelial growth and conidial germination of numerous plant pathogenic fungi on solid media. A greenhouse experiment showed that application of NKG-1 fermentation broth prior to inoculation of Botrytis cinerea, the cause of gray tomato mold, inhibited growth of the mold by 60%. Furthermore, application of a 100x dilution of NKG-1 fermentation broth to tomato seedlings yielded a significant increase in seedling fresh weight (27.4%), seedling length (12.5%), and root length (57.7%) compared to the control. When the same dosage was applied in the field, we observed increases in tomato plant height (14.7%), stem diameter (12.7%), crown width (16.3%), and maximum fruit diameter (11.5%). These results suggest that NKG-1 has potential commercial application as a biofertilizer or biocontrol agent.	[Ge, Beibei; Liu, Binghua; Zhao, Wenjun; Shi, Liming; Zhang, Kecheng] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Thinn Thinn Nwet] Kyaukse Technol Univ, Dept Biotechnol, Kyaukse, Mandalay, Myanmar	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Zhang, KC (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	zhangkecheng@sina.com			National Natural Science Foundation [31401796, 31371985]; Special Fund for Agro-Scientific Research in the Public Interest in China [201303025]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-Scientific Research in the Public Interest in China	This work was supported by grants from the National Natural Science Foundation (31401796, 31371985) and the Special Fund for Agro-Scientific Research in the Public Interest in China (201303025).	Abdallah RAB, 2006, BIOL CONTROL, V97, P80; Almoneafy A. A., 2012, African Journal of Biotechnology, V11, P7193; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Cavaglieri L, 2005, RES MICROBIOL, V156, P748, DOI 10.1016/j.resmic.2005.03.001; Chandankere R, 2013, BIOCHEM ENG J, V74, P46, DOI 10.1016/j.bej.2013.02.018; Chaves JQ, 2011, INT J FOOD MICROBIOL, V147, P12, DOI 10.1016/j.ijfoodmicro.2011.02.029; Choi O, 2008, PLANT PHYSIOL, V146, P657, DOI 10.1104/pp.107.112748; De Cal A, 2009, BIOL CONTROL, V46, P267; FERREIRA JHS, 1991, PHYTOPATHOLOGY, V81, P283, DOI 10.1094/Phyto-81-283; Garrity G.M., 2004, BERGEYS MANUAL SYSTE; GEISSBUHLER H, 1982, SCIENCE, V217, P505, DOI 10.1126/science.217.4559.505; Goudjal Y, 2014, MICROBIOL RES, V169, P59, DOI 10.1016/j.micres.2013.06.014; Huang XQ, 2012, MICROBIOL RES, V167, P135, DOI 10.1016/j.micres.2011.06.002; Joshi S, 2008, BIORESOURCE TECHNOL, V99, P4603, DOI 10.1016/j.biortech.2007.07.030; Koumoutsi A, 2004, J BACTERIOL, V186, P1084, DOI 10.1128/JB.186.4.1084-1096.2004; Lee JP, 2006, BIOL CONTROL, V37, P329, DOI 10.1016/j.biocontrol.2006.01.001; Leelasuphakul W, 2008, POSTHARVEST BIOL TEC, V48, P113, DOI 10.1016/j.postharvbio.2007.09.024; Ling N, 2010, BIOCONTROL, V55, P673, DOI 10.1007/s10526-010-9290-1; Liu B, 2010, PESTIC BIOCHEM PHYS, V98, P305, DOI 10.1016/j.pestbp.2010.07.001; Lucy M, 2004, ANTON LEEUW INT J G, V86, P25; Ma Y, 2008, BIOL CONTROL, V44, P24, DOI 10.1016/j.biocontrol.2007.10.005; Mehta P, 2014, ACTA PHYSIOL PLANT, V36, P2033, DOI 10.1007/s11738-014-1581-1; Meschke H, 2010, MICROB BIOTECHNOL, V3, P428, DOI 10.1111/j.1751-7915.2010.00165.x; Montealegre JR, 2003, ELECTRON J BIOTECHN, V6, P115, DOI 10.2225/vol6-issue2-fulltext-8; Muslim A., 2003, Mycoscience, V44, P77, DOI 10.1007/s10267-002-0084-x; Naureen Z, 2009, CROP PROT, V28, P1052, DOI 10.1016/j.cropro.2009.08.007; Nielsen MN, 1998, APPL ENVIRON MICROB, V64, P3563; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Sadeghi A., 2006, Pakistan Journal of Biological Sciences, V9, P904, DOI 10.3923/pjbs.2006.904.910; Shan HY, 2013, CROP PROT, V44, P29, DOI 10.1016/j.cropro.2012.10.012; Smibert Robert M., 1994, P607; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tindall BJ., 2007, METHODS GEN MOL MICR, V3, P330, DOI DOI 10.1128/9781555817497.CH15; Toure Y, 2004, J APPL MICROBIOL, V96, P1151, DOI 10.1111/j.1365-2672.2004.02252.x; Xue QY, 2009, BIOL CONTROL, V48, P252, DOI 10.1016/j.biocontrol.2008.11.004; Zhang QL, 2012, BIORESOURCE TECHNOL, V108, P35, DOI 10.1016/j.biortech.2011.12.139; Zhang Y, 2015, PLANT SOIL, V392, P309, DOI 10.1007/s11104-015-2464-y; Zhao QY, 2013, BIOCONTROL, V58, P283, DOI 10.1007/s10526-012-9496-5; Zou CS, 2010, J MICROBIOL, V48, P460, DOI 10.1007/s12275-010-0068-z	40	21	32	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166079	10.1371/journal.pone.0166079	http://dx.doi.org/10.1371/journal.pone.0166079			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832162	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000062
J	Gupta, S; Chaudhary, K; Dhanda, SK; Kumar, R; Kumar, S; Sehgal, M; Nagpal, G; Raghava, GPS				Gupta, Sudheer; Chaudhary, Kumardeep; Dhanda, Sandeep Kumar; Kumar, Rahul; Kumar, Shailesh; Sehgal, Manika; Nagpal, Gandharva; Raghava, Gajendra P. S.			A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer	PLOS ONE			English	Article							T-CELL EPITOPES; IN-SILICO PREDICTION; HLA-DR; C-KIT; IDENTIFICATION; PEPTIDES; ANTIGENS; MELANOMA; LIGANDS; MOUSE	Due to advancement in sequencing technology, genomes of thousands of cancer tissues or cell-lines have been sequenced. Identification of cancer-specific epitopes or neoepitopes from cancer genomes is one of the major challenges in the field of immunotherapy or vaccine development. This paper describes a platform Cancertope, developed for designing genome-based immunotherapy or vaccine against a cancer cell. Broadly, the integrated resources on this platform are apportioned into three precise sections. First section explains a cancer-specific database of neoepitopes generated from genome of 905 cancer cell lines. This database harbors wide range of epitopes (e.g., B-cell, CD8(+) T-cell, HLA class I, HLA class II) against 60 cancer-specific vaccine antigens. Second section describes a partially personalized module developed for predicting potential neoepitopes against a user-specific cancer genome. Finally, we describe a fully personalized module developed for identification of neoepitopes from genomes of cancerous and healthy cells of a cancer-patient. In order to assist the scientific community, wide range of tools are incorporated in this platform that includes screening of epitopes against human reference proteome (http://vvvvw.imtech. res.inkaghavaibancertope/).	[Gupta, Sudheer; Chaudhary, Kumardeep; Dhanda, Sandeep Kumar; Kumar, Rahul; Kumar, Shailesh; Sehgal, Manika; Nagpal, Gandharva; Raghava, Gajendra P. S.] CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), CSIR Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India.	raghava@imtech.res.in	Dhanda, Sandeep Kumar/J-8471-2016; Kumar, Rahul/ABB-3530-2020; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; kumar, rahul/GZG-2171-2022; Chaudhary, Kumardeep/Q-9740-2018	Dhanda, Sandeep Kumar/0000-0003-1381-7434; Raghava, Gajendra P.S./0000-0002-8902-2876; Chaudhary, Kumardeep/0000-0002-4117-6403; Kumar, Rahul/0000-0002-6927-5390; Gupta, Sudheer/0000-0002-6836-6696; Kumar, Shailesh/0000-0002-1872-9903	project Open Source Drug Discovery (OSDD); GENESIS [BSC0121]	project Open Source Drug Discovery (OSDD); GENESIS	Authors are thankful to project Open Source Drug Discovery (OSDD) and GENESIS BSC0121.	Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Ashman LK, 2013, EXPERT OPIN INV DRUG, V22, P103, DOI 10.1517/13543784.2013.740010; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bergot Anne-Sophie, 2011, Cancers (Basel), V3, P3461, DOI 10.3390/cancers3033461; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bodey B, 2000, ANTICANCER RES, V20, P2665; Brossart P, 1999, BLOOD, V93, P4309, DOI 10.1182/blood.V93.12.4309.412k19_4309_4317; Brown SD, 2014, GENOME RES, V24, P743, DOI 10.1101/gr.165985.113; Cai A, 2012, CLIN CANCER RES, V18, P5761, DOI 10.1158/1078-0432.CCR-12-1182; Castle JC, 2012, CANCER RES, V72, P1081, DOI 10.1158/0008-5472.CAN-11-3722; Dhanda SK, 2016, BRIEF BIOINFORM; Emens LA, 2008, EXPERT OPIN EMERG DR, V13, P295, DOI [10.1517/14728214.13.2.295, 10.1517/14728214.13.2.295 ]; Fidler IJ, 2012, HUM VACC IMMUNOTHER, V8, P1141, DOI 10.4161/hv.19643; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Fisk B, 1997, INT J ONCOL, V10, P159; Igney FH, 2002, J LEUKOCYTE BIOL, V71, P907; Karosiene E, 2013, IMMUNOGENETICS, V65, P711, DOI 10.1007/s00251-013-0720-y; Kato M, 2004, CANCER RES, V64, P801, DOI 10.1158/0008-5472.CAN-03-2532; Khalili JS, 2012, ONCOIMMUNOLOGY, V1, P1281, DOI 10.4161/onci.21511; Kringelum JV, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002829; Kwak LW, 2011, CANCER PREV RES, V4, P954, DOI 10.1158/1940-6207.CAPR-11-0236; Lata Sneh, 2009, BMC Res Notes, V2, P61, DOI 10.1186/1756-0500-2-61; Li J, 2010, HUM MUTAT, V31, P219, DOI 10.1002/humu.21176; Lin HH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S12-S22; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Morrow MP, 2013, EXPERT REV VACCINES, V12, P271, DOI [10.1586/ERV.13.23, 10.1586/erv.13.23]; Mustafa AS, 2011, CLIN VACCINE IMMUNOL, V18, P1752, DOI 10.1128/CVI.05260-11; Mustafa AS, 2006, TUBERCULOSIS, V86, P115, DOI 10.1016/j.tube.2005.05.001; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Roider J, 2014, IMMUNOLOGY, V143, P193, DOI 10.1111/imm.12301; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Saha Sudipto, 2007, V409, P387, DOI 10.1007/978-1-60327-118-9_29; Schirle M, 2000, EUR J IMMUNOL, V30, P2216, DOI 10.1002/1521-4141(2000)30:18<2216::AID-IMMU2216>3.3.CO;2-F; Schuler Mathias M., 2007, V409, P75; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Somasundaram R, 2006, CANCER RES, V66, P3287, DOI 10.1158/0008-5472.CAN-05-1932; Sweredoski MJ, 2009, PROTEIN ENG DES SEL, V22, P113, DOI 10.1093/protein/gzn075; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Warren RL, 2010, HUM IMMUNOL, V71, P245, DOI 10.1016/j.humimm.2009.12.007; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078389; Zhang LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030483; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166372	10.1371/journal.pone.0166372	http://dx.doi.org/10.1371/journal.pone.0166372			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832200	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000113
J	Janssens, W; Goedecke, J; de Bree, GJ; Aderibigbe, SA; Akande, TM; Mesnard, A				Janssens, Wendy; Goedecke, Jann; de Bree, Godelieve J.; Aderibigbe, Sunday A.; Akande, Tanimola M.; Mesnard, Alice			The Financial Burden of Non-Communicable Chronic Diseases in Rural Nigeria: Wealth and Gender Heterogeneity in Health Care Utilization and Health Expenditures	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; CHOICE; PROVIDER; INDIA; DISTANCE; SEEKING; AFRICA; ACCESS	Objectives Better insights into health care utilization and out-of-pocket expenditures for non-communicable chronic diseases (NCCD) are needed to develop accessible health care and limit the increasing financial burden of NCCDs in Sub-Saharan Africa. Methods A household survey was conducted in rural Kwara State, Nigeria, among 5,761 individuals. Data were obtained using biomedical and socio-economic questionnaires. Health care utilization, NCCD-related health expenditures and distances to health care providers were compared by sex and by wealth quintile, and a Heckman regression model was used to estimate health expenditures taking selection bias in health care utilization into account. Results The prevalence of NCCDs in our sample was 6.2%. NCCD-affected individuals from the wealthiest quintile utilized formal health care nearly twice as often as those from the lowest quintile (87.8% vs 46.2%, p = 0.002). Women reported foregone formal care more often than men (43.5% vs. 27.0%, p = 0.058). Health expenditures relative to annual consumption of the poorest quintile exceeded those of the highest quintile 2.2-fold, and the poorest quintile exhibited a higher rate of catastrophic health spending (10.8% among NCCD-affected households) than the three upper quintiles (4.2% to 6.7%). Long travel distances to the nearest provider, highest for the poorest quintile, were a significant deterrent to seeking care. Using distance to the nearest facility as instrument to account for selection into health care utilization, we estimated out-of-pocket health care expenditures for NCCDs to be significantly higher in the lowest wealth quintile compared to the three upper quintiles. Conclusions Facing potentially high health care costs and poor accessibility of health care facilities, many individuals suffering from NCCDs particularly women and the poor forego formal care, thereby increasing the risk of more severe illness in the future. When seeking care, the poor spend less on treatment than the rich, suggestive of lower quality care, while their expenditures represent a higher share of their annual household consumption. This calls for targeted interventions that enhance health care accessibility and provide financial protection from the consequences of NCCDs, especially for vulnerable populations.	[Janssens, Wendy] Vrije Univ Amsterdam, Fac Econ, Amsterdam, Netherlands; [Janssens, Wendy] Tinbergen Inst, Amsterdam, Netherlands; [Janssens, Wendy] Amsterdam Inst Int Dev, Amsterdam, Netherlands; [Goedecke, Jann] Katholieke Univ Leuven, Fac Econ & Business, Campus Brussel, Brussels, Belgium; [Goedecke, Jann] Univ Agder, Sch Business & Law, Kristiansand, Norway; [de Bree, Godelieve J.] PharmAccess Fdn, Amsterdam, Netherlands; [de Bree, Godelieve J.] Univ Amsterdam, Acad Med Ctr, Ctr Trop & Travel Med, Amsterdam, Netherlands; [Aderibigbe, Sunday A.; Akande, Tanimola M.] Univ Ilorin, Dept Epidemiol & Community Hlth, Teaching Hosp, Ilorin, Nigeria; [Mesnard, Alice] City Univ London, London, England; [Mesnard, Alice] Inst Fiscal Studies, London, England; [Mesnard, Alice] CEPR, London, England; [Mesnard, Alice] Ctr Global Dev, London, England	Vrije Universiteit Amsterdam; Tinbergen Institute; KU Leuven; University of Agder; University of Amsterdam; Academic Medical Center Amsterdam; University of Ilorin; City University London; University of London; London School Economics & Political Science; Centre for Economic Policy Research - UK; Center for Global Development - Europe	Goedecke, J (corresponding author), Katholieke Univ Leuven, Fac Econ & Business, Campus Brussel, Brussels, Belgium.; Goedecke, J (corresponding author), Univ Agder, Sch Business & Law, Kristiansand, Norway.	janng@uia.no	Akande, Tanimola Makanjuola/U-1362-2019	Goedecke, Jann/0000-0002-2288-8464; Janssens, Wendy/0000-0002-2085-8608	Health Insurance Fund; Netherlands Organisation for Scientific Research [451-10-002]; Agence Frangaise de Developpement (AFD); Institut de recherche pour le developpement (IRD); Agence inter-etablissements de recherche pour le developpement (AIRD); William and Flora Hewlett foundation	Health Insurance Fund; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Agence Frangaise de Developpement (AFD); Institut de recherche pour le developpement (IRD); Agence inter-etablissements de recherche pour le developpement (AIRD); William and Flora Hewlett foundation	The authors thank the Health Insurance Fund (www.hifund.org) for funding the data collection. The Netherlands Organisation for Scientific Research (www.nwo.nl/en) has provided funding for research time of WJ under grant nr. 451-10-002. The financial support through the grant "Health risks and Migration" by Agence Frangaise de Developpement (AFD), Institut de recherche pour le developpement (IRD), Agence inter-etablissements de recherche pour le developpement (AIRD) and the William and Flora Hewlett foundation is greatly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Addo J, 2007, HYPERTENSION, V50, P1012, DOI 10.1161/HYPERTENSIONAHA.107.093336; Adisa O, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0188-5; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Akin JS, 1999, HEALTH POLICY PLANN, V14, P135, DOI 10.1093/heapol/14.2.135; Amaghionyeodiwe LA, 2008, HEALTH CARE MANAG SC, V11, P215, DOI 10.1007/s10729-007-9038-3; Arsanjani JJ, 2015, LECT NOTES GEOINF CA, P1, DOI 10.1007/978-3-319-14280-7; Binnendijk E, 2012, TROP MED INT HEALTH, V17, P1376, DOI 10.1111/j.1365-3156.2012.03070.x; Borah BJ, 2006, HEALTH ECON, V15, P915, DOI 10.1002/hec.1166; BURBIDGE JB, 1988, J AM STAT ASSOC, V83, P123, DOI 10.2307/2288929; Central Bank of Nigeria, ANN REP STAT ACC; Chuma J, 2007, TROP MED INT HEALTH, V12, P673, DOI 10.1111/j.1365-3156.2007.01825.x; Dean N, 2015, J SURV STAT METHODOL, V3, P484, DOI [10.1093/jssam/smv024, DOI 10.1093/JSSAM/SMV024]; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; DOR A, 1987, J HEALTH ECON, V6, P291, DOI 10.1016/0167-6296(87)90017-8; Ensor T, 2004, HEALTH POLICY PLANN, V19, P69, DOI 10.1093/heapol/czh009; ESCOBAR ML, 2011, IMPACT HLTH INSURANC; Fagbamigbe AF, 2015, HEALTH ECON REV, V5, DOI 10.1186/s13561-015-0043-9; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gotsadze G, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-69; Habtom GK, 2007, HEALTH POLICY, V80, P202, DOI 10.1016/j.healthpol.2006.02.012; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hjortsberg C, 2003, HEALTH ECON, V12, P755, DOI 10.1002/hec.839; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Huber S, 2016, STATA J, V16, P416, DOI 10.1177/1536867X1601600209; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Klemick H, 2009, AM J AGR ECON, V91, P347, DOI 10.1111/j.1467-8276.2009.01252.x; Louw QA, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-105; Marquez PV, 2013, CHALLENGE NONCOMMUNI; Matul M., 2013, 17 MICR INN FAC; Ministry of Health Nigeria (TWG-NSHDP/HEALTH SECTOR DEVELOPMENT TEAM), 2009, NAT STRAT HLTH DEV P; Mittal BV, 2010, AM J KIDNEY DIS, V55, P590, DOI 10.1053/j.ajkd.2009.06.044; Mohanty Sanjay K., 2009, Genus, V65, P113; Murray C.J.L., 2003, HLTH SYSTEMS PERFORM; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Onwujekwe O, 2005, SOC SCI MED, V61, P455, DOI 10.1016/j.socscimed.2004.11.066; Onwujekwe Obinna, 2005, Health Policy, V71, P383, DOI 10.1016/j.healthpol.2004.06.006; Onwujekwe O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040811; Puhani PA, 2000, J ECON SURV, V14, P53, DOI 10.1111/1467-6419.00104; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Sarma S, 2009, APPL HEALTH ECON HEA, V7, P265, DOI 10.2165/10899650-000000000-00000; Smith-Spangler CM, 2012, DIABETES CARE, V35, P319, DOI 10.2337/dc11-1770; Steyn K, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P247; Su TT, 2006, B WORLD HEALTH ORGAN, V84, P21, DOI 10.2471/BLT.05.023739; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organization, 2013, PROJ MORT BURD DIS 2; World Health Organization (WHO), 2016, GLOBAL STATUS REPORT; WYSZEWIANSKI L, 1986, INQUIRY-J HEALTH CAR, V23, P382; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5	51	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166121	10.1371/journal.pone.0166121	http://dx.doi.org/10.1371/journal.pone.0166121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832107	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000066
J	Kalra, S; Pradeep, MA; Mohanty, AK; Kaushik, JK				Kalra, Shalini; Pradeep, Mangottil Ayyappan; Mohanty, Ashok K.; Kaushik, Jai K.			Structural, Functional and Phylogenetic Analysis of Sperm Lysozyme-Like Proteins	PLOS ONE			English	Article							EGG-WHITE LYSOZYME; X-RAY-STRUCTURE; PROTEOMIC ANALYSIS; SUBSITE-F; CARBOHYDRATE INTERACTIONS; STOMACH LYSOZYMES; MOLECULAR-DYNAMICS; CATALYTIC ACTION; BINDING ABILITY; RAINBOW-TROUT	Sperm lysozyme-like proteins belonging to c-type lysozyme family evolved in multiple forms. Lysozyme-like proteins, viz., LYZL2, LYZL3 or SLLP1, LYZL4, LYZL5 and LYZL6 are expressed in the testis of mammals. Not all members of LYZL family have been uniformly and unambiguously identified in the genome and proteome of mammals. Some studies suggested a role of SLLP1 and LYZL4 in fertilization; however, the function of other LYZL proteins is unknown. We identified all known forms of LYZL proteins in buffalo sperm by LC-MS/MS. Cloning and sequence analysis of the Lyz/cDNA showed 38-50% identity at amino acid level among the buffalo LYZL paralogs, complete conservation of eight cysteines and other signature sequences of c-type lysozyme family. Catalytic residues in SLLP1, LYZL4 and LYZL5 have undergone replacement. The substrate binding residues showed significant variation in LYZL proteins. Residues at sites 62, 101, 114 in LYZL4; 101 in SLLP1; 37, 62, and 101 in LYZL6 were more variable among diverse species. Sites 63 and 108 occupied by tryptophan were least tolerant to variation. Site 37 also showed lower tolerance to substitution in SLLP1, LYZL4 and LYZL5, but more variable in non-testicular lysozymes. Models of LYZL proteins were created by homology modeling and the substrate binding pockets were analyzed in term of binding energies and contacting residues of LYZL proteins with tri-N-acetylglucosamine (NAG)3 in the A-B-C and B-C-D binding mode. Except LYZL6, LYZL proteins did not show significant difference in binding energies in comparison to hen egg white lysozyme in the A-B-C mode. (NAG)3 binding energy in the B-C-D mode was higher by 1.3-2.2 kcal/mol than in A-B-C mode. Structural analysis indicated that (NAG)3 was involved in making more extensive interactions including hydrogen bonding with LYZL proteins in B-C-D mode than in A-B-C mode. Despite large sequence divergence among themselves and with respect to c-type lysozymes, substrate binding residues as well as hydrogen bonding network between (NAG)3 and proteins were mostly conserved. LYZL5 in buffalo and other mammalian species contained additional 10-12 amino acid sequence at c-terminal that matched with ankyrin repeat domain-containing protein 27. Phylogenetic analysis indicated LYZL2 to be most ancient among all the LYZL proteins and that the evolution of LYZL proteins occurred through several gene duplications preceding the speciation of mammals from other vertebrates as distant as reptiles and amphibians.	[Kalra, Shalini; Pradeep, Mangottil Ayyappan; Mohanty, Ashok K.; Kaushik, Jai K.] Natl Dairy Res Inst, BTIS SubDIC Anim Biotechnol Ctr, Karnal 132001, Haryana, India; [Pradeep, Mangottil Ayyappan] Cent Marine Fisheries Res Inst, Marine Biotechnol Div, Kochi 682018, Kerala, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Central Marine Fisheries Research Institute	Kaushik, JK (corresponding author), Natl Dairy Res Inst, BTIS SubDIC Anim Biotechnol Ctr, Karnal 132001, Haryana, India.	jaikr1@gmail.com			Council for Scientific and Industrial Research, New Delhi	Council for Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	SK was supported by the Junior and Senior Research Fellowships of Council for Scientific and Industrial Research, New Delhi, for doctoral program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SK was supported by the Junior and Senior Research Fellowships of Council for Scientific and Industrial Research, New Delhi, for doctoral program. The authors thank the Department of Biotechnology, Ministry of Science and Technology for providing computational facility under the framework of BTISnet.	Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0007-2; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaral A, 2014, J PROTEOME RES, V13, P5670, DOI 10.1021/pr500652y; Amaral A, 2013, MOL CELL PROTEOMICS, V12, P330, DOI 10.1074/mcp.M112.020552; Baker MA, 2007, PROTEOM CLIN APPL, V1, P524, DOI 10.1002/prca.200601013; Baker MA, 2013, PROTEOMICS, V13, P61, DOI 10.1002/pmic.201200350; Baldwin E, 1996, J MOL BIOL, V259, P542, DOI 10.1006/jmbi.1996.0338; BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P378, DOI 10.1098/rspb.1967.0035; Byrne K, 2012, PROTEOMICS, V12, P3559, DOI 10.1002/pmic.201200133; CHEETHAM JC, 1992, J MOL BIOL, V224, P613, DOI 10.1016/0022-2836(92)90548-X; Chiu WWC, 2004, HUM REPROD, V19, P243, DOI 10.1093/humrep/deh050; de Mateo S, 2007, PROTEOMICS, V7, P4264, DOI 10.1002/pmic.200700521; de Mateo S, 2011, PROTEOMICS, V11, P2714, DOI 10.1002/pmic.201000799; DOBSON DE, 1984, J BIOL CHEM, V259, P1607; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gadave KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087618; Garcia-Hernandez E, 2003, PROTEIN SCI, V12, P135, DOI 10.1110/ps.0222503; Gu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019386; Guyonnet B, 2012, MOL CELL PROTEOMICS, V11, P758, DOI 10.1074/mcp.M112.020339; HADFIELD AT, 1994, J MOL BIOL, V243, P856, DOI 10.1006/jmbi.1994.1688; Harata K, 1997, ACTA CRYSTALLOGR D, V53, P650, DOI 10.1107/S0907444997005362; HARATA K, 1993, J MOL BIOL, V233, P524, DOI 10.1006/jmbi.1993.1529; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Imoto T, 1972, ENZYMES, V7, P665; INOUE M, 1992, BIOCHEMISTRY-US, V31, P5545, DOI 10.1021/bi00139a017; Irwin D.M., 1996, Experientia Supplementum (Basel), V75, P347; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; IRWIN DM, 1989, J BIOL CHEM, V264, P11387; IRWIN DM, 1990, J BIOL CHEM, V265, P4944; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; KARLSEN S, 1995, ACTA CRYSTALLOGR D, V51, P962, DOI 10.1107/S0907444995005105; Kaushik JK, 2006, BIOCHEMISTRY-US, V45, P7100, DOI 10.1021/bi052610n; Kawaguchi Y, 2015, BIOSCI BIOTECH BIOCH, V79, P196, DOI 10.1080/09168451.2014.963502; Kawamura S, 2004, BIOSCI BIOTECH BIOCH, V68, P593, DOI 10.1271/bbb.68.593; Kawamura S, 2008, BIOSCI BIOTECH BIOCH, V72, P823, DOI 10.1271/bbb.70694; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; Konagurthu AS, 2006, PROTEINS, V64, P559, DOI 10.1002/prot.20921; KORNEGAY JR, 1994, MOL BIOL EVOL, V11, P921; Kovac JR, 2013, FERTIL STERIL, V99, P998, DOI 10.1016/j.fertnstert.2013.01.111; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krieger E, 2012, METHODS MOL BIOL, V819, P405, DOI 10.1007/978-1-61779-465-0_25; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KUMAGAI I, 1989, J BIOCHEM-TOKYO, V105, P946, DOI 10.1093/oxfordjournals.jbchem.a122784; KUMAGAI I, 1987, J BIOCHEM-TOKYO, V102, P733, DOI 10.1093/oxfordjournals.jbchem.a122111; KUMAGAI I, 1992, J BIOL CHEM, V267, P4608; KUMAGAI I, 1993, EUR J BIOCHEM, V212, P151, DOI 10.1111/j.1432-1033.1993.tb17645.x; Kwon WS, 2015, MOL CELL PROTEOMICS, V14, P1230, DOI 10.1074/mcp.M114.045369; Le SQ, 1993, MOL BIOL EVOL, V18, P691; LUMB KJ, 1994, J MOL BIOL, V235, P1072, DOI 10.1006/jmbi.1994.1058; MAENAKA K, 1995, J MOL BIOL, V247, P281, DOI 10.1006/jmbi.1994.0139; Maenaka K, 1998, BBA-PROTEIN STRUCT M, V1384, P23, DOI 10.1016/S0167-4838(97)00199-4; Maenaka K, 1998, BIOCHEM J, V333, P71, DOI 10.1042/bj3330071; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; MARDH PA, 1974, SCAND J UROL NEPHROL, V8, P179, DOI 10.3109/00365597409132126; Martinez-Heredia J, 2006, PROTEOMICS, V6, P4356, DOI 10.1002/pmic.200600094; McKenzie H.A., 1996, Experientia Supplementum (Basel), V75, P365; MCKENZIE HA, 1991, ADV PROTEIN CHEM, V41, P173; McReynolds S, 2014, FERTIL STERIL, V102, P692, DOI 10.1016/j.fertnstert.2014.05.021; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; MULVEY RS, 1973, BIOCHEMISTRY-US, V12, P2683, DOI 10.1021/bi00738a021; MULVEY RS, 1974, BIOCHEMISTRY-US, V13, P782, DOI 10.1021/bi00701a021; Muraki M, 2000, BIOCHEMISTRY-US, V39, P292, DOI 10.1021/bi991402q; MURAKI M, 1991, BIOCHIM BIOPHYS ACTA, V1079, P229, DOI 10.1016/0167-4838(91)90130-R; MURAKI M, 1989, EUR J BIOCHEM, V179, P573, DOI 10.1111/j.1432-1033.1989.tb14585.x; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Naz RK, 2010, J REPROD IMMUNOL, V84, P24, DOI 10.1016/j.jri.2009.10.006; NITTA K, 1988, BIOL CHEM H-S, V369, P671, DOI 10.1515/bchm3.1988.369.2.671; Ose T, 2009, J BIOCHEM, V146, P651, DOI 10.1093/jb/mvp110; Paasch U, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.007187; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PHILLIPS DC, 1966, SCI AM, V215, P78, DOI 10.1038/scientificamerican1166-78; Puri P, 2008, BIOL REPROD, V79, P1183, DOI 10.1095/biolreprod.108.068734; Qasba PK, 1997, CRIT REV BIOCHEM MOL, V32, P255, DOI 10.3109/10409239709082574; RUPLEY JA, 1967, PROC R SOC SER B-BIO, V167, P416, DOI 10.1098/rspb.1967.0038; Saadi HAS, 2013, J PROTEOMICS, V82, P64, DOI 10.1016/j.jprot.2013.02.027; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Schafer IB, 2012, NAT STRUCT MOL BIOL, V19, P1300, DOI 10.1038/nsmb.2414; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; SONG HW, 1994, J MOL BIOL, V244, P522, DOI 10.1006/jmbi.1994.1750; STEWART CB, 1987, NATURE, V330, P401, DOI 10.1038/330401a0; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Swegen A, 2015, REPRODUCTION, V149, P235, DOI 10.1530/REP-14-0500; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Toshima G, 2003, BIOSCI BIOTECH BIOCH, V67, P540, DOI 10.1271/bbb.67.540; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Vollan VB, 1999, ACTA CRYSTALLOGR D, V55, P60, DOI 10.1107/S0907444998006623; Von Dreele RB, 2005, ACTA CRYSTALLOGR D, V61, P22, DOI 10.1107/S0907444904025715; Wagner A, 2014, REPROD SCI, V10, P1; Wang GG, 2013, J PROTEOMICS, V79, P114, DOI 10.1016/j.jprot.2012.12.008; Wei J, 2013, ASIAN J ANDROL, V15, P824, DOI 10.1038/aja.2013.93; Yu M, 1996, MOL PHYLOGENET EVOL, V5, P298, DOI 10.1006/mpev.1996.0025; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zheng H, 2015, ANDROLOGY-US, V3, P756, DOI 10.1111/andr.12057; Zhong Y, 2013, J COMPUT CHEM, V34, P163, DOI 10.1002/jcc.23109	98	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166321	10.1371/journal.pone.0166321	http://dx.doi.org/10.1371/journal.pone.0166321			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832206	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000097
J	Kohajda, Z; Farkas-Morvay, N; Jost, N; Nagy, N; Geramipour, A; Horvath, A; Varga, RS; Hornyik, T; Corici, C; Acsai, K; Horvath, B; Prorok, J; Ordog, B; Deri, S; Toth, D; Levijoki, J; Pollesello, P; Koskelainen, T; Otsomaa, L; Toth, A; Baczko, I; Lepran, I; Nanasi, PP; Papp, JG; Varro, A; Virag, L				Kohajda, Zsofia; Farkas-Morvay, Nikolett; Jost, Norbert; Nagy, Norbert; Geramipour, Amir; Horvath, Andras; Varga, Richard S.; Hornyik, Tibor; Corici, Claudia; Acsai, Karoly; Horvath, Balazs; Prorok, Janos; Ordog, Balks; Deri, Szilvia; Toth, Daniel; Levijoki, Jouko; Pollesello, Piero; Koskelainen, Tuula; Otsomaa, Leena; Toth, Andras; Baczko, Istvan; Lepran, Istvan; Nanasi, Peter P.; Papp, Julius Gy; Varro, Andras; Virag, Laszlo			The Effect of a Novel Highly Selective Inhibitor of the Sodium/Calcium Exchanger (NCX) on Cardiac Arrhythmias in In Vitro and In Vivo Experiments	PLOS ONE			English	Article							SODIUM-CALCIUM EXCHANGE; REPERFUSION-INDUCED ARRHYTHMIAS; OUABAIN-INDUCED ARRHYTHMIAS; RAT VENTRICULAR MYOCYTES; NA+/CA2+ EXCHANGE; NA/CA EXCHANGE; REPOLARIZATION RESERVE; POTASSIUM CHANNELS; IONIC CURRENTS; CA2+ OVERLOAD	Background In this study the effects of a new, highly selective sodium-calcium exchanger (NCX) inhibitor, ORM-10962 were investigated on cardiac NCX current, Ca2+ transients, cell shortening and in experimental arrhythmias. The level of selectivity of the novel inhibitor on several major transmembrane ion currents (L-type Ca2+ current, major repolarizing K+ currents, late Na+ current, Na+/K+ pump current) was also determined. Methods Ion currents in single dog ventricular cells (cardiac myocytes; CM), and action potentials in dog cardiac multicellular preparations were recorded utilizing the whole-cell patch clamp and standard microelectrode techniques, respectively. Ca2+ transients and cell shortening were measured in fluorescent dye loaded isolated dog myocytes. Antiarrhythmic effects of ORM-10962 were studied in anesthetized ouabain (10 mu g/kg/min i.v.) pretreated guinea pigs and in ischemia-reperfusion models (I/R) of anesthetized coronary artery occluded rats and Langendorff perfused guinea pigs hearts. Results ORM-10962 significantly reduced the inward/outward NCX currents with estimated EC50 values of 55/67 nM, respectively. The compound, even at a high concentration of 1 mu M, did not modify significantly the magnitude of I-CaL in CMs, neither had any apparent influence on the inward rectifier, transient outward, the rapid and slow components of the delayed rectifier potassium currents, the late and peak sodium and Na+/K+ pump currents. NCX inhibition exerted moderate positive inotropic effect under normal condition, negative inotropy when reverse, and further positive inotropic effect when forward mode was facilitated. In dog Purkinje fibres 1 mu M ORM-10962 decreased the amplitude of digoxin induced delayed afterdepolarizations (DADs). Pre-treatment with 0.3 mg/kg ORM-10962 (i.v.) 10 min before starting ouabain infusion significantly delayed the development and recurrence of ventricular extra-systoles (by about 50%) or ventricular tachycardia (by about 30%) in anesthetized guinea pigs. On the contrary, ORM-10962 pre-treatment had no apparent influence on the time of onset or the severity of I/R induced arrhythmias in anesthetized rats and in Langendorff perfused guinea-pig hearts. Conclusions The present study provides strong evidence for a high efficacy and selectivity of the NCX-inhibitory effect of ORM-10962. Selective NCX inhibition can exert positive as well as negative inotropic effect depending on the actual operation mode of NCX. Selective NCX blockade may contribute to the prevention of DAD based arrhythmogenesis, in vivo, however, its effect on I/R induced arrhythmias is still uncertain.	[Farkas-Morvay, Nikolett; Geramipour, Amir; Horvath, Andras; Varga, Richard S.; Hornyik, Tibor; Corici, Claudia; Prorok, Janos; Ordog, Balks; Deri, Szilvia; Toth, Andras; Baczko, Istvan; Lepran, Istvan; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary; [Kohajda, Zsofia; Jost, Norbert; Nagy, Norbert; Horvath, Andras; Acsai, Karoly; Toth, Daniel; Toth, Andras; Papp, Julius Gy; Varro, Andras; Virag, Laszlo] Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary; [Jost, Norbert; Lepran, Istvan] Victor Babes Univ Med & Pharm, Dept Pathophysiol, Timisoara, Romania; [Horvath, Balazs; Nanasi, Peter P.] Univ Debrecen, Dept Physiol, Fac Med, Debrecen, Hungary; [Nanasi, Peter P.] Univ Debrecen, Dept Dent Physiol & Pharmacol, Fac Dent, Debrecen, Hungary; [Levijoki, Jouko; Pollesello, Piero; Koskelainen, Tuula; Otsomaa, Leena] Orion Pharma, Espoo, Finland	Szeged University; Hungarian Academy of Sciences; Victor Babes University of Medicine & Pharmacy, Timisoara; University of Debrecen; University of Debrecen; Orion Corporation	Virag, L (corresponding author), Univ Szeged, Dept Pharmacol & Pharmacotherapy, Fac Med, Szeged, Hungary.; Virag, L (corresponding author), Hungarian Acad Sci, MTA SZTE Res Grp Cardiovasc Pharmacol, Szeged, Hungary.	varrot.andras@med.u_szeged.hu	Baczko, István/I-7752-2019; Horvath, Balazs/T-6637-2019; Pollesello, Piero/I-6884-2019	Baczko, István/0000-0002-9588-0797; Pollesello, Piero/0000-0001-6994-768X; Ordog, Balazs/0000-0002-8971-3079; Nagy, Norbert/0000-0002-4557-8442	Hungarian Scientific Research Fund [OTKA NK-104331, K100151, NN-109904, ANN-113273]; National Office for Research and Technology-Baross and Anyos Jedlik Programmes [REG-DA-09-2-2009-0115-NCXINHIB, NKFP_07_01-RYT07_AF]; Hungarian Academy of Sciences; Ministry of National Education; national excellence program of the ministry of human capacities [UNKP-16-3 - IKT/147-1787/8/2016-OSZT-95]; CNCS UEFISCDI [PN-II-ID-PCE-2012-4-0512]; Orion Pharma	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Office for Research and Technology-Baross and Anyos Jedlik Programmes; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Ministry of National Education; national excellence program of the ministry of human capacities; CNCS UEFISCDI(Consiliul National al Cercetarii Stiintifice (CNCS)Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii (UEFISCDI)); Orion Pharma	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA NK-104331 for AV, K100151 for IB, NN-109904 for NJ and ANN-113273 for AT), National Office for Research and Technology-Baross and Anyos Jedlik Programmes (REG-DA-09-2-2009-0115-NCXINHIB for NJ and AT and NKFP_07_01-RYT07_AF for AV and NJ), the Hungarian Academy of Sciences (for AV, NJ and AT), the Ministry of National Education, the UNKP-16-3 - IKT/147-1787/8/2016-OSZT-95 (new national excellence program of the ministry of human capacities, FOR ZK), CNCS UEFISCDI, project number PN-II-ID-PCE-2012-4-0512 (for NJ and IB) and by the Orion Pharma. The funders provided support in the form of salaries for some authors (JL, PP, TK, LO by Orion Pharma), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders read the manuscript and agreed to publish the paper in PLOS ONE.	Acsai K, 2007, EUR J PHARMACOL, V576, P1, DOI 10.1016/j.ejphar.2007.07.047; Antoons G, 2012, PHARMACOL THERAPEUT, V134, P26, DOI 10.1016/j.pharmthera.2011.12.001; Baczko I, 1997, J CARDIOVASC PHARM, V29, P196, DOI 10.1097/00005344-199702000-00007; Baczko I, 2003, J PHYSIOL-LONDON, V550, P889, DOI 10.1113/jphysiol.2003.043372; Banyasz T, 2012, HEART RHYTHM, V9, P134, DOI 10.1016/j.hrthm.2011.08.029; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; Biliczki P, 2002, BRIT J PHARMACOL, V137, P361, DOI 10.1038/sj.bjp.0704881; Birinyi P, 2005, N-S ARCH PHARMACOL, V372, P63, DOI 10.1007/s00210-005-1079-x; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; BRIDGE JHB, 1991, ANN NY ACAD SCI, V639, P34, DOI 10.1111/j.1749-6632.1991.tb17287.x; Carmeliet E, 1999, PHYSIOL REV, V79, P917, DOI 10.1152/physrev.1999.79.3.917; EISNER DA, 1985, AM J PHYSIOL, V248, pC189, DOI 10.1152/ajpcell.1985.248.3.C189; Elias CL, 2001, AM J PHYSIOL-HEART C, V281, pH1334, DOI 10.1152/ajpheart.2001.281.3.H1334; Gandhi A, 2013, CARDIOVASC THER, V31, pE115, DOI 10.1111/1755-5922.12045; Grandi E, 2010, J MOL CELL CARDIOL, V48, P112, DOI 10.1016/j.yjmcc.2009.09.019; HILGEMANN DW, 1988, PROG BIOPHYS MOL BIO, V51, P1, DOI 10.1016/0079-6107(88)90009-0; HILGEMANN DW, 1989, PFLUG ARCH EUR J PHY, V415, P247, DOI 10.1007/BF00370601; Hobai IA, 2004, CIRC RES, V95, P292, DOI 10.1161/01.RES.0000136817.28691.2d; Hobai IA, 1997, PFLUG ARCH EUR J PHY, V433, P455, DOI 10.1007/s004240050300; Hryshko, 2001, HDB PHYSL; Iwamoto T, 2004, MOL PHARMACOL, V66, P45, DOI 10.1124/mol.66.1.45; Jost N, 2013, J PHYSIOL-LONDON, V591, P4189, DOI 10.1113/jphysiol.2013.261198; LEPRAN I, 1992, J CARDIOVASC PHARM, V19, P40, DOI 10.1097/00005344-199201000-00006; Livshitz L, 2012, J PHYSIOL-LONDON, V590, P4423, DOI 10.1113/jphysiol.2012.228791; Lu HR, 1999, EUR J PHARMACOL, V365, P233, DOI 10.1016/S0014-2999(98)00878-4; Miyamoto S, 2002, JPN J PHARMACOL, V90, P229, DOI 10.1254/jjp.90.229; Morita N, 2011, AM J PHYSIOL-HEART C, V301, pH180, DOI 10.1152/ajpheart.00128.2011; Nagasawa Y, 2005, EUR J PHARMACOL, V506, P249, DOI 10.1016/j.ejphar.2004.11.011; Nagy N, 2014, BRIT J PHARMACOL, V171, P5665, DOI 10.1111/bph.12867; Nagy ZA, 2004, BRIT J PHARMACOL, V143, P827, DOI 10.1038/sj.bjp.0706026; NOBLE D, 1991, ANN NY ACAD SCI, V639, P334, DOI 10.1111/j.1749-6632.1991.tb17323.x; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Ozdemir S, 2008, CIRC RES, V102, P1398, DOI 10.1161/CIRCRESAHA.108.173922; Schafer C, 2001, CARDIOVASC RES, V51, P241, DOI 10.1016/S0008-6363(01)00282-6; Sipido KR, 2000, CIRCULATION, V102, P2137, DOI 10.1161/01.CIR.102.17.2137; Szepesi J, 2015, J PHYSIOL PHARMACOL, V66, P215; Takahashi K, 2003, EUR J PHARMACOL, V458, P155, DOI 10.1016/S0014-2999(02)02732-2; Tanaka H, 2002, BRIT J PHARMACOL, V135, P1096, DOI 10.1038/sj.bjp.0704574; THOMAS GP, 1986, BRIT J PHARMACOL, V89, P385, DOI 10.1111/j.1476-5381.1986.tb10271.x; Varga Z, 2012, MOL PHARMACOL, V82, P372, DOI 10.1124/mol.112.078006; Venetucci LA, 2007, ANN NY ACAD SCI, V1099, P315, DOI 10.1196/annals.1387.033; Voigt N, 2012, CIRCULATION, V125, P2059, DOI 10.1161/CIRCULATIONAHA.111.067306; WALLENSTEIN S, 1980, CIRC RES, V47, P1, DOI 10.1161/01.RES.47.1.1; Watano T, 1999, BRIT J PHARMACOL, V127, P1846, DOI 10.1038/sj.bjp.0702740; Yamamura K, 2001, CARDIOVASC RES, V52, P397, DOI 10.1016/S0008-6363(01)00409-6	47	36	36	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166041	10.1371/journal.pone.0166041	http://dx.doi.org/10.1371/journal.pone.0166041			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832106	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000387725000057
J	Marchioro, CA				Marchioro, Cesar A.			Global Potential Distribution of Bactrocera carambolae and the Risks for Fruit Production in Brazil	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; ECOLOGICAL NICHE MODELS; BIOLOGICAL INVASIONS; CLIMATE-CHANGE; LEPIDOPTERA-NOCTUIDAE; DIPTERA TEPHRITIDAE; SAMPLING BIAS; COMPLEXITY; PERFORMANCE; MOVEMENT	The carambola fruit fly, Bactrocera carambolae, is a tephritid native to Asia that has invaded South America through small-scale trade of fruits from Indonesia. The economic losses associated with biological invasions of other fruit flies around the world and the polyphagous behaviour of B. carambolae have prompted much concern among government agencies and farmers with the potential spread of this pest. Here, ecological niche models were employed to identify suitable environments available to B. carambolae in a global scale and assess the extent of the fruit acreage that may be at risk of attack in Brazil. Overall, 30 MaxEnt models built with different combinations of environmental predictors and settings were evaluated for predicting the potential distribution of the carambola fruit fly. The best model was selected based on threshold-independent and threshold-dependent metrics. Climatically suitable areas were identified in tropical and subtropical regions of Central and South America, Sub-Saharan Africa, west and east coast of India and northern Australia. The suitability map of B. carambola was intersected against maps of fruit acreage in Brazil. The acreage under potential risk of attack varied widely among fruit species, which is expected because the production areas are concentrated in different regions of the country. The production of cashew is the one that is at higher risk, with almost 90% of its acreage within the suitable range of B. carambolae, followed by papaya (78%), tangerine (51%), guava (38%), lemon (30%), orange (29%), mango (24%) and avocado (20%). This study provides an important contribution to the knowledge of the ecology of B. carambolae, and the information generated here can be used by government agencies as a decision-making tool to prevent the carambola fruit fly spread across the world.	[Marchioro, Cesar A.] Univ Fed Santa Catarina, Dept Agr Biodivers & Forest, Ctr Rural Sci, Campus Curitibanos, Curitibanos, SC, Brazil	Universidade Federal de Santa Catarina (UFSC)	Marchioro, CA (corresponding author), Univ Fed Santa Catarina, Dept Agr Biodivers & Forest, Ctr Rural Sci, Campus Curitibanos, Curitibanos, SC, Brazil.	cesmarc@gmail.com	Marchioro, Cesar Augusto/AAU-7562-2021	Marchioro, Cesar Augusto/0000-0002-7257-8114				[Anonymous], FRUIT FLIES EC IMPOR; Bacon SJ, 2014, DIVERS DISTRIB, V20, P84, DOI 10.1111/ddi.12149; Barve N, 2011, ECOL MODEL, V222, P1810, DOI 10.1016/j.ecolmodel.2011.02.011; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Broennimann O, 2007, ECOL LETT, V10, P701, DOI 10.1111/j.1461-0248.2007.01060.x; Broennimann O, 2008, BIOL LETTERS, V4, P585, DOI 10.1098/rsbl.2008.0254; Brown JL, 2014, METHODS ECOL EVOL, V5, P694, DOI 10.1111/2041-210X.12200; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; De Meyer M, 2010, B ENTOMOL RES, V100, P35, DOI 10.1017/S0007485309006713; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; DREW RAI, 1994, B ENTOMOL RES, P1, DOI 10.1017/S1367426900000278; Duyck PF, 2004, ECOL ENTOMOL, V29, P511, DOI 10.1111/j.0307-6946.2004.00638.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Estay SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102592; FAO, 2013, OR PROD COUNTR; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Froerer K. M., 2010, American Entomologist, V56, P88; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hill MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090121; Hulme PE, 2009, SCIENCE, V324, P40, DOI 10.1126/science.1171111; Jimenez-Valverde A, 2014, BIODIVERS CONSERV, V23, P369, DOI 10.1007/s10531-013-0606-1; Jimenez-Valverde A, 2013, GLOBAL ECOL BIOGEOGR, V22, P508, DOI 10.1111/geb.12007; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Kumar S, 2015, J ECON ENTOMOL, V108, P1708, DOI 10.1093/jee/tov166; Kumar S, 2009, FRONT ECOL ENVIRON, V7, P415, DOI 10.1890/080054; Lemos LD, 2014, FLA ENTOMOL, V97, P841, DOI 10.1653/024.097.0274; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Martinez-Meyer Enrique, 2005, Biodiversity Informatics, V2, P42; Measey GJ, 2012, BIOL INVASIONS, V14, P2255, DOI 10.1007/s10530-012-0227-8; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Meyer ALS, 2014, AM J PRIMATOL, V76, P551, DOI 10.1002/ajp.22247; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Muscarella R, 2014, METHODS ECOL EVOL, V5, P1198, DOI 10.1111/2041-210X.12261; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peck SL, 2005, J ECON ENTOMOL, V98, P1539, DOI 10.1603/0022-0493-98.5.1539; Peterson A.T., 2011, ECOLOGICAL NICHES GE, P314; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pomari-Fernandes A., 2015, Current Agricultural Science and Technology, V21, P1; Qin YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116424; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rodda GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014670; Rutherford M. C., 1997, P91; Shcheglovitova M, 2013, ECOL MODEL, V269, P9, DOI 10.1016/j.ecolmodel.2013.08.011; Sheppard CS, 2013, WEED RES, V53, P259, DOI 10.1111/wre.12021; Silva OLR, 1997, MOSCA CARAMBOLA BACT, P10; Slater H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032202; Slva RA, 2005, REV CIENTIFICA ELETR, P4; SPECHT A, 2013, PESQUI AGROPECU BRAS, V48, P689; Syfert MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055158; Tingley R, 2014, P NATL ACAD SCI USA, V111, P10233, DOI 10.1073/pnas.1405766111; Van Sauers-Muller A, 2005, NEOTROP ENTOMOL, V34, P203, DOI 10.1590/S1519-566X2005000200008; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Venette RC, 2010, BIOSCIENCE, V60, P349, DOI 10.1525/bio.2010.60.5.5; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Warren DL, 2014, DIVERS DISTRIB, V20, P334, DOI 10.1111/ddi.12160; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x; West AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117893; Wittenberg R., 2001, Invasive alien species: a toolkit of best prevention and management practices, DOI 10.1079/9780851995694.0000; Zhu GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031246	65	16	18	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166142	10.1371/journal.pone.0166142	http://dx.doi.org/10.1371/journal.pone.0166142			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832144	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000068
J	Moon, JH; Kim, KM; Kim, JH; Moon, JH; Choi, SH; Lim, S; Lim, JY; Kim, KW; Park, KS; Jang, HC				Moon, Joon Ho; Kim, Kyoung Min; Kim, Jung Hee; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Lim, Jae-Young; Kim, Ki Woong; Park, Kyong Soo; Jang, Hak Chul			Predictive Values of the New Sarcopenia Index by the Foundation for the National Institutes of Health Sarcopenia Project for Mortality among Older Korean Adults	PLOS ONE			English	Article							MUSCLE MASS; SKELETAL-MUSCLE; CONSENSUS; RISK; MEN; ASSOCIATION; IMPAIRMENT; STRENGTH; CRITERIA	Objective We evaluated the Foundation for the National Institutes of Health (FNIH) Sarcopenia Project's recommended criteria for sarcopenia's association with mortality among older Korean adults. Methods We conducted a community-based prospective cohort study which included 560 (285 men and 275 women) older Korean adults aged >= 65 years. Muscle mass (appendicular skeletal muscle mass-to-body mass index ratio (ASM/BMI)), handgrip strength, and walking velocity were evaluated in association with all-cause mortality during 6-year follow-up. Both the lowest quintile for each parameter (ethnic-specific cutoff) and FNIH-recommended values were used as cutoffs. Results Forty men (14.0%) and 21 women (7.6%) died during 6-year follow-up. The deceased subjects were older and had lower ASM, handgrip strength, and walking velocity. Sarcopenia defined by both low lean mass and weakness had a 4.13 (95% CI, 1.69-10.11) times higher risk of death, and sarcopenia defined by a combination of low lean mass, weakness, and slowness had a 9.56 (3.16-28.90) times higher risk of death after adjusting for covariates in men. However, these significant associations were not observed in women. In terms of cutoffs of each parameter, using the lowest quintile showed better predictive values in mortality than using the FNIH-recommended values. Moreover, new muscle mass index, ASM/BMI, provided better prognostic values than ASM/height 2 in all associations. Conclusions New sarcopenia definition by FNIH was better able to predict 6-year mortality among Korean men. Moreover, ethnic-specific cutoffs, the lowest quintile for each parameter, predicted the higher risk of mortality than the FNIH-recommended values.	[Moon, Joon Ho; Kim, Kyoung Min; Kim, Jung Hee; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Park, Kyong Soo; Jang, Hak Chul] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Moon, Joon Ho; Kim, Jung Hee; Park, Kyong Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Kim, Kyoung Min; Moon, Jae Hoon; Choi, Sung Hee; Lim, Soo; Jang, Hak Chul] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; [Lim, Jae-Young] Seoul Natl Univ, Bundang Hosp, Dept Rehabil Med, Seongnam, South Korea; [Kim, Ki Woong] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Jang, HC (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea.; Jang, HC (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea.	janghak@snu.ac.kr	Park, Kyong Soo/C-2265-2008; Lim, Soo/AAU-8107-2020; Lim, Jae-Young/J-5622-2012	Park, Kyong Soo/0000-0003-3597-342X; Lim, Soo/0000-0002-4137-1671; Lim, Jae-Young/0000-0002-9454-0344; CHOI, SUNG HEE/0000-0003-0740-8116; Moon, Joon Ho/0000-0003-1897-0905; Kim, Kyoung Min/0000-0001-8150-0266	National Research Foundation Grant - Ministry of Education, Science, and Technology, Republic of Korea [2006-2005410]; Seoul National University Bundang Hospital [02-2011-015]	National Research Foundation Grant - Ministry of Education, Science, and Technology, Republic of Korea; Seoul National University Bundang Hospital	This work was supported by National Research Foundation Grant by Ministry of Education, Science, and Technology, Republic of Korea (2006-2005410, URL: http://www.nrf.re.kr/) and the grant from Seoul National University Bundang Hospital (02-2011-015, URL: https.//www.snubh.org/).	Arango-Lopera VE, 2013, J NUTR HEALTH AGING, V17, P259, DOI 10.1007/s12603-012-0434-0; Baumgartner RN, 1998, AM J EPIDEMIOL, V147, P755, DOI 10.1093/oxfordjournals.aje.a009520; Castillo EM, 2003, AM J PREV MED, V25, P226, DOI 10.1016/S0749-3797(03)00197-1; Cawthon PM, 2013, GERONTOLOGIST, V53, P594, DOI 10.1093/gerona/glu023; Cawthon PM, 2015, J AM GERIATR SOC, V63, P2247, DOI 10.1111/jgs.13788; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Kim JH, 2014, J GERONTOL A-BIOL, V69, P1244, DOI 10.1093/gerona/glu050; Kim KM, 2014, IJC METAB ENDOCR, V4, P63, DOI 10.1016/j.ijcme.2014.06.001; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Landi F, 2012, CLIN NUTR, V31, P652, DOI 10.1016/j.clnu.2012.02.007; Landi F, 2012, J AM MED DIR ASSOC, V13, P121, DOI 10.1016/j.jamda.2011.07.004; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; MATHIOWETZ V, 1985, J HAND SURG-AM, V10A, P694, DOI 10.1016/S0363-5023(85)80210-0; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Moon JH, 2016, J NUTR HEALTH AGING, V20, P496, DOI 10.1007/s12603-015-0613-x; Morley JE, 2008, J NUTR HEALTH AGING, V12, P452, DOI 10.1007/BF02982705; Newman AB, 2006, J GERONTOL A-BIOL, V61, P72, DOI 10.1093/gerona/61.1.72; Park J. H., 2007, PSYCHIAT INVEST, V4, P84; ROSENBERG IH, 1995, ANN INTERN MED, V123, P727, DOI 10.7326/0003-4819-123-9-199511010-00014; SALLIS JF, 1985, AM J EPIDEMIOL, V121, P91, DOI 10.1093/oxfordjournals.aje.a113987; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; The Population Reference Bureau, 2014, 2014 WORLD POP DAT S; Won C.W., 2002, J KOREAN GERIATRICS, V6, P273; Woo J, 2014, EUR GERIATR MED, V5, P155, DOI 10.1016/j.eurger.2014.04.003; Woo J, 2015, J GERONTOL A; Woo J, 2009, J AM GERIATR SOC, V57, P2224, DOI 10.1111/j.1532-5415.2009.02566.x	32	27	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166344	10.1371/journal.pone.0166344	http://dx.doi.org/10.1371/journal.pone.0166344			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832145	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000104
J	Pettengill, JB; Pightling, AW; Baugher, JD; Rand, H; Strain, E				Pettengill, James B.; Pightling, Arthur W.; Baugher, Joseph D.; Rand, Hugh; Strain, Errol			Real-Time Pathogen Detection in the Era of Whole-Genome Sequencing and Big Data: Comparison of k-mer and Site-Based Methods for Inferring the Genetic Distances among Tens of Thousands of Salmonella Samples	PLOS ONE			English	Article							SURVEILLANCE; PIPELINE	The adoption of whole-genome sequencing within the public health realm for molecular characterization of bacterial pathogens has been followed by an increased emphasis on real-time detection of emerging outbreaks (e.g., food-borne Salmonellosis). In turn, large databases of whole-genome sequence data are being populated. These databases currently contain tens of thousands of samples and are expected to grow to hundreds of thousands within a few years. For these databases to be of optimal use one must be able to quickly interrogate them to accurately determine the genetic distances among a set of samples. Being able to do so is challenging due to both biological (evolutionary diverse samples) and computational (petabytes of sequence data) issues. We evaluated seven measures of genetic distance, which were estimated from either k-mer profiles (Jaccard, Euclidean, Manhattan, Mash Jaccard, and Mash distances) or nucleotide sites (NUCmer and an extended multi-locus sequence typing (MLST) scheme). When analyzing empirical data (whole-genome sequence data from 18,997 Salmonella isolates) there are features (e.g., genomic, assembly, and contamination) that cause distances inferred from k-mer profiles, which treat absent data as informative, to fail to accurately capture the distance between samples when compared to distances inferred from differences in nucleotide sites. Thus, site-based distances, like NUCmer and extended MLST, are superior in performance, but accessing the computing resources necessary to perform them may be challenging when analyzing large databases.	[Pettengill, James B.; Pightling, Arthur W.; Baugher, Joseph D.; Rand, Hugh; Strain, Errol] US FDA, Biostat & Bioinformat Staff, Ctr Food Safety & Appl Nutr, 5001 Campus Dr, College Pk, MD 20740 USA	US Food & Drug Administration (FDA)	Strain, E (corresponding author), US FDA, Biostat & Bioinformat Staff, Ctr Food Safety & Appl Nutr, 5001 Campus Dr, College Pk, MD 20740 USA.	errol.strain@fda.hhs.gov	PIGHTLING, ARTHUR/AAD-6621-2020	Baugher, Joseph/0000-0003-2466-3047	U.S. Department of Energy; FDA Center for Food Safety and Applied Nutrition; FDA	U.S. Department of Energy(United States Department of Energy (DOE)); FDA Center for Food Safety and Applied Nutrition; FDA(United States Department of Health & Human Services)	This project was supported in part by an appointment to the Research Participation Program at the Center for Food Safety and Applied Nutrition, Office of Foods and Veterinary Medicine, U.S. Food and Drug Administration, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and FDA.; We thank A. Schpuntoff for assistance with conducting the analyses on the high performance computing cluster and FDA Center for Food Safety and Applied Nutrition for supporting this research.	Achtman M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002776; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Broder AZ, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P21, DOI 10.1109/SEQUEN.1997.666900; Carrillo CD, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00057; Davis S, 2015, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.20; den Bakker HC, 2014, EMERG INFECT DIS, V20, P1306, DOI 10.3201/eid2008.131399; Deng XY, 2016, ANNU REV FOOD SCI T, V7, P353, DOI 10.1146/annurev-food-041715-033259; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Gardner SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081760; Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Ondov BD, 2015, FAST GENOME METAGENO, DOI [10.1101/029827, DOI 10.1101/029827]; Pightling AW, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0526-1; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Tettelin H, 2008, CURR OPIN MICROBIOL, V11, P472, DOI 10.1016/j.mib.2008.09.006; Timme RE, 2013, GENOME BIOL EVOL, V5, P2109, DOI 10.1093/gbe/evt159; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46	23	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166162	10.1371/journal.pone.0166162	http://dx.doi.org/10.1371/journal.pone.0166162			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832109	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000070
J	Lino, VTS; Rodrigues, NCP; O'Dwyer, G; de Noronha Andrade, MK; Mattos, IE; Portela, MC				Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; O'Dwyer, Gisele; de Noronha Andrade, Monica Kramer; Mattos, Ines Echenique; Portela, Margareth Crisostomo			Handgrip Strength and Factors Associated in Poor Elderly Assisted at a Primary Care Unit in Rio de Janeiro, Brazil	PLOS ONE			English	Article							MENTAL-STATE-EXAMINATION; SELF-RATED HEALTH; GRIP STRENGTH; MUSCLE STRENGTH; GAIT SPEED; OLDER; SARCOPENIA; POPULATION; DEPRESSION; FRAILTY	Introduction Sarcopenia is a condition diagnosed when the patient presents low muscle mass, plus low muscle strength or low physical performance. Muscle weakness in the oldest (dynapenia) is a major public health concern because it predicts future all-cause mortality and is associated with falls, disability, cardiovascular mortality and morbidity. Grip strength is a simple method for assessment of muscle function in clinical practice. Objective To estimate the grip strength and identify factors associated with handgrip strength variation in elderly people with low socioeconomic status. Methods Cross-sectional study based on a multidimensional assessment of primary care users that were 60 years or older. The sample size was calculated using an estimated prevalence of depression in older adults of 20%. A kappa coefficient of 0.6 with a 95% confidence interval was used to generate a conservative sample size of 180 individuals. Procedures: tests and scales to assess humor, cognition (MMSE), basic (ADL) and instrumental activities (IADL) of daily living, mobility (Timed Up and Go), strength, height, Body Mass Index (BMI) and social support were applied. Questions about falls, chronic diseases and self-rated health (SRH) were also included. Statistical Analysis: Mean, standard deviation and statistical tests were used to compare grip strength means by demographic and health factors. A multivariate linear model was used to explain the relationship of the predictors with grip strength. Results The group was composed predominantly by women (73%) with a very low level of education (mean 3 years of schooling), mean age of 73.09 (+/- 7.05) years old, good mobility and without IADL impairment. Mean grip strength of male and female were 31.86Kg (SD 5.55) and 21.69Kg (SD 4.48) [p-0.0001], respectively. Low grip strength was present in 27.7% of women and 39.6% of men. As expected, men and younger participants had higher grip strength than women and older individuals. In the adjusted model, age (p-0.03), female sex (p-0.0001), mobility (p-0.05), height (p-0.03) and depression (p-0.03) were independently associated with low grip strength. For every second more in the mobility test, there was a mean decrease of 0.08 Kg in the grip strength. Elders with depression had a mean reduction of 1.74Kg in the grip strength in relation to those in the comparison groups. There was an average reduction of 8.36Kg in the grip strength of elderly females relative to males. For each year of age after 60 years, it was expected an average reduction of 0.11 Kg in the grip strength. Conclusion our results suggest that low grip strength is associated with age, female sex, height, depression and mobility problems in poor elderly. Grip strength can be a simple, quick and inexpensive means of stratifying elders' risk of sarcopenia in the primary care setting. Efforts should be made to recognize weaker persons and the conditions associated to low grip strength in order to target early interventions to prevent frailty and disability.	[Saraiva Lino, Valeria Teresa; Pinheiro Rodrigues, Nadia Cristina; O'Dwyer, Gisele; de Noronha Andrade, Monica Kramer] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Primary Care, Rio De Janeiro, RJ, Brazil; [Mattos, Ines Echenique] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Portela, Margareth Crisostomo] Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Hlth Adm & Planning, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Lino, VTS (corresponding author), Fundacao Oswaldo Cruz, Natl Publ Hlth Sch, Dept Primary Care, Rio De Janeiro, RJ, Brazil.	valerialino@ensp.fiocruz.br	Portela, Margareth C/G-6699-2012; Lino, Valeria/ADI-4254-2022	Portela, Margareth C/0000-0002-9858-9276; 				Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P547, DOI [10.1007/s12603-014-0465-9, 10.1007/s12603-013-0424-x]; Almeida OP, 1998, ARQ NEURO-PSIQUIAT, V56, P605, DOI 10.1590/S0004-282X1998000400014; [Anonymous], 2009, WINPEPI PEPI FOR WIN; BERTOLUCCI PHF, 1994, ARQ NEURO-PSIQUIAT, V52, P1, DOI 10.1590/S0004-282X1994000100001; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Boirie Y, 2009, J NUTR HEALTH AGING, V13, P717, DOI 10.1007/s12603-009-0203-x; Busch TD, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0031-2; Carvalho M, 2012, INTEGRATED TERRITORY; Confortin SC, 2015, J GERIATR PHYS THER, V38, P162, DOI 10.1519/JPT.0000000000000027; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Alexandre TD, 2014, J NUTR HEALTH AGING, V18, P751, DOI [10.1007/s12603-014-0450-3, 10.1007/s12603-014-0540-2]; Bez JPD, 2014, CIENC SAUDE COLETIVA, V19, P3343, DOI 10.1590/1413-81232014198.09592013; Del-Ben Cristina Marta, 2001, Revista Brasileira de Psiquiatria, V23, P156, DOI 10.1590/S1516-44462001000300008; Dodds RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113637; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fukumori N, 2015, AGE AGEING, V44, P592, DOI 10.1093/ageing/afv013; Griep Rosane Harter, 2005, Cad. Saúde Pública, V21, P703, DOI 10.1590/S0102-311X2005000300004; Hairi FM, 2010, J EPIDEMIOL COMMUN H, V64, P829, DOI 10.1136/jech.2009.088476; Hansen AW, 2013, PREV MED, V57, P792, DOI 10.1016/j.ypmed.2013.08.029; Health Mo, 2009, VIGITEL BRAZ 2009 PR, P150; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kim NH, 2011, J AM GERIATR SOC, V59, P2062, DOI 10.1111/j.1532-5415.2011.03664.x; Leong DP, 2015, LANCET, V386, P266, DOI 10.1016/S0140-6736(14)62000-6; Li CY, 2007, J AM GERIATR SOC, V55, P596, DOI 10.1111/j.1532-5415.2007.01103.x; LIPSCHITZ DA, 1994, PRIMARY CARE, V21, P55; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P1265, DOI 10.1017/S1041610211002110; Moreira VG, 2013, CLINICS, V68, P979, DOI 10.6061/clinics/2013(07)15; Pasco JA, 2015, CURR OSTEOPOROS REP, V13, P351, DOI 10.1007/s11914-015-0279-7; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Ramlagan Shandir, 2014, BMC Res Notes, V7, P8, DOI 10.1186/1756-0500-7-8; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; Lino VTS, 2014, CAD SAUDE PUBLICA, V30, P2691, DOI 10.1590/0102-311X00023114; Sayer AA, 2006, AM J EPIDEMIOL, V164, P665, DOI 10.1093/aje/kwj255; Sayer AA, 2015, LANCET, V386, P226, DOI 10.1016/S0140-6736(14)62349-7; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Souza Edinilsa Ramos de, 2008, Ciênc. saúde coletiva, V13, P1153, DOI 10.1590/S1413-81232008000400011; Stenholm S, 2012, J AM GERIATR SOC, V60, P77, DOI 10.1111/j.1532-5415.2011.03779.x; Syddall HE, 2009, J NUTR HEALTH AGING, V13, P57, DOI 10.1007/s12603-009-0010-4	41	38	44	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166373	10.1371/journal.pone.0166373	http://dx.doi.org/10.1371/journal.pone.0166373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EB9ON	27832209	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000114
J	Sharma, RK; Sonkar, K; Sinha, N; Rebala, P; Albani, AE; Behari, A; Reddy, DN; Farooqui, A; Kapoor, VK				Sharma, Raj Kumar; Sonkar, Kanchan; Sinha, Neeraj; Rebala, Pradeep; Albani, Ahmad Ebrah; Behari, Anu; Reddy, Duvvuri Nageshwar; Farooqui, Alvina; Kapoor, Vinay Kumar			Gallstones: A Worldwide Multifaceted Disease and Its Correlations with Gallbladder Carcinoma	PLOS ONE			English	Article							CANCER; DIET; RISK	Background Gallstones (GS) associated diseases are among the most recurrent and frequent diseases delineated in India and United Arab Emirates. Several reports suggest that the association of GS with gallbladder cancer (GBC) is very high in Northern part of India; however, its occurrence in UAE and Southern part of India is notably low. Therefore, in the present study, we aimed to perform compositional analysis of GS in three different geographical areas by Solid State Nuclear Magnetic Resonance and Fourier Transformed Infrared spectroscopy. Methods Natural abundance C-13 cross polarization magic angle spinning Nuclear Magnetic Resonance and Fourier Transform Infrared spectroscopy is employed for the analysis of human gallstone. Results Cholesterol, bilirubin and calcium carbonate were present in variant concentrations in GS obtained from three different geographical regions. Cholesterol was present predominantly in gallstones from North India. Bilirubin was found to be a main constituent in gallstones pertaining to South India. Whereas GS from UAE showed both cholesterol and bilirubin as their major constituents. Calcium carbonate was found in varying concentrations in gallstones acquired from different regions. Conclusion Variation in environmental condition and dietary habits may contribute and affect the GS formation. Alterations in bile composition influence the GB and augment the crystallization of cholesterol. Analysis of different geographical regions GS could be an important stride to understand the etiology of GS diseases.	[Sharma, Raj Kumar; Sonkar, Kanchan; Sinha, Neeraj] Sanjay Gandhi Post Grad Inst Med Sci SGPGIMS Camp, Ctr Biomed Res, Lucknow, Uttar Pradesh, India; [Sharma, Raj Kumar; Farooqui, Alvina] Integral Univ, Dept Biosci, Kursi Rd, Lucknow, Uttar Pradesh, India; [Sonkar, Kanchan] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Rebala, Pradeep; Reddy, Duvvuri Nageshwar] Asian Inst Gastroenterol, Dept Surg Gastroenterol, Hyderabad, Andhra Pradesh, India; [Albani, Ahmad Ebrah] Zayad Mil Hosp, Dept Surg, Abu Dhabi, U Arab Emirates; [Behari, Anu; Kapoor, Vinay Kumar] SGPGIMS, Dept Surg Gastroenterol, Raibarelly Rd, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Integral University; University of Pennsylvania; Pennsylvania Medicine; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Sinha, N (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci SGPGIMS Camp, Ctr Biomed Res, Lucknow, Uttar Pradesh, India.	neerajcbmr@gmail.com	Sharma, Raj Kumar/AAQ-5288-2021; Sonkar, Kanchan/AAF-9054-2019	Sharma, Raj Kumar/0000-0003-0623-3238; Sinha, Neeraj/0000-0003-3235-6127				AHO AJ, 1985, SCAND J GASTROENTERO, V20, P901, DOI 10.3109/00365528509088843; Akoka S, 1999, ANAL CHEM, V71, P2554, DOI 10.1021/ac981422i; Athanasiadou D, 2013, J TRACE ELEM MED BIO, V27, P79, DOI 10.1016/j.jtemb.2012.08.004; Attili AF, 1998, HEPATOLOGY, V27, P1492, DOI 10.1002/hep.510270605; CAREY MC, 1996, BILE ACIDS CHOLESTAS, P147; Chhabra D, 2012, ASIAN PAC J CANCER P, V13, P187, DOI 10.7314/APJCP.2012.13.1.187; CHOUDHURI G, 1995, J GASTROEN HEPATOL, V10, P241, DOI 10.1111/j.1440-1746.1995.tb01087.x; Jayalakshmi K, 2009, SOLID STATE NUCL MAG, V36, P60, DOI 10.1016/j.ssnmr.2009.06.001; Jayanthi V, 2005, Indian J Gastroenterol, V24, P97; Kapoor VK, 2007, J HEPATO-BILIARY-PAN, V14, P366, DOI 10.1007/s00534-006-1189-y; Kapoor VK, 2006, J SURG ONCOL, V93, P607, DOI 10.1002/jso.20525; Kapoor VK, 2003, NATL MED J INDIA, V16, P209; Kleiner O, 2002, BMC GASTROENTEROL, V2, P11; LOWENFELS AB, 1985, JNCI-J NATL CANCER I, V75, P77; Misciagna G, 1999, AM J CLIN NUTR, V69, P120; Rai RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083478; Raman RG., 2008, ROMANIAN J BIOPHYS, V18, P309; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Sikkandar S., 2011, INT J CHEM TECH RES, V3, P149; Srivastava M, 2008, HEPATOL RES, V38, P997, DOI 10.1111/j.1872-034X.2008.00356.x; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; Sum PL, 1999, TXB GASTROENTEROLOGY, V2, P2258; SUTOR DJ, 1969, GUT, V10, P681, DOI 10.1136/gut.10.8.681; SUTOR DJ, 1971, GUT, V12, P55, DOI 10.1136/gut.12.1.55; van Erpecum KJ, 2005, BIOL CELL, V97, P815, DOI 10.1042/BC20040088; Wistuba II, 2004, NAT REV CANCER, V4, P695, DOI 10.1038/nrc1429	26	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166351	10.1371/journal.pone.0166351	http://dx.doi.org/10.1371/journal.pone.0166351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832205	Green Submitted, gold, Green Published			2022-12-26	WOS:000387725000106
J	Ahmad, A; Mitrofanova, A; Bielawski, J; Yang, YD; Marples, B; Fornoni, A; Zeidan, YH				Ahmad, Anis; Mitrofanova, Alla; Bielawski, Jacek; Yang, Yidong; Marples, Brian; Fornoni, Alessia; Zeidan, Youssef H.			Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes	FASEB JOURNAL			English	Article						lipids; cancer; ceramide; radioprotection	ACID CERAMIDASE; RESISTANCE; SPHINGOLIPIDS; NEPHROPATHY; RITUXIMAB; PREVENTS; NEPHRIN; PATHWAY	The molecular mechanisms responsible for the development of proteinuria and glomerulosclerosis in radiation nephropathy remain largely unknown. Podocytes are increasingly recognized as key players in the pathogenesis of proteinuria in primary and secondary glomerular disorders. The lipid-modulating enzyme sphingomyelin phosphodiesterase acid-like 3B (SMPDL3b) is a key determinant of podocyte injury and a known off target of the anti-CD20 antibody rituximab (RTX). The current study investigates the role of sphingolipids in radiation-induced podocytopathy. After a single dose of radiation (8 Gy), several ceramide species were significantly elevated. In particular, C16:00, C24:00, and C24:1 ceramides were the most abundant ceramide species detected. These changes were paralleled by a time-dependent drop in SMPDL3b protein, sphingosine, and sphingosine-1-phosphate levels. Interestingly, SMPDL3b-overexpressing podocytes had higher basal levels of sphingosine-1-phosphate and maintained basal ceramide levels after irradiation. Morphologically, irradiated podocytes demonstrated loss of filopodia and remodeling of cortical actin. Furthermore, the actin binding protein ezrin relocated from the plasma membrane to the cytosol as early as 2 h after radiation. In contrast, SMPDL3b overexpressing podocytes were protected from radiation-induced cytoskeletal remodeling. Treatment with RTX before radiation exposure partially protected podocytes from SMPDL3b loss, cytoskeletal remodeling, and caspase 3 cleavage. Our results demonstrate that radiation injury induces early cytoskeletal remodeling, down-regulation of SMPDL3b, and elevation of cellular ceramide levels. Overexpression of SMPDL3b and pretreatment with RTX confer a radioprotective effect in cultured podocytes. These findings indicate a potential role for SMPDL3b and RTX in radiation-induced podocytopathy.	[Ahmad, Anis; Yang, Yidong; Marples, Brian; Zeidan, Youssef H.] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Dept Radiat Oncol, Miami, FL 33136 USA; [Mitrofanova, Alla; Fornoni, Alessia] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL 33136 USA; [Mitrofanova, Alla] Univ Miami, Dept Surg, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Div Nephrol, Miami, FL 33136 USA; [Mitrofanova, Alla; Fornoni, Alessia] Univ Miami, Dept Med, Miami, FL 33136 USA; [Bielawski, Jacek] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Beirut, Lebanon	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Medical University of South Carolina; American University of Beirut	Zeidan, YH (corresponding author), Amer Univ Beirut, Med Ctr, Dept Radiat Oncol, POB 11-0236, Beirut 11072020, Lebanon.	yz09@aub.edu.lb	Mitrofanova, Alla/L-1590-2019; Zeidan, Youssef H./H-7578-2019; Ahmad, Anis/AAA-7263-2019	Mitrofanova, Alla/0000-0001-5065-9522; Zeidan, Youssef H./0000-0002-1951-8585; Ahmad, Anis/0000-0001-9820-2126; fornoni, Alessia/0000-0002-1313-7773	U.S. National Institutes of Health [DK104753, DK090316]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090316, R01DK104753] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.F. is an inventor of pending patents aimed to diagnose or treat proteinuric renal diseases, and stands to gain royalties from their future commercialization. A.F. is also a consultant for Hoffman-La Roche, Genentech, Jannsen, Mesoblast, Abbvie, Boehringer Ingelheim, Alexion, and Bristol- Myers Squibb. A.F. is funded by U.S. National Institutes of Health Grants DK104753 and DK090316.	Aureli M, 2014, GLYCOCONJUGATE J, V31, P449, DOI 10.1007/s10719-014-9541-y; Basic-Jukic N, 2013, CURR PHARM DESIGN, V19, P6046; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; CASSADY JR, 1995, INT J RADIAT ONCOL, V31, P1249, DOI 10.1016/0360-3016(94)00428-N; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Cohen EP, 2003, SEMIN NEPHROL, V23, P486, DOI 10.1016/S0270-9295(03)00093-7; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; LUXTON RW, 1961, LANCET, V2, P1221; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00127; Oikawa T, 1997, KIDNEY INT, V51, P164, DOI 10.1038/ki.1997.20; Perosa F, 2006, BLOOD, V107, P1070, DOI 10.1182/blood-2005-04-1769; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; Sha H, 2016, ONCOTARGET, V7, P18825, DOI 10.18632/oncotarget.7939; STEPHENS LC, 1995, INT J RADIAT ONCOL, V31, P865, DOI 10.1016/0360-3016(94)00437-4; Tasaki M, 2014, J AM SOC NEPHROL, V25, P737, DOI 10.1681/ASN.2013040363; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yang GY, 2010, INT J RADIAT ONCOL, V78, P539, DOI 10.1016/j.ijrobp.2009.07.1744; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zeng J, 2014, LANCET ONCOL, V15, pE426, DOI 10.1016/S1470-2045(14)70026-9	35	29	30	3	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					771	780		10.1096/fj.201600618R	http://dx.doi.org/10.1096/fj.201600618R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836988	Green Published			2022-12-26	WOS:000394235400029
J	Ojelabi, OA; Lloyd, KP; Simon, AH; De Zutter, JK; Carruthers, A				Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; Simon, Andrew H.; De Zutter, Julie K.; Carruthers, Anthony			WZB117 (2-Fluoro-6-(m-hydroxybenzoyloxy) Phenyl m-Hydroxybenzoate) Inhibits GLUT1-mediated Sugar Transport by Binding Reversibly at the Exofacial Sugar Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE GLUCOSE-TRANSPORT; HEXOSE TRANSFER SYSTEM; DEFICIENCY SYNDROME; HUMAN ERYTHROCYTES; MONOSACCHARIDE TRANSPORT; SEQUENCE DETERMINANTS; CYTOCHALASIN-B; CANCER; METABOLISM; GLYCOLYSIS	WZB117 (2-fluoro-6-(m-hydroxybenzoyloxy) phenyl m-hydroxybenzoate) inhibits passive sugar transport in human erythrocytes and cancer cell lines and, by limiting glycolysis, inhibits tumor growth in mice. This study explores how WZB117 inhibits the erythrocyte sugar transporter glucose transport protein 1 (GLUT1) and examines the transporter isoform specificity of inhibition. WZB117 reversibly and competitively inhibits erythrocyte 3-O-methylglucose (3MG) uptake with K-i(app) = 6 mu M but is a noncompetitive inhibitor of sugar exit. Cytochalasin B (CB) is a reversible, noncompetitive inhibitor of 3MG uptake with K-i(app) = 0.3 mu M but is a competitive inhibitor of sugar exit indicating that WZB117 and CB bind at exofacial and endofacial sugar binding sites, respectively. WZB117 inhibition of GLUTs expressed in HEK293 cells follows the order of potency: insulin-regulated GLUT4 >> GLUT1 approximate to neuronal GLUT3. This may explain WZB117-induced murine lipodystrophy. Molecular docking suggests the following. 1) The WZB117 binding envelopes of exofacial GLUT1 and GLUT4 conformers differ significantly. 2) GLUT1 and GLUT4 exofacial conformers present multiple, adjacent glucose binding sites that overlap with WZB117 binding envelopes. 3) The GLUT1 exofacial conformer lacks a CB binding site. 4) The inward GLUT1 conformer presents overlapping endofacial WZB117, D-glucose, and CB binding envelopes. Interrogating the GLUT1 mechanism using WZB117 reveals that subsaturating WZB117 and CB stimulate erythrocyte 3MG uptake. Extracellular WZB117 does not affect CB binding to GLUT1, but intracellular WZB117 inhibits CB binding. These findings are incompatible with the alternating conformer carrier for glucose transport but are consistent with either a multisubunit, allosteric transporter, or a transporter in which each subunit presents multiple, interacting ligand binding sites.	[Ojelabi, Ogooluwa A.; Lloyd, Kenneth P.; Simon, Andrew H.; De Zutter, Julie K.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Room 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu			National Institutes of Health [DK036081, DK044888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK036081 and DK044888. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAKER GF, 1978, J PHYSIOL-LONDON, V278, P377, DOI 10.1113/jphysiol.1978.sp012310; Baracca A, 2010, BBA-BIOENERGETICS, V1797, P314, DOI 10.1016/j.bbabio.2009.11.006; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BARNETT JEG, 1975, BIOCHEM J, V145, P417, DOI 10.1042/bj1450417a; BASKETTER DA, 1978, J PHYSIOL-LONDON, V278, P389, DOI 10.1113/jphysiol.1978.sp012311; Blodgett DM, 2015, DIABETES, V64, P3172, DOI 10.2337/db15-0039; Brockmann K, 2009, BRAIN DEV-JPN, V31, P545, DOI 10.1016/j.braindev.2009.02.008; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3898, DOI 10.1021/bi00230a014; CARRUTHERS A, 1986, BIOCHEMISTRY-US, V25, P3592, DOI 10.1021/bi00360a018; CARRUTHERS A, 1991, BIOCHEMISTRY-US, V30, P3907, DOI 10.1021/bi00230a015; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; Cunningham P, 2006, J BIOL CHEM, V281, P5797, DOI 10.1074/jbc.M509422200; Cunningham P, 2014, J MEMBRANE BIOL, V247, P1161, DOI 10.1007/s00232-014-9711-7; Cunningham P, 2013, J MEMBRANE BIOL, V246, P495, DOI 10.1007/s00232-013-9564-5; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; De Giorgis V, 2013, SEIZURE-EUR J EPILEP, V22, P803, DOI 10.1016/j.seizure.2013.07.003; De Vivo DC, 2002, J CHILD NEUROL, V17, pS15; De Zutter JK, 2013, J BIOL CHEM, V288, P20734, DOI 10.1074/jbc.M113.469023; Deng D, 2015, NATURE, V526, P391, DOI 10.1038/nature14655; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; DEVES R, 1978, BIOCHIM BIOPHYS ACTA, V510, P339, DOI 10.1016/0005-2736(78)90034-2; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; GORGA FR, 1982, BIOCHEMISTRY-US, V21, P1905, DOI 10.1021/bi00537a031; Graybill C, 2006, BIOCHEMISTRY-US, V45, P8096, DOI 10.1021/bi060398x; Hamill S, 1999, BIOCHEMISTRY-US, V38, P16974, DOI 10.1021/bi9918792; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; HELGERSON AL, 1987, J BIOL CHEM, V262, P5464; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JAMES DE, 1989, NATURE, V338, P83, DOI 10.1038/338083a0; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; Klepper J, 2008, EPILEPSIA, V49, P46, DOI 10.1111/j.1528-1167.2008.01833.x; KRUPKA RM, 1981, J BIOL CHEM, V256, P5410; Leitch JM, 2009, AM J PHYSIOL-CELL PH, V296, pC151, DOI 10.1152/ajpcell.00359.2008; Li Q, 2004, AM J PHYSIOL-GASTR L, V287, pG236, DOI 10.1152/ajpgi.00396.2003; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; Liu Y, 2012, MOL CANCER THER, V11, P1672, DOI 10.1158/1535-7163.MCT-12-0131; Madej MG, 2014, P NATL ACAD SCI USA, V111, pE719, DOI 10.1073/pnas.1400336111; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; Naftalin RJ, 2003, BRIT J PHARMACOL, V140, P487, DOI 10.1038/sj.bjp.0705460; Palorini R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.257; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Sage JM, 2015, AM J PHYSIOL-CELL PH, V308, pC827, DOI 10.1152/ajpcell.00001.2015; Sage JM, 2014, AM J PHYSIOL-CELL PH, V306, pC910, DOI 10.1152/ajpcell.00044.2014; Segel I. H., 1975, ENZYME KINETICS, P355; Shibuya K, 2015, ONCOTARGET, V6, P651, DOI 10.18632/oncotarget.2892; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; Vollers SS, 2012, J BIOL CHEM, V287, P42533, DOI 10.1074/jbc.M112.369587; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Xintaropoulou C, 2015, ONCOTARGET, V6, P25677, DOI 10.18632/oncotarget.4499; Zhang WH, 2010, BIOORG MED CHEM LETT, V20, P2191, DOI 10.1016/j.bmcl.2010.02.027; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	60	54	55	2	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2016	291	52					26762	26772		10.1074/jbc.M116.759175	http://dx.doi.org/10.1074/jbc.M116.759175			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EH2BE	27836974	Green Published, hybrid			2022-12-26	WOS:000391571400015
J	Geier, U; Bussing, A; Kruse, P; Greiner, R; Buchecker, K				Geier, Uwe; Buessing, Arndt; Kruse, Pamela; Greiner, Ramona; Buchecker, Kirsten			Development and Application of a Test for Food-Induced Emotions	PLOS ONE			English	Article							MOOD; QUESTIONNAIRE; CONSUMPTION; RESPONSES; LIKING; 1ST	This study aimed to develop a test to measure food-induced emotions suitable for stable food and beverages. All of the experiments were conducted under the conditions of a consumer sensory evaluation according to German standard DIN 10974. Test development included descriptors' derivation and factor analysis as well as a comparison between the new test (empathic food test, EFT) and a hedonic sensory test and an unspecific psychological test, known as a multidimensional mood questionnaire (MDMQ). Nineteen sensory experts derived twelve items using free-choice profiling. After an exploratory factor analyses, ten of the intended twelve items were integrated into two scales. To compare the new questionnaire (EFT) to the MDMQ and a hedonic test, panels of 59 (EFT), 64 (MDMQ) and 63 (hedonic sensory test) untrained individuals described their perceptions after consuming sensorially similar pairs of milk, water, bread and sugar. The benchmark of comparison was the power to discriminate between the food pairs. Test-retest replicability was demonstrated. All three tests presented slight differences in sample preference and effect size depending on the offered products. These findings underscore the need to test new methods with a wide range of products. Further research is needed to investigate the relationship between sensorial perception and emotional response.	[Geier, Uwe; Greiner, Ramona] Forschungsring eV, Brandschneise 5, D-64295 Darmstadt, Germany; [Buessing, Arndt] Univ Witten Herdecke, Dept Human Med, Gerhard Kienle Weg 4, D-58313 Herdecke, Germany; [Kruse, Pamela; Buchecker, Kirsten] Technol Transfer Zentrum Ttz Bremerhaven, Fischkai 1, D-27572 Bremerhaven, Germany	Witten Herdecke University	Geier, U (corresponding author), Forschungsring eV, Brandschneise 5, D-64295 Darmstadt, Germany.	geier@forschungsring.de		Bussing, Arndt/0000-0002-5025-7950	Mahle Stiftung GmbH; Software AG Stiftung; Zukunftstiftung Landwirtschaft	Mahle Stiftung GmbH; Software AG Stiftung; Zukunftstiftung Landwirtschaft	This research was supported by the Mahle Stiftung GmbH, the Software AG Stiftung, and the Zukunftstiftung Landwirtschaft. UG and RG receive salary from Forschungsring e.V., and KB and PK receive salary from ttz Bremerhaven. The authors of the Forschungsring e.V. (UG and RG) were responsible for coordination, conceptualization, administration and methodology in the study, while the authors of the It Bremerhaven (KB and PK) were in charge of realization of the experiments in the laboratory. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, 8599 ISO; [Anonymous], 2008, 10974 DIN; [Anonymous], 2014, 11136 ISO; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Bryan J, 2012, APPETITE, V58, P339, DOI 10.1016/j.appet.2011.11.009; Cohen J.E., 1988, STAT POWER ANAL BEHA; Deutsche Gesellschaft fur Pschologie (DGPs), 2015, ETH RICHTL DGPS BDP; Durrschmid K., 2008, J EMAHRUNGSMEDZIN, V10, P15; Ferrarini R, 2010, FOOD QUAL PREFER, V21, P720, DOI 10.1016/j.foodqual.2010.06.004; Geier U, 2012, J SCI FOOD AGR, V92, P2753, DOI 10.1002/jsfa.5699; Gmuer A, 2015, FOOD QUAL PREFER, V40, P77, DOI 10.1016/j.foodqual.2014.09.001; Gutjar S, 2015, FOOD RES INT, V76, P216, DOI 10.1016/j.foodres.2014.12.022; Hays W.L., 1994, STATISTICS-ABINGDON, V5th ed.; Hendy HM, 2012, APPETITE, V58, P771, DOI 10.1016/j.appet.2011.11.014; Institute of Food Science and Teschnology, 2015, IFST GUID ETH PROF P; ISO, 2003, SENS AN METH GEN GUI; Jager G, 2014, FOOD QUAL PREFER, V37, P87, DOI 10.1016/j.foodqual.2014.04.010; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Khoury B, 2015, J PSYCHOSOM RES, V78, P519, DOI 10.1016/j.jpsychores.2015.03.009; King SC, 2013, FOOD QUAL PREFER, V28, P8, DOI 10.1016/j.foodqual.2012.08.007; King SC, 2010, FOOD QUAL PREFER, V21, P168, DOI 10.1016/j.foodqual.2009.02.005; Koster EP, 2015, FOOD RES INT, V76, P180, DOI 10.1016/j.foodres.2015.04.006; Leitch KA, 2015, FOOD RES INT, V76, P283, DOI 10.1016/j.foodres.2015.04.039; Manzocco L, 2013, FOOD QUAL PREFER, V28, P17, DOI 10.1016/j.foodqual.2012.08.014; McNair P.M., 1971, PROFILE MOOD STATES; Meiselman HL, 2015, FOOD RES INT, V76, P192, DOI 10.1016/j.foodres.2015.04.015; Mojet J, 2015, FOOD RES INT, V76, P224, DOI 10.1016/j.foodres.2015.06.031; Ng M, 2013, FOOD QUAL PREFER, V29, P146, DOI 10.1016/j.foodqual.2013.03.006; Ng M, 2013, FOOD QUAL PREFER, V28, P193, DOI 10.1016/j.foodqual.2012.08.012; Nummenmaa L, 2014, P NATL ACAD SCI USA, V111, P646, DOI 10.1073/pnas.1321664111; Olabi A, 2015, FOOD QUAL PREFER, V40, P110, DOI 10.1016/j.foodqual.2014.09.003; Piqueras-Fiszman B, 2014, FOOD QUAL PREFER, V35, P24, DOI 10.1016/j.foodqual.2014.01.007; Porcherot C, 2015, FOOD QUAL PREFER, V39, P277, DOI 10.1016/j.foodqual.2014.07.016; Porcherot C, 2010, FOOD QUAL PREFER, V21, P938, DOI 10.1016/j.foodqual.2010.03.012; Siegrist M, 2015, FOOD QUAL PREFER, V39, P183, DOI 10.1016/j.foodqual.2014.07.010; Spinelli S, 2014, FOOD QUAL PREFER, V37, P109, DOI 10.1016/j.foodqual.2013.11.009; Steyer, 1997, MEHRDIMENSIONALE BEF; Steyer R., 1994, DIAGNOSTICA, V40, P320; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; The Market Research Society (MRS), 2014, COD COND, P1; Thomson DMH, 2010, FOOD QUAL PREFER, V21, P1117, DOI 10.1016/j.foodqual.2010.04.011; Walsh AM, 2015, FOOD RES INT, V76, P293, DOI 10.1016/j.foodres.2015.02.027; Zhang BY, 2015, FOOD QUAL PREFER, V41, P172, DOI 10.1016/j.foodqual.2014.12.004	44	10	10	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165991	10.1371/journal.pone.0165991	http://dx.doi.org/10.1371/journal.pone.0165991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC7WC	27861503	Green Published, gold, Green Submitted			2022-12-26	WOS:000388350300019
J	Markopoulou, K; Chase, BA; Robowski, P; Strongosky, A; Narozanska, E; Sitek, EJ; Berdynski, M; Barcikowska, M; Baker, MC; Rademakers, R; Slawek, J; Klein, C; Huckelheim, K; Kasten, M; Wszolek, ZK				Markopoulou, Katerina; Chase, Bruce A.; Robowski, Piotr; Strongosky, Audrey; Narozanska, Ewa; Sitek, Emilia J.; Berdynski, Mariusz; Barcikowska, Maria; Baker, Matt C.; Rademakers, Rosa; Slawek, Jaroslaw; Klein, Christine; Hueckelheim, Katja; Kasten, Meike; Wszolek, Zbigniew K.			Assessment of Olfactory Function in MAPT-Associated Neurodegenerative Disease Reveals Odor-Identification Irreproducibility as a Non-Disease-Specific, General Characteristic of Olfactory Dysfunction	PLOS ONE			English	Article							MONTREAL COGNITIVE ASSESSMENT; LEWY BODY DISEASE; PARKINSONS-DISEASE; FRONTOTEMPORAL DEMENTIA; NONMOTOR SYMPTOMS; SCREENING TOOL; TAU GENE; IMPAIRMENT; MUTATION; N279K	Olfactory dysfunction is associated with normal aging, multiple neurodegenerative disorders, including Parkinson's disease, Lewy body disease and Alzheimer's disease, and other diseases such as diabetes, sleep apnea and the autoimmune disease myasthenia gravis. The wide spectrum of neurodegenerative disorders associated with olfactory dysfunction suggests different, potentially overlapping, underlying pathophysiologies. Studying olfactory dysfunction in presymptomatic carriers of mutations known to cause familial parkinsonism provides unique opportunities to understand the role of genetic factors, delineate the salient characteristics of the onset of olfactory dysfunction, and understand when it starts relative to motor and cognitive symptoms. We evaluated olfactory dysfunction in 28 carriers of two MAPT mutations (p.N279K, p.P301L), which cause frontotemporal dementia with parkinsonism, using the University of Pennsylvania Smell Identification Test. Olfactory dysfunction in carriers does not appear to be allele specific, but is strongly age-dependent and precedes symptomatic onset. Severe olfactory dysfunction, however, is not a fully penetrant trait at the time of symptom onset. Principal component analysis revealed that olfactory dysfunction is not odor-class specific, even though individual odor responses cluster kindred members according to genetic and disease status. Strikingly, carriers with incipient olfactory dysfunction show poor inter-test consistency among the sets of odors identified incorrectly in successive replicate tests, even before severe olfactory dysfunction appears. Furthermore, when 78 individuals without neurodegenerative disease and 14 individuals with sporadic Parkinson's disease were evaluated twice at a one-year interval using the Brief Smell Identification Test, the majority also showed inconsistency in the sets of odors they identified incorrectly, independent of age and cognitive status. While these findings may reflect the limitations of these tests used and the sample sizes, olfactory dysfunction appears to be associated with the inability to identify odors reliably and consistently, not with the loss of an ability to identify specific odors. Irreproducibility in odor identification appears to be a non-disease-specific, general feature of olfactory dysfunction that is accelerated or accentuated in neurodegenerative disease. It may reflect a fundamental organizational principle of the olfactory system, which is more "error-prone" than other sensory systems.	[Markopoulou, Katerina] NorthShore Univ Hlth Syst, Evanston, IL USA; [Chase, Bruce A.] Univ Nebraska, Dept Biol, Omaha, NE 68182 USA; [Robowski, Piotr; Narozanska, Ewa; Sitek, Emilia J.; Slawek, Jaroslaw] Med Univ Gdansk, Dept Neurol & Psychiat Nursing, Gdansk, Poland; [Robowski, Piotr; Narozanska, Ewa; Sitek, Emilia J.; Slawek, Jaroslaw] Copernicus PL Sp Zoo, St Adalbert Hosp, Dept Neurol, Gdansk, Poland; [Strongosky, Audrey; Baker, Matt C.; Rademakers, Rosa] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Berdynski, Mariusz; Barcikowska, Maria] Polish Acad Sci, Dept Neurodegenerat Disorders, Mossakowski Med Res Ctr, Warsaw, Poland; [Klein, Christine; Hueckelheim, Katja; Kasten, Meike] Univ Lubeck, Inst Neurogenet, Lubeck, Germany; [Hueckelheim, Katja; Kasten, Meike] Univ Lubeck, Dept Psychiat & Psychotherapy, Lubeck, Germany; [Wszolek, Zbigniew K.] Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL USA	NorthShore University Health System; University of Nebraska System; Fahrenheit Universities; Medical University Gdansk; Mayo Clinic; Polish Academy of Sciences; Mossakowski Medical Research Institute of the Polish Academy of Sciences; University of Lubeck; University of Lubeck; Mayo Clinic	Markopoulou, K (corresponding author), NorthShore Univ Hlth Syst, Evanston, IL USA.	amarkopoulou@northshore.org	Berdyński, Mariusz/W-2382-2018; Sitek, Emilia/AAJ-2666-2021; Sitek, Emilia/I-6913-2013; Klein, Christine/AGK-8003-2022; Wszolek, Zbigniew K./AAB-1431-2019	Berdyński, Mariusz/0000-0003-2076-4318; Sitek, Emilia/0000-0003-4141-072X; Sitek, Emilia/0000-0003-4141-072X; Slawek, Jaroslaw/0000-0001-6816-0877; Klein, Christine/0000-0003-2102-3431; Kasten, Meike/0000-0003-1910-6035	NIH [NS057567, P50 NS072187, R01 NS080882, R01 NS065782, R01 AG026251, R01 NS076471, P50 AG16574]; Mayo Clinic Center for Regenerative Medicine; Center for Individualized Medicine; Mayo Clinic Neuroscience Focused Research Team Grant; German Research Foundation [KL 1134/11-1, KL 1134/12-1, KL 1134/13-1, SFB 936, SFB 134, KA 3179/2-1]; German Federal Ministry of Education and Research (BMBF) [01ED1406]; StemBANCC [15439-2]; Hermann and Lilly Schilling Foundation; ALS Therapy Alliance; Consortium for Frontotemporal Degeneration Research; FIRE program at the University of Nebraska at Omaha; UCRCA program at the University of Nebraska at Omaha	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Center for Regenerative Medicine; Center for Individualized Medicine; Mayo Clinic Neuroscience Focused Research Team Grant; German Research Foundation(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); StemBANCC; Hermann and Lilly Schilling Foundation; ALS Therapy Alliance; Consortium for Frontotemporal Degeneration Research; FIRE program at the University of Nebraska at Omaha; UCRCA program at the University of Nebraska at Omaha	KM, PR, AS, EN, EJS, MBer, MBar, MCB, JS and KH report no disclosure. ZKW is funded by the NIH (NS057567, P50 NS072187; http://www.ninds.nh.gov), the Mayo Clinic Center for Regenerative Medicine and Center for Individualized Medicine, the Mayo Clinic Neuroscience Focused Research Team Grant, and a gift from Carl Edward Bolch Jr. and Susan Bass Bolch. CK is funded by the German Research Foundation (KL 1134/11-1; KL 1134/12-1; KL 1134/13-1, SFB 936; SFB 134; www.dfg.de/en/research_funding/programmes/index.jsp), the German Federal Ministry of Education and Research (BMBF) (01ED1406; www.bmbf.de), and StemBANCC (15439-2; stembaocc.org) and is the recipient of a career development award from the Hermann and Lilly Schilling Foundation (www.schilling-stiftung.de). MK is funded by the German Research Foundation (KA 3179/2-1). RR is funded by the NIH (R01 NS080882, R01 NS065782, R01 AG026251, R01 NS076471, and P50 AG16574), the ALS Therapy Alliance (alstherapyalliance.org), and the Consortium for Frontotemporal Degeneration Research (http://memory.ucsf.edu/ftd/research/laboratory/cfr). BAC is funded by the FIRE and UCRCA programs at the University of Nebraska at Omaha (http://www.unomaha.edu/office-of-research-and-creative-activity). Individuals employed or contracted by the funders, other than the named authors, played no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Alves J, 2014, WORLD J CLIN CASES, V2, P661, DOI 10.12998/wjcc.v2.i11.661; Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787; Arvanitakis Z, 2007, PARKINSONISM RELAT D, V13, P230, DOI 10.1016/j.parkreldis.2006.10.007; Audouze K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093037; Bohnen NI, 2007, J NEUROL, V254, P84, DOI 10.1007/s00415-006-0284-y; Bohnen NI, 2013, J NEURAL TRANSM, V120, P571, DOI 10.1007/s00702-012-0956-y; Borghammer P, 2014, INT J CLIN PRACT, V68, P1345, DOI 10.1111/ijcp.12445; Braga-Neto P, 2011, PARKINSONISM RELAT D, V17, P353, DOI 10.1016/j.parkreldis.2011.02.004; Cain WS, 1998, CHEM SENSES, V23, P309, DOI 10.1093/chemse/23.3.309; Cavaco S, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/976589; Chou KL, 2009, PARKINSONISM RELAT D, V15, P640, DOI 10.1016/j.parkreldis.2009.03.004; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Godoy MDCL, 2015, INT ARCH OTORHINOLAR, V19, P176, DOI 10.1055/s-0034-1390136; Devanand DP, 2010, NEUROBIOL AGING, V31, P1593, DOI 10.1016/j.neurobiolaging.2008.09.008; Doty RL, 2007, PARKINSONISM RELAT D, V13, pS225, DOI 10.1016/S1353-8020(08)70006-3; Doty RL, 2008, ANN NEUROL, V63, P7, DOI 10.1002/ana.21327; Doty RL, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00020; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Doty RL, 2012, NEUROBIOL DIS, V46, P527, DOI 10.1016/j.nbd.2011.10.026; DOTY RL, 1992, J NEUROL NEUROSUR PS, V55, P138, DOI 10.1136/jnnp.55.2.138; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006; Filippi M, 2013, LANCET NEUROL, V12, P12, DOI 10.1016/S1474-4422(12)70288-0; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Fullard ME, 2016, PARKINSONISM RELAT D, V25, P45, DOI 10.1016/j.parkreldis.2016.02.013; Georgiopoulos C, 2015, J NEUROL, V262, P2154, DOI 10.1007/s00415-015-7830-4; Ghosh S, 2013, AM J ALZHEIMERS DIS; Giessel AJ, 2014, CURR OPIN NEUROBIOL, V24, P120, DOI 10.1016/j.conb.2013.09.010; Gill DJ, 2008, MOVEMENT DISORD, V23, P1043, DOI 10.1002/mds.22017; Goedert M, 2005, BBA-MOL BASIS DIS, V1739, P240, DOI 10.1016/j.bbadis.2004.08.007; GOETZ CG, 1995, MOVEMENT DISORD, V10, P263, DOI 10.1002/mds.870100305; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Goldman JG, 2014, CURR OPIN NEUROL, V27, P434, DOI 10.1097/WCO.0000000000000112; Grant AC, 2014, EPILEPSY BEHAV, V32, P102, DOI 10.1016/j.yebeh.2014.01.011; Gwet KL., 2008, WILEY ENCY CLIN TRIA, P473, DOI DOI 10.1002/9780471462422.EOCT631; Hagenah JM, 2008, J NEUROL NEUROSUR PS, V79, P1071, DOI 10.1136/jnnp.2007.142174; Hawkes C, 2006, ADV OTO-RHINO-LARYNG, V63, P133, DOI 10.1159/000093759; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Ibarretxe-Bilbao N, 2010, MOVEMENT DISORD, V25, P1888, DOI 10.1002/mds.23208; Iranzo A, 2013, PARKINSONISM RELAT D, V19, P600, DOI 10.1016/j.parkreldis.2013.02.009; Joseph A, 2016, J NEUROL NEUROSUR PS, V87, P1146, DOI 10.1136/jnnp-2015-312600; Kalbe E, 2008, PARKINSONISM RELAT D, V14, P93, DOI 10.1016/j.parkreldis.2007.06.008; Kasten M, 2013, INT J EPIDEMIOL, V42, P128, DOI 10.1093/ije/dys202; Kulisevsky J, 2009, MOVEMENT DISORD, V24, P1103, DOI 10.1002/mds.22506; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leon-Sarmiento FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045544; Hernandez NL, 2015, NEUROLOGIA, V30, P496, DOI 10.1016/j.nrl.2014.03.010; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Luzzi S, 2007, NEUROPSYCHOLOGIA, V45, P1823, DOI 10.1016/j.neuropsychologia.2006.12.008; Mahlknecht P, 2016, MOVEMENT DISORD, V31, P1408, DOI 10.1002/mds.26637; Mahlknecht P, 2015, NEUROLOGY, V84, P654, DOI 10.1212/WNL.0000000000001265; Malek N, 2016, ACTA NEUROL SCAND, V134, P271, DOI 10.1111/ane.12538; McLaughlin NCR, 2008, ARCH CLIN NEUROPSYCH, V23, P119, DOI 10.1016/j.acn.2007.07.008; Menon C, 2013, CLIN NEUROPSYCHOL, V27, P946, DOI 10.1080/13854046.2013.796406; Mori K, 2011, ANNU REV NEUROSCI, V34, P467, DOI 10.1146/annurev-neuro-112210-112917; Narozanska E, 2011, EUR J NEUROL, V18, P535, DOI 10.1111/j.1468-1331.2010.03107.x; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Pardini M, 2009, ARCH NEUROL-CHICAGO, V66, P92, DOI 10.1001/archneurol.2008.521; Picillo M, 2014, NEUROL SCI, V35, P379, DOI 10.1007/s10072-013-1522-6; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; R Core Team, 2021, R LANGUAGE ENV STAT; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Roberts RO, 2016, JAMA NEUROL, V73, P93, DOI 10.1001/jamaneurol.2015.2952; Rolheiser TM, 2011, J NEUROL, V258, P1254, DOI 10.1007/s00415-011-5915-2; Ross GW, 2008, ANN NEUROL, V63, P167, DOI 10.1002/ana.21291; Rossi M, 2016, MOVEMENT DISORD, V31, P1414, DOI 10.1002/mds.26687; Salihoglu M, 2014, LARYNGOSCOPE, V124, P2190, DOI 10.1002/lary.24565; Saunders-Pullman R, 2011, NEUROLOGY, V77, P319, DOI 10.1212/WNL.0b013e318227041c; Saunders-Pullman R, 2014, ANN CLIN TRANSL NEUR, V1, P670, DOI 10.1002/acn3.95; Scherfler C, 2013, BRAIN, V136, P3028, DOI 10.1093/brain/awt234; Schwab R.S., 1969, 3 S PARK DIS, P152; Secundo L, 2015, P NATL ACAD SCI USA, V112, P8750, DOI 10.1073/pnas.1424826112; Seelaar H, 2011, J NEUROL NEUROSUR PS, V82, P476, DOI 10.1136/jnnp.2010.212225; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Siderowf A, 2012, MOVEMENT DISORD, V27, P406, DOI 10.1002/mds.24892; Silveira-Moriyama L, 2015, NAT REV NEUROL, V11, P5, DOI 10.1038/nrneurol.2014.235; Silveira-Moriyama L, 2009, MOVEMENT DISORD, V24, P1144, DOI 10.1002/mds.22494; Sitek EJ, 2009, ACTA NEUROPSYCHIATR, V21, P209, DOI 10.1111/j.1601-5215.2009.00367.x; Skorpil M, 2012, J PARKINSON DIS, V2, P171, DOI 10.3233/JPD-2012-12091; Swallow DMA, 2016, J PARKINSON DIS, V6, P289, DOI 10.3233/JPD-150741; Tan LZ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156639; Taylor S, 2016, MOVEMENT DISORD, V31, P344, DOI 10.1002/mds.26456; Tsuboi Y, 2002, ARCH NEUROL-CHICAGO, V59, P943, DOI 10.1001/archneur.59.6.943; Tunc S, 2015, MOVEMENT DISORD, V30, P531, DOI 10.1002/mds.26100; Uchida N, 2014, ANNU REV NEUROSCI, V37, P363, DOI 10.1146/annurev-neuro-071013-013941; Velayudhan L, 2013, INT PSYCHOGERIATR, V25, P1157, DOI 10.1017/S1041610213000446; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z; Whitcroft KL, 2017, LARYNGOSCOPE, V127, P291, DOI 10.1002/lary.26229; Whitwell JL, 2009, NEUROLOGY, V73, P1058, DOI 10.1212/WNL.0b013e3181b9c8b9; Wilson DA, 2014, PROG BRAIN RES, V208, P275, DOI 10.1016/B978-0-444-63350-7.00011-5; Wittchen H.-U., 1997, SKID STRUKTURIERTES; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; WSZOLEK ZK, 1992, ANN NEUROL, V32, P312, DOI 10.1002/ana.410320303; Xiao Q, 2014, NEUROSCI BULL, V30, P134, DOI 10.1007/s12264-013-1390-3; Yoshida I, 2007, J NEUROSCI, V27, P9105, DOI 10.1523/JNEUROSCI.2720-07.2007; Zou YM, 2016, NEUROPSYCH DIS TREAT, V12, P869, DOI 10.2147/NDT.S104886	100	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0165112	10.1371/journal.pone.0165112	http://dx.doi.org/10.1371/journal.pone.0165112			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC2AC	27855167	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200008
J	Hubert-Dibon, G; Bru, M; Le Guen, CG; Launay, E; Roy, A				Hubert-Dibon, Gaelle; Bru, Marie; Le Guen, Christele Gras; Launay, Elise; Roy, Arnaud			Health-Related Quality of Life for Children and Adolescents with Specific Language Impairment: A Cohort Study by a Learning Disabilities Reference Center	PLOS ONE			English	Article							CROSS-CULTURAL SURVEY; SOCIAL-BEHAVIOR; YOUNG-PEOPLE; DIFFICULTIES; VICTIMIZATION; DETERMINANTS; CHILDHOOD; DISORDER; HISTORY; SAMPLE	Objectives To assess the health-related quality of life (HRQOL) of children with specific language impairment (SLI). Study Design In a prospective sample at a Learning Disabilities Reference Center, proxy-rated HRQOL (KIDSCREEN-27) was assessed for children with SLI and unaffected children from January 1, 2014 to March 31, 2015. Quality of life predictors for children with SLI were evaluated by recording the length and number of speech therapy and psychotherapy sessions and the specific school organization that the children had participated in. The KIDSCREEN scores of the two groups were compared using nonparametric statistics. Results The questionnaires were completed by the parents of 67 children with SLI and 67 unaffected children. For children with SLI, the mean HRQOL scores were significantly lower for physical and psychological well-being, autonomy and parent relation, social support, and school environment compared to the reference group, controlling for age and parental education (beta = -6.7 (- 12.7;-.7) P = 0.03, beta = -4.9 (-9.5;-.3) P = 0.04, beta = -8.4 (-14.2;-2.6) P = 0.005, beta = -11.6 (-19.5;-3.7) P = 0.004, beta = -7.1(-12.4;-1.7) P = 0.010, respectively). Multivariate analyses in the group of children with SLI found that children who had undergone psychotherapy sessions or who had been enrolled in specific schooling programs had reduced HRQOL scores in social support and school environment and that children who were in a special class had higher scores in physical well-being.Conclusion Children with SLI had significantly lower HRQOL scores as compared to unaffected children. Measurement of HRQOL could serve as one of the strategies employed throughout the follow-up of these individuals to provide them with the most appropriate and comprehensive care possible. Conclusion Children with SLI had significantly lower HRQOL scores as compared to unaffected children. Measurement of HRQOL could serve as one of the strategies employed throughout the follow-up of these individuals to provide them with the most appropriate and comprehensive care possible.	[Hubert-Dibon, Gaelle; Bru, Marie; Le Guen, Christele Gras; Launay, Elise] Univ Hosp Nantes, Dept Pediat, Nantes, France; [Bru, Marie; Roy, Arnaud] Univ Hosp Nantes, Learning Disabil Reference Ctr, Nantes, France; [Roy, Arnaud] Univ Angers, Psychol Lab Pays Loire, Angers, France	Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Universite d'Angers	Hubert-Dibon, G (corresponding author), Univ Hosp Nantes, Dept Pediat, Nantes, France.	gaelle.hubert@chu-nantes.fr		Launay, Elise/0000-0002-4081-4653; GRAS-LE GUEN, Christele/0000-0001-9060-2344				Aaronson N, 2002, QUAL LIFE RES, V11, P193; Arkkila E, 2011, FOLIA PHONIATR LOGO, V63, P27, DOI 10.1159/000319735; Arkkila E, 2009, INT J PEDIATR OTORHI, V73, P1288, DOI 10.1016/j.ijporl.2009.05.023; Beitchman JH, 2008, J CHILD PSYCHOL PSYC, V49, P626, DOI 10.1111/j.1469-7610.2008.01878.x; Conti-Ramsden G, 2004, J SPEECH LANG HEAR R, V47, P145, DOI 10.1044/1092-4388(2004/013); Conti-Ramsden G, 2013, RES DEV DISABIL, V34, P4161, DOI 10.1016/j.ridd.2013.08.043; Conti-Ramsden G, 2012, LANG SPEECH HEAR SER, V43, P507, DOI 10.1044/0161-1461(2012/11-0067); Croteau C, 2015, J COMMUN DISORD, V58, P21, DOI 10.1016/j.jcomdis.2015.07.005; Delahaie M, 2004, EVOLUTION LANGAGE CH; Dey M, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-73; Durkin K, 2007, CHILD DEV, V78, P1441, DOI 10.1111/j.1467-8624.2007.01076.x; Finlay JCS, 2013, RES DEV DISABIL, V34, P2533, DOI 10.1016/j.ridd.2013.05.015; Flapper BCT, 2013, RES DEV DISABIL, V34, P756, DOI 10.1016/j.ridd.2012.10.014; GoorhuisBrouwer SM, 1996, FOLIA PHONIATR LOGO, V48, P269, DOI 10.1159/000266421; Hart KI, 2004, J SPEECH LANG HEAR R, V47, P647, DOI 10.1044/1092-4388(2004/050); Johnson CJ, 2010, AM J SPEECH-LANG PAT, V19, P51, DOI 10.1044/1058-0360(2009/08-0083); Law J, 2009, J SPEECH LANG HEAR R, V52, P1401, DOI 10.1044/1092-4388(2009/08-0142); Lee CW, 2000, J CLIN EPIDEMIOL, V53, P451, DOI 10.1016/S0895-4356(99)00221-8; Mansour ME, 2003, PEDIATRICS, V111, P1372, DOI 10.1542/peds.111.6.1372; Nicola K, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0326-1; Plante E, 1998, J SPEECH LANG HEAR R, V41, P951, DOI 10.1044/jslhr.4104.951; Ravens-Sieberer U, 2001, SOZ PRAVENTIV MED, V46, P294, DOI 10.1007/BF01321080; Ravens-Sieberer U, 2008, VALUE HEALTH, V11, P645, DOI 10.1111/j.1524-4733.2007.00291.x; Ravens-Sieberer U, 2007, QUAL LIFE RES, V16, P1347, DOI 10.1007/s11136-007-9240-2; Records N., 1992, AM J SPEECH-LANG PAT, V1, P44, DOI DOI 10.1044/1058-0360.0102.44; Redmond SM, 2011, LANG SPEECH HEAR SER, V42, P520, DOI 10.1044/0161-1461(2011/10-0078); Reilly S, 2014, INT J LANG COMM DIS, V49, P416, DOI 10.1111/1460-6984.12102; Robitail S, 2007, QUAL LIFE RES, V16, P1335, DOI 10.1007/s11136-007-9241-1; Schoon I, 2010, PEDIATRICS, V126, pE73, DOI 10.1542/peds.2009-3282; Schoon I, 2010, PEDIATRICS, V125, pE459, DOI 10.1542/peds.2008-2111; Soares-Boucaud I, 2009, DYSPHASIES DEV TROUB; Spurrier NJ, 2003, AUST NZ J PUBL HEAL, V27, P27, DOI 10.1111/j.1467-842X.2003.tb00376.x; St Clair MC, 2011, J COMMUN DISORD, V44, P186, DOI 10.1016/j.jcomdis.2010.09.004; Sylvestre A, 2016, DISABIL REHABIL, V38, P1146, DOI 10.3109/09638288.2015.1074730; The KIDSCREEN Group Europe, 2006, KIDSCREEN QUEST QUAL; US Department of Health and Human Services Center for Disease Control and Prevention, 2000, MEAS HLTH DAYS; van Agt H, 2011, DEV MED CHILD NEUROL, V53, P81, DOI 10.1111/j.1469-8749.2010.03794.x; van Agt HME, 2005, QUAL LIFE RES, V14, P1345, DOI 10.1007/s11136-004-6013-z; von Rueden U, 2006, J EPIDEMIOL COMMUN H, V60, P130, DOI 10.1136/jech.2005.039792; Wadman R, 2011, INT J LANG COMM DIS, V46, P641, DOI 10.1111/j.1460-6984.2011.00033.x; Wadman R, 2011, J ADOLESCENCE, V34, P421, DOI 10.1016/j.adolescence.2010.06.010; Young AR, 2002, J CHILD PSYCHOL PSYC, V43, P635, DOI 10.1111/1469-7610.00052	42	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166541	10.1371/journal.pone.0166541	http://dx.doi.org/10.1371/journal.pone.0166541			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EC1ZU	27851795	gold, Green Published, Green Submitted			2022-12-26	WOS:000387909300063
J	Dirihan, S; Helander, M; Vare, H; Gundel, PE; Garibaldi, LA; Irisarri, JGN; Saloniemi, I; Saikkonen, K				Dirihan, Serdar; Helander, Marjo; Vare, Henry; Gundel, Pedro E.; Garibaldi, Lucas A.; Irisarri, J. Gonzalo N.; Saloniemi, Irma; Saikkonen, Kari			Geographic Variation in Festuca rubra L. Ploidy Levels and Systemic Fungal Endophyte Frequencies	PLOS ONE			English	Article							VERTICAL TRANSMISSION; PLANT; POLYPLOIDY; GRASSES; EVOLUTION; SYMBIOSIS; TOLERANCE; MUTUALISM; WILD	Polyploidy and symbiotic Epichloe fungal endophytes are common and heritable characteristics that can facilitate environmental range expansion in grasses. Here we examined geographic patterns of polyploidy and the frequency of fungal endophyte colonized plants in 29 Festuca rubra L. populations from eight geographic sites across latitudes from Spain to northernmost Finland and Greenland. Ploidy seemed to be positively and negatively correlated with latitude and productivity, respectively. However, the correlations were nonlinear; 84% of the plants were hexaploids (2n = 6x = 42), and the positive correlation between ploidy level and latitude is the result of only four populations skewing the data. In the southern-most end of the gradient 86% of the plants were tetraploids (2n = 4x = 28), whereas in the northernmost end of the gradient one population had only octoploid plants (2n = 8x = 56). Endophytes were detected in 22 out of the 29 populations. Endophyte frequencies varied among geographic sites, and populations and habitats within geographic sites irrespective of ploidy, latitude or productivity. The highest overall endophyte frequencies were found in the southernmost end of the gradient, Spain, where 69% of plants harbored endophytes. In northern Finland, endophytes were detected in 30% of grasses but endophyte frequencies varied among populations from 0% to 75%, being higher in meadows compared to riverbanks. The endophytes were detected in 36%, 30% and 27% of the plants in Faroe Islands, Iceland and Switzerland, respectively. Practically all examined plants collected from southern Finland and Greenland were endophyte-free, whereas in other geographic sites endophyte frequencies were highly variable among populations. Common to all populations with high endophyte frequencies is heavy vertebrate grazing. We propose that the detected endophyte frequencies and ploidy levels mirror past distribution history of F. rubra after the last glaciation period, and local adaptations to past or prevailing selection forces such as vertebrate grazing.	[Dirihan, Serdar; Helander, Marjo; Saloniemi, Irma] Univ Turku, Dept Biol, Turku, Finland; [Helander, Marjo; Saikkonen, Kari] Nat Resources Inst Finland Luke, Turku, Finland; [Vare, Henry] Univ Helsinki, Bot Museum, Finnish Museum Nat Hist, Helsinki, Finland; [Gundel, Pedro E.; Irisarri, J. Gonzalo N.] Univ Buenos Aires, CONICET, Fac Agron, IFEVA, Buenos Aires, DF, Argentina; [Garibaldi, Lucas A.] UNRN, Grp Invest Agroecol AGRECO, San Carlos De Bariloche, Rio Negro, Argentina; [Garibaldi, Lucas A.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina	University of Turku; Natural Resources Institute Finland (Luke); University of Helsinki; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Dirihan, S (corresponding author), Univ Turku, Dept Biol, Turku, Finland.	serdir@utu.fi	Saloniemi, Irma/C-8893-2011; Gundel, Pedro/A-5314-2013; Garibaldi, Lucas A/D-7302-2013	Gundel, Pedro/0000-0003-3246-0282; Helander, Marjo/0000-0002-9759-4321; Irisarri, Gonzalo/0000-0001-8610-3040; Garibaldi, Lucas Alejandro/0000-0003-0725-4049; Vare, Henry/0000-0002-6170-885X	Academy of Finland [137909, 281354, 292732]; INTERACT under the European Community's Seventh Framework Programme [262693]	Academy of Finland(Academy of Finland); INTERACT under the European Community's Seventh Framework Programme	This work was supported by the Academy of Finland grants 137909, 281354 and 292732 Fund receiver author: KS, as well as INTERACT (Grant Agreement No. 262693) under the European Community's Seventh Framework Programme.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Afkhami ME, 2014, ECOL LETT, V17, P1265, DOI 10.1111/ele.12332; Aiken S.G., 1990, FESCUE GRASSES CANAD; Bao GS, 2015, FUNGAL ECOL, V17, P114, DOI 10.1016/j.funeco.2015.05.006; Bazely DR, 1997, J APPL ECOL, V34, P847, DOI 10.2307/2405276; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Chao DY, 2013, SCIENCE, V341, P658, DOI 10.1126/science.1240561; Cheplick GP, 2009, ECOLOGY EVOLUTION GR; Cheplick Gregory P., 1998, P84, DOI 10.1017/CBO9780511525445.005; Clay K, 1999, SCIENCE, V285, P1742, DOI 10.1126/science.285.5434.1742; Clay K, 2002, AM NAT, V160, pS99, DOI 10.1086/342161; CLAY K, 1990, ANNU REV ECOL SYST, V21, P275, DOI 10.1146/annurev.es.21.110190.001423; CLAY K, 1988, ECOLOGY, V69, P10, DOI 10.2307/1943155; Colpaert A, 2003, ARCTIC, V56, P147; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DARLINGTON C. D., 1969, The handling of chromosomes.; Dirihan S, 2013, CARYOLOGIA, V66, P251, DOI 10.1080/00087114.2013.849414; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; EWALD PW, 1987, ANN NY ACAD SCI, V503, P295, DOI 10.1111/j.1749-6632.1987.tb40616.x; Faeth SH, 2004, ECOL LETT, V7, P304, DOI 10.1111/j.1461-0248.2004.00578.x; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; FINE PEM, 1975, ANN NY ACAD SCI, V266, P173, DOI 10.1111/j.1749-6632.1975.tb35099.x; Granath G, 2007, ECOGRAPHY, V30, P422, DOI [10.1111/j.2007.0906-7590.05027.x, 10.1111/j.0906-7590.2007.05027.x]; Gundel PE, 2014, PLANT SYST EVOL, V300, P1683, DOI 10.1007/s00606-014-0994-z; HARBERD D. J., 1961, NEW PHYTOL, V60, P184, DOI 10.1111/j.1469-8137.1961.tb06251.x; Herre EA, 1999, TRENDS ECOL EVOL, V14, P49, DOI 10.1016/S0169-5347(98)01529-8; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Kim S, 2012, PLANT SYST EVOL, V298, P1073, DOI 10.1007/s00606-012-0617-5; Kover PX, 1998, AM NAT, V152, P165, DOI 10.1086/286159; LIPSITCH M, 1995, P ROY SOC B-BIOL SCI, V260, P321, DOI 10.1098/rspb.1995.0099; LOVE ASKELL, 1957, PROC GENET SOC CANADA, V2, P23; Maechler M., 2011, LME4 LINEAR MIXED EF; MuMIn K., 2012, MULTIMODEL INFERENCE; Neiman M, 2013, HEREDITY, V110, P152, DOI 10.1038/hdy.2012.78; Nemani R, 1997, ECOL APPL, V7, P79, DOI 10.1890/1051-0761(1997)007[0079:LCCUMR]2.0.CO;2; Pandit MK, 2014, NEW PHYTOL, V203, P687; Paruelo JM, 1997, ECOLOGY, V78, P953, DOI 10.1890/0012-9658(1997)078[0953:AEFNFT]2.0.CO;2; Pineiro G, 2006, ECOSYSTEMS, V9, P357, DOI 10.1007/s10021-005-0013-x; PRINCE SD, 1991, INT J REMOTE SENS, V12, P1301, DOI 10.1080/01431169108929727; R Core Team, 2021, R LANGUAGE ENV STAT; Ramsey J, 2011, P NATL ACAD SCI USA, V108, P7096, DOI 10.1073/pnas.1016631108; Saikkonen K, 2002, P ROY SOC B-BIOL SCI, V269, P1397, DOI 10.1098/rspb.2002.2006; Saikkonen K, 2000, ECOGRAPHY, V23, P360, DOI 10.1034/j.1600-0587.2000.d01-1645.x; Saikkonen K, 1998, ANNU REV ECOL SYST, V29, P319, DOI 10.1146/annurev.ecolsys.29.1.319; Saikkonen K, 2004, TRENDS PLANT SCI, V9, P275, DOI 10.1016/j.tplants.2004.04.005; Saikkonen K, 2006, TRENDS PLANT SCI, V11, P428, DOI 10.1016/j.tplants.2006.07.001; Saikkonen K, 2013, AGR ECOSYST ENVIRON, V165, P1, DOI 10.1016/j.agee.2012.12.002; Saikkonen K, 2012, NAT CLIM CHANGE, V2, P239, DOI [10.1038/NCLIMATE1430, 10.1038/nclimate1430]; Saikkonen K, 2010, FUNGAL DIVERS, V41, P101, DOI 10.1007/s13225-010-0023-7; Sampoux JP, 2009, J BIOGEOGR, V36, P1978, DOI 10.1111/j.1365-2699.2009.02133.x; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; SELLERS PJ, 1992, REMOTE SENS ENVIRON, V42, P187, DOI 10.1016/0034-4257(92)90102-P; Semmartin M, 2015, J ECOL, V103, P184, DOI 10.1111/1365-2745.12343; sitelova T, 2013, NEW PHYTOL, V199, P1022, DOI [10.1111/nph.12348, DOI 10.1111/NPH.12348]; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; Song ML, 2015, FUNGAL ECOL, V13, P44, DOI 10.1016/j.funeco.2014.07.004; Stebbins G. L., 1971, CHROMOSOMAL EVOLUTIO; STEBBINS GL, 1984, BOT HELV, V94, P1; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Thompson J. N., 2005, INTERSPEC INTERACT; TUCKER CJ, 1985, REMOTE SENS ENVIRON, V17, P233, DOI 10.1016/0034-4257(85)90097-5; Wali PR, 2007, MICROB ECOL, V53, P20, DOI 10.1007/s00248-006-9076-2; Wallace A.R., 1876, GEOGRAPHICAL DISTRIB, VI; Yang XH, 2011, PLANT CELL TISS ORG, V104, P387, DOI 10.1007/s11240-010-9826-1; Zabalgogeazcoa I, 2013, FUNGAL DIVERS, V60, P25, DOI 10.1007/s13225-013-0233-x; Zuur A, 2009, MIXED EFFECTS MODELS	66	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166264	10.1371/journal.pone.0166264	http://dx.doi.org/10.1371/journal.pone.0166264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846291	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000387794600044
J	Kong, J; Wang, O; Nie, M; Shi, J; Hui, YY; Jiang, Y; Li, M; Xia, WB; Meng, XW; Xing, XP				Kong, Jing; Wang, Ou; Nie, Min; Shi, Jie; Hui, Yingying; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping			Clinical and Genetic Analysis of Multiple Endocrine Neoplasia Type 1-Related Primary Hyperparathyroidism in Chinese	PLOS ONE			English	Article							MEN1 GENE; MUTATION; BONE; EXPRESSION; GUIDELINES; SEVERITY; FAMILY	Objective Multiple endocrine neoplasia type 1-related primary hyperparathyroidism (MHPT) differs in many aspects from sporadic PHPT (SHPT). The aims of this study were to summarize the clinical features and genetic background of Chinese MHPT patients and compare the severity of the disease with those of SHPT. Design and Methods A total of 40 MHPT (27 sporadic, 7 families) and 169 SHPT cases of Chinese descent were retrospectively analyzed. X-rays and ultrasound were used to assess the bone and urinary system. Dual energy x-ray absorptiometry (DXA) were performed to measure bone mineral density (BMD). Besides direct sequencing of the MEN1 and CDKN1B genes, multiplex ligation- dependent probe amplification (MLPA) was used to screen gross deletion for the MEN1 gene. Results Compared with SHPT patients, MHPT patients showed lower prevalence of typical X-ray changes related to PHPT (26.3% vs. 55.7%, P = 0.001) but higher prevalence of urolithiasis/renal calcification (40.2% vs. 60.0%, P = 0.024). MHPT patients showed higher phosphate level (0.84 vs. 0.73mmol/L, P< 0.05) but lower ALP (103.0 vs. 174.0U/L, P< 0.001) and PTH (4.0 vs. 9.8xupper limit, P< 0.001) levels than SHPT patients. There were no significant differences in BMD Z-scores at the lumbar spine and femoral neck between the two groups. Mutations in the MEN1 gene were detected in 27 MHPT cases. Among the nine novel mutations were novel, one of them involved the deletion of exon 5 and 6. Conclusions MHPT patients experienced more common kidney complications but less skeletal issues, and a milder biochemical manifestation compared with SHPT patients. MEN1 mutation detection rate was 79.4% and 9 of the identified mutations were novel.	[Kong, Jing; Wang, Ou; Nie, Min; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China; [Kong, Jing; Wang, Ou; Nie, Min; Shi, Jie; Hui, Yingying; Jiang, Yan; Li, Mei; Xia, Weibo; Meng, Xunwu; Xing, Xiaoping] Peking Union Med Coll, Beijing, Peoples R China; [Shi, Jie] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Hui, Yingying] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Lab Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, O (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Natl Hlth & Family Planning Commiss, Dept Endocrinol,Key Lab Endocrinol, Beijing, Peoples R China.; Wang, O (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	wang_ou2010@126.com; xiaopingxing@126.com			National Natural Science Foundation of China [81100559]; National Key Program of Clinical Science [WBYZ 2011-873]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Program of Clinical Science	This work was supported by the National Natural Science Foundation of China (grant number 81100559) and National Key Program of Clinical Science (grant number WBYZ 2011-873).	Agarwal SK, 2013, FRONT HORM RES, V41, P1, DOI 10.1159/000345666; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; Burgess JR, 1999, ARCH SURG-CHICAGO, V134, P1119, DOI 10.1001/archsurg.134.10.1119; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Christopoulos C, 2005, BJU INT, V96, P884, DOI 10.1111/j.1464-410X.2005.05731.x; Cosme Angel, 2008, Gastroenterol Hepatol, V31, P637, DOI 10.1016/S0210-5705(08)75811-4; Eller-Vainicher C, 2009, J BONE MINER RES, V24, P1404, DOI [10.1359/JBMR.090304, 10.1359/jbmr.090304]; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Jap TS, 2005, CLIN ENDOCRINOL, V62, P336, DOI 10.1111/j.1365-2265.2005.02219.x; [贾慧英 JIA Hui-ying], 2009, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V25, P478; Jiang XH, 2007, ENDOCR-RELAT CANCER, V14, P1073, DOI 10.1677/ERC-07-0015; [姜晓华 JIANG Xiaohua], 2006, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V22, P37; LAMERS CBHW, 1979, AM J MED, V66, P422, DOI 10.1016/0002-9343(79)91062-3; Lemos MC, 2008, HUM MUTAT, V29, P22, DOI 10.1002/humu.20605; Li JL, 2013, PANCREAS, V42, P353, DOI 10.1097/MPA.0b013e318258f233; Liu W, 2013, EUR REV MED PHARMACO, V17, P3111; Lourenco DM, 2008, EUR J ENDOCRINOL, V159, P259, DOI 10.1530/EJE-08-0153; Lourenco DM, 2012, CLINICS, V67, P99, DOI 10.6061/clinics/2012(Sup01)17; Lourenco DM, 2010, J BONE MINER RES, V25, P2382, DOI 10.1002/jbmr.125; Marcocci C, 2012, THER ADV MUSCULOSKEL, V4, P357, DOI 10.1177/1759720X12441869; Ning ZW, 2015, MOL MED REP, V12, P6152, DOI 10.3892/mmr.2015.4138; Owens M, 2008, CLIN ENDOCRINOL, V68, P350, DOI 10.1111/j.1365-2265.2007.03045.x; Pontikides N, 2014, J BONE MINER METAB, V32, P351, DOI 10.1007/s00774-013-0551-9; Raef H, 2011, CLIN ENDOCRINOL, V75, P791, DOI 10.1111/j.1365-2265.2011.04134.x; Rubin MR, 2008, J CLIN ENDOCR METAB, V93, P3462, DOI 10.1210/jc.2007-1215; Sakurai A, 2012, CLIN ENDOCRINOL, V76, P533, DOI 10.1111/j.1365-2265.2011.04227.x; Thakker RV, 2012, J CLIN ENDOCR METAB, V97, P2990, DOI 10.1210/jc.2012-1230; Tham E, 2007, J CLIN ENDOCR METAB, V92, P3389, DOI 10.1210/jc.2007-0476; Tso AWK, 2003, CLIN ENDOCRINOL, V59, P129, DOI 10.1046/j.1365-2265.2003.01812.x; Turner JJO, 2010, HUM MUTAT, V31, pE1089, DOI 10.1002/humu.21170; Xu D, 2013, J NANCHANG U MED SCI, V53, P99; Xu HY, 2013, ZHEJIANG YI XUE, V35, P1002; Yu W, 1996, CHIN J RAD, V30, P625; Zatelli MC, 2014, FAM CANCER, V13, P273, DOI 10.1007/s10689-014-9702-y; Zhang H, 2012, J NANOMATER, V2012, DOI [10.1155/2012/217412, 10.1186/2049-1891-3-26]	35	9	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166634	10.1371/journal.pone.0166634	http://dx.doi.org/10.1371/journal.pone.0166634			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846313	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600094
J	Kuo, YM; Yu, HL; Kuan, WH; Kuo, MH; Lin, HJ				Kuo, Yi-Ming; Yu, Hwa-Lung; Kuan, Wen-Hui; Kuo, Mei-Hwa; Lin, Hsing-Juh			Factors Controlling Changes in Epilithic Algal Biomass in the Mountain Streams of Subtropical Taiwan	PLOS ONE			English	Article							AGRICULTURAL STREAMS; PERIPHYTON GROWTH; DIATOM COMMUNITY; DISSOLVED-OXYGEN; NUTRIENT; HABITAT; RIVER; DYNAMICS; LIMITATION; ABUNDANCE	In upstream reaches, epilithic algae are one of the major primary producers and their biomass may alter the energy flow of food webs in stream ecosystems. However, the overgrowth of epilithic algae may deteriorate water quality. In this study, the effects of environmental variables on epilithic algal biomass were examined at 5 monitoring sites in mountain streams of the Wuling basin of subtropical Taiwan over a 5-year period (20062011) by using a generalized additive model (GAM). Epilithic algal biomass and some variables observed at pristine sites obviously differed from those at the channelized stream with intensive agricultural activity. The results of the optimal GAM showed that water temperature, turbidity, current velocity, dissolved oxygen (DO), pH, and ammonium N (NH4-N) were the main factors explaining seasonal variations of epilithic algal biomass in the streams. The change points of smoothing curves for velocity, DO, NH4-N, pH, turbidity, and water temperature were approximately 0.40 m s(-1), 8.0 mg L-1, 0.01 mg L-1, 8.5, 0.60 NTU, and 15 degrees C, respectively. When aforementioned variables were greater than relevant change points, epilithic algal biomass was increased with pH and water temperature, and decreased with water velocity, DO, turbidity, and NH4-N. These change points may serve as a framework for managing the growth of epilithic algae. Understanding the relationship between environmental variables and epilithic algal biomass can provide a useful approach for maintaining the functioning in stream ecosystems.	[Kuo, Yi-Ming] China Univ Geosci, Sch Environm Studies, Lab Basin Hydrol & Wetland Ecorestorat, Wuhan 430074, Peoples R China; [Yu, Hwa-Lung] Natl Taiwan Univ, Dept Bioenvironm Syst Engn, Taipei 10617, Taiwan; [Kuan, Wen-Hui] Ming Chi Univ Technol, Dept Safety Hlth & Environm Engn, New Taipei 24301, Taiwan; [Kuo, Mei-Hwa] Natl Chung Hsing Univ, Dept Entomol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan; [Lin, Hsing-Juh] Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan; [Lin, Hsing-Juh] Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan	China University of Geosciences; National Taiwan University; Ming Chi University of Technology; National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Academia Sinica - Taiwan	Lin, HJ (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Natl Chung Hsing Univ, Res Ctr Global Change Biol, Taichung 402, Taiwan.; Lin, HJ (corresponding author), Acad Sinica, Biodivers Res Ctr, Taipei 115, Taiwan.	hjlin@dragon.nchu.edu.tw		Lin, Hsing-Juh/0000-0001-8322-7195; , Yi-Ming/0000-0003-1049-8116	National Science Council in Taiwan [NSC 101-2313-B-451-003]; Natural Science Foundation of Hubei Province of China [2015CFA050]; Taiwan's Shei-Pa National Park Headquarters; Ministry of Science and Technology [MOST103-2621-M-002-002]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Taiwan's Shei-Pa National Park Headquarters; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was financially supported by the National Science Council in Taiwan (NSC 101-2313-B-451-003) to YMK; the Natural Science Foundation of Hubei Province of China (2015CFA050) to YMK; Taiwan's Shei-Pa National Park Headquarters and by Ministry of Science and Technology under Grant MOST103-2621-M-002-002 to HJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allan JD, 2006, STREAM ECOLOGY STRUC; [Anonymous], 1986, PLANT PHYSIOL; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baulch HM, 2009, CAN J FISH AQUAT SCI, V66, P1989, DOI 10.1139/F09-122; Biggs BJF, 2000, J N AM BENTHOL SOC, V19, P17, DOI 10.2307/1468279; Biggs BJF, 1998, J PHYCOL, V34, P598, DOI 10.1046/j.1529-8817.1998.340598.x; Bowman MF, 2005, CAN J FISH AQUAT SCI, V62, P174, DOI 10.1139/F04-244; Breneman A, 2007, J GEOPHYS RES-SPACE, V112, DOI 10.1029/2006JA012058; Brenning A, 2009, REMOTE SENS ENVIRON, V113, P239, DOI 10.1016/j.rse.2008.09.005; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Carslaw DC, 2007, ATMOS ENVIRON, V41, P5289, DOI 10.1016/j.atmosenv.2007.02.032; Chang HY, 2012, FRESHWATER BIOL, V57, P1839, DOI 10.1111/j.1365-2427.2012.02843.x; Chapra SC, 1997, SURFACE WATER QUALIT; Chung LC, 2008, ZOOL STUD, V47, P25; Clesceri L.S., 1998, STANDARD METHODS EXA; DeNicola DM, 2003, ARCH HYDROBIOL, V157, P67, DOI 10.1127/0003-9136/2003/0157-0067; Dodds WK, 1998, WATER RES, V32, P1455, DOI 10.1016/S0043-1354(97)00370-9; Dodds WK, 2002, CAN J FISH AQUAT SCI, V59, P865, DOI 10.1139/F02-063; DUNCAN SW, 1989, J PHYCOL, V25, P455, DOI 10.1111/j.1529-8817.1989.tb00250.x; Figueroa-Nieves D, 2006, HYDROBIOLOGIA, V568, P287, DOI 10.1007/s10750-006-0114-3; GEORGE DG, 1978, J ECOL, V66, P133, DOI 10.2307/2259185; Hastie T., 1986, STAT SCI, V1, P297; Heath MW, 2015, RIVER RES APPL, V31, P98, DOI 10.1002/rra.2722; Heinanen S, 2008, ECOGRAPHY, V31, P601, DOI 10.1111/j.0906-7590.2008.05410.x; Hill BH, 2000, J N AM BENTHOL SOC, V19, P50, DOI 10.2307/1468281; HILL WR, 1988, J PHYCOL, V24, P125; Hill WR, 2002, FRESHWATER BIOL, V47, P1245, DOI 10.1046/j.1365-2427.2002.00837.x; Holomuzki JR, 2010, J N AM BENTHOL SOC, V29, P220, DOI 10.1899/08-044.1; HORNER RR, 1990, FRESHWATER BIOL, V24, P215, DOI 10.1111/j.1365-2427.1990.tb00704.x; Hsu CB, 2010, AQUAT BIOL, V10, P227, DOI 10.3354/ab00280; Jorgensen SE, 2000, ECOL MODEL, V126, P249, DOI 10.1016/S0304-3800(00)00268-4; Kivrak E, 2012, J FRESHWATER ECOL, V27, P443, DOI 10.1080/02705060.2012.671147; Kottelat M., 1996, IUCN RED LIST THREAT; Lin HJ, 2012, AQUAT BIOL, V17, P269, DOI 10.3354/ab00481; Lindstrom EA, 2004, HYDROBIOLOGIA, V521, P63, DOI 10.1023/B:HYDR.0000026351.68927.ee; Lobban CS, 1988, EXPT PHYCOLOGY LAB M; LOHMAN K, 1992, CAN J FISH AQUAT SCI, V49, P1198, DOI 10.1139/f92-135; Merritt R.W., 1996, INTRO AQUATIC INSECT; Miltner RJ, 2010, ENVIRON MANAGE, V45, P842, DOI 10.1007/s00267-010-9439-9; Mosisch TD, 1999, AQUAT BOT, V64, P167, DOI 10.1016/S0304-3770(99)00014-5; MUNN MD, 1989, HYDROBIOLOGIA, V174, P89, DOI 10.1007/BF00014057; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Pan YD, 1999, J PHYCOL, V35, P460, DOI 10.1046/j.1529-8817.1999.3530460.x; Park NW, 2008, INT J REMOTE SENS, V29, P247, DOI 10.1080/01431160701227661; Quinn JM, 1997, NEW ZEAL J MAR FRESH, V31, P665, DOI 10.1080/00288330.1997.9516797; Ritter A, 2009, VADOSE ZONE J, V8, P437, DOI 10.2136/vzj2008.0054; Robinson CT, 2008, ECOL APPL, V18, P511, DOI 10.1890/07-0886.1; Robinson KL, 2009, CAN J CIVIL ENG, V36, P492, DOI 10.1139/L08-126; ROUT J, 1994, HYDROBIOLOGIA, V291, P61, DOI 10.1007/BF00024239; Sanchez E, 2007, ECOL INDIC, V7, P315, DOI 10.1016/j.ecolind.2006.02.005; Schlink U, 2006, ENVIRON MODELL SOFTW, V21, P547, DOI 10.1016/j.envsoft.2004.12.002; Scrimgeour GJ, 2000, CAN J FISH AQUAT SCI, V57, P1342, DOI 10.1139/cjfas-57-7-1342; Soininen J, 2004, AQUAT ECOL, V38, P63, DOI 10.1023/B:AECO.0000021004.06965.bd; Soininen J, 2002, ARCH HYDROBIOL, V154, P1; Tao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032020; Tien CJ, 2009, CHEMOSPHERE, V76, P1288, DOI 10.1016/j.chemosphere.2009.06.013; Townsend SA, 2012, FRESHW SCI, V31, P1233, DOI 10.1899/11-163.1; Tsai JW, 2014, MAR FRESHWATER RES, V65, P25, DOI 10.1071/MF13058; Uehlinger U, 1996, FRESHWATER BIOL, V36, P249, DOI 10.1046/j.1365-2427.1996.00082.x; VanDam H, 1995, FRESHWATER BIOL, V34, P579, DOI 10.1111/j.1365-2427.1995.tb00915.x; VanNieuwenhuyse EE, 1996, CAN J FISH AQUAT SCI, V53, P99, DOI 10.1139/cjfas-53-1-99; Vermaat JE, 1994, LAKE VELUWE MACROPHY, V21, P193, DOI DOI 10.1007/978-94-011-2032-6; Wintle BA, 2005, AUSTRAL ECOL, V30, P719, DOI 10.1111/j.1442-9993.2005.01514.x; Yeh CH, 2006, TECHNICAL REPORT; Yu SF, 2009, BOT STUD, V50, P73; Zuur Alain F., 2009, P1	67	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166604	10.1371/journal.pone.0166604	http://dx.doi.org/10.1371/journal.pone.0166604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846322	Green Published, Green Submitted, gold			2022-12-26	WOS:000387794600090
J	Lennard, KS; Goosen, RW; Blackburn, JM				Lennard, Katie S.; Goosen, Ryan W.; Blackburn, Jonathan M.			Bacterially-Associated Transcriptional Remodelling in a Distinct Genomic Subtype of Colorectal Cancer Provides a Plausible Molecular Basis for Disease Development	PLOS ONE			English	Article							ENTEROCOCCUS-FAECALIS; EXTRACELLULAR-SUPEROXIDE; OXIDATIVE STRESS; EPITHELIAL-CELLS; MESSENGER-RNA; EXPRESSION; FUSOBACTERIUM; INSTABILITY; COAGGREGATION; PROTEIN	The relevance of specific microbial colonisation to colorectal cancer (CRC) disease pathogenesis is increasingly recognised, but our understanding of possible underlying molecular mechanisms that may link colonisation to disease in vivo remains limited. Here, we investigate the relationships between the most commonly studied CRC-associated bacteria (Enterotoxigenic Bacteroides fragilis, pks+ Escherichia coli, Fusobacterium spp., afaC+ E. coli, Enterococcus faecalis & Enteropathogenic E. coli) and altered transcriptomic and methylation profiles of CRC patients, in order to gain insight into the potential contribution of these bacteria in the aetiopathogenesis of CRC. We show that colonisation by E. faecalis and high levels of Fusobacterium is associated with a specific transcriptomic subtype of CRC that is characterised by CpG island methylation, microsatellite instability and a significant increase in inflammatory and DNA damage pathways. Analysis of the significant, bacterially- associated changes in host gene expression, both at the level of individual genes as well as pathways, revealed a transcriptional remodeling that provides a plausible mechanistic link between specific bacterial colonisation and colorectal cancer disease development and progression in this subtype; these included upregulation of REG3A, REG1A and REG1P in the case of high-level colonization by Fusobacterium, and CXCL10 and BMI1 in the case of colonisation by E. faecalis. The enrichment of both E. faecalis and Fusobacterium in this CRC subtype suggests that polymicrobial colonisation of the colonic epithelium may well be an important aspect of colonic tumourigenesis.	[Blackburn, Jonathan M.] Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa; Univ Cape Town, Dept Integrat Biomed Sci, Cape Town, South Africa	University of Cape Town; University of Cape Town	Blackburn, JM (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Cape Town, South Africa.	jonathan.blackburn@uct.ac.za		Blackburn, Jonathan/0000-0001-8988-9595	Cancer Association of South Africa (CANSA); National Research Foundation (NRF); Harry Crossley Foundation; German Academic Exchange Service (DAAD); UCT; NRF; University of Cape Town	Cancer Association of South Africa (CANSA); National Research Foundation (NRF); Harry Crossley Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); UCT; NRF; University of Cape Town	This work was supported by Cancer Association of South Africa (CANSA: www.cansa.org.za) to JMB and the National Research Foundation (NRF: www.nrf.ac.za) to JMB. The Harry Crossley Foundation, the German Academic Exchange Service (DAAD), UCT, and the NRF provided financial support through bursaries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We wish to thank the Cancer Association of South Africa (CANSA) for their financial support of this project. KSL thanks the University of Cape Town, the Harry Crossley Foundation, the National Research Foundation (NRF) and the German Academic Exchange Service (DAAD) for their financial support through bursaries. RWG thanks UCT and the NRF for their financial support through bursaries. JMB thanks the NRF for a South African Research Chair grant. We thank Ms Alvera Vorster and Henry Adeola for their technical assistance.	Ak S, 2013, J SURG RES, V185, P626, DOI 10.1016/j.jss.2013.07.014; Allen-Vercoe E, 2014, IMMUNOL LETT, V162, P54, DOI 10.1016/j.imlet.2014.05.014; Astrosini C, 2008, INT J CANCER, V123, P409, DOI 10.1002/ijc.23466; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Banerjea A, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-21; Barnett MPG, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-39; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Cavard C, 2006, ONCOGENE, V25, P599, DOI 10.1038/sj.onc.1208860; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Diaz PI, 2000, FEMS MICROBIOL LETT, V187, P31, DOI 10.1016/S0378-1097(00)00174-9; Du JJ, 2010, MED ONCOL, V27, P1273, DOI 10.1007/s12032-009-9373-y; Granlund AV, 2013, CELL TISSUE RES, V352, P639, DOI 10.1007/s00441-013-1592-z; Hinoue T, 2012, GENOME RES, V22, P271, DOI 10.1101/gr.117523.110; Hoffmann M, 2009, J PROTEOME RES, V8, P1183, DOI 10.1021/pr800785m; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Johnson EM, 2006, J ENDODONT, V32, P946, DOI 10.1016/j.joen.2006.03.023; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jorissen RN, 2008, CLIN CANCER RES, V14, P8061, DOI 10.1158/1078-0432.CCR-08-1431; Kayaoglu G, 2004, CRIT REV ORAL BIOL M, V15, P308, DOI 10.1177/154411130401500506; Kloor M, 2010, INT J CANCER, V127, P1001, DOI 10.1002/ijc.25283; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Pun JCS, 2014, MOL CLIN ONCOL, V2, P817, DOI 10.3892/mco.2014.321; Rechreche H, 1999, INT J CANCER, V81, P688, DOI 10.1002/(SICI)1097-0215(19990531)81:5<688::AID-IJC3>3.0.CO;2-R; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Schwitalle Y, 2008, GASTROENTEROLOGY, V134, P988, DOI 10.1053/j.gastro.2008.01.015; Siegmund KD, 2004, BIOINFORMATICS, V20, P1896, DOI 10.1093/bioinformatics/bth176; Silva VL, 2005, MICROB PATHOGENESIS, V39, P131, DOI 10.1016/j.micpath.2005.07.002; Steeves CH, 2011, PROTEOMICS, V11, P2027, DOI 10.1002/pmic.201000631; Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606; Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5; Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865; Tateishi K, 2006, CLIN CANCER RES, V12, P6960, DOI 10.1158/1078-0432.CCR-06-0449; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462; Viljoen KS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-14; Wang DZ, 2013, ANNU REV MED, V64, P131, DOI 10.1146/annurev-med-112211-154330; Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040; Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551; Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16; Yoshino N, 2005, AM J GASTROENTEROL, V100, P2157, DOI 10.1111/j.1572-0241.2005.41915.x	48	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166282	10.1371/journal.pone.0166282	http://dx.doi.org/10.1371/journal.pone.0166282			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846243	gold, Green Published, Green Submitted			2022-12-26	WOS:000387794600046
J	Samsa, LA; Ito, CE; Brown, DR; Qian, L; Liu, JD				Samsa, Leigh Ann; Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong			IgG-Containing Isoforms of Neuregulin-1 Are Dispensable for Cardiac Trabeculation in Zebrafish	PLOS ONE			English	Article							RECOMBINANT HUMAN NEUREGULIN-1; SCHWANN-CELL MIGRATION; CHRONIC HEART-FAILURE; CARDIOVASCULAR-SYSTEM; CHAMBER MATURATION; MYOCARDIUM; GENOME; ERBB2; SPECIFICATION; CONSEQUENCES	The Neuregulin-1 (Nrg1) signaling pathway has been widely implicated in many aspects of heart development including cardiac trabeculation. Cardiac trabeculation is an important morphogenetic process where clusters of ventricular cardiomyocytes extrude and expand into the lumen of the ventricular chambers. In mouse, Nrg1 isoforms containing an immunoglobulin- like (IgG) domain are essential for cardiac trabeculation through interaction with heterodimers of the epidermal growth factor-like (EGF-like) receptors ErbB2/ErbB4. Recent reports have underscored the importance of Nrg1 signaling in cardiac homeostasis and disease, however, placental development has precluded refined evaluation of the role of this pathway in mammals. ErbB2 has been shown to have a developmentally conserved role in cardiac trabeculation in zebrafish, a vertebrate model organism with completely external development, but the requirement for Nrg1 has not been examined. We found that among the multiple Nrg1 isoforms, the IgG domain-containing, type I Nrg1 (nrg1-I) is the only isoform detectable in the heart. Then, using CRISPR/Cas9 gene editing, we targeted the IgG domain of Nrg1 to produce novel alleles, nrg1(nc28) and nrg1(nc29), encoding nrg1-I and nrg1-II truncations. Our results indicated that zebrafish deficient for nrg1-I developed trabeculae in an ErbB2-dependent manner. Further, these mutants survive to reproductive adulthood with no overt cardiovascular defects. We also found that additional EGF-like ligands were expressed in the zebrafish heart during development of trabeculae. Together, these results suggest that Nrg1 is not the primary effector of trabeculation and/or that other EGF-like ligand(s) activates the ErbB2/ErbB4 pathway, either through functioning as the primary ligand or acting in a redundant manner. Overall, our work provides an example of cross-species differences in EGF family member requirements for an evolutionary conserved process.	[Samsa, Leigh Ann] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Samsa, Leigh Ann; Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA; [Ito, Cade Ellis; Brown, Daniel Ross; Qian, Li; Liu, Jiandong] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Liu, JD (corresponding author), Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27514 USA.; Liu, JD (corresponding author), Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27514 USA.	jiandong_liu@med.unc.edu	, Zebrafish Aquaculture Facility/AAE-2716-2022; , Histology Research Core Facility/ABF-6317-2021	Samsa, Leigh/0000-0002-7629-0660	National Institutes of Health T32 grant [HL069768-14]; National Institutes of Health/National Institute of General Medical Science grant [5K12GM678-17]; American Heart Association Scientist Development Grant [13SDG17060010]; Ellison Medical Foundation New Scholar Grant [AG-NS-1064-13]; National Institutes of Health/National Heart, Lung, and Blood Institute [R00 HL109079]; American Heart Association [15GRNT25530005]; National Institutes of Health T32 grant [HL069768-14]; National Institutes of Health/National Institute of General Medical Science grant [5K12GM678-17]; American Heart Association Scientist Development Grant [13SDG17060010]; Ellison Medical Foundation New Scholar Grant [AG-NS-1064-13]; National Institutes of Health/National Heart, Lung, and Blood Institute [R00 HL109079]; American Heart Association [15GRNT25530005]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069768, R00HL109079, R01HL128331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Science grant; American Heart Association Scientist Development Grant(American Heart Association); Ellison Medical Foundation New Scholar Grant; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Institutes of Health T32 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/National Institute of General Medical Science grant; American Heart Association Scientist Development Grant(American Heart Association); Ellison Medical Foundation New Scholar Grant; National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	LAS is supported by National Institutes of Health T32 grant (HL069768-14; PI, Christopher Mack). DRB is supported by National Institutes of Health/National Institute of General Medical Science grant 5K12GM678-17 (PI, Linda Dyksta). This study was supported by the American Heart Association Scientist Development Grant (13SDG17060010 to LQ) and the Ellison Medical Foundation New Scholar Grant (AG-NS-1064-13 to LQ). National Institutes of Health/National Heart, Lung, and Blood Institute (R00 HL109079 grant to JL) and American Heart Association (grant 15GRNT25530005 to JL).r We thank the University of North Carolina Olympus Imaging Research Center for confocal microscope use, and the University of North Carolina Zebrafish Aquaculture Core Facility for fish care and microscope use. Histology services provided by the Histology Research Core Facility in the Department of Cell Biology and Physiology at the University of North Carolina, Chapel Hill NC. L.A.S. is supported by National Institutes of Health T32 grant (HL069768-14; PI, Christopher Mack). D.R.B. is supported by National Institutes of Health/National Institute of General Medical Science grant 5K12GM678-17 (PI, Linda Dyksta). This study was supported by the American Heart Association Scientist Development Grant (13SDG17060010 to L.Q.) and the Ellison Medical Foundation New Scholar Grant (AG-NS-1064-13 to L.Q.). National Institutes of Health/National Heart, Lung, and Blood Institute (R00 HL109079 grant to J.L.) and American Heart Association (grant 15GRNT25530005 to J.L.).	Abdallah SJ, 2015, J EXP BIOL, V218, P1777, DOI 10.1242/jeb.116343; Bang A, 2004, J FISH BIOL, V64, P1285, DOI 10.1111/j.0022-1112.2004.00391.x; Brown DR, 2016, J CARDIOVASC DEV DIS, P3; Chang NN, 2013, CELL RES, V23, P465, DOI 10.1038/cr.2013.45; Chen JN, 1996, DEVELOPMENT, V123, P293; Dahlem TJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002861; Fang SJ, 2010, CHINESE MED J-PEKING, V123, P3597, DOI 10.3760/cma.j.issn.0366-6999.2010.24.018; Formiga FR, 2014, J CONTROL RELEASE, V173, P132, DOI 10.1016/j.jconrel.2013.10.034; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; Gemberling M, 2015, ELIFE, V4, DOI 10.7554/eLife.05871; Glasauer SMK, 2014, MOL GENET GENOMICS, V289, P1045, DOI 10.1007/s00438-014-0889-2; Guo YF, 2012, CHINESE MED J-PEKING, V125, P807, DOI 10.3760/cma.j.issn.0366-6999.2012.05.015; Hill MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055741; Honjo Y, 2008, DEVELOPMENT, V135, P2615, DOI 10.1242/dev.022178; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jabbour A, 2011, EUR J HEART FAIL, V13, P83, DOI 10.1093/eurjhf/hfq152; Jenni R, 1999, NEW ENGL J MED, V340, P966, DOI 10.1056/NEJM199903253401215; Jinn SW, 2005, DEVELOPMENT, V132, P5199, DOI 10.1242/dev.02087; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Liu JD, 2010, CIRC RES, V106, P1818, DOI 10.1161/CIRCRESAHA.110.217950; Liu XF, 2006, J AM COLL CARDIOL, V48, P1438, DOI 10.1016/j.jacc.2006.05.057; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Schier H, 2005, P NATL ACAD SCI USA, V102, P1496, DOI 10.1073/pnas.0409361102; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Milan DJ, 2006, DEVELOPMENT, V133, P1125, DOI 10.1242/dev.02279; Minot C. S., 1901, Journal of the Boston Society of Medical Sciences, Vv, P325; Montero JC, 2000, MOL CELL NEUROSCI, V16, P631, DOI 10.1006/mcne.2000.0896; Moran AE, 2014, GLOB HEART, V9, P3, DOI 10.1016/j.gheart.2014.03.1220; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Newbern J, 2010, SEMIN CELL DEV BIOL, V21, P922, DOI 10.1016/j.semcdb.2010.08.008; Parker SE, 2010, BIRTH DEFECTS RES A, V88, P1008, DOI 10.1002/bdra.20735; Pentassuglia L, 2009, EXP CELL RES, V315, P627, DOI 10.1016/j.yexcr.2008.08.015; Perlin JR, 2011, DEVELOPMENT, V138, P4639, DOI 10.1242/dev.068072; Peshkovsky C, 2011, DEV DYNAM, V240, P446, DOI 10.1002/dvdy.22526; Rees BB, 2001, J EXP ZOOL, V289, P266, DOI 10.1002/1097-010X(20010401/30)289:4&lt;266::AID-JEZ7&gt;3.0.CO;2-5; Rothschild SC, 2009, DEV BIOL, V330, P175, DOI 10.1016/j.ydbio.2009.03.024; Rupert CE, 2015, BIOMARK INSIGHTS, V10, P1, DOI [10.4137/BMI.S20061, 10.4137/BMIMI.S20061]; RYCHTER Z, 1971, Folia Morphologica (Prague), V19, P31; Samsa LA, 2016, ISOLATION CHARACTERI; Samsa LA, 2015, DEVELOPMENT, V142, P4080, DOI 10.1242/dev.125724; Samsa LA, 2013, AM J MED GENET C, V163, P157, DOI 10.1002/ajmg.c.31366; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Strecker R, 2011, COMP BIOCHEM PHYS C, V153, P318, DOI 10.1016/j.cbpc.2010.12.002; Taveggia C, 2005, NEURON, V47, P681, DOI 10.1016/j.neuron.2005.08.017; Vermot J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000246; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yokozeki T, 2007, GENES CELLS, V12, P329, DOI 10.1111/j.1365-2443.2007.01060.x	61	8	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166734	10.1371/journal.pone.0166734	http://dx.doi.org/10.1371/journal.pone.0166734			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846271	gold, Green Submitted, Green Published			2022-12-26	WOS:000387794600104
J	Nadeau, MB; Khasa, DP				Nadeau, Martin B.; Khasa, Damase P.			Edaphic Selection Pressures as Drivers of Contrasting White Spruce Ectomycorrhizal Fungal Community Structure and Diversity in the Canadian Boreal Forest of Abitibi-Temiscamingue Region	PLOS ONE			English	Article							NUTRIENT-UPTAKE; PICEA-GLAUCA; INOCULATION; MYCORRHIZAE; GRADIENT; NURSERY; GROWTH; PLANTS; SUCCESSION; SEEDLINGS	Little is known about edaphic selection pressures as drivers of contrasting white spruce ectomycorrhizal fungal community structure and diversity in the Canadian boreal forest. We hypothesized that community composition differs among the four sites sampled-nursery, mining site, forest edge, and natural forest. Ectomycorrhizal (ECM) fungal community structure and diversity was studied at the four locations with soil fertility gradient through morphomolecular and phylogenetic analyses in relationships with rhizospheric soil chemical properties. 41 different species were identified. Mining site had a significantly different species composition than the surrounding environments. Soil pH and percentage of roots colonized by ECM fungi increased while soil P, N, Fe, C, K, Mg, Al, Ca, and Na contents declined across the soil fertility gradient: nursery -> natural forest -> forest edge -> mining site. Contrary to the preference of acid soils by ECM fungi, a few ecologically adapted to high pH, poor soil chemical fertility, and low organic matter content colonize white spruce roots on the non-acidogenic mining site, allowing natural regeneration of white spruce seedlings. Other ECM fungi are adapted to high fertigation level of commercial nursery. This study clearly shows the contrasting difference in white spruce ectomycorrhizal fungal community structure and diversity driven by edaphic selection pressures.	[Nadeau, Martin B.] Univ Laval, Ctr Forest Res, Inst Integrat & Syst Biol, Quebec City, PQ G1V 0A6, Canada; Univ Laval, Canadian Res Chair Forest & Environm Genom, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University	Nadeau, MB (corresponding author), Univ Laval, Ctr Forest Res, Inst Integrat & Syst Biol, Quebec City, PQ G1V 0A6, Canada.	martin.beaudoin-nadeau.1@ulaval.ca		Khasa, Damase/0000-0002-9336-7770	Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was financially supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Natural Sciences and Engineering Research Council of Canada (NSERC) provided financial support for this study. Furthermore, we are grateful to Andre Gagne and Marie-Eve Beaulieu for their invaluable help and advice over the course of this research. The authors also thank Mathieu Boudreau for his assistance in the laboratory, Alain Brousseau for performing the soil chemical analyses, and Mark Mazerolle for his statistical guidance. Lastly, we are grateful to Drs. Suzanne Simard (University of British Columbia) and Line Lapointe (Universite Laval) for their careful review that helped improve the quality of the manuscript. We are also immensely grateful to Dr W.F.J. Parsons from the Centre d'etude de la foret (CEF) for his constructive comments on an earlier version of the manuscript.	Adriaensen K, 2005, APPL ENVIRON MICROB, V71, P7279, DOI 10.1128/AEM.71.11.7279-7284.2005; Allen EB, 2003, ECOL APPL, V13, P1701, DOI 10.1890/02-5309; Allen MF, 2003, ANNU REV PHYTOPATHOL, V41, P271, DOI 10.1146/annurev.phyto.41.052002.095518; AMACHER MC, 1990, SOIL SCI SOC AM J, V54, P1036, DOI 10.2136/sssaj1990.03615995005400040018x; Bahram M, 2012, NEW PHYTOL, V193, P465, DOI 10.1111/j.1469-8137.2011.03927.x; Balogh-Brunstad Z, 2008, GEOCHIM COSMOCHIM AC, V72, P2601, DOI 10.1016/j.gca.2008.04.003; Baxter JW, 2001, NEW PHYTOL, V152, P139, DOI 10.1046/j.0028-646x.2001.00245.x; Beaudoin-Nadeau M, 2016, CAN J MICROBIOL, V62, P543, DOI 10.1139/cjm-2015-0703; Berner C, 2012, MYCORRHIZA, V22, P615, DOI 10.1007/s00572-012-0438-y; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; BRUNS TD, 1995, PLANT SOIL, V170, P63, DOI 10.1007/BF02183055; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burns RM, 1990, AGR HDB, V654; Cairney JWG, 1999, MYCORRHIZA, V9, P125, DOI 10.1007/s005720050297; Colpaert JV, 2011, ANN FOREST SCI, V68, P17, DOI 10.1007/s13595-010-0003-9; Colpaert JV, 2000, NEW PHYTOL, V147, P367, DOI 10.1046/j.1469-8137.2000.00694.x; Colpaert JV., 2008, STRESS YEASTS FILAME, P157, DOI [10.1016/S0275-0287(08)80053-7, DOI 10.1016/S0275-0287(08)80053-7]; Dahlberg A, 2001, NEW PHYTOL, V150, P555, DOI 10.1046/j.1469-8137.2001.00142.x; DeBellis T, 2006, MICROB ECOL, V52, P114, DOI 10.1007/s00248-006-9038-8; DIXON RK, 1988, PLANT SOIL, V105, P265, DOI 10.1007/BF02376791; Erlandson SR, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiv148; Gagne A, 2006, CAN J FOREST RES, V36, P1684, DOI 10.1139/X06-063; Gehring CA, 1998, ECOLOGY, V79, P1562, DOI 10.1890/0012-9658(1998)079[1562:EFCSOP]2.0.CO;2; Hoffland E, 2004, FRONT ECOL ENVIRON, V2, P258; Hogberg MN, 2007, OECOLOGIA, V150, P590, DOI 10.1007/s00442-006-0562-5; Hunt GA, 1991, FRDA HDB; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; Jumpponen A., 2005, MYCOL SER, V23, P139, DOI DOI 10.1201/CRCMYCOLOGY; KEIZER PJ, 1994, MYCORRHIZA, V4, P147, DOI 10.1007/BF00203533; Kennedy P, 2010, NEW PHYTOL, V187, P895, DOI 10.1111/j.1469-8137.2010.03399.x; Kernaghan G, 2003, MICROB ECOL, V45, P128, DOI 10.1007/s00248-002-1024-1; Korkama T, 2006, NEW PHYTOL, V171, P815, DOI 10.1111/j.1469-8137.2006.01786.x; Kranabetter JM, 2009, MYCORRHIZA, V19, P99, DOI 10.1007/s00572-008-0208-z; Krpata D, 2008, MYCOL RES, V112, P1069, DOI 10.1016/j.mycres.2008.02.004; LAMHAMEDI MS, 1991, CAN J BOT, V69, P1927, DOI 10.1139/b91-242; Landeweert R, 2001, TRENDS ECOL EVOL, V16, P248, DOI 10.1016/S0169-5347(01)02122-X; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Lilleskov EA, 2001, ECOL APPL, V11, P397, DOI 10.1890/1051-0761(2001)011[0397:EFACCO]2.0.CO;2; McCune B., 1999, MULTIVARIATE ANAL EC; MRNF, 2012, VEG ZON BIOCL DOM QU; Nadeau MB, 2016, MICROBES PLANT STRES; Nienstaedt H, 1990, AGR HDB, V654; Nilsson LO, 2005, NEW PHYTOL, V165, P613, DOI 10.1111/j.1469-8137.2004.01233.x; Nilsson LO, 2003, NEW PHYTOL, V158, P409, DOI 10.1046/j.1469-8137.2003.00728.x; Peck JE, 2010, MUTIVARIATE ANAL COM; QuikChem Systems, 1992, 13107062D QUIKCHEM S; Quoreshi AM, 2008, BIOMASS BIOENERG, V32, P381, DOI 10.1016/j.biombioe.2007.10.010; Quoreshi A. M., 2007, Native Plants Journal, V8, P271, DOI 10.2979/NPJ.2007.8.3.271; Quoreshi AM, 2008, NEW FOREST, V35, P235, DOI 10.1007/s11056-007-9074-3; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Roy S, 2007, CAN J BOT, V85, P237, DOI 10.1139/B07-017; SAS Institute Inc, 2014, SAS 9 4 SOFTW; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Smits MM, 2012, GEOBIOLOGY, V10, P445, DOI 10.1111/j.1472-4669.2012.00331.x; Sutton RF, USITC PUBL; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Toljander JF, 2006, NEW PHYTOL, V170, P873, DOI 10.1111/j.1469-8137.2006.01718.x; Twieg BD, 2007, NEW PHYTOL, V176, P437, DOI 10.1111/j.1469-8137.2007.02173.x; Twieg BD, 2009, MYCORRHIZA, V19, P305, DOI 10.1007/s00572-009-0232-7; Villeneuve N, 1989, CAN J BOT, V67, P2616; Wallander H, 2004, SYMBIOSIS, V37, P249; Wright SHA, 2009, MYCORRHIZA, V19, P267, DOI 10.1007/s00572-008-0218-x; Wurzburger N, 2001, CAN J BOT, V79, P1211, DOI 10.1139/cjb-79-10-1211; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	65	4	4	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166420	10.1371/journal.pone.0166420	http://dx.doi.org/10.1371/journal.pone.0166420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835688	Green Published, gold, Green Submitted			2022-12-26	WOS:000387779200048
J	Kunisawa, S; Fushimi, K; Imanaka, Y				Kunisawa, Susumu; Fushimi, Kiyohide; Imanaka, Yuichi			Reducing Length of Hospital Stay Does Not Increase Readmission Rates in Early-Stage Gastric, Colon, and Lung Cancer Surgical Cases in Japanese Acute Care Hospitals	PLOS ONE			English	Article							COLORECTAL RESECTION; EARLY DISCHARGE	Background The Japanese government has worked to reduce the length of hospital stay by introducing a per-diem hospital payment system that financially incentivizes the timely discharge of patients. However, there are concerns that excessively reducing length of stay may reduce healthcare quality, such as increasing readmission rates. The objective of this study was to investigate the temporal changes in length of stay and readmission rates as quality indicators in Japanese acute care hospitals. Methods We used an administrative claims database under the Diagnosis Procedure Combination Per-Diem Payment System for Japanese hospitals. Using this database, we selected hospitals that provided data continuously from July 2010 to March 2014 to enable analyses of temporal changes in length of stay and readmission rates. We selected stage I (T1N0M0) gastric, colon, and lung cancer surgical patients who had been discharged alive from the index hospitalization. The outcome measures were length of stay during the index hospitalization and unplanned emergency readmissions within 30 days after discharge. Results From among 804 hospitals, we analyzed 42,585, 15,467, and 40,156 surgical patients for gastric, colon, and lung cancer, respectively. Length of stay was reduced by approximately 0.5 days per year. In contrast, readmission rates were generally stable at approximately 2% or had decreased slightly over the 4-year period. Conclusions In early-stage gastric, colon, and lung cancer surgical patients in Japan, reductions in length of stay did not result in increased readmission rates.	[Kunisawa, Susumu; Imanaka, Yuichi] Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Tokyo, Japan	Kyoto University; Tokyo Medical & Dental University (TMDU)	Imanaka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Healthcare Econ & Qual Management, Kyoto, Japan.	imanaka-y@umin.net	KUNISAWA, Susumu/HCH-1094-2022		Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan [H28-seisaku-shitei-009]; Japan Society for the Promotion of Science [16H02634]	Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by a Health and Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare, Japan (H28-seisaku-shitei-009), http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/hokabunya/kenkyujigyou/, and a Grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (16H02634), https://www.jsps.go.jp/i-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brooke BS, 2013, J VASC SURG, V57, P734, DOI 10.1016/j.jvs.2012.07.055; Gash KJ, 2012, COLORECTAL DIS, V14, P1287, DOI 10.1111/j.1463-1318.2012.02969.x; Hamada H, 2012, HEALTH POLICY, V107, P194, DOI 10.1016/j.healthpol.2012.01.002; Hoffman RL, 2014, J SURG RES, V190, P579, DOI 10.1016/j.jss.2014.02.006; Mackenzie SJ, 2016, J HEALTHC QUAL, V38, P187, DOI 10.1111/jhq.12080; Ministry of Health Labour and Welfare, HEIS 26 NEND BYOSH K, V26; Ministry of Health Labour and Welfare, 2014, HEIS 25 NEN IN PRESS; Ministry of Health Labour and Welfare, 2015, YOK SAIN KEIN; OECD Indicators, 2015, HLTH GLANC 2015; Otsubo T, 2012, READMISSION RATE HLT, V67, P62	10	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166269	10.1371/journal.pone.0166269	http://dx.doi.org/10.1371/journal.pone.0166269			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832182	gold, Green Published, Green Submitted			2022-12-26	WOS:000387725000086
J	Li, W; Lu, JX; Lu, K; Yuan, JL; Huang, JH; Du, H; Li, JN				Li, Wei; Lu, Junxing; Lu, Kun; Yuan, Jianglian; Huang, Jieheng; Du, Hai; Li, Jiana			Cloning and Phylogenetic Analysis of Brassica napus L. Caffeic Acid O-Methyltransferase 1 Gene Family and Its Expression Pattern under Drought Stress	PLOS ONE			English	Article							WALL RELATED GENES; ARABIDOPSIS-THALIANA; DOWN-REGULATION; GENOME SIZE; N-ACETYLSEROTONIN; INTRON EVOLUTION; LEAF SENESCENCE; MELATONIN; LIGNIN; MAIZE	For many plants, regulating lignin content and composition to improve lodging resistance is a crucial issue. Caffeic acid O-methyltransferase (COMT) is a lignin monomer-specific enzyme that controls S subunit synthesis in plant vascular cell walls. Here, we identified 12 BnCOMT1 gene homologues, namely BnCOMT1-1 to BnCOMT1-12. Ten of 12 genes were composed of four highly conserved exons and three weakly conserved introns. The length of intron I, in particular, showed enormous diversification. Intron I of homologous BnCOMT1 genes showed high identity with counterpart genes in Brassica rapa and Brassica oleracea, and intron I from positional close genes in the same chromosome were relatively highly conserved. A phylogenetic analysis suggested that COMT genes experience considerable diversification and conservation in Brassicaceae species, and some COMT1 genes are unique in the Brassica genus. Our expression studies indicated that BnCOMT1 genes were differentially expressed in different tissues, with BnCOMT1-4, BnCOMT1-5, BnCOMT1-8, and BnCOMT1-10 exhibiting stem specificity. These four BnCOMT1 genes were expressed at all developmental periods (the bud, early flowering, late flowering and mature stages) and their expression level peaked in the early flowering stage in the stem. Drought stress augmented and accelerated lignin accumulation in high-lignin plants but delayed it in low-lignin plants. The expression levels of BnCOMT1s were generally reduced in water deficit condition. The desynchrony of the accumulation processes of total lignin and BnCOMT1s transcripts in most growth stages indicated that BnCOMT1s could be responsible for the synthesis of a specific subunit of lignin or that they participate in other pathways such as the melatonin biosynthesis pathway.	[Li, Wei; Lu, Kun; Yuan, Jianglian; Huang, Jieheng; Du, Hai; Li, Jiana] Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China; [Lu, Junxing] Chongqing Normal Univ, Coll Life Sci, Chongqing Key Lab Mol Biol Plants Environm Adapt, Chongqing 401331, Peoples R China	Southwest University - China; Chongqing Normal University	Li, JN (corresponding author), Southwest Univ, Chongqing Engn Res Ctr Rapeseed, Coll Agron & Biotechnol, Chongqing 400715, Peoples R China.	lin1950@swu.edu.cn	Lu, Kun/C-2597-2008; Du, Hai/AHD-1445-2022; Lu, Junxing/GZH-2188-2022	Lu, Kun/0000-0003-1370-8633; Lu, Junxing/0000-0002-1447-2768; Du, Hai/0000-0003-4274-5724	973 Project [2015CB150201]; National Science Foundation of China [U1302266, 31271756, 31571701]; National Key Research and Development Plan [2016YFD0101007]; National Key Technology Support Program [2013BAD01B03-12]; 111 Project [B12006]	973 Project(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Plan; National Key Technology Support Program(National Key Technology R&D Program); 111 Project(Ministry of Education, China - 111 Project)	The 973 Project (2015CB150201), the National Science Foundation of China (U1302266, 31271756, and 31571701), the National Key Research and Development Plan (2016YFD0101007), the National Key Technology Support Program (2013BAD01B03-12) and the 111 Project (B12006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez S, 2008, PLANT CELL ENVIRON, V31, P325, DOI 10.1111/j.1365-3040.2007.01770.x; Arnao MB, 2014, TRENDS PLANT SCI, V19, P789, DOI 10.1016/j.tplants.2014.07.006; ATANASSOVA R, 1995, PLANT J, V8, P465, DOI 10.1046/j.1365-313X.1995.8040465.x; Bajrovic K, 1999, J FOREST RES, V4, P161, DOI [10.1007/BF02762242, DOI 10.1007/BF02762242]; Bajwa VS, 2014, J PINEAL RES, V56, P238, DOI 10.1111/jpi.12115; Bongoni R, 2014, PLANT FOOD HUM NUTR, V69, P228, DOI 10.1007/s11130-014-0420-2; Bout S, 2003, MOL GENET GENOMICS, V269, P205, DOI 10.1007/s00438-003-0824-4; Bradnam KR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003093; BUGOS RC, 1991, PLANT MOL BIOL, V17, P1203, DOI 10.1007/BF00028736; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byeon Y, 2015, J EXP BOT, V66, P6917, DOI 10.1093/jxb/erv396; Byeon Y, 2014, J PINEAL RES, V57, P219, DOI 10.1111/jpi.12160; Byeon Y, 2014, J PINEAL RES, V56, P107, DOI 10.1111/jpi.12103; Castillo-Davis CI, 2002, NAT GENET, V31, P415, DOI 10.1038/ng940; Chai YR, 2009, MOL GENET GENOMICS, V281, P109, DOI 10.1007/s00438-008-0399-1; Chen GQ, 2013, PLANT J, V74, P663, DOI 10.1111/tpj.12151; Comeron JM, 2000, GENETICS, V156, P1175; Deutsch M, 1999, NUCLEIC ACIDS RES, V27, P3219, DOI 10.1093/nar/27.15.3219; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Guillaumie S, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-71; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Haberer G, 2005, PLANT PHYSIOL, V139, P1612, DOI 10.1104/pp.105.068718; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jiang Y-R, 2009, WATER RESOURCE PROTE, V25, P25, DOI DOI 10.1007/S11103-008-9408-3; Jiang YQ, 2009, MOL GENET GENOMICS, V282, P503, DOI 10.1007/s00438-009-0481-3; Johnston JS, 2005, ANN BOT-LONDON, V95, P229, DOI 10.1093/aob/mci016; Kang K, 2013, J PINEAL RES, V55, P7, DOI 10.1111/jpi.12011; Kenrick P, 1997, NATURE, V389, P33, DOI 10.1038/37918; Kim JH, 2007, PLANT J, V49, P1008, DOI 10.1111/j.1365-313X.2006.03019.x; KUBITZKI K, 1987, J PLANT PHYSIOL, V131, P17, DOI 10.1016/S0176-1617(87)80263-8; Lagercrantz U, 1998, GENETICS, V150, P1217; Lee HY, 2014, J PINEAL RES, V57, P418, DOI 10.1111/jpi.12181; Lee HY, 2014, J PINEAL RES, V57, P262, DOI 10.1111/jpi.12165; Li YC, 2012, BIOTECHNOL BIOFUELS, V5, DOI [10.1186/1754-6834-5-71, 10.1186/1754-6834-5-2]; Liang WW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-392; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2002, P NATL ACAD SCI USA, V99, P6118, DOI 10.1073/pnas.092595699; Lysak MA, 2005, GENOME RES, V15, P516, DOI 10.1101/gr.3531105; Matsunaga W, 2012, PLANT CELL PHYSIOL, V53, P824, DOI 10.1093/pcp/pcr179; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Moinuddin SGA, 2010, ORG BIOMOL CHEM, V8, P3928, DOI 10.1039/c004817h; Moura-Sobczak J., 2011, EUCALYPTUS BMC PROC, V5, P103, DOI [10. 1186/1753-6561-5-S7-P103, DOI 10.1186/1753-6561-5-S7-P103]; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Park S, 2012, J PINEAL RES, V52, P211, DOI [10.1111/j.1600-079X.2011.00930.x, 10.1111/j.1600-079X.2012.01029.x]; Parkin IAP, 2003, GENOME, V46, P291, DOI [10.1139/g03-006, 10.1139/G03-006]; Parsch J, 2003, GENETICS, V165, P1843; Pfalz M, 2011, PLANT CELL, V23, P716, DOI 10.1105/tpc.110.081711; Piquemal J, 2002, PLANT PHYSIOL, V130, P1675, DOI 10.1104/pp.012237; Ren XY, 2006, TRENDS GENET, V22, P528, DOI 10.1016/j.tig.2006.08.008; Rutter MT, 2012, TRENDS PLANT SCI, V17, P204, DOI 10.1016/j.tplants.2012.01.006; Schnable JC, 2012, GENOME BIOL EVOL, V4, P265, DOI 10.1093/gbe/evs009; Sena JS, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-95; Srivastava S, 2015, PHYSIOL MOL BIOL PLA, V21, P197, DOI 10.1007/s12298-015-0289-z; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tiryaki I, 2012, J PINEAL RES, V52, P332, DOI 10.1111/j.1600-079X.2011.00947.x; Town CD, 2006, PLANT CELL, V18, P1348, DOI 10.1105/tpc.106.041665; U. N., 1935, Japanese Journal of Botany, V7, P389; VanDoorsselaere J, 1995, PLANT J, V8, P855, DOI 10.1046/j.1365-313X.1995.8060855.x; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; VIGNOLS F, 1995, PLANT CELL, V7, P407, DOI 10.1105/tpc.7.4.407; Vinogradov AE, 1999, J MOL EVOL, V49, P376, DOI 10.1007/PL00006561; Wang P, 2013, J PINEAL RES, V55, P424, DOI 10.1111/jpi.12091; Wang P, 2013, J PINEAL RES, V54, P292, DOI [10.1111/j.1600-079X.2012.00999.x, 10.1111/jpi.12017]; Wendel JF, 2002, MOL BIOL EVOL, V19, P2346, DOI 10.1093/oxfordjournals.molbev.a004062; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Xie ZX, 2003, CURR BIOL, V13, P784, DOI 10.1016/S0960-9822(03)00281-1; Yang B, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-68; Yang L, 2006, RUSS J PLANT PHYSL+, V53, P390, DOI 10.1134/S1021443706030150; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang N, 2013, J PINEAL RES, V54, P15, DOI 10.1111/j.1600-079X.2012.01015.x; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	71	12	13	7	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0165975	10.1371/journal.pone.0165975	http://dx.doi.org/10.1371/journal.pone.0165975			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832102	Green Submitted, Green Published, gold			2022-12-26	WOS:000387725000051
J	Mimoun, C; Fauconnier, A; Varas, C; Huchon, C				Mimoun, Camille; Fauconnier, Arnaud; Varas, Catalina; Huchon, Cyrille			Is a Self-Assessed Questionnaire Useful for the Diagnosis of Ectopic Pregnancy in Hospitalized Patients?	PLOS ONE			English	Article							UNITED-STATES; LAPAROSCOPY; PREDICTION; MODEL	Background Delayed diagnosis of ectopic pregnancy (EP) is responsible for maternal morbidity and mortality. Our objective was to develop and validate decision rules for the diagnosis of EP, in patients in their first trimester of pregnancy with symptoms, based solely on a self-assessment questionnaire. Methods From September 2006 to March 2008, 574 patients, who have consulted for acute pelvic pain at the gynecologic emergency department (ED) of five hospitals, completed a Self Assessment Questionnaire for Gynecological Emergencies (SAO-GE). We included for our study only women in their first trimester of pregnancy experiencing acute pelvic pain and/or vaginal bleeding who were hospitalized (262 patients). Two-thirds of patients were selected to derive the SAO-GE EP score which was built on multiple logistic regression. One third of patients were used for internal validation. Results Five variables were independently and significantly (p<0.05) associated with EP: no frequent need to change sanitary towels (aDOR = 6.1; 95% CI [2.1-17.8]), duration of bleeding > 24 hours (aDOR = 4,3; 95% CI [1,7-11,0]), pain during coughing (aDOR = 3.1; CI 95% [1,4-6,7]), brown discharge (aDOR = 3.0; 95% CI [1.3-7.1]) and unilateral pelvic pain (aDOR = 2.7; 95% CI [1.3-5.9]). The SAO-GE ectopic pregnancy score was based on these five criteria with values ranging from 0 to 100. The low-risk group of EP (score<25) had a sensitivity of 95.9% 95% CI [89.8-98,9] and an LR-of 0.2 95% CI [0.1-0.5]. The high-risk group (score>70) had a specificity of 97.4 95% CI [90.9-99.7] and a LR+ of 12.3 95% CI [3.0-49.8]. The percentages of EP observed in the validation sample were: 0% in the low-risk group and 88.9% in the high-risk group. Discussion These prediction rules that classify patients in a low-risk or high-risk group may prove useful for triaging pregnant women in their first trimester with symptoms before complementary exams.	[Mimoun, Camille; Fauconnier, Arnaud; Huchon, Cyrille] Univ Versailles St Quentin, Ctr Hosp Intercommunal Poissy St Germai, Dept Gynecol & Obstet, Poissy, France; [Mimoun, Camille; Fauconnier, Arnaud; Varas, Catalina; Huchon, Cyrille] Univ Versailles St Quentin, Res Unit EA Risk & Safety Clin Med Women & Perina, Poissy, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Mimoun, C (corresponding author), Univ Versailles St Quentin, Ctr Hosp Intercommunal Poissy St Germai, Dept Gynecol & Obstet, Poissy, France.; Mimoun, C (corresponding author), Univ Versailles St Quentin, Res Unit EA Risk & Safety Clin Med Women & Perina, Poissy, France.	camillemimoun@hotmail.com			l'Association maternites et medecine de la reproduction Poissy-Saint Germain	l'Association maternites et medecine de la reproduction Poissy-Saint Germain	Camille Mimoun has received funding from l'Association maternites et medecine de la reproduction Poissy-Saint Germain.	ABBOTT J, 1990, AM J EMERG MED, V8, P515, DOI 10.1016/0735-6757(90)90154-R; Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; ANKUM WM, 1993, HUM REPROD, V8, P1301, DOI 10.1093/oxfordjournals.humrep.a138246; Ardaens Y, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, pS28; Berg CJ, 2011, OBSTET GYNECOL, V117, P1230, DOI 10.1097/AOG.0b013e31821769ed; Bouquier J, 2014, SEX TRANSM DIS, V41, P525, DOI 10.1097/OLQ.0000000000000169; Bouyer J, 2002, HUM REPROD, V17, P3224, DOI 10.1093/humrep/17.12.3224; Buckley RG, 1998, ACAD EMERG MED, V5, P951, DOI 10.1111/j.1553-2712.1998.tb02770.x; Colaizzi P., 1978, PSYCHOL RES PHENOMEN; Condous G, 2005, HUM REPROD, V20, P1404, DOI 10.1093/humrep/deh770; Coste J, 1997, AM J EPIDEMIOL, V145, P278; Dart RG, 1999, ANN EMERG MED, V33, P283, DOI 10.1016/S0196-0644(99)70364-1; Demco L, 1998, J AM ASSOC GYN LAP, V5, P241, DOI 10.1016/S1074-3804(98)80026-1; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Fauconnier A, 2013, HUM REPROD, V28, P2686, DOI 10.1093/humrep/det310; HARRELL FE, 1984, STAT MED, V3, P143, DOI 10.1002/sim.4780030207; Hoover KW, 2010, OBSTET GYNECOL, V115, P495, DOI 10.1097/AOG.0b013e3181d0c328; Huchon C, 2012, HUM REPROD, V27, P2359, DOI 10.1093/humrep/des186; Huchon C, 2012, ACAD EMERG MED, V19, P24, DOI 10.1111/j.1553-2712.2011.01238.x; Mol BWJ, 1998, FERTIL STERIL, V70, P972, DOI 10.1016/S0015-0282(98)00278-7	20	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0155054	10.1371/journal.pone.0155054	http://dx.doi.org/10.1371/journal.pone.0155054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832075	Green Published, Green Submitted, gold			2022-12-26	WOS:000387725000001
J	Schumacher, FR; Schubert, S; Hannus, M; Sonnichsen, B; Ittrich, C; Kreideweiss, S; Kurz, T; Rippmann, JF				Schumacher, Frances-Rose; Schubert, Steffen; Hannus, Michael; Soennichsen, Birte; Ittrich, Carina; Kreideweiss, Stefan; Kurz, Thimo; Rippmann, Joerg F.			RNAi Screen for NRF2 Inducers Identifies Targets That Rescue Primary Lung Epithelial Cells from Cigarette Smoke Induced Radical Stress	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; INDUCED EMPHYSEMA; ERR-ALPHA; KEAP1; DYSFUNCTION; ACTIVATION; STRATEGIES; PATHWAYS	Chronic Obstructive Pulmonary Disease (COPD) is a highly prevalent condition characterized by inflammation and progressive obstruction of the airways. At present, there is no treatment that suppresses the chronic inflammation of the disease, and COPD patients often succumb to the condition. Excessive oxidative stress caused by smoke inhalation is a major driving force of the disease. The transcription factor NRF2 is a critical player in the battle against oxidative stress and its function is impaired in COPD. Increasing NRF2 activity may therefore be a viable therapeutic option for COPD treatment. We show that down regulation of KEAP1, a NRF2 inhibitor, protects primary human lung epithelial cells from cigarette-smoke-extract (CSE) induced cell death in an established in vitro model of radical stress. To identify new potential drug targets with a similar effect, we performed a siRNA screen of the 'druggable' genome using a NRF2 transcriptional reporter cell line. This screen identified multiple genes that when down regulated increased NRF2 transcriptional activity and provided a survival benefit in the in vitro model. Our results suggest that inhibiting components of the ubiquitin-proteasome system will have the strongest effects on NRF2 transcriptional activity by increasing NRF2 levels. We also find that down regulation of the small GTPase Rab28 or the Estrogen Receptor ESRRA provide a survival benefit. Rab28 knockdown increased NRF2 protein levels, indicating that Rab28 may regulate NRF2 proteolysis. Conversely ESRRA down regulation increased NRF2 transcriptional activity without affecting NRF2 levels, suggesting a proteasome-independent mechanism.	[Ittrich, Carina; Kreideweiss, Stefan; Rippmann, Joerg F.] Boehringer Ingelheim Pharma GmbH & Co KG, Res Germany, D-8400 Biberach, Germany; [Schubert, Steffen; Hannus, Michael; Soennichsen, Birte] Cenix BioSci GmbH, D-01307 Dresden, Germany; [Schumacher, Frances-Rose; Kurz, Thimo] Univ Dundee, Sir James Black Ctr, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dow St, Dundee DD1 5EH, Scotland; [Schumacher, Frances-Rose] Genentech Inc, Dept Prot Chem, Prote & Biol Resource Management, 1 DNA Way, San Francisco, CA 94080 USA; [Schubert, Steffen] Silence Therapeut, D-13125 Berlin, Germany; [Hannus, Michael] Life Sci Inkubator Sachsen, D-01307 Dresden, Germany; [Soennichsen, Birte] SiTools Biotech GmbH, D-82152 Planegg, Germany; [Kurz, Thimo] Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland	Boehringer Ingelheim; University of Dundee; Roche Holding; Genentech; University of Glasgow	Kurz, T (corresponding author), Univ Dundee, Sir James Black Ctr, Prot Phosphorylat & Ubiquitylat Unit, MRC, Dow St, Dundee DD1 5EH, Scotland.; Kurz, T (corresponding author), Univ Glasgow, Inst Mol Cell & Syst Biol, Glasgow G12 8QQ, Lanark, Scotland.	thimo.kurz@glasgow.ac.uk		Kurz, Thimo/0000-0003-0700-6993	Medical Research Council Grant [MRC_MC_UU_12016/7]; University of Glasgow; Boehringer-Ingelheim Funds; MRC [MC_UU_12016/7] Funding Source: UKRI	Medical Research Council Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Glasgow; Boehringer-Ingelheim Funds(Boehringer Ingelheim); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Grant MRC_MC_UU_12016/7 (mre.ac.uk) to the MRC Protein Phosphorylation and Ubiquitylation Unit, by start-up funds from the University of Glasgow to TK and by Boehringer-Ingelheim Funds to SK and JR. Boehringer-Ingelheim Pharma GmbH & Co. and Cenix BioScience GmbH provided support in the form of salaries for authors CI, SK, JR and MH, SS, BS, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Blake DJ, 2010, AM J RESP CELL MOL, V42, P524, DOI 10.1165/rcmb.2009-0054OC; Blanco-Ayala T, 2014, FREE RADICAL RES, V48, P623, DOI 10.3109/10715762.2014.899694; Bodas M, 2012, CURR MOL MED, V12, P807, DOI 10.2174/156652412801318809; Chisamore MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005624; CHURCH DF, 1985, ENVIRON HEALTH PERSP, V64, P111, DOI 10.2307/3430003; Dimopoulos MA, 2015, NAT REV CLIN ONCOL, V12, P42, DOI 10.1038/nrclinonc.2014.200; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Gershon AS, 2011, LANCET, V378, P991, DOI 10.1016/S0140-6736(11)60990-2; Goven D, 2008, THORAX, V63, P916, DOI 10.1136/thx.2007.091181; Huss JM, 2015, BBA-MOL BASIS DIS, V1852, P1912, DOI 10.1016/j.bbadis.2015.06.016; Tran I, 2015, AM J RESP CELL MOL, V53, P159, DOI 10.1165/rcmb.2014-0107OC; Iizuka T, 2005, GENES CELLS, V10, P1113, DOI 10.1111/j.1365-2443.2005.00905.x; Ishii Y, 2005, J IMMUNOL, V175, P6968, DOI 10.4049/jimmunol.175.10.6968; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kageyama S, 2014, J BIOL CHEM, V289, P24944, DOI 10.1074/jbc.M114.580357; Kansanen E, 2012, FREE RADICAL BIO MED, V52, P973, DOI 10.1016/j.freeradbiomed.2011.11.038; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Lin JL, 2010, COPD, V7, P291, DOI 10.3109/15412555.2010.496818; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Malhotra D, 2010, NUCLEIC ACIDS RES, V38, P5718, DOI 10.1093/nar/gkq212; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Parsons BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008471; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Rangasamy T, 2004, J CLIN INVEST, V114, P1248, DOI 10.1172/JCI200421146; Roosing S, 2013, AM J HUM GENET, V93, P110, DOI 10.1016/j.ajhg.2013.05.005; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Spira A, 2004, AM J RESP CELL MOL, V31, P601, DOI 10.1165/rcmb.2004-0273OC; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tian H, 2012, CANCER LETT, V325, P26, DOI 10.1016/j.canlet.2012.06.007; Willy PJ, 2004, P NATL ACAD SCI USA, V101, P8912, DOI 10.1073/pnas.0401420101; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	39	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166352	10.1371/journal.pone.0166352	http://dx.doi.org/10.1371/journal.pone.0166352			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832175	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000387725000107
J	Virtue, A; Johnson, C; Lopez-Pastrana, J; Shao, Y; Fu, HF; Li, XY; Li, YF; Yin, Y; Mai, JT; Rizzo, V; Tordoff, M; Bagi, Z; Shan, HM; Jiang, XH; Wang, H; Yang, XF				Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Tordoff, Michael; Bagi, Zsolt; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng			MicroRNA-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity, and Non-alcoholic Fatty Liver Disease A NOVEL MOUSE MODEL OF OBESITY PARADOX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLAMMATORY MONOCYTE DIFFERENTIATION; PERCUTANEOUS CORONARY INTERVENTION; BODY-MASS INDEX; METABOLIC SYNDROME; APOLIPOPROTEIN-E; EXPRESSION; IMPACT; CELLS; MECHANISMS; MICE	Obesity paradox (OP) describes a widely observed clinical finding of improved cardiovascular fitness and survival in some overweight or obese patients. The molecular mechanisms underlying OP remain enigmatic partly due to a lack of animal models mirroring OP in patients. Using apolipoprotein E knockout (ApoE(-/-)) mice on high-fat (HF) diet as an atherosclerotic obesity model, we demonstrated: 1) microRNA-155 (miRNA-155, miR-155) is significantly upregulated in aortas of ApoE(-/-) mice; and miR-155 deficiency in ApoE(-/-) mice inhibits atherosclerosis; 2) ApoE(-/-)/miR-155(-/-) (DKO) mice show HF diet-induced obesity, adipocyte hypertrophy and present with nonalcoholic fatty liver disease (NAFLD); 3) DKO mice demonstrate HF diet-induced elevations of plasma leptin, resistin, fed-state and fasting insulin, increased expression of adipogenic transcription factors, but lack glucose intolerance and insulin resistance. Our results are the first to present an OP model using DKO mice with features of decreased atherosclerosis, increased obesity and NAFLD. Our findings suggest the mechanistic role of reduced miR-155 expression in OP and present a new OP working model based on a single miRNA deficiency in diet-induced obese atherogenic mice. Furthermore, our results serve as a breakthrough in understanding the potential mechanism underlying OP and provide a new biomarker and novel therapeutic target for OP-related metabolic diseases.	[Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Metab Dis Res, Philadelphia, PA 19140 USA; [Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Cardiovasc Res, Philadelphia, PA 19140 USA; [Virtue, Anthony; Johnson, Candice; Lopez-Pastrana, Jahaira; Shao, Ying; Fu, Hangfei; Li, Xinyuan; Li, Ya-Feng; Yin, Ying; Mai, Jietang; Rizzo, Victor; Shan, Huimin; Jiang, Xiaohua; Wang, Hong; Yang, Xiao-Feng] Temple Univ, Lewis Katz Sch Med, Dept Pharmacol, Ctr Thrombosis Res, Philadelphia, PA 19140 USA; [Tordoff, Michael] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Bagi, Zsolt] Augusta Univ, Vasc Biol Ctr, Augusta, GA 30912 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Monell Chemical Senses Center; University System of Georgia; Augusta University	Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Metab Dis Res, 3500 North Broad St,MERB-1059, Philadelphia, PA 19140 USA.; Yang, XF (corresponding author), Temple Univ, Lewis Katz Sch Med, Ctr Cardiovasc Res, 3500 North Broad St,MERB-1059, Philadelphia, PA 19140 USA.	xfyang@temple.edu	Li, Xinyuan/B-1139-2015; Li, Xinyuan/Z-6299-2019; Li, YaFeng/J-6247-2013	Li, Xinyuan/0000-0002-6746-8367; Li, Xinyuan/0000-0002-6746-8367; Li, YaFeng/0000-0002-7500-0959; Bagi, Zsolt/0000-0001-8755-2980	National Institutes of Health [U24-DK093000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132399, R01HL116917, R01HL138749, R01HL117654, R01HL108910, R01HL131460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104116, U24DK093000, R01DK113775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Part of this work was performed at the National Mouse Metabolic Phenotyping Center at University of Massachusetts Medical School funded by National Institutes of Health Grant U24-DK093000.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Bjorndal B, 2011, J OBES, V2011, DOI 10.1155/2011/490650; Chen Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2742; Cheng WW, 2011, INT J MOL MED, V27, P393, DOI 10.3892/ijmm.2011.598; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Coppieters KT, 2014, MOL METAB, V3, P275, DOI 10.1016/j.molmet.2013.12.005; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170; Dixon JB, 2015, INT J OBESITY, V39, P82, DOI 10.1038/ijo.2014.59; Doherty TM, 2005, ARTERIOSCL THROM VAS, V25, pE38, DOI 10.1161/01.ATV.0000161318.83751.08; Donners MMPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035877; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Economou EK, 2015, ATHEROSCLEROSIS, V241, P624, DOI 10.1016/j.atherosclerosis.2015.06.037; Fang P, 2014, DIABETES, V63, P4275, DOI 10.2337/db14-0809; Ferreira DMS, 2014, FEBS J, V281, P2503, DOI 10.1111/febs.12806; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gruberg L, 2002, J AM COLL CARDIOL, V39, P578, DOI 10.1016/S0735-1097(01)01802-2; Gurm HS, 2002, AM J CARDIOL, V90, P42, DOI 10.1016/S0002-9149(02)02384-6; Hainer V, 2013, DIABETES CARE, V36, pS276, DOI 10.2337/dcS13-2023; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hosin AA, 2014, J VASC RES, V51, P338, DOI 10.1159/000368193; Huang YD, 1998, J BIOL CHEM, V273, P26388, DOI 10.1074/jbc.273.41.26388; Khattab AA, 2008, AM J CARDIOL, V101, P1550, DOI 10.1016/j.amjcard.2008.02.034; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kortelainen ML, 2011, AM J FOREN MED PATH, V32, P372, DOI 10.1097/PAF.0b013e318219cd89; Lakner AM, 2011, WORLD J GASTROENTERO, V17, P2536, DOI 10.3748/wjg.v17.i20.2536; Lavie CJ, 2015, NAT REV ENDOCRINOL, V11, P55, DOI 10.1038/nrendo.2014.165; Lavie CJ, 2013, JACC-HEART FAIL, V1, P93, DOI 10.1016/j.jchf.2013.01.006; Mestas J, 2008, TRENDS CARDIOVAS MED, V18, P228, DOI 10.1016/j.tcm.2008.11.004; Miller AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072324; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; Niedziela J, 2014, EUR J EPIDEMIOL, V29, P801, DOI 10.1007/s10654-014-9961-9; Nogueras S, 2008, AM J PHYSIOL-HEART C, V294, pH708, DOI 10.1152/ajpheart.00466.2007; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Pulkkinen KH, 2011, FREE RADICAL BIO MED, V51, P2124, DOI 10.1016/j.freeradbiomed.2011.09.014; Raitoharju E, 2013, CLIN CHEM, V59, P1708, DOI 10.1373/clinchem.2013.204917; Raitoharju E, 2011, ATHEROSCLEROSIS, V219, P211, DOI 10.1016/j.atherosclerosis.2011.07.020; Rocha VZ, 2009, NAT REV CARDIOL, V6, P399, DOI 10.1038/nrcardio.2009.55; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sha XJ, 2015, J BIOL CHEM, V290, P19307, DOI 10.1074/jbc.M115.663286; Skarn M, 2012, STEM CELLS DEV, V21, P873, DOI 10.1089/scd.2010.0503; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun XH, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0372-2; Tang T, 2010, J BIOL CHEM, V285, P4637, DOI 10.1074/jbc.M109.068007; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Virtue A, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-66; Virtue A, 2011, FRONT BIOSCI-LANDMRK, V16, P3133, DOI 10.2741/3901; Wang BX, 2014, CURR DIABETES REV, V10, P131, DOI 10.2174/1573399810666140508121012; Wang F, 2013, VITAM HORM, V91, P49, DOI 10.1016/B978-0-12-407766-9.00003-1; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xiong Z, 2008, FRONT BIOSCI-LANDMRK, V13, P7143, DOI 10.2741/3217; Xiong ZY, 2009, ATHEROSCLEROSIS, V203, P401, DOI 10.1016/j.atherosclerosis.2008.07.041; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yin Y, 2015, ARTERIOSCL THROM VAS, V35, P804, DOI 10.1161/ATVBAHA.115.305282; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DQ, 2009, CIRCULATION, V120, P1893, DOI 10.1161/CIRCULATIONAHA.109.866889; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	69	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 27	2017	292	4					1267	1287		10.1074/jbc.M116.739839	http://dx.doi.org/10.1074/jbc.M116.739839			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EJ6OX	27856635	Green Published, hybrid			2022-12-26	WOS:000393339800011
J	Otte, K; Kayser, B; Mansow-Model, S; Verrel, J; Paul, F; Brandt, AU; Schmitz-Hubsch, T				Otte, Karen; Kayser, Bastian; Mansow-Model, Sebastian; Verrel, Julius; Paul, Friedemann; Brandt, Alexander U.; Schmitz-Hubsch, Tanja			Accuracy and Reliability of the Kinect Version 2 for Clinical Measurement of Motor Function	PLOS ONE			English	Article							XBOX ONE KINECT; MICROSOFT KINECT; CONCURRENT VALIDITY; MULTIPLE-SCLEROSIS; MOTION CAPTURE; REPEATABILITY; BALANCE; PEOPLE	Background The introduction of low cost optical 3D motion tracking sensors provides new options for effective quantification of motor dysfunction. Objective The present study aimed to evaluate the Kinect V2 sensor against a gold standard motion capture system with respect to accuracy of tracked landmark movements and accuracy and repeatability of derived clinical parameters. Methods Nineteen healthy subjects were concurrently recorded with a Kinect V2 sensor and an optical motion tracking system (Vicon). Six different movement tasks were recorded with 3D full-body kinematics from both systems. Tasks included walking in different conditions, balance and adaptive postural control. After temporal and spatial alignment, agreement of movements signals was described by Pearson's correlation coefficient and signal to noise ratios per dimension. From these movement signals, 45 clinical parameters were calculated, including ranges of motions, torso sway, movement velocities and cadence. Accuracy of parameters was described as absolute agreement, consistency agreement and limits of agreement. Intra-session reliability of 3 to 5 measurement repetitions was described as repeatability coefficient and standard error of measurement for each system. Results Accuracy of Kinect V2 landmark movements was moderate to excellent and depended on movement dimension, landmark location and performed task. Signal to noise ratio provided information about Kinect V2 landmark stability and indicated larger noise behaviour in feet and ankles. Most of the derived clinical parameters showed good to excellent absolute agreement (30 parameters showed ICC(3,1) > 0.7) and consistency (38 parameters showed r > 0.7) between both systems. Conclusion Given that this system is low-cost, portable and does not require any sensors to be attached to the body, it could provide numerous advantages when compared to established markeror wearable sensor based system. The Kinect V2 has the potential to be used as a reliable and valid clinical measurement tool.	[Otte, Karen; Kayser, Bastian; Mansow-Model, Sebastian] Motognosis UG Hattungsbeschrankt, Berlin, Germany; [Verrel, Julius] Max Planck Inst Human Dev, Ctr Lifespan Psychol, Berlin, Germany; [Paul, Friedemann; Brandt, Alexander U.; Schmitz-Hubsch, Tanja] Charite Univ Med Berlin, NeuroCure Clin Res Ctr, Berlin, Germany; [Paul, Friedemann; Brandt, Alexander U.; Schmitz-Hubsch, Tanja] Charite Univ Med Berlin, Clin & Expt Multiple Sclerosis Res Ctr, Berlin, Germany; [Paul, Friedemann; Schmitz-Hubsch, Tanja] Charite Univ Med Berlin, Dept Neurol, Berlin, Germany; [Paul, Friedemann; Brandt, Alexander U.] Max Delbruck Ctr Mol Med, Expt & Clin Res Ctr, Berlin, Germany; [Paul, Friedemann; Brandt, Alexander U.] Charite Univ Med Berlin, Berlin, Germany	Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Otte, K (corresponding author), Motognosis UG Hattungsbeschrankt, Berlin, Germany.	karen.otte@rinotognosis.com	Paul, Friedemann/ABF-9415-2020	paul, friedemann/0000-0002-6378-0070; Verrel, Julius/0000-0001-5850-5202	Motognosis UG	Motognosis UG	The company "Motognosis UG" provided support in the form of salaries for authors KO, BK and SMM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2008, 15882008 IEEE, P1, DOI [10.1109/1EEESTD.2008.4579760, DOI 10.1109/IEEESTD.2008.4579760]; Behrens J, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-89; Behrens JR, 2016, MULT SCLER J, V22, P1596, DOI 10.1177/1352458515625807; Bonnechere B, 2014, TELEMED E-HEALTH, V20, P451, DOI 10.1089/tmj.2013.0247; Clark RA, 2015, GAIT POSTURE, V42, P210, DOI 10.1016/j.gaitpost.2015.03.005; Galna B, 2014, GAIT POSTURE, V39, P1062, DOI 10.1016/j.gaitpost.2014.01.008; Geerse DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139913; Heldman DA, 2014, PARKINSONISM RELAT D, V20, P590, DOI 10.1016/j.parkreldis.2014.02.022; Huber ME, 2015, PHYSIOTHERAPY, V101, P389, DOI 10.1016/j.physio.2015.02.002; Kuster RP, 2016, GAIT POSTURE, V47, P80, DOI 10.1016/j.gaitpost.2016.04.004; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; Mentiplay BF, 2015, J BIOMECH, V48, P2166, DOI 10.1016/j.jbiomech.2015.05.021; Plonus M., 2001, ELECTR COMMUN, P1; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Schmitz A, 2014, J BIOMECH, V47, P587, DOI 10.1016/j.jbiomech.2013.11.031; Spain RI, 2012, GAIT POSTURE, V35, P573, DOI 10.1016/j.gaitpost.2011.11.026; Stein J., 2003, DIGITAL SIGNAL PROCE; Walker M., 1999, DEALING COMPUTER LAT; Wang QF, 2015, 2015 IEEE INTERNATIONAL CONFERENCE ON HEALTHCARE INFORMATICS (ICHI 2015), P380, DOI 10.1109/ICHI.2015.54; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; Xu X, 2015, APPL ERGON, V49, P47, DOI 10.1016/j.apergo.2015.01.005; Yeung LF, 2014, GAIT POSTURE, V40, P532, DOI 10.1016/j.gaitpost.2014.06.012	23	135	136	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166532	10.1371/journal.pone.0166532	http://dx.doi.org/10.1371/journal.pone.0166532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861541	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000388350300070
J	Roda, A; Nachman, G; Weihman, S; Cong, MY; Zimmerman, F				Roda, Amy; Nachman, Gosta; Weihman, Scott; Cong, Mary Yong; Zimmerman, Fredrick			Reproductive Ecology of the Giant African Snail in South Florida: Implications for Eradication Programs	PLOS ONE			English	Article							FULICA GASTROPODA PULMONATA; ACHATINA-FULICA; BEHAVIOR	Giant African snail (Achatina fulica (Bowdich, 1822)), an important invasive snail, was recently found in South Florida, USA. An extensive eradication effort was initiated consisting of pesticide applications, debris removal and hand collections. We studied the reproduction capacity and population dynamics of snails collected from 22 populations for two years to help evaluate the likely success of the eradication program. A total of 23,890 snails, ranging from 25-131 mm, were measured, dissected and the number of eggs in each snail counted. Gravid snails ranged from 48-128 mm. Only 5% of snails had eggs, which were found year round. As the snails increased in size, they were more likely to include reproducing individuals. However, the percentage of gravid snails peaked when snails were approximately 90 mm. Although more prevalent, small (<65 mm) adults contributed fewer eggs to the population than the larger snails. We evaluated the effect of control measures on six populations having > 1000 adult snails and used data from the two largest populations to investigate how environmental factors (temperature, humidity, and rainfall) interacted with population dynamics and control measures. More snails were collected in weeks with high humidity and more gravid snails were collected when the temperature was higher. The addition of metaldehyde pesticides had the greatest impact on population dynamics by reducing snail numbers. In populations with fewer snails, their numbers were already declining before the use of metaldehyde, although the new treatment accelerated the process. As a consequence of the eradication program, egg-producing snails were no longer collected from most populations by the end of the study. The aggressive and persistent control efforts apparently lead to reduced populations of egg producing snails, eventually resulting in local extinctions of this important pest.	[Roda, Amy; Weihman, Scott] US Anim & Plant Hlth Inspect Serv, Miami Lab, Ctr Plant Hlth Sci & Technol, Plant Protect & Quarantine,USDA APHIS, Miami, FL 20737 USA; [Nachman, Gosta] Univ Copenhagen, Sect Ecol & Evolut, Dept Biol, Copenhagen, Denmark; [Cong, Mary Yong] Florida Dept Agr & Consumer Serv, Div Plant Ind, Giant African Land Snail Eradicat Program, Miami, FL USA; [Zimmerman, Fredrick] US Anim & Plant Hlth Inspect Serv, Miami Plant Inspect Stn, Plant Protect & Quarantine, USDA, Miami, FL USA	United States Department of Agriculture (USDA); University of Copenhagen; United States Department of Agriculture (USDA)	Roda, A (corresponding author), US Anim & Plant Hlth Inspect Serv, Miami Lab, Ctr Plant Hlth Sci & Technol, Plant Protect & Quarantine,USDA APHIS, Miami, FL 20737 USA.	Amy.L.Roda@APHIS.USDA.GOV			United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine	United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine	This work was supported by the United States Department of Agriculture, Animal Plant Health Inspection Service, Plant Protection and Quarantine.	Albuquerque FS, 2009, BRAZ J BIOL, V69, P879, DOI 10.1590/S1519-69842009000400016; Albuquerque FS, 2008, BRAZ J BIOL, V68, P837, DOI 10.1590/S1519-69842008000400020; Astromomical Applications Department, 2011, FRACT MOON ILL; Borrero Francisco J., 2009, Tentacle, V17, P6; CABI. org, 2015, DAT LISS FUL GIANT A; da Silva EC, 2014, BIOTA NEOTROP, V14, DOI 10.1590/1676-0603000414; DUN G.S, 1967, PAPUA NEW GUINEA AGR J, V18, P123; Fontanilla IKC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105151; Kekauoha W., 1966, Nautilus, V80, P39; KEKAUOHA WILLARD, 1966, NAUTILUS, V80-80, P3; Kumschick S, 2016, BIOL INVASIONS, V18, P1077, DOI 10.1007/s10530-016-1086-5; LANGE W. HARRY, 1950, PACIFIC SCI, V4, P323; Mead AR, 1961, FACTORS FAVORING DIS, P17; MUNIAPPAN R, 1986, OLEAGINEUX, V41, P183; NGOWSIRI U, 1989, J SCI SOC THAILAND, V15, P237; Ohbayashi T, 2007, JPN J APPL ENTOMOL Z, V51, P221, DOI 10.1303/jjaez.2007.221; PAWSON PA, 1984, J MOLLUS STUD, V50, P85, DOI 10.1093/oxfordjournals.mollus.a065855; PETERSON GEORGE D., 1957, HILGARDIA, V26, P643; Pollard GV., 2008, P CARIBB FOOD CROPS, V44, P126; Poucher C., 1975, P FLOR STAT HORT SOC, P523; PPQPPQ, 2013, FIND NO SIGN IMP FON, P1; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raut S. K., 2002, P55, DOI 10.1079/9780851993201.0055; RAUT S K, 1991, Malacological Review, V24, P79; Salmijah S., 2000, Plant Protection Quarterly, V15, P2; Sarma RR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143724; Smith JW, 2005, AM MALA B, V20, P133; Smith TR, 2013, FLA ENTOMOL, V96, P396, DOI 10.1653/024.096.0202; TILLIER S, 1992, PAC SCI, V46, P396; TOMIYAMA K, 1992, J ETHOL, V10, P139, DOI 10.1007/BF02350118; Tomiyama Kiyonori, 1992, Venus the Japanese Journal of Malacology, V51, P293; Tomiyama Koyonori, 1993, Venus the Japanese Journal of Malacology, V52, P87; van der Meer Mohr JC, 1949, TREUBIA, V20, P1; Watson BJ, 1985, QUEENSLAND AGR J JAN	34	12	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0165408	10.1371/journal.pone.0165408	http://dx.doi.org/10.1371/journal.pone.0165408			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861504	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300008
J	Sato, H; Takahashi, Y; Kimihira, L; Iseki, C; Kato, H; Suzuki, Y; Igari, R; Sato, H; Koyama, S; Arawaka, S; Kawanami, T; Miyajima, M; Samejima, N; Sato, S; Kameda, M; Yamada, S; Kita, D; Kaijima, M; Date, I; Sonoda, Y; Kayama, T; Kuwana, N; Aral, H; Kato, T				Sato, Hidenori; Takahashi, Yoshimi; Kimihira, Luna; Iseki, Chifumi; Kato, Hajime; Suzuki, Yuya; Igari, Ryosuke; Sato, Hiroyasu; Koyama, Shingo; Arawaka, Shigeki; Kawanami, Toru; Miyajima, Masakazu; Samejima, Naoyuki; Sato, Shinya; Kameda, Masahiro; Yamada, Shinya; Kita, Daisuke; Kaijima, Mitsunobu; Date, Isao; Sonoda, Yukihiko; Kayama, Takamasa; Kuwana, Nobumasa; Aral, Hajime; Kato, Takeo			A Segmental Copy Number Loss of the SFMBT1 Gene Is a Genetic Risk for Shunt-Responsive, Idiopathic Normal Pressure Hydrocephalus (iNPH): A Case-Control Study	PLOS ONE			English	Article							ASSOCIATION; COMMUNITY; PROTEIN; NPH	Little is known about genetic risk factors for idiopathic normal pressure hydrocephalus (iNPH). We examined whether a copy number loss in intron 2 of the SFMBT1 gene could be a genetic risk for shunt-responsive, definite iNPH. Quantitative and digital PCR analyses revealed that 26.0% of shunt-responsive definite iNPH patients (n = 50) had such a genetic change, as compared with 4.2% of the healthy elderly (n = 191) (OR = 7.94, 95% CI: 2.82-23.79, p = 1.8 x 10(-5)) and 6.3% of patients with Parkinson's disease (n = 32) (OR = 5.18, 95% CI: 1.1-50.8, p = 0.038). The present study demonstrates that a copy number loss within intron 2 of the SFMBT1 gene may be a genetic risk factor for shunt-responsive definite iNPH.	[Sato, Hidenori; Takahashi, Yoshimi; Kimihira, Luna; Iseki, Chifumi; Kato, Hajime; Suzuki, Yuya; Igari, Ryosuke; Sato, Hiroyasu; Koyama, Shingo; Arawaka, Shigeki; Kawanami, Toru; Kato, Takeo] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata, Japan; [Sato, Hidenori] Yamagata Univ, Dept Genom Cohort Res, Genom Informat Anal Unit, Fac Med, Yamagata, Japan; [Miyajima, Masakazu; Aral, Hajime] Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Samejima, Naoyuki; Kuwana, Nobumasa] Tokyo Kyosai Hosp, Dept Neurosurg, Tokyo, Japan; [Sato, Shinya; Sonoda, Yukihiko; Kayama, Takamasa] Yamagata Univ, Dept Neurosurg, Fac Med, Yamagata, Japan; [Kameda, Masahiro; Date, Isao] Okayama Univ, Dept Neurol Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Yamada, Shinya] Toshiba Rinkan Hosp, Dept Neurosurg, Sagamihara, Kanagawa, Japan; [Kita, Daisuke] Noto Gen Hosp, Dept Neurosurg, Nanao, Japan; [Kaijima, Mitsunobu] Megumino Hosp, Dept Neurosurg, Eniwa, Japan; [Iseki, Chifumi] Yamagata Univ, Dept Clin Neurosci, Fac Med, Yamagata, Japan; [Kita, Daisuke] Yokohama Sakae Kyosai Hosp, Dept Stroke Care & Neurosurg, Yokohama, Kanagawa, Japan	Yamagata University; Yamagata University; Juntendo University; Yamagata University; Okayama University; Toshiba Corporation; Yamagata University	Kato, T (corresponding author), Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata, Japan.	tkato@med.id.yamagata-u.ac.jp	ISEKI, CHIFUMI/AIE-8333-2022	Arawaka, Shigeki/0000-0002-1505-3012	Research committee of idiopathic normal pressure hydrocephalus, studies on the etiology, diagnosis and therapy - Ministry of Health, Lobor and Welfare of Japan [2014-Nanchi-General-052]	Research committee of idiopathic normal pressure hydrocephalus, studies on the etiology, diagnosis and therapy - Ministry of Health, Lobor and Welfare of Japan	This work was supported by the Research committee of idiopathic normal pressure hydrocephalus, studies on the etiology, diagnosis and therapy, supported by the Ministry of Health, Lobor and Welfare of Japan (2014-Nanchi-General-052). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; Arawaka S, 2006, J NEUROSCI, V26, P9227, DOI 10.1523/JNEUROSCI.0341-06.2006; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper GM, 2008, NAT GENET, V40, P1199, DOI 10.1038/ng.236; Cusimano MD, 2011, CAN J NEUROL SCI, V38, P274, DOI 10.1017/S031716710001146X; Daimon M, 2008, BIOCHEM BIOPH RES CO, V374, P576, DOI 10.1016/j.bbrc.2008.07.065; Gudmundsson G, 2009, ACTA NEUROCHIR, V151, P1511, DOI 10.1007/s00701-009-0429-8; Hakim S, 1965, J Neurol Sci, V2, P307, DOI 10.1016/0022-510X(65)90016-X; Iseki C, 2014, J NEUROL SCI, V339, P108, DOI 10.1016/j.jns.2014.01.033; Iseki C, 2009, J NEUROL SCI, V277, P54, DOI 10.1016/j.jns.2008.10.004; Kato T, 2013, J NEUROL TRANSL NEUR, V1, P1008; Kato T, 2011, INTERNAL MED, V50, P297, DOI 10.2169/internalmedicine.50.4505; Kazui H, 2015, LANCET NEUROL, V14, P585, DOI 10.1016/S1474-4422(15)00046-0; Kim JK, 2001, MOL CELL BIOL, V21, P7787, DOI 10.1128/MCB.21.22.7787-7795.2001; Kitagaki H, 1998, AM J NEURORADIOL, V19, P1277; Kubo Y, 2008, DEMENT GERIATR COGN, V25, P37, DOI 10.1159/000111149; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McGirr A, 2012, J NEUROL SCI, V321, P82, DOI 10.1016/j.jns.2012.07.062; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Nacmias B, 1997, NEUROSCI LETT, V229, P177, DOI 10.1016/S0304-3940(97)00449-7; PORTENOY RK, 1984, ARCH NEUROL-CHICAGO, V41, P335, DOI 10.1001/archneur.1984.04050150117029; Pyykko OT, 2012, J NEUROL NEUROSUR PS, V83, P1119, DOI [10.1136/jnnp-2012-303849, 10.1136/jnnp-2011-303849]; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Takahashi Y, 2011, J NEUROL SCI, V308, P149, DOI 10.1016/j.jns.2011.06.018; Usui H, 2000, GENE, V248, P127, DOI 10.1016/S0378-1119(00)00131-1; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025	28	16	17	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2016	11	11							e0166615	10.1371/journal.pone.0166615	http://dx.doi.org/10.1371/journal.pone.0166615			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC7WC	27861535	Green Published, Green Submitted, gold			2022-12-26	WOS:000388350300078
J	Crisman, TJ; Zelaya, I; Laks, DR; Zhao, YN; Kawaguchi, R; Gao, FY; Komblum, HI; Coppola, G				Crisman, Thomas J.; Zelaya, Ivette; Laks, Dan R.; Zhao, Yining; Kawaguchi, Riki; Gao, Fuying; Komblum, Harley I.; Coppola, Giovanni			Identification of an Efficient Gene Expression Panel for Glioblastoma Classification	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SELECTION; GLIOMA; TOOL; VISUALIZATION; DISCOVERY; DISTINCT; GRADE; IDH1; SP1	We present here a novel genetic algorithm-based random forest (GARF) modeling technique that enables a reduction in the complexity of large gene disease signatures to highly accurate, greatly simplified gene panels. When applied to 803 glioblastoma multiforme samples, this method allowed the 840-gene Verhaak et al. gene panel (the standard in the field) to be reduced to a 48-gene classifier, while retaining 90.91% classification accuracy, and outperforming the best available alternative methods. Additionally, using this approach we produced a 32-gene panel which allows for better consistency between RNA-seq and microarray-based classifications, improving cross-platform classification retention from 69.67% to 86.07%. A webpage producing these classifications is available at http://simplegbm.semel.ucla.edu.	[Crisman, Thomas J.; Zelaya, Ivette; Zhao, Yining; Kawaguchi, Riki; Gao, Fuying; Komblum, Harley I.; Coppola, Giovanni] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Crisman, Thomas J.; Zelaya, Ivette; Zhao, Yining; Kawaguchi, Riki; Gao, Fuying; Komblum, Harley I.; Coppola, Giovanni] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Laks, Dan R.] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; [Komblum, Harley I.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Komblum, Harley I.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Coppola, G (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.; Coppola, G (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA.	gcoppola@ucla.edu	Kawaguchi, Riki/AAV-6090-2020	Crisman, Thomas/0000-0001-6235-8110; Laks, Dan/0000-0002-9691-8339	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; University of California, Los Angeles; National Institutes of Health [T32MH073526, P30NS062691]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER	Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; University of California, Los Angeles(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The work was supported by the following: The Dr. Miriam and Sheldon G. Adelson Medical Research Foundation (H.K., G.C.); University of California, Los Angeles (The Philip Whitcome Pre-Doctoral Fellowship in Molecular Biology to D.R.L.); and National Institutes of Health (T32MH073526 to T.J.C., P30NS062691 to G.C.).	Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Britto R, 2007, CANCER BIOL THER, V6, P413, DOI 10.4161/cbt.6.3.3756; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Dabney AR, 2006, BIOINFORMATICS, V22, P122, DOI 10.1093/bioinformatics/bti756; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Diaz-Uriarte R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-328; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Grzmil M, 2011, CANCER RES, V71, P2392, DOI 10.1158/0008-5472.CAN-10-3112; Guan HY, 2012, INT J CANCER, V130, P593, DOI 10.1002/ijc.26049; Heimberger AB, 2005, CLIN CANCER RES, V11, P267; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Liu CT, 2000, J BIOL CHEM, V275, P20315, DOI 10.1074/jbc.M909046199; Madhavan S, 2009, MOL CANCER RES, V7, P157, DOI 10.1158/1541-7786.MCR-08-0435; Monti S, 2003, MACH LEARN, V52, P91, DOI 10.1023/A:1023949509487; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Pal S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku121; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; R Core Team, 2021, R LANGUAGE ENV STAT; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Safe S, 2014, EXPERT OPIN THER TAR, V18, P759, DOI 10.1517/14728222.2014.914173; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; SCHREIBER E, 1994, NEUROSURGERY, V34, P129; Schwartzentruber J, 2012, NATURE, V484, P130, DOI 10.1038/nature11026; Shyu, 1992, STAT MODELS; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Waller CL, 1999, J CHEM INF COMP SCI, V39, P345, DOI 10.1021/ci980405r; Yeung KY, 2005, BIOINFORMATICS, V21, P2394, DOI 10.1093/bioinformatics/bti319; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0164649	10.1371/journal.pone.0164649	http://dx.doi.org/10.1371/journal.pone.0164649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27855170	Green Published, gold, Green Submitted			2022-12-26	WOS:000387910200006
J	Fenton, IS; Pearson, PN; Jones, TD; Purvis, A				Fenton, Isabel S.; Pearson, Paul N.; Jones, Tom Dunkley; Purvis, Andy			Environmental Predictors of Diversity in Recent Planktonic Foraminifera as Recorded in Marine Sediments	PLOS ONE			English	Article							GLOBAL PATTERNS; SPECIES RICHNESS; METABOLIC THEORY; TEMPERATURE; EVOLUTION; GRADIENT; TROPICS; BIODIVERSITY; EXTINCTION; SPECIATION	Global diversity patterns are thought to result from a combination of environmental and historical factors. This study tests the set of ecological and evolutionary hypotheses proposed to explain the global variation in present-day coretop diversity in the macroperforate planktonic foraminifera, a clade with an exceptional fossil record. Within this group, marine surface sediment assemblages are thought to represent an accurate, although centennial to millennial time-averaged, representation of recent diversity patterns. Environmental variables chosen to capture ocean temperature, structure, productivity and seasonality were used to model a range of diversity measures across the world's oceans. Spatial autoregressive models showed that the same broad suite of environmental variables were important in shaping each of the four largely independent diversity measures (rarefied species richness, Simpson's evenness, functional richness and mean evolutionary age). Sea-surface temperature explains the largest portion of diversity in all four diversity measures, but not in the way predicted by the metabolic theory of ecology. Vertical structure could be linked to increased diversity through the strength of stratification, but not through the depth of the mixed layer. There is limited evidence that seasonal turnover explains diversity patterns. There is evidence for functional redundancy in the low-latitude sites. The evolutionary mechanism of deep-time stability finds mixed support whilst there is relatively little evidence for an out-of-the-tropics model. These results suggest the diversity patterns of planktonic foraminifera cannot be explained by any one environmental variable or proposed mechanism, but instead reflect multiple processes acting in concert.	[Fenton, Isabel S.; Purvis, Andy] Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England; [Fenton, Isabel S.; Purvis, Andy] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England; [Pearson, Paul N.] Cardiff Univ, Sch Earth & Ocean Sci, Cardiff CF10 3AT, S Glam, Wales; [Jones, Tom Dunkley] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham B15 2TT, W Midlands, England	Natural History Museum London; Imperial College London; Cardiff University; University of Birmingham	Fenton, IS (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.; Fenton, IS (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot SL5 7PY, Berks, England.	isabel.fenton@cantab.net	Purvis, Andy/A-7529-2008; Fenton, Isabel S/V-3240-2019; Jones, Tom Dunkley/A-8441-2008	Purvis, Andy/0000-0002-8609-6204; Fenton, Isabel S/0000-0001-7174-0725; Jones, Tom Dunkley/0000-0002-9518-8143	Natural Environment Research Council UK (NERC grant) [NE/I005595/1]; NERC; NERC [NE/I00551X/1, NE/I005870/1, NE/I005595/1, NE/M003736/1] Funding Source: UKRI; Natural Environment Research Council [NE/I005595/1, NE/I00551X/1, 1233267, NE/M003736/1, NE/I005870/1] Funding Source: researchfish	Natural Environment Research Council UK (NERC grant)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council UK ("Descent into the Icehouse" project), http://www.nerc.ac.uk/, (NERC grant NE/I005595/1), as part of ISF's PhD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Michal Kaera, Brian Huber and an anonymous reviewer for their thoughtful comments; these have significantly improved the manuscript. We are very grateful to researchers in the Purvis lab and in the NERC funded "Descent into the Icehouse" project for the support they have provided during the writing of this paper.	Al-Saboui N, 2007, MAR MICROPALEONTOL, V63, P75, DOI 10.1016/j.marmicro.2006.11.002; Allen AP, 2006, ECOL LETT, V9, P947, DOI 10.1111/j.1461-0248.2006.00946.x; Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; [Anonymous], 2004, STAT ANAL DATA DISPL; [Anonymous], 2014, R LANG ENV STAT COMP; Antonov J. I., 2010, WORLD OCEAN ATLAS 20, V2; Archer DE, 1996, GLOBAL BIOGEOCHEM CY, V10, P159, DOI 10.1029/95GB03016; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aze T, 2011, BIOL REV, V86, P900, DOI 10.1111/j.1469-185X.2011.00178.x; Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; BE AWH, 1985, MAR MICROPALEONTOL, V9, P307, DOI 10.1016/0377-8398(85)90002-7; Beale CM, 2010, ECOL LETT, V13, P246, DOI 10.1111/j.1461-0248.2009.01422.x; Beaugrand G, 2013, GLOBAL ECOL BIOGEOGR, V22, P440, DOI 10.1111/geb.12009; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; BIJMA J, 1990, J FORAMIN RES, V20, P95, DOI 10.2113/gsjfr.20.2.95; Birch H, 2013, MAR MICROPALEONTOL, V101, P127, DOI 10.1016/j.marmicro.2013.02.002; Bivand R, 2014, R SPDEP SPATIAL DEPE; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clarke Andrew, 2003, P130; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Cooper N, 2010, AM NAT, V175, P727, DOI 10.1086/652466; Coxall HK, 2007, PALEOBIOLOGY, V33, P495, DOI 10.1666/06034.1; Crame JA, 2000, GEOL SOC SPEC PUBL, V177, P347, DOI 10.1144/GSL.SP.2000.177.01.23; Crawley M.J., 2007, R BOOK; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; ECONOMOS AC, 1979, GERONTOLOGY, V26, P82, DOI 10.1159/000212399; Ezard THG, 2015, PALEOCEANOGRAPHY, V30, P151, DOI 10.1002/2014PA002735; Ezard THG, 2012, BIOL LETTERS, V8, P139, DOI 10.1098/rsbl.2011.0699; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Feldman AH, 2003, EVOLUTIONARY ORIGIN; Fritz SA, 2013, TRENDS ECOL EVOL, V28, P509, DOI 10.1016/j.tree.2013.05.004; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; Garcia H. E., 2010, WORLD OCEAN ATLAS 20, V3; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hawkins BA, 2007, ECOLOGY, V88, P1877, DOI 10.1890/06-1444.1; Hemleben C., 1989, MODERN PLANKTONIC FO, DOI [DOI 10.1016/S0016-6995(89)80108-1, DOI 10.1007/978-1-4612-3544-6_2]; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; JABLONSKI D, 1993, NATURE, V364, P142, DOI 10.1038/364142a0; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Jablonski David, 2003, P368; Jablonski D, 2013, P NATL ACAD SCI USA, V110, P10487, DOI 10.1073/pnas.1308997110; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Kasemann SA, 2008, EARTH PLANET SC LETT, V271, P292, DOI 10.1016/j.epsl.2008.04.007; Kidwell SM, 2013, PALAEONTOLOGY, V56, P487, DOI 10.1111/pala.12042; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kreft H, 2007, P NATL ACAD SCI USA, V104, P5925, DOI 10.1073/pnas.0608361104; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; Kucera M, 2013, WELLINGTON KAOHSIUNG; Kucera M, 2007, DEV MARINE GEOL, V1, P213, DOI 10.1016/S1572-5480(07)01011-1; Locarnini R. A., 2010, NOAA ATLAS NESDIS, V68, P1; Longhurst AR, 2007, ECOLOGICAL GEOGRAPHY; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; McKinney ML, 1998, BIODIVERSITY DYNAMICS, P1; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Montegut CD, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003953; MOORE TC, 1981, PALAEOGEOGR PALAEOCL, V35, P357, DOI 10.1016/0031-0182(81)90102-4; Morey AE, 2005, QUATERNARY SCI REV, V24, P925, DOI 10.1016/j.quascirev.2003.09.011; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Peters SE, 2013, NATURE, V493, P398, DOI 10.1038/nature11815; Pigot AL, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001260; Powell MG, 2012, J BIOGEOGR, V39, P1687, DOI 10.1111/j.1365-2699.2012.02719.x; Powell MG, 2002, GEOLOGY, V30, P331, DOI 10.1130/0091-7613(2002)030<0331:IIEASA>2.0.CO;2; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Purvis A, 2011, PHILOS T R SOC B, V366, P2462, DOI 10.1098/rstb.2011.0025; Rombouts I, 2009, P ROY SOC B-BIOL SCI, V276, P3053, DOI 10.1098/rspb.2009.0742; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Rutherford S, 1999, NATURE, V400, P749, DOI 10.1038/23449; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Schabenberger O., 2004, STAT METHODS SPATIAL; Schiebel Ralf, 2005, Palaeontologische Zeitschrift, V79, P135; Schlitzer R., 2021, OCEAN DATA VIEW VS 5; SEN GUPTA B. K., 2002, MODERN FORAMINIFERA; Siccha M, 2009, MAR MICROPALEONTOL, V72, P146, DOI 10.1016/j.marmicro.2009.04.002; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Stephens PA, 1999, OIKOS, V87, P185, DOI 10.2307/3547011; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Vaquer-Sunyer R, 2008, P NATL ACAD SCI USA, V105, P15452, DOI 10.1073/pnas.0803833105; Veal A, 2010, COPES RULE CENOZOIC; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Wade BS, 2011, EARTH-SCI REV, V104, P111, DOI 10.1016/j.earscirev.2010.09.003; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Weiner AKM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092148; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zaric S, 2005, MAR MICROPALEONTOL, V55, P75, DOI 10.1016/j.marmicro.2005.01.002; [No title captured]	99	21	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0165522	10.1371/journal.pone.0165522	http://dx.doi.org/10.1371/journal.pone.0165522			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851751	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000387909300019
J	Wang, Z; Ramsey, BJ; Wang, DL; Wong, K; Li, HS; Wang, E; Bao, ZR				Wang, Zi; Ramsey, Benjamin J.; Wang, Dali; Wong, Kwai; Li, Husheng; Wang, Eric; Bao, Zhirong			An Observation-Driven Agent-Based Modeling and Analysis Framework for C-elegans Embryogenesis	PLOS ONE			English	Article							SINGLE-CELL RESOLUTION; CAENORHABDITIS-ELEGANS; MORPHOGENESIS; SIMULATION; EMBRYO	With cutting-edge live microscopy and image analysis, biologists can now systematically track individual cells in complex tissues and quantify cellular behavior over extended time windows. Computational approaches that utilize the systematic and quantitative data are needed to understand how cells interact in vivo to give rise to the different cell types and 3D morphology of tissues. An agent-based, minimum descriptive modeling and analysis framework is presented in this paper to study C. elegans embryogenesis. The framework is designed to incorporate the large amounts of experimental observations on cellular behavior and reserve data structures/interfaces that allow regulatory mechanisms to be added as more insights are gained. Observed cellular behaviors are organized into lineage identity, timing and direction of cell division, and path of cell movement. The framework also includes global parameters such as the eggshell and a clock. Division and movement behaviors are driven by statistical models of the observations. Data structures/interfaces are reserved for gene list, cell-cell interaction, cell fate and landscape, and other global parameters until the descriptive model is replaced by a regulatory mechanism. This approach provides a framework to handle the ongoing experiments of single-cell analysis of complex tissues where mechanistic insights lag data collection and need to be validated on complex observations.	[Wang, Zi; Li, Husheng] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN USA; [Ramsey, Benjamin J.; Wong, Kwai] Univ Tennessee, Joint Inst Computat Sci, Knoxville, TN USA; [Wang, Dali] Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA; [Wang, Eric] Farragut High Sch, Knoxville, TN USA; [Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory; Memorial Sloan Kettering Cancer Center	Wang, DL (corresponding author), Oak Ridge Natl Lab, Climate Change Sci Inst, Oak Ridge, TN 37830 USA.	wangd@ornl.gov	Wang, Dali/AAU-3519-2021	Wang, Dali/0000-0001-6806-5108; Wang, Zi/0000-0002-5081-661X	NIH [R01GM097576, P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by an NIH research project grant to Z. Bao at MSKCC (R01GM097576, with a subcontract to D. Wang at UTK). Research in the Bao lab is also supported by an NIH center grant to MSKCC (P30CA008748).; This study is supported by an NIH research project grant to Z. Bao at MSKCC (R01GM097576, with a subcontract to D. Wang at UTK). Research in the Bao lab is also supported by an NIH center grant to MSKCC (P30CA008748).	Atwell K, 2015, DEVELOPMENT, V142, P3902, DOI 10.1242/dev.126359; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Du Z, 2015, DEV CELL, V34, P592, DOI 10.1016/j.devcel.2015.07.014; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Giurumescu CA, 2012, DEVELOPMENT, V139, P4271, DOI 10.1242/dev.086256; Gontis V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102201; Gorochowski TE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042790; Hench J, 2009, DEV BIOL, V333, P1, DOI 10.1016/j.ydbio.2009.06.014; Kim M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093661; Kyoda K, 2013, NUCLEIC ACIDS RES, V41, pD732, DOI 10.1093/nar/gks1107; Macal CM, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P2, DOI 10.1109/WSC.2005.1574234; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Polhill JG, 2008, JASSS-J ARTIF SOC S, V11; Railsback S., 2012, AGENT BASED INDIVIDU; Reece J. B., 2011, CAMPBELL BIOL, V10th, P321; Rizzi B, 2014, J CHEM BIOL, V7, P17, DOI [10.1007/912154-013-0101-x, DOI 10.1007/912154-013-0101-X]; Rizzi Barbara, 2014, Journal of Chemical Biology, V7, P17, DOI 10.1007/s12154-013-0101-x; Sakamoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151157; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Setty Y, 2012, BIOINFORMATICS, V28, P2022, DOI 10.1093/bioinformatics/bts307; Setty Y, 2012, DEVELOPMENT, V139, P47, DOI 10.1242/dev.067512; Setty Y, 2008, P NATL ACAD SCI USA, V105, P20374, DOI 10.1073/pnas.0808725105; Voss-Bohme A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042852	25	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166551	10.1371/journal.pone.0166551	http://dx.doi.org/10.1371/journal.pone.0166551			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851808	Green Published, Green Submitted, gold			2022-12-26	WOS:000387909300065
J	Wu, Y; Li, YH; Yu, SB; Li, WG; Liu, XS; Zhao, L; Lu, JX				Wu, Yuan; Li, Yin-hu; Yu, Shuan-bao; Li, Wen-ge; Liu, Xiao-shu; Zhao, Lei; Lu, Jin-xing			A Genome-Wide Transcriptional Analysis of Yeast-Hyphal Transition in Candida tropicalis by RNA-Seq	PLOS ONE			English	Article							ALBICANS; EPIDEMIOLOGY; LANDSCAPE; PATHOGENICITY; MORPHOLOGY; EVOLUTION; VIRULENCE	Candida tropicalis is considered as the leading pathogen in nosocomial fungemia and hepatosplenic fungal infections in patients with cancer, particularly in leukemia. The yeast-filament transition is required for virulent infection by Candida. Several studies have explored the genome-wide transcription profile of Candida, however, no report on the transcriptional profile of C. tropicalis under yeast-filament transition has been published. In this study, the transcriptomes of three C. tropicalis isolates with different adhesion and biofilm formation abilities, identified in our previous studies, were analyzed in both the yeast and filament states using RNA-Seq. Differentially expressed genes were found for each isolate during the transition. A total of 115 genes were up-or down-regulated in the two hyphal-producing isolates (ZRCT 4 and ZRCT 45). Among these differentially expressed genes, only two were down-regulated during the yeast-filament transition. Furthermore, six filament associated genes were up-regulated in the hyphae-producing isolates. According to Candida Hypha Growth Database established in this study, 331 hyphae-related genes were discovered in C. tropicalis. ALS1 and ALS3 were down-regulated and up-regulated, respectively, during filamentous growth of C. tropicalis. These findings proved a better understanding of gene expression dynamics during the yeast-filament transition in C. tropicalis.	[Wu, Yuan; Yu, Shuan-bao; Li, Wen-ge; Liu, Xiao-shu; Lu, Jin-xing] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Chang Bai Rd 155, Beijing, Peoples R China; [Li, Yin-hu] BGI Shenzhen, Microbial Res Dept, Main Bldg, Shenzhen, Peoples R China; [Zhao, Lei] Univ Iowa, Carver Coll Med, Holden Comprehens Canc Ctr, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Beijing Genomics Institute (BGI); University of Iowa	Lu, JX (corresponding author), Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Collaborat Innovat Ctr Diag & Treatment Infect Di, Natl Inst Communicable Dis Control & Prevent, Chang Bai Rd 155, Beijing, Peoples R China.	lujinxing@icdc.cn	Li, Yinhu/U-9020-2019		National Natural Science Foundation of China [81301409]; National Key Technology Support Program [2012BAI11B05]; National Sci-Tech Key Project [2013ZX10004203-002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); National Sci-Tech Key Project	This research was supported by the National Natural Science Foundation of China (Youth Project no. 81301409), the National Key Technology Support Program (grant no. 2012BAI11B05), and the National Sci-Tech Key Project (grant no. 2013ZX10004203-002).	Bedini A, 2006, CLIN MICROBIOL INFEC, V12, P75, DOI 10.1111/j.1469-0691.2005.01310.x; Biswas S, 2007, MICROBIOL MOL BIOL R, V71, P348, DOI 10.1128/MMBR.00009-06; Bruno VM, 2010, GENOME RES, V20, P1451, DOI 10.1101/gr.109553.110; Butler G, 2009, NATURE, V459, P657, DOI 10.1038/nature08064; Carlisle PL, 2013, MOL BIOL CELL, V24, P246, DOI 10.1091/mbc.E12-01-0065; Cerqueira GC, 2014, NUCLEIC ACIDS RES, V42, pD705, DOI 10.1093/nar/gkt1029; Chalmers C, 2011, MYCOSES, V54, pE795, DOI 10.1111/j.1439-0507.2011.02027.x; Chen YY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072483; Colombo AL, 2006, J CLIN MICROBIOL, V44, P2816, DOI 10.1128/JCM.00773-06; Desnos-Ollivier M, 2008, EMERG INFECT DIS, V14, P557, DOI 10.3201/eid1404.071083; Diekema D, 2012, DIAGN MICR INFEC DIS, V73, P45, DOI 10.1016/j.diagmicrobio.2012.02.001; Falagas ME, 2010, INT J INFECT DIS, V14, pE954, DOI 10.1016/j.ijid.2010.04.006; Galan-Ladero MA, 2010, MED MYCOL, V48, P207, DOI 10.3109/13693780902801242; Goldani LZ, 2010, BRAZ J INFECT DIS, V14, P631, DOI 10.1590/S1413-86702010000600014; Grumaz C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-212; Guida A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-628; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lackey E, 2013, EUKARYOT CELL, V12, P1356, DOI 10.1128/EC.00164-13; Lin JQ, 2013, FUNGAL GENET BIOL, V56, P78, DOI 10.1016/j.fgb.2013.04.007; Linde J, 2015, NUCLEIC ACIDS RES, V43, P1392, DOI 10.1093/nar/gku1357; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Nantel A, 2002, MOL BIOL CELL, V13, P3452, DOI 10.1091/mbc.E02-05-0272; Negri M, 2012, EUR J CLIN MICROBIOL, V31, P1399, DOI 10.1007/s10096-011-1455-z; Novodvorska M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-246; Sherry L, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-182; Silva S, 2011, CLIN MICROBIOL INFEC, V17, P264, DOI 10.1111/j.1469-0691.2010.03248.x; Silva S, 2011, TRENDS MICROBIOL, V19, P241, DOI 10.1016/j.tim.2011.02.003; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv711; Thompson DS, 2011, EUKARYOT CELL, V10, P1173, DOI 10.1128/EC.05085-11; Wang B, 2010, NUCLEIC ACIDS RES, V38, P5075, DOI 10.1093/nar/gkq256; Yu SB, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01175; Yu Shuanbao, 2015, Zhonghua Liu Xing Bing Xue Za Zhi, V36, P1162; Zhang QY, 2016, MOL MICROBIOL, V99, P528, DOI 10.1111/mmi.13247	34	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2016	11	11							e0166645	10.1371/journal.pone.0166645	http://dx.doi.org/10.1371/journal.pone.0166645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC1ZU	27851809	gold, Green Submitted, Green Published			2022-12-26	WOS:000387909300076
J	Burkhardt, D; Bartosova, M; Schaefer, B; Grabe, N; Lahrmann, B; Nasser, H; Freise, C; Schneider, A; Lingnau, A; Degenhardt, P; Ranchin, B; Sallay, P; Cerkauskiene, R; Malina, M; Ariceta, G; Schmitt, CP; Querfeld, U				Burkhardt, Dorothea; Bartosova, Maria; Schaefer, Betti; Grabe, Niels; Lahrmann, Bernd; Nasser, Hamoud; Freise, Christian; Schneider, Axel; Lingnau, Anja; Degenhardt, Petra; Ranchin, Bruno; Sallay, Peter; Cerkauskiene, Rimante; Malina, Michal; Ariceta, Gema; Schmitt, Claus Peter; Querfeld, Uwe			Reduced Microvascular Density in Omental Biopsies of Children with Chronic Kidney Disease	PLOS ONE			English	Article							ENDOTHELIAL-CELL APOPTOSIS; CAPILLARY RAREFACTION; RENAL-FUNCTION; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; RATS; VEGF; ANGIOGENESIS; DYSFUNCTION; HEART	Background Endothelial dysfunction is an early manifestation of cardiovascular disease (CVD) and consistently observed in patients with chronic kidney disease (CKD). We hypothesized that CKD is associated with systemic damage to the microcirculation, preceding macrovascular pathology. To assess the degree of "uremic microangiopathy", we have measured microvascular density in biopsies of the omentum of children with CKD. Patients and Methods Omental tissue was collected from 32 healthy children (0-18 years) undergoing elective abdominal surgery and from 23 age-matched cases with stage 5 CKD at the time of catheter insertion for initiation of peritoneal dialysis. Biopsies were analyzed by independent observers using either a manual or an automated imaging system for the assessment of microvascular density. Quantitative immunohistochemistry was performed for markers of autophagy and apoptosis, and for the abundance of the angiogenesis-regulating proteins VEGF-A, VEGF-R2, Angpt1 and Angpt2. Results Microvascular density was significantly reduced in uremic children compared to healthy controls, both by manual imaging with a digital microscope (median surface area 0.61% vs. 0.95%, p<0.0021 and by automated quantification (total microvascular surface area 0.89% vs. 1.17% p = 0.01). Density measured by manual imaging was significantly associated with age, height, weight and body surface area in CKD patients and healthy controls. In multivariate analysis, age and serum creatinine level were the only independent, significant predictors of microvascular density (r(2) = 0.73). There was no immunohistochemical evidence for apoptosis or autophagy. Quantitative staining showed similar expression levels of the angiogenesis regulators VEGF-A, VEGF-receptor 2 and Angpt1 (p = 0.11), but Angpt2 was significantly lower in CKD children (p = 0.01). Conclusions Microvascular density is profoundly reduced in omental biopsies of children with stage 5 CKD and associated with diminished Angpt2 signaling. Microvascular rarefaction could be an early systemic manifestation of CKD-induced cardiovascular disease.	[Burkhardt, Dorothea; Querfeld, Uwe] Charite, Dept Pediat Nephrol, Berlin, Germany; [Bartosova, Maria; Schaefer, Betti; Schmitt, Claus Peter] Heidelberg Univ, Ctr Pediat & Adolescent Med, Heidelberg, Germany; [Grabe, Niels; Lahrmann, Bernd] Heidelberg Univ, Hamamatsu Imaging & Anal TIGA Ctr, Bioquant, Heidelberg, Germany; [Nasser, Hamoud; Freise, Christian; Querfeld, Uwe] Charite, Ctr Cardiovasc Res, Berlin, Germany; [Schneider, Axel; Degenhardt, Petra] Charite, Dept Pediat Surg, Berlin, Germany; [Lingnau, Anja] Charite, Dept Pediat Urol, Berlin, Germany; [Degenhardt, Petra] Klinikum Ernst Von Bergmann, Dept Pediat Surg, Potsdam, Germany; [Ranchin, Bruno] Hop Femme Mere Enfant, Hosp Civils Lyon, Serv Nephrol Pediat & Epicime, Ctr Invest Clin 1407, Lyon, France; [Sallay, Peter] Semmelweis Univ, Dept Pediat 1, Budapest, Hungary; [Cerkauskiene, Rimante] Vilnius Univ Hosp Santariskiu Klin, Childrens Hosp, Coordinating Ctr Childrens Rare Dis, Vilnius, Lithuania; [Malina, Michal] Charles Univ Prague, Fac Med 2, Dept Pediat, Prague 5, Czech Republic; [Ariceta, Gema] Hosp Univ Vall dHebron, Serv Nefrol Pediat, Barcelona, Spain	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Ernst von Bergmann; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); Semmelweis University; Vilnius University Hospital Santariskiu Klinikos; Charles University Prague; Hospital Universitari Vall d'Hebron	Querfeld, U (corresponding author), Charite, Dept Pediat Nephrol, Berlin, Germany.; Querfeld, U (corresponding author), Charite, Ctr Cardiovasc Res, Berlin, Germany.	uwaquerfeld@charite.de	Malina, Michal/A-5037-2012; Freise, Christian/P-4285-2019; Freise, Christian/H-9892-2012; Querfeld, Uwe/AAF-6330-2020; Grabe, Niels/I-6214-2016; Grabe, Niels/AAP-6493-2020	Malina, Michal/0000-0002-9434-1521; Freise, Christian/0000-0003-2602-226X; Degenhardt, Petra/0000-0001-7506-9457; Grabe, Niels/0000-0003-1732-3706; Querfeld, Uwe/0000-0001-6783-3822	Medical Faculty of Heidelberg; European Training and Research in PD consortium, EuTriPD [287813]; Else-Kroner-Fresenius Stiftung [2011-A19]; ERA-EDTA; KfH Foundation for Preventive Medicine	Medical Faculty of Heidelberg; European Training and Research in PD consortium, EuTriPD; Else-Kroner-Fresenius Stiftung; ERA-EDTA; KfH Foundation for Preventive Medicine	BS was funded by the Medical Faculty of Heidelberg, and MB by the European Training and Research in PD consortium, EuTriPD (FP7, 287813). Christian Freise was supported by the Else-Kroner-Fresenius Stiftung (2011-A19). Further support was received from ERA-EDTA, and the KfH Foundation for Preventive Medicine.	Adair A, 2007, TRANSPLANTATION, V83, P1542, DOI 10.1097/01.tp.0000266689.93615.cd; Amann K, 1998, J AM SOC NEPHROL, V9, P1018; Amann K, 1997, AM J KIDNEY DIS, V30, P382, DOI 10.1016/S0272-6386(97)90283-3; AMANN K, 1992, KIDNEY INT, V42, P1079, DOI 10.1038/ki.1992.390; ANDERSON TJ, 1995, J AM COLL CARDIOL, V26, P1235, DOI 10.1016/0735-1097(95)00327-4; Baffert F, 2006, AM J PHYSIOL-HEART C, V290, pH547, DOI 10.1152/ajpheart.00616.2005; Baumann M, 2009, KIDNEY BLOOD PRESS R, V32, P428, DOI 10.1159/000264650; Bonamy AKE, 2007, J INTERN MED, V262, P635, DOI 10.1111/j.1365-2796.2007.01868.x; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Carroll JF, 2008, OBESITY, V16, P600, DOI 10.1038/oby.2007.92; Collins D, 2009, J GASTROINTEST SURG, V13, P1138, DOI 10.1007/s11605-009-0855-1; David S, 2010, NEPHROL DIAL TRANSPL, V25, P2571, DOI 10.1093/ndt/gfq060; Deva R, 2011, CLIN J AM SOC NEPHRO, V6, P1866, DOI 10.2215/CJN.10321110; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Drueke TB, 2010, NAT REV NEPHROL, V6, P723, DOI 10.1038/nrneph.2010.143; Edwards-Richards A, 2014, CLIN KIDNEY J, V7, P569, DOI 10.1093/ckj/sfu106; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Feihl F, 2009, CURR HYPERTENS REP, V11, P182, DOI 10.1007/s11906-009-0033-6; Fliser D, 2011, KIDNEY INT SUPPL, V1, P6, DOI 10.1038/kisup.2011.6; Flisinski M, 2008, RENAL FAILURE, V30, P443, DOI 10.1080/08860220801985694; Franke D, 2010, NEPHROL DIAL TRANSPL, V25, P3918, DOI 10.1093/ndt/gfq300; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Hsu YJ, 2015, J VASC SURG, V62, P210, DOI 10.1016/j.jvs.2014.02.040; Jacobi J, 2006, KIDNEY INT, V69, P2013, DOI 10.1038/sj.ki.5000448; Kang DH, 2001, J AM SOC NEPHROL, V12, P1448, DOI 10.1681/ASN.V1271448; Kobayashi N, 2005, ARTERIOSCL THROM VAS, V25, P2114, DOI 10.1161/01.ATV.0000178993.13222.f2; Kom C, 2015, DEV CELL, V34, P5, DOI 10.1016/j.devcel.2015.06.004; Lobov IB, 2002, P NATL ACAD SCI USA, V99, P11205, DOI 10.1073/pnas.172161899; Lockhart CJ, 2009, CLIN SCI, V116, P175, DOI 10.1042/CS20080069; Maric-Bilkan C, 2012, AM J PHYSIOL-RENAL, V302, pF308, DOI 10.1152/ajprenal.00421.2011; Mayer G, 2011, NEPHROL DIAL TRANSPL, V26, P1132, DOI 10.1093/ndt/gfq832; Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x; Nussenzweig SC, 2015, CIRC RES, V116, P480, DOI 10.1161/CIRCRESAHA.116.303805; Ooi QL, 2011, CLIN J AM SOC NEPHRO, V6, P1872, DOI 10.2215/CJN.10291110; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Pries AR, 2014, PHYSIOLOGY, V29, P446, DOI 10.1152/physiol.00012.2014; Rizzardi AE, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-42; Sabanayagam C, 2009, AM J EPIDEMIOL, V169, P625, DOI 10.1093/aje/kwn367; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Schaefer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep21344; Schwartz GJ, 2009, J AM SOC NEPHROL, V20, P629, DOI 10.1681/ASN.2008030287; Shimizu A, 1997, AM J PATHOL, V151, P1231; Shroff RC, 2008, CIRCULATION, V118, P1748, DOI 10.1161/CIRCULATIONAHA.108.783738; Shroff RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056273; Singh AK, 2008, CELL TISSUE RES, V332, P81, DOI 10.1007/s00441-007-0560-x; Stam F, 2006, J AM SOC NEPHROL, V17, P537, DOI 10.1681/ASN.2005080834; Thang OHD, 2011, NEPHROL DIAL TRANSPL, V26, P3529, DOI 10.1093/ndt/gfr089; Tornig J, 1996, J AM SOC NEPHROL, V7, P667; Tran ED, 2011, MICROCIRCULATION, V18, P228, DOI 10.1111/j.1549-8719.2011.00082.x; Tsai YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135181; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377	53	12	13	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166050	10.1371/journal.pone.0166050	http://dx.doi.org/10.1371/journal.pone.0166050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846250	Green Submitted, Green Published, gold			2022-12-26	WOS:000387794600029
J	Chen, XD; Tzekov, R; Su, MY; Hong, HY; Min, W; Han, AD; Li, WS				Chen, Xiaodong; Tzekov, Radouil; Su, Mingyang; Hong, Haiyan; Min, Wang; Han, Aidong; Li, Wensheng			Auranofin Inhibits Retinal Pigment Epithelium Cell Survival through Reactive Oxygen Species-Dependent Epidermal Growth Factor Receptor/Mitogen-Activated Protein Kinase Signaling Pathway	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; INDUCED APOPTOSIS; RHEUMATOID-ARTHRITIS; THIOREDOXIN; STRESS; PHOSPHORYLATION; DIFFERENTIATION; MECHANISMS; MIGRATION; CANCER	Abnormal survival of retinal pigment epithelium (RPE) cells contributes to the pathogenesis of proliferative vitreoretinopathy (PVR), a sight-threatening disease. In this study, we explored the effect of the anti-rheumatic agent auranofin (AF) on RPE cell survival and studied the underlying signaling mechanisms in vitro. Our results showed that AF inhibited ARPE-19 cell survival in a dose and time-dependent manner. Application of AF induced several effects: a significant decrease in total epidermal growth factor receptor (EGFR) and an increase in phosphorylated EGFR and mitogen-activated protein kinase (MAPK), including extracellular signal-regulated kinase (ERK), P38 mitogen-activated protein kinase (P38MAPK), c-Jun N-terminal kinase (JNK), c-Jun, mitogen activated protein kinase activated protein kinase 2(MAPKAPK2), and heat shock protein 27 (HSP27). AF also inhibited epidermal growth factor (EGF)-dependent cell proliferation and migration through affecting EGFR/MAPK signaling. The antioxidant N-acetylcysteine (NAC) blocked the AF-induced increase of reactive oxygen species (ROS) production, the reduction of total EGFR, and the phosphorylation of multiple nodes in EGFR/MAPK signaling pathway. P38MAPK inhibitor SB203580, but not inhibitors of EGFR (erlotinib), ERK (FR180204) and JNK (SP600125), suppressed AF-induced phosphorylation of EGFR/p38MAPK/MAPKAPK2/Hsp27. In conclusion, the ROS-dependent phosphorylation of EGFR/MAPK is an important signaling pathway for AF-induced inhibition of RPE cell survival, and AF may have the potential for treatment of abnormal survival of RPE cells in PVR.	[Chen, Xiaodong; Li, Wensheng] Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China; [Chen, Xiaodong] First Hosp Xian, Shanxi Inst Ophthalmol, Shanxi Prov Key Lab Ophthalmol, Dept Ophthalmol, Xian, Shanxi, Peoples R China; [Chen, Xiaodong; Su, Mingyang; Hong, Haiyan; Han, Aidong] Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA; [Tzekov, Radouil] Roskamp Inst, Sarasota, FL USA; [Min, Wang] Yale Univ, Sch Med, Dept Pathol, Interdept Program Vasc Biol & Therapeut, New Haven, CT 06510 USA	Xiamen University; Xiamen University; State University System of Florida; University of South Florida; Yale University	Li, WS (corresponding author), Xiamen Univ, Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China.; Han, AD (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China.	ahan@xmu.edu.cn; drlws@qq.com	chen, xia/GXM-5435-2022; chen, xi/GXH-3653-2022; chen, xia/GYR-3948-2022	Tzekov, Radouil/0000-0002-3662-9818	China Postdoctoral Science Foundation Funded Project [2015M582044]; National Natural Science Foundation of China [81570875, 31170685, 90919036]; Health Systems Young Personnel Training Projects Foundation in Fujian Province of China [2013-ZQN-JC-37]; Science and Technology Program Foundation of Xiamen City in China [3502720144044]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115148] Funding Source: NIH RePORTER	China Postdoctoral Science Foundation Funded Project(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Systems Young Personnel Training Projects Foundation in Fujian Province of China; Science and Technology Program Foundation of Xiamen City in China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The study design, data collection and analysis, decision to publish, or preparation of the manuscript were supported by grants from the China Postdoctoral Science Foundation Funded Project (No.2015M582044 to XC [http://jj.chinapostdoctor.org.cn], the National Natural Science Foundation of China (No. 81570875 to WL; 31170685 and 90919036 to AH [http://www.nsfc.gov.cn] the Health Systems Young Personnel Training Projects Foundation in Fujian Province of China (No. 2013-ZQN-JC-37 to WL [http://www.fjhfpc.gov.cn] Science and Technology Program Foundation of Xiamen City in China (No. 3502720144044 to WL [http://www.xminfo.net.cn].	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Pastor JC, 2016, PROG RETIN EYE RES, V51, P125, DOI 10.1016/j.preteyeres.2015.07.005; Chen XD, 2014, ANTI-CANCER AGENT ME, V14, P946, DOI 10.2174/1871520614666140610102651; Chen Z, 2010, PATHOBIOLOGY, V77, P88, DOI 10.1159/000278290; Cohen-Kutner M, 2013, BIOCHEM PHARMACOL, V85, P977, DOI 10.1016/j.bcp.2013.01.003; Defoe DM, 2004, EXP EYE RES, V79, P51, DOI 10.1016/j.exer.2004.02.017; Ducournau Y, 2012, GRAEF ARCH CLIN EXP, V250, P409, DOI 10.1007/s00417-011-1797-3; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Filosto S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023240; FINKELSTEIN AE, 1976, ANN RHEUM DIS, V35, P251, DOI 10.1136/ard.35.3.251; FROSCIO M, 1988, SCAND J RHEUMATOL, V17, P281, DOI 10.3109/03009748809098797; FROSCIO M, 1987, BIOCHEM PHARMACOL, V36, P769, DOI 10.1016/0006-2952(87)90733-7; Gurgis FMS, 2014, MOL PHARMACOL, V85, P345, DOI 10.1124/mol.113.090365; He SK, 2010, INVEST OPHTH VIS SCI, V51, P543, DOI 10.1167/iovs.09-3475; Kalariya NM, 2009, EXP EYE RES, V89, P494, DOI 10.1016/j.exer.2009.05.011; Lee JS, 2006, ARCH TOXICOL, V80, P337, DOI 10.1007/s00204-005-0052-2; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li H, 2016, ONCOTARGET, V7, P3548, DOI 10.18632/oncotarget.6516; Liu J, 2000, INFLAMM RES, V49, P445, DOI 10.1007/s000110050615; Madeira JM, 2013, LIFE SCI, V92, P1072, DOI 10.1016/j.lfs.2013.04.005; Madeira J. M., 2012, Inflammopharmacology, V20, P297, DOI 10.1007/s10787-012-0149-1; MATSUBARA T, 1987, J CLIN INVEST, V79, P1440, DOI 10.1172/JCI112972; Meng L, 2010, P NATL ACAD SCI USA, V107, P3900, DOI 10.1073/pnas.0913759107; Morescalchi F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/269787; Palma-Nicolas JP, 2008, BIOSCIENCE REP, V28, P307, DOI 10.1042/BSR20080083; Park SJ, 2005, BRIT J PHARMACOL, V146, P506, DOI 10.1038/sj.bjp.0706360; Pastor JC, 2002, PROG RETIN EYE RES, V21, P127, DOI 10.1016/S1350-9462(01)00023-4; Roder C, 2015, DRUGS R&D, V15, P13, DOI 10.1007/s40268-015-0083-y; Roduit R, 2008, APOPTOSIS, V13, P343, DOI 10.1007/s10495-008-0179-8; Samuel W, 2008, J NEUROCHEM, V106, P591, DOI 10.1111/j.1471-4159.2008.05409.x; Steindl-Kuscher K, 2011, GRAEF ARCH CLIN EXP, V249, P1195, DOI 10.1007/s00417-011-1673-1; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tamagno E, 2003, EXP NEUROL, V180, P144, DOI 10.1016/S0014-4886(02)00059-6; Tan XJ, 2016, TRENDS CELL BIOL, V26, P352, DOI 10.1016/j.tcb.2015.12.006; Tian XY, 2012, J MOL CELL CARDIOL, V52, P237, DOI 10.1016/j.yjmcc.2011.10.013; WARD JR, 1983, ARTHRITIS RHEUM, V26, P1303, DOI 10.1002/art.1780261102; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188; Yan F, 2007, OPHTHALMOLOGICA, V221, P244, DOI 10.1159/000101926; Zou P, 2015, ONCOTARGET, V6, P36505, DOI 10.18632/oncotarget.5364	40	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166386	10.1371/journal.pone.0166386	http://dx.doi.org/10.1371/journal.pone.0166386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846303	Green Published, gold, Green Submitted			2022-12-26	WOS:000387794600055
J	Mendo, T; Simon, C; Green, B; Gardner, C				Mendo, Tania; Simon, Cedric; Green, Bridget; Gardner, Caleb			Spatial Variability in Condition of Southern Rock Lobsters (Jasus edwardsii) at the Start of the Tasmanian Fishing Season	PLOS ONE			English	Article							NUTRITIONAL CONDITION; RESPIRATORY RESPONSES; LIVE TRANSPORT; SURVIVAL; RESERVES	The southern rock lobster (Jasus edwardsii) industry in Australia favours red lobsters, which are usually caught in shallow waters, over paler (brindle) lobsters. This preference is driven partly by the Chinese market, where red is associated with luck and prosperity, and additionally, by the widely held perception within the industry that brindles have greater mortality rates during out of water transport than reds. Limited scientific evidence supports these industry observations; however, these studies did not evaluate the initial condition of lobsters. This study aimed first, to determine which variables better describe condition in J. edwardsii and second, to compare condition among lobsters in several sites around Tasmania at the typical time of high transport mortality. Male lobsters were collected from the South West, South East, East and North coast of Tasmania in late November/December 2014, which correspond to the start of the Tasmanian fishing season. A comprehensive condition assessment was applied by measuring tissue proximal composition, Brix index, Total Haemocyte Count, pH, haemocyanin and another 16 haemolymph parameters of interest. A useful framework to compare condition in J. edwardsii was established by first, using Brix index as a measure of nutritional condition, second, using pH, magnesium, and bicarbonate to evaluate differences in physiological condition and finally, using THC counts as a proxy for lobster health condition. Lobsters from different sites had different nutritional, physiological and health condition, consistent with industry observations, however our results indicate that some red shallow water lobsters exhibited poorer nutritional and health condition, while some deep water brindle lobsters were in good condition. Differences in condition could not be directly associated to catch depth of lobsters and was related to other spatially discrete factors which sometimes vary over distances < 3 km.	[Mendo, Tania; Simon, Cedric; Green, Bridget; Gardner, Caleb] Univ Tasmania, Fisheries & Aquaculture Ctr, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia; [Mendo, Tania] Univ St Andrews, Scottish Oceans Inst, St Andrews KY1 6LB, Fife, Scotland; [Simon, Cedric] CSIRO, Bribie Isl Res Ctr, 144 North St, Woorim 4507, Australia	University of Tasmania; University of St Andrews; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland Department of Agriculture & Fisheries	Mendo, T (corresponding author), Univ Tasmania, Fisheries & Aquaculture Ctr, Inst Marine & Antarctic Studies, Private Bag 49, Hobart, Tas 7001, Australia.; Mendo, T (corresponding author), Univ St Andrews, Scottish Oceans Inst, St Andrews KY1 6LB, Fife, Scotland.	tm96@st-andrews.ac.uk	Simon, Cedric/ABC-3830-2020; Simon, Cedric/AAX-5264-2020; Mendo, Tania/AAH-7734-2020; Gardner, Caleb/I-7086-2013	Simon, Cedric/0000-0002-7535-3332; Simon, Cedric/0000-0002-7535-3332; Mendo, Tania/0000-0003-4397-2064; Gardner, Caleb/0000-0003-0324-4337	Australian Seafood Cooperative Research Centre; Fisheries Research and Development Corporation [2014/726]; Australian Research Council's Industrial Transformation Research Program [IH120100032]; Tasmanian Department of Primary Industry, Parks, Water and the Environment	Australian Seafood Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Fisheries Research and Development Corporation; Australian Research Council's Industrial Transformation Research Program(Australian Research Council); Tasmanian Department of Primary Industry, Parks, Water and the Environment	This research was funded by the Australian Seafood Cooperative Research Centre and the Fisheries Research and Development Corporation (project number 2014/726) (http://www.seafoodcrc.com/) (http://frdc.com.au/Pages/home.aspx). The Australian Research Council's Industrial Transformation Research Program (project number IH120100032) is gratefully acknowledged for providing further financial support for two authors to present this work at the Crustacean Society and International Association of Astacology Mid-year Meeting, 19-23 July 2015 (http://www.arc.gov.au/industrial-transformation-research-programme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Field and laboratory technical support was provided by Neville Barrett, Justin Hulls, Colin Fry, Keerthi Elizabeth Chinappa and Michael Porteus. Ben Lawler helped with collection of lobsters and Michael Blake of SALCO provided access to lobsters and valuable project support. The project was also supported by the Tasmanian Department of Primary Industry, Parks, Water and the Environment, especially James Parkinson. Many volunteers assisted with laboratory work and fieldwork throughout the project. We thank Dr Andrea Battison (CrustiPath) for her assistance with the analysis of haemolymph biochemistry.	Bartlett MS, 1937, PROC R SOC LON SER-A, V160, P0268, DOI 10.1098/rspa.1937.0109; Battison A, 2014, MOULT RECOVERY LOBST; Chandrapavan A, 2011, MAR FRESHW BEHAV PHY, V44, P21, DOI 10.1080/10236244.2010.533518; Chandrapavan A, 2009, J EXP MAR BIOL ECOL, V375, P9, DOI 10.1016/j.jembe.2009.04.021; Chandrapavan A, 2009, NEW ZEAL J MAR FRESH, V43, P537, DOI 10.1080/00288330909510020; Ciaramella MA, 2014, J CRUSTACEAN BIOL, V34, P629, DOI 10.1163/1937240X-00002262; DEFUR PL, 1990, BIOL BULL, V178, P46, DOI 10.2307/1541536; Fotedar S, 2011, J INVERTEBR PATHOL, V106, P143, DOI 10.1016/j.jip.2010.09.011; HAGERMAN L, 1983, MAR BIOL, V77, P11, DOI 10.1007/BF00393205; HAGERMAN L, 1973, Ophelia, V12, P141; Hawthorne P, 2009, EFFECTS DEEP WATER H; Huberty CJ, 2000, HDB APPL MULTIVARIAT; Jussila J, 1997, MAR FRESHWATER RES, V48, P863, DOI 10.1071/MF97216; Konosu S, 2000, SPINY LOBSTERS, P625; Linnane A, 2014, TACTICAL RES FUND AS; McLeod LE, 2004, J SHELLFISH RES, V23, P257; Morris S, 1999, COMP BIOCHEM PHYS A, V122, P299, DOI 10.1016/S1095-6433(99)00003-3; MORRITT D, 1993, COMP BIOCHEM PHYS A, V106, P19, DOI 10.1016/0300-9629(93)90032-Y; Musgrove RJB, 2000, J CRUSTACEAN BIOL, V20, P44, DOI 10.1651/0278-0372(2000)020[0044:MSITSR]2.0.CO;2; Oliver MD, 2001, MAR FRESHWATER RES, V52, P1395, DOI 10.1071/MF01030; Paterson BD, 2005, NEW ZEAL J MAR FRESH, V39, P1129, DOI 10.1080/00288330.2005.9517380; Quinn GP, 2003, EXPT DESIGN DATA ANA; R Development Core Team, R FDN R LANG ENV STA; Simon CJ, 2015, PHYSIOL BIOCHEM ZOOL, V88, P266, DOI 10.1086/681000; Simon CJ, 2016, COMP BIOCHEM PHYS A, V201, P101, DOI 10.1016/j.cbpa.2016.07.001; Simon CJ, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159671, DOI 10.1371/J0URNAL.P0NE.0159671]; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Taylor HH, 1997, MAR FRESHWATER RES, V48, P817, DOI 10.1071/MF97197; Taylor HH, 1997, MAR FRESHWATER RES, V48, P889, DOI 10.1071/MF97071; Wagner T, 2004, CAN J FISH AQUAT SCI, V61, P1066, DOI [10.1139/f04-050, 10.1139/F04-050]; WRIGHT SP, 1992, BIOMETRICS, V48, P1005, DOI 10.2307/2532694; Zuur Alain F., 2009, P1	32	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2016	11	11							e0166343	10.1371/journal.pone.0166343	http://dx.doi.org/10.1371/journal.pone.0166343			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0MG	27846289	Green Published, gold			2022-12-26	WOS:000387794600047
J	Navarro-Quiroz, E; Pacheco-Lugo, L; Lorenzi, H; Diaz-Olmos, Y; Almendrales, L; Rico, E; Navarro, R; Espana-Puccini, P; Iglesias, A; Egea, E; Aroca, G				Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Lorenzi, Hernan; Diaz-Olmos, Yirys; Almendrales, Lisneth; Rico, Edwin; Navarro, Roberto; Espana-Puccini, Pierine; Iglesias, Antonio; Egea, Eduardo; Aroca, Gustavo			High-Throughput Sequencing Reveals Circulating miRNAs as Potential Biomarkers of Kidney Damage in Patients with Systemic Lupus Erythematosus	PLOS ONE			English	Article							MICRORNA EXPRESSION; NEPHRITIS; CELLS; GLOMERULONEPHRITIS; MECHANISMS; DISEASE; RNA	Renal involvement is one of the most severe manifestations of systemic lupus erythematosus (SLE). Renal biopsy is the gold standard when it comes to knowing whether a patient has lupus nephritis, and the degree of renal disease present. However, the biopsy has various complications, bleeding being the most common. Therefore, the development of alternative, non-invasive diagnostic tests for kidney disease in patients with SLE is a priority. Micro RNAs (miRNAs) are differentially expressed in various tissues, and changes in their expression have been associated with several pathological processes. The aim of this study was to identify changes in the abundance of miRNAs in plasma samples from patients with lupus nephritis that could potentially allow the diagnosis of renal damage in SLE patients. This is an observational case-control cross-sectional study, in which we characterized the differential abundance profiles of miRNAs among patients with different degrees of lupus compared with SLE patients without renal involvement and healthy control individuals. We found 89 miRNAs with changes in their abundance between lupus nephritis patients and healthy controls, and 17 miRNAs that showed significant variations between SLE patients with or without renal involvement. Validation for qPCR of a group of miRNAs on additional samples from lupus patients with or without nephritis, and from healthy individuals, showed that five miRNAs presented an average detection sensitivity of 97%, a specificity of 70.3%, a positive predictive value of 82.5%, a negative predictive value of 96% and a diagnosis efficiency of 87.9%. These results strongly suggest that miR-221- 5p, miR-380-3p, miR-556-5p, miR-758-3p and miR-3074-3p are potential diagnostic biomarkers of lupus nephritis in patients with SLE. The observed differential pattern of miRNA abundance may have functional implications in the pathophysiology of SLE renal damage.	[Navarro-Quiroz, Elkin; Pacheco-Lugo, Lisandro; Diaz-Olmos, Yirys; Almendrales, Lisneth; Rico, Edwin; Aroca, Gustavo] Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia; [Lorenzi, Hernan] J Craig Venter Inst, Dept Infect Dis, Rockville, MD USA; [Navarro, Roberto] Univ Cooperat Colombia, Grp Genet, Santa Marta, Colombia; [Espana-Puccini, Pierine] Monomeros, Barranquilla, Colombia; [Iglesias, Antonio] Univ Nacl Colombia, Unidad Reumatol, Bogota, Colombia; [Egea, Eduardo] Univ Norte, Grp Invest Inmunol & Biol Mol, Barranquilla, Colombia; [Aroca, Gustavo] Clin Costa, Barranquilla, Colombia	J. Craig Venter Institute; Universidad Cooperativa de Colombia; Universidad Nacional de Colombia; Universidad del Norte	Navarro-Quiroz, E (corresponding author), Univ Simon Bolivar, Grp Nefrol, Barranquilla, Colombia.	enavarro26@unisimonbolivar.edu.co	Aroca Martinez, Gustavo/N-9133-2013; QUIROZ, ROBERTO CARLOS NAVARRO/P-9517-2017; Quiroz, Elkin Navarro/AAB-6381-2019; Aroca, Gustavo/P-9173-2016; Navarro-Quiroz, Elkin/P-5715-2016	Aroca Martinez, Gustavo/0000-0002-9222-3257; QUIROZ, ROBERTO CARLOS NAVARRO/0000-0002-3604-3702; Quiroz, Elkin Navarro/0000-0001-7567-6409; Aroca, Gustavo/0000-0002-9222-3257; Navarro-Quiroz, Elkin/0000-0001-7567-6409; Pacheco-Lugo, Lisandro/0000-0002-9248-4596; egea, eduardo/0000-0001-7548-1257; Lorenzi, Hernan/0000-0003-0910-7894	Colciencias Codigo [125356934453]; Numero de la convocatoria [569, 0032-2013]; Programa Nacional de Ciencias Basicas	Colciencias Codigo; Numero de la convocatoria; Programa Nacional de Ciencias Basicas	This work was supported by Colciencias Codigo 125356934453, Numero de la convocatoria 569, Numero de contrato 0032-2013, Programa Nacional de Ciencias Basicas.; Research supported by Colciencias grants 125356934453.	Ardekani Ali M., 2010, Avicenna Journal of Medical Biotechnology, V2, P161; Azkargorta M, 2006, PROTEOMICS, V6, pS42, DOI 10.1002/pmic.200500438; Balakrishnan I, 2014, STEM CELLS, V32, P662, DOI 10.1002/stem.1531; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; Ben-Sasson SZ, 2009, P NATL ACAD SCI USA, V106, P7119, DOI 10.1073/pnas.0902745106; Dai Y, 2007, LUPUS, V16, P939, DOI 10.1177/0961203307084158; Dai Y, 2009, RHEUMATOL INT, V29, P749, DOI 10.1007/s00296-008-0758-6; Dooley MA, 1997, KIDNEY INT, V51, P1188, DOI 10.1038/ki.1997.162; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hosmer D. W., APPL LOGISTIC REGRES; Jones B, 2014, LUPUS NEPHRITIS NUCL, V10, P4, DOI [10.1038/nrneph.2013.246, DOI 10.1038/NRNEPH.2013.246]; Kameswaran V, 2014, CELL METAB, V19, P135, DOI 10.1016/j.cmet.2013.11.016; Karginov FV, 2013, GENE DEV, V27, P1624, DOI 10.1101/gad.215939.113; Korbet SM, 2000, AM J KIDNEY DIS, V35, P904, DOI 10.1016/S0272-6386(00)70262-9; Li Yajuan, 2013, Genomics Proteomics & Bioinformatics, V11, P158, DOI 10.1016/j.gpb.2013.05.003; Lu J, 2012, NEPHROLOGY, V17, P346, DOI 10.1111/j.1440-1797.2012.01573.x; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mok CC, 2005, ARTHRITIS RHEUM-US, V52, P2774, DOI 10.1002/art.21224; Mok CC, 2004, AM J MED, V117, P791, DOI 10.1016/j.amjmed.2004.04.029; Mok CC, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/638413; Olin AI, 2014, ARTHRITIS RHEUMATOL, V66, P397, DOI 10.1002/art.38250; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SABATINI M, 1988, P NATL ACAD SCI USA, V85, P5235, DOI 10.1073/pnas.85.14.5235; Sato N, 2011, LUPUS, V20, P1378, DOI 10.1177/0961203311415561; Soto H, 1997, NEPHROL DIAL TRANSPL, V12, P273, DOI 10.1093/ndt/12.2.273; Te JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010344; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Weening JJ, 2004, J AM SOC NEPHROL, V15, P241, DOI 10.1097/01.ASN.0000108969.21691.5D	28	34	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2016	11	11							e0166202	10.1371/journal.pone.0166202	http://dx.doi.org/10.1371/journal.pone.0166202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0HG	27835701	gold, Green Published, Green Submitted			2022-12-26	WOS:000387779200032
J	Pompeiano, A; Damiani, CR; Stefanini, S; Vernieri, P; Reyes, TH; Volterrani, M; Guglielminetti, L				Pompeiano, Antonio; Damiani, Claudia Roberta; Stefanini, Sara; Vernieri, Paolo; Reyes, Thais Huarancca; Volterrani, Marco; Guglielminetti, Lorenzo			Seedling Establishment of Tall Fescue Exposed to Long-Term Starvation Stress	PLOS ONE			English	Article							FESTUCA-ARUNDINACEA SCHREB; ABSCISIC-ACID; ALPHA-AMYLASE; SIGNAL-TRANSDUCTION; MONOCLONAL-ANTIBODY; GENOME PLASTICITY; SUGAR STARVATION; CEREAL SEEDS; TEMPERATURE; GERMINATION	In germinating seeds under unfavorable environmental conditions, the mobilization of stores in the cotyledons is delayed, which may result in a different modulation of carbohydrates balance and a decrease in seedling vigor. Tall fescue (Festuca arundinacea Schreb.) caryopses grown at 4 degrees C in the dark for an extended period in complete absence of nutrients, showed an unexpected ability to survive. Seedlings grown at 4 degrees C for 210 days were morphologically identical to seedlings grown at 23 degrees C for 21 days. After 400 days, seedlings grown at 4 degrees C were able to differentiate plastids to chloroplast in just few days once transferred to the light and 23 degrees C. Tall fescue exposed to prolonged period at 4 degrees C showed marked anatomical changes: cell wall thickening, undifferentiated plastids, more root hairs and less xylem lignification. Physiological modifications were also observed, in particular related to sugar content, GA and ABA levels and amylolytic enzymes pattern. The phytohormones profiles exhibited at 4 and 23 degrees C were comparable when normalized to the respective physiological states. Both the onset and the completion of germination were linked to GA and ABA levels, as well as to the ratio between these two hormones. All plants showed a sharp decline in carbohydrate content, with a consequent onset of gradual sugar starvation. This explained the slowed then full arrest in growth under both treatment regimes. The analysis of amylolytic activity showed that Ca2+ played a central role in the stabilization of several isoforms. Overall, convergence of starvation and hormone signals meet in crosstalk to regulate germination, growth and development in tall fescue.	[Pompeiano, Antonio] Global Change Res Inst CAS, Lab Ecol Plant Physiol, Brno, Czech Republic; [Damiani, Claudia Roberta] Fed Univ Grande Dourados, Dourados, Brazil; [Stefanini, Sara; Vernieri, Paolo; Reyes, Thais Huarancca; Volterrani, Marco; Guglielminetti, Lorenzo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy	Czech Academy of Sciences; Global Change Research Centre of the Czech Academy of Sciences; Universidade Federal da Grande Dourados; University of Pisa	Guglielminetti, L (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	lorenzo.guglielminetti@unipi.it	Huarancca Reyes, Thais/ABI-2552-2020; Pompeiano, Antonio/A-1330-2017	Huarancca Reyes, Thais/0000-0003-2988-0980; Pompeiano, Antonio/0000-0001-7375-1014; Damiani, Claudia Roberta/0000-0003-1418-4851; GUGLIELMINETTI, LORENZO/0000-0002-0250-454X				ANCHORDOGUY TJ, 1987, CRYOBIOLOGY, V24, P324, DOI 10.1016/0011-2240(87)90036-8; Bartholomew PW, 2005, CROP SCI, V45, P529, DOI 10.2135/cropsci2005.0529; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Burns JC, 1979, ADAPTATION TALL FESC, P9; BUSH DS, 1989, J BIOL CHEM, V264, P19392; BUSH DS, 1986, PLANT PHYSIOL, V82, P566, DOI 10.1104/pp.82.2.566; Ceccarelli M, 1997, THEOR APPL GENET, V94, P309, DOI 10.1007/s001220050416; Ceccarelli M, 2002, THEOR APPL GENET, V104, P901, DOI 10.1007/s00122-001-0862-4; DANIELSON HR, 1976, CROP SCI, V16, P317, DOI 10.2135/cropsci1976.0011183X001600030001x; de Mendiburu F., 2019, AGRICOLAE STAT PROCE; Dierking RM, 2012, CROP SCI, V52, P460, DOI 10.2135/cropsci2011.03.0160; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Gianinetti A, 2007, J EXP BOT, V58, P3449, DOI 10.1093/jxb/erm198; GUGLIELMINETTI L, 1995, PLANT PHYSIOL, V109, P1069, DOI 10.1104/pp.109.3.1069; Guglielminetti L, 2000, J PLANT RES, V113, P185, DOI 10.1007/PL00013929; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hopkins AA, 2009, AGRONOMY MONOGRAPHS, P339; HURRY VM, 1995, PLANT PHYSIOL, V109, P697, DOI 10.1104/pp.109.2.697; Ikeda A, 2002, PLANT CELL PHYSIOL, V43, P974, DOI 10.1093/pcp/pcf115; JONES RL, 1967, PLANTA, V72, P155, DOI 10.1007/BF00387479; Karssen C. M., 1986, Plant growth substances 1985. Proceedings of the 12th international conference on plant growth substances., P315; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Lu HF, 2008, AGR FOREST METEOROL, V148, P931, DOI 10.1016/j.agrformet.2008.01.004; Paparelli E, 2013, PLANT CELL, V25, P3760, DOI 10.1105/tpc.113.115519; Penfield S, 2009, P ROY SOC B-BIOL SCI, V276, P3561, DOI 10.1098/rspb.2009.0592; PERATA P, 1993, PLANTA, V191, P402, DOI 10.1007/BF00195699; PERATA P, 1992, PLANTA, V188, P611, DOI 10.1007/BF00197056; Pompeiano A, 2013, J PLANT RES, V126, P787, DOI 10.1007/s10265-013-0567-1; Qian Y. L., 2001, International Turfgrass Society Research Journal, V9, P334; R Core Team, 2013, R LANG ENV STAT COMP; Saxena P, 2014, CROP SCI, V54, P1205, DOI 10.2135/cropsci2013.08.0565; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; THOMAS H, 1995, NEW PHYTOL, V130, P125, DOI 10.1111/j.1469-8137.1995.tb01822.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; TOBIAS RB, 1992, PLANT PHYSIOL, V99, P146, DOI 10.1104/pp.99.1.146; Ufele R, 1999, ANN BOT-LONDON, V83, P577, DOI [10.1006/anbo.1999.0864, DOI 10.1006/ANBO.1999.0864]; VERNIERI P, 1989, J PLANT PHYSIOL, V134, P441, DOI 10.1016/S0176-1617(89)80007-0; WALKERSIMMONS MK, 1991, PLANT PHYSIOL, V95, P46, DOI 10.1104/pp.95.1.46; Yamaguchi S, 2008, ANNU REV PLANT BIOL, V59, P225, DOI 10.1146/annurev.arplant.59.032607.092804; Yoshida R, 1996, PLANT PHYSIOL, V110, P997, DOI 10.1104/pp.110.3.997; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687; Zhang HX, 2013, CROP SCI, V53, P240, DOI 10.2135/cropsci2012.02.0085	42	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2016	11	11							e0166131	10.1371/journal.pone.0166131	http://dx.doi.org/10.1371/journal.pone.0166131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9ON	27832166	Green Published, gold, Green Submitted			2022-12-26	WOS:000387725000067
J	Yang, S; Yao, HP; Li, M; Li, H; Wang, F				Yang, Shuai; Yao, Haipei; Li, Min; Li, Hui; Wang, Fang			Long Non-Coding RNA MALAT1 Mediates Transforming Growth Factor Beta1-Induced Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							PROLIFERATIVE VITREORETINOPATHY; TGF-BETA; CANCER METASTASIS; TUMOR-GROWTH; PROMOTES; MECHANISMS; CARCINOMA; MIGRATION	Purpose To study the role of long non-coding RNA (lncRNA) MALAT1 in transforming growth factor beta 1 (TGF-beta 1)-induced epithelial-mesenchymal transition (EMT) of retinal pigment epithelial (RPE) cells. Methods ARPE-19 cells were cultured and exposed to TGF-beta 1. The EMT of APRE-19 cells is confirmed by morphological change, as well as the increased expression of alpha-smooth muscle actin (alpha SMA) and fibronectin, and the down-regulation of E-cadherin and Zona occludin-1( ZO-1) at both mRNA and protein levels. The expression of lncRNA MALAT1 in RPE cells were detected by quantitative real-time PCR. Knockdown of MALAT1 was achieved by transfecting a small interfering RNA (SiRNA). The effect of inhibition of MALAT1 on EMT, migration, proliferation, and TGF beta signalings were observed. MALAT1 expression was also detected in primary RPE cells incubated with proliferative vitreoretinopathy (PVR) vitreous samples. Results The expression of MALAT1 is significantly increased in RPE cells incubated with TGF beta 1. MALAT1 silencing attenuates TGF beta 1-induced EMT, migration, and proliferation of RPE cells, at least partially through activating Smad2/3 signaling. MALAT1 is also significantly increased in primary RPE cells incubated with PVR vitreous samples. Conclusion LncRNA MALAT1 is involved in TGF beta 1-induced EMT of human RPE cells and provides new understandings for the pathogenesis of PVR.	[Yang, Shuai; Yao, Haipei; Li, Min; Li, Hui; Wang, Fang] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200072, Peoples R China	Tongji University	Wang, F (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Ophthalmol, Shanghai 200072, Peoples R China.	18917683335@163.com		Yang, Shuai/0000-0001-8359-4032	National Natural Science Foundation of China [81300772, 81500727, 81271029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by National Natural Science Foundation of China (No. 81300772(HL), 81500727(ML) and No. 81271029(FW)) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaans J, 2013, INVEST OPHTH VIS SCI, V54, P8306, DOI 10.1167/iovs.13-12383; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; Chen X, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1155/2014/956141; Chen XY, 2014, INT J MOL MED, V33, P1195, DOI 10.3892/ijmm.2014.1688; Dvashi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122229; Fan Y, 2014, CLIN CANCER RES, V20, P1531, DOI 10.1158/1078-0432.CCR-13-1455; Feist RM, 2014, GRAEF ARCH CLIN EXP, V252, P347, DOI 10.1007/s00417-013-2531-0; Gamulescu MA, 2006, EXP EYE RES, V83, P212, DOI 10.1016/j.exer.2005.12.007; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Hatanaka H, 2012, INVEST OPHTH VIS SCI, V53, P6955, DOI 10.1167/iovs.12-10488; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Kim Ivana K, 2002, Ophthalmol Clin North Am, V15, P81; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Li H, 2014, BIOCHEM BIOPH RES CO, V446, P347, DOI 10.1016/j.bbrc.2014.02.119; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; MACHEMER R, 1978, AM J OPHTHALMOL, V85, P181, DOI 10.1016/S0002-9394(14)75946-X; Matouk IJ, 2014, BBA-MOL CELL RES, V1843, P1414, DOI 10.1016/j.bbamcr.2014.03.023; Mony S, 2013, EXP EYE RES, V115, P113, DOI 10.1016/j.exer.2013.06.007; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Ren SC, 2013, J UROLOGY, V190, P2278, DOI 10.1016/j.juro.2013.07.001; Sadaka A, 2012, CLIN OPHTHALMOL, V6, P1325, DOI 10.2147/OPTH.S27896; Schmidt LH, 2011, J THORAC ONCOL, V6, P1984, DOI 10.1097/JTO.0b013e3182307eac; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Umazume K, 2012, INVEST OPHTH VIS SCI, V53, P4910, DOI 10.1167/iovs.12-9768; Xu CA, 2011, INT J ONCOL, V39, P169, DOI 10.3892/ijo.2011.1007; Yang S, 2015, DISCOV MED, V20, P207; Ying L, 2012, MOL BIOSYST, V8, P2289, DOI 10.1039/c2mb25070e; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhou X, 2015, SCI REP-UK, V5, DOI 10.1038/srep15972	32	95	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 28	2016	11	3							e0152687	10.1371/journal.pone.0152687	http://dx.doi.org/10.1371/journal.pone.0152687			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9VL	27019196	Green Published, Green Submitted, gold			2022-12-26	WOS:000396347600001
J	Yang, T; Zhang, TL; Guo, YH; Liu, X				Yang, Tao; Zhang, Tian-lei; Guo, You-hao; Liu, Xing			Identification of Hybrids in Potamogeton: Incongruence between Plastid and ITS Regions Solved by a Novel Barcoding Marker PHYB	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; AQUATIC PLANT; CONCERTED EVOLUTION; NUCLEAR; PHYTOCHROME; GENE; SEQUENCES; HYBRIDIZATION; UTILITY; FAMILY	Potamogeton is one of the most difficult groups to clarify in aquatic plants, which has an extensive range of interspecific morphological and ecological diversity. Internal transcribed spacer (ITS) is prevalent for phylogenetic analysis in plants. However, most researches demonstrate that ITS has a high percentage of homoplasy in phylogenetic datasets. In this study, eighteen materials were collected in Potamogeton from China and incongruence was shown between the rbcL and ITS phylogenies. To solve the discrepancy, we employed a novel barcode PHYB to improve resolution and accuracy of the phylogenetic relationships. The PHYB phylogeny successfully resolved the incongruence between the rbcL and ITS phylogenies. In addition, six hybrids were confirmed using PHYB, including P. compressus x P pusillus, P. octandrus x P. oxyphyllus, P. gramineus x P. lucens, P. distinctus x P. natans, P. distinctus x P. wrightii, and S. pectinata x S. amblyophylla. Whereas, only one hybrid was identified (P. compressus x P. pusillus) by ITS, indicating that ITS homoplasy was present in Potamogeton and ITS was completely homogenized to one parental lineage. Thus, ITS might have limited utility for phylogenetic relationships in Potamogeton. It is recommended that a three-locus combination of chloroplast DNA gene, ITS and PHYB is potential to effectively reveal more robust phylogenetic relationships and species identification.	[Yang, Tao; Zhang, Tian-lei; Guo, You-hao; Liu, Xing] Wuhan Univ, Coll Life Sci, Lab Plant Systemat & Evolutionary Biol, Wuhan, Hubei, Peoples R China	Wuhan University	Guo, YH; Liu, X (corresponding author), Wuhan Univ, Coll Life Sci, Lab Plant Systemat & Evolutionary Biol, Wuhan, Hubei, Peoples R China.	yhguo@whu.edu.cn; xingliu@whu.edu.cn		Yang, Shuai/0000-0001-8359-4032	National Natural Science Foundation of China [30870168, 31170203]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China 30870168 (http://www.letpub.com.cn/) (XL, data collection and analysis, decision to publish, or preparation of the manuscript); and National Natural Science Foundation of China 31170203 (http://www.letpub.com.cn/).	Aguilar JF, 1999, MOL ECOL, V8, P1341, DOI 10.1046/j.1365-294X.1999.00690.x; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Bailey CD, 1999, MOL PHYLOGENET EVOL, V13, P20, DOI 10.1006/mpev.1999.0627; Childs KL, 1997, PLANT PHYSIOL, V113, P611, DOI 10.1104/pp.113.2.611; CLACK T, 1994, PLANT MOL BIOL, V25, P413, DOI 10.1007/BF00043870; Cronn RC, 2002, AM J BOT, V89, P707, DOI 10.3732/ajb.89.4.707; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Du ZY, 2010, PLANT SYST EVOL, V287, P57, DOI 10.1007/s00606-010-0289-y; Du ZY, 2009, AQUAT BOT, V91, P47, DOI 10.1016/j.aquabot.2009.02.006; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Franzke A, 1999, THEOR APPL GENET, V98, P831, DOI 10.1007/s001220051140; Hagstrom JO, 1916, PLOS ONE, DOI DOI 10.1371/JOURNAL.PONE.0155446; Hoot SB, 2001, AM FERN J, V91, P166, DOI 10.1640/0002-8444(2001)091[0166:TUONIA]2.0.CO;2; Iida S, 2002, J PLANT RES, V115, P11, DOI 10.1007/s102650200002; Iida S, 2007, J PLANT RES, V120, P473, DOI 10.1007/s10265-007-0087-y; Ito Yu, 2014, Biodivers Data J, pe1073, DOI 10.3897/BDJ.2.e1073; Ito Y, 2010, AM J BOT, V97, P1156, DOI 10.3732/ajb.0900168; Kaplan Z, 2008, FOLIA GEOBOT, V43, P159, DOI 10.1007/s12224-008-9010-0; King RA, 2001, BOT J LINN SOC, V135, P67, DOI 10.1006/bojl.2000.0354; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LES DH, 1993, AQUAT BOT, V44, P181, DOI 10.1016/0304-3770(93)90071-4; Les Donald H., 1996, Novon, V6, P389, DOI 10.2307/3392046; Les DH, 2009, SYST BOT, V34, P643, DOI 10.1600/036364409790139727; Li GQ, 2004, BRIEF BIOINFORM, V5, P378, DOI 10.1093/bib/5.4.378; Lihova J, 2006, MOL PHYLOGENET EVOL, V39, P759, DOI 10.1016/j.ympev.2006.01.027; Lindqvist C, 2006, CLADISTICS, V22, P568, DOI 10.1111/j.1096-0031.2006.00124.x; Mathews S, 1999, SCIENCE, V286, P947, DOI 10.1126/science.286.5441.947; Mathews S, 2000, AM J BOT, V87, P96, DOI 10.2307/2656688; MATHEWS S, 1995, ANN MO BOT GARD, V82, P296, DOI 10.2307/2399882; Mathews S, 1997, PLANT CELL ENVIRON, V20, P666, DOI 10.1046/j.1365-3040.1997.d01-117.x; Mathews S, 1996, MOL BIOL EVOL, V13, P1141, DOI 10.1093/oxfordjournals.molbev.a025677; Morton BR, 1996, P NATL ACAD SCI USA, V93, P11735, DOI 10.1073/pnas.93.21.11735; Nishimoto Y, 2003, GENES GENET SYST, V78, P139, DOI 10.1266/ggs.78.139; Preston CD., 1995, PONDWEEDS GREAT BRIT; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; Sang T, 1997, MOL BIOL EVOL, V14, P994, DOI 10.1093/oxfordjournals.molbev.a025716; Sang T, 2002, CRIT REV BIOCHEM MOL, V37, P121, DOI 10.1080/10409230290771474; Simmons MP, 2001, AM J BOT, V88, P313, DOI 10.2307/2657021; Tamura K., 2013, MOL BIOL EVOL, P197, DOI DOI 10.1093/M0LBEV/MST197; Wang QD, 2007, PLANT SYST EVOL, V267, P65, DOI 10.1007/s00606-006-0499-5; WENDEL JF, 1995, P NATL ACAD SCI USA, V92, P280, DOI 10.1073/pnas.92.1.280; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiegleb G, 1998, FOLIA GEOBOT, V33, P241, DOI 10.1007/BF03216205; WIEGLEB G, 1990, PLANT SYST EVOL, V169, P245, DOI 10.1007/BF00937678; Yeh KC, 1997, SCIENCE, V277, P1505, DOI 10.1126/science.277.5331.1505; Zhang T, 2008, AQUAT BOT, V89, P34, DOI 10.1016/j.aquabot.2008.02.002	46	95	104	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2016	11	11							e0166177	10.1371/journal.pone.0166177	http://dx.doi.org/10.1371/journal.pone.0166177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC2AC	27019196	Green Submitted, Green Published, gold			2022-12-26	WOS:000387910200020
